PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Diao, HY; Li, XX; Hu, S; Liu, YH				Diao, Hongyu; Li, Xinxing; Hu, Sheng; Liu, Yunhui			Gene Expression Profiling Combined with Bioinformatics Analysis Identify Biomarkers for Parkinson Disease	PLOS ONE			English	Article							DIFFERENTIALLY COEXPRESSED GENES; ALPHA-SYNUCLEIN; CEREBROSPINAL-FLUID; ACTIVATION; DEATH; DJ-1; ENVIRONMENT; DISCOVERY; PATHWAY; STAT4	Parkinson disease (PD) progresses relentlessly and affects approximately 4% of the population aged over 80 years old. It is difficult to diagnose in its early stages. The purpose of our study is to identify molecular biomarkers for PD initiation using a computational bioinformatics analysis of gene expression. We downloaded the gene expression profile of PD from Gene Expression Omnibus and identified differentially coexpressed genes (DCGs) and dysfunctional pathways in PD patients compared to controls. Besides, we built a regulatory network by mapping the DCGs to known regulatory data between transcription factors (TFs) and target genes and calculated the regulatory impact factor of each transcription factor. As the results, a total of 1004 genes associated with PD initiation were identified. Pathway enrichment of these genes suggests that biological processes of protein turnover were impaired in PD. In the regulatory network, HLF, E2F1 and STAT4 were found have altered expression levels in PD patients. The expression levels of other transcription factors, NKX3-1, TAL1, RFX1 and EGR3, were not found altered. However, they regulated differentially expressed genes. In conclusion, we suggest that HLF, E2F1 and STAT4 may be used as molecular biomarkers for PD; however, more work is needed to validate our result.	[Diao, Hongyu; Li, Xinxing; Liu, Yunhui] China Med Univ, Shengjing Hosp, Dept Neurosurg, Shenyang, Peoples R China; [Hu, Sheng] Second Peoples Hosp Chaoyang City, Dept Neurosurg, Chaoyang, Peoples R China	China Medical University	Liu, YH (corresponding author), China Med Univ, Shengjing Hosp, Dept Neurosurg, Shenyang, Peoples R China.	liuyh@sj-hospital.org			Liaoning Science and Technology Plan Projects [2008820]	Liaoning Science and Technology Plan Projects	This research is supported by Liaoning Science and Technology Plan Projects (No. 2008820). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACON CM, 1995, P NATL ACAD SCI USA, V92, P7307, DOI 10.1073/pnas.92.16.7307; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergmann S, 2004, PLOS BIOL, V2, P85, DOI 10.1371/journal.pbio.0020009; Chade AR, 2006, J NEURAL TRANSM-SUPP, P147; Cooper CS, 2007, NAT CLIN PRACT UROL, V4, P677, DOI 10.1038/ncpuro0946; Davie CA, 2008, BRIT MED BULL, V86, P109, DOI 10.1093/bmb/ldn013; Devic I, 2011, BRAIN, V134, DOI 10.1093/brain/awr015; Douglas PM, 2010, J CELL BIOL, V190, P719, DOI 10.1083/jcb.201005144; Elbaz A, 2007, CR BIOL, V330, P318, DOI 10.1016/j.crvi.2007.02.018; Foulds P, 2010, NAT REV NEUROL, V6, P359, DOI 10.1038/nrneurol.2010.78; Gehrke S, 2010, NATURE, V466, P637, DOI 10.1038/nature09191; Godau J, 2010, J NEUROL NEUROSUR PS, V81, P536, DOI 10.1136/jnnp.2009.175752; Guttula SV, 2012, INT J ALZHEIMERS DIS, V2012; Hashimoto M, 1999, BRAIN PATHOL, V9, P707; Hatano T, 2009, J NEUROCHEM, V111, P1075, DOI 10.1111/j.1471-4159.2009.06403.x; Hitzler JK, 1999, BRAIN RES, V820, P1, DOI 10.1016/S0006-8993(98)00999-8; Hoglinger GU, 2007, P NATL ACAD SCI USA, V104, P3585, DOI 10.1073/pnas.0611671104; Honda H, 1999, BLOOD, V93, P2780; Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008; Hou ST, 2002, J BIOL CHEM, V277, P48764, DOI 10.1074/jbc.M206336200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; INABA T, 1992, SCIENCE, V257, P531, DOI 10.1126/science.1386162; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Jiang SX, 2007, MOL CELL BIOL, V27, P1696, DOI 10.1128/MCB.01760-06; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Liu BH, 2010, BIOINFORMATICS, V26, P2637, DOI 10.1093/bioinformatics/btq471; Maita C, 2008, NEUROSCI LETT, V431, P86, DOI 10.1016/j.neulet.2007.11.027; Nagatsu T, 2005, CURR PHARM DESIGN, V11, P999, DOI 10.2174/1381612053381620; Ohrfelt A, 2009, NEUROSCI LETT, V450, P332, DOI 10.1016/j.neulet.2008.11.015; Reverter A, 2010, BIOINFORMATICS, V26, P896, DOI 10.1093/bioinformatics/btq051; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Sato S, 2005, NEUROLOGY, V64, P1081, DOI 10.1212/01.WNL.0000154597.24838.6B; Scherzer CR, 2007, P NATL ACAD SCI USA, V104, P955, DOI 10.1073/pnas.0610204104; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith RA, 2003, MOL BRAIN RES, V116, P70, DOI 10.1016/S0169-328X(03)00253-5; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Team R. D. C, 2011, R LANG ENV STAT COMP; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; Waragai M, 2006, BIOCHEM BIOPH RES CO, V345, P967, DOI 10.1016/j.bbrc.2006.05.011; YAMAMOTO K, 1994, MOL CELL BIOL, V14, P4342, DOI 10.1128/MCB.14.7.4342; Yu H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-315	43	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52319	10.1371/journal.pone.0052319	http://dx.doi.org/10.1371/journal.pone.0052319			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23284986	Green Published, Green Submitted, gold			2022-12-27	WOS:000313051500027
J	Banerjee, B; Musk, M; Sutanto, EN; Yerkovich, ST; Hopkins, P; Knight, DA; Lindsey-Temple, S; Stick, SM; Kicic, A; Chambers, DC				Banerjee, Balarka; Musk, Michael; Sutanto, Erika N.; Yerkovich, Stephanie T.; Hopkins, Peter; Knight, Darryl A.; Lindsey-Temple, Suzanna; Stick, Stephen M.; Kicic, Anthony; Chambers, Daniel C.			Regional Differences in Susceptibiity of Bronchial Epithelium to Mesenchymal Transition and Inhibition by the Macrolide Antibiotic Azithromycin	PLOS ONE			English	Article							BRONCHIOLITIS-OBLITERANS-SYNDROME; LUNG-TRANSPLANT RECIPIENTS; GROWTH-FACTOR-BETA; RENAL-ALLOGRAFT RECIPIENTS; MYCOPHENOLATE-MOFETIL; PSEUDOMONAS-AERUGINOSA; PULMONARY-FIBROSIS; TGF-BETA; FIBROBLAST PROLIFERATION; MYOFIBROBLAST TRANSITION	Objective: Dysregulated repair following epithelial injury is a key forerunner of disease in many organs, and the acquisition of a mesenchymal phenotype by the injured epithelial cells (epithelial to mesenchymal transition, EMT) may serve as a source of fibrosis. The macrolide antibiotic azithromycin and the DNA synthesis inhibitor mycophenolate are in clinical use but their mechanism of action remains unknown in post-transplant bronchiolitis obliterans syndrome (BOS). Here we determined if regional variation in the EMT response to TGF beta 1 underlies the bronchiolocentric fibrosis leading to BOS and whether EMT could be inhibited by azithromycin or mycophenolate. Methods/Results: We found that small and large airway epithelial cells from stable lung transplant patients underwent EMT when stimulated with TGF beta 1, however mesenchymal protein expression was higher and loss of epithelial protein expression more complete in small airway epithelial cells. This regional difference was not mediated by changes in expression of the TGF beta RII or Smad3 activation. Azithromycin potentially inhibited EMT in both small and large airway epithelial cells by inhibiting Smad3 expression, but not activation. Conclusion: Collectively, these observations provide a biologic basis for a previously unexplained but widely observed clinical phenomena, and a platform for the development of new approaches to fibrotic diseases.	[Banerjee, Balarka; Stick, Stephen M.; Kicic, Anthony] Univ Western Australia, Sch Paediat & Child Hlth, Nedlands, WA 6009, Australia; [Banerjee, Balarka] Univ Western Australia, Sch Med & Pharmacol, Nedlands, WA 6009, Australia; [Banerjee, Balarka; Musk, Michael] Royal Perth Hosp, Western Australia Lung Transplant Program, Perth, WA, Australia; [Stick, Stephen M.; Kicic, Anthony] Princess Margaret Hosp Children, Dept Resp Med, Perth, WA, Australia; [Sutanto, Erika N.; Stick, Stephen M.; Kicic, Anthony] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Subiaco, WA, Australia; [Knight, Darryl A.] Univ British Columbia, James Hogg Res Ctr Cardiovasc & Pulm Res, Vancouver, BC V5Z 1M9, Canada; [Knight, Darryl A.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Lindsey-Temple, Suzanna] Sir Charles Gairdner Hosp, Lung Inst Western Australia, Ctr Asthma & Allergy Res Inst CAARR, Perth, WA, Australia; [Yerkovich, Stephanie T.; Hopkins, Peter; Chambers, Daniel C.] Univ Queensland, Sch Med, Herston, Qld, Australia; [Chambers, Daniel C.] Prince Charles Hosp, Queensland Lung Transplant Serv, Brisbane, Qld 4032, Australia	University of Western Australia; University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Western Australia; Telethon Kids Institute; University of Western Australia; University of British Columbia; University of British Columbia; University of Queensland; Prince Charles Hospital	Chambers, DC (corresponding author), Univ Queensland, Sch Med, Herston, Qld, Australia.	Daniel_Chambers@health.qld.gov.au	Stick, Stephen/O-5683-2014; Kicic, Anthony/ABA-1252-2021; Yerkovich, Stephanie/A-9004-2011; Chambers, Daniel/B-1325-2011; Stick, Stephen/AAA-5945-2021; Stick, Stephen/GZG-7584-2022; Hopkins, Peter/B-1329-2011	Kicic, Anthony/0000-0002-0008-9733; Stick, Stephen/0000-0002-5386-8482; Sutanto, Erika/0000-0002-4224-2839; Chambers, Daniel/0000-0002-9553-5870; Yerkovich, Stephanie/0000-0003-4163-4782	Western Australian Lung Transplant Foundation, University of Western Australia; McCusker Foundation; Canada Research Chairs program; Michael Smith foundation for Health Research	Western Australian Lung Transplant Foundation, University of Western Australia; McCusker Foundation; Canada Research Chairs program(Canada Research Chairs); Michael Smith foundation for Health Research(Michael Smith Foundation for Health Research)	The project was funded by the Western Australian Lung Transplant Foundation, University of Western Australia and the McCusker Foundation. Stephen M. Stick is an NHMRC practitioner fellow. Darryl A. Knight is supported by the Canada Research Chairs program and Michael Smith foundation for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 2005, INT J ARTIF ORGANS, V28, P164, DOI 10.1177/039139880502800213; Angel LF, 2006, AM J RESP CRIT CARE, V173, P465, DOI 10.1164/ajrccm.173.4.465; Asgrimsson V, 2006, ANTIMICROB AGENTS CH, V50, P1805, DOI 10.1128/AAC.50.5.1805-1812.2006; Azzola A, 2004, TRANSPLANTATION, V77, P275, DOI 10.1097/01.TP.0000101822.50960.AB; Banerjee B, 2011, J HEART LUNG TRANSPL, V30, P1175, DOI 10.1016/j.healun.2011.06.007; Banerjee B, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-99; Bonk T, 2003, CLIN CHEM, V49, P552, DOI 10.1373/49.4.552; Borthwick LA, 2011, EUR RESPIR J, V37, P1237, DOI 10.1183/09031936.00088410; Borthwick LA, 2010, AM J TRANSPLANT, V10, P498, DOI 10.1111/j.1600-6143.2009.02953.x; Botha P, 2008, TRANSPLANTATION, V85, P771, DOI 10.1097/TP.0b013e31816651de; Buckley ST, 2010, CELL TISSUE RES, V342, P39, DOI 10.1007/s00441-010-1029-x; Christie JD, 2009, J HEART LUNG TRANSPL, V28, P1031, DOI 10.1016/j.healun.2009.08.004; El-Gamel A, 1999, J HEART LUNG TRANSPL, V18, P828, DOI 10.1016/S1053-2498(99)00047-9; Estenne M, 2002, J HEART LUNG TRANSPL, V21, P297, DOI 10.1016/S1053-2498(02)00398-4; Evans RA, 2003, EXP CELL RES, V282, P90, DOI 10.1016/S0014-4827(02)00015-0; Forrest IA, 2005, J HEART LUNG TRANSPL, V24, pS48, DOI 10.1016/j.healun.2004.11.040; Friess H, 1998, ANN SURG, V227, P95, DOI 10.1097/00000658-199801000-00014; Gao R, 2006, TRANSPL P, V38, P2154, DOI 10.1016/j.transproceed.2006.06.006; Gerhardt SG, 2003, AM J RESP CRIT CARE, V168, P121, DOI 10.1164/rccm.200212-1424BC; Glanville AR, 2008, AM J RESP CRIT CARE, V177, P1033, DOI 10.1164/rccm.200706-951OC; Groetzner J, 2006, TRANSPLANTATION, V81, P355, DOI 10.1097/01.tp.0000195781.02268.5e; Gulhati P, 2011, CANCER RES, V71, P3246, DOI 10.1158/0008-5472.CAN-10-4058; Hackett TL, 2009, AM J RESP CRIT CARE, V180, P122, DOI 10.1164/rccm.200811-1730OC; Halldorsson S, 2010, AM J RESP CELL MOL B, V42; Halloran P, 1997, TRANSPLANTATION, V63, P39, DOI 10.1097/00007890-199701150-00008; He JQ, 2008, EUR RESPIR J, V32, P755, DOI 10.1183/09031936.00129107; Hodge S, 2009, AM J TRANSPLANT, V9, P727, DOI 10.1111/j.1600-6143.2009.02558.x; Ikegami T, 2007, CELLS TISSUES ORGANS, V185, P213, DOI 10.1159/000101322; Imamura Y, 2004, ANTIMICROB AGENTS CH, V48, P3457, DOI 10.1128/AAC.48.9.3457-3461.2004; Jain R, 2010, J HEART LUNG TRANSPL, V29, P531, DOI 10.1016/j.healun.2009.12.003; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kawashima M, 2010, MOL VIS, V16, P2727; Kiss A, 1997, CLIN CANCER RES, V3, P1059; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McDyer John F, 2007, Proc Am Thorac Soc, V4, P37, DOI 10.1513/pats.200605-107JG; Ojo AO, 2000, TRANSPLANTATION, V69, P2405, DOI 10.1097/00007890-200006150-00033; Osunkwo I, 2004, BIOL BLOOD MARROW TR, V10, P246, DOI 10.1016/j.bbmt.2003.11.005; Petrova DT, 2010, THER DRUG MONIT, V32, P405, DOI 10.1097/FTD.0b013e3181e44260; Poulalhon N, 2006, J BIOL CHEM, V281, P33045, DOI 10.1074/jbc.M606366200; Qu N, 2005, J HEART LUNG TRANSPL, V24, P882, DOI 10.1016/j.healun.2004.04.020; Quaggin SE, 2011, KIDNEY INT, V80, P41, DOI 10.1038/ki.2011.77; Reka AK, 2011, J THORAC ONCOL, V6, P1784, DOI 10.1097/JTO.0b013e31822adfb0; Remuzzi G, 2004, LANCET, V364, P503, DOI 10.1016/S0140-6736(04)16808-6; Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108; Roos N, 2007, J PHARMACOL EXP THER, V321, P583, DOI 10.1124/jpet.106.117051; Sato M, 2009, AM J TRANSPLANT, V9, P1981, DOI 10.1111/j.1600-6143.2009.02770.x; Scott AIR, 2005, DRUGS, V65, P761, DOI 10.2165/00003495-200565060-00004; Selman M, 2001, RESP RES, V3, DOI 10.1186/rr175; Snell GI, 2006, AM J TRANSPLANT, V6, P169, DOI 10.1111/j.1600-6143.2005.01134.x; Speich R, 1997, TRANSPLANTATION, V64, P533, DOI 10.1097/00007890-199708150-00027; Steinkamp G, 2008, RESP MED, V102, P1643, DOI 10.1016/j.rmed.2008.03.009; Tateda K, 2001, ANTIMICROB AGENTS CH, V45, P1930, DOI 10.1128/AAC.45.6.1930-1933.2001; Taura K, 2010, HEPATOLOGY, V51, P1027, DOI 10.1002/hep.23368; Theruvath TP, 2001, TRANSPLANTATION, V72, P77, DOI 10.1097/00007890-200107150-00016; Vanaudenaerde BM, 2008, EUR RESPIR J, V32, P832, DOI 10.1183/09031936.00134307; Verleden GM, 2006, AM J RESP CRIT CARE, V174, P566, DOI 10.1164/rccm.200601-071OC; Verleden GM, 2004, TRANSPLANTATION, V77, P1465, DOI 10.1097/01.TP.0000122412.80864.43; Whyte RI, 1997, ANN THORAC SURG, V64, P945, DOI 10.1016/S0003-4975(97)00845-X; Wu Z, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-1; Wuyts WA, 2010, EXP LUNG RES, V36, P602, DOI 10.3109/01902148.2010.492895; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; Yates B, 2005, AM J RESP CRIT CARE, V172, P772, DOI 10.1164/rccm.200411-1537OC; Yu CH, 2008, EXP LUNG RES, V34, P343, DOI 10.1080/01902140802093238	63	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52309	10.1371/journal.pone.0052309	http://dx.doi.org/10.1371/journal.pone.0052309			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284981	gold, Green Submitted, Green Published			2022-12-27	WOS:000313158800045
J	Ren, HY; Schonbach, P; Wan, HW; Gierus, M; Taube, F				Ren, Haiyan; Schoenbach, Philipp; Wan, Hongwei; Gierus, Martin; Taube, Friedhelm			Effects of Grazing Intensity and Environmental Factors on Species Composition and Diversity in Typical Steppe of Inner Mongolia, China	PLOS ONE			English	Article							GRASSLAND COMMUNITIES; ECOSYSTEM FUNCTION; WATER SOURCES; STOCKING RATE; BIODIVERSITY; VEGETATION; RESPONSES; PRODUCTIVITY; ECOLOGY; RICHNESS	In the present study, we aim to analyze the effect of grazing, precipitation and temperature on plant species dynamics in the typical steppe of Inner Mongolia, P. R. China. By uncoupling biotic and abiotic factors, we provide essential information on the main drivers determining species composition and species diversity. Effects of grazing by sheep were studied in a controlled experiment along a gradient of seven grazing intensities (from ungrazed to very heavily grazed) during six consecutive years (2005-2010). The results show that plant species composition and diversity varied among years but were little affected by grazing intensity, since the experimental years were much dryer than the long term average, the abiotic constraints may have overridden any grazing effect. Among-year differences were predominantly determined by the abiotic factors of precipitation and temperature. Most of the variation in species dynamics and coexistence between C3 and C4 species was explained by seasonal weather conditions, i.e. precipitation and temperature regime during the early-season (March-June) were most important in determining vegetation dynamics. The dominant C3 species Stipa grandis was highly competitive in March-June, when the temperature levels were low and rainfall level was high. In contrast, the most common C4 species Cleistogenes squarrosa benefited from high early-season temperature levels and low early-season rainfall. However, biomass of Stipa grandis was positively correlated with temperature in March, when effective mean temperature ranges from 0 to 5 degrees C and thus promotes vernalization and vegetative sprouting. Our results suggest that, over a six-year term, it is temporal variability in precipitation and temperature rather than grazing that determines vegetation dynamics and species co-existence of grazed steppe ecosystems. Furthermore, our data support that the variability in the biomass of dominant species, rather than diversity, determine ecosystem functioning. The present study provides fundamental knowledge on the complex interaction of grazing - vegetation - climate.	[Ren, Haiyan; Schoenbach, Philipp; Wan, Hongwei; Gierus, Martin; Taube, Friedhelm] Univ Kiel, Inst Crop Sci & Plant Breeding Grass & Forage Sci, Kiel, Germany	University of Kiel	Ren, HY (corresponding author), Univ Kiel, Inst Crop Sci & Plant Breeding Grass & Forage Sci, Kiel, Germany.	hren@email.uni-kiel.de	Gierus, Martin/H-7135-2012	Gierus, Martin/0000-0001-6909-0356; Taube, Friedhelm/0000-0001-7175-2881	National Nature Science Foundation of China; Deutsche Forschungsgemeinschaft (DFG)	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Financial support was provided by the National Nature Science Foundation of China and the Deutsche Forschungsgemeinschaft (DFG) for the research group 536 MAGIM (Matter fluxes of grasslands in Inner Mongolia as influenced by stocking rate) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella SR, 2012, FOREST ECOL MANAG, V271, P65, DOI 10.1016/j.foreco.2012.01.035; Adler PB, 2007, OIKOS, V116, P221, DOI [10.1111/j.2006.0030-1299.15327.x, 10.1111/j.0030-1299.2007.15327.x]; Auerswald K, 2012, BASIC APPL ECOL, V9, P1439; Bai YF, 2007, J APPL ECOL, V44, P1023, DOI 10.1111/j.1365-2664.2007.01351.x; Bullock JM, 2001, J APPL ECOL, V38, P253, DOI 10.1046/j.1365-2664.2001.00599.x; Chen SH, 2001, ROOTS GRASSLAND PLAN; Chen SP, 2005, ENVIRON EXP BOT, V53, P65, DOI 10.1016/j.envexpbot.2004.03.002; Chou WW, 2008, GLOBAL CHANGE BIOL, V14, P1382, DOI 10.1111/j.1365-2486.2008.01572.x; Christensen L, 2004, CLIMATIC CHANGE, V63, P351, DOI 10.1023/B:CLIM.0000018513.60904.fe; Cingolani AM, 2005, ECOL APPL, V15, P757, DOI 10.1890/03-5272; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Distel RA, 2005, J ARID ENVIRON, V62, P351, DOI 10.1016/j.jaridenv.2004.12.001; Fanselow N, 2011, PLANT SOIL, V340, P279, DOI 10.1007/s11104-010-0694-6; Fynn RWS, 2000, J APPL ECOL, V37, P491, DOI 10.1046/j.1365-2664.2000.00513.x; Golluscio RA, 1998, GRASS FORAGE SCI, V53, P47, DOI 10.1046/j.1365-2494.1998.00103.x; Grace JB, 2007, ECOL LETT, V10, P680, DOI 10.1111/j.1461-0248.2007.01058.x; Grime JP, 1997, SCIENCE, V277, P1260, DOI 10.1126/science.277.5330.1260; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Knapp AK, 2001, SCIENCE, V291, P481, DOI 10.1126/science.291.5503.481; LAUENROTH WK, 1992, ECOL APPL, V2, P397, DOI 10.2307/1941874; Lavrenko E. M., 1993, ECOSY WORLD B, P3; Liang C, 2002, J APPL ECOL, V39, P584, DOI 10.1046/j.1365-2664.2002.00735.x; Liu N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036434; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Lundholm JT, 2004, OECOLOGIA, V141, P346, DOI 10.1007/s00442-003-1454-6; Lyons KG, 2005, CONSERV BIOL, V19, P1019, DOI 10.1111/j.1523-1739.2005.00106.x; Merritt DJ, 2007, AUST J BOT, V55, P336, DOI 10.1071/BT06106; MILCHUNAS DG, 1993, ECOL MONOGR, V63, P327, DOI 10.2307/2937150; MILCHUNAS DG, 1989, VEGETATIO, V80, P11, DOI 10.1007/BF00049137; MILCHUNAS DG, 1988, AM NAT, V132, P87, DOI 10.1086/284839; Murphy BP, 2007, GLOBAL ECOL BIOGEOGR, V16, P160, DOI 10.1111/j.1466-8238.2006.00285.x; Naeem S, 2003, ECOL LETT, V6, P567, DOI 10.1046/j.1461-0248.2003.00471.x; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; POTVIN C, 1984, PLANT PHYSIOL, V75, P1054, DOI 10.1104/pp.75.4.1054; REDMANN RE, 1995, PHOTOSYNTHETICA, V31, P251; Reich PB, 2004, P NATL ACAD SCI USA, V101, P10101, DOI 10.1073/pnas.0306602101; Ronnenberg K, 2008, PLANT ECOL, V196, P269, DOI 10.1007/s11258-007-9351-4; Sasaki T, 2009, J ARID ENVIRON, V73, P949, DOI 10.1016/j.jaridenv.2009.04.008; Sasaki T, 2008, J ECOL, V96, P145, DOI 10.1111/j.1365-2745.2007.01315.x; Schiborra A, 2010, J ANIM PHYSIOL AN N, V94, P446, DOI 10.1111/j.1439-0396.2009.00928.x; Schonbach P, 2012, GRASS FORAGE SCI, V67, P535, DOI 10.1111/j.1365-2494.2012.00874.x; Schonbach P, 2009, CROP PASTURE SCI, V60, P963, DOI 10.1071/CP09048; Schonbach P, 2011, PLANT SOIL, V340, P103, DOI 10.1007/s11104-010-0366-6; SHMIDA A, 1985, J BIOGEOGR, V12, P1, DOI 10.2307/2845026; Spehn EM, 2002, OIKOS, V98, P205, DOI 10.1034/j.1600-0706.2002.980203.x; Stumpp M, 2005, MT RES DEV, V25, P244, DOI 10.1659/0276-4741(2005)025[0244:IOGLAD]2.0.CO;2; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; Wang YuHui, 2004, Acta Phytoecologica Sinica, V28, P507; Wittmer MHOM, 2010, GLOBAL CHANGE BIOL, V16, P605, DOI 10.1111/j.1365-2486.2009.02033.x; Yang H, 2011, PLANT SOIL, V340, P303, DOI 10.1007/s11104-010-0307-4; Yuan WP, 2005, CHINESE J APPL ECOLO, V16, P605; Zemmrich A, 2010, J ARID ENVIRON, V74, P1271, DOI 10.1016/j.jaridenv.2010.05.014; Zhan X, 2007, J ARID ENVIRON, V68, P298, DOI 10.1016/j.jaridenv.2006.05.012; Zheng SX, 2011, PLANT SOIL, V340, P141, DOI 10.1007/s11104-010-0369-3	57	56	63	6	156	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52180	10.1371/journal.pone.0052180	http://dx.doi.org/10.1371/journal.pone.0052180			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284925	Green Published, gold, Green Submitted			2022-12-27	WOS:000313158800038
J	Tang, SQ; Gong, YC; Edwards, EA				Tang, Shuiquan; Gong, Yunchen; Edwards, Elizabeth A.			Semi-Automatic In Silico Gap Closure Enabled De Novo Assembly of Two Dehalobacter Genomes from Metagenomic Data	PLOS ONE			English	Article							SEQUENCE	Typically, the assembly and closure of a complete bacterial genome requires substantial additional effort spent in a wet lab for gap resolution and genome polishing. Assembly is further confounded by subspecies polymorphism when starting from metagenome sequence data. In this paper, we describe an in silico gap-resolution strategy that can substantially improve assembly. This strategy resolves assembly gaps in scaffolds using pre-assembled contigs, followed by verification with read mapping. It is capable of resolving assembly gaps caused by repetitive elements and subspecies polymorphisms. Using this strategy, we realized the de novo assembly of the first two Dehalobacter genomes from the metagenomes of two anaerobic mixed microbial cultures capable of reductive dechlorination of chlorinated ethanes and chloroform. Only four additional PCR reactions were required even though the initial assembly with Newbler v. 2.5 produced 101 contigs within 9 scaffolds belonging to two Dehalobacter strains. By applying this strategy to the re-assembly of a recently published genome of Bacteroides, we demonstrate its potential utility for other sequencing projects, both metagenomic and genomic.	[Tang, Shuiquan; Edwards, Elizabeth A.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada; [Gong, Yunchen] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON, Canada	University of Toronto; University of Toronto	Edwards, EA (corresponding author), Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada.	elizabeth.edwards@utoronto.ca	Edwards, Elizabeth/GXV-2307-2022	Edwards, Elizabeth/0000-0002-8071-338X	Government of Canada through Genome Canada; Ontario Genomics Institute [2009-OGI-ABC-1405]; Government of Ontario through the ORF-GL2 program; United States Department of Defense through the Strategic Environmental Research and Development Program (SERDP) [W912HQ-07-C-0036, ER-1586]; Government of Ontario; Natural Sciences and Engineering Research Council of Canada (NSERC PGS B)	Government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute; Government of Ontario through the ORF-GL2 program; United States Department of Defense through the Strategic Environmental Research and Development Program (SERDP); Government of Ontario; Natural Sciences and Engineering Research Council of Canada (NSERC PGS B)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Metagenome sequencing of the ACT-3 culture was provided by the U.S. Deparment of Energy Joint Genome Institute through the Community Sequencing Program (CSP 2010). Support was provided by the Government of Canada through Genome Canada and the Ontario Genomics Institute (2009-OGI-ABC-1405). Support was also provided by the Government of Ontario through the ORF-GL2 program and the United States Department of Defense through the Strategic Environmental Research and Development Program (SERDP) under contract W912HQ-07-C-0036 (project ER-1586). S. T. received awards from the Government of Ontario through the Ontario Graduate Scholarships in Science and Technology (OGSST) and the Natural Sciences and Engineering Research Council of Canada (NSERC PGS B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assefa S, 2009, BIOINFORMATICS, V25, P1968, DOI 10.1093/bioinformatics/btp347; Boetzer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r56; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Chain PSG, 2009, SCIENCE, V326, P236, DOI 10.1126/science.1180614; Drummond A. J., 2011, GENEIOUS V5 4 2; Ettwig KF, 2010, NATURE, V464, P543, DOI 10.1038/nature08883; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Gronow S, 2011, STAND GENOMIC SCI, V4, P191, DOI 10.4056/sigs.1704212; Grostern A, 2010, ENVIRON MICROBIOL, V12, P1053, DOI 10.1111/j.1462-2920.2009.02150.x; Grostern A, 2006, APPL ENVIRON MICROB, V72, P7849, DOI 10.1128/AEM.01269-06; Huang WC, 2008, GENOME RES, V18, P1538, DOI 10.1101/gr.076067.108; Iverson V, 2012, SCIENCE, V335, P587, DOI 10.1126/science.1212665; Kingsford C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-21; Koren S, 2011, BIOINFORMATICS, V27, P2964, DOI 10.1093/bioinformatics/btr520; Lapidus A, 2008, ADV GENOME BIOL TECH; Laserson J, 2011, J COMPUT BIOL, V18, P429, DOI 10.1089/cmb.2010.0244; Mardis E, 2002, GENOME RES, V12, P669, DOI 10.1101/gr.032102; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martin HG, 2006, NAT BIOTECHNOL, V24, P1263, DOI 10.1038/nbt1247; Peng Y, 2011, BIOINFORMATICS, V27, pI94, DOI 10.1093/bioinformatics/btr216; Simmons SL, 2008, PLOS BIOL, V6, P1427, DOI 10.1371/journal.pbio.0060177; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Tang S, 2012, IDENTIFICATION UNPUB; Tsai IJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r41; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	26	29	30	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52038	10.1371/journal.pone.0052038	http://dx.doi.org/10.1371/journal.pone.0052038			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284863	gold, Green Submitted, Green Published			2022-12-27	WOS:000313158800024
J	Wilke, M; Bot, A; Jorna, H; Scholte, BJ; de Jonge, HR				Wilke, Martina; Bot, Alice; Jorna, Huub; Scholte, Bob J.; de Jonge, Hugo R.			Rescue of Murine F508del CFTR Activity in Native Intestine by Low Temperature and Proteasome Inhibitors	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; RETICULUM-ASSOCIATED DEGRADATION; DELTA-F508 HOMOZYGOUS TWINS; SMALL-MOLECULE CORRECTORS; CYSTIC-FIBROSIS; CHLORIDE CONDUCTANCE; ENDOCYTIC TRAFFICKING; ANTITUMOR-ACTIVITY; MOUSE MODELS; IN-VITRO	Most patients with Cystic Fibrosis (CF) carry at least one allele with the F508del mutation, resulting in a CFTR chloride channel protein with a processing, gating and stability defect, but with substantial residual activity when correctly sorted to the apical membranes of epithelial cells. New therapies are therefore aimed at improving the folding and trafficking of F508del CFTR, (CFTR correctors) or at enhancing the open probability of the CFTR chloride channel (CFTR potentiators). Preventing premature breakdown of F508del CFTR is an alternative or additional strategy, which is investigated in this study. We established an ex vivo assay for murine F508del CFTR rescue in native intestinal epithelium that can be used as a pre-clinical test for candidate therapeutics. Overnight incubation of muscle stripped ileum in modified William's E medium at low temperature (26 degrees C), and 4 h or 6 h incubation at 37 degrees C with different proteasome inhibitors (PI: ALLN, MG-132, epoxomicin, PS341/bortezomib) resulted in fifty to hundred percent respectively of the wild type CFTR mediated chloride secretion (forskolin induced short-circuit current). The functional rescue was accompanied by enhanced expression of the murine F508del CFTR protein at the apical surface of intestinal crypts and a gain in the amount of complex-glycosylated CFTR (band C) up to 20% of WT levels. Sustained rescue in the presence of brefeldin A shows the involvement of a post-Golgi compartment in murine F508del CFTR degradation, as was shown earlier for its human counterpart. Our data show that proteasome inhibitors are promising candidate compounds for improving rescue of human F508del CFTR function, in combination with available correctors and potentiators.	[Wilke, Martina] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Bot, Alice] Erasmus MC, Dept Biochem, Rotterdam, Netherlands; [Jorna, Huub] Erasmus MC, Erasmus Lab, Anim Sci Ctr, Rotterdam, Netherlands; [Scholte, Bob J.] Erasmus MC, Dept Cell Biol, Rotterdam, Netherlands; [de Jonge, Hugo R.] Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Wilke, M (corresponding author), Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands.	m.wilke@erasmusmc.nl			EU [QLG1-CT-2001-01005]; Cystic Fibrosis Foundation (CFF-USA) [DEJONG04G0]; Dutch Stomach Liver Intestine Society (MLD-Stichting) [6-11]; Sophia-Foundation [506]	EU(European Commission); Cystic Fibrosis Foundation (CFF-USA); Dutch Stomach Liver Intestine Society (MLD-Stichting); Sophia-Foundation	This work was supported by grants from the EU (grant QLG1-CT-2001-01005), the Cystic Fibrosis Foundation (CFF-USA; grant DEJONG04G0), The Dutch Stomach Liver Intestine Society (MLD-Stichting: grant 6-11), and the Sophia-Foundation (grant number 506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksandrov AA, 2010, J MOL BIOL, V401, P194, DOI 10.1016/j.jmb.2010.06.019; Becq F, 1999, J BIOL CHEM, V274, P27415, DOI 10.1074/jbc.274.39.27415; Belcher CN, 2010, CURR MOL MED, V10, P82, DOI 10.2174/156652410791065408; Bjerknes M, 2006, METHOD ENZYMOL, V419, P337, DOI 10.1016/S0076-6879(06)19014-X; Bobadilla JL, 2002, HUM MUTAT, V19, P575, DOI 10.1002/humu.10041; Bodas M, 2010, DISCOV MED, V9, P346; Bronsveld I, 2001, J CLIN INVEST, V108, P1705; Bronsveld I, 2000, GASTROENTEROLOGY, V119, P32, DOI 10.1053/gast.2000.8524; Carlile GW, 2007, CHEMBIOCHEM, V8, P1012, DOI 10.1002/cbic.200700027; Chauhan D, 2011, CLIN CANCER RES, V17, P5311, DOI 10.1158/1078-0432.CCR-11-0476; Chen D, 2011, CURR CANCER DRUG TAR, V11, P239, DOI 10.2174/156800911794519752; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cholon DM, 2010, AM J PHYSIOL-LUNG C, V298, pL304, DOI 10.1152/ajplung.00016.2009; Coppinger JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037682; Cormet-Boyaka E, 2009, FASEB J; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; Davis NB, 2004, J CLIN ONCOL, V22, P115, DOI 10.1200/JCO.2004.07.165; deCarvalho ACV, 2002, J BIOL CHEM, V277, P35896, DOI 10.1074/jbc.M205644200; DeJonge H, 2004, J CYSTIC FI IN PRESS, V3; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; DRUMM ML, 1991, SCIENCE, V254, P1797, DOI 10.1126/science.1722350; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Fischer H, 2001, AM J PHYSIOL-LUNG C, V281, pL52, DOI 10.1152/ajplung.2001.281.1.L52; Fisher JT, 2012, J BIOL CHEM, V287, P21673, DOI 10.1074/jbc.M111.336537; French PJ, 1996, J CLIN INVEST, V98, P1304, DOI 10.1172/JCI118917; French PJ, 1997, AM J PHYSIOL-CELL PH, V273, pC747, DOI 10.1152/ajpcell.1997.273.2.C747; Gee HY, 2011, CELL, V146, P746, DOI 10.1016/j.cell.2011.07.021; Gelman MS, 2002, J BIOL CHEM, V277, P11709, DOI 10.1074/jbc.M111958200; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Kalid O, 2010, J COMPUT AID MOL DES, V24, P971, DOI 10.1007/s10822-010-9390-0; KARTNER N, 1992, NAT GENET, V1, P321, DOI 10.1038/ng0892-321; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Lee EC, 2011, CLIN CANCER RES, V17, P7313, DOI 10.1158/1078-0432.CCR-11-0636; Luciani A, 2010, NAT CELL BIOL; Luciani A, 2012, AUTOPHAGY, V8, P1657, DOI 10.4161/auto.21483; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Norez C, 2006, FEBS LETT, V580, P2081, DOI 10.1016/j.febslet.2006.03.010; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Orlowski RZ, 2002, J CLIN ONCOL, V20, P4420, DOI 10.1200/JCO.2002.01.133; Owsianik G, 2003, FEBS LETT, V554, P173, DOI 10.1016/S0014-5793(03)01162-1; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Pedemonte N, 2010, AM J PHYSIOL-CELL PH, V298, pC866, DOI 10.1152/ajpcell.00404.2009; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Rabeh WM, 2012, CELL, V148, P150, DOI 10.1016/j.cell.2011.11.024; Rennolds J, 2008, BIOCHEM BIOPH RES CO, V366, P1025, DOI 10.1016/j.bbrc.2007.12.065; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Richardson PG, 2005, CELL CYCLE, V4, P290; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Robert R, 2010, MOL PHARM; Rowe SM, 2010, PULM PHARMACOL THER, V23, P268, DOI 10.1016/j.pupt.2010.02.001; Rubenstein RC, 2000, AM J PHYSIOL-CELL PH, V278, pC259, DOI 10.1152/ajpcell.2000.278.2.C259; Sato S, 1998, J BIOL CHEM, V273, P7189, DOI 10.1074/jbc.273.13.7189; TREZISE AEO, 1991, NATURE, V353, P434, DOI 10.1038/353434a0; Turnbull EL, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S11; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; VANDOMMELEN FS, 1986, BIOCHEM J, V236, P771, DOI 10.1042/bj2360771; VANDOORNINCK JH, 1995, EMBO J, V14, P4403, DOI 10.1002/j.1460-2075.1995.tb00119.x; Varga K, 2008, BIOCHEM J, V410, P555, DOI 10.1042/BJ20071420; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; Vij N, 2006, J BIOL CHEM, V281, P17369, DOI 10.1074/jbc.M600509200; Vij Neeraj, 2010, Journal of Nanobiotechnology, V8, P22, DOI 10.1186/1477-3155-8-22; Vij N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004664; Wang Y, 2006, MOL PHARMACOL, V70, P297, DOI 10.1124/mol.106.023994; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wellhauser L, 2009, MOL PHARMACOL, V75, P1430, DOI 10.1124/mol.109.055608; Wilke M, 2011, J CYST FIBROS, V10, pS152, DOI 10.1016/S1569-1993(11)60020-9; Xiao F, 2012, J PHYSL	70	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52070	10.1371/journal.pone.0052070	http://dx.doi.org/10.1371/journal.pone.0052070			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284872	Green Published, gold, Green Submitted			2022-12-27	WOS:000313158800027
J	Cole, VJ; Johnson, LG; McQuaid, CD				Cole, Victoria J.; Johnson, Linda G.; McQuaid, Christopher D.			Effects of Patch-Size on Populations of Intertidal Limpets, Siphonaria spp., in a Linear Landscape	PLOS ONE			English	Article							LARVAL DEVELOPMENT; ASSEMBLAGES; DYNAMICS; ORGANISM; FISH; FRAGMENTATION; HETEROGENEITY; AVAILABILITY; COLONIZATION; RECRUITMENT	Organisms with different life-histories and abilities to disperse often utilise habitat patches in different ways. We investigated the influence of the size of patches of rock (separated by stretches of sand) on the density of pulmonate limpets (Siphonaria spp.) along 1500 km of the linear landscape of the South African coastline. We compared the influence of patch-size on two congeneric species with different modes of development, S. serrata a direct developer, and S. concinna a planktonic developer. We tested the spatial and temporal consistency of the effects of patch-size by sampling 7 independent regions spanning the distributional range of both species of limpets, and by sampling one region at monthly intervals for 1 year. Within each region or month, 4 small patches (<20 m in length) interspersed with the 4 large patches (>60 m in length) were sampled. Across the entire geographic range and throughout the year, there were more of both species of limpets in large patches than in small patches. In most regions, there was greater variability in large patches than small patches. Variability within patches in a single region was similar throughout the year, with greater variability of both species in large than in small patches. We found little influence of the mode of development on the response of limpets to patch-size. Our findings highlight the importance of understanding patterns of distribution of species with respect to habitat heterogeneity in linear landscapes, and contradict the idea that organism mobility at an early ontogenetic stage directly affects habitat use.	[Cole, Victoria J.; Johnson, Linda G.; McQuaid, Christopher D.] Rhodes Univ, Dept Zool & Entomol, Coastal Res Grp, ZA-6140 Grahamstown, South Africa	Rhodes University	Cole, VJ (corresponding author), Rhodes Univ, Dept Zool & Entomol, Coastal Res Grp, ZA-6140 Grahamstown, South Africa.	victoriajcole@gmail.com	McQuaid, Christopher/AAT-3725-2020; Cole, Victoria/V-2870-2017	McQuaid, Christopher/0000-0002-3473-8308; Cole, Victoria/0000-0002-9594-2775	South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; Rhodes University	South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; Rhodes University	Research was funded by the South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation (C. D. M.) and a Rhodes University Postdoctoral Fellowship (V.J.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 1997, J EXP MAR BIOL ECOL, V215, P269, DOI 10.1016/S0022-0981(96)02770-0; Anderson MJ, 1999, OECOLOGIA, V118, P87, DOI 10.1007/s004420050706; Bender DJ, 1998, ECOLOGY, V79, P517, DOI 10.2307/176950; BRANCH GM, 1985, J EXP MAR BIOL ECOL, V87, P153, DOI 10.1016/0022-0981(85)90088-7; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; CHAMBERS RJ, 1994, J MOLLUS STUD, V60, P415, DOI 10.1093/mollus/60.4.415; CHAMBERS RJ, 1994, J MOLLUS STUD, V60, P263, DOI 10.1093/mollus/60.3.263; Cole VJ, 2007, J EXP MAR BIOL ECOL, V348, P191, DOI 10.1016/j.jembe.2007.05.001; Cole VJ, 2010, ECOLOGY, V91, P3549, DOI 10.1890/09-2152.1; Cole VJ, 2005, MAR ENVIRON RES, V60, P195, DOI 10.1016/j.marenvres.2004.10.004; Connell SD, 1999, J EXP MAR BIOL ECOL, V241, P15, DOI 10.1016/S0022-0981(99)00067-2; Connor EF, 2000, ECOLOGY, V81, P734, DOI 10.2307/177373; CREESE RG, 1982, OECOLOGIA, V53, P337, DOI 10.1007/BF00389010; Eggleston DB, 1999, J EXP MAR BIOL ECOL, V236, P107, DOI 10.1016/S0022-0981(98)00192-0; Eggleston DB, 1998, J EXP MAR BIOL ECOL, V223, P111, DOI 10.1016/S0022-0981(97)00154-8; Fagan WF, 2002, ECOLOGY, V83, P3243, DOI 10.2307/3072074; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; FORMAN RTT, 1981, BIOSCIENCE, V31, P733, DOI 10.2307/1308780; Goodsell PJ, 2007, MAR ECOL PROG SER, V351, P15, DOI 10.3354/meps07144; Gotelli NJ, 1999, EVOL ECOL RES, V1, P835; Gray DR, 1997, J MOLLUS STUD, V63, P121, DOI 10.1093/mollus/63.2.121; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; HOLT RD, 1985, THEOR POPUL BIOL, V28, P181, DOI 10.1016/0040-5809(85)90027-9; KEOUGH MJ, 1984, ECOLOGY, V65, P423, DOI 10.2307/1941405; LITTLER MM, 1983, MAR ECOL PROG SER, V11, P129, DOI 10.3354/meps011129; MacArthur R.H., 1967, THEORY ISLAND BIOGEO; MCNEILL SE, 1993, J BIOGEOGR, V20, P429, DOI 10.2307/2845591; MCQUAID CD, 1990, OECOLOGIA, V84, P142, DOI 10.1007/BF00665608; McQuaid CD, 1999, J EXP MAR BIOL ECOL, V237, P141, DOI 10.1016/S0022-0981(99)00011-8; Meyer DL, 2009, ESTUAR COAST, V32, P797, DOI 10.1007/s12237-009-9164-x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; PICKETT STA, 1985, ECOLOGY NATURAL DIST, P472; Porri F, 2006, MAR ECOL PROG SER, V315, P141, DOI 10.3354/meps315141; POSSINGHAM HP, 1990, ECOLOGY, V71, P973, DOI 10.2307/1937366; QUINN GP, 1988, J EXP MAR BIOL ECOL, V117, P115, DOI 10.1016/0022-0981(88)90221-3; ROBBINS BD, 1994, TRENDS ECOL EVOL, V9, P301, DOI 10.1016/0169-5347(94)90041-8; SIMBERLOFF D, 1976, ECOLOGY, V57, P629, DOI 10.2307/1936179; SOUSA WP, 1984, ECOLOGY, V65, P1918, DOI 10.2307/1937789; Underwood A.J., 2002, GMAV 5 WINDOWS ANAL; Underwood AJ, 1996, OECOLOGIA, V107, P212, DOI 10.1007/BF00327905; Underwood AJ, 1996, J EXP MAR BIOL ECOL, V197, P63, DOI 10.1016/0022-0981(95)00145-X; Underwood AJ, 1997, EXPT ECOLOGY, P181	42	5	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52076	10.1371/journal.pone.0052076	http://dx.doi.org/10.1371/journal.pone.0052076			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284875	gold, Green Published			2022-12-27	WOS:000312794500085
J	Corser, CA; McLenachan, PA; Pierson, MJ; Harrison, GLA; Penny, D				Corser, Chris A.; McLenachan, Patricia A.; Pierson, Melanie J.; Harrison, G. L. Abby; Penny, David			The Q2 Mitochondrial Haplogroup in Oceania	PLOS ONE			English	Article							Y-CHROMOSOME; FOUNDING POPULATION; GENOME VARIATION; NEW-ZEALAND; MTDNA; PACIFIC; ISLAND; HISTORY; ORIGIN; TREES	Many details surrounding the origins of the peoples of Oceania remain to be resolved, and as a step towards this we report seven new complete mitochondrial genomes from the Q2a haplogroup, from Papua New Guinea, Fiji and Kiribati. This brings the total to eleven Q2 genomes now available. The Q haplogroup (that includes Q2) is an old and diverse lineage in Near Oceania, and is reasonably common; within our sample set of 430, 97 are of the Q haplogroup. However, only 8 are Q2, and we report 7 here. The tree with all complete Q genomes is proven to be minimal. The dating estimate for the origin of Q2 (around 35 Kya) reinforces the understanding that humans have been in Near Oceania for tens of thousands of years; nevertheless the Polynesian maternal haplogroups remain distinctive. A major focus now, with regard to Polynesian ancestry, is to address the differences and timing of the 'Melanesian' contribution to the maternal and paternal lineages as people moved further and further into Remote Oceania. Input from other fields such as anthropology, history and linguistics is required for a better understanding and interpretation of the genetic data.	[Corser, Chris A.; McLenachan, Patricia A.; Harrison, G. L. Abby; Penny, David] Massey Univ, Inst Mol BioSci, Palmerston North, New Zealand; [Pierson, Melanie J.] Univ Auckland, Dept Anthropol, Auckland 1, New Zealand; [Harrison, G. L. Abby] Univ Oxford, Oxford, England	Massey University; University of Auckland; University of Oxford	Penny, D (corresponding author), Massey Univ, Inst Mol BioSci, Palmerston North, New Zealand.	D.Penny@massey.ac.nz			Wellcome Trust [AL061746 Goding]; Royal Society of NZ	Wellcome Trust(Wellcome TrustEuropean Commission); Royal Society of NZ(Royal Society of New Zealand)	The Wellcome Trust funded the project under a Collaborative Research Initiative Grant 'AL061746 Goding', 16th Feb 2001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CAC acknowledges a Teacher Fellowship from the Royal Society of NZ. We thank Patrick Biggs and Bennet McComish for assembling a Q2a mitochondrial genome from output from the Solexa DNA Sequencer, and Angela McGraughan for completing the PD047 genome.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Achilli A, 2005, AM J HUM GENET, V76, P883, DOI 10.1086/430073; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Atkinson QD, 2009, P ROY SOC B-BIOL SCI, V276, P367, DOI 10.1098/rspb.2008.0785; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Collins LJ, 2008, GENOME INFORM SER, V21, P3; Cox MP, 2008, HUM BIOL, V80, P335, DOI 10.3378/1534-6617-80.4.335; Currie TE, 2010, NATURE, V467, P801, DOI 10.1038/nature09461; Derrick RA., 1950, HIST FIJI; Friedlaender J, 2005, MOL BIOL EVOL, V22, P1506, DOI 10.1093/molbev/msi142; Gignoux CR, 2011, P NATL ACAD SCI USA, V108, P6044, DOI 10.1073/pnas.0914274108; Gray RD, 2009, SCIENCE, V323, P479, DOI 10.1126/science.1166858; Gray RD, 2000, NATURE, V405, P1052, DOI 10.1038/35016575; Hage P, 2003, CURR ANTHROPOL, V44, pS121, DOI 10.1086/379272; Harrison A, 2011, VIRUSES-BASEL, V3, P83, DOI 10.3390/v3020083; Harrison GL, 2008, THESIS; HENDY MD, 1978, J THEOR BIOL, V71, P441, DOI 10.1016/0022-5193(78)90171-6; Henn BM, 2012, P NATL ACAD SCI USA, V109, P17758, DOI 10.1073/pnas.1212380109; Hill C, 2007, AM J HUM GENET, V80, P29, DOI 10.1086/510412; Holland BR, 2005, MOL BIOL EVOL, V22, P235, DOI 10.1093/molbev/msi010; Holland BR, 2004, MOL BIOL EVOL, V21, P1459, DOI 10.1093/molbev/msh145; Howe KR, 2006, VAKA MOANA VOYAGES O; Hudjashov G, 2007, P NATL ACAD SCI USA, V104, P8726, DOI 10.1073/pnas.0702928104; Hurles ME, 2005, AM J HUM GENET, V76, P894, DOI 10.1086/430051; Hurles ME, 2003, TRENDS ECOL EVOL, V18, P531, DOI 10.1016/S0169-5347(03)00245-3; Ingman M, 2003, GENOME RES, V13, P1600, DOI 10.1101/gr.686603; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; JOBLING M, 2004, HUMAN EVOLUTIONARY G, P15253; Jordan FM, 2009, P ROY SOC B-BIOL SCI, V276, P1957, DOI 10.1098/rspb.2009.0088; Kayser M, 2008, MOL BIOL EVOL, V25, P1362, DOI 10.1093/molbev/msn078; Kayser M, 2008, AM J HUM GENET, V82, P194, DOI 10.1016/j.ajhg.2007.09.010; Kirch PV, 2000, ON THE ROAD OF THE W; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Lum JK, 1998, AM J HUM GENET, V63, P613, DOI 10.1086/301949; McComish BJ, 2010, GENOME BIOL EVOL, V2, P410, DOI 10.1093/gbe/evq029; Miles JAR, 1997, INFECTIOUS DISEASES; Mona S, 2009, MOL BIOL EVOL, V26, P1865, DOI 10.1093/molbev/msp097; Moodley Y, 2009, SCIENCE, V323, P527, DOI 10.1126/science.1166083; Murray-McIntosh RP, 1998, P NATL ACAD SCI USA, V95, P9047, DOI 10.1073/pnas.95.15.9047; Oppenheimer SJ, 2001, NATURE, V410, P166, DOI 10.1038/35065520; Pala M, 2009, AM J HUM GENET, V84, P814, DOI 10.1016/j.ajhg.2009.05.004; PAWLEY A, 1993, ANNU REV ANTHROPOL, V22, P425; Penny D, 2002, J POLYNESIAN SOC, V111, P207; PENNY D, 1991, PHYLOGENETIC ANALYSIS OF DNA SEQUENCES, P155; Pierson MJ, 2006, MOL BIOL EVOL, V23, P1966, DOI 10.1093/molbev/msl063; Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967; Salas A, 2005, BIOCHEM BIOPH RES CO, V335, P891, DOI 10.1016/j.bbrc.2005.07.161; Scott MW, 2007, THE SEVERED SNAKE MA; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Steel M, 2004, APPL MATH LETT, V17, P785, DOI 10.1016/j.aml.2004.06.006; Summerhayes GR, 2010, SCIENCE, V330, P78, DOI 10.1126/science.1193130; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Trejaut JA, 2005, PLOS BIOL, V3, P1362, DOI 10.1371/journal.pbio.0030247; Tuffley C, 2012, MOL BIOL EVOL, V29, P3703, DOI 10.1093/molbev/mss172; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Whyte ALH, 2005, HUM BIOL, V77, P157, DOI 10.1353/hub.2005.0045; Wollstein A, 2010, CURR BIOL, V20, P1983, DOI 10.1016/j.cub.2010.10.040; Wyeth EH, 2005, ARTHRITIS RHEUM-US, V52, pS582; Wyeth EH, 2007, THESIS	60	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52022	10.1371/journal.pone.0052022	http://dx.doi.org/10.1371/journal.pone.0052022			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284859	Green Submitted, Green Published, gold			2022-12-27	WOS:000312794500079
J	Kallijarvi, J; Stratoulias, V; Virtanen, K; Hietakangas, V; Heino, TI; Saarma, M				Kallijarvi, Jukka; Stratoulias, Vassilis; Virtanen, Kristel; Hietakangas, Ville; Heino, Tapio I.; Saarma, Mart			Characterization of Drosophila GDNF Receptor-Like and Evidence for Its Evolutionarily Conserved Interaction with Neural Cell Adhesion Molecule (NCAM)/FasII	PLOS ONE			English	Article							FAMILY; EXPRESSION; NEURTURIN; HYBRIDIZATION; BINDING; PROTEIN; LIGAND; RNA	Background: Glial cell line-derived neurotrophic factor (GDNF) family ligands are secreted growth factors distantly related to the TGF-beta superfamily. In mammals, they bind to the GDNF family receptor alpha (Gfr alpha) and signal through the Ret receptor tyrosine kinase. In order to gain insight into the evolution of the Ret-Gfr-Gdnf signaling system, we have cloned and characterized the first invertebrate Gfr-like cDNA (DmGfrl) from Drosophila melanogaster and generated a DmGfrl mutant allele. Results: We found that DmGfrl encodes a large GPI-anchored membrane protein with four GFR-like domains. In line with the fact that insects lack GDNF ligands, DmGfrl mediated neither Drosophila Ret phosphorylation nor mammalian RET phosphorylation. In situ hybridization analysis revealed that DmGfrl is expressed in the central and peripheral nervous systems throughout Drosophila development, but, surprisingly, DmGfrl and DmRet expression patterns were largely non-overlapping. We generated a DmGfrl null allele by genomic FLP deletion and found that both DmGfrl null females and males are viable but display fertility defects. The female fertility defect manifested as dorsal appendage malformation, small size and reduced viability of eggs laid by mutant females. In male flies DmGfrl interacted genetically with the Drosophila Ncam (neural cell adhesion molecule) homolog FasII to regulate fertility. Conclusion: Our results suggest that Ret and Gfrl did not function as an in cis receptor-coreceptor pair before the emergence of GDNF family ligands, and that the Ncam-Gfr interaction predated the in cis Ret-Gfr interaction in evolution. The fertility defects that we describe in DmGfrl null flies suggest that GDNF receptor-like has an evolutionarily ancient role in regulating male fertility and a previously unrecognized role in regulating oogenesis. Significance: These results shed light on the evolutionary aspects of the structure, expression and function of Ret-Gfr alpha and Ncam-Gfr alpha signaling complexes.	[Kallijarvi, Jukka; Virtanen, Kristel; Hietakangas, Ville; Saarma, Mart] Univ Helsinki, Inst Biotechnol, Viikki Bioctr, Helsinki, Finland; [Stratoulias, Vassilis; Heino, Tapio I.] Univ Helsinki, Dept Biosci, Viikki Bioctr, Helsinki, Finland	University of Helsinki; University of Helsinki	Kallijarvi, J (corresponding author), Univ Helsinki, Inst Biotechnol, Viikki Bioctr, Viikinkaari 9, Helsinki, Finland.	jukka.kallijarvi@helsinki.fi	Kallijarvi, Jukka/AAV-5091-2021; Stratoulias, Vassilis/P-6724-2018; Stratoulias, Vassilis/M-7074-2019	Kallijarvi, Jukka/0000-0003-3773-7025; Stratoulias, Vassilis/0000-0002-9724-6589; Stratoulias, Vassilis/0000-0002-9724-6589; Hietakangas, Ville/0000-0002-9900-7549	Academy of Finland [1121015]	Academy of Finland(Academy of Finland)	This study was funded by the Academy of Finland (grant 1121015) as a part of JK's post-doctoral researcher's project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam G, 2003, DEVELOPMENT, V130, P2397, DOI 10.1242/dev.00460; Airaksinen MS, 2006, BRAIN BEHAV EVOLUT, V68, P181, DOI 10.1159/000094087; Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Barnett MW, 2002, J CELL SCI, V115, P4495, DOI 10.1242/jcs.00114; Bespalov MM, 2007, TRENDS PHARMACOL SCI, V28, P68, DOI 10.1016/j.tips.2006.12.005; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; Eketjall S, 1999, EMBO J, V18, P5901, DOI 10.1093/emboj/18.21.5901; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Golden JP, 1999, EXP NEUROL, V158, P504, DOI 10.1006/exnr.1999.7127; Golden JP, 1998, J COMP NEUROL, V398, P139, DOI 10.1002/(SICI)1096-9861(19980817)398:1<139::AID-CNE9>3.0.CO;2-2; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; Hahn M, 2001, P NATL ACAD SCI USA, V98, P1053, DOI 10.1073/pnas.021558598; Hatinen T, 2007, MOL CELL NEUROSCI, V34, P155, DOI 10.1016/j.mcn.2006.10.009; Hidalgo A, 2006, BRAIN BEHAV EVOLUT, V68, P173, DOI 10.1159/000094086; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Lindholm P, 2010, DEV NEUROBIOL, V70, P360, DOI 10.1002/dneu.20760; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Nagaso H, 2001, J HISTOCHEM CYTOCHEM, V49, P1177, DOI 10.1177/002215540104900911; Okada R, 2009, J COMP NEUROL, V514, P74, DOI 10.1002/cne.21971; Palgi M, 2009, P NATL ACAD SCI USA, V106, P2429, DOI 10.1073/pnas.0810996106; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Parkash V, 2008, J BIOL CHEM, V283, P35164, DOI 10.1074/jbc.M802543200; Parker JS, 2001, PROTEINS, V45, P71, DOI 10.1002/prot.1125; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Read RD, 2005, GENETICS, V171, P1057, DOI 10.1534/genetics.104.038018; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Schwientek T, 2007, PROTEOMICS, V7, P3264, DOI 10.1002/pmic.200600793; SUGAYA R, 1994, MECH DEVELOP, V45, P139, DOI 10.1016/0925-4773(94)90027-2; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; Wasbrough ER, 2010, J PROTEOMICS, V73, P2171, DOI 10.1016/j.jprot.2010.09.002; White IJ, 2000, J CELL SCI, V113, P721; Zhao J, 2003, CELL, V113, P755, DOI 10.1016/S0092-8674(03)00400-8; Zhu BF, 2008, PLOS BIOL, V6, P2476, DOI 10.1371/journal.pbio.0060284	35	10	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51997	10.1371/journal.pone.0051997	http://dx.doi.org/10.1371/journal.pone.0051997			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284846	gold, Green Published, Green Submitted			2022-12-27	WOS:000312794500074
J	Mathieu, E; Lamirault, G; Toquet, C; Lhommet, P; Rederstorff, E; Sourice, S; Biteau, K; Hulin, P; Forest, V; Weiss, P; Guicheux, J; Lemarchand, P				Mathieu, Eva; Lamirault, Guillaume; Toquet, Claire; Lhommet, Pierre; Rederstorff, Emilie; Sourice, Sophie; Biteau, Kevin; Hulin, Philippe; Forest, Virginie; Weiss, Pierre; Guicheux, Jerome; Lemarchand, Patricia			Intramyocardial Delivery of Mesenchymal Stem Cell-Seeded Hydrogel Preserves Cardiac Function and Attenuates Ventricular Remodeling after Myocardial Infarction	PLOS ONE			English	Article							HYDROXYPROPYL METHYLCELLULOSE; 3-DIMENSIONAL CULTURE; SKELETAL MYOBLASTS; GENERAL-PROPERTIES; TRANSPLANTATION; HEART; ECHOCARDIOGRAPHY; INJECTION; SURVIVAL; MATRIX	Background: To improve the efficacy of bone marrow-derived mesenchymal stem cell (MSC) therapy targeted to infarcted myocardium, we investigated whether a self-setting silanized hydroxypropyl methylcellulose (Si-HPMC) hydrogel seeded with MSC (MSC+hydrogel) could preserve cardiac function and attenuate left ventricular (LV) remodeling during an 8-week follow-up study in a rat model of myocardial infarction (MI). Methodology/Principal Finding: Si-HPMC hydrogel alone, MSC alone or MSC+hydrogel were injected into the myocardium immediately after coronary artery ligation in female Lewis rats. Animals in the MSC+hydrogel group showed an increase in cardiac function up to 28 days after MI and a mid-term prevention of cardiac function alteration at day 56. Histological analyses indicated that the injection of MSC+hydrogel induced a decrease in MI size and an increase in scar thickness and ultimately limited the transmural extent of MI. These findings show that intramyocardial injection of MSC+hydrogel induced short-term recovery of ventricular function and mid-term attenuation of remodeling after MI. Conclusion/Significance: These beneficial effects may be related to the specific scaffolding properties of the Si-HPMC hydrogel that may provide the ability to support MSC injection and engraftment within myocardium.	[Mathieu, Eva; Lamirault, Guillaume; Lhommet, Pierre; Biteau, Kevin; Forest, Virginie; Lemarchand, Patricia] CNRS, Inst Thorax, INSERM, UMR1087,UMR6291, Nantes, France; [Mathieu, Eva; Lamirault, Guillaume; Lhommet, Pierre; Rederstorff, Emilie; Sourice, Sophie; Biteau, Kevin; Hulin, Philippe; Forest, Virginie; Weiss, Pierre; Guicheux, Jerome; Lemarchand, Patricia] Univ Nantes, Nantes, France; [Toquet, Claire] CHU Nantes, Serv Anat Pathol, EA Biometadys, F-44035 Nantes 01, France; [Rederstorff, Emilie; Sourice, Sophie; Weiss, Pierre; Guicheux, Jerome] INSERM, U791, Lab Osteoarticular & Dent Tissue Engn, Grp STEP Skeletal Tissue Engn & Physiopathol, Nantes, France; [Hulin, Philippe] Nantes Univ MicroPICell, Cellular & Tissular Imaging Core Facil, Nantes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; Nantes Universite; CHU de Nantes; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Institut National de la Sante et de la Recherche Medicale (Inserm)	Lemarchand, P (corresponding author), CNRS, Inst Thorax, INSERM, UMR1087,UMR6291, Nantes, France.	patricia.lemarchand@univ-nantes.fr	WEISS, Pierre/AAE-9260-2020; Weiss, Pierre/P-1372-2014; Lamirault, Guillaume/G-3699-2010; lemarchand, patricia/C-3247-2011; guicheux, Jerome/F-7767-2013	WEISS, Pierre/0000-0002-6159-8590; Weiss, Pierre/0000-0002-6159-8590; Lamirault, Guillaume/0000-0001-6490-1279; lemarchand, patricia/0000-0002-5330-2008; guicheux, Jerome/0000-0003-2754-3024	National Institute for Health and Medical Research; Fondation de l'Avenir pour la recherche medicale appliquee [ET0 570]; French Ministry of Research and Technology	National Institute for Health and Medical Research(Institut National de la Sante et de la Recherche Medicale (Inserm)); Fondation de l'Avenir pour la recherche medicale appliquee; French Ministry of Research and Technology	This work was supported by grants from the National Institute for Health and Medical Research and "Fondation de l'Avenir pour la recherche medicale appliquee, ET0 570". Eva Mathieu received a fellowship from the French Ministry of Research and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Aguado BA, 2012, TISSUE ENG PT A, V18, P806, DOI [10.1089/ten.tea.2011.0391, 10.1089/ten.TEA.2011.0391]; Berry MF, 2006, AM J PHYSIOL-HEART C, V290, pH2196, DOI 10.1152/ajpheart.01017.2005; Bolognese L, 2002, CIRCULATION, V106, P2351, DOI 10.1161/01.CIR.0000036014.90197.FA; BOOR PJ, 1985, AM J PATHOL, V121, P39; Bourges X, 2002, BIOPOLYMERS, V63, P232, DOI 10.1002/bip.10053; Bourges X, 2002, ADV COLLOID INTERFAC, V99, P215, DOI 10.1016/S0001-8686(02)00035-0; Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005; Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040; Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Dai WD, 2005, CIRCULATION, V112, P214, DOI 10.1161/CIRCULATIONAHA.104.527937; Dobner S, 2009, J CARD FAIL, V15, P629, DOI 10.1016/j.cardfail.2009.03.003; Elnakish MT, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/646038; Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fatimi A, 2008, BIOMATERIALS, V29, P533, DOI 10.1016/j.biomaterials.2007.10.032; Fatimi A, 2009, ACTA BIOMATER, V5, P3423, DOI 10.1016/j.actbio.2009.05.030; Fernandes S, 2006, CARDIOVASC RES, V69, P348, DOI 10.1016/j.cardiores.2005.10.003; FOLLAND ED, 1979, CIRCULATION, V60, P760, DOI 10.1161/01.CIR.60.4.760; Imanishi Y, 2008, J MOL CELL CARDIOL, V44, P662, DOI 10.1016/j.yjmcc.2007.11.001; Jiang XJ, 2009, J BIOMED MATER RES A, V90A, P472, DOI 10.1002/jbm.a.32118; Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49; Kanashiro-Takeuchi RM, 2010, P NATL ACAD SCI USA, V107, P2604, DOI 10.1073/pnas.0914138107; Karaoz E, 2009, HISTOCHEM CELL BIOL, V132, P533, DOI 10.1007/s00418-009-0629-6; Laib S, 2009, BIOMATERIALS, V30, P1568, DOI 10.1016/j.biomaterials.2008.11.031; Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; LEHOCZKY J, 1964, ARCH PATHOL, V78, P37; Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010; Li LL, 2008, TRANSPL INT, V21, P1181, DOI 10.1111/j.1432-2277.2008.00742.x; Maurel A, 2005, TRANSPLANTATION, V80, P660, DOI 10.1097/01.tp.0000172178.35488.31; Merceron C, 2011, CELL TRANSPLANT, V20, P1575, DOI 10.3727/096368910X557191; Mias C, 2008, STEM CELLS, V26, P1749, DOI 10.1634/stemcells.2007-1000; Mias C, 2009, STEM CELLS, V27, P2734, DOI 10.1002/stem.169; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nagaya N, 2005, CIRCULATION, V112, P1128, DOI 10.1161/CIRCULATIONAHA.104.500447; Niagara MI, 2007, CIRC RES, V100, P545, DOI 10.1161/01.RES.0000258460.41160.ef; Poulsen SH, 2001, DAN MED BULL, V48, P199; Rane AA, 2011, J AM COLL CARDIOL, V58, P2615, DOI 10.1016/j.jacc.2011.11.001; Rane AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021571; Savoye C, 2006, AM J CARDIOL, V98, P1144, DOI 10.1016/j.amjcard.2006.06.011; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Sherman Warren, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS57, DOI 10.1038/ncpcardio0446; Singelyn JM, 2010, J CARDIOVASC TRANSL, V3, P478, DOI 10.1007/s12265-010-9202-x; Takagawa J, 2007, J APPL PHYSIOL, V102, P2104, DOI 10.1152/japplphysiol.00033.2007; Tang YL, 2005, J AM COLL CARDIOL, V46, P1339, DOI 10.1016/j.jacc.2005.05.079; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Trojani C, 2005, BIOMATERIALS, V26, P5509, DOI 10.1016/j.biomaterials.2005.02.001; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Verma A, 2008, JACC-CARDIOVASC IMAG, V1, P582, DOI 10.1016/j.jcmg.2008.05.012; Vinatier C, 2007, J BIOMED MATER RES A, V80A, P66, DOI 10.1002/jbm.a.30867; Vinatier C, 2005, BIOMATERIALS, V26, P6643, DOI 10.1016/j.biomaterials.2005.04.057; Vunjak-Novakovic G, 2010, TISSUE ENG PART B-RE, V16, P169, DOI [10.1089/ten.teb.2009.0352, 10.1089/ten.TEB.2009.0352]; Wang T, 2009, ACTA BIOMATER, V5, P2939, DOI 10.1016/j.actbio.2009.04.040; Ye ZY, 2011, ADV DRUG DELIVER REV, V63, P688, DOI 10.1016/j.addr.2011.02.007; Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367; Zhang XL, 2010, EXP BIOL MED, V235, P1505, DOI 10.1258/ebm.2010.010175	58	65	69	7	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51991	10.1371/journal.pone.0051991	http://dx.doi.org/10.1371/journal.pone.0051991			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284842	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500072
J	Menalled, LB; Kudwa, AE; Miller, S; Fitzpatrick, J; Watson-Johnson, J; Keating, N; Ruiz, M; Mushlin, R; Alosio, W; McConnell, K; Connor, D; Murphy, C; Oakeshott, S; Kwan, M; Beltran, J; Ghavami, A; Brunner, D; Park, LC; Ramboz, S; Howland, D				Menalled, Liliana B.; Kudwa, Andrea E.; Miller, Sam; Fitzpatrick, Jon; Watson-Johnson, Judy; Keating, Nicole; Ruiz, Melinda; Mushlin, Richard; Alosio, William; McConnell, Kristi; Connor, David; Murphy, Carol; Oakeshott, Steve; Kwan, Mei; Beltran, Jose; Ghavami, Afshin; Brunner, Dani; Park, Larry C.; Ramboz, Sylvie; Howland, David			Comprehensive Behavioral and Molecular Characterization of a New Knock-In Mouse Model of Huntington's Disease: zQ175	PLOS ONE			English	Article							MESSENGER-RNA; MUTANT HUNTINGTIN; GENE-EXPRESSION; STRIATAL NEURONS; TRANSGENIC MICE; PRECISION GRIP; EARLY MOTOR; REPEAT; ONSET; LENGTH	Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder characterized by motor, cognitive and psychiatric manifestations. Since the mutation responsible for the disease was identified as an unstable expansion of CAG repeats in the gene encoding the huntingtin protein in 1993, numerous mouse models of HD have been generated to study disease pathogenesis and evaluate potential therapeutic approaches. Of these, knock-in models best mimic the human condition from a genetic perspective since they express the mutation in the appropriate genetic and protein context. Behaviorally, however, while some abnormal phenotypes have been detected in knock-in mouse models, a model with an earlier and more robust phenotype than the existing models is required. We describe here for the first time a new mouse line, the zQ175 knock-in mouse, derived from a spontaneous expansion of the CAG copy number in our CAG 140 knock-in colony [1]. Given the inverse relationship typically observed between age of HD onset and length of CAG repeat, since this new mouse line carries a significantly higher CAG repeat length it was expected to be more significantly impaired than the parent line. Using a battery of behavioral tests we evaluated both heterozygous and homozygous zQ175 mice. Homozygous mice showed motor and grip strength abnormalities with an early onset (8 and 4 weeks of age, respectively), which were followed by deficits in rotarod and climbing activity at 30 weeks of age and by cognitive deficits at around 1 year of age. Of particular interest for translational work, we also found clear behavioral deficits in heterozygous mice from around 4.5 months of age, especially in the dark phase of the diurnal cycle. Decreased body weight was observed in both heterozygotes and homozygotes, along with significantly reduced survival in the homozygotes. In addition, we detected an early and significant decrease of striatal gene markers from 12 weeks of age. These data suggest that the zQ175 knock-in line could be a suitable model for the evaluation of therapeutic approaches and early events in the pathogenesis of HD.	[Park, Larry C.; Howland, David] CHDI Management CHDI Fdn, Princeton, NJ USA; [Menalled, Liliana B.; Kudwa, Andrea E.; Miller, Sam; Fitzpatrick, Jon; Watson-Johnson, Judy; Keating, Nicole; Ruiz, Melinda; Mushlin, Richard; Alosio, William; Connor, David; Murphy, Carol; Oakeshott, Steve; Kwan, Mei; Beltran, Jose; Ghavami, Afshin; Brunner, Dani; Ramboz, Sylvie] PsychoGenics Inc, Tarrytown, NY USA		Howland, D (corresponding author), CHDI Management CHDI Fdn, Princeton, NJ USA.	David.Howland@CHDIFoundation.org			CHDI Foundation	CHDI Foundation	CHDI Foundation is a not-for-profit biomedical research organization exclusively dedicated to discovering and developing therapeutics that slow the progression of Huntington's disease. The research described was conducted by PsychoGenics under a fee-for-service agreement for CHDI Foundation in collaboration with and funded by CHDI Foundation. The funder, through CHDI Management, fully participated in study design, data collection and analysis, the decision to publish, and preparation of the manuscript. CHDI Foundation has recently provided financial support to the Public Library of Science for PLOS Currents: Huntington Disease.	ALBIN RL, 1991, ANN NEUROL, V30, P542, DOI 10.1002/ana.410300406; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Augood SJ, 1997, ANN NEUROL, V42, P215, DOI 10.1002/ana.410420213; Benn CL, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-17; Bibb JA, 2000, P NATL ACAD SCI USA, V97, P6809, DOI 10.1073/pnas.120166397; Brooks S, 2010, BRAIN RES B; Brooks SP, 2006, BRAIN RES BULL, V69, P452, DOI 10.1016/j.brainresbull.2006.02.011; Chan EYW, 2002, HUM MOL GENET, V11, P1939, DOI 10.1093/hmg/11.17.1939; Denovan-Wright EM, 2000, NEUROSCIENCE, V98, P705, DOI 10.1016/S0306-4522(00)00157-3; Fellows S, 1997, NEUROSCI LETT, V226, P103, DOI 10.1016/S0304-3940(97)00264-4; Gordon AM, 2000, EXP NEUROL, V163, P136, DOI 10.1006/exnr.2000.7348; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Hebb ALO, 2004, NEUROSCIENCE, V123, P967, DOI 10.1016/j.neuroscience.2003.11.009; Heng MY, 2007, J NEUROSCI, V27, P8989, DOI 10.1523/JNEUROSCI.1830-07.2007; Heng MY, 2010, HUM MOL GENET, V19, P3702, DOI 10.1093/hmg/ddq285; Hickey MA, 2008, NEUROSCIENCE, V157, P280, DOI 10.1016/j.neuroscience.2008.08.041; Hickey MA, 2003, CYTOGENET GENOME RES, V100, P276, DOI 10.1159/000072863; Hockly E, 2002, ANN NEUROL, V51, P235, DOI 10.1002/ana.10094; Hu H, 2004, EUR J NEUROSCI, V20, P3351, DOI 10.1111/j.1460-9568.2004.03796.x; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Lione LA, 1999, J NEUROSCI, V19, P10428; Lloret A, 2006, HUM MOL GENET, V15, P2015, DOI 10.1093/hmg/ddl125; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; McCaw EA, 2004, EUR J BIOCHEM, V271, P4909, DOI 10.1111/j.1432-1033.2004.04460.x; Menalled L, 2000, EXP NEUROL, V162, P328, DOI 10.1006/exnr.1999.7327; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Menalled LB, 2002, TRENDS PHARMACOL SCI, V23, P32, DOI 10.1016/S0165-6147(00)01884-8; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Menalled Liliana B, 2005, NeuroRx, V2, P465, DOI 10.1602/neurorx.2.3.465; Morton AJ, 2006, NAT METHODS, V3, P767, DOI 10.1038/nmeth1006-767; Murphy C, IMPAIRMENTS SI UNPUB; RICHFIELD EK, 1995, ANN NEUROL, V37, P335, DOI 10.1002/ana.410370309; Rising AC, 2011, EXP NEUROL, V228, P173, DOI 10.1016/j.expneurol.2010.12.017; ROOS RAC, 1993, J NEUROL NEUROSUR PS, V56, P98, DOI 10.1136/jnnp.56.1.98; SANBERG PR, 1981, MED J AUSTRALIA, V1, P407, DOI 10.5694/j.1326-5377.1981.tb135681.x; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; Squitieri F, 2003, BRAIN, V126, P946, DOI 10.1093/brain/awg077; Trembath MK, 2010, MOVEMENT DISORD, V25, P1444, DOI 10.1002/mds.23108; van Dellen A, 2000, NATURE, V404, P721, DOI 10.1038/35008142; von Horsten S, 2003, HUM MOL GENET, V12, P617, DOI 10.1093/hmg/ddg075; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; Woodman B, 2007, BRAIN RES BULL, V72, P83, DOI 10.1016/j.brainresbull.2006.11.004	45	248	255	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e49838	10.1371/journal.pone.0049838	http://dx.doi.org/10.1371/journal.pone.0049838			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284626	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500009
J	Silva, MCPE; Dias, ACF; van Elsas, JD; Salles, JF				Pereira e Silva, Michele C.; Franco Dias, Armando Cavalcante; van Elsas, Jan Dirk; Salles, Joana Falcao			Spatial and Temporal Variation of Archaeal, Bacterial and Fungal Communities in Agricultural Soils	PLOS ONE			English	Article							MICROBIAL COMMUNITY; BETA-DIVERSITY; KINGDOM CRENARCHAEOTA; PROKARYOTIC DIVERSITY; PHYLOGENETIC ANALYSIS; GRADIENT; PH; RHIZOSPHERE; ABUNDANCE; DYNAMICS	Background: Soil microbial communities are in constant change at many different temporal and spatial scales. However, the importance of these changes to the turnover of the soil microbial communities has been rarely studied simultaneously in space and time. Methodology/Principal Findings: In this study, we explored the temporal and spatial responses of soil bacterial, archaeal and fungal beta-diversities to abiotic parameters. Taking into account data from a 3-year sampling period, we analyzed the abundances and community structures of Archaea, Bacteria and Fungi along with key soil chemical parameters. We questioned how these abiotic variables influence the turnover of bacterial, archaeal and fungal communities and how they impact the long-term patterns of changes of the aforementioned soil communities. Interestingly, we found that the bacterial and fungal b-diversities are quite stable over time, whereas archaeal diversity showed significantly higher fluctuations. These fluctuations were reflected in temporal turnover caused by soil management through addition of N-fertilizers. Conclusions: Our study showed that management practices applied to agricultural soils might not significantly affect the bacterial and fungal communities, but cause slow and long-term changes in the abundance and structure of the archaeal community. Moreover, the results suggest that, to different extents, abiotic and biotic factors determine the community assembly of archaeal, bacterial and fungal communities.	[Pereira e Silva, Michele C.; van Elsas, Jan Dirk; Salles, Joana Falcao] Univ Groningen, Ctr Life Sci, Dept Microbial Ecol, Groningen, Netherlands; [Franco Dias, Armando Cavalcante] Univ Sao Paulo, Dept Soil Sci, Luiz de Queiroz Coll Agr, Sao Paulo, Brazil	University of Groningen; Universidade de Sao Paulo	Silva, MCPE (corresponding author), Univ Groningen, Ctr Life Sci, Dept Microbial Ecol, Groningen, Netherlands.	m.silva@rug.nl	Dias, Armando Cavalcante Franco/F-5878-2012; de Cassia Pereira e Silva, Michele/D-3918-2016; Dias, Armando Cavalcante Franco/O-1477-2019; Falcao Salles, Joana/A-7313-2008; Pereira e Silva, Michele de Cássia/H-6958-2013; Salles, Joana Falcao/AAG-7070-2020	Dias, Armando Cavalcante Franco/0000-0002-2651-6270; de Cassia Pereira e Silva, Michele/0000-0002-6426-8474; Dias, Armando Cavalcante Franco/0000-0002-2651-6270; Falcao Salles, Joana/0000-0003-4317-7263; Salles, Joana Falcao/0000-0003-4317-7263	NWO-ERGO Programme	NWO-ERGO Programme	This work was supported by the NWO-ERGO Programme and was part of a collaborative project with Utrecht University, Utrecht, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWARTHA HG, 1953, AUST J ZOOL, V1, P174, DOI 10.1071/ZO9530174; Angeler DG, 2009, ECOLOGY, V90, P3245, DOI 10.1890/07-0391.1; Bach HJ, 2002, J MICROBIOL METH, V49, P235, DOI 10.1016/S0167-7012(01)00370-0; Baez S, 2006, ECOLOGY, V87, P2746, DOI 10.1890/0012-9658(2006)87[2746:BROPCS]2.0.CO;2; Bailey VL, 2002, SOIL BIOL BIOCHEM, V34, P997, DOI 10.1016/S0038-0717(02)00033-0; Baker BJ, 2010, P NATL ACAD SCI USA, V107, P8806, DOI 10.1073/pnas.0914470107; Bano N, 2004, APPL ENVIRON MICROB, V70, P781, DOI 10.1128/AEM.70.2.781-789.2004; Bardgett Richard D., 2005, P100, DOI 10.1017/CBO9780511541926.007; Bates ST, 2011, ISME J, V5, P908, DOI 10.1038/ismej.2010.171; Bengtson P, 2012, APPL ENVIRON MICROB, V78, P5906, DOI 10.1128/AEM.01476-12; Bomberg M, 2007, MICROB ECOL, V54, P406, DOI 10.1007/s00248-007-9232-3; Bossuyt H, 2001, APPL SOIL ECOL, V16, P195, DOI 10.1016/S0929-1393(00)00116-5; Brons JK, 2008, APPL ENVIRON MICROB, V74, P2717, DOI 10.1128/AEM.02195-07; Buckley DH, 1998, APPL ENVIRON MICROB, V64, P4333; Chesson P, 1997, AM NAT, V150, P519, DOI 10.1086/286080; Collins SL, 2006, ECOLOGY, V87, P2058, DOI 10.1890/0012-9658(2006)87[2058:SIOFAG]2.0.CO;2; Collins SL, 2000, OIKOS, V91, P285, DOI 10.1034/j.1600-0706.2000.910209.x; Curtis TP, 2002, P NATL ACAD SCI USA, V99, P10494, DOI 10.1073/pnas.142680199; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; Feeley KJ, 2011, ECOLOGY, V92, P871, DOI 10.1890/10-0724.1; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Flohre A, 2011, ECOL APPL, V21, P1772, DOI 10.1890/10-0645.1; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gomes NCM, 2001, PLANT SOIL, V232, P167, DOI 10.1023/A:1010350406708; Gorley C.K., 2006, GETTING STARTED PRIM; Griffiths RI, 2011, ENVIRON MICROBIOL, V13, P1642, DOI 10.1111/j.1462-2920.2011.02480.x; Hallam SJ, 2006, P NATL ACAD SCI USA, V103, P18296, DOI 10.1073/pnas.0608549103; Hill TCJ, 2003, FEMS MICROBIOL ECOL, V43, P1, DOI 10.1111/j.1574-6941.2003.tb01040.x; Hogberg MN, 2007, OECOLOGIA, V150, P590, DOI 10.1007/s00442-006-0562-5; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Jia ZJ, 2009, ENVIRON MICROBIOL, V11, P1658, DOI 10.1111/j.1462-2920.2009.01891.x; Jung J, 2011, RES MICROBIOL, V162, P1018, DOI 10.1016/j.resmic.2011.07.007; Jurgens G, 1997, APPL ENVIRON MICROB, V63, P803, DOI 10.1128/AEM.63.2.803-805.1997; Kampichler C, 2005, PEDOBIOLOGIA, V49, P41, DOI 10.1016/j.pedobi.2004.07.011; Kemnitz D, 2007, FEMS MICROBIOL ECOL, V60, P442, DOI 10.1111/j.1574-6941.2007.00310.x; King AJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1055; Kropf S, 2004, J STAT PLAN INFER, V125, P31, DOI 10.1016/j.jspi.2003.07.021; Langenheder S, 2012, ISME J, V6, P1107, DOI 10.1038/ismej.2011.177; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Lehtovirta LE, 2009, FEMS MICROBIOL ECOL, V70, P367, DOI 10.1111/j.1574-6941.2009.00748.x; Lennon JJ, 2001, J ANIM ECOL, V70, P966, DOI 10.1046/j.0021-8790.2001.00563.x; Leps J, 2003, MULTIVARIATE ANAL EC; LEWONTIN RC, 1969, P NATL ACAD SCI USA, V62, P1056, DOI 10.1073/pnas.62.4.1056; Lindstrom ES, 2012, ENV MICROBIOL REP, V4, P1, DOI 10.1111/j.1758-2229.2011.00257.x; Lipson DA, 2002, MICROB ECOL, V43, P307, DOI 10.1007/s00248-001-1057-x; Magurran AE, 2010, PHILOS T R SOC B, V365, P3593, DOI 10.1098/rstb.2010.0296; Martiny JBH, 2011, P NATL ACAD SCI USA, V108, P7850, DOI 10.1073/pnas.1016308108; MYERS RM, 1985, NUCLEIC ACIDS RES, V13, P3131, DOI 10.1093/nar/13.9.3131; Nevarez L, 2009, INT J FOOD MICROBIOL, V130, P166, DOI 10.1016/j.ijfoodmicro.2009.01.013; Nicol GW, 2004, ENVIRON MICROBIOL, V6, P861, DOI 10.1111/j.1462-2920.2004.00627.x; Ochsenreiter T, 2003, ENVIRON MICROBIOL, V5, P787, DOI 10.1046/j.1462-2920.2003.00476.x; Ouverney CC, 2000, APPL ENVIRON MICROB, V66, P4829, DOI 10.1128/AEM.66.11.4829-4833.2000; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; RADEMAKER JLW, 1999, MOL MICROBIAL ECOLOG, P1; Rasche F, 2011, ISME J, V5, P389, DOI 10.1038/ismej.2010.138; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Schmidt SK, 2007, ECOLOGY, V88, P1379, DOI 10.1890/06-0164; Singh BK, 2010, NAT REV MICROBIOL, V8, P779, DOI 10.1038/nrmicro2439; Smit E, 1999, APPL ENVIRON MICROB, V65, P2614; Thibault KM, 2004, ECOLOGY, V85, P2649, DOI 10.1890/04-0321; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; Tourna M, 2008, ENVIRON MICROBIOL, V10, P1357, DOI 10.1111/j.1462-2920.2007.01563.x; Treseder KK, 2004, NEW PHYTOL, V164, P347, DOI 10.1111/j.1469-8137.2004.01159.x; UEDA T, 1995, EUR J SOIL SCI, V46, P415, DOI 10.1111/j.1365-2389.1995.tb01337.x; Walker CB, 2010, P NATL ACAD SCI USA, V107, P8818, DOI 10.1073/pnas.0913533107; Wang JJ, 2008, ENVIRON MICROBIOL, V10, P2537, DOI 10.1111/j.1462-2920.2008.01678.x; WHEELER KA, 1991, INT J FOOD MICROBIOL, V12, P141, DOI 10.1016/0168-1605(91)90063-U; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019950	75	41	42	1	185	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51554	10.1371/journal.pone.0051554	http://dx.doi.org/10.1371/journal.pone.0051554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284712	Green Submitted, Green Published, gold			2022-12-27	WOS:000312794500033
J	Thriemer, K; Ley, BB; Ame, SS; Deen, JL; Pak, GD; Chang, NY; Hashim, R; Schmied, WH; Busch, CJL; Nixon, S; Morrissey, A; Puri, MK; Ochiai, RL; Wierzba, T; Clemens, JD; Ali, M; Jiddawi, MS; von Seidlein, L; Ali, SM				Thriemer, Kamala; Ley, Benedikt B.; Ame, Shaali S.; Deen, Jaqueline L.; Pak, Gi Deok; Chang, Na Yoon; Hashim, Ramadhan; Schmied, Wolfgang Hellmut; Busch, Clara Jana-Lui; Nixon, Shanette; Morrissey, Anne; Puri, Mahesh K.; Ochiai, R. Leon; Wierzba, Thomas; Clemens, John D.; Ali, Mohammad; Jiddawi, Mohammad S.; von Seidlein, Lorenz; Ali, Said M.			Clinical and Epidemiological Features of Typhoid Fever in Pemba, Zanzibar: Assessment of the Performance of the WHO Case Definitions	PLOS ONE			English	Article							DIAGNOSIS; CHILDREN; SALMONELLOSIS; TANZANIA	Background: The gold standard for diagnosis of typhoid fever is blood culture (BC). Because blood culture is often not available in impoverished settings it would be helpful to have alternative diagnostic approaches. We therefore investigated the usefulness of clinical signs, WHO case definition and Widal test for the diagnosis of typhoid fever. Methodology/Principal Findings: Participants with a body temperature >= 37.5 degrees C or a history of fever were enrolled over 17 to 22 months in three hospitals on Pemba Island, Tanzania. Clinical signs and symptoms of participants upon presentation as well as blood and serum for BC and Widal testing were collected. Clinical signs and symptoms of typhoid fever cases were compared to other cases of invasive bacterial diseases and BC negative participants. The relationship of typhoid fever cases with rainfall, temperature, and religious festivals was explored. The performance of the WHO case definitions for suspected and probable typhoid fever and a local cut off titre for the Widal test was assessed. 79 of 2209 participants had invasive bacterial disease. 46 isolates were identified as typhoid fever. Apart from a longer duration of fever prior to admission clinical signs and symptoms were not significantly different among patients with typhoid fever than from other febrile patients. We did not detect any significant seasonal patterns nor correlation with rainfall or festivals. The sensitivity and specificity of the WHO case definition for suspected and probable typhoid fever were 82.6% and 41.3% and 36.3 and 99.7% respectively. Sensitivity and specificity of the Widal test was 47.8% and 99.4 both forfor O-agglutinin and H-agglutinin at a cut-off titre of 1:80. Conclusions/Significance: Typhoid fever prevalence rates on Pemba are high and its clinical signs and symptoms are nonspecific. The sensitivity of the Widal test is low and the WHO case definition performed better than the Widal test.	[Thriemer, Kamala; Ley, Benedikt B.; Deen, Jaqueline L.; Pak, Gi Deok; Chang, Na Yoon; Hashim, Ramadhan; Schmied, Wolfgang Hellmut; Busch, Clara Jana-Lui; Puri, Mahesh K.; Ochiai, R. Leon; Wierzba, Thomas; Clemens, John D.; Ali, Mohammad] Int Vaccine Inst, Seoul, South Korea; [Thriemer, Kamala] Inst Trop Med, B-2000 Antwerp, Belgium; [Ley, Benedikt B.] Univ Vienna, Bioctr, Vienna, Austria; [Ame, Shaali S.; Ali, Said M.] Publ Hlth Lab Pemba, Ivo De Carneri, Chake Chake, Tanzania; [Ame, Shaali S.; Jiddawi, Mohammad S.; Ali, Said M.] Minist Hlth & Social Welf, Zanzibar, Tanzania; [Deen, Jaqueline L.; von Seidlein, Lorenz] Menzies Sch Hlth Res, Casuarina, NT, Australia; [Nixon, Shanette; Morrissey, Anne] Duke Univ, KCMC Collaborat, Moshi, Tanzania	International Vaccine Institute; Institute of Tropical Medicine (ITM); University of Vienna; Charles Darwin University; Menzies School of Health Research; Duke University	Thriemer, K (corresponding author), Int Vaccine Inst, Seoul, South Korea.	kthriemer@itg.be	Schmied, Wolfgang/AAU-9961-2020; Ali, Mohammad/E-2365-2017	Schmied, Wolfgang/0000-0001-7625-0995; Ali, Mohammad/0000-0003-1410-388X; Thriemer, Kamala/0000-0001-7536-7497; Ochiai, Leon/0000-0002-5079-6786; Ley, Benedikt/0000-0002-5734-0845	Swedish International Development Cooperation Agency (SIDA)	Swedish International Development Cooperation Agency (SIDA)	This work has been supported by a grant from the Swedish International Development Cooperation Agency (SIDA) to the International Vaccine Institute (IVI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhutta ZA, 1996, ANN TROP PAEDIATR, V16, P299, DOI 10.1080/02724936.1996.11747842; Crump JA, 2012, CLIN INFECT DIS, V54, P1107, DOI 10.1093/cid/cis024; Hosoglu S, 2006, T ROY SOC TROP MED H, V100, P1068, DOI 10.1016/j.trstmh.2005.12.007; Keddy KH, 2011, B WORLD HEALTH ORGAN, V89, P640, DOI 10.2471/BLT.11.087627; Ley B, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-147; Ley B, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-180; Mindy J., 2003, MANUAL LAB IDENTIFIC; Mtove G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009244; Thriemer Kamala, 2012, BMC Res Notes, V5, P113, DOI 10.1186/1756-0500-5-113; Thriemer K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030350; Vollaard AM, 2005, T ROY SOC TROP MED H, V99, P440, DOI 10.1016/j.trstmh.2004.09.012; World Health Organization, 2012, WHOIVB1202	12	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51823	10.1371/journal.pone.0051823	http://dx.doi.org/10.1371/journal.pone.0051823			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284780	Green Submitted, Green Published, gold			2022-12-27	WOS:000312794500051
J	Flavel, SC; Koch, JD; White, JM; Todd, G				Flavel, Stanley C.; Koch, Jenna D.; White, Jason M.; Todd, Gabrielle			Illicit Stimulant Use in Humans Is Associated with a Long-Term Increase in Tremor	PLOS ONE			English	Article							MDMA ECSTASY; RAT-BRAIN; (+/-)3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; CLINICAL-PHARMACOLOGY; DOPAMINE TRANSPORTER; PARKINSONS-DISEASE; MOVEMENT-DISORDERS; COCAINE; NEURONS	Use of illicit stimulants such as methamphetamine, cocaine, and ecstasy is a significant health problem. The United Nations Office on Drugs and Crime estimates that 14-57 million people use stimulants each year. Chronic use of illicit stimulants can cause neurotoxicity in animals and humans but the long-term functional consequences are not well understood. Stimulant users self-report problems with tremor whilst abstinent. Thus, the aim of the current study was to investigate the long-term effect of stimulant use on human tremor during rest and movement. We hypothesized that individuals with a history of stimulant use would exhibit abnormally large tremor during rest and movement. Tremor was assessed in abstinent ecstasy users (n = 9; 22 +/- 3 yrs) and abstinent users of amphetamine-like drugs (n = 7; 33 +/- 9 yrs) and in two control groups: non-drug users (n = 23; 27 +/- 8 yrs) and cannabis users (n = 12; 24 +/- 7 yrs). Tremor was measured with an accelerometer attached to the index finger at rest (30 s) and during flexion and extension of the index finger (30 s). Acceleration traces were analyzed with fast-Fourier transform. During movement, tremor amplitude was significantly greater in ecstasy users than in non-drug users (frequency range 3.9-13.3 Hz; P<0.05), but was unaffected in cannabis users or users of amphetamine-like drugs. The peak frequency of tremor did not significantly differ between groups nor did resting tremor. In conclusion, abstinent ecstasy users exhibit an abnormally large tremor during movement. Further work is required to determine if the abnormality translates to increased risk of movement disorders in this population.	[Flavel, Stanley C.; Koch, Jenna D.; White, Jason M.; Todd, Gabrielle] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia; [White, Jason M.; Todd, Gabrielle] Univ S Australia, Sansom Inst, Adelaide, SA 5001, Australia	University of South Australia; University of South Australia	Todd, G (corresponding author), Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia.	gabrielle.todd@unisa.edu.au	Todd, Gabrielle/K-7122-2012; White, Jason M/A-2795-2011	Todd, Gabrielle/0000-0002-2465-6026; White, Jason M/0000-0001-6750-1078	Clive and Vera Ramaciotti Foundation [2974/2010]; National Health and Medical Research Council of Australia [627003]; University of South Australia	Clive and Vera Ramaciotti Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of South Australia	This work was supported by the Clive and Vera Ramaciotti Foundation (Establishment Grant, ID 2974/2010), National Health and Medical Research Council of Australia (GT holds a Career Development Award; ID 627003), and University of South Australia (GT holds a RsearchSA Fellowship, SF held an Australian Postgraduate Award, and JK held a South Australia Rural Health Scholarship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIHW, 2005, STAT DRUG US AUSTR 2, V62, P1; AIHW, 2011, 2010 NAT DRUG STRAT, P1; Baker SN, 2007, CURR OPIN NEUROBIOL, V17, P649, DOI 10.1016/j.conb.2008.01.007; BAUER LO, 1993, PSYCHIAT RES, V47, P69, DOI 10.1016/0165-1781(93)90056-M; Beck A.T., 1996, PSYCHOL ASSESS, V2, DOI DOI 10.1037/T00742-000; BENOWITZ NL, 1993, PHARMACOL TOXICOL, V72, P3, DOI 10.1111/j.1600-0773.1993.tb01331.x; Benton AL, 1983, MULTILINGUAL APHASIA; Bousman CA, 2010, J INT NEUROPSYCH SOC, V16, P1047, DOI 10.1017/S1355617710000846; Buchert R, 2003, J NUCL MED, V44, P375; Callaghan RC, 2010, MOVEMENT DISORD, V25, P2333, DOI 10.1002/mds.23263; CARDOSO F, 1993, NEUROL CLIN, V11, P625, DOI 10.1016/S0733-8619(18)30143-9; CARDOSO FEC, 1993, MOVEMENT DISORD, V8, P175, DOI 10.1002/mds.870080210; Catalano G, 1997, SOUTH MED J, V90, P1050, DOI 10.1097/00007611-199710000-00017; COMMINS DL, 1987, J PHARMACOL EXP THER, V241, P338; Cosentino C, 2004, MOVEMENT DISORD, V19, P1386, DOI 10.1002/mds.20306; Dafters RI, 1999, PSYCHOPHARMACOLOGY, V145, P82, DOI 10.1007/s002130051035; Demirkiran M, 1996, CLIN NEUROPHARMACOL, V19, P157, DOI 10.1097/00002826-199619020-00004; Diaz-Martinez A, 1998, CLIN THER, V20, P467, DOI 10.1016/S0149-2918(98)80056-8; Downes Michael A, 2005, Emerg Med Australas, V17, P277; Esteban B, 2001, PSYCHOPHARMACOLOGY, V154, P251, DOI 10.1007/s002130000645; FACTOR SA, 1988, ANN NEUROL, V23, P423, DOI 10.1002/ana.410230431; Farmer SF, 1998, J PHYSIOL-LONDON, V509, P3, DOI 10.1111/j.1469-7793.1998.003bo.x; FISCHER C, 1995, J NEUROSCI, V15, P5476; FREEMAN JS, 1993, J NEUROL NEUROSUR PS, V56, P1078, DOI 10.1136/jnnp.56.10.1078; Frei E, 2001, HUM BRAIN MAPP, V14, P152, DOI 10.1002/hbm.1049; Greco PG, 2003, EUR J PHARMACOL, V479, P117, DOI 10.1016/j.ejphar.2003.08.062; Green AR, 2003, PHARMACOL REV, V55, P463, DOI 10.1124/pr.55.3.3; GRIGSBY J, 1995, PERCEPT MOTOR SKILL, V80, P732, DOI 10.2466/pms.1995.80.3.732; Hallett M, 1998, MOVEMENT DISORD, V13, P43; Hatzidimitriou G, 1999, J NEUROSCI, V19, P5096; Jones DC, 2005, J PHARMACOL EXP THER, V313, P422, DOI 10.1124/jpet.104.077628; KEARCOLWELL JJ, 1978, J CLIN PSYCHOL, V34, P437, DOI 10.1002/1097-4679(197804)34:2<437::AID-JCLP2270340239>3.0.CO;2-K; Kish SJ, 2010, J PSYCHOPHARMACOL, V24, P281, DOI 10.1177/0269881108097724; Lew R, 1996, J PHARMACOL EXP THER, V276, P855; LUNDH H, 1981, J NEUROL NEUROSUR PS, V44, P728, DOI 10.1136/jnnp.44.8.728; Lyons KE, 2008, CNS DRUGS, V22, P1037, DOI 10.2165/0023210-200822120-00006; McAuley JH, 2000, BRAIN, V123, P1545, DOI 10.1093/brain/123.8.1545; McCann UD, 1998, LANCET, V352, P1433, DOI 10.1016/S0140-6736(98)04329-3; MCCANN UD, 1994, NEUROPSYCHOPHARMACOL, V10, P129, DOI 10.1038/npp.1994.15; Morefield KM, 2011, ADDICTION, V106, P1293, DOI 10.1111/j.1360-0443.2011.03399.x; Mrazik M, 2010, ARCH CLIN NEUROPSYCH, V25, P236, DOI 10.1093/arclin/acq006; Mueller M, 2011, SYNAPSE, V65, P983, DOI 10.1002/syn.20925; Parrott AC, 2002, HUM PSYCHOPHARM CLIN, V17, P309, DOI 10.1002/hup.415; PASCUALLEONE A, 1990, NEUROLOGY, V40, P999, DOI 10.1212/WNL.40.6.999; PRIORI A, 1995, MOVEMENT DISORD, V10, P353, DOI 10.1002/mds.870100323; Raethjen J, 2001, J NEUROL NEUROSUR PS, V70, P78, DOI 10.1136/jnnp.70.1.78; Reneman L, 2002, NEUROPSYCHOPHARMACOL, V26, P387, DOI 10.1016/S0893-133X(01)00366-9; RICAURTE GA, 1992, J PHARMACOL EXP THER, V261, P616; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Rothwell JC, 1998, MOVEMENT DISORD, V13, P24; SCHMIDT CJ, 1987, BIOCHEM PHARMACOL, V36, P4095, DOI 10.1016/0006-2952(87)90566-1; Scholey AB, 2004, ADDICT BEHAV, V29, P743, DOI 10.1016/j.addbeh.2004.02.022; Selvaraj S, 2009, BRIT J PSYCHIAT, V194, P355, DOI 10.1192/bjp.bp.108.050344; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; Thompson G.B., 1992, PSYCHOL ASSESSMENT, V4, P363; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Toomey R, 2003, ARCH GEN PSYCHIAT, V60, P303, DOI 10.1001/archpsyc.60.3.303; VALLBO AB, 1993, J PHYSIOL-LONDON, V469, P673, DOI 10.1113/jphysiol.1993.sp019837; Vickers D, 1972, Perception, V1, P263, DOI 10.1068/p010263; Volkow ND, 2001, AM J PSYCHIAT, V158, P377, DOI 10.1176/appi.ajp.158.3.377; Wechsler D, 1987, WMS R WECHSLER MEMOR; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; Yamamoto Bryan K., 2005, Critical Reviews in Neurobiology, V17, P87	63	19	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52025	10.1371/journal.pone.0052025	http://dx.doi.org/10.1371/journal.pone.0052025			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	056JC	23272201	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000312483300049
J	Nimitphong, H; Holick, MF; Fried, SK; Lee, MJ				Nimitphong, Hataikarn; Holick, Michael F.; Fried, Susan K.; Lee, Mi-Jeong			25-Hydroxyvitamin D-3 and 1,25-Dihydroxyvitamin D-3 Promote the Differentiation of Human Subcutaneous Preadipocytes	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; ENERGY-EXPENDITURE; GENE-EXPRESSION; IDENTIFICATION; ADIPOGENESIS; FAT; OBESITY; METABOLISM; CELLS	1,25(OH)(2)D-3 inhibits adipogenesis in mouse 3T3-L1 adipocytes, but little is known about its effects or local metabolism in human adipose tissue. We showed that vitamin D receptor (VDR) and 1 alpha-hydroxylase (CYP27B1), the enzyme that activates 25(OH)D-3 to 1,25(OH)(2)D-3, were expressed in human adipose tissues, primary preadipocytes and newly-differentiated adipocytes. Preadipocytes and newly-differentiated adipocytes were responsive to 1,25(OH)(2)D-3, as indicated by a markedly increased expression of CYP24A1, a primary VDR target. 1,25(OH)(2)D-3 enhanced adipogenesis as determined by increased expression of adipogenic markers and triglyceride accumulation (50% to 150%). The magnitude of the effect was greater in the absence of thiazolidinediones. 1,25(OH)(2)D-3 was equally effective when added after the removal of differentiation cocktail on day 3, but it had no effect when added only during the induction period (day 0-3), suggesting that 1,25(OH)(2)D-3 promoted maturation. 25(OH)D-3 also stimulated CYP24A1 expression and adipogenesis, most likely through its conversion to 1,25(OH)(2)D-3. Consistent with this possibility, incubation of preadipocytes with 25(OH)D-3 led to 1,25(OH)(2)D-3 accumulation in the media. 1,25(OH)(2)D-3 also enhanced adipogenesis in primary mouse preadipocytes. We conclude that vitamin D status may regulate human adipose tissue growth and remodeling.	[Nimitphong, Hataikarn; Holick, Michael F.; Fried, Susan K.; Lee, Mi-Jeong] Boston Univ, Sch Med, Dept Med, Sect Endocrinol Diabet & Nutr, Boston, MA 02118 USA; [Nimitphong, Hataikarn] Ramathibodi Hosp, Dept Med, Sect Endocrinol & Metab, Bangkok, Thailand	Boston University; Mahidol University	Lee, MJ (corresponding author), Boston Univ, Sch Med, Dept Med, Sect Endocrinol Diabet & Nutr, Boston, MA 02118 USA.	mijlee@bu.edu	Lee, Mi-Jeong/ABE-1084-2020; Lee, Mi-Jeong/GXV-9843-2022	Lee, Mi-Jeong/0000-0002-8171-7913; Lee, Mi-Jeong/0000-0002-8171-7913; Holick, Michael/0000-0001-6023-9062; Fried, Susan K./0000-0003-1101-9332	National Institutes of Health [DK-52398, DK-080448, P30 DK-046200]; Ramathibodi Hospital, Mahidol University, Thailand; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052398, R01DK080448, P30DK046200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ramathibodi Hospital, Mahidol University, Thailand; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (DK-52398, DK-080448, and P30 DK-046200). HN was supported by a research fellowship training grant from Ramathibodi Hospital, Mahidol University, Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blumberg JM, 2006, J BIOL CHEM, V281, P11205, DOI 10.1074/jbc.M510343200; Butler AA, 2010, DIABETES, V59, P323, DOI 10.2337/db09-1471; Ching S, 2011, J CELL BIOCHEM, V112, P3393, DOI 10.1002/jcb.23273; DeLuca HF, 2011, ARCH BIOCHEM BIOPHYS, V505, P226, DOI 10.1016/j.abb.2010.10.012; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Hauner H, 2000, METH MOL B, V155, P239; Kelly KA, 1998, ENDOCRINOLOGY, V139, P2622, DOI 10.1210/en.139.5.2622; Kong J, 2006, AM J PHYSIOL-ENDOC M, V290, pE916, DOI 10.1152/ajpendo.00410.2005; Lahnalampi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012991; Lee MJ, 2012, OBESITY SILVER SPRIN, DOI [10.1038/ oby.2012.116, DOI 10.1038/0BY.2012.116]; Lenders CM, 2009, AM J CLIN NUTR, V90, P459, DOI 10.3945/ajcn.2008.27275; Li J, 2008, J STEROID BIOCHEM, V112, P122, DOI 10.1016/j.jsbmb.2008.09.006; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Looker AC, 2008, AM J CLIN NUTR, V88, P1519, DOI 10.3945/ajcn.2008.26182; Lorente-Cebrian S, 2012, EUR J NUTR, V51, P335, DOI 10.1007/s00394-011-0218-z; Lou YR, 2010, J STEROID BIOCHEM, V118, P162, DOI 10.1016/j.jsbmb.2009.11.011; Mitri J, 2011, AM J CLIN NUTR, V94, P486, DOI 10.3945/ajcn.111.011684; Monkawa T, 2000, KIDNEY INT, V58, P559, DOI 10.1046/j.1523-1755.2000.00202.x; Nagpal S, 2005, ENDOCR REV, V26, P662, DOI 10.1210/er.2004-0002; Narvaez CJ, 2009, ENDOCRINOLOGY, V150, P651, DOI 10.1210/en.2008-1118; Overbergh L, 2000, CLIN EXP IMMUNOL, V120, P139, DOI 10.1046/j.1365-2249.2000.01204.x; Samuel S, 2008, NUTR REV, V66, pS116, DOI 10.1111/j.1753-4887.2008.00094.x; Shi H, 2001, FASEB J, V15, P2751, DOI 10.1096/fj.01-0584fje; Siersbaek R, 2011, EMBO J, V30, P1459, DOI 10.1038/emboj.2011.65; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Tchkonia T, 2007, AM J PHYSIOL-ENDOC M, V292, pE298, DOI 10.1152/ajpendo.00202.2006; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Valina-Toth ALB, 2010, CLIN ENDOCRINOL, V72, P595, DOI 10.1111/j.1365-2265.2009.03676.x; White UA, 2010, MOL CELL ENDOCRINOL, V318, P10, DOI 10.1016/j.mce.2009.08.023; Wong KE, 2011, J BIOL CHEM, V286, P33804, DOI 10.1074/jbc.M111.257568; Wong KE, 2009, AM J PHYSIOL-ENDOC M, V296, pE820, DOI 10.1152/ajpendo.90763.2008; Wood RJ, 2008, NUTR REV, V66, P40, DOI 10.1111/j.1753-4887.2007.00004.x; Yang HN, 2011, BIOMATERIALS, V32, P5924, DOI 10.1016/j.biomaterials.2011.04.072; Yang RZ, 2006, AM J PHYSIOL-ENDOC M, V290, pE1253, DOI 10.1152/ajpendo.00572.2004; Zehnder D, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133621	37	97	99	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52171	10.1371/journal.pone.0052171	http://dx.doi.org/10.1371/journal.pone.0052171			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272223	gold, Green Published, Green Submitted			2022-12-27	WOS:000312483300067
J	Ninomiya, T; Sawamura, H; Inoue, K; Takada, M				Ninomiya, Taihei; Sawamura, Hiromasa; Inoue, Ken-ichi; Takada, Masahiko			Multisynaptic Inputs from the Medial Temporal Lobe to V4 in Macaques	PLOS ONE			English	Article							RETROGRADE TRANSNEURONAL TRANSPORT; CENTRAL-NERVOUS-SYSTEM; AREA V4; ENTORHINAL CORTEX; RHESUS-MONKEY; HIPPOCAMPAL-FORMATION; CORTICAL CONNECTIONS; VISUAL-CORTEX; PARAHIPPOCAMPAL CORTICES; RECIPROCAL CONNECTIONS	Retrograde transsynaptic transport of rabies virus was employed to undertake the top-down projections from the medial temporal lobe (MTL) to visual area V4 of the occipitotemporal visual pathway in Japanese monkeys (Macaca fuscata). On day 3 after rabies injections into V4, neuronal labeling was observed prominently in the temporal lobe areas that have direct connections with V4, including area TF of the parahippocampal cortex. Furthermore, conspicuous neuron labeling appeared disynaptically in area TH of the parahippocampal cortex, and areas 35 and 36 of the perirhinal cortex. The labeled neurons were located predominantly in deep layers. On day 4 after the rabies injections, labeled neurons were found in the hippocampal formation, along with massive labeling in the parahippocampal and perirhinal cortices. In the hippocampal formation, the densest neuron labeling was seen in layer 5 of the entorhinal cortex, and a small but certain number of neurons were labeled in other regions, such as the subicular complex and CA1 and CA3 of the hippocampus proper. The present results indicate that V4 receives major input from the hippocampus proper via the entorhinal cortex, as well as "short-cut'' pathways that bypass the entorhinal cortex. These multisynaptic pathways may define an anatomical basis for hippocampal-cortical interactions involving lower visual areas. The multisynaptic input from the MTL to V4 is likely to provide mnemonic information about object recognition that is accomplished through the occipitotemporal pathway.	[Ninomiya, Taihei; Sawamura, Hiromasa; Inoue, Ken-ichi; Takada, Masahiko] Tokyo Metropolitan Inst Neurosci, Dept Syst Neurosci, Fuchu, Tokyo 183, Japan; [Ninomiya, Taihei; Inoue, Ken-ichi; Takada, Masahiko] Kyoto Univ, Primate Res Inst, Syst Neurosci Sect, Inuyama, Aichi 484, Japan; [Sawamura, Hiromasa] Univ Tokyo, Dept Ophthalmol, Bunkyo Ku, Tokyo 113, Japan	Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science; Kyoto University; University of Tokyo	Ninomiya, T (corresponding author), Tokyo Metropolitan Inst Neurosci, Dept Syst Neurosci, Fuchu, Tokyo 183, Japan.	ninomiya@pri.kyoto-u.ac.jp	Inoue, Ken-ichi/K-4103-2015	Inoue, Ken-ichi/0000-0002-5683-5280	Ministry of Education, Culture, Sports, Science, and Technology of Japan [20019011, 19790162, 22790202]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research on Priority Areas-Integrative Brain Research (20019011) to H. S., as well as Young Scientists (B) (19790162) and (22790202) to H. S. from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMARAL DG, 1987, J COMP NEUROL, V264, P326, DOI 10.1002/cne.902640305; AMARAL DG, 1983, BRAIN RES, V275, P263, DOI 10.1016/0006-8993(83)90987-3; Blatt GJ, 1998, J COMP NEUROL, V392, P92, DOI 10.1002/(SICI)1096-9861(19980302)392:1<92::AID-CNE7>3.0.CO;2-K; Bonda E, 2000, EUR J NEUROSCI, V12, P1971, DOI 10.1046/j.1460-9568.2000.00082.x; BOUSSAOUD D, 1991, J COMP NEUROL, V306, P554, DOI 10.1002/cne.903060403; Chun MM, 1998, COGNITIVE PSYCHOL, V36, P28, DOI 10.1006/cogp.1998.0681; Connor CE, 1996, J NEUROPHYSIOL, V75, P1306, DOI 10.1152/jn.1996.75.3.1306; DeWeerd P, 1996, VISUAL NEUROSCI, V13, P529, DOI 10.1017/S0952523800008208; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Felleman DJ, 1997, J NEUROSCI, V17, P3185; Gallant JL, 1996, J NEUROPHYSIOL, V76, P2718, DOI 10.1152/jn.1996.76.4.2718; Girard P, 2002, CEREB CORTEX, V12, P1146, DOI 10.1093/cercor/12.11.1146; INSAUSTI R, 1987, J COMP NEUROL, V264, P356, DOI 10.1002/cne.902640306; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Kelly RM, 2000, J NEUROSCI METH, V103, P63, DOI 10.1016/S0165-0270(00)00296-X; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.3.CO;2-X; LEVAY S, 1990, EXP BRAIN RES, V82, P77; MAUNSELL JHR, 1987, ANNU REV NEUROSCI, V10, P363, DOI 10.1146/annurev.ne.10.030187.002051; Merigan WH, 1998, VISUAL NEUROSCI, V15, P359, DOI 10.1017/S0952523898152112; Milner AD, 2008, NEUROPSYCHOLOGIA, V46, P774, DOI 10.1016/j.neuropsychologia.2007.10.005; Miyachi S, 2005, J NEUROSCI, V25, P2547, DOI 10.1523/JNEUROSCI.4186-04.2005; Nassi JJ, 2006, NEURON, V50, P319, DOI 10.1016/j.neuron.2006.03.019; Nassi JJ, 2006, J NEUROSCI, V26, P12789, DOI 10.1523/JNEUROSCI.4044-06.2006; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; Ninomiya T, 2011, CEREB CORTEX, V21, P2797, DOI 10.1093/cercor/bhr078; Orban GA, 2008, PHYSIOL REV, V88, P59, DOI 10.1152/physrev.00008.2007; Pasupathy A, 1999, J NEUROPHYSIOL, V82, P2490, DOI 10.1152/jn.1999.82.5.2490; Pistorio AL, 2006, J NEUROSCI METH, V153, P135, DOI 10.1016/j.jneumeth.2005.10.014; Raiguel S, 2006, J NEUROSCI, V26, P6589, DOI 10.1523/JNEUROSCI.0457-06.2006; Rainer G, 2004, PLOS BIOL, V2, P275, DOI 10.1371/journal.pbio.0020044; Rosene D. L., 1987, CEREB CORTEX, V6, P345, DOI DOI 10.1007/978-1-4615-6616-8_9; SAUNDERS RC, 1988, J COMP NEUROL, V271, P153, DOI 10.1002/cne.902710202; SAUNDERS RC, 1988, J COMP NEUROL, V271, P185, DOI 10.1002/cne.902710203; SCHILLER PH, 1995, NATURE, V376, P342, DOI 10.1038/376342a0; SCHILLER PH, 1991, SCIENCE, V251, P1251, DOI 10.1126/science.2006413; SELTZER B, 1978, BRAIN RES, V149, P1, DOI 10.1016/0006-8993(78)90584-X; Suzuki WA, 2003, J COMP NEUROL, V463, P67, DOI 10.1002/cne.10744; SUZUKI WA, 1994, J NEUROSCI, V14, P1856, DOI 10.1523/JNEUROSCI.14-03-01856.1994; Tokuno H, 1998, NEUROSCI RES, V31, P251, DOI 10.1016/S0168-0102(98)00041-8; UGOLINI G, 1995, J COMP NEUROL, V356, P457, DOI 10.1002/cne.903560312; Ungerleider LG, 2008, CEREB CORTEX, V18, P477, DOI 10.1093/cercor/bhm061; von Bonin G., 1947, NEOCORTEX MACACA MUL; WITTER MP, 1991, J COMP NEUROL, V307, P437, DOI 10.1002/cne.903070308; Xiao YP, 1999, CEREB CORTEX, V9, P792, DOI 10.1093/cercor/9.8.792; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; Yukie M, 2000, J COMP NEUROL, V423, P282, DOI 10.1002/1096-9861(20000724)423:2<282::AID-CNE7>3.0.CO;2-Z; ZEKI S, 1983, PROC R SOC SER B-BIO, V217, P449, DOI 10.1098/rspb.1983.0020; ZEKI SM, 1973, BRAIN RES, V53, P422, DOI 10.1016/0006-8993(73)90227-8	49	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52115	10.1371/journal.pone.0052115	http://dx.doi.org/10.1371/journal.pone.0052115			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272220	Green Published, gold, Green Submitted			2022-12-27	WOS:000312483300065
J	Varga, A; Marcus, AP; Himoto, M; Iwai, S; Szuts, D				Varga, Agnes; Marcus, Adam P.; Himoto, Masayuki; Iwai, Shigenori; Szuets, David			Analysis of CPD Ultraviolet Lesion Bypass in Chicken DT40 Cells: Polymerase eta and PCNA Ubiquitylation Play Identical Roles	PLOS ONE			English	Article							YEAST DNA-POLYMERASE; CYCLOBUTANE PYRIMIDINE DIMERS; DAMAGE TOLERANCE PATHWAY; REV1 PROTEIN INTERACTS; THYMINE-THYMINE DIMER; TRANSLESION SYNTHESIS; ERROR-FREE; 2-POLYMERASE MECHANISMS; POSTREPLICATION REPAIR; INDUCED MUTAGENESIS	Translesion synthesis (TLS) provides a mechanism of copying damaged templates during DNA replication. This potentially mutagenic process may operate either at the replication fork or at post-replicative gaps. We used the example of T-T cyclobutane pyrimidine dimer (CPD) bypass to determine the influence of polymerase recruitment via PCNA ubiquitylation versus the REV1 protein on the efficiency and mutagenic outcome of TLS. Using mutant chicken DT40 cell lines we show that, on this numerically most important UV lesion, defects in polymerase eta or in PCNA ubiquitylation similarly result in the long-term failure of lesion bypass with persistent strand gaps opposite the lesion, and the elevation of mutations amongst successful TLS events. Our data suggest that PCNA ubiquitylation promotes CPD bypass mainly by recruiting polymerase eta, resulting in the majority of CPD lesions bypassed in an error-free manner. In contrast, we find that polymerase zeta is responsible for the majority of CPD-dependent mutations, but has no essential function in the completion of bypass. These findings point to a hierarchy of access of the different TLS polymerases to the lesion, suggesting a temporal order of their recruitment. The similarity of REV1 and REV3 mutant phenotypes confirms that the involvement of polymerase zeta in TLS is largely determined by its recruitment to DNA by REV1. Our data demonstrate the influence of the TLS polymerase recruitment mechanism on the success and accuracy of bypass.	[Varga, Agnes; Szuets, David] Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary; [Marcus, Adam P.] Univ London, Div Biomed Sci, London, England; [Himoto, Masayuki; Iwai, Shigenori] Osaka Univ, Div Chem, Grad Sch Engn Sci, Osaka, Japan	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; University of London; Osaka University	Szuts, D (corresponding author), Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary.	szuts@enzim.hu	Szuts, David/N-1149-2016	Szuts, David/0000-0001-7985-0136; Nagy, Agnes/0000-0002-7639-0987	St George's, University of London; Hungarian Academy of Sciences [LP2011-015]	St George's, University of London; Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by St George's, University of London, and by the Hungarian Academy of Sciences (Momentum grant LP2011-015 to D.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya N, 2006, MOL CELL BIOL, V26, P9555, DOI 10.1128/MCB.01671-06; Arakawa H, 2006, PLOS BIOL, V4, P1947, DOI 10.1371/journal.pbio.0040366; BABA TW, 1985, VIROLOGY, V144, P139, DOI 10.1016/0042-6822(85)90312-5; BANERJEE SK, 1988, P NATL ACAD SCI USA, V85, P8141, DOI 10.1073/pnas.85.21.8141; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Chen CC, 2006, DNA REPAIR, V5, P1475, DOI 10.1016/j.dnarep.2006.07.007; Crevel G, 2012, J CELL SCI, V125, P965, DOI 10.1242/jcs.094409; Daigaku Y, 2010, NATURE, V465, P951, DOI 10.1038/nature09097; Diamant N, 2012, NUCLEIC ACIDS RES, V40, P170, DOI 10.1093/nar/gkr596; Edmunds CE, 2008, MOL CELL, V30, P519, DOI 10.1016/j.molcel.2008.03.024; Elvers I, 2011, NUCLEIC ACIDS RES, V39, P7049, DOI 10.1093/nar/gkr420; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; Gibbs PEM, 2005, GENETICS, V169, P575, DOI 10.1534/genetics.104.034611; Guo CX, 2006, MOL CELL, V23, P265, DOI 10.1016/j.molcel.2006.05.038; Guo CX, 2003, EMBO J, V22, P6621, DOI 10.1093/emboj/cdg626; Guo DY, 2001, NUCLEIC ACIDS RES, V29, P2875, DOI 10.1093/nar/29.13.2875; Hendel A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002262; Hirota K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001151; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Ikehata H, 2008, J INVEST DERMATOL, V128, P2289, DOI 10.1038/jid.2008.61; Ikehata H, 2011, J RADIAT RES, V52, P115, DOI 10.1269/jrr.10175; Jans J, 2005, CURR BIOL, V15, P105, DOI 10.1016/j.cub.2005.01.001; Jansen JG, 2009, DNA REPAIR, V8, P1444, DOI 10.1016/j.dnarep.2009.09.006; Jansen JG, 2009, MOL CELL BIOL, V29, P3113, DOI 10.1128/MCB.00071-09; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 2012, P NATL ACAD SCI US; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Karras GI, 2010, CELL, V141, P255, DOI 10.1016/j.cell.2010.02.028; Kawamoto T, 2005, MOL CELL, V20, P793, DOI 10.1016/j.molcel.2005.10.016; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; LEHMANN AR, 1975, P NATL ACAD SCI USA, V72, P219, DOI 10.1073/pnas.72.1.219; LEHMANN AR, 1972, J MOL BIOL, V66, P319, DOI 10.1016/0022-2836(72)90418-4; LEMONTT JF, 1971, GENETICS, V68, P21; Livneh Z, 2010, CELL CYCLE, V9, P729, DOI 10.4161/cc.9.4.10727; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; McIlwraith MJ, 2005, MOL CELL, V20, P783, DOI 10.1016/j.molcel.2005.10.001; Murakumo Y, 2001, J BIOL CHEM, V276, P35644, DOI 10.1074/jbc.M102051200; MURATA T, 1990, NUCLEIC ACIDS RES, V18, P7279, DOI 10.1093/nar/18.24.7279; Narita T, 2010, GENES CELLS, V15, P1228, DOI 10.1111/j.1365-2443.2010.01457.x; Nelson JR, 1996, SCIENCE, V272, P1646, DOI 10.1126/science.272.5268.1646; Ohashi E, 2004, GENES CELLS, V9, P523, DOI 10.1111/j.1356-9597.2004.00747.x; Ozgenc AI, 2005, J BACTERIOL, V187, P1974, DOI 10.1128/JB.187.6.1974-1984.2005; Parker JL, 2007, NUCLEIC ACIDS RES, V35, P881, DOI 10.1093/nar/gkl1102; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; RAO BS, 1988, NUCLEIC ACIDS RES, V16, P4171, DOI 10.1093/nar/16.9.4171; Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8; Ross AL, 2005, NUCLEIC ACIDS RES, V33, P1280, DOI 10.1093/nar/gki279; RUPP WD, 1968, J MOL BIOL, V31, P291, DOI 10.1016/0022-2836(68)90445-2; Sale JE, 2009, PHILOS T R SOC B, V364, P595, DOI 10.1098/rstb.2008.0197; Servant L, 2002, J BIOL CHEM, V277, P50046, DOI 10.1074/jbc.M207101200; Shachar S, 2009, EMBO J, V28, P383, DOI 10.1038/emboj.2008.281; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Stone JE, 2011, DNA REPAIR, V10, P826, DOI 10.1016/j.dnarep.2011.04.032; Szuts D, 2008, NUCLEIC ACIDS RES, V36, P6767, DOI 10.1093/nar/gkn651; Takeda DY, 2005, GENE DEV, V19, P2827, DOI 10.1101/gad.1369805; Temviriyanukul P, 2012, DNA REPAIR, V11, P550, DOI 10.1016/j.dnarep.2012.03.007; Thomas NE, 2006, J INVEST DERMATOL, V126, P1693, DOI 10.1038/sj.jid.5700458; Tissier A, 2004, DNA REPAIR, V3, P1503, DOI 10.1016/j.dnarep.2004.06.015; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; Ulrich HD, 2011, FEBS LETT, V585, P2861, DOI 10.1016/j.febslet.2011.05.028; Unk I, 2010, DNA REPAIR AMST; Unk I, 2006, P NATL ACAD SCI USA, V103, P18107, DOI 10.1073/pnas.0608595103; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Yoon JH, 2009, P NATL ACAD SCI USA, V106, P18219, DOI 10.1073/pnas.0910121106; You YH, 2001, J BIOL CHEM, V276, P44688, DOI 10.1074/jbc.M107696200; Zhang HS, 2005, P NATL ACAD SCI USA, V102, P15954, DOI 10.1073/pnas.0504586102; Zhang YB, 2002, J BIOL CHEM, V277, P44582, DOI 10.1074/jbc.M207297200; Ziv O, 2009, P NATL ACAD SCI USA, V106, P11552, DOI 10.1073/pnas.0812548106	68	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52472	10.1371/journal.pone.0052472	http://dx.doi.org/10.1371/journal.pone.0052472			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272247	Green Submitted, gold, Green Published			2022-12-27	WOS:000312483300089
J	Golla, K; Cherukuvada, B; Ahmed, F; Kondapi, AK				Golla, Kishore; Cherukuvada, Bhaskar; Ahmed, Farhan; Kondapi, Anand K.			Efficacy, Safety and Anticancer Activity of Protein Nanoparticle-Based Delivery of Doxorubicin through Intravenous Administration in Rats	PLOS ONE			English	Article							SOLID LIPID NANOPARTICLES; PRIMARY LIVER-CANCER; HEPATOCELLULAR-CARCINOMA; TISSUE DISTRIBUTION; NON-STEALTH; PHARMACOKINETICS; DRUG; CHEMOEMBOLIZATION; POLYMERSOMES; IRON	Background and Aims: Doxorubicin is a potent anticancer drug and a major limiting factor that hinders therapeutic use as its high levels of systemic circulation often associated with various off-target effects, particularly cardiotoxicity. The present study focuses on evaluation of the efficacy of doxorubicin when it is loaded into the protein nanoparticles and delivered intravenously in rats bearing Hepatocellular carcinoma (HCC). The proteins selected as carrier were Apotransferrin and Lactoferrin, since the receptors for these two proteins are known to be over expressed on cancer cells due to their iron transport capacity. Methods: Doxorubicin loaded apotransferrin (Apodoxonano) and lactoferrin nanoparticles (Lactodoxonano) were prepared by sol-oil chemistry. HCC in the rats was induced by 100 mg/l of diethylnitrosamine (DENA) in drinking water for 8 weeks. Rats received 5 doses of 2 mg/kg drug equivalent nanoparticles through intravenous administration. Pharmacokinetics and toxicity of nanoformulations was evaluated in healthy rats and anticancer activity was studied in DENA treated rats. The anticancer activity was evaluated through counting of the liver nodules, H & E analysis and by estimating the expression levels of angiogenic and antitumor markers. Results: In rats treated with nanoformulations, the numbers of liver nodules were found to be significantly reduced. They showed highest drug accumulation in liver (22.4 and 19.5 mu g/g). Both nanoformulations showed higher localization compared to doxorubicin (Doxo) when delivered in the absence of a carrier. Higher amounts of Doxo (195 mu g/g) were removed through kidney, while Apodoxonano and Lactodoxonano showed only a minimal amount of removal (<40 mu g/g), suggesting the extended bioavailability of Doxo when delivered through nanoformulation. Safety analysis shows minimal cardiotoxicity due to lower drug accumulation in heart in the case of nanoformulation. Conclusion: Drug delivery through nanoformulations not only minimizes the cardiotoxicity of doxorubicin but also enhances the efficacy and bioavailability of the drug in a target-specific manner.	[Cherukuvada, Bhaskar; Ahmed, Farhan; Kondapi, Anand K.] Univ Hyderabad, Dept Biotechnol, Hyderabad 500134, Andhra Pradesh, India; [Golla, Kishore; Kondapi, Anand K.] Univ Hyderabad, Dept Biochem, Hyderabad 500134, Andhra Pradesh, India; [Golla, Kishore; Kondapi, Anand K.] Univ Hyderabad, Ctr Nanotechnol, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad; University of Hyderabad; University of Hyderabad	Kondapi, AK (corresponding author), Univ Hyderabad, Dept Biotechnol, Hyderabad 500134, Andhra Pradesh, India.	akondapi@gmail.com		Ahmed, Farhan/0000-0002-3420-5405	Department of Science and Technology, Government of India; Department of Biotechnology, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work is carried out in a research project funded by the Department of Science and Technology, and Department of Biotechnology, Government of India through research projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MJ, 1973, P NATL ACAD SCI USA, V70, P1968, DOI 10.1073/pnas.70.7.1968; Ahmed F, 2006, J CONTROL RELEASE, V116, P150, DOI 10.1016/j.jconrel.2006.07.012; Al-Abd AM, 2010, J CONTROL RELEASE, V142, P101, DOI 10.1016/j.jconrel.2009.10.003; Alhareth K, 2012, EUR J PHARM BIOPHARM, V81, P453, DOI 10.1016/j.ejpb.2012.03.009; Ayen WY, 2012, PHARM RES; Bae S, 2012, BIOMATERIALS, V33, P1536, DOI 10.1016/j.biomaterials.2011.10.050; Borbath I, 2010, CHEM-BIOL INTERACT, V183, P238, DOI 10.1016/j.cbi.2009.10.011; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Cao H, 2011, HEPATOLOGY, V54, P1819, DOI 10.1002/hep.24572; CHIANNILKULACHAI N, 1990, CANCER CHEMOTH PHARM, V26, P122, DOI 10.1007/BF02897257; CHIANNILKULCHAI N, 1989, SELECT CANCER THER, V5, P1, DOI 10.1089/sct.1989.5.1; COHN EJ, 1946, J AM CHEM SOC, V68, P459, DOI 10.1021/ja01207a034; COLOMBO M, 1989, LANCET, V2, P1006; FALKSON G, 1978, CANCER, V42, P2149, DOI 10.1002/1097-0142(197811)42:5<2149::AID-CNCR2820420510>3.0.CO;2-5; Fiume L, 2005, J HEPATOL, V43, P645, DOI 10.1016/j.jhep.2005.02.045; Fleming MD, 1998, P NATL ACAD SCI USA, V95, P1148, DOI 10.1073/pnas.95.3.1148; Fundaro A, 2000, PHARMACOL RES, V42, P337, DOI 10.1006/phrs.2000.0695; GABIZON A, 1994, CANCER RES, V54, P987; Gabizon AA, 2001, CANCER INVEST, V19, P424, DOI 10.1081/CNV-100103136; Hamad I, 2008, EXPERT OPIN DRUG DEL, V5, P205, DOI 10.1517/17425247.5.2.205; Holmstrom P, 2006, LIVER INT, V26, P976, DOI 10.1111/j.1478-3231.2006.01316.x; Kataoka K, 2000, J CONTROL RELEASE, V64, P143, DOI 10.1016/S0168-3659(99)00133-9; Krishna ADS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007240; Li XM, 2009, INT J PHARMACEUT, V373, P116, DOI 10.1016/j.ijpharm.2009.01.023; Lin HL, 2000, CANCER-AM CANCER SOC, V89, P983, DOI 10.1002/1097-0142(20000901)89:5<983::AID-CNCR7>3.3.CO;2-7; Lin RY, 2005, BIOMATERIALS, V26, P4476, DOI 10.1016/j.biomaterials.2004.11.014; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Lo CM, 2002, HEPATOLOGY, V35, P1164, DOI 10.1053/jhep.2002.33156; MORGAN EH, 1986, BIOCHEM J, V237, P163, DOI 10.1042/bj2370163; OKADA S, 1993, ONCOLOGY, V50, P22; Pang ZQ, 2008, J CONTROL RELEASE, V128, P120, DOI 10.1016/j.jconrel.2008.03.007; Parkin DM, 2005, CA CANC J CLIN, V55, P74; Schneider Y., 1984, NATO ASI SERIES LIFE, DOI [10.1007/978-1-4684-4862-7_1, DOI 10.1007/978-1-4684-4862-7_1]; Sharma AK, 1999, J MOL BIOL, V289, P303, DOI 10.1006/jmbi.1999.2767; Sheela A, 2003, METHOD ENZYMOL, V391, P71; Shuai XT, 2004, J CONTROL RELEASE, V98, P415, DOI 10.1016/j.jconrel.2004.06.003; Thomas MB, 2005, J CLIN ONCOL, V23, P2892, DOI 10.1200/JCO.2005.03.196; Tseng HH, 2009, J CANCER RES CLIN, V135, P1413, DOI 10.1007/s00432-009-0585-5; Upadhyay KK, 2010, BIOMATERIALS, V31, P2882, DOI 10.1016/j.biomaterials.2009.12.043; URSINI F, 1985, BIOCHIM BIOPHYS ACTA, V839, P62, DOI 10.1016/0304-4165(85)90182-5; Varela M, 2007, J HEPATOL, V46, P474, DOI 10.1016/j.jhep.2006.10.020; VERDUN C, 1990, CANCER CHEMOTH PHARM, V26, P13, DOI 10.1007/BF02940287; Wong HL, 2006, J CONTROL RELEASE, V116, P275, DOI 10.1016/j.jconrel.2006.09.007; Xu JP, 2005, J CONTROL RELEASE, V107, P502, DOI 10.1016/j.jconrel.2005.06.013; Xu ZH, 2009, BIOMATERIALS, V30, P226, DOI 10.1016/j.biomaterials.2008.09.014; Yang HI, 2002, NEW ENGL J MED, V347, P168, DOI 10.1056/NEJMoa013215; Yokoyama M, 1998, J CONTROL RELEASE, V50, P79, DOI 10.1016/S0168-3659(97)00115-6; Yoo HS, 2001, J CONTROL RELEASE, V70, P63, DOI 10.1016/S0168-3659(00)00340-0; Zara GP, 2002, J DRUG TARGET, V10, P327, DOI 10.1080/10611860290031868; Zara GP, 1999, PHARMACOL RES, V40, P281, DOI 10.1006/phrs.1999.0509; Zhang J, 2007, NANOMED-NANOTECHNOL, V3, P258, DOI 10.1016/j.nano.2007.08.002; Zhao NN, 2010, J BIOL CHEM, V285, P32141, DOI 10.1074/jbc.M110.143248	52	46	47	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e51960	10.1371/journal.pone.0051960	http://dx.doi.org/10.1371/journal.pone.0051960			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284832	Green Submitted, gold, Green Published			2022-12-27	WOS:000313158800017
J	Heikkinen, T; Lehtimaki, K; Vartiainen, N; Puolivali, J; Hendricks, SJ; Glaser, JR; Bradaia, A; Wadel, K; Touller, C; Kontkanen, O; Yrjanheikki, JM; Buisson, B; Howland, D; Beaumont, V; Munoz-Sanjuan, I; Park, LC				Heikkinen, Taneli; Lehtimaki, Kimmo; Vartiainen, Nina; Puolivali, Jukka; Hendricks, Susan J.; Glaser, Jack R.; Bradaia, Amyaouch; Wadel, Kristian; Touller, Chrystelle; Kontkanen, Outi; Yrjanheikki, Juha M.; Buisson, Bruno; Howland, David; Beaumont, Vahri; Munoz-Sanjuan, Ignacio; Park, Larry C.			Characterization of Neurophysiological and Behavioral Changes, MRI Brain Volumetry and 1H MRS in zQ175 Knock-In Mouse Model of Huntington's Disease	PLOS ONE			English	Article							STRIATAL NEURONAL LOSS; SPINY NEURONS; CORTICOSTRIATAL PATHWAY; TRINUCLEOTIDE REPEAT; BASAL GANGLIA; EARLY MOTOR; CAG REPEAT; BLOOD-FLOW; HD GENE; H-1 MRS	Huntington's disease (HD) is an autosomal neurodegenerative disorder, characterized by severe behavioral, cognitive, and motor deficits. Since the discovery of the huntingtin gene (HTT) mutation that causes the disease, several mouse lines have been developed using different gene constructs of Htt. Recently, a new model, the zQ175 knock-in (KI) mouse, was developed (see description by Menalled et al, [1]) in an attempt to have the Htt gene in a context and causing a phenotype that more closely mimics HD in humans. Here we confirm the behavioral phenotypes reported by Menalled et al [1], and extend the characterization to include brain volumetry, striatal metabolite concentration, and early neurophysiological changes. The overall reproducibility of the behavioral phenotype across the two independent laboratories demonstrates the utility of this new model. Further, important features reminiscent of human HD pathology are observed in zQ175 mice: compared to wild-type neurons, electrophysiological recordings from acute brain slices reveal that medium spiny neurons from zQ175 mice display a progressive hyperexcitability; glutamatergic transmission in the striatum is severely attenuated; decreased striatal and cortical volumes from 3 and 4 months of age in homo-and heterozygous mice, respectively, with whole brain volumes only decreased in homozygotes. MR spectroscopy reveals decreased concentrations of N-acetylaspartate and increased concentrations of glutamine, taurine and creatine + phosphocreatine in the striatum of 12-month old homozygotes, the latter also measured in 12-month-old heterozygotes. Motor, behavioral, and cognitive deficits in homozygotes occur concurrently with the structural and metabolic changes observed. In sum, the zQ175 KI model has robust behavioral, electrophysiological, and histopathological features that may be valuable in both furthering our understanding of HD-like pathophyisology and the evaluation of potential therapeutic strategies to slow the progression of disease.	[Howland, David; Beaumont, Vahri; Munoz-Sanjuan, Ignacio; Park, Larry C.] CHDI Management CHDI Fdn, Los Angeles, CA USA; [Heikkinen, Taneli; Lehtimaki, Kimmo; Vartiainen, Nina; Puolivali, Jukka; Kontkanen, Outi; Yrjanheikki, Juha M.] Charles River Discovery Res Serv, Kuopio, Finland; [Hendricks, Susan J.; Glaser, Jack R.] MBF Labs, Williston, VA USA; [Bradaia, Amyaouch; Wadel, Kristian; Touller, Chrystelle; Buisson, Bruno] Neuroserv SARL, Aix En Provence, France		Park, LC (corresponding author), CHDI Management CHDI Fdn, Los Angeles, CA USA.	larry.park@chdifoundation.org	Lehtimäki, Kimmo K/A-6018-2009	Lehtimäki, Kimmo K/0000-0003-2750-8229; Beaumont, Vahri/0000-0002-6488-2175; BRADAIA, Amyaouch/0000-0001-9664-4641	CHDI Foundation	CHDI Foundation	CHDI Foundation is a not-for-profit biomedical research organization exclusively dedicated to discovering and developing therapeutics that slow the progression of Huntington's disease. The research described was conducted by Charles River under a fee-for-service agreement for CHDI Foundation in collaboration with and funded by CHDI Foundation. The funder, through CHDI Management, fully participated in study design, data collection and analysis, the decision to publish, and preparation of the manuscript. CHDI Foundation has recently provided financial support to the Public Library of Science for PLoS Currents: Huntington Disease.	Ariano MA, 2005, J NEUROPHYSIOL, V93, P2565, DOI 10.1152/jn.00791.2004; Aylward EH, 2004, NEUROLOGY, V63, P66, DOI 10.1212/01.WNL.0000132965.14653.D1; Aylward EH, 1998, NEUROLOGY, V50, P252, DOI 10.1212/WNL.50.1.252; Aziz NA, 2008, NEUROLOGY, V71, P1506, DOI 10.1212/01.wnl.0000334276.09729.0e; Browne SE, 2006, ANTIOXID REDOX SIGN, V8, P2061, DOI 10.1089/ars.2006.8.2061; Cayzac S, 2011, P NATL ACAD SCI USA, V108, P9280, DOI 10.1073/pnas.1016190108; Cepeda C, 2003, J NEUROSCI, V23, P961; Cepeda C, 2007, PROG NEUROBIOL, V81, P253, DOI 10.1016/j.pneurobio.2006.11.001; Cepeda C, 2010, ASN NEURO, V2, DOI 10.1042/AN20090058; Demougeot C, 2004, J NEUROCHEM, V90, P776, DOI 10.1111/j.1471-4159.2004.02583.x; Ding J, 2008, J NEUROSCI, V28, P6483, DOI 10.1523/JNEUROSCI.0435-08.2008; Doig NM, 2010, J NEUROSCI, V30, P14610, DOI 10.1523/JNEUROSCI.1623-10.2010; Dorner JL, 2009, BRAIN RES, V1290, P111, DOI 10.1016/j.brainres.2009.07.019; Ferrante RJ, 2000, J NEUROSCI, V20, P4389, DOI 10.1523/JNEUROSCI.20-12-04389.2000; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Hamilton JM, 2003, NEUROPSYCHOLOGIA, V41, P614, DOI 10.1016/S0028-3932(02)00218-X; Hansson O, 1999, P NATL ACAD SCI USA, V96, P8727, DOI 10.1073/pnas.96.15.8727; Harris GJ, 1999, BRAIN, V122, P1667, DOI 10.1093/brain/122.9.1667; Harris GJ, 1996, ARCH NEUROL-CHICAGO, V53, P316, DOI 10.1001/archneur.1996.00550040044013; Heng MY, 2008, NEUROBIOL DIS, V32, P1, DOI 10.1016/j.nbd.2008.06.005; Hickey MA, 2008, NEUROSCIENCE, V157, P280, DOI 10.1016/j.neuroscience.2008.08.041; Hoang TQ, 1998, NEUROLOGY, V50, P1033, DOI 10.1212/WNL.50.4.1033; Klapstein GJ, 2001, J NEUROPHYSIOL, V86, P2667, DOI 10.1152/jn.2001.86.6.2667; Lawrence AD, 1998, TRENDS COGN SCI, V2, P379, DOI 10.1016/S1364-6613(98)01231-5; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Menalled LB, 2012, PLOS ONE IN PRESS; Menalled Liliana B, 2005, NeuroRx, V2, P465, DOI 10.1602/neurorx.2.3.465; Miller BR, 2008, J NEUROPHYSIOL, V100, P2205, DOI 10.1152/jn.90606.2008; Miller BR, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00026; Miller BR, 2010, NEUROBIOL DIS, V37, P106, DOI 10.1016/j.nbd.2009.09.013; Milnerwood AJ, 2007, J PHYSIOL-LONDON, V585, P817, DOI 10.1113/jphysiol.2007.142448; Milnerwood AJ, 2010, TRENDS NEUROSCI, V33, P513, DOI 10.1016/j.tins.2010.08.002; NORREMOLLE A, 1993, HUM MOL GENET, V2, P1475, DOI 10.1093/hmg/2.9.1475; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Paulsen JS, 2008, J NEUROL NEUROSUR PS, V79, P874, DOI 10.1136/jnnp.2007.128728; Pouladi MA, 2012, HUM MOL GENET, V21, P2219, DOI 10.1093/hmg/dds037; Ramaswamy S, 2007, ILAR J, V48, P356, DOI 10.1093/ilar.48.4.356; Ramaswamy S, 2009, NEUROBIOL DIS, V34, P40, DOI 10.1016/j.nbd.2008.12.005; Raymond LA, 2011, NEUROSCIENCE, V198, P252, DOI 10.1016/j.neuroscience.2011.08.052; Rosas HD, 2008, BRAIN, V131, P1057, DOI 10.1093/brain/awn025; Rosas HD, 2001, NEUROLOGY, V57, P1025, DOI 10.1212/WNL.57.6.1025; Rosas HD, 2002, NEUROLOGY, V58, P695, DOI 10.1212/WNL.58.5.695; Rubinsztein DC, 1996, AM J HUM GENET, V59, P16; Sanchez-Pernaute R, 1999, NEUROLOGY, V53, P806, DOI 10.1212/WNL.53.4.806; Schmitz C, 2000, J CHEM NEUROANAT, V20, P93, DOI 10.1016/S0891-0618(00)00066-1; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Sturrock A, 2010, NEUROLOGY, V75, P1702, DOI 10.1212/WNL.0b013e3181fc27e4; Tabrizi SJ, 2012, LANCET NEUROL, V11, P42, DOI 10.1016/S1474-4422(11)70263-0; Tkac I, 2007, J NEUROCHEM, V100, P1397, DOI 10.1111/j.1471-4159.2006.04323.x; Traficante A, 2007, NEUROREPORT, V18, P1997, DOI 10.1097/WNR.0b013e3282f262ca; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Weir DW, 2011, LANCET NEUROL, V10, P573, DOI 10.1016/S1474-4422(11)70070-9; Woodman B, 2007, BRAIN RES BULL, V72, P83, DOI 10.1016/j.brainresbull.2006.11.004	55	152	154	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e50717	10.1371/journal.pone.0050717	http://dx.doi.org/10.1371/journal.pone.0050717			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284644	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500015
J	Hofgaard, PO; Jodal, HC; Bommert, K; Huard, B; Caers, J; Carlsen, H; Schwarzer, R; Schunemann, N; Jundt, F; Lindeberg, MM; Bogen, B				Hofgaard, Peter O.; Jodal, Henriette C.; Bommert, Kurt; Huard, Bertrand; Caers, Jo; Carlsen, Harald; Schwarzer, Rolf; Schuenemann, Nicole; Jundt, Franziska; Lindeberg, Mona M.; Bogen, Bjarne			A Novel Mouse Model for Multiple Myeloma (MOPC315.BM) That Allows Noninvasive Spatiotemporal Detection of Osteolytic Disease	PLOS ONE			English	Article							CD4(+) T-CELLS; TUMOR-SPECIFIC ANTIGEN; PLASMA-CELLS; B-CELL; C57BL/KALWRIJ MOUSE; BONE-DISEASE; SCID MICE; IDIOTYPE; DIFFERENTIATION; RESISTANCE	Multiple myeloma (MM) is a lethal human cancer characterized by a clonal expansion of malignant plasma cells in bone marrow. Mouse models of human MM are technically challenging and do not always recapitulate human disease. Therefore, new mouse models for MM are needed. Mineral-oil induced plasmacytomas (MOPC) develop in the peritoneal cavity of oil-injected BALB/c mice. However, MOPC typically grow extramedullary and are considered poor models of human MM. Here we describe an in vivo-selected MOPC315 variant, called MOPC315.BM, which can be maintained in vitro. When injected i.v. into BALB/c mice, MOPC315.BM cells exhibit tropism for bone marrow. As few as 10(4) MOPC315.BM cells injected i.v. induced paraplegia, a sign of spinal cord compression, in all mice within 3-4 weeks. MOPC315.BM cells were stably transfected with either firefly luciferase (MOPC315.BM.Luc) or DsRed (MOPC315.BM.DsRed) for studies using noninvasive imaging. MOPC315.BM.Luc cells were detected in the tibiofemoral region already 1 hour after i.v. injection. Bone foci developed progressively, and as of day 5, MM cells were detected in multiple sites in the axial skeleton. Additionally, the spleen (a hematopoietic organ in the mouse) was invariably affected. Luminescent signals correlated with serum myeloma protein concentration, allowing for easy tracking of tumor load with noninvasive imaging. Affected mice developed osteolytic lesions. The MOPC315.BM model employs a common strain of immunocompetent mice (BALB/c) and replicates many characteristics of human MM. The model should be suitable for studies of bone marrow tropism, development of osteolytic lesions, drug testing, and immunotherapy in MM.	[Hofgaard, Peter O.; Jodal, Henriette C.; Lindeberg, Mona M.; Bogen, Bjarne] Univ Oslo, Ctr Immune Regulat, Inst Immunol, Oslo, Norway; [Hofgaard, Peter O.; Jodal, Henriette C.; Lindeberg, Mona M.; Bogen, Bjarne] Oslo Univ Hosp, Oslo, Norway; [Bommert, Kurt] Univ Hosp Wurzburg, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany; [Bommert, Kurt] Univ Hosp Wurzburg, Dept Internal Med 2, Div Haematol & Med Oncol, Wurzburg, Germany; [Huard, Bertrand] Univ Hosp Geneva, Div Hematol, Geneva, Switzerland; [Huard, Bertrand] Univ Geneva, Med Ctr, Dept Pathol Immunol, CH-1211 Geneva, Switzerland; [Caers, Jo] Univ Liege, Dept Hematol, Liege, Belgium; [Carlsen, Harald] Univ Oslo, Inst Nutr Res, Oslo, Norway; [Schwarzer, Rolf; Schuenemann, Nicole; Jundt, Franziska] Charite, Dept Hematol Oncol & Tumor Immunol, Campus Virchow Clin, Mol Krebsforschungszentrum, D-13353 Berlin, Germany; [Jundt, Franziska] Max Delbruck Ctr Mol Med, Berlin, Germany	University of Oslo; University of Oslo; University of Wurzburg; University of Wurzburg; University of Geneva; University of Geneva; University of Liege; University of Oslo; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Bogen, B (corresponding author), Univ Oslo, Ctr Immune Regulat, Inst Immunol, Oslo, Norway.	bjarne.bogen@medisin.uio.no	huard, bertrand/L-8011-2013; Jundt, Franziska/E-9748-2014; Bommert, Kurt/G-9247-2011	huard, bertrand/0000-0003-1358-6576; Jundt, Franziska/0000-0002-8661-7110; Schwarzer, Rolf/0000-0002-8934-8788; Jodal, Henriette Cecilie/0000-0001-6957-9469; Carlsen, Harald/0000-0001-5123-5756; Caers, Jo/0000-0002-3175-1195	Norwegian Cancer Society [420042 71237-PR-2006-0303]; Multiple Myeloma Research Foundation; Deutsche Forschungsgemeinschaft [CRU216, TRR54/B6]; FNRS Belgium; Deutsche Krebshilfe [108658]	Norwegian Cancer Society(Norwegian Cancer Society); Multiple Myeloma Research Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); FNRS Belgium(Fonds de la Recherche Scientifique - FNRS); Deutsche Krebshilfe(Deutsche Krebshilfe)	The work was supported by grants from The Norwegian Cancer Society (420042 71237-PR-2006-0303) (http://www.kreftforeningen.no), the Multiple Myeloma Research Foundation (http://www.themmrf.org/), Deutsche Forschungsgemeinschaft (http://www.dfg.de/) CRU216 (KB) and TRR54/B6 (FJ), FNRS Belgium (http://www1.frs-fnrs.be/) (JC), and from the Deutsche Krebshilfe 108658 (http://www.krebshilfe.de) (FJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KC, 2007, EXP HEMATOL, V35, P155, DOI 10.1016/j.exphem.2007.01.024; BAKKUS MHC, 1994, BRIT J HAEMATOL, V87, P68, DOI 10.1111/j.1365-2141.1994.tb04872.x; BOGEN B, 1995, EUR J IMMUNOL, V25, P3079, DOI 10.1002/eji.1830251114; Calimeri T, 2011, LEUKEMIA, V25, P707, DOI 10.1038/leu.2010.300; Carrasco DR, 2007, CANCER CELL, V11, P349, DOI 10.1016/j.ccr.2007.02.015; Chesi M, 2008, CANCER CELL, V13, P167, DOI 10.1016/j.ccr.2008.01.007; Cheung WC, 2004, J CLIN INVEST, V113, P1763, DOI 10.1172/JCI200420369; Corthay A, 2005, IMMUNITY, V22, P371, DOI 10.1016/j.immuni.2005.02.003; Corthay A, 2009, CANCER RES, V69, P5901, DOI 10.1158/0008-5472.CAN-08-4816; DALEY MJ, 1978, J IMMUNOL METHODS, V24, P47, DOI 10.1016/0022-1759(78)90085-6; Dellacasagrande J, 2003, SCAND J IMMUNOL, V57, P534, DOI 10.1046/j.1365-3083.2003.01263.x; Dembic Z, 2000, P NATL ACAD SCI USA, V97, P2697, DOI 10.1073/pnas.050579897; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; EISEN HN, 1968, BIOCHEMISTRY-US, V7, P4126, DOI 10.1021/bi00851a048; FEOZUPPARDI FJ, 1992, BLOOD, V80, P2843; Garrett IR, 1997, BONE, V20, P515, DOI 10.1016/S8756-3282(97)00056-2; Haabeth OAW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1239; Hideshima T, 2001, CANCER RES, V61, P3071; Hideshima T, 2004, BLOOD, V104, P607, DOI 10.1182/blood-2004-01-0037; Hjorth-Hansen H, 1999, J BONE MINER RES, V14, P256, DOI 10.1359/jbmr.1999.14.2.256; HUANG YW, 1993, CANCER RES, V53, P1392; KOBAYASHI H, 1962, J NATL CANCER I, V28, P649; LAURITZSEN GF, 1993, CELL IMMUNOL, V148, P177, DOI 10.1006/cimm.1993.1100; LAURITZSEN GF, 1994, P NATL ACAD SCI USA, V91, P5700, DOI 10.1073/pnas.91.12.5700; LYNCH RG, 1972, P NATL ACAD SCI USA, V69, P1540, DOI 10.1073/pnas.69.6.1540; MANNING LS, 1992, BRIT J CANCER, V66, P1088, DOI 10.1038/bjc.1992.415; MELLSTEDT H, 1974, CLIN EXP IMMUNOL, V17, P371; Menu E, 2004, BLOOD CELL MOL DIS, V33, P111, DOI 10.1016/j.bcmd.2004.04.012; Mitsiades CS, 2007, HEMATOL ONCOL CLIN N, V21, P1051, DOI 10.1016/j.hoc.2007.08.003; Miyakawa Y, 2004, BIOCHEM BIOPH RES CO, V313, P258, DOI 10.1016/j.bbrc.2003.11.120; Mori Y, 2004, BLOOD, V104, P2149, DOI 10.1182/blood-2004-01-0236; Nachtrab F, 2008, NUCL SCI S 2008 NSS, P532; O'Connor BP, 2003, IMMUNOL REV, V194, P61, DOI 10.1034/j.1600-065X.2003.00055.x; Oyajobi BO, 2007, MOL CANCER THER, V6, P1701, DOI 10.1158/1535-7163.MCT-07-0121; Pilarski LM, 2000, BLOOD, V95, P1056, DOI 10.1182/blood.V95.3.1056.003k26_1056_1065; Potter M, 2003, IMMUNOL REV, V194, P177, DOI 10.1034/j.1600-065X.2003.00061.x; POTTER M, 1972, PHYSIOL REV, V52, P631, DOI 10.1152/physrev.1972.52.3.631; POTTER M, 1957, P SOC EXP BIOL MED, V94, P327; RADL J, 1979, J IMMUNOL, V122, P609; RADL J, 1988, AM J PATHOL, V132, P593; Radl J, 1999, PATHOL BIOL, V47, P109; ROHRER JW, 1977, J IMMUNOL, V119, P861; Salamon M, 2008, NUCL INSTRUMENTS M A, P591; Sweeney TJ, 1999, P NATL ACAD SCI USA, V96, P12044, DOI 10.1073/pnas.96.21.12044; Szczepek AJ, 1998, BLOOD, V92, P2844, DOI 10.1182/blood.V92.8.2844.420k17_2844_2855; Tsunenari T, 1997, BLOOD, V90, P2437; Vanderkerken K, 1997, BRIT J CANCER, V76, P451, DOI 10.1038/bjc.1997.409; Vanderkerken K, 2003, IMMUNOL REV, V194, P196, DOI 10.1034/j.1600-065X.2003.00035.x; Vanderkerken K, 2000, BRIT J CANCER, V82, P953, DOI 10.1054/bjoc.1999.1024; Vanderkerken K, 1996, BRIT J CANCER, V73, P1463, DOI 10.1038/bjc.1996.277; WILTSHAW E, 1976, MEDICINE, V55, P217, DOI 10.1097/00005792-197605000-00002; Yaccoby S, 1998, BLOOD, V92, P2908, DOI 10.1182/blood.V92.8.2908.420a32_2908_2913	52	46	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51892	10.1371/journal.pone.0051892	http://dx.doi.org/10.1371/journal.pone.0051892			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284805	Green Published, Green Accepted, gold			2022-12-27	WOS:000312794500063
J	Odrowaz, Z; Sharrocks, AD				Odrowaz, Zaneta; Sharrocks, Andrew D.			The ETS Transcription Factors ELK1 and GABPA Regulate Different Gene Networks to Control MCF10A Breast Epithelial Cell Migration	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; CYCLE PROGRESSION; IN-VIVO; CYTOKINESIS; EXPRESSION; KINESIN; FAMILY	Members of the ETS transcription factor family often target the same binding regions and hence have the potential to regulate the same genes and downstream biological processes. However, individual family members also preferentially bind to other genomic regions, thus providing the potential for controlling distinct transcriptional programmes and generating specific biological effects. The ETS transcription factor ELK1 controls cell migration in breast epithelial cells through targeting a cohort of genes, independently from another family member GABPA, and therefore achieves biological specificity. Here, we demonstrate that GABPA also controls cell migration in breast epithelial cells. However, GABPA controls the expression of a different network of target genes to ELK1. Both direct and indirect target genes for GABPA are identified and amongst the direct targets we confirm the importance of RAC1 and KIF20A for cell migration. Therefore, although ELK1 and GABPA ultimately control the same biological process, they do so by regulating different cohorts of target genes associated with cytoskeletal functions and cell migration control.	[Odrowaz, Zaneta; Sharrocks, Andrew D.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Sharrocks, AD (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	a.d.sharrocks@manchester.ac.uk	Sharrocks, Andrew/J-6756-2013		Wellcome Trust; Royal Society-Wolfson	Wellcome Trust(Wellcome TrustEuropean Commission); Royal Society-Wolfson(Royal Society of London)	This work was supported by grants from the Wellcome Trust, and a Royal Society-Wolfson award to ADS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boros J, 2009, GENOME RES, V19, P1963, DOI 10.1101/gr.093047.109; Briguet A, 2000, J NEUROSCI, V20, P5989, DOI 10.1523/JNEUROSCI.20-16-05989.2000; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Carstanjen D, 2005, J IMMUNOL, V174, P4613, DOI 10.4049/jimmunol.174.8.4613; Crook MF, 2008, FASEB J, V22, P225, DOI 10.1096/fj.07-8573com; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Fontijn RD, 2001, MOL CELL BIOL, V21, P2944, DOI 10.1128/MCB.21.8.2944-2955.2001; Hill E, 2000, EMBO J, V19, P5711, DOI 10.1093/emboj/19.21.5711; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Hollenhorst PC, 2011, GENE DEV, V25, P2147, DOI 10.1101/gad.17546311; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Hollenhorst PC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000778; Odrowaz Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002694; Schaeffer L, 1998, EMBO J, V17, P3078, DOI 10.1093/emboj/17.11.3078; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Yang ZF, 2007, NAT CELL BIOL, V9, P339, DOI 10.1038/ncb1548; Yu SY, 2011, BLOOD, V117, P2166, DOI 10.1182/blood-2010-09-306563; Zhao WM, 2005, P NATL ACAD SCI USA, V102, P13158, DOI 10.1073/pnas.0504145102	20	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e49892	10.1371/journal.pone.0049892	http://dx.doi.org/10.1371/journal.pone.0049892			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284628	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500010
J	Johannesen, J; Foissac, X; Kehrli, P; Maixner, M				Johannesen, Jes; Foissac, Xavier; Kehrli, Patrik; Maixner, Michael			Impact of Vector Dispersal and Host-Plant Fidelity on the Dissemination of an Emerging Plant Pathogen	PLOS ONE			English	Article							HYALESTHES-OBSOLETUS; GRAPEVINE YELLOWS; STOLBUR PHYTOPLASMA; BOIS NOIR; BORRELIA-BURGDORFERI; FLAVESCENCE-DOREE; CONIFER PATHOGEN; DISEASE; DIVERSITY; DYNAMICS	Dissemination of vector-transmitted pathogens depend on the survival and dispersal of the vector and the vector's ability to transmit the pathogen, while the host range of vector and pathogen determine the breath of transmission possibilities. In this study, we address how the interaction between dispersal and plant fidelities of a pathogen (stolbur phytoplasma tuf-a) and its vector (Hyalesthes obsoletus: Cixiidae) affect the emergence of the pathogen. Using genetic markers, we analysed the geographic origin and range expansion of both organisms in Western Europe and, specifically, whether the pathogen's dissemination in the northern range is caused by resident vectors widening their host-plant use from field bindweed to stinging nettle, and subsequent host specialisation. We found evidence for common origins of pathogen and vector south of the European Alps. Genetic patterns in vector populations show signals of secondary range expansion in Western Europe leading to dissemination of tuf-a pathogens, which might be newly acquired and of hybrid origin. Hence, the emergence of stolbur tuf-a in the northern range was explained by secondary immigration of vectors carrying stinging nettle-specialised tuf-a, not by widening the host-plant spectrum of resident vectors with pathogen transmission from field bindweed to stinging nettle nor by primary co-migration from the resident vector's historical area of origin. The introduction of tuf-a to stinging nettle in the northern range was therefore independent of vector's host-plant specialisation but the rapid pathogen dissemination depended on the vector's host shift, whereas the general dissemination elsewhere was linked to plant specialisation of the pathogen but not of the vector.	[Johannesen, Jes] Johannes Gutenberg Univ Mainz, Inst Zool, Saarstr 21, D-6500 Mainz, Germany; [Foissac, Xavier] INRA, Fruit Biol & Pathol UMR1332, Villenave Dornon, France; [Foissac, Xavier] Univ Bordeaux Segalen, Fruit Biol & Pathol UMR1332, Villenave Dornon, France; [Kehrli, Patrik] Stn Rech Agroscope Changins Wadenswil ACW, Nyon, Switzerland; [Maixner, Michael] Julius Kuhn Inst, Inst Plant Protect Fruit Crops & Viticulture, Bernkastel Kues, Germany	Johannes Gutenberg University of Mainz; INRAE; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Swiss Federal Research Station Agroscope; Julius Kuhn-Institut	Johannesen, J (corresponding author), Johannes Gutenberg Univ Mainz, Inst Zool, Saarstr 21, D-6500 Mainz, Germany.	jesjo@uni-mainz.de	Foissac, Xavier/ABI-7227-2020; Foissac, Xavier/B-7662-2015	Foissac, Xavier/0000-0002-2170-5793; Foissac, Xavier/0000-0002-2170-5793; Kehrli, Patrik/0000-0003-0937-0561	Stiftung Rheinland-Pfalz fur Innovation [0861]	Stiftung Rheinland-Pfalz fur Innovation	This research was funded by "Stiftung Rheinland-Pfalz fur Innovation,'' grant number 0861 (http://www.stiftung-innovation.rlp.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini E, 2011, PETRIA, V21, P85; Aplin KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026357; Arnaud G, 2007, APPL ENVIRON MICROB, V73, P4001, DOI 10.1128/AEM.02323-06; Bai XD, 2004, FEMS MICROBIOL LETT, V235, P249, DOI [10.1111/j.1574-6968.2004.tb09596.x, 10.1016/j.femsle.2004.04.043]; Bertaccini A, 2007, B INSECTOLOGY, VLX; Bertaccini A, 2011, 2 INT PHYT WORK GROU, VLXIV; BLATTNY C., 1954, Phytopathologische Zeitschrift, V22, P381; Bojnansky V, 1955, POLNOHOSPODARSTVO, V2, P326; Boudon-Padieu E, 2008, P INT MULT C U DIJ, P1; Brasier CM, 2001, BIOSCIENCE, V51, P123, DOI 10.1641/0006-3568(2001)051[0123:REOIPP]2.0.CO;2; Bressan A, 2007, ANN APPL BIOL, V150, P331, DOI 10.1111/j.1744-7348.2007.00134.x; Brinkerhoff RJ, 2011, FRONT ECOL ENVIRON, V9, P103, DOI 10.1890/090062; Chen HY, 2005, J MED ENTOMOL, V42, P899, DOI 10.1603/0022-2585(2005)042[0899:EASDOL]2.0.CO;2; Christensen NM, 2005, TRENDS PLANT SCI, V10, P526, DOI 10.1016/j.tplants.2005.09.008; Cimerman A, 2009, APPL ENVIRON MICROB, V75, P2951, DOI 10.1128/AEM.02613-08; Cimerman A, 2006, APPL ENVIRON MICROB, V72, P3274, DOI 10.1128/AEM.72.5.3274-3283.2006; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Credi R., 2006, 15 M ICVG STELL S AF, P182; Daire X, 1997, EUR J PLANT PATHOL, V103, P507, DOI 10.1023/A:1008641411025; Ember I, 2011, EUR J PLANT PATHOL, V130, P367, DOI 10.1007/s10658-011-9759-5; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fabiszewski AM, 2010, ECOL APPL, V20, P582, DOI 10.1890/08-0820.1; Fabre A, 2011, GENE, V472, P37, DOI 10.1016/j.gene.2010.10.012; Fialova R, 2009, J PLANT PATHOL, V91, P411; Filippin L, 2009, PLANT PATHOL, V58, P826, DOI 10.1111/j.1365-3059.2009.02092.x; Firrao G, 2004, INT J SYST EVOL MICR, V54, P1243, DOI 10.1099/ijs.0.02854-0; FOS A, 1992, PLANT DIS, V76, P1092, DOI 10.1094/PD-76-1092; Fu YX, 1997, GENETICS, V147, P915; Gladieux P, 2011, MOL ECOL, V20, P4521, DOI 10.1111/j.1365-294X.2011.05288.x; Herschler A, 1937, DTSCH WEIN BAU, V16, P177; Hoch H., 1985, Marburger Entomologische Publikationen, V2, P1; Hogenhout SA, 2003, TRENDS MICROBIOL, V11, P264, DOI 10.1016/S0966-842X(03)00120-3; Humphrey PT, 2010, EVOLUTION, V64, P2653, DOI 10.1111/j.1558-5646.2010.01001.x; Imo M, 2011, EUR J ENTOMOL, V108, P161, DOI 10.14411/eje.2011.019; Johannesen J, 2008, ENTOMOL EXP APPL, V126, P217, DOI 10.1111/j.1570-7458.2007.00655.x; Kast WK, 2008, 1 EUR BOIS WORKSH 20; Kehrli P., 2011, IOBC/WPRS Bulletin, V67, P3; Kessler S, 2011, ENTOMOL EXP APPL, V139, P60, DOI 10.1111/j.1570-7458.2011.01107.x; Kuntzmann P., 2008, IOBC/WPRS Bulletin, V36, P127; Langer M, 2004, VITIS, V43, P191; Lee IM, 1998, INT J SYST BACTERIOL, V48, P1153, DOI 10.1099/00207713-48-4-1153; Lee IM, 2000, ANNU REV MICROBIOL, V54, P221, DOI 10.1146/annurev.micro.54.1.221; Lessio F, 2007, J PLANT PATHOL, V89, P97; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maixner M, 2000, VITIS, V39, P83; MAIXNER M, 1995, EUR J PLANT PATHOL, V101, P241, DOI 10.1007/BF01874780; Maixner M., 2011, PETRIA, V21, P95; Maixner M, 2009, P 16 M ICVG DIJ FRAN, P141; Maixner M, 2007, B INSECTOL, V60, P399; Malembic-Maher S, 2010, 18 INT C INT ORG MYC, P52; Mannelli A, 2012, FEMS MICROBIOL REV, V36, P837, DOI 10.1111/j.1574-6976.2011.00312.x; Marin M, 2009, FOREST PATHOL, V39, P249, DOI 10.1111/j.1439-0329.2009.00585.x; Mendgen K., 1971, Weinberg und Keller, V18, P345; Nunney L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015488; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sergel R., 1986, ABHANDLUGEN NATURWIS, V25, P81; Sforza R, 1998, J PHYTOPATHOL, V146, P549, DOI 10.1111/j.1439-0434.1998.tb04753.x; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Swofford D.L., 1999, PHYLOGENETIC ANAL US; TAJIMA F, 1989, GENETICS, V123, P585; Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103; Thompson J. N., 2005, INTERSPEC INTERACT; Tsui CKM, 2012, MOL ECOL, V21, P71, DOI 10.1111/j.1365-294X.2011.05366.x; van Putten WF, 2007, INT J PLANT SCI, V168, P421, DOI 10.1086/511050; Wagner W., 1939, Jahrbuch des Nassauischen Vereins fuer Naturkunde, V86, P77; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Weintraub PG, 2006, ANNU REV ENTOMOL, V51, P91, DOI 10.1146/annurev.ento.51.110104.151039	68	49	50	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51809	10.1371/journal.pone.0051809	http://dx.doi.org/10.1371/journal.pone.0051809			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284774	Green Published, Green Submitted, gold			2022-12-27	WOS:000312694300046
J	Tegel, W; Elburg, R; Hakelberg, D; Stauble, H; Buntgen, U				Tegel, Willy; Elburg, Rengert; Hakelberg, Dietrich; Staeuble, Harald; Buentgen, Ulf			Early Neolithic Water Wells Reveal the World's Oldest Wood Architecture	PLOS ONE			English	Article							CENTRAL-EUROPE; HOLOCENE	The European Neolithization similar to 6000-4000 BC represents a pivotal change in human history when farming spread and the mobile style of life of the hunter-foragers was superseded by the agrarian culture. Permanent settlement structures and agricultural production systems required fundamental innovations in technology, subsistence, and resource utilization. Motivation, course, and timing of this transformation, however, remain debatable. Here we present annually resolved and absolutely dated dendroarchaeological information from four wooden water wells of the early Neolithic period that were excavated in Eastern Germany. A total of 151 oak timbers preserved in a waterlogged environment were dated between 5469 and 5098 BC and reveal unexpectedly refined carpentry skills. The recently discovered water wells enable for the first time a detailed insight into the earliest wood architecture and display the technological capabilities of humans similar to 7000 years ago. The timbered well constructions made of old oak trees feature an unopened tree-ring archive from which annually resolved and absolutely dated environmental data can be culled. Our results question the principle of continuous evolutionary development in prehistoric technology, and contradict the common belief that metal was necessary for complex timber constructions. Early Neolithic craftsmanship now suggests that the first farmers were also the first carpenters.	[Tegel, Willy; Hakelberg, Dietrich] Univ Freiburg, Inst Forest Growth IWW, D-79106 Freiburg, Germany; [Elburg, Rengert; Staeuble, Harald] Archaeol Heritage Off Saxony, Dresden, Germany; [Buentgen, Ulf] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland; [Buentgen, Ulf] Oeschger Ctr Climate Change Res, Bern, Switzerland	University of Freiburg; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Bern	Tegel, W (corresponding author), Univ Freiburg, Inst Forest Growth IWW, Hugstetter Str 55, D-79106 Freiburg, Germany.	tegel@dendro.de	Tegel, Willy/M-8187-2014; buentgen, ulf/J-6952-2013	Petraglia, Michael/0000-0003-2522-5727; Tegel, Willy/0000-0003-4707-2848; Elburg, Rengert/0000-0001-5595-8900	German Research Foundation [SP 437/16-1]	German Research Foundation(German Research Foundation (DFG))	WT and DH received funding from the German Research Foundation, project #SP 437/16-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold B, 1995, PIROGUES MONOXYLES E, V1; Barker G, 2011, NATURE, V473, P163, DOI 10.1038/473163a; Becker B., 1978, DENDROCHRONOLOGY EUR, V51, P59; Bramanti B, 2009, SCIENCE, V326, P137, DOI 10.1126/science.1176869; Clark P, 2004, DOVER BRONZE AGE BOA, P124; Edwards CJ, 2007, P ROY SOC B-BIOL SCI, V274, P1377, DOI 10.1098/rspb.2007.0020; Haak W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000536; Haase D, 2007, QUATERNARY SCI REV, V26, P1301, DOI 10.1016/j.quascirev.2007.02.003; Herbig C, 2012, SCHRIFTEN, V18, P147; Hodder I., 1990, DOMESTICATION EUROPE; HOFFMANN P, 1990, ADV CHEM SER, P35; Kalis AJ, 2003, QUATERNARY SCI REV, V22, P33, DOI 10.1016/S0277-3791(02)00181-6; Kreuz A.M., 1990, ERSTEN BAUERN MITTEL; Kreuz A, 2011, VEG HIST ARCHAEOBOT, V20, P333, DOI 10.1007/s00334-011-0294-2; Lobisser WFA, 1998, BRUNNEN JUNGSTEINZEI, P177; Luley H, 1992, URGESCHICHTLICHER HA; Luning J., 2000, UNIVERSITATSFORSCHUN, V58; Mayewski PA, 2004, QUATERNARY RES, V62, P243, DOI 10.1016/j.yqres.2004.07.001; Mazurie de Keroualin K, 2003, GENESE DIFFUSION AGR; Mitchell FJG, 2005, J ECOL, V93, P168, DOI 10.1111/j.1365-2745.2004.00964.x; Modderman P.J.R., 1988, BER RIJKSD OUDHEIDKD, V38, P63; Petrequin P., 1993, ECOLOGIE OUTIL HACHE; Ramminger B, 2007, WIRTSCHAFTSARCHALOGI; Renfrew C., 2007, PREHISTORY MAKING HU; Renssen H, 2009, NAT GEOSCI, V2, P410, DOI 10.1038/NGEO513; Schiffer M.B., 1987, FORMATION PROCESSES; Spurk M, 2002, HOLOCENE, V12, P707, DOI 10.1191/0959683602hl583rp; Spurk M, 1998, RADIOCARBON, V40, P1107, DOI 10.1017/S0033822200019159; Stauble H, 1995, RADIOCARBON, V37, P227, DOI 10.1017/S003382220003068X; Stauble H., 2005, HAUSER ABSOLUTE DATI; Stehli P, 1982, SIEDLUNGEN KULTUR LI, P271; Thorpe I.J.N., 1996, ORIGINS AGR EUROPE; Wanner H, 2008, QUATERNARY SCI REV, V27, P1791, DOI 10.1016/j.quascirev.2008.06.013; Weisdorf JL, 2005, J ECON SURV, V19, P561, DOI 10.1111/j.0950-0804.2005.00259.x; Whittle A., 1996, EUROPE NEOLITHIC CRE; Zvelebil M., 2004, LBK DIALOGUES STUDIE, P183	36	72	75	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51374	10.1371/journal.pone.0051374	http://dx.doi.org/10.1371/journal.pone.0051374			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284685	Green Submitted, Green Published, gold			2022-12-27	WOS:000312694300021
J	Friedman, J; Korman, M				Friedman, Jason; Korman, Maria			Kinematic Strategies Underlying Improvement in the Acquisition of a Sequential Finger Task with Self-Generated vs. Cued Repetition Training	PLOS ONE			English	Article							MOVEMENT SEQUENCES; MOTOR SEQUENCE; TIME-COURSE; SLEEP; SKILL; CONSOLIDATION; FEEDBACK; PERFORMANCE; CORTEX; MODEL	Many motor skills, such as typing, consist of articulating simple movements into novel sequences that are executed faster and smoother with practice. Dynamics of re-organization of these movement sequences with multi-session training and its dependence on the amount of self-regulation of pace during training is not yet fully understood. In this study, participants practiced a sequence of key presses. Training sessions consisted of either externally (Cued) or self-initiated (Uncued) training. Long-term improvements in performance speed were mainly due to reducing gaps between finger movements in both groups, but Uncued training induced higher gains. The underlying kinematic strategies producing these changes and the representation of the trained sequence differed significantly across subjects, although net gains in speed were similar. The differences in long-term memory due to the type of training and the variation in strategies between subjects, suggest that the different neural mechanisms may subserve the improvements observed in overall performance.	[Friedman, Jason] Macquarie Univ, Dept Cognit Sci, Sydney, NSW 2109, Australia; [Friedman, Jason] Macquarie Univ, ARC Ctr Excellence Cognit & Its Disorders, Sydney, NSW 2109, Australia; [Korman, Maria] Univ Haifa, Fac Social Welf & Hlth Sci, Dept Occupat Therapy, IL-31999 Haifa, Israel	Macquarie University; Macquarie University; University of Haifa	Friedman, J (corresponding author), Tel Aviv Univ, Dept Phys Therapy, IL-69978 Tel Aviv, Israel.	jason@post.tau.ac.il	Korman, Maria/GWQ-3314-2022; Friedman, Jason/B-4690-2008	Korman, Maria/0000-0003-1895-0189; Friedman, Jason/0000-0001-8845-5082	Macquarie University	Macquarie University	This research has been supported in part by a Macquarie University Safety Net Grant to Friedman. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschersleben G, 2004, SCI PSYCH S, P117; Aschersleben G, 2002, BRAIN COGNITION, V48, P66, DOI 10.1006/brcg.2001.1304; Blackburn CS, 2000, J ACOUST SOC AM, V107, P1659, DOI 10.1121/1.428450; Blischke K, 2008, J HUM KINET, V20, P23, DOI 10.2478/v10078-008-0015-9; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brown RM, 2007, NAT NEUROSCI, V10, P148, DOI 10.1038/nn1836; Chiviacowsky S, 2005, RES Q EXERCISE SPORT, V76, P42; Doyon J, 2009, EXP BRAIN RES, V195, P15, DOI 10.1007/s00221-009-1748-y; Engel KC, 1997, EXP BRAIN RES, V113, P189, DOI 10.1007/BF02450317; Goebl W, 2008, EXP BRAIN RES, V186, P471, DOI 10.1007/s00221-007-1252-1; Guadagnoli MA, 2004, J MOTOR BEHAV, V36, P212, DOI 10.3200/JMBR.36.2.212-224; Huet M, 2009, HUM MOVEMENT SCI, V28, P450, DOI 10.1016/j.humov.2008.12.004; Janelle CM, 1997, RES Q EXERCISE SPORT, V68, P269, DOI 10.1080/02701367.1997.10608008; Jerde TE, 2003, J NEUROSCI, V23, P2383; KARNI A, 1995, NATURE, V377, P155; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Karni A, 1996, COGNITIVE BRAIN RES, V5, P39, DOI 10.1016/S0926-6410(96)00039-0; Keetch KM, 2007, RES Q EXERCISE SPORT, V78, P476; Korman M, 2003, P NATL ACAD SCI USA, V100, P12492, DOI 10.1073/pnas.2035019100; Korman M, 2007, NAT NEUROSCI, V10, P1206, DOI 10.1038/nn1959; Krakauer JW, 2006, TRENDS NEUROSCI, V29, P58, DOI 10.1016/j.tins.2005.10.003; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; Lewis PA, 2006, TRENDS COGN SCI, V10, P401, DOI 10.1016/j.tics.2006.07.006; Lewis PA, 2011, NEUROPSYCHOLOGIA, V49, P115, DOI 10.1016/j.neuropsychologia.2010.10.025; Luft AR, 2005, MOL NEUROBIOL, V32, P205, DOI 10.1385/MN:32:3:205; Maquet P, 2003, J NEUROSCI, V23, P1432, DOI 10.1523/JNEUROSCI.23-04-01432.2003; Nudo RJ, 1996, J NEUROSCI, V16, P785; O'Reilly JX, 2008, J NEUROPHYSIOL, V99, P2731, DOI 10.1152/jn.01141.2007; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Orban P, 2011, NEUROSCIENCE, V179, P94, DOI 10.1016/j.neuroscience.2011.01.040; Panzer S, 2006, J MOTOR BEHAV, V38, P60, DOI 10.3200/JMBR.38.1.60-70; Rozanov S, 2010, BRAIN RES, V1331, P80, DOI 10.1016/j.brainres.2010.03.019; SOECHTING JF, 1992, J NEUROPHYSIOL, V67, P1275, DOI 10.1152/jn.1992.67.5.1275; Sosnik R, 2004, EXP BRAIN RES, V156, P422, DOI 10.1007/s00221-003-1799-4; TERZUOLO CA, 1980, NEUROSCIENCE, V5, P1085, DOI 10.1016/0306-4522(80)90188-8; Verwey WB, 2003, PSYCHOL RES-PSYCH FO, V67, P106, DOI 10.1007/s00426-002-0120-7; Verwey WB, 2003, J MOTOR BEHAV, V35, P171, DOI 10.1080/00222890309602131; Viviani P., 1983, LANGUAGE PRODUCTION, V2, P103; Walker MP, 2003, LEARN MEMORY, V10, P275, DOI 10.1101/lm.58503; WRIGHT CE, 1993, ACTA PSYCHOL, V82, P5, DOI 10.1016/0001-6918(93)90003-A; Wrisberg CA, 2002, PERCEPT MOTOR SKILL, V94, P792, DOI 10.2466/PMS.94.2.792-794; Wulf G, 2005, RES Q EXERCISE SPORT, V76, P107	42	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52063	10.1371/journal.pone.0052063	http://dx.doi.org/10.1371/journal.pone.0052063			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	056JC	23272210	gold, Green Submitted, Green Published			2022-12-27	WOS:000312483300056
J	Regazzetti, C; Dumas, K; Le Marchand-Brustel, Y; Peraldi, P; Tanti, JF; Giorgetti-Peraldi, S				Regazzetti, Claire; Dumas, Karine; Le Marchand-Brustel, Yannick; Peraldi, Pascal; Tanti, Jean-Francois; Giorgetti-Peraldi, Sophie			Regulated in Development and DNA Damage Responses-1 (REDD1) Protein Contributes to Insulin Signaling Pathway in Adipocytes	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; SKELETAL-MUSCLE; MTORC1 REPRESSOR; ENERGY STRESS; EXPRESSION; HYPOXIA; GROWTH; INHIBITION; PHOSPHORYLATION; TARGET	REDD1 (Regulated in development and DNA damage response 1) is a hypoxia and stress response gene and is a negative regulator of mTORC1. Since mTORC1 is involved in the negative feedback loop of insulin signaling, we have studied the role of REDD1 on insulin signaling pathway and its regulation by insulin. In human and murine adipocytes, insulin transiently stimulates REDD1 expression through a MEK dependent pathway. In HEK-293 cells, expression of a constitutive active form of MEK stabilizes REDD1 and protects REDD1 from proteasomal degradation mediated by CUL4A-DDB1 ubiquitin ligase complex. In 3T3-L1 adipocytes, silencing of REDD1 with siRNA induces an increase of mTORC1 activity as well as an inhibition of insulin signaling pathway and lipogenesis. Rapamycin, a mTORC1 inhibitor, restores the insulin signaling after downregulation of REDD1 expression. This observation suggests that REDD1 positively regulates insulin signaling through the inhibition of mTORC1 activity. In conclusion, our results demonstrate that insulin increases REDD1 expression, and that REDD1 participates in the biological response to insulin.	[Regazzetti, Claire; Dumas, Karine; Le Marchand-Brustel, Yannick; Tanti, Jean-Francois; Giorgetti-Peraldi, Sophie] Mediterranean Res Ctr Mol Med, INSERM, U1065, Team Cellular & Mol Physiopathol Obes & Diabet, Nice, France; [Peraldi, Pascal] Fac Med Nice, INSERM, UMR 1091, UMR CNRS 7277, F-06034 Nice, France; [Regazzetti, Claire; Dumas, Karine; Le Marchand-Brustel, Yannick; Peraldi, Pascal; Tanti, Jean-Francois; Giorgetti-Peraldi, Sophie] Univ Nice Sophia Antipolis, UFR Med, Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Giorgetti-Peraldi, S (corresponding author), Mediterranean Res Ctr Mol Med, INSERM, U1065, Team Cellular & Mol Physiopathol Obes & Diabet, Nice, France.	peraldis@unice.fr	Peraldi, Pascal/O-4592-2016	Peraldi, Pascal/0000-0003-0205-9252; Giorgetti-Peraldi, Sophie/0000-0002-2751-2618; Regazzetti, Claire/0000-0002-8094-5885; Tanti, Jean-Francois/0000-0003-1782-1318	INSERM, France; Societe Francophone du Diabete, Agence Nationale de la Recherche [ANR-09-GENO-036]; Association for Research on Diabetes (Paris, France); University of Nice-Sophia Antipolis; Region Provence- Alpes-Cote-d'Azur; Conseil General des Alpes Maritimes; European Commission [LSHM-CT-2005-018734]; Ministere de la recherche et de l'education; Societe Francophone du Diabete	INSERM, France(Institut National de la Sante et de la Recherche Medicale (Inserm)); Societe Francophone du Diabete, Agence Nationale de la Recherche(French National Research Agency (ANR)); Association for Research on Diabetes (Paris, France); University of Nice-Sophia Antipolis; Region Provence- Alpes-Cote-d'Azur(Region Provence-Alpes-Cote d'Azur); Conseil General des Alpes Maritimes(Region Provence-Alpes-Cote d'Azur); European Commission(European CommissionEuropean Commission Joint Research Centre); Ministere de la recherche et de l'education; Societe Francophone du Diabete	This work was supported by INSERM, France, Societe Francophone du Diabete, Agence Nationale de la Recherche (ANR-09-GENO-036), the Association for Research on Diabetes (Paris, France), the University of Nice-Sophia Antipolis, Region Provence- Alpes-Cote-d'Azur, Conseil General des Alpes Maritimes. This work is part of the project "Hepatic and Adipose Tissue and Functions in the Metabolic Syndrome'' (HEPADIP), which is supported by the European Commission as an integrated Project under the 6th Framework Program, Contract LSHM-CT-2005-018734. C. R. is a recipient of a fellowship from Ministere de la recherche et de l'education (2008-2011) and Societe Francophone du Diabete (2011-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-101; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Catania C, 2011, INT J OBESITY, V35, P751, DOI 10.1038/ijo.2010.208; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Favier FB, 2010, AM J PHYSIOL-REG I, V298, pR1659, DOI 10.1152/ajpregu.00550.2009; Frost RA, 2009, J CELL BIOCHEM, V108, P1192, DOI 10.1002/jcb.22349; Goenaga D, 2009, MOL ENDOCRINOL, V23, P1043, DOI 10.1210/me.2008-0360; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Hulmi JJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE307, DOI 10.1152/ajpendo.00398.2011; Jin HO, 2007, CELL SIGNAL, V19, P1393, DOI 10.1016/j.cellsig.2006.12.014; Jin HO, 2009, FREE RADICAL BIO MED, V46, P1158, DOI 10.1016/j.freeradbiomed.2009.01.015; Katiyar S, 2009, EMBO REP, V10, P866, DOI 10.1038/embor.2009.93; Kilroy G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006940; Kimball SR, 2008, J BIOL CHEM, V283, P3465, DOI 10.1074/jbc.M706643200; Kimball SR, 2012, BIOCHEM BIOPH RES CO, V427, P485, DOI 10.1016/j.bbrc.2012.09.074; Laplante M, 2012, CELL METAB, V16, P202, DOI 10.1016/j.cmet.2012.07.008; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; McGhee NK, 2009, J NUTR, V139, P828, DOI 10.3945/jn.108.099846; Murdaca J, 2004, J BIOL CHEM, V279, P26754, DOI 10.1074/jbc.M311802200; Plaisant M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016798; Regazzetti C, 2010, J BIOL CHEM, V285, P5157, DOI 10.1074/jbc.M109.047688; Regazzetti C, 2009, DIABETES, V58, P95, DOI 10.2337/db08-0457; Ren SC, 2012, J MOL MED, V90, P1121, DOI 10.1007/s00109-012-0885-0; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Schneider A, 2008, NEOPLASIA, V10, P1295, DOI 10.1593/neo.08586; Shimizu N, 2011, CELL METAB, V13, P170, DOI 10.1016/j.cmet.2011.01.001; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; Siddle Kenneth, 2012, Front Endocrinol (Lausanne), V3, P34, DOI 10.3389/fendo.2012.00034; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tanti JF, 2009, CURR OPIN PHARMACOL, V9, P753, DOI 10.1016/j.coph.2009.07.004; Tanti JF, 1996, J BIOL CHEM, V271, P25227, DOI 10.1074/jbc.271.41.25227; Vega-Rubin-de-Celis S, 2010, BIOCHEMISTRY-US, V49, P2491, DOI 10.1021/bi902135e; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	40	30	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52154	10.1371/journal.pone.0052154	http://dx.doi.org/10.1371/journal.pone.0052154			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272222	gold, Green Submitted, Green Published			2022-12-27	WOS:000312483300066
J	Krolewski, RC; Packard, A; Jang, W; Wildner, H; Schwob, JE				Krolewski, Richard C.; Packard, Adam; Jang, Woochan; Wildner, Hendrik; Schwob, James E.			Ascl1 (Mash1) Knockout Perturbs Differentiation of Nonneuronal Cells in Olfactory Epithelium	PLOS ONE			English	Article							GLOBOSE BASAL-CELLS; PROGENITOR-CELL; ELECTRON-MICROSCOPY; NOTCH1 EXPRESSION; NEURON LINEAGE; HES GENES; MOUSE; NEUROGENESIS; PROLIFERATION; REGENERATION	The embryonic olfactory epithelium (OE) generates only a very few olfactory sensory neurons when the basic helix-loop-helix transcription factor, ASCL1 (previously known as MASH1) is eliminated by gene mutation. We have closely examined the structure and composition of the OE of knockout mice and found that the absence of neurons dramatically affects the differentiation of multiple other epithelial cell types as well. The most prominent effect is observed within the two known populations of stem and progenitor cells of the epithelium. The emergence of horizontal basal cells, a multipotent progenitor population in the adult epithelium, is anomalous in the Ascl1 knockout mice. The differentiation of globose basal cells, another multipotent progenitor population in the adult OE, is also aberrant. All of the persisting globose basal cells are marked by SOX2 expression, suggesting a prominent role for SOX2 in progenitors upstream of Ascl1. However, NOTCH1-expressing basal cells are absent from the knockout; since NOTCH1 signaling normally acts to suppress Ascl1 via HES1 and drives sustentacular (Sus) cell differentiation during adult epithelial regeneration, its absence suggests reciprocity between neurogenesis and the differentiation of Sus cells. Indeed, the Sus cells of the mutant mice express a markedly lower level of HES1, strengthening that notion of reciprocity. Duct/gland development appears normal. Finally, the expression of cKIT by basal cells is also undetectable, except in those small patches where neurogenesis escapes the effects of Ascl1 knockout and neurons are born. Thus, persistent neurogenic failure distorts the differentiation of multiple other cell types in the olfactory epithelium.	[Krolewski, Richard C.; Packard, Adam; Jang, Woochan; Schwob, James E.] Tufts Univ, Sch Med, Dept Anat & Cellular Biol, Boston, MA 02111 USA; [Krolewski, Richard C.; Packard, Adam] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Program Cellular Mol & Dev Biol, Boston, MA 02111 USA; [Wildner, Hendrik] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland	Tufts University; Tufts University; University of Zurich	Schwob, JE (corresponding author), Tufts Univ, Sch Med, Dept Anat & Cellular Biol, Boston, MA 02111 USA.	jim.schwob@tufts.edu		Krolewski, Richard/0000-0001-5974-079X	National Institutes of Health (NIH) [RO1 DC002167, F30 DC010276]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F30DC010276, R01DC002167] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the National Institutes of Health (NIH) to JES (RO1 DC002167) and to RCK (F30 DC010276). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Cai J, 2009, DEV BIOL, V326, P420, DOI 10.1016/j.ydbio.2008.11.021; Cau E, 2000, DEVELOPMENT, V127, P2323; Cau E, 1997, DEVELOPMENT, V124, P1611; Cau E, 2002, DEVELOPMENT, V129, P1871; Chen XY, 2004, J COMP NEUROL, V469, P457, DOI 10.1002/cne.11031; CUSCHIERI A, 1975, J ANAT, V119, P277; CUSCHIERI A, 1975, J ANAT, V119, P471; Dahl L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002025; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; GRAZIADEI GAM, 1979, J NEUROCYTOL, V8, P197; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Guo Z, 2007, 220092007 SOC NEUR; Guo Z, 2010, J COMP NEUROL, V518, P4395, DOI 10.1002/cne.22463; Hoflinger S, 2004, J IMMUNOL, V173, P3935, DOI 10.4049/jimmunol.173.6.3935; HOLBROOK EH, 1995, J COMP NEUROL, V363, P129, DOI 10.1002/cne.903630111; Ingram WJ, 2008, ONCOGENE, V27, P1489, DOI 10.1038/sj.onc.1210767; Ishida T, 2008, NEUROSCI LETT, V441, P277, DOI 10.1016/j.neulet.2008.06.045; Ito T, 2000, DEVELOPMENT, V127, P3913; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Kageyama R, 2008, DEV GROWTH DIFFER, V50, pS97, DOI 10.1111/j.1440-169X.2008.00993.x; Kageyama R, 2009, CURR OPIN CELL BIOL, V21, P733, DOI 10.1016/j.ceb.2009.08.009; Kawauchi S, 2009, DEVELOPMENT, V136, P1453, DOI 10.1242/dev.034967; Leung CT, 2007, NAT NEUROSCI, V10, P720, DOI 10.1038/nn1882; Longbottom R, 2009, P NATL ACAD SCI USA, V106, P18728, DOI 10.1073/pnas.0902593106; Lukin K, 2008, SEMIN IMMUNOL, V20, P221, DOI 10.1016/j.smim.2008.07.004; Manglapus GL, 2004, J COMP NEUROL, V479, P216, DOI 10.1002/cne.20316; Murdoch B, 2008, J NEUROSCI, V28, P4271, DOI 10.1523/JNEUROSCI.5566-07.2008; Murray RGE, 2003, ASM NEWS, V69, P1; Noda M, 1981, BIOMEDICAL RES S, P449; Orita Y, 2006, ACTA OTO-LARYNGOL, V126, P498, DOI 10.1080/00016480500437419; Packard A, 2011, J COMP NEUROL, V519, P3580, DOI 10.1002/cne.22726; Packard A, 2011, J NEUROSCI, V31, P8748, DOI 10.1523/JNEUROSCI.0681-11.2011; Rodriguez S, 2008, DEV BIOL, V314, P40, DOI 10.1016/j.ydbio.2007.10.056; Schwarting GA, 2007, J MOL HISTOL, V38, P543, DOI 10.1007/s10735-007-9110-9; Schwob James E., 2002, Anatomical Record, V269, P33, DOI 10.1002/ar.10047; Schwob JE, 2008, OLFACTION TASTE, P591; Shou J, 1999, NAT NEUROSCI, V2, P339, DOI 10.1038/7251; Shou JY, 2000, DEVELOPMENT, V127, P5403; SMART IHM, 1971, J ANAT, V109, P243; STEFANINI M, 1967, NATURE, V216, P173, DOI 10.1038/216173a0; Wang X, 2008, J CELL BIOL, V183, P37, DOI 10.1083/jcb.200804030; Weiler E, 1997, J NEUROSCI, V17, P3610; Weiler E, 1998, GLIA, V22, P315, DOI 10.1002/(SICI)1098-1136(199804)22:4<315::AID-GLIA1>3.0.CO;2-2; White PM, 2006, NATURE, V441, P984, DOI 10.1038/nature04849; Wildner H, 2006, DEVELOPMENT, V133, P2105, DOI 10.1242/dev.02345; WILSON POG, 1988, BRIT J EXP PATHOL, V69, P91	47	31	33	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51737	10.1371/journal.pone.0051737	http://dx.doi.org/10.1371/journal.pone.0051737			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284756	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000312435900051
J	Li, GS; Li, HD; Yang, J; Zhang, WQ; Hou, ZS; Li, QC; Zhang, Y				Li, Gui-Shuang; Li, Hai-De; Yang, Jie; Zhang, Wen-Quan; Hou, Zong-Shen; Li, Qing-Chen; Zhang, Yun			Feasibility and Safety of Transthoracic Echocardiography-Guided Transcatheter Closure of Atrial Septal Defects with Deficient Superior-Anterior Rims	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; PERCUTANEOUS CLOSURE; OCCLUDER; UPDATE; ADULTS	Although previous studies showed that transthoracic echocardiography (TTE) can be used to guide transcatheter closure of atrial septal defect (ASD), whether TTE can be used to guide transcatheter closure of secundum ASD with a deficient superior-anterior rim is unknown and this critical issue was addressed in the present study. A total of 280 patients with secundum ASD who underwent transcatheter ASD closure were recruited and divided into groups A and B depending on ASD superior-anterior rim >4 mm (n = 118) or <= 4 mm (n = 162). TTE was used to guide Amplatzer-type septal occluder (ASO) positioning and assess residual shunt. Procedure success was defined as no, trivial and small residual shunt immediately after the procedure as assessed by color Doppler flow imaging. Group A and group B did not differ in complication rate (8.55% vs. 7.55%), procedure success rate (98.3% vs. 95.0%) or complete closure rate immediately after the procedure (89.7% vs. 89.3%) or at 6-month follow-up (98.3% vs. 96.8%). The mean procedure and fluoroscopy time in group B were much longer than those in group A. In conclusion, the absence of a sufficient superior-anterior rim in patients undergoing percutaneous closure of secundum-type ASDs using fluoroscopic and TTE guidance is associated with slightly greater device malposition and migration as well as increased procedural and fluoroscopic times, but the overall complication rate did not differ with TTE guidance when compared to historical controls that used TEE guidance.	[Li, Gui-Shuang; Hou, Zong-Shen; Li, Qing-Chen; Zhang, Yun] Shandong Univ, Qilu Hosp, Dept Cardiol, Chinese Minist Educ,Key Lab Cardiovasc Remodeling, Jinan 250100, Shandong, Peoples R China; [Li, Gui-Shuang; Hou, Zong-Shen; Li, Qing-Chen; Zhang, Yun] Shandong Univ, Qilu Hosp, Dept Cardiol, Chinese Minist Hlth, Jinan 250100, Shandong, Peoples R China; [Li, Hai-De] Yishui Peoples Hosp, Yishui, Shandong, Peoples R China; [Yang, Jie] Shandong Univ, Qilu Hosp, Dept Pediat, Jinan 250100, Shandong, Peoples R China; [Zhang, Wen-Quan] Dezhou Peoples Hosp, Dezhou, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University	Zhang, Y (corresponding author), Shandong Univ, Qilu Hosp, Dept Cardiol, Chinese Minist Educ,Key Lab Cardiovasc Remodeling, Jinan 250100, Shandong, Peoples R China.	zhangyun@sdu.edu.cn			National 973 Basic Research Program of China [2012CB518603, 2011CB503906]; tackle key problems in science and technology of Shandong Province [2010GSF10232]; National High-tech Research and Development Program of China [2012AA02A510]; Program of Introducing Talents of Discipline to Universities [B07035]; State Program of National Natural Science Foundation of China for Innovative Research Group [81021001]; State Key Program of National Natural Science of China [60831003]	National 973 Basic Research Program of China(National Basic Research Program of China); tackle key problems in science and technology of Shandong Province; National High-tech Research and Development Program of China(National High Technology Research and Development Program of China); Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project); State Program of National Natural Science Foundation of China for Innovative Research Group(National Natural Science Foundation of China (NSFC)); State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National 973 Basic Research Program of China (No. 2012CB518603, 2011CB503906), the tackle key problems in science and technology of Shandong Province (No. 2010GSF10232), the National High-tech Research and Development Program of China (No. 2012AA02A510), the Program of Introducing Talents of Discipline to Universities (No. B07035), the State Program of National Natural Science Foundation of China for Innovative Research Group (No. 81021001), and the State Key Program of National Natural Science of China (No. 60831003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres NA, 2005, J AM SOC ECHOCARDIOG, V18, P91, DOI 10.1016/j.echo.2004.11.004; BOUTIN C, 1993, CIRCULATION, V88, P621, DOI 10.1161/01.CIR.88.2.621; Cao QL, 2000, EUR HEART J, V21, P941, DOI 10.1053/euhj.1999.1909; Cheitlin MD, 2003, J AM SOC ECHOCARDIOG, V16, P1091, DOI 10.1016/S0894-7317(03)00685-0; Du ZD, 2002, J AM COLL CARDIOL, V39, P1836, DOI 10.1016/S0735-1097(02)01862-4; Du ZD, 2002, AM J CARDIOL, V90, P865, DOI 10.1016/S0002-9149(02)02709-1; Fischer G, 2003, HEART, V89, P199, DOI 10.1136/heart.89.2.199; Hijazi ZM, 2001, CATHETER CARDIO INTE, V52, P194, DOI 10.1002/1522-726X(200102)52:2<194::AID-CCD1046>3.3.CO;2-W; Huang CF, 2007, J FORMOS MED ASSOC, V106, P986, DOI 10.1016/S0929-6646(08)60073-X; Li GS, 2008, CHINESE MED J-PEKING, V121, P973, DOI 10.1097/00029330-200806010-00003; Li GS, 2009, ULTRASOUND MED BIOL, V35, P58, DOI 10.1016/j.ultrasmedbio.2008.06.008; Lin SM, 2003, ANESTH ANALG, V96, P1584, DOI 10.1213/01.ANE.0000062651.59656.B4; Podnar T, 2001, CATHETER CARDIO INTE, V53, P386, DOI 10.1002/ccd.1187; Rastogi N, 2009, PEDIATR CARDIOL, V30, P888, DOI 10.1007/s00246-009-9452-z; Therrien J, 2001, CAN J CARDIOL, V17, P940; Wang JK, 2004, AM HEART J, V148, P511, DOI 10.1016/j.ahj.2004.01.030; [朱鲜阳 Zhu Xianyang], 2011, [介入放射学杂志, Journal of Interventional Radiology], V20, P3	17	7	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51117	10.1371/journal.pone.0051117	http://dx.doi.org/10.1371/journal.pone.0051117			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284660	gold, Green Published, Green Submitted			2022-12-27	WOS:000312435900012
J	Singh, MM; Howard, A; Irwin, ME; Gao, Y; Lu, XL; Multani, A; Chandra, J				Singh, Melissa M.; Howard, Adrienne; Irwin, Mary E.; Gao, Yin; Lu, Xiaolin; Multani, Asha; Chandra, Joya			Expression and Activity of Fyn Mediate Proliferation and Blastic Features of Chronic Myelogenous Leukemia	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; SRC-FAMILY KINASES; PROTEIN-TYROSINE KINASES; BCR-ABL; GENE-EXPRESSION; SIGNAL-TRANSDUCTION; MOUSE OOCYTES; UP-REGULATION; TUMOR-CELLS; C-SRC	The BCR-ABL1 oncogene is a tyrosine kinase that activates many signaling pathways, resulting in the induction of chronic myeloid leukemia (CML). Kinase inhibitors, such as imatinib, have been developed for the treatment of CML; however, the terminal, blast crisis phase of the disease remains a clinical challenge. Blast crisis CML is difficult to treat due to resistance to tyrosine kinase inhibitors, increased genomic instability and acquired secondary mutations. Our recent studies uncovered a role for Fyn in promoting BCR-ABL1 mediated cell growth and sensitivity to imatinib. Here we demonstrate that Fyn contributes to BCR-ABL1 induced genomic instability, a feature of blast crisis CML. Bone marrow cells and mouse embryonic fibroblasts derived from Fyn knockout mice transduced with BCR-ABL1 display slowed growth and clonogenic potential as compared to Fyn wild-type BCR-ABL1 expressing counterparts. K562 cells overexpressing constitutively active Fyn kinase were larger in size and displayed an accumulation of genomic abnormalities such as chromosomal aberrations and polyploidy. Importantly, loss of Fyn protected mouse embryonic fibroblast cells from increased number of chromosomal aberrations and fragments induced by BCR-ABL1. Together, these results reveal a novel role for Fyn in regulating events required for genomic maintenance and suggest that Fyn kinase activity plays a role in the progression of CML to blast crisis.	[Singh, Melissa M.; Howard, Adrienne; Irwin, Mary E.; Gao, Yin; Lu, Xiaolin; Chandra, Joya] Univ Texas MD Anderson Canc Ctr, Dept Pediat Res, Houston, TX 77030 USA; [Multani, Asha] Univ Texas MD Anderson Canc Ctr, Mol Cytogenet Core Facil, Houston, TX 77030 USA; [Howard, Adrienne; Chandra, Joya] Univ Texas Houston, Hlth Sci Ctr, Grad Sch Biomed Sci, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Chandra, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pediat Res, Houston, TX 77030 USA.	jchandra@mdanderson.org	lu, xl/HDO-8340-2022; Chandra, Joya/ABC-7869-2021	Chandra, Joya/0000-0002-2077-9715	National Institutes of Health [R01CA115811, F32CA150610, F32CA171905]; MD Anderson's Cancer Center [CA016672]; NATIONAL CANCER INSTITUTE [F32CA171905, P30CA016672, F32CA150610, R01CA115811] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MD Anderson's Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research is supported by the National Institutes of Health through R01CA115811 (to JC), F32CA150610 (to MMS), F32CA171905 (to MEI) and MD Anderson's Cancer Center Support Grant (CA016672). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALITALO R, 1990, LEUKEMIA RES, V14, P501, DOI 10.1016/0145-2126(90)90002-Q; Ban KC, 2008, BLOOD, V111, P2904, DOI 10.1182/blood-2007-05-091769; Bhatt AS, 2005, ONCOGENE, V24, P5333, DOI 10.1038/sj.onc.1208582; Bihani T, 2004, CELL CYCLE, V3, P1201; Bihani T, 2007, J BIOL CHEM, V282, P2666, DOI 10.1074/jbc.M608127200; BOLEN JB, 1992, FASEB J, V6, P3403, DOI 10.1096/fasebj.6.15.1281458; Calabretta B, 2004, BLOOD, V103, P4010, DOI 10.1182/blood-2003-12-4111; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; COOPER JA, 1993, CELL, V73, P1051, DOI 10.1016/0092-8674(93)90634-3; Coyne CB, 2006, CELL, V124, P119, DOI 10.1016/j.cell.2005.10.035; DanhauserRiedl S, 1996, CANCER RES, V56, P3589; DAVIDSON D, 1994, J BIOL CHEM, V269, P10956; Dingemans AMC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-152; Doggrell SA, 2005, EXPERT OPIN INV DRUG, V14, P89, DOI 10.1517/13543784.14.1.89; Doki N, 2012, INT J HEMATOL, V95, P167, DOI 10.1007/s12185-011-0994-5; Fenouille N, 2010, CANCER RES, V70, P9659, DOI 10.1158/0008-5472.CAN-10-2034; Fibach E, 2005, CURR PROTOC IMMUNOL, DOI [10.1002/0471142735.im22f07s69, DOI 10.1002/0471142735.IM22F07S69]; Fusaki N, 1997, J BIOL CHEM, V272, P6214, DOI 10.1074/jbc.272.10.6214; Gao Y, 2009, J BIOL CHEM, V284, P7114, DOI 10.1074/jbc.M804801200; Giehl M, 2005, LEUKEMIA, V19, P1192, DOI 10.1038/sj.leu.2403779; Gorre ME, 2002, BLOOD, V100, P3041, DOI 10.1182/blood-2002-05-1361; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; Grosso S, 2009, MOL CANCER THER, V8, P1924, DOI 10.1158/1535-7163.MCT-09-0168; Hu YG, 2004, NAT GENET, V36, P453, DOI 10.1038/ng1343; Juric D, 2007, J CLIN ONCOL, V25, P1341, DOI 10.1200/JCO.2006.09.3534; Kantarjian HM, 2012, BLOOD, V119, P1123, DOI 10.1182/blood-2011-08-376087; Klejman A, 2002, EMBO J, V21, P5766, DOI 10.1093/emboj/cdf562; Kukharskyy V, 2004, EXP CELL RES, V298, P218, DOI 10.1016/j.yexcr.2004.04.016; Lam LT, 2000, J BIOL CHEM, V275, P19676, DOI 10.1074/jbc.M002866200; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Levi M, 2010, MOL CELL ENDOCRINOL, V314, P228, DOI 10.1016/j.mce.2009.08.027; Levi M, 2010, REPRODUCTION, V140, P827, DOI 10.1530/REP-10-0312; Levi M, 2010, CELL CYCLE, V9, P1577, DOI 10.4161/cc.9.8.11299; LEY SC, 1994, J CELL BIOL, V125, P639, DOI 10.1083/jcb.125.3.639; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Lionberger JM, 2000, J BIOL CHEM, V275, P18581, DOI 10.1074/jbc.C000126200; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; McGinnis LK, 2009, DEV BIOL, V327, P280, DOI 10.1016/j.ydbio.2008.11.038; Melo JV, 2007, NAT REV CANCER, V7, P441, DOI 10.1038/nrc2147; Meyn MA, 2006, J BIOL CHEM, V281, P30907, DOI 10.1074/jbc.M605902200; MURPHY SM, 1993, MOL CELL BIOL, V13, P5290, DOI 10.1128/MCB.13.9.5290; Namekata K, 2010, P NATL ACAD SCI USA, V107, P7586, DOI 10.1073/pnas.0914514107; NOWELL PC, 1961, JNCI-J NATL CANCER I, V27, P1013; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Payne CM, 2008, CLIN EXP GASTROENTER, V1, P19; Penserga ETP, 2007, ONCOGENE, V26, P11, DOI 10.1038/sj.onc.1209756; Phipps DJ, 1997, BLOOD, V90, P3603, DOI 10.1182/blood.V90.9.3603; Quackenbush RC, 2000, BLOOD, V95, P2913, DOI 10.1182/blood.V95.9.2913.009k32_2913_2921; Radich JP, 2006, P NATL ACAD SCI USA, V103, P2794, DOI 10.1073/pnas.0510423103; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Resh MD, 1998, INT J BIOCHEM CELL B, V30, P1159, DOI 10.1016/S1357-2725(98)00089-2; ROCHE S, 1995, SCIENCE, V269, P1567, DOI 10.1126/science.7545311; Roginskaya V, 1999, LEUKEMIA, V13, P855, DOI 10.1038/sj.leu.2401429; ROWLEY JD, 1980, CLIN HAEMATOL, V9, P55; RUTHERFORD TR, 1979, NATURE, V280, P164, DOI 10.1038/280164a0; SEIDELDUGAN C, 1992, MOL CELL BIOL, V12, P1835, DOI 10.1128/MCB.12.4.1835; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sette C, 2002, EMBO J, V21, P5386, DOI 10.1093/emboj/cdf553; Shattil SJ, 1998, BLOOD, V91, P2645, DOI 10.1182/blood.V91.8.2645.2645_2645_2657; Shet AS, 2002, LEUKEMIA, V16, P1402, DOI 10.1038/sj.leu.2402577; Skorski T, 2002, NAT REV CANCER, V2, P351, DOI 10.1038/nrc799; TALAMONTI MS, 1993, J CLIN INVEST, V91, P53, DOI 10.1172/JCI116200; Talmor A, 1998, DEV BIOL, V194, P38, DOI 10.1006/dbio.1997.8816; TENHOEVE J, 1994, BLOOD, V84, P1731; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Wilson MB, 2002, ONCOGENE, V21, P8075, DOI 10.1038/sj.onc.1206008; Zamoyska R, 2003, IMMUNOL REV, V191, P107, DOI 10.1034/j.1600-065X.2003.00015.x	67	25	27	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51611	10.1371/journal.pone.0051611	http://dx.doi.org/10.1371/journal.pone.0051611			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284724	Green Submitted, gold, Green Published			2022-12-27	WOS:000312435900033
J	Wei, JR; Huang, JP				Wei, Jianrong; Huang, Jiping			An Exotic Long-Term Pattern in Stock Price Dynamics	PLOS ONE			English	Article							FINANCIAL-MARKETS; EFFICIENT; BEHAVIOR; SYSTEM	Background: To accurately predict the movement of stock prices is always of both academic importance and practical value. So far, a lot of research has been reported to help understand the behavior of stock prices. However, some of the existing theories tend to render us the belief that the time series of stock prices are unpredictable on a long-term timescale. The question arises whether the long-term predictability exists in stock price dynamics. Methodology/Principal Findings: In this work, we analyze the price reversals in the US stock market and the Chinese stock market on the basis of a renormalization method. The price reversals are divided into two types: retracements (the downward trends after upward trends) and rebounds (the upward trends after downward trends), of which the intensities are described by dimensionless quantities, R-t and R-b, respectively. We reveal that for both mature and emerging markets, the distribution of either retracements R-t or rebounds R-b shows two characteristic values, 0.335 and 0.665, both of which are robust over the long term. Conclusions/Significance: The methodology presented here provides a way to quantify the stock price reversals. Our findings strongly support the existence of the long-term predictability in stock price dynamics, and may offer a hint on how to predict the long-term movement of stock prices.	[Huang, Jiping] Fudan Univ, Dept Phys, Shanghai 200433, Peoples R China; Fudan Univ, State Key Lab Surface Phys, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Huang, JP (corresponding author), Fudan Univ, Dept Phys, Shanghai 200433, Peoples R China.	jphuang@fudan.edu.cn			National Natural Science Foundation of China [11075035, 11222544]; Fok Ying Tung Education Foundation [131008]; Shanghai Rising-Star Program [12QA1400200]; CNKBRSF [2011CB922004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fok Ying Tung Education Foundation(Fok Ying Tung Education Foundation); Shanghai Rising-Star Program; CNKBRSF(National Basic Research Program of China)	The authors acknowledge the financial support by the National Natural Science Foundation of China under Grant Nos. 11075035 and 11222544, by Fok Ying Tung Education Foundation (No. 131008), by Shanghai Rising-Star Program (No. 12QA1400200), and by CNKBRSF (2011CB922004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya S., 2006, ANN ECON FINANC, V7, P219; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Caraiani P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040693; Cont R, 2001, QUANT FINANC, V1, P223, DOI [10.1080/713665670, 10.1088/1469-7688/1/2/304]; FAMA EF, 1970, J FINANC, V25, P383, DOI 10.2307/2325486; Fama EF, 1965, FINANC ANAL J, V21, P55, DOI 10.2469/faj.v51.n1.1861; Farmer JD, 2009, NATURE, V460, P685, DOI 10.1038/460685a; Fuentes MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008243; HSIEH DA, 1991, J FINANC, V46, P1839, DOI 10.2307/2328575; Johnson N. F., 2003, FINANCIAL MARKET COM; Kenett D.Y., 2010, AUCO CZECH EC REV, V4, P330; Kenett DY, 2012, EPL-EUROPHYS LETT, V99, DOI 10.1209/0295-5075/99/38001; Kenett DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031144; Kenett DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019378; Lux T., 2000, INT J THEORETICAL AP, V3, P675, DOI DOI 10.1142/S0219024900000826; MALKIEL BG, 1989, SCIENCE, V243, P1313, DOI 10.1126/science.243.4896.1313; Mantegna RN, 1996, NATURE, V383, P587, DOI 10.1038/383587a0; MANTEGNA RN, 1995, NATURE, V376, P46, DOI 10.1038/376046a0; Mantegna RN, 1999, PHYSICA A, V274, P216, DOI 10.1016/S0378-4371(99)00395-7; Mittermayer M.A., 2004, P 37 HAW INT C SOC S; Pai PF, 2005, OMEGA-INT J MANAGE S, V33, P497, DOI 10.1016/j.omega.2004.07.024; Peters E.E., 1994, FRACTAL MARKET ANAL; Prechter R., 1998, ELLIOTT WAVE PRINCIP; Preis T, 2011, P NATL ACAD SCI USA, V108, P7674, DOI 10.1073/pnas.1019484108; Preis T, 2010, J STAT PHYS, V138, P431, DOI 10.1007/s10955-009-9914-y; Schoneburg E., 1990, Neurocomputing, V2, P17, DOI 10.1016/0925-2312(90)90013-H; Shapira Y, 2011, AIP ADV, V1, DOI 10.1063/1.3598412; Shapira Y, 2009, EUR PHYS J B, V72, P657, DOI 10.1140/epjb/e2009-00384-y; Song KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033588; Trippi R.R., 1995, CHAOS NONLINEAR DYNA; Wang W, 2009, P NATL ACAD SCI USA, V106, P8423, DOI 10.1073/pnas.0811782106; Wang YF, 2002, EXPERT SYST APPL, V22, P33, DOI 10.1016/S0957-4174(01)00047-1	32	8	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51666	10.1371/journal.pone.0051666	http://dx.doi.org/10.1371/journal.pone.0051666			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284734	Green Published, Green Submitted, gold			2022-12-27	WOS:000312435900039
J	Crawford, DC; Jiang, XP; Taylor, A; Moulder, KL; Mennerick, S				Crawford, Devon C.; Jiang, Xiaoping; Taylor, Amanda; Moulder, Krista L.; Mennerick, Steven			Differential Requirement for Protein Synthesis in Presynaptic Unmuting and Muting in Hippocampal Glutamate Terminals	PLOS ONE			English	Article							LONG-TERM POTENTIATION; ACTIVE ZONE; NEUROTRANSMITTER RELEASE; SYNAPTIC-TRANSMISSION; POSTSYNAPTIC MECHANISMS; TRANSCRIPTION FACTOR; GENE-TRANSCRIPTION; PHORBOL ESTERS; GRANULE CELLS; LATE-PHASE	Synaptic function and plasticity are crucial for information processing within the nervous system. In glutamatergic hippocampal neurons, presynaptic function is silenced, or muted, after strong or prolonged depolarization. This muting is neuroprotective, but the underlying mechanisms responsible for muting and its reversal, unmuting, remain to be clarified. Using cultured rat hippocampal neurons, we found that muting induction did not require protein synthesis; however, slow forms of unmuting that depend on protein kinase A (PKA), including reversal of depolarization-induced muting and forskolin-induced unmuting of basally mute synapses, required protein synthesis. In contrast, fast unmuting of basally mute synapses by phorbol esters was protein synthesis-independent. Further studies of recovery from depolarization-induced muting revealed that protein levels of Rim1 and Munc13-1, which mediate vesicle priming, correlated with the functional status of presynaptic terminals. Additionally, this form of unmuting was prevented by both transcription and translation inhibitors, so proteins are likely synthesized de novo after removal of depolarization. Phosphorylated cyclic adenosine monophosphate response element-binding protein (pCREB), a nuclear transcription factor, was elevated after recovery from depolarization-induced muting, consistent with a model in which PKA-dependent mechanisms, possibly including pCREB-activated transcription, mediate slow unmuting. In summary, we found that protein synthesis was required for slower, PKA-dependent unmuting of presynaptic terminals, but it was not required for muting or a fast form of unmuting. These results clarify some of the molecular mechanisms responsible for synaptic plasticity in hippocampal neurons and emphasize the multiple mechanisms by which presynaptic function is modulated. Citation: Crawford DC, Jiang X, Taylor A, Moulder KL, Mennerick S (2012) Differential Requirement for Protein Synthesis in Presynaptic Unmuting and Muting in Hippocampal Glutamate Terminals. PLoS ONE 7(12): e51930. doi:10.1371/journal.pone.0051930	[Crawford, Devon C.; Jiang, Xiaoping; Taylor, Amanda; Moulder, Krista L.; Mennerick, Steven] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Crawford, Devon C.] Washington Univ, Sch Med, Grad Program Neurosci, St Louis, MO 63110 USA; [Mennerick, Steven] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Mennerick, Steven] Washington Univ, Sch Med, Taylor Family Inst Innovat Psychiat Res, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Mennerick, S (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.	menneris@psychiatry.wustl.edu	Mennerick, Steven/O-2806-2017	Mennerick, Steven/0000-0003-0868-0664; Crawford, Devon/0000-0002-9354-4976	National Institutes of Health [NS066611, DA015948, MH078823, NS52823]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS066611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA015948] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The studies were supported by the National Institutes of Health grants NS066611 (DCC), DA015948 (KLM), MH078823 (SM), and NS52823 (SM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Andrews-Zwilling YS, 2006, J BIOL CHEM, V281, P19720, DOI 10.1074/jbc.M601421200; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; Bramham CR, 2008, CURR OPIN NEUROBIOL, V18, P524, DOI 10.1016/j.conb.2008.09.013; Calakos N, 2004, NEURON, V42, P889, DOI 10.1016/j.neuron.2004.05.014; Chang CY, 2010, J NEUROSCI, V30, P10048, DOI 10.1523/JNEUROSCI.1159-10.2010; Chavis P, 1998, NEURON, V20, P773, DOI 10.1016/S0896-6273(00)81015-6; Crawford DC, 2012, NEUROSCIENTIST, V18, P216, DOI 10.1177/1073858411418525; Crawford DC, 2011, J NEUROSCI, V31, P979, DOI 10.1523/JNEUROSCI.4960-10.2011; Crawford DC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008166; Deng LB, 2011, NEURON, V69, P317, DOI 10.1016/j.neuron.2011.01.005; DUBINSKY JM, 1990, J NEUROBIOL, V21, P414, DOI 10.1002/neu.480210304; DUFFY C, 1981, SCIENCE, V212, P1148, DOI 10.1126/science.7233208; Duncan RR, 1999, J BIOL CHEM, V274, P27347, DOI 10.1074/jbc.274.39.27347; GERBER G, 1989, J NEUROSCI, V9, P3606; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Goold CP, 2010, NEURON, V68, P512, DOI 10.1016/j.neuron.2010.09.020; Hogins J, 2011, NEUROBIOL DIS, V43, P516, DOI 10.1016/j.nbd.2011.05.005; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Jancic D, 2009, CEREB CORTEX, V19, P2535, DOI 10.1093/cercor/bhp004; Jiang XP, 2010, J NEUROSCI, V30, P1798, DOI 10.1523/JNEUROSCI.4965-09.2010; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kaeser PS, 2012, P NATL ACAD SCI USA, V109, P11830, DOI 10.1073/pnas.1209318109; Kaneko M, 2004, J NEUROSCI, V24, P5202, DOI 10.1523/JNEUROSCI.0999-04.2004; Kauderer BS, 2000, P NATL ACAD SCI USA, V97, P13342, DOI 10.1073/pnas.97.24.13342; Khodthong C, 2011, CELL METAB, V14, P254, DOI 10.1016/j.cmet.2011.07.002; Kohara K, 2001, NEUROSCI RES, V41, P79, DOI 10.1016/S0168-0102(01)00267-X; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; Lonart G, 2003, CELL, V115, P49, DOI 10.1016/S0092-8674(03)00727-X; Ma L, 1999, NAT NEUROSCI, V2, P24, DOI 10.1038/4525; Manahan-Vaughan D, 2000, J NEUROSCI, V20, P8572, DOI 10.1523/JNEUROSCI.20-22-08572.2000; MEINKOTH JL, 1993, MOL CELL BIOCHEM, V128, P179, DOI 10.1007/BF01076769; MENNERICK S, 1995, J NEUROPHYSIOL, V73, P320, DOI 10.1152/jn.1995.73.1.320; Moulder KL, 2004, NEURON, V42, P423, DOI 10.1016/S0896-6273(04)00184-9; Moulder KL, 2003, J NEUROSCI, V23, P1825; Moulder KL, 2010, J VIS EXP, V35, pe1676; Moulder KL, 2008, J NEUROSCI, V28, P5159, DOI 10.1523/JNEUROSCI.5317-07.2008; Moulder KL, 2006, J NEUROSCI, V26, P6618, DOI 10.1523/JNEUROSCI.5498-05.2006; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Ninan I, 2004, NEURON, V42, P129, DOI 10.1016/S0896-6273(04)00143-6; Pfeiffer BE, 2006, J NEUROSCI, V26, P7147, DOI 10.1523/JNEUROSCI.1797-06.2006; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; Sajikumar S, 2005, CURR OPIN NEUROBIOL, V15, P607, DOI 10.1016/j.conb.2005.08.009; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Sokolova IV, 2006, J NEUROPHYSIOL, V95, P2570, DOI 10.1152/jn.00617.2005; STANTON PK, 1984, J NEUROSCI, V4, P3080; Stevens CF, 1998, NEURON, V21, P885, DOI 10.1016/S0896-6273(00)80603-0; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Ting JT, 2007, P NATL ACAD SCI USA, V104, P353, DOI 10.1073/pnas.0608807104; Tong G, 1996, NEURON, V16, P1147, DOI 10.1016/S0896-6273(00)80141-5; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Watts VJ, 2005, PHARMACOL THERAPEUT, V106, P405, DOI 10.1016/j.pharmthera.2004.12.005; Waung MW, 2009, CURR OPIN NEUROBIOL, V19, P319, DOI 10.1016/j.conb.2009.03.011	63	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51930	10.1371/journal.pone.0051930	http://dx.doi.org/10.1371/journal.pone.0051930			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272190	Green Submitted, Green Published, gold			2022-12-27	WOS:000312386600049
J	Pfister, TD; Hollingshead, M; Kinders, RJ; Zhang, YP; Evrard, YA; Ji, JP; Khin, SA; Borgel, S; Stotler, H; Carter, J; Divelbiss, R; Kummar, S; Pommier, Y; Parchment, RE; Tomaszewski, JE; Doroshow, JH				Pfister, Thomas D.; Hollingshead, Melinda; Kinders, Robert J.; Zhang, Yiping; Evrard, Yvonne A.; Ji, Jiuping; Khin, Sonny A.; Borgel, Suzanne; Stotler, Howard; Carter, John; Divelbiss, Raymond; Kummar, Shivaani; Pommier, Yves; Parchment, Ralph E.; Tomaszewski, Joseph E.; Doroshow, James H.			Development and Validation of an Immunoassay for Quantification of Topoisomerase I in Solid Tumor Tissues	PLOS ONE			English	Article							DNA COVALENT COMPLEXES; PARP INHIBITOR ABT-888; ADP-RIBOSE POLYMERASE; CELL-LINES; CAMPTOTHECIN ACTIVITY; CLEAVAGE COMPLEXES; COLORECTAL-CANCER; ANTICANCER DRUG; PHASE-I; TOPOTECAN	Background: Topoisomerase I (Top1) is a proven target for cancer therapeutics. Recent data from the Fluorouracil, Oxaliplatin, CPT-11: Use and Sequencing (FOCUS) trial demonstrated that nuclear staining of Top1 correlates with chemotherapeutic efficacy. Such a correlation may help identify patients likely to respond to Top1 inhibitors and illuminate their mechanism of action. Cellular response to Top1 inhibitors is complex, but Top1 target engagement is a necessary first step in this process. This paper reports the development and validation of a quantitative immunoassay for Top1 in tumors. Methodology/Principal Findings: We have developed and validated a two-site enzyme chemiluminescent immunoassay for quantifying Top1 levels in tumor biopsies. Analytical validation of the assay established the inter-day coefficient of variation at 9.3%+/- 3.4% and a 96.5%+/- 7.3% assay accuracy. Preclinical fit-for-purpose modeling of topotecan time- and dose-effects was performed using topotecan-responsive and -nonresponsive xenografts in athymic nude mice. Higher baseline levels of Top1 were observed in topotecan-responsive than -nonresponsive tumors. Top1 levels reached a maximal decrease 4 to 7 hours following treatment of engrafted mice with topotecan and the indenoisoquinoline NSC 724998. Conclusions/Significance: Our analysis of Top1 levels in control and treated tumors supports the previously proposed mechanism of action for Top1 inhibitor efficacy, wherein higher baseline Top1 levels lead to formation of more covalent-complex-dependent double-strand break damage and, ultimately, cell death. In contrast, xenografts with lower baseline Top1 levels accumulate fewer double-stand breaks, and may be more resistant to Top1 inhibitors. Our results support further investigation into the use of Top1 levels in tumors as a potential predictive biomarker. The Top1 immunoassay described in this paper has been incorporated into a Phase I clinical trial at the National Cancer Institute to assess pharmacodynamic response in tumor biopsies and determine whether baseline Top1 levels are predictive of response to indenoisoquinoline Top1 inhibitors.	[Pfister, Thomas D.; Kinders, Robert J.; Khin, Sonny A.; Parchment, Ralph E.] Frederick Natl Lab Canc Res, SAIC Frederick Inc, Appl Dev Res Support Directorate, Lab Human Toxicol & Pharmacol, Frederick, MD USA; [Hollingshead, Melinda] Frederick Natl Lab Canc Res, Biol Testing Branch, Dev Therapeut Program, Frederick, MD USA; [Zhang, Yiping; Ji, Jiuping] Frederick Natl Lab Canc Res, SAIC Frederick Inc, Natl Clin Target Validat Lab, Frederick, MD USA; [Kummar, Shivaani; Tomaszewski, Joseph E.; Doroshow, James H.] NCI, Div Canc Treatment & Diag, Ctr Canc Res, Bethesda, MD 20892 USA; [Pommier, Yves; Doroshow, James H.] NCI, Mol Pharmacol Lab, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pfister, TD (corresponding author), Frederick Natl Lab Canc Res, SAIC Frederick Inc, Appl Dev Res Support Directorate, Lab Human Toxicol & Pharmacol, Frederick, MD USA.	pfistert@mail.nih.gov			National Cancer Institute, National Institutes of Health (NIH) [HHSN261200800001E]; Intramural Research Program of the NIH; National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC006150, ZIABC011078, ZIABC006161] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole or in part by federal funds from the National Cancer Institute, National Institutes of Health (NIH), under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. This research was supported [in part] by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony S, 2003, CANCER RES, V63, P7428; Antony S, 2007, CANCER RES, V67, P10397, DOI 10.1158/0008-5472.CAN-07-0938; Baker AF, 2005, CLIN CANCER RES, V11, P4338, DOI 10.1158/1078-0432.CCR-05-0422; Balasubramanian BN, 2004, J MED CHEM, V47, P1609, DOI 10.1021/jm034197s; BEIDLER DR, 1995, MOL PHARMACOL, V47, P907; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Bookman MA, 1998, J CLIN ONCOL, V16, P3345, DOI 10.1200/JCO.1998.16.10.3345; Braun MS, 2008, J CLIN ONCOL, V26, P2690, DOI 10.1200/JCO.2007.15.5580; Burgess DJ, 2008, P NATL ACAD SCI USA, V105, P9053, DOI 10.1073/pnas.0803513105; BURKE TG, 1994, J MED CHEM, V37, P40, DOI 10.1021/jm00027a005; COVEY JM, 1989, CANCER RES, V49, P5016; Desai SD, 2000, ANN NY ACAD SCI, V922, P306; Desai SD, 2003, MOL CELL BIOL, V23, P2341, DOI 10.1128/MCB.23.7.2341-2350.2003; Desai SD, 2001, CANCER RES, V61, P5926; Devy J, 2004, ANTICANCER RES, V24, P1745; Ferrier CM, 1999, BRIT J CANCER, V79, P1534, DOI 10.1038/sj.bjc.6690245; Fu Q, 1999, MOL PHARMACOL, V55, P677; Furuta T, 2002, P AM ASSOC CANC RES, V43, P835; GIOVANELLA BC, 1989, SCIENCE, V246, P1046, DOI 10.1126/science.2555920; GOLDWASSER F, 1995, CANCER RES, V55, P2116; Hollingshead MG, 2007, P 2007 AACR NCI EORT, P262; HSIANG YH, 1988, CANCER RES, V48, P1722; Kinders RJ, 2008, CLIN CANCER RES, V14, P6877, DOI 10.1158/1078-0432.CCR-08-0214; Kinders RJ, 2010, CLIN CANCER RES, V16, P5447, DOI 10.1158/1078-0432.CCR-09-3076; Koopman M, 2007, LANCET, V370, P135, DOI 10.1016/S0140-6736(07)61086-1; Koopman M, 2009, EUR J CANCER, V45, P1999, DOI 10.1016/j.ejca.2009.04.017; Kummar S, 2011, CANCER RES, V71, P5626, DOI 10.1158/0008-5472.CAN-11-1227; Kurtzberg LS, 2008, MOL CANCER THER, V7, P3212, DOI 10.1158/1535-7163.MCT-08-0568; Li TK, 2003, CANCER RES, V63, P8400; Liebes L, 1998, CLIN CANCER RES, V4, P545; Lin CP, 2008, J BIOL CHEM, V283, P21074, DOI 10.1074/jbc.M803493200; Lin CP, 2009, J BIOL CHEM, V284, P28084, DOI 10.1074/jbc.M109.030601; Makeyev Y, 2012, DNA TOPOISOMERASES C, P245; Miao ZH, 2007, CANCER RES, V67, P8752, DOI 10.1158/0008-5472.CAN-06-4554; Nechiporchik N, 2010, EJC SUPPL, V8, P64, DOI 10.1016/S1359-6349(10)71894-2; Pfister TD, 2009, MOL CANCER THER, V8, P1878, DOI 10.1158/1535-7163.MCT-09-0016; Plowman J, 1997, ANTICANCER DRUG DEV, P101; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pommier Y, 2009, CHEM REV, V109, P2894, DOI 10.1021/cr900097c; Pommier Y, 2009, MOL CANCER THER, V8, P1008, DOI 10.1158/1535-7163.MCT-08-0706; ROWINSKY EK, 1992, J CLIN ONCOL, V10, P647, DOI 10.1200/JCO.1992.10.4.647; Sooryakumar D, 2011, MOL CANCER THER, V10, P1490, DOI 10.1158/1535-7163.MCT-10-1043; Teicher BA, 2008, BIOCHEM PHARMACOL, V75, P1262, DOI 10.1016/j.bcp.2007.10.016; Urasaki Y, 2001, CANCER RES, V61, P504; Wang LH, 2010, CLIN CANCER RES, V16, P1073, DOI 10.1158/1078-0432.CCR-09-2799; Yeh I-Tien, 2002, Am J Clin Pathol, V117 Suppl, pS26; Yu NY, 2007, ANTICANCER RES, V27, P2541; Zamboni WC, 1998, J NATL CANCER I, V90, P505, DOI 10.1093/jnci/90.7.505	48	16	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e50494	10.1371/journal.pone.0050494	http://dx.doi.org/10.1371/journal.pone.0050494			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23284638	Green Published, Green Submitted, gold			2022-12-27	WOS:000313051500005
J	Hou, XH; Tang, ZL; Liu, HL; Wang, N; Ju, HM; Li, K				Hou, Xinhua; Tang, Zhonglin; Liu, Honglin; Wang, Ning; Ju, Huiming; Li, Kui			Discovery of MicroRNAs Associated with Myogenesis by Deep Sequencing of Serial Developmental Skeletal Muscles in Pigs	PLOS ONE			English	Article							OSTEOBLAST DIFFERENTIATION; PROMOTES MIGRATION; EXPRESSION; BONE; INVASION; CELLS; BMP2; MYOD; MYOBLASTS; PROFILES	MicroRNAs (miRNAs) are short, single-stranded non-coding RNAs that repress their target genes by binding their 3' UTRs. These RNAs play critical roles in myogenesis. To gain knowledge about miRNAs involved in the regulation of myogenesis, porcine longissimus muscles were collected from 18 developmental stages (33-, 40-, 45-, 50-, 55-, 60-, 65-, 70-, 75-, 80-, 85-, 90-, 95-, 100- and 105-day post-gestation fetuses, 0 and 10-day postnatal piglets and adult pigs) to identify miRNAs using Solexa sequencing technology. We detected 197 known miRNAs and 78 novel miRNAs according to comparison with known miRNAs in the miRBase (release 17.0) database. Moreover, variations in sequence length and single nucleotide polymorphisms were also observed in 110 known miRNAs. Expression analysis of the 11 most abundant miRNAs were conducted using quantitative PCR (qPCR) in eleven tissues (longissimus muscles, leg muscles, heart, liver, spleen, lung, kidney, stomach, small intestine and colon), and the results revealed that ssc-miR-378, ssc-miR-1 and ssc-miR-206 were abundantly expressed in skeletal muscles. During skeletal muscle development, the expression level of ssc-miR-378 was low at 33 days post-coitus (dpc), increased at 65 and 90 dpc, peaked at postnatal day 0, and finally declined and maintained a comparatively stable level. This expression profile suggested that ssc-miR-378 was a new candidate miRNA for myogenesis and participated in skeletal muscle development in pigs. Target prediction and KEGG pathway analysis suggested that bone morphogenetic protein 2 (BMP2) and mitogen-activated protein kinase 1 (MAPK1), both of which were relevant to proliferation and differentiation, might be the potential targets of miR-378. Luciferase activities of report vectors containing the 3'UTR of porcine BMP2 or MAPK1 were downregulated by miR-378, which suggested that miR-378 probably regulated myogenesis though the regulation of these two genes.	[Hou, Xinhua; Liu, Honglin] Nanjing Agr Univ, Coll Anim Sci & Technol, Dept Anim Genet Breeding & Reprod, Nanjing, Jiangsu, Peoples R China; [Hou, Xinhua; Tang, Zhonglin; Ju, Huiming; Li, Kui] Chinese Acad Agr Sci, Inst Anim Sci, Minist Agr, Key Lab Farm Anim Genet Resources & Germplasm Inn, Beijing 100193, Peoples R China; [Wang, Ning] NE Agr Univ, Coll Anim Sci & Technol, Haerbin, Peoples R China	Nanjing Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Ministry of Agriculture & Rural Affairs; Northeast Agricultural University - China	Tang, ZL (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Minist Agr, Key Lab Farm Anim Genet Resources & Germplasm Inn, Beijing 100193, Peoples R China.	zhonglinqy_99@sina.com; liuhonglin@njau.edu.cn	liu, honglin/HDN-0409-2022	liu, honglin/0000-0002-1254-3163	National Natural Science Foundation of China [30830080, 31171192 31000993]; National Basic Research Program of China [2009CB941604]; National Key Project [2009ZX08010-022B, 2011ZX08009-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National Key Project	This work was supported by National Natural Science Foundation of China (30830080, 31171192 31000993), National Basic Research Program of China (2009CB941604) and National Key Project (2009ZX08010-022B, 2011ZX08009-001). The funders had no role in study design, data collection and analysis, dicision to publish, or preparation of the manuscript.	Ai J, 2010, BIOCHEM BIOPH RES CO, V391, P73, DOI 10.1016/j.bbrc.2009.11.005; Aoyama K, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-44; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Bonfini L, 1996, TRENDS BIOCHEM SCI, V21, P257, DOI 10.1016/S0968-0004(96)10033-5; Cardinali B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007607; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Clape C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007542; Crist CG, 2009, P NATL ACAD SCI USA, V106, P13383, DOI 10.1073/pnas.0900210106; Dong QC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010147; Fernandez-Valverde SL, 2010, RNA, V16, P1881, DOI 10.1261/rna.2379610; Fujita Y, 2010, J BIOL CHEM, V285, P19076, DOI 10.1074/jbc.M109.079525; Gagan J, 2011, J BIOL CHEM, V286, P19431, DOI 10.1074/jbc.M111.219006; Jin H, 2012, APPL MICROBIOL BIOT, V93, P1715, DOI 10.1007/s00253-011-3865-3; Kahai S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007535; Kang MH, 2010, EXP CELL RES, V316, P24, DOI 10.1016/j.yexcr.2009.10.010; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Katagiri T, 2002, GENES CELLS, V7, P949, DOI 10.1046/j.1365-2443.2002.00573.x; Katagiri T, 1997, EXP CELL RES, V230, P342, DOI 10.1006/excr.1996.3432; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; LEFAUCHEUR L, 1995, DEV DYNAM, V203, P27, DOI 10.1002/aja.1002030104; Liang SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018409; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Lu YH, 2004, BIOCHEM BIOPH RES CO, V313, P709, DOI 10.1016/j.bbrc.2003.12.007; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Martineza I, 2011, P NATL ACAD SCI USA, V108, P522, DOI 10.1073/pnas.1017346108; MASCARELLO F, 1992, J ANIM SCI, V70, P1806, DOI 10.2527/1992.7061806x; McDaneld TG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-77; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Nielsen M, 2010, ANIM GENET, V41, P159, DOI 10.1111/j.1365-2052.2009.01981.x; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Shin KH, 2011, BIOCHEM BIOPH RES CO, V404, P896, DOI 10.1016/j.bbrc.2010.12.055; Shingara J, 2005, RNA, V11, P1461, DOI 10.1261/rna.2610405; Suga T, 2007, CELL TISSUE RES, V329, P103, DOI 10.1007/s00441-007-0416-4; Suzuki D, 2012, CALCIFIED TISSUE INT, V91, P88, DOI 10.1007/s00223-012-9614-5; Sweetman D, 2008, DEV BIOL, V321, P491, DOI 10.1016/j.ydbio.2008.06.019; Tang ZL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r115; Tian YY, 2010, J BIOL CHEM, V285, P7986, DOI 10.1074/jbc.M109.062877; Trang P, 2010, ONCOGENE, V29, P1580, DOI 10.1038/onc.2009.445; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220; Wei Q, 2001, FEBS LETT, V490, P171, DOI 10.1016/S0014-5793(01)02120-2; WIGMORE PMC, 1983, J ANAT, V137, P235; Xie SS, 2010, ANIM GENET, V41, P179, DOI 10.1111/j.1365-2052.2009.01991.x; Xu CQ, 2007, J CELL SCI, V120, P3045, DOI 10.1242/jcs.010728; Yamamoto N, 1997, BIOCHEM BIOPH RES CO, V238, P574, DOI 10.1006/bbrc.1997.7325; Zhang J, 2012, J BIOL CHEM, V287, P21093, DOI 10.1074/jbc.M111.330381; Zhang JM, 1999, EMBO J, V18, P926, DOI 10.1093/emboj/18.4.926; Zhao SP, 2012, INT J BIOL SCI, V8, P459, DOI 10.7150/ijbs.3821; Zhou B, 2010, ANIM GENET, V41, P499, DOI 10.1111/j.1365-2052.2010.02026.x	53	67	79	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52123	10.1371/journal.pone.0052123	http://dx.doi.org/10.1371/journal.pone.0052123			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284895	Green Submitted, gold, Green Published			2022-12-27	WOS:000313158800032
J	Yao, PP; Qian, L; Xia, Y; Xu, F; Yang, ZN; Xie, RH; Li, X; Liang, WF; Huang, XX; Zhu, ZY; Zhu, HP				Yao, Ping-Ping; Qian, Lei; Xia, Yong; Xu, Fang; Yang, Zhang-Nv; Xie, Rong-Hui; Li, Xiao; Liang, Wei-Feng; Huang, Xiao-Xiao; Zhu, Zhi-Yong; Zhu, Han-Ping			Enterovirus 71-Induced Neurological Disorders in Young Gerbils, Meriones unguiculatus: Development and Application of a Neurological Disease Model	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; 71 INFECTION; MOUTH-DISEASE; NEWBORN MICE; OUTBREAK; CHILDREN; TAIWAN; LETHAL; HAND; FOOT	A reliable disease model mimicking Enterovirus 71 (EV71) infection in humans is essential for understanding pathogenesis and for developing a safe and effective vaccine. Commonly used rodent models including mouse or rat models are not suitable for vaccine evaluation because the rodents are resistant to EV71 infection after they reach the age of 6 days. In this study, 21-day-old gerbils inoculated intraperitoneally (IP) with a non mouse-adapted EV71 strain developed neurological lesion-related signs including hind limb paralysis, slowness, ataxia and lethargy similar to those of central nervous system (CNS) infection of EV71 in humans. The infected gerbils eventually died of the neurological lesions and EV71 could be isolated from lung, liver, spleen, kidney, heart, spinal cord, brain cortex, brainstem and skeletal muscle. Significantly high virus replication was detected in spinal cord, brainstem and skeletal muscle by cellular analysis, real-time quantitative PCR (RT-PCR) and immunohistochemical staining. Histopathologic changes such as neuronal degeneration, neuronal loss and neuronophagia were observed in spinal cord, brain cortex, brainstem, and skeletal muscle along with necrotizing myositis and splenic atrophy. Gerbils that received two doses of inactive whole-virus vaccine showed no EV71-specific symptoms after challenged with EV71. In contrast, gerbils that received mock vaccination died of EV71-induced neuropathology after challenged with EV71. The result indicates that gerbils can serve as a reliable disease model for evaluating safety and efficacy of EV71 vaccine.	[Yao, Ping-Ping; Qian, Lei; Xia, Yong; Xu, Fang; Yang, Zhang-Nv; Xie, Rong-Hui; Zhu, Zhi-Yong; Zhu, Han-Ping] Zhejiang Prov Ctr Dis Prevent & Control, Key Lab Vaccine Hemorrhag Fever Renal Syndrome, Hangzhou, Zhejiang, Peoples R China; [Li, Xiao] First Municipal Hosp Hangzhou, Dept Pathol, Hangzhou, Zhejiang, Peoples R China; [Liang, Wei-Feng; Huang, Xiao-Xiao] Hangzhou Sixth Peoples Hosp, Hangzhou, Zhejiang, Peoples R China		Zhu, HP (corresponding author), Zhejiang Prov Ctr Dis Prevent & Control, Key Lab Vaccine Hemorrhag Fever Renal Syndrome, Hangzhou, Zhejiang, Peoples R China.	hanpingzhu@yahoo.com.cn			Natural Science Foundation of Zhejiang Province [Y3100701]; Medical and Technological Project of Zhejiang Province [2010KYB027]	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Medical and Technological Project of Zhejiang Province	The work was granted by Natural Science Foundation of Zhejiang Province (Y3100701) and Medical and Technological Project of Zhejiang Province (2010KYB027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bek EJ, 2011, VACCINE, V29, P4829, DOI 10.1016/j.vaccine.2011.04.070; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chen CY, 2001, AM J NEURORADIOL, V22, P200; Chen YC, 2004, J GEN VIROL, V85, P69, DOI 10.1099/vir.0.19423-0; Chung CY, 2010, VACCINE, V28, P6951, DOI 10.1016/j.vaccine.2010.08.052; Chung YC, 2008, VACCINE, V26, P1855, DOI 10.1016/j.vaccine.2008.01.058; CROSS J H, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P183; Foo DGW, 2007, MICROBES INFECT, V9, P1299, DOI 10.1016/j.micinf.2007.06.002; GILBERT GL, 1988, PEDIATR INFECT DIS J, V7, P484, DOI 10.1097/00006454-198807000-00007; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; HSIUNG GD, 1994, HSIUNGS DIAGNOSTIC V, P119; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Ito Y, 1997, J CLIN MICROBIOL, V35, P1710, DOI 10.1128/JCM.35.7.1710-1714.1997; Khong WX, 2011, J VIROL, V85, P3067, DOI 10.1128/JVI.01779-10; Liu CC, 2000, J CLIN VIROL, V17, P23, DOI 10.1016/S1386-6532(00)00068-8; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; Nagata N, 2002, J MED VIROL, V67, P207, DOI 10.1002/jmv.2209; Ong KC, 2008, J NEUROPATH EXP NEUR, V67, P532, DOI 10.1097/NEN.0b013e31817713e7; Ong KC, 2010, J VIROL, V84, P661, DOI 10.1128/JVI.00999-09; REED L. J., 1938, AMER JOUR HYG, V27, P493; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Shimizu H, 1999, JPN J INFECT DIS, V52, P12; SHINDAROV LM, 1979, J HYG EPID MICROB IM, V23, P284; Tan EL, 2008, J CLIN VIROL, V42, P203, DOI 10.1016/j.jcv.2008.01.001; Tung Wong Siew, 2007, Genet Vaccines Ther, V5, P6, DOI 10.1186/1479-0556-5-6; Wang SM, 2003, J INFECT DIS, V188, P564, DOI 10.1086/376998; Wang SM, 1999, CLIN INFECT DIS, V29, P184, DOI 10.1086/520149; Wang YF, 2004, J VIROL, V78, P7916, DOI 10.1128/JVI.78.15.7916-7924.2004; Wu CN, 2001, VACCINE, V20, P895, DOI 10.1016/S0264-410X(01)00385-1; Xu J, 2010, VACCINE, V28, P3516, DOI 10.1016/j.vaccine.2010.03.003; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Yu CK, 2000, J BIOMED SCI, V7, P523, DOI 10.1007/BF02253368; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhu ZY, 1986, VIROLOGICA SINICA, V1, P19	34	24	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e51996	10.1371/journal.pone.0051996	http://dx.doi.org/10.1371/journal.pone.0051996			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284845	Green Published, Green Submitted, gold			2022-12-27	WOS:000313158800020
J	Bjorck, HM; Renner, J; Maleki, S; Nilsson, SFE; Kihlberg, J; Folkersen, L; Karlsson, M; Ebbers, T; Eriksson, P; Lanne, T				Bjorck, Hanna M.; Renner, Johan; Maleki, Shohreh; Nilsson, Siv F. E.; Kihlberg, Johan; Folkersen, Lasse; Karlsson, Matts; Ebbers, Tino; Eriksson, Per; Lanne, Toste			Characterization of Shear-Sensitive Genes in the Normal Rat Aorta Identifies Hand2 as a Major Flow-Responsive Transcription Factor	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ENDOTHELIAL-CELLS; DISTURBED FLOW; IN-VIVO; STRESS; EXPRESSION; ACTIVATION; MECHANISMS; CHANNELS; OSCILLATIONS	Objective: Shear forces play a key role in the maintenance of vessel wall integrity. Current understanding regarding shear-dependent gene expression is mainly based on in vitro or in vivo observations with experimentally deranged shear, hence reflecting acute molecular events in relation to flow. Our objective was to combine computational fluid dynamic (CFD) simulations with global microarray analysis to study flow-dependent vessel wall biology in the aortic wall under physiological conditions. Methods and Results: Male Wistar rats were used. Animal-specific wall shear stress (WSS) magnitude and vector direction were estimated using CFD based on aortic geometry and flow information acquired by magnetic resonance imaging. Two distinct flow pattern regions were identified in the normal rat aortic arch; the distal part of the lesser curvature being exposed to low WSS and a non-uniform vector direction, and a region along the greater curvature being subjected to markedly higher levels of WSS and a uniform vector direction. Microarray analysis identified numerous novel mechanosensitive genes, including Trpc4 and Fgf12, and confirmed well-known ones, e. g. Klf2 and Nrf2. Gene ontology analysis revealed an over-representation of genes involved in transcriptional regulation. The most differentially expressed gene, Hand2, is a transcription factor previously shown to be involved in extracellular matrix remodeling. HAND2 protein was endothelial specific and showed higher expression in the regions exposed to low WSS with disturbed flow. Conclusions: Microarray analysis validated the CFD-defined WSS regions in the rat aortic arch, and identified numerous novel shear-sensitive genes. Defining the functional importance of these genes in relation to atherosusceptibility may provide important insight into the understanding of vascular pathology.	[Bjorck, Hanna M.; Kihlberg, Johan; Ebbers, Tino; Lanne, Toste] Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth Sci, Div Cardiovasc Med, Linkoping, Sweden; [Bjorck, Hanna M.; Renner, Johan; Kihlberg, Johan; Karlsson, Matts; Ebbers, Tino; Lanne, Toste] Linkoping Univ, Ctr Med Image Sci & Visualizat CMIV, Linkoping, Sweden; [Renner, Johan; Karlsson, Matts; Ebbers, Tino] Linkoping Univ, Dept Management & Engn, Div Appl Thermodynam & Fluid Mech, Linkoping, Sweden; [Maleki, Shohreh; Folkersen, Lasse; Eriksson, Per] Karolinska Inst, Dept Med, Ctr Mol Med, Atherosclerosis Res Unit, Solna, Sweden; [Nilsson, Siv F. E.] Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth Sci, Div Drug Res, Linkoping, Sweden; [Kihlberg, Johan] Linkoping Univ Hosp, Div Radiol, S-58185 Linkoping, Sweden	Linkoping University; Linkoping University; Linkoping University; Karolinska Institutet; Linkoping University; Linkoping University	Bjorck, HM (corresponding author), Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth Sci, Div Cardiovasc Med, Linkoping, Sweden.	hanna.bjorck@ki.se	Ebbers, Tino/ABB-8488-2021; Björck, Hanna/AFU-6554-2022	Ebbers, Tino/0000-0003-1395-8296; Eriksson, Per/0000-0002-5635-2692; Lanne, Toste/0000-0002-9095-403X; Folkersen, Lasse/0000-0003-0708-9530	Swedish Heart-Lung Foundation; Swedish Research Council; European Commission (FAD) [Health-F2-2008-200647]; County Council of Ostergotland; Elanora Demeroutis Foundation, Linkoping; Goljes Memorial Foundation; Linkoping University Heart Foundation	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Commission (FAD)(European CommissionEuropean Commission Joint Research Centre); County Council of Ostergotland; Elanora Demeroutis Foundation, Linkoping; Goljes Memorial Foundation; Linkoping University Heart Foundation	The study was supported by grants from the Swedish Heart-Lung Foundation; the Swedish Research Council; the European Commission (FAD;Health-F2-2008-200647); County Council of Ostergotland; Elanora Demeroutis Foundation, Linkoping; Goljes Memorial Foundation and Linkoping University Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmmed GU, 2005, PFLUG ARCH EUR J PHY, V451, P131, DOI 10.1007/s00424-005-1461-z; Berk BC, 2008, CIRCULATION, V117, P1082, DOI 10.1161/CIRCULATIONAHA.107.720730; Boon RA, 2009, HAMOSTASEOLOGIE, V29, P39, DOI 10.1055/s-0037-1616937; Chien S, 2008, ANN BIOMED ENG, V36, P554, DOI 10.1007/s10439-007-9426-3; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Civelek M, 2009, CIRC RES, V105, P453, DOI 10.1161/CIRCRESAHA.109.203711; Conway DE, 2010, AM J PHYSIOL-HEART C, V298, pH367, DOI 10.1152/ajpheart.00565.2009; Dekker RJ, 2002, BLOOD, V100, P1689, DOI 10.1182/blood-2002-01-0046; Di A, 2010, CURR OPIN PHARMACOL, V10, P127, DOI 10.1016/j.coph.2009.11.010; Du J, 2008, AM J PHYSIOL-RENAL, V294, pF909, DOI 10.1152/ajprenal.00606.2007; Fledderus JO, 2008, ARTERIOSCL THROM VAS, V28, P1339, DOI 10.1161/ATVBAHA.108.165811; Fledderus JO, 2007, BLOOD, V109, P4249, DOI 10.1182/blood-2006-07-036020; Garcia-Cardena G, 2001, ANN NY ACAD SCI, V947, P1; Gautam M, 2006, CELL BIOCHEM BIOPHYS, V46, P277, DOI 10.1385/CBB:46:3:277; Greve JM, 2006, AM J PHYSIOL-HEART C, V291, pH1700, DOI 10.1152/ajpheart.00274.2006; Heiberg Einar, 2010, BMC Med Imaging, V10, P1, DOI 10.1186/1471-2342-10-1; Helmlinger G, 1996, J VASC RES, V33, P360, DOI 10.1159/000159164; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Janiczek RL, 2011, MAGN RESON MED, V66, P1382, DOI 10.1002/mrm.22937; Jow F, 1999, J MEMBRANE BIOL, V171, P127, DOI 10.1007/s002329900565; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; LaMack JA, 2010, ANN BIOMED ENG, V38, P2252, DOI 10.1007/s10439-010-0030-6; Liu SQ, 2003, AM J PHYSIOL-HEART C, V285, pH1072, DOI 10.1152/ajpheart.01009.2002; Marconcini L, 1999, P NATL ACAD SCI USA, V96, P9671, DOI 10.1073/pnas.96.17.9671; Metodieva SN, 2011, TUMORI, V97, P86, DOI 10.1177/030089161109700116; Mohan S, 1999, AM J PHYSIOL-CELL PH, V276, pC1100, DOI 10.1152/ajpcell.1999.276.5.C1100; Nagel T, 1999, ARTERIOSCL THROM VAS, V19, P1825, DOI 10.1161/01.ATV.19.8.1825; Nayak L, 2011, ANTIOXID REDOX SIGN, V15, P1449, DOI 10.1089/ars.2010.3647; Ni CW, 2010, BLOOD, V116, pE66, DOI 10.1182/blood-2010-04-278192; Passerini AG, 2004, P NATL ACAD SCI USA, V101, P2482, DOI 10.1073/pnas.0305938101; PFEILSCHIFTER J, 1984, BIOCHEM J, V223, P855, DOI 10.1042/bj2230855; Renner J., 2009, WSEAS Transactions on Fluid Mechanics, V4, P148; Rowell J, 2010, J CARDIOVASC TRANSL, V3, P516, DOI 10.1007/s12265-010-9208-4; Suo J, 2007, ARTERIOSCL THROM VAS, V27, P346, DOI 10.1161/01.ATV.0000253492.45717.46; Tada S, 2002, AM J PHYSIOL-HEART C, V282, pH576, DOI 10.1152/ajpheart.00751.2001; Villarreal G, 2010, BIOCHEM BIOPH RES CO, V391, P984, DOI 10.1016/j.bbrc.2009.12.002; WANG DM, 1995, J BIOMECH ENG-T ASME, V117, P358, DOI 10.1115/1.2794192; Wang LY, 2012, CIRC-CARDIOVASC GENE, V5, P234, DOI 10.1161/CIRCGENETICS.111.961763; Wang NP, 2006, BIOCHEM BIOPH RES CO, V341, P1244, DOI 10.1016/j.bbrc.2006.01.089; Wang Q, 2010, DEV CELL, V18, P157, DOI 10.1016/j.devcel.2009.11.004; Wasserman SM, 2002, PHYSIOL GENOMICS, V12, P13, DOI 10.1152/physiolgenomics.00102.2002; White SJ, 2011, J CELL PHYSIOL, V226, P2841, DOI 10.1002/jcp.22629; Willett NJ, 2010, ARTERIOSCL THROM VAS, V30, P2099, DOI 10.1161/ATVBAHA.110.211532; Wu JH, 2008, J BIOL CHEM, V283, P3942, DOI 10.1074/jbc.M707882200; Yamagishi H, 2000, J CLIN INVEST, V105, P261, DOI 10.1172/JCI8856; Yin CY, 2010, DEV CELL, V18, P973, DOI 10.1016/j.devcel.2010.05.009; Yip KP, 2011, AM J PHYSIOL-RENAL, V300, pF540, DOI 10.1152/ajprenal.00544.2009	48	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52227	10.1371/journal.pone.0052227	http://dx.doi.org/10.1371/journal.pone.0052227			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284944	gold, Green Published, Green Submitted			2022-12-27	WOS:000312794500119
J	Kim, MI; Shin, I; Cho, S; Lee, J; Rhee, S				Kim, Myung-Il; Shin, Inchul; Cho, Suhee; Lee, Jeehyun; Rhee, Sangkee			Structural and Functional Insights into (S)-Ureidoglycolate Dehydrogenase, a Metabolic Branch Point Enzyme in Nitrogen Utilization	PLOS ONE			English	Article							NAD(P)H-DEPENDENT OXIDOREDUCTASES; CRYSTAL-STRUCTURE; ALLANTOIN; FAMILY; DEGRADATION; CATABOLISM; SOFTWARE; PATHWAY; MODEL	Nitrogen metabolism is one of essential processes in living organisms. The catabolic pathways of nitrogenous compounds play a pivotal role in the storage and recovery of nitrogen. In Escherichia coli, two different, interconnecting metabolic routes drive nitrogen utilization through purine degradation metabolites. The enzyme (S)-ureidoglycolate dehydrogenase (AllD), which is a member of L-sulfolactate dehydrogenase-like family, converts (S)-ureidoglycolate, a key intermediate in the purine degradation pathway, to oxalurate in an NAD(P)-dependent manner. Therefore, AllD is a metabolic branch-point enzyme for nitrogen metabolism in E. coli. Here, we report crystal structures of AllD in its apo form, in a binary complex with NADH cofactor, and in a ternary complex with NADH and glyoxylate, a possible spontaneous degradation product of oxalurate. Structural analyses revealed that NADH in an extended conformation is bound to an NADH-binding fold with three distinct domains that differ from those of the canonical NADH-binding fold. We also characterized ligand-induced structural changes, as well as the binding mode of glyoxylate, in the active site near the NADH nicotinamide ring. Based on structural and kinetic analyses, we concluded that AllD selectively utilizes NAD+ as a cofactor, and further propose that His116 acts as a general catalytic base and that a hydride transfer is possible on the B-face of the nicotinamide ring of the cofactor. Other residues conserved in the active sites of this novel L-sulfolactate dehydrogenase-like family also play essential roles in catalysis.	[Kim, Myung-Il; Shin, Inchul; Cho, Suhee; Lee, Jeehyun; Rhee, Sangkee] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Rhee, Sangkee] Seoul Natl Univ, Ctr Fungal Pathogenesis, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Rhee, S (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.	srheesnu@snu.ac.kr			Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center) [PJ008059]; Rural Development Administration; National Research Foundation [R11-2008-062-01002-0, 2010-0025883]; Ministry of Education, Science and Technology, Republic of Korea	Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center)(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); National Research Foundation; Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a grant from the Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center number PJ008059), Rural Development Administration, and from National Research Foundation (R11-2008-062-01002-0 and 2010-0025883), the Ministry of Education, Science and Technology, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Atkins C, 2000, PROKARYOTIC NITROGEN FIXATION, P559; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cendron L, 2007, J BIOL CHEM, V282, P18182, DOI 10.1074/jbc.M701297200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cusa E, 1999, J BACTERIOL, V181, P7479, DOI 10.1128/JB.181.24.7479-7484.1999; Desimone M, 2002, PLANT CELL, V14, P847, DOI 10.1105/tpc.010458; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forouhar F, 2004, J BIOL CHEM, V279, P13148, DOI 10.1074/jbc.M313580200; French JB, 2010, J BIOL CHEM, V285, P35446, DOI 10.1074/jbc.M110.156034; Goto M, 2005, J BIOL CHEM, V280, P40875, DOI 10.1074/jbc.M507399200; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hennebry SC, 2009, FEBS J, V276, P5367, DOI 10.1111/j.1742-4658.2009.07246.x; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Irimia A, 2004, EMBO J, V23, P1234, DOI 10.1038/sj.emboj.7600147; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kim K, 2007, J BIOL CHEM, V282, P23457, DOI 10.1074/jbc.M703211200; Kim K, 2009, J MOL BIOL, V387, P1067, DOI 10.1016/j.jmb.2009.02.041; Muramatsu H, 2005, J BIOL CHEM, V280, P5329, DOI 10.1074/jbc.M411918200; Muramatsu H, 2005, J BIOSCI BIOENG, V99, P541, DOI 10.1263/jbb.99.541; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ramazzina I, 2006, NAT CHEM BIOL, V2, P144, DOI 10.1038/nchembio768; Ramazzina I, 2008, J BIOL CHEM, V283, P23295, DOI 10.1074/jbc.M801195200; Rintoul MR, 2002, J MOL BIOL, V324, P599, DOI 10.1016/S0022-2836(02)01134-8; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; Serventi F, 2010, ACS CHEM BIOL, V5, P203, DOI 10.1021/cb900248n; Shin I, 2012, J BIOL CHEM, V287, P18796, DOI 10.1074/jbc.M111.331819; VANDERDRIFT C, 1971, ARCH BIOCHEM BIOPHYS, V145, P465, DOI 10.1016/S0003-9861(71)80006-1; VOGELS GD, 1976, BACTERIOL REV, V40, P403, DOI 10.1128/MMBR.40.2.403-468.1976; Wang WH, 2008, PLANT SCI, V175, P467, DOI 10.1016/j.plantsci.2008.05.018; Werner AK, 2010, NAT CHEM BIOL, V6, P19, DOI [10.1038/NCHEMBIO.265, 10.1038/nchembio.265]	33	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52066	10.1371/journal.pone.0052066	http://dx.doi.org/10.1371/journal.pone.0052066			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284870	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500081
J	Lai, CTM; Chow, PC; Wong, SJ; Chan, KW; Cheung, YF				Lai, Clare T. M.; Chow, Pak-cheong; Wong, Sophia J.; Chan, Koon-wing; Cheung, Yiu-fai			Circulating Annexin A5 Levels after Atrial Switch for Transposition of the Great Arteries: Relationship with Ventricular Deformation and Geometry	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; CARDIOVASCULAR MAGNETIC-RESONANCE; LATE GADOLINIUM ENHANCEMENT; SYSTEMIC RIGHT VENTRICLE; HEART-FAILURE; DILATED CARDIOMYOPATHY; MYOCARDIAL-INFARCTION; COLLAGEN; PLASMA; APOPTOSIS	Background: Inflammatory cytokines, cardiomyocyte apoptosis, and altered collagen turnover may contribute to unfavourable ventricular remodeling. This unfavourable ventricular remodelling is well documented in patients after atrial switch operation for complete transposition of the great arteries. We therefore tested if levels of circulating markers of inflammation, apoptosis, collagen synthesis, and extracellular matrix degradation are altered in patients after atrial switch operation for transposition of the great arteries. Methods and Results: Circulating tumour necrosis factor (TNF)-alpha, annexin A5 (AnxA5), carboxy-terminal propeptide of type I procollagen (PICP), amino-terminal propeptide of type III procollagen (PIIINP), matrix metalloproteinase-1 (MMP-1), and tissue inhibitor of metalloproteinase-1 (TIMP-1) levels were determined in 27 patients aged 25.2+/-3.1 years and 20 controls. Ventricular myocardial deformation and left ventricular eccentricity index (EI) were determined by speckle tracking and two-dimensional echocardiography, respectively. Compared with controls, patients had significantly higher circulating AnxA5 (p<0.001) and TNF-alpha (p = 0.018) levels, but similar PICP, PIIINP, MMP-1 and TIMP-1 levels. For the whole cohort, plasma AnxA5 correlated with serum TNF-alpha (p = 0.002), systemic ventricular global longitudinal strain (GLS) and systolic and early diastolic strain rate (all p<0.001), and subpulmonary ventricular GLS and early diastolic strain rate (both p<0.001). In patients, plasma AnxA5 level correlated positively with subpulmonary ventricular EI (p = 0.027). Multiple linear regression analysis identified systemic ventricular GLS (beta = -0.50, p<0.001) and serum TNF-alpha (beta = 0.29, p = 0.022) as significant correlates of plasma AnxA5. Conclusions: Elevated plasma AnxA5 level in patients after atrial switch operation is associated with impaired systemic myocardial deformation, increased subpulmonary ventricular eccentricity, and increased serum TNF-alpha level.	[Lai, Clare T. M.; Chow, Pak-cheong; Wong, Sophia J.; Chan, Koon-wing; Cheung, Yiu-fai] Univ Hong Kong, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Cheung, YF (corresponding author), Univ Hong Kong, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China.	xfcheung@hku.hk	CHOW, PAK CHEONG/GYU-4767-2022; Cheung, Yiu Fai/C-4240-2009	Cheung, Yiu Fai/0000-0002-7279-4992				Awad AE, 2010, AM J PHYSIOL-CELL PH, V298, pC679, DOI 10.1152/ajpcell.00351.2009; Babu-Narayan SV, 2005, CIRCULATION, V111, P2091, DOI 10.1161/01.CIR.0000162463.61626.3B; Boersma HH, 2005, J NUCL MED, V46, P2035; Boyajyan AS, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-55; Bradham WS, 2002, CARDIOVASC RES, V53, P822, DOI 10.1016/S0008-6363(01)00503-X; Campian ME, 2009, J NUCL MED, V50, P1371, DOI 10.2967/jnumed.108.061366; Chow PC, 2008, HEART, V94, P855, DOI 10.1136/hrt.2007.131862; Chow PC, 2011, INT J CARDIOL, V152, P28, DOI 10.1016/j.ijcard.2010.05.078; DIEZ J, 1995, CIRCULATION, V91, P1450, DOI 10.1161/01.CIR.91.5.1450; Dos L, 2005, HEART, V91, P652, DOI 10.1136/hrt.2003.029769; Fedak PWM, 2005, CARDIOVASC PATHOL, V14, P1, DOI 10.1016/j.carpath.2004.12.002; GENGE BR, 1992, J BONE MINER RES, V7, P807, DOI 10.1002/jbmr.5650070710; George J, 2005, AM HEART J, V150, P484, DOI 10.1016/j.ahj.2004.11.016; Hammerschmidt S, 2004, AM J RESP CELL MOL, V30, P396, DOI 10.1165/rcmb.2003-0136OC; Haudek SB, 2007, J CLIN INVEST, V117, P2692, DOI 10.1172/JCI29134; Hrycek A, 2012, RHEUMATOL INT, V32, P1335, DOI 10.1007/s00296-011-1793-2; Kaneko N, 1996, CLIN CHIM ACTA, V251, P65, DOI 10.1016/0009-8981(96)06294-8; Kapadia SR, 2000, J AM COLL CARDIOL, V36, P208, DOI 10.1016/S0735-1097(00)00721-X; Khairy P, 2004, CARDIOL YOUNG, V14, P284, DOI 10.1017/S1047951104003063; Lopez B, 2006, J AM COLL CARDIOL, V48, P89, DOI 10.1016/j.jacc.2006.01.077; Lopez B, 2010, CIRCULATION, V121, P1645, DOI 10.1161/CIRCULATIONAHA.109.912774; Lubiszewska B, 2000, J AM COLL CARDIOL, V36, P1365, DOI 10.1016/S0735-1097(00)00864-0; Matsuda R, 2003, RESUSCITATION, V57, P171, DOI 10.1016/S0300-9572(03)00034-0; Radauceanu A, 2008, J CARD FAIL, V14, P467, DOI 10.1016/j.cardfail.2008.02.014; Ravassa S, 2007, EUR HEART J, V28, P2785, DOI 10.1093/eurheartj/ehm370; Ravassa S, 2010, CARDIOVASC RES, V88, P304, DOI 10.1093/cvr/cvq183; Redheuil A, 2008, J CARDIOVASC MAGN R, pA195; ROMISCH J, 1992, BLOOD COAGUL FIBRIN, V3, P11; Roos-Hesselink JW, 2004, EUR HEART J, V25, P1264, DOI 10.1016/j.ehj.2004.03.009; Rossi A, 2004, HEART, V90, P650, DOI 10.1136/hrt.2002.005371; RYAN T, 1985, J AM COLL CARDIOL, V5, P918, DOI 10.1016/S0735-1097(85)80433-2; Schwartzkopff B, 2002, EUR J HEART FAIL, V4, P439, DOI 10.1016/S1388-9842(02)00092-2; Sharma R, 2003, AM J CARDIOL, V92, P188, DOI 10.1016/S0002-9149(03)00536-8; Siwik DA, 2000, CIRC RES, V86, P1259, DOI 10.1161/01.RES.86.12.1259; Timonen P, 2008, INT J CARDIOL, V124, P293, DOI 10.1016/j.ijcard.2007.02.004; van Tits LJ, 2009, BIOCHEM BIOPH RES CO, V390, P161, DOI 10.1016/j.bbrc.2009.09.102; VANHEERDE WL, 1995, THROMB HAEMOSTASIS, V73, P172; Vohringer M, 2007, HERZ, V32, P129, DOI 10.1007/s00059-007-2972-5; Warnes CA, 2006, CIRCULATION, V114, P2699, DOI 10.1161/CIRCULATIONAHA.105.592352	39	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52125	10.1371/journal.pone.0052125	http://dx.doi.org/10.1371/journal.pone.0052125			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284897	Green Published, gold			2022-12-27	WOS:000312794500096
J	Diamond, JM; Porteous, MK; Cantu, E; Meyer, NJ; Shah, RJ; Lederer, DJ; Kawut, SM; Lee, J; Bellamy, SL; Palmer, SM; Lama, VN; Bhorade, SM; Crespo, M; Demissie, E; Wille, K; Orens, J; Shah, PD; Weinacker, A; Weill, D; Arcasoy, S; Wilkes, DS; Ware, LB; Christie, JD				Diamond, Joshua M.; Porteous, Mary K.; Cantu, Edward; Meyer, Nuala J.; Shah, Rupal J.; Lederer, David J.; Kawut, Steven M.; Lee, James; Bellamy, Scarlett L.; Palmer, Scott M.; Lama, Vibha N.; Bhorade, Sangeeta M.; Crespo, Maria; Demissie, Ejigayehu; Wille, Keith; Orens, Jonathan; Shah, Pali D.; Weinacker, Ann; Weill, David; Arcasoy, Selim; Wilkes, David S.; Ware, Lorraine B.; Christie, Jason D.		Lung Transplant Outcomes Grp	Elevated Plasma Angiopoietin-2 Levels and Primary Graft Dysfunction after Lung Transplantation	PLOS ONE			English	Article							ISHLT WORKING GROUP; CARDIOPULMONARY BYPASS; CIRCULATING ANGIOPOIETIN-2; VASCULAR-PERMEABILITY; PULMONARY; ENDOTHELIN-1; MORTALITY; CHILDREN; OUTCOMES; SEPSIS	Introduction: Primary graft dysfunction (PGD) is a significant contributor to early morbidity and mortality after lung transplantation. Increased vascular permeability in the allograft has been identified as a possible mechanism leading to PGD. Angiopoietin-2 serves as a partial antagonist to the Tie-2 receptor and induces increased endothelial permeability. We hypothesized that elevated Ang2 levels would be associated with development of PGD. Methods: We performed a case-control study, nested within the multi-center Lung Transplant Outcomes Group cohort. Plasma angiopoietin-2 levels were measured pre-transplant and 6 and 24 hours post-reperfusion. The primary outcome was development of grade 3 PGD in the first 72 hours. The association of angiopoietin-2 plasma levels and PGD was evaluated using generalized estimating equations (GEE). Results: There were 40 PGD subjects and 79 non-PGD subjects included for analysis. Twenty-four PGD subjects (40%) and 47 non-PGD subjects (59%) received a transplant for the diagnosis of idiopathic pulmonary fibrosis (IPF). Among all subjects, GEE modeling identified a significant change in angiopoietin-2 level over time in cases compared to controls (p = 0.03). The association between change in angiopoietin-2 level over the perioperative time period was most significant in patients with a pre-operative diagnosis of IPF (p = 0.02); there was no statistically significant correlation between angiopoietin-2 plasma levels and the development of PGD in the subset of patients transplanted for chronic obstructive pulmonary disease (COPD) (p = 0.9). Conclusions: Angiopoietin-2 levels were significantly associated with the development of PGD after lung transplantation. Further studies examining the regulation of endothelial cell permeability in the pathogenesis of PGD are indicated.	[Diamond, Joshua M.; Meyer, Nuala J.; Shah, Rupal J.; Kawut, Steven M.; Lee, James; Bellamy, Scarlett L.; Demissie, Ejigayehu; Christie, Jason D.] Univ Penn, Perelman Sch Med, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA; [Porteous, Mary K.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Cantu, Edward] Univ Penn, Sch Med, Div Cardiovasc Surg, Philadelphia, PA 19104 USA; [Lederer, David J.; Arcasoy, Selim] Columbia Univ Coll Phys & Surg, Div Pulm Allergy & Crit Care Med, New York, NY USA; [Kawut, Steven M.; Demissie, Ejigayehu; Christie, Jason D.] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Kawut, Steven M.] Univ Penn, Sch Med, Penn Cardiovasc Inst, Philadelphia, PA 19104 USA; [Palmer, Scott M.] Duke Univ, Div Pulm Allergy & Crit Care Med, Raleigh, NC USA; [Lama, Vibha N.] Univ Michigan, Div Pulm Allergy & Crit Care Med, Ann Arbor, MI 48109 USA; [Bhorade, Sangeeta M.] Univ Chicago, Div Pulm & Crit Care Med, Chicago, IL 60637 USA; [Wille, Keith] Univ Alabama Birmingham, Div Pulm & Crit Care Med, Birmingham, AL USA; [Orens, Jonathan; Shah, Pali D.] Johns Hopkins Univ Hosp, Dept Med, Div Pulm Allergy & Crit Care Med, Baltimore, MD 21205 USA; [Weinacker, Ann; Weill, David] Stanford Univ, Div Pulm & Crit Care Med, Palo Alto, CA 94304 USA; [Wilkes, David S.] Indiana Univ Sch Med, Div Pulm Allergy Crit Care & Occupat Med, Indianapolis, IN USA; [Wilkes, David S.] Indiana Univ, Hlth Lung Transplant Program, Indianapolis, IN 46204 USA; [Ware, Lorraine B.] Vanderbilt Univ, Dept Med, Nashville, TN USA; [Ware, Lorraine B.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN USA; [Crespo, Maria] Univ Pittsburgh, Div Pulm Allergy & Crit Care, Pittsburgh, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Columbia University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Duke University; University of Michigan System; University of Michigan; University of Chicago; University of Alabama System; University of Alabama Birmingham; Johns Hopkins University; Johns Hopkins Medicine; Stanford University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; Vanderbilt University; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Diamond, JM (corresponding author), Univ Penn, Perelman Sch Med, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA.	joshua.diamond@uphs.upenn.edu	Ware, Lorraine/AAJ-9307-2021; Arcasoy, Selim M/AAR-6637-2020; Lederer, David/W-7957-2018	Ware, Lorraine/0000-0002-9429-4702; Lederer, David/0000-0001-5258-0228; Palmer, Scott/0000-0002-1370-3771; Bellamy, Scarlett/0000-0002-2906-4046; Christie, Jason/0000-0003-0519-218X	National Institutes of Health [R01 HL087115, R01 HL081619, K24 HL103844, K12 HL090021]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081619, K12HL090021, R01HL087115, K23HL102254, K24HL103836, K23HL116656, T32HL007891, K24HL103844] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by National Institutes of Health grants R01 HL087115, R01 HL081619, K24 HL103844, and K12 HL090021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBA R, 1994, ANN THORAC SURG, V57, P715, DOI 10.1016/0003-4975(94)90573-8; Arcasoy SM, 2005, J HEART LUNG TRANSPL, V24, P1483, DOI 10.1016/j.healun.2004.11.314; Bhandari V, 2006, NAT MED, V12, P1286, DOI 10.1038/nm1494; Brudney CS, 2005, J CARDIOTHOR VASC AN, V19, P188, DOI 10.1053/j.jvca.2005.01.029; Christie JD, 2010, J HEART LUNG TRANSPL, V29, P1231, DOI 10.1016/j.healun.2010.05.013; Christie JD, 2005, J HEART LUNG TRANSPL, V24, P1454, DOI 10.1016/j.healun.2004.11.049; Christie JD, 2005, AM J RESP CRIT CARE, V171, P1312, DOI 10.1164/rccm.200409-1243OC; Christie JD, 2003, CHEST, V124, P1232, DOI 10.1378/chest.124.4.1232; Christie JD, 1998, CHEST, V114, P51, DOI 10.1378/chest.114.1.51; Diamond JM, 2011, AM J TRANSPLANT, V11, P561, DOI 10.1111/j.1600-6143.2010.03431.x; Diamond JM, 2011, AM J TRANSPLANT, V11, P2517, DOI 10.1111/j.1600-6143.2011.03702.x; Diamond JM, 2010, CURR OPIN ORGAN TRAN, V15, P552, DOI 10.1097/MOT.0b013e32833e1415; Fang XH, 2010, J BIOL CHEM, V285, P26211, DOI 10.1074/jbc.M110.119917; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Fremont RD, 2010, J TRAUMA, V68, P1121, DOI 10.1097/TA.0b013e3181c40728; Gallagher DC, 2008, SHOCK, V29, P656, DOI 10.1097/SHK.0b013e31815dd92f; Gammie JS, 1998, J THORAC CARDIOV SUR, V115, P990, DOI 10.1016/S0022-5223(98)70396-4; Giuliano JS, 2008, INTENS CARE MED, V34, P1851, DOI 10.1007/s00134-008-1174-9; Giuliano JS, 2007, SHOCK, V28, P650, DOI 10.1097/shk.0b013e318123867b; Krenn K, 2007, AM J TRANSPLANT, V7, P700, DOI 10.1111/j.1600-6143.2006.01673.x; Krenn K, 2007, EUR J CARDIO-THORAC, V32, P35, DOI 10.1016/j.ejcts.2007.04.006; Kumpers P, 2010, EUR HEART J, V31, P2291, DOI 10.1093/eurheartj/ehq226; Kuntz CL, 2009, CLIN TRANSPLANT, V23, P819, DOI 10.1111/j.1399-0012.2008.00951.x; Lederer DJ, 2011, AM J RESP CRIT CARE, V184, P1055, DOI 10.1164/rccm.201104-0728OC; Lee James C, 2009, Proc Am Thorac Soc, V6, P39, DOI 10.1513/pats.200808-082GO; Lee WL, 2011, CURR OPIN HEMATOL, V18, P191, DOI 10.1097/MOH.0b013e328345a3d1; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Margaritopoulos GA, 2010, INT J MOL MED, V26, P919, DOI 10.3892/ijmm_00000543; Mei SHJ, 2007, PLOS MED, V4, P1525, DOI 10.1371/journal.pmed.0040269; Meyer NJ, 2011, AM J RESP CRIT CARE, V183, P1344, DOI 10.1164/rccm.201005-0701OC; Minhas N, 2010, FASEB J, V24, P873, DOI 10.1096/fj.09-134445; Ong T, 2010, CRIT CARE MED, V38, P1845, DOI 10.1097/CCM.0b013e3181eaa5bf; Orfanos SE, 2007, CRIT CARE MED, V35, P199, DOI 10.1097/01.CCM.0000251640.77679.D7; Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046; Salama M, 2010, AM J TRANSPLANT, V10, P628, DOI 10.1111/j.1600-6143.2009.02957.x; Taghavi S, 2002, J HEART LUNG TRANSPL, V21, P600, DOI 10.1016/S1053-2498(01)00346-1	36	23	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51932	10.1371/journal.pone.0051932	http://dx.doi.org/10.1371/journal.pone.0051932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284823	gold, Green Published, Green Submitted			2022-12-27	WOS:000312694300063
J	Suetta, C; Frandsen, U; Jensen, L; Jensen, MM; Jespersen, JG; Hvid, LG; Bayer, M; Petersson, SJ; Schroder, HD; Andersen, JL; Heinemeier, KM; Aagaard, P; Schjerling, P; Kjaer, M				Suetta, Charlotte; Frandsen, Ulrik; Jensen, Line; Jensen, Mette Munk; Jespersen, Jakob G.; Hvid, Lars G.; Bayer, Monika; Petersson, Stine J.; Schroder, Henrik D.; Andersen, Jesper L.; Heinemeier, Katja M.; Aagaard, Per; Schjerling, Peter; Kjaer, Michael			Aging Affects the Transcriptional Regulation of Human Skeletal Muscle Disuse Atrophy	PLOS ONE			English	Article							HUMAN QUADRICEPS MUSCLE; NF-KAPPA-B; UBIQUITIN LIGASES; PROTEIN-SYNTHESIS; GENE-EXPRESSION; MESSENGER-RNA; LIMB IMMOBILIZATION; PROTEASOME PATHWAY; APOPTOSIS; RAT	Important insights concerning the molecular basis of skeletal muscle disuse-atrophy and aging related muscle loss have been obtained in cell culture and animal models, but these regulatory signaling pathways have not previously been studied in aging human muscle. In the present study, muscle atrophy was induced by immobilization in healthy old and young individuals to study the time-course and transcriptional factors underlying human skeletal muscle atrophy. The results reveal that irrespectively of age, mRNA expression levels of MuRF-1 and Atrogin-1 increased in the very initial phase (2-4 days) of human disuse-muscle atrophy along with a marked reduction in PGC-1 alpha and PGC-1 beta (1-4 days) and a similar to 10% decrease in myofiber size (4 days). Further, an age-specific decrease in Akt and S6 phosphorylation was observed in young muscle within the first days (1-4 days) of immobilization. In contrast, Akt phosphorylation was unchanged in old muscle after 2 days and increased after 4 days of immobilization. Further, an age-specific down-regulation of MuRF-1 and Atrogin-1 expression levels was observed following 2 weeks of immobilization, along with a slowing atrophy response in aged skeletal muscle. Neither the immediate loss of muscle mass, nor the subsequent age-differentiated signaling responses could be explained by changes in inflammatory mediators, apoptosis markers or autophagy indicators. Collectively, these findings indicate that the time-course and regulation of human skeletal muscle atrophy is age dependent, leading to an attenuated loss in aging skeletal muscle when exposed to longer periods of immobility-induced disuse.	[Suetta, Charlotte; Jensen, Line; Jespersen, Jakob G.; Bayer, Monika; Andersen, Jesper L.; Heinemeier, Katja M.; Schjerling, Peter; Kjaer, Michael] Univ Copenhagen, Bispebjerg Hosp, Fac Hlth Sci, Inst Sports Med, Copenhagen, Denmark; [Suetta, Charlotte; Jensen, Line; Jespersen, Jakob G.; Bayer, Monika; Andersen, Jesper L.; Heinemeier, Katja M.; Schjerling, Peter; Kjaer, Michael] Univ Copenhagen, Bispebjerg Hosp, Fac Hlth Sci, Ctr Healthy Aging, Copenhagen, Denmark; [Frandsen, Ulrik; Jensen, Line; Jensen, Mette Munk; Hvid, Lars G.; Aagaard, Per] Univ So Denmark, Inst Exercise Physiol & Clin Biomech, Odense, Denmark; [Petersson, Stine J.; Schroder, Henrik D.] Odense Univ Hosp, Dept Clin Pathol, DK-5000 Odense, Denmark; [Suetta, Charlotte] Univ Copenhagen, Glostrup Hosp, Dept Clin Physiol & Nucl Med, Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Bispebjerg Hospital; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Copenhagen	Suetta, C (corresponding author), Univ Copenhagen, Bispebjerg Hosp, Fac Hlth Sci, Inst Sports Med, Copenhagen, Denmark.	csuetta@gmail.com	Schjerling, Peter/F-6194-2011; Schrøder, Henrik Daa/E-2077-2013; Bayer, Monika/ABE-4909-2020; Andersen, Jesper L/W-6813-2019; Kjaer, Michael/W-6842-2019; suetta, charlotte/AAK-1257-2020	Schjerling, Peter/0000-0001-7138-3211; Schrøder, Henrik Daa/0000-0001-7588-235X; Kjaer, Michael/0000-0002-4582-8755; Dalgaard, Line Barner/0000-0001-7676-5323; Aagaard, Per/0000-0002-9773-7361; G Hvid, Lars/0000-0003-3233-0429	Danish National Research Council; Danish Rheumatology Association, Faculty of Health Sciences, University of Copenhagen; Danish Ministry of Culture, MYOAGE [223576]; European Commission; Nordea Foundation; Lundbeck Foundation	Danish National Research Council(Danmarks Grundforskningsfond); Danish Rheumatology Association, Faculty of Health Sciences, University of Copenhagen; Danish Ministry of Culture, MYOAGE; European Commission(European CommissionEuropean Commission Joint Research Centre); Nordea Foundation; Lundbeck Foundation(Lundbeckfonden)	The study was supported by grants from the Danish National Research Council, the Danish Rheumatology Association, Faculty of Health Sciences, University of Copenhagen, The Danish Ministry of Culture, MYOAGE (nr. 223576) funded by the European Commission under FP7, The Nordea Foundation and the Lundbeck Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006518; Alway SE, 2001, EXP PHYSIOL, V86, P509, DOI 10.1113/eph8602235; Bar-Shai M, 2005, ANN NY ACAD SCI, V1057, P431, DOI 10.1196/annals.1356.034; BERGSTROM J, 1962, SCAND J CLIN LAB INV, V14, P1; Bloomfield SA, 1997, MED SCI SPORT EXER, V29, P197, DOI 10.1097/00005768-199702000-00006; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; BOOTH FW, 1979, J APPL PHYSIOL, V47, P974, DOI 10.1152/jappl.1979.47.5.974; Brault JJ, 2010, J BIOL CHEM, V285, P19460, DOI 10.1074/jbc.M110.113092; BROOKE MH, 1970, ARCH NEUROL-CHICAGO, V23, P369, DOI 10.1001/archneur.1970.00480280083010; Bruunsgaard H, 2003, AM J MED, V115, P278, DOI 10.1016/S0002-9343(03)00329-2; Bruunsgaard H, 2003, IMMUNOL ALLERGY CLIN, V23, P15, DOI 10.1016/S0889-8561(02)00056-5; Bruusgaard JC, 2008, J CLIN INVEST, V118, P1450, DOI 10.1172/JCI34022; Calura E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-630; Carlson ME, 2009, EMBO MOL MED, V1, P381, DOI 10.1002/emmm.200900045; Chen YW, 2007, PHYSIOL GENOMICS, V31, P510, DOI 10.1152/physiolgenomics.00115.2006; Cuthbertson D, 2004, FASEB J, V18, P422, DOI 10.1096/fj.04-2640fje; de Boer MD, 2007, J PHYSIOL-LONDON, V585, P241, DOI 10.1113/jphysiol.2007.142828; Dirks A, 2002, AM J PHYSIOL-REG I, V282, pR519, DOI 10.1152/ajpregu.00458.2001; Dupont-Versteegden EE, 2005, EXP GERONTOL, V40, P473, DOI 10.1016/j.exger.2005.04.003; Dupont-Versteegden EE, 2006, AM J PHYSIOL-REG I, V291, pR1730, DOI 10.1152/ajpregu.00176.2006; Ferrando AA, 1996, AM J PHYSIOL-ENDOC M, V270, pE627, DOI 10.1152/ajpendo.1996.270.4.E627; FURUNO K, 1990, J BIOL CHEM, V265, P8550; GIBSON JNA, 1987, CLIN SCI, V72, P503, DOI 10.1042/cs0720503; Glover EI, 2008, J PHYSIOL-LONDON, V586, P6049, DOI 10.1113/jphysiol.2008.160333; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Grounds MD, 1998, ANN NY ACAD SCI, V854, P78, DOI 10.1111/j.1749-6632.1998.tb09894.x; Guerra B, 2011, J APPL PHYSIOL, V110, P1708, DOI 10.1152/japplphysiol.00091.2011; Gustafsson T, 2010, J APPL PHYSIOL, V109, P721, DOI 10.1152/japplphysiol.00110.2009; Hunter RB, 2002, FASEB J, V16, P529, DOI 10.1096/fj.01-0866com; Hvid L, 2010, J APPL PHYSIOL, V109, P1628, DOI 10.1152/japplphysiol.00637.2010; Jagoe RT, 2001, CURR OPIN CLIN NUTR, V4, P183, DOI 10.1097/00075197-200105000-00003; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Jones SW, 2004, FASEB J, V18, P1025, DOI 10.1096/fj.03-1228fje; Kadi F, 2004, J PHYSIOL-LONDON, V558, P1005, DOI 10.1113/jphysiol.2004.065904; Kimball SR, 2004, AM J PHYSIOL-ENDOC M, V287, pE772, DOI 10.1152/ajpendo.00535.2003; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Leger B, 2008, REJUV RES, V11, P163, DOI 10.1089/rej.2007.0588; Leger B, 2006, J PHYSIOL-LONDON, V576, P923, DOI 10.1113/jphysiol.2006.116715; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malmgren LT, 2001, OTOLARYNG HEAD NECK, V125, P34, DOI 10.1067/mhn.2001.116449; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Marcinek DJ, 2005, J PHYSIOL-LONDON, V569, P467, DOI 10.1113/jphysiol.2005.097782; Marzetti E, 2008, MECH AGEING DEV, V129, P542, DOI 10.1016/j.mad.2008.05.005; Marzetti E, 2009, MECH AGEING DEV, V130, P272, DOI 10.1016/j.mad.2008.12.008; Paddon-Jones D, 2006, J CLIN ENDOCR METAB, V91, P4836, DOI 10.1210/jc.2006-0651; Phillips T, 2005, FASEB J, V19, P668, DOI 10.1096/fj.04-2870fje; Pistilli EE, 2006, J GERONTOL A-BIOL, V61, P245, DOI 10.1093/gerona/61.3.245; Pistilli EE, 2006, APOPTOSIS, V11, P2115, DOI 10.1007/s10495-006-0194-6; Raffaello A, 2006, PHYSIOL GENOMICS, V25, P60, DOI 10.1152/physiolgenomics.00051.2005; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Sacheck JM, 2004, AM J PHYSIOL-ENDOC M, V287, pE591, DOI 10.1152/ajpendo.00073.2004; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Senf SM, 2010, AM J PHYSIOL-CELL PH, V298, pC38, DOI 10.1152/ajpcell.00315.2009; Siu PM, 2005, AM J PHYSIOL-CELL PH, V288, pC338, DOI 10.1152/ajpcell.00239.2004; Stevenson EJ, 2003, J PHYSIOL-LONDON, V551, P33, DOI 10.1113/jphysiol.2003.044701; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Strasser H, 2000, J UROLOGY, V164, P1781, DOI 10.1016/S0022-5347(05)67106-6; Suetta C, 2009, J APPL PHYSIOL, V107, P1172, DOI 10.1152/japplphysiol.00290.2009; Suetta C, 2008, J APPL PHYSIOL, V105, P180, DOI 10.1152/japplphysiol.01354.2007; THOMASON DB, 1989, AM J PHYSIOL, V257, pR300, DOI 10.1152/ajpregu.1989.257.2.R300; THOMASON DB, 1990, J APPL PHYSIOL, V68, P1, DOI 10.1152/jappl.1990.68.1.1; WATSON PA, 1984, AM J PHYSIOL, V247, pC39, DOI 10.1152/ajpcell.1984.247.1.C39; Whitman SA, 2005, PFLUG ARCH EUR J PHY, V450, P437, DOI 10.1007/s00424-005-1473-8; Zhao JH, 2008, AUTOPHAGY, V4, P378, DOI 10.4161/auto.5633; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	68	111	111	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51238	10.1371/journal.pone.0051238	http://dx.doi.org/10.1371/journal.pone.0051238			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284670	Green Published, gold, Green Submitted			2022-12-27	WOS:000312694300016
J	Bretler, DM; Hansen, PR; Lindhardsen, J; Ahlehoff, O; Andersson, C; Jensen, TB; Raunso, J; Torp-Pedersen, C; Gislason, GH				Bretler, Ditte-Marie; Hansen, Peter Riis; Lindhardsen, Jesper; Ahlehoff, Ole; Andersson, Charlotte; Jensen, Thomas Bo; Raunso, Jakob; Torp-Pedersen, Christian; Gislason, Gunnar Hilmar			Hormone Replacement Therapy and Risk of New-Onset Atrial Fibrillation after Myocardial Infarction - A Nationwide Cohort Study	PLOS ONE			English	Article							ESTROGEN PLUS PROGESTIN; CARDIOVASCULAR EVENTS; POSTMENOPAUSAL WOMEN; MORTALITY; POPULATION; FLUTTER; PREVALENCE; VALIDATION; PREVENTION; DIAGNOSIS	Objectives: Our aim was to assess the association between use of hormone replacement therapy (HRT) and risk of new-onset atrial fibrillation (AF) after myocardial infarction. Design, Setting and Participants: We used Danish nationwide registers of hospitalizations and prescriptions to identify all women admitted with myocardial infarction in the period 1997 to 2009 and with no known diagnosis of AF. Their use of overall HRT and HRT categories was assessed. Multivariable Cox proportional hazards analysis was used to calculate the risk of new-onset AF first year after discharge, comparing use of HRT to no use. Main Outcome Measures: New-onset atrial fibrillation. Results: In the period 1997 to 2009, 32 925 women were discharged alive after MI. In the first year after MI, new-onset AF was diagnosed in 1381 women (4.2%). Unadjusted incidence rates of AF decreased with use of HRT (incidence rate 37.4 for use of overall HRT and 53.7 for no use). Overall HRT was associated with a decreased risk of AF (HR 0.82, 95% confidence interval [CI] 0.68-1.00). The lowest risk of AF was found in women >= 80 years old for use of overall HRT and vaginal estrogen (HR 0.63, CI 0.42-0.94, and HR 0.58, CI 0.34-0.99, respectively). Decreased risk of AF with use of overall HRT and HRT categories was also found in other age groups. Conclusions: Use of HRT is associated with a decreased risk of new-onset AF in women with myocardial infarction first year after discharge. The underlying mechanisms remain to be determined. Unmeasured confounding might be one of them.	[Bretler, Ditte-Marie; Hansen, Peter Riis; Lindhardsen, Jesper; Ahlehoff, Ole; Andersson, Charlotte; Jensen, Thomas Bo; Raunso, Jakob; Torp-Pedersen, Christian; Gislason, Gunnar Hilmar] Univ Copenhagen, Gentofte Hosp, Dept Cardiol, Hellerup, Denmark; [Torp-Pedersen, Christian] Univ Copenhagen, Panum Inst, Fac Hlth Sci, DK-2200 Copenhagen, Denmark; [Raunso, Jakob] Univ Copenhagen, Hosp Holbaek, Dept Internal Med, Holbaek, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Holbaek Hospital; University of Copenhagen	Bretler, DM (corresponding author), Univ Copenhagen, Gentofte Hosp, Dept Cardiol, Hellerup, Denmark.	dimabr01@geh.regionh.dk	Torp-Pedersen, Christian/E-5931-2013; Gislason, Gunnar/B-7561-2009; Andersson, Charlotte/P-4849-2014; Hansen, Peter Riis/AAR-7659-2020; Jensen, Thomas Bo/H-9518-2019	Gislason, Gunnar/0000-0002-0548-402X; Jensen, Thomas Bo/0000-0002-8920-9374; Hansen, Peter Riis/0000-0002-9056-535X	Danish Heart Foundation [08-4-R65-A1904-B844-22440F]; Lundbeck Foundation [R31-A2566]; Novo Nordisk Foundation	Danish Heart Foundation; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	DMB was supported by the Danish Heart Foundation [grant 08-4-R65-A1904-B844-22440F], and the Lundbeck Foundation [grant R31-A2566]. Dr. Gislason has received a research grant from the Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khalili F, 1998, AM J CARDIOL, V82, P215, DOI 10.1016/S0002-9149(98)00314-2; Andersson P, 2012, J INTERN MED, V272, P170, DOI 10.1111/j.1365-2796.2012.02519.x; Aronson D, 2011, AM J CARDIOL, V107, P1738, DOI 10.1016/j.amjcard.2011.02.334; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Berry JD, 2010, AM J CARDIOL, V105, P844, DOI 10.1016/j.amjcard.2009.11.039; Boos CJ, 2006, EUR HEART J, V27, P136, DOI 10.1093/eurheartj/ehi645; Bretler DM, 2011, BRIT J CLIN PHARMACO, V71, P105, DOI 10.1111/j.1365-2125.2010.03790.x; Cavasin MA, 2003, AM J PHYSIOL-HEART C, V284, pH1560, DOI 10.1152/ajpheart.01087.2002; Christiansen CF, 2009, ARCH INTERN MED, V169, P1677, DOI 10.1001/archinternmed.2009.297; Cirillo DJ, 2005, JAMA-J AM MED ASSOC, V293, P330, DOI 10.1001/jama.293.3.330; Conen D, 2011, JAMA-J AM MED ASSOC, V305, P2080, DOI 10.1001/jama.2011.659; Ekholm O, 2009, SCAND J PUBLIC HEALT, V37, P758, DOI 10.1177/1403494809341095; Ettinger B, 2011, MENOPAUSE; Frost L, 2004, ARCH INTERN MED, V164, P1993, DOI 10.1001/archinte.164.18.1993; Frost L, 2007, AM J MED, V120, P47, DOI 10.1016/j.amjmed.2005.12.027; Gaist D, 1997, DAN MED BULL, V44, P445; Gislason GH, 2006, EUR HEART J, V27, P1153, DOI 10.1093/eurheartj/ehi705; Gorodeski EZ, 2010, MENOPAUSE, V17, P443, DOI 10.1097/gme.0b013e3181d0edaa; Guazzi M, 2009, HEART, V95, P102, DOI 10.1136/hrt.2007.135277; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Humphries KH, 2001, CIRCULATION, V103, P2365; Iwakura A, 2006, CIRCULATION, V113, P1605, DOI 10.1161/CIRCULATIONAHA.105.553925; Jabre P, 2011, CIRCULATION, V123, P2094, DOI 10.1161/CIRCULATIONAHA.110.990192; Jons C, 2010, EUR J ECHOCARDIOGR, V11, P602, DOI 10.1093/ejechocard/jeq024; Karim R, 2010, MENOPAUSE, V17, P785, DOI 10.1097/gme.0b013e3181cc50b2; Kumler T, 2008, EUR J HEART FAIL, V10, P658, DOI 10.1016/j.ejheart.2008.05.006; Lokkegaard EL, 2004, ACTA OBSTET GYN SCAN, V83, P476, DOI 10.1111/j.0001-6349.2004.00376.x; Lokkegaard E, 2007, ACTA OBSTET GYN SCAN, V86, P1342, DOI 10.1080/00016340701505523; Maalouf NM, 2010, ARCH INTERN MED, V170, P1678, DOI 10.1001/archinternmed.2010.342; Macchia A, 2008, EUR J CLIN PHARMACOL, V64, P627, DOI 10.1007/s00228-008-0464-z; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Magnani JW, 2012, AM HEART J, V163, P729, DOI 10.1016/j.ahj.2012.01.010; Margolis DJ, 2002, LANCET, V359, P675, DOI 10.1016/S0140-6736(02)07806-6; Mitchell GF, 2007, JAMA-J AM MED ASSOC, V297, P709, DOI 10.1001/jama.297.7.709; Mukamal KJ, 2005, CIRCULATION, V112, P1736, DOI 10.1161/CIRCULATIONAHA.105.547844; Olesen Jonas Bjerring, 2011, BMJ, V342, pd124, DOI 10.1136/bmj.d124; Olesen JB, 2011, PHARMACOEPIDEM DR S, V20, P146, DOI 10.1002/pds.2073; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Schmidt M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3450; Shinmura K, 2008, CARDIOVASC RES, V79, P387, DOI 10.1093/cvr/cvn086; Smith PJW, 2000, CIRCULATION, V102, P2983; Tang JY, 2011, J NATL CANCER I, V103, P1469, DOI 10.1093/jnci/djr333; Tu JV, 2001, J AM COLL CARDIOL, V37, P992, DOI 10.1016/S0735-1097(01)01109-3; van Eickels M, 2003, J AM COLL CARDIOL, V41, P2084, DOI 10.1016/S0735-1097(03)00423-6; Vermeulen MJ, 2007, J CLIN EPIDEMIOL, V60, P971, DOI 10.1016/j.jclinepi.2006.12.009; Vestergaard P, 2010, CALCIFIED TISSUE INT, V86, P335, DOI 10.1007/s00223-010-9349-0; Zanger D, 2000, J AM COLL CARDIOL, V36, P1797, DOI 10.1016/S0735-1097(00)00952-9	49	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51580	10.1371/journal.pone.0051580	http://dx.doi.org/10.1371/journal.pone.0051580			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284717	Green Published, Green Submitted, gold			2022-12-27	WOS:000312435900029
J	Ramos-Cejudo, J; Gutierrez-Fernandez, M; Rodriguez-Frutos, B; Alcaide, ME; Sanchez-Cabo, F; Dopazo, A; Diez-Tejedor, E				Ramos-Cejudo, Jaime; Gutierrez-Fernandez, Maria; Rodriguez-Frutos, Berta; Exposito Alcaide, Mercedes; Sanchez-Cabo, Fatima; Dopazo, Ana; Diez-Tejedor, Exuperio			Spatial and Temporal Gene Expression Differences in Core and Periinfarct Areas in Experimental Stroke: A Microarray Analysis	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; ARTERY OCCLUSION; UP-REGULATION; HUMAN BRAIN; RAT-BRAIN; MECHANISMS; PENUMBRA; REPAIR; INJURY; OLIGODENDROCYTES	Background: A large number of genes are regulated to promote brain repair following stroke. The thorough analysis of this process can help identify new markers and develop therapeutic strategies. This study analyzes gene expression following experimental stroke. Methodology/Principal Findings: A microarray study of gene expression in the core, periinfarct and contralateral cortex was performed in adult Sprague-Dawley rats (n = 60) after 24 hours (acute phase) or 3 days (delayed stage) of permanent middle cerebral artery (MCA) occlusion. Independent qRT-PCR validation (n = 12) was performed for 22 of the genes. Functional data were evaluated by Ingenuity Pathway Analysis. The number of genes differentially expressed was 2,612 (24 h) and 5,717 (3 d) in the core; and 3,505 (24 h) and 1,686 (3 d) in the periinfarct area (logFC>vertical bar 1 vertical bar; adjP<0.05). Expression of many neurovascular unit development genes was altered at 24 h and 3 d including HES2, OLIG2, LINGO1 and NOGO-A; chemokines like CXCL1 and CXCL12, stress-response genes like HIF-1A, and trophic factors like BDNF or BMP4. Nearly half of the detected genes (43%) had not been associated with stroke previously. Conclusions: This comprehensive study of gene regulation in the core and periinfarct areas at different times following permanent MCA occlusion provides new data that can be helpful in translational research.	[Ramos-Cejudo, Jaime; Gutierrez-Fernandez, Maria; Rodriguez-Frutos, Berta; Exposito Alcaide, Mercedes; Diez-Tejedor, Exuperio] Univ Autonoma Madrid, Dept Neurol, Madrid, Spain; [Ramos-Cejudo, Jaime; Gutierrez-Fernandez, Maria; Rodriguez-Frutos, Berta; Exposito Alcaide, Mercedes; Diez-Tejedor, Exuperio] Univ Autonoma Madrid, Hlth Res Inst, Neurosci Area IdiPAZ, Neurosci & Cerebrovasc Res Lab,La Paz Univ Hosp,S, Madrid, Spain; [Sanchez-Cabo, Fatima] CNIC, Bioinformat Unit, Madrid, Spain; [Dopazo, Ana] CNIC, Genom Unit, Madrid, Spain	Autonomous University of Madrid; Autonomous University of Madrid; Hospital Universitario La Paz; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Diez-Tejedor, E (corresponding author), Univ Autonoma Madrid, Dept Neurol, Madrid, Spain.	edieztejedor@hotmail.com	Dopazo, Ana/N-1159-2014; Sanchez-Cabo, Fatima/AAC-5563-2020; Sanchez-Cabo, Fatima/N-5030-2014	Dopazo, Ana/0000-0002-4910-1684; Sanchez-Cabo, Fatima/0000-0003-1881-1664; Sanchez-Cabo, Fatima/0000-0003-1881-1664; Diez Tejedor, Exuperio/0000-0003-2295-1707; Ramos-Cejudo, Jaime/0000-0002-0993-9909	Spanish Ministry of Science [PS09/01606]; RENEVAS, Carlos III Research Institute, Ministry of Science and Innovation [RD07/0026/2003]	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); RENEVAS, Carlos III Research Institute, Ministry of Science and Innovation	This work was supported by grants from PS09/01606 (Spanish Ministry of Science) and by RENEVAS (RD07/0026/2003 - Spanish Neurovascular Network), Carlos III Research Institute, Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2010, STROKE, V41, P898, DOI 10.1161/STROKEAHA.109.572552; Bejot Y, 2011, NEUROCHEM INT, V58, P102, DOI 10.1016/j.neuint.2010.10.019; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Broughton BRS, 2009, STROKE, V40, pE331, DOI 10.1161/STROKEAHA.108.531632; Candelario-Jalil E, 2009, CURR OPIN INVEST DR, V10, P644; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Cau E, 2000, DEVELOPMENT, V127, P2323; Cramer SC, 2008, ANN NEUROL, V63, P549, DOI 10.1002/ana.21412; Cramer SC, 2008, ANN NEUROL, V63, P272, DOI 10.1002/ana.21393; Cui X, 2009, J NEUROSCI RES, V87, P86, DOI 10.1002/jnr.21836; De Val S, 2009, DEV CELL, V16, P180, DOI 10.1016/j.devcel.2009.01.014; DELOSMONTEROS AE, 1988, J NEUROSCI RES, V21, P181, DOI 10.1002/jnr.490210210; Di Lazzaro V, 2007, NEUROSCI LETT, V422, P128, DOI 10.1016/j.neulet.2007.06.001; Foley LM, 2010, TRANSL STROKE RES, V1, P220, DOI 10.1007/s12975-010-0032-6; Gutierrez M, 2009, CEREBROVASC DIS, V27, P177, DOI 10.1159/000200457; Gutierrez-Fernandez M, 2011, NEUROSCIENCE, V175, P394, DOI 10.1016/j.neuroscience.2010.11.054; Hayashi T, 1997, STROKE, V28, P2039, DOI 10.1161/01.STR.28.10.2039; Hossmann KA, 2008, NEUROPHARMACOLOGY, V55, P257, DOI 10.1016/j.neuropharm.2007.12.004; Kendziorski C, 2005, P NATL ACAD SCI USA, V102, P4252, DOI 10.1073/pnas.0500607102; Lo EH, 2008, NAT MED, V14, P497, DOI 10.1038/nm1735; Lu AG, 2003, J CEREBR BLOOD F MET, V23, P786, DOI 10.1097/01.WCB.0000062340.80057.06; Marsh BJ, 2009, NEUROSCIENCE, V158, P1007, DOI 10.1016/j.neuroscience.2008.07.067; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Nagel S, 2011, BRAIN RES, V1368, P264, DOI 10.1016/j.brainres.2010.10.057; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Popp A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004764; Ramos-Cabrer P, 2011, STROKE, V42, pS7, DOI 10.1161/STROKEAHA.110.596684; Risher WC, 2010, J NEUROSCI, V30, P9859, DOI 10.1523/JNEUROSCI.1917-10.2010; Robin AM, 2006, J CEREBR BLOOD F MET, V26, P125, DOI 10.1038/sj.jcbfm.9600172; Schonemeier B, 2008, J NEUROIMMUNOL, V198, P39, DOI 10.1016/j.jneuroim.2008.04.010; Simon RP, 2012, STROKE, V43, P286, DOI 10.1161/STROKEAHA.111.622225; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sobrado M, 2011, NEUROIMAGE, V57, P45, DOI 10.1016/j.neuroimage.2011.04.045; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Tanaka K, 2003, BRAIN RES, V989, P172, DOI 10.1016/S0006-8993(03)03317-1; Tang Y, 2002, EUR J NEUROSCI, V15, P1937, DOI 10.1046/j.1460-9568.2002.02030.x; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Zhan XH, 2010, J CEREBR BLOOD F MET, V30, P110, DOI 10.1038/jcbfm.2009.189; Zhao XH, 2010, NEURON, V65, P612, DOI 10.1016/j.neuron.2010.02.018; Zoghbi HY, 2010, NEURON, V68, P165, DOI 10.1016/j.neuron.2010.10.015	41	51	51	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52121	10.1371/journal.pone.0052121	http://dx.doi.org/10.1371/journal.pone.0052121			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284893	Green Published, gold, Green Submitted			2022-12-27	WOS:000312435900077
J	Vishwakarma, V; Pati, NB; Chandel, HS; Sahoo, SS; Saha, B; Suar, M				Vishwakarma, Vikalp; Pati, Niladri Bhusan; Chandel, Himanshu Singh; Sahoo, Sushree Sangeeta; Saha, Bhaskar; Suar, Mrutyunjay			Evaluation of Salmonella enterica Serovar Typhimurium TTSS-2 Deficient fur Mutant as Safe Live-Attenuated Vaccine Candidate for Immunocompromised Mice	PLOS ONE			English	Article							III SECRETION SYSTEM; IN-VIVO; COLITIS MODEL; MOUSE MODEL; T-CELLS; INFECTION; ENTERITIDIS; PROTECTION; STRAIN; HOST	Salmonella enterica serovar Typhimurium has been extensively exploited as live attenuated vaccines (LAV) which generally confers better protection than killed or subunit vaccines. However, many LAV are limited by their inherent ability to access systemic organs in many of the vaccinated hosts, especially those which are immunocompromised. We evaluated the efficacy of a live-attenuated SPI2-deficient (Delta ssaV) S. Typhimurium vaccine candidate (MT13) that additionally devoids the ferric uptake regulator (fur). We used specific pathogen free (SPF) streptomycin-pretreated mouse colitis model that included healthy C57BL/6 and immunocompromised iNos(-/-), IL10(-/-) and CD40L(-/-) in the background of C57BL/6 mice to assess the efficacy of developed vaccine candidate. In our study, the S. Typhimurium MT13 strain was established as a safe vaccine candidate to be administered in immunocompromised mice as it was found to be systemically attenuated without conferring significant pathological signs and growth defect within the host. In bacterial challenge experiment, the MT13-vaccinated C57BL/6 mice were protected from subsequent wild-type S. Typhimurium infection by inducing proficient mucosal immunity. The MT13 strain elicited efficient O-antigen specific mucosal secretory IgA associated protective response which was comparable with its parental ssaV mutant. Vaccination with MT13 also showed proficient T-cell activation in host mice; which has direct relation with pathogen clearance from host tissues. Collectively, these data implicate the possible application of SPI-2 deficient fur mutant (MT13) as a novel live attenuated vaccine strain with adept immunogenicity and improved safety, even in immunocompromised hosts. Further, this vaccine candidate can be employed to express heterologous antigens targeted against several other diseases, especially related to enterocolitic pathogens.	[Vishwakarma, Vikalp; Pati, Niladri Bhusan; Sahoo, Sushree Sangeeta; Suar, Mrutyunjay] KIIT Univ, Sch Biotechnol, Bhubaneswar, Odisha, India; [Chandel, Himanshu Singh; Saha, Bhaskar] Natl Ctr Cell Sci, Pune, Maharashtra, India	Kalinga Institute of Industrial Technology (KIIT); Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Suar, M (corresponding author), KIIT Univ, Sch Biotechnol, Bhubaneswar, Odisha, India.	msbiotek@yahoo.com	Sahoo, Sushree/AAA-8361-2022	Suar, Mrutyunjay/0000-0003-4815-5477; VISHWAKARMA, VIKALP/0000-0001-5555-2126	Department of Biotechnology, Ministry of Science and Technology, New Delhi, India [BT/PR14489/Med/29/207/2010]	Department of Biotechnology, Ministry of Science and Technology, New Delhi, India(Department of Biotechnology (DBT) India)	This study was funded by the Department of Biotechnology, Ministry of Science and Technology, New Delhi, India (grant BT/PR14489/Med/29/207/2010) to MS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APTER FM, 1993, INFECT IMMUN, V61, P5279, DOI 10.1128/IAI.61.12.5279-5285.1993; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Bjarnason J, 2003, J BACTERIOL, V185, P4973, DOI 10.1128/JB.185.16.4973-4982.2003; Campoy S, 2002, MICROBIOL-SGM, V148, P1039, DOI 10.1099/00221287-148-4-1039; CHUTTANI C S, 1973, Bulletin of the World Health Organization, V48, P754; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dougan G, 2011, IMMUNOL REV, V240, P196, DOI 10.1111/j.1600-065X.2010.00999.x; EISENSTEIN TK, 1984, J INFECT DIS, V150, P425, DOI 10.1093/infdis/150.3.425; El Ghany MA, 2007, INFECT IMMUN, V75, P1835, DOI 10.1128/IAI.01655-06; Ellermeier JR, 2008, J BACTERIOL, V190, P476, DOI 10.1128/JB.00926-07; Endt K, 2012, ANTIMICROB AGENTS CH, V56, P2295, DOI 10.1128/AAC.05819-11; Endt K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001097; Fierer J, 2012, INFECT IMMUN, V80, P3360, DOI 10.1128/IAI.00404-12; Fraillery D, 2007, CLIN VACCINE IMMUNOL, V14, P1285, DOI 10.1128/CVI.00164-07; Garmory HS, 2002, FEMS MICROBIOL REV, V26, P339, DOI 10.1016/S0168-6445(02)00113-4; GAUTREAUX MD, 1994, INFECT IMMUN, V62, P2874, DOI 10.1128/IAI.62.7.2874-2884.1994; GERMANIER R, 1975, J INFECT DIS, V131, P553, DOI 10.1093/infdis/131.5.553; Gunn BM, 2010, CLIN VACCINE IMMUNOL, V17, P354, DOI 10.1128/CVI.00412-09; Hall HK, 1996, J BACTERIOL, V178, P5683, DOI 10.1128/jb.178.19.5683-5691.1996; Hansen-Wester I, 2001, MICROBES INFECT, V3, P549, DOI 10.1016/S1286-4579(01)01411-3; Hapfelmeier S, 2005, J IMMUNOL, V174, P1675, DOI 10.4049/jimmunol.174.3.1675; Hegazy WAH, 2012, FUTURE MICROBIOL, V7, P111, DOI [10.2217/fmb.11.144, 10.2217/FMB.11.144]; Husseiny MI, 2005, INFECT IMMUN, V73, P1598, DOI 10.1128/IAI.73.3.1598-1605.2005; Hutchings AB, 2004, J VIROL, V78, P947, DOI 10.1128/JVI.78.2.947-957.2004; Johanns TM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001043; Johnson M, 2011, INT J MED MICROBIOL, V301, P44, DOI 10.1016/j.ijmm.2010.05.003; Karasova D, 2009, VACCINE, V27, P5265, DOI 10.1016/j.vaccine.2009.06.060; Konjufca V, 2006, INFECT IMMUN, V74, P6785, DOI 10.1128/IAI.00851-06; Ku YW, 2005, INFECT IMMUN, V73, P8194, DOI 10.1128/IAI.73.12.8194-8203.2005; Lesic B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-20; Levine MM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-129; Li YH, 2009, P NATL ACAD SCI USA, V106, P593, DOI 10.1073/pnas.0811697106; McSorley SJ, 2002, IMMUNITY, V16, P365, DOI 10.1016/S1074-7613(02)00289-3; MILLER SI, 1990, RES MICROBIOL, V141, P817, DOI 10.1016/0923-2508(90)90115-7; Mtove G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009244; Nadjm B, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1350; Nagarajan AG, 2009, VACCINE, V27, P2804, DOI 10.1016/j.vaccine.2009.02.092; Negi VD, 2007, VACCINE, V25, P5315, DOI 10.1016/j.vaccine.2007.05.015; Roland KL, 2005, CURR OPIN MOL THER, V7, P62; Roux CM, 2010, INFECT IMMUN, V78, P1520, DOI 10.1128/IAI.00887-09; Rychlik I, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-268; Santander J, 2012, INFECT IMMUN, V80, P2689, DOI 10.1128/IAI.00013-12; Spreng S, 2006, METHODS, V38, P133, DOI 10.1016/j.ymeth.2005.09.012; Suar M, 2006, INFECT IMMUN, V74, P632, DOI 10.1128/IAI.74.1.632-644.2006; Suar M, 2009, INFECT IMMUN, V77, P3569, DOI 10.1128/IAI.00511-09; Teixido L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019711; Troxell B, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-236; Troxell B, 2011, J BACTERIOL, V193, P497, DOI 10.1128/JB.00942-10; TSOLIS RM, 1995, J BACTERIOL, V177, P4628, DOI 10.1128/jb.177.16.4628-4637.1995; Vishwakarma V, 2012, INFECT IMMUN, V80, P3236, DOI 10.1128/IAI.00180-12; Yoo, 2007, J MICROBIOL BIOTECHN, V17, P1452; Yrlid U, 2001, INFECT IMMUN, V69, P5726, DOI 10.1128/IAI.69.9.5726-5735.2001	53	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52043	10.1371/journal.pone.0052043	http://dx.doi.org/10.1371/journal.pone.0052043			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284865	gold, Green Published, Green Submitted			2022-12-27	WOS:000312435900072
J	Mittal, N				Mittal, Nikhil			Cell Surface Concentrations and Concentration Ranges for Testing In Vitro Autocrine Loops and Small Molecules	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; TRANSPORT; BIOMARKER; SURVIVAL; ASSAYS; LIGAND; SERUM; MODEL	A common assumption made when performing in vitro cellular assays is that the concentration of substances in the culture system is uniform. However, since the cells that internalize and secrete substances reside at the bottom of the well, it is conceivable that a concentration gradient could arise across the fluid layer. Importantly, the concentration of a substance in the vicinity of a cell, which is the concentration of interest, cannot be measured via existing methods. In this work a simple strategy for estimating the concentration of a chemical species at the surface of a cell is presented. Finally, this result is used to outline a method for determining the appropriate concentration ranges for testing in vitro autocrine loops and small molecules.	Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Mittal, N (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA.	nvmittal@partners.org		Mittal, Nikhil/0000-0002-2360-7134				Aziz N, 1999, CLIN DIAGN LAB IMMUN, V6, P89, DOI 10.1128/CDLI.6.1.89-95.1999; Batsilas L, 2003, BIOPHYS J, V85, P3659, DOI 10.1016/S0006-3495(03)74783-3; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Chaigneau C, 2007, CLIN CHEM LAB MED, V45, P1390, DOI 10.1515/CCLM.2007.160; Ellison D, 2009, MOL BIOSYST, V5, P1004, DOI 10.1039/b905602e; Guo Y, 2005, STEM CELLS, V23, P1324, DOI 10.1634/stemcells.2005-0085; He L, 2003, BIOTECHNOL PROGR, V19, P544; KNAUER DJ, 1984, J BIOL CHEM, V259, P5623; Lengelle J, 2008, CYTOKINE, V44, P275, DOI 10.1016/j.cyto.2008.08.010; Li F, 2006, INT FREQ CONTR S EXP, P538; Monine MI, 2005, BIOPHYS J, V88, P2384, DOI 10.1529/biophysj.104.051425; Netti PA, 2000, CANCER RES, V60, P2497; Ramanujan S, 2002, BIOPHYS J, V83, P1650, DOI 10.1016/S0006-3495(02)73933-7; Shvartsman SY, 2001, BIOPHYS J, V81, P1854, DOI 10.1016/S0006-3495(01)75837-7; SPORN MB, 1980, NEW ENGL J MED, V303, P878, DOI 10.1056/NEJM198010093031511; THAVASU PW, 1992, J IMMUNOL METHODS, V153, P115, DOI 10.1016/0022-1759(92)90313-I; Vander AJ, 2001, HUMAN PHYSL MECH BOD, Vxviii; Wilder PJ, 1997, DEV BIOL, V192, P614, DOI 10.1006/dbio.1997.8777	18	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e51796	10.1371/journal.pone.0051796	http://dx.doi.org/10.1371/journal.pone.0051796			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23284769	gold, Green Published			2022-12-27	WOS:000313051500014
J	Alhaddad, A; Durieu, C; Dantelle, G; Le Cam, E; Malvy, C; Treussart, F; Bertrand, JR				Alhaddad, Anna; Durieu, Catherine; Dantelle, Geraldine; Le Cam, Eric; Malvy, Claude; Treussart, Francois; Bertrand, Jean-Remi			Influence of the Internalization Pathway on the Efficacy of siRNA Delivery by Cationic Fluorescent Nanodiamonds in the Ewing Sarcoma Cell Model	PLOS ONE			English	Article							IN-VIVO; DIAMOND NANOPARTICLES; QUANTUM DOTS; EXPRESSION; VECTOR; GROWTH; GENE; SIZE	Small interfering RNAs (siRNAs) are powerful tools commonly used for the specific inhibition of gene expression. However, vectorization is required to facilitate cell penetration and to prevent siRNA degradation by nucleases. We have shown that diamond nanocrystals coated with cationic polymer can be used to carry siRNAs into Ewing sarcoma cells, in which they remain traceable over long periods, due to their intrinsic stable fluorescence. We tested two cationic polymers, polyallylamine and polyethylenimine. The release of siRNA, accompanied by Ewing sarcoma EWS-Fli1 oncogene silencing, was observed only with polyethylenimine. We investigated cell penetration and found that the underlying mechanisms accounted for these differences in behavior. Using drugs selectively inhibiting particular pathways and a combination of fluorescence and electronic microscopy, we showed that siRNA gene silencing occurred only if the siRNA: cationic nanodiamond complex followed the macropinocytosis route. These results have potential implications for the design of efficient drug-delivery vectors.	[Treussart, Francois] Ecole Normale Super, Lab Photon Quant & Mol, CNRS, UMR 8537, Cachan, France; [Alhaddad, Anna; Malvy, Claude; Bertrand, Jean-Remi] Univ Paris 11, Vectorol & Therapeut Anticancereuses UMR 8203, CNRS, Inst Gustave Roussy, Villejuif, France; [Durieu, Catherine; Le Cam, Eric] Univ Paris 11, Signalisat Noyaux & Innovat Cancerol UMR 8126, CNRS, Inst Gustave Roussy, Villejuif, France; [Dantelle, Geraldine] Ecole Polytech, Phys Mat Condensee Lab, CNRS, UMR 7643, F-91128 Palaiseau, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Institut Polytechnique de Paris; UDICE-French Research Universities; Sorbonne Universite	Treussart, F (corresponding author), Ecole Normale Super, Lab Photon Quant & Mol, CNRS, UMR 8537, Cachan, France.	francois.treussart@ens-cachan.fr; jean-remi.bertrand@igr.fr	TREUSSART, François/M-3274-2013; , Dantelle/C-8296-2017	TREUSSART, François/0000-0002-1755-0688; , Dantelle/0000-0001-5499-8070; Le cam, Eric/0000-0002-6832-6117; Durieu, Catherine/0000-0003-0988-1169	Pole de Recherche et d'Enseignement Superieur "UniverSud Paris"; Centre National de la Recherche Scientifique (CNRS) "international joint project for scientific cooperation" grant; Region Ile-de-France in the framework of C'Nano IdF; CNRS; CEA; Ministry of Higher Education and Research; Region Ile-de-France, France	Pole de Recherche et d'Enseignement Superieur "UniverSud Paris"; Centre National de la Recherche Scientifique (CNRS) "international joint project for scientific cooperation" grant; Region Ile-de-France in the framework of C'Nano IdF(Region Ile-de-France); CNRS(Centre National de la Recherche Scientifique (CNRS)); CEA(French Atomic Energy Commission); Ministry of Higher Education and Research(Ministry of Higher Education & Scientific Research (MHESR)); Region Ile-de-France, France(Region Ile-de-France)	This work has been supported by the Pole de Recherche et d'Enseignement Superieur "UniverSud Paris", by a Centre National de la Recherche Scientifique (CNRS) "international joint project for scientific cooperation" grant, and by the Region Ile-de-France in the framework of C'Nano IdF. C'Nano IdF is the nanoscience competence center of Paris Region, supported by CNRS, CEA, Ministry of Higher Education and Research and Region Ile-de-France, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhaddad A, 2011, SMALL, V7, P3087, DOI 10.1002/smll.201101193; Amsellem V, 2005, EXP CELL RES, V304, P443, DOI 10.1016/j.yexcr.2004.10.035; Arvand A, 2001, ONCOGENE, V20, P5747, DOI 10.1038/sj.onc.1204598; Bareford LA, 2007, ADV DRUG DELIVER REV, V59, P748, DOI 10.1016/j.addr.2007.06.008; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Brandenberger C, 2010, SMALL, V6, P1669, DOI 10.1002/smll.201000528; Chang YR, 2008, NAT NANOTECHNOL, V3, P284, DOI 10.1038/nnano.2008.99; Chow EK, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001713; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Creusat G, 2010, BIOCONJUGATE CHEM, V21, P994, DOI 10.1021/bc100010k; Dantelle G, 2010, J LUMIN, V130, P1655, DOI 10.1016/j.jlumin.2009.12.003; Faklaris O, 2009, ACS NANO, V3, P3955, DOI 10.1021/nn901014j; Faklaris O, 2008, SMALL, V4, P2236, DOI 10.1002/smll.200800655; Fang CY, 2011, SMALL; Fu CC, 2007, P NATL ACAD SCI USA, V104, P727, DOI 10.1073/pnas.0605409104; Fuchs B, 2004, CLIN CANCER RES, V10, P1344, DOI 10.1158/1078-0432.CCR-03-0038; Hillaireau H, 2009, CELL MOL LIFE SCI, V66, P2873, DOI 10.1007/s00018-009-0053-z; KANASEKI T, 1969, J CELL BIOL, V42, P202, DOI 10.1083/jcb.42.1.202; Kontny U, 2006, HEMATOL ONCOL, V24, P14, DOI 10.1002/hon.766; Krueger A, 2012, ADV FUNCT MATER, V22, P890, DOI 10.1002/adfm.201102670; Ordonez JL, 2009, CANCER RES, V69, P7140, DOI 10.1158/0008-5472.CAN-08-4041; Lunov O, 2011, ACS NANO, V5, P1657, DOI 10.1021/nn2000756; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Mohan N, 2010, NANO LETT, V10, P3692, DOI 10.1021/nl1021909; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Paulussen M, 2001, Paediatr Drugs, V3, P899, DOI 10.2165/00128072-200103120-00003; Resch-Genger U, 2008, NAT METHODS, V5, P763, DOI [10.1038/nmeth.1248, 10.1038/NMETH.1248]; Rondin L, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.115449; Schrand AM, 2007, J PHYS CHEM B, V111, P2, DOI 10.1021/jp066387v; Schrand AM, 2011, NANOSCALE, V3, P435, DOI 10.1039/c0nr00408a; Scotlandi K, 1998, CANCER RES, V58, P4127; Shen JN, 2011, NANOSCALE, V3, P4314, DOI 10.1039/c1nr10580a; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P424, DOI 10.1016/S0962-8924(00)89101-1; TABATA Y, 1988, BIOMATERIALS, V9, P356, DOI 10.1016/0142-9612(88)90033-6; Thomas V, 2012, ACTA BIOMATER, V8, P1939, DOI 10.1016/j.actbio.2012.01.033; Toub N, 2006, OLIGONUCLEOTIDES, V16, P158, DOI 10.1089/oli.2006.16.158; Treussart F, 2006, PHYSICA B, V376, P926, DOI 10.1016/j.physb.2005.12.232; Vaijayanthimala V, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/42/425103; Zhang XQ, 2009, ACS NANO, V3, P2609, DOI 10.1021/nn900865g; Zhu Y, 2012, THERANOSTICS, V2, P302, DOI 10.7150/thno.3627; Zwerner JP, 2008, ONCOGENE, V27, P3282, DOI 10.1038/sj.onc.1210991	42	48	49	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52207	10.1371/journal.pone.0052207	http://dx.doi.org/10.1371/journal.pone.0052207			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284935	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500112
J	Hsu, CH; Shen, TL; Chang, CF; Chang, YY; Huang, LY				Hsu, Chun-Hua; Shen, Tang-Long; Chang, Chi-Fon; Chang, Yu-Yung; Huang, Lin-Ya			Solution Structure of the Oncogenic MIEN1 Protein Reveals a Thioredoxin-Like Fold with a Redox-Active Motif	PLOS ONE			English	Article							MULTIDIMENSIONAL NMR METHODS; 17Q12 AMPLICON; KINASE-B; ACTIVATION; C17ORF37; CANCER; SUPERFAMILY; ASSIGNMENTS; MIGRATION; STRATEGY	The novel tumor biomarker MIEN1, identified by representational difference analysis, is overexpressed in breast cancer and prostate cancer. MIEN1 is considered an oncogenic protein, because MIEN1 overexpression functionally enhances migration and invasion of tumor cells via modulating the activity of AKT. However, the structure and molecular function of MIEN1 is little understood. Here, we report the solution structure of MIEN1, which adopts a thioredoxin-like fold with a redox-active motif. Comparison of backbone chemical shifts showed that most of the residues for both oxidized and reduced MIEN1 possessed the same backbone conformation, with differences limited to the active motif and regions in proximity. The redox potential of this disulfide bond was measured as -225 mV, which compares well with that of disulfides for other thioredoxin-like proteins. Overall, our results suggest that MIEN1 may have an important regulatory role in phosphorylation of AKT with its redox potential.	[Hsu, Chun-Hua; Chang, Yu-Yung] Natl Taiwan Univ, Dept Agr Chem, Taipei 10764, Taiwan; [Hsu, Chun-Hua] Natl Taiwan Univ, Degree Program Genome & Syst Biol, Taipei 10764, Taiwan; [Shen, Tang-Long; Huang, Lin-Ya] Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 10764, Taiwan; [Chang, Chi-Fon] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan	Hsu, CH (corresponding author), Natl Taiwan Univ, Dept Agr Chem, Taipei 10764, Taiwan.	andyhsu@ntu.edu.tw	HSU, CHUN-HUA/W-4554-2019	HSU, CHUN-HUA/0000-0002-0008-7383; Chang, Chi-Fon/0000-0002-2961-0748; Shen, Tang-Long/0000-0001-6264-3608	National Science Council in Taiwan [NSC99-2119-M-002-010]; Excellent Research Projects of National Taiwan University [ERP-101R8600]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); Excellent Research Projects of National Taiwan University	The work was supported by grants from National Science Council in Taiwan awarded to CHH (NSC99-2119-M-002-010), and partial grants to CHH (ERP-101R8600) from Excellent Research Projects of National Taiwan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aachmann FL, 2007, J BIOL CHEM, V282, P37036, DOI 10.1074/jbc.M705410200; Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; BAX A, 1994, CURR OPIN STRUC BIOL, V4, P738, DOI 10.1016/S0959-440X(94)90173-2; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dasgupta S, 2009, ONCOGENE, V28, P2860, DOI 10.1038/onc.2009.145; Dasgupta S, 2011, J BIOL CHEM, V286, P25935, DOI 10.1074/jbc.M111.254599; Evans EE, 2006, MOL CANCER THER, V5, P2919, DOI 10.1158/1535-7163.MCT-06-0389; Farmer BT, 1996, NAT STRUCT BIOL, V3, P995, DOI 10.1038/nsb1296-995; Fomenko DE, 2007, SCIENCE, V315, P387, DOI 10.1126/science.1133114; Gardner KH, 1998, ANNU REV BIOPH BIOM, V27, P357, DOI 10.1146/annurev.biophys.27.1.357; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hancock John T., 2008, V476, P1, DOI 10.1007/978-1-59745-129-1_1; Hiraoka D, 2011, ONCOGENE, V30, P4487, DOI 10.1038/onc.2011.155; Hsu CH, 2003, J MOL BIOL, V326, P1189, DOI 10.1016/S0022-2836(02)01472-9; Hsu CH, 2011, NUCLEIC ACIDS RES, V39, P6764, DOI 10.1093/nar/gkr283; Hsu CH, 2010, J BIOCHEM, V148, P209, DOI 10.1093/jb/mvq058; Huang X, 2003, STRUCTURE, V11, P21, DOI 10.1016/S0969-2126(02)00937-1; Kanelis V, 2001, IUBMB LIFE, V52, P291, DOI 10.1080/152165401317291147; Katz E, 2010, BRIT J CANCER, V103, P401, DOI 10.1038/sj.bjc.6605763; Kauraniemi P, 2006, ENDOCR-RELAT CANCER, V13, P39, DOI 10.1677/erc.1.01147; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; LOGAN TM, 1992, FEBS LETT, V314, P413, DOI 10.1016/0014-5793(92)81517-P; LYONS BA, 1993, BIOCHEMISTRY-US, V32, P7839, DOI 10.1021/bi00082a001; Maqani N, 2006, MOL CANCER RES, V4, P449, DOI 10.1158/1541-7786.MCR-06-0058; Markley JL, 1998, J BIOMOL NMR, V12, P1, DOI 10.1023/A:1008290618449; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Mossner E, 1998, PROTEIN SCI, V7, P1233; Murata H, 2003, J BIOL CHEM, V278, P50226, DOI 10.1074/jbc.M310171200; Pan JL, 2006, PROTEIN SCI, V15, P2217, DOI 10.1110/ps.062268106; Pedone E, 2010, CELL MOL LIFE SCI, V67, P3797, DOI 10.1007/s00018-010-0449-9; Qi Y, 2005, PROTEINS, V58, P376, DOI 10.1002/prot.20329; ROST J, 1964, NATURE, V201, P185, DOI 10.1038/201185a0; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schrodinger L., 2020, PYMOL; Sen CK, 2000, CURR TOP CELL REGUL, V36, P1; Sreerama N, 2004, METHOD ENZYMOL, V383, P318; Testa JR, 2005, ONCOGENE, V24, P7391, DOI 10.1038/sj.onc.1209100; Underhill DM, 2007, TRENDS IMMUNOL, V28, P66, DOI 10.1016/j.it.2006.12.004; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Yang CJ, 2010, BIOMOL NMR ASSIGN, V4, P191, DOI 10.1007/s12104-010-9218-9; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	49	10	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52292	10.1371/journal.pone.0052292	http://dx.doi.org/10.1371/journal.pone.0052292			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284973	Green Published, gold			2022-12-27	WOS:000312794500135
J	Zembe, YZ; Townsend, L; Thorson, A; Ekstrom, AM				Zembe, Yanga Z.; Townsend, Loraine; Thorson, Anna; Ekstrom, Anna Mia			Predictors of Inconsistent Condom Use among a Hard to Reach Population of Young Women with Multiple Sexual Partners in Peri-Urban South Africa	PLOS ONE			English	Article							ECONOMIC ASYMMETRIES; ADOLESCENT GIRLS; HIV PREVALENCE; RISK; AGE; BEHAVIOR; INFECTION; EPIDEMICS; EXPLAIN	Background: Evidence suggests that multiple concurrent sexual partnering may be a key driver of the high HIV prevalence among young women in South Africa. However, little is known about whether and to what extent women who have multiple sexual partners also engage in other high risk sexual behaviors such as inconsistent condom use. And yet, multiple concurrent sexual partnering is of little epidemiological relevance if all partners in these sexual networks use condoms consistently. This study assesses the prevalence of sexual risk behaviors and HIV, and predictors of inconsistent condom use among women aged 16-24 with multiple sexual partners in a peri-urban setting in South Africa. Methods: We used Respondent Driven Sampling, a sampling strategy for hard-to-reach populations to recruit 259 women aged 16-24 in a bio-behavioral cross-sectional survey in the Western Cape province. Estimates of population proportions and 95% confidence intervals (CIs) were calculated using the Respondent-Driven Sampling Analysis Tool 5.6 (RDSAT). The primary outcome was inconsistent condom use in the past three months. Results: Young women reported an average of 7 partners in the past 3 months and a high prevalence of sexual risk behaviors: concurrency (87%), transactional sex (91%) and age mixing (59%). Having >5 sexual partners in the last 3 months doubled the risk of unprotected sex (OR 2.43, CI 1.39-4.25). HIV prevalence was 4% among 16-19 year olds, increasing threefold (12%) at age 20-24. Discussion: Multiple sexual partnering, where a high number of partners are acquired in a short space of time, is a fertile context for unprotected and risky sexual behavior. The young women featured in this survey present with a constellation of high-risk sexual behaviors that cluster to form a risk syndrome. Carefully tailored repeat bio-behavioral surveillance surveys are recommended for this sub-population.	[Zembe, Yanga Z.; Townsend, Loraine] Med Res Council S Africa, Hlth Syst Res Unit, Cape Town, South Africa; [Zembe, Yanga Z.; Thorson, Anna; Ekstrom, Anna Mia] Karolinska Inst, Div Global Hlth IHCAR, Stockholm, Sweden; [Zembe, Yanga Z.; Thorson, Anna; Ekstrom, Anna Mia] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden	South African Medical Research Council; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Zembe, YZ (corresponding author), Med Res Council S Africa, Hlth Syst Res Unit, Cape Town, South Africa.	yanga.zembe@mrc.ac.za	Ekström, Anna Mia/H-6901-2013	Thorson, Anna/0000-0002-8703-6561	Centers for Diseases Control and Prevention; Fogarty AIDS Research Training Program	Centers for Diseases Control and Prevention; Fogarty AIDS Research Training Program	Funding was received from the Centers for Diseases Control and Prevention and the Fogarty AIDS Research Training Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDSSTAR One, 2008, ADDR MULT CONC SEX P; Baird S, 2009, WORLD BANK IMPACT EV; Chopra M, 2009, JAIDS-J ACQ IMM DEF, V51, P72, DOI 10.1097/QAI.0b013e31819907de; Dunkle KL, 2005, INT J STD AIDS, V16, P256, DOI 10.1258/0956462053420220; Hallett TB, 2007, SEX TRANSM INFECT, V83, pI50, DOI 10.1136/sti.2006.023606; Halperin DT, 2004, LANCET, V364, P4, DOI 10.1016/S0140-6736(04)16606-3; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hunter M., 2002, AFRICAN STUDIES, V61, P1, DOI DOI 10.1080/00020180220140091; Hunter M, 2007, SOC SCI MED, V64, P689, DOI 10.1016/j.socscimed.2006.09.015; JESSOR R, 1991, J ADOLESCENT HEALTH, V12, P597, DOI 10.1016/1054-139X(91)90007-K; Jewkes R, 2012, SOC SCI MED, V74, P1729, DOI 10.1016/j.socscimed.2011.05.020; Jewkes R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-325; Kelly RJ, 2003, JAIDS-J ACQ IMM DEF, V32, P446, DOI 10.1097/00126334-200304010-00016; Leclerc-Madlala S, 2003, SOC DYNAMICS, V29, P213, DOI 10.1080/02533950308628681; Leclerc-Madlala S, 2008, AIDS, V22, pS17, DOI 10.1097/01.aids.0000341774.86500.53; Lu X, 2011, J ROYAL STAT SOC A; Luke N, 2005, INT FAM PLAN PERSPEC, V31, P6, DOI 10.1363/3100605; Luke N, 2003, STUD FAMILY PLANN, V34, P67, DOI 10.1111/j.1728-4465.2003.00067.x; Luke N., 2002, CROSS GENERATIONAL T; Lurie MN, 2010, AIDS BEHAV, V14, P17, DOI 10.1007/s10461-009-9583-5; Mah T, 2008, 225 CSSR; Mah TL, 2010, AIDS BEHAV, V14, P25, DOI 10.1007/s10461-009-9617-z; Mah TL, 2009, 251 CSSR; Manzini N, 2001, REPROD HEALTH MATTER, V9, P44, DOI 10.1016/S0968-8080(01)90007-2; Morrell R, 2009, GENDER EQUALITY SA S; Parker W, 2007, CONCURRENT SEXUAL PA; Pettifor AE, 2011, J ADOLESCENT HEALTH, V49, P237, DOI 10.1016/j.jadohealth.2010.10.002; Preston-Whyte E, 2000, FRAMING SEXUAL SUBJE; Ramirez-Valles J, 2008, AM J PUBLIC HEALTH, V98, P6; Richards JE, 2008, INT J STD AIDS, V19, P768, DOI 10.1258/ijsa.2008.008076; Sabin K, 2010, METHODOL INNOV ONLIN, V5, P38, DOI [10.4256/mio.2010.0017, DOI 10.4256/MIO.2010.0017]; Sawers L, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-34; SHISANA O, 2005, S AFRICAN NATL HIV P; Shisana O, 2009, S AFRICAN NATL HIV P; Townsend L, 2011, AIDS BEHAV, V15, P132, DOI 10.1007/s10461-010-9680-5; UNAIDS, 2010, PROGR REP NAT RESP 2; Wechsberg WM, 2006, AIDS BEHAV, V10, P131, DOI 10.1007/s10461-005-9036-8; Western Cape Provincial Government, 2001, PROV POP STAT W CAP; Wojcicki JM, 2002, CULT MED PSYCHIAT, V26, P339, DOI 10.1023/A:1021291922026; Wojcicki JM, 2002, MED ANTHROPOL Q, V16, P267, DOI 10.1525/maq.2002.16.3.267	41	20	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51998	10.1371/journal.pone.0051998	http://dx.doi.org/10.1371/journal.pone.0051998			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	060RA	23284847	gold, Green Published, Green Submitted			2022-12-27	WOS:000312794500075
J	Fitzpatrick, R; Thums, M; Bell, I; Meekan, MG; Stevens, JD; Barnett, A				Fitzpatrick, Richard; Thums, Michele; Bell, Ian; Meekan, Mark G.; Stevens, John D.; Barnett, Adam			A Comparison of the Seasonal Movements of Tiger Sharks and Green Turtles Provides Insight into Their Predator-Prey Relationship	PLOS ONE			English	Article							FRENCH FRIGATE SHOALS; GALEOCERDO-CUVIER; HABITAT USE; FORAGING BEHAVIOR; APEX PREDATOR; SITE FIDELITY; PATTERNS; ECOLOGY; RISK; DIET	During the reproductive season, sea turtles use a restricted area in the vicinity of their nesting beaches, making them vulnerable to predation. At Raine Island (Australia), the highest density green turtle Chelonia mydas rookery in the world, tiger sharks Galeocerdo cuvier have been observed to feed on green turtles, and it has been suggested that they may specialise on such air-breathing prey. However there is little information with which to examine this hypothesis. We compared the spatial and temporal components of movement behaviour of these two potentially interacting species in order to provide insight into the predator-prey relationship. Specifically, we tested the hypothesis that tiger shark movements are more concentrated at Raine Island during the green turtle nesting season than outside the turtle nesting season when turtles are not concentrated at Raine Island. Turtles showed area-restricted search behaviour around Raine Island for similar to 3-4 months during the nesting period (November-February). This was followed by direct movement (transit) to putative foraging grounds mostly in the Torres Straight where they switched to area-restricted search mode again, and remained resident for the remainder of the deployment (53-304 days). In contrast, tiger sharks displayed high spatial and temporal variation in movement behaviour which was not closely linked to the movement behaviour of green turtles or recognised turtle foraging grounds. On average, tiger sharks were concentrated around Raine Island throughout the year. While information on diet is required to determine whether tiger sharks are turtle specialists our results support the hypothesis that they target this predictable and plentiful prey during turtle nesting season, but they might not focus on this less predictable food source outside the nesting season.	[Barnett, Adam] Deakin Univ, Sch Life & Environm Sci, Melbourne, Vic, Australia; [Fitzpatrick, Richard] James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld, Australia; [Fitzpatrick, Richard; Barnett, Adam] Reef Channel, Cairns, Qld, Australia; [Thums, Michele; Meekan, Mark G.] Univ Western Australia, Oceans Inst, Crawley, WA, Australia; [Thums, Michele] Univ Western Australia, Sch Environm Syst Engn, Crawley, WA, Australia; [Thums, Michele; Meekan, Mark G.] Univ Western Australia, Australian Inst Marine Sci, Crawley, WA, Australia; [Bell, Ian] Queensland Dept Environm & Heritage Protect, Townsville, Qld, Australia; [Stevens, John D.] CSIRO, Marine & Atmospher Res, Hobart, Tas, Australia; [Barnett, Adam] Univ Tasmania, Fisheries Aquaculture & Coasts Ctr, Inst Marine & Antarct Studies, Hobart, Tas, Australia	Deakin University; James Cook University; University of Western Australia; University of Western Australia; Australian Institute of Marine Science; University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Tasmania	Barnett, A (corresponding author), Deakin Univ, Sch Life & Environm Sci, Melbourne, Vic, Australia.	adam.barnett@utas.edu.au	Thums, Michele/A-3850-2013	Thums, Michele/0000-0002-8669-8440; Meekan, Mark/0000-0002-3067-9427; , Adam/0000-0001-7430-8428	Digital Dimensions, Australia; commercial source, Digital Dimensions	Digital Dimensions, Australia; commercial source, Digital Dimensions	Funding was supplied by Digital Dimensions, Australia, through the production of documentaries related to shark research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this project was from a commercial source, Digital Dimensions. RF and AB are affiliated with a commercial company The Reef Channel. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Abrantes KG, 2011, MAR ECOL PROG SER, V442, P133, DOI 10.3354/meps09395; Bailey H, 2008, J EXP MAR BIOL ECOL, V356, P128, DOI 10.1016/j.jembe.2007.12.020; Bailey Helen, 2010, Endangered Species Research, V10, P93, DOI 10.3354/esr00239; Barnett A, 2012, OIKOS, V121, P882, DOI 10.1111/j.1600-0706.2011.20000.x; Barnett A, 2011, ANIM BEHAV, V81, P1039, DOI 10.1016/j.anbehav.2011.02.011; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Estes JA, 1996, PREDATION DIVERSITY, P857; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Hammerschlag N, 2011, J EXP MAR BIOL ECOL, V398, P1, DOI 10.1016/j.jembe.2010.12.012; Hammerschlag N, 2012, FUNCT ECOL, V26, P567, DOI 10.1111/j.1365-2435.2012.01973.x; Hays GC, 2007, J EXP MAR BIOL ECOL, V349, P52, DOI 10.1016/j.jembe.2007.04.016; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Heithaus MR, 2008, J EXP MAR BIOL ECOL, V356, P43, DOI 10.1016/j.jembe.2007.12.013; Heithaus MR, 2007, J ANIM ECOL, V76, P837, DOI 10.1111/j.1365-2656.2007.01260.x; Heithaus MR, 2007, MAR BIOL, V151, P1455, DOI 10.1007/s00227-006-0583-y; Heithaus MR, 2003, J THEOR BIOL, V223, P79, DOI 10.1016/S0022-5193(03)00073-0; Heithaus MR, 2002, MAR BIOL, V140, P237, DOI 10.1007/s00227-001-0711-7; Holland KN, 1999, MAR BIOL, V134, P665, DOI 10.1007/s002270050582; Jonsen ID, 2007, MAR ECOL PROG SER, V337, P255, DOI 10.3354/meps337255; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Jonsen ID, 2003, ECOLOGY, V84, P3055, DOI 10.1890/02-0670; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; Laroche RK, 2008, ANIM BEHAV, V76, P1901, DOI 10.1016/j.anbehav.2008.06.025; Laundre JW, 2010, ECOLOGY, V91, P2995, DOI 10.1890/08-2345.1; Limpus CJ, 2008, BIOL REV MARINE TURT; Limpus Colin J., 2003, Memoirs of the Queensland Museum, V49, P349; Lowe Christopher G., 2006, Atoll Research Bulletin, P281; Matich P, 2011, J ANIM ECOL, V80, P294, DOI 10.1111/j.1365-2656.2010.01753.x; MENGE BA, 1990, TRENDS ECOL EVOL, V5, P52, DOI 10.1016/0169-5347(90)90048-I; Meyer CG, 2010, MAR BIOL, V157, P1857, DOI 10.1007/s00227-010-1457-x; Meyer CG, 2009, MAR ECOL PROG SER, V381, P223, DOI 10.3354/meps07951; Papastamatiou YP, 2010, J EXP MAR BIOL ECOL, V386, P94, DOI 10.1016/j.jembe.2010.02.009; Pinheiro J, 2012, LINEAR NONLINEAR MIX; Plummer M., 2003, P 3 INT WORKSH DISTR; R Development Core Team, 2012, R LANG ENV STAT COMP; Simpfendorfer CA, 2001, ENVIRON BIOL FISH, V61, P37, DOI 10.1023/A:1011021710183; TERBORGH J, 1988, CONSERV BIOL, V2, P402, DOI 10.1111/j.1523-1739.1988.tb00207.x; Vincent C, 2002, MAR MAMMAL SCI, V18, P156, DOI 10.1111/j.1748-7692.2002.tb01025.x; Wirsing AJ, 2011, FRONT ECOL ENVIRON, V9, P335, DOI 10.1890/090226; Wirsing AJ, 2010, ANIM BEHAV, V79, P531, DOI 10.1016/j.anbehav.2009.12.014; Witt MJ, 2010, ANIM BEHAV, V80, P571, DOI 10.1016/j.anbehav.2010.05.022	41	51	52	2	143	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51927	10.1371/journal.pone.0051927	http://dx.doi.org/10.1371/journal.pone.0051927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284819	Green Published, gold, Green Accepted			2022-12-27	WOS:000312694300059
J	Fudickar, AM; Partecke, J				Fudickar, Adam M.; Partecke, Jesko			The Flight Apparatus of Migratory and Sedentary Individuals of a Partially Migratory Songbird Species	PLOS ONE			English	Article							BIRDS; ECOMORPHOLOGY; EVOLUTION; BEHAVIOR; WINGS	Variations in the geometry of the external flight apparatus of birds are beneficial for different behaviors. Long-distance flight is less costly with more pointed wings and shorter tails; however these traits decrease maneuverability at low speeds. Selection has led to interspecific differences in these and other flight apparatuses in relation to migration distance. If these principles are general, how are the external flight apparatus within a partially migratory bird species shaped in which individuals either migrate or stay at their breeding grounds? We resolved this question by comparing the wing pointedness and tail length (relative to wing length) of migrant and resident European blackbirds (Turdus merula) breeding in the same population. We predicted that migrant blackbirds would have more pointed wings and shorter tails than residents. Contrary to our predictions, there were no differences between migrants and residents in either measure. Our results indicate that morphological differences between migrants and residents in this partially migratory population may be constrained.	[Fudickar, Adam M.; Partecke, Jesko] Max Planck Inst Ornithol, Radolfzell am Bodensee, Germany; [Fudickar, Adam M.] Univ Konstanz, Dept Biol, Constance, Germany	Max Planck Society; University of Konstanz	Fudickar, AM (corresponding author), Max Planck Inst Ornithol, Radolfzell am Bodensee, Germany.	afudickar@gmail.com		Fudickar, Adam/0000-0001-5517-7063	Max-Planck-Society; International Max Planck Research School for Organismal Biology	Max-Planck-Society(Max Planck Society); International Max Planck Research School for Organismal Biology	The Max-Planck-Society provided funding for the project. AMF was also supported by the International Max Planck Research School for Organismal Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, ECONOMIST 0326; Bearhop S, 2005, SCIENCE, V310, P502, DOI 10.1126/science.1115661; BERTHOLD P, 1982, EXPERIENTIA, V38, P805, DOI 10.1007/BF01972282; Bowlin MS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002154; Chapman BB, 2011, OIKOS, V120, P1764, DOI 10.1111/j.1600-0706.2011.20131.x; Fiedler W, 2005, ANN NY ACAD SCI, V1046, P253, DOI 10.1196/annals.1343.022; Fitzpatrick S, 1998, J AVIAN BIOL, V29, P248, DOI 10.2307/3677107; Forschler MI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018732; Fudickar AM, 2012, METHODS ECOL EVOL, V3, P47, DOI 10.1111/j.2041-210X.2011.00136.x; Gerson AR, 2011, SCIENCE, V333, P1434, DOI 10.1126/science.1210449; Hatchwell BJ, 1996, J APPL ECOL, V33, P1114, DOI 10.2307/2404691; Kays R, 2011, COMPUT J, V54, P1931, DOI 10.1093/comjnl/bxr072; Kipp F.A., 1959, VOGELWARTE, V20, P77; MARCHETTI K, 1995, J AVIAN BIOL, V26, P177, DOI 10.2307/3677316; Mitchell GW, 2012, J ANIM ECOL, V81, P1024, DOI 10.1111/j.1365-2656.2012.01978.x; Naef-Daenzer B, 2007, J AVIAN BIOL, V38, P404, DOI 10.1111/j.2007.0908-8857.03863.x; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Partecke J, 2007, ECOLOGY, V88, P882, DOI 10.1890/06-1105; Piersma T, 1998, J AVIAN BIOL, V29, P511, DOI 10.2307/3677170; Ramenofsky M, 2007, BIOSCIENCE, V57, P135, DOI 10.1641/B570208; Rolshausen G, 2009, CURR BIOL, V19, P2097, DOI 10.1016/j.cub.2009.10.061; SCHWABL H, 1983, J ORNITHOL, V124, P101, DOI 10.1007/BF01640158; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Svensson L., 1992, IDENTIFICATION GUIDE; Thomas ALR, 1996, J THEOR BIOL, V183, P237, DOI 10.1006/jtbi.1996.0217; Weimerskirch H, 2001, NATURE, V413, P697, DOI 10.1038/35099670; WINKLER H, 1992, IBIS, V134, P21	27	14	15	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51920	10.1371/journal.pone.0051920	http://dx.doi.org/10.1371/journal.pone.0051920			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284817	Green Submitted, gold, Green Published			2022-12-27	WOS:000312694300057
J	Stimpert, AK; Peavey, LE; Friedlaender, AS; Nowacek, DP				Stimpert, Alison K.; Peavey, Lindsey E.; Friedlaender, Ari S.; Nowacek, Douglas P.			Humpback Whale Song and Foraging Behavior on an Antarctic Feeding Ground	PLOS ONE			English	Article							EASTERN NORTH PACIFIC; MEGAPTERA-NOVAEANGLIAE; ACOUSTIC DETECTIONS; HAWAIIAN; WESTERN; KINEMATICS; MIGRATION; WATERS	Reports of humpback whale (Megaptera novaeangliae) song chorusing occurring outside the breeding grounds are becoming more common, but song structure and underwater behavior of individual singers on feeding grounds and migration routes remain unknown. Here, ten humpback whales in the Western Antarctic Peninsula were tagged in May 2010 with non-invasive, suction-cup attached tags to study foraging ecology and acoustic behavior. Background song was identified on all ten records, but additionally, acoustic records of two whales showed intense and continuous singing, with a level of organization and structure approaching that of typical breeding ground song. The songs, produced either by the tagged animals or close associates, shared phrase types and theme structure with one another, and some song bouts lasted close to an hour. Dive behavior of tagged animals during the time of sound production showed song occurring during periods of active diving, sometimes to depths greater than 100 m. One tag record also contained song in the presence of feeding lunges identified from the behavioral sensors, indicating that mating displays occur in areas worthy of foraging. These data show behavioral flexibility as the humpbacks manage competing needs to continue to feed and to prepare for the breeding season during late fall. This may also signify an ability to engage in breeding activities outside of the traditional, warm water breeding ground locations.	[Stimpert, Alison K.] USN, Dept Oceanog, Postgrad Sch, Monterey, CA 93943 USA; [Peavey, Lindsey E.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Friedlaender, Ari S.; Nowacek, Douglas P.] Duke Univ, Marine Lab, Nicholas Sch Environm, Beaufort, NC 28516 USA; [Nowacek, Douglas P.] Duke Univ, Marine Lab, Pratt Sch Engn, Beaufort, NC 28516 USA	United States Department of Defense; United States Navy; Naval Postgraduate School; University of California System; University of California Santa Barbara; Duke University; Duke University	Stimpert, AK (corresponding author), USN, Dept Oceanog, Postgrad Sch, Monterey, CA 93943 USA.	akstimpe@nps.edu		Stimpert, Alison/0000-0002-9400-0305; Peavey Reeves, Lindsey/0000-0003-4900-5921	National Science Foundation [ANT-07-39483]; Acoustical Society of America	National Science Foundation(National Science Foundation (NSF)); Acoustical Society of America	This material is based upon work supported by the National Science Foundation under Grant No. ANT-07-39483. The authors also gratefully acknowledge funding support from the F. V. Hunt Fellowship of the Acoustical Society of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Au WWL, 2006, J ACOUST SOC AM, V120, P1103, DOI 10.1121/1.2211547; BAKER CS, 1984, CAN J ZOOL, V62, P1922, DOI 10.1139/z84-282; Cerchio S, 2001, ANIM BEHAV, V62, P313, DOI 10.1006/anbe.2001.1747; Charif RA, 2001, MAR MAMMAL SCI, V17, P751, DOI 10.1111/j.1748-7692.2001.tb01297.x; Cholewiak DM, 2008, THESIS CORNELL U; CLAPHAM PJ, 1990, MAR MAMMAL SCI, V6, P155, DOI 10.1111/j.1748-7692.1990.tb00238.x; Clark CW, 2004, P ROY SOC B-BIOL SCI, V271, P1051, DOI 10.1098/rspb.2004.2699; Darling JD, 2006, BEHAVIOUR, V143, P1051, DOI 10.1163/156853906778607381; Darling JD, 2005, MAR MAMMAL SCI, V21, P557, DOI 10.1111/j.1748-7692.2005.tb01249.x; Darling JD, 2001, MAR MAMMAL SCI, V17, P570, DOI 10.1111/j.1748-7692.2001.tb01005.x; Alves LCPD, 2009, MAR MAMMAL SCI, V25, P416, DOI 10.1111/j.1748-7692.2008.00249.x; Dunlop RA, 2007, J ACOUST SOC AM, V122, P2893, DOI 10.1121/1.2783115; FRANKEL AS, 1995, CAN J ZOOL, V73, P1134, DOI 10.1139/z95-135; Frazer LN, 2000, IEEE J OCEANIC ENG, V25, P160, DOI 10.1109/48.820748; Garland EC, 2011, CURR BIOL, V21, P687, DOI 10.1016/j.cub.2011.03.019; Goldbogen JA, 2006, J EXP BIOL, V209, P1231, DOI 10.1242/jeb.02135; HELWEG DA, 1994, ETHOLOGY, V98, P298, DOI 10.1111/j.1439-0310.1994.tb01078.x; HELWEG DA, 1992, MARINE MAMMAL SENSORY SYSTEMS, P459; Jensen FH, 2009, MAR ECOL PROG SER, V395, P161, DOI 10.3354/meps08204; Johnson M, 2009, MAR ECOL PROG SER, V395, P55, DOI 10.3354/meps08255; Johnson MP, 2003, IEEE J OCEANIC ENG, V28, P3, DOI 10.1109/JOE.2002.808212; MATTILA DK, 1987, J MAMMAL, V68, P880, DOI 10.2307/1381574; MCSWEENEY DJ, 1989, MAR MAMMAL SCI, V5, P139, DOI 10.1111/j.1748-7692.1989.tb00328.x; MEDRANO L, 1994, CAN J ZOOL, V72, P1771, DOI 10.1139/z94-239; MILLS HG, 2005, J ACOUST SOC AM, V117, P2525; Noad MJ, 2000, NATURE, V408, P537, DOI 10.1038/35046199; Norris TF, 1999, J ACOUST SOC AM, V106, P506, DOI 10.1121/1.427071; Nowacek DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019173; Oleson EM, 2007, MAR ECOL PROG SER, V330, P269, DOI 10.3354/meps330269; Parks S. E., 2011, Endangered Species Research, V15, P63, DOI 10.3354/esr00368; PAYNE RS, 1971, SCIENCE, V173, P585, DOI 10.1126/science.173.3997.585; Reidenberg JS, 2007, ANAT REC, V290, P745, DOI 10.1002/ar.20544; Robbins Jooke, 2011, Endangered Species Research, V13, P117, DOI 10.3354/esr00328; Schneider JN, 2010, THESIS U BUFFALO; Simon M, 2012, J EXP BIOL, V215, P3786, DOI 10.1242/jeb.071092; Simon M, 2010, J ACOUST SOC AM, V128, P3200, DOI 10.1121/1.3495946; Smith JN, 2008, ANIM BEHAV, V76, P467, DOI 10.1016/j.anbehav.2008.02.013; Soto NA, 2006, MAR MAMMAL SCI, V22, P690, DOI 10.1111/j.1748-7692.2006.00044.x; Stammerjohn SE, 2008, DEEP-SEA RES PT II, V55, P2041, DOI 10.1016/j.dsr2.2008.04.026; Stevick PT, 2011, BIOL LETTERS, V7, P299, DOI 10.1098/rsbl.2010.0717; Stimpert AK, 2010, THESIS U HAWAII MANO; Stimpert AK, 2011, J ACOUST SOC AM, V129, P476, DOI 10.1121/1.3504708; TYACK P, 1981, BEHAV ECOL SOCIOBIOL, V8, P105, DOI 10.1007/BF00300822; Tyson RB, 2012, MAR ECOL PROG SER, V457, P209, DOI 10.3354/meps09708; Vu ET, 2012, AQUAT BIOL, V14, P175, DOI 10.3354/ab00390; Ware C, 2011, MAR MAMMAL SCI, V27, P587, DOI 10.1111/j.1748-7692.2010.00427.x; WEINRICH M, 1995, MAR MAMMAL SCI, V11, P251, DOI 10.1111/j.1748-7692.1995.tb00524.x; WEINRICH MT, 1992, ANIM BEHAV, V44, P1059, DOI 10.1016/S0003-3472(05)80318-5; WHITEHEAD H, 1983, CAN J ZOOL, V61, P1391, DOI 10.1139/z83-186; WINN HE, 1978, MAR BIOL, V47, P97, DOI 10.1007/BF00395631; Wright TF, 2010, ETHOL ECOL EVOL, V22, P393, DOI 10.1080/03949370.2010.505580; Zerbini AN, 2006, MAR ECOL PROG SER, V313, P295, DOI 10.3354/meps313295; Zimmer WMX, 2005, J ACOUST SOC AM, V117, P3919, DOI 10.1121/1.1910225	54	53	55	0	127	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51214	10.1371/journal.pone.0051214	http://dx.doi.org/10.1371/journal.pone.0051214			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284666	Green Published, gold, Green Submitted			2022-12-27	WOS:000312694300015
J	Tang, XL; Yang, L; He, ZY; Liu, JF				Tang, Xulei; Yang, Lin; He, Zhiyu; Liu, Jingfang			Insulin Glargine and Cancer Risk in Patients with Diabetes: A Meta-Analysis	PLOS ONE			English	Article							SHORT-TERM INCIDENCE; LONG-ACTING INSULIN; ANALOG GLARGINE; NPH INSULIN; CELL-PROLIFERATION; MITOGENIC POTENCY; MALIGNANCIES	Aim: The role of insulin glargine as a risk factor for cancer is controversial in human studies. The aim of this meta-analysis was to evaluate the relationship between insulin glargine and cancer incidence. Methods: All observational studies and randomized controlled trials evaluating the relationship of insulin glargine and cancer risk were identified in PubMed, Embase, Web of Science, Cochrane Library and the Chinese Biomedical Medical Literature Database, through March 2012. Odds ratios (ORs) with corresponding 95% confidence interval (CI) were calculated with a random-effects model. Confidence in the estimates of the obtained effects (quality of evidence) was assessed by using the Grading of Recommendations Assessment, Development, and Evaluation approach. Results: A total of 11 studies including 448,928 study subjects and 19,128 cancer patients were finally identified for the meta-analysis. Insulin glargine use was associated with a lower odds of cancer compared with non-glargine insulin use (OR 0.81, 95% CI 0.68 to 0.98, P = 0.03; very low-quality evidence). Glargine did not increase the odds of breast cancer (OR 0.99, 95% CI 0.68 to 1.46, P = 0.966; very low-quality evidence). Compared with non-glargine insulin, no significant association was found between insulin glargine and prostate cancer, pancreatic cancer and respiratory tract cancer. Insulin glargine use was associated with lower odds of other site-specific cancer. Conclusions: Results from the meta-analysis don't support the link between insulin glargine and an increased risk of cancer and the confidence in the estimates of the effects is very low. Further studies are needed to examine the relation between insulin glargine and cancer risk, especially breast cancer.	[Tang, Xulei; Yang, Lin; Liu, Jingfang] Lanzhou Univ, Dept Endocrinol, Hosp 1, Lanzhou 730000, Gansu, Peoples R China; [He, Zhiyu] Lanzhou Univ, Dept Internal Med, Clin Med Sch 1, Lanzhou 730000, Gansu, Peoples R China	Lanzhou University; Lanzhou University	Tang, XL (corresponding author), Lanzhou Univ, Dept Endocrinol, Hosp 1, Lanzhou 730000, Gansu, Peoples R China.	xulei_tang@126.com						Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Blin P, 2012, DIABETOLOGIA; Bodmer M, 2010, DIABETES CARE, V33, P1304, DOI 10.2337/dc09-1791; Boyle P, 2011, DIABETES, V60, pA356; CHANG C, 2011, FILM COMMENT, V47, P6, DOI DOI 10.1371/J0URNAL.P0NE.0021368]; Colhoun HM, 2009, DIABETOLOGIA, V52, P1755, DOI 10.1007/s00125-009-1453-1; Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6; Dawson LK, 2010, AM J HEALTH-SYST PH, V67, P2025, DOI 10.2146/ajhp100109; Dejgaard A, 2009, DIABETOLOGIA, V52, P2507, DOI 10.1007/s00125-009-1568-4; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Du XL, 2012, INT J BIOL MARKER, V27, P241, DOI 10.5301/JBM.2012.9349; Eckardt K, 2007, DIABETOLOGIA, V50, P2534, DOI 10.1007/s00125-007-0815-9; Erbel S, 2008, DIABETES CARE, V31, P1105, DOI 10.2337/dc07-2015; Gerstein HC, 2012, NEW ENGL J MED, V367, P319, DOI 10.1056/NEJMoa1203858; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Heinemann L, 2000, DIABETES CARE, V23, P644, DOI 10.2337/diacare.23.5.644; Hemkens LG, 2009, DIABETOLOGIA, V52, P1732, DOI 10.1007/s00125-009-1418-4; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Home PD, 2009, DIABETOLOGIA, V52, P2499, DOI 10.1007/s00125-009-1530-5; Jonasson JM, 2009, DIABETOLOGIA, V52, P1745, DOI 10.1007/s00125-009-1444-2; Liefvendahl E, 2008, HORM METAB RES, V40, P369, DOI 10.1055/s-2008-1062739; Ljung R, 2011, ACTA ONCOL, V50, P685, DOI 10.3109/0284186X.2011.558913; Mannucci E, 2010, DIABETES CARE, V33, P1997, DOI 10.2337/dc10-0476; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Morden NE, 2011, DIABETES CARE, V34, P1965, DOI 10.2337/dc11-0699; Muller K, 2010, DIABETOLOGIA, V53, P1001, DOI 10.1007/s00125-010-1674-3; Nagel Jutta M., 2010, Hormones & Cancer, V1, P320, DOI 10.1007/s12672-010-0020-z; Rosenstock J, 2005, DIABETES CARE, V28, P950, DOI 10.2337/diacare.28.4.950; Rosenstock J, 2009, DIABETOLOGIA, V52, P1971, DOI 10.1007/s00125-009-1452-2; Ruiter R, 2012, DIABETOLOGIA, V55, P51, DOI 10.1007/s00125-011-2312-4; Shukla A, 2009, ENDOCR-RELAT CANCER, V16, P429, DOI 10.1677/ERC-08-0240; Smith U, 2009, DIABETOLOGIA, V52, P1699, DOI 10.1007/s00125-009-1441-5; Staiger K, 2007, HORM METAB RES, V39, P65, DOI 10.1055/s-2007-957352; Staiger K, 2005, DIABETOLOGIA, V48, P1898, DOI 10.1007/s00125-005-1874-4; Stammberger I, 2002, INT J TOXICOL, V21, P171, DOI 10.1080/10915810290096306; Stammberger I, 2012, INT J TOXICOL; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Suissa S, 2011, DIABETOLOGIA, V54, P2254, DOI 10.1007/s00125-011-2190-9; Teng JA, 2011, HORM METAB RES, V43, P519, DOI 10.1055/s-0031-1280780; The GRADE Working Group, 2019, GRADE HDB GRADING QU; van Staa TP, 2011, DIABETOLOGIA; Wada T, 2008, DIABETES RES CLIN PR, V81, P269, DOI 10.1016/j.diabres.2008.05.007; Weinstein D, 2009, DIABETES-METAB RES, V25, P41, DOI 10.1002/dmrr.912; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029	45	25	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51814	10.1371/journal.pone.0051814	http://dx.doi.org/10.1371/journal.pone.0051814			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284776	Green Submitted, Green Published, gold			2022-12-27	WOS:000312694300047
J	Garzon, I; Carriel, V; Marin-Fernandez, AB; Oliveira, AC; Garrido-Gomez, J; Campos, A; Sanchez-Quevedo, MD; Alaminos, M				Garzon, Ingrid; Carriel, Victor; Belen Marin-Fernandez, Ana; Celeste Oliveira, Ana; Garrido-Gomez, Juan; Campos, Antonio; del Carmen Sanchez-Quevedo, Maria; Alaminos, Miguel			A Combined Approach for the Assessment of Cell Viability and Cell Functionality of Human Fibrochondrocytes for Use in Tissue Engineering	PLOS ONE			English	Article							X-RAY-MICROANALYSIS; TEMPOROMANDIBULAR-JOINT DISC; ELEMENTAL CONCENTRATIONS; ARTICULAR-CARTILAGE; ENDOTHELIAL-CELLS; STEM-CELLS; CHONDROCYTES; DIFFERENTIATION; DISORDERS; THERAPY	Temporo-mandibular joint disc disorders are highly prevalent in adult populations. Autologous chondrocyte implantation is a well-established method for the treatment of several chondral defects. However, very few studies have been carried out using human fibrous chondrocytes from the temporo-mandibular joint (TMJ). One of the main drawbacks associated to chondrocyte cell culture is the possibility that chondrocyte cells kept in culture tend to de-differentiate and to lose cell viability under in in-vitro conditions. In this work, we have isolated human temporo-mandibular joint fibrochondrocytes (TMJF) from human disc and we have used a highly-sensitive technique to determine cell viability, cell proliferation and gene expression of nine consecutive cell passages to determine the most appropriate cell passage for use in tissue engineering and future clinical use. Our results revealed that the most potentially viable and functional cell passages were P5-P6, in which an adequate equilibrium between cell viability and the capability to synthesize all major extracellular matrix components exists. The combined action of pro-apoptotic (TRAF5, PHLDA1) and anti-apoptotic genes (SON, HTT, FAIM2) may explain the differential cell viability levels that we found in this study. These results suggest that TMJF should be used at P5-P6 for cell therapy protocols.	[Garzon, Ingrid; Carriel, Victor; Celeste Oliveira, Ana; Garrido-Gomez, Juan; Campos, Antonio; del Carmen Sanchez-Quevedo, Maria; Alaminos, Miguel] Univ Granada, Dept Histol, Tissue Engn Grp, Granada, Spain; [Belen Marin-Fernandez, Ana] Univ Hosp Virgen de las Nieves, Div Oral & Maxillofacial Surg, Granada, Spain; [Garrido-Gomez, Juan] Univ Hosp San Cecilio, Div Trauma & Orthoped Surg, Granada, Spain	University of Granada; Hospital Universitario Virgen de las Nieves; Hospital Universitario San Cecilio	Alaminos, M (corresponding author), Univ Granada, Dept Histol, Tissue Engn Grp, Granada, Spain.	malaminos@ugr.es	ARAYA, VICTOR CARRIEL/H-9425-2018; Oliveira, Ana Carolina/GRF-1435-2022; ALAMINOS, MIGUEL/N-9960-2016	ARAYA, VICTOR CARRIEL/0000-0002-8114-5644; ALAMINOS, MIGUEL/0000-0003-4876-2672; Campos, A/0000-0003-4061-8182	University of Granada-Campus de Excelencia Internacional, Subprograma de I+D+I y Transferencia; Spanish Ministry of Economy and Competitiveness (INNPACTO program) [IPT-300000-2010-017]; European Regional Development Fund, European Union	University of Granada-Campus de Excelencia Internacional, Subprograma de I+D+I y Transferencia; Spanish Ministry of Economy and Competitiveness (INNPACTO program); European Regional Development Fund, European Union	This work was supported by University of Granada-Campus de Excelencia Internacional, Subprograma de I+D+I y Transferencia and by the Spanish Ministry of Economy and Competitiveness, grant IPT-300000-2010-017 (INNPACTO program), co-financed by the European Regional Development Fund, European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn EY, 2011, MOL CELL, V42, P185, DOI 10.1016/j.molcel.2011.03.014; Alaminos M, 2008, EXP EYE RES, V86, P758, DOI 10.1016/j.exer.2008.02.003; Alaminos M, 2007, J CELL PHYSIOL, V211, P692, DOI 10.1002/jcp.20976; Allen KD, 2007, TISSUE ENG, V13, P101, DOI 10.1089/ten.2006.0094; Almarza AJ, 2004, ANN BIOMED ENG, V32, P2, DOI 10.1023/B:ABME.0000007786.37957.65; Almarza AJ, 2011, ANN BIOMED ENG, V39, P2479, DOI 10.1007/s10439-011-0364-8; Anderson DEJ, 2009, ARCH ORAL BIOL, V54, P138, DOI 10.1016/j.archoralbio.2008.09.018; Anderson DEJ, 2008, ANN BIOMED ENG, V36, P1992, DOI 10.1007/s10439-008-9572-2; BOEKESTEIN A, 1985, HISTOCHEMISTRY, V82, P257, DOI 10.1007/BF00501402; Dai JW, 2011, MED HYPOTHESES, V77, P132, DOI 10.1016/j.mehy.2011.03.045; Darling EM, 2005, J ORTHOP RES, V23, P425, DOI 10.1016/j.orthres.2004.08.008; Di Francesco A, 1998, ARCH BIOCHEM BIOPHYS, V360, P149, DOI 10.1006/abbi.1998.0937; Elder BD, 2009, BIOMATERIALS, V30, P3749, DOI 10.1016/j.biomaterials.2009.03.050; Garzon I, 2012, TISSUE ENG PART C-ME, V18, P408, DOI [10.1089/ten.tec.2011.0508, 10.1089/ten.TEC.2011.0508]; Hayes AJ, 2007, J HISTOCHEM CYTOCHEM, V55, P853, DOI 10.1369/jhc.7A7210.2007; Hecht JT, 2005, DIFFERENTIATION, V73, P212, DOI 10.1111/j.1432-0436.2005.00025.x; Johns DE, 2008, J DENT RES, V87, P548; Kalpakci KN, 2011, ACTA BIOMATER, V7, P1710, DOI 10.1016/j.actbio.2010.12.015; Landesberg R, 1996, ARCH ORAL BIOL, V41, P761, DOI 10.1016/S0003-9969(96)00068-4; Lee NK, 2002, J BIOCHEM MOL BIOL, V35, P61; Maenpaa K, 2010, J R SOC INTERFACE, V7, P177, DOI 10.1098/rsif.2009.0117; Moioli EK, 2007, ADV DRUG DELIVER REV, V59, P308, DOI 10.1016/j.addr.2007.03.019; Peterson L, 2000, CLIN ORTHOP RELAT R, P212, DOI 10.1097/00003086-200005000-00020; Rangone H, 2004, PATHOL BIOL, V52, P338, DOI 10.1016/j.patbio.2003.06.004; Richardson JB, 1999, J BONE JOINT SURG BR, V81B, P1064, DOI 10.1302/0301-620X.81B6.9343; Rodriguez-Morata A, 2008, ANN VASC SURG, V22, P440, DOI 10.1016/j.avsg.2008.03.004; Roomans Godfried M., 2002, European Cells & Materials, V3, P1; Salido M, 2004, CELL BIOL INT, V28, P397, DOI 10.1016/j.cellbi.2004.03.008; SANCHEZQUEVEDO MC, 1989, BONE MINER, V6, P323, DOI 10.1016/0169-6009(89)90037-8; Shukla S, 2011, APOPTOSIS, V16, P162, DOI 10.1007/s10495-010-0556-y; Tanaka E, 2008, J DENT RES, V87, P296, DOI 10.1177/154405910808700406; WARLEY A, 1990, J MICROSC-OXFORD, V157, P135, DOI 10.1111/j.1365-2818.1990.tb02954.x; WARLEY A, 1994, CELL BIOL INT, V18, P915, DOI 10.1006/cbir.1994.1131; Xia Z, 2012, CELL TISSUE BANK	34	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51961	10.1371/journal.pone.0051961	http://dx.doi.org/10.1371/journal.pone.0051961			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272194	gold, Green Published, Green Submitted			2022-12-27	WOS:000312483300043
J	Wong, MCS; Lau, TCM; Lee, A				Wong, Martin C. S.; Lau, Tony C. M.; Lee, Albert			The Impact of Leadership Programme on Self-Esteem and Self-Efficacy in School: A Randomized Controlled Trial	PLOS ONE			English	Article							HEALTH-PROMOTING SCHOOLS	Background: Leadership training programs by experiential learning among adolescents are very popular worldwide and in particular developed countries, but there exists few studies which formally assessed their impact on the psychological wellbeing of program participants. This study evaluated the effectiveness of leadership training programs on self-esteem and self-efficacy among adolescents. Methodology/Principal Findings: a total of 180 students of the same grade of one secondary school were randomized into an intervention (n = 50) and a control group (n = 130). The students in the intervention group participated in a 6-month program of leadership training and service learning, while the control group did not participate in any training. Their self-esteem and self-efficacy were assessed by Rosenberg Self-Esteem questionnaire and Chinese Adaptation of the General Self-Efficacy Scale, respectively, before and after the program. Both scales have been recognized internationally as valid and reliable survey instruments to measure these psychological attributes. The scores were compared by Student's tests according to gender. A total of 180 students were enrolled during the study period October, 2009 to May, 2010. Their mean age was 15.18 years (0.62) and 56.7% were male. Students allocated to the intervention and control group had statistically similar demographic characteristics except gender (male 36.0% vs. 64.6%, p = 0.001). Overall, the self-esteem scores increased by 1.28 and decreased by 0.30 (p = 0.161) while the self-efficacy scores increased by 0.26 and decreased by 0.76 (p = 0.429) in the intervention and control group, respectively. Among female students, the intervention group showed significant improvements in both self-esteem (2.38 vs. 20.24, p, 0.001) and self-efficacy (1.32 vs. -0.04, p = 0.043). Conclusions/Significance: Leadership training program were not found to be effective to enhance self-esteem and self-efficacy in adolescents, except girls who showed modest increase in these outcomes. Future research should assess the reasons why these programs are effective among female.	[Wong, Martin C. S.; Lau, Tony C. M.; Lee, Albert] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Fac Med, Sch Publ Hlth & Primary Care,Prince Wales Hosp, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital	Wong, MCS (corresponding author), Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Fac Med, Sch Publ Hlth & Primary Care,Prince Wales Hosp, Shatin, Hong Kong, Peoples R China.	wong_martin@cuhk.edu.hk	Wong, Martin/L-4568-2014	Wong, Martin/0000-0001-7706-9370	Committee on the Promotion of Civic Education; Board of Management of the Chinese Permanent Cemeteries	Committee on the Promotion of Civic Education; Board of Management of the Chinese Permanent Cemeteries	This work was supported by the Committee on the Promotion of Civic Education and the Board of Management of the Chinese Permanent Cemeteries. The partner associations were Hong Kong Young Women's Christian Association (YWCA), Hong Kong Red Cross Princess Alexandra School and Hong Kong Playground Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, HONG KONG SPEC ADM R; [Anonymous], 2005, RCY; Astin AW, 1998, J COLL STUDENT DEV, V39, P251; Backer-Fulghum LM, 2012, ADDICT BEHAV, V37, P477, DOI 10.1016/j.addbeh.2011.12.012; BANDURA A, 1981, J PERS SOC PSYCHOL, V41, P586, DOI 10.1037/0022-3514.41.3.586; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bandura A, 1994, ENCY HUMAN BEHAV, DOI DOI 10.1002/9780470479216.CORPSY0836; Baumeister R.F., 1993, SELF ESTEEM PUZZLE L; Beck AT, 2001, BEHAV RES THER, V39, P115, DOI 10.1016/S0005-7967(00)00028-0; Blascovich J., 1991, MEAS PERSONALITY SOC, VVolume 1, P115, DOI DOI 10.1002/JTS.20680; CHENG ST, 1995, PERCEPT MOTOR SKILL, V81, P431, DOI 10.1177/003151259508100214; Corporation for National and Community Service, 2006, SUMM REP NAT EV LEAR; Diekstra R.F., 2008, SOCIAL EMOTIONAL ED, P255; Donders W., 2004, KIND ADOLESCENT, V25, P74; Durlak JA, 2011, CHILD DEV, V82, P405, DOI 10.1111/j.1467-8624.2010.01564.x; Eyler J., 1999, WHERES LEARNING SERV; Falci CD, 2011, SOC SCI RES, V40, P586, DOI 10.1016/j.ssresearch.2010.12.013; Harter S., 1990, THRESHOLD DEV ADOLES, P352; Harter S., 1993, SELF ESTEEM PUZZLE L, P87, DOI [DOI 10.1007/978-1-4684-8956-9_5, 10.1007/978-1-4684-8956-9_5]; HIRSCH BJ, 1991, J YOUTH ADOLESCENCE, V20, P53, DOI 10.1007/BF01537351; Howard RW, 2006, MENTOR TUTOR, V14, P5, DOI 10.1080/13611260500432160; Larson S, 2005, RECLAIMING CHILDREN, V4, P27; Launen EK, 2005, RECLAIMING CHILDREN, V14, P137; Mann M, 2004, HEALTH EDUC RES, V19, P357, DOI 10.1093/her/cyg041; McClure AC, 2010, ACAD PEDIATR, V10, P238, DOI 10.1016/j.acap.2010.03.007; Moser J. M., 2005, TECH DIRECTIONS, V64, P18; Muris P, 2003, PERS INDIV DIFFER, V35, P1791, DOI 10.1016/S0191-8869(03)00004-7; Muris Peter, 2005, Eat Behav, V6, P11, DOI 10.1016/j.eatbeh.2004.03.002; National Commission on Service-Learning, 2002, LEARNING DEED POWER; Pipher M., 1994, REVIVING OPHELIA SAV; Pollack WS., 1999, REAL BOYS RESCUING O; Richardson S., 2006, TECHNIQUES CONNECTIN, P38; Rosenberg M., 1965, SOC ADOLESCENT SELF, DOI 10.1515/9781400876136; Ross CE, 2000, SOCIOL EDUC, V73, P270, DOI 10.2307/2673234; Schwarzer R., 1995, JERUSALEM; Schwarzer R., 1992, SELF EFFICACY THOUGH, P217; Stice E, 2002, PSYCHOL BULL, V128, P825, DOI 10.1037//0033-2909.128.5.825; WALKER LS, 1986, J YOUTH ADOLESCENCE, V15, P315, DOI 10.1007/BF02145728; Wayne PL, 2012, STUDENT LEADERSHIP T; Wong MCS, 2009, J EPIDEMIOL COMMUN H, V63, P209, DOI 10.1136/jech.2008.074260; Wong MCS, 2009, HEALTH PROMOT INT, V24, P149, DOI 10.1093/heapro/dap010; ZHANG JX, 1995, PSYCHOLOGIA, V38, P174	42	20	20	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52023	10.1371/journal.pone.0052023	http://dx.doi.org/10.1371/journal.pone.0052023			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	056JC	23272199	Green Submitted, gold, Green Published			2022-12-27	WOS:000312483300047
J	Huuskonen, A; Lappalainen, J; Oksala, N; Santtila, M; Hakkinen, K; Kyrolainen, H; Atalay, M				Huuskonen, Antti; Lappalainen, Jani; Oksala, Niku; Santtila, Matti; Hakkinen, Keijo; Kyrolainen, Heikki; Atalay, Mustafa			Aerobic Fitness Does Not Modify the Effect of FTO Variation on Body Composition Traits	PLOS ONE			English	Article							LEPTIN RECEPTOR GENE; PHYSICAL-ACTIVITY; CARDIORESPIRATORY FITNESS; G-2548A POLYMORPHISM; OBESITY; ASSOCIATION; WEIGHT; WOMEN; MASS; DETERMINANTS	Purpose: Poor physical fitness and obesity are risk factors for all cause morbidity and mortality. We aimed to clarify whether common genetic variants of key energy intake determinants in leptin (LEP), leptin receptor (LEPR), and fat mass and obesity-associated (FTO) are associated with aerobic and neuromuscular performance, and whether aerobic fitness can alter the effect of these genotypes on body composition. Methods: 846 healthy Finnish males of Caucasian origin were genotyped for FTO (rs8050136), LEP (rs7799039) and LEPR (rs8179183 and rs1137101) single nucleotide polymorphisms (SNPs), and studied for associations with maximal oxygen consumption, body fat percent, serum leptin levels, waist circumference and maximal force of leg extensor muscles. Results: Genotype AA of the FTO SNP rs8050136 associated with higher BMI and greater waist circumference compared to the genotype CC. In general linear model, no significant interaction for FTO genotype-relative VO(2)max (mL.kg(-1).min(-1)) or FTO genotype-absolute VO(2)max (L.min(-1)) on BMI or waist circumference was found. Main effects of aerobic performance on body composition traits were significant (p < 0.001). Logistic regression modelling found no significant interaction between aerobic fitness and FTO genotype. LEP SNP rs7799039, LEPR SNPs rs8179183 and rs1137101 did not associate with any of the measured variables, and no significant interactions of LEP or LEPR genotype with aerobic fitness were observed. In addition, none of the studied SNPs associated with aerobic or neuromuscular performance. Conclusions: Aerobic fitness may not modify the effect of FTO variation on body composition traits. However, relative aerobic capacity associates with lower BMI and waist circumference regardless of the FTO genotype. FTO, LEP and LEPR genotypes unlikely associate with physical performance.	[Huuskonen, Antti; Lappalainen, Jani; Oksala, Niku; Atalay, Mustafa] Univ Eastern Finland, Inst Biomed, Kuopio, Finland; [Oksala, Niku] Tampere Univ Hosp, Dept Surg, Tampere, Finland; [Santtila, Matti] Finnish Def Forces, Personnel Div, Helsinki, Finland; [Hakkinen, Keijo; Kyrolainen, Heikki] Univ Jyvaskyla, Dept Biol Phys Act, Jyvaskyla, Finland	University of Eastern Finland; Tampere University; Tampere University Hospital; University of Jyvaskyla	Huuskonen, A (corresponding author), Univ Eastern Finland, Inst Biomed, Kuopio, Finland.	antti.huuskonen@fimnet.fi		Kyrolainen, Heikki/0000-0003-3822-1733	Research Council for Physical Education and Sports; Finnish Ministry of Education; TBGS Graduate School; Yrjo Jahnsson Foundation; Scientific Advisory Board of Defense, Finland; COST actions [B35, BM0602]	Research Council for Physical Education and Sports; Finnish Ministry of Education; TBGS Graduate School; Yrjo Jahnsson Foundation; Scientific Advisory Board of Defense, Finland; COST actions(European Cooperation in Science and Technology (COST))	This work was funded by the Research Council for Physical Education and Sports, Finnish Ministry of Education, TBGS Graduate School, Yrjo Jahnsson Foundation, the Scientific Advisory Board of Defense, Finland and COST actions B35 and BM0602. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad T, 2010, AM HEART J, V160, P1163, DOI 10.1016/j.ahj.2010.08.002; Ben Ali S, 2009, ARCH MED RES, V40, P186, DOI 10.1016/j.arcmed.2009.02.008; Berentzen T, 2008, J CLIN ENDOCR METAB, V93, P2904, DOI 10.1210/jc.2008-0007; Bouchard C, 1998, MED SCI SPORT EXER, V30, P252, DOI 10.1097/00005768-199802000-00013; Bouchard C, 2008, OBESITY, V16, pS5, DOI 10.1038/oby.2008.528; Brookes AJ, 1999, GENE, V234, P177, DOI 10.1016/S0378-1119(99)00219-X; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Demura Shinichi, 2004, Journal of Physiological Anthropology and Applied Human Science, V23, P93, DOI 10.2114/jpa.23.93; Fairbrother UL, 2007, J BONE MINER RES, V22, P544, DOI 10.1359/jbmr.070114; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Furusawa T, 2010, HUM GENET, V127, P287, DOI 10.1007/s00439-009-0768-9; Hakkinen A, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-15; Hoffstedt J, 2002, HORM METAB RES, V34, P355, DOI 10.1055/s-2002-33466; Huuskonen A, 2010, CELL BIOCHEM FUNCT, V28, P306, DOI 10.1002/cbf.1658; Huygens W, 2004, CAN J APPL PHYSIOL, V29, P186, DOI 10.1139/h04-014; Kelesidis T, 2010, ANN INTERN MED, V152, P93, DOI 10.7326/0003-4819-152-2-201001190-00008; Kilpelainen TO, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001116; Laukkanen JA, 2009, AM J CARDIOL, V103, P1598, DOI 10.1016/j.amjcard.2009.01.371; Loos RJF, 2006, INT J OBESITY, V30, P183, DOI 10.1038/sj.ijo.0803127; Mammes O, 2000, ANN HUM GENET, V64, P391, DOI 10.1017/S0003480000008277; Mangge H, 2011, J OBES, V2011, DOI 10.1155/2011/186368; Masuo K, 2008, HYPERTENS RES, V31, P1093, DOI 10.1291/hypres.31.1093; McPherson R, 2007, CAN J CARDIOL, V23, p23A, DOI 10.1016/S0828-282X(07)71002-4; Mergen H, 2007, ENDOCR J, V54, P89, DOI 10.1507/endocrj.K06-023; Mitchell JA, 2010, OBESITY, V18, P641, DOI 10.1038/oby.2009.311; Paracchini V, 2005, AM J EPIDEMIOL, V162, P101, DOI 10.1093/aje/kwi174; Peng SH, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-71; Pyrzak B, 2009, EUR J MED RES, V14, P201, DOI 10.1186/2047-783X-14-S4-201; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Shapiro A, 2008, DIABETES, V57, P614, DOI 10.2337/db07-0863; Silver K, 1997, DIABETES, V46, P1898, DOI 10.2337/diab.46.11.1898; Sui XM, 2010, MED SCI SPORT EXER, V42, P872, DOI 10.1249/MSS.0b013e3181c47b65; Uitenbroek D, 2004, SAMPLE SIZE SISA 201; van Rossum CTM, 2003, OBES RES, V11, P377, DOI 10.1038/oby.2003.51; Wang TN, 2006, OBESITY, V14, P183, DOI 10.1038/oby.2006.23; Wauters M, 2002, OBES RES, V10, P394, DOI 10.1038/oby.2002.54; Zhang Y, 2010, NUTR METAB CARDIOVAS, V20, P386, DOI 10.1016/j.numecd.2010.02.001; Zimmermann E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015958	39	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51635	10.1371/journal.pone.0051635	http://dx.doi.org/10.1371/journal.pone.0051635			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284729	Green Submitted, Green Published, gold			2022-12-27	WOS:000312435900036
J	Lorenzen, JM; Martino, F; Scheffner, I; Brocker, V; Leitolf, H; Haller, H; Gwinner, W				Lorenzen, Johan M.; Martino, Filippo; Scheffner, Irina; Broecker, Verena; Leitolf, Holger; Haller, Hermann; Gwinner, Wilfried			Fetuin, Matrix-Gla Protein and Osteopontin in Calcification of Renal Allografts	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; TYRAMINE AMPLIFICATION TECHNIQUE; VASCULAR CALCIFICATION; CARDIOVASCULAR MORTALITY; CLINICAL-IMPLICATIONS; PROTOCOL BIOPSIES; EPITHELIAL-CELLS; STONES; URINE; GENE	Background: Calcification of renal allografts is common in the first year after transplantation and is related to hyperparathyroidism. It is associated with an impaired long-term function of the graft (Am J Transplant 5:1934-41, 2005). Aim of this study is to examine the role of the anti-calcifying/calcifying factors in the pathophysiology of renal allograft calcification. Methods: We analyzed protocol allograft biopsies, blood and urine samples of 31 patients with and 27 patients without allograft calcification taken at 6 weeks, 3 and 6 months after transplantation. Patient demographical data, cold ischemia time, initial graft function and donor characteristics were comparable between the two groups. Biopsies were stained for osteopontin, fetuin, and matrix-gla-protein. Serum and urine electrolytes, matrix-gla-protein, fetuin, Vitamin D and intact parathyroid hormone in serum and osteopontin (OPN) in urine were examined. Results: Serum levels of fetuin and matrix-Gla protein as well as urinary levels of OPN showed specific time dependent changes (6 weeks vs. 3 months vs. 6 months; all p<0.0001). In patients with calcifications, urinary levels of OPN were decreased by 55% at 6 weeks and increased thereafter, showing 54% higher levels at 6 months compared to patients without calcification (6 weeks: p<0.01, 6 months: p<0.05). Local protein expression of fetuin-A, matrix-Gla protein and OPN in the graft was specifically increased around calcified plaques, without differences in the mRNA tissue expression. Conclusion: Anticalcifying factors show significant changes in the early phase after renal transplantation, which may be important for the prevention of allograft calcification. The differences in OPN indicate an involvement of this factor in the regulation of calcification.	[Lorenzen, Johan M.; Martino, Filippo; Scheffner, Irina; Haller, Hermann; Gwinner, Wilfried] Hannover Med Sch, Div Nephrol & Hypertens, Dept Med, Hannover, Germany; [Broecker, Verena] Hannover Med Sch, Dept Pathol, Hannover, Germany; [Leitolf, Holger] Hannover Med Sch, Div Endocrinol, Dept Med, Hannover, Germany; [Lorenzen, Johan M.; Martino, Filippo] Hannover Med Sch, IMTTS, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School	Gwinner, W (corresponding author), Hannover Med Sch, Div Nephrol & Hypertens, Dept Med, Hannover, Germany.	Gwinner.Wilfried@mh-hannover.de		Lorenzen, Johan/0000-0002-9132-948X	German Ministry for Education and Research (IFB-Tx); German Research Foundation [DFG LO 1736/1-1]	German Ministry for Education and Research (IFB-Tx); German Research Foundation(German Research Foundation (DFG))	This work was supported by a grant of the German Ministry for Education and Research (IFB-Tx to W.G. and J.L.) as well as the German Research Foundation (DFG LO 1736/1-1 to JL). The German Research Foundation funded the cost of Open Access publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselman M, 2003, J AM SOC NEPHROL, V14, P3155, DOI 10.1097/01.ASN.0000099380.18995.F7; Brancaccio D, 2005, AM J NEPHROL, V25, P548, DOI 10.1159/000088809; Chapman JR, 2005, J AM SOC NEPHROL, V16, P3015, DOI 10.1681/ASN.2005050463; CONN KM, 1985, BONE, V6, P33, DOI 10.1016/8756-3282(85)90404-1; Curhan GC, 2001, KIDNEY INT, V59, P2290, DOI 10.1046/j.1523-1755.2001.0590062290.x; FRASER JD, 1988, J BIOL CHEM, V263, P11033; Gao B, 2007, J UROLOGY, V177, P2361, DOI 10.1016/j.juro.2007.01.118; Gwinner W, 2008, AM J TRANSPLANT, V8, P1684, DOI 10.1111/j.1600-6143.2008.02293.x; Gwinner W, 2005, AM J TRANSPLANT, V5, P1934, DOI 10.1111/j.1600-6143.2005.00938.x; Jahnen-Dechent W, 2005, ANONYMOUS BIOMINERAL, P243; Jahnen-Dechent W, 2004, ANONYMOUS BIOMINERAL, P243; Ketteler M, 2003, LANCET, V361, P827, DOI 10.1016/S0140-6736(03)12710-9; LIESKE JC, 1995, AM J PHYSIOL-RENAL, V268, pF604, DOI 10.1152/ajprenal.1995.268.4.F604; Lorenzen J, 2008, J AM SOC NEPHROL, V19, P884, DOI 10.1681/ASN.2007040486; Lorenzen J, 2010, EUR J CLIN INVEST, V40, P294, DOI 10.1111/j.1365-2362.2010.02271.x; Lorenzen JM, 2010, ATHEROSCLEROSIS, V209, P184, DOI 10.1016/j.atherosclerosis.2009.09.009; Mazzaferro S, 2007, AM J NEPHROL, V27, P75, DOI 10.1159/000099095; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P1289, DOI 10.1111/j.1600-6143.2004.00515.x; Mengel M, 1999, HISTOCHEM J, V31, P195, DOI 10.1023/A:1003554217994; Moe SM, 2005, KIDNEY INT, V67, P2295, DOI 10.1111/j.1523-1755.2005.00333.x; Nankivell Brian J., 2003, New England Journal of Medicine, V349, P2326, DOI 10.1056/NEJMoa020009; Parks JH, 2004, KIDNEY INT, V66, P777, DOI 10.1111/j.1523-1755.2004.00803.x; Schlieper G, 2007, SEMIN DIALYSIS, V20, P113, DOI 10.1111/j.1525-139X.2007.00257.x; Schurgers LJ, 2005, ARTERIOSCL THROM VAS, V25, P1629, DOI 10.1161/01.ATV.0000173313.46222.43; Speer MY, 2002, J EXP MED, V196, P1047, DOI 10.1084/jem.20020911; Spronk HMH, 2001, BIOCHEM BIOPH RES CO, V289, P485, DOI 10.1006/bbrc.2001.5996; Steitz SA, 2002, AM J PATHOL, V161, P2035, DOI 10.1016/S0002-9440(10)64482-3; Stubbs J, 2007, SEMIN DIALYSIS, V20, P302, DOI 10.1111/j.1525-139X.2007.00308.x; Verhulst A, 2005, KIDNEY INT, V68, P1643, DOI 10.1111/j.1523-1755.2005.00584.x; Vivek KR, 2003, J UROLOGY, V170, P221, DOI 10.1097/01.ju.0000059540.36463.9f; vonWasielewski R, 1997, J HISTOCHEM CYTOCHEM, V45, P1455, DOI 10.1177/002215549704501102; Yasui T, 1999, UROL RES, V27, P225, DOI 10.1007/s002400050114	32	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52039	10.1371/journal.pone.0052039	http://dx.doi.org/10.1371/journal.pone.0052039			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284864	Green Published, gold, Green Submitted			2022-12-27	WOS:000312435900071
J	Sandoval, D; Barrera, JG; Stefater, MA; Sisley, S; Woods, SC; D'Alessio, DD; Seeley, RJ				Sandoval, Darleen; Barrera, Jason G.; Stefater, Margaret A.; Sisley, Stephanie; Woods, Stephen C.; D'Alessio, David D.; Seeley, Randy J.			The Anorectic Effect of GLP-1 in Rats Is Nutrient Dependent	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; FOOD-INTAKE; BODY-WEIGHT; RECEPTOR ACTIVATION; GLUCOSE; HYPERGLYCEMIA; INFUSION; MEDIATE; GLUCOPRIVATION; SUPPRESSION	GLP-1-induced insulin secretion from the beta-cell is dependent upon glucose availability. The purpose of the current study was to determine whether CNS GLP-1 signaling is also glucose-dependent. We found that fasting blunted the ability of 3rd cerebroventricularly (i3vt)-administered GLP-1 to reduce food intake. However, fasted animals maintained the anorexic response to melanotan II, a melanocortin receptor agonist, indicating a specific effect of fasting on GLP-1 action. We also found that i3vt administration of leptin, which is also decreased with fasting, was not able to potentiate GLP-1 action in fasted animals. However, we did find that CNS glucose sensing is important in GLP-1 action. Specifically, we found that i3vt injection of 2DG, a drug that blocks cellular glucose utilization, and AICAR which activates AMPK, both blocked GLP-1-induced reductions in food intake. To examine the role of glucokinase, an important CNS glucose sensor, we studied glucokinase-heterozygous knockout mice, but found that they responded normally to peripherally administered GLP-1 and exendin-4. Interestingly, oral, but not i3vt or IP glucose potentiated GLP-1's anorectic action. Thus, CNS and peripheral fuel sensing are both important in GLP-1-induced reductions in food intake.	[Sandoval, Darleen; Barrera, Jason G.; Stefater, Margaret A.; Sisley, Stephanie; D'Alessio, David D.; Seeley, Randy J.] Univ Cincinnati, Div Endocrinol & Metab, Cincinnati, OH 45221 USA; [Woods, Stephen C.] Univ Cincinnati, Dept Psychiat, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Sandoval, D (corresponding author), Univ Cincinnati, Div Endocrinol & Metab, Cincinnati, OH 45221 USA.	darleen.sandoval@uc.edu	Sisley, Stephanie/AGP-7748-2022	Sisley, Stephanie/0000-0003-2900-7014; Seeley, Randy/0000-0002-3721-5625	National Institutes of Health [DK75365, DK54080, DK54890, DK056863, DK 017844]; Ethicon Endo-Surgeries; Roche; Mannkind; Ethicon Endosurgery; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054890, P01DK056863, R01DK054080, R01DK017844, K01DK075365, R01DK082480, R01DK057900, R37DK017844] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ethicon Endo-Surgeries; Roche(Roche Holding); Mannkind; Ethicon Endosurgery; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (DK75365 to D.S., DK54080, DK54890 and DK056863 to R.J.S. and DK 017844 to S.C.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and we have the following conflicts: Drs. Sandoval, Seeley, Woods, and D'Alessio receive funding from Ethicon Endo-Surgeries. Dr. Seeley currently has stock/stock options with Zafgen and consults for Zafgen, Eli Lilly and Ethicon Endo-Surgeries. Dr. Sandoval has received grant support from Roche, Mannkind, and Ethicon Endosurgery. Dr. D'Alessio has grant funding from Mannkind. The remaining authors disclose no conflicts. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. None of the above research funding was used to support this study.	Amato A, 2010, NEUROGASTROENT MOTIL, V22, P664; Barrera JG, 2009, DIABETES; DALESSIO D, 1993, DIGESTION, V54, P377; DAVIS JD, 1981, SCIENCE, V212, P81, DOI 10.1126/science.7193909; DunnMeynell AA, 1997, BRAIN RES, V748, P100, DOI 10.1016/S0006-8993(96)01280-2; Gielkens HAJ, 1998, METABOLISM, V47, P321, DOI 10.1016/S0026-0495(98)90264-5; Gilbert M, 2003, DIABETES, V52, P277, DOI 10.2337/diabetes.52.2.277; Grill HJ, 2004, AM J PHYSIOL-REG I, V287, pR1190, DOI 10.1152/ajpregu.00163.2004; Hayes MR, 2011, CELL METAB, V13, P320, DOI 10.1016/j.cmet.2011.02.001; Hayes MR, 2009, ENDOCRINOLOGY, V150, P2654, DOI 10.1210/en.2008-1479; Hudson B, 2004, PHYSIOL BEHAV, V82, P241, DOI 10.1016/j.physbeh.2004.03.032; Kanoski SE, 2011, ENDOCRINOLOGY, V152, P3103, DOI 10.1210/en.2011-0174; Kinzig KP, 2002, J NEUROSCI, V22, P10470; Knauf C, 2008, DIABETES, V57, P2603, DOI 10.2337/db07-1788; KREYMANN B, 1987, LANCET, V2, P1300; KURATA K, 1986, PHYSIOL BEHAV, V37, P615, DOI 10.1016/0031-9384(86)90295-7; MAYER J, 1955, ANN NY ACAD SCI, V63, P15, DOI 10.1111/j.1749-6632.1955.tb36543.x; McMahon LR, 1998, AM J PHYSIOL-REG I, V274, pR23, DOI 10.1152/ajpregu.1998.274.1.R23; Meier JJ, 2002, EUR J PHARMACOL, V440, P269, DOI 10.1016/S0014-2999(02)01434-6; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; MOJSOV S, 1987, J CLIN INVEST, V79, P616, DOI 10.1172/JCI112855; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; QUALMANN C, 1995, SCAND J GASTROENTERO, V30, P892, DOI 10.3109/00365529509101597; RITTER RC, 1980, AM J PHYSIOL, V238, pE141, DOI 10.1152/ajpendo.1980.238.2.E141; Russell AW, 2001, DIABETIC MED, V18, P718, DOI 10.1046/j.1464-5491.2001.00545.x; Sanders NM, 2001, DIABETES, V50, pA53; Schick RR, 2003, AM J PHYSIOL-REG I, V284, pR1427, DOI 10.1152/ajpregu.00479.2002; Seeley RJ, 2002, AM J PHYSIOL-REG I, V283, pR46, DOI 10.1152/ajpregu.00021.2002; Tang-Christensen M, 1998, DIABETES, V47, P530, DOI 10.2337/diabetes.47.4.530; TangChristensen M, 1996, AM J PHYSIOL-REG I, V271, pR848, DOI 10.1152/ajpregu.1996.271.4.R848; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; Vahl TP, 2007, ENDOCRINOLOGY, V148, P4965, DOI 10.1210/en.2006-0153; vanDijk G, 1996, AM J PHYSIOL-REG I, V271, pR1096, DOI 10.1152/ajpregu.1996.271.4.R1096; vanDijk G, 1997, NATURE, V385, P214, DOI 10.1038/385214a0; Washington MC, 2010, BRAIN RES, V1344, P124, DOI 10.1016/j.brainres.2010.05.002; WEIR GC, 1989, DIABETES, V38, P338, DOI 10.2337/diabetes.38.3.338; Williams DL, 2006, DIABETES, V55, P3387, DOI 10.2337/db06-0558; WOODS SC, 1984, AM J PHYSIOL, V247, pR393, DOI 10.1152/ajpregu.1984.247.2.R393	38	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51870	10.1371/journal.pone.0051870	http://dx.doi.org/10.1371/journal.pone.0051870			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284795	Green Submitted, gold, Green Published			2022-12-27	WOS:000312435900060
J	Wang, EM; Aslanzadeh, V; Papa, F; Zhu, HY; de la Grange, P; Cambi, F				Wang, Erming; Aslanzadeh, Vahid; Papa, Filomena; Zhu, Haiyan; de la Grange, Pierre; Cambi, Franca			Global Profiling of Alternative Splicing Events and Gene Expression Regulated by hnRNPH/F	PLOS ONE			English	Article							TRANSCRIPTIONAL CONTROL; HUMAN TISSUES; G RUNS; BINDING; OLIGODENDROCYTES; PROTEIN; MOUSE; DIFFERENTIATION; MECHANISMS; COMPLEXES	In this study, we have investigated the global impact of heterogeneous nuclear Ribonuclear Protein (hnRNP) H/F-mediated regulation of splicing events and gene expression in oligodendrocytes. We have performed a genome-wide transcriptomic analysis at the gene and exon levels in Oli-neu cells treated with siRNA that targets hnRNPH/F compared to untreated cells using Affymetrix Exon Array. Gene expression levels and regulated exons were identified with the GenoSplice EASANA algorithm. Bioinformatics analyses were performed to determine the structural properties of G tracts that correlate with the function of hnRNPH/F as enhancers vs. repressors of exon inclusion. Different types of alternatively spliced events are regulated by hnRNPH/F. Intronic G tracts density, length and proximity to the 59 splice site correlate with the hnRNPH/F enhancer function. Additionally, 6% of genes are differently expressed upon knock down of hnRNPH/F. Genes that regulate the transition of oligodendrocyte progenitor cells to oligodendrocytes are differentially expressed in hnRNPH/F depleted Oli-neu cells, resulting in a decrease of negative regulators and an increase of differentiation-inducing regulators. The changes were confirmed in developing oligodendrocytes in vivo. This is the first genome wide analysis of splicing events and gene expression regulated by hnRNPH/F in oligodendrocytes and the first report that hnRNPH/F regulate genes that are involved in the transition from oligodendrocyte progenitor cells to oligodendrocytes.	[Wang, Erming; Papa, Filomena; Zhu, Haiyan; Cambi, Franca] Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA; [Aslanzadeh, Vahid] Univ Zanjan, Dept Biotechnol, Res Inst Physiol & Biotechnol, Zanjan, Iran; [de la Grange, Pierre] Hop St Louis, GenoSplice Technol, Paris, France	University of Kentucky; University Zanjan; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Cambi, F (corresponding author), Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA.	franca.cambi@uky.edu	zhu, xueqiong/U-1320-2019	Aslanzadeh, Vahid/0000-0002-4500-1627; de la Grange, Pierre/0000-0001-6361-1878	National Institutes of Health/National Institute of Neurological Disorders and Stroke [RO1NS053905, ARRA R01NS053905-03S]; University of Kentucky Research Foundation; NIH Shared Instrument Program [S10 RR026827-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053905] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University of Kentucky Research Foundation; NIH Shared Instrument Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work as supported by the following funding agencies: National Institutes of Health/National Institute of Neurological Disorders and Stroke (RO1NS053905 and ARRA R01NS053905-03S) and Microarray Pilot grant from the University of Kentucky Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Gene Yeo for critical reading of the manuscript. We thank the personnel at the Microarray Core facility for the excellent technical support in performing the exon arrays studies and Ms. Jennifer Strange for excellent technical assistance with the FACS isolation of OL. The FACS sorting facility at the University of Kentucky is in part supported by NIH Shared Instrument Program (S10 RR026827-01A1).	Alkan SA, 2006, BIOCHEM J, V393, P361, DOI 10.1042/BJ20050538; Belachew S, 2002, J NEUROSCI, V22, P8553; Caputi M, 2001, J BIOL CHEM, V276, P43850, DOI 10.1074/jbc.M102861200; Chen CD, 1999, GENE DEV, V13, P593, DOI 10.1101/gad.13.5.593; de la Grange P, 2005, NUCLEIC ACIDS RES, V33, P4276, DOI 10.1093/nar/gki738; de la Grange P, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-180; de la Grange P, 2010, NUCLEIC ACIDS RES, V38, P2825, DOI 10.1093/nar/gkq008; Dominguez C, 2010, NAT STRUCT MOL BIOL, V17, P853, DOI 10.1038/nsmb.1814; Hicks MJ, 2010, MOL CELL BIOL, V30, P1878, DOI 10.1128/MCB.01071-09; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huelga SC, 2012, CELL REP, V1, P167, DOI 10.1016/j.celrep.2012.02.001; JUNG M, 1995, EUR J NEUROSCI, V7, P1245, DOI 10.1111/j.1460-9568.1995.tb01115.x; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu ZX, 2011, HUM MOL GENET, V20, P1084, DOI 10.1093/hmg/ddq553; Maggipinto M, 2004, J NEUROSCI RES, V75, P614, DOI 10.1002/jnr.20014; Marcucci R, 2007, NUCLEIC ACIDS RES, V35, P132, DOI 10.1093/nar/gkl965; MATUNIS MJ, 1994, NUCLEIC ACIDS RES, V22, P1059, DOI 10.1093/nar/22.6.1059; Millevoi S, 2010, NUCLEIC ACIDS RES, V38, P2757, DOI 10.1093/nar/gkp1176; Reed R, 2000, CURR OPIN CELL BIOL, V12, P340, DOI 10.1016/S0955-0674(00)00097-1; REED R, 1986, CELL, V46, P681, DOI 10.1016/0092-8674(86)90343-0; Schaub MC, 2007, J BIOL CHEM, V282, P13617, DOI 10.1074/jbc.M700774200; Tang XM, 1998, J CELL BIOCHEM, V68, P128, DOI 10.1002/(SICI)1097-4644(19980101)68:1<128::AID-JCB13>3.0.CO;2-D; Venables JP, 2008, MOL CELL BIOL, V28, P6033, DOI 10.1128/MCB.00726-08; Veraldi KL, 2001, MOL CELL BIOL, V21, P1228, DOI 10.1128/MCB.21.4.1228-1238.2001; Wang EM, 2007, NUCLEIC ACIDS RES, V35, P4164, DOI 10.1093/nar/gkm387; Wang EM, 2012, J NEUROSCI RES, V90, P1701, DOI 10.1002/jnr.23055; Wang E, 2011, J BIOL CHEM, V286, P4059, DOI 10.1074/jbc.M110.199927; Wang EM, 2009, J BIOL CHEM, V284, P11194, DOI 10.1074/jbc.M809373200; Wang E, 2008, EXP NEUROL, V214, P322, DOI 10.1016/j.expneurol.2008.09.001; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Wegner M, 2000, GLIA, V29, P118, DOI 10.1002/(SICI)1098-1136(20000115)29:2<118::AID-GLIA4>3.0.CO;2-Q; Wegner M, 2008, J MOL NEUROSCI, V35, P3, DOI 10.1007/s12031-007-9008-8; White R, 2008, J CELL BIOL, V181, P579, DOI 10.1083/jcb.200706164; Xiao XS, 2009, NAT STRUCT MOL BIOL, V16, P1094, DOI 10.1038/nsmb.1661; Yao WG, 2008, GROWTH HORM IGF RES, V18, P517, DOI 10.1016/j.ghir.2008.04.006; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Yeo G, 2004, P NATL ACAD SCI USA, V101, P15700, DOI 10.1073/pnas.0404901101; Yeo G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r74; Yuan XQ, 2002, J NEUROSCI RES, V70, P529, DOI 10.1002/jnr.10368; Zhu H, 2012, GLIA, V60, P69, DOI 10.1002/glia.21248; Zhu H, 2011, QKI PLP PATHWAY CONT	43	38	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51266	10.1371/journal.pone.0051266	http://dx.doi.org/10.1371/journal.pone.0051266			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284676	Green Published, Green Submitted, gold			2022-12-27	WOS:000312435900018
J	Glatman-Freedman, A; Portelli, I; Jacobs, SK; Mathew, JI; Slutzman, JE; Goldfrank, LR; Smith, SW				Glatman-Freedman, Aharona; Portelli, Ian; Jacobs, Susan K.; Mathew, Justin I.; Slutzman, Jonathan E.; Goldfrank, Lewis R.; Smith, Silas W.			Attack Rates Assessment of the 2009 Pandemic H1N1 Influenza A in Children and Their Contacts: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							NEW-YORK-CITY; CONFIRMED HOUSEHOLD TRANSMISSION; VIRUS-INFECTION; SCHOOL; OUTBREAK; INTERVENTIONS; CLOSURE	Background: The recent H1N1 influenza A pandemic was marked by multiple reports of illness and hospitalization in children, suggesting that children may have played a major role in the propagation of the virus. A comprehensive detailed analysis of the attack rates among children as compared with their contacts in various settings is of great importance for understanding their unique role in influenza pandemics. Methodology/Principal Findings: We searched MEDLINE (PubMed) and Embase for published studies reporting outbreak investigations with direct measurements of attack rates of the 2009 pandemic H1N1 influenza A among children, and quantified how these compare with those of their contacts. We identified 50 articles suitable for review, which reported school, household, travel and social events. The selected reports and our meta-analysis indicated that children had significantly higher attack rates as compared to adults, and that this phenomenon was observed for both virologically confirmed and clinical cases, in various settings and locations around the world. The review also provided insight into some characteristics of transmission between children and their contacts in the various settings. Conclusion/Significance: The consistently higher attack rates of the 2009 pandemic H1N1 influenza A among children, as compared to adults, as well as the magnitude of the difference is important for understanding the contribution of children to disease burden, for implementation of mitigation strategies directed towards children, as well as more precise mathematical modeling and simulation of future influenza pandemics.	[Glatman-Freedman, Aharona] New York Med Coll, Dept Family & Community Med, Valhalla, NY 10595 USA; [Glatman-Freedman, Aharona] NYU, Global Publ Hlth Masters Program, New York, NY USA; [Portelli, Ian; Goldfrank, Lewis R.; Smith, Silas W.] NYU, Sch Med, Dept Emergency Med, New York, NY USA; [Portelli, Ian; Goldfrank, Lewis R.; Smith, Silas W.] NYU, Ctr Catastrophe Preparedness & Response, New York, NY USA; [Jacobs, Susan K.] NYU, Elmer Holmes Bobst Lib, New York, NY USA; [Mathew, Justin I.] CUNY Hunter Coll, New York, NY 10021 USA; [Slutzman, Jonathan E.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Emergency Med,Massachusetts Gen Hosp, Boston, MA 02115 USA	New York Medical College; New York University; New York University; New York University; New York University; City University of New York (CUNY) System; Hunter College (CUNY); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Massachusetts General Hospital	Glatman-Freedman, A (corresponding author), New York Med Coll, Dept Family & Community Med, Valhalla, NY 10595 USA.	af1200@nyu.edu		Jacobs, Susan Kaplan/0000-0002-9959-5627	United States Department of Defense [W81XW4-07-1-0517, DOD 2007-NYU-001]; New York University/Polytechnic Seed Funding; Nan A. Lightstone Foundation	United States Department of Defense(United States Department of Defense); New York University/Polytechnic Seed Funding; Nan A. Lightstone Foundation	L.R.G. is a recipient of the United States Department of Defense contract numbers W81XW4-07-1-0517 (Agents of Opportunity) and DOD 2007-NYU-001 (LaSER PLAN C: Pandemic Influenza) as well as New York University/Polytechnic Seed Funding (Pandemic Influenza complex modeling). A.G.-F. is a recipient of the Nan A. Lightstone Foundation grant for innovation in infectious disease research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P481; Arinaminpathy N, 2012, EPIDEMIOL INFECT, V140, P1102, DOI 10.1017/S0950268811001518; Baker MG, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2424; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Calatayud L, 2010, EPIDEMIOL INFECT, V138, P183, DOI 10.1017/S0950268809991191; Carcione D, 2011, EURO SURVEILL, V16; Carrillo-Santisteve P, 2010, EUROSURVEILLANCE, V15, p[19599, 1]; Cauchemez S, 2011, P NATL ACAD SCI USA, V108, P2825, DOI 10.1073/pnas.1008895108; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Cauchemez S, 2009, LANCET INFECT DIS, V9, P473, DOI 10.1016/S1473-3099(09)70176-8; CDC, 2010, MMWR-MORBID MORTAL W, V58, P1444; Chang LY, 2011, EMERG INFECT DIS, V17, P1928, DOI 10.3201/eid1710.101662; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Crum-Cianflone NF, 2009, CLIN INFECT DIS, V49, P1801, DOI 10.1086/648508; Cutler J, 2009, CAN MED ASSOC J, V181, P159, DOI 10.1503/cmaj.090859; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; France AM, 2010, J INFECT DIS, V201, P984, DOI 10.1086/651145; Ghani AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004383; Goldstein E, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-211; Guinard A, 2009, EUROSURVEILLANCE, V14, P17; Gurav YK, 2010, INDIAN J MED RES, V132, P67; Halder N, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-221; Han K, 2009, EMERG INFECT DIS, V15, P1578, DOI 10.3201/eid1510.091013; Health Protection Agency Health Protection Scotland National Public Health Service for Wales HPA Northern Ireland Swine influenza investigation teams, 2009, EUROSURVEILLANCE, V14, P1; Hermes J, 2011, INFLUENZA OTHER RESP, V5, pR499, DOI 10.1111/j.1750-2659.2011.00251.x; Hirotsu N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031519; Huai Y, 2010, INFLUENZA OTHER RESP, V4, P259, DOI 10.1111/j.1750-2659.2010.00150.x; Jackson ML, 2011, CLIN INFECT DIS, V53, P455, DOI 10.1093/cid/cir437; Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Kar-Purkayastha I, 2009, EUROSURVEILLANCE, V14, P8; Komiya N, 2010, J INFECTION, V61, P284, DOI 10.1016/j.jinf.2010.06.019; Lau LLH, 2012, EPIDEMIOLOGY, V23, P531, DOI 10.1097/EDE.0b013e31825588b8; Lee DH, 2010, AM J INFECT CONTROL, V38, pE43, DOI 10.1016/j.ajic.2010.05.017; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; Leung YH, 2010, EPIDEMIOL INFECT, V21, P1; Li T, 2010, J CLIN VIROL; Li TG, 2011, J CLIN VIROL, V50, P235, DOI 10.1016/j.jcv.2010.11.012; Looker C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013702; Loustalot F, 2011, CLIN INFECT DIS, V52, pS146, DOI 10.1093/cid/ciq057; Marchbanks TL, 2011, CLIN INFECT DIS, V52, pS154, DOI 10.1093/cid/ciq058; Mardani J, 2011, INFLUENZA OTHER RESP, V5, P47, DOI 10.1111/j.1750-2659.2010.00169.x; Mckenzie JF, 2008, INTRO COMMUNITY HLTH, P62; Morgan OW, 2010, EMERG INFECT DIS, V16, P631, DOI 10.3201/eid1604.091658; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; New York City Department Of Health And Mental Hygiene, ST FRANC PREP UPD SW; Nougairede A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009214; Odaira F, 2009, EUROSURVEILLANCE, V14, P2; Pang XH, 2011, EMERG INFECT DIS, V17, P1824, DOI 10.3201/eid1710.101344; Papenburg J, 2010, CLIN INFECT DIS, V51, P1033, DOI 10.1086/656582; Pebody RG, 2011, EMERG INFECT DIS, V17, P990, DOI [10.3201/eid1706.101161, 10.3201/eid/1706.101161]; Pedroni E, 2010, EURO SURVEILL, V15; Peltola V, 2012, INFLUENZA OTHER RESP, V6, pe21, DOI 10.1111/j.1750-2659.2011.00289.x; Pestre V, 2012, SCAND J INFECT DIS, V44, P225, DOI 10.3109/00365548.2011.631936; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; Savage R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-234; Sikora C, 2010, J CLIN VIROL, V49, P90, DOI 10.1016/j.jcv.2010.06.015; Smith A, 2009, EUROSURVEILLANCE, V14, P10; Suess T, 2010, AM J EPIDEMIOL, V171, P1157, DOI 10.1093/aje/kwq071; Tabu C., 2009, Morbidity and Mortality Weekly Report, V58, P1143; Tsalik EL, 2010, J CLIN VIROL, V47, P286, DOI 10.1016/j.jcv.2009.12.012; van Boven M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011442; van Gemert C, 2011, EMERG INFECT DIS, V17, P1599, DOI 10.3201/eid1709.101948; Vera D. M., 2010, Morbidity and Mortality Weekly Report, V59, P162; Ward KA, 2010, EMERG INFECT DIS, V16, P1731, DOI 10.3201/eid1611.100477; WHO website, PAND H1N1 2009 UPD 8; Witkop CT, 2010, AM J PREV MED, V38, P121, DOI 10.1016/j.amepre.2009.10.005; World Health Organization, 2000, WKLY EPIDEMIOL REC, V75, P288	67	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50228	10.1371/journal.pone.0050228	http://dx.doi.org/10.1371/journal.pone.0050228			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23284603	gold, Green Published			2022-12-27	WOS:000312376100058
J	Schmedt, T; Chen, YM; Nguyen, TT; Li, SM; Bonanno, JA; Jurkunas, UV				Schmedt, Thore; Chen, Yuming; Nguyen, Tracy T.; Li, Shimin; Bonanno, Joseph A.; Jurkunas, Ula V.			Telomerase Immortalization of Human Corneal Endothelial Cells Yields Functional Hexagonal Monolayers	PLOS ONE			English	Article							CARBONIC-ANHYDRASE; CELLULAR SENESCENCE; MOLECULAR-MECHANISMS; CL-/HCO3-EXCHANGE; EPITHELIAL-CELLS; NEURAL CREST; EXPRESSION; TRANSPORT; LIFE; DONORS	Human corneal endothelial cells (HCEnCs) form a monolayer of hexagonal cells whose main function is to maintain corneal clarity by regulating corneal hydration. HCEnCs are derived from neural crest and are arrested in the post-mitotic state. Thus cell loss due to aging or corneal endothelial disorders leads to corneal edema and blindness-the leading indication for corneal transplantation. Here we show the existence of morphologically distinct subpopulations of HCEnCs that are interspersed among primary cells and exhibit enhanced self-renewal competence and lack of phenotypic signs of cellular senescence. Colonies of these uniform and hexagonal HCEnCs (HCEnC-21) were selectively isolated and demonstrated high proliferative potential that was dependent on endogenous upregulation of telomerase and cyclin D/CDK4. Further transduction of HCEnC-21 with telomerase yielded a highly proliferative corneal endothelial cell line (HCEnT-21T) that was devoid of oncogenic transformation and retained critical corneal endothelial cell characteristics and functionality. This study will significantly impact the fields of corneal cell biology and regenerative medicine.	[Schmedt, Thore; Chen, Yuming; Jurkunas, Ula V.] Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Dept Ophthalmol,Schepens Eye Res Inst, Boston, MA 02115 USA; [Nguyen, Tracy T.; Li, Shimin; Bonanno, Joseph A.] Indiana Univ, Sch Optometry, Bloomington, IN USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; Indiana University System; Indiana University Bloomington	Jurkunas, UV (corresponding author), Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Dept Ophthalmol,Schepens Eye Res Inst, Boston, MA 02115 USA.	ula.jurkunas@schepens.harvard.edu			National Institutes of Health/National Eye Institute [R01EY020581]; Massachusetts Lions Eye Research Fund; NATIONAL EYE INSTITUTE [R01EY020581, P30EY019008] Funding Source: NIH RePORTER	National Institutes of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Massachusetts Lions Eye Research Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health/National Eye Institute R01EY020581 and Massachusetts Lions Eye Research Fund grants to UVJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2009, MOL CELL, V36, P2, DOI 10.1016/j.molcel.2009.09.021; Azizi B, 2011, INVEST OPHTH VIS SCI, V52, P9291, DOI 10.1167/iovs.11-8312; BARRY PA, 1995, INVEST OPHTH VIS SCI, V36, P1115; Baumer Y, 2010, CELL MOL LIFE SCI, V67, P2451, DOI 10.1007/s00018-010-0349-z; Becker HM, 2005, J BIOL CHEM, V280, P39882, DOI 10.1074/jbc.M503081200; Becker HM, 2010, J MEMBRANE BIOL, V234, P125, DOI 10.1007/s00232-010-9240-y; Bednarz J, 2000, ACTA OPHTHALMOL SCAN, V78, P130, DOI 10.1034/j.1600-0420.2000.078002130.x; Beebe DC, 2000, DEV BIOL, V220, P424, DOI 10.1006/dbio.2000.9638; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bonanno JA, 1998, INVEST OPHTH VIS SCI, V39, P2713; BONANNO JA, 1992, INVEST OPHTH VIS SCI, V33, P3068; Bonanno JA, 2012, EXP EYE RES, V95, P2, DOI 10.1016/j.exer.2011.06.004; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Choudhary Bibha, 2012, Front Biosci (Schol Ed), V4, P16; CRISTOFALO VJ, 1988, EXP GERONTOL, V23, P297, DOI 10.1016/0531-5565(88)90032-0; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; Egan CA, 1998, INVEST OPHTH VIS SCI, V39, P648; Enomoto K, 2006, INVEST OPHTH VIS SCI, V47, P4330, DOI 10.1167/iovs.05-1581; FISCELLA M, 1993, ONCOGENE, V8, P1519; Griffith M, 1999, SCIENCE, V286, P2169, DOI 10.1126/science.286.5447.2169; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Huang B, 2003, ARCH OPHTHALMOL-CHIC, V121, P840, DOI 10.1001/archopht.121.6.840; Huang L, 2010, INVEST OPHTH VIS SCI, V51, P3943, DOI 10.1167/iovs.09-4970; Huang X, 2004, DEV BIOL, V275, P1, DOI 10.1016/j.ydbio.2004.07.033; JAUNIN P, 1993, J CELL BIOL, V123, P1751, DOI 10.1083/jcb.123.6.1751; Jiang XR, 1999, NAT GENET, V21, P111, DOI 10.1038/5056; Joyce Nancy C, 2004, Cornea, V23, pS8, DOI 10.1097/01.ico.0000136666.63870.18; Joyce NC, 2005, EXP EYE RES, V81, P629, DOI 10.1016/j.exer.2005.06.012; Joyce NC, 2003, PROG RETIN EYE RES, V22, P359, DOI 10.1016/S1350-9462(02)00065-4; Joyce NC, 1998, INVEST OPHTH VIS SCI, V39, P2572; Joyce NC, 1996, INVEST OPHTH VIS SCI, V37, P645; KLYCE SD, 1981, J PHYSIOL-LONDON, V321, P49, DOI 10.1113/jphysiol.1981.sp013971; Lee JG, 2012, INVEST OPHTH VIS SCI, V53, P1530, DOI 10.1167/iovs.11-9102; Lee KM, 2004, CYTOTECHNOLOGY, V45, P33, DOI 10.1007/s10616-004-5123-3; Levy SG, 1996, CURR EYE RES, V15, P45, DOI 10.3109/02713689609017610; LINGREL JB, 1994, J BIOL CHEM, V269, P19659; Liu SH, 2010, INVEST OPHTH VIS SCI, V51, P3993, DOI 10.1167/iovs.09-5108; Nguyen TT, 2011, INVEST OPHTH VIS SCI, V52, P8086, DOI 10.1167/iovs.11-8086; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Peh GSL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028310; Robertson DM, 2005, INVEST OPHTH VIS SCI, V46, P470, DOI 10.1167/iovs.04-0528; Roy NS, 2007, NAT PROTOC, V2, P2815, DOI 10.1038/nprot.2007.402; Senoo T, 2000, INVEST OPHTH VIS SCI, V41, P660; Sheerin AN, 2012, AGING CELL, V11, P234, DOI 10.1111/j.1474-9726.2011.00776.x; Shivanna M, 2009, EXP EYE RES, V89, P950, DOI 10.1016/j.exer.2009.08.004; Srinivas SP, 2010, OPTOMETRY VISION SCI, V87, P239, DOI 10.1097/OPX.0b013e3181d39464; Wetzel P, 2001, J PHYSIOL-LONDON, V531, P743, DOI 10.1111/j.1469-7793.2001.0743h.x; WILSON SE, 1993, INVEST OPHTH VIS SCI, V34, P2112; Yang JW, 1999, J BIOL CHEM, V274, P26141, DOI 10.1074/jbc.274.37.26141; Yokoi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029677; Zhu C, 2004, INVEST OPHTH VIS SCI, V45, P1743, DOI 10.1167/iovs.03-0814	52	61	61	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e51427	10.1371/journal.pone.0051427	http://dx.doi.org/10.1371/journal.pone.0051427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284695	Green Published, Green Submitted, gold			2022-12-27	WOS:000313158800011
J	Xu, J; Nonogaki, M; Madhira, R; Ma, HY; Hermanson, O; Kioussi, C; Gross, MK				Xu, Jun; Nonogaki, Mariko; Madhira, Ravi; Ma, Hsiao-Yen; Hermanson, Ola; Kioussi, Chrissa; Gross, Michael K.			Population-Specific Regulation of Chmp2b by Lbx1 during Onset of Synaptogenesis in Lateral Association Interneurons	PLOS ONE			English	Article							MOUSE SPINAL-CORD; EARLY REFLEX PATHWAY; ESCRT-III COMPLEX; FRONTOTEMPORAL DEMENTIA; MULTIVESICULAR BODIES; TRANSCRIPTIONAL NETWORK; SYNAPTIC JUNCTIONS; NERVOUS-SYSTEM; GOLGI ANALYSIS; MOTOR-NEURONS	Chmp2b is closely related to Vps2, a key component of the yeast protein complex that creates the intralumenal vesicles of multivesicular bodies. Dominant negative mutations in Chmp2b cause autophagosome accumulation and neurodegenerative disease. Loss of Chmp2b causes failure of dendritic spine maturation in cultured neurons. The homeobox gene Lbx1 plays an essential role in specifying postmitotic dorsal interneuron populations during late pattern formation in the neural tube. We have discovered that Chmp2b is one of the most highly regulated cell-autonomous targets of Lbx1 in the embryonic mouse neural tube. Chmp2b was expressed and depended on Lbx1 in only two of the five nascent, Lbx1-expressing, postmitotic, dorsal interneuron populations. It was also expressed in neural tube cell populations that lacked Lbx1 protein. The observed population-specific expression of Chmp2b indicated that only certain population-specific combinations of sequence specific transcription factors allow Chmp2b expression. The cell populations that expressed Chmp2b corresponded, in time and location, to neurons that make the first synapses of the spinal cord. Chmp2b protein was transported into neurites within the motor-and association-neuropils, where the first synapses are known to form between E11.5 and E12.5 in mouse neural tubes. Selective, developmentally-specified gene expression of Chmp2b may therefore be used to endow particular neuronal populations with the ability to mature dendritic spines. Such a mechanism could explain how mammalian embryos reproducibly establish the disynaptic cutaneous reflex only between particular cell populations.	[Xu, Jun; Nonogaki, Mariko; Madhira, Ravi; Ma, Hsiao-Yen; Kioussi, Chrissa; Gross, Michael K.] Oregon State Univ, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Hermanson, Ola] Karolinska Inst, Dept Neurosci, Stockholm, Sweden	Oregon State University; Karolinska Institutet	Gross, MK (corresponding author), Oregon State Univ, Dept Pharmaceut Sci, Corvallis, OR 97331 USA.	michael.gross@oregonstate.edu	, Ola/AAF-5126-2021; Xu, Jun/K-1233-2016	Xu, Jun/0000-0003-4221-5563; Kioussi, Chrissa/0000-0001-8226-9908; Nonogaki, Mariko/0000-0001-9893-719X; Hermanson, Ola/0000-0001-9320-7921	National Institutes of Health-NIAMS [AR054406]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054406] Funding Source: NIH RePORTER	National Institutes of Health-NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by National Institutes of Health-NIAMS grant AR054406 to Chrissa Kioussi. URL of the funder: http://www.niams.nih.gov/default.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belly A, 2010, J CELL SCI, V123, P2943, DOI 10.1242/jcs.068817; Bolouri H, 2002, BIOESSAYS, V24, P1118, DOI 10.1002/bies.10189; Bolouri H, 2002, DEV BIOL, V246, P2, DOI 10.1006/dbio.2002.0617; Caspary T, 2003, NAT REV NEUROSCI, V4, P289, DOI 10.1038/nrn1073; Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221; Cheng LP, 2005, NAT NEUROSCI, V8, P1510, DOI 10.1038/nn1569; Cox LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009872; Davidson E.H., 2006, REGULATORY GENOME; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Davidson EH, 2003, P NATL ACAD SCI USA, V100, P1475, DOI 10.1073/pnas.0437746100; Ferrari R, 2010, ALZHEIMER DIS ASS DI; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Froud KE, 2011, AUSTR NEUR SOC ANN M; Ghanim M, 2010, J NEUROL, V257, P2032, DOI 10.1007/s00415-010-5655-8; Ghazi-Noori S, 2012, BRAIN, V135, P819, DOI 10.1093/brain/aws006; Glasgow SM, 2005, DEVELOPMENT, V132, P5461, DOI 10.1242/dev.02167; Gowan K, 2001, NEURON, V31, P219, DOI 10.1016/S0896-6273(01)00367-1; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; Gross MK, 2000, DEVELOPMENT, V127, P413; Helms AW, 2003, CURR OPIN NEUROBIOL, V13, P42, DOI 10.1016/S0959-4388(03)00010-2; HENRIKSON CK, 1974, J NEUROCYTOL, V3, P659, DOI 10.1007/BF01097190; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Istrail S, 2007, DEV BIOL, V310, P187, DOI 10.1016/j.ydbio.2007.08.009; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kioussi C, 2006, P NATL ACAD SCI USA, V103, P18621, DOI 10.1073/pnas.0609055103; Kioussi C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002179; Kriks S, 2005, DEVELOPMENT, V132, P2991, DOI 10.1242/dev.01878; Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029; Lee KJ, 1998, GENE DEV, V12, P3394, DOI 10.1101/gad.12.21.3394; Li SG, 2010, GENESIS, V48, P667, DOI 10.1002/dvg.20669; Lundfald L, 2007, EUR J NEUROSCI, V26, P2989, DOI 10.1111/j.1460-9568.2007.05906.x; Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100; MATUS A, 1986, NEUROSCIENCE, V17, P371, DOI 10.1016/0306-4522(86)90253-8; Miesegaes GR, 2009, DEV BIOL, V327, P339, DOI 10.1016/j.ydbio.2008.12.016; Mizuguchi R, 2006, NAT NEUROSCI, V9, P770, DOI 10.1038/nn1706; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; Nickerson DP, 2007, EMBO REP, V8, P644, DOI 10.1038/sj.embor.7401004; Nickerson DP, 2010, MOL BIOL CELL, V21, P1023, DOI 10.1091/mbc.E09-09-0776; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Ozaki S, 1997, J COMP NEUROL, V380, P215; PARKINSON N, 2006, NEUROLOGY; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Rizzu P, 2006, AM J MED GENET B, V141B, P944, DOI 10.1002/ajmg.b.30410; Saueressig H, 1999, DEVELOPMENT, V126, P4201; Skibinski G, 2005, NAT GENET, V37, P806, DOI 10.1038/ng1609; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; van der Zee J, 2008, HUM MOL GENET, V17, P313, DOI 10.1093/hmg/ddm309; VAUGHN JE, 1978, J NEUROCYTOL, V7, P337, DOI 10.1007/BF01176998; VAUGHN JE, 1974, J CELL BIOL, V60, P664, DOI 10.1083/jcb.60.3.664; VAUGHN JE, 1989, SYNAPSE, V3, P255, DOI 10.1002/syn.890030312; VAUGHN JE, 1973, J COMP NEUROL, V148, P177, DOI 10.1002/cne.901480205; VAUGHN JE, 1977, J COMP NEUROL, V175, P79, DOI 10.1002/cne.901750106; VAUGHN JE, 1975, J COMP NEUROL, V161, P541, DOI 10.1002/cne.901610405; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; WENTWORTH LE, 1984, J COMP NEUROL, V222, P81, DOI 10.1002/cne.902220108; WENTWORTH LE, 1984, J COMP NEUROL, V222, P96, DOI 10.1002/cne.902220109; Wildner H, 2006, DEVELOPMENT, V133, P2105, DOI 10.1242/dev.02345; Willis W.D., 2004, SENSORY MECH SPINAL, V207, P1067, DOI [10.1126/science.207.4435.1067.b, DOI 10.1126/SCIENCE.207.4435.1067.B]; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836	65	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e48573	10.1371/journal.pone.0048573	http://dx.doi.org/10.1371/journal.pone.0048573			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284619	Green Published, Green Submitted, gold			2022-12-27	WOS:000313158800002
J	Brugger, SD; Frei, L; Frey, PM; Aebi, S; Muhlemann, K; Hilty, M				Brugger, Silvio D.; Frei, Laurence; Frey, Pascal M.; Aebi, Suzanne; Muehlemann, Kathrin; Hilty, Markus			16S rRNA Terminal Restriction Fragment Length Polymorphism for the Characterization of the Nasopharyngeal Microbiota	PLOS ONE			English	Article							1ST 2 YEARS; STREPTOCOCCUS-PNEUMONIAE; OTITIS-MEDIA; T-RFLP; DIVERSITY; CHILDREN; COLONIZATION; EPIDEMIOLOGY; COMMUNITIES; LIFE	A novel non-culture based 16S rRNA Terminal Restriction Fragment Length Polymorphism (T-RFLP) method using the restriction enzymes Tsp509I and Hpy166II was developed for the characterization of the nasopharyngeal microbiota and validated using recently published 454 pyrosequencing data. 16S rRNA gene T-RFLP for 153 clinical nasopharyngeal samples from infants with acute otitis media (AOM) revealed 5 Tsp509I and 6 Hpy166II terminal fragments (TFs) with a prevalence of >10%. Cloning and sequencing identified all TFs with a prevalence >6% allowing a sufficient description of bacterial community changes for the most important bacterial taxa. The conjugated 7-valent pneumococcal polysaccharide vaccine (PCV-7) and prior antibiotic exposure had significant effects on the bacterial composition in an additive main effects and multiplicative interaction model (AMMI) in concordance with the 16S rRNA 454 pyrosequencing data. In addition, the presented T-RFLP method is able to discriminate S. pneumoniae from other members of the Mitis group of streptococci, which therefore allows the identification of one of the most important human respiratory tract pathogens. This is usually not achieved by current high throughput sequencing protocols. In conclusion, the presented 16S rRNA gene T-RFLP method is a highly robust, easy to handle and a cheap alternative to the computationally demanding next-generation sequencing analysis. In case a lot of nasopharyngeal samples have to be characterized, it is suggested to first perform 16S rRNA T-RFLP and only use next generation sequencing if the T-RFLP nasopharyngeal patterns differ or show unknown TFs.	[Brugger, Silvio D.; Frei, Laurence; Frey, Pascal M.; Aebi, Suzanne; Muehlemann, Kathrin; Hilty, Markus] Univ Bern, Inst Infect Dis, Bern, Switzerland; [Brugger, Silvio D.] Univ Hosp Bern, Dept Gen Internal Med, CH-3010 Bern, Switzerland; [Muehlemann, Kathrin; Hilty, Markus] Univ Hosp Bern, Dept Infect Dis, CH-3010 Bern, Switzerland	University of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Hilty, M (corresponding author), Univ Bern, Inst Infect Dis, Bern, Switzerland.	markus.hilty@ifik.unibe.ch	Hilty, Markus/H-9560-2019; Kummer, Juerg/B-3322-2011; Brugger, Silvio Daniel/AAY-7090-2020	Hilty, Markus/0000-0002-2418-6474; Brugger, Silvio Daniel/0000-0001-9492-9088; Frey, Pascal/0000-0001-6161-0919	Swiss National Science Foundation [323500-119214]; Swiss Society of Hospital Hygiene & the Swiss Society for Infectious Diseases	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Society of Hospital Hygiene & the Swiss Society for Infectious Diseases	This study was supported by the Swiss National Science Foundation (M.D.-Ph.D. scholarship 323500-119214 to S. D. B.) and the 2012 Award of the Swiss Society of Hospital Hygiene & the Swiss Society for Infectious Diseases to M. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brugger SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011638; Brugger SD, 2009, J CLIN MICROBIOL, V47, P1750, DOI 10.1128/JCM.01877-08; Cabrera-Rubio R, 2012, J CLIN MICROBIOL; Camarinha-Silva A, 2012, FEMS MICROBIOL ECOL, V79, P98, DOI 10.1111/j.1574-6941.2011.01197.x; Culman SW, 2008, J MICROBIOL METH, V75, P55, DOI 10.1016/j.mimet.2008.04.011; Culman SW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-171; Faden H, 1997, J INFECT DIS, V175, P1440, DOI 10.1086/516477; FADEN H, 1990, PEDIATR INFECT DIS J, V9, P623; FADEN H, 1994, J INFECT DIS, V169, P1312, DOI 10.1093/infdis/169.6.1312; FADEN H, 1995, J INFECT DIS, V172, P132, DOI 10.1093/infdis/172.1.132; Frank DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010598; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hathaway LJ, 2007, J CLIN MICROBIOL, V45, P803, DOI 10.1128/JCM.02169-06; Hilty M, 2012, J INFECT DIS, V205, P1048, DOI 10.1093/infdis/jis024; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Horz HP, 2012, ENV MICROBIOL REP, V4, P390, DOI 10.1111/j.1758-2229.2012.00340.x; Jakobsson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009836; KAWAMURA Y, 1995, INT J SYST BACTERIOL, V45, P406, DOI 10.1099/00207713-45-2-406; Muhlemann K, 2003, J INFECT DIS, V187, P589, DOI 10.1086/367994; Scholz CFP, 2012, J CLIN MICROBIOL, V50, P1968, DOI 10.1128/JCM.00365-12; Sim K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032543; Smith CJ, 2005, FEMS MICROBIOL ECOL, V54, P375, DOI 10.1016/j.femsec.2005.05.002; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991	24	13	16	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52241	10.1371/journal.pone.0052241	http://dx.doi.org/10.1371/journal.pone.0052241			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284951	gold, Green Published, Green Submitted			2022-12-27	WOS:000312794500123
J	Hutton, C; Balteau, E; Lutti, A; Josephs, O; Weiskopf, N				Hutton, Chloe; Balteau, Evelyne; Lutti, Antoine; Josephs, Oliver; Weiskopf, Nikolaus			Modelling Temporal Stability of EPI Time Series Using Magnitude Images Acquired with Multi-Channel Receiver Coils	PLOS ONE			English	Article							TO-NOISE RATIOS; PHYSIOLOGICAL NOISE; PHASED-ARRAY; MR-IMAGES; FMRI; BRAIN; RECONSTRUCTION; OPTIMIZATION; PARAMETERS	In 2001, Krueger and Glover introduced a model describing the temporal SNR (tSNR) of an EPI time series as a function of image SNR (SNR0). This model has been used to study physiological noise in fMRI, to optimize fMRI acquisition parameters, and to estimate maximum attainable tSNR for a given set of MR image acquisition and processing parameters. In its current form, this noise model requires the accurate estimation of image SNR. For multi-channel receiver coils, this is not straightforward because it requires export and reconstruction of large amounts of k-space raw data and detailed, custom-made image reconstruction methods. Here we present a simple extension to the model that allows characterization of the temporal noise properties of EPI time series acquired with multi-channel receiver coils, and reconstructed with standard root-sum-of-squares combination, without the need for raw data or custom-made image reconstruction. The proposed extended model includes an additional parameter kappa which reflects the impact of noise correlations between receiver channels on the data and scales an apparent image SNR (SNR0') measured directly from root-sum-of-squares reconstructed magnitude images so that kappa = SNR0'/SNR0 (under the condition of SNR0>50 and number of channels <= 32). Using Monte Carlo simulations we show that the extended model parameters can be estimated with high accuracy. The estimation of the parameter kappa was validated using an independent measure of the actual SNR0 for non-accelerated phantom data acquired at 3T with a 32-channel receiver coil. We also demonstrate that compared to the original model the extended model results in an improved fit to human task-free non-accelerated fMRI data acquired at 7T with a 24-channel receiver coil. In particular, the extended model improves the prediction of low to medium tSNR values and so can play an important role in the optimization of high-resolution fMRI experiments at lower SNR levels.	[Hutton, Chloe; Lutti, Antoine; Josephs, Oliver; Weiskopf, Nikolaus] UCL, UCL Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England; [Balteau, Evelyne] Univ Liege, Cyclotron Res Ctr, Liege, Belgium	University of London; University College London; University of Liege	Hutton, C (corresponding author), UCL, UCL Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England.	chuttonster@gmail.com	Weiskopf, Nikolaus/B-9357-2008; Lutti, Antoine/O-6777-2017	Weiskopf, Nikolaus/0000-0001-5239-1881; Lutti, Antoine/0000-0003-3281-5477	Wellcome Trust [091593/Z/10/Z]; Transregional Collaborative Research Centre [SFB/TRR 62]; German Research Foundation (DFG)	Wellcome Trust(Wellcome TrustEuropean Commission); Transregional Collaborative Research Centre; German Research Foundation (DFG)(German Research Foundation (DFG))	This research and open access to the publication were funded by the Wellcome Trust (091593/Z/10/Z). Data were acquired at the 7T MRI system at the Otto-von-Guericke University of Magdeburg, Germany which is supported by the Transregional Collaborative Research Centre SFB/TRR 62 "Companion-Technology for Cognitive Technical Systems" funded by the German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bodurka J, 2007, NEUROIMAGE, V34, P542, DOI 10.1016/j.neuroimage.2006.09.039; Constantinides CD, 1997, MAGNET RESON MED, V38, P852, DOI 10.1002/mrm.1910380524; Dietrich O, 2007, J MAGN RESON IMAGING, V26, P375, DOI 10.1002/jmri.20969; EDELSTEIN WA, 1986, MAGNET RESON MED, V3, P604, DOI 10.1002/mrm.1910030413; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Friedman L, 2006, J MAGN RESON IMAGING, V23, P827, DOI 10.1002/jmri.20583; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P10, DOI 10.1016/B978-012372560-8/50002-4; Gilbert G, 2007, J MAGN RESON IMAGING, V26, P1678, DOI 10.1002/jmri.21171; Gonzalez-Castillo J, 2011, NEUROIMAGE, V54, P2764, DOI 10.1016/j.neuroimage.2010.11.020; Greve DN, 2011, MAGN RESON MED, V65, P1053, DOI 10.1002/mrm.22691; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; HAYES CE, 1990, MAGNET RESON MED, V16, P181, DOI 10.1002/mrm.1910160202; Hutton C, 2011, NEUROIMAGE, V57, P101, DOI 10.1016/j.neuroimage.2011.04.018; Hutton C, 2002, NEUROIMAGE, V16, P217, DOI 10.1006/nimg.2001.1054; Josephs O, P ISMRM; Kellman P, 2005, MAGNET RESON MED, V54, P1439, DOI 10.1002/mrm.20713; Koay CG, 2006, J MAGN RESON, V179, P317, DOI 10.1016/j.jmr.2006.01.016; Kruger G, 2001, MAGNET RESON MED, V46, P631, DOI 10.1002/mrm.1240; Lutti A, 2010, P J ANN M ISMRM ESMR; REDPATH TW, 1992, MAGNET RESON MED, V24, P85, DOI 10.1002/mrm.1910240109; ROEMER PB, 1990, MAGNET RESON MED, V16, P192, DOI 10.1002/mrm.1910160203; Triantafyllou C, 2005, NEUROIMAGE, V26, P243, DOI 10.1016/j.neuroimage.2005.01.007; Triantafyllou C, 2011, NEUROIMAGE, V55, P597, DOI 10.1016/j.neuroimage.2010.11.084; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Weiskopf N, 2006, NEUROIMAGE, V33, P493, DOI 10.1016/j.neuroimage.2006.07.029; Wiggins GC, 2006, MAGN RESON MED, V56, P216, DOI 10.1002/mrm.20925; Wright PJ, 2008, MAGN RESON MATER PHY, V21, P121, DOI 10.1007/s10334-008-0104-8	28	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52075	10.1371/journal.pone.0052075	http://dx.doi.org/10.1371/journal.pone.0052075			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284874	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500084
J	Nwugo, CC; Arivett, BA; Zimbler, DL; Gaddy, JA; Richards, AM; Actis, LA				Nwugo, Chika C.; Arivett, Brock A.; Zimbler, Daniel L.; Gaddy, Jennifer A.; Richards, Ashley M.; Actis, Luis A.			Effect of Ethanol on Differential Protein Production and Expression of Potential Virulence Functions in the Opportunistic Pathogen Acinetobacter baumannii	PLOS ONE			English	Article							INDOLE-3-ACETIC-ACID BIOSYNTHESIS; 5-HYDROXYINDOLEACETIC ACID; NECROTIZING FASCIITIS; INDOLEACETIC-ACID; BIOFILM FORMATION; ABIOTIC SURFACES; GENE-EXPRESSION; TRYPTOPHAN; IDENTIFICATION; STRAINS	Acinetobacter baumannii persists in the medical environment and causes severe human nosocomial infections. Previous studies showed that low-level ethanol exposure increases the virulence of A. baumannii ATCC 17978. To better understand the mechanisms involved in this response, 2-D gel electrophoresis combined with mass spectrometry was used to investigate differential protein production in bacteria cultured in the presence or absence of ethanol. This approach showed that the presence of ethanol significantly induces and represses the production of 22 and 12 proteins, respectively. Although over 25% of the ethanol-induced proteins were stress-response related, the overall bacterial viability was uncompromised when cultured under these conditions. Production of proteins involved in lipid and carbohydrate anabolism was increased in the presence of ethanol, a response that correlates with increased carbohydrate biofilm content, enhanced biofilm formation on abiotic surfaces and decrease bacterial motility on semi-solid surfaces. The presence of ethanol also induced the acidification of bacterial cultures and the production of indole-3-acetic acid (IAA), a ubiquitous plant hormone that signals bacterial stress-tolerance and promotes plant-bacteria interactions. These responses could be responsible for the significantly enhanced virulence of A. baumannii ATCC 17978 cells cultured in the presence of ethanol when tested with the Galleria mellonella experimental infection model. Taken together, these observations provide new insights into the effect of ethanol in bacterial virulence. This alcohol predisposes the human host to infections by A. baumannii and could favor the survival and adaptation of this pathogen to medical settings and adverse host environments.	[Nwugo, Chika C.; Arivett, Brock A.; Zimbler, Daniel L.; Gaddy, Jennifer A.; Richards, Ashley M.; Actis, Luis A.] Miami Univ, Dept Microbiol, Oxford, OH 45056 USA	University System of Ohio; Miami University	Actis, LA (corresponding author), Miami Univ, Dept Microbiol, Oxford, OH 45056 USA.	actisla@muohio.edu	Arivett, Brock/T-2569-2018	Arivett, Brock/0000-0002-1291-3814	NSF [0420479, CHE0839233]; Miami University;  [AI070174]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070174] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Miami University; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funds from Public Health AI070174 and NSF 0420479 grant awards (to LAA) and Miami University research funds. The MALDI-TOF data were collected using instrumentation purchased with NSF grant award CHE0839233. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DG, 2003, BIOFOULING, V19, P139, DOI [10.1080/0892701031000072190, 10.1038/nrmicro2415]; Anstey NM, 2002, J CLIN MICROBIOL, V40, P685, DOI 10.1128/JCM.40.2.685-686.2002; Bailey KL, 2009, ALCOHOL CLIN EXP RES, V33, P499, DOI 10.1111/j.1530-0277.2008.00862.x; Basse CW, 1996, EUR J BIOCHEM, V242, P648, DOI 10.1111/j.1432-1033.1996.0648r.x; BergogneBerezin E, 1996, CLIN MICROBIOL REV, V9, P148, DOI 10.1128/CMR.9.2.148; Bianco C, 2006, MICROBIOL-SGM, V152, P2421, DOI 10.1099/mic.0.28765-0; Bianco C, 2006, ARCH MICROBIOL, V185, P373, DOI 10.1007/s00203-006-0103-y; Brachelente C, 2007, VET DERMATOL, V18, P432, DOI 10.1111/j.1365-3164.2007.00624.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Camarena L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000834; Centers for Disease Control and Prevention, 2004, MMWR MORB MORTAL WKL, V53, P1063; Chang HY, 1996, MICROB PATHOGENESIS, V20, P255, DOI 10.1006/mpat.1996.0024; Chaplin M.F., 1986, MASS SPECTROM, P1; Charnot-Katsikas A, 2009, J CLIN MICROBIOL, V47, P258, DOI 10.1128/JCM.01250-08; Chen Hsin-Pai, 2005, Journal of Microbiology Immunology and Infection, V38, P127; Chen MZ, 2001, CHEST, V120, P1072, DOI 10.1378/chest.120.4.1072; CHILCOTE DD, 1972, CLIN CHEM, V18, P1376; Choi AHK, 2009, J BACTERIOL, V191, P5953, DOI 10.1128/JB.00647-09; Choi CH, 2005, CELL MICROBIOL, V7, P1127, DOI 10.1111/j.1462-5822.2005.00538.x; Choi CH, 2008, CELL MICROBIOL, V10, P309, DOI 10.1111/j.1462-5822.2007.01041.x; Corradino B, 2010, INT J LOW EXTR WOUND, V9, P152, DOI 10.1177/1534734610389598; Dallo SF, 2012, SCI WORLD J, DOI 10.1100/2012/128705; Davis KA, 2005, EMERG INFECT DIS, V11, P1218, DOI 10.3201/1108.050103; Dijkshoorn L, 1996, J CLIN MICROBIOL, V34, P1519, DOI 10.1128/JCM.34.6.1519-1525.1996; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Edwards J, 2007, J MED MICROBIOL, V56, P1595, DOI 10.1099/jmm.0.47442-0; Erridge C, 2007, J MED MICROBIOL, V56, P165, DOI 10.1099/jmm.0.46823-0; Fernandez-Reyes M, 2009, PROTEOMICS, V9, P1632, DOI 10.1002/pmic.200800434; Gaddy JA, 2012, INFECT IMMUN, V80, P1015, DOI 10.1128/IAI.06279-11; Gaddy JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09; GLICKMANN E, 1995, APPL ENVIRON MICROB, V61, P793, DOI 10.1128/AEM.61.2.793-796.1995; Goodarzi H, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.33; Guerrero DM, 2010, SURG INFECT, V11, P49, DOI 10.1089/sur.2009.022; Guillet G, 2000, PLANT PHYSIOL, V122, P933, DOI 10.1104/pp.122.3.933; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hood MI, 2010, ANTIMICROB AGENTS CH, V54, P1029, DOI 10.1128/AAC.00963-09; Hoshi A, 2009, P NATL ACAD SCI USA, V106, P6416, DOI 10.1073/pnas.0813038106; Idris EE, 2007, MOL PLANT MICROBE IN, V20, P619, DOI 10.1094/MPMI-20-6-0619; INGRAM LO, 1984, ADV MICROB PHYSIOL, V25, P253; Jacobs AC, 2010, INFECT IMMUN, V78, P1952, DOI 10.1128/IAI.00889-09; Kampf G, 2004, CLIN MICROBIOL REV, V17, P863, DOI 10.1128/CMR.17.4.863-893.2004; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kavanagh K, 2004, FEMS MICROBIOL REV, V28, P101, DOI 10.1016/j.femsre.2003.09.002; Knapp S, 2006, AM J RESP CRIT CARE, V173, P122, DOI 10.1164/rccm.200505-730OC; KOGA J, 1994, BBA-PROTEIN STRUCT M, V1209, P241, DOI 10.1016/0167-4838(94)90191-0; KOGA J, 1992, J BIOL CHEM, V267, P15823; KORNBERG HL, 1966, BIOCHEM J, V99, P1; KORNBERG HL, 1957, NATURE, V179, P988, DOI 10.1038/179988a0; Lin GH, 2012, ANTON LEEUW INT J G, V101, P881, DOI 10.1007/s10482-012-9704-4; Loehfelm TW, 2008, J BACTERIOL, V190, P1036, DOI 10.1128/JB.01416-07; MORITA I, 1990, J CHROMATOGR-BIOMED, V526, P367, DOI 10.1016/S0378-4347(00)82520-7; Murray CK, 2006, MIL MED, V171, P821, DOI 10.7205/MILMED.171.9.821; Mussi MA, 2010, J BACTERIOL, V192, P6336, DOI 10.1128/JB.00917-10; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Nwugo CC, 2011, J PROTEOMICS, V74, P44, DOI 10.1016/j.jprot.2010.07.010; OBERHANSLI T, 1991, J GEN MICROBIOL, V137, P2273, DOI 10.1099/00221287-137-10-2273; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Pirog T. P., 2002, Mikrobiologiya, V71, P222; Pratt LA, 1996, MOL MICROBIOL, V20, P911, DOI 10.1111/j.1365-2958.1996.tb02532.x; RABIN RS, 1993, J BACTERIOL, V175, P3259, DOI 10.1128/jb.175.11.3259-3268.1993; Russo TA, 2010, INFECT IMMUN, V78, P3993, DOI 10.1128/IAI.00366-10; Sambrook J., 2001, MOL CLONING LAB MANU; SANDLIN RC, 1995, INFECT IMMUN, V63, P229, DOI 10.1128/IAI.63.1.229-237.1995; SLAUCH JM, 1989, J MOL BIOL, V210, P281, DOI 10.1016/0022-2836(89)90330-6; Smani Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033073; Smith MG, 2004, MOL CELL BIOL, V24, P3874, DOI 10.1128/MCB.24.9.3874-3884.2004; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; Ramirez MS, 2010, J CLIN MICROBIOL, V48, P1488, DOI 10.1128/JCM.01264-09; Spaepen S, 2007, FEMS MICROBIOL REV, V31, P425, DOI 10.1111/j.1574-6976.2007.00072.x; STRUELENS MJ, 1993, J HOSP INFECT, V25, P15, DOI 10.1016/0195-6701(93)90005-K; SUGINO H, 1992, J BACTERIOL, V174, P2485, DOI 10.1128/jb.174.8.2485-2492.1992; Teufel R, 2010, P NATL ACAD SCI USA, V107, P14390, DOI 10.1073/pnas.1005399107; Thomas JG, 1997, PROTEIN EXPRES PURIF, V11, P289, DOI 10.1006/prep.1997.0796; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Towner KJ, 2009, J HOSP INFECT, V73, P355, DOI 10.1016/j.jhin.2009.03.032; van den Broek PJ, 2006, CLIN MICROBIOL INFEC, V12, P837, DOI 10.1111/j.1469-0691.2006.01510.x; van Dessel H, 2004, RES MICROBIOL, V155, P105, DOI 10.1016/j.resmic.2003.10.003; Verstraeten N, 2008, TRENDS MICROBIOL, V16, P496, DOI 10.1016/j.tim.2008.07.004; Villegas MV, 2003, INFECT CONT HOSP EP, V24, P284, DOI 10.1086/502205; YAMAMOTO S, 1994, ARCH MICROBIOL, V162, P249, DOI 10.1007/s002030050133; Yang SH, 2007, APPL ENVIRON MICROB, V73, P1079, DOI 10.1128/AEM.01770-06; YOUNG SN, 1981, J NEUROL NEUROSUR PS, V44, P323, DOI 10.1136/jnnp.44.4.323	82	46	46	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51936	10.1371/journal.pone.0051936	http://dx.doi.org/10.1371/journal.pone.0051936			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284824	gold, Green Submitted, Green Published			2022-12-27	WOS:000312794500067
J	Prochnow, N; Abdulazim, A; Kurtenbach, S; Wildforster, V; Dvoriantchikova, G; Hanske, J; Petrasch-Parwez, E; Shestopalov, VI; Dermietzel, R; Manahan-Vaughan, D; Zoidl, G				Prochnow, Nora; Abdulazim, Amr; Kurtenbach, Stefan; Wildfoerster, Verena; Dvoriantchikova, Galina; Hanske, Julian; Petrasch-Parwez, Elisabeth; Shestopalov, Valery I.; Dermietzel, Rolf; Manahan-Vaughan, Denise; Zoidl, Georg			Pannexin1 Stabilizes Synaptic Plasticity and Is Needed for Learning	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; HIPPOCAMPAL AREA CA1; RECOGNITION MEMORY; OBJECT RECOGNITION; ATP RELEASE; 1 CHANNELS; HEMICHANNELS; RATS; ACTIVATION; ASTROCYTES	Pannexin 1 (Panx1) represents a class of vertebrate membrane channels, bearing significant sequence homology with the invertebrate gap junction proteins, the innexins and more distant similarities in the membrane topologies and pharmacological sensitivities with gap junction proteins of the connexin family. In the nervous system, cooperation among pannexin channels, adenosine receptors, and K-ATP channels modulating neuronal excitability via ATP and adenosine has been recognized, but little is known about the significance in vivo. However, the localization of Panx1 at postsynaptic sites in hippocampal neurons and astrocytes in close proximity together with the fundamental role of ATP and adenosine for CNS metabolism and cell signaling underscore the potential relevance of this channel to synaptic plasticity and higher brain functions. Here, we report increased excitability and potently enhanced early and persistent LTP responses in the CA1 region of acute slice preparations from adult Panx1(-/-) mice. Adenosine application and N-methyl-D-aspartate receptor (NMDAR)-blocking normalized this phenotype, suggesting that absence of Panx1 causes chronic extracellular ATP/adenosine depletion, thus facilitating postsynaptic NMDAR activation. Compensatory transcriptional up-regulation of metabotropic glutamate receptor 4 (grm4) accompanies these adaptive changes. The physiological modification, promoted by loss of Panx1, led to distinct behavioral alterations, enhancing anxiety and impairing object recognition and spatial learning in Panx1(-/-) mice. We conclude that ATP release through Panx1 channels plays a critical role in maintaining synaptic strength and plasticity in CA1 neurons of the adult hippocampus. This result provides the rationale for in-depth analysis of Panx1 function and adenosine based therapies in CNS disorders.	[Prochnow, Nora; Abdulazim, Amr; Wildfoerster, Verena; Hanske, Julian; Petrasch-Parwez, Elisabeth; Dermietzel, Rolf; Manahan-Vaughan, Denise; Zoidl, Georg] Ruhr Univ Bochum, Fac Med, Bochum, Germany; [Kurtenbach, Stefan] Ruhr Univ Bochum, Fac Biol & Biotechnol, Bochum, Germany; [Dvoriantchikova, Galina; Shestopalov, Valery I.] Univ Miami, Sch Med, Bascom Palmer Eye Res Inst, Miami, FL USA; [Zoidl, Georg] York Univ, Fac Hlth, Toronto, ON M3J 2R7, Canada	Ruhr University Bochum; Ruhr University Bochum; Bascom Palmer Eye Institute; University of Miami; York University - Canada	Zoidl, G (corresponding author), Ruhr Univ Bochum, Fac Med, Univ Str 150, Bochum, Germany.	gzoidl@yorku.ca	Shestopalov, Valery/AAE-9838-2020; Kurtenbach, Stefan/H-3786-2019	Kurtenbach, Stefan/0000-0002-7445-596X; Manahan-Vaughan, Denise/0000-0002-9283-9609; Shestopalov, Valery/0000-0002-1568-6637	FoRUM start up grant [F570-05]; Sophia and Fritz Heinemann Foundation; National Institutes of Health [EY017991, EY021517]; Canada Research Chair Molecular and Cellular Neuroscience/CIHR; NSERC; NATIONAL EYE INSTITUTE [R01EY021517, R21EY017991] Funding Source: NIH RePORTER	FoRUM start up grant; Sophia and Fritz Heinemann Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canada Research Chair Molecular and Cellular Neuroscience/CIHR; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was funded by FoRUM start up grant F570-05; Sophia and Fritz Heinemann Foundation (N.P.); National Institutes of Health grants EY017991 and EY021517 (V.I.S.); and Canada Research Chair Molecular and Cellular Neuroscience/CIHR, NSERC (G.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Buvinic S, 2009, J BIOL CHEM, V284, P34490, DOI 10.1074/jbc.M109.057315; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Clarke JR, 2010, P NATL ACAD SCI USA, V107, P2652, DOI 10.1073/pnas.0915059107; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Dahl G, 2012, BRAIN RES; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Dvoriantchikova G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031991; Garre JM, 2010, P NATL ACAD SCI USA, V107, P22659, DOI 10.1073/pnas.1013793107; GEREAU RW, 1995, J NEUROSCI, V15, P6879; Goh JJ, 2012, CEREBRAL CORTEX; Grover LM, 2009, LEARN MEMORY, V16, P69, DOI 10.1101/lm.1179109; Gulbransen BD, 2012, NAT MED, V18, P600, DOI 10.1038/nm.2679; Hamil NE, 2012, EPILEPSIA, V53, P177, DOI 10.1111/j.1528-1167.2011.03340.x; Hohnadel E, 2007, NEUROPHARMACOLOGY, V52, P542, DOI 10.1016/j.neuropharm.2006.08.025; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Iglesias R, 2008, AM J PHYSIOL-CELL PH, V295, pC752, DOI 10.1152/ajpcell.00228.2008; Iglesias R, 2009, CELL COMMUN ADHES, V16, P131, DOI 10.3109/15419061003642618; Iglesias R, 2009, J NEUROSCI, V29, P7092, DOI 10.1523/JNEUROSCI.6062-08.2009; Iwabuchi S, 2011, NEUROCHEM INT, V58, P376, DOI 10.1016/j.neuint.2010.12.013; Kawamura M, 2010, J NEUROSCI, V30, P3886, DOI 10.1523/JNEUROSCI.0055-10.2010; Kienitz MC, 2011, J BIOL CHEM, V286, P290, DOI 10.1074/jbc.M110.163477; Kim JE, 2011, J CLIN INVEST, V121, P2037, DOI 10.1172/JCI44818; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; MacVicar BA, 2010, TRENDS NEUROSCI, V33, P93, DOI 10.1016/j.tins.2009.11.007; Manahan-Vaughan D, 2008, HIPPOCAMPUS, V18, P125, DOI 10.1002/hipo.20367; Mohammad-Zadeh M, 2009, NEUROSCIENCE, V158, P1632, DOI 10.1016/j.neuroscience.2008.11.008; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; Orellana JA, 2011, J NEUROCHEM, V118, P826, DOI 10.1111/j.1471-4159.2011.07210.x; Penuela S, 2012, J BIOL CHEM; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Prochnow N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019437; Qiu F, 2009, AM J PHYSIOL-CELL PH, V296, pC250, DOI 10.1152/ajpcell.00433.2008; Ray A, 2005, EUR J NEUROSCI, V21, P3277, DOI 10.1111/j.1460-9568.2005.04139.x; Santiago MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025178; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; Schneider M, 2005, EXP NEUROL, V195, P185, DOI 10.1016/j.expneurol.2005.04.014; Schneider M, 2002, BEHAV PHARMACOL, V13, P29, DOI 10.1097/00008877-200202000-00003; Sperlagh B, 2011, CURR TOP MED CHEM, V11, P1034, DOI 10.2174/156802611795347564; Suadicani SO, 2012, GLIA, V60, P1106, DOI 10.1002/glia.22338; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; Tymianski M, 2011, NAT NEUROSCI, V14, P1369, DOI 10.1038/nn.2951; Vianna EPM, 2005, EPILEPSIA, V46, P166, DOI 10.1111/j.1528-1167.2005.01027.x; Vogt A, 2005, MOL BRAIN RES, V141, P113, DOI 10.1016/j.molbrainres.2005.08.002; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7; Zoidl G, 2007, NEUROSCIENCE, V146, P9, DOI 10.1016/j.neuroscience.2007.01.061	49	89	89	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51767	10.1371/journal.pone.0051767	http://dx.doi.org/10.1371/journal.pone.0051767			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284764	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500045
J	Ramirez-Latorre, JA				Ramirez-Latorre, Jose A.			Functional Upregulation of Ca2+ -Activated K+ Channels in the Development of Substantia Nigra Dopamine Neurons	PLOS ONE			English	Article							PARS COMPACTA NEURONS; POTASSIUM CHANNELS; CALCIUM-CHANNELS; HIGH-FREQUENCY; BASAL GANGLIA; BK CHANNELS; POSTNATAL-DEVELOPMENT; RAT; CONDUCTANCE; EXPRESSION	Many connections in the basal ganglia are made around birth when animals are exposed to a host of new affective, cognitive, and sensori-motor stimuli. It is thought that dopamine modulates cortico-striatal synapses that result in the strengthening of those connections that lead to desired outcomes. We propose that there must be a time before which stimuli cannot be processed into functional connections, otherwise it would imply an effective link between stimulus, response, and reward in uterus. Consistent with these ideas, we present evidence that early in development dopamine neurons are electrically immature and do not produce high-frequency firing in response to salient stimuli. We ask first, what makes dopamine neurons immature? and second, what are the implications of this immaturity for the basal ganglia? As an answer to the first question, we find that at birth the outward current is small (3nS-V), insensitive to Ca2+, TEA, BK, and SK blockers. Rapidly after birth, the outward current increases to 15nS-V and becomes sensitive to Ca2+, TEA, BK, and SK blockers. We make a detailed analysis of the kinetics of the components of the outward currents and produce a model for BK and SK channels that we use to reproduce the outward current, and to infer the geometrical arrangement of BK and Ca2+ channels in clusters. In the first cluster, T-type Ca2+ and BK channels are coupled within distances of similar to 20 nm (200 parallel to). The second cluster consists of L-type Ca2+ and BK channels that are spread over distances of at least 60 nm. As for the second question, we propose that early in development, the mechanism of action selection is in a "locked-in" state that would prevent dopamine neurons from reinforcing cortico-striatal synapses that do not have a functional experiential-based value.	[Ramirez-Latorre, Jose A.] Columbia Univ, Ctr Neurobiol, New York, NY USA	Columbia University	Ramirez-Latorre, JA (corresponding author), Univ Rosario, Fac Med, Grp Neurociencias NEUROS, Bogota, Colombia.	jose.ramirezl@urosario.edu.co			Colciencias; Limback Foundation	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Limback Foundation	Funding provided by Colciencias and a Limback Foundation Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2009, NEUROSCIENCE, V161, P95, DOI 10.1016/j.neuroscience.2009.03.022; ALBIN RL, 1995, TRENDS NEUROSCI, V18, P63; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Ben-Ari Y, 2010, TRENDS NEUROSCI, V33, P485, DOI 10.1016/j.tins.2010.08.005; Blythe SN, 2007, J NEUROPHYSIOL, V97, P2837, DOI 10.1152/jn.01157.2006; Blythe SN, 2009, J NEUROSCI, V29, P15531, DOI 10.1523/JNEUROSCI.2961-09.2009; Cameron JS, 2001, P NATL ACAD SCI USA, V98, P2832, DOI 10.1073/pnas.041394098; CARDOZO DL, 1995, J NEUROPHYSIOL, V74, P1137, DOI 10.1152/jn.1995.74.3.1137; Carlsson T, 2011, J NEUROCHEM, V117, P1066, DOI 10.1111/j.1471-4159.2011.07284.x; CHERGUI K, 1993, EUR J NEUROSCI, V5, P137, DOI 10.1111/j.1460-9568.1993.tb00479.x; Cohen BN, 2012, NEUROSCIENCE, V200, P31, DOI 10.1016/j.neuroscience.2011.10.047; Cueni L, 2009, PFLUG ARCH EUR J PHY, V457, P1161, DOI 10.1007/s00424-008-0582-6; Cui GH, 2004, J NEUROSCI, V24, P11079, DOI 10.1523/JNEUROSCI.2713-04.2004; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Durante P, 2004, J NEUROPHYSIOL, V91, P1450, DOI 10.1152/jn.01015.2003; EBIHARA S, 1995, J PHYSIOL-LONDON, V484, P77, DOI 10.1113/jphysiol.1995.sp020649; ELKINS T, 1986, P NATL ACAD SCI USA, V83, P8415, DOI 10.1073/pnas.83.21.8415; Faber ESL, 2003, J PHYSIOL-LONDON, V552, P483, DOI 10.1113/jphysiol.2003.050120; Fakler B, 2008, NEURON, V59, P873, DOI 10.1016/j.neuron.2008.09.001; Ferrari DC, 2012, FRONTIERS IN CELLULA, V6, P1; Franciolini F, 2001, PFLUG ARCH EUR J PHY, V441, P629, DOI 10.1007/s004240000471; GARRIS PA, 1994, J NEUROSCI, V14, P6084; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; GONON FG, 1988, NEUROSCIENCE, V24, P19, DOI 10.1016/0306-4522(88)90307-7; GRACE AA, 1984, J NEUROSCI, V4, P2877; Gu N, 2007, J PHYSIOL-LONDON, V580, P859, DOI 10.1113/jphysiol.2006.126367; Guzman JN, 2009, J NEUROSCI, V29, P11011, DOI 10.1523/JNEUROSCI.2519-09.2009; HAINSWORTH AH, 1991, NEUROSCIENCE, V43, P81, DOI 10.1016/0306-4522(91)90419-O; HARRIS NC, 1989, NEUROSCIENCE, V31, P355, DOI 10.1016/0306-4522(89)90379-5; Hicks GA, 1998, J PHYSIOL-LONDON, V508, P721, DOI 10.1111/j.1469-7793.1998.721bp.x; Hille B, 1984, IONIC CHANNELS EXCIT; Hyland BI, 2002, NEUROSCIENCE, V114, P475, DOI 10.1016/S0306-4522(02)00267-1; Imlach WL, 2008, J PHARMACOL EXP THER, V327, P657, DOI 10.1124/jpet.108.143933; Iribe Y, 1999, J NEUROPHYSIOL, V82, P925, DOI 10.1152/jn.1999.82.2.925; Jaaro-Peled H, 2009, TRENDS NEUROSCI, V32, P485, DOI 10.1016/j.tins.2009.05.007; KANG Y, 1993, NEUROSCI RES, V18, P209, DOI 10.1016/0168-0102(93)90056-V; Katayama J, 2003, NEUROSCI RES, V45, P101, DOI 10.1016/S0168-0102(02)00202-X; LACEY MG, 1989, J NEUROSCI, V9, P1233; Lee CR, 2009, J NEURAL TRANSM-SUPP, P71, DOI 10.1007/978-3-211-92660-4_6; Lee US, 2010, TRENDS NEUROSCI, V33, P415, DOI 10.1016/j.tins.2010.06.004; Lee US, 2009, J PHYSIOL-LONDON, V587, P1481, DOI 10.1113/jphysiol.2009.169243; Liu JX, 2008, MOL PHARMACOL, V74, P628, DOI 10.1124/mol.108.048694; Lobb CJ, 2011, J NEUROPHYSIOL, V105, P2501, DOI 10.1152/jn.01076.2010; Lokwan SJA, 1999, NEUROSCIENCE, V92, P245, DOI 10.1016/S0306-4522(98)00748-9; MacDonald SHF, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-37; MANLEY LD, 1992, J NEUROCHEM, V58, P1491, DOI 10.1111/j.1471-4159.1992.tb11369.x; MARCHAND R, 1983, NEUROSCIENCE, V9, P373, DOI 10.1016/0306-4522(83)90300-7; MARTY A, 1981, NATURE, V291, P497, DOI 10.1038/291497a0; MCGUIGAN JAS, 1991, CAN J PHYSIOL PHARM, V69, P1733, DOI 10.1139/y91-257; Meyer D, 1997, DEVELOPMENT, V124, P3575; Neuhoff H, 2002, J NEUROSCI, V22, P1290, DOI 10.1523/JNEUROSCI.22-04-01290.2002; Olsen ML, 2005, J NEUROSCI RES, V81, P179, DOI 10.1002/jnr.20543; Pouvreau S, 2004, J PHYSIOL-LONDON, V555, P365, DOI 10.1113/jphysiol.2003.055285; Puopolo M, 2007, J NEUROSCI, V27, P645, DOI 10.1523/JNEUROSCI.4341-06.2007; Pyott SJ, 2004, J NEUROSCI, V24, P9469, DOI 10.1523/JNEUROSCI.3162-04.2004; Redgrave P, 2010, NAT REV NEUROSCI, V11, P760, DOI 10.1038/nrn2915; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; SHERMAN A, 1990, BIOPHYS J, V58, P985, DOI 10.1016/S0006-3495(90)82443-7; Shi WX, 2009, J NEURAL TRANSM-SUPP, P103, DOI 10.1007/978-3-211-92660-4_8; SHULTS CW, 1990, NEUROSCIENCE, V38, P427, DOI 10.1016/0306-4522(90)90039-7; Smith GD, 2001, METH NE FRO NEUROSCI, P49; Smith GD, 1996, BIOPHYS J, V70, P2527, DOI 10.1016/S0006-3495(96)79824-7; Smith Y, 1998, NEUROSCIENCE, V86, P353; SOLARO CR, 1995, J NEUROSCI, V15, P6110; Su WT, 2010, NEUROSCI LETT, V471, P1, DOI 10.1016/j.neulet.2009.12.058; Sun XL, 2003, J NEUROSCI, V23, P3639; TEPPER JM, 1994, NEUROSCIENCE, V60, P469, DOI 10.1016/0306-4522(94)90258-5; TEPPER JM, 1990, DEV BRAIN RES, V54, P21, DOI 10.1016/0165-3806(90)90061-3; Thomas D, 2000, CELL CALCIUM, V28, P213, DOI 10.1054/ceca.2000.0152; TRENT F, 1991, EUR J PHARMACOL, V204, P265, DOI 10.1016/0014-2999(91)90851-G; Vandael DH, 2010, MOL NEUROBIOL, V42, P185, DOI 10.1007/s12035-010-8151-3; VOORN P, 1988, NEUROSCIENCE, V25, P857, DOI 10.1016/0306-4522(88)90041-3; Watmuff B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031999; WISGIRDA ME, 1994, P NATL ACAD SCI USA, V91, P2858, DOI 10.1073/pnas.91.7.2858; Wolfart J, 2002, J NEUROSCI, V22, P3404; YUNG WH, 1991, J PHYSIOL-LONDON, V436, P643, DOI 10.1113/jphysiol.1991.sp018571; Yurek DM, 2004, BRAIN RES, V1028, P116, DOI 10.1016/j.brainres.2004.08.066; Zhang L, 2006, MED HYPOTHESES, V67, P41, DOI 10.1016/j.mehy.2005.09.055	80	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51610	10.1371/journal.pone.0051610	http://dx.doi.org/10.1371/journal.pone.0051610			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284723	Green Accepted, gold, Green Published			2022-12-27	WOS:000312794500036
J	Trindade, BC; Sorgi, CA; Nicolete, LDD; Malta, TM; Pinto, MT; Takayanagui, OM; Covas, DT; Martins, OA; Kashima, S; Faccioli, LH				Trindade, Bruno Caetano; Sorgi, Carlos Arterio; de Figueiredo Nicolete, Larissa Deadame; Malta, Tathiane Maistro; Pinto, Mariana Tomazini; Takayanagui, Osvaldo Massaiti; Covas, Dimas Tadeu; Martins Filho, Olindo Assis; Kashima, Simone; Faccioli, Lucia Helena			Leukotrienes Are Upregulated and Associated with Human T-Lymphotropic Virus Type 1 (HTLV-1)-Associated Neuroinflammatory Disease	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MYELOPATHY/TROPICAL SPASTIC PARAPARESIS; PROVIRAL LOAD; CEREBROSPINAL-FLUID; CYSTEINYL-LEUKOTRIENES; HAM/TSP PATIENTS; INFECTION; RECEPTORS; RELEASE; TUBERCULOSIS	Leukotrienes (LTs) are lipid mediators involved in several inflammatory disorders. We investigated the LT pathway in human T-lymphotropic virus type 1 (HTLV-1) infection by evaluating LT levels in HTLV-1-infected patients classified according to the clinical status as asymptomatic carriers (HACs) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients. Bioactive LTB4 and CysLTs were both increased in the plasma and in the supernatant of peripheral blood mononuclear cell cultures of HTLV-1-infected when compared to non-infected. Interestingly, CysLT concentrations were increased in HAM/TSP patients. Also, the concentration of plasma LTB4 and LTC4 positively correlated with the HTLV-1 proviral load in HTLV-1-infected individuals. The gene expression levels of LT receptors were differentially modulated in CD4(+) and CD8(+) T cells of HTLV-1-infected patients. Analysis of the overall plasma signature of immune mediators demonstrated that LT and chemokine amounts were elevated during HTLV-1 infection. Importantly, in addition to CysLTs, IP-10 was also identified as a biomarker for HAM/TSP activity. These data suggest that LTs are likely to be associated with HTLV-1 infection and HAM/TSP development, suggesting their putative use for clinical monitoring.	[Trindade, Bruno Caetano; Sorgi, Carlos Arterio; Faccioli, Lucia Helena] Univ Sao Paulo, Lab Inflamacao & Imunol Parasitoses, Fac Ciencias Farmaceut Ribeirao Preto, Sao Paulo, Brazil; [Trindade, Bruno Caetano; Martins Filho, Olindo Assis] Fundacao Oswaldo Cruz, Lab Biomarcadores Diagnost & Monitoracao, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [de Figueiredo Nicolete, Larissa Deadame; Malta, Tathiane Maistro; Pinto, Mariana Tomazini; Covas, Dimas Tadeu; Kashima, Simone] Inst Nacl Ciencia & Tecnol Celulas Tronco & Terap, Sao Paulo, Brazil; [Takayanagui, Osvaldo Massaiti] Univ Sao Paulo, Dept Neurociencias & Ciencias Comportamento, Fac Med Ribeirao Preto, Sao Paulo, Brazil; [Covas, Dimas Tadeu] Univ Sao Paulo, Dept Clin Med, Fac Med Ribeirao Preto, Sao Paulo, Brazil	Universidade de Sao Paulo; Fundacao Oswaldo Cruz; Universidade de Sao Paulo; Universidade de Sao Paulo	Faccioli, LH (corresponding author), Univ Sao Paulo, Lab Inflamacao & Imunol Parasitoses, Fac Ciencias Farmaceut Ribeirao Preto, Sao Paulo, Brazil.	faccioli@fcfrp.usp.br	Faccioli, Lúcia Helena/AGH-5297-2022; Martins-Filho, Olindo Assis/ABE-6278-2021; Covas, Dimas/AAL-8499-2021; Pinto, Mariana/B-6129-2017; Malta, Tathiane/N-1686-2013; Lucia, Faccioli/G-8976-2015; Sorgi, Carlos Artério/AAA-6284-2020; Covas, Dimas T/C-5431-2013; Kashima, Simone/G-4876-2012; Takayanagui, Osvaldo M/C-8159-2013; Sorgi, Carlos Arterio/ABE-4246-2020; Sorgi, Carlos/O-2839-2017	Faccioli, Lúcia Helena/0000-0002-4999-8305; Martins-Filho, Olindo Assis/0000-0002-5494-4889; Pinto, Mariana/0000-0002-5176-7776; Malta, Tathiane/0000-0003-1129-5791; Lucia, Faccioli/0000-0002-4999-8305; Sorgi, Carlos Artério/0000-0001-7528-9935; Covas, Dimas T/0000-0002-7364-2595; Kashima, Simone/0000-0002-1487-0141; Takayanagui, Osvaldo M/0000-0002-8190-0275; Sorgi, Carlos/0000-0001-7528-9935	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao Hemocentro de Ribeirao Preto; CNPq	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Hemocentro de Ribeirao Preto; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding provided by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico and Fundacao Hemocentro de Ribeirao Preto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Virginia Mara de Deus Wagatsuma and Evandra Strazza Rodrigues, from the Hemocentro Foundation of Ribeirao Preto, for their technical assistance. LHF, OAMF, DTC and OMT are thankful to CNPq for the PQ fellowship Program.	AHMADZADEH N, 1991, INFLAMMATION, V15, P497, DOI 10.1007/BF00923346; Best I, 2006, CLIN EXP IMMUNOL, V146, P226, DOI 10.1111/j.1365-2249.2006.03208.x; Brink C, 2003, PHARMACOL REV, V55, P195, DOI 10.1124/pr.55.1.8; Cannas A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-333; Capra V, 2007, MED RES REV, V27, P469, DOI 10.1002/med.20071; Carvalho EM, 2001, J ACQ IMMUN DEF SYND, V27, P1, DOI 10.1097/00126334-200105010-00001; CLAESSON HE, 1992, INT J IMMUNOPHARMACO, V14, P441, DOI 10.1016/0192-0561(92)90174-J; Coffey MJ, 1999, BLOOD, V94, P3897, DOI 10.1182/blood.V94.11.3897.423k12_3897_3905; Cooper Sarah A, 2009, Pract Neurol, V9, P16, DOI 10.1136/jnnp.2008.167155; de Souza JG, 2011, J CLIN VIROL, V50, P13, DOI 10.1016/j.jcv.2010.09.007; Flamand L, 2004, J INFECT DIS, V189, P2001, DOI 10.1086/386374; Flamand L, 2007, J IMMUNOL, V178, P8036, DOI 10.4049/jimmunol.178.12.8036; Flamand N, 2007, CELL MOL LIFE SCI, V64, P2657, DOI 10.1007/s00018-007-7228-2; FROLDI M, 1992, J NEUROIMMUNOL, V38, P155, DOI 10.1016/0165-5728(92)90100-Y; Gaudreault E, 2008, J IMMUNOL, V180, P6211, DOI 10.4049/jimmunol.180.9.6211; Goncalves DU, 2010, CLIN MICROBIOL REV, V23, P577, DOI 10.1128/CMR.00063-09; GOUT O, 1990, NEW ENGL J MED, V322, P383, DOI 10.1056/NEJM199002083220607; Guerreiro JB, 2006, CLIN EXP IMMUNOL, V145, P296, DOI 10.1111/j.1365-2249.2006.03150.x; Haddad R, 2011, AIDS RES HUM RETROV, V27, P283, DOI 10.1089/aid.2010.0165; Ichiyama T, 2005, CLIN EXP ALLERGY, V35, P1214, DOI 10.1111/j.1365-2222.2005.02323.x; Izumo S, 2010, NEUROPATHOLOGY, V30, P480, DOI 10.1111/j.1440-1789.2010.01135.x; Kabeer BSA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-135; Keating SM, 2011, AIDS, V25, P1823, DOI 10.1097/QAD.0b013e3283489d1f; Kihara Y, 2010, BIOCHEM BIOPH RES CO, V394, P673, DOI 10.1016/j.bbrc.2010.03.049; LEWIS RA, 1984, J CLIN INVEST, V73, P889, DOI 10.1172/JCI111312; Luiza-Silva M, 2011, J INFECT DIS, V204, P873, DOI 10.1093/infdis/jir439; Machado ER, 2005, J IMMUNOL, V175, P3892, DOI 10.4049/jimmunol.175.6.3892; Matsuo M, 1996, PEDIATR NEUROL, V14, P121, DOI 10.1016/0887-8994(96)83272-3; Matsuzaki T, 2001, J NEUROVIROL, V7, P228; Medeiros AI, 2004, INFECT IMMUN, V72, P1637, DOI 10.1128/IAI.72.3.1637-1644.2004; Medeiros AI, 2008, J IMMUNOL, V181, P8544, DOI 10.4049/jimmunol.181.12.8544; Moriuchi M, 2001, J VIROL, V75, P192, DOI 10.1128/JVI.75.1.192-198.2001; Nassar GM, 1997, KIDNEY INT, V51, P1520, DOI 10.1038/ki.1997.209; NEU I, 1992, ACTA NEUROL SCAND, V86, P586, DOI 10.1111/j.1600-0404.1992.tb05491.x; Okubo M, 2010, GLIA, V58, P599, DOI 10.1002/glia.20948; Okunishi K, 2011, BBA-GEN SUBJECTS, V1810, P1096, DOI 10.1016/j.bbagen.2011.02.005; Olindo S, 2005, J NEUROL SCI, V237, P53, DOI 10.1016/j.jns.2005.05.010; Peres CM, 2007, MICROBES INFECT, V9, P483, DOI 10.1016/j.micinf.2007.01.006; Peres-Buzalaf C, 2011, PROSTAG LEUKOTR ESS, V85, P75, DOI 10.1016/j.plefa.2011.04.024; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; POULIOT M, 1994, J IMMUNOL, V152, P851; Santos SB, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-7; Takenouchi N, 2003, J NEUROVIROL, V9, P29, DOI 10.1080/13550280390173418; Toulza F, 2010, J IMMUNOL, V185, P183, DOI 10.4049/jimmunol.0903846; Umehara F, 2003, GANN MONOGR CANC RES, P141; Verdonck K, 2007, LANCET INFECT DIS, V7, P266, DOI 10.1016/S1473-3099(07)70081-6; Wang LF, 2011, J IMMUNOL, V187, P2336, DOI 10.4049/jimmunol.1100333; Watanabe T, 1997, INT J HEMATOL, V66, P257; Yoshikawa K, 2011, PROSTAG LEUKOTR ESS, V85, P43, DOI 10.1016/j.plefa.2011.04.022	49	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51873	10.1371/journal.pone.0051873	http://dx.doi.org/10.1371/journal.pone.0051873			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284797	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500058
J	Hwang, YC; Ahn, HY; Lee, WJ; Park, CY; Park, SW				Hwang, You-Cheol; Ahn, Hong-Yup; Lee, Woo Je; Park, Cheol-Young; Park, Sung-Woo			An Equation to Estimate the Concentration of Serum Apolipoprotein B	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; MYOCARDIAL-INFARCTION; RISK; MANAGEMENT; DISEASE; EVENTS; PLASMA; LIPIDS	Background: Several large prospective studies have demonstrated that apolipoprotein B (apoB) has greater value in predicting cardiovascular risk than any other lipid measurements. Currently, however, serum apoB levels are not routinely measured, because of the additional cost. The aim of this study was to develop an equation to estimate apoB from conventional lipid measurements including total cholesterol, HDL cholesterol, and triglycerides. Methods: Data from a total of 78,127 subjects (47,057 men and 31,070 women), aged 15 to 88 years (mean age 41.8 years) were reviewed to develop an apoB equation. Additional datasets from the same institution and the NHANES obtained in 2007-2008 were used for internal (n = 73,445) and external validation (n = 3,097), respectively. Results: We developed an apoB equation based on a linear regression model that contains total cholesterol, triglycerides, and HDL cholesterol as terms (model 1). To more precisely estimate the serum apoB level, we adjusted mode1 1 using a cutoff serum triglyceride value of 270 mg/dl (model 2). Model 2 showed more randomly distributed residuals in patients with diabetes, atherogenic dyslipidemia, and those taking lipid-lowering agents than model 1. The residuals in the development, internal validation, and external validation datasets were also randomly distributed around 0 with no clear trends. Conclusion: The new equation we developed to estimate serum apoB concentrations is accurate and can be used in diverse subgroups of patients including those with diabetes, atherogenic dyslipidemia, and those taking lipid-lowering agents.	[Park, Cheol-Young; Park, Sung-Woo] Sungkyunkwan Univ, Sch Med, Dept Internal Med, Div Endocrinol & Metab,Kangbuk Samsung Hosp, Seoul, South Korea; [Hwang, You-Cheol] Kyung Hee Univ, Div Endocrinol & Metab, Dept Med, Sch Med,Kyung Hee Univ Hosp Gangdong, Seoul, South Korea; [Ahn, Hong-Yup] Dongguk Univ Seoul, Dept Stat, Seoul, South Korea; [Lee, Woo Je] Univ Ulsan, Coll Med, Dept Internal Med, Asan Med Ctr, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Kyung Hee University; Kyung Hee University Hospital; Dongguk University; University of Ulsan	Park, CY (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Internal Med, Div Endocrinol & Metab,Kangbuk Samsung Hosp, Seoul, South Korea.	cydoctor@chol.com	Hwang, You-Cheol/AAA-4616-2022; Ahn, Hongyup/M-5043-2017; Park, Cheol-Young/C-6690-2018	Ahn, Hongyup/0000-0001-8149-6981; Park, Cheol-Young/0000-0002-9415-9965; Hwang, You-Cheol/0000-0003-4033-7874				Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Barter PJ, 2006, J INTERN MED, V259, P247, DOI 10.1111/j.1365-2796.2006.01616.x; Brunzell JD, 2008, DIABETES CARE, V31, P811, DOI 10.2337/dc08-9018; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gotto AM, 2000, CIRCULATION, V101, P477, DOI 10.1161/01.CIR.101.5.477; Kastelein JJP, 2008, CIRCULATION, V117, P3002, DOI 10.1161/CIRCULATIONAHA.107.713438; Marcovina S, 2006, J INTERN MED, V259, P437, DOI 10.1111/j.1365-2796.2006.01648.x; MCNAMARA JR, 1990, CLIN CHEM, V36, P36; McQueen MJ, 2008, LANCET, V372, P224, DOI 10.1016/S0140-6736(08)61076-4; Moss AJ, 1999, CIRCULATION, V99, P2517, DOI 10.1161/01.CIR.99.19.2517; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Sniderman AD, 2003, CLIN BIOCHEM, V36, P499, DOI 10.1016/S0009-9120(03)00117-6; Walldius G, 2001, LANCET, V358, P2026, DOI 10.1016/S0140-6736(01)07098-2	15	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51607	10.1371/journal.pone.0051607	http://dx.doi.org/10.1371/journal.pone.0051607			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284722	Green Published, Green Submitted, gold			2022-12-27	WOS:000312694300032
J	Lu, QB; Zhang, XA; Wo, Y; Xu, HM; Li, XJ; Wang, XJ; Ding, SJ; Chen, XD; He, C; Liu, LJ; Li, H; Yang, H; Li, TY; Liu, W; Cao, WC				Lu, Qing-Bin; Zhang, Xiao-Ai; Wo, Ying; Xu, Hong-Mei; Li, Xiu-Jun; Wang, Xian-Jun; Ding, Shu-Jun; Chen, Xiao-Dan; He, Cui; Liu, Li-Juan; Li, Hao; Yang, Hong; Li, Ting-Yu; Liu, Wei; Cao, Wu-Chun			Circulation of Coxsackievirus A10 and A6 in Hand-Foot-Mouth Disease in China, 2009-2011	PLOS ONE			English	Article							ENTEROVIRUS SEROTYPES; OUTBREAK; ONYCHOMADESIS; EPIDEMIOLOGY; INFECTIONS; SINGAPORE; STRAINS; TAIWAN; PCR; A2	Coxsackieviruses A10 (CV-A10) and A6 (CV-A6) have been associated with increasingly occurred sporadic hand-foot-mouth disease (HFMD) cases and outbreak events globally. However, our understanding of epidemiological and genetic characteristics of these new agents remains far from complete. This study was to explore the circulation of CV-A10 and CV-A6 in HFMD and their genetic characteristics in China. A hospital based surveillance was performed in three heavily inflicted regions with HFMD from March 2009 to August 2011. Feces samples were collected from children with clinical diagnosis of HFMD. The detection and genotyping of enteroviruses was performed by real-time PCR and sequencing of 5'UTR/VP1 regions. Phylogenetic analysis and selection pressure were performed based on the VP1 sequences. Logistic regression model was used to identify the effect of predominant enterovirus serotypes in causing severe HFMD. The results showed 92.0% of 1748 feces samples were detected positive for enterovirus, with the most frequently presented serotypes as EV-71 (944, 54.0%) and CV-A16 (451, 25.8%). CV-A10 and CV-A6 were detected as a sole pathogen in 82 (4.7%) and 44 (2.5%) cases, respectively. Infection with CV-A10 and EV-71 were independently associated with high risk of severe HFMD (OR = 2.66, 95% CI: 1.40-5.06; OR = 4.81, 95% CI: 3.07-7.53), when adjusted for age and sex. Phylogenetic analysis revealed that distinct geographic and temporal origins correlated with the gene clusters based on VP1 sequences. An overall v value of the VP1 was 0.046 for CV-A10 and 0.047 for CV-A6, and no positively selected site was detected in VP1 of both CV-A10 and CV-A6, indicating that purifying selection shaped the evolution of CV-A10 and CV-A6. Our study demonstrates variety of enterovirus genotypes as viral pathogens in causing HFMD in China. CV-A10 and CV-A6 were co-circulating together with EV-71 and CV-A16 in recent years. CV-A10 infection might also be independently associated with severe HFMD.	[Lu, Qing-Bin; Zhang, Xiao-Ai; Wo, Ying; Chen, Xiao-Dan; He, Cui; Liu, Li-Juan; Li, Hao; Yang, Hong; Liu, Wei; Cao, Wu-Chun] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Lu, Qing-Bin; Li, Xiu-Jun] Shandong Univ, Dept Epidemiol & Hlth Stat, Jinan 250100, Peoples R China; [Xu, Hong-Mei; Li, Ting-Yu] Chongqing Med Univ, Childrens Hosp, Chongqing, Peoples R China; [Wang, Xian-Jun; Ding, Shu-Jun] Shandong Prov Dis Prevent & Control Ctr, Dept Infect Dis Control, Jinan, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Shandong University; Chongqing Medical University	Liu, W (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	liu_weis@sohu.com; caowc@nic.bmi.ac.cn	xu, hong/GSD-8903-2022	Lu, Qing-Bin/0000-0002-2804-0827; Liu, Wei/0000-0002-9302-8170	China Mega-Project on Infectious Disease Prevention [2009ZX10004-204]; National Science Fund for Distinguished Young Scholars [30725032]; Shandong Scientific and Technical Supporting Program [2009GG10002055]	China Mega-Project on Infectious Disease Prevention; National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Shandong Scientific and Technical Supporting Program	This study was supported by the grants of China Mega-Project on Infectious Disease Prevention (2009ZX10004-204), National Science Fund for Distinguished Young Scholars (30725032) and Shandong Scientific and Technical Supporting Program (2009GG10002055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Blomqvist S, 2010, J CLIN VIROL, V48, P49, DOI 10.1016/j.jcv.2010.02.002; Bracho MA, 2011, EMERG INFECT DIS, V17, P2223, DOI 10.3201/eid1712.110395; Chen SP, 2010, J MICROBIOL IMMUNOL, V43, P99, DOI 10.1016/S1684-1182(10)60016-3; Fujimoto T, 2012, EMERG INFECT DIS, V18, P337, DOI 10.3201/eid1802.111147; Gopalkrishna V, 2012, J MED MICROBIOL, V61, P420, DOI 10.1099/jmm.0.036400-0; Hu YF, 2011, J CLIN MICROBIOL, V49, P2426, DOI 10.1128/JCM.00007-11; Lewis-Rogers N, 2009, MOL BIOL EVOL, V26, P969, DOI 10.1093/molbev/msp009; Li X. T., 2011, INT J VIROL, V18, P5; Lo SH, 2011, J MICROBIOL IMMUNOL, V44, P252, DOI 10.1016/j.jmii.2011.01.031; Davia JL, 2011, PEDIATR DERMATOL, V28, P1, DOI 10.1111/j.1525-1470.2010.01161.x; Ma E, 2010, INT J INFECT DIS, V14, pE775, DOI 10.1016/j.ijid.2010.02.2265; Mirand A, 2012, CLIN MICROBIOL INFEC, V18, pE110, DOI 10.1111/j.1469-0691.2012.03789.x; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Osterback R, 2009, EMERG INFECT DIS, V15, P1485, DOI 10.3201/eid1509.090438; Ryu WS, 2010, J CLIN MICROBIOL, V48, P2490, DOI 10.1128/JCM.02369-09; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Tryfonos C, 2011, J MED MICROBIOL, V60, P1433, DOI 10.1099/jmm.0.029892-0; Verstrepen WA, 2002, J CLIN VIROL, V25, pS39, DOI 10.1016/S1386-6532(02)00032-X; Wang Y-Q, 2011, INT J VIROL, V18, P75; Wang Zhao-guo, 2011, Chinese Journal of Virology, V27, P438; Wei SH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-346; Wu Y, 2010, INT J INFECT DIS, V14, pE1076, DOI 10.1016/j.ijid.2010.07.006; Yang F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-508; [杨赫 Yang He], 2010, [中华传染病杂志, Chinese Journal of Infections Diseases], V28, P385; Yozwiak NL, 2010, J VIROL, V84, P9047, DOI 10.1128/JVI.00698-10; Zhang CM, 2009, INT J ENVIRON POLLUT, V38, P151, DOI 10.1504/IJEP.2009.026658; Zhang J, 2011, BIOMED ENVIRON SCI, V24, P214, DOI 10.3967/0895-3988.2011.03.002; Zhu Bing, 2010, Zhonghua Er Ke Za Zhi, V48, P127	29	126	176	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52073	10.1371/journal.pone.0052073	http://dx.doi.org/10.1371/journal.pone.0052073			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272213	Green Submitted, Green Published, gold			2022-12-27	WOS:000312483300059
J	Johnson, S; Issac, B; Zhao, SP; Bisht, M; Celiku, O; Tofilon, P; Camphausen, K; Shankavaram, U				Johnson, Seth; Issac, Biju; Zhao, Shuping; Bisht, Mohit; Celiku, Orieta; Tofilon, Philip; Camphausen, Kevin; Shankavaram, Uma			StRAP: An Integrated Resource for Profiling High-Throughput Cancer Genomic Data from Stress Response Studies	PLOS ONE			English	Article							GENE-EXPRESSION; MICROARRAY DATA; RADIATION-THERAPY; PLATFORMS; RADIOTHERAPY; BIOLOGY; SYSTEMS; TOOL	The increasing availability and maturity of DNA microarray technology has led to an explosion of cancer profiling studies for identifying cancer biomarkers, and predicting treatment response. Uncovering complex relationships, however, remains the most challenging task as it requires compiling and efficiently querying data from various sources. Here, we describe the Stress Response Array Profiler (StRAP), an open-source, web-based resource for storage, profiling, visualization, and sharing of cancer genomic data. StRAP houses multi-cancer microarray data with major emphasis on radiotherapy studies, and takes a systems biology approach towards the integration, comparison, and cross-validation of multiple cancer profiling studies. The database is a comprehensive platform for comparative analysis of gene expression data. For effective use of arrays, we provide user-friendly and interactive visualization tools that can display the data and query results. StRAP is web-based, platform-independent, and freely accessible at http://strap.nci.nih.gov/.	[Johnson, Seth; Zhao, Shuping; Bisht, Mohit; Celiku, Orieta; Tofilon, Philip; Camphausen, Kevin; Shankavaram, Uma] NCI, Radiat Oncol Branch, NIH, Bethesda, MD 20892 USA; [Johnson, Seth; Zhao, Shuping] SAIC Frederick Inc, Natl Canc Inst Frederick, Frederick, MD USA; [Issac, Biju] Univ Miami, Sylvester Comprehens Canc Ctr, Div Bioinformat, Coral Gables, FL 33124 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of Miami	Shankavaram, U (corresponding author), NCI, Radiat Oncol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	uma@mail.nih.gov		Issac, Biju/0000-0002-7311-678X; Celiku, Orieta/0000-0002-0500-1032	National Institutes of Health, National Cancer Institute, Center for Cancer Research	National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman NS, 2006, GENET RES, V88, P153, DOI 10.1017/S0016672307008476; Amundson SA, 2004, CANCER RES, V64, P6368, DOI 10.1158/0008-5472.CAN-04-1883; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bargaje R, 2010, RNA, V16, P16, DOI 10.1261/rna.1688110; Bevilacqua V, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S7-S9; Burnet NG, 2000, BRIT MED J, V320, P198, DOI 10.1136/bmj.320.7229.198; Cerami EG, 2011, NUCLEIC ACIDS RES, V39, pD685, DOI 10.1093/nar/gkq1039; Chon BH, 2002, ONCOLOGIST, V7, P136, DOI 10.1634/theoncologist.7-2-136; Chon HS, 2011, CANCER CONTROL, V18, P8, DOI 10.1177/107327481101800102; Clarke R, 2008, NAT REV CANCER, V8, P37, DOI 10.1038/nrc2294; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; Jarvinen AK, 2004, GENOMICS, V83, P1164, DOI 10.1016/j.ygeno.2004.01.004; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Mah N, 2004, PHYSIOL GENOMICS, V16, P361, DOI 10.1152/physiolgenomics.00080.2003; Parkinson H, 2011, NUCLEIC ACIDS RES, V39, pD1002, DOI 10.1093/nar/gkq1040; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; Prasad TSK, 2009, METHODS MOL BIOL, V577, P67, DOI 10.1007/978-1-60761-232-2_6; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Rieger KE, 2004, P NATL ACAD SCI USA, V101, P6635, DOI 10.1073/pnas.0307761101; Rodningen AK, 2005, RADIOTHER ONCOL, V77, P231, DOI 10.1016/j.radonc.2005.09.020; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shankavaram UT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-277; Stafford P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1133; Tan PK, 2003, NUCLEIC ACIDS RES, V31, P5676, DOI 10.1093/nar/gkg763; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zhang YY, 2009, METHODS MOL BIOL, V573, P259, DOI 10.1007/978-1-60761-247-6_15	27	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51693	10.1371/journal.pone.0051693	http://dx.doi.org/10.1371/journal.pone.0051693			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284744	Green Published, Green Submitted, gold			2022-12-27	WOS:000312435900045
J	Reniers, G; Armbruster, B				Reniers, Georges; Armbruster, Benjamin			HIV Status Awareness, Partnership Dissolution and HIV Transmission in Generalized Epidemics	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; COPD; POPULATION	Objectives: HIV status aware couples with at least one HIV positive partner are characterized by high separation and divorce rates. This phenomenon is often described as a corollary of couples HIV Testing and Counseling (HTC) that ought to be minimized. In this contribution, we demonstrate the implications of partnership dissolution in serodiscordant couples for the propagation of HIV. Methods: We develop a compartmental model to study epidemic outcomes of elevated partnership dissolution rates in serodiscordant couples and parameterize it with estimates from population-based data (Rakai, Uganda). Results: Via its effect on partnership dissolution, every percentage point increase in HIV status awareness reduces HIV incidence in monogamous populations by 0.27 percent for women and 0.63 percent for men. These effects are even larger when the assumption of monogamy can be relaxed, but are moderated by other behavior changes (e. g., increased condom use) in HIV status aware serodiscordant partnerships. When these behavior changes are taken into account, each percentage point increase in HIV status awareness reduces HIV incidence by 0.13 and 0.32 percent for women and men, respectively (assuming monogamy). The partnership dissolution effect exists because it decreases the fraction of serodiscordant couples in the population and prolongs the time that individuals spend outside partnerships. Conclusion: Our model predicts that elevated partnership dissolution rates in HIV status aware serodiscordant couples reduce the spread of HIV. As a consequence, the full impact of couples HTC for HIV prevention is probably larger than recognized to date. Particularly high partnership dissolution rates in female positive serodiscordant couples contribute to the gender imbalance in HIV infections.	[Reniers, Georges] Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA; [Reniers, Georges] Univ London London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1E 7HT, England; [Armbruster, Benjamin] Northwestern Univ, Evanston, IL USA	Princeton University; University of London; London School of Hygiene & Tropical Medicine; Northwestern University	Reniers, G (corresponding author), Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA.	georges.reniers@lshtm.ac.uk	Armbruster, Benjamin/B-7455-2009	Reniers, Georges/0000-0001-6582-1692	National Institute of Child Health and Human Development (NICHD) Center Grant [R24HD047879]; NICHD [R24 HD066613]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD066613, R24HD066613, R24HD047879] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development (NICHD) Center Grant; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was made possible with financial support from a National Institute of Child Health and Human Development (NICHD) Center Grant to the Office of Population Research at Princeton University (R24HD047879) and an NICHD grant to the University of Colorado Population Center (R24 HD066613). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert P, 2012, THORAX, V67, P701, DOI 10.1136/thoraxjnl-2011-201458; Fletcher MJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-612; Foster Talia S, 2006, COPD, V3, P211, DOI 10.1080/15412550601009396; GOLD, GLOB IN CHRON OBSTR; Gruffydd-Jones K, 2011, PRIM CARE RESP J, V20, P199, DOI 10.4104/pcrj.2011.00011; Halbert RJ, 2006, EUR RESPIR J, V28, P523, DOI 10.1183/09031936.06.00124605; Kainu A, 2008, CHEST, V134, P387, DOI 10.1378/chest.07-2207; Nakahara N, 2012, INT J CLIN IN PRESS; Nurmagambetov Tursynbek, 2006, COPD, V3, P203, DOI 10.1080/15412550600977320; Procopiou PA, 2010, J MED CHEM, V53, P4522, DOI 10.1021/jm100326d; Salpeter SR, 2004, DRUG AGING, V21, P405, DOI 10.2165/00002512-200421060-00005; Sovani MP, 2004, DRUG SAFETY, V27, P689, DOI 10.2165/00002018-200427100-00001; WILLIAMS EJ, 1949, AUST J SCI RES SER A, V2, P149, DOI 10.1071/CH9490149	13	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e50669	10.1371/journal.pone.0050669	http://dx.doi.org/10.1371/journal.pone.0050669			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284641	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000312435900007
J	Malti, T; Gummerum, M; Keller, M; Chaparro, MP; Buchmann, M				Malti, Tina; Gummerum, Michaela; Keller, Monika; Chaparro, Maria Paula; Buchmann, Marlis			Early Sympathy and Social Acceptance Predict the Development of Sharing in Children	PLOS ONE			English	Article							BEHAVIOR; COOPERATION; ALTRUISM; COMPETENCE; CHILDHOOD	Sharing is a fascinating activity of the human species and an important basis for the development of fairness, care, and cooperation in human social interaction. Economic research has proposed that sharing, or the willingness to sacrifice own resources for others, has its roots in social emotions such as sympathy. However, only few cross-sectional experiments have investigated children's other-regarding preferences, and the question how social-emotional skills influence the willingness to share valuable resources has not been tested. In the present longitudinal-experimental study, a sample of 175 6-year-old children, their primary caregivers, and their teachers is examined over a 3-year period of time. Data are analyzed by means of growth curve modeling. The findings show that sharing valuable resources strongly increases in children from 6 to 9 years of age. Increases in sharing behavior are associated with the early-developing ability to sympathize with anonymous others. Sharing at 7 years of age is predicted by feelings of social acceptance at 6 years of age. These findings hold after controlling for children's IQ and SES. Girls share more equally than boys at 6 and 7 years of age, however, this gender difference disappears at the age of 9 years. These results indicate that human sharing strongly increases in middle childhood and, that this increase is associated with sympathy towards anonymous others and with feelings of social acceptance. Additionally, sharing develops earlier in girls than in boys. This developmental perspective contributes to new evidence on change in sharing and its social-emotional roots. A better understanding of the factors underlying differences in the development of sharing and pro-social orientations should also provide insights into the development of atypical, anti-social orientations which exhibit social-emotional differences such as aggression and bullying behavior. Citation: Malti T, Gummerum M, Keller M, Chaparro MP, Buchmann M (2012) Early Sympathy and Social Acceptance Predict the Development of Sharing in Children. PLoS ONE 7(12): e52017. doi:10.1371/journal.pone.0052017	[Malti, Tina; Chaparro, Maria Paula] Univ Toronto, Dept Psychol, Mississauga, ON L5L 1C6, Canada; [Gummerum, Michaela] Univ Plymouth, Dept Psychol, Plymouth PL4 8AA, Devon, England; [Keller, Monika] Max Planck Inst Human Dev, Berlin, Germany; [Malti, Tina; Buchmann, Marlis] Univ Zurich, Jacobs Ctr Prod Youth Dev, Zurich, Switzerland	University of Toronto; University Toronto Mississauga; University of Plymouth; Max Planck Society; University of Zurich	Malti, T (corresponding author), Univ Toronto, Dept Psychol, Mississauga, ON L5L 1C6, Canada.	tina.malti@utoronto.ca			Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research was funded by the Swiss National Science Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almas I, 2010, SCIENCE, V328, P1176, DOI 10.1126/science.1187300; Arsenio WF, 2006, HANDBOOK OF MORAL DEVELOPMENT, P581; Benenson JF, 2007, EVOL HUM BEHAV, V28, P168, DOI 10.1016/j.evolhumbehav.2006.10.003; Brosnan SF, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00043; Croson R, 2009, J ECON LIT, V47, P448, DOI 10.1257/jel.47.2.448; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; Deci E. L., 2002, HDB SELF DETERMINATI, P3, DOI DOI 10.1006/CEPS.1999.1020; Eisenberg N, 1996, CHILD DEV, V67, P2227, DOI 10.2307/1131620; Eisenberg N, 2000, ANNU REV PSYCHOL, V51, P665, DOI 10.1146/annurev.psych.51.1.665; Eisenberg N, 2006, HANDBOOK OF MORAL DEVELOPMENT, P517; Eisenberg N, 1999, CHILD DEV, V70, P1360, DOI 10.1111/1467-8624.00100; Eisenberg N., 1987, EMPATHY ITS DEV, P292; Eisenberg N., 2006, HDB CHILD PSYCHOL VO, V(6th ed., pp., P646, DOI 10.1002/9780470147658.chpsy0311; Eisenberg N., 1986, ALTRUISTIC COGNITION; Fehr E, 2002, HUM NATURE-INT BIOS, V13, P1, DOI 10.1007/s12110-002-1012-7; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Flavell JH, 2004, MERRILL PALMER QUART, V50, P274, DOI 10.1353/mpq.2004.0018; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Gummerum M., 2009, EVOL PSYCHOL-US, V7, DOI [10.1177/147470490900700212, DOI 10.1177/147470490900700212]; Gummerum M, 2008, HUM DEV, V51, P235, DOI 10.1159/000151494; Gummerum M, 2008, CHILD DEV, V79, P562, DOI 10.1111/j.1467-8624.2008.01143.x; Gummerum M, 2010, J ECON PSYCHOL, V31, P25, DOI 10.1016/j.joep.2009.09.002; Harbaugh WT, 2000, ECON INQ, V38, P95, DOI 10.1093/ei/38.1.95; Hart CH, 2000, INT J BEHAV DEV, V24, P73, DOI 10.1080/016502500383494; HARTER S, 1984, CHILD DEV, V55, P1969, DOI 10.2307/1129772; Hoffman M. L., 2001, EMPATHY MORAL DEV IM; Houser D, 2009, J ECON PSYCHOL, V30, P634, DOI 10.1016/j.joep.2009.05.002; Jensen K, 2006, P ROY SOC B-BIOL SCI, V273, P1013, DOI 10.1098/rspb.2005.3417; Knafo A, 2006, DEV PSYCHOL, V42, P771, DOI 10.1037/0012-1649.42.5.771; Knafo A, 2008, EMOTION, V8, P737, DOI 10.1037/a0014179; Leman PJ, 2009, SOC DEV, V18, P711, DOI 10.1111/j.1467-9507.2008.00486.x; [朱莉琪 ZHU LiQi], 2008, [心理学报, Acta Psychologica Sinica], V40, P402; Malti T, 2012, CHILD DEV; Malti T, 2012, J ABNORM CH IN PRESS; Malti T, 2009, CHILD DEV, V80, P442, DOI 10.1111/j.1467-8624.2009.01271.x; Maslow AH, 1943, PSYCHOL REV, V50, P370, DOI 10.1037/h0054346; Muthen L.K., 2010, MPLUS USERS GUIDE; Olson KR, 2008, COGNITION, V108, P222, DOI 10.1016/j.cognition.2007.12.003; Ongley S., HDB MORAL DEV; Ongley SF, 2012, ROLE MORAL EMO UNPUB; Perren S, 2006, J CHILD PSYCHOL PSYC, V47, P45, DOI 10.1111/j.1469-7610.2005.01445.x; PIACENTINI JC, 1992, J ABNORM CHILD PSYCH, V20, P51, DOI 10.1007/BF00927116; Rubin K.H., 2006, HDB CHILD PSYCHOL, P571, DOI 10.1002/9780470147658.chpsy0310; RUSHTON JP, 1983, PSYCHOL BULL, V94, P18, DOI 10.1037/0033-2909.94.1.18; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Sutter M, 2007, GAME ECON BEHAV, V59, P364, DOI 10.1016/j.geb.2006.07.006; Sutter M, 2007, J ECON PSYCHOL, V28, P69, DOI 10.1016/j.joep.2006.09.001; Vonk J, 2008, ANIM BEHAV, V75, P1757, DOI 10.1016/j.anbehav.2007.09.036; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; Warneken F, 2007, INFANCY, V11, P271, DOI 10.1111/j.1532-7078.2007.tb00227.x; Warneken F, 2011, PSYCHOL SCI, V22, P267, DOI 10.1177/0956797610395392; Watson M., 2003, LEARNING TRUST TRANS; ZAHNWAXLER C, 1992, DEV PSYCHOL, V28, P126, DOI 10.1037/0012-1649.28.1.126	53	41	44	5	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e52017	10.1371/journal.pone.0052017	http://dx.doi.org/10.1371/journal.pone.0052017			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055AH	23272197	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000312386600052
J	Conlon, EM; Postier, BL; Methe, BA; Nevin, KP; Lovley, DR				Conlon, Erin M.; Postier, Bradley L.; Methe, Barbara A.; Nevin, Kelly P.; Lovley, Derek R.			A Bayesian Model for Pooling Gene Expression Studies That Incorporates Co-Regulation Information	PLOS ONE			English	Article							MICROARRAY DATA; OPERON; METAANALYSIS; BENEFITS	Current Bayesian microarray models that pool multiple studies assume gene expression is independent of other genes. However, in prokaryotic organisms, genes are arranged in units that are co-regulated (called operons). Here, we introduce a new Bayesian model for pooling gene expression studies that incorporates operon information into the model. Our Bayesian model borrows information from other genes within the same operon to improve estimation of gene expression. The model produces the gene-specific posterior probability of differential expression, which is the basis for inference. We found in simulations and in biological studies that incorporating co-regulation information improves upon the independence model. We assume that each study contains two experimental conditions: a treatment and control. We note that there exist environmental conditions for which genes that are supposed to be transcribed together lose their operon structure, and that our model is best carried out for known operon structures.	[Conlon, Erin M.] Univ Massachusetts, Dept Math & Stat, Amherst, MA 01003 USA; [Postier, Bradley L.; Methe, Barbara A.; Nevin, Kelly P.; Lovley, Derek R.] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Conlon, EM (corresponding author), Univ Massachusetts, Dept Math & Stat, Amherst, MA 01003 USA.	econlon@mathstat.umass.edu	Nevin, Kelly/AAA-4626-2019		Office of Science (BER), United States Department of Energy [DE-FC02-02ER63446]	Office of Science (BER), United States Department of Energy(United States Department of Energy (DOE))	This research was supported by the Office of Science (BER), United States Department of Energy, grant number DE-FC02-02ER63446. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bockhorst J, 2003, BIOINFORMATICS, V19, P1227, DOI 10.1093/bioinformatics/btg147; Broet P, 2002, J COMPUT BIOL, V9, P671, DOI 10.1089/106652702760277381; Choi JK, 2003, BIOINFORMATICS, V19, pi84, DOI 10.1093/bioinformatics/btg1010; Conlon EM, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-247; Conlon EM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-80; de Hoon MJL, 2004, BIOINFORMATICS, V20, P101, DOI 10.1093/bioinformatics/bth927; Do KA, 2005, J R STAT SOC C-APPL, V54, P627, DOI 10.1111/j.1467-9876.2005.05593.x; Efron B, 2001, J AM STAT ASSOC, V96, P1151, DOI 10.1198/016214501753382129; Genovese C, 2002, J ROY STAT SOC B, V64, P499, DOI 10.1111/1467-9868.00347; Genovese C, 2003, BAYESIAN STAT; Gottardo R, 2003, BIOSTATISTICS, V4, P597, DOI 10.1093/biostatistics/4.4.597; Iber D, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100084; Ibrahim JG, 2002, J AM STAT ASSOC, V97, P88, DOI 10.1198/016214502753479257; Ishwaran H, 2003, J AM STAT ASSOC, V98, P438, DOI 10.1198/016214503000224; Ishwaran H, 2005, J AM STAT ASSOC, V100, P764, DOI 10.1198/016214505000000051; Jung YY, 2006, BIOMETRICAL J, V48, P435, DOI 10.1002/bimj.200410230; Kendziorski CM, 2003, STAT MED, V22, P3899, DOI 10.1002/sim.1548; Lonnstedt I, 2002, STAT SINICA, V12, P31; Lonnstedt I, 2005, BIOSTATISTICS, V6, P279, DOI 10.1093/biostatistics/kxi009; Methe BA, 2005, APPL ENVIRON MICROB, V71, P2530, DOI 10.1128/AEM.71.5.2530-2538.2005; Newton MA, 2004, BIOSTATISTICS, V5, P155, DOI 10.1093/biostatistics/5.2.155; Newton MA, 2001, J COMPUT BIOL, V8, P37, DOI 10.1089/106652701300099074; Pin C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-455; Postier B, 2008, J MICROBIOL METH, V74, P26, DOI 10.1016/j.mimet.2007.07.004; Price MN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-19; Sabatti C, 2002, NUCLEIC ACIDS RES, V30, P2886, DOI 10.1093/nar/gkf388; Scharpf RB, 2009, J AM STAT ASSOC, V104, P1295, DOI 10.1198/jasa.2009.ap07611; Segal E, 2003, BIOINFORMATICS, V19, pi273, DOI 10.1093/bioinformatics/btg1038; Shen RL, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-94; STOREY J, 2003, ANAL GENE EXPRESSION; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Townsend JP, 2002, GENOME BIOL, V3; Tseng GC, 2001, NUCLEIC ACIDS RES, V29, P2549, DOI 10.1093/nar/29.12.2549; Tseng GC, 2012, NUCLEIC ACIDS RES, V40, P3785, DOI 10.1093/nar/gkr1265; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang Z, 2011, P NATL ACAD SCI USA, V108, pE67, DOI 10.1073/pnas.1100059108; Xiao GH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-87	39	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52137	10.1371/journal.pone.0052137	http://dx.doi.org/10.1371/journal.pone.0052137			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23284902	Green Published, gold			2022-12-27	WOS:000313051500023
J	De Rosa, A; Pellegatta, S; Rossi, M; Tunici, P; Magnoni, L; Speranza, MC; Malusa, F; Miragliotta, V; Mori, E; Finocchiaro, G; Bakker, A				De Rosa, Antonella; Pellegatta, Serena; Rossi, Marco; Tunici, Patrizia; Magnoni, Letizia; Speranza, Maria Carmela; Malusa, Federico; Miragliotta, Vincenzo; Mori, Elisa; Finocchiaro, Gaetano; Bakker, Annette			A Radial Glia Gene Marker, Fatty Acid Binding Protein 7 (FABP7), Is Involved in Proliferation and Invasion of Glioblastoma Cells	PLOS ONE			English	Article							MALIGNANT-GLIOMA-CELL; HUMAN BRAIN-TUMORS; CANCER STEM-CELL; B-FABP; EXPRESSION; LINES; PROGNOSIS; IDENTIFICATION; DOUBLECORTIN; PROFILES	Glioblastoma multiforme (GBM) is among the most deadly cancers. A number of studies suggest that a fraction of tumor cells with stem cell features (Glioma Stem-like Cells, GSC) might be responsible for GBM recurrence and aggressiveness. GSC similarly to normal neural stem cells, can form neurospheres (NS) in vitro, and seem to mirror the genetic features of the original tumor better than glioma cells growing adherently in the presence of serum. Using cDNA microarray analysis we identified a number of relevant genes for glioma biology that are differentially expressed in adherent cells and neurospheres derived from the same tumor. Fatty acid-binding protein 7 (FABP7) was identified as one of the most highly expressed genes in NS compared to their adherent counterpart. We found that down-regulation of FABP7 expression in NS by small interfering RNAs significantly reduced cell proliferation and migration. We also evaluated the potential involvement of FABP7 in response to radiotherapy, as this treatment may cause increased tumor infiltration. Migration of irradiated NS was associated to increased expression of FABP7. In agreement with this, in vivo reduced tumorigenicity of GBM cells with down-regulated expression of FABP7 was associated to decreased expression of the migration marker doublecortin. Notably, we observed that PPAR antagonists affect FABP7 expression and decrease the migration capability of NS after irradiation. As a whole, the data emphasize the role of FABP7 expression in GBM migration and provide translational hints on the timing of treatment with anti-FABP7 agents like PPAR antagonists during GBM evolution.	[De Rosa, Antonella; Rossi, Marco; Tunici, Patrizia; Magnoni, Letizia; Malusa, Federico; Mori, Elisa; Bakker, Annette] Siena Biotech Spa, Siena, Italy; [Pellegatta, Serena; Speranza, Maria Carmela; Finocchiaro, Gaetano] Neurol Inst C Besta, Unit Mol Neurooncol, Milan, Italy; [Pellegatta, Serena; Speranza, Maria Carmela; Finocchiaro, Gaetano] European Inst Oncol, Dept Expt Oncol, Milan, Italy; [Miragliotta, Vincenzo] Univ Pisa, Dept Anim Pathol Prophylaxis & Food Hyg, Pisa, Italy	Siena Biotech; IRCCS Istituto Neurologico Besta; IRCCS European Institute of Oncology (IEO); University of Pisa	De Rosa, A (corresponding author), Siena Biotech Spa, Siena, Italy.	aderosa@sienabiotech.it	Finocchiaro, Gaetano/B-6898-2013; Pellegatta, Serena/AAL-3693-2021; Miragliotta, Vincenzo/K-7361-2015	Pellegatta, Serena/0000-0001-7804-9486; Miragliotta, Vincenzo/0000-0001-7896-5695; bakker, annette/0000-0001-8420-7831; Rossi, Marco/0000-0002-3601-3343; Finocchiaro, Gaetano/0000-0003-3583-4040; Speranza, Maria Carmela/0000-0001-8531-9739	Monte Dei Paschi Foundation	Monte Dei Paschi Foundation	The work was supported by Monte Dei Paschi Foundation that is a funder of Siena Biotech S. P. A. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The collaboration between Siena Biotech and IRCCS Besta has only a scientific purpose without any financial contribution.	Arai Y, 2005, J NEUROSCI, V25, P9752, DOI 10.1523/JNEUROSCI.2512-05.2005; Bazan NG, 2005, BRAIN PATHOL, V15, P159; Bisgrove DA, 2000, J BIOL CHEM, V275, P30668, DOI 10.1074/jbc.M003828200; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brun M, 2009, J MOL BIOL, V391, P282, DOI 10.1016/j.jmb.2009.06.041; Daou MC, 2005, ACTA NEUROPATHOL, V110, P472, DOI 10.1007/s00401-005-1070-0; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Godbout R, 1998, ONCOGENE, V16, P1955, DOI 10.1038/sj.onc.1201740; Hau P, 2007, DIS MARKERS, V23, P97, DOI 10.1155/2007/159242; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Josephson R, 1998, DEVELOPMENT, V125, P3087; Kaloshi G, 2007, J NEURO-ONCOL, V84, P245, DOI 10.1007/s11060-007-9377-4; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Li AG, 2008, MOL CANCER RES, V6, P21, DOI 10.1158/1541-7786.MCR-07-0280; Liang Y, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-97; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Llaguno SRA, 2009, CLIN CANCER RES, V15, P7124, DOI 10.1158/1078-0432.CCR-09-0433; Lottaz C, 2010, CANCER RES, V70, P2030, DOI 10.1158/0008-5472.CAN-09-1707; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Masui K, 2008, BRAIN TUMOR PATHOL, V25, P1, DOI 10.1007/s10014-007-0225-1; Mita R, 2007, NEOPLASIA, V9, P734, DOI 10.1593/neo.07439; Mita R, 2010, J BIOL CHEM, V285, P37005, DOI 10.1074/jbc.M110.170076; Montemayor C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008910; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Oeemig JS, 2009, BIOMOL NMR ASSIGN, V3, P89, DOI 10.1007/s12104-009-9148-6; Pelizzola M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-335; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Shimizu F, 1997, BBA-GENE STRUCT EXPR, V1354, P24, DOI 10.1016/S0167-4781(97)00115-2; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Singh SK, CANC RES, V63, P5821; Slipicevic A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-276; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stillwell W, 2003, CHEM PHYS LIPIDS, V126, P1, DOI 10.1016/S0009-3084(03)00101-4; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Tunici P, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-25; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Wang J, 2008, INT J CANCER, V122, P761, DOI 10.1002/ijc.23130	41	72	75	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52113	10.1371/journal.pone.0052113	http://dx.doi.org/10.1371/journal.pone.0052113			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284888	Green Published, gold, Green Submitted			2022-12-27	WOS:000313158800030
J	Diomede, L; Soria, C; Romeo, M; Giorgetti, S; Marchese, L; Mangione, PP; Porcari, R; Zorzoli, I; Salmona, M; Bellotti, V; Stoppini, M				Diomede, Luisa; Soria, Cristina; Romeo, Margherita; Giorgetti, Sofia; Marchese, Loredana; Mangione, Patrizia Palma; Porcari, Riccardo; Zorzoli, Irene; Salmona, Mario; Bellotti, Vittorio; Stoppini, Monica			C. elegans Expressing Human beta(2)-Microglobulin: A Novel Model for Studying the Relationship between the Molecular Assembly and the Toxic Phenotype	PLOS ONE			English	Article							TRANSGENIC CAENORHABDITIS-ELEGANS; AMYLOID-INDUCED TOXICITY; LIFE-SPAN; BETA-2-MICROGLOBULIN; PROTEIN; AGGREGATION; NEMATODE; VARIANT; MITOCHONDRIA; HEMODIALYSIS	Availability of living organisms to mimic key step of amyloidogenesis of human protein has become an indispensable tool for our translation approach aiming at filling the deep gap existing between the biophysical and biochemical data obtained in vitro and the pathological features observed in patients. Human beta(2)-microglobulin (beta(2)-m) causes systemic amyloidosis in haemodialysed patients. The structure, misfolding propensity, kinetics of fibrillogenesis and cytotoxicity of this protein, in vitro, have been studied more extensively than for any other globular protein. However, no suitable animal model for beta(2)-m amyloidosis has been so far reported. We have now established and characterized three new transgenic C. elegans strains expressing wild type human beta(2)-m and two highly amyloidogenic isoforms: P32G variant and the truncated form Delta N6 lacking of the 6 N-terminal residues. The expression of human beta(2)-m affects the larval growth of C. elegans and the severity of the damage correlates with the intrinsic propensity to self-aggregate that has been reported in previous in vitro studies. We have no evidence of the formation of amyloid deposits in the body-wall muscles of worms. However, we discovered a strict correlation between the pathological phenotype and the presence of oligomeric species recognized by the A11 antibody. The strains expressing human beta(2)-m exhibit a locomotory defect quantified with the body bends assay. Here we show that tetracyclines can correct this abnormality confirming that these compounds are able to protect a living organism from the proteotoxicity of human beta(2)-m.	[Diomede, Luisa; Romeo, Margherita; Salmona, Mario] Ist Ric Farmacol Mario Negri, Dept Mol Biochem & Pharmacol, Milan, Italy; [Soria, Cristina; Giorgetti, Sofia; Marchese, Loredana; Mangione, Patrizia Palma; Porcari, Riccardo; Bellotti, Vittorio; Stoppini, Monica] Univ Pavia, Inst Biochem, Dept Mol Med, I-27100 Pavia, Italy; [Mangione, Patrizia Palma; Bellotti, Vittorio] UCL, Div Med, Ctr Amyloidosis & Acute Phase Prot, London, England; [Zorzoli, Irene] Univ Pavia, Dept Internal Med & Clin Therapeut, I-27100 Pavia, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Pavia; University of London; University College London; University of Pavia	Bellotti, V (corresponding author), Univ Pavia, Inst Biochem, Dept Mol Med, Via Palestro 3, I-27100 Pavia, Italy.	vbellot@unipv.it	Diomede, Luisa/P-3417-2014; salmona, mario/AAA-7116-2020; Giorgetti, Sofia/AAD-4341-2019; salmona, mario/ABI-4066-2020; Bellotti, Vittorio/A-6201-2014	Diomede, Luisa/0000-0002-2258-0531; salmona, mario/0000-0002-9098-9873; Giorgetti, Sofia/0000-0001-9438-6511; Bellotti, Vittorio/0000-0001-8678-662X; Mangione, Palma/0000-0003-0260-1400; Romeo, Margherita/0000-0002-3020-8545	Cariplo Foundation [2009-2543, 2011-2096]; Intesa San Paolo Foundation; Italian Ministry of University and Research [FIRB RBFR109EOS, PRIN 20083ERXWS]; Regione Lombardia; Fondazione Banca del Monte di Lombardia; MRC UK; Medical Research Council [MR/K000187/1] Funding Source: researchfish; MRC [MR/K000187/1] Funding Source: UKRI	Cariplo Foundation(Fondazione Cariplo); Intesa San Paolo Foundation; Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Regione Lombardia(Regione Lombardia); Fondazione Banca del Monte di Lombardia; MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was partly supported by Cariplo Foundation (Project n. 2009-2543, and 2011-2096), Intesa San Paolo Foundation, the Italian Ministry of University and Research (Projects FIRB RBFR109EOS and PRIN 20083ERXWS), Regione Lombardia, Fondazione Banca del Monte di Lombardia and MRC UK: strategic award to Vittorio Bellotti. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavez S, 2011, NATURE, V472, P226, DOI 10.1038/nature09873; BYERLY L, 1976, DEV BIOL, V51, P23, DOI 10.1016/0012-1606(76)90119-6; Cardoso I, 2006, FASEB J, V20, P234, DOI 10.1096/fj.05-4509com; Choi HS, 2006, J IMMUNOASS IMMUNOCH, V27, P31, DOI 10.1080/15321810500403722; Corazza A, 2004, J BIOL CHEM, V279, P9176, DOI 10.1074/jbc.M310779200; Diomede L, 2010, NEUROBIOL DIS, V40, P424, DOI 10.1016/j.nbd.2010.07.002; Domanska K, 2011, P NATL ACAD SCI USA, V108, P1314, DOI 10.1073/pnas.1008560108; Eichner T, 2011, MOL CELL, V41, P161, DOI 10.1016/j.molcel.2010.11.028; Esposito G, 2000, PROTEIN SCI, V9, P831, DOI 10.1110/ps.9.5.831; Faber PW, 1999, P NATL ACAD SCI USA, V96, P179, DOI 10.1073/pnas.96.1.179; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; Fogolari F, 2007, BIOPHYS J, V92, P1673, DOI 10.1529/biophysj.106.098483; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; GEJYO F, 1986, NEW ENGL J MED, V314, P585; Giorgetti S, 2011, J BIOL CHEM, V286, P2121, DOI 10.1074/jbc.M110.178376; Gutierrez-Zepeda A, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-54; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Hutter H, 2000, SCIENCE, V287, P989, DOI 10.1126/science.287.5455.989; Jahn TR, 2006, NAT STRUCT MOL BIOL, V13, P195, DOI 10.1038/nsmb1058; Lakso M, 2003, J NEUROCHEM, V86, P165, DOI 10.1046/j.1471-4159.2003.01809.x; Liao VHC, 2011, MECH AGEING DEV, V132, P480, DOI 10.1016/j.mad.2011.07.008; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Link CD, 2001, NEUROBIOL AGING, V22, P217, DOI 10.1016/S0197-4580(00)00237-2; Link CD, 2005, GENES BRAIN BEHAV, V4, P147, DOI 10.1111/j.1601-183X.2004.00105.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo Y, 2006, LIFE SCI, V78, P2066, DOI 10.1016/j.lfs.2005.12.004; Luo Y, 2009, METHODS BEHAV ANAL N; Meratan AA, 2011, J MOL BIOL, V409, P826, DOI 10.1016/j.jmb.2011.04.045; Miller DM, 1995, METHOD CELL BIOL, V48, P365; Monti M, 2005, BBA-PROTEINS PROTEOM, V1753, P44, DOI 10.1016/j.bbapap.2005.09.004; Pagani L, 2011, INT J ALZHEIMERS DIS, DOI DOI 10.4061/2011/925050; Piazza R, 2006, EUR BIOPHYS J BIOPHY, V35, P439, DOI 10.1007/s00249-006-0051-0; Prahlad V, 2011, P NATL ACAD SCI USA, V108, P14204, DOI 10.1073/pnas.1106557108; Relini A, 2008, J BIOL CHEM, V283, P4912, DOI 10.1074/jbc.M702712200; Sosa MAG, 2012, HUM GENET, V131, P535, DOI 10.1007/s00439-011-1119-1; Stoppini M, 2005, BBA-PROTEINS PROTEOM, V1753, P23, DOI 10.1016/j.bbapap.2005.07.019; Tsang WY, 2003, BBA-MOL BASIS DIS, V1638, P91, DOI 10.1016/S0925-4439(03)00079-6; Valleix S, 2012, NEW ENGL J MED, V366, P2276, DOI 10.1056/NEJMoa1201356; Wolozin B, 2011, PROG MOL BIOL TRANSL, V100, P499, DOI 10.1016/B978-0-12-384878-9.00015-7; Zhang PY, 2010, AMYLOID, V17, P50, DOI 10.3109/13506129.2010.483116	40	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52314	10.1371/journal.pone.0052314	http://dx.doi.org/10.1371/journal.pone.0052314			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284985	Green Published, gold, Green Submitted			2022-12-27	WOS:000313158800047
J	Song, WT; Li, YZ; Zhao, YW; Liu, Y; Niu, YZ; Pang, RY; Miao, GD; Liao, XL; Shao, CW; Gao, FT; Chen, SL				Song, Wentao; Li, Yangzhen; Zhao, Yongwei; Liu, Yang; Niu, Yuze; Pang, Renyi; Miao, Guidong; Liao, Xiaolin; Shao, Changwei; Gao, Fengtao; Chen, Songlin			Construction of a High-Density Microsatellite Genetic Linkage Map and Mapping of Sexual and Growth-Related Traits in Half-Smooth Tongue Sole (Cynoglossus semilaevis)	PLOS ONE			English	Article							COMPARATIVE GENOME ANALYSIS; TROUT ONCORHYNCHUS-MYKISS; JAPANESE FLOUNDER; AFLP MARKERS; SEA-BASS; LINKED MARKERS; LOCI; IDENTIFICATION; FISH; QTL	High-density genetic linkage maps of half-smooth tongue sole were developed with 1007 microsatellite markers, two SCAR markers and an F1 family containing 94. The female map was composed of 828 markers in 21 linkage groups, covering a total of 1447.3 cM, with an average interval 1.83 cM between markers. The male map consisted of 794 markers in 21 linkage groups, spanning 1497.5 cM, with an average interval of 1.96 cM. The female and male maps had 812 and 785 unique positions, respectively. The genome length of half-smooth tongue sole was estimated to be 1527.7 cM for the females and 1582.1 cM for the males. Based on estimations of the map lengths, the female and male maps covered 94.74 and 94.65% of the genome, respectively. The consensus map was composed of 1007 microsatellite markers and two SCAR markers in 21 linkage groups, covering a total of 1624 cM with an average interval of 1.67 cM. Furthermore, 159 sex-linked SSR markers were identified. Five sex-linked microsatellite markers were confirmed in their association with sex in a large number of individuals selected from different families. These sex-linked markers were mapped on the female map LG1f with zero recombination. Two QTLs that were identified for body weight, designated as We-1 and We-2, accounted for 26.39% and 10.60% of the phenotypic variation. Two QTLs for body width, designated Wi-1 and Wi-2, were mapped in LG4f and accounted for 14.33% and 12.83% of the phenotypic variation, respectively. Seven sex-related loci were mapped in LG1f, LG14f and LG1m by CIM, accounting for 12.5-25.2% of the trait variation. The results should prove to be very useful for improving growth traits using molecular MAS.	[Song, Wentao; Li, Yangzhen; Zhao, Yongwei; Liu, Yang; Niu, Yuze; Pang, Renyi; Miao, Guidong; Liao, Xiaolin; Shao, Changwei; Gao, Fengtao; Chen, Songlin] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China; [Song, Wentao] Weihai Vocat Coll, Dept Biol & Chem Engn, Weihai, Peoples R China; [Li, Yangzhen; Liu, Yang; Niu, Yuze] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Shanghai, Peoples R China	Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Shanghai Ocean University	Chen, SL (corresponding author), Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China.	chensl@ysfri.ac.cn	Shao, Changwei/I-2054-2016	Shao, Changwei/0000-0002-6953-2203; Liu, Yang/0000-0002-8195-7706	Special Fund for Agro-Scientific Research in the Public Interest of China [200903046]; State 863 High-Technology R&D Project of China [2012AA092203, 2012AA10A403-2]; National Nature Science Foundation of China [31130057]; Taishan Scholar Project Fund of Shandong of China	Special Fund for Agro-Scientific Research in the Public Interest of China; State 863 High-Technology R&D Project of China(National High Technology Research and Development Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholar Project Fund of Shandong of China	This work was supported by grants from Special Fund for Agro-Scientific Research in the Public Interest (200903046) of China, State 863 High-Technology R&D Project of China (2012AA092203, 2012AA10A403-2), National Nature Science Foundation of China (31130057), and Taishan Scholar Project Fund of Shandong of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Bouza C, 2007, GENETICS, V177, P2457, DOI 10.1534/genetics.107.075416; Castano-Sanchez C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-554; Cervantes-Flores JC, 2008, MOL BREEDING, V21, P511, DOI 10.1007/s11032-007-9150-6; Cervera MT, 2001, GENETICS, V158, P787; CHAKRAVARTI A, 1991, GENETICS, V128, P175; Chen SL, 2008, AQUACULTURE, V283, P7, DOI 10.1016/j.aquaculture.2008.07.015; Chen SL, 2007, MAR BIOTECHNOL, V9, P273, DOI 10.1007/s10126-006-6081-x; Chen SL, 2009, MAR BIOTECHNOL, V11, P243, DOI 10.1007/s10126-008-9139-0; Cheng L, 2010, ANIM GENET, V41, P191, DOI 10.1111/j.1365-2052.2009.01985.x; Chistiakov DA, 2005, GENETICS, V170, P1821, DOI 10.1534/genetics.104.039719; Cnaani A, 2003, AQUACULTURE, V223, P117, DOI 10.1016/S0044-8486(03)00163-7; Cnaani A, 2008, BIOL LETTERS, V4, P700, DOI 10.1098/rsbl.2008.0286; Coimbra MRM, 2003, AQUACULTURE, V220, P203, DOI 10.1016/S0044-8486(02)00353-8; Deng SP, 2009, AQUACULTURE, V287, P211, DOI 10.1016/j.aquaculture.2008.10.034; Ezaz MT, 2004, MAR BIOTECHNOL, V6, P435, DOI 10.1007/s10126-004-3004-6; Falconer D. S., 1996, INTRO QUANTITATIVE G; Faris JD, 1998, GENETICS, V149, P319; Felip A, 2005, AQUACULTURE, V247, P35, DOI 10.1016/j.aquaculture.2005.02.014; Fishman L, 2001, GENETICS, V159, P1701; Fuji K, 2006, AQUACULTURE, V254, P203, DOI 10.1016/j.aquaculture.2005.11.024; Fuji K, 2010, AQUACULTURE, V308, pS51, DOI 10.1016/j.aquaculture.2010.06.035; Gilbey J, 2004, ANIM GENET, V35, P98, DOI 10.1111/j.1365-2052.2004.01091.x; Guyomard R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-302; Hubert S, 2004, GENETICS, V168, P351, DOI 10.1534/genetics.104.027342; Kai W, 2005, GENETICS, V171, P227, DOI 10.1534/genetics.105.042051; Kang JH, 2008, INT J BIOL SCI, V4, P143, DOI 10.7150/ijbs.4.143; Kasha K J, 1970, Nature, V225, P874, DOI 10.1038/225874a0; Kucuktas H, 2009, GENETICS, V181, P1649, DOI 10.1534/genetics.108.098855; Lee BY, 2005, GENETICS, V170, P237, DOI 10.1534/genetics.104.035022; Li L, 2004, MAR BIOTECHNOL, V6, P26, DOI 10.1007/s10126-003-0001-0; Liao M, 2007, ANIM GENET, V38, P364, DOI 10.1111/j.1365-2052.2007.01617.x; Liao X, 2007, MOL ECOL NOTES, V7, P1147, DOI 10.1111/j.1471-8286.2007.01812.x; Liao XL, 2009, MAR BIOTECHNOL, V11, P699, DOI 10.1007/s10126-009-9184-3; Liu YG, 2008, MOL ECOL RESOUR, V8, P202, DOI 10.1111/j.1471-8286.2007.01923.x; Liu YG, 2007, MOL ECOL NOTES, V7, P1242, DOI 10.1111/j.1471-8286.2007.01844.x; Liu ZJ, 2004, AQUACULTURE, V238, P1, DOI 10.1016/j.aquaculture.2004.05.027; Liu ZJ, 2003, GENETICS, V165, P687; Maliepaard C, 1997, GENET RES, V70, P237, DOI 10.1017/S0016672397003005; Massault C, 2010, ANIM GENET, V41, P337, DOI 10.1111/j.1365-2052.2009.02010.x; Matsuda M, 2003, ZOOL SCI, V20, P159, DOI 10.2108/zsj.20.159; Miao GD, 2011, J WORLD AQUACULT SOC, V42, P462, DOI 10.1111/j.1749-7345.2011.00487.x; Moen T, 2004, ANIM GENET, V35, P81, DOI 10.1111/j.1365-2052.2004.01097.x; Ozaki A, 2001, MOL GENET GENOMICS, V265, P23, DOI 10.1007/s004380000392; Reid DP, 2007, GENETICS, V177, P1193, DOI 10.1534/genetics.107.075374; Reid DP, 2005, HEREDITY, V94, P166, DOI 10.1038/sj.hdy.6800590; Rexroad CE, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-74; Rodriguez-Ramilo ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-541; Sakamoto T, 2000, GENETICS, V155, P1331; Sambrook J., 2001, MOL CLONING LAB MAMU; Senger F, 2006, GENOMICS, V87, P793, DOI 10.1016/j.ygeno.2005.11.019; Sha ZX, 2011, J FISH BIOL, V78, P322, DOI 10.1111/j.1095-8649.2010.02793.x; Shao CW, 2010, MAR BIOTECHNOL, V12, P558, DOI 10.1007/s10126-009-9242-x; Shikano Takahito, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-119; Shimoda N, 1999, GENOMICS, V58, P219, DOI 10.1006/geno.1999.5824; Tripathi N, 2009, P ROY SOC B-BIOL SCI, V276, P2195, DOI 10.1098/rspb.2008.1930; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Wang CM, 2011, MAR BIOTECHNOL, V13, P74, DOI 10.1007/s10126-010-9271-5; Wang CM, 2007, GENETICS, V175, P907, DOI 10.1534/genetics.106.059972; Wang CM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-174; Wang WJ, 2010, AQUACULT INT, V18, P825, DOI 10.1007/s10499-009-9303-1; Wang XB, 2008, MOL ECOL RESOUR, V8, P1303, DOI 10.1111/j.1755-0998.2008.02137.x; Xia JH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-135; You EM, 2010, ANIM GENET, V41, P365, DOI 10.1111/j.1365-2052.2009.02014.x; ZAMIR D, 1986, BOT GAZ, V147, P355, DOI 10.1086/337602; Zhang LS, 2007, GENETICA, V131, P37, DOI 10.1007/s10709-006-9111-8; Zhong QW, 2009, CONSERV GENET, V10, P1617, DOI 10.1007/s10592-009-9809-0; Zhuang ZM, 2006, J APPL ICHTHYOL, V22, P437, DOI 10.1111/j.1439-0426.2006.00765.x	68	48	61	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52097	10.1371/journal.pone.0052097	http://dx.doi.org/10.1371/journal.pone.0052097			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284884	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500089
J	Subramanian, H; Gupta, K; Ali, H				Subramanian, Hariharan; Gupta, Kshitij; Ali, Hydar			Roles for NHERF1 and NHERF2 on the Regulation of C3a Receptor Signaling in Human Mast Cells	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; RENAL PHOSPHATE-TRANSPORT; NA+/H+-EXCHANGER; PARATHYROID-HORMONE; CHEMOKINE PRODUCTION; FACTOR-I; PLASMA-MEMBRANE; PDZ DOMAINS; KINASE; PHOSPHORYLATION	Background: The anaphylatoxin C3a binds to the G protein coupled receptor (GPCR, C3aR) and activates divergent signaling pathways to induce degranulation and cytokine production in human mast cells. Adapter proteins such as the Na+/H+ exchange regulatory factor (NHERF1 and NHERF2) have been implicated in regulating functions of certain GPCRs by binding to the class I PDZ (PSD-95/Dlg/Zo1) motifs present on their cytoplasmic tails. Although C3aR possesses a class I PDZ motif, the possibility that it interacts with NHERF proteins to modulate signaling in human mast cells has not been determined. Methodology/Principal Findings: Using reverse transcription PCR and Western blotting, we found that NHERF1 and NHERF2 are expressed in human mast cell lines (HMC-1, LAD2) and CD34(+)-derived primary human mast cells. Surprisingly, however, C3aR did not associate with these adapter proteins. To assess the roles of NHERFs on signaling downstream of C3aR, we used lentiviral shRNA to stably knockdown the expression of these proteins in human mast cells. Silencing the expression of NHERF1 and NHERF2 had no effect on C3aR desensitization, agonist-induced receptor internalization, ERK/Akt phosphorylation or chemotaxis. However, loss of NHERF1 and NHERF2 resulted in significant inhibition of C3a-induced mast cell degranulation, NF-kappa B activation and chemokine production. Conclusion/Significance: This study demonstrates that although C3aR possesses a class I PDZ motif, it does not associate with NHERF1 and NHERF2. Surprisingly, these proteins provide stimulatory signals for C3a-induced degranulation, NF-kappa B activation and chemokine generation in human mast cells. These findings reveal a new level of complexity for the functional regulation of C3aR by NHERFs in human mast cells.	[Subramanian, Hariharan; Gupta, Kshitij; Ali, Hydar] Univ Penn, Sch Dent Med, Dept Pathol, Philadelphia, PA 19104 USA	University of Pennsylvania	Ali, H (corresponding author), Univ Penn, Sch Dent Med, Dept Pathol, Philadelphia, PA 19104 USA.	alih@upenn.edu	Subramanian, Hariharan/AHC-5755-2022		National Institutes of Health [AI-080852]; American Heart Association [12POST9260009]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI080852] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant to HA from the National Institutes of Health (AI-080852) and a grant to HS from the American Heart Association (12POST9260009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed J, 2001, J IMMUNOL, V167, P3559, DOI 10.4049/jimmunol.167.7.3559; Ali H, 2000, J IMMUNOL, V165, P7215, DOI 10.4049/jimmunol.165.12.7215; Ardura JA, 2011, PHARMACOL REV, V63, P882, DOI 10.1124/pr.110.004176; Becamel Carine, 2002, Biological Procedures Online, V4, P94, DOI 10.1251/bpo39; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Capuano P, 2007, AM J PHYSIOL-CELL PH, V292, pC927, DOI 10.1152/ajpcell.00126.2006; CIVITELLI R, 1989, J IMMUNOL, V143, P4000; Cunningham R, 2005, AM J PHYSIOL-RENAL, V289, pF933, DOI 10.1152/ajprenal.00005.2005; Fukuoka Y, 2008, J IMMUNOL, V180, P6307, DOI 10.4049/jimmunol.180.9.6307; Guo Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022559; Gupta K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046369; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Hall RA, 1999, J BIOL CHEM, V274, P24328, DOI 10.1074/jbc.274.34.24328; Hammad MM, 2010, J BIOL CHEM, V285, P34653, DOI 10.1074/jbc.M110.106591; Hartmann K, 1997, BLOOD, V89, P2863, DOI 10.1182/blood.V89.8.2863; Huang P, 2004, J BIOL CHEM, V279, P25002, DOI 10.1074/jbc.M313366200; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Kashem SW, 2011, EUR J PHARMACOL, V668, P299, DOI 10.1016/j.ejphar.2011.06.027; Kirshenbaum AS, 2003, LEUKEMIA RES, V27, P677, DOI 10.1016/S0145-2126(02)00343-0; Lee-Kwon W, 2003, AM J PHYSIOL-CELL PH, V285, pC1527, DOI 10.1152/ajpcell.00017.2003; Mahon MJ, 2002, NATURE, V417, P858, DOI 10.1038/nature00816; Mahon MJ, 2004, J BIOL CHEM, V279, P23550, DOI 10.1074/jbc.M313229200; Molina JR, 2010, CANCER RES, V70, P6697, DOI 10.1158/0008-5472.CAN-10-1271; Nemeth ZH, 2002, AM J PHYSIOL-CELL PH, V283, pC396, DOI 10.1152/ajpcell.00491.2001; Nemeth ZH, 2001, BBA-MOL CELL RES, V1539, P233, DOI 10.1016/S0167-4889(01)00111-2; Nilsson G, 1996, J IMMUNOL, V157, P1693; ORLINSKA U, 1995, IMMUNOPHARMACOLOGY, V30, P41, DOI 10.1016/0162-3109(95)00006-F; Radinger M., 2011, CURR PROTOC IMMUNOL; Raghuram V, 2003, P NATL ACAD SCI USA, V100, P9620, DOI 10.1073/pnas.1633250100; Rivera J, 2008, CURR ALLERGY ASTHM R, V8, P14, DOI 10.1007/s11882-008-0004-z; Sarker R, 2011, AM J PHYSIOL-CELL PH, V300, pC771, DOI 10.1152/ajpcell.00119.2010; Schafer B, 2013, J ALLERGY CLIN IMMUN, V131, P541, DOI 10.1016/j.jaci.2012.05.009; Singh AK, 2009, J CLIN INVEST, V119, P540, DOI 10.1172/JCI35541; Subramanian H, 2011, J BIOL CHEM, V286, P44739, DOI 10.1074/jbc.M111.277152; Subramanian H, 2011, MOL PHARMACOL, V79, P1005, DOI 10.1124/mol.111.071472; Suh PG, 2001, BIOCHEM BIOPH RES CO, V288, P1, DOI 10.1006/bbrc.2001.5710; Venkatesha RT, 2005, MOL IMMUNOL, V42, P581, DOI 10.1016/j.molimm.2004.09.009; Vibhuti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019585; Voltz JW, 2007, J BIOL CHEM, V282, P33879, DOI 10.1074/jbc.M703481200; Wang B, 2008, MOL BIOL CELL, V19, P1637, DOI 10.1091/mbc.E07-11-1114; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Wang B, 2010, J BIOL CHEM, V285, P26976, DOI 10.1074/jbc.M110.147785; Wang B, 2009, MOL PHARMACOL, V75, P1189, DOI 10.1124/mol.108.054486; Weinman EJ, 2007, J CLIN INVEST, V117, P3412, DOI 10.1172/JCI32738; Weinman EJ, 2010, J BIOL CHEM, V285, P25134, DOI 10.1074/jbc.M110.132423; Weinman EJ, 2010, J BIOL CHEM, V285, P13454, DOI 10.1074/jbc.M109.094359; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; Wheeler D, 2008, MOL ENDOCRINOL, V22, P1163, DOI 10.1210/me.2007-0461; Wheeler D, 2007, J BIOL CHEM, V282, P25076, DOI 10.1074/jbc.M701544200; Wu YN, 2012, J BIOL CHEM, V287, P5744, DOI 10.1074/jbc.M111.315762; Yun CC, 2005, AM J PHYSIOL-CELL PH, V289, pC2, DOI 10.1152/ajpcell.00610.2004; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010; Zhang YN, 2006, J BIOL CHEM, V281, P22299, DOI 10.1074/jbc.M602902200	53	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51355	10.1371/journal.pone.0051355	http://dx.doi.org/10.1371/journal.pone.0051355			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284683	gold, Green Published, Green Submitted			2022-12-27	WOS:000312794500026
J	Bhattacharjee, PS; Huq, TS; Potter, V; Young, A; Davenport, IR; Graves, R; Mandal, TK; Clement, C; McFerrin, HE; Muniruzzaman, S; Ireland, SK; Hill, JM				Bhattacharjee, Partha S.; Huq, Tashfin S.; Potter, Valencia; Young, Anna; Davenport, Ian R.; Graves, Richard; Mandal, Tarun K.; Clement, Christian; McFerrin, Harris E.; Muniruzzaman, Syed; Ireland, Shubha K.; Hill, James M.			High-Glucose-Induced Endothelial Cell Injury Is Inhibited by a Peptide Derived from Human Apolipoprotein E	PLOS ONE			English	Article							E MIMETIC PEPTIDE; DIABETIC-NEPHROPATHY; BARRIER FUNCTION; GROWTH-FACTOR; HEPARAN; PROTEIN; PROTEOGLYCANS; PERMEABILITY; ACTIVATION; MECHANISM	Although the importance of human apolipoprotein E (apoE) in vascular diseases has clearly been established, most of the research on apoE has focused on its role in cholesterol metabolism. In view of the observation that apoE and its functional domains impact extracellular matrix (ECM) remodeling, we hypothesized that apoE could also confer protection against ECM degradation by mechanisms independent of its role in cholesterol and lipoprotein transport. The ECM degrading enzyme, heparanase, is secreted by cells as pro-heparanase that is internalized through low-density lipoprotein (LDL) receptor-related protein-1 (LRP-1) to become enzymatically active. Both apoE and pro-heparanase bind the LRP-1. We further hypothesized that an apoE mimetic peptide (apoEdp) would inhibit the production of active heparanase by blocking LRP-1-mediated uptake of pro-heparanase and thereby decrease degradation of the ECM. To test this hypothesis, we induced the expression of heparanase by incubating human retinal endothelial cells (hRECs) with high glucose (30 mM) for 72 hours. We found that elevated expression of heparanase by high glucose was associated with increased shedding of heparan sulfate (Delta HS) and the tight junction protein occludin. Treatment of hRECs with 100 mM apoEdp in the presence of high glucose significantly reduced the expression of heparanase, shedding of DHS, and loss of occludin as detected by Western blot analysis. Either eye drop treatment of 1% apoEdp topically 4 times a day for 14 consecutive days or intraperitoneal injection (40 mg/kg) of apoEdp daily for 14 consecutive days in an in vivo mouse model of streptozotocin-induced diabetes inhibited the loss of tight junction proteins occludin and zona occludin- 1 (ZO-1). These findings imply a functional relationship between apoE and endothelial cell matrix because the deregulation of these molecules can be inhibited by a short peptide derived from the receptor-binding region of apoE. Thus, strategies targeting ECM-degrading enzymes could be therapeutically beneficial for treating diabetic retinopathy.	[Bhattacharjee, Partha S.; Davenport, Ian R.; McFerrin, Harris E.; Muniruzzaman, Syed; Ireland, Shubha K.] Xavier Univ Louisiana, Dept Biol, New Orleans, LA USA; [Bhattacharjee, Partha S.; Clement, Christian; Hill, James M.] Louisiana State Univ, Hlth Sci Ctr, Dept Ophthalmol, New Orleans, LA USA; [Potter, Valencia] Univ S Alabama, Sch Med, Mobile, AL 36688 USA; [Huq, Tashfin S.] Tulane Sch Med, New Orleans, LA USA; [Young, Anna] Allegheny Coll, Meadville, PA 16335 USA; [Graves, Richard; Mandal, Tarun K.] Xavier Univ Louisiana, Coll Pharm, New Orleans, LA USA; [Hill, James M.] Louisiana State Univ, Hlth Sci Ctr, Ctr Neurosci, New Orleans, LA USA; [Hill, James M.] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA USA; [Hill, James M.] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol, New Orleans, LA USA	Xavier University of Louisiana; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of South Alabama; Tulane University; Allegheny College; Xavier University of Louisiana; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Bhattacharjee, PS (corresponding author), Xavier Univ Louisiana, Dept Biol, New Orleans, LA USA.	pbhattac@xula.edu		Young, Anna/0000-0003-2900-8228; Mandal, Tarun/0000-0002-4966-2094	National Eye Institute (NEI), National Institutes of Health (NIH) [R01-EY006311, R01-EY14289, NIH-R21-EY019144]; National Center of Research Resources (NCRR) [P20RR016456]; National Institute of General Medical Sciences (NIGMS) [P20GM103424]; NIH-RCMI from the National Institute on Minority Health and Health Disparities [5G12RR026260]; Louisiana States University (LSU) Health Sciences Center; Transitional Research Initiative Grant; Research to Prevent Blindness (RPB) Senior Scientific Investigator Award; RPB, New York, New York; Louisiana Biotechnology Research Network; Louisiana Lions Eye Foundation, New Orleans; Louisiana Board of Regents; Lions International United States of America; Louisiana Cancer Research Consortium; Direct For Mathematical & Physical Scien [1005026] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR026260, P20RR016456] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R21EY019144, R01EY006311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103424] Funding Source: NIH RePORTER	National Eye Institute (NEI), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Center of Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH-RCMI from the National Institute on Minority Health and Health Disparities; Louisiana States University (LSU) Health Sciences Center; Transitional Research Initiative Grant; Research to Prevent Blindness (RPB) Senior Scientific Investigator Award; RPB, New York, New York; Louisiana Biotechnology Research Network; Louisiana Lions Eye Foundation, New Orleans; Louisiana Board of Regents; Lions International United States of America; Louisiana Cancer Research Consortium; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This publication was made possible in part by grant numbers R01-EY006311 and R01-EY14289 (JMH), NIH-R21-EY019144 (PSB) from the National Eye Institute (NEI), National Institutes of Health (NIH); grant number P20RR016456 from the National Center of Research Resources (NCRR); and P20GM103424 (HEM, JMH) from the National Institute of General Medical Sciences (NIGMS); the NIH-RCMI grant #5G12RR026260 from the National Institute on Minority Health and Health Disparities. This research was funded in part by an unrestricted research grant from the Louisiana States University (LSU) Health Sciences Center; Transitional Research Initiative Grant (JMH); Research to Prevent Blindness (RPB) Senior Scientific Investigator Award (JMH); an unrestricted grant to the LSU Eye Center from RPB, New York, New York; the Louisiana Biotechnology Research Network (JMH); the Louisiana Lions Eye Foundation, New Orleans (JMH); the Louisiana Vaccine Center (JMH) sponsored by the Louisiana Board of Regents; and Lions International United States of America (JMH); and Louisiana Cancer Research Consortium (PSB). The contents are solely the responsibility of the authors and do not necessarily represent the official views of the NEI, NCRR, NIGMS, or NIH. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Amand HL, 2012, BIOCH BIOPHYS ACTA; Barber AJ, 2003, INVEST OPHTH VIS SCI, V44, P5410, DOI 10.1167/iovs.03-0244; Bhattacharjee PS, 2008, INVEST OPHTH VIS SCI, V49, P4263, DOI 10.1167/iovs.08-2077; Bhattacharjee PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015905; Bhattacharjee PS, 2009, CURR EYE RES, V34, P99, DOI 10.1080/02713680802647662; Dobson CB, 2006, J INFECT DIS, V193, P442, DOI 10.1086/499280; Gil N, 2012, DIABETES, V61, P208, DOI 10.2337/db11-1024; Haas AK, 2012, BIOCHEM J, V442, P583, DOI 10.1042/BJ20111973; HARDEBO JE, 1985, ACTA PHYSIOL SCAND, V125, P495, DOI 10.1111/j.1748-1716.1985.tb07746.x; Harhaj NS, 2004, INT J BIOCHEM CELL B, V36, P1206, DOI 10.1016/j.biocel.2003.08.007; HEDMAN K, 1982, CELL, V28, P663, DOI 10.1016/0092-8674(82)90221-5; HOOK M, 1984, ANNU REV BIOCHEM, V53, P847; Joussen Antonia M, 2007, Dev Ophthalmol, V39, P1, DOI 10.1159/000098495; KAMATA K, 1992, LIFE SCI, V50, P1379, DOI 10.1016/0024-3205(92)90256-O; Katz A, 2002, ISRAEL MED ASSOC J, V4, P996; KRAEMER PM, 1971, BIOCHEMISTRY-US, V10, P1437, DOI 10.1021/bi00784a026; Laskowitz DT, 2007, J NEUROTRAUM, V24, P1093, DOI 10.1089/neu.2006.0192; LEE TS, 1989, P NATL ACAD SCI USA, V86, P5141, DOI 10.1073/pnas.86.13.5141; Miyamoto K, 2000, AM J PATHOL, V156, P1733, DOI 10.1016/S0002-9440(10)65044-4; Moss SE, 1998, OPHTHALMOLOGY, V105, P998, DOI 10.1016/S0161-6420(98)96025-0; Muir H, 1977, Soc Gen Physiol Ser, V32, P87; Poon GMK, 2007, BIOCHEM SOC T, V35, P788, DOI 10.1042/BST0350788; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Roider J, 2000, BRIT J OPHTHALMOL, V84, P40, DOI 10.1136/bjo.84.1.40; RUDERMAN NB, 1992, FASEB J, V6, P2905, DOI 10.1096/fasebj.6.11.1644256; Shafat I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017312; VANDENBORN J, 1992, KIDNEY INT, V41, P115, DOI 10.1038/ki.1992.15; VANDENBORN J, 1993, KIDNEY INT, V43, P454, DOI 10.1038/ki.1993.67; Vreys V, 2005, J BIOL CHEM, V280, P33141, DOI 10.1074/jbc.M503007200; Zhu YJ, 2003, J BIOL CHEM, V278, P36257, DOI 10.1074/jbc.M303171200	31	19	19	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52152	10.1371/journal.pone.0052152	http://dx.doi.org/10.1371/journal.pone.0052152			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284911	gold, Green Published, Green Submitted			2022-12-27	WOS:000312694300076
J	Grisa, L; Leonel, ML; Goncalves, MIR; Pletsch, F; Sade, ER; Custodio, G; Zagonel, IPS; Longui, CA; Figueiredo, BC				Grisa, Leila; Leonel, Maria L.; Goncalves, Maria I. R.; Pletsch, Francisco; Sade, Elis R.; Custodio, Gislaine; Zagonel, Ivete P. S.; Longui, Carlos A.; Figueiredo, Bonald C.			Impact of Early Postnatal Androgen Exposure on Voice Development	PLOS ONE			English	Article							CONGENITAL ADRENAL-HYPERPLASIA; SPEAKING FUNDAMENTAL-FREQUENCY; ADRENOCORTICAL TUMORS; XENOPUS-LAEVIS; TESTOSTERONE GEL; MUTATION; LARYNX; VOCALIZATIONS; DEFICIENCY; CHILDHOOD	Background: The impact of early postnatal androgen exposure on female laryngeal tissue may depend on certain characteristics of this exposure. We assessed the impact of the dose, duration, and timing of early androgen exposure on the vocal development of female subjects who had been treated for adrenocortical tumor (ACT) in childhood. Methods: The long-term effects of androgen exposure on the fundamental vocal frequency (F0), vocal pitch, and final height and the presence of virilizing signs were examined in 9 adult (age, 18.4 to 33.5 years) and 10 adolescent (13.6 to 17.8 years) female ACT patients. We also compared the current values with values obtained 0.9 years to 7.4 years after these subjects had undergone ACT surgery, a period during which they had shown normal androgen levels. Results: Of the 19 subjects, 17 (89%) had been diagnosed with ACT before 4 years of age, 1 (5%) at 8.16 years, and 1 (5%) at 10.75 years. Androgen exposure (2 to 30 months) was sufficiently strong to cause pubic hair growth in all subjects and clitoromegaly in 74% (14/19) of the subjects, but did not reduce their height from the target value. Although androgen exposure induced a remarkable reduction in F0 (132 Hz) and moderate pitch virilization in 1 subject and partial F0 virilization, resulting in F0 of 165 and 169 Hz, in 2 subjects, the majority had normal F0 ranging from 189 to 245 Hz. Conclusions: Female laryngeal tissue is less sensitive to androgen exposure between birth and adrenarche than during other periods. Differential larynx sensitivity to androgen exposure in childhood and F0 irreversibility in adulthood are age-, concentration-, duration-, and timing-dependent events that may also be affected by exposure to inhibitory or stimulatory hormones. Further studies are required to better characterize each of these factors.	[Grisa, Leila; Sade, Elis R.; Custodio, Gislaine; Zagonel, Ivete P. S.; Figueiredo, Bonald C.] Inst Pesquisa Pele Pequeno Principe, Curitiba, Parana, Brazil; [Grisa, Leila; Sade, Elis R.; Figueiredo, Bonald C.] Hosp Pequeno Principe, Curitiba, Parana, Brazil; [Grisa, Leila; Zagonel, Ivete P. S.; Figueiredo, Bonald C.] Fac Pequeno Principe, Curitiba, Parana, Brazil; [Leonel, Maria L.] Inst Voz Maringa, Maringa, Parana, Brazil; [Goncalves, Maria I. R.] Univ Fed Sao Paulo, Dept Fonoaudiol, Sao Paulo, Brazil; [Pletsch, Francisco] Clin Voz, Curitiba, Parana, Brazil; [Longui, Carlos A.] Irmandade Santa Casa Misericordia Sao Paulo, Sao Paulo, Brazil; [Figueiredo, Bonald C.] Univ Fed Parana, Dept Saude Comunitaria, BR-80060000 Curitiba, Parana, Brazil	Hospital Pequeno Principe; Hospital Pequeno Principe; Hospital Pequeno Principe; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Parana	Figueiredo, BC (corresponding author), Inst Pesquisa Pele Pequeno Principe, Curitiba, Parana, Brazil.	bonaldf@pelepequenoprincipe.org.br	Longui, Carlos A/B-8112-2013; Gonçalves, Maria I R/N-8916-2017; de Figueiredo, Bonald Cavalcante/AAD-6672-2021	de Figueiredo, Bonald Cavalcante/0000-0002-1051-2056	Brazilian State of Parana Secretary of Science, Technology and Higher Education (SETI); Brazilian National Council for Research and Development (CNPq), (Curitiba, Brazil); Raul Carneiro Hospital Association for Childhood Protection (AHPIRC); American Lebanese Syrian Associated Charities (ALSAC); SETI; AHPIRC; CNPq; ALSAC	Brazilian State of Parana Secretary of Science, Technology and Higher Education (SETI); Brazilian National Council for Research and Development (CNPq), (Curitiba, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Raul Carneiro Hospital Association for Childhood Protection (AHPIRC); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); SETI; AHPIRC; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); ALSAC(American Lebanese Syrian Associated Charities (ALSAC))	This project was funded by grants from the Brazilian State of Parana Secretary of Science, Technology and Higher Education (SETI, 2008), the Brazilian National Council for Research and Development (CNPq, 2009), (Curitiba, Brazil), the Raul Carneiro Hospital Association for Childhood Protection (AHPIRC), and the American Lebanese Syrian Associated Charities (ALSAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SETI funded equipments and transportation of all participants; AHPIRC funded all laryngological exams; CNPq and ALSAC provided additional support for the ACT project (materials, statistical analysis and scholarship).	Abitbol J, 1999, J VOICE, V13, P424, DOI 10.1016/S0892-1997(99)80048-4; Behlau M., 2001, VOZ LIVRO ESPECIALIS, VI; Behlau M, 1998, REV SOC BRAS FONOAUD, V2, P56; Brachet C, 2005, EUR J PEDIATR, V164, P646, DOI 10.1007/s00431-005-1714-z; Carlson AD, 1999, J STEROID BIOCHEM, V69, P19, DOI 10.1016/S0960-0760(99)00059-X; Custodio G, 2012, MOL CELL ENDOCRINOL, V351, P44, DOI 10.1016/j.mce.2011.10.019; Custodio G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018015; Damrose EJ, 2009, AURIS NASUS LARYNX, V36, P110, DOI 10.1016/j.anl.2008.03.002; de Ronde W, 2009, HUM REPROD, V24, P425, DOI 10.1093/humrep/den372; Figueiredo BC, 2006, J MED GENET, V43, P91, DOI 10.1136/jmg.2004.030551; Figueiredo BC, 2005, J CLIN ENDOCR METAB, V90, P615, DOI 10.1210/jc.2004-0942; Figueiredo BC, 1999, J CLIN ENDOCR METAB, V84, P1116, DOI 10.1210/jc.84.3.1116; Gonçalves Maria Inês Rebelo, 2009, Braz. j. otorhinolaryngol., V75, P680; HOLLIEN H, 1972, J SPEECH HEAR RES, V15, P155, DOI 10.1044/jshr.1501.155; HOLLIEN H, 1994, J ACOUST SOC AM, V96, P2646, DOI 10.1121/1.411275; KROOK MIP, 1988, FOLIA PHONIATR, V40, P82, DOI 10.1159/000265888; Leonel MLL, 2003, THESIS U TUIUTI PARA; Longui CA, 2004, J MED GENET, V41, P354, DOI 10.1136/jmg.2004.018978; Longui CA, 2006, ENDOCRINOLOGIA PEDIA, P31; Michalkiewicz E, 2004, J CLIN ONCOL, V22, P838, DOI 10.1200/JCO.2004.08.085; Moore C, 2005, J CLIN ENDOCR METAB, V90, P4128, DOI 10.1210/jc.2004-2558; Nygren U, 2009, CLIN ENDOCRINOL, V70, P18, DOI 10.1111/j.1365-2265.2008.03347.x; Ogden CL, 2002, PEDIATRICS, V109, P45, DOI 10.1542/peds.109.1.45; Patel A, 2010, INT J PEDIATR ENDOCR, DOI 10.1155/2010/867471; Pattie MA, 1998, J VOICE, V12, P366, DOI 10.1016/S0892-1997(98)80027-1; Pianovski MAD, 2006, PEDIATR BLOOD CANCER, V47, P56, DOI 10.1002/pbc.20624; PInho SMR, 2001, TOPICOS VOZ, P19; Plack C.J., 2005, PITCH NEURAL CODING, DOI [10.1007/0-387-28958-5, DOI 10.1007/0-387-28958-5]; Ribeiro RC, 2001, P NATL ACAD SCI USA, V98, P9330, DOI 10.1073/pnas.161479898; Ruel TD, 1998, J COMP PHYSIOL A, V182, P35; SASSOON DA, 1987, J NEUROSCI, V7, P3198; SIMPSON HB, 1990, J NEUROSCI, V10, P1541; STOICHEFF ML, 1981, J SPEECH HEAR RES, V24, P437, DOI 10.1044/jshr.2403.437; TOBIAS ML, 1987, J NEUROSCI, V7, P3191; TOBIAS ML, 1988, J NEUROSCI, V8, P2422; Wasserman JD, 2012, MOL CELL ENDOCRINOL, V351, P101, DOI 10.1016/j.mce.2011.09.010; Wit JM, 2002, J PEDIATR ENDOCR MET, V15, P1229; Yamaguchi A, 2000, J NEUROSCI, V20, P1559; Yamaguchi A, 2010, DEV NEUROBIOL, V70, P862, DOI 10.1002/dneu.20822	39	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e50242	10.1371/journal.pone.0050242	http://dx.doi.org/10.1371/journal.pone.0050242			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284635	Green Published, Green Submitted, gold			2022-12-27	WOS:000312694300010
J	Wang, WP; Tzeng, TY; Wang, JY; Lee, DC; Lin, YH; Wu, PC; Chen, YP; Chiu, IM; Chi, YH				Wang, Wan-Ping; Tzeng, Tsai-Yu; Wang, Jing-Ya; Lee, Don-Ching; Lin, Yu-Hsiang; Wu, Pei-Chun; Chen, Yen-Po; Chiu, Ing-Ming; Chi, Ya-Hui			The EP300, KDM5A, KDM6A and KDM6B Chromatin Regulators Cooperate with KLF4 in the Transcriptional Activation of POU5F1	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; HUMAN FIBROBLASTS; OCT4; GENE; DIFFERENTIATION; EXPRESSION; INDUCTION; P300; SOX2; DEDIFFERENTIATION	POU5F1 is essential for maintaining pluripotency in embryonic stem cells (ESCs). It has been reported that the constitutive activation of POU5F1 is sustained by the core transcriptional regulatory circuitry in ESCs; however, the means by which POU5F1 is epigenetically regulated remains enigmatic. In this study a fluorescence-based reporter system was used to monitor the interplay of 5 reprogramming-associated TFs and 17 chromatin regulators in the transcription of POU5F1. We show the existence of a stoichiometric effect for SOX2, POU5F1, NANOG, MYC and KLF4, in regulating POU5F1 transcription. Chromatin regulators EP300, KDM5A, KDM6A and KDM6B cooperate with KLF4 in promoting the transcription of POU5F1. Moreover, inhibiting HDAC activities induced the expression of Pou5f1 in mouse neural stem cells (NSCs) in a spatial-and temporal-dependent manner. Quantitative chromatin immunoprecipitation-PCR (ChIP-qPCR) shows that treatment with valproic acid (VPA) increases the recruitment of Kdm5a and Kdm6a to proximal promoter (PP) and proximal enhancer (PE) of Pou5f1 whereas enrichment of Ep300 and Kdm6b was seen in PP but not PE of Pou5f1 promoter. These findings reveal the interplay between the chromatin regulators and histone modifications in the expression of POU5F1.	[Wang, Wan-Ping; Wang, Jing-Ya; Lee, Don-Ching; Chen, Yen-Po; Chiu, Ing-Ming; Chi, Ya-Hui] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan; [Tzeng, Tsai-Yu; Lin, Yu-Hsiang; Wu, Pei-Chun] Natl Yang Ming Univ, VYM Genome Res Ctr, Taipei 112, Taiwan; [Chen, Yen-Po] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan; [Chi, Ya-Hui] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Yang Ming Chiao Tung University; National Tsing Hua University; China Medical University Taiwan	Chi, YH (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan.	ychi@nhri.org.tw	Chi, Ya-Hui/ABE-8550-2020; Chiu, Ing-Ming/B-1534-2008; Chi, Ya-Hui/B-1080-2010	Chi, Ya-Hui/0000-0002-9216-0938; Tzeng, Tsai-Yu/0000-0001-7334-6270	National Health Research Institutes [(NHRI) 98A1-CSPP11-014, NHRI 99A1-CSPP11-014]	National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan)	Work in the authors' laboratories was supported by grants to YHC (National Health Research Institutes (NHRI) 98A1-CSPP11-014, NHRI 99A1-CSPP11-014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Amabile G, 2009, TRENDS MOL MED, V15, P59, DOI 10.1016/j.molmed.2008.12.003; Benkirane M, 1998, J BIOL CHEM, V273, P24898, DOI 10.1074/jbc.273.38.24898; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Evans PM, 2007, J BIOL CHEM, V282, P33994, DOI 10.1074/jbc.M701847200; Gao Y, 2010, MOL REPROD DEV, V77, P540, DOI 10.1002/mrd.21180; Gu PL, 2005, MOL CELL BIOL, V25, P3492, DOI 10.1128/MCB.25.9.3492-3505.2005; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Ho R, 2011, J CELL PHYSIOL, V226, P868, DOI 10.1002/jcp.22450; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jopling C, 2011, NAT REV MOL CELL BIO, V12, P79, DOI 10.1038/nrm3043; Kellner S, 2010, HISTOL HISTOPATHOL, V25, P405, DOI 10.14670/HH-25.405; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee DC, 2009, MOL CELL NEUROSCI, V41, P348, DOI 10.1016/j.mcn.2009.04.010; Lowry WE, 2008, NAT BIOTECHNOL, V26, P1246, DOI 10.1038/nbt1108-1246; Mansour AA, 2012, NATURE; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Pan GJ, 2002, CELL RES, V12, P321, DOI 10.1038/sj.cr.7290134; Pan GJ, 2006, FASEB J, V20, P1730, DOI 10.1096/fj.05-5543fje; Papp B, 2011, CELL RES, V21, P486, DOI 10.1038/cr.2011.28; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Pei DQ, 2009, J BIOL CHEM, V284, P3365, DOI 10.1074/jbc.R800063200; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Sun GQ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/835968; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wei Z, 2009, STEM CELLS, V27, P2969, DOI 10.1002/stem.231; Xu Y, 2008, NATURE, V453, P338, DOI 10.1038/nature07042; Yu IT, 2009, NEUROPHARMACOLOGY, V56, P473, DOI 10.1016/j.neuropharm.2008.09.019; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhong XM, 2009, J BIOL CHEM, V284, P9168, DOI 10.1074/jbc.M805562200	48	9	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52556	10.1371/journal.pone.0052556	http://dx.doi.org/10.1371/journal.pone.0052556			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272250	Green Published, Green Submitted, gold			2022-12-27	WOS:000312483300092
J	Vecellio, M; Meraviglia, V; Nanni, S; Barbuti, A; Scavone, A; DiFrancesco, D; Farsetti, A; Pompilio, G; Colombo, GI; Capogrossi, MC; Gaetano, C; Rossini, A				Vecellio, Matteo; Meraviglia, Viviana; Nanni, Simona; Barbuti, Andrea; Scavone, Angela; DiFrancesco, Dario; Farsetti, Antonella; Pompilio, Giulio; Colombo, Gualtiero I.; Capogrossi, Maurizio C.; Gaetano, Carlo; Rossini, Alessandra			In Vitro Epigenetic Reprogramming of Human Cardiac Mesenchymal Stromal Cells into Functionally Competent Cardiovascular Precursors	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; RETINOIC ACID; BONE-MARROW; PROGENITOR CELLS; CORD BLOOD; DIFFERENTIATION; MOUSE; ACTIVATION; EXPRESSION; CARDIOMYOCYTES	Adult human cardiac mesenchymal-like stromal cells (CStC) represent a relatively accessible cell type useful for therapy. In this light, their conversion into cardiovascular precursors represents a potential successful strategy for cardiac repair. The aim of the present work was to reprogram CStC into functionally competent cardiovascular precursors using epigenetically active small molecules. CStC were exposed to low serum (5% FBS) in the presence of 5 mu M all-trans Retinoic Acid (ATRA), 5 mM Phenyl Butyrate (PB), and 200 mu M diethylenetriamine/nitric oxide (DETA/NO), to create a novel epigenetically active cocktail (EpiC). Upon treatment the expression of markers typical of cardiac resident stem cells such as c-Kit and MDR-1 were up-regulated, together with the expression of a number of cardiovascular-associated genes including KDR, GATA6, Nkx2.5, GATA4, HCN4, NaV1.5, and alpha-MHC. In addition, profiling analysis revealed that a significant number of microRNA involved in cardiomyocyte biology and cell differentiation/proliferation, including miR 133a, 210 and 34a, were up-regulated. Remarkably, almost 45% of EpiC-treated cells exhibited a TTX-sensitive sodium current and, to a lower extent in a few cells, also the pacemaker I-f current. Mechanistically, the exposure to EpiC treatment introduced global histone modifications, characterized by increased levels of H3K4Me3 and H4K16Ac, as well as reduced H4K20Me3 and H3s10P, a pattern compatible with reduced proliferation and chromatin relaxation. Consistently, ChIP experiments performed with H3K4me3 or H3s10P histone modifications revealed the presence of a specific EpiC-dependent pattern in c-Kit, MDR-1, and Nkx2.5 promoter regions, possibly contributing to their modified expression. Taken together, these data indicate that CStC may be epigenetically reprogrammed to acquire molecular and biological properties associated with competent cardiovascular precursors.	[Gaetano, Carlo] Goethe Univ Frankfurt, Dept Cardiol, Div Cardiovasc Epigenet, Frankfurt, Germany; [Vecellio, Matteo; Pompilio, Giulio; Rossini, Alessandra] Univ Milan, Dipartimento Sci Clin & Comunita, Milan, Italy; [Vecellio, Matteo; Meraviglia, Viviana; Pompilio, Giulio] IRCCS, Ctr Cardiol Monzino, Lab Biol Vasc & Med Rigenerativa, Milan, Italy; [Nanni, Simona] Univ Cattolica Sacro Cuore, Ist Patol Med, Rome, Italy; [Barbuti, Andrea; Scavone, Angela; DiFrancesco, Dario] Univ Milan, Dipartimento Biosci, PaceLab, Milan, Italy; [Farsetti, Antonella] Ist Nazl Tumori Regina Elena, Rome, Italy; [Farsetti, Antonella] CNR, Ist Neurobiol & Med Mol, Rome, Italy; [Colombo, Gualtiero I.] IRCCS, Ctr Cardiol Monzino, Lab Immunol & Genom Funz, Milan, Italy; [Capogrossi, Maurizio C.] IRCCS, Ist Dermopat Immacolata, Lab Patol Vasc, Rome, Italy	Goethe University Frankfurt; University of Milan; IRCCS Centro Cardiologico Monzino; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Milan; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Consiglio Nazionale delle Ricerche (CNR); IRCCS Centro Cardiologico Monzino; IRCCS Istituto Dermopatico dell'Immacolata (IDI)	Gaetano, C (corresponding author), Goethe Univ Frankfurt, Dept Cardiol, Div Cardiovasc Epigenet, Frankfurt, Germany.	Gaetano@em.uni-frankfurt.de; alessandra.rossini@unimi.it	Vecellio, Matteo Luca/AAA-9143-2022; Pompilio, Giulio/J-6701-2014; Meraviglia, Viviana/J-4823-2016; Colombo, Gualtiero I./B-4737-2010; Rossini, Alessandra/N-8446-2013; Farsetti, Antonella/I-8710-2018; Gaetano, Carlo/P-9997-2019; DiFrancesco, Dario/G-8408-2017; Vecellio, Matteo Luca/HGB-6768-2022; Barbuti, Andrea/N-9805-2013	Vecellio, Matteo Luca/0000-0002-8643-1316; Pompilio, Giulio/0000-0003-2581-5735; Meraviglia, Viviana/0000-0002-9571-0309; Colombo, Gualtiero I./0000-0002-7348-1939; Rossini, Alessandra/0000-0002-0440-1130; Farsetti, Antonella/0000-0002-8603-7925; Gaetano, Carlo/0000-0002-5238-1832; DiFrancesco, Dario/0000-0002-7322-1790; Vecellio, Matteo Luca/0000-0002-8643-1316; Barbuti, Andrea/0000-0002-4521-4913	Italian Ministry of Health (RC); Italian Ministry of Education, University and Research [FIRB-MIUR RBFR087JMZ, FIRB-MIUR RBFR10URHP_001, PRIN-MIUR 2008NY72S, PRIN-MIUR 2008ETWBTW]; LOEWE-CGT centre of excellence	Italian Ministry of Health (RC)(Ministry of Health, Italy); Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); LOEWE-CGT centre of excellence	The present study was supported by the Italian Ministry of Health (RC 2010-2011) and by the Italian Ministry of Education, University and Research (FIRB-MIUR RBFR087JMZ to A.R. and A.F; FIRB-MIUR RBFR10URHP_001 to S.N; PRIN-MIUR 2008NY72S to A.F; PRIN-MIUR 2008ETWBTW to DD). C.G. is supported by the LOEWE-CGT centre of excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2003, ARTERIOSCL THROM VAS, V23, P404, DOI 10.1161/01.ATV.0000059405.51042.A0; Anastasia L, 2010, CELL DEATH DIFFER, V17, P1230, DOI 10.1038/cdd.2010.14; Anversa P, 2006, CIRCULATION, V113, P1451, DOI 10.1161/CIRCULATIONAHA.105.595181; Avitabile D, 2011, AM J PHYSIOL-HEART C, V300, pH1875, DOI 10.1152/ajpheart.00523.2010; Barbuti A, 2009, J MOL CELL CARDIOL, V46, P343, DOI 10.1016/j.yjmcc.2008.12.001; Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Bearzi C, 2009, P NATL ACAD SCI USA, V106, P15885, DOI 10.1073/pnas.0907622106; Boettger T, 2012, CIRC RES, V110, P1000, DOI 10.1161/CIRCRESAHA.111.247742; Boni A, 2008, P NATL ACAD SCI USA, V105, P15529, DOI 10.1073/pnas.0808357105; Chandler NJ, 2009, CIRCULATION, V119, P1562, DOI 10.1161/CIRCULATIONAHA.108.804369; Cho J, 2009, J BIOL CHEM, V284, P36647, DOI 10.1074/jbc.M109.019109; Cottage CT, 2010, CIRC RES, V106, P891, DOI 10.1161/CIRCRESAHA.109.208629; Das S, 2010, CANCER RES, V70, P7874, DOI 10.1158/0008-5472.CAN-10-1534; Dietze EC, 2003, BIOCHEM BIOPH RES CO, V302, P841, DOI 10.1016/S0006-291X(03)00266-3; Galvez BG, 2008, CELL DEATH DIFFER, V15, P1417, DOI 10.1038/cdd.2008.75; Goto S, 1999, ANAL BIOCHEM, V272, P135, DOI 10.1006/abio.1999.4163; Gu MF, 2000, J BIOL CHEM, V275, P11389, DOI 10.1074/jbc.275.15.11389; Haufe V, 2005, J PHYSIOL-LONDON, V564, P683, DOI 10.1113/jphysiol.2004.079681; Hosoda T, 2011, CIRCULATION, V123, P1287, DOI 10.1161/CIRCULATIONAHA.110.982918; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Karamboulas C, 2006, J CELL SCI, V119, P4305, DOI 10.1242/jcs.03185; Kim HW, 2009, J BIOL CHEM, V284, P33161, DOI 10.1074/jbc.M109.020925; Kourmouli N, 2004, J CELL SCI, V117, P2491, DOI 10.1242/jcs.01238; Kudo T, 2011, GENES CELLS, V16, P1121, DOI 10.1111/j.1365-2443.2011.01556.x; Li L, 2012, CLIN EXP MED; Liu J, 2011, J CELL MOL MED, V15, P1474, DOI 10.1111/j.1582-4934.2010.01104.x; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; Liu SP, 2009, CELL TRANSPLANT, V18, P1039, DOI 10.3727/096368909X471224; Maitra M, 2009, DEV BIOL, V326, P368, DOI 10.1016/j.ydbio.2008.11.004; Majumdar A, 2011, J BIOL CHEM; Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298; Martin-Rendon E, 2008, VOX SANG, V95, P137, DOI 10.1111/j.1423-0410.2008.01076.x; Mattout A, 2011, J MOL CELL BIOL; McManus KJ, 2006, BIOCHEM CELL BIOL, V84, P640, DOI 10.1139/O06-086; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Mujoo K, 2008, P NATL ACAD SCI USA, V105, P18924, DOI 10.1073/pnas.0810230105; Nanni S, 2009, J CLIN INVEST, V119, P1093, DOI 10.1172/JCI35079; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pan J, 2007, VITAM HORM, V75, P257, DOI 10.1016/S0083-6729(06)75010-5; Piccolo FM, 2011, PHILOS T R SOC B, V366, P2260, DOI 10.1098/rstb.2011.0004; Rosati J, 2011, ARTERIOSCL THROM VAS, V31, P898, DOI 10.1161/ATVBAHA.110.214478; Rossini A, 2011, CARDIOVASC RES, V89, P650, DOI 10.1093/cvr/cvq290; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sevignani C, 2006, MAMM GENOME, V17, P189, DOI 10.1007/s00335-005-0066-3; Sluijter JPG, 2010, ARTERIOSCL THROM VAS, V30, P859, DOI 10.1161/ATVBAHA.109.197434; Spallotta F, 2010, STEM CELLS, V28, P431, DOI 10.1002/stem.300; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tjwa M, 2008, CIRC RES, V103, P4, DOI 10.1161/CIRCRESAHA.108.179994; Ventura C, 2007, J BIOL CHEM, V282, P14243, DOI 10.1074/jbc.M609350200; Wada H, 2002, J CELL BIOL, V156, P983, DOI 10.1083/jcb.200106057; Wu SM, 2011, CELL CYCLE, V10, P68, DOI 10.4161/cc.10.1.14363; Yasui K, 2001, CIRC RES, V88, P536, DOI 10.1161/01.RES.88.5.536; Ybarra N, 2011, NITRIC OXIDE-BIOL CH, V24, P25, DOI 10.1016/j.niox.2010.09.008; Zhang QZ, 2011, CELL RES, V21, P579, DOI 10.1038/cr.2010.163	58	26	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51694	10.1371/journal.pone.0051694	http://dx.doi.org/10.1371/journal.pone.0051694			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284745	Green Published, Green Submitted, gold			2022-12-27	WOS:000312435900046
J	Pascoal, S; Carvalho, G; Creer, S; Mendo, S; Hughes, R				Pascoal, Sonia; Carvalho, Gary; Creer, Simon; Mendo, Sonia; Hughes, Roger			Plastic and Heritable Variation in Shell Thickness of the Intertidal Gastropod Nucella lapillus Associated with Risks of Crab Predation and Wave Action, and Sexual Maturation	PLOS ONE			English	Article							MARINE SNAIL; EVOLUTION; DOGWHELK; GROWTH; PREY; RESPONSES; DEFENSES; ECOTYPES; SHAPE; CUES	The intertidal snail Nucella lapillus generally has thicker shells at sites sheltered from wave action, where crabs are abundant and pose a high risk of predation, than at exposed sites where crabs are rare. We studied two populations showing the opposite trend. We reciprocally transplanted snails between field sites and measured shell length, width and lip thickness of those recaptured 12 months later. Snails transplanted to the sheltered site grew larger than sheltered-site residents, which in turn grew larger than transplants to the exposed site. Relative shell-lip thickness was greater in residents at the exposed site than at the sheltered site. Transplants from shelter to exposure developed relatively thicker shells than their controls and relatively thinner shells from exposure to shelter. Progeny of the two populations were reared for 12 months in a common garden experiment presenting effluent from crabs feeding on broken conspecifics as the treatment and fresh seawater as the control. The crab-effluent treatment decreased foraging activity, concomitantly reducing cumulative somatic growth and reproductive output. Juveniles receiving crab-effluent grew slower in shell length while developing relatively thicker shell lips than controls, the level of response being similar between lineages. F-2 progeny of the exposed-site lineage showed similar trends to the F(1)s; sheltered-site F(2)s were too few for statistical analysis. At sexual maturity, shell-lip thickness was greater in snails receiving crab-effluent than in controls, indicating plasticity, but was also greater in the exposed-site than in the sheltered- site lineage, indicating heritable variation, probably in degree of sexual thickening of the shell lip. Results corroborate hypotheses that 'defensive' shell thickening is a passive consequence of starvation and that heritable and plastic control of defensive shell morphology act synergistically. Shell thickening of juveniles was similar between lineages, contrary to hypotheses predicting differential strengths of plasticity in populations from low- or high-risk habitats. Citation: Pascoal S, Carvalho G, Creer S, Mendo S, Hughes R (2012) Plastic and Heritable Variation in Shell Thickness of the Intertidal Gastropod Nucella lapillus Associated with Risks of Crab Predation and Wave Action, and Sexual Maturation. PLoS ONE 7(12): e52134. doi:10.1371/journal.pone.0052134	[Pascoal, Sonia; Carvalho, Gary; Creer, Simon; Hughes, Roger] Bangor Univ, Sch Biol Sci, Environm Ctr Wales, Mol Ecol & Fisheries Genet Lab, Bangor, Gwynedd, Wales; [Pascoal, Sonia; Mendo, Sonia] Univ Aveiro, CESAM Ctr Environm & Marine Studies, P-3800 Aveiro, Portugal; [Pascoal, Sonia; Mendo, Sonia] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal	Bangor University; Universidade de Aveiro; Universidade de Aveiro	Hughes, R (corresponding author), Bangor Univ, Sch Biol Sci, Environm Ctr Wales, Mol Ecol & Fisheries Genet Lab, Bangor, Gwynedd, Wales.	r.n.hughes@bangor.ac.uk	Mendo, Sonia/E-1095-2011	Mendo, Sonia/0000-0001-5057-5660	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/27711/2006]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by Fundacao para a Ciencia e a Tecnologia (FCT) through Ph.D. grant SFRH/BD/27711/2006 awarded to Sonia Pascoal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SL, 2006, MAR ENVIRON RES, V62, pS317, DOI 10.1016/j.marenvres.2006.04.011; APPLETON RD, 1988, P NATL ACAD SCI USA, V85, P4387, DOI 10.1073/pnas.85.12.4387; Bourdeau PE, 2012, J ANIM ECOL, V81, P849, DOI 10.1111/j.1365-2656.2012.01965.x; Bourdeau PE, 2010, P ROY SOC B-BIOL SCI, V277, P455, DOI 10.1098/rspb.2009.1295; Brookes JI, 2007, J EVOLUTION BIOL, V20, P1015, DOI 10.1111/j.1420-9101.2007.01299.x; BURROWS MT, 1989, J MOLLUS STUD, V55, P285, DOI 10.1093/mollus/55.2.285; Carvajal-Rodriguez A, 2005, ONLINE J BIOINFORMAT, V6, P34; CROTHERS J H, 1985, Field Studies, V6, P291; CURREY JD, 1982, J ANIM ECOL, V51, P47, DOI 10.2307/4309; Edgell TC, 2008, EVOLUTION, V62, P1216, DOI 10.1111/j.1558-5646.2008.00350.x; ETTER RJ, 1988, EVOLUTION, V42, P322, DOI 10.1111/j.1558-5646.1988.tb04136.x; Hollander J, 2006, EVOLUTION, V60, P2490; Hollander J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-333; Hughes R.N., 1986, FUNCTIONAL BIOL MARI; HUGHES RN, 1979, J ANIM ECOL, V48, P65, DOI 10.2307/4100; Hughes RN, 2001, ANIM BEHAV, V61, P711, DOI 10.1006/anbe.2000.1640; Johannesson K, 1997, BIOL J LINN SOC, V61, P267; KITCHING JA, 1966, J ANIM ECOL, V35, P113, DOI 10.2307/2693; Moody RM, 2012, J EXP MAR BIOL ECOL, V413, P78, DOI 10.1016/j.jembe.2011.11.029; PALMER AR, 1990, HYDROBIOLOGIA, V193, P155, DOI 10.1007/BF00028074; Pascoal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030289; Rohlf FJ, 2003, SYST BIOL, V52, P66, DOI 10.1080/10635150390132759; Rohlf FJ, 1998, SYST BIOL, V47, P147, DOI 10.1080/106351598261094; SEELEY RH, 1986, P NATL ACAD SCI USA, V83, P6897, DOI 10.1073/pnas.83.18.6897; Sepulveda RD, 2012, J MOLLUS STUD, V78, P173, DOI 10.1093/mollus/eyr058; Trussell GC, 2002, ECOLOGY, V83, P1635, DOI 10.2307/3071984; Trussell GC, 2003, ECOLOGY, V84, P629, DOI 10.1890/0012-9658(2003)084[0629:TMEIRI]2.0.CO;2; Trussell GC, 2001, GENETICA, V112, P321, DOI 10.1023/A:1013364527698; Trussell GC, 2011, ECOLOGY, V92, P1799, DOI 10.1890/10-2222.1; VADAS RL, 1994, OECOLOGIA, V100, P439, DOI 10.1007/BF00317866; VERMEIJ GJ, 1982, NATURE, V299, P349, DOI 10.1038/299349a0	31	15	15	3	208	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e52134	10.1371/journal.pone.0052134	http://dx.doi.org/10.1371/journal.pone.0052134			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272221	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386600056
J	Anguille, S; Lion, E; Tel, J; de Vries, IJM; Coudere, K; Fromm, PD; Van Tendeloo, VF; Smits, EL; Berneman, ZN				Anguille, Sebastien; Lion, Eva; Tel, Jurjen; de Vries, I. Jolanda M.; Coudere, Karen; Fromm, Phillip D.; Van Tendeloo, Viggo F.; Smits, Evelien L.; Berneman, Zwi N.			Interleukin-15-Induced CD56(+) Myeloid Dendritic Cells Combine Potent Tumor Antigen Presentation with Direct Tumoricidal Potential	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; CD8(+) T-CELLS; IN-VITRO; GRANZYME-B; INTERFERON-ALPHA; IFN-GAMMA; NK; CYTOTOXICITY; ACTIVATION; EXPRESSION	Dendritic cells (DCs) are the quintessential antigen-presenting cells of the human immune system and play a prime role in coordinating innate and adaptive immune responses, explaining the strong and still growing interest in their application for cancer immunotherapy. Much current research in the field of DC-based immunotherapy focuses on optimizing the culture conditions for in vitro DC generation in order to assure that DCs with the best possible immunogenic qualities are being used for immunotherapy. In this context, monocyte-derived DCs that are alternatively induced by interleukin-15 (IL-15 DCs) have attracted recent attention due to their superior immunostimulatory characteristics. In this study, we show that IL-15 DCs, in addition to potent tumor antigen-presenting function, possess tumoricidal potential and thus qualify for the designation of killer DCs. Notwithstanding marked expression of the natural killer (NK) cell marker CD56 on a subset of IL-15 DCs, we found no evidence of a further phenotypic overlap between IL-15 DCs and NK cells. Allostimulation and antigen presentation assays confirmed that IL-15 DCs should be regarded as bona fide myeloid DCs not only from the phenotypic but also from the functional point of view. Concerning their cytotoxic activity, we demonstrate that IL-15 DCs are able to induce apoptotic cell death of the human K562 tumor cell line, while sparing tumor antigen-specific T cells. The cytotoxicity of IL-15 DCs is predominantly mediated by granzyme B and, to a small extent, by tumor necrosis factor-alpha (TNF-alpha)-related apoptosis-inducing ligand (TRAIL) but is independent of perforin, Fas ligand and TNF-alpha. In conclusion, our data provide evidence of a previously unappreciated role for IL-15 in the differentiation of human monocytes towards killer DCs. The observation that IL-15 DCs have killer DC capacity lends further support to their implementation in DC-based immunotherapy protocols.	[Anguille, Sebastien; Lion, Eva; Coudere, Karen; Van Tendeloo, Viggo F.; Smits, Evelien L.; Berneman, Zwi N.] Univ Antwerp, Fac Med & Hlth Sci, Vaccine & Infect Dis Inst VAXINFECTIO, Lab Expt Hematol, B-2020 Antwerp, Belgium; [Anguille, Sebastien; Smits, Evelien L.; Berneman, Zwi N.] Univ Antwerp Hosp, Ctr Cell Therapy & Regenerat Med, Antwerp, Belgium; [Tel, Jurjen; de Vries, I. Jolanda M.] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Tel, Jurjen; de Vries, I. Jolanda M.] Nijmegen Ctr Mol Life Sci, Dept Tumor Immunol, Nijmegen, Netherlands; [Fromm, Phillip D.] ANZAC Res Inst, Dendrit Cell Biol & Therapeut Grp, Sydney, NSW, Australia	University of Antwerp; University of Antwerp; Radboud University Nijmegen; Radboud University Nijmegen; University of Sydney; ANZAC Research Institute	Anguille, S (corresponding author), Univ Antwerp, Fac Med & Hlth Sci, Vaccine & Infect Dis Inst VAXINFECTIO, Lab Expt Hematol, B-2020 Antwerp, Belgium.	sebastien.anguille@uza.be	Smits, Evelien/A-3520-2014; Tel, Jurjen/A-2712-2016; de Vries, Jolanda I.J.M./F-5563-2010; Research Institute, ANZAC/CAE-9030-2022; Van Tendeloo, Viggo FI/A-1233-2010; Ekanayake, Kanchana/P-8817-2016	Smits, Evelien/0000-0001-9255-3435; Tel, Jurjen/0000-0002-7213-3422; de Vries, Jolanda I.J.M./0000-0002-8653-4040; Van Tendeloo, Viggo FI/0000-0003-3217-9917; Berneman, Zwi/0000-0002-9133-4588; Lion, Eva/0000-0002-2420-0301	Research Foundation Flanders (FWO Vlaanderen); Belgian Foundation against Cancer (Stichting tegen Kanker); Methusalem program of the Flemish Government; Interuniversity Attraction Pole program (IAP) of the Belgian Government [P6/41]; Belgian Hercules Foundation; Belgian Foundation against Cancer; Belgian public utility foundation VOCATIO; Emmanuel van der Schueren Fellowship of the Flemish League against Cancer (Vlaamse Liga tegen Kanker); Netherlands Organization for Scientific Research (NWO ZonMW); Institute for the Promotion of Innovation through Science and Technology (IWT)	Research Foundation Flanders (FWO Vlaanderen)(FWO); Belgian Foundation against Cancer (Stichting tegen Kanker); Methusalem program of the Flemish Government; Interuniversity Attraction Pole program (IAP) of the Belgian Government; Belgian Hercules Foundation; Belgian Foundation against Cancer; Belgian public utility foundation VOCATIO; Emmanuel van der Schueren Fellowship of the Flemish League against Cancer (Vlaamse Liga tegen Kanker); Netherlands Organization for Scientific Research (NWO ZonMW)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development); Institute for the Promotion of Innovation through Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported in part by research grants of the Research Foundation Flanders (FWO Vlaanderen, www.fwo.be), the Belgian Foundation against Cancer (Stichting tegen Kanker, www.kanker.be), the Methusalem program of the Flemish Government attributed to Prof Herman Goossens (University of Antwerp, Belgium), the Interuniversity Attraction Pole program (IAP # P6/41) of the Belgian Government and the Belgian Hercules Foundation (www.herculesstichting.be). SA is a PhD fellow of the Research Foundation Flanders and received financial support from the Belgian Foundation against Cancer and the Belgian public utility foundation VOCATIO (www.vocatio.be). EL holds an Emmanuel van der Schueren Fellowship of the Flemish League against Cancer (Vlaamse Liga tegen Kanker, www.tegenkanker.be). JT was supported by a grant from The Netherlands Organization for Scientific Research (NWO ZonMW, www.zonmw.nl). YW is funded by a PhD grant of the Institute for the Promotion of Innovation through Science and Technology (IWT, www.iwt.be). NC and ELS are post-doctoral fellows of the Research Foundation Flanders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AAZ, 2008, CLIN CANCER RES, V14, P4232, DOI 10.1158/1078-0432.CCR-07-4912; Anguille S, 2012, LEUKEMIA, V26, P2186, DOI 10.1038/leu.2012.145; Anguille S, 2011, LEUKEMIA, V25, P739, DOI 10.1038/leu.2010.324; Anguille S, 2012, B CANCER, V99, P635, DOI 10.1684/bdc.2012.1587; Anguille S, 2012, CYTOTHERAPY, V14, P647, DOI 10.3109/14653249.2012.693744; Anguille S, 2011, HUM VACCINES, V7, P579, DOI 10.4161/hv.7.5.14652; Anguille S, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-109; Barblu L, 2012, J INFECT DIS, V206, P790, DOI 10.1093/infdis/jis384; Bigley V, 2010, BLOOD, V116, P2859, DOI 10.1182/blood-2010-05-285676; Blasius AL, 2007, J EXP MED, V204, P2561, DOI 10.1084/jem.20070991; Caminschi I, 2007, J EXP MED, V204, P2579, DOI 10.1084/jem.20071351; Chan CW, 2008, CELL DEATH DIFFER, V15, P58, DOI 10.1038/sj.cdd.4402235; Chan CW, 2006, NAT MED, V12, P207, DOI 10.1038/nm1352; Chapoval AI, 2000, BLOOD, V95, P2346, DOI 10.1182/blood.V95.7.2346.007k05_2346_2351; Chauvin C, 2008, J IMMUNOL, V181, P11, DOI 10.4049/jimmunol.181.1.11; Choy JC, 2004, ARTERIOSCL THROM VAS, V24, P2245, DOI 10.1161/01.ATV.0000147162.51930.b7; Cookson S, 2003, BLOOD, V102, P2195, DOI 10.1182/blood-2003-01-0232; Correia MP, 2011, IMMUNOBIOLOGY, V216, P604, DOI 10.1016/j.imbio.2010.09.012; Drobits B, 2012, J CLIN INVEST, V122, P575, DOI 10.1172/JCI61034; Dubsky P, 2007, EUR J IMMUNOL, V37, P1678, DOI 10.1002/eji.200636329; Fanger NA, 1999, J EXP MED, V190, P1155, DOI 10.1084/jem.190.8.1155; Farag SS, 2006, BLOOD REV, V20, P123, DOI 10.1016/j.blre.2005.10.001; Figdor CG, 2004, NAT MED, V10, P475, DOI 10.1038/nm1039; Hanna J, 2004, J CLIN INVEST, V114, P1612, DOI 10.1172/JCI200422787; Harris KM, 2011, J LEUKOCYTE BIOL, V90, P727, DOI 10.1189/jlb.0311132; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; Kalb ML, 2012, J IMMUNOL, V188, P1583, DOI 10.4049/jimmunol.1102437; Kelly-Rogers J, 2006, HUM IMMUNOL, V67, P863, DOI 10.1016/j.humimm.2006.08.292; Koski GK, 2012, J IMMUNOTHER, V35, P54, DOI 10.1097/CJI.0b013e318235f512; LaCasse CJ, 2011, J IMMUNOL, V187, P6310, DOI 10.4049/jimmunol.1101812; LANIER LL, 1994, J IMMUNOL, V153, P2417; LANIER LL, 1989, J EXP MED, V169, P2233, DOI 10.1084/jem.169.6.2233; Larmonier N, 2010, CANCER IMMUNOL IMMUN, V59, P1, DOI 10.1007/s00262-009-0736-1; Lion E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020952; Luckey U, 2011, J CLIN INVEST, V121, P3860, DOI 10.1172/JCI45963; Manna PP, 2013, CYTOKINE, V61, P118, DOI 10.1016/j.cyto.2012.09.004; Manna PP, 2002, J LEUKOCYTE BIOL, V72, P312; Matsui T, 2009, J IMMUNOL, V182, P6815, DOI 10.4049/jimmunol.0802008; Milush JM, 2009, BLOOD, V114, P4823, DOI 10.1182/blood-2009-04-216374; Mohamadzadeh M, 2001, J EXP MED, V194, P1013, DOI 10.1084/jem.194.7.1013; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Papewalis C, 2008, J IMMUNOL, V180, P1462, DOI 10.4049/jimmunol.180.3.1462; Pardo J, 2007, CELL DEATH DIFFER, V14, P1768, DOI 10.1038/sj.cdd.4402183; Pillarisetty VG, 2005, J IMMUNOL, V174, P2612, DOI 10.4049/jimmunol.174.5.2612; Pipkin ME, 2007, CURR OPIN IMMUNOL, V19, P301, DOI 10.1016/j.coi.2007.04.011; Pittet MJ, 2000, J IMMUNOL, V164, P1148, DOI 10.4049/jimmunol.164.3.1148; Provasi E, 2012, NAT MED, V18, P807, DOI 10.1038/nm.2700; ROBERTSON MJ, 1990, J IMMUNOL, V145, P3194; Santin AD, 2001, CLIN CANCER RES, V7, p804S; Schmitz M, 2005, J IMMUNOL, V174, P4127, DOI 10.4049/jimmunol.174.7.4127; Smits ELJM, 2009, HUM GENE THER, V20, P1106, DOI 10.1089/hum.2009.145; Spits H, 2007, IMMUNITY, V26, P11, DOI 10.1016/j.immuni.2007.01.004; Stary G, 2007, J EXP MED, V204, P1441, DOI 10.1084/jem.20070021; STEINMAN RM, 1980, IMMUNOL REV, V53, P127, DOI 10.1111/j.1600-065X.1980.tb01042.x; Suss G, 1996, J EXP MED, V183, P1789, DOI 10.1084/jem.183.4.1789; Taieb J, 2006, NAT MED, V12, P214, DOI 10.1038/nm1356; Tel J, 2012, BLOOD, V120, P3936, DOI 10.1182/blood-2012-06-435941; Thiery J, 2011, NAT IMMUNOL, V12, P770, DOI 10.1038/ni.2050; Urban EM, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-50; Vidalain PO, 2001, J IMMUNOL, V167, P3765, DOI 10.4049/jimmunol.167.7.3765; Vosshenrich CAJ, 2007, J EXP MED, V204, P2569, DOI 10.1084/jem.20071451; Walzer T, 2007, CURR OPIN IMMUNOL, V19, P365, DOI 10.1016/j.coi.2007.04.004; Welte S, 2006, NAT IMMUNOL, V7, P1334, DOI 10.1038/ni1402; Wesa AK, 2008, CELL DEATH DIFFER, V15, P51, DOI 10.1038/sj.cdd.4402243	64	46	49	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e51851	10.1371/journal.pone.0051851	http://dx.doi.org/10.1371/journal.pone.0051851			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23284789	Green Published, gold, Green Submitted			2022-12-27	WOS:000313051500015
J	Schnitzer, SA; Mangan, SA; Dalling, JW; Baldeck, CA; Hubbell, SP; Ledo, A; Muller-Landau, H; Tobin, MF; Aguilar, S; Brassfield, D; Hernandez, A; Lao, S; Perez, R; Valdes, O; Yorke, SR				Schnitzer, Stefan A.; Mangan, Scott A.; Dalling, James W.; Baldeck, Claire A.; Hubbell, Stephen P.; Ledo, Alicia; Muller-Landau, Helene; Tobin, Michael F.; Aguilar, Salomon; Brassfield, David; Hernandez, Andres; Lao, Suzanne; Perez, Rolando; Valdes, Oldemar; Yorke, Suzanne Rutishauser			Liana Abundance, Diversity, and Distribution on Barro Colorado Island, Panama	PLOS ONE			English	Article							TROPICAL FOREST; HABITAT ASSOCIATIONS; TREE REGENERATION; RAIN-FOREST; CANOPY LIANAS; SPECIES-AREA; PATTERNS; BIOMASS; GAPS; MORTALITY	Lianas are a key component of tropical forests; however, most surveys are too small to accurately quantify liana community composition, diversity, abundance, and spatial distribution - critical components for measuring the contribution of lianas to forest processes. In 2007, we tagged, mapped, measured the diameter, and identified all lianas >= 1 cm rooted in a 50-ha plot on Barro Colorado Island, Panama (BCI). We calculated liana density, basal area, and species richness for both independently rooted lianas and all rooted liana stems (genets plus clones). We compared spatial aggregation patterns of liana and tree species, and among liana species that varied in the amount of clonal reproduction. We also tested whether liana and tree densities have increased on BCI compared to surveys conducted 30-years earlier. This study represents the most comprehensive spatially contiguous sampling of lianas ever conducted and, over the 50 ha area, we found 67,447 rooted liana stems comprising 162 species. Rooted lianas composed nearly 25% of the woody stems (trees and lianas), 35% of woody species richness, and 3% of woody basal area. Lianas were spatially aggregated within the 50-ha plot and the liana species with the highest proportion of clonal stems more spatially aggregated than the least clonal species, possibly indicating clonal stem recruitment following canopy disturbance. Over the past 30 years, liana density increased by 75% for stems >= 1 cm diameter and nearly 140% for stems >= 5 cm diameter, while tree density on BCI decreased 11.5%; a finding consistent with other neotropical forests. Our data confirm that lianas contribute substantially to tropical forest stem density and diversity, they have highly clumped distributions that appear to be driven by clonal stem recruitment into treefall gaps, and they are increasing relative to trees, thus indicating that lianas will play a greater role in the future dynamics of BCI and other neotropical forests.	[Schnitzer, Stefan A.; Mangan, Scott A.; Ledo, Alicia; Tobin, Michael F.; Valdes, Oldemar; Yorke, Suzanne Rutishauser] Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53201 USA; [Schnitzer, Stefan A.; Mangan, Scott A.; Dalling, James W.; Hubbell, Stephen P.; Muller-Landau, Helene; Aguilar, Salomon; Brassfield, David; Hernandez, Andres; Lao, Suzanne; Perez, Rolando; Valdes, Oldemar] Smithsonian Trop Res Inst, Balboa, Panama; [Dalling, James W.] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA; [Baldeck, Claire A.] Univ Illinois, Program Ecol Evolut & Conservat Biol, Urbana, IL 61801 USA; [Hubbell, Stephen P.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Ledo, Alicia] Univ Politecn Madrid, ETSI Montes, Madrid, Spain	University of Wisconsin System; University of Wisconsin Milwaukee; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Los Angeles; Universidad Politecnica de Madrid	Schnitzer, SA (corresponding author), Univ Wisconsin, Dept Biol Sci, POB 413, Milwaukee, WI 53201 USA.	S1@uwm.edu	HERNANDEZ-GARCIA, ANDRES/B-9051-2014	HERNANDEZ-GARCIA, ANDRES/0000-0002-5343-5513; Muller-Landau, Helene C./0000-0002-3526-9021; Dalling, James/0000-0002-6488-9895; Schnitzer, Stefan/0000-0002-2715-9455	National Science Foundation [DEB-0613666, DEB-0845071]; UWM Research Growth Initiative; UWM Office for Undergraduate Research; UWM Center for Latin American and Caribbean Studies	National Science Foundation(National Science Foundation (NSF)); UWM Research Growth Initiative; UWM Office for Undergraduate Research; UWM Center for Latin American and Caribbean Studies	The study was made possible by financial support from the National Science Foundation (DEB-0613666, DEB-0845071), UWM Research Growth Initiative, UWM Office for Undergraduate Research, and the UWM Center for Latin American and Caribbean Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen BP, 2007, FOREST ECOL MANAG, V242, P17, DOI 10.1016/j.foreco.2007.01.027; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Andrade JL, 2005, TREES-STRUCT FUNCT, V19, P282, DOI 10.1007/s00468-004-0388-x; Benitez-Malvido J, 2003, CONSERV BIOL, V17, P389, DOI 10.1046/j.1523-1739.2003.01120.x; Cai ZQ, 2009, OECOLOGIA, V161, P25, DOI 10.1007/s00442-009-1355-4; Chave J, 2008, J TROP ECOL, V24, P355, DOI 10.1017/S0266467408005075; Condit R, 1996, J ECOL, V84, P549, DOI 10.2307/2261477; Condit R, 1998, TROPICAL FOREST CENS; Croat T.B., 1978, FLORA BARRO COLORADO; Dalling JW, 2012, J ECOL, V100, P1174, DOI 10.1111/j.1365-2745.2012.01989.x; DeWalt SJ, 2010, BIOTROPICA, V42, P309, DOI 10.1111/j.1744-7429.2009.00589.x; Enquist BJ, 2011, GLOBAL CHANGE BIOL, V17, P1408, DOI 10.1111/j.1365-2486.2010.02326.x; Feeley KJ, 2011, ECOLOGY, V92, P871, DOI 10.1890/10-0724.1; Foster JR, 2008, REMOTE SENS ENVIRON, V112, P2104, DOI 10.1016/j.rse.2007.07.027; Foster PF, 1997, AM J BOT, V84, P1078, DOI 10.2307/2446151; Gentry A.H., 1991, BIOL VINES, P3; Gerwing JJ, 2006, BIOTROPICA, V38, P256, DOI 10.1111/j.1744-7429.2006.00134.x; Gerwing JJ, 2004, FOREST ECOL MANAG, V190, P57, DOI 10.1016/j.foreco.2003.10.006; Goreaud F, 2003, J VEG SCI, V14, P681, DOI 10.1658/1100-9233(2003)014[0681:AMOBIW]2.0.CO;2; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Hubbell S.P., 1983, TROPICAL RAIN FOREST, P25; Ingwell LL, 2010, J ECOL, V98, P879, DOI 10.1111/j.1365-2745.2010.01676.x; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Leigh EG, 1999, TROPICAL FOREST ECOL; Londre RA, 2006, ECOLOGY, V87, P2973, DOI 10.1890/0012-9658(2006)87[2973:TDOLAT]2.0.CO;2; Mascaro J, 2004, FOREST ECOL MANAG, V190, P3, DOI 10.1016/j.foreco.2003.10.002; Mohan JE, 2006, P NATL ACAD SCI USA, V103, P9086, DOI 10.1073/pnas.0602392103; Ohser J., 1983, MATH OPER STAT, V14, P63, DOI [10.1080/02331888308801687, DOI 10.1080/02331888308801687]; PENALOSA J, 1984, BIOTROPICA, V16, P1, DOI 10.2307/2387886; Perez-Salicrup DR, 2001, BIOTROPICA, V33, P34, DOI 10.1111/j.1744-7429.2001.tb00155.x; Phillips OL, 2005, ECOLOGY, V86, P1250, DOI 10.1890/04-1446; Phillips OL, 2002, NATURE, V418, P770, DOI 10.1038/nature00926; Phillips OL, 2004, PHILOS T R SOC B, V359, P381, DOI 10.1098/rstb.2003.1438; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Plotkin JB, 2000, J THEOR BIOL, V207, P81, DOI 10.1006/jtbi.2000.2158; Powers JS, 2004, J TROP ECOL, V20, P587, DOI 10.1017/S0266467404001877; PUTZ FE, 1984, ECOLOGY, V65, P1713, DOI 10.2307/1937767; RIPLEY BD, 1976, J APPL PROBAB, V13, P255, DOI 10.2307/3212829; Romero-Saltos HG., 2011, THESIS U MIAMI; Russo SE, 2008, J ECOL, V96, P192, DOI 10.1111/j.1365-2745.2007.01330.x; Schnitzer SA, 2000, J ECOL, V88, P655, DOI 10.1046/j.1365-2745.2000.00489.x; Schnitzer SA, 2000, TRENDS ECOL EVOL, V15, P375, DOI 10.1016/S0169-5347(00)01913-3; Schnitzer SA, 2002, TRENDS ECOL EVOL, V17, P223, DOI 10.1016/S0169-5347(02)02491-6; Schnitzer SA, 2005, AM NAT, V166, P262, DOI 10.1086/431250; Schnitzer SA, 2005, J ECOL, V93, P1115, DOI 10.1111/j.1365-2745.2005.01056.x; Schnitzer SA, 2004, FOREST ECOL MANAG, V190, P87, DOI 10.1016/j.foreco.2003.10.008; Schnitzer SA, 2001, ECOLOGY, V82, P913, DOI 10.1890/0012-9658(2001)082[0913:TGATMO]2.0.CO;2; Schnitzer SA, BIOTROPICA IN PRESS; Schnitzer SA, 2008, TROPICAL FOREST COMM, P196; Schnitzer SA, 2008, FOREST ECOL MANAG, V255, P1044, DOI 10.1016/j.foreco.2007.10.012; Schnitzer SA, 2006, BIOTROPICA, V38, P581, DOI 10.1111/j.1744-7429.2006.00187.x; Schnitzer SA, 2011, PLANT SIGNAL BEHAV, V6, P598, DOI 10.4161/psb.6.4.15373; Schnitzer SA, 2011, ECOL LETT, V14, P397, DOI 10.1111/j.1461-0248.2011.01590.x; Schnitzer SA, 2010, ECOL LETT, V13, P849, DOI 10.1111/j.1461-0248.2010.01480.x; STOYAN D, 1984, MATH NACHR, V116, P197, DOI 10.1002/mana.19841160115; Stoyan D., 1994, FRACTALS RANDOM SHAP; Swaine MD, 2007, PLANT ECOL, V192, P271, DOI 10.1007/s11258-007-9319-4; Tobin MF, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00322.1; Toledo-Aceves T, 2008, J VEG SCI, V19, P717, DOI 10.3170/2008-8-18444; van der Heijden GMF, 2009, J BIOGEOGR, V36, P1561, DOI 10.1111/j.1365-2699.2009.02099.x; van der Heijden GMF, 2008, J VEG SCI, V19, P747, DOI 10.3170/2008-8-18459; Wright SJ, 2006, ECOL LETT, V9, P35, DOI 10.1111/j.1461-0248.2005.00851.x; Wright SJ, 2005, J TROP ECOL, V21, P307, DOI 10.1017/S0266467405002294; Wright SJ, 2004, ECOLOGY, V85, P484, DOI 10.1890/02-0757; Zhu SD, 2009, PLANT ECOL, V204, P295, DOI 10.1007/s11258-009-9592-5	65	124	130	2	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52114	10.1371/journal.pone.0052114	http://dx.doi.org/10.1371/journal.pone.0052114			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284889	Green Published, gold, Green Submitted			2022-12-27	WOS:000313158800031
J	Bobinet, M; Vignard, V; Rogel, A; Khammari, A; Dreno, B; Lang, F; Labarriere, N				Bobinet, Mathilde; Vignard, Virginie; Rogel, Anne; Khammari, Amir; Dreno, Brigitte; Lang, Francois; Labarriere, Nathalie			MELOE-1 Antigen Contains Multiple HLA Class II T Cell Epitopes Recognized by Th1 CD4+T Cells from Melanoma Patients	PLOS ONE			English	Article							CANCER-PATIENTS; PEPTIDE VACCINE; LONG PEPTIDE; COLORECTAL-CANCER; HELPER-CELLS; IFN-GAMMA; IN-VIVO; IMMUNITY; IMMUNOTHERAPY; LYMPHOCYTES	MELOE-1 is an overexpressed melanoma antigen containing a HLA-A2 restricted epitope, involved in melanoma immunosurveillance of patients adoptively transferred with tumour infiltrating lymphocytes (TIL). The use of the full-length antigen (46 aa) for anti-melanoma vaccination could be considered, subject to the presence of Th epitopes all along MELOE-1 sequence. Thus, in this study we evaluated in vitro the immunoprevalence of the different regions of MELOE-1 (i.e. their ability to induce CD4 T cell responses in vitro from PBMC). Stimulation of PBMC from healthy subjects with MELOE-1 induced the amplification of CD4 T cells specific for various regions of the protein in multiple HLA contexts, for each tested donor. We confirmed these results in a panel of melanoma patients, and documented that MELOE-1 specific CD4 T cells, were mainly Th1 cells, presumably favourable to the amplification of CD8 specific T cells. Using autologous DC, we further showed that these class II epitopes could be naturally processed from MELOE-1 whole protein and identified minimal epitopes derived from each region of MELOE-1, and presented in four distinct HLA contexts. In conclusion, vaccination with MELOE-1 whole polypeptide should induce specific Th1 CD4 responses in a majority of melanoma patients, stimulating the amplification of CD8 effector cells, reactive against melanoma cells.	[Bobinet, Mathilde; Vignard, Virginie; Rogel, Anne; Khammari, Amir; Dreno, Brigitte; Lang, Francois; Labarriere, Nathalie] INSERM, U892, Nantes, France; [Bobinet, Mathilde; Vignard, Virginie; Rogel, Anne; Khammari, Amir; Dreno, Brigitte; Lang, Francois; Labarriere, Nathalie] Univ Nantes, Nantes, France; [Bobinet, Mathilde; Vignard, Virginie; Rogel, Anne; Khammari, Amir; Dreno, Brigitte; Lang, Francois; Labarriere, Nathalie] CNRS, UMR 6299, Nantes, France; [Vignard, Virginie; Khammari, Amir; Dreno, Brigitte] Ctr Hosp Univ CHU Nantes, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Centre National de la Recherche Scientifique (CNRS); Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Nantes Universite; CHU de Nantes	Labarriere, N (corresponding author), INSERM, U892, Nantes, France.	nathalie.labarriere@nantes.inserm.fr	LANG, François/K-7403-2015; Vignard, Virginie/K-7540-2015; Labarriere, Nathalie/H-8876-2015	LANG, François/0000-0002-0762-4647; Vignard, Virginie/0000-0002-6702-2824; Labarriere, Nathalie/0000-0002-1407-6546; Rogel, Anne/0000-0002-8788-566X	Inserm; Ligue Regionale contre le cancer (comite) [85]	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ligue Regionale contre le cancer (comite)	This work was supported by a grant from Inserm-transfer (Maturation/proof of concept projects). Mathilde Bobinet was supported by the Ligue Regionale contre le cancer (comite 85). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arden Bernhard, 1995, Immunogenetics, V42, P455; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Bijker MS, 2007, J IMMUNOL, V179, P5033, DOI 10.4049/jimmunol.179.8.5033; Bos R, 2010, CANCER RES, V70, P8368, DOI 10.1158/0008-5472.CAN-10-1322; Chauvin JM, 2012, J IMMUNOL, V188, P2102, DOI 10.4049/jimmunol.1101807; Davodeau F, 2001, EMBO J, V20, P4717, DOI 10.1093/emboj/20.17.4717; FAYOLLE C, 1991, J IMMUNOL, V147, P4069; Fourcade J, 2010, J IMMUNOL, V184, P6709, DOI 10.4049/jimmunol.0903612; Francois V, 2009, CANCER RES, V69, P4335, DOI 10.1158/0008-5472.CAN-08-3726; Friedman KM, 2012, J IMMUNOTHER; Gervois N, 2000, CLIN CANCER RES, V6, P1459; Gnjatic S, 2003, P NATL ACAD SCI USA, V100, P8862, DOI 10.1073/pnas.1133324100; Godet Y, 2008, J EXP MED, V205, P2673, DOI 10.1084/jem.20081356; Godet Y, 2010, EUR J IMMUNOL, V40, P1786, DOI 10.1002/eji.200940132; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Kennedy R, 2008, IMMUNOL REV, V222, P129, DOI 10.1111/j.1600-065X.2008.00616.x; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Knutson KL, 2005, CANCER IMMUNOL IMMUN, V54, P721, DOI 10.1007/s00262-004-0653-2; Knutson KL, 2001, J CLIN INVEST, V107, P477, DOI 10.1172/JCI11752; Kyte JA, 2009, CANCER IMMUNOL IMMUN, V58, P1609, DOI 10.1007/s00262-009-0670-2; Mandic M, 2005, J IMMUNOL, V174, P1751, DOI 10.4049/jimmunol.174.3.1751; Melief CJM, 2008, NAT REV CANCER, V8, P351, DOI 10.1038/nrc2373; Mumberg D, 1999, P NATL ACAD SCI USA, V96, P8633, DOI 10.1073/pnas.96.15.8633; Qin ZH, 2000, IMMUNITY, V12, P677, DOI 10.1016/S1074-7613(00)80218-6; Robbins PF, 2002, J IMMUNOL, V169, P6036, DOI 10.4049/jimmunol.169.10.6036; Rogel A, 2011, CANCER IMMUNOL IMMUN, V60, P327, DOI 10.1007/s00262-010-0938-6; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Schultz ES, 2000, CANCER RES, V60, P6272; Schwartzentruber DJ, 2011, NEW ENGL J MED, V364, P2119, DOI 10.1056/NEJMoa1012863; Smith CM, 2004, NAT IMMUNOL, V5, P1143, DOI 10.1038/ni1129; Speetjens FM, 2009, CLIN CANCER RES, V15, P1086, DOI 10.1158/1078-0432.CCR-08-2227; Toes REM, 1996, P NATL ACAD SCI USA, V93, P7855, DOI 10.1073/pnas.93.15.7855; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Wang HY, 2004, IMMUNITY, V20, P107, DOI 10.1016/S1074-7613(03)00359-5; Wang XF, 2008, J IMMUNOL, V181, P431, DOI 10.4049/jimmunol.181.1.431; Welters MJP, 2008, CLIN CANCER RES, V14, P178, DOI 10.1158/1078-0432.CCR-07-1880; Zarour HM, 2002, CANCER RES, V62, P213	38	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51716	10.1371/journal.pone.0051716	http://dx.doi.org/10.1371/journal.pone.0051716			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284752	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500042
J	Heinonen, I; Nesterov, SV; Kemppainen, J; Fujimoto, T; Knuuti, J; Kalliokoski, KK				Heinonen, Ilkka; Nesterov, Sergey V.; Kemppainen, Jukka; Fujimoto, Toshihiko; Knuuti, Juhani; Kalliokoski, Kari K.			Increasing Exercise Intensity Reduces Heterogeneity of Glucose Uptake in Human Skeletal Muscles	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; POTENTIAL DISTRIBUTION PATTERN; BROWN ADIPOSE-TISSUE; BLOOD-FLOW; FIBER TYPE; SPATIAL HETEROGENEITY; GLYCOGEN DEPLETION; KNEE EXTENSION; CYCLE EXERCISE; NITRIC-OXIDE	Proper muscle activation is a key feature of survival in different tasks in daily life as well as sports performance, but can be impaired in elderly and in diseases. Therefore it is also clinically important to better understand the phenomenon that can be elucidated in humans non-invasively by positron emission tomography (PET) with measurements of spatial heterogeneity of glucose uptake within and among muscles during exercise. We studied six healthy young men during 35 minutes of cycling at relative intensities of 30% (low), 55% (moderate), and 75% (high) of maximal oxygen consumption on three separate days. Glucose uptake in the quadriceps femoris muscle group (QF), the main force producing muscle group in recreational cycling, and its four individual muscles, was directly measured using PET and 18F-fluoro-deoxyglucose. Within-muscle heterogeneity was determined by calculating the coefficient of variance (CV) of glucose uptake in PET image voxels within the muscle of interest, and among-muscles heterogeneity of glucose uptake in QF was expressed as CV of the mean glucose uptake values of its separate muscles. With increasing intensity, within-muscle heterogeneity decreased in the entire QF as well as within its all four individual parts. Among-muscles glucose uptake heterogeneity also decreased with increasing intensity. However, mean glucose uptake was consistently lower and heterogeneity higher in rectus femoris muscle that is known to consist of the highest percentage of fast twitch type II fibers, compared to the other three QF muscles. In conclusion, these results show that in addition to increased contribution of distinct muscle parts, with increases in exercise intensity there is also an enhanced recruitment of muscle fibers within all of the four heads of QF, despite established differences in muscle-part specific fiber type distributions. Glucose uptake heterogeneity may serve as a useful non-invasive tool to elucidate muscle activation in aging and diseased populations.	[Heinonen, Ilkka; Nesterov, Sergey V.; Kemppainen, Jukka; Knuuti, Juhani; Kalliokoski, Kari K.] Univ Turku, Turku PET Ctr, Turku, Finland; [Heinonen, Ilkka; Nesterov, Sergey V.; Kemppainen, Jukka; Knuuti, Juhani; Kalliokoski, Kari K.] Turku Univ Hosp, FIN-20520 Turku, Finland; [Heinonen, Ilkka] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Nesterov, Sergey V.] IM Sechenov Inst Evolutionary Biochem & Physiol, St Petersburg, Russia; [Fujimoto, Toshihiko] Tohoku Univ, Ctr Adv Higher Educ, Sendai, Miyagi 980, Japan	University of Turku; University of Turku; University of Turku; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry; Tohoku University	Heinonen, I (corresponding author), Univ Turku, Turku PET Ctr, Turku, Finland.	ilkka.heinonen@utu.fi	Nesterov, Sergey/AAN-4049-2020; Kalliokoski, Kari K/B-8891-2015; Knuuti, Juhani/AAA-7472-2019; Kemppainen, Jukka/U-4260-2019	Nesterov, Sergey/0000-0002-6549-8749; Knuuti, Juhani/0000-0003-3156-9593; Kalliokoski, Kari/0000-0002-8893-7126; Kemppainen, Jukka/0000-0001-9390-1198	Ministry of Education of the State of Finland [74/627/2006, 58/627/2007, 45/627/2008]; Academy of Finland [108539, 214329, 251572]; Finnish Cultural Foundation	Ministry of Education of the State of Finland; Academy of Finland(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	The present study was financially supported by the Ministry of Education of the State of Finland (Grants 74/627/2006, 58/627/2007, and 45/627/2008), Academy of Finland (Grants 108539 and 214329, 251572 and Centre of Excellence funding), and the Finnish Cultural Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG RB, 1985, J EXP BIOL, V115, P201; Bradley SJ, 1999, DIABETES, V48, P1815, DOI 10.2337/diabetes.48.9.1815; BROOKS GA, 1994, J APPL PHYSIOL, V76, P2253, DOI 10.1152/jappl.1994.76.6.2253; Brooks GA, 2009, J PHYSIOL-LONDON, V587, P5591, DOI 10.1113/jphysiol.2009.178350; Chin LMK, 2011, J APPL PHYSIOL, V111, P1259, DOI 10.1152/japplphysiol.01216.2010; EDGERTON VR, 1975, HISTOCHEM J, V7, P259, DOI 10.1007/BF01003594; Fujimoto T, 2000, EUR J APPL PHYSIOL, V83, P297, DOI 10.1007/s004210000254; Fujimoto T, 1996, LANCET, V348, P266, DOI 10.1016/S0140-6736(05)65572-9; Fujimoto T, 2003, MED SCI SPORT EXER, V35, P777, DOI 10.1249/01.MSS.0000065070.49295.C0; GOLLNICK PD, 1974, J PHYSIOL-LONDON, V241, P45, DOI 10.1113/jphysiol.1974.sp010639; Gondoh Y, 2009, J APPL PHYSIOL, V107, P599, DOI 10.1152/japplphysiol.90821.2008; Goodyear LJ, 1998, ANNU REV MED, V49, P235, DOI 10.1146/annurev.med.49.1.235; Heinonen I, 2007, J APPL PHYSIOL, V103, P2042, DOI 10.1152/japplphysiol.00567.2007; Heinonen I, 2010, J APPL PHYSIOL, V108, P378, DOI 10.1152/japplphysiol.00745.2009; Heinonen IH, 2010, AM J PHYSIOL-REG I, V299, pR72, DOI 10.1152/ajpregu.00056.2010; Helge JW, 2007, J PHYSIOL-LONDON, V581, P1247, DOI 10.1113/jphysiol.2007.128348; HENRIKSEN EJ, 1990, AM J PHYSIOL, V259, pE593, DOI 10.1152/ajpendo.1990.259.4.E593; Hodson-Tole EF, 2009, J COMP PHYSIOL B, V179, P57, DOI 10.1007/s00360-008-0289-1; HULTMAN E, 1995, P NUTR SOC, V54, P107, DOI 10.1079/PNS19950041; Iemitsu M, 2000, MED SCI SPORT EXER, V32, P2067, DOI 10.1097/00005768-200012000-00016; IVERSEN PO, 1991, AM J PHYSIOL, V260, pH1795, DOI 10.1152/ajpheart.1991.260.6.H1795; JAMES DE, 1989, NATURE, V338, P83, DOI 10.1038/338083a0; Jensen TE, 2012, J PHYSIOL-LONDON, V590, P1069, DOI 10.1113/jphysiol.2011.224972; Jeukendrup AE, 2002, ANN NY ACAD SCI, V967, P217; JOHNSON MA, 1973, J NEUROL SCI, V18, P111, DOI 10.1016/0022-510X(73)90023-3; Kalliokoski KK, 2006, EXERC SPORT SCI REV, V34, P164, DOI 10.1249/01.jes.0000240018.07502.48; Kalliokoski KK, 2006, AM J PHYSIOL-REG I, V291, pR803, DOI 10.1152/ajpregu.00808.2005; Kemppainen J, 2002, J PHYSIOL-LONDON, V542, P403, DOI 10.1113/jphysiol.2002.018135; KERN M, 1990, BIOCHEM J, V270, P397, DOI 10.1042/bj2700397; Koga S, 2007, J APPL PHYSIOL, V103, P2049, DOI 10.1152/japplphysiol.00627.2007; Koga S, 2011, AM J PHYSIOL-REG I, V301, pR534, DOI 10.1152/ajpregu.00101.2011; Laine M, 1998, J CLIN INVEST, V101, P1156, DOI 10.1172/JCI1065; Laughlin M H, 1985, Exerc Sport Sci Rev, V13, P95; LILLIOJA S, 1987, J CLIN INVEST, V80, P415, DOI 10.1172/JCI113088; MARETTE A, 1992, AM J PHYSIOL, V263, pC443, DOI 10.1152/ajpcell.1992.263.2.C443; Masud M, 2009, ANN NUCL MED, V23, P81, DOI 10.1007/s12149-008-0212-6; Nuutila P, 1996, J CLIN INVEST, V97, P1741, DOI 10.1172/JCI118601; Orava J, 2011, CELL METAB, V14, P272, DOI 10.1016/j.cmet.2011.06.012; Peltoniemi P, 2001, J CLIN ENDOCR METAB, V86, P5525, DOI 10.1210/jc.86.11.5525; Peltoniemi P, 2000, AM J PHYSIOL-ENDOC M, V279, pE1122, DOI 10.1152/ajpendo.2000.279.5.E1122; Ray CA, 1998, J APPL PHYSIOL, V85, P1194, DOI 10.1152/jappl.1998.85.3.1194; ROMIJN JA, 1993, AM J PHYSIOL, V265, pE380, DOI 10.1152/ajpendo.1993.265.3.E380; SALE DG, 1987, EXERCISE SPORT SCI R, V15, P95; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Tashiro M, 1999, J NUCL MED, V40, P70; Utriainen T, 1996, AM J PHYSIOL-ENDOC M, V270, pE905, DOI 10.1152/ajpendo.1996.270.5.E905; van Hall G, 2010, ACTA PHYSIOL, V199, P499, DOI 10.1111/j.1748-1716.2010.02122.x; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; VOLLESTAD NK, 1985, ACTA PHYSIOL SCAND, V125, P395, DOI 10.1111/j.1748-1716.1985.tb07735.x; Watanabe K, 2012, DIABETES RES CLIN PR, V97, P468, DOI 10.1016/j.diabres.2012.03.004; Watanabe K, 2012, J ELECTROMYOGR KINES, V22, P74, DOI 10.1016/j.jelekin.2011.09.010; Yamano S, 2006, RES VET SCI, V80, P109, DOI 10.1016/j.rvsc.2005.04.006	52	36	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52191	10.1371/journal.pone.0052191	http://dx.doi.org/10.1371/journal.pone.0052191			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284929	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500110
J	Marseille, E; Giganti, MJ; Mwango, A; Chisembele-Taylor, A; Mulenga, L; Over, M; Kahn, JG; Stringer, JSA				Marseille, Elliot; Giganti, Mark J.; Mwango, Albert; Chisembele-Taylor, Angela; Mulenga, Lloyd; Over, Mead; Kahn, James G.; Stringer, Jeffrey S. A.			Taking ART to Scale: Determinants of the Cost and Cost-Effectiveness of Antiretroviral Therapy in 45 Clinical Sites in Zambia	PLOS ONE			English	Article							SOUTH-AFRICA; CARE; HIV; MORTALITY; COUNTRIES; CHILDREN; OUTCOMES; HEALTH; UGANDA	Background: We estimated the unit costs and cost-effectiveness of a government ART program in 45 sites in Zambia supported by the Centre for Infectious Disease Research Zambia (CIDRZ). Methods: We estimated per person-year costs at the facility level, and support costs incurred above the facility level and used multiple regression to estimate variation in these costs. To estimate ART effectiveness, we compared mortality in this Zambian population to that of a cohort of rural Ugandan HIV patients receiving co-trimoxazole (CTX) prophylaxis. We used micro-costing techniques to estimate incremental unit costs, and calculated cost-effectiveness ratios with a computer model which projected results to 10 years. Results: The program cost $69.7 million for 125,436 person-years of ART, or $556 per ART-year. Compared to CTX prophylaxis alone, the program averted 33.3 deaths or 244.5 disability adjusted life-years (DALYs) per 100 person-years of ART. In the base-case analysis, the net cost per DALY averted was $833 compared to CTX alone. More than two-thirds of the variation in average incremental total and on-site cost per patient-year of treatment is explained by eight determinants, including the complexity of the patient-case load, the degree of adherence among the patients, and institutional characteristics including, experience, scale, scope, setting and sector. Conclusions and Significance: The 45 sites exhibited substantial variation in unit costs and cost-effectiveness and are in the mid-range of cost-effectiveness when compared to other ART programs studied in southern Africa. Early treatment initiation, large scale, and hospital setting, are associated with statistically significantly lower costs, while others (rural location, private sector) are associated with shifting cost from on- to off-site. This study shows that ART programs can be significantly less costly or more cost-effective when they exploit economies of scale and scope, and initiate patients at higher CD4 counts.	[Marseille, Elliot] Hlth Strategies Int, Oakland, CA 94609 USA; [Giganti, Mark J.; Chisembele-Taylor, Angela; Mulenga, Lloyd; Stringer, Jeffrey S. A.] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Over, Mead] Ctr Global Dev, Washington, DC USA; [Mwango, Albert] Zambian Minist Hlth, Lusaka, Zambia; [Kahn, James G.] Super Models Global Hlth, Oakland, CA USA; [Kahn, James G.] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Marseille, E (corresponding author), Hlth Strategies Int, Oakland, CA 94609 USA.	emarseille@comcast.net	Stringer, Jeffrey S. A./AAU-2342-2021	Stringer, Jeffrey/0000-0002-9590-7216	U.S. Centers for Disease Control and Prevention [U62/CCU12354]	U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The program that this work describes is supported through a multi-country grant from the U.S. Centers for Disease Control and Prevention (U62/CCU12354). The corresponding author had full access to all data in the study and takes final responsibility for the decision to submit the paper for publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the funding agencies.	[AVERTing HIV AIDS], 2011, PRESIDENTS EMERGENCY; Babigumira JB, 2009, PHARMACOECONOMICS, V27, P963, DOI 10.2165/11318230-000000000-00000; Badri M, 2006, PLOS MED, V3, P48, DOI 10.1371/journal.pmed.0030004; Bikilla AD, 2009, COST EFF RESOUR ALLO, V7, P6, DOI DOI 10.1186/1478-7547-7-6; Bolton-Moore C, 2007, JAMA-J AM MED ASSOC, V298, P1888, DOI 10.1001/jama.298.16.1888; Boulle A, 2002, SAMJ S AFR MED J, V92, P811; Cleary S, 2004, COST EFFECTIVENESS O; Cleary S, 2004, RESOURCE REQUIREMENT; Dezii C M, 2001, Manag Care, V10, P42; Donald PR, 2009, NEW ENGL J MED, V360, P2393, DOI 10.1056/NEJMp0903806; Drummond M.F., 1997, METHODS FOR THE ECON; Galarraga O, 2011, PHARMACOECONOMICS, V29, P579, DOI 10.2165/11586120-000000000-00000; Galaty D, 2004, SCALING UP ANTIRETRO; Geffen N, 2003, REPORT ISSUED BY CEN; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Govender V, 2000, REPORT FROM PHR AND; Government of the Republic of Zambia, 2010, ZAMBIA COUNTRY REPOR; Hogan DR, 2005, BRIT MED J, V331, P1431, DOI 10.1136/bmj.38643.368692.68; Hounton SH, 2008, AIDS CARE, V20, P582, DOI 10.1080/09540120701868303; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Kevany S, 2009, SAMJ S AFR MED J, V99, P320; Kombe G, 2003, APPLICATION OF THE A; Kombe G, 2005, THE HUMAN AND FINANC; Kremer JM, 2009, ARTHRITIS RHEUM-US, V60, P1895, DOI 10.1002/art.24567; Marseille E, 2009, APPL HEALTH ECON HEA, V7, P229, DOI 10.2165/11318740-000000000-00000; Mermin J, 2005, AIDS, V19, P1035, DOI 10.1097/01.aids.0000174449.32756.c7; Mermin J, 2008, LANCET, V371, P752, DOI 10.1016/S0140-6736(08)60345-1; Morgan MG, 1990, UNCERTAINTY A GUIDE; Sikka R, 2005, AM J MANAG CARE, V11, P453; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; The U.S. President's Emergency Plan for AIDS Relief (PEPFAR), 2011, PEPFAR OPERATIONAL P; The World Bank, 1993, WORLD DEVELOPMENT RE; UNAIDS, 2008, 2008 REPORT ON THE G; UNAIDS/World Health Organization, 2008, EPIDEMIOLOGICAL FACT; World Health Organization, 2007, MATERNAL MORTALITY I; World Health Organization, 2009, RAPID ADVICE ANTIRET; Zwillich T, 2009, LANCET, V373, P1325, DOI 10.1016/S0140-6736(09)60755-8	37	38	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51993	10.1371/journal.pone.0051993	http://dx.doi.org/10.1371/journal.pone.0051993			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284843	Green Published, gold			2022-12-27	WOS:000312794500073
J	Villamizar, N; Ribas, L; Piferrer, F; Vera, LM; Sanchez-Vazquez, FJ				Villamizar, Natalia; Ribas, Laia; Piferrer, Francesc; Vera, Luisa M.; Javier Sanchez-Vazquez, Francisco			Impact of Daily Thermocycles on Hatching Rhythms, Larval Performance and Sex Differentiation of Zebrafish	PLOS ONE			English	Article							CYCLING TEMPERATURE CONDITIONS; SOLE SOLEA-SENEGALENSIS; ANTI-MULLERIAN HORMONE; DANIO-RERIO; LOCOMOTOR-ACTIVITY; CIRCADIAN-RHYTHMS; EMBRYONIC-DEVELOPMENT; GONAD DEVELOPMENT; GENE-EXPRESSION; LIGHT	In the wild, water temperature cycles daily: it warms up after sunrise, and cools rapidly after sunset. Surprisingly, the impact of such daily thermocycles during the early development of fish remains neglected. We investigated the influence of constant vs daily thermocycles in zebrafish, from embryo development to sexual differentiation, by applying four temperature regimens: two constant (24 degrees C and 28 degrees C) and two daily thermocycles: 28:24 degrees C, TC (thermophase coinciding with daytime, and cryophase coinciding with night-time) and 24:28 degrees C, CT (opposite to TC) in a 12:12 h light: dark cycle (LD). Embryo development was temperature-dependent but enhanced at 28 degrees C and TC. Hatching rhythms were diurnal (around 4 h after lights on), but temperature-and cycle-sensitive, since hatching occurred sooner at 28 degrees C (48 hours post fertilization; hpf) while it was delayed at 24 degrees C (96 hpf). Under TC, hatching occurred at 72 hpf, while under CT hatching displayed two peaks (at 70 hpf and 94 hpf). In constant light (LL) or darkness (DD), hatching rhythms persisted with tau close to 24 h, suggesting a clock-controlled "gating" mechanism. Under 28 degrees C or TC, larvae showed the best performance (high growth and survival, and low malformations). The sex ratio was strongly influenced by temperature, as the proportion of females was higher in CT and TC (79 and 83% respectively), contrasting with 28 degrees C and 24 degrees C, which led to more males (83 and 76%). Ovarian aromatase (cyp19a) expression in females was highest in TC and CT (6.5 and 4.6 fold higher than at 28 degrees C, respectively); while anti-mullerian hormone (amh) expression in males increased in testis at 24 degrees C (3.6 fold higher compared to TC) and particularly at 28 degrees C (14.3 fold increase). Taken together, these findings highlight the key role of environmental cycles during early development, which shaped the daily rhythms in fish embryo and larvae, and ultimately influenced sex differentiation.	[Villamizar, Natalia; Vera, Luisa M.; Javier Sanchez-Vazquez, Francisco] Univ Murcia, Dept Physiol, Fac Biol, Murcia, Spain; [Ribas, Laia; Piferrer, Francesc] CSIC, Inst Ciencies Mar, Barcelona, Spain	University of Murcia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Sanchez-Vazquez, FJ (corresponding author), Univ Murcia, Dept Physiol, Fac Biol, Reg Campus Int Excellence,Campus Mare Nostrum, Murcia, Spain.	javisan@um.es	Ribas, Laia/E-1466-2013; Piferrer, Francesc/A-5634-2012; Vera, Luisa María/L-6972-2014; Sanchez Vazquez, Francisco Javier/J-7712-2016	Ribas, Laia/0000-0001-5538-6236; Piferrer, Francesc/0000-0003-0903-4736; Vera, Luisa María/0000-0003-0999-055X; Villamizar, Natalia/0000-0002-3673-233X; Sanchez Vazquez, Francisco Javier/0000-0002-2366-9714	Spanish Ministry of Economic Affairs and Competitiveness (MINECO) [AGL2010-22139-C03-01, CDS2007-0002]	Spanish Ministry of Economic Affairs and Competitiveness (MINECO)	This research was funded by the Spanish Ministry of Economic Affairs and Competitiveness (MINECO) by projects "Circasole" AGL2010-22139-C03-01 granted to FJSV (http://www.mineco.gob.es), and AQUAGENOMICS (Consolider-Ingenio Program; CDS2007-0002) granted to FJSV and FP (http://www.idi.mineco.gob.es). Thanks are also due to COST ACTION FA0801 (Larvanet)(http://www.larvanet.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abozaid H, 2011, SEX DEV, V5, P259, DOI 10.1159/000330120; Anderson JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040701; Ayson FG, 2006, GEN COMP ENDOCR, V149, P261, DOI 10.1016/j.ygcen.2006.06.006; Baroiller JF, 1999, CELL MOL LIFE SCI, V55, P910, DOI 10.1007/s000180050344; Bennett WA, 1997, COPEIA, P77; BERGMAN E, 1987, ENVIRON BIOL FISH, V19, P45, DOI 10.1007/BF00002736; Blanco-Vives B, 2012, J BIOL RHYTHM, V27, P135, DOI 10.1177/0748730411435303; Blanco-Vives B, 2011, CHRONOBIOL INT, V28, P300, DOI 10.3109/07420528.2011.560316; Blanco-Vives B, 2009, PHYSIOL BEHAV, V98, P268, DOI 10.1016/j.physbeh.2009.05.015; Boothroyd CE, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030054; Bradley KM, 2011, G3-GENES GENOM GENET, V1, P3, DOI 10.1534/g3.111.000190; BROOKS S, 1994, J FISH BIOL, V45, P699, DOI 10.1006/jfbi.1994.1169; Dekens MPS, 2008, EMBO J, V27, P2757, DOI 10.1038/emboj.2008.183; Dekens MPS, 2003, CURR BIOL, V13, P2051, DOI 10.1016/j.cub.2003.10.022; del Pozo A, 2011, CHRONOBIOL INT, V28, P39, DOI 10.3109/07420528.2010.530728; DIANA JS, 1984, J FISH BIOL, V24, P165, DOI 10.1111/j.1095-8649.1984.tb04787.x; Dunlap JC, 2004, CHRONOBIOLOGY, P89; Fenske M, 2005, ENVIRON TOXICOL CHEM, V24, P1088, DOI 10.1897/04-096R1.1; Lopez-Olmeda JF, 2009, CHRONOBIOL INT, V26, P200, DOI 10.1080/07420520902765928; Godwin J, 2003, EVOL DEV, V5, P40, DOI 10.1046/j.1525-142X.2003.03007.x; GOOLISH EM, 1984, AQUACULTURE, V36, P27, DOI 10.1016/0044-8486(84)90051-6; Guiguen Y, 2010, GEN COMP ENDOCR, V165, P352, DOI 10.1016/j.ygcen.2009.03.002; HENRY JAC, 1984, COMP BIOCHEM PHYS A, V77, P727, DOI 10.1016/0300-9629(84)90193-2; HUEY RB, 1993, AM NAT, V142, pS21, DOI 10.1086/285521; Hurd MW, 2002, J BIOL RHYTHM, V17, P307, DOI 10.1177/074873002129002618; Hurd MW, 1998, PHYSIOL BEHAV, V65, P465, DOI 10.1016/S0031-9384(98)00183-8; Idda ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034203; JOHNSTON IA, 1995, J EXP BIOL, V198, P1389; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lahiri K, 2005, PLOS BIOL, V3, P2005, DOI 10.1371/journal.pbio.0030351; LAURENCE GC, 1976, J CONSEIL, V36, P220; Leet JK, 2011, J APPL TOXICOL, V31, P379, DOI 10.1002/jat.1682; Liew WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034397; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Olmeda JF, 2011, J THERM BIOL, V36, P91, DOI 10.1016/j.jtherbio.2010.12.005; Lopez-Olmeda JF, 2006, CHRONOBIOL INT, V23, P537, DOI 10.1080/07420520600651065; Maack G, 2003, J FISH BIOL, V62, P895, DOI 10.1046/j.1095-8649.2003.00074.x; Meseguer C, 2008, CHRONOBIOL INT, V25, P666, DOI 10.1080/07420520802380018; Myers EM, 2003, CHRONOBIOL INT, V20, P775, DOI 10.1081/CBI-120024214; Navarro-Martin L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002447; Nusslein-Volhard C, 2002, ZEBRAFISH PRACTICAL, P303, DOI [10.1017/S0016672303216384, DOI 10.1017/S0016672303216384]; Oliveira C, 2009, COMP BIOCHEM PHYS A, V152, P168, DOI 10.1016/j.cbpa.2008.09.012; Orban L, 2009, MOL CELL ENDOCRINOL, V312, P35, DOI 10.1016/j.mce.2009.04.014; Ospina-Alvarez N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002837; Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113; Penman DJ, 2008, REV FISH SCI, V16, P16, DOI 10.1080/10641260802324610; QUI J, 1996, J BIOL RHYTHM, V11, P75; REFINETTI R, 1988, PHYSIOL BEHAV, V43, P121, DOI 10.1016/0031-9384(88)90107-2; Rensing L, 2002, CHRONOBIOL INT, V19, P807, DOI 10.1081/CBI-120014569; Rodriguez-Mari A, 2005, GENE EXPR PATTERNS, V5, P655, DOI 10.1016/j.modgep.2005.02.008; Saunders DS, 2002, INSECT CLOCKS; Schaefer J, 2006, J FISH BIOL, V69, P722, DOI 10.1111/j.1095-8649.2006.01145.x; Schroter C, 2008, DEV DYNAM, V237, P545, DOI 10.1002/dvdy.21458; Shimizu T, 2011, BIOCHEM BIOPH RES CO, V412, P132, DOI 10.1016/j.bbrc.2011.07.058; Siegfried KR, 2008, DEV BIOL, V324, P277, DOI 10.1016/j.ydbio.2008.09.025; Tamai TK, 2004, CURR BIOL, V14, pR104, DOI 10.1016/j.cub.2004.01.014; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Tong SK, 2010, DEV BIOL, V344, P849, DOI 10.1016/j.ydbio.2010.05.515; Tsukuda H, 1974, ENV CONTROL BIOL, V12, P93; Uchida D, 2004, COMP BIOCHEM PHYS A, V137, P11, DOI 10.1016/S1095-6433(03)00178-8; Vatine G, 2011, FEBS LETT, V585, P1485, DOI 10.1016/j.febslet.2011.04.007; Vera LM, 2010, AQUACULTURE, V307, P29, DOI 10.1016/j.aquaculture.2010.06.028; Villamizar N, 2012, AQUACULTURE, V354, P117, DOI 10.1016/j.aquaculture.2012.03.028; Villamizar N, 2011, AQUACULTURE, V315, P86, DOI 10.1016/j.aquaculture.2010.10.036; Wang XG, 2007, DEV DYNAM, V236, P1329, DOI 10.1002/dvdy.21129; WOOD A, 1994, DEV DYNAM, V201, P151, DOI 10.1002/aja.1002010206	66	42	42	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52153	10.1371/journal.pone.0052153	http://dx.doi.org/10.1371/journal.pone.0052153			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284912	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500104
J	Senter, E; Sheikh, S; Dotu, I; Ponty, Y; Clote, P				Senter, Evan; Sheikh, Saad; Dotu, Ivan; Ponty, Yann; Clote, Peter			Using the Fast Fourier Transform to Accelerate the Computational Search for RNA Conformational Switches	PLOS ONE			English	Article							SECONDARY STRUCTURE; STRUCTURAL NEIGHBORS; SAMPLING ALGORITHM; ENERGY LANDSCAPE; RIBOSWITCHES; PATHWAYS; DESIGN; IDENTIFICATION	Using complex roots of unity and the Fast Fourier Transform, we design a new thermodynamics-based algorithm, FFTbor, that computes the Boltzmann probability that secondary structures differ by k base pairs from an arbitrary initial structure of a given RNA sequence. The algorithm, which runs in quartic time O(n(4)) and quadratic space O(n(2)), is used to determine the correlation between kinetic folding speed and the ruggedness of the energy landscape, and to predict the location of riboswitch expression platform candidates. A web server is available at http://bioinformatics.bc.edu/clotelab/FFTbor/.	[Senter, Evan; Dotu, Ivan; Clote, Peter] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA; [Sheikh, Saad] Univ Florida, Dept Comp Sci, Gainesville, FL USA; [Ponty, Yann] Ecole Polytech, Lab Informat, Palaiseau, France	Boston College; State University System of Florida; University of Florida; Institut Polytechnique de Paris	Clote, P (corresponding author), Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA.	clote@bc.edu	Ponty, Yann/AAC-7046-2020	Ponty, Yann/0000-0002-7615-3930; Dotu, Ivan/0000-0002-0438-9557	National Science Foundation [DMS-1016618, DMS-0817971]; Division Of Mathematical Sciences [1016618] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Source of funding provided by National Science Foundation grants DMS-1016618 and DMS-0817971 to PC, www.nsf.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Goodger C, 2005, NUCLEIC ACIDS RES, P33; ALTSCHUL SF, 1985, MOL BIOL EVOL, V2, P526; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andronescu M, 2004, J MOL BIOL, V336, P607, DOI 10.1016/j.jmb.2003.12.041; Bengert P, 2004, NUCLEIC ACIDS RES, V32, pW154, DOI 10.1093/nar/gkh352; Bergig Oriel, 2004, In Silico Biology, V4, P593; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Busch A, 2006, BIOINFORMATICS, V22, P1823, DOI 10.1093/bioinformatics/btl194; Chang TH, 2009, RNA, V15, P1426, DOI 10.1261/rna.1623809; Clote P, 2005, BIOINFORMATICS, V21, P4140, DOI 10.1093/bioinformatics/bti669; Clote P, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S5-S6; Cormen T, 1990, ALGORITHMS; Ding Y, 2003, NUCLEIC ACIDS RES, V31, P7280, DOI 10.1093/nar/gkg938; Dotu I, 2010, NUCLEIC ACIDS RES, V38, P1711, DOI 10.1093/nar/gkp1054; Flamm C, 2000, RNA, V6, P325, DOI 10.1017/S1355838200992161; Flamm C, 2001, RNA, V7, P254, DOI 10.1017/S1355838201000863; Freyhult E, 2007, BIOINFORMATICS, V23, P2054, DOI 10.1093/bioinformatics/btm314; Freyhult Eva, 2005, Appl Bioinformatics, V4, P53, DOI 10.2165/00822942-200504010-00006; Frigo M, 2005, P IEEE, V93, P216, DOI 10.1109/JPROC.2004.840301; Gardner PP, 2011, NUCLEIC ACIDS RES, V39, pD141, DOI 10.1093/nar/gkq1129; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Higham NJ, 2004, IMA J NUMER ANAL, V24, P547, DOI 10.1093/imanum/24.4.547; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Knight TF, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100028; Mandal M, 2004, NAT STRUCT MOL BIOL, V11, P29, DOI 10.1038/nsmb710; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Nawrocki EP, 2009, INFERNAL 1 0 INFEREN; NUSSINOV R, 1980, P NATL ACAD SCI-BIOL, V77, P6309, DOI 10.1073/pnas.77.11.6309; Serganov A, 2004, CHEM BIOL, V11, P1729, DOI 10.1016/j.chembiol.2004.11.018; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; Singh P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-325; Tucker BJ, 2005, CURR OPIN STRUC BIOL, V15, P342, DOI 10.1016/j.sbi.2005.05.003; Waldispuhl J, 2011, J COMPUT BIOL, V18, P1465, DOI 10.1089/cmb.2011.0181; Waldispuhl J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000124; Waldminghaus T, 2008, BIOL CHEM, V389, P1319, DOI 10.1515/BC.2008.150; Wolynes PG, 2005, PHILOS T R SOC A, V363, P453, DOI 10.1098/rsta.2004.1502; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; Zadeh JN, 2011, J COMPUT CHEM, V32, P439, DOI 10.1002/jcc.21633; Zar JH, 1999, BIOSTATISTICAL ANAL	40	17	17	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e50506	10.1371/journal.pone.0050506	http://dx.doi.org/10.1371/journal.pone.0050506			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284639	Green Published, gold, Green Submitted			2022-12-27	WOS:000312694300011
J	Guo, H; Ming, J; Liu, CP; Li, Z; Zhang, N; Cheng, HT; Wang, W; Shi, W; Shen, N; Zhao, QZ; Li, DP; Yi, PF; Wang, LQ; Wang, R; Xin, Y; Zhao, XW; Nie, X; Huang, T				Guo, Hui; Ming, Jie; Liu, Chunping; Li, Zhi; Zhang, Ning; Cheng, Hongtao; Wang, Wei; Shi, Wei; Shen, Na; Zhao, Qunzi; Li, Dapeng; Yi, Pengfei; Wang, Longqiang; Wang, Rui; Xin, Yue; Zhao, Xiangwang; Nie, Xiu; Huang, Tao			A Common Polymorphism near the ESR1 Gene Is Associated with Risk of Breast Cancer: Evidence from a Case-Control Study and a Meta-Analysis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCUS; ESTROGEN-RECEPTOR; ALLELES; CHINESE; VARIANTS; BRCA2; MARKERS; 6Q25.1; 1P11.2	Background: Genome-wide association studies have reported that a polymorphism near the estrogen receptor gene (ESR1) (rs2046210) is associated with a risk of breast cancer, with the A allele conferring an increased risk. However, considering the controversial results from more recent replicated studies, we conducted a case-control study in an independent Chinese Han population and a meta-analysis to clarify the association of this polymorphism with breast cancer risk. Method and Findings: A hospital-based case-control study including 461 cases and 537 controls from a Chinese Han population was conducted initially, and this study showed that the rs2046210 A allele was significantly associated with breast cancer risk, with an OR of 1.32 (95% CI = 1.10-1.59). Subsequently, a meta-analysis integrating the current study and previous publications with a total of 53,379 cases and 55,493 controls was performed to further confirm our findings. Similarly, a significant association between this polymorphism and breast cancer risk was also observed in the overall population especially among Asians, with ORs for per A allele of 1.14 (95% CI = 1.10-1.18) in the overall population and 1.27 (95% CI = 1.23-1.31) in the Asian population. Conclusion: Our results provide strong evidence to support that the common polymorphism near the ESR1 gene, rs2046210, is associated with an increased risk of breast cancer in Asian and European populations but not in Africans, although the biological mechanisms need to be further investigated.	[Nie, Xiu] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Pathol, Wuhan 430074, Peoples R China; [Cheng, Hongtao; Wang, Wei] Hubei Canc Hosp, Dept Breast Surg, Wuhan, Peoples R China; [Guo, Hui; Ming, Jie; Liu, Chunping; Li, Zhi; Zhang, Ning; Shi, Wei; Shen, Na; Zhao, Qunzi; Li, Dapeng; Yi, Pengfei; Wang, Longqiang; Wang, Rui; Xin, Yue; Zhao, Xiangwang; Huang, Tao] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Breast & Thyroid Surg, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Nie, X (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Pathol, Wuhan 430074, Peoples R China.	niexiuyishi@126.com; huangtaowh@gmail.com			National Natural Science Foundation of China [30972935, 81001171, 81202094]; Key Technologies R & D Program of Hubei Province [2007AA302B07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Technologies R & D Program of Hubei Province	This work was supported by the National Natural Science Foundation of China (grants 30972935, 81001171 and 81202094) and Key Technologies R & D Program of Hubei Province (grant 2007AA302B07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou AC, 2011, HUM MOL GENET, V20, P3304, DOI 10.1093/hmg/ddr226; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Cai QY, 2011, HUM MOL GENET, V20, P4991, DOI 10.1093/hmg/ddr405; Cai QY, 2011, CANCER RES, V71, P1344, DOI 10.1158/0008-5472.CAN-10-2733; Cai QY, 2003, CANCER EPIDEM BIOMAR, V12, P853; Campa D, 2011, JNCI-J NATL CANCER I, V103, P1252, DOI 10.1093/jnci/djr265; Carlson RWAD, 2012, NCCN CLIN PRACTICE G; Clemons M, 2001, NEW ENGL J MED, V344, P276, DOI 10.1056/NEJM200101253440407; Dai JC, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3101; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Easton D F, 1999, Breast Cancer Res, V1, P14, DOI 10.1186/bcr6; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fletcher O, 2011, JNCI-J NATL CANCER I, V103, P425, DOI 10.1093/jnci/djq563; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Han J, 2011, BREAST CANCER RES TR, V129, P901, DOI 10.1007/s10549-011-1527-x; Han W, 2011, CANCER EPIDEM BIOMAR, V20, P793, DOI 10.1158/1055-9965.EPI-10-1282; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang YD, 2011, BREAST CANCER RES TR, V128, P251, DOI 10.1007/s10549-010-1327-8; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Kibriya MG, 2009, BREAST CANCER RES TR, V114, P463, DOI 10.1007/s10549-008-0039-9; Kim HC, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3158; Kiyotani K, 2012, HUM MOL GENET, V21, P1665, DOI 10.1093/hmg/ddr597; Lakhani SR, 2002, J CLIN ONCOL, V20, P2310, DOI 10.1200/JCO.2002.09.023; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Li Guoliang, 2011, Chin J Cancer, V30, P138; Li N, 2010, BREAST CANCER RES TR, V121, P177, DOI 10.1007/s10549-009-0532-9; Long JR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002532; Long JR, 2010, CANCER EPIDEM BIOMAR, V19, P2357, DOI 10.1158/1055-9965.EPI-10-0054; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Mullen B, 2001, PERS SOC PSYCHOL B, V27, P1450, DOI 10.1177/01461672012711006; Mulligan AM, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3052; Nathanson KN, 2001, NAT MED, V7, P552, DOI 10.1038/87876; Pabalan NA, 2010, ASIAN PAC J CANCER P, V11, P33; Shu XO, 2012, CANCER RES, V72, P1182, DOI 10.1158/0008-5472.CAN-11-2561; Stacey SN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001029; Stevens KN, 2011, CANCER RES, V71, P6240, DOI 10.1158/0008-5472.CAN-11-1266; Sueta A, 2012, BREAST CANCER RES TR, V132, P711, DOI 10.1007/s10549-011-1904-5; Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; Zheng W, 2010, JNCI-J NATL CANCER I, V102, P972, DOI 10.1093/jnci/djq170; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318; Zhong H, 2010, GENET EPIDEMIOL, V34, P78, DOI 10.1002/gepi.20437	48	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52445	10.1371/journal.pone.0052445	http://dx.doi.org/10.1371/journal.pone.0052445			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272245	Green Published, gold, Green Submitted			2022-12-27	WOS:000312483300087
J	Barnwal, RP; Agarwal, G; Chary, KVR				Barnwal, Ravi Pratap; Agarwal, Geetika; Chary, Kandala V. R.			Guanidine-HCl Dependent Structural Unfolding of M-Crystallin: Fluctuating Native State Like Topologies and Intermolecular Association	PLOS ONE			English	Article							AMINO-ACID-RESIDUES; BACKBONE DYNAMICS; LENS CRYSTALLINS; SECONDARY STRUCTURE; PROTEIN RESPONSE; NMR-SPECTROSCOPY; DENATURED STATE; PRION PROTEIN; CA2+ BINDING; DISEASE	Numerous experimental techniques and computational studies, proposed in recent times, have revolutionized the understanding of protein-folding paradigm. The complete understanding of protein folding and intermediates are of medical relevance, as the aggregation of misfolding proteins underlies various diseases, including some neurodegenerative disorders. Here, we describe the unfolding of M-crystallin, a beta gamma-crystallin homologue protein from archaea, from its native state to its denatured state using multidimensional NMR and other biophysical techniques. The protein, which was earlier characterized to be a predominantly beta-sheet protein in its native state, shows different structural propensities (alpha and beta), under different denaturing conditions. In 2 M GdmCl, the protein starts showing two distinct sets of peaks, with one arising from a partially unfolded state and the other from a completely folded state. The native secondary structural elements start disappearing as the denaturant concentration approaches 4 M. Subsequently, the protein is completely unfolded when the denaturant concentration is 6 M. The N-15 relaxation data (T-1/T-2), heteronuclear H-1-N-15 Overhauser effects (nOes), NOESY data, and other biophysical data taken together indicate that the protein shows a consistent, gradual change in its structural and motional preferences with increasing GdmCl concentration.	[Barnwal, Ravi Pratap; Agarwal, Geetika; Chary, Kandala V. R.] Tata Inst Fundamental Res, Dept Chem Sci, Bombay 400005, Maharashtra, India	Tata Institute of Fundamental Research (TIFR)	Barnwal, RP (corresponding author), Univ Washington, Dept Chem, Seattle, WA 98195 USA.	barnwal@u.washington.edu; chary@tifr.res.in	Barnwal, Ravi Pratap/G-7191-2012	Barnwal, Ravi Pratap/0000-0003-3156-5357	Department of Science and Technology; Department of Biotechnology; Council of Scientific and Industrial Research; Tata Institute of Fundamental Research, Mumbai	Department of Science and Technology(Department of Science & Technology (India)); Department of Biotechnology; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Tata Institute of Fundamental Research, Mumbai	The facilities provided by the National Facility for High Field NMR, and the support of the Department of Science and Technology, Department of Biotechnology, Council of Scientific and Industrial Research, and Tata Institute of Fundamental Research, Mumbai, are greatly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almstedt K, 2004, J MOL BIOL, V342, P619, DOI 10.1016/j.jmb.2004.07.024; Aravind P, 2009, BIOCHEMISTRY-US, V48, P12180, DOI 10.1021/bi9017076; Barnwal RP, 2011, PROTEINS, V79, P569, DOI 10.1002/prot.22905; Barnwal RP, 2009, BIOMOL NMR ASSIGN, V3, P107, DOI 10.1007/s12104-009-9152-x; Barnwal RP, 2008, J BIOMOL NMR, V42, P149, DOI 10.1007/s10858-008-9273-z; Barnwal RP, 2008, J BIOMOL NMR, V41, P191, DOI 10.1007/s10858-008-9254-2; Barnwal RP, 2007, J BIOMOL NMR, V39, P259, DOI 10.1007/s10858-007-9200-8; Barnwal RP, 2009, J MOL BIOL, V386, P675, DOI 10.1016/j.jmb.2008.12.058; Barnwal RP, 2008, CURR SCI, V94, P5; Baxter NJ, 1997, J BIOMOL NMR, V9, P359, DOI 10.1023/A:1018334207887; Benedek GB, 1997, INVEST OPHTH VIS SCI, V38, P1911; Bevington PR, 2003, DATA REDUCTION ERROR, Vxi; Bezsonova I, 2007, J AM CHEM SOC, V129, P1826, DOI 10.1021/ja065173o; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Chary K. V. R., 2008, NMR BIOL SYSTEMS MOL; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dyson HJ, 1998, NAT STRUCT BIOL, V5, P499, DOI 10.1038/739; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Eliezer D, 2000, BIOCHEMISTRY-US, V39, P2894, DOI 10.1021/bi992545f; Eliezer D, 1998, NAT STRUCT BIOL, V5, P148; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FARROW NA, 1995, J BIOMOL NMR, V6, P153, DOI 10.1007/BF00211779; Felitsky DJ, 2008, P NATL ACAD SCI USA, V105, P6278, DOI 10.1073/pnas.0710641105; Forman MS, 2003, TRENDS NEUROSCI, V26, P407, DOI 10.1016/S0166-2236(03)00197-8; Gerum C, 2009, ANGEW CHEM INT EDIT, V48, P9452, DOI 10.1002/anie.200903771; Gong H, 2008, P NATL ACAD SCI USA, V105, P3321, DOI 10.1073/pnas.0712240105; Hung HC, 2003, B MATH BIOL, V65, P553, DOI 10.1016/S0092-8240(03)00024-7; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kazmirski SL, 1998, J MOL BIOL, V277, P487, DOI 10.1006/jmbi.1998.1634; Kazmirski SL, 1998, J MOL BIOL, V284, P793, DOI 10.1006/jmbi.1998.2192; Kazmirski SL, 2001, P NATL ACAD SCI USA, V98, P4349, DOI 10.1073/pnas.071054398; Kneller JM, 2002, J AM CHEM SOC, V124, P1852, DOI 10.1021/ja017461k; KORDEL J, 1992, BIOCHEMISTRY-US, V31, P4856; Kretschmar W, 1999, J MOL BIOL, V289, P701, DOI 10.1006/jmbi.1999.2833; Kudo T, 2002, ANN NY ACAD SCI, V977, P349, DOI 10.1111/j.1749-6632.2002.tb04837.x; Kumar A, 2006, BIOPHYS J, V90, P2498, DOI 10.1529/biophysj.105.071746; Kumar A, 2006, J MOL BIOL, V361, P180, DOI 10.1016/j.jmb.2006.06.003; Lefevre JF, 1996, BIOCHEMISTRY-US, V35, P2674, DOI 10.1021/bi9526802; Lundstrom P, 2005, P NATL ACAD SCI USA, V102, P16984, DOI 10.1073/pnas.0504361102; Ma B, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.100; Meinhold DW, 2011, P NATL ACAD SCI USA, V108, P9078, DOI 10.1073/pnas.1105682108; Mishra A, 2012, J MOL BIOL, V415, P75, DOI 10.1016/j.jmb.2011.10.037; Mok KH, 2007, NATURE, V447, P106, DOI 10.1038/nature05728; Patel S, 2004, BIOCHEMISTRY-US, V43, P1724, DOI 10.1021/bi0347104; Rezaei H, 2002, J MOL BIOL, V322, P799, DOI 10.1016/S0022-2836(02)00856-2; ROSE GD, 1985, SCIENCE, V229, P834, DOI 10.1126/science.4023714; Santucci R, 2008, MINI-REV MED CHEM, V8, P57, DOI 10.2174/138955708783331522; Scheibel T, 2006, HANDB EXP PHARM, V172, P199; Scriven P, 2007, J MOL MED, V85, P331, DOI 10.1007/s00109-006-0150-5; Shtilerman M, 1999, SCIENCE, V284, P822, DOI 10.1126/science.284.5415.822; Silva JL, 2006, BBA-PROTEINS PROTEOM, V1764, P443, DOI 10.1016/j.bbapap.2005.11.012; Sinha D, 2012, TRANSGENIC RES, V21, P1033, DOI 10.1007/s11248-012-9608-0; Slavotinek AM, 2001, TRENDS GENET, V17, P528, DOI 10.1016/S0168-9525(01)02413-1; Solomon B, 2002, CURR MED CHEM, V9, P1737; Suman SK, 2011, J BIOL CHEM, V286, P43891, DOI 10.1074/jbc.M111.247890; Wenk M, 1998, EUR J BIOCHEM, V255, P604, DOI 10.1046/j.1432-1327.1998.2550604.x; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; WISTOW G, 1990, J MOL EVOL, V30, P140, DOI 10.1007/BF02099940; WISTOW GJ, 1988, ANNU REV BIOCHEM, V57, P479, DOI 10.1146/annurev.bi.57.070188.002403; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003	62	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e42948	10.1371/journal.pone.0042948	http://dx.doi.org/10.1371/journal.pone.0042948			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284604	gold, Green Published, Green Submitted			2022-12-27	WOS:000312435900001
J	Gautrey, HL; Tyson-Capper, AJ				Gautrey, Hannah L.; Tyson-Capper, Alison J.			Regulation of Mcl-1 by SRSF1 and SRSF5 in Cancer Cells	PLOS ONE			English	Article							SPLICING FACTOR SF2/ASF; HUMAN BREAST-CANCER; TRANSLATIONAL CONTROL; APOPTOSIS; IDENTIFICATION; PROTOONCOGENE; EXPRESSION; OLIGONUCLEOTIDES; PROLIFERATION; CARCINOMA	Up-regulation of the apoptosis-regulatory gene Mcl-1 (myeloid cell leukemia-1) occurs in different cancer types and is linked with drug resistance to cancer therapies. It is well known that Mcl-1 pre-mRNA undergoes alternative splicing events to produce two functionally distinct proteins, Mcl-1S (pro-apoptotic) and Mcl-lL (anti-apoptotic); the latter isoform is predominant in different cancers including breast and ovarian cancer cells. In the present study we report that the RNA-binding protein (RBP) and proto-oncogene SRSF1 (serine and arginine-rich splicing factor 1) influences splicing of Mcl-1 in both MCF-7 and MDA-MB-231 breast cancer cells and JAR choriocarcinoma cells; we also show for the first time that another RBP SRSF5 affects splicing of Mcl-1 in the MCF-7 cells. Moreover, we report that SRSF1 is involved in other aspects of Mcl-1 regulation with knockdown of SRSF1, by RNAi, resulting in a significant decrease in Mcl-1 protein levels in MCF-7 cells but an increase in JAR cells, respectively, by potentially affecting protein stability and translation of Mcl-l. The key findings from this study highlight the importance of the cellular context of different cancer cells for the function of multifunctional RBPs like SRSF1 and have implications for therapeutic approaches employed to target Mcl-1.	[Gautrey, Hannah L.; Tyson-Capper, Alison J.] Newcastle Univ, Inst Cellular Med, Fac Med Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Tyson-Capper, AJ (corresponding author), Newcastle Univ, Inst Cellular Med, Fac Med Sci, Framlington Pl, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	Alison.Tyson-Capper@ncl.ac.uk			JGW Patterson Foundation; Newcastle Healthcare Charity (RVI/NGH); Newcastle upon Tyne Hospitals NHS Charity	JGW Patterson Foundation; Newcastle Healthcare Charity (RVI/NGH); Newcastle upon Tyne Hospitals NHS Charity	This work was supported by a grant awarded from the JGW Patterson Foundation and supplementary funding from the Newcastle Healthcare Charity (RVI/NGH) and Newcastle upon Tyne Hospitals NHS Charity (FH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichberger KJ, 2005, BLOOD, V105, P3303, DOI 10.1182/blood-2004-02-0749; Akgul C, 2004, CELL MOL LIFE SCI, V61, P2189, DOI 10.1007/s00018-004-4001-7; Akgul C, 2009, CELL MOL LIFE SCI, V66, P1326, DOI 10.1007/s00018-008-8637-6; Anczukow O, 2012, NAT STRUCT MOL BIOL, V19, P220, DOI 10.1038/nsmb.2207; Bae J, 2000, J BIOL CHEM, V275, P25255, DOI 10.1074/jbc.M909826199; Benjamin CW, 1998, MOL PHARMACOL, V53, P446, DOI 10.1124/mol.53.3.446; Bingle CD, 2000, J BIOL CHEM, V275, P22136, DOI 10.1074/jbc.M909572199; Brenner D, 2009, CURR OPIN CELL BIOL, V21, P871, DOI 10.1016/j.ceb.2009.09.004; Bushell M, 2008, MOL CELL, V30, P262, DOI 10.1016/j.molcel.2008.04.007; Chetoui N, 2008, MOL CANCER RES, V6, P42, DOI 10.1158/1541-7786.MCR-07-0080; Ding QQ, 2007, CANCER RES, V67, P4564, DOI 10.1158/0008-5472.CAN-06-1788; Ghigna C, 2005, MOL CELL, V20, P881, DOI 10.1016/j.molcel.2005.10.026; Goncalves V, 2009, HUM MOL GENET, V18, P3696, DOI 10.1093/hmg/ddp317; Grosso AR, 2008, EMBO REP, V9, P1087, DOI 10.1038/embor.2008.189; Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021; Huang CS, 2007, CLIN CHIM ACTA, V384, P69, DOI 10.1016/j.cca.2007.06.001; Jia R, 2010, INT J BIOL SCI, V6, P806; Karni R, 2008, P NATL ACAD SCI USA, V105, P15323, DOI 10.1073/pnas.0801376105; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Michlewski G, 2008, MOL CELL, V30, P179, DOI 10.1016/j.molcel.2008.03.013; Mills JR, 2008, P NATL ACAD SCI USA, V105, P10853, DOI 10.1073/pnas.0804821105; Mitchell C, 2010, CANCER BIOL THER, V10, P907, DOI 10.4161/cbt.10.9.13273; Moore MJ, 2010, CELL, V142, P625, DOI 10.1016/j.cell.2010.07.019; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Olshavsky NA, 2010, CANCER RES, V70, P3975, DOI 10.1158/0008-5472.CAN-09-3468; Placzek WJ, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.18; Pradelli LA, 2010, ONCOGENE, V29, P1641, DOI 10.1038/onc.2009.448; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; Shieh JJ, 2009, J INVEST DERMATOL, V129, P2497, DOI 10.1038/jid.2009.83; Sieghart W, 2006, J HEPATOL, V44, P151, DOI 10.1016/j.jhep.2005.09.010; Stewart ML, 2010, NAT CHEM BIOL, V6, P595, DOI [10.1038/NCHEMBIO.391, 10.1038/nchembio.391]; Thomas LW, 2010, FEBS LETT, V584, P2981, DOI 10.1016/j.febslet.2010.05.061; Venables JP, 2008, CANCER RES, V68, P9525, DOI 10.1158/0008-5472.CAN-08-1769; Wu H, 2010, MOL CELL, V38, P67, DOI 10.1016/j.molcel.2010.02.021; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	36	60	65	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51497	10.1371/journal.pone.0051497	http://dx.doi.org/10.1371/journal.pone.0051497			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284704	Green Published, gold, Green Submitted			2022-12-27	WOS:000312435900025
J	Neron, S; Roy, A; Dumont, N				Neron, Sonia; Roy, Annie; Dumont, Nellie			Large-Scale In Vitro Expansion of Polyclonal Human Switched-Memory B Lymphocytes	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; EPSTEIN-BARR-VIRUS; CD40 STIMULATION; T-CELLS; INTRAVENOUS IMMUNOGLOBULIN; THERAPEUTIC ANTIBODIES; CANCER-IMMUNOTHERAPY; LIGAND; IGG; SUBPOPULATIONS	Polyclonal preparations of therapeutic immunoglobulins, namely intravenous immunoglobulins (IVIg), are essential in the treatment of immunodeficiency and are increasingly used for the treatment of autoimmune and inflammatory diseases. Currently, patients' accessibility to IVIg depends exclusively upon volunteer blood donations followed by the fractionation of pooled human plasma obtained from thousands of individuals. Presently, there are no in vitro cell culture procedures allowing the preparation of polyclonal human antibodies. All in vitro human therapeutic antibodies that are currently generated are based on monoclonal antibodies, which are mostly issued from genetic engineering or single cell antibody technologies. Here, we describe an in vitro cell culture system, using CD40-CD154 interactions, that leads to a 1x10(6)-fold expansion of switched memory B lymphocytes in approximately 50 days. These expanded cells secrete polyclonal IgG, which distribution into IgG(1), IgG(2), IgG(3) and IgG(4) is similar to that of normal human serum. Such in vitro generated IgG showed relatively low self-reactivity since they interacted moderately with only 24 human antigens among a total of 9484 targets. Furthermore, up to one liter of IgG secreting cells can be produced in about 40 days. This experimental model, providing large-scale expansion of human B lymphocytes, represents a critical step toward the in vitro production of polyclonal human IgG and a new method for the ex vivo expansion of B cells for therapeutic purposes.	[Neron, Sonia; Roy, Annie; Dumont, Nellie] Hema Quebec, Ingn Cellulaire, Rech & Dev, Quebec City, PQ, Canada; [Neron, Sonia] Univ Laval, Fac Sci & Genie, Dept Biochim & Microbiol, Quebec City, PQ G1K 7P4, Canada	Hema-Quebec; Laval University	Neron, S (corresponding author), Hema Quebec, Ingn Cellulaire, Rech & Dev, Quebec City, PQ, Canada.	sonia.neron@hema-quebec.qc.ca						Al Tabaa Y, 2009, BLOOD, V113, P604, DOI 10.1182/blood-2008-02-136903; Ballow M, 2009, CLIN EXP IMMUNOL, V158, P14, DOI [10.1111/j.1365-2249.2009.04023.X, 10.1111/j.1365-2249.2009.04023.x]; BANCHEREAU J, 1991, SCIENCE, V251, P70, DOI 10.1126/science.1702555; Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; Beerli RR, 2010, MABS, P2; Bussone G, 2009, PROTEOMICS, V9, P2253, DOI 10.1002/pmic.200800819; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Deneys V, 2001, J IMMUNOL METHODS, V253, P23, DOI 10.1016/S0022-1759(01)00338-6; Ducas E, 2009, J IMMUNOL METHODS, V344, P133, DOI 10.1016/j.jim.2009.03.009; Durandy A, 2009, CLIN EXP IMMUNOL, V158, P2, DOI [10.1111/j.1365-2249.2009.04022.X, 10.1111/j.1365-2249.2009.04022.x]; Elovaara I, 2010, ACTA NEUROL SCAND, V122, P309, DOI 10.1111/j.1600-0404.2009.01317.x; Fecteau JF, 2009, IMMUNOLOGY, V128, pe353, DOI 10.1111/j.1365-2567.2008.02976.x; Fecteau JF, 2003, J IMMUNOL, V171, P4621, DOI 10.4049/jimmunol.171.9.4621; Frandsen TP, 2011, BIOTECHNOL BIOENG, V108, P2171, DOI 10.1002/bit.23166; HAMILTON RG, 1987, CLIN CHEM, V33, P1707; Johansson C, 2005, CLIN EXP IMMUNOL, V141, P279, DOI 10.1111/j.1365-2249.2005.02843.x; Kondo E, 2009, CLIN EXP IMMUNOL, V155, P249, DOI 10.1111/j.1365-2249.2008.03820.x; Kuppers R, 2003, NAT REV IMMUNOL, V3, P801, DOI 10.1038/nri1201; Kuroiwa Y, 2009, NAT BIOTECHNOL, V27, P173, DOI 10.1038/nbt.1521; Lapointe R, 2003, CANCER RES, V63, P2836; Neron S, 1996, IMMUNOL INVEST, V25, P79; Neron S, 2006, INT IMMUNOL, V18, P375, DOI 10.1093/intimm/dxh377; Neron S, 2005, IMMUNOLOGY, V116, P454, DOI 10.1111/j.1365-2567.2005.02244.x; Neron S, 2011, ADV MED BIOL, P145; Neron S, 2012, BIOCH ANAL BIOCH S, pS8, DOI [10.4172/2161-1009.S4178-4001, DOI 10.4172/2161-1009.S4178-4001]; Neron S, 2007, TRANSFUSION, V47, P1042, DOI 10.1111/j.1537-2995.2007.01233.x; Neron S, 2011, ARCH IMMUNOL THER EX, V59, P25, DOI 10.1007/s00005-010-0108-8; Perez-Andres M, 2010, CYTOM PART B-CLIN CY, V78B, pS47, DOI 10.1002/cyto.b.20547; Radosevich M, 2010, VOX SANG, V98, P12, DOI 10.1111/j.1423-0410.2009.01226.x; Robak T, 2011, ASH ANN M, V118, P527; Robinson WH, 2002, NAT MED, V8, P295, DOI 10.1038/nm0302-295; Roughan JE, 2010, J VIROL, V84, P1158, DOI 10.1128/JVI.01780-09; Roughan JE, 2009, J VIROL, V83, P3968, DOI 10.1128/JVI.02609-08; Salfeld JG, 2007, NAT BIOTECHNOL, V25, P1369, DOI 10.1038/nbt1207-1369; Schultze JL, 1997, J CLIN INVEST, V100, P2757, DOI 10.1172/JCI119822; Schultze JL, 2004, TRENDS IMMUNOL, V25, P659, DOI 10.1016/j.it.2004.09.016; Souza TA, 2007, J IMMUNOL, V179, P3153, DOI 10.4049/jimmunol.179.5.3153; Tiller T, 2011, NEW BIOTECHNOL, V28, P453, DOI 10.1016/j.nbt.2011.03.014; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Waltz E, 2006, NAT BIOTECHNOL, V24, P1181, DOI 10.1038/nbt1006-1181; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Wiesner M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001464; Wu C, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-370; Zheng J, 2010, CELL MOL IMMUNOL, V7, P44, DOI 10.1038/cmi.2009.103	44	11	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51946	10.1371/journal.pone.0051946	http://dx.doi.org/10.1371/journal.pone.0051946			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284827	Green Published, Green Submitted, gold			2022-12-27	WOS:000312435900065
J	Ritchie, IRW; Dyck, DJ				Ritchie, Ian R. W.; Dyck, David J.			Rapid Loss of Adiponectin-Stimulated Fatty Acid Oxidation in Skeletal Muscle of Rats Fed a High Fat Diet Is Not Due to Altered Muscle Redox State	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; INSULIN-RESISTANCE; SOLEUS MUSCLE; MITOCHONDRIAL DYSFUNCTION; GLOBULAR ADIPONECTIN; GLUCOSE-TRANSPORT; STRESS; GLUTATHIONYLATION; ACETYLCYSTEINE	A high fat (HF) diet rapidly impairs the ability of adiponectin (Ad) to stimulate fatty acid (FA) oxidation in oxidative soleus muscle, but the underlying mechanism remains elusive. Mere days of HF feeding also increase the muscle's production and accumulation of reactive oxygen species (ROS) and shift cellular redox to a more oxidized state. It seems plausible that this shift towards a more oxidized state might act as negative feedback to suppress the ability of Ad to stimulate FA oxidation and generate more ROS. Therefore, we sought to determine whether i)a shift towards a more oxidized redox state (reduction in GSH/2GSSG) coincided with impaired Ad-stimulated palmitate oxidation in oxidative and glycolytic rodent muscle after 5 days of HF feeding (60% kCal), and ii)if supplementation with the antioxidant, N-acetylcysteine (NAC) could prevent the HF-diet induced impairment in Ad-response. Globular Ad (gAd) increased palmitate oxidation in isolated soleus and EDL muscles by 42% and 34%, respectively (P<0.05) but this was attenuated with HF feeding in both muscles. HF feeding decreased total GSH (-26%, p<0.05) and GSH/2GSSG (-49%, p<0.05) in soleus, but not EDL. Supplementation with NAC prevented the HF diet-induced reductions in GSH and GSH/2GSSG in soleus, but did not prevent the loss of Ad response in either muscle. Furthermore, direct incubations with H2O2 did not impair Ad-stimulated FA oxidation in either muscle. In conclusion, our data indicates that skeletal muscle Ad resistance is rapidly induced in both oxidative and glycolytic muscle, independently of altered cellular redox state.	[Ritchie, Ian R. W.; Dyck, David J.] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada	University of Guelph	Dyck, DJ (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada.	ddyck@uoguelph.ca			Natural Sciences and Engineering Research Council of Canada [RGPIN 217437-11]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding was provided by Natural Sciences and Engineering Research Council of Canada (RGPIN 217437-11). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht SC, 2011, CELL METAB, V14, P819, DOI 10.1016/j.cmet.2011.10.010; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Barazzoni R, 2012, DIABETOLOGIA, V55, P773, DOI 10.1007/s00125-011-2396-x; Barrett WC, 1999, BIOCHEMISTRY-US, V38, P6699, DOI 10.1021/bi990240v; Biswas S, 2006, BIOCHEM PHARMACOL, V71, P551, DOI 10.1016/j.bcp.2005.10.044; Bonen A, 2009, AM J PHYSIOL-REG I, V297, pR1202, DOI 10.1152/ajpregu.90820.2008; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Bruce CR, 2005, DIABETES, V54, P3154, DOI 10.2337/diabetes.54.11.3154; Campbell SE, 2004, J BIOL CHEM, V279, P36235, DOI 10.1074/jbc.M400566200; Griffith OW, 1999, ADV ENZYMOL RAMB, V73, P209, DOI 10.1002/9780470123195.ch7; Horowitz JF, 1999, AM J PHYSIOL-ENDOC M, V276, pE278, DOI 10.1152/ajpendo.1999.276.2.E278; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Klatt P, 1999, FASEB J, V13, P1481, DOI 10.1096/fasebj.13.12.1481; Matuszczak Y, 2005, MUSCLE NERVE, V32, P633, DOI 10.1002/mus.20385; Mullen KL, 2007, AM J PHYSIOL-ENDOC M, V293, pE83, DOI 10.1152/ajpendo.00545.2006; Mullen KL, 2009, AM J PHYSIOL-REG I, V296, pR243, DOI 10.1152/ajpregu.90774.2008; NEMANI R, 1993, ARCH BIOCHEM BIOPHYS, V300, P24, DOI 10.1006/abbi.1993.1004; Pineda-Molina E, 2001, BIOCHEMISTRY-US, V40, P14134, DOI 10.1021/bi011459o; Pinheiro CHJ, 2012, SCAND J MED SCI SPOR, V22, P24, DOI 10.1111/j.1600-0838.2010.01143.x; Raddatz E, 2011, AM J PHYSIOL-HEART C, V300, pH820, DOI 10.1152/ajpheart.00827.2010; Ritchie IRW, 2011, AM J PHYSIOL-REG I, V300, pR492, DOI 10.1152/ajpregu.00602.2010; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Seifert EL, 2010, J BIOL CHEM, V285, P5748, DOI 10.1074/jbc.M109.026203; Steinberg GR, 2000, AM J PHYSIOL-ENDOC M, V279, pE1374, DOI 10.1152/ajpendo.2000.279.6.E1374; Tishinsky JM, 2012, AM J PHYSIOL-REG I, V302, pR598, DOI 10.1152/ajpregu.00328.2011; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Wouters MA, 2011, INT J BIOCHEM CELL B, V43, P1079, DOI 10.1016/j.biocel.2011.04.002; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557	32	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52193	10.1371/journal.pone.0052193	http://dx.doi.org/10.1371/journal.pone.0052193			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284930	gold, Green Submitted, Green Published			2022-12-27	WOS:000312435900084
J	Yu, ZB; Han, SP; Chu, JH; Xu, ZY; Zhu, C; Guo, XR				Yu, Zhangbin; Han, Shuping; Chu, Jiahui; Xu, Zhongya; Zhu, Chun; Guo, Xirong			Trends in Overweight and Obesity among Children and Adolescents in China from 1981 to 2010: A Meta-Analysis	PLOS ONE			English	Article							BODY-MASS INDEX; CORONARY-HEART-DISEASE; UNITED-STATES; CHILDHOOD OBESITY; RISK-FACTORS; SOCIOECONOMIC-STATUS; ADULT HYPERTENSION; PRESCHOOL-CHILDREN; FEEDING BEHAVIORS; MAINLAND CHINA	Background: Overweight/obesity is a serious public health problem that affects a large part of the world population across all age and racial/ethnic groups. However, there has not been a meta-analysis of the prevalence of childhood and adolescent overweight/obesity in China during the past 30 years. Methods: The China National Knowledge Infrastructure and Wanfang DATA, MEDLINE, EMBASE and Cumulative Index to Nursing and Allied Health Literature were searched for relevant studies published between January 1970 and June 2012. The prevalence of overweight/obesity over time was pooled using Stata/SE, version 9. Summary statistics (odds ratios, ORs) were used to compare sex-specific and urban-rural preponderance of overweight/obesity using Review Manager. Results: After screening 1326 papers, we included 35 papers (41 studies), most of medium quality. The prevalence of overweight/obesity increased from 1.8% (95% confidence interval [CI], 0.4%-3.1%) and 0.4% (95% CI, -0.1% to -0.8%) respectively in 1981-1985 to 13.1% (95% CI, 11.2%-15.0%) and 7.5% (95% CI, 6.6%-8.4%) respectively in 2006-2010. The average annual increase was 8.3% and 12.4% respectively. Boys were more likely to be overweight/obese than girls (OR, 1.36; 95% CI, 1.24-1.49 and OR, 1.68; 95% CI, 1.52-1.86 respectively). The prevalence of overweight/obesity was higher in urban areas than in rural areas (OR, 1.66; 95% CI, 1.54-1.79 and OR, 1.97; 95% CI, 1.68-2.30 respectively). For age-specific subgroup analyses, both overweight and obesity increased more rapidly in the toddler stage than in other developmental stages. Sensitivity analyses showed that sample-size differences, study quality, overweight/obesity criteria and geographical distribution affected overweight/obesity prevalence. Conclusions: Toddlers and urban boys were at particularly high risk; the prevalence in these groups increased more rapidly than in their counterparts. Public health prevention strategies are urgently needed to modify health behaviors of children and adolescents and control overweight/obesity in China.	[Yu, Zhangbin; Han, Shuping; Chu, Jiahui; Xu, Zhongya; Zhu, Chun; Guo, Xirong] Nanjing Med Univ, Nanjing Matern & Child Hlth Care Hosp, Dept Pediat, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Chu, Jiahui; Xu, Zhongya] Nanjing Med Univ, Sch Clin Med 1, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Guo, XR (corresponding author), Nanjing Med Univ, Nanjing Matern & Child Hlth Care Hosp, Dept Pediat, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	xrguo@njmu.edu.cn			National Key Basic Research Program of China [2013CB530604]; National Natural Science Foundation of China [81270928]; Priority Academic Program Development of Jiangsu Higher Education Institutions [201104013]; Natural Science Foundation of Jiangsu Province [BK2011107]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by grants from the National Key Basic Research Program of China (2013CB530604), the National Natural Science Foundation of China (grant no. 81270928), the Priority Academic Program Development of Jiangsu Higher Education Institutions (grant no. 201104013), and the Natural Science Foundation of Jiangsu Province (grant no. BK2011107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed ML, 2009, TRENDS ENDOCRIN MET, V20, P237, DOI 10.1016/j.tem.2009.02.004; Andegiorgish AK, 2012, EUR J PEDIATR, V171, P697, DOI 10.1007/s00431-011-1636-x; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Baskin ML, 2005, OBES REV, V6, P5, DOI 10.1111/j.1467-789X.2005.00165.x; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Benton D, 2004, INT J OBESITY, V28, P858, DOI 10.1038/sj.ijo.0802532; Boehmer Tegan K, 2007, Prev Chronic Dis, V4, pA56; Bovet P, 2008, OBES REV, V9, P511, DOI 10.1111/j.1467-789X.2008.00513.x; Burdette HL, 2005, PEDIATRICS, V116, P657, DOI 10.1542/peds.2004-2443; Cao ZQ, 2012, AM J HYPERTENS, V25, P576, DOI 10.1038/ajh.2012.5; Carruth BR, 2004, J AM DIET ASSOC, V104, pS51, DOI 10.1016/j.jada.2003.10.019; Chan L, 2011, MATERN CHILD HLTH J, V15, P1363, DOI 10.1007/s10995-010-0686-4; Chen CM, 2008, OBES REV, V9, P14, DOI 10.1111/j.1467-789X.2007.00433.x; Chen C M, 1986, Food Nutr (Roma), V12, P58; Chen CM, 2009, GUIDELINE PREVENTION; Chen M, 2002, CHINA PUBLIC HLTH, V18, P161; Chen TJ, 2011, ACTA PAEDIATR, V100, P1583, DOI 10.1111/j.1651-2227.2011.02397.x; Cheng TO, 2005, INT J CARDIOL, V98, P173, DOI 10.1016/j.ijcard.2004.08.019; Chinese National Survey on Students Constitution and Health (CNSSCH), 1993, 1991 CHIN NAT SURV S; Chinese National Survey on Students Constitution and Health (CNSSCH), 1997, 1995 CHIN NAT SURV S; Chinese National Survey on Students Constitution and Health (CNSSCH), 2007, 2005 CHIN NAT SURV S; Chinese National Survey on Students Constitution and Health (CNSSCH), 1987, 1985 CHIN NAT SURV S; Chinese National Survey on Students Constitution and Health (CNSSCH), 2002, 2000 CHIN NAT SURV S; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Cui ZH, 2010, INT J PEDIATR OBES, V5, P365, DOI 10.3109/17477166.2010.490262; Davis AM, 2011, J PEDIATR PSYCHOL, V36, P669, DOI 10.1093/jpepsy/jsq117; Ding Z, 1998, Zhonghua Yi Xue Za Zhi, V78, P121; DING Z, 1989, Acta Nutrimenta Sinica, V11, P266; Ding ZY, 1988, J CLIN  PEDIAT, V6, P293; Ge K, 1995, DIETARY NUTR STATUS; Group of China Obesity Task Force, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P97; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hui L, 2003, HEALTH PLACE, V9, P371, DOI 10.1016/S1353-8292(03)00049-2; James WPT, 2008, OBES REV, V9, P2, DOI 10.1111/j.1467-789X.2007.00430.x; Ji CY, 2008, OBES REV, V9, P78, DOI 10.1111/j.1467-789X.2007.00443.x; Ko GTC, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-10; Kollias A, 2011, J PEDIATR ENDOCR MET, V24, P929, DOI 10.1515/JPEM.2011.309; Lawlor DA, 2005, CIRCULATION, V111, P1891, DOI 10.1161/01.CIR.0000161798.45728.4D; LEBOEUFYDE C, 1995, SPINE, V20, P2112, DOI 10.1097/00007632-199510000-00009; Levine JA, 2008, CHINESE MED J-PEKING, V121, P1043, DOI 10.1097/00029330-200806010-00015; Li Li-ming, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P478; Li LL, 2007, HENAN J PREVENT MED, V18, P18; Liang YJ, 2012, PEDIATR OBES, V7, P355, DOI 10.1111/j.2047-6310.2012.00066.x; Liu JM, 2007, ARCH MED RES, V38, P882, DOI 10.1016/j.arcmed.2007.05.006; Liu XJ, 2012, CHIN J SCL HLTH, V33, P209; [吕建中 LV Jian-zhong], 2009, [中华流行病学杂志, Chinese Journal of Epidemiology], V30, P868; Ma YN, 2011, ARCH MED RES, V42, P633, DOI 10.1016/j.arcmed.2011.10.011; Maclaren NK, 2007, CELL BIOCHEM BIOPHYS, V48, P73, DOI 10.1007/s12013-007-0017-6; Ming C, 2012, J CHILD HEALTH CARE, V20, P224; National Task Force on Childhood Obesity National Center for Women's and Children's Health, 2008, Zhonghua Er Ke Za Zhi, V46, P179; Ogden CL, 2002, PEDIATRICS, V109, P45, DOI 10.1542/peds.109.1.45; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Park MH, 2012, OBES REV, V13, P985, DOI 10.1111/j.1467-789X.2012.01015.x; Popkin BM, 2010, INT J EPIDEMIOL, V39, P1435, DOI 10.1093/ije/dyp322; Sabo RT, 2012, OBESITY, V20, P1741, DOI 10.1038/oby.2012.58; Sandhu N, 2008, J PEDIATR ENDOCR MET, V21, P631; Scaglioni S, 2008, BRIT J NUTR, V99, pS22, DOI 10.1017/S0007114508892471; Shan XY, 2010, INT J PEDIATR OBES, V5, P383, DOI 10.3109/17477160903572001; Shang XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043183; Sjoberg A, 2011, OBES REV, V12, P305, DOI 10.1111/j.1467-789X.2010.00838.x; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tzamaloukas AH, 2003, JPEN-PARENTER ENTER, V27, P340, DOI 10.1177/0148607103027005340; Vander Wal JS, 2011, PEDIATR CLIN N AM, V58, P1393, DOI 10.1016/j.pcl.2011.09.008; Virdis A, 2009, CURR PHARM DESIGN, V15, P1063, DOI 10.2174/138161209787846900; Wang DM, 2012, CHIN J SCL HLTH, V33, P248; Wang HY, 2011, CHIN J PRIMARY MED P, V18, P353; Wang J.L., 2008, J CHILD HEALTH CARE, V16, P55; Wang SF, 2005, MATERN CHILD HLTH J, V20, P169; Wang YF, 2001, INT J EPIDEMIOL, V30, P1129, DOI 10.1093/ije/30.5.1129; Wei M, 2007, J PREV MED, V19, P349; Wisniewski AB, 2009, GENDER MED, V6, P76, DOI 10.1016/j.genm.2008.12.001; Wolman Julia, 2008, Community Pract, V81, P28; Wu Jing, 2008, Zhongguo Dang Dai Er Ke Za Zhi, V10, P231; Xi B, 2012, OBES REV, V13, P287, DOI 10.1111/j.1467-789X.2011.00944.x; Xiong F, 2005, CHONGQING MED J, V34, P1838, DOI [DOI 10.3969/J.ISSN.1671-8348.2005.12.033, 10.3969/j.issn.1671-8348.2005.12.033]; Yang JH, 2007, SOC SCI MED, V64, P2043, DOI 10.1016/j.socscimed.2007.02.024; Zhang JM, 2003, ANTHOLOGY MED, V22, P41; Zhang MY, 2012, PEDIATR DIABETES, V13, P572, DOI 10.1111/j.1399-5448.2012.00877.x; Zhang X., 2011, PUBLIC HEALTH NUTR, P1; Zhang YX, 2012, J PUBLIC HEALTH-UK, V34, P131, DOI 10.1093/pubmed/fdr053; Zhao W, 2008, OBES REV, V9, P62, DOI 10.1111/j.1467-789X.2007.00440.x; Zuo H, 2000, SHAANXI MED J, V29, P693	85	99	107	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51949	10.1371/journal.pone.0051949	http://dx.doi.org/10.1371/journal.pone.0051949			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284829	Green Published, gold, Green Submitted			2022-12-27	WOS:000312435900066
J	Bracht, T; Federspiel, A; Schnell, S; Horn, H; Hofle, O; Wiest, R; Dierks, T; Strik, W; Muller, TJ; Walther, S				Bracht, Tobias; Federspiel, Andrea; Schnell, Susanne; Horn, Helge; Hoefle, Oliver; Wiest, Roland; Dierks, Thomas; Strik, Werner; Mueller, Thomas J.; Walther, Sebastian			Cortico-Cortical White Matter Motor Pathway Microstructure Is Related to Psychomotor Retardation in Major Depressive Disorder	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CEREBRAL-BLOOD-FLOW; DIFFUSION-TENSOR; UNIPOLAR DEPRESSION; BASAL GANGLIA; STRUCTURAL CONNECTIVITY; RATING-SCALE; BRAIN; CORTEX; INTEGRITY	Alterations of brain structure and function have been associated with psychomotor retardation in major depressive disorder (MDD). However, the association of motor behaviour and white matter integrity of motor pathways in MDD is unclear. The aim of the present study was to first investigate structural connectivity of white matter motor pathways in MDD. Second, we explore the relation of objectively measured motor activity and white matter integrity of motor pathways in MDD. Therefore, 21 patients with MDD and 21 healthy controls matched for age, gender, education and body mass index underwent diffusion tensor imaging and 24 hour actigraphy (measure of the activity level) the same day. Applying a probabilistic fibre tracking approach we extracted connection pathways between the dorsolateral prefrontal cortex (dlPFC), the rostral anterior cingulate cortex (rACC), the pre-supplementary motor area (pre-SMA), the SMA-proper, the primary motor cortex (M1), the caudate nucleus, the putamen, the pallidum and the thalamus. Patients had lower activity levels and demonstrated increased mean diffusivity (MD) in pathways linking left pre-SMA and SMA-proper, and right SMA-proper and M1. Exploratory analyses point to a positive association of activity level and mean-fractional anisotropy in the right rACC-pre-SMA connection in MDD. Only MDD patients with low activity levels had a negative linear association of activity level and mean-MD in the left dlPFC-pre-SMA connection. Our results point to structural alterations of cortico-cortical white matter motor pathways in MDD. Altered white matter organisation of rACC-pre-SMA and dlPFC-pre-SMA pathways may contribute to movement initiation in MDD.	[Bracht, Tobias; Horn, Helge; Hoefle, Oliver; Strik, Werner; Mueller, Thomas J.; Walther, Sebastian] Univ Bern, Univ Hosp Psychiat, Bern, Switzerland; [Federspiel, Andrea; Dierks, Thomas] Univ Bern, Dept Psychiat Neurophysiol, Bern, Switzerland; [Schnell, Susanne] Univ Med Ctr Freiburg, Dept Diagnost Radiol, Freiburg, Germany; [Schnell, Susanne] Northwestern Univ, Feinberg Sch Med, Dept Radiol, Chicago, IL 60611 USA; [Schnell, Susanne] Northwestern Univ, Feinberg Sch Med, Dept Biomed Engn, Chicago, IL 60611 USA; [Wiest, Roland] Univ Bern, Inst Diagnost & Intervent Neuroradiol, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Freiburg; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Bern	Bracht, T (corresponding author), Univ Bern, Univ Hosp Psychiat, Bern, Switzerland.	bracht@puk.unibe.ch	Müller, Thomas/D-1212-2010; Dierks, Thomas/B-7092-2012; Bracht, Tobias/B-1719-2014; Strik, Werner Konrad/N-7807-2013; Walther, Sebastian/E-3486-2010; Federspiel, Andrea/E-8342-2010; Schnell, Susanne/I-4168-2019	Müller, Thomas/0000-0001-9315-8138; Dierks, Thomas/0000-0002-4173-5308; Strik, Werner Konrad/0000-0001-7108-1993; Walther, Sebastian/0000-0003-4026-3561; Federspiel, Andrea/0000-0003-3211-2675; Schnell, Susanne/0000-0001-6009-4756	Eli-Lilly; Bristol-Myers-Squibb; Lundbeck; Boehringer-Ingelheim; Vifor; Pfizer; AstraZeneca; Janssen-Cilag; Sanofi-Aventis; Glaxo-Smith-Kline; Desitin-Pharma; Sandoz	Eli-Lilly(Eli Lilly); Bristol-Myers-Squibb(Bristol-Myers Squibb); Lundbeck(Lundbeck Corporation); Boehringer-Ingelheim(Boehringer Ingelheim); Vifor; Pfizer(Pfizer); AstraZeneca(AstraZeneca); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Sanofi-Aventis(Sanofi-Aventis); Glaxo-Smith-Kline(GlaxoSmithKline); Desitin-Pharma; Sandoz(Novartis)	Dr. Horn has received speaker's fees from Eli-Lilly, Bristol-Myers-Squibb, Lundbeck, Boehringer-Ingelheim and Vifor. Prof. Strik received speaker's fees from/is advisory board member of Eli-Lilly, Pfizer and Lundbeck. Prof. Muller has received research support from Eli-Lilly, speaker's fees from AstraZeneca, Bristol-Myers-Squibb, Janssen-Cilag, Eli-Lilly, Pfizer, Sanofi-Aventis, Glaxo-Smith-Kline, Desitin-Pharma and Vifor. Prof. Muller is advisory board member of Eli-Lilly, Janssen-Cillag, Board Sandoz and Lundbeck; he has been a consultant to Janssen-Cilag and Glaxo-Smith-Kline. Dr. Walther received speakers fees from Sandoz and Janssen-cilag. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Assaf Y, 2008, MAGN RESON MED, V59, P1347, DOI 10.1002/mrm.21577; Ballard IC, 2011, J NEUROSCI, V31, P10340, DOI 10.1523/JNEUROSCI.0895-11.2011; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; BENCH CJ, 1993, PSYCHOL MED, V23, P579, DOI 10.1017/S0033291700025368; Benedetti F, 2011, BIPOLAR DISORD, V13, P414, DOI 10.1111/j.1399-5618.2011.00938.x; Berle Jan O, 2010, BMC Res Notes, V3, P149, DOI 10.1186/1756-0500-3-149; Blood AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013945; Bracht T, 2009, PSYCHIAT RES-NEUROIM, V174, P217, DOI 10.1016/j.pscychresns.2009.05.001; Brambilla P, 2009, CURR PHARM DESIGN, V15, P2632, DOI 10.2174/138161209788957519; Buyukdura JS, 2011, PROG NEURO-PSYCHOPH, V35, P395, DOI 10.1016/j.pnpbp.2010.10.019; Caligiuri MP, 2003, J AFFECT DISORDERS, V77, P135, DOI 10.1016/S0165-0327(02)00107-6; Calugi S, 2011, J AFFECT DISORDERS, V129, P296, DOI 10.1016/j.jad.2010.08.004; Cheng YQ, 2010, NEUROSCI LETT, V480, P30, DOI 10.1016/j.neulet.2010.05.075; Chiu PH, 2007, AM J PSYCHIAT, V164, P608, DOI 10.1176/appi.ajp.164.4.608; Cole J, 2012, BRIT J PSYCHIAT, V201, P33, DOI 10.1192/bjp.bp.111.100594; Deichmann R, 2004, NEUROIMAGE, V21, P757, DOI 10.1016/j.neuroimage.2003.09.062; Deoni SCL, 2008, MAGN RESON MED, V60, P1372, DOI 10.1002/mrm.21704; Der-Avakian A, 2012, TRENDS NEUROSCI, V35, P68, DOI 10.1016/j.tins.2011.11.005; Exner C, 2009, J AFFECT DISORDERS, V119, P156, DOI 10.1016/j.jad.2009.03.015; Fahn S, 1987, RECENT DEV PARKINSON; Frodl T, 2012, J PSYCHIATR NEUROSCI, V37, P37, DOI 10.1503/jpn.110028; Graybiel AM, 2000, CURR BIOL, V10, pR509, DOI 10.1016/S0960-9822(00)00593-5; Groenewegen Henk J., 2003, Neural Plasticity, V10, P107, DOI 10.1155/NP.2003.107; Habas C, 2010, NEURORADIOLOGY, V52, P47, DOI 10.1007/s00234-009-0572-1; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hanggi J, 2010, HUM BRAIN MAPP, V31, P1196, DOI 10.1002/hbm.20928; Haggard P, 2008, NAT REV NEUROSCI, V9, P934, DOI 10.1038/nrn2497; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hasan KM, 2001, J MAGN RESON IMAGING, V13, P769, DOI 10.1002/jmri.1107; Hua KG, 2009, CEREB CORTEX, V19, P1889, DOI 10.1093/cercor/bhn215; Huang H, 2011, NEUROPSYCHOPHARMACOL, V36, P684, DOI 10.1038/npp.2010.199; Jancke L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004785; Jeurissen B, 2012, HUM BRAIN M IN PRESS; Keedwell PA, 2012, BIOL PSYCHIAT, V72, P296, DOI 10.1016/j.biopsych.2012.01.022; Korgaonkar MS, 2012, NEUROREPORT, V23, P566, DOI 10.1097/WNR.0b013e3283546264; Korgaonkar MS, 2011, HUM BRAIN MAPP, V32, P2161, DOI 10.1002/hbm.21178; Kreher BW, 2008, NEUROIMAGE, V43, P81, DOI 10.1016/j.neuroimage.2008.06.023; Langer N, 2012, NEUROLOGY, V78, P182, DOI 10.1212/WNL.0b013e31823fcd9c; Lemke MR, 1997, NEUROPSYCHOBIOLOGY, V36, P57, DOI 10.1159/000119362; Liao Y, 2012, J PSYCHIATR NEUROSCI, V37; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Marks BL, 2011, BRIT J SPORT MED, V45, P1208, DOI 10.1136/bjsm.2009.068114; Martinot MLP, 2001, AM J PSYCHIAT, V158, P314, DOI 10.1176/appi.ajp.158.2.314; MAYBERG HS, 1994, J NUCL MED, V35, P929; Meyer JH, 2006, AM J PSYCHIAT, V163, P1594, DOI 10.1176/appi.ajp.163.9.1594; Middelkoop HAM, 1997, PSYCHOPHYSIOLOGY, V34, P199, DOI 10.1111/j.1469-8986.1997.tb02132.x; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Naismith S, 2002, AM J PSYCHIAT, V159, P2096, DOI 10.1176/appi.ajp.159.12.2096; Narita H, 2004, PSYCHIAT CLIN NEUROS, V58, P389, DOI 10.1111/j.1440-1819.2004.01273.x; Nieuwenhuys R., 2008, HUMAN CENTRAL NERVOU; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parker GJM, 2003, J MAGN RESON IMAGING, V18, P242, DOI 10.1002/jmri.10350; Razavi N, 2011, PSYCHIAT RES, V190, P212, DOI 10.1016/j.psychres.2011.05.028; Rusch N, 2010, PSYCHIAT RES-NEUROIM, V181, P151, DOI 10.1016/j.pscychresns.2009.08.004; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Schrijvers D, 2008, J AFFECT DISORDERS, V109, P1, DOI 10.1016/j.jad.2007.10.019; Schrijvers D, 2008, CORTEX, V44, P569, DOI 10.1016/j.cortex.2007.08.014; Sobin C, 1997, AM J PSYCHIAT, V154, P4; Stanley N, 1999, NEUROPSYCHOBIOLOGY, V39, P44, DOI 10.1159/000026559; Taubert M, 2011, NEUROIMAGE, V57, P1492, DOI 10.1016/j.neuroimage.2011.05.078; TEICHER MH, 1995, HARVARD REV PSYCHIAT, V3, P18, DOI 10.3109/10673229509017161; Todder D, 2009, WORLD J BIOL PSYCHIA, V10, P276, DOI 10.3109/15622970701403081; Ullsperger M, 2006, J COGNITIVE NEUROSCI, V18, P651, DOI 10.1162/jocn.2006.18.4.651; Umarova RM, 2010, CEREB CORTEX, V20, P121, DOI 10.1093/cercor/bhp086; Versace A, 2010, BIOL PSYCHIAT, V68, P560, DOI 10.1016/j.biopsych.2010.04.036; Videbech P, 2002, BIOL PSYCHIAT, V52, P1031, DOI 10.1016/S0006-3223(02)01482-8; Vogt B. A., 2009, CINGULATE NEUROBIOLO; Volkers AC, 2002, EUR NEUROPSYCHOPHARM, V12, P273, DOI 10.1016/S0924-977X(02)00019-6; Vry MS, 2012, EXP BRAIN RES, V219, P203, DOI 10.1007/s00221-012-3079-7; Wacker J, 2009, NEUROIMAGE, V46, P327, DOI 10.1016/j.neuroimage.2009.01.058; Walther S, 2012, J AFFECT DISORDERS, V136, P124, DOI 10.1016/j.jad.2011.08.020; Walther S, 2012, NEUROBIOL DIS, V47, P13, DOI 10.1016/j.nbd.2012.03.019; Walther S, 2011, PSYCHIAT RES-NEUROIM, V192, P117, DOI 10.1016/j.pscychresns.2010.12.002; Walther S, 2011, NEUROBIOL DIS, V42, P276, DOI 10.1016/j.nbd.2011.01.017; Walther S, 2010, J CLIN PSYCHOPHARM, V30, P181, DOI 10.1097/JCP.0b013e3181d2ef6f; Walther S, 2009, PSYCHIAT RES, V169, P187, DOI 10.1016/j.psychres.2008.06.020; Zhang AF, 2012, NEUROPSYCHOPHARMACOL, V37, P959, DOI 10.1038/npp.2011.279; Zhu XL, 2011, BRAIN RES, V1369, P223, DOI 10.1016/j.brainres.2010.10.104; Zou K, 2008, J PSYCHIATR NEUROSCI, V33, P525; Zuo NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037561	85	54	55	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52238	10.1371/journal.pone.0052238	http://dx.doi.org/10.1371/journal.pone.0052238			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284950	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500122
J	Hallin, S; Welsh, A; Stenstrom, J; Hallet, S; Enwall, K; Bru, D; Philippot, L				Hallin, Sara; Welsh, Allana; Stenstrom, John; Hallet, Stephanie; Enwall, Karin; Bru, David; Philippot, Laurent			Soil Functional Operating Range Linked to Microbial Biodiversity and Community Composition Using Denitrifiers as Model Guild	PLOS ONE			English	Article							EVOLUTIONARY HISTORY; ECOSYSTEM FUNCTION; NITROUS-OXIDE; DIVERSITY; BACTERIA; PRODUCTIVITY; ECOLOGY; FERTILIZATION; PHYLOGENIES; GRADIENTS	Soil microorganisms are key players in biogeochemical cycles. Yet, there is no consistent view on the significance of microbial biodiversity for soil ecosystem functioning. According to the insurance hypothesis, declines in ecosystem functioning due to reduced biodiversity are more likely to occur under fluctuating, extreme or rapidly changing environmental conditions. Here, we compare the functional operating range, a new concept defined as the complete range of environmental conditions under which soil microbial communities are able to maintain their functions, between four naturally assembled soil communities from a long-term fertilization experiment. A functional trait approach was adopted with denitrifiers involved in nitrogen cycling as our model soil community. Using short-term temperature and salt gradients, we show that the functional operating range was broader and process rates were higher when the soil community was phylogenetically more diverse. However, key bacterial genotypes played an important role for maintaining denitrification as an ecosystem functioning under certain conditions.	[Hallin, Sara; Welsh, Allana; Stenstrom, John; Enwall, Karin] Swedish Univ Agr Sci, Dept Microbiol, S-75007 Uppsala, Sweden; [Hallet, Stephanie; Bru, David; Philippot, Laurent] INRA, UMR Agroecol, F-21034 Dijon, France	Swedish University of Agricultural Sciences; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Hallin, S (corresponding author), Swedish Univ Agr Sci, Dept Microbiol, Box 7025, S-75007 Uppsala, Sweden.	Sara.Hallin@slu.se	Hallin, Sara/H-4648-2012; Stenström, John/GYA-6846-2022; Bru, David/A-9702-2016; Philippot, Laurent/G-5598-2011	Hallin, Sara/0000-0002-9069-9024; Philippot, Laurent/0000-0003-3461-4492; Bru, David/0000-0002-1011-017X	Environment and Agronomy research division; International Relations Department of the INRA; Department of Microbiology of the Swedish University of Agricultural Sciences in Uppsala; Swedish Research Council Formas [2007-1197]; European Commission [FP7-264465]	Environment and Agronomy research division; International Relations Department of the INRA; Department of Microbiology of the Swedish University of Agricultural Sciences in Uppsala; Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); European Commission(European CommissionEuropean Commission Joint Research Centre)	The Environment and Agronomy research division and the International Relations Department of the INRA and the Department of Microbiology of the Swedish University of Agricultural Sciences in Uppsala are gratefully acknowledged for supporting and hosting L. Philippot's sabbatical in Sweden. The Swedish Research Council Formas (contract 2007-1197) and the European Commission within EcoFINDERS project (FP7-264465) are acknowledged for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buckley DH, 2001, MICROB ECOL, V42, P11, DOI 10.1007/s002480000108; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Craig MacLean R, 2005, ECOL LETT, V8, P38, DOI 10.1111/j.1461-0248.2004.00689.x; Dandie CE, 2007, SYST APPL MICROBIOL, V30, P128, DOI 10.1016/j.syapm.2006.05.002; EXCOFFIER L, 1992, GENETICS, V131, P479; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; GABEL RA, 1973, ANESTHESIOLOGY, V38, P75, DOI 10.1097/00000542-197301000-00019; Griffiths BS, 2000, OIKOS, V90, P279, DOI 10.1034/j.1600-0706.2000.900208.x; Gu LH, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002119; Hallin S, 2009, ISME J, V3, P597, DOI 10.1038/ismej.2008.128; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hol WHG, 2010, ECOL LETT, V13, P292, DOI 10.1111/j.1461-0248.2009.01424.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Horner-Devine MC, 2006, ECOLOGY, V87, pS100, DOI 10.1890/0012-9658(2006)87[100:PCAOIB]2.0.CO;2; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Jones CM, 2008, MOL BIOL EVOL, V25, P1955, DOI 10.1093/molbev/msn146; Jousset A, 2011, ECOL LETT, V14, P537, DOI 10.1111/j.1461-0248.2011.01613.x; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Lamb EG, 2011, GLOBAL CHANGE BIOL, V17, P3187, DOI 10.1111/j.1365-2486.2011.02431.x; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Maherali H, 2007, SCIENCE, V316, P1746, DOI 10.1126/science.1143082; Mao YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024750; Mounier E, 2004, ENVIRON MICROBIOL, V6, P301, DOI 10.1111/j.1462-2920.2004.00571.x; O'Mullan GD, 2005, APPL ENVIRON MICROB, V71, P697, DOI 10.1128/AEM.71.2.697-705.2005; Orcutt FS, 1937, SOIL SCI, V44, P203, DOI 10.1097/00010694-193709000-00003; Oren A, 2011, ENVIRON MICROBIOL, V13, P1908, DOI 10.1111/j.1462-2920.2010.02365.x; Pell M, 1996, SOIL BIOL BIOCHEM, V28, P393, DOI 10.1016/0038-0717(95)00149-2; Petric I, 2011, J MICROBIOL METH, V84, P454, DOI 10.1016/j.mimet.2011.01.016; Pfisterer AB, 2004, BASIC APPL ECOL, V5, P5, DOI 10.1078/1439-1791-00215; Philippot L, 2005, CURR OPIN MICROBIOL, V8, P234, DOI 10.1016/j.mib.2005.04.003; Philippot L, 2007, ADV AGRON, V96, P249, DOI 10.1016/S0065-2113(07)96003-4; Ptacnik R, 2008, P NATL ACAD SCI USA, V105, P5134, DOI 10.1073/pnas.0708328105; Ramirez KS, 2010, ECOLOGY, V91, P3463, DOI 10.1890/10-0426.1; Rosch C, 2002, APPL ENVIRON MICROB, V68, P3818, DOI 10.1128/AEM.68.8.3818-3829.2002; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Smith MD, 2003, ECOL LETT, V6, P509, DOI 10.1046/j.1461-0248.2003.00454.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; TILMAN D, 1987, ECOL MONOGR, V57, P189, DOI 10.2307/2937080; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Tuomi M, 2008, ECOL MODEL, V211, P182, DOI 10.1016/j.ecolmodel.2007.09.003; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Wawrik B, 2005, APPL ENVIRON MICROB, V71, P6776, DOI 10.1128/AEM.71.11.6776-6783.2005; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wertz S, 2006, ENVIRON MICROBIOL, V8, P2162, DOI 10.1111/j.1462-2920.2006.01098.x; Wilson SD, 2002, ECOLOGY, V83, P492, DOI 10.1890/0012-9658(2002)083[0492:QVIOFS]2.0.CO;2; Wittebolle L, 2009, NATURE, V458, P623, DOI 10.1038/nature07840; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	50	19	19	0	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51962	10.1371/journal.pone.0051962	http://dx.doi.org/10.1371/journal.pone.0051962			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284833	Green Published, gold			2022-12-27	WOS:000312794500069
J	Dixon, ML; Christoff, K				Dixon, Matthew L.; Christoff, Kalina			The Decision to Engage Cognitive Control Is Driven by Expected Reward-Value: Neural and Behavioral Evidence	PLOS ONE			English	Article							PREFRONTAL CORTEX; ORBITOFRONTAL CORTEX; SELF-CONTROL; REPETITION SUPPRESSION; MOTIVATIONAL CONTEXT; SYSTEMS; UNCERTAINTY; CINGULATE; UNDERLIE; NEURONS	Cognitive control is a fundamental skill reflecting the active use of task-rules to guide behavior and suppress inappropriate automatic responses. Prior work has traditionally used paradigms in which subjects are told when to engage cognitive control. Thus, surprisingly little is known about the factors that influence individuals' initial decision of whether or not to act in a reflective, rule-based manner. To examine this, we took three classic cognitive control tasks (Stroop, Wisconsin Card Sorting Task, Go/No-Go task) and created novel 'free-choice' versions in which human subjects were free to select an automatic, pre-potent action, or an action requiring rule-based cognitive control, and earned varying amounts of money based on their choices. Our findings demonstrated that subjects' decision to engage cognitive control was driven by an explicit representation of monetary rewards expected to be obtained from rule-use. Subjects rarely engaged cognitive control when the expected outcome was of equal or lesser value as compared to the value of the automatic response, but frequently engaged cognitive control when it was expected to yield a larger monetary outcome. Additionally, we exploited fMRI-adaptation to show that the lateral prefrontal cortex (LPFC) represents associations between rules and expected reward outcomes. Together, these findings suggest that individuals are more likely to act in a reflective, rule-based manner when they expect that it will result in a desired outcome. Thus, choosing to exert cognitive control is not simply a matter of reason and willpower, but rather, conforms to standard mechanisms of value-based decision making. Finally, in contrast to current models of LPFC function, our results suggest that the LPFC plays a direct role in representing motivational incentives.	[Dixon, Matthew L.; Christoff, Kalina] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Christoff, Kalina] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Dixon, ML (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	mattdixon@psych.ubc.ca		Dixon, Matthew/0000-0001-8033-8113	Natural Sciences and Engineering Council of Canada [05-5918]	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Natural Sciences and Engineering Council of Canada, grant # 05-5918 (to KC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badre D, 2012, NEURON, V73, P595, DOI 10.1016/j.neuron.2011.12.025; Baumeister RF, 2007, SOC PERSONAL PSYCHOL, V1, P115, DOI 10.1111/j.1751-9004.2007.00001.x; Baumgartner T, 2011, NAT NEUROSCI, V14, P1468, DOI 10.1038/nn.2933; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brett M., 2002, 8 INT C FUNCT MAPP H, DOI DOI 10.1016/S1053-8119(02)90010-8; BUCKLESS FA, 1990, ACCOUNT REV, V65, P933; Bunge SA, 2003, J NEUROPHYSIOL, V90, P3419, DOI 10.1152/jn.00910.2002; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; De Baene W, 2011, HUM BRAIN MAPP; de Gardelle V, 2012, CEREB CORTEX; Diekhof EK, 2010, J NEUROSCI, V30, P1488, DOI 10.1523/JNEUROSCI.4690-09.2010; Figner B, 2010, NAT NEUROSCI, V13, P538, DOI 10.1038/nn.2516; Fujita K, 2011, PERS SOC PSYCHOL REV; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; Henson RNA, 2003, PROG NEUROBIOL, V70, P53, DOI 10.1016/S0301-0082(03)00086-8; Histed MH, 2009, NEURON, V63, P244, DOI 10.1016/j.neuron.2009.06.019; Hofmann W, 2009, PERSPECT PSYCHOL SCI, V4, P162, DOI 10.1111/j.1745-6924.2009.01116.x; Jenkins AC, 2008, P NATL ACAD SCI USA, V105, P4507, DOI 10.1073/pnas.0708785105; Jimura K, 2010, P NATL ACAD SCI USA, V107, P8871, DOI 10.1073/pnas.1002007107; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kahnt T, 2011, J NEUROSCI, V31, P14624, DOI 10.1523/JNEUROSCI.3412-11.2011; Kilner JM, 2009, J NEUROSCI, V29, P10153, DOI 10.1523/JNEUROSCI.2668-09.2009; Kim S, 2008, NEURON, V59, P161, DOI 10.1016/j.neuron.2008.05.010; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Kouneiher F, 2009, NAT NEUROSCI, V12, P939, DOI 10.1038/nn.2321; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; Li JA, 2011, P NATL ACAD SCI USA, V108, P55, DOI 10.1073/pnas.1014938108; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Lundqvist D., 1998, KAROLINSKA DIRECTED; Macey PM, 2004, NEUROIMAGE, V22, P360, DOI 10.1016/j.neuroimage.2003.12.042; Martinez A., 1998, AR FACE DATABASE CVC; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Muller NG, 2012, CEREB CORTEX; O'Reilly RC, 2006, NEURAL COMPUT, V18, P283, DOI 10.1162/089976606775093909; Pessoa L, 2009, TRENDS COGN SCI, V13, P160, DOI 10.1016/j.tics.2009.01.006; Peters J, 2010, BEHAV BRAIN RES, V213, P135, DOI 10.1016/j.bbr.2010.04.031; Phillips PJ, 1998, IMAGE VISION COMPUT, V16, P295, DOI 10.1016/S0262-8856(97)00070-X; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Pochon JB, 2002, P NATL ACAD SCI USA, V99, P5669, DOI 10.1073/pnas.082111099; Race EA, 2009, J COGNITIVE NEUROSCI, V21, P1766, DOI 10.1162/jocn.2009.21132; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Rangel A, 2010, CURR OPIN NEUROBIOL, V20, P262, DOI 10.1016/j.conb.2010.03.001; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rosnow RL, 1996, PSYCHOL SCI, V7, P253, DOI 10.1111/j.1467-9280.1996.tb00369.x; Rushworth MFS, 2007, TRENDS COGN SCI, V11, P168, DOI 10.1016/j.tics.2007.01.004; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Salimpoor VN, 2010, J COGNITIVE NEUROSCI, V22, P790, DOI 10.1162/jocn.2009.21234; Savine AC, 2010, J NEUROSCI, V30, P10294, DOI 10.1523/JNEUROSCI.2052-10.2010; Seo H, 2007, CEREB CORTEX, V17, pI110, DOI 10.1093/cercor/bhm064; Summerfield C, 2009, TRENDS COGN SCI, V13, P403, DOI 10.1016/j.tics.2009.06.003; Tobler PN, 2009, P NATL ACAD SCI USA, V106, P7185, DOI 10.1073/pnas.0809599106; Turk-Browne NB, 2007, CEREB CORTEX, V17, P425, DOI 10.1093/cercor/bhj159; Venkatraman V, 2009, NEURON, V62, P593, DOI 10.1016/j.neuron.2009.04.007; Vuilleumier P, 2005, J COGNITIVE NEUROSCI, V17, P1245, DOI 10.1162/0898929055002409; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334; Wallis JD, 2010, CURR OPIN NEUROBIOL, V20, P191, DOI 10.1016/j.conb.2010.02.009; Walton ME, 2010, NEURON, V65, P927, DOI 10.1016/j.neuron.2010.02.027; Watanabe M, 2002, J NEUROSCI, V22, P2391, DOI 10.1523/JNEUROSCI.22-06-02391.2002; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; Watanabe M, 2007, CEREB CORTEX, V17, pI101, DOI 10.1093/cercor/bhm067; Weber BJ, 2008, BRAIN RES, V1234, P104, DOI 10.1016/j.brainres.2008.07.105; Yeterian EH, 2012, CORTEX, V48, P58, DOI 10.1016/j.cortex.2011.03.004	68	72	73	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51637	10.1371/journal.pone.0051637	http://dx.doi.org/10.1371/journal.pone.0051637			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284730	Green Submitted, Green Published, gold			2022-12-27	WOS:000312694300034
J	Pauli, JN; Peery, MZ				Pauli, Jonathan N.; Peery, M. Zachariah			Unexpected Strong Polygyny in the Brown-Throated Three-Toed Sloth	PLOS ONE			English	Article							MATING SYSTEM; MICROSATELLITE ANALYSIS; MULTIPLE PATERNITY; COMPUTER-PROGRAM; BRADYPUS; ECOLOGY; BIRDS	Promiscuous mating strategies are much more common than previously appreciated. So much so, that several authors have proposed that promiscuity is the "rule" rather than the exception in vertebrate mating systems. Decreasing species mobility and increasing habitat fragmentation have both been suggested to reduce the "polygyny potential" of the environment and promote other mating strategies like promiscuity in females. We explored the social and genetic mating system for one of the most sedentary extant mammals, the brown-throated three-toed sloth (Bradypus variegatus), within a highly fragmented Neotropical habitat. Surprisingly, we found that three-toed sloths were strongly polygynous, with males excluding male competitors from their core ranges, and exhibiting strong reproductive skew. Indeed, only 25% of all resident adult males sired offspring and one individual sired half of all sampled juveniles. Paradoxically, a sedentary life-history strategy seems to facilitate polygyny in fragmented landscapes because multiple females can persist within small patches of habitat, and be monopolized by a single male. Our work demonstrates that strong polygyny can arise in systems in which the polygyny potential should be extremely low, and other strategies, including promiscuity, would be favoured. Mating systems can be influenced by a multitude of factor and are dynamic, varying among taxa, over time, and across habitats; consequently, mating systems remain difficult to predict based on general ecological principles.	[Pauli, Jonathan N.; Peery, M. Zachariah] Univ Wisconsin Madison, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Pauli, JN (corresponding author), Univ Wisconsin Madison, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA.	jnpauli@wisc.edu			Milwaukee Public Museum; University of Wisconsin-Madison; American Society of Mammalogists; Department of Forest and Wildlife Ecology at the University of Wisconsin-Madison	Milwaukee Public Museum; University of Wisconsin-Madison; American Society of Mammalogists; Department of Forest and Wildlife Ecology at the University of Wisconsin-Madison	Funding was provided by the Milwaukee Public Museum, the University of Wisconsin-Madison, and through a fellowship awarded by the American Society of Mammalogists. Publication costs were paid for by the Department of Forest and Wildlife Ecology at the University of Wisconsin-Madison. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beasley JC, 2010, J HERED, V101, P368, DOI 10.1093/jhered/esp114; Bishop JM, 2007, BIOL LETTERS, V3, P176, DOI 10.1098/rsbl.2006.0607; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Crawford JC, 2008, J MAMMAL, V89, P575, DOI 10.1644/07-MAMM-A-251R1.1; DAVIES NB, 1984, J ANIM ECOL, V53, P895, DOI 10.2307/4666; DeYoung RW, 2002, J MAMMAL, V83, P884, DOI 10.1644/1545-1542(2002)083&lt;0884:MPIWTD&gt;2.0.CO;2; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Fieberg J, 2005, J WILDLIFE MANAGE, V69, P1346, DOI 10.2193/0022-541X(2005)69[1346:QHOTIO]2.0.CO;2; Flatz R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033654; GREENE HW, 1989, BIOTROPICA, V21, P369, DOI 10.2307/2388289; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Hoffman JI, 2003, EVOLUTION, V57, P1917; Holdridge LR, 1967, LIFE ZONE ECOLOGY; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kays RW, 2000, MOL ECOL, V9, P743, DOI 10.1046/j.1365-294x.2000.00921.x; Lara-Ruiz P, 2005, J ZOOL, V267, P63, DOI 10.1017/S0952836905007259; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; McEachern MB, 2009, ANIM BEHAV, V77, P449, DOI 10.1016/j.anbehav.2008.10.024; Millspaugh JJ., 2001, RADIO TRACKING ANIMA; Moss WE, 2012, CONSERV GENET RESOUR, V4, P1037, DOI 10.1007/s12686-012-9701-y; Munroe KE, 2011, BEHAV ECOL SOCIOBIOL, V65, P1811, DOI 10.1007/s00265-011-1189-z; NAGY KA, 1980, J MAMMAL, V61, P465, DOI 10.2307/1379840; Patzenhauerova H, 2010, BEHAV ECOL SOCIOBIOL, V64, P757, DOI 10.1007/s00265-009-0893-4; Peery MZ, 2012, ANIM BEHAV, V84, P555, DOI 10.1016/j.anbehav.2012.06.007; R Core Team, 2012, R LANG ENV STAT COMP; Reynolds JD, 1996, TRENDS ECOL EVOL, V11, pA68, DOI 10.1016/0169-5347(96)81045-7; Say L, 2003, MOL ECOL, V12, P2793, DOI 10.1046/j.1365-294X.2003.01945.x; SHUSTER SM, 2003, MG BEH ECOL, pR7; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Taube E, 2001, MAMMAL REV, V31, P173, DOI 10.1046/j.1365-2907.2001.00085.x; Vanpe C, 2009, BIOL J LINN SOC, V97, P128, DOI 10.1111/j.1095-8312.2009.01196.x; Vaughan C, 2007, BIODIVERS CONSERV, V16, P2293, DOI 10.1007/s10531-007-9191-5; WAAGE JK, 1976, SCIENCE, V193, P157, DOI 10.1126/science.193.4248.157; Wolff JO, 2004, TRENDS ECOL EVOL, V19, P127, DOI 10.1016/j.tree.2003.12.009; WOODROFFE R, 1995, J ZOOL, V235, P237	37	25	28	0	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51389	10.1371/journal.pone.0051389	http://dx.doi.org/10.1371/journal.pone.0051389			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284687	Green Published, Green Submitted, gold			2022-12-27	WOS:000312694300023
J	Li, X; Feng, YF; Wang, CT; Li, GC; Lei, W; Zhang, ZY; Wang, L				Li, Xiang; Feng, Ya-Fei; Wang, Cheng-Tao; Li, Guo-Chen; Lei, Wei; Zhang, Zhi-Yong; Wang, Lin			Evaluation of Biological Properties of Electron Beam Melted Ti6Al4V Implant with Biomimetic Coating In Vitro and In Vivo	PLOS ONE			English	Article							POROUS TITANIUM IMPLANTS; CALCIUM-PHOSPHATE; APATITE FORMATION; ORTHOPEDIC APPLICATIONS; TI-6AL-4V STRUCTURES; TREATED TITANIUM; BONE INGROWTH; SURFACE; FABRICATION; SCAFFOLD	Background: High strength porous titanium implants are widely used for the reconstruction of craniofacial defects because of their similar mechanical properties to those of bone. The recent introduction of electron beam melting (EBM) technique allows a direct digitally enabled fabrication of patient specific porous titanium implants, whereas both their in vitro and in vivo biological performance need further investigation. Methods: In the present study, we fabricated porous Ti6Al4V implants with controlled porous structure by EBM process, analyzed their mechanical properties, and conducted the surface modification with biomimetic approach. The bioactivities of EBM porous titanium in vitro and in vivo were evaluated between implants with and without biomimetic apatite coating. Results: The physical property of the porous implants, containing the compressive strength being 163 - 286 MPa and the Young's modulus being 14.5-38.5 GPa, is similar to cortical bone. The in vitro culture of osteoblasts on the porous Ti6Al4V implants has shown a favorable circumstance for cell attachment and proliferation as well as cell morphology and spreading, which were comparable with the implants coating with bone-like apatite. In vivo, histological analysis has obtained a rapid ingrowth of bone tissue from calvarial margins toward the center of bone defect in 12 weeks. We observed similar increasing rate of bone ingrowth and percentage of bone formation within coated and uncoated implants, all of which achieved a successful bridging of the defect in 12 weeks after the implantation. Conclusions: This study demonstrated that the EBM porous Ti6Al4V implant not only reduced the stress-shielding but also exerted appropriate osteoconductive properties, as well as the apatite coated group. The results opened up the possibility of using purely porous titanium alloy scaffolds to reconstruct specific bone defects in the maxillofacial and orthopedic fields.	[Feng, Ya-Fei; Lei, Wei; Zhang, Zhi-Yong; Wang, Lin] Fourth Mil Med Univ, Xijing Hosp, Dept Orthopaed, Xian 710032, Peoples R China; [Li, Xiang; Wang, Cheng-Tao] Shanghai Jiao Tong Univ, Sch Mech Engn, State Key Lab Mech Syst & Vibrat, Shanghai 200030, Peoples R China; [Li, Guo-Chen] Fourth Mil Med Univ, Dept Orthopaed, Tangdu Hosp, Xian 710032, Peoples R China; [Zhang, Zhi-Yong] Shanghai Jiao Tong Univ, Dept Plast & Reconstruct Surg, Shanghai Peoples Hosp 9, Shanghai Key Lab Tissue Engn,Sch Med, Shanghai 200030, Peoples R China	Air Force Military Medical University; Shanghai Jiao Tong University; Air Force Military Medical University; Shanghai Jiao Tong University	Zhang, ZY (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Orthopaed, Xian 710032, Peoples R China.	mr.zhiyong@gmail.com; wanglinxj@fmmu.edu.cn	zhang, zhiyong/G-3227-2010; Wang, Lin/J-8805-2018	zhang, zhiyong/0000-0001-7903-1544; Wang, Lin/0000-0001-5937-6318; Lei, Wei/0000-0002-7346-6915	XIJING ZHUTUI Foundation [XJZT10M07]; National Key Technology RD Program [2012BAI18B07]; Ph.D. Programs Foundation of the Ministry of Education of China [20100073120051]; Research Project of State Key Laboratory of Mechanical System and Vibration [MSV201114]	XIJING ZHUTUI Foundation; National Key Technology RD Program(National Key Technology R&D Program); Ph.D. Programs Foundation of the Ministry of Education of China(Ministry of Education, China); Research Project of State Key Laboratory of Mechanical System and Vibration	The authors would like to thank Contract Grant Sponsor: XIJING ZHUTUI Foundation (XJZT10M07), the Project supported by National Key Technology R&D Program (2012BAI18B07), the Ph.D. Programs Foundation of the Ministry of Education of China (Grant No. 20100073120051) and the Research Project of State Key Laboratory of Mechanical System and Vibration (Grant No. MSV201114) for their support to this work. The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.0.CO;2-J; Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9; Aparecida AH, 2009, J MATER SCI-MATER M, V20, P1215, DOI 10.1007/s10856-008-3682-0; Barrere F, 2003, J BIOMED MATER RES B, V67B, P655, DOI 10.1002/jbm.b.10057; Ben-Nissan B, 2004, BIOMATERIALS, V25, P4971, DOI 10.1016/j.biomaterials.2004.02.006; Boonrungsiman S, 2012, P NATL ACAD SCI USA, V109, P14170, DOI 10.1073/pnas.1208916109; Fujibayashi S, 2011, EUR SPINE J, V20, P1486, DOI 10.1007/s00586-011-1728-3; Goransson A, 2003, BIOMATERIALS, V24, P197, DOI 10.1016/S0142-9612(02)00277-6; Goyenvalle E, 2006, BIOMATERIALS, V27, P1119, DOI 10.1016/j.biomaterials.2005.07.039; HAHN H, 1970, Journal of Biomedical Materials Research, V4, P571, DOI 10.1002/jbm.820040407; Hansson S, 1999, J BIOMECH, V32, P829, DOI 10.1016/S0021-9290(99)00058-5; Heinl P, 2008, ACTA BIOMATER, V4, P1536, DOI 10.1016/j.actbio.2008.03.013; Hollander DA, 2006, BIOMATERIALS, V27, P955, DOI 10.1016/j.biomaterials.2005.07.041; Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5; Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.005; Jalota S, 2007, MAT SCI ENG C-BIO S, V27, P432, DOI 10.1016/j.msec.2006.05.052; Jonasova L, 2004, BIOMATERIALS, V25, P1187, DOI 10.1016/j.biomaterials.2003.08.009; Kienapfel H, 1999, J ARTHROPLASTY, V14, P355, DOI 10.1016/S0883-5403(99)90063-3; Kim HM, 1997, J BIOMED MATER RES, V38, P121; Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017; Krishna BV, 2007, ACTA BIOMATER, V3, P997, DOI 10.1016/j.actbio.2007.03.008; Kroger H, 1998, CLIN ORTHOP RELAT R, P66; Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9; Li JP, 2007, BIOMATERIALS, V28, P2810, DOI 10.1016/j.biomaterials.2007.02.020; Li JP, 2007, BIOMATERIALS, V28, P4209, DOI 10.1016/j.biomaterials.2007.05.042; Li JP, 2006, BIOMATERIALS, V27, P1223, DOI 10.1016/j.biomaterials.2005.08.033; Li LH, 2004, BIOMATERIALS, V25, P2867, DOI 10.1016/j.biomaterials.2003.09.048; Li X, 2009, MATER LETT, V63, P403, DOI 10.1016/j.matlet.2008.10.065; Lopez-Heredia MA, 2008, J BIOMED MATER RES A, V85A, P664, DOI 10.1002/jbm.a.31468; Lopez-Heredia MA, 2008, BIOMATERIALS, V29, P2608, DOI 10.1016/j.biomaterials.2008.02.021; Ma J, 2003, BIOMATERIALS, V24, P3505, DOI 10.1016/S0142-9612(03)00203-5; Nebe JB, 2008, ACTA BIOMATER, V4, P1985, DOI 10.1016/j.actbio.2008.05.028; Nishiguchi S, 1999, BIOMATERIALS, V20, P491, DOI 10.1016/S0142-9612(98)90203-4; O'Hare P, 2010, BIOMATERIALS, V31, P515, DOI 10.1016/j.biomaterials.2009.09.067; Parthasarathy J, 2010, J MECH BEHAV BIOMED, V3, P249, DOI 10.1016/j.jmbbm.2009.10.006; PILLIAR RM, 1987, J BIOMED MATER RES-A, V21, P1; Ponader S, 2008, J BIOMED MATER RES A, V84A, P1111, DOI 10.1002/jbm.a.31540; Ponader S, 2010, J BIOMED MATER RES A, V92A, P56, DOI 10.1002/jbm.a.32337; Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002; Sader MS, 2005, CLIN ORAL IMPLAN RES, V16, P667, DOI 10.1111/j.1600-0501.2005.01135.x; Sugita Y, 2011, BIOMATERIALS, V32, P8374, DOI 10.1016/j.biomaterials.2011.07.077; Takemoto M, 2005, BIOMATERIALS, V26, P6014, DOI 10.1016/j.biomaterials.2005.03.019; Thomsen P, 2009, J BIOMED MATER RES B, V90B, P35, DOI 10.1002/jbm.b.31250; Zhao LZ, 2010, BIOMATERIALS, V31, P5072, DOI 10.1016/j.biomaterials.2010.03.014; Zhao LZ, 2010, J BIOMED MATER RES A, V92A, P432, DOI 10.1002/jbm.a.32348	45	47	57	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52049	10.1371/journal.pone.0052049	http://dx.doi.org/10.1371/journal.pone.0052049			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272208	Green Published, Green Submitted, gold			2022-12-27	WOS:000312483300054
J	Castelnuovo, B; Kiragga, A; Afayo, V; Ncube, M; Orama, R; Magero, S; Okwi, P; Manabe, YC; Kambugu, A				Castelnuovo, Barbara; Kiragga, Agnes; Afayo, Victor; Ncube, Malisa; Orama, Richard; Magero, Stephen; Okwi, Peter; Manabe, Yukari C.; Kambugu, Andrew			Implementation of Provider-Based Electronic Medical Records and Improvement of the Quality of Data in a Large HIV Program in Sub-Saharan Africa	PLOS ONE			English	Article							PATIENT FLOW; SETTINGS; KAMPALA; UGANDA; SYSTEM; CARE	Introduction: Starting in June 2010 the Infectious Diseases Institute (IDI) clinic (a large urban HIV out-patient facility) switched to provider-based Electronic Medical Records (EMR) from paper EMR entered in the database by data-entry clerks. Standardized clinics forms were eliminated but providers still fill free text clinical notes in physical patients' files. The objective of this study was to compare the rate of errors in the database before and after the introduction of the provider-based EMR. Methods and Findings: Data in the database pre and post provider-based EMR was compared with the information in the patients' files and classified as correct, incorrect, and missing. We calculated the proportion of incorrect, missing and total error for key variables (toxicities, opportunistic infections, reasons for treatment change and interruption). Proportions of total errors were compared using chi-square test. A survey of the users of the EMR was also conducted. We compared data from 2,382 visits (from 100 individuals) of a retrospective validation conducted in 2007 with 34,957 visits (from 10,920 individuals) of a prospective validation conducted in April-August 2011. The total proportion of errors decreased from 66.5% in 2007 to 2.1% in 2011 for opportunistic infections, from 51.9% to 3.5% for ART toxicity, from 82.8% to 12.5% for reasons for ART interruption and from 94.1% to 0.9% for reasons for ART switch (all P < 0.0001). The survey showed that 83% of the providers agreed that provider-based EMR led to improvement of clinical care, 80% reported improved access to patients' records, and 80% appreciated the automation of providers' tasks. Conclusions: The introduction of provider-based EMR improved the quality of data collected with a significant reduction in missing and incorrect information. The majority of providers and clients expressed satisfaction with the new system. We recommend the use of provider-based EMR in large HIV programs in Sub-Saharan Africa.	[Castelnuovo, Barbara; Kiragga, Agnes; Afayo, Victor; Ncube, Malisa; Orama, Richard; Magero, Stephen; Okwi, Peter; Manabe, Yukari C.; Kambugu, Andrew] Makerere Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda; [Manabe, Yukari C.] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA	Johns Hopkins University	Castelnuovo, B (corresponding author), Makerere Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda.	bcastelnuovo@idi.co.ug			International epidemiologic Database to Evaluate AIDS (IeDEA)	International epidemiologic Database to Evaluate AIDS (IeDEA)	This work was partially funded by the International epidemiologic Database to Evaluate AIDS (IeDEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Allen Christian, 2006, AMIA Annu Symp Proc, P840; Amoroso CL, 2010, STUD HEALTH TECHNOL, V160, P337, DOI 10.3233/978-1-60750-588-4-337; Castelnuovo B, 2009, INT J STD AIDS, V20, P123, DOI 10.1258/ijsa.2008.008174; Cebul RD, 2011, NEW ENGL J MED, V365, P825, DOI 10.1056/NEJMsa1102519; Colebunders R, 2007, AIDS CARE, V19, P149, DOI 10.1080/09540120600762078; Douglas G P, 2005, AMIA Annu Symp Proc, P942; Douglas GP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000319; Duda SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033908; Forster M, 2008, B WORLD HEALTH ORGAN, V86, P939, DOI 10.2471/BLT.07.049908; Fraser Hamish S F, 2006, AMIA Annu Symp Proc, P264; Fraser HSF, 2004, BMJ-BRIT MED J, V329, P1142, DOI 10.1136/bmj.329.7475.1142; Gearing Pauline, 2006, J Healthc Inf Manag, V20, P40; Harries AD, 2007, B WORLD HEALTH ORGAN, V85, P152, DOI 10.2471/BLT.06.032060; HORBAR JD, 1995, CONTROL CLIN TRIALS, V16, P51, DOI 10.1016/0197-2456(94)00019-Y; Kiragga AN, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-3; Payne TH, 2010, J AM MED INFORM ASSN, V17, P108, DOI 10.1197/jamia.M3173; Rotich JK, 2003, J AM MED INFORM ASSN, V10, P295, DOI 10.1197/jamia.M1301; Simba Daudi O, 2004, Afr Health Sci, V4, P194; Smith CJ, 2004, HIV MED, V5, P88, DOI 10.1111/j.1468-1293.2004.00191.x; Waters E, 2010, STUD HEALTH TECHNOL, V160, P96, DOI 10.3233/978-1-60750-588-4-96; Williams Faustine, 2008, Inform Prim Care, V16, P139	21	43	43	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51631	10.1371/journal.pone.0051631	http://dx.doi.org/10.1371/journal.pone.0051631			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055RZ	23284728	Green Published, Green Submitted, gold			2022-12-27	WOS:000312435900035
J	Duncan, C; Chauvenet, ALM; McRae, LM; Pettorelli, N				Duncan, Clare; Chauvenet, Alienor L. M.; McRae, Louise M.; Pettorelli, Nathalie			Predicting the Future Impact of Droughts on Ungulate Populations in Arid and Semi-Arid Environments	PLOS ONE			English	Article							ELEPHANT LOXODONTA-AFRICANA; NATIONAL-PARK; CLIMATE-CHANGE; DYNAMICS; RAINFALL; DECLINE; VULNERABILITY; SERENGETI; MORTALITY; ECOSYSTEM	Droughts can have a severe impact on the dynamics of animal populations, particularly in semi-arid and arid environments where herbivore populations are strongly limited by resource availability. Increased drought intensity under projected climate change scenarios can be expected to reduce the viability of such populations, yet this impact has seldom been quantified. In this study, we aim to fill this gap and assess how the predicted worsening of droughts over the 21st century is likely to impact the population dynamics of twelve ungulate species occurring in arid and semi-arid habitats. Our results provide support to the hypotheses that more sedentary, grazing and mixed feeding species will be put at high risk from future increases in drought intensity, suggesting that management intervention under these conditions should be targeted towards species possessing these traits. Predictive population models for all sedentary, grazing or mixed feeding species in our study show that their probability of extinction dramatically increases under future emissions scenarios, and that this extinction risk is greater for smaller populations than larger ones. Our study highlights the importance of quantifying the current and future impacts of increasing extreme natural events on populations and species in order to improve our ability to mitigate predicted biodiversity loss under climate change.	[Duncan, Clare; Chauvenet, Alienor L. M.; McRae, Louise M.; Pettorelli, Nathalie] Zool Soc London, Inst Zool, London NW1 4RY, England; [Chauvenet, Alienor L. M.] Univ London Imperial Coll Sci Technol & Med, Div Biol, Ascot, Berks, England	Zoological Society of London; Imperial College London	Pettorelli, N (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.	Nathalie.Pettorelli@ioz.ac.uk	Duncan, Clare/V-6005-2019; Chauvenet, Alienor/L-9135-2015; Pettorelli, Nathalie/AAW-8438-2021	Duncan, Clare/0000-0001-5315-2997; Chauvenet, Alienor/0000-0002-3743-7375; 				[Anonymous], 2012, MAN RISKS EXTR EV DI; ARMBRUSTER P, 1993, CONSERV BIOL, V7, P602, DOI 10.1046/j.1523-1739.1993.07030602.x; Augustine DJ, 2010, AFR J ECOL, V48, P1009, DOI 10.1111/j.1365-2028.2010.01207.x; BENSHAHAR R, 1993, J TROP ECOL, V9, P249, DOI 10.1017/S0266467400007252; Berger J, 2004, CONSERV BIOL, V18, P320, DOI 10.1111/j.1523-1739.2004.00548.x; Boone Randall B., 2004, African Journal of Range & Forage Science, V21, P147, DOI 10.2989/10220110409485847; Bouche P, 2012, BIOTECHNOL AGRON SOC, V16, P77; Brockett BH, 2002, S AFR J WILDL RES, V32, P121; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Chege G, 2008, LEWA WILDLIFE CONSER; Clutton-Brock T.H., 1988, P1; Collen B, 2011, PHILOS T R SOC B, V366, P2577, DOI 10.1098/rstb.2011.0015; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; Dai AG, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015541; Dai AG, 2011, WIRES CLIM CHANGE, V2, P45, DOI 10.1002/wcc.81; de Leeuw J, 2001, BIOL CONSERV, V100, P297, DOI 10.1016/S0006-3207(01)00034-9; Du Toit JT, 1999, BIODIVERS CONSERV, V8, P1643, DOI 10.1023/A:1008959721342; DUNHAM KM, 1994, J ZOOL, V234, P489, DOI 10.1111/j.1469-7998.1994.tb04862.x; EMSLIE R, 2011, IUCN RED LIST THREAT; Epps CW, 2004, CONSERV BIOL, V18, P102, DOI 10.1111/j.1523-1739.2004.00023.x; Erasmus BFN, 2002, GLOBAL CHANGE BIOL, V8, P679, DOI 10.1046/j.1365-2486.2002.00502.x; Foden W., 2008, 2008 REV IUCN RED LI, P77; Foley C, 2008, BIOL LETTERS, V4, P541, DOI 10.1098/rsbl.2008.0370; Gasaway WC, 1996, CAN J ZOOL, V74, P1556, DOI 10.1139/z96-170; Gaylard A., 2003, KRUGER EXPERIENCE EC, P171; Georgiadis N, 2003, J APPL ECOL, V40, P125, DOI 10.1046/j.1365-2664.2003.00796.x; Harrington R, 1999, BIOL CONSERV, V90, P69, DOI 10.1016/S0006-3207(98)00120-7; Heim RR, 2002, B AM METEOROL SOC, V83, P1149, DOI 10.1175/1520-0477-83.8.1149; Heim RR, 2000, ROUTLEDGE HAZARDS DI, P159; HILLMAN J C, 1977, East African Wildlife Journal, V15, P1, DOI 10.1111/j.1365-2028.1977.tb00374.x; Illius AW, 2000, OIKOS, V89, P283, DOI 10.1034/j.1600-0706.2000.890209.x; *INT PAN CLIM CHAN, 2007, CLIM CHANG 2007 PHYS; IPCC, 2001, CLIMATE CHANGE 2001, DOI DOI 10.1017/CBO9781107415379; Isaac NJB, 2004, P ROY SOC B-BIOL SCI, V271, P1135, DOI 10.1098/rspb.2004.2724; IUCN SSC ANTELOPE SPECIALIST GROUP, 2008, IUCN RED LIST THREAT; Jachmann H., 2001, ESTIMATING ABUNDANCE, DOI 10.1007/978-1-4615-1381-0; Jolles AE, 2005, ECOLOGY, V86, P2358, DOI 10.1890/05-0038; Joly DO, 2004, CAN J ZOOL, V82, P1165, DOI 10.1139/Z04-072; Kay RNB, 1997, J ARID ENVIRON, V37, P683, DOI 10.1006/jare.1997.0299; Keyantash J, 2002, B AM METEOROL SOC, V83, P1167, DOI 10.1175/1520-0477(2002)083&lt;1191:TQODAE&gt;2.3.CO;2; Knight MH, 1995, AFR J ECOL, V33, P377, DOI 10.1111/j.1365-2028.1995.tb01047.x; Leirs H, 1997, NATURE, V389, P176, DOI 10.1038/38271; Loveridge AJ, 2006, J ZOOL, V270, P523, DOI 10.1111/j.1469-7998.2006.00181.x; MAGIN CD, 1989, AFR J ECOL, V27, P297, DOI 10.1111/j.1365-2028.1989.tb01023.x; Mallon D. P., 2008, IUCN RED LIST THREAT; Mbaiwa J.E., 2006, INT J WILDERNESS, V12, P41; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Novellie P, 2008, IUCN RED LIST THREAT; Ogutu JO, 2008, J ANIM ECOL, V77, P814, DOI 10.1111/j.1365-2656.2008.01392.x; Ogutu JO, 2003, ECOL LETT, V6, P412, DOI 10.1046/j.1461-0248.2003.00447.x; Ogutu JO, 2012, BIODIVERS CONSERV, V21, P1033, DOI 10.1007/s10531-012-0239-9; Olech W, 2008, IUCN RED LIST THREAT; Owen-Smith N, 2006, ECOL MONOGR, V76, P73, DOI 10.1890/04-1101; Owen-Smith N, 2005, J ANIM ECOL, V74, P774, DOI 10.1111/j.1365-2656.2005.00974.x; OwenSmith N, 1996, S AFR J WILDL RES, V26, P107; Palmer W.C., 1965, 45 WEATH BUR; Ponce VM, 2000, J HYDROL ENG, V5, P222, DOI 10.1061/(ASCE)1084-0699(2000)5:2(222); Robinson Robert A., 2009, Endangered Species Research, V7, P87, DOI 10.3354/esr00095; Rubel F, 2010, METEOROL Z, V19, P135, DOI 10.1127/0941-2948/2010/0430; RUTHERFORD MC, 1980, S AFR J SCI, V76, P53; Saltz D, 2002, ZEBRA ASSESS HORSES; Saltz D, 2006, CONSERV BIOL, V20, P1402, DOI 10.1111/j.1523-1739.2006.00486.x; Sheffield J, 2008, CLIM DYNAM, V31, P79, DOI 10.1007/s00382-007-0340-z; Sinclair ARE, 2007, CONSERV BIOL, V21, P580, DOI 10.1111/j.1523-1739.2007.00699.x; Society A.M., 1997, B AM METEOROL SOC, V78, P847; South African National Parks, 2008, S AFR NAT PARKS DAT; Spinage C. A., 1982, TERRITORIAL ANTELOPE, P350; Team RDC, 2012, R LANG ENV STAT COMP; Thuiller W, 2006, GLOBAL CHANGE BIOL, V12, P424, DOI 10.1111/j.1365-2486.2006.01115.x; UNEP/CMS, 2006, MIGR SPEC CLIM CHANG; VanDierendonck MC, 1996, CONSERV BIOL, V10, P728, DOI 10.1046/j.1523-1739.1996.10030728.x; Verlinden A, 1998, AFR J ECOL, V36, P117; WALKER BH, 1987, J APPL ECOL, V24, P381, DOI 10.2307/2403882; Wells N, 2004, J CLIMATE, V17, P2335, DOI 10.1175/1520-0442(2004)017&lt;2335:ASPDSI&gt;2.0.CO;2; Wilson DE, 2011, HOOFED MAMMALS, V2; WWF/ZSL, 2012, LIV PLAN DAT; YOUNG TP, 1994, CONSERV BIOL, V8, P410, DOI 10.1046/j.1523-1739.1994.08020410.x	77	41	43	0	128	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51490	10.1371/journal.pone.0051490	http://dx.doi.org/10.1371/journal.pone.0051490			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284700	Green Published, Green Submitted, gold			2022-12-27	WOS:000312435900023
J	Sampath, H; Vartanian, V; Rollins, MR; Sakumi, K; Nakabeppu, Y; Lloyd, RS				Sampath, Harini; Vartanian, Vladimir; Rollins, M. Rick; Sakumi, Kunihiko; Nakabeppu, Yusaku; Lloyd, R. Stephen			8-Oxoguanine DNA Glycosylase (OGG1) Deficiency Increases Susceptibility to Obesity and Metabolic Dysfunction	PLOS ONE			English	Article							OXIDATIVE DAMAGE; SER326CYS POLYMORPHISM; GENE-EXPRESSION; REPAIR ENZYME; PPAR-GAMMA; CANCER; LUNG; ACCUMULATION; KNOCKOUT; DISEASE	Oxidative damage to DNA is mainly repaired via base excision repair, a pathway that is catalyzed by DNA glycosylases such as 8-oxoguanine DNA glycosylase (OGG1). While OGG1 has been implicated in maintaining genomic integrity and preventing tumorigenesis, we report a novel role for OGG1 in altering cellular and whole body energy homeostasis. OGG1-deficient (Ogg1(-/-)) mice have increased adiposity and hepatic steatosis following exposure to a high-fat diet (HFD), compared to wild-type (WT) animals. Ogg1(-/-) animals also have higher plasma insulin levels and impaired glucose tolerance upon HFD feeding, relative to WT counterparts. Analysis of energy expenditure revealed that HFD-fed Ogg1(-/-) mice have a higher resting VCO2 and consequently, an increased respiratory quotient during the resting phase, indicating a preference for carbohydrate metabolism over fat oxidation in these mice. Additionally, microarray and quantitative PCR analyses revealed that key genes of fatty acid oxidation, including carnitine palmitoyl transferase-1, and the integral transcriptional co-activator Pgc-1 alpha were significantly downregulated in Ogg1(-/-) livers. Multiple genes involved in TCA cycle metabolism were also significantly reduced in livers of Ogg1(-/-) mice. Furthermore, hepatic glycogen stores were diminished, and fasting plasma ketones were significantly reduced in Ogg1(-/-) mice. Collectively, these data indicate that OGG1 deficiency alters cellular substrate metabolism, favoring a fat sparing phenotype, that results in increased susceptibility to obesity and related pathologies in Ogg1(-/-) mice.	[Sakumi, Kunihiko; Nakabeppu, Yusaku] Kyushu Univ, Div Neurofunct Genom, Dept Immunobiol & Neurosci, Med Inst Bioregulat, Fukuoka 812, Japan; [Sakumi, Kunihiko; Nakabeppu, Yusaku] Kyushu Univ, Res Ctr Nucleotide Pool, Fukuoka 812, Japan; [Sampath, Harini; Vartanian, Vladimir; Rollins, M. Rick; Lloyd, R. Stephen] Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Dept Mol & Med Genet, Portland, OR 97201 USA	Kyushu University; Kyushu University; Oregon Health & Science University	Nakabeppu, Y (corresponding author), Kyushu Univ, Div Neurofunct Genom, Dept Immunobiol & Neurosci, Med Inst Bioregulat, Fukuoka 812, Japan.	yusaku@bioreg.kyushu-u.ac.jp; lloydst@ohsu.edu	Nakabeppu, Yusaku/A-8902-2011; Sakumi, Kunihiko/G-4808-2011	Nakabeppu, Yusaku/0000-0002-6739-242X; Lloyd, R. Stephen/0000-0001-7273-372X	American Heart Association [11POST7480004]; National Institutes of Health (NIH) [R01 DK075974]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075974] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22221004] Funding Source: KAKEN	American Heart Association(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by American Heart Association Postdoctoral grant 11POST7480004 (HS) and National Institutes of Health (NIH) R01 DK075974 (RSL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai T, 2006, TOXICOLOGY, V221, P179, DOI 10.1016/j.tox.2006.01.004; Burgess SC, 2006, J BIOL CHEM, V281, P19000, DOI 10.1074/jbc.M600050200; Cardozo-Pelaez F, 2005, GENE EXPRESSION, V12, P315, DOI 10.3727/000000005783992007; Casorelli I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012070; Chevillard S, 1998, ONCOGENE, V16, P3083, DOI 10.1038/sj.onc.1202096; Daimon M, 2009, BIOCHEM BIOPH RES CO, V386, P26, DOI 10.1016/j.bbrc.2009.05.119; Dezor M, 2011, FOLIA NEUROPATHOL, V49, P123; Dorszewska J, 2009, DNA CELL BIOL, V28, P579, DOI 10.1089/dna.2009.0926; Feilchenfeldt J, 2004, CANCER LETT, V203, P25, DOI 10.1016/j.canlet.2003.08.024; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Fukae J, 2005, ACTA NEUROPATHOL, V109, P256, DOI 10.1007/s00401-004-0937-9; Hazra TK, 2007, DNA REPAIR, V6, P470, DOI 10.1016/j.dnarep.2006.10.011; Iida T, 2002, ACTA NEUROPATHOL, V103, P20, DOI 10.1007/s004010100418; Jiang WG, 2003, INT J CANCER, V106, P752, DOI 10.1002/ijc.11302; Kaneko T, 1996, MUTAT RES-DNAGING G, V316, P277, DOI 10.1016/S0921-8734(96)90010-7; Kim HJ, 2011, ACTA BIOCH BIOPH SIN, V43, P589, DOI 10.1093/abbs/gmr053; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Klungland A, 2007, DNA REPAIR, V6, P481, DOI 10.1016/j.dnarep.2006.10.012; Li GP, 2012, FREE RADICAL BIO MED, V52, P392, DOI 10.1016/j.freeradbiomed.2011.10.490; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Liu C, 2011, ACTA BIOCH BIOPH SIN, V43, P248, DOI 10.1093/abbs/gmr007; Lu RZ, 1997, CURR BIOL, V7, P397, DOI 10.1016/S0960-9822(06)00187-4; Mao GG, 2007, NUCLEIC ACIDS RES, V35, P2759, DOI 10.1093/nar/gkm189; MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992; Nakabeppu Y, 2007, J NEUROSCI RES, V85, P919, DOI 10.1002/jnr.21191; Nemec AA, 2010, SEMIN CANCER BIOL, V20, P320, DOI 10.1016/j.semcancer.2010.10.010; Nishioka K, 1999, MOL BIOL CELL, V10, P1637, DOI 10.1091/mbc.10.5.1637; Okasaka T, 2009, J HUM GENET, V54, P739, DOI 10.1038/jhg.2009.108; Paz-Elizur T, 2008, CANCER LETT, V266, P60, DOI 10.1016/j.canlet.2008.02.032; Puigserver P, 2005, INT J OBESITY, V29, pS5, DOI 10.1038/sj.ijo.0802905; Radak Z, 2002, PFLUG ARCH EUR J PHY, V445, P273, DOI 10.1007/s00424-002-0918-6; Radak Z, 2011, FREE RADICAL BIO MED, V51, P417, DOI 10.1016/j.freeradbiomed.2011.04.018; Radak Z, 2010, FREE RADICAL BIO MED, V49, P587, DOI 10.1016/j.freeradbiomed.2010.05.008; Radicella JP, 1997, P NATL ACAD SCI USA, V94, P8010, DOI 10.1073/pnas.94.15.8010; Rosenquist TA, 1997, P NATL ACAD SCI USA, V94, P7429, DOI 10.1073/pnas.94.14.7429; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Sakumi K, 2003, CANCER RES, V63, P902; Sampath H, 2012, FREE RADICAL RES, V46, P460, DOI 10.3109/10715762.2012.655730; Sampath H, 2011, AM J PHYSIOL-ENDOC M, V300, pE724, DOI 10.1152/ajpendo.00387.2010; Shao C, 2008, FREE RADICAL BIO MED, V45, P813, DOI 10.1016/j.freeradbiomed.2008.06.003; Thameem F, 2010, HUM HERED, V70, P97, DOI 10.1159/000291964; Thomas D, 1997, MOL GEN GENET, V254, P171, DOI 10.1007/s004380050405; Torisu K, 2005, J BIOCHEM, V138, P763, DOI 10.1093/jb/mvi168; Vartanian V, 2006, P NATL ACAD SCI USA, V103, P1864, DOI 10.1073/pnas.0507444103; Watkins G, 2004, ONCOL REP, V12, P483; Wood LJ, 2006, BIOL RES NURS, V8, P157, DOI 10.1177/1099800406290932	46	87	89	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51697	10.1371/journal.pone.0051697	http://dx.doi.org/10.1371/journal.pone.0051697			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284747	Green Submitted, Green Published, gold			2022-12-27	WOS:000312435900047
J	Tiwari, BM; Kannan, N; Vemu, L; Raghunand, TR				Tiwari, Bhavana Mishra; Kannan, Nisha; Vemu, Lakshmi; Raghunand, Tirumalai R.			The Mycobacterium tuberculosis PE Proteins Rv0285 and Rv1386 Modulate Innate Immunity and Mediate Bacillary Survival in Macrophages	PLOS ONE			English	Article							MULTIGENE FAMILY; PGRS PROTEINS; EXPRESSION; SMEGMATIS; IL-10; GENE; LOCALIZATION; APOPTOSIS; NECROSIS; COMPLEX	The unique PE/PPE multigene family of proteins occupies almost 10% of the coding sequence of Mycobacterium tuberculosis (M.tb), the causative agent of human tuberculosis. Although some members of this family have been shown to be involved in pathways essential to M.tb pathogenesis, their precise physiological functions remain largely undefined. Here, we investigate the roles of the conserved members of the 'PE only' subfamily Rv0285 (PE5) and Rv1386 (PE15) in mediating host-pathogen interactions. Recombinant Mycobacterium smegmatis strains expressing PE5 and PE15 showed enhanced survival vs controls in J774.1 and THP-1 macrophages - this increase in viable counts was correlated with a reduction in transcript levels of inducible nitric oxide synthase. An up-regulation of anti- and down-regulation of pro-inflammatory cytokine levels was also observed in infected macrophages implying an immuno-modulatory function for these proteins. Induction of IL-10 production upon infection of THP-1 macrophages was associated with increased phosphorylation of the MAP Kinases p38 and ERK1/2, which was abolished in the presence of the pharmacological inhibitors SB203580 and PD98059. The PE5-PPE4 and PE15-PPE20 gene pairs were observed to be co-operonic in M.tb, hinting at an additional level of complexity in the functioning of these proteins. We conclude that M.tb exploits the PE proteins to evade the host immune response by altering the Th1 and Th2 type balance thereby favouring in vivo bacillary survival.	[Tiwari, Bhavana Mishra; Kannan, Nisha; Raghunand, Tirumalai R.] CSIR Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India; [Vemu, Lakshmi] Nizams Inst Med Sci, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Nizam's Institute of Medical Sciences	Raghunand, TR (corresponding author), CSIR Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India.	raghu@ccmb.res.in		Tiwari, Dr. Bhavana/0000-0002-3772-7487	Department of Science and Technology, Government of India [SR/SO/HS-115/2009]; Council of Scientific and Industrial Research (CSIR), Government of India; CSIR; CCMB	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India); CCMB	This work was supported by the Department of Science and Technology, Government of India (SR/SO/HS-115/2009 (to TRR) and the Council of Scientific and Industrial Research (CSIR), Government of India. BMT was supported by a Junior Research Fellowship from the CSIR. NK was supported by a fellowship from CCMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhter Y, 2012, BIOCHIMIE, V94, P110, DOI 10.1016/j.biochi.2011.09.026; Anes E, 2006, CELL MICROBIOL, V8, P939, DOI 10.1111/j.1462-5822.2005.00675.x; Balaji KN, 2007, MICROBES INFECT, V9, P271, DOI 10.1016/j.micinf.2006.11.013; Banu S, 2002, MOL MICROBIOL, V44, P9, DOI 10.1046/j.1365-2958.2002.02813.x; Basu S, 2007, J BIOL CHEM, V282, P1039, DOI 10.1074/jbc.M604379200; Brennan MJ, 2002, TRENDS MICROBIOL, V10, P246, DOI 10.1016/S0966-842X(02)02335-1; Brennan MJ, 2001, INFECT IMMUN, V69, P7326, DOI 10.1128/IAI.69.12.7326-7333.2001; Campuzano J, 2007, VACCINE, V25, P3722, DOI 10.1016/j.vaccine.2006.12.042; Cascioferro A, 2007, MOL MICROBIOL, V66, P1536, DOI 10.1111/j.1365-2958.2007.06023.x; Cascioferro A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027713; Chaitra MG, 2005, VACCINE, V23, P1265, DOI 10.1016/j.vaccine.2004.08.046; Chaturvedi R, 2010, J BIOL CHEM, V285, P30389, DOI 10.1074/jbc.M110.135251; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Daim S, 2011, J MED MICROBIOL, V60, P582, DOI 10.1099/jmm.0.026047-0; Daleke MH, 2012, P NATL ACAD SCI USA, V109, P11342, DOI 10.1073/pnas.1119453109; Delogu G, 2004, MOL MICROBIOL, V52, P725, DOI 10.1111/j.1365-2958.2004.04007.x; Delogu G, 2001, INFECT IMMUN, V69, P5606, DOI 10.1128/IAI.69.9.5606-5611.2001; Dheenadhayalan V, 2006, MICROBES INFECT, V8, P262, DOI 10.1016/j.micinf.2005.06.021; Dheenadhayalan V, 2006, J BACTERIOL, V188, P3721, DOI 10.1128/JB.188.10.3721-3725.2006; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Gupta D, 2010, J IMMUNOL, V184, P5444, DOI 10.4049/jimmunol.0903283; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Huang Y, 2010, MOL CELL BIOCHEM, V340, P223, DOI 10.1007/s11010-010-0421-x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lin PL, 2010, J IMMUNOL, V185, P15, DOI 10.4049/jimmunol.0903856; Malen H, 2007, PROTEOMICS, V7, P1702, DOI 10.1002/pmic.200600853; McEvoy CRE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030593; Mukhopadhyay S, 2011, TUBERCULOSIS, V91, P441, DOI 10.1016/j.tube.2011.04.004; Murray PJ, 1999, INFECT IMMUN, V67, P3087, DOI 10.1128/IAI.67.6.3087-3095.1999; Nair S, 2009, J IMMUNOL, V183, P6269, DOI 10.4049/jimmunol.0901367; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Ramakrishnan L, 2000, SCIENCE, V288, P1436, DOI 10.1126/science.288.5470.1436; Redpath S, 2001, TRENDS MICROBIOL, V9, P86, DOI 10.1016/S0966-842X(00)01919-3; Riley R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000174; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sampson SL, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/497203; Sampson SL, 2001, TUBERCULOSIS, V81, P305, DOI 10.1054/tube.2001.0304; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Singh A, 2006, P NATL ACAD SCI USA, V103, P11346, DOI 10.1073/pnas.0602817103; Singh PP, 2008, MICROBIOL-SGM, V154, P3469, DOI 10.1099/mic.0.2008/019968-0; Spratt JM, 2005, PLASMID, V53, P269, DOI 10.1016/j.plasmid.2004.11.002; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tundup S, 2006, FEBS LETT, V580, P1285, DOI 10.1016/j.febslet.2006.01.042; Tundup S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003586; Voskuil MI, 2004, TUBERCULOSIS, V84, P256, DOI 10.1016/j.tube.2003.12.014; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205	51	74	77	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51686	10.1371/journal.pone.0051686	http://dx.doi.org/10.1371/journal.pone.0051686			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284742	gold, Green Published, Green Submitted			2022-12-27	WOS:000312435900043
J	Zhang, YJ; Duan, L; Zhang, H; Biswal, BB; Lu, CM; Zhu, CZ				Zhang, Yu-Jin; Duan, Lian; Zhang, Han; Biswal, Bharat B.; Lu, Chun-Ming; Zhu, Chao-Zhe			Determination of Dominant Frequency of Resting-State Brain Interaction within One Functional System	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; INTRINSIC CONNECTIVITY NETWORKS; CEREBRAL HEMODYNAMICS; CORTICAL NETWORKS; BOLD SIGNAL; OSCILLATIONS; FMRI; FLUCTUATIONS; DYNAMICS; SYNCHRONIZATION	Accumulating evidence has revealed that the resting-state functional connectivity (RSFC) is frequency specific and functional system dependent. Determination of dominant frequency of RSFC (RSFCdf) within a functional system, therefore, is of importance for further understanding the brain interaction and accurately assessing the RSFC within the system. Given the unique advantages over other imaging techniques, functional near-infrared spectroscopy (fNIRS) holds distinct merits for RSFCdf determination. However, an obstacle that hinders fNIRS from potential RSFCdf investigation is the interference of various global noises in fNIRS data which could bring spurious connectivity at the frequencies unrelated to spontaneous neural activity. In this study, we first quantitatively evaluated the interferences of multiple systemic physiological noises and the motion artifact by using simulated data. We then proposed a functional system dependent and frequency specific analysis method to solve the problem by introducing anatomical priori information on the functional system of interest. Both the simulated and real resting-state fNIRS experiments showed that the proposed method outperforms the traditional one by effectively eliminating the negative effects of the global noises and significantly improving the accuracy of the RSFCdf estimation. The present study thus provides an effective approach to RSFCdf determination for its further potential applications in basic and clinical neurosciences.	[Zhang, Yu-Jin; Duan, Lian; Zhang, Han; Lu, Chun-Ming; Zhu, Chao-Zhe] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Biswal, Bharat B.] Univ Med & Dent New Jersey, Dept Radiol, Newark, NJ 07103 USA	Beijing Normal University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Zhu, CZ (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	czzhu@bnu.edu.cn	Chaozhe, Zhu/AAK-7737-2020	Chaozhe, Zhu/0000-0002-9247-9607; Zhang, Han/0000-0002-6645-8810; Duan, Lian/0000-0002-9215-5194	Natural Science Foundation of China [30970773]; Program for New Century Excellent Talents in University [NCET-11-0046]; Engagement Fund of Outstanding Doctoral Dissertation of Beijing Normal University [2009044]; Fundamental Research Funds for the Central Universities; National Natural Science Foundation of China [31221003]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Engagement Fund of Outstanding Doctoral Dissertation of Beijing Normal University; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China, grant number 30970773 (http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm); Program for New Century Excellent Talents in University, grant number NCET-11-0046 (http://www.dost.moe.edu.cn/xzzx/rcxmgsxz/20120411142542); Engagement Fund of Outstanding Doctoral Dissertation of Beijing Normal University, grant number 2009044 (http://graduate.bnu.edu.cn/NewsList.aspx?ColumnId = 179#); Fundamental Research Funds for the Central Universities. This work is also supported by the National Natural Science Foundation of China, grant number 31221003 (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baria AT, 2011, J NEUROSCI, V31, P7910, DOI 10.1523/JNEUROSCI.1296-11.2011; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Boas DA, 2004, NEUROIMAGE, V23, pS275, DOI 10.1016/j.neuroimage.2004.07.011; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; COPE M, 1988, MED BIOL ENG COMPUT, V26, P289, DOI 10.1007/BF02447083; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Cui X, 2010, NEUROIMAGE, V49, P3039, DOI 10.1016/j.neuroimage.2009.11.050; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Franceschini MA, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2363365; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Homae F, 2010, J NEUROSCI, V30, P4877, DOI 10.1523/JNEUROSCI.5618-09.2010; Hoshi Y, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2804911; Huppert TJ, 2009, APPL OPTICS, V48, pD280, DOI 10.1364/AO.48.00D280; Jann K, 2010, NEUROIMAGE, V51, P365, DOI 10.1016/j.neuroimage.2010.02.024; Katura T, 2006, NEUROIMAGE, V31, P1592, DOI 10.1016/j.neuroimage.2006.02.010; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Lowe MJ, 2008, HUM BRAIN MAPP, V29, P818, DOI 10.1002/hbm.20576; Lu CM, 2010, J NEUROSCI METH, V186, P242, DOI 10.1016/j.jneumeth.2009.11.010; Lu H, 2007, P NATL ACAD SCI USA, V104, P18265, DOI 10.1073/pnas.0705791104; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mesquita RC, 2010, BIOMED OPT EXPRESS, V1, P324, DOI 10.1364/BOE.1.000324; Minagawa-Kawai Y, 2008, DEV NEUROBIOL, V68, P712, DOI 10.1002/dneu.20618; Obrig H, 2000, NEUROIMAGE, V12, P623, DOI 10.1006/nimg.2000.0657; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Robertson FC, 2010, IEEE T BIO-MED ENG, V57, P1377, DOI 10.1109/TBME.2009.2038667; Saager R, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2940587; Sadaghiani S, 2010, J NEUROSCI, V30, P10243, DOI 10.1523/JNEUROSCI.1004-10.2010; Salvador R, 2008, NEUROIMAGE, V39, P279, DOI 10.1016/j.neuroimage.2007.08.018; Salvador R, 2005, PHILOS T R SOC B, V360, P937, DOI 10.1098/rstb.2005.1645; Sasai S, 2011, NEUROIMAGE, P1053; Sasai S, 2010, 16 ANN M ORG HUM BRA; Sato H, 2004, NEUROIMAGE, V21, P1554, DOI 10.1016/j.neuroimage.2003.12.017; Schnitzler A, 2005, NAT REV NEUROSCI, V6, P285, DOI 10.1038/nrn1650; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shmueli K, 2007, NEUROIMAGE, V38, P306, DOI 10.1016/j.neuroimage.2007.07.037; Sun FT, 2004, NEUROIMAGE, V21, P647, DOI 10.1016/j.neuroimage.2003.09.056; Tong YJ, 2010, NEUROIMAGE, V53, P553, DOI 10.1016/j.neuroimage.2010.06.049; van Buuren M, 2009, HUM BRAIN MAPP, V30, P3031, DOI 10.1002/hbm.20729; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; White BR, 2009, NEUROIMAGE, V47, P148, DOI 10.1016/j.neuroimage.2009.03.058; Wise RG, 2004, NEUROIMAGE, V21, P1652, DOI 10.1016/j.neuroimage.2003.11.025; Wu CWW, 2008, NEUROIMAGE, V42, P1047, DOI 10.1016/j.neuroimage.2008.05.035; Zhang H., 2010, NEUROIMAGE; Zhang H, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3591020; Zhang H, 2011, NEUROIMAGE, V55, P607, DOI 10.1016/j.neuroimage.2010.12.007; Zhang H, 2010, NEUROIMAGE, V51, P1414, DOI 10.1016/j.neuroimage.2010.03.039; Zhang Q, 2009, NEUROIMAGE, V45, P788, DOI 10.1016/j.neuroimage.2008.12.048; Zhang YJ, 2010, 16 ANN M ORG HUM BRA; Zhang YJ, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3462973	52	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51584	10.1371/journal.pone.0051584	http://dx.doi.org/10.1371/journal.pone.0051584			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284719	gold, Green Submitted, Green Published			2022-12-27	WOS:000312435900031
J	Peltier, E; Peltier, C; Tahar, S; Alliot-Lugaz, E; Cazals, Y				Peltier, Elisabeth; Peltier, Cedric; Tahar, Stephanie; Alliot-Lugaz, Evelyne; Cazals, Yves			Long-Term Tinnitus Suppression with Linear Octave Frequency Transposition Hearing Aids	PLOS ONE			English	Article							MECHANISMS; REGION	Over the last three years of hearing aid dispensing, it was observed that among 74 subjects fitted with a linear octave frequency transposition (LOFT) hearing aid, 60 reported partial or complete tinnitus suppression during day and night, an effect still lasting after several months or years of daily use. We report in more details on 38 subjects from whom we obtained quantified measures of tinnitus suppression through visual analog scaling and several additional psychoacoustic and audiometric measures. The long-term suppression seems independent of subject age, and of duration and subjective localization of tinnitus. A small but significant correlation was found with audiogram losses but not with high frequency loss slope. Long-term tinnitus suppression was observed for different etiologies, but with a low success rate for sudden deafness. It should be noted that a majority of subjects (23) had a history of noise exposure. Tinnitus suppression started after a few days of LOFT hearing aid use and reached a maximum after a few weeks of daily use. For nine subjects different amounts of frequency shifting were tried and found more or less successful for long-term tinnitus suppression, no correlation was found with tinnitus pitch. When the use of the LOFT hearing aid was stopped tinnitus reappeared within a day, and after re-using the LOFT aid it disappeared again within a day. For about one third of the 38 subjects a classical amplification or a non linear frequency compression aid was also tried, and no such tinnitus suppression was observed. Besides improvements in audiometric sensitivity to high frequencies and in speech discrimination scores, LOFT can be considered as a remarkable opportunity to suppress tinnitus over a long time scale. From a pathophysiological viewpoint these observations seem to fit with a possible re-attribution of activity to previously deprived cerebral areas corresponding to high frequency coding.	[Cazals, Yves] Aix Marseille Univ, Lab Neurosci Integrat & Adaptat, CNRS, UMR Federat Rech Cerveau Comportement Cognit 7260, Marseille, France; [Peltier, Elisabeth; Peltier, Cedric; Tahar, Stephanie; Alliot-Lugaz, Evelyne] Lab Chelles Surdite, Chelles, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Cazals, Y (corresponding author), Aix Marseille Univ, Lab Neurosci Integrat & Adaptat, CNRS, UMR Federat Rech Cerveau Comportement Cognit 7260, Marseille, France.	yves.cazals@univ-amu.fr						Anari M, 1999, SCAND AUDIOL, V28, P219, DOI 10.1080/010503999424653; ATHERLEY GR, 1968, J ACOUST SOC AM, V44, P1503, DOI 10.1121/1.1911288; BERGMAN A, 1990, AUDITORY SCENE ANAL; Cazals Y, 1983, Rev Laryngol Otol Rhinol (Bord), V104, P433; Del Bo L, 2007, PROG BRAIN RES, V166, P341, DOI 10.1016/S0079-6123(07)66032-4; Del Bo L, 2008, OTOLARYNG HEAD NECK, V139, P391, DOI 10.1016/j.otohns.2008.06.019; Diesch E, 2010, NEUROIMAGE, V50, P1545, DOI 10.1016/j.neuroimage.2010.01.067; Dutt SN, 2002, J LARYNGOL OTOL, V116, P2, DOI 10.1258/0022215021911275; Eggermont JJ, 2012, HEAR RES; Fullgrabe C, 2010, INT J AUDIOL, V49, P420, DOI 10.3109/14992020903505521; Henry JA, 2005, J SPEECH LANG HEAR R, V48, P1204, DOI 10.1044/1092-4388(2005/084); HENRY JA, 1999, P 6 INT TINN SEM, P51; Hobson J, 2010, COCHRANE DB SYST REV, V12; Holmes S, 2009, J CLIN NURS, V18, P2927, DOI 10.1111/j.1365-2702.2009.02909.x; Jastreboff PJ, 1996, AM J OTOL, V17, P236; McDermott HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022358; Moffat G, 2009, HEARING RES, V254, P82, DOI 10.1016/j.heares.2009.04.016; Norena A, 2002, AUDIOL NEURO-OTOL, V7, P358, DOI 10.1159/000066156; Roberts LE, 2008, JARO-J ASSOC RES OTO, V9, P417, DOI 10.1007/s10162-008-0136-9; Robinson JD, 2009, INT J AUDIOL, V48, P384, DOI 10.1080/14992020902803138; Simpson Andrea, 2009, Trends Amplif, V13, P87, DOI 10.1177/1084713809336421; Terry A M, 1983, Br J Audiol, V17, P245, DOI 10.3109/03005368309081485; Trotrer MI, 2008, J LARYNGOL OTOL, V122, P1052, DOI 10.1017/S002221510800203X; Tucker DA, 2005, OTOLARYNG HEAD NECK, V132, P20, DOI 10.1016/j.otohns.2005.08.016; VERNON J, 1990, AM J OTOLARYNG, V11, P44, DOI 10.1016/0196-0709(90)90169-V; Vickers DA, 2001, J ACOUST SOC AM, V110, P1164, DOI 10.1121/1.1381534; Wegel RL, 1931, ARCHIV OTOLARYNGOL, V14, P158	27	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51915	10.1371/journal.pone.0051915	http://dx.doi.org/10.1371/journal.pone.0051915			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284815	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500066
J	Powell, DJ; Schlotz, W				Powell, Daniel J.; Schlotz, Wolff			Daily Life Stress and the Cortisol Awakening Response: Testing the Anticipation Hypothesis	PLOS ONE			English	Article							COEFFICIENT ALPHA; PSYCHOSOCIAL STRESS; ASSOCIATIONS; GLUCOCORTICOIDS; COVARIANCE; SECRETION; SYMPTOMS; WEEKEND; WOMEN; RISE	The cortisol awakening response (CAR) is a distinct facet of the circadian cortisol rhythm associated with various health conditions and risk factors. It has repeatedly been suggested that the CAR could be a result of the anticipated demands of the upcoming day (stress anticipation) and could support coping with daily life stress. In a sample of 23 healthy participants CARs were assessed on two consecutive days by measures of salivary cortisol upon awakening (S1) and 30 and 45 minutes later, which were aggregated to the area under the curve increase (AUCI). Stress anticipation was assessed immediately after awakening. On the same days, daily life stress and distress were assessed six times per day based on a quasi-randomized design using handheld computers. Associations were tested by day using regression analysis and standard multilevel/mixed effects models for longitudinal data. The CAR AUCI moderated the effect of daily life stress on distress; higher CAR increases were associated with attenuated distress responses to daily life stress on both days (day 1: p = .039; day 2: p = .004) adjusted for age, gender, sleep quality, time of awakening and oral contraceptive use. Lagged-effects and redundancy models showed that this effect was not due to prior-day CAR increases but specific for same day CARs. On day 2, associations between daily life stress and distress were stronger when individuals showed a higher S1 cortisol level, but this effect was similar for S1 on day 1, and the day 2 effect of S1 became non-significant when S1 on day 1 was controlled. No associations were found between stress anticipation and CARs. Findings indicate that the CAR increase is associated with successful coping with same-day daily life stress.	[Powell, Daniel J.; Schlotz, Wolff] Univ Southampton, Fac Social & Human Sci, Southampton, Hants, England; [Schlotz, Wolff] Univ Regensburg, Inst Psychol, D-8400 Regensburg, Germany	University of Southampton; University of Regensburg	Schlotz, W (corresponding author), Univ Southampton, Fac Social & Human Sci, Southampton, Hants, England.	wolff.schlotz@ur.de	Schlotz, Wolff/AAI-9549-2020	Schlotz, Wolff/0000-0003-2356-7766; Powell, Daniel/0000-0003-4995-6057	School of Psychology, University of Southampton; German Research Foundation (DFG)	School of Psychology, University of Southampton; German Research Foundation (DFG)(German Research Foundation (DFG))	This study was financially supported by the School of Psychology, University of Southampton. Publication of this work was supported by the German Research Foundation (DFG) within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam EK, 2006, P NATL ACAD SCI USA, V103, P17058, DOI 10.1073/pnas.0605053103; Adam EK, 2010, PSYCHONEUROENDOCRINO, V35, P921, DOI 10.1016/j.psyneuen.2009.12.007; Asparouhov T, 2009, STRUCT EQU MODELING, V16, P397, DOI 10.1080/10705510903008204; Bengtsson I, 2010, METABOLISM, V59, P1012, DOI 10.1016/j.metabol.2009.10.024; Bohmelt AH, 2005, PSYCHOSOM MED, V67, P288, DOI 10.1097/01.psy.0000157064.72831.ba; Bruehl H, 2009, PSYCHONEUROENDOCRINO, V34, P815, DOI 10.1016/j.psyneuen.2008.12.010; Bryk A. S., 1992, HIERARCHICAL LINEAR; Buchanan TW, 2004, BIOL PSYCHIAT, V56, P651, DOI 10.1016/j.biopsych.2004.08.014; Chida Y, 2009, BIOL PSYCHOL, V80, P265, DOI 10.1016/j.biopsycho.2008.10.004; Clow A, 2010, NEUROSCI BIOBEHAV R, V35, P97, DOI 10.1016/j.neubiorev.2009.12.011; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037/0021-9010.78.1.98; Costanzo ES, 2012, HEALTH PSYCHOL, V31, P360, DOI 10.1037/a0027018; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; DeSantis AS, 2012, PSYCHONEUROENDOCRINO, V37, P1009, DOI 10.1016/j.psyneuen.2011.11.009; DRESSENDORFER RA, 1992, J STEROID BIOCHEM, V43, P683, DOI 10.1016/0960-0760(92)90294-S; Edwards S, 2003, PSYCHOSOM MED, V65, P320, DOI 10.1097/01.PSY.0000033123.70631.8E; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fries E, 2009, INT J PSYCHOPHYSIOL, V72, P67, DOI 10.1016/j.ijpsycho.2008.03.014; Gouin JP, 2012, HEALTH PSYCHOL, V31, P264, DOI 10.1037/a0025536; Hedeker D., 2006, LONGITUDINAL DATA AN; Hellhammer J, 2007, PSYCHONEUROENDOCRINO, V32, P80, DOI 10.1016/j.psyneuen.2006.10.005; Henckens MJAG, 2010, J NEUROSCI, V30, P12725, DOI 10.1523/JNEUROSCI.3112-10.2010; Het S, 2007, BEHAV NEUROSCI, V121, P11, DOI 10.1037/0735-7044.121.1.11; Het S, 2012, PSYCHOSOM MED, V74, P23, DOI 10.1097/PSY.0b013e31823a4a25; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Inslicht SS, 2011, BIOL PSYCHIAT, V70, P1055, DOI 10.1016/j.biopsych.2011.06.030; Kern S, 2011, PSYCHONEUROENDOCRINO, V36, P1505, DOI 10.1016/j.psyneuen.2011.04.004; Kunz-Ebrecht SR, 2004, PSYCHONEUROENDOCRINO, V29, P516, DOI 10.1016/S0306-4530(03)00072-6; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Long JS, 1997, REGRESSION MODELS CA; Mikolajczak M, 2010, PSYCHONEUROENDOCRINO, V35, P752, DOI 10.1016/j.psyneuen.2009.11.003; MUNCK A, 1984, ENDOCR REV, V5, P25, DOI 10.1210/edrv-5-1-25; Nater UM, 2008, J CLIN ENDOCR METAB, V93, P703, DOI 10.1210/jc.2007-1747; Powell D, 2009, THESIS U SOUTHAMPTON; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Pruessner JC, 1997, LIFE SCI, V61, P2539, DOI 10.1016/S0024-3205(97)01008-4; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Roberts ADL, 2004, BRIT J PSYCHIAT, V184, P136, DOI 10.1192/bjp.184.2.136; Rohleder N, 2007, PERS SOC PSYCHOL B, V33, P69, DOI 10.1177/0146167206293986; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schlotz W, 2004, PSYCHOSOM MED, V66, P207, DOI 10.1097/01.psy.0000116715.78238.56; Schlotz W., 2011, HDB RES METHODS STUD, P193; Schlotz W, 2008, PSYCHOSOM MED, V70, P787, DOI 10.1097/PSY.0b013e3181810658; Schulz P, 1998, STRESS MEDICINE, V14, P91, DOI 10.1002/(SICI)1099-1700(199804)14:2<91::AID-SMI765>3.0.CO;2-S; Sheng YY, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00034; Shiffman S, 2008, ANNU REV CLIN PSYCHO, V4, P1, DOI 10.1146/annurev.clinpsy.3.022806.091415; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Stalder T, 2010, PSYCHONEUROENDOCRINO, V35, P209, DOI 10.1016/j.psyneuen.2009.06.006; Steptoe A, 2004, INT J OBESITY, V28, P1168, DOI 10.1038/sj.ijo.0802715; Stetler C, 2004, PSYCHONEUROENDOCRINO, V29, P1250, DOI 10.1016/j.psyneuen.2004.03.003; Thorn L, 2006, PSYCHONEUROENDOCRINO, V31, P1009, DOI 10.1016/j.psyneuen.2006.05.012; Wilhelm I, 2007, PSYCHONEUROENDOCRINO, V32, P358, DOI 10.1016/j.psyneuen.2007.01.008; Wirtz PH, 2007, PSYCHONEUROENDOCRINO, V32, P430, DOI 10.1016/j.psyneuen.2007.02.006; Wolf OT, 2005, PSYCHONEUROENDOCRINO, V30, P101, DOI 10.1016/j.psyneuen.2004.05.001; Zoccola PM, 2011, PSYCHONEUROENDOCRINO, V36, P592, DOI 10.1016/j.psyneuen.2010.10.004	55	70	70	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52067	10.1371/journal.pone.0052067	http://dx.doi.org/10.1371/journal.pone.0052067			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284871	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500082
J	Pul, R; Morbiducci, F; Skuljec, J; Skripuletz, T; Singh, V; Diederichs, U; Garde, N; Voss, EV; Trebst, C; Stangel, M				Pul, Refik; Morbiducci, Franco; Skuljec, Jelena; Skripuletz, Thomas; Singh, Vikramjeet; Diederichs, Ute; Garde, Niklas; Voss, Elke Verena; Trebst, Corinna; Stangel, Martin			Glatiramer Acetate Increases Phagocytic Activity of Human Monocytes In Vitro and in Multiple Sclerosis Patients	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; DENDRITIC CELLS; CD14(++)CD16(+) MONOCYTES; NEURITE OUTGROWTH; CD16(+) MONOCYTES; CNS REMYELINATION; RECEPTOR; IL-10; MACROPHAGES; DISEASE	Beside its effects on T cells, a direct influence on cells of the myelo-monocytic lineage by GA becomes evident. Recently, we demonstrated that GA drives microglia to adopt properties of type II antigen presenting cells (APC) and increases their phagocytic activity. In the present work, we focused on human blood monocytes in order to examine whether GA may increase phagocytic activity in vivo and to evaluate the molecular mechanisms explaining this new discovered mode of action. Peripheral blood mononuclear cells (PBMC) were obtained using a Biocoll-Isopaque gradient and monocytes were subsequently isolated by using CD14 MicroBeads. Phagocytic activity was determined by flow cytometric measurement of the ingestion of fluorescent beads. Flow cytometry was also used to assess monocytic differentiation and expression of phagocytic receptors. Monocytes of GA treated MS patients exhibited a significantly higher phagocytic activity than those of healthy controls or non-treated MS patients. In vitro, a significant phagocytic response was already detectable after 1 h of GA treatment at the concentrations of 62.5 and 125 mu g/ml. A significant increase at all concentrations of GA was observed after 3 h and 24 h, respectively. Only monocytes co-expressing CD16, particularly CD14(++)CD16(+) cells, were observed to phagocytose. Treatment of monocytes with IL-10 and supernatants from GA-treated monocytes did not alter phagocytosis. We observed a decrease in CD11c expression by GA while no changes were found in the expression of CD11b, CD36, CD51/61, CD91, TIM-3, and CD206. In our blocking assays, treatment with anti-CD14, anti-CD16, anti-TIM3, anti-CD210, and particularly anti-CD36 antibodies led to a decrease in phagocytosis. Our results demonstrate a new mechanism of action of GA treatment that augments phagocytic activity of human monocytes in vivo and in vitro. This activity seems to arise from the CD14(++)CD16(+) monocyte subset.	[Pul, Refik; Morbiducci, Franco; Skuljec, Jelena; Skripuletz, Thomas; Singh, Vikramjeet; Diederichs, Ute; Garde, Niklas; Voss, Elke Verena; Trebst, Corinna; Stangel, Martin] Hannover Med Sch, Dept Neurol, D-3000 Hannover, Germany; [Singh, Vikramjeet; Stangel, Martin] Ctr Syst Neurosci, Hannover, Germany	Hannover Medical School	Stangel, M (corresponding author), Hannover Med Sch, Dept Neurol, D-3000 Hannover, Germany.	Stangel.Martin@MH-Hannover.de	Singh, Vikramjeet/E-4397-2013; Skuljec, Jelena/ABF-6712-2020; Stangel, Martin/AAH-5345-2020	Singh, Vikramjeet/0000-0003-0287-7554; Skuljec, Jelena/0000-0001-8509-6563; Singh, Vikramjeet/0000-0002-7361-8317; Schuster, Ute/0000-0002-3162-3775	TEVA Pharmaceutical Industries; German Research Foundation (DFG); Baxter; Bayer HealthCare; Biogen; Novartis; Sanofi-Aventis; Merck Serono; Merck; Bayer Health Care; Biogen Idec; Diamed Medizintechnik GmbH; Fresenius Medical Care; Sanofi-Avnetis; Talecris Biotherapeutics GmbH; CSL Behring; Merck-Serono; Talecris; Teva	TEVA Pharmaceutical Industries(Teva Pharmaceutical Industries); German Research Foundation (DFG)(German Research Foundation (DFG)); Baxter; Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals); Biogen(Biogen); Novartis(Novartis); Sanofi-Aventis(Sanofi-Aventis); Merck Serono(Merck & Company); Merck(Merck & Company); Bayer Health Care(Bayer AGBayer Healthcare Pharmaceuticals); Biogen Idec(Biogen); Diamed Medizintechnik GmbH; Fresenius Medical Care; Sanofi-Avnetis; Talecris Biotherapeutics GmbH; CSL Behring; Merck-Serono(Merck & Company); Talecris; Teva(Teva Pharmaceutical Industries)	This study was partially supported by TEVA Pharmaceutical Industries. The open access publication has been supported by the German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.; RP declares that he has received travel funds from Baxter, Bayer HealthCare, Biogen, Novartis, Sanofi-Aventis, and Merck Serono in the last six years. TS declares that he has received travel funds from Novartis, Merck, and Bayer Healthcare. NG, FM and JS declare that they have no competing interests. CT has received honoraria for consultation and expert testimony as well as travel grants from Bayer Health Care, Biogen Idec, Diamed Medizintechnik GmbH, Fresenius Medical Care, Merck Serono, Novartis, Sanofi-Avnetis, Talecris Biotherapeutics GmbH, and Teva Pharmaceutical Industries. MS has received honoraria for scientific lectures and/or travel funds from Baxter, Bayer Healthcare, Biogen Idec, CSL Behring, Merck-Serono, Novartis, Sanofi-Aventis, Talecris, and Teva. EVV declares that she received travel funds from Novartis and speakers honoraria from Biogen idec in the last six years. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ancuta P, 2003, J EXP MED, V197, P1701, DOI 10.1084/jem.20022156; Antonov AS, 2004, AM J PATHOL, V165, P247, DOI 10.1016/S0002-9440(10)63293-2; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Boven LA, 2006, BRAIN, V129, P517, DOI 10.1093/brain/awh707; Burger D, 2009, P NATL ACAD SCI USA, V106, P4355, DOI 10.1073/pnas.0812183106; Capsoni F, 1998, CELL IMMUNOL, V189, P51, DOI 10.1006/cimm.1998.1349; CAPSONI F, 1995, J LEUKOCYTE BIOL, V58, P351, DOI 10.1002/jlb.58.3.351; Castano D, 2011, TUBERCULOSIS, V91, P348, DOI 10.1016/j.tube.2011.04.002; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Han JY, 2009, JAIDS-J ACQ IMM DEF, V52, P553, DOI 10.1097/QAI.0b013e3181c1d4fe; Hata K, 2006, J CELL BIOL, V173, P47, DOI 10.1083/jcb.200508143; Hussien Y, 2001, J NEUROIMMUNOL, V121, P102, DOI 10.1016/S0165-5728(01)00432-5; INGALLS RR, 1995, J EXP MED, V181, P1473, DOI 10.1084/jem.181.4.1473; Jung S, 2004, J NEUROIMMUNOL, V148, P63, DOI 10.1016/j.jneuroim.2003.11.014; KEIZER GD, 1987, EUR J IMMUNOL, V17, P1317, DOI 10.1002/eji.1830170915; Kim HJ, 2004, J IMMUNOL, V172, P7144, DOI 10.4049/jimmunol.172.11.7144; Kotter MR, 2001, GLIA, V35, P204, DOI 10.1002/glia.1085; Kotter MR, 2006, J NEUROSCI, V26, P328, DOI 10.1523/JNEUROSCI.2615-05.2006; Kotter MR, 2005, NEUROBIOL DIS, V18, P166, DOI 10.1016/j.nbd.2004.09.019; Li H, 1996, NEUROPATH APPL NEURO, V22, P207; Lingnau M, 2007, HUM IMMUNOL, V68, P730, DOI 10.1016/j.humimm.2007.06.004; Mahad DJ, 2004, J NEUROPATH EXP NEUR, V63, P262, DOI 10.1093/jnen/63.3.262; Mosig S, 2009, FASEB J, V23, P866, DOI 10.1096/fj.08-118240; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Nham SU, 1999, BIOCHEM BIOPH RES CO, V264, P630, DOI 10.1006/bbrc.1999.1564; Passacquale G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025595; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Pul R, 2011, J NEUROIMMUNE PHARM, V6, P381, DOI 10.1007/s11481-010-9248-1; Rogacev KS, 2011, EUR HEART J, V32, P84, DOI 10.1093/eurheartj/ehq371; Rossol M, 2012, ARTHRITIS RHEUM-US, V64, P671, DOI 10.1002/art.33418; Ruggieri M, 2006, J NEUROL, V253, P231, DOI 10.1007/s00415-005-0965-y; Sand KL, 2009, CELL MOL LIFE SCI, V66, P1446, DOI 10.1007/s00018-009-8726-1; SIMON SI, 1988, BIOPHYS J, V53, P163, DOI 10.1016/S0006-3495(88)83078-9; Skrzeczynska-Moncznik J, 2008, SCAND J IMMUNOL, V67, P152, DOI 10.1111/j.1365-3083.2007.02051.x; Stangel M, 2000, J NEUROIMMUNOL, V106, P137, DOI 10.1016/S0165-5728(00)00210-1; Stapulionis R, 2008, J IMMUNOL, V180, P3946, DOI 10.4049/jimmunol.180.6.3946; Then BF, 2004, J NEUROIMMUNOL, V146, P176; Toker A, 2011, SCAND J IMMUNOL, V74, P235, DOI 10.1111/j.1365-3083.2011.02575.x; Trebst C, 2001, AM J PATHOL, V159, P1701, DOI 10.1016/S0002-9440(10)63017-9; Vieira PL, 2003, J IMMUNOL, V170, P4483, DOI 10.4049/jimmunol.170.9.4483; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Weber MS, 2007, NAT MED, V13, P935, DOI 10.1038/nm1620; Weber MS, 2004, BRAIN, V127, P1370, DOI 10.1093/brain/awh163; Yang L, 2008, J IMMUNOL, V180, P4409, DOI 10.4049/jimmunol.180.7.4409; Zawada AM, 2011, BLOOD, V118, pE50, DOI 10.1182/blood-2011-01-326827; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	50	32	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51867	10.1371/journal.pone.0051867	http://dx.doi.org/10.1371/journal.pone.0051867			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284793	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500055
J	Schneider, A; Ruppert, M; Hendrich, O; Giang, T; Ogueta, M; Hampel, S; Vollbach, M; Buschges, A; Scholz, H				Schneider, Andrea; Ruppert, Manuela; Hendrich, Oliver; Giang, Thomas; Ogueta, Maite; Hampel, Stefanie; Vollbach, Marvin; Bueschges, Ansgar; Scholz, Henrike			Neuronal Basis of Innate Olfactory Attraction to Ethanol in Drosophila	PLOS ONE			English	Article							OCTOPAMINERGIC NEURONS; CENTRAL COMPLEX; FRUIT-FLY; MELANOGASTER; BEHAVIOR; FLIES; STIMULATION; MECHANISMS; DOPAMINE; TYRAMINE	The decision to move towards a mating partner or a food source is essential for life. The mechanisms underlying these behaviors are not well understood. Here, we investigated the role of octopamine - the invertebrate analogue of noradrenaline - in innate olfactory attraction to ethanol. We confirmed that preference is caused via an olfactory stimulus by dissecting the function of the olfactory co-receptor Orco (formally known as OR83b). Orco function is not required for ethanol recognition per se, however it plays a role in context dependent recognition of ethanol. Odor-evoked ethanol preference requires the function of Tbh (Tyramine beta hydroxalyse), the rate-limiting enzyme of octopamine synthesis. In addition, neuronal activity in a subset of octopaminergic neurons is necessary for olfactory ethanol preference. Notably, a specific neuronal activation pattern of tyraminergic/octopaminergic neurons elicit preference and is therefore sufficient to induce preference. In contrast, dopamine dependent increase in locomotor activity is not sufficient for olfactory ethanol preference. Consistent with the role of noradrenaline in mammalian drug induced rewards, we provide evidence that in adult Drosophila the octopaminergic neurotransmitter functions as a reinforcer and that the molecular dissection of the innate attraction to ethanol uncovers the basic properties of a response selection system.	[Schneider, Andrea; Ruppert, Manuela; Hendrich, Oliver; Giang, Thomas; Vollbach, Marvin; Bueschges, Ansgar; Scholz, Henrike] Univ Cologne, Bioctr, Inst Zool, Dept Anim Physiol Neurobiol, D-50931 Cologne, Germany; [Ogueta, Maite] Inst Neurociencias Castilla & Leon, Dept Biol Celular & Patol, Salamanca, Spain; [Hampel, Stefanie] Howard Hughes Med Inst, Ashburn, VA USA	University of Cologne; Howard Hughes Medical Institute	Scholz, H (corresponding author), Univ Cologne, Bioctr, Inst Zool, Dept Anim Physiol Neurobiol, D-50931 Cologne, Germany.	henrike.scholz@uni-koeln.de	Scholz, Henrike/ABE-1063-2020	Ogueta, Maite/0000-0002-4777-8317; Hendrich, Oliver/0000-0003-1185-520X; Hampel, Stefanie/0000-0001-8287-549X	DFG [656/4-1, 656/7-1]	DFG(German Research Foundation (DFG))	This work was supported by the DFG 656/4-1 and DFG656/7-1 to H.S. (http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Bellmann D, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00027; Brembs B, 2007, J NEUROSCI, V27, P11122, DOI 10.1523/JNEUROSCI.2704-07.2007; Buschges A, 2011, CURR BIOL, V21, pR513, DOI 10.1016/j.cub.2011.05.029; BULTHOFF H, 1982, BIOL CYBERN, V45, P63, DOI 10.1007/BF00387215; Busch S, 2009, J COMP NEUROL, V513, P643, DOI 10.1002/cne.21966; Busto GU, 2010, PHYSIOLOGY, V25, P338, DOI 10.1152/physiol.00026.2010; Cole SH, 2005, J BIOL CHEM, V280, P14948, DOI 10.1074/jbc.M414197200; Dierks A, 2008, J INSECT PHYSIOL, V54, P1363, DOI 10.1016/j.jinsphys.2008.07.008; Farooqui T, 2003, J NEUROSCI, V23, P5370; Fishilevich E, 2005, CURR BIOL, V15, P2086, DOI 10.1016/j.cub.2005.11.016; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Glanzman DL, 2011, P NATL ACAD SCI USA, V108, P14711, DOI 10.1073/pnas.1111230108; Hammer M, 1998, LEARN MEMORY, V5, P146; HAMMER M, 1993, NATURE, V366, P59, DOI 10.1038/366059a0; Hardie RC, 2001, NEURON, V30, P149, DOI 10.1016/S0896-6273(01)00269-0; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Kitamoto T, 2002, J NEUROGENET, V16, P205, DOI 10.1080/01677060216295; Kong EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009954; Kononenko NL, 2009, J COMP NEUROL, V512, P433, DOI 10.1002/cne.21911; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; MCKENZIE JA, 1972, OECOLOGIA, V10, P373, DOI 10.1007/BF00345738; Monastirioti M, 1996, J NEUROSCI, V16, P3900; MONASTIRIOTI M, 1995, J COMP NEUROL, V356, P275, DOI 10.1002/cne.903560210; Ogueta M, 2010, CHEM SENSES, V35, P813, DOI 10.1093/chemse/bjq084; OLDS J, 1954, J COMP PHYSIOL PSYCH, V47, P419, DOI 10.1037/h0058775; Pophof B, 2000, J COMP PHYSIOL A, V186, P307, DOI 10.1007/s003590050431; REDGRAVE P, 1981, BRIT MED BULL, V37, P141, DOI 10.1093/oxfordjournals.bmb.a071691; Scholz H, 2005, J NEUROBIOL, V63, P199, DOI 10.1002/neu.20127; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; Siegmund T, 2001, J COMP NEUROL, V431, P481, DOI 10.1002/1096-9861(20010319)431:4<481::AID-CNE1084>3.0.CO;2-7; Sinakevitch I, 2006, J COMP NEUROL, V494, P460, DOI 10.1002/cne.20799; Sinakevitch I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014536; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Waddell S, 2010, TRENDS NEUROSCI, V33, P457, DOI 10.1016/j.tins.2010.07.001; Weinshenker D, 2007, NEUROPSYCHOPHARMACOL, V32, P1433, DOI 10.1038/sj.npp.1301263; WISE RA, 1992, SYNAPSE, V10, P247, DOI 10.1002/syn.890100307; Zhou C, 2008, NAT NEUROSCI, V11, P1059, DOI 10.1038/nn.2164; Zhu JW, 2003, J CHEM ECOL, V29, P899, DOI 10.1023/A:1022931816351	44	34	34	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52007	10.1371/journal.pone.0052007	http://dx.doi.org/10.1371/journal.pone.0052007			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284851	gold, Green Published, Green Submitted			2022-12-27	WOS:000312794500077
J	Wu, LM; Hu, MH; Tong, XH; Han, H; Shen, N; Jin, RT; Wang, W; Zhou, GX; He, GP; Liu, YS				Wu, Li-Min; Hu, Mei-Hong; Tong, Xian-Hong; Han, Hui; Shen, Ni; Jin, Ren-Tao; Wang, Wei; Zhou, Gui-Xiang; He, Guo-Ping; Liu, Yu-Sheng			Chronic Unpredictable Stress Decreases Expression of Brain-Derived Neurotrophic Factor (BDNF) in Mouse Ovaries: Relationship to Oocytes Developmental Potential	PLOS ONE			English	Article							FOLLICULAR-FLUID; EMBRYO DEVELOPMENT; GROWTH-FACTOR; DEPRESSION; GONADOTROPIN; RECEPTOR; IMPACT; MODEL; RAT; INFERTILITY	Background: Brain-derived neurotropic factor (BDNF) was originally described in the nervous system but has been shown to be expressed in ovary tissues recently, acting as a paracrine/autocrine regulator required for developments of follicles and oocytes. Although it is generally accepted that chronic stress impairs female reproduction and decreases the expression of BDNF in limbic structures of central nervous system, which contributes to mood disorder. However, it is not known whether chronic stress affects oocytes developments, nor whether it affects expression of BDNF in ovary. Methods: Mice were randomly assigned into control group, stressed group, BDNF-treated group and BDNF-treated stressed group. The chronic unpredictable mild stress model was used to produce psychosocial stress in mice, and the model was verified by open field test and hypothalamic-pituitary-adrenal (HPA) axis activity. The methods of immunohistochemistry and western blotting were used to detect BDNF protein level and distribution. The number of retrieved oocytes, oocyte maturation, embryo cleavage and the rates of blastocyst formation after parthenogenetic activation were evaluated. Results: Chronic unpredictable stress decreased the BDNF expression in antral follicles, but didn't affect the BDNF expression in primordial, primary and secondary follicles. Chronic unpredictable stress also decreased the number of retrieved oocytes and the rate of blastocyst formation, which was rescued by exogenous BDNF treatment. Conclusion: BDNF in mouse ovaries may be related to the decreased number of retrieved oocytes and impaired oocytes developmental potential induced by chronic unpredictable stress.	[Wu, Li-Min; Hu, Mei-Hong; Tong, Xian-Hong; Shen, Ni; Jin, Ren-Tao; Zhou, Gui-Xiang; He, Guo-Ping; Liu, Yu-Sheng] Anhui Med Univ, Anhui Prov Hosp, Ctr Reprod Med, Hefei, Peoples R China; [Han, Hui] Anhui Coll Tradit Chinese Med, Dept Neurol, Affiliated Hosp 1, Hefei, Peoples R China; [Wang, Wei] Anhui Med Univ, Anhui Prov Hosp, Dept Endocrinol, Hefei, Peoples R China	Anhui Medical University; Anhui University of Chinese Medicine; Anhui Medical University	Wu, LM (corresponding author), Anhui Med Univ, Anhui Prov Hosp, Ctr Reprod Med, Hefei, Peoples R China.	wlm@ustc.edu.cn; shengzhizhongxin@126.com	Wang, Wei/AAC-4057-2019	Wang, Wei/0000-0002-4123-8280	National Natural Science Foundation of China 20 [81000237, 81001519, 81100558]; Natural Science 2 Foundation of Anhui Provincial of China [090413262X]	National Natural Science Foundation of China 20; Natural Science 2 Foundation of Anhui Provincial of China	This research was supported by the National Natural Science Foundation of China 20 (NO. 81000237, NO. 81001519 and 1 NO. 81100558) and the Natural Science 2 Foundation of Anhui Provincial of China (NO. 090413262X).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RA, 2010, FERTIL STERIL, V93, P1394, DOI 10.1016/j.fertnstert.2009.04.007; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Boivin J, 1996, HUM REPROD, V11, P903; Boivin J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d223; Breen KM, 2007, ENDOCRINOLOGY, V148, P1882, DOI 10.1210/en.2006-0973; Chand D, 2011, GEN COMP ENDOCR, V171, P253, DOI 10.1016/j.ygcen.2011.02.022; Cousineau TM, 2007, BEST PRACT RES CL OB, V21, P293, DOI 10.1016/j.bpobgyn.2006.12.003; da Silva SJM, 2005, REPRODUCTION, V129, P423, DOI 10.1530/rep.1.00471; Delafoy L, 2006, GUT, V55, P940, DOI 10.1136/gut.2005.064063; Dorfman A, 2003, BIOL REPROD, V68, P2038, DOI 10.1095/biolreprod.102.008318; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Gatt JM, 2009, MOL PSYCHIATR, V14, P681, DOI 10.1038/mp.2008.143; Gore AC, 2006, MOL CELL ENDOCRINOL, V256, P40, DOI 10.1016/j.mce.2006.06.002; Hall CS, 1934, J COMP PSYCHOL, V18, P385, DOI 10.1037/h0071444; Harel S, 2006, MOL HUM REPROD, V12, P357, DOI 10.1093/molehr/gal033; Jensen T, 2001, J EXP BIOL, V204, P2087; Kawamura K, 2005, P NATL ACAD SCI USA, V102, P9206, DOI 10.1073/pnas.0502442102; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Larsen MH, 2010, J PSYCHIATR RES, V44, P808, DOI 10.1016/j.jpsychires.2010.01.005; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARCUS GJ, 1990, MOL REPROD DEV, V26, P159, DOI 10.1002/mrd.1080260210; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Miao YL, 2009, HUM REPROD UPDATE, V15, P573, DOI 10.1093/humupd/dmp014; Russo N, 2012, GYNECOL ENDOCRINOL, V28, P241, DOI 10.3109/09513590.2011.613969; Rygula R, 2005, BEHAV BRAIN RES, V162, P127, DOI 10.1016/j.bbr.2005.03.009; Sadeu JC, 2012, REPROD BIOMED ONLINE, V24, P174, DOI 10.1016/j.rbmo.2011.11.011; Seifer DB, 2002, J CLIN ENDOCR METAB, V87, P655, DOI 10.1210/jc.87.2.655; Shooshtary F.Z., 2009, J FAM REPROD HLTH, V3, P101; Wang X, 2011, J ASSIST REPROD GEN, V28, P1053, DOI 10.1007/s10815-011-9635-4; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; Wu LM, 2007, NEUROPSYCHOPHARMACOL, V32, P2500, DOI 10.1038/sj.npp.1301386; Wu LM, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.093468; Yu Y, 2012, HUM REPROD, V27, P2146, DOI 10.1093/humrep/des099; Zhao P, 2011, HUM REPROD, V26, P695, DOI 10.1093/humrep/deq390	34	31	34	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52331	10.1371/journal.pone.0052331	http://dx.doi.org/10.1371/journal.pone.0052331			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284991	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500145
J	Yong-Gonzales, V; Hang, LE; Castellucci, F; Branzei, D; Zhao, XL				Yong-Gonzales, Vladimir; Hang, Lisa E.; Castellucci, Federica; Branzei, Dana; Zhao, Xiaolan			The Smc5-Smc6 Complex Regulates Recombination at Centromeric Regions and Affects Kinetochore Protein Sumoylation during Normal Growth	PLOS ONE			English	Article							DAMAGED REPLICATION FORKS; SACCHAROMYCES-CEREVISIAE; DNA-REPAIR; SMC5/6 COMPLEX; SUMO LIGASE; CHROMOSOME TRANSMISSION; CHECKPOINT RESPONSES; SPINDLE ELONGATION; GLOBAL ANALYSIS; YEAST	The Smc5-Smc6 complex in Saccharomyces cerevisiae is both essential for growth and important for coping with genotoxic stress. While it facilitates damage tolerance throughout the genome under genotoxin treatment, its function during unperturbed growth is mainly documented for repetitive DNA sequence maintenance. Here we provide physical and genetic evidence showing that the Smc5-Smc6 complex regulates recombination at non-repetitive loci such as centromeres in the absence of DNA damaging agents. Mutating Smc6 results in the accumulation of recombination intermediates at centromeres and other unique sequences as assayed by 2D gel analysis. In addition, smc6 mutant cells exhibit increased levels of Rad52 foci that co-localize with centromere markers. A rad52 mutation that decreases centromeric, but not overall, levels of Rad52 foci in smc6 mutants suppresses the nocodazole sensitivity of these cells, suggesting that the Smc6-mediated regulation of recombination at centromeric regions impacts centromere-related functions. In addition to influencing recombination, the SUMO ligase subunit of the Smc5-Smc6 complex promotes the sumoylation of two kinetochore proteins and affects mitotic spindles. These results suggest that the Smc5-Smc6 complex regulates both recombination and kinetochore sumoylation to facilitate chromosomal maintenance during growth.	[Yong-Gonzales, Vladimir; Hang, Lisa E.; Zhao, Xiaolan] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; [Hang, Lisa E.] Weill Cornell Grad Sch Med Sci, Program Biochem, New York, NY USA; [Hang, Lisa E.] Weill Cornell Grad Sch Med Sci, Cell Biol Program, New York, NY USA; [Hang, Lisa E.] Weill Cornell Grad Sch Med Sci, Program Mol Biol, New York, NY USA; [Castellucci, Federica; Branzei, Dana] FIRC Inst Mol Oncol, IFOM, Milan, Italy	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; IFOM - FIRC Institute of Molecular Oncology	Zhao, XL (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA.	zhaox1@mskcc.org	Branzei, Dana/A-2806-2015; Branzei, Dana/GOG-9093-2022	Branzei, Dana/0000-0002-0544-4888; Branzei, Dana/0000-0002-0544-4888; Zhao, Xiaolan/0000-0002-8302-6905	National Institute of General Medical Science [R01 GM080670]; American Cancer Society [RSG-12-013-01-CCG]; Associazione Italiana per la Ricerca sul Cancro [IG 10637]; ERC [242928]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080670] Funding Source: NIH RePORTER	National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Cancer Society(American Cancer Society); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); ERC(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of General Medical Science grant R01 GM080670 and American Cancer Society Research Scholar Grant RSG-12-013-01-CCG to X. Zhao and by the Associazione Italiana per la Ricerca sul Cancro grant IG 10637 and the ERC grant 242928 to D. Branzei. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmannova V, 2010, NUCLEIC ACIDS RES, V38, P4708, DOI 10.1093/nar/gkq195; Andrews EA, 2005, MOL CELL BIOL, V25, P185, DOI 10.1128/MCB.25.1.185-196.2005; Bermudez-Lopez M, 2010, NUCLEIC ACIDS RES, V38, P6502, DOI 10.1093/nar/gkq546; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Bustard DE, 2012, J BIOL CHEM, V287, P11374, DOI 10.1074/jbc.M111.336263; Chavez A, 2010, J BIOL CHEM, V285, P11922, DOI 10.1074/jbc.M109.041277; Chen YH, 2009, P NATL ACAD SCI USA, V106, P21252, DOI 10.1073/pnas.0908258106; Choi KY, 2010, MOL BIOL CELL, V21, P2306, DOI 10.1091/mbc.E10-01-0050; Cost GJ, 2006, GENETICS, V172, P2185, DOI 10.1534/genetics.105.053876; Cremona CA, 2012, MOL CELL, V45, P422, DOI 10.1016/j.molcel.2011.11.028; Denison C, 2005, MOL CELL PROTEOMICS, V4, P246, DOI 10.1074/mcp.M400154-MCP200; Fousteri MI, 2000, EMBO J, V19, P1691, DOI 10.1093/emboj/19.7.1691; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GREENFEDER SA, 1992, MOL CELL BIOL, V12, P4056, DOI 10.1128/MCB.12.9.4056; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hazbun TR, 2003, MOL CELL, V12, P1353, DOI 10.1016/S1097-2765(03)00476-3; Hu B, 2005, MOL MICROBIOL, V55, P1735, DOI 10.1111/j.1365-2958.2005.04531.x; Hwang JY, 2008, DNA REPAIR, V7, P1426, DOI 10.1016/j.dnarep.2008.05.006; Irmisch A, 2009, EMBO J, V28, P144, DOI 10.1038/emboj.2008.273; Ivessa AS, 2003, MOL CELL, V12, P1525, DOI 10.1016/S1097-2765(03)00456-8; Kotwaliwale C, 2006, CELL, V127, P1105, DOI 10.1016/j.cell.2006.11.032; LEHMANN AR, 1995, MOL CELL BIOL, V15, P7067; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; Lindroos HB, 2006, MOL CELL, V22, P755, DOI 10.1016/j.molcel.2006.05.014; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Montpetit B, 2006, J CELL BIOL, V174, P653, DOI 10.1083/jcb.200605019; Mortensen UH, 2002, GENETICS, V161, P549; Mukhopadhyay D, 2010, CELL CYCLE, V9, P3194, DOI 10.4161/cc.9.16.12619; MURRAY JM, 1994, MOL CELL BIOL, V14, P4878, DOI 10.1128/MCB.14.7.4878; Noel JF, 2011, DNA REPAIR, V10, P271, DOI 10.1016/j.dnarep.2010.11.010; Onoda F, 2004, DNA REPAIR, V3, P429, DOI 10.1016/j.dnarep.2003.12.007; Panse VG, 2004, J BIOL CHEM, V279, P41346, DOI 10.1074/jbc.M407950200; Pebernard S, 2008, EMBO J, V27, P3011, DOI 10.1038/emboj.2008.220; Potts PR, 2005, MOL CELL BIOL, V25, P7021, DOI 10.1128/MCB.25.16.7021-7032.2005; Sacher M, 2006, NAT CELL BIOL, V8, P1284, DOI 10.1038/ncb1488; Sollier J, 2009, MOL BIOL CELL, V20, P1671, DOI 10.1091/mbc.E08-08-0875; SPENCER F, 1990, GENETICS, V124, P237; Straight AF, 1996, CURR BIOL, V6, P1599, DOI 10.1016/S0960-9822(02)70783-5; Takahashi Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000215; Torres-Rosell J, 2005, NAT CELL BIOL, V7, P412, DOI 10.1038/ncb1239; Torres-Rosell J, 2007, NAT CELL BIOL, V9, P923, DOI 10.1038/ncb1619; Torres-Rosell J, 2007, SCIENCE, V315, P1411, DOI 10.1126/science.1134025; Vanoli F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001205; Verdaasdonk JS, 2011, NAT REV MOL CELL BIO, V12, P320, DOI 10.1038/nrm3107; Verkade HM, 1999, MOL BIOL CELL, V10, P2905, DOI 10.1091/mbc.10.9.2905; Wehrkamp-Richter S, 2012, NUCL ACIDS RES; Westermann S, 2007, ANNU REV BIOCHEM, V76, P563, DOI 10.1146/annurev.biochem.76.052705.160607; Widlund PO, 2006, MOL BIOL CELL, V17, P1065, DOI 10.1091/mbc.E05-07-0640; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Wykoff DD, 2005, MOL CELL PROTEOMICS, V4, P73, DOI 10.1074/mcp.M400166-MCP200; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	53	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51540	10.1371/journal.pone.0051540	http://dx.doi.org/10.1371/journal.pone.0051540			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284708	gold, Green Submitted, Green Published			2022-12-27	WOS:000312794500032
J	Carvalho, GMD; Brazil, RP; Saraiva, L; Quaresma, PF; Botelho, HA; Ramos, MCDF; Zenobio, APLD; Meira, PCLSE; Sanguinette, CD; Andrade, JD				de Lima Carvalho, Gustavo Mayr; Brazil, Reginaldo Pecanha; Saraiva, Lara; Quaresma, Patricia Flavia; Botelho, Helbert Antonio; das Neves Farah Ramos, Mariana Campos; Lusardo de Almeida Zenobio, Ana Paula; Lamy Serra e Meira, Paula Cavalcante; Sanguinette, Cristiani de Castilho; Andrade Filho, Jose Dilermando			Hourly Activity and Natural Infection of Sandflies (Diptera: Psychodidae) Captured from the Aphotic Zone of a Cave, Minas Gerais State, Brazil	PLOS ONE			English	Article							LUTZOMYIA-NEIVAI; PHLEBOTOMINAE; LEISHMANIA	Sandflies are holometabolous insects that are of great epidemiological importance in the neotropical region as vectors of leishmaniases. Caves are ecotopes that significantly differ from external environments and, among the insects that live or visit their internal area and adjacent environment, sandflies are commonly found. Based on this context, the objective of this work was to examine the period of activity of sandflies in the cave environment in the aphotic zone. Thus, four sandfly captures were conducted, one in each season of the year, in a cave where studies on the bioecological aspects of sandfly fauna have been conducted since 2008. In this same study, we have also noticed the presence of flagellates in some captured females. Catches were carried out for 24 hours using a Shannon trap, light bait, and cave walls were actively searched. We collected a total of 638 sandflies, representing 11 species. The most abundant species and with more intense period of activity were, in descending order: Lu. cavernicola (62%), Ev. spelunca (16%) and Ev. sallesi (14%). A total of 69 females were dissected to check for natural infection, and in five specimens we found living flagellated forms: two Ev. spelunca, two Ev. sallesi and one Sc. sordellii. This study shows that the activity of some species caught in the aphotic zone of the cave, especially Lu. cavernicola, differs from what has already been reported in previous sandfly captures, which are almost always conducted at night and during twilight. The existence of sandflies that were naturally infected with flagellates and the lack of awareness regarding the behaviour of sandflies in cave environments are strong indicators of the need for further study on this group of insects in this ecotope, as a safety measure to protect the visitors of such environment.	[de Lima Carvalho, Gustavo Mayr; Saraiva, Lara; Quaresma, Patricia Flavia; Botelho, Helbert Antonio; das Neves Farah Ramos, Mariana Campos; Lusardo de Almeida Zenobio, Ana Paula; Lamy Serra e Meira, Paula Cavalcante; Sanguinette, Cristiani de Castilho; Andrade Filho, Jose Dilermando] Ctr Pesquisas Rene Rachou Portuguese Fundacao Osw, Grp Estudos Leishmanioses, Belo Horizonte, MG, Brazil; [Brazil, Reginaldo Pecanha] Inst Oswaldo Cruz Portuguese Fundacao Oswaldo Cru, Dept Fisiol & Bioquim Insetos, Rio De Janeiro, Brazil		Andrade, JD (corresponding author), Ctr Pesquisas Rene Rachou Portuguese Fundacao Osw, Grp Estudos Leishmanioses, Belo Horizonte, MG, Brazil.	jandrade@cpqrr.fiocruz.br	Quaresma, Patricia/W-3876-2019; Brazil, Reginaldo Peçanha/AAF-6777-2019; Andrade Filho, José Dilermando/B-7852-2013	Andrade Filho, José Dilermando/0000-0002-9754-8464	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [APQ-0235709]; Programa Pesquisador Mineiro (FAPEMIG) [00130-12]	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Programa Pesquisador Mineiro (FAPEMIG)	Funding provided by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (Process: APQ-0235709);Programa Pesquisador Mineiro (FAPEMIG)-00130-12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves VR, 2008, MEM I OSWALDO CRUZ, V103, P251, DOI 10.1590/S0074-02762008005000012; Alves VR, 2011, MEM I OSWALDO CRUZ, V106, P353, DOI 10.1590/S0074-02762011000300016; Bermudez H., 1991, Parassitologia (Rome), V33, P127; Brazil RP, 1999, MED VET ENTOMOL, V13, P463, DOI 10.1046/j.1365-2915.1999.00181.x; Carvalho GML, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-158; Chance ML, 1985, LEISHMANIASIS; Culver DC, 1982, CAVE LIFE EVOLUTION; Carvalho GMD, 2010, MEM I OSWALDO CRUZ, V105, P336, DOI 10.1590/S0074-02762010000300017; Fuenzalida AD, 2011, MEM I OSWALDO CRUZ, V106, P635, DOI 10.1590/S0074-02762011000500020; FORATTINI OP, 1953, ARQ FAC HIG S PUB U, V7, P158; Galati E. A. B., 2003, FLEBOTOMINEOS BRASIL, P23; Galati EAB, 2006, MEM I OSWALDO CRUZ, V101, P175, DOI 10.1590/S0074-02762006000200010; Galati Eunice A. B., 2003, Rev. Bras. entomol., V47, P283, DOI 10.1590/S0085-56262003000200017; Galati EAB, 2010, REV BRAS ENTOMOL, V54, P677, DOI 10.1590/S0085-56262010000400021; Galati Eunice A. Bianchi, 2003, Rev. Bras. entomol., V47, P455, DOI 10.1590/S0085-56262003000300016; Galati Eunice Aparecida Bianchi, 2003, Rev. Bras. entomol., V47, P63, DOI 10.1590/S0085-56262003000100010; Gontijo Célia Maria Ferreira, 2004, Rev. bras. epidemiol., V7, P338; HOLSINGER JR, 1988, BRIMLEYANA, P1; Instituto Brasileiro de Geografia e Estat o A stica (IBGE), CENS DEM; Lino CF, 2007, PROVINCIAS ESPELEOLO; POULSON TL, 1969, SCIENCE, V165, P971; Saraiva L, 2009, J MED ENTOMOL, V46, P1159, DOI 10.1603/033.046.0525; Schonian G, 2003, DIAGN MICR INFEC DIS, V47, P349, DOI 10.1016/S0732-8893(03)00093-2; Shannon RC, 1939, METHODS COLLECTING F; Young David G., 1994, Memoirs of the American Entomological Institute (Gainesville), V54, P1	25	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52254	10.1371/journal.pone.0052254	http://dx.doi.org/10.1371/journal.pone.0052254			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284957	Green Submitted, Green Published, gold			2022-12-27	WOS:000312694300084
J	Fuermaier, ABM; Tucha, L; Koerts, J; Mueller, AK; Lange, KW; Tucha, O				Fuermaier, Anselm B. M.; Tucha, Lara; Koerts, Janneke; Mueller, Anna K.; Lange, Klaus W.; Tucha, Oliver			Measurement of Stigmatization towards Adults with Attention Deficit Hyperactivity Disorder	PLOS ONE			English	Article							MENTAL-HEALTH PROBLEMS; ADHD STIGMA; DEFICIT/HYPERACTIVITY DISORDER; CHILDHOOD DEPRESSION; CHILDREN; ILLNESS; ATTITUDES; PEOPLE; CONSEQUENCES; KNOWLEDGE	Objectives: In general, assessment tools for stigma in mental disorders such as attention deficit hyperactivity disorder (ADHD) are lacking. Moreover, misbeliefs and misconceptions about ADHD are common, in particular with regard to the adult form of ADHD. The aim of the present study was to develop a questionnaire measuring stigma in adults with ADHD and to demonstrate its sensitivity. Methods: A questionnaire initially containing 64 items associated with stigma in adults with ADHD was developed. A total number of 1261 respondents were included in the analyses. The psychometric properties were investigated on a sample of 1033 participants. The sensitivity of the questionnaire was explored on 228 participants consisting of teachers, physicians and control participants. Results: Thirty-seven items were extracted due to exploratory factor analysis (EFA) and the internal consistency of items. Confirmatory factor analysis (CFA) revealed good psychometric properties of a 6-factor structure. Teachers and physicians differed significantly in their stigmatizing attitudes from control participants. Conclusions: The present data shed light on various dimensions of stigma in adult ADHD. Reliability and Social Functioning, Malingering and Misuse of Medication, Ability to Take Responsibility, Norm-violating and Externalizing Behavior, Consequences of Diagnostic Disclosure and Etiology represent critical aspects associated with stigmatization.	[Lange, Klaus W.] Univ Regensburg, Dept Expt Psychol, Regensburg, Germany; [Fuermaier, Anselm B. M.; Tucha, Lara; Koerts, Janneke; Mueller, Anna K.; Tucha, Oliver] Univ Groningen, Univ Med Ctr Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands	University of Regensburg; University of Groningen	Lange, KW (corresponding author), Univ Regensburg, Dept Expt Psychol, Regensburg, Germany.	klaus.lange@psychologie.uni-regensburg.de	Tucha, Oliver/AAD-1403-2019	Muller, Anna Katharina/0000-0002-4522-0950; Fuermaier, Anselm/0000-0002-2331-0840				Angermeyer MC, 2006, ACTA PSYCHIAT SCAND, V113, P163, DOI 10.1111/j.1600-0447.2005.00699.x; Banaji MR, 1996, PSYCHOL SCI, V7, P136, DOI 10.1111/j.1467-9280.1996.tb00346.x; Bell L, 2011, PSYCHOL SCHOOLS, V48, P184, DOI 10.1002/pits.20536; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Berger BE, 2001, RES NURS HEALTH, V24, P518, DOI 10.1002/nur.10011; Biederman J, 2005, BIOL PSYCHIAT, V57, P1215, DOI 10.1016/j.biopsych.2004.10.020; Canu Will H, 2007, J Atten Disord, V10, P261, DOI 10.1177/1087054706288106; Canu WH, 2008, J ATTEN DISORD, V11, P700, DOI 10.1177/1087054707305090; Cohen J.E., 1988, STAT POWER ANAL BEHA; Coleman D, 2009, PSYCHIAT SERV, V60, P950, DOI 10.1176/appi.ps.60.7.950; Comrey A, 1992, 1 COURSE FACTOR ANAL, V2nd, P2; Corrigan PW, 2010, CLIN PSYCHOL REV, V30, P907, DOI 10.1016/j.cpr.2010.06.004; Demaio CM, 2006, DISS ABSTR INT B, V66; dosReis S, 2010, PSYCHIAT SERV, V61, P811, DOI 10.1176/ps.2010.61.8.811; Ghanizadeh A, 2006, PATIENT EDUC COUNS, V63, P84, DOI 10.1016/j.pec.2005.09.002; Goffman E. M., 1963, BEHAV PUBLIC PLACES; Harrison AG, 2008, DYSLEXIA, V14, P228, DOI 10.1002/dys.366; Haslam N, 2005, REV GEN PSYCHOL, V9, P35, DOI 10.1037/1089-2680.9.1.35; Hasson-Ohayon I, 2011, COMPR PSYCHIAT, V52, P75, DOI 10.1016/j.comppsych.2010.04.008; Hinkin TR, 1998, ORGAN RES METHODS, V1, P104, DOI 10.1177/109442819800100106; Hooper D., 2008, EJBRM, V6, P53, DOI DOI 10.21427/D7CF7R; Hoza B, 2005, J CONSULT CLIN PSYCH, V73, P411, DOI 10.1037/0022-006X.73.3.411; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; J?reskog, 2006, LISREL 8 80 WINDOWS; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; Kellison I, 2010, PSYCHIAT RES, V178, P363, DOI 10.1016/j.psychres.2009.04.022; Kendall J, 2002, ADV NURS SCI, V25, P22, DOI 10.1097/00012272-200212000-00003; Koro-Ljungberg M, 2009, J FAM ISSUES, V30, P1175, DOI 10.1177/0192513X09333707; Livingston JD, 2010, SOC SCI MED, V71, P2150, DOI 10.1016/j.socscimed.2010.09.030; Martin JK, 2007, J HEALTH SOC BEHAV, V48, P50, DOI 10.1177/002214650704800104; McLeod JD, 2004, J HEALTH SOC BEHAV, V45, P53, DOI 10.1177/002214650404500104; Mueller AK, 2012, ADHD-ATTEND DEFICIT, V4, P101, DOI 10.1007/s12402-012-0085-3; Ohan JL, 2011, J SCHOOL PSYCHOL, V49, P81, DOI 10.1016/j.jsp.2010.10.001; Pescosolido BA, 2008, J AM ACAD CHILD PSY, V47, P339, DOI 10.1097/chi.0b013e318160e3a0; Pescosolido BA, 2007, PSYCHIAT SERV, V58, P619, DOI 10.1176/appi.ps.58.5.619; Rusch N, 2010, Z PSYCHIATR PSYCH PS, V58, P287, DOI 10.1024/1661-4747/a000039; Rusch N, 2005, EUR PSYCHIAT, V20, P529, DOI 10.1016/j.eurpsy.2005.04.004; Schmitz MF, 2003, CULT PSYCHOL, V9, P383, DOI 10.1177/1354067X0394004; Steiger JH, 2007, PERS INDIV DIFFER, V42, P893, DOI 10.1016/j.paid.2006.09.017; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; STINE JJ, 1994, J CHILD ADOL PSYCHOP, V4, P75, DOI 10.1089/cap.1994.4.75; Sullivan BK, 2007, APPL NEUROPSYCHOL, V14, P189, DOI 10.1080/09084280701509083; Walker JS, 2008, J AM ACAD CHILD PSY, V47, P912, DOI 10.1097/CHI.0b013e318179961a; WEINER B, 1988, J PERS SOC PSYCHOL, V55, P738, DOI 10.1037/0022-3514.55.5.738; Wheaton B., 1977, SOCIOL METHODOL, V8, P84, DOI [10.2307/270754, DOI 10.2307/270754]	45	17	17	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51755	10.1371/journal.pone.0051755	http://dx.doi.org/10.1371/journal.pone.0051755			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	059HF	23284760	Green Submitted, gold, Green Published			2022-12-27	WOS:000312694300040
J	Mitchell, BD; Lee, WJ; Tolea, MI; Shields, K; Ashktorab, Z; Magder, LS; Ryan, KA; Pollin, TI; McArdle, PF; Shuldiner, AR; Schaffer, AA				Mitchell, Braxton D.; Lee, Woei-Jyh; Tolea, Magdalena I.; Shields, Kelsey; Ashktorab, Zahra; Magder, Laurence S.; Ryan, Kathleen A.; Pollin, Toni I.; McArdle, Patrick F.; Shuldiner, Alan R.; Schaeffer, Alejandro A.			Living the Good Life? Mortality and Hospital Utilization Patterns in the Old Order Amish	PLOS ONE			English	Article							AMERICAN ANABAPTIST GENEALOGY; PHYSICAL-ACTIVITY; CORONARY-ARTERY; RISK-FACTORS; ASSOCIATION; CALCIFICATION; DISEASE	Lifespan increases observed in the United States and elsewhere throughout the developed world, have been attributed in part to improvements in medical care access and technology and to healthier lifestyles. To differentiate the relative contributions of these two factors, we have compared lifespan in the Old Order Amish (OOA), a population with historically low use of medical care, with that of Caucasian participants from the Framingham Heart Study (FHS), focusing on individuals who have reached at least age 30 years. Analyses were based on 2,108 OOA individuals from the Lancaster County, PA community born between 1890 and 1921 and 5,079 FHS participants born approximately the same time. Vital status was ascertained on 96.9% of the OOA cohort through 2011 and through systematic follow-up of the FHS cohort. The lifespan part of the study included an enlargement of the Anabaptist Genealogy Database to 539,822 individuals, which will be of use in other studies of the Amish. Mortality comparisons revealed that OOA men experienced better longevity (p<0.001) and OOA women comparable longevity than their FHS counterparts. We further documented all OOA hospital discharges in Lancaster County, PA during 2002-2004 and compared OOA discharge rates to Caucasian national rates obtained from the National Hospital Discharge Survey for the same time period. Both OOA men and women experienced markedly lower rates of hospital discharges than their non-Amish counterparts, despite the increased lifespan. We speculate that lifestyle factors may predispose the OOA to greater longevity and perhaps to lesser hospital use. Identifying these factors, which might include behaviors such as lesser tobacco use, greater physical activity, and/or enhanced community assimilation, and assessing their transferability to non-Amish communities may produce significant gains to the public health.	[Mitchell, Braxton D.; Shields, Kelsey; Ryan, Kathleen A.; Pollin, Toni I.; McArdle, Patrick F.; Shuldiner, Alan R.] Univ Maryland, Sch Med, Dept Med, Program Personalized & Genom Med, Baltimore, MD 21201 USA; [Lee, Woei-Jyh; Ashktorab, Zahra; Schaeffer, Alejandro A.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Dept Hlth & Human Serv, Bethesda, MD 20894 USA; [Tolea, Magdalena I.; Magder, Laurence S.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Program Personalized & Genom Med, Baltimore, MD 21201 USA; [Shuldiner, Alan R.] Vet Adm Med Ctr, Geriatr Res & Educ Clin Ctr, Baltimore, MD 21218 USA	University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); University System of Maryland; University of Maryland Baltimore; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Mitchell, BD (corresponding author), Univ Maryland, Sch Med, Dept Med, Program Personalized & Genom Med, Baltimore, MD 21201 USA.	bmitchel@medicine.umaryland.edu	Mitchell, Braxton/CAF-0876-2022; Schaffer, Alejandro/N-1222-2019; Schaffer, Alejandro A/F-2902-2012	Shuldiner, Alan/0000-0001-9921-4305; Mitchell, Braxton/0000-0003-4920-4744	National Institutes of Health [R01 HL69313, R01 DK54261, R01 AG1872801, R01 HL088119, R01 AR046838, U01 HL72515]; National Institutes of Health, National Library of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069313, R01HL088119, U01HL072515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054261, P30DK072488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018728] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM000097] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by research grants R01 HL69313, R01 DK54261, R01 AG1872801, R01 HL088119, R01 AR046838, and U01 HL72515 from the National Institutes of Health. KS was supported by a summer internship made available through the Mid-Atlantic Nutrition and Obesity Research Center (P30 DK072488). This research was supported in part by the Intramural Research Program of the National Institutes of Health, National Library of Medicine. The authors also gratefully acknowledge the support and helpful discussions with our Amish liaisons and field workers and with our Amish Research Clinic Community Board, including Mr. Davie Stoltzfus, who is in charge of Amish Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala R, 1999, AM J MED GENET, V86, P156, DOI 10.1002/(SICI)1096-8628(19990910)86:2<156::AID-AJMG13>3.0.CO;2-5; Agarwala R, 1998, GENOME RES, V8, P211, DOI 10.1101/gr.8.3.211; Agarwala R, 2003, AM J MED GENET C, V121C, P32, DOI 10.1002/ajmg.c.20004; Agarwala R, 2001, HUM BIOL, V73, P533, DOI 10.1353/hub.2001.0045; Bielak LF, 2008, ATHEROSCLEROSIS, V196, P888, DOI 10.1016/j.atherosclerosis.2007.01.041; Bodenheimer T, 2005, ANN INTERN MED, V142, P847, DOI 10.7326/0003-4819-142-10-200505170-00010; Campbell H, 2007, HUM MOL GENET, V16, P233, DOI 10.1093/hmg/ddl473; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P300; Centers for Medicare andMedicaid Services, 2010, NAT HLTH EXP DAT 201; Cohen S, 2004, AM PSYCHOL, V59, P676, DOI 10.1037/0003-066X.59.8.676; Cummings AC, 2012, ANN HUM GENET, V76, P342, DOI 10.1111/j.1469-1809.2012.00721.x; Edwards RD, 2011, POPUL DEV REV, V37, P499, DOI 10.1111/j.1728-4457.2011.00432.x; Ferketich AK, 2008, J RURAL HEALTH, V24, P84, DOI 10.1111/j.1748-0361.2008.00141.x; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; FUCHS JA, 1990, HEALTH EDUC QUART, V17, P197, DOI 10.1177/109019819001700206; Gallagher Jr TE, 2002, CHURCH DIRECTORY LAN; Gingerich HF, 2002, AMISH AMISH MENNONIT; Hairston KG, 2013, DIABETES CARE, V36, P873, DOI 10.2337/dc12-0934; HAMMAN RF, 1981, AM J EPIDEMIOL, V114, P845, DOI 10.1093/oxfordjournals.aje.a113255; Hewner SJ, 1998, AM J HUM BIOL, V10, P619, DOI 10.1002/(SICI)1520-6300(1998)10:5<619::AID-AJHB8>3.0.CO;2-8; Hoffmann R, 2011, SOC SCI MED, V72, P1986, DOI 10.1016/j.socscimed.2011.04.019; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Hsueh WC, 2000, DIABETES CARE, V23, P595, DOI 10.2337/diacare.23.5.595; KANNEL WB, 1979, CIRCULATION, V59, P8, DOI 10.1161/01.CIR.59.1.8; Krumholz HM, 2011, CIRCULATION, V124, P1038, DOI 10.1161/CIRCULATIONAHA.111.044107; Lee WJ, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-68; Lilienfeld AM, 1980, FDN EPIDEMIOLOGY; Mitchell BD, 2008, AM HEART J, V155, P823, DOI 10.1016/j.ahj.2008.01.019; MORTON NE, 1956, P NATL ACAD SCI USA, V42, P855, DOI 10.1073/pnas.42.11.855; Post W, 2007, CIRCULATION, V115, P717, DOI 10.1161/CIRCULATIONAHA.106.637512; Rampersaud E, 2008, ARCH INTERN MED, V168, P1791, DOI 10.1001/archinte.168.16.1791; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; SCHULL WJ, 1972, AM J HUM GENET, V24, P425; Sempos CT, 1998, ANN EPIDEMIOL, V8, P289, DOI 10.1016/S1047-2797(97)00233-0; Snitker S, 2003, LANCET, V361, P87, DOI 10.1016/S0140-6736(03)12156-3; Streeten EA, 2005, J CLIN ENDOCR METAB, V90, P4536, DOI 10.1210/jc.2004-1924; Streeten EA, 2004, J BONE MINER RES, V19, P308, DOI 10.1359/JBMR.0301223; Tolea M, 2007, THESIS U MARYLAND BA	38	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51560	10.1371/journal.pone.0051560	http://dx.doi.org/10.1371/journal.pone.0051560			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284714	Green Published, Green Submitted, gold			2022-12-27	WOS:000312694300031
J	Soennesyn, H; Nilsen, DW; Oppedal, K; Greve, OJ; Beyer, MK; Aarsland, D				Soennesyn, Hogne; Nilsen, Dennis W.; Oppedal, Ketil; Greve, Ole Jacob; Beyer, Mona K.; Aarsland, Dag			Relationship between Orthostatic Hypotension and White Matter Hyperintensity Load in Older Patients with Mild Dementia	PLOS ONE			English	Article							VASCULAR RISK-FACTORS; LATE-LIFE DEPRESSION; E EPSILON-4 ALLELE; LEWY BODIES; BLOOD-PRESSURE; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; SIGNAL HYPERINTENSITIES; CARDIOVASCULAR-DISEASE; DIAGNOSTIC-CRITERIA	Background/Objectives: White matter hyperintensities (WMH) in magnetic resonance imaging (MRI) scans of the brain, and orthostatic hypotension (OH) are both common in older people. We tested the hypothesis that OH is associated with WMH. Design: Cross-sectional study. Setting: Secondary care outpatient clinics in geriatric medicine and old age psychiatry in western Norway. Participants: 160 older patients with mild dementia, diagnosed according to standardised criteria. Measurements: OH was diagnosed according to the consensus definition, measuring blood pressure (BP) in the supine position and within 3 minutes in the standing position. MRI scans were performed according to a common protocol at three centres, and the volumes of WMH were quantified using an automated method (n = 82), followed by manual editing. WMH were also quantified using the visual Scheltens scale (n = 139). Multiple logistic regression analyses were applied, with highest vs. lowest WMH quartile as response. Results: There were no significant correlations between WMH volumes and systolic or diastolic orthostatic BP drops, and no significant correlations between Scheltens scores of WMH and systolic or diastolic BP drops. In the multivariate analyses, only APOE epsilon 4 status remained a significant predictor for WMH using the automated method (p = 0.037, OR 0.075 (0.007-0.851)), whereas only age remained a significant predictor for WMH scores (p = 0.019, OR 1.119 (1.018-1.230)). Conclusion: We found no association between OH and WMH load in a sample of older patients with mild dementia.	[Soennesyn, Hogne; Oppedal, Ketil; Aarsland, Dag] Stavanger Univ Hosp, Ctr Age Related Med, Stavanger, Norway; [Nilsen, Dennis W.] Stavanger Univ Hosp, Dept Cardiol, Stavanger, Norway; [Nilsen, Dennis W.] Univ Bergen, Inst Med, Bergen, Norway; [Oppedal, Ketil] Univ Stavanger, Dept Elect Engn & Comp Sci, Stavanger, Norway; [Greve, Ole Jacob] Stavanger Univ Hosp, Dept Radiol, Stavanger, Norway; [Beyer, Mona K.] Oslo Univ Hosp, Dept Radiol & Nucl Med, Oslo, Norway; [Soennesyn, Hogne] Stavanger Univ Hosp, MoodNet Res Grp, Stavanger, Norway; [Aarsland, Dag] Karolinska Inst, Alzheimers Dis Res Ctr, Dept Neurobiol Ward Sci & Soc, Stockholm, Sweden	Stavanger University Hospital; Stavanger University Hospital; University of Bergen; Universitetet i Stavanger; Stavanger University Hospital; University of Oslo; Stavanger University Hospital; Karolinska Institutet	Soennesyn, H (corresponding author), Stavanger Univ Hosp, Ctr Age Related Med, Stavanger, Norway.	hogne.soennesyn@sus.no	Nilsen, Dennis/AAM-4344-2020	Aarsland, Dag/0000-0001-6314-216X	Western Norway Regional Health Authority [911694]; MoodNet Research Group	Western Norway Regional Health Authority; MoodNet Research Group	This study was supported financially by Grant 911694 from the Western Norway Regional Health Authority (http://www.helse-vest.no/fagfolk/forskning/det-regionale-samarbeidsorganet/Sider/side.aspx), and by two grants from MoodNet Research Group (http://www.helse-bergen.no/moodnet) (grant numbers not available). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Aarsland D, 2004, J GERIATR PSYCH NEUR, V17, P137, DOI 10.1177/0891988704267470; Aarsland D, 2008, DEMENT GERIATR COGN, V26, P445, DOI 10.1159/000165917; AD Oppedal K, 2012, DEMENT GERI IN PRESS; Allan LM, 2007, J NEUROL NEUROSUR PS, V78, P671, DOI 10.1136/jnnp.2006.102343; Allan LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005521; Andersson M, 2008, INT J GERIATR PSYCH, V23, P192, DOI 10.1002/gps.1861; Appel J, 2009, AM J NEURORADIOL, V30, P1870, DOI 10.3174/ajnr.A1693; Ballard C, 2000, ANN NY ACAD SCI, V903, P442, DOI 10.1111/j.1749-6632.2000.tb06396.x; Barber R, 1999, J NEUROL NEUROSUR PS, V67, P66, DOI 10.1136/jnnp.67.1.66; Barber R, 1999, ARCH NEUROL-CHICAGO, V56, P961, DOI 10.1001/archneur.56.8.961; Bigler ED, 2002, ALZ DIS ASSOC DIS, V16, P161, DOI 10.1097/00002093-200207000-00006; BRETELER MMB, 1994, NEUROLOGY, V44, P1246, DOI 10.1212/WNL.44.7.1246; BRUN A, 1994, J NEUROL NEUROSUR PS, V57, P416; Colloby SJ, 2011, BRIT J PSYCHIAT, V199, P404, DOI 10.1192/bjp.bp.110.090423; CONWELL Y, 1993, J AM GERIATR SOC, V41, P38, DOI 10.1111/j.1532-5415.1993.tb05945.x; Cooke J, 2009, QJM-INT J MED, V102, P335, DOI 10.1093/qjmed/hcp020; Crisby M, 2010, CURR ALZHEIMER RES, V7, P534, DOI 10.2174/156720510792231694; Debette S, 2011, NEUROLOGY, V77, P461, DOI 10.1212/WNL.0b013e318227b227; Dufouil C, 2001, NEUROLOGY, V56, P921, DOI 10.1212/WNL.56.7.921; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Firbank MJ, 2004, AM J GERIAT PSYCHIAT, V12, P606, DOI 10.1176/appi.ajgp.12.6.606; Godin O, 2008, BIOL PSYCHIAT, V63, P663, DOI 10.1016/j.biopsych.2007.09.006; Ha AD, 2011, PARKINSONISM RELAT D, V17, P625, DOI 10.1016/j.parkreldis.2011.05.020; Hajjar I, 2011, CIRCULATION, V123, P858, DOI 10.1161/CIRCULATIONAHA.110.978114; Herrmann LL, 2008, J NEUROL NEUROSUR PS, V79, P619, DOI 10.1136/jnnp.2007.124651; Hirono N, 2000, STROKE, V31, P1263, DOI 10.1161/01.STR.31.6.1263; Hogh P, 2007, ACTA NEUROL SCAND, V115, P248, DOI 10.1111/j.1600-0404.2006.00779.x; Holland CM, 2008, STROKE, V39, P1127, DOI 10.1161/STROKEAHA.107.497438; Hong YJ, 2011, J ALZHEIMERS DIS, V24, P519, DOI 10.3233/JAD-2011-101611; Kapeller P, 2003, STROKE, V34, P441, DOI 10.1161/01.STR.0000049766.26453.E9; Kenny RA, 2004, J NEUROL NEUROSUR PS, V75, P966, DOI 10.1136/jnnp.2003.023812; Knopman DS, 2011, NEUROLOGY, V76, P1879, DOI 10.1212/WNL.0b013e31821d753f; Liao DP, 1997, NEUROEPIDEMIOLOGY, V16, P149, DOI 10.1159/000368814; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mehrabian S, 2010, J NEUROL SCI, V299, P45, DOI 10.1016/j.jns.2010.08.056; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Passant U, 1997, INT J GERIATR PSYCH, V12, P395, DOI 10.1002/(SICI)1099-1166(199703)12:3<395::AID-GPS527>3.3.CO;2-R; Paternoster L, 2009, STROKE, V40, P2020, DOI 10.1161/STROKEAHA.108.542050; RAIHA I, 1993, ACTA NEUROL SCAND, V87, P286; Raz N, 2012, BBA-MOL BASIS DIS, V1822, P361, DOI 10.1016/j.bbadis.2011.08.007; Richardson J, 2009, AM J GERIAT PSYCHIAT, V17, P996, DOI 10.1097/JGP.0b013e3181b4bf35; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; RUTAN GH, 1992, HYPERTENSION, V19, P508, DOI 10.1161/01.HYP.19.6.508; Schatz IJ, 1996, NEUROLOGY, V46, P1470, DOI 10.1212/wnl.46.5.1470; SCHELTENS P, 1993, J NEUROL SCI, V114, P7, DOI 10.1016/0022-510X(93)90041-V; SCHELTENS P, 1995, NEUROLOGY, V45, P883, DOI 10.1212/WNL.45.5.883; Schmidt R, 1997, STROKE, V28, P951, DOI 10.1161/01.STR.28.5.951; Soennesyn H, 2012, DEMENT GER COGN D EX, V2, P97, DOI 10.1159/000335497; Sonnesyn H, 2009, DEMENT GERIATR COGN, V28, P307, DOI 10.1159/000247586; Teodorczuk A, 2010, PSYCHOL MED, V40, P603, DOI 10.1017/S0033291709990857; Thomas AJ, 2002, ANN NY ACAD SCI, V977, P333, DOI 10.1111/j.1749-6632.2002.tb04835.x; Verwoert GC, 2008, J AM GERIATR SOC, V56, P1816, DOI 10.1111/j.1532-5415.2008.01946.x; Vuorinen M, 2011, DEMENT GERIATR COGN, V31, P119, DOI 10.1159/000323810; Wakefield DB, 2010, J AM GERIATR SOC, V58, P275, DOI 10.1111/j.1532-5415.2009.02699.x; YLIKOSKI A, 1995, STROKE, V26, P1171, DOI 10.1161/01.STR.26.7.1171	56	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52196	10.1371/journal.pone.0052196	http://dx.doi.org/10.1371/journal.pone.0052196			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284932	Green Published, gold			2022-12-27	WOS:000312694300079
J	Andrassy, M; Volz, HC; Schuessler, A; Gitsioudis, G; Hofmann, N; Laohachewin, D; Wienbrandt, AR; Kaya, Z; Bierhaus, A; Giannitsis, E; Katus, HA; Korosoglou, G				Andrassy, Martin; Volz, H. Christian; Schuessler, Alena; Gitsioudis, Gitsios; Hofmann, Nina; Laohachewin, Danai; Wienbrandt, Alexandra R.; Kaya, Ziya; Bierhaus, Angelika; Giannitsis, Evangelos; Katus, Hugo A.; Korosoglou, Grigorios			HMGB1 Is Associated with Atherosclerotic Plaque Composition and Burden in Patients with Stable Coronary Artery Disease	PLOS ONE			English	Article							C-REACTIVE PROTEIN; MOBILITY GROUP BOX-1; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; SMOOTH-MUSCLE-CELLS; HEART-DISEASE; HIGH-MOBILITY-GROUP-BOX-1 PROTEIN; INFLAMMATION; LESIONS; RISK; MECHANISMS	Objectives: The role of inflammation in atherosclerosis is widely appreciated. High mobility group box 1 (HMGB1), an injury-associated molecular pattern molecule acting as a mediator of inflammation, has recently been implicated in the development of atherosclerosis. In this study, we sought to investigate the association of plasma HMGB1 with coronary plaque composition in patients with suspected or known coronary artery disease (CAD). Design: HMGB1, high sensitive troponin T (hsTnT) and high sensitive C-reactive protein (hsCRP) were determined in 152 consecutive patients with suspected or known stable CAD who underwent clinically indicated 256-slice coronary computed tomography angiography (CCTA). Using CCTA, we assessed 1) coronary calcification, 2) non-calcified plaque burden and 3) the presence of vascular remodeling in areas of non-calcified plaques. Results: Using univariate analysis, hsCRP, hsTnT and HMGB1 as well as age, and atherogenic risk factors were associated with non-calcified plaque burden (r = 0.21, p = 0.009; r = 0.48, p<0.001 and r = 0.34, p<0.001, respectively). By multivariate analysis, hsTnT and HMGB1 remained independent predictors of the non-calcified plaque burden (r = 0.48, p<0.01 and r = 0.34, p<0.001, respectively), whereas a non-significant trend was noticed for hs-CRP (r = 0.21, p = 0.07). By combining hsTnT and HMGB1, a high positive predictive value for the presence of non-calcified and remodeled plaque (96% and 77%, respectively) was noted in patients within the upper tertiles for both biomarkers, which surpassed the positive predictive value of each marker separately. Conclusions: In addition to hs-TnT, a well-established cardiovascular risk marker, HMGB1 is independently associated with non-calcified plaque burden in patients with stable CAD, while the predictive value of hs-CRP is lower. Complementary value was observed for hs-TnT and HMGB1 for the prediction of complex coronary plaque.	[Andrassy, Martin; Volz, H. Christian; Schuessler, Alena; Gitsioudis, Gitsios; Hofmann, Nina; Laohachewin, Danai; Wienbrandt, Alexandra R.; Kaya, Ziya; Giannitsis, Evangelos; Katus, Hugo A.; Korosoglou, Grigorios] Heidelberg Univ, Dept Cardiol, D-6900 Heidelberg, Germany; [Bierhaus, Angelika] Heidelberg Univ, Dept Internal Med & Clin Chem 3, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Andrassy, M (corresponding author), Heidelberg Univ, Dept Cardiol, Bergheimer Str 58, D-6900 Heidelberg, Germany.	martin.andrassy@med.uni-heidelberg.de; gkorosoglou@hotmail.com	Gitsioudis, Gitsios/GSJ-4171-2022		Carl Baresel Stiftung; German Research Foundation [403/2-1]; German Heart Foundation [F/36/08]; European Foundation for the Study of Diabetes	Carl Baresel Stiftung; German Research Foundation(German Research Foundation (DFG)); German Heart Foundation; European Foundation for the Study of Diabetes	This study was supported by the Carl Baresel Stiftung (MA), the German Research Foundation (MA, 403/2-1), the German Heart Foundation (MA, F/36/08) and the European Foundation for the Study of Diabetes (MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrassy M, 2011, J INTERN MED, V270, P245, DOI 10.1111/j.1365-2796.2011.02369.x; Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Bischoff B, 2009, JACC-CARDIOVASC IMAG, V2, P940, DOI 10.1016/j.jcmg.2009.02.015; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Cormode DP, 2010, RADIOLOGY, V256, P774, DOI 10.1148/radiol.10092473; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; DEFEYTER PJ, 1995, CIRCULATION, V92, P1408, DOI 10.1161/01.CIR.92.6.1408; Eisenhardt SU, 2009, CIRC RES, V105, P128, DOI 10.1161/CIRCRESAHA.108.190611; Hadamitzky M, 2011, CIRC-CARDIOVASC IMAG, V4, P16, DOI 10.1161/CIRCIMAGING.110.955351; Hammer-Hansen S, 2009, AM HEART J, V157, P481, DOI 10.1016/j.ahj.2008.10.011; Harja E, 2008, J CLIN INVEST, V118, P183, DOI 10.1172/JCI32703; Heusch G, 2004, J MOL CELL CARDIOL, V37, P23, DOI 10.1016/j.yjmcc.2004.04.011; Hoffmann U, 2006, J AM COLL CARDIOL, V47, P1655, DOI 10.1016/j.jacc.2006.01.041; Hosch W, 2011, EUR J RADIOL; Inoue K, 2007, CARDIOVASC PATHOL, V16, P136, DOI 10.1016/j.carpath.2006.11.006; Ito T, 2007, J THROMB HAEMOST, V5, P109, DOI 10.1111/j.1538-7836.2006.02255.x; Jeremias A, 2005, ANN INTERN MED, V142, P786, DOI 10.7326/0003-4819-142-9-200505030-00015; Kalinina N, 2004, ARTERIOSCL THROM VAS, V24, P2320, DOI 10.1161/01.ATV.0000145573.36113.8a; Kanellakis P, 2011, ARTERIOSCL THROM VAS, V31, P313, DOI 10.1161/ATVBAHA.110.218669; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Korosoglou G, 2011, HEART, V97, P823, DOI 10.1136/hrt.2010.193201; Korosoglou G, 2010, EUR RADIOL, V20, P1841, DOI 10.1007/s00330-010-1753-3; Laufer EM, 2010, ARTERIOSCL THROM VAS, V30, P1269, DOI 10.1161/ATVBAHA.109.200394; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Mann J, 1999, HEART, V82, P265, DOI 10.1136/hrt.82.3.265; Motoyama S, 2007, J AM COLL CARDIOL, V50, P319, DOI 10.1016/j.jacc.2007.03.044; Motoyama S, 2009, J AM COLL CARDIOL, V54, P49, DOI 10.1016/j.jacc.2009.02.068; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Omland T, 2009, NEW ENGL J MED, V361, P2538, DOI 10.1056/NEJMoa0805299; Pohle K, 2007, ATHEROSCLEROSIS, V190, P174, DOI 10.1016/j.atherosclerosis.2006.01.013; Porto A, 2006, FASEB J, V20, P2565, DOI 10.1096/fj.06-5867fje; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Sanz J, 2008, NATURE, V451, P953, DOI 10.1038/nature06803; Schlueter C, 2005, AM J PATHOL, V166, P1259, DOI 10.1016/S0002-9440(10)62344-9; Soro-Paavonen A, 2008, DIABETES, V57, P2461, DOI 10.2337/db07-1808; Volz HC, 2010, SEMIN THROMB HEMOST, V36, P185, DOI 10.1055/s-0030-1251503; Wang H, 2004, J INTERN MED, V255, P320, DOI 10.1111/j.1365-2796.2003.01302.x; Wensley F, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d548; Xu H, 2010, J IMMUNOL, V184, P1492, DOI 10.4049/jimmunol.0902660; Yamada S, 2006, CLIN CHIM ACTA, V372, P173, DOI 10.1016/j.cca.2006.04.016; Yan XX, 2009, ATHEROSCLEROSIS, V205, P544, DOI 10.1016/j.atherosclerosis.2008.12.016	43	42	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52081	10.1371/journal.pone.0052081	http://dx.doi.org/10.1371/journal.pone.0052081			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284878	Green Published, Green Submitted, gold			2022-12-27	WOS:000312435900074
J	Chen, MH; Huang, J; Chen, WM; Larson, MG; Fox, CS; Vasan, RS; Seshadri, S; O'Donnell, CJ; Yang, Q				Chen, Ming-Huei; Huang, Jie; Chen, Wei-Min; Larson, Martin G.; Fox, Caroline S.; Vasan, Ramachandran S.; Seshadri, Sudha; O'Donnell, Christopher J.; Yang, Qiong			Using Family-Based Imputation in Genome-Wide Association Studies with Large Complex Pedigrees: The Framingham Heart Study	PLOS ONE			English	Article							GENETIC-LOCI; ALZHEIMER-DISEASE; URIC-ACID; FIBRINOGEN; VARIANTS; DESIGN; RISK; MAPS	Imputation has been widely used in genome-wide association studies (GWAS) to infer genotypes of un-genotyped variants based on the linkage disequilibrium in external reference panels such as the HapMap and 1000 Genomes. However, imputation has only rarely been performed based on family relationships to infer genotypes of un-genotyped individuals. Using 8998 Framingham Heart Study (FHS) participants genotyped with Affymetrix 550K SNPs, we imputed genotypes of same set of SNPs for additional 3121 participants, most of whom were never genotyped due to lack of DNA sample. Prior to imputation, 122 pedigrees were too large to be handled by the imputation software Merlin. Therefore, we developed a novel pedigree splitting algorithm that can maximize the number of genotyped relatives for imputing each un-genotyped individual, while keeping new sub-pedigrees under a pre-specified size. In GWAS of four phenotypes available in FHS (Alzheimer disease, circulating levels of fibrinogen, high-density lipoprotein cholesterol, and uric acid), we compared results using genotyped individuals only with results using both genotyped and imputed individuals. We studied the impact of applying different imputation quality filtering thresholds on the association results and did not found a universal threshold that always resulted in a more significant p-value for previously identified loci. However most of these loci had a lower p-value when we only included imputed genotypes with with >= 60% SNP- and >= 50% person-specific imputation certainty. In summary, we developed a novel algorithm for splitting large pedigrees for imputation and found a plausible imputation quality filtering threshold based on FHS. Further examination may be required to generalize this threshold to other studies.	[Chen, Ming-Huei; Larson, Martin G.; Yang, Qiong] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA; [Chen, Ming-Huei; Seshadri, Sudha] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Chen, Ming-Huei; Huang, Jie; Larson, Martin G.; Fox, Caroline S.; Vasan, Ramachandran S.; Seshadri, Sudha; O'Donnell, Christopher J.; Yang, Qiong] NHLBI, Framingham Heart Study, Framingham, MA USA; [Huang, Jie] Wellcome Trust Sanger Inst, Cambridge, England; [Chen, Wei-Min] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Larson, Martin G.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Fox, Caroline S.] Brigham & Womens Hosp, Div Endocrinol Hypertens & Diabet, Boston, MA USA; [O'Donnell, Christopher J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med,Div Cardiol, Boston, MA USA	Boston University; Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Wellcome Trust Sanger Institute; University of Virginia; Boston University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Yang, Q (corresponding author), Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA.	qyang@bu.edu	Ramachandran, Vasan/Y-2527-2019; Yang, Qiong/G-5438-2014	Ramachandran, Vasan/0000-0001-7357-5970; Larson, Martin/0000-0002-9631-1254; Seshadri, Sudha/0000-0001-6135-2622; Yang, Qiong/0000-0002-3658-1375; Chen, Ming-Huei/0000-0003-3551-8726	National Heart, Lung, and Blood Institute [N01-HC-25195]; Affymetrix, Inc [N02-HL-6-4278]; NIH [R01 NS017950-28, R01-HL093328-01]; Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine; Boston Medical Center;  [R01HL093328];  [R01HL093029];  [R01NS017950]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093328, R01HL093029, ZIAHL006094, ZIAHL006002, ZIAHL006175, R01HL064278, ZIAHL006173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG008122] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Affymetrix, Inc; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine; Boston Medical Center; ; ; ; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors were supported in part by the National Heart, Lung, and Blood Institute's Framingham Heart Study (Con-tract No. N01-HC-25195) and grant numbers R01HL093328, R01HL093029, R01NS017950 and R01HL093029. The research was conducted in part using data and resources from the Framingham Heart Study of the National Heart Lung and Blood Institute of the National Institutes of Health and Boston University School of Medicine. The analyses reflect intellectual input and resource development from the Framingham Heart Study investigators participating in the SNP Health Association Resource (SHARe) project. This work was partially supported by the National Heart, Lung and Blood Institute's Framingham Heart Study (Contract No. N01-HC-25195), its contract with Affymetrix, Inc for genotyping services (Contract No. N02-HL-6-4278) and NIH grants R01 NS017950-28 and R01-HL093328-01. A portion of this research utilized the Linux Cluster for Genetic Analysis (LinGA-II) funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Chen MH, 2010, BIOINFORMATICS, V26, P580, DOI 10.1093/bioinformatics/btp710; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; CLAUSS A., 1957, ACTA HAEMATOL, V17, P237; CROWLEY LV, 1964, CLIN CHEM, V10, P838; DAWBER TR, 1963, ANN NY ACAD SCI, V107, P539, DOI 10.1111/j.1749-6632.1963.tb13299.x; Dehghan A, 2008, LANCET, V372, P1953, DOI 10.1016/S0140-6736(08)61343-4; Dehghan A, 2009, CIRC-CARDIOVASC GENE, V2, P125, DOI 10.1161/CIRCGENETICS.108.825224; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Gudbjartsson DF, 2005, NAT GENET, V37, P1015, DOI 10.1038/ng1005-1015; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; KANNEL WB, 1987, JAMA-J AM MED ASSOC, V258, P1183, DOI 10.1001/jama.258.9.1183; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Splansky GL, 2007, AM J EPIDEMIOL, V165, P1328, DOI 10.1093/aje/kwm021; Srivastava M, 1990, REGRESSION ANAL THEO; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Therneau TM, 2003, J COMPUT GRAPH STAT, V12, P156, DOI 10.1198/1061860031365	23	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51589	10.1371/journal.pone.0051589	http://dx.doi.org/10.1371/journal.pone.0051589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284720	Green Published, gold, Green Submitted			2022-12-27	WOS:000312435900032
J	de Mulder, M; Yebra, G; Navas, A; de Jose, MI; Gurbindo, MD; Gonzalez-Tome, MI; Mellado, MJ; Saavedra-Lozano, J; Munoz-Fernandez, MA; de Ory, SJ; Ramos, JT; Holguin, A				de Mulder, Miguel; Yebra, Gonzalo; Navas, Adriana; Isabel de Jose, Maria; Dolores Gurbindo, Maria; Isabel Gonzalez-Tome, Maria; Jose Mellado, Maria; Saavedra-Lozano, Jesus; Angeles Munoz-Fernandez, Maria; Jimenez de Ory, Santiago; Tomas Ramos, Jose; Holguin, Africa		Madrid Cohort HIV Infected Childre	High Drug Resistance Prevalence among Vertically HIV-Infected Patients Transferred from Pediatric Care to Adult Units in Spain	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; PERINATALLY ACQUIRED HIV; TO-CHILD-TRANSMISSION; VIROLOGICAL RESPONSE; ADOLESCENTS; IRELAND; KINGDOM; MUTATIONS; OUTCOMES; NAIVE	Background: Antiretroviral treatment (ART) has contributed to increased life expectancy of HIV-1 infected children. In developed countries, an increasing number of children reaching adulthood are transferred to adult units. The objectives were to describe the demographic and clinical features, ART history, antiviral drug resistance and drug susceptibility in HIV-1 perinatally infected adolescents transferred to adult care units in Spain from the Madrid Cohort of HIV-1 infected children. Methods: Clinical, virological and immunological features of HIV-1 vertically infected patients in the Madrid Cohort of HIV-infected children were analyzed at the time of transfer. Pol sequences from each patient were recovered before transfer. Resistance mutations according to the InternationaI AIDS Society 2011 list were identified and interpreted using the Stanford algorithm. Results were compared to the non-transferred HIV-1 infected pediatric cohort from Madrid. Results: One hundred twelve infected patients were transferred to adult units between 1997 and 2011. They were mainly perinatally infected (93.7%), with a mean nadir CD4+-T-cells count of 10% and presented moderate or severe clinical symptoms (75%). By the time of transfer, the mean age was 18.9 years, the mean CD4+T-cells count was 627.5 cells/ml, 64.2% presented more than 350 CD4+T-cells/ml and 47.3% had <= 200 RNA-copies/ml. Most (97.3%) were ART experienced receiving Highly Active ART (HAART) (84.8%). Resistance prevalence among pretreated was 50.9%, 76.9% and 36.5% for Protease Inhibitors (PI), Nucleoside Reverse Transcriptase Inhibitors (NRTI) and Non-NRTI (NNRTI), respectively. Resistance mutations were significantly higher among transferred patients compared to non-transferred for the PI+NRTI combination (19% vs. 8.4%). Triple resistance was similar to non-transferred pediatric patients (17.3% vs. 17.6%). Conclusion: Despite a good immunological and virological control before transfer, we found high levels of resistance to PI, NRTI and triple drug resistance in HIV-1 infected adolescents transferred to adult units.	[de Mulder, Miguel; Yebra, Gonzalo; Holguin, Africa] Hosp Univ Ramon & Cajal, Dept Microbiol & Parasitol, Mol Epidemiol Lab HIV 1, IRYCIS, Madrid, Spain; [Navas, Adriana] Hosp Univ Infanta Leonor, Dept Pediat, Madrid, Spain; [Isabel de Jose, Maria] Hosp Univ La Paz, Dept Pediat, Madrid, Spain; [Dolores Gurbindo, Maria; Saavedra-Lozano, Jesus] Hosp Gen Univ Gregorio Maranon, Dept Pediat, Madrid, Spain; [Isabel Gonzalez-Tome, Maria] Hosp Univ Doce Octubre, Dept Pediat, Madrid, Spain; [Jose Mellado, Maria] Hosp Carlos III, Dept Pediat, Madrid, Spain; [Angeles Munoz-Fernandez, Maria; Jimenez de Ory, Santiago] Hosp Gen Univ Gregorio Maranon, Mol Immunobiol Lab, Madrid, Spain; [Tomas Ramos, Jose] Hosp Univ Getafe, Dept Pediat, Madrid, Spain	Hospital Universitario Ramon y Cajal; Hospital Universitario Infanta Leonor; Hospital Universitario La Paz; General University Gregorio Maranon Hospital; Hospital Universitario 12 de Octubre; Hospital Carlos III; General University Gregorio Maranon Hospital; Hospital Universitario de Getafe	Holguin, A (corresponding author), Hosp Univ Ramon & Cajal, Dept Microbiol & Parasitol, Mol Epidemiol Lab HIV 1, IRYCIS, Madrid, Spain.	aholguin.hciii@salud.madrid.org	Roa, Miguel Angel/D-1088-2016; Delgado, Rafael/C-4910-2016; de Mulder Rougvie, Miguel/AAG-6224-2020; Holguín, Africa/AAF-9001-2021	Roa, Miguel Angel/0000-0003-1933-3000; Delgado, Rafael/0000-0002-6912-4736; de Mulder Rougvie, Miguel/0000-0002-8026-7076; Holguín, Africa/0000-0002-1330-8050; Munoz-Fernandez/0000-0002-0813-4500; Blazquez-Gamero, Daniel/0000-0001-6483-8329; Yebra, Gonzalo/0000-0002-3472-3667; Mellado Pena, Maria Jose/0000-0003-2251-9666	Fondo de Investigaciones Sanitarias (FIS) from Ministerio de Ciencia e Innovacion [PI09/00284, PI07/0236]; Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE) [360829/09]; Consejeria de Educacion de la Comunidad de Madrid and Fondo Social Europeo (FSE); Agencia Lain Entralgo	Fondo de Investigaciones Sanitarias (FIS) from Ministerio de Ciencia e Innovacion(Instituto de Salud Carlos III); Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE); Consejeria de Educacion de la Comunidad de Madrid and Fondo Social Europeo (FSE)(European Social Fund (ESF)); Agencia Lain Entralgo	This work was supported in part by grants from Fondo de Investigaciones Sanitarias (FIS) from Ministerio de Ciencia e Innovacion (grants PI09/00284 and PI07/0236) and from Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE, grant 360829/09). MDM is supported by PI09/00284 and PI07/0236. GY is supported by Consejeria de Educacion de la Comunidad de Madrid and Fondo Social Europeo (FSE). AH is supported by Agencia Lain Entralgo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammaranond P, 2012, FUND CLIN PHARMACOL, V26, P146, DOI 10.1111/j.1472-8206.2011.01009.x; Andiman WA, 2011, J PEDIATR-US, V159, P714, DOI 10.1016/j.jpeds.2011.06.040; [Anonymous], 1994, Morbidity and Mortality Weekly Report, V43, P1; Bain-Brickley D., 2011, COCHRANE DB SYST REV, V12; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Briz V, 2012, PEDIATR INFECT DIS J, V31, P1048, DOI 10.1097/INF.0b013e3182684d8e; Castro H, 2011, LANCET, V377, P1580, DOI 10.1016/S0140-6736(11)60208-0; Charpentier C, 2012, AIDS RES HUM RETROV, V28, P87, DOI [10.1089/aid.2011.0035, 10.1089/AID.2011.0035]; de Mulder M, 2012, PEDIATR INFECT DIS J, V31, pE213, DOI 10.1097/INF.0b013e3182678c7c; de Mulder M, 2011, J ANTIMICROB CHEMOTH, V66, P2362, DOI 10.1093/jac/dkr305; Descamps D, 2010, J ANTIMICROB CHEMOTH, V65, P2620, DOI 10.1093/jac/dkq380; Ding H, 2009, ARCH PEDIAT ADOL MED, V163, P1100, DOI 10.1001/archpediatrics.2009.204; Dollfus C, 2010, CLIN INFECT DIS, V51, P214, DOI 10.1086/653674; European Centre for Disease Prevention and Control, 2011, HIV AIDS SURV EUR 20; Fernandez-Ibieta M, 2007, An Pediatr (Barc), V67, P109; Foster C, 2010, EXPERT REV ANTI-INFE, V8, P1403, DOI 10.1586/ERI.10.129; Foster C, 2009, AIDS PATIENT CARE ST, V23, P159, DOI 10.1089/apc.2008.0153; Frange P, 2010, AIDS, V24, P1771, DOI 10.1097/QAD.0b013e32833a0993; Garcia-Merino I, 2010, AIDS RES HUM RETROV, V26, P241, DOI 10.1089/aid.2009.0122; Garcia-Merino I, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-27; Germanaud D, 2010, J ANTIMICROB CHEMOTH, V65, P118, DOI 10.1093/jac/dkp412; Giaquinto C, 2005, CLIN INFECT DIS, V40, P458, DOI 10.1086/427287; Gifford RJ, 2009, BIOINFORMATICS, V25, P1197, DOI 10.1093/bioinformatics/btp134; Gordon DE, 2012, PAEDIATR PERINAT EP, V26, P131, DOI 10.1111/j.1365-3016.2011.01243.x; Guillen S, 2012, ENFERM INFEC MICR CL, V30, P131, DOI 10.1016/j.eimc.2011.09.007; Holguin A, 2008, J MED VIROL, V80, P383, DOI 10.1002/jmv.21105; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Judd A, 2009, HIV MED, V10, P253, DOI 10.1111/j.1468-1293.2008.00676.x; Judd A, 2007, CLIN INFECT DIS, V45, P918, DOI 10.1086/521167; Kapogiannis BG, 2011, CLIN INFECT DIS, V53, P1024, DOI 10.1093/cid/cir641; Karchava M, 2006, JAIDS-J ACQ IMM DEF, V42, P614, DOI 10.1097/01.qai.0000225871.87456.e7; Kenny J, 2012, HIV MED, V13, P304, DOI 10.1111/j.1468-1293.2011.00967.x; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Nglazi MD, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-21; Palladino C, 2008, AIDS, V22, P2199, DOI 10.1097/QAD.0b013e328310fa96; Patel K, 2008, CLIN INFECT DIS, V46, P507, DOI 10.1086/526524; Rutstein RM, 2005, MED CARE, V43, P15; Saavedra-Lozano J, 2011, 18 C RETR OPP INF FE; Schmid J, 2005, SCAND J INFECT DIS, V37, P344, DOI 10.1080/00365540510031700; SINIVIH, 2011, AR VIG VIH COND RIES; Townsend CL, 2008, AIDS, V22, P973, DOI 10.1097/QAD.0b013e3282f9b67a; US Public Health Service Task Force, REC US ANT DRUGS PRE; van Rossum AMC, 2002, LANCET INFECT DIS, V2, P93, DOI 10.1016/S1473-3099(02)00183-4; Welch S, 2009, HIV MED, V10, P591, DOI 10.1111/j.1468-1293.2009.00759.x; World Health Organization (WHO), 2011, EP UPD HLTH SECT PRO; Yebra G, 2012, J CLIN MICROBIOL, V50, P407, DOI 10.1128/JCM.05798-11	46	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52155	10.1371/journal.pone.0052155	http://dx.doi.org/10.1371/journal.pone.0052155			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284913	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000312435900081
J	Feng, XB; Wang, DD; Chen, JJ; Lu, L; Hua, BZ; Li, X; Tsao, BP; Sun, LY				Feng, Xuebing; Wang, Dandan; Chen, Jingjing; Lu, Lin; Hua, Bingzhu; Li, Xia; Tsao, Betty P.; Sun, Lingyun			Inhibition of Aberrant Circulating Tfh Cell Proportions by Corticosteroids in Patients with Systemic Lupus Erythematosus	PLOS ONE			English	Article							FOLLICULAR-HELPER-CELLS; CENTER B-CELL; T-CELLS; DISEASE; IL-21; MICE; GLUCOCORTICOIDS; INTERLEUKIN-21; MECHANISMS; EXPRESSION	Objective: To observe the proportion of peripheral T follicular helper (Tfh) cells in patients with systemic lupus erythematosus (SLE) and to assess the role of steroids on Tfh cells from SLE patients. Methods: Peripheral blood mononuclear cells (PBMCs) from 42 SLE patients and 22 matched healthy subjects were collected to assess proportions of circulating CXCR5(+)PD1(+)/CD4(+) T cells (Tfh), CD4(+)CCR6(+) T cells (Th17-like) and CD19(+)CD138(+) plasma cells by flow cytometry. 8 of the patients had their blood redrawn within one week after receiving methylprednisolone pulse treatment. Disease activity was evaluated by SLE disease activity index. To test the effect of IL-21 and corticosteroids on Tfh cells in vitro, PBMCs harvested from another 15 SLE patients were cultured with medium, IL-21, or IL-21+ dexamethasone for 24 hours and 72 hours. PBMCs from an independent 23 SLE patients were cultured with different concentrations of dexamethasone for 24 hours. Results: Compared to normal controls, percentages of circulating Tfh cells, but not Th17 cells, were elevated in SLE patients and correlated with disease activity. Proportions of Tfh cells in SLE patients were positively correlated with those of plasma cells and serum levels of antinuclear antibodies. After methylprednisolone pulse treatment, both percentages and absolute numbers of circulating Tfh cells were significantly decreased. In vitro cultures showed an increase of Tfh cell proportion after IL-21 stimulation that was totally abolished by the addition of dexamethasone. Both 0.5 and 1 mu M dexamethasone decreased Tfh cells dose dependently (overall p = 0.013). Conclusions: We demonstrated that elevated circulating Tfh cell proportions in SLE patients correlated with their disease activities, and circulating levels of plasma cells and ANA. Corticosteroids treatment down-regulated aberrant circulating Tfh cell proportions both in vivo and in vitro, making Tfh cells a new treatment target for SLE patients.	[Feng, Xuebing; Wang, Dandan; Chen, Jingjing; Lu, Lin; Hua, Bingzhu; Li, Xia; Sun, Lingyun] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Rheumatol, Nanjing, Jiangsu, Peoples R China; [Tsao, Betty P.] Univ Calif Los Angeles, David Geffen Sch Med, Div Rheumatol, Los Angeles, CA 90095 USA	Nanjing University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Feng, XB (corresponding author), Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Rheumatol, Nanjing, Jiangsu, Peoples R China.	fengxuebing@hotmail.com; lingyunsun2001@yahoo.com.cn	chen, JJ/HGB-6029-2022	Tsao, Betty/0000-0001-7938-5975; Feng, Xuebing/0000-0002-9837-9690	National Natural Science Foundation of China [30972735, 81172846]; Jiangsu Province's Key Provincial Talents Program, "Six Talent Summit" Program; Nanjing Medical Science and Technique Development Foundation; NIAMS NIH [RO1 43814]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province's Key Provincial Talents Program, "Six Talent Summit" Program; Nanjing Medical Science and Technique Development Foundation; NIAMS NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Natural Science Foundation of China (grant number 30972735, 81172846), Jiangsu Province's Key Provincial Talents Program, "Six Talent Summit" Program and Nanjing Medical Science and Technique Development Foundation. B.P.T. was supported by RO1 43814 from the the NIAMS NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alunno A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/823085; Appel H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3370; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Cepika AM, 2010, SCAND J IMMUNOL, V72, P434, DOI 10.1111/j.1365-3083.2010.02450.x; Deenick EK, 2011, IMMUNOLOGY, V134, P361, DOI 10.1111/j.1365-2567.2011.03487.x; Dolff S, 2011, ARTHRITIS RES THER, V13, pR157, DOI DOI 10.1186/AR3474; Fagerli UM, 2011, ONCOGENE, V30, P3198, DOI 10.1038/onc.2011.79; Feng JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021698; Feng XB, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2972; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Harrison OJ, 2008, IMMUNOL LETT, V121, P13, DOI 10.1016/j.imlet.2008.07.011; Herber D, 2007, J IMMUNOL, V178, P3822, DOI 10.4049/jimmunol.178.6.3822; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Kerfoot SM, 2011, IMMUNITY, V34, P947, DOI 10.1016/j.immuni.2011.03.024; King JK, 2007, BEST PRACT RES CL RH, V21, P971, DOI 10.1016/j.berh.2007.09.002; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Lucas JA, 2008, J IMMUNOL, V181, P2513, DOI 10.4049/jimmunol.181.4.2513; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; Maranville JC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002162; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Patakas A, 2011, IMMUNOL LETT, V138, P38, DOI 10.1016/j.imlet.2011.03.002; Prado C, 2011, RHEUMATOLOGY, V50, P1794, DOI 10.1093/rheumatology/ker227; Recher M, 2012, BLOOD, V119, P2819, DOI 10.1182/blood-2011-09-379412; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Shah K, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2964; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Terrier B, 2012, J RHEUMATOL, V39, P1819, DOI 10.3899/jrheum.120468; Nguyen V, 2012, J IMMUNOL, V189, P1081, DOI 10.4049/jimmunol.1200318; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Zeller GC, 2006, J AM SOC NEPHROL, V17, P122, DOI 10.1681/ASN.2005080802; Zhang WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022659	33	76	82	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51982	10.1371/journal.pone.0051982	http://dx.doi.org/10.1371/journal.pone.0051982			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284839	Green Published, Green Submitted, gold			2022-12-27	WOS:000312435900068
J	Klancnik, A; Mozina, SS; Zhang, QJ				Klancnik, Anja; Mozina, Sonja Smole; Zhang, Qijing			Anti-Campylobacter Activities and Resistance Mechanisms of Natural Phenolic Compounds in Campylobacter	PLOS ONE			English	Article							MULTIDRUG EFFLUX PUMP; ANTIMICROBIAL ACTIVITY; ERYTHROMYCIN RESISTANCE; ANTIBIOTIC-RESISTANCE; MACROLIDE RESISTANCE; CMER FUNCTIONS; CMEABC; JEJUNI; IDENTIFICATION; FOOD	Background: Campylobacter is a major foodborne pathogen and alternative antimicrobials are needed to prevent or decrease Campylobacter contamination in foods or food producing animals. The objectives of this study are to define the anti-Campylobacter activities of natural phenolic compounds of plant origin and to determine the roles of bacterial drug efflux systems in the resistance to these natural phenolics in Campylobacter jejuni. Methodology/Principal Findings: Anti-Campylobacter activities were evaluated by an MIC assay using microdilution coupled with ATP measurement. Mutants of the cmeB and cmeF efflux genes and the cmeR transcriptional repressor gene were compared with the wild-type strain for their susceptibilities to phenolics in the absence and presence of efflux-pump inhibitors (EPIs). The phenolic compounds produced significant, but variable activities against both antibiotic-susceptible and antibiotic resistant Campylobacter. The highest anti-Campylobacter activity was seen with carnosic and rosmarinic acids in their pure forms or in enriched plant extracts. Inactivation of cmeB rendered C. jejuni significantly more susceptible to the phenolic compounds, while mutation of cmeF or cmeR only produced a moderate effect on the MICs. Consistent with the results from the efflux pump mutants, EPIs, especially phenylalanine-arginine beta-naphthylamide and NMP, significantly reduced the MICs of the tested phenolic compounds. Further reduction of MICs by the EPIs was also observed in the cmeB and cmeF mutants, suggesting that other efflux systems are also involved in Campylobacter resistance to phenolic compounds. Conclusion/Significance: Natural phenolic compounds of plant origin have good anti-Campylobacter activities and can be further developed for potential use in controlling Campylobacter. The drug efflux systems in Campylobacter contribute significantly to its resistance to the phenolics and EPIs potentiate the anti-Campylobacter activities of plant phenolic compounds.	[Zhang, Qijing] Iowa State Univ, Dept Vet Microbiol & Prevent Med, Ames, IA 50011 USA; [Klancnik, Anja; Mozina, Sonja Smole] Univ Ljubljana, Biotech Fac, Dept Food Sci & Technol, Ljubljana, Slovenia	Iowa State University; University of Ljubljana	Zhang, QJ (corresponding author), Iowa State Univ, Dept Vet Microbiol & Prevent Med, Ames, IA 50011 USA.	zhang123@iastate.edu	Klančnik, Anja/I-4571-2012; Zhang, Qijing/B-7530-2012	Klančnik, Anja/0000-0003-1632-5785; 	Ministry of Higher Education, Science and Technology of the Republic of Slovenia [Z1-2190]; BI-SLO-USA; National Institutes of Health [R01DK063008]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063008] Funding Source: NIH RePORTER	Ministry of Higher Education, Science and Technology of the Republic of Slovenia; BI-SLO-USA; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the Ministry of Higher Education, Science and Technology of the Republic of Slovenia for the Z1-2190 Post-doctoral project of A.K., the bilateral project between Slovenia and the U.S.A. (BI-SLO-USA 2011/12), and the National Institutes of Health grant R01DK063008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar F, 2008, EFSA J, V721, P1; Akiba M, 2006, J ANTIMICROB CHEMOTH, V57, P52, DOI 10.1093/jac/dki419; Altekruse SF, 2003, J AM VET MED ASSOC, V223, P445, DOI 10.2460/javma.2003.223.445; Baydar NG, 2004, FOOD CONTROL, V15, P335, DOI 10.1016/S0956-7135(03)00083-5; Cagliero C, 2005, J ANTIMICROB CHEMOTH, V56, P948, DOI 10.1093/jac/dki292; Cowan MM, 1999, CLIN MICROBIOL REV, V12, P564, DOI 10.1128/CMR.12.4.564; Cushnie TPT, 2005, INT J ANTIMICROB AG, V26, P343, DOI 10.1016/j.ijantimicag.2005.09.002; Gibreel A, 2005, ANTIMICROB AGENTS CH, V49, P2753, DOI 10.1128/AAC.49.7.2753-2759.2005; Guo BQ, 2008, J BACTERIOL, V190, P1879, DOI 10.1128/JB.01796-07; Guo BQ, 2010, FOODBORNE PATHOG DIS, V7, P77, DOI 10.1089/fpd.2009.0354; Hannula M, 2008, J MED MICROBIOL, V57, P851, DOI 10.1099/jmm.0.47823-0; Hemaiswarya S, 2008, PHYTOMEDICINE, V15, P639, DOI 10.1016/j.phymed.2008.06.008; Horiuchi K, 2007, BIOL PHARM BULL, V30, P287, DOI 10.1248/bpb.30.287; Katalinic V, 2013, INT J FOOD PROP, V16, P45, DOI 10.1080/10942912.2010.526274; Katalinic V, 2010, FOOD CHEM, V119, P715, DOI 10.1016/j.foodchem.2009.07.019; Klancnik A, 2010, J MICROBIOL METH, V81, P121, DOI 10.1016/j.mimet.2010.02.004; Klancnik A, 2009, J FOOD PROTECT, V72, P1744, DOI 10.4315/0362-028X-72.8.1744; Kurek A, 2011, POL J MICROBIOL, V60, P3, DOI 10.33073/pjm-2011-001; Kurincic M, 2007, INT J FOOD MICROBIOL, V120, P186, DOI 10.1016/j.ijfoodmicro.2007.03.012; Kurincic M, 2012, MICROBIAL D IN PRESS; Lin J, 2005, ANTIMICROB AGENTS CH, V49, P1067, DOI 10.1128/AAC.49.3.1067-1075.2005; Lin J, 2002, ANTIMICROB AGENTS CH, V46, P2124, DOI 10.1128/AAC.46.7.2124-2131.2002; Lin J, 2005, J BACTERIOL, V187, P7417, DOI 10.1128/JB.187.21.7417-7424.2005; Luangtongkum T, 2009, FUTURE MICROBIOL, V4, P189, DOI 10.2217/17460913.4.2.189; Mavri A, 2012, CHEM BIODIVERS, V9, P1545, DOI 10.1002/cbdv.201100337; Moore JE, 2006, MICROBES INFECT, V8, P1955, DOI 10.1016/j.micinf.2005.12.030; Moreno S, 2006, FREE RADICAL RES, V40, P223, DOI 10.1080/10715760500473834; Mozina SS, 2011, TRENDS FOOD SCI TECH, V22, P91, DOI 10.1016/j.tifs.2010.09.003; Murphy C, 2006, J APPL MICROBIOL, V100, P623, DOI 10.1111/j.1365-2672.2006.02903.x; Park SF, 2002, INT J FOOD MICROBIOL, V74, P177, DOI 10.1016/S0168-1605(01)00678-X; Payot S, 2004, INT J ANTIMICROB AG, V23, P468, DOI 10.1016/j.ijantimicag.2003.12.008; Pumbwe L, 2002, FEMS MICROBIOL LETT, V206, P185, DOI 10.1111/j.1574-6968.2002.tb11007.x; Puupponen-Pimia R, 2005, J APPL MICROBIOL, V98, P991, DOI 10.1111/j.1365-2672.2005.02547.x; Si WD, 2006, J CHROMATOGR A, V1125, P204, DOI 10.1016/j.chroma.2006.05.061; Taguri T, 2004, BIOL PHARM BULL, V27, P1965, DOI 10.1248/bpb.27.1965; WANG Y, 1990, J BACTERIOL, V172, P949, DOI 10.1128/JB.172.2.949-955.1990; Zorman T, 2002, FOOD TECHNOL BIOTECH, V40, P177	37	37	37	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51800	10.1371/journal.pone.0051800	http://dx.doi.org/10.1371/journal.pone.0051800			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284770	Green Published, Green Submitted, gold			2022-12-27	WOS:000312435900054
J	Rasheed-Depardieu, C; Parent, C; Crevecoeur, M; Parelle, J; Tatin-Froux, F; Le Provost, G; Capelli, N				Rasheed-Depardieu, Claire; Parent, Claire; Crevecoeur, Michele; Parelle, Julien; Tatin-Froux, Fabienne; Le Provost, Gregoire; Capelli, Nicolas			Identification and Expression of Nine Oak Aquaporin Genes in the Primary Root Axis of Two Oak Species, Quercus petraea and Quercus robur	PLOS ONE			English	Article							MAJOR INTRINSIC PROTEINS; PLASMA-MEMBRANE AQUAPORINS; WATER-TRANSPORT; ARABIDOPSIS; CHANNEL; MAIZE; FAMILY; RICE; CELL; QUANTIFICATION	Aquaporins (AQPs) belong to the Major Intrinsic Protein family that conducts water and other small solutes across biological membranes. This study aimed to identify and characterize AQP genes in the primary root axis of two oak species, Quercus petraea and Quercus robur. Nine putative AQP genes were cloned, and their expression was profiled in different developmental root zones by real-time PCR. A detailed examination of the predicted amino acid sequences and subsequent phylogenetic analysis showed that the isolated AQPs could be divided into two subfamilies, which included six plasma membrane intrinsic proteins (PIPs) and three tonoplast intrinsic proteins (TIPs). We characterized the anatomical features of the roots and defined three developmental root zones: the immature, transition and mature zones. Expression analysis of the AQPs was performed according to these root developmental stages. Our results showed that the expression of PIP2;3 and TIP1 was significantly higher in Quercus petraea compared with Quercus robur in the three root zones. However, PIP2;1 and TIP2;1 were found to be differentially expressed in the mature zone of the two oak species. Of the nine AQP genes identified and analyzed, we highlighted four genes that might facilitate a deeper understanding of how these two closely related tree species adapted to different environments.	[Rasheed-Depardieu, Claire; Parent, Claire; Parelle, Julien; Tatin-Froux, Fabienne; Capelli, Nicolas] Univ Franche Comte, UMR Chronoenvironm 6249, F-25030 Besancon, France; [Crevecoeur, Michele] Univ Geneva, Dept Bot & Biol Vegetale, Geneva, Switzerland; [Le Provost, Gregoire] INRA, UMR BIOGECO 1202, Cestas, France; [Le Provost, Gregoire] Univ Bordeaux, UMR BIOGECO 1202, Talence, France	Universite de Franche-Comte; University of Geneva; INRAE; UDICE-French Research Universities; Universite de Bordeaux	Capelli, N (corresponding author), Univ Franche Comte, UMR Chronoenvironm 6249, F-25030 Besancon, France.	nicolas.capelli@univ-fcomte.fr		Parelle, Julien/0000-0002-9209-3755; TATIN-FROUX, Fabienne/0000-0001-8663-305X	French research ministry; University of Franche-Comte; regional council of Franche-Comte	French research ministry(Ministry of Research, France); University of Franche-Comte; regional council of Franche-Comte(Region Bourgogne-Franche-Comte)	This work was supported by a doctoral fellowship from the French research ministry to C. Rasheed-Depardieu. The authors are also indebted to the University of Franche-Comte and the regional council of Franche-Comte for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandersson E, 2010, PLANT J, V61, P650, DOI 10.1111/j.1365-313X.2009.04087.x; Almeida-Rodriguez AM, 2011, PLANT CELL ENVIRON, V34, P1318, DOI 10.1111/j.1365-3040.2011.02331.x; Audigeos D, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-202; Ayadi M, 2011, PLANT PHYSIOL BIOCH, V49, P1029, DOI 10.1016/j.plaphy.2011.06.002; Bansal A, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-27; Barrieu F, 1998, PLANT PHYSIOL, V117, P1153, DOI 10.1104/pp.117.4.1153; Beebo A, 2009, PLANT MOL BIOL, V70, P193, DOI 10.1007/s11103-009-9465-2; Besse M, 2011, J EXP BOT, V62, P4127, DOI 10.1093/jxb/err175; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Bramley H, 2009, PLANT PHYSIOL, V150, P348, DOI 10.1104/pp.108.134098; BREDA N, 1993, ANN SCI FOREST, V50, P571, DOI 10.1051/forest:19930606; BRUNDRETT MC, 1988, PROTOPLASMA, V146, P133, DOI 10.1007/BF01405922; Chaumont F, 2000, PLANT PHYSIOL, V122, P1025, DOI 10.1104/pp.122.4.1025; Chaumont F, 1998, PLANT PHYSIOL, V117, P1143, DOI 10.1104/pp.117.4.1143; Enstone DE, 2005, PLANT CELL ENVIRON, V28, P444, DOI 10.1111/j.1365-3040.2005.01286.x; Fetter K, 2004, PLANT CELL, V16, P215, DOI 10.1105/tpc.017194; Fouquet R, 2008, PLANT CELL REP, V27, P1541, DOI 10.1007/s00299-008-0566-1; Froger A, 1998, PROTEIN SCI, V7, P1458, DOI 10.1002/pro.5560070623; Gattolin S, 2010, BIOCHEM SOC T, V38, P769, DOI 10.1042/BST0380769; Gattolin S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-133; Gupta AB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-134; Hachez C, 2006, PLANT MOL BIOL, V62, P305, DOI 10.1007/s11103-006-9022-1; Heymann JB, 2000, J MOL BIOL, V295, P1039, DOI 10.1006/jmbi.1999.3413; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Javot H, 2003, PLANT CELL, V15, P509, DOI 10.1105/tpc.008888; Johanson U, 2001, PLANT PHYSIOL, V126, P1358, DOI 10.1104/pp.126.4.1358; Johansson I, 1998, PLANT CELL, V10, P451, DOI 10.1105/tpc.10.3.451; Kaldenhoff R, 1998, PLANT J, V14, P121, DOI 10.1046/j.1365-313X.1998.00111.x; Knipfer T, 2011, J EXP BOT, V62, P717, DOI 10.1093/jxb/erq312; Krishnamurthy P, 2011, J EXP BOT, V62, P4215, DOI 10.1093/jxb/err135; Lagree V, 1999, J BIOL CHEM, V274, P6817, DOI 10.1074/jbc.274.11.6817; Le Provost G, 2012, TREE PHYSIOL, V32, P119, DOI 10.1093/treephys/tpr123; Leitao L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033219; LEVY G, 1992, FOREST ECOL MANAG, V55, P51, DOI 10.1016/0378-1127(92)90091-M; Ma S, 2004, PLANT J, V40, P845, DOI 10.1111/j.1365-313X.2004.02265.x; MAGGIO A, 1995, PLANT PHYSIOL, V109, P331, DOI 10.1104/pp.109.1.331; Mariette S, 2002, SILVAE GENET, V51, P72; Maurel C, 1997, P NATL ACAD SCI USA, V94, P7103, DOI 10.1073/pnas.94.13.7103; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; Nardini A, 1999, ANN FOR SCI, V56, P371, DOI 10.1051/forest:19990502; Parent C, 2011, PLANT CELL ENVIRON, V34, P1113, DOI 10.1111/j.1365-3040.2011.02309.x; Park W, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-142; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Quigley F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2001-3-1-research0001; Sakurai J, 2005, PLANT CELL PHYSIOL, V46, P1568, DOI 10.1093/pcp/pci172; Soukup A, 2004, BIOL PLANTARUM, V48, P481, DOI 10.1023/B:BIOP.0000047141.49470.77; Steudle E, 1996, PLANT SOIL, V187, P67, DOI 10.1007/BF00011658; Steudle E, 1996, J EXP BOT, V47, P387, DOI 10.1093/jxb/47.3.387; Steudle E, 2000, PLANT SOIL, V226, P45, DOI 10.1023/A:1026439226716; Suga S, 2004, PLANT CELL PHYSIOL, V45, P823, DOI 10.1093/pcp/pch120; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ueno S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-650; Vandeleur RK, 2009, PLANT PHYSIOL, V149, P445, DOI 10.1104/pp.108.128645; Verdaguer D, 1997, CAN J BOT, V75, P769, DOI 10.1139/b97-087; Viklund H, 2008, BIOINFORMATICS, V24, P1662, DOI 10.1093/bioinformatics/btn221; Wallace IS, 2004, PLANT PHYSIOL, V135, P1059, DOI 10.1104/pp.103.033415; Yamada K, 2011, PLANT BIOTECHNOL-NAR, V28, P509, DOI 10.5511/plantbiotechnology.11.0922a; YAMADA S, 1995, PLANT CELL, V7, P1129, DOI 10.1105/tpc.7.8.1129; Zardoya R, 2005, BIOL CELL, V97, P397, DOI 10.1042/BC20040134; Zhang MH, 2010, J BIOL CHEM, V285, P41982, DOI 10.1074/jbc.M110.101790; Zhao CX, 2008, COLLOID SURFACE B, V62, P163, DOI 10.1016/j.colsurfb.2007.10.015	64	9	9	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51838	10.1371/journal.pone.0051838	http://dx.doi.org/10.1371/journal.pone.0051838			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284785	Green Published, gold, Green Submitted			2022-12-27	WOS:000312435900057
J	Harris, B; Klein, R; Jerosch-Herold, M; Hoffman, EA; Ahmed, FS; Jacobs, DR; Klein, BEK; Wong, TY; Lima, JAC; Cotch, MF; Barr, G				Harris, Bianca; Klein, Ronald; Jerosch-Herold, Michael; Hoffman, Eric A.; Ahmed, Firas S.; Jacobs, David R., Jr.; Klein, Barbara E. K.; Wong, Tien Y.; Lima, Joao A. C.; Cotch, Mary Frances; Barr, Graham			The Association of Systemic Microvascular Changes with Lung Function and Lung Density: A Cross-Sectional Study	PLOS ONE			English	Article							RETINAL VASCULAR CALIBER; AIR-FLOW OBSTRUCTION; ATHEROSCLEROSIS MESA; CARDIOVASCULAR MORTALITY; MYOCARDIAL-PERFUSION; ALBUMIN EXCRETION; MEDIATED DILATION; REFERENCE VALUES; RISK-FACTORS; EX-SMOKERS	Smoking causes endothelial dysfunction and systemic microvascular disease with resultant end-organ damage in the kidneys, eyes and heart. Little is known about microvascular changes in smoking-related lung disease. We tested if microvascular changes in the retina, kidneys and heart were associated with obstructive spirometry and low lung density on computed tomography. The Multi-Ethnic Study of Atherosclerosis recruited participants age 45-84 years without clinical cardiovascular disease. Measures of microvascular function included retinal arteriolar and venular caliber, urine albumin-to-creatinine ratio and, in a subset, myocardial blood flow on magnetic resonance imaging. Spirometry was measured following ATS/ERS guidelines. Low attenuation areas (LAA) were measured on lung fields of cardiac computed tomograms. Regression models adjusted for pulmonary and cardiac risk factors, medications and body size. Among 3,397 participants, retinal venular caliber was inversely associated with forced expiratory volume in one second (FEV1) (P<0.001) and FEV1/forced vital capacity (FVC) ratio (P = 0.04). Albumin-to-creatinine ratio was inversely associated with FEV1 (P = 0.002) but not FEV1/FVC. Myocardial blood flow (n = 126) was associated with lower FEV1 (P = 0.02), lower FEV1/FVC (P = 0.001) and greater percentage LAA (P = 0.04). Associations were of greater magnitude among smokers. Low lung function was associated with microvascular changes in the retina, kidneys and heart, and low lung density was associated with impaired myocardial microvascular perfusion. These cross-sectional results suggest that microvascular damage with end-organ dysfunction in all circulations may pertain to the lung, that lung dysfunction may contribute to systemic microvascular disease, or that there may be a shared predisposition.	[Harris, Bianca; Ahmed, Firas S.; Barr, Graham] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10027 USA; [Klein, Ronald; Klein, Barbara E. K.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI USA; [Jerosch-Herold, Michael] Univ Minnesota, Sch Med, Dept Radiol, Minneapolis, MN 55455 USA; [Jerosch-Herold, Michael] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Radiol, Boston, MA USA; [Hoffman, Eric A.] Univ Iowa, Dept Radiol, Iowa City, IA 52242 USA; [Ahmed, Firas S.] Columbia Univ, Coll Phys & Surg, Dept Radiol, New York, NY USA; [Jacobs, David R., Jr.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Jacobs, David R., Jr.] Univ Oslo, Dept Nutr, Oslo, Norway; [Wong, Tien Y.] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Wong, Tien Y.] Natl Univ Singapore, Singapore Eye Res Inst, Singapore 117548, Singapore; [Lima, Joao A. C.] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Lima, Joao A. C.] Johns Hopkins Univ, Dept Radiol, Baltimore, MD USA; [Cotch, Mary Frances] NEI, Div Epidemiol & Clin Applicat, NIH, Bethesda, MD 20892 USA; [Barr, Graham] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	Columbia University; University of Wisconsin System; University of Wisconsin Madison; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Iowa; Columbia University; University of Minnesota System; University of Minnesota Twin Cities; University of Oslo; Centre for Eye Research Australia; University of Melbourne; National University of Singapore; Singapore National Eye Center; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Columbia University	Barr, G (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10027 USA.	rgb9@columbia.edu	Wong, Tien Yin/AAC-9724-2020; Jerosch-Herold, Michael/R-9824-2019	Wong, Tien Yin/0000-0002-8448-1264; Klein, Ronald/0000-0002-4428-6237; Cotch, Mary Frances/0000-0002-2046-4350; Hoffman, Eric/0000-0001-8456-9437; Jacobs, David/0000-0002-7232-0543	National Institutes of Health [R01-HL077612, R01-HL093081, R01-HL075476]; Vida Diagnostics;  [N01-HC95159-HC95169];  [UL1-TR000040]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095159] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000040] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [ZIAEY000403] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077612, R01HL093081, R01HL075476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vida Diagnostics; ; ; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by National Institutes of Health R01-HL077612, R01-HL093081, and R01-HL075476. MESA is supported by N01-HC95159-HC95169 and UL1-TR000040. A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding was provided by federal sources, an interest in Vida Diagnostics (EA Hoffman) and a gift of a fish oil supplement, Omax3, provided by Cenestra Health for a federally funded randomized clinical trial (RG Barr). These conflicts-of-interest do not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Alford SK, 2010, P NATL ACAD SCI USA, V107, P7485, DOI 10.1073/pnas.0913880107; Bakke PS, 2011, EUR RESPIR J, V38, P1261, DOI 10.1183/09031936.00193809; Barr RG, 2012, EUR RESPIR J, V39, P846, DOI 10.1183/09031936.00165410; Barr RG, 2007, AM J RESP CRIT CARE, V176, P1200, DOI 10.1164/rccm.200707-980OC; Barr RG, 2010, NEW ENGL J MED, V362, P217, DOI 10.1056/NEJMoa0808836; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Calabrese C, 2006, RESP MED, V100, P1415, DOI 10.1016/j.rmed.2005.11.009; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Casanova C, 2010, AM J RESP CRIT CARE, V182, P1004, DOI 10.1164/rccm.201003-0360OC; Chandra D, 2012, CHEST, V142, P655, DOI 10.1378/chest.11-1456; Chester AH, 1998, CARDIOVASC RES, V38, P814, DOI 10.1016/S0008-6363(98)00054-6; COXSON HO, 1995, J APPL PHYSIOL, V79, P1525, DOI 10.1152/jappl.1995.79.5.1525; Damico R, 2011, AM J RESP CELL MOL, V44, P323, DOI 10.1165/rcmb.2009-0379OC; Di Stefano A, 1998, AM J RESP CRIT CARE, V158, P1277, DOI 10.1164/ajrccm.158.4.9802078; Eickhoff P, 2008, AM J RESP CRIT CARE, V178, P1211, DOI 10.1164/rccm.200709-1412OC; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; Forey BA, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-36; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Giordano RJ, 2008, J BIOL CHEM, V283, P29447, DOI 10.1074/jbc.M804595200; Gooding KM, 2010, DIABETOLOGIA, V53, P2029, DOI 10.1007/s00125-010-1805-x; Gordon C, 2011, AM J RESP CRIT CARE, V184, P224, DOI 10.1164/rccm.201012-2061OC; Hallan S, 2007, ARCH INTERN MED, V167, P2490, DOI 10.1001/archinte.167.22.2490; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hankinson JL, 2010, CHEST, V137, P138, DOI 10.1378/chest.09-0919; Hashimoto M, 2005, CHEST, V127, P965, DOI 10.1378/chest.127.3.965; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Hoffman EA, 2009, ACAD RADIOL, V16, P689, DOI 10.1016/j.acra.2008.12.024; Hu SY, 2001, IEEE T MED IMAGING, V20, P490, DOI 10.1109/42.929615; Jerosch-Herold M, 2002, MED PHYS, V29, P886, DOI 10.1118/1.1473135; Kramer H, 2005, HYPERTENSION, V46, P38, DOI 10.1161/01.HYP.0000171189.48911.18; McGeechan K, 2009, ANN INTERN MED, V151, P404, DOI 10.7326/0003-4819-151-6-200909150-00005; MEHROTRA PP, 1983, J AM COLL CARDIOL, V2, P233, DOI 10.1016/S0735-1097(83)80158-2; Mendes ES, 2006, CHEST, V129, P893, DOI 10.1378/chest.129.4.893; Michaud SE, 2006, J MOL CELL CARDIOL, V41, P275, DOI 10.1016/j.yjmcc.2006.05.004; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Minino Arialdi M, 2011, Natl Vital Stat Rep, V59, P1; Nana-Sinkam SP, 2007, AM J RESP CRIT CARE, V175, P676, DOI 10.1164/rccm.200605-724OC; Nguyen TT, 2010, STROKE, V41, P1343, DOI 10.1161/STROKEAHA.110.581017; Nguyen TT, 2008, DIABETES CARE, V31, P544, DOI 10.2337/dc07-1528; O'Rourke MF, 2005, HYPERTENSION, V46, P200, DOI 10.1161/01.HYP.0000168052.00426.65; Ozer T, 2006, EUR J RADIOL, V57, P63, DOI 10.1016/j.ejrad.2005.06.010; Panting JR, 2002, NEW ENGL J MED, V346, P1948, DOI 10.1056/NEJMoa012369; Pesci A, 1998, EUR RESPIR J, V12, P380, DOI 10.1183/09031936.98.12020380; Polatli M, 2008, J THROMB THROMBOLYS, V26, P97, DOI 10.1007/s11239-007-0073-1; Reddy S, 2005, ABSTRACT PRESENTED A; Rennard Stephen I, 2008, Proc Am Thorac Soc, V5, P878, DOI 10.1513/pats.200804-035QC; Rodriguez J, 2010, ANN INTERN MED, V152, P201, DOI 10.7326/0003-4819-152-4-201002160-00004; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Schweitzer KS, 2011, AM J PHYSIOL-LUNG C, V301, pL836, DOI 10.1152/ajplung.00385.2010; Seimetz M, 2011, CELL, V147, P293, DOI 10.1016/j.cell.2011.08.035; Sharma J, 2012, AM J PHYSIOL-LUNG C, V302, pL47, DOI 10.1152/ajplung.00179.2011; Soltani A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-105; Stehouwer CDA, 2006, J AM SOC NEPHROL, V17, P2106, DOI 10.1681/ASN.2005121288; Takahashi T, 2012, THORAX, V67, P1067, DOI 10.1136/thoraxjnl-2011-201395; Wang JJ, 2007, EUR HEART J, V28, P1984, DOI 10.1093/eurheartj/ehm221; Wang L, 2006, J AM COLL CARDIOL, V47, P565, DOI 10.1016/j.jacc.2005.09.036; WILLIAMSON JR, 1993, DIABETES, V42, P801, DOI 10.2337/diabetes.42.6.801; Wong TY, 2006, INVEST OPHTH VIS SCI, V47, P2341, DOI 10.1167/iovs.05-1539; Wong TY, 2001, LANCET, V358, P1134, DOI 10.1016/S0140-6736(01)06253-5; Yoshida T, 2007, PHYSIOL REV, V87, P1047, DOI 10.1152/physrev.00048.2006; Zanini A, 2009, THORAX, V64, P1019, DOI 10.1136/thx.2009.114629	62	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e50224	10.1371/journal.pone.0050224	http://dx.doi.org/10.1371/journal.pone.0050224			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284634	Green Published, gold			2022-12-27	WOS:000312794500012
J	Prabhu, A; Sarcar, B; Kahali, S; Shan, Y; Chinnaiyan, P				Prabhu, Antony; Sarcar, Bhaswati; Kahali, Soumen; Shan, Yuan; Chinnaiyan, Prakash			Targeting the Unfolded Protein Response in Glioblastoma Cells with the Fusion Protein EGF-SubA	PLOS ONE			English	Article							STRESS CHAPERONE GRP78/BIP; MALIGNANT GLIOMAS; TUMOR-DEVELOPMENT; CANCER; INDUCTION; CYTOTOXIN; LINES	Rapidly growing tumors require efficient means to allow them to adapt to fluctuating microenvironments consisting of hypoxia, nutrient deprivation, and acidosis. The unfolded protein response (UPR) represents a defense mechanism allowing cells to respond to these adverse conditions. The chaperone protein GRP78 serves as a master UPR regulator that is aberrantly expressed in a variety of cancers, including glioma. Therefore, cancer cells may be particularly reliant upon the adaptive mechanisms offered by the UPR and targeting GRP78 may represent a unique therapeutic strategy. Here we report that diffuse expression of GRP78 protein is present in Grade III-IV, but not Grade I-II glioma. To determine the role GRP78 plays in glioblastoma tumorigenesis, we explored the anti-tumor activity of the novel fusion protein EGF-SubA, which combines EGF with the cytotoxin SubA that has been recently shown to selectively cleave GRP78. EGF-SubA demonstrated potent tumor-specific proteolytic activity and cytotoxicity in glioblastoma lines and potentiated the anti-tumor activity of both temozolomide and ionizing radiation. To determine if the tumor microenvironment influences EGF-SubA activity, we maintained cells in acidic conditions that led to both UPR activation and increased EGF-SubA induced cytotoxicity. EGF-SubA was well tolerated in mice and led to a significant tumor growth delay in a glioma xenograft mouse model. The UPR is emerging as an important adaptive pathway contributing to glioma tumorigenesis. Targeting its primary mediator, the chaperone protein GRP78, through specific, proteolytic cleavage with the immunotoxin EGF-SubA represents a novel and promising multi-targeted approach to cancer therapy.	[Prabhu, Antony; Sarcar, Bhaswati; Kahali, Soumen; Shan, Yuan; Chinnaiyan, Prakash] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Chinnaiyan, P (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA.	prakash.chinnaiyan@moffitt.org	Dayalan, Antony Herold Prabhu Packiam/J-8625-2019	Dayalan, Antony Herold Prabhu Packiam/0000-0003-2401-0118	Ben and Catherine Ivy Foundation; American Cancer Society [RSG-11-029-01-CSM]	Ben and Catherine Ivy Foundation; American Cancer Society(American Cancer Society)	PC is currently funded by The Ben and Catherine Ivy Foundation and The American Cancer Society (RSG-11-029-01-CSM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backer JM, 2009, NEOPLASIA, V11, P1165, DOI 10.1593/neo.09878; Backer MV, 2011, METHOD ENZYMOL, V491, P37, DOI 10.1016/B978-0-12-385928-0.00003-1; Dong DZ, 2008, CANCER RES, V68, P498, DOI 10.1158/0008-5472.CAN-07-2950; Dong DZ, 2005, CANCER RES, V65, P5785, DOI 10.1158/0008-5472.CAN-05-0754; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Ghosh R, 2010, PLOS ONE, V5, pA104, DOI 10.1371/journal.pone.0009575; Jamora C, 1996, P NATL ACAD SCI USA, V93, P7690, DOI 10.1073/pnas.93.15.7690; Ke N, 2011, METHODS MOL BIOL, V740, P33, DOI 10.1007/978-1-61779-108-6_6; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Lee HK, 2008, NEURO-ONCOLOGY, V10, P236, DOI 10.1215/15228517-2008-006; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Pootrakul L, 2006, CLIN CANCER RES, V12, P5987, DOI 10.1158/1078-0432.CCR-06-0133; Pyrko P, 2007, CANCER RES, V67, P9809, DOI 10.1158/0008-5472.CAN-07-0625; Sarcar B, 2011, MOL CANCER THER, V10, P2405, DOI 10.1158/1535-7163.MCT-11-0469; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Virrey JJ, 2008, MOL CANCER RES, V6, P1268, DOI 10.1158/1541-7786.MCR-08-0060; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501	23	21	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52265	10.1371/journal.pone.0052265	http://dx.doi.org/10.1371/journal.pone.0052265			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284962	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500130
J	Tsai, YC; Riess, O; Soehn, AS; Nguyen, HP				Tsai, Yu-Chun; Riess, Olaf; Soehn, Anne S.; Huu Phuc Nguyen			The Guanine Nucleotide Exchange Factor Kalirin-7 Is a Novel Synphilin-1 Interacting Protein and Modifies Synphilin-1 Aggregate Transport and Formation	PLOS ONE			English	Article							HUNTINGTIN-ASSOCIATED PROTEIN-1; LEWY-BODY FORMATION; REGULATES AGGRESOME FORMATION; PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; SPINE MORPHOGENESIS; MUTANT HUNTINGTIN; IN-VIVO; INCLUSIONS; HDAC6	Synphilin-1 has been identified as an interaction partner of alpha-synuclein, a key protein in the pathogenesis of Parkinson disease (PD). To further explore novel binding partners of synphilin-1, a yeast two hybrid screening was performed and kalirin-7 was identified as a novel interactor. We then investigated the effect of kalirin-7 on synphilin-1 aggregate formation. Coexpression of kalirin-7 and synphilin-1 caused a dramatic relocation of synphilin-1 cytoplasmic small inclusions to a single prominent, perinuclear inclusion. These perinuclear inclusions were characterized as being aggresomes according to their colocalization with microtubule organization center markers, and their formation was microtubule-dependent. Furthermore, kalirin-7 increased the susceptibility of synphilin-1 inclusions to be degraded as demonstrated by live cell imaging and quantification of aggregates. However, the kalirin-7-mediated synphilin-1 aggresome response was not dependent on the GEF activity of kalirin-7 since various dominant negative small GTPases could not inhibit the formation of aggresomes. Interestingly, the aggresome response was blocked by HDAC6 catalytic mutants and the HDAC inhibitor trichostatin A (TSA). Moreover, kalirin-7 decreased the level of acetylated alpha-tubulin in response to TSA, which suggests an effect of kalirin-7 on HDAC6-mediated protein transportation and aggresome formation. In summary, this is the first report demonstrating that kalirin-7 leads to the recruitment of synphilin-1 into aggresomes in a HDAC6-dependent manner and also links kalirin-7 to microtubule dynamics.	[Tsai, Yu-Chun; Riess, Olaf; Soehn, Anne S.; Huu Phuc Nguyen] Univ Tubingen, Dept Med Genet, Tubingen, Germany	Eberhard Karls University of Tubingen	Nguyen, HP (corresponding author), Univ Tubingen, Dept Med Genet, Tubingen, Germany.	hoa.nguyen@med.uni-tuebingen.de	Nguyen, Huu Phuc/HDO-3462-2022; Nguyen, Huu Phuc/F-5390-2015	Nguyen, Huu Phuc/0000-0001-6139-788X; Nguyen, Huu Phuc/0000-0001-6139-788X	DFG [RI 682/10-1]; European Union [20235]; Landesgraduiertenforderungsgesetz (LGFG) Baden-Wurttemberg	DFG(German Research Foundation (DFG)); European Union(European Commission); Landesgraduiertenforderungsgesetz (LGFG) Baden-Wurttemberg	This work was supported by the DFG (grant number RI 682/10-1). YCT was a fellow of the Early Stage Training Network NEUROTRAIN (funded by the European Union research program FP6-Mobility 20235) and she has received a stipend according to the Landesgraduiertenforderungsgesetz (LGFG) Baden-Wurttemberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MR, 1997, J BIOL CHEM, V272, P12667, DOI 10.1074/jbc.272.19.12667; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Avraham E, 2005, J BIOL CHEM, V280, P42877, DOI 10.1074/jbc.M505608200; Bobrowska A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020696; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Boyault C, 2007, ONCOGENE, V26, P5468, DOI 10.1038/sj.onc.1210614; Burnett BG, 2005, P NATL ACAD SCI USA, V102, P4330, DOI 10.1073/pnas.0407252102; Cahill ME, 2009, P NATL ACAD SCI USA, V106, P13058, DOI 10.1073/pnas.0904636106; Chakrabarti K, 2005, MOL CELL BIOL, V25, P5106, DOI 10.1128/MCB.25.12.5106-5118.2005; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Colomer V, 1997, HUM MOL GENET, V6, P1519, DOI 10.1093/hmg/6.9.1519; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Engelender S, 1997, HUM MOL GENET, V6, P2205, DOI 10.1093/hmg/6.13.2205; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; Fox JH, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-26; Funayama M, 2002, ANN NEUROL, V51, P296, DOI 10.1002/ana.10113; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; Gietz RD, 2001, BIOTECHNIQUES, V30, P816, DOI 10.2144/01304rv02; Guardiola AR, 2002, J BIOL CHEM, V277, P3350, DOI 10.1074/jbc.M109861200; Hayashi-Takagi A, 2010, NAT NEUROSCI, V13, P327, DOI 10.1038/nn.2487; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Ito T, 2003, J BIOL CHEM, V278, P29106, DOI 10.1074/jbc.M302763200; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Johnson RC, 2000, J BIOL CHEM, V275, P19324, DOI 10.1074/jbc.M000676200; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Krug T, 2010, HUM GENET, V127, P513, DOI 10.1007/s00439-010-0790-y; Kruger R, 2004, CELL TISSUE RES, V318, P195, DOI 10.1007/s00441-004-0953-z; Lee G, 2002, J NEUROCHEM, V83, P346, DOI 10.1046/j.1471-4159.2002.01136.x; Lee HJ, 1990, NEURONAL PROPERTIES, P1779; Li SH, 1998, J NEUROSCI, V18, P1261, DOI 10.1523/jneurosci.18-04-01261.1998; Liani E, 2004, P NATL ACAD SCI USA, V101, P5500, DOI 10.1073/pnas.0401081101; Lim KL, 2006, NEUROBIOL AGING, V27, P524, DOI 10.1016/j.neurobiolaging.2005.07.023; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Ma XM, 2008, J NEUROSCI, V28, P711, DOI 10.1523/JNEUROSCI.5283-07.2008; Ma XM, 2008, J NEUROSCI, V28, P12368, DOI 10.1523/JNEUROSCI.4269-08.2008; Marx FP, 2003, HUM MOL GENET, V12, P1223, DOI 10.1093/hmg/ddg134; Marx FP, 2007, FASEB J, V21, P1759, DOI 10.1096/fj.06-6734com; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; May V, 2002, J NEUROSCI, V22, P6980; McGuire JR, 2006, J BIOL CHEM, V281, P3552, DOI 10.1074/jbc.M509806200; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Murray IVJ, 2003, ACTA NEUROPATHOL, V105, P177, DOI 10.1007/s00401-002-0629-2; Nagano Y, 2003, J BIOL CHEM, V278, P51504, DOI 10.1074/jbc.M306347200; O'Farrell C, 2001, MOL BRAIN RES, V97, P94, DOI 10.1016/S0169-328X(01)00292-3; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Penzes P, 2000, J BIOL CHEM, V275, P6395, DOI 10.1074/jbc.275.9.6395; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Penzes P, 2008, TRENDS NEUROSCI, V31, P419, DOI 10.1016/j.tins.2008.06.001; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ratovitski EA, 1999, J BIOL CHEM, V274, P993, DOI 10.1074/jbc.274.2.993; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Ribeiro CS, 2002, J BIOL CHEM, V277, P23927, DOI 10.1074/jbc.M201115200; Schiller MR, 2008, EXP CELL RES, V314, P2674, DOI 10.1016/j.yexcr.2008.05.011; Schiller MR, 2005, EXP CELL RES, V307, P402, DOI 10.1016/j.yexcr.2005.03.024; Segev N, 2011, SEMIN CELL DEV BIOL, V22, P1, DOI 10.1016/j.semcdb.2010.12.004; Soehn AS, 2010, NEUROGENETICS, V11, P203, DOI 10.1007/s10048-009-0215-z; Takahashi T, 2006, FEBS LETT, V580, P4479, DOI 10.1016/j.febslet.2006.07.019; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Tanaka M, 2004, J BIOL CHEM, V279, P4625, DOI 10.1074/jbc.M310994200; Tanji K, 2006, AM J PATHOL, V169, P553, DOI 10.2353/ajpath.2006.051067; Tran ADA, 2007, J CELL SCI, V120, P1469, DOI 10.1242/jcs.03431; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Verhey KJ, 2007, CELL CYCLE; Vilarino-Guell C, 2011, AM J HUM GENET, V89, P162, DOI 10.1016/j.ajhg.2011.06.001; Viswanathan J, 2011, TRAFFIC, V12, P330, DOI 10.1111/j.1600-0854.2010.01149.x; Wang LY, 2007, AM J HUM GENET, V80, P650, DOI 10.1086/512981; Weiss A, 2008, J NEUROCHEM, V104, P846, DOI 10.1111/j.1471-4159.2007.05032.x; Wong ESP, 2008, HUM MOL GENET, V17, P2570, DOI 10.1093/hmg/ddn157; Xie YY, 2010, FASEB J, V24, P196, DOI 10.1096/fj.09-133082; Xie Z, 2008, J NEUROSCI, V28, P6079, DOI 10.1523/JNEUROSCI.1170-08.2008; Xie Z, 2007, NEURON, V56, P640, DOI 10.1016/j.neuron.2007.10.005; Youn H, 2007, J ALZHEIMERS DIS, V12, P271; Zaarur N, 2008, J BIOL CHEM, V283, P27575, DOI 10.1074/jbc.M802216200; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zhang Y, 2006, J BIOL CHEM, V281, P2401, DOI 10.1074/jbc.C500241200; Zheng SQ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000838; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P8923, DOI 10.1073/pnas.0903621106; Zilberman Y, 2009, J CELL SCI, V122, P3531, DOI 10.1242/jcs.046813; Zimprich A, 2011, AM J HUM GENET, V89, P168, DOI 10.1016/j.ajhg.2011.06.008	84	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51999	10.1371/journal.pone.0051999	http://dx.doi.org/10.1371/journal.pone.0051999			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284848	Green Submitted, gold, Green Published			2022-12-27	WOS:000312794500076
J	Wang, F; He, L; Dai, WQ; Xu, YP; Wu, D; Lin, CL; Wu, SM; Cheng, P; Zhang, Y; Shen, M; Wang, CF; Lu, J; Zhou, YQ; Xu, XF; Xu, L; Guo, CY				Wang, Fan; He, Lei; Dai, Wei-Qi; Xu, Ya-Ping; Wu, Dong; Lin, Chun-Lei; Wu, Shu-Mei; Cheng, Ping; Zhang, Yan; Shen, Miao; Wang, Chen-Feng; Lu, Jie; Zhou, Ying-Qun; Xu, Xuan-Fu; Xu, Ling; Guo, Chuan-Yong			Salinomycin Inhibits Proliferation and Induces Apoptosis of Human Hepatocellular Carcinoma Cells In Vitro and In Vivo	PLOS ONE			English	Article							TUMOR-CELLS; WNT; OVEREXPRESSION; METASTASIS; MUTATIONS; CA2+	The anti-tumor antibiotic salinomycin (Sal) was recently identified as a selective inhibitor of breast cancer stem cells; however, the effect of Sal on hepatocellular carcinoma (HCC) is not clear. This study aimed to determine the anti-tumor efficacy and mechanism of Sal on HCC. HCC cell lines (HepG2, SMMC-7721, and BEL-7402) were treated with Sal. Cell doubling time was determinated by drawing growth curve, cell viability was evaluated using the Cell Counting Kit 8. The fraction of CD133(+) cell subpopulations was assessed by flow cytometry. We found that Sal inhibits proliferation and decreases PCNA levels as well as the proportion of HCC CD133(+) cell subpopulations in HCC cells. Cell cycle was analyzed using flow cytometry and showed that Sal caused cell cycle arrest of the various HCC cell lines in different phases. Cell apoptosis was evaluated using flow cytometry and Hoechst 33342 staining. Sal induced apoptosis as characterized by an increase in the Bax/Bcl-2 ratio. Several signaling pathways were selected for further mechanistic analyses using real time-PCR and Western blot assays. Compared to control, beta-catenin expression is significantly down-regulated upon Sal addition. The Ca2+ concentration in HCC cells was examined by flow cytometry and higher Ca2+ concentrations were observed in Sal treatment groups. The anti-tumor effect of Sal was further verified in vivo using the hepatoma orthotopic tumor model and the data obtained showed that the size of liver tumors in Sal-treated groups decreased compared to controls. Immunohistochemistry and TUNEL staining also demonstrated that Sal inhibits proliferation and induces apoptosis in vivo. Finally, the role of Sal on in vivo Wnt/beta-catenin signaling was evaluated by Western blot and immunohistochemistry. This study demonstrates Sal inhibits proliferation and induces apoptosis of HCC cells in vitro and in vivo and one potential mechanism is inhibition of Wnt/beta-catenin signaling via increased intracellular Ca2+ levels.	[Wang, Fan; He, Lei; Dai, Wei-Qi; Xu, Ya-Ping; Wu, Dong; Lin, Chun-Lei; Wu, Shu-Mei; Cheng, Ping; Zhang, Yan; Shen, Miao; Wang, Chen-Feng; Lu, Jie; Zhou, Ying-Qun; Xu, Xuan-Fu; Xu, Ling; Guo, Chuan-Yong] Tongji Univ Med, Shanghai Peoples Hosp 10, Dept Gastroenterol, Shanghai, Peoples R China	Tongji University	Xu, L (corresponding author), Tongji Univ Med, Shanghai Peoples Hosp 10, Dept Gastroenterol, Shanghai, Peoples R China.	xuling606@sina.com; guochuanyong@hotmail.com		Guo, Chuanyong/0000-0002-6527-4673	National Natural Science Foundation of China [81101579]; Shanghai Science and Technology Innovation Plan of Action for international cooperation projects [11430702400]; China Foundation for Hepatitis Prevention and Control WBN Liver Disease Research Fund [20100021]; Shanghai Health Bureau issues [2011287]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Innovation Plan of Action for international cooperation projects; China Foundation for Hepatitis Prevention and Control WBN Liver Disease Research Fund; Shanghai Health Bureau issues	This work was supported by the National Natural Science Foundation of China (no. 81101579), the Shanghai Science and Technology Innovation Plan of Action for international cooperation projects (no. 11430702400), the China Foundation for Hepatitis Prevention and Control WBN Liver Disease Research Fund (no. 20100021), and the Shanghai Health Bureau issues (No. 2011287). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cui J, 2001, J CANCER RES CLIN, V127, P577, DOI 10.1007/s004320100259; Devereux TR, 2001, MOL CARCINOGEN, V31, P68, DOI 10.1002/mc.1041; Dong TT, 2011, ANN SURG ONCOL, V18, P1797, DOI 10.1245/s10434-011-1561-2; Fuchs D, 2009, BIOCHEM BIOPH RES CO, V390, P743, DOI 10.1016/j.bbrc.2009.10.042; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hou Y, 2012, CELL RES, V22, P259, DOI 10.1038/cr.2011.139; Hsu HC, 2000, AM J PATHOL, V157, P763, DOI 10.1016/S0002-9440(10)64590-7; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kim KY, 2011, BIOCHEM BIOPH RES CO, V413, P80, DOI 10.1016/j.bbrc.2011.08.054; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Kudo M, 2011, DIGEST DIS, V29, P289, DOI 10.1159/000327562; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Lee S, 2003, CURR OPIN GENET DEV, V13, P90, DOI 10.1016/S0959-437X(02)00014-X; Leibowitz Brian, 2010, Cancer Biol Ther, V9, P417, DOI 10.4161/cbt.9.6.11392; Lu DS, 2011, P NATL ACAD SCI USA, V108, P13253, DOI 10.1073/pnas.1110431108; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Mathai JP, 2005, J BIOL CHEM, V280, P23829, DOI 10.1074/jbc.M500800200; Maye P, 2004, J BIOL CHEM, V279, P24659, DOI 10.1074/jbc.M311724200; MITANI M, 1975, BIOCHEM BIOPH RES CO, V66, P1231, DOI 10.1016/0006-291X(75)90490-8; MIYAZAKI Y, 1974, J ANTIBIOT, V27, P814, DOI 10.7164/antibiotics.27.814; NAITO S, 1986, CANCER RES, V46, P4109; Park CH, 2005, CARCINOGENESIS, V26, P1929, DOI 10.1093/carcin/bgi145; Piao LS, 2012, CANCER LETT, V315, P129, DOI 10.1016/j.canlet.2011.10.012; Ryder SD, 2003, GUT, V52, pIII1, DOI 10.1136/gut.52.suppl_3.iii1; Slusarski DC, 1997, DEV BIOL, V182, P114, DOI 10.1006/dbio.1996.8463; Story Phillipa, 2004, N Z Med J, V117, pU799; Wang LY, 2011, HEPATO-GASTROENTEROL, V58, P1757; Wong CM, 2001, CANCER-AM CANCER SOC, V92, P136, DOI 10.1002/1097-0142(20010701)92:1<136::AID-CNCR1301>3.0.CO;2-R; Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137	30	90	98	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e50638	10.1371/journal.pone.0050638	http://dx.doi.org/10.1371/journal.pone.0050638			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284640	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500014
J	Chen, R; Chang, GB; Zhang, Y; Dai, AQ; Ma, T; Li, JC; Zhai, F; Hua, DK; Xia, MX; Chen, GH				Chen, Rong; Chang, Guobin; Zhang, Ying; Dai, Aiqin; Ma, Teng; Li, Jianchao; Zhai, Fei; Hua, Dengke; Xia, Mingxiu; Chen, Guohong			Cloning of the Quail PIWI Gene and Characterization of PIWI Binding to Small RNAs	PLOS ONE			English	Article							GERMLINE STEM-CELLS; MICRORNA EXPRESSION; CHICKEN-EMBRYO; DROSOPHILA; PATHWAY; FAMILY; SPERMATOGENESIS; IDENTIFICATION; PROTEIN; TESTES	The PIWI protein regulates gene expression at the epigenetic and post-transcriptional level with a variety of endogenous small non-coding RNAs. In poultry, the biological function of the PIWI protein and PIWI binding to small RNAs had not been determined. The present study cloned and analyzed the sequences of the PIWIL1 protein. We also characterized PIWIL1 binding to small RNAs from adult quail testis, where the PIWIL1 protein is specifically expressed. Small RNAs showed a strong peak at 24-27 nt in the testicular RNA library, mapped primarily to repeat sequences and were similar to rasiRNAs. MicroRNAs (miRNAs) were abundant in the ovarian RNA library at a peak of 22 nt.	[Chen, Rong; Chang, Guobin; Zhang, Ying; Dai, Aiqin; Ma, Teng; Li, Jianchao; Zhai, Fei; Hua, Dengke; Xia, Mingxiu; Chen, Guohong] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Peoples R China	Yangzhou University	Chen, GH (corresponding author), Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Peoples R China.	ghchen@yzu.edu.cn			National Natural Science Foundation of China [31172199]; Natural Science Foundation of Jiangsu Province [BK2009190]; priority academic program development of Jiangsu Higher Education Institutions; National High Technology Research and Development Program [2011AA100305]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); priority academic program development of Jiangsu Higher Education Institutions; National High Technology Research and Development Program(National High Technology Research and Development Program of China)	This work was supported by grants from the National Natural Science Foundation of China (31172199) (http://159.226.244.22/portal/Proj_List.asp), the Natural Science Foundation of Jiangsu Province (BK2009190), and the priority academic program development of Jiangsu Higher Education Institutions(http://202.119.175.131/pages/xkmd.aspx). This study was also supported by National High Technology Research and Development Program (2011AA100305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin A, 2005, FEBS LETT, V579, P5830, DOI 10.1016/j.febslet.2005.08.009; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Bannister SC, 2009, BIOL REPROD, V81, P165, DOI 10.1095/biolreprod.108.074005; Barh D, 2010, CURR ONCOL, V17, P70; Betel D, 2007, PLOS COMPUT BIOL, V3, P2219, DOI 10.1371/journal.pcbi.0030222; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Chang GB, 2011, THAI J VET MED, V41, P193; Chen Rong, 2011, Scientia Agricultura Sinica, V44, P1727; Cox DN, 2000, DEVELOPMENT, V127, P503; Cutting AD, 2012, CHROMOSOME RES, V20, P201, DOI 10.1007/s10577-011-9263-y; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Klattenhoff C, 2007, DEV CELL, V12, P45, DOI 10.1016/j.devcel.2006.12.001; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lee JH, 2006, HUM MOL GENET, V15, P201, DOI 10.1093/hmg/ddi430; Lian J, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-13; Lin HF, 1997, DEVELOPMENT, V124, P2463; LIN M, 1992, CELL TISSUE RES, V267, P591, DOI 10.1007/BF00319382; Megosh HB, 2006, CURR BIOL, V16, P1884, DOI 10.1016/j.cub.2006.08.051; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Qiao D, 2002, ONCOGENE, V21, P3988, DOI 10.1038/sj.onc.1205505; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Tian F, 2012, GENOMICS, V99, P152, DOI 10.1016/j.ygeno.2011.11.004; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Wang XG, 2012, POULTRY SCI, V91, P139, DOI 10.3382/ps.2011-01656; Xu HT, 2006, FEBS LETT, V580, P3610, DOI 10.1016/j.febslet.2006.05.044; Yang H, 2012, MOL CELL BIOCHEM, V360, P347, DOI 10.1007/s11010-011-1074-0; Yang N, 2008, CANCER RES, V68, P10307, DOI 10.1158/0008-5472.CAN-08-1954	34	7	8	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51724	10.1371/journal.pone.0051724	http://dx.doi.org/10.1371/journal.pone.0051724			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284755	Green Submitted, Green Published, gold			2022-12-27	WOS:000312694300037
J	Huerga, H; Varaine, F; Okwaro, E; Bastard, M; Ardizzoni, E; Sitienei, J; Chakaya, J; Bonnet, M				Huerga, Helena; Varaine, Francis; Okwaro, Eric; Bastard, Mathieu; Ardizzoni, Elisa; Sitienei, Joseph; Chakaya, Jeremiah; Bonnet, Maryline			Performance of the 2007 WHO Algorithm to Diagnose Smear-Negative Pulmonary Tuberculosis in a HIV Prevalent Setting	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; FLUORESCENCE MICROSCOPY; COST-EFFECTIVENESS; CULTURE; IMPLEMENTATION; INFECTION; COUNTRY; PEOPLE; UGANDA; MEDIA	Background: The 2007 WHO algorithm for diagnosis of smear-negative pulmonary tuberculosis (PTB) including Mycobacterium tuberculosis (MTB) culture was evaluated in a HIV prevalent area of Kenya. Methods: PTB smear-negative adult suspects were included in a prospective diagnostic study (2009-2011). In addition, program data (2008-2009) were retrospectively analysed. At the first consultation, clinical examination, chest X-ray, and sputum culture (Thin-Layer-Agar and Lowenstein-Jensen) were performed. Patients not started on TB treatment were clinically re-assessed after antibiotic course. The algorithm performance was calculated using culture as reference standard. Results: 380 patients were included prospectively and 406 analyzed retrospectively. Culture was positive for MTB in 17.5% (61/348) and 21.8% (72/330) of cases. Sensitivity of the clinical-radiological algorithm was 55.0% and 31.9% in the prospective study and the program data analysis, respectively. Specificity, positive and negative predictive values were 72.9%, 29.7% and 88.6% in the prospective study and 79.8%, 30.7% and 80.8% in the program data analysis. Performing culture increased the number of confirmed TB patients started on treatment by 43.3% in the prospective study and by 44.4% in the program data analysis. Median time to treatment of confirmed TB patients was 6 days in the prospective study and 27 days in the retrospective study. Inter-reader agreement for X-ray interpretation between the study clinician and a radiologist was low (Kappa coefficient = 0.11, 95%CI: 0.09-0.12). In a multivariate logistic analysis, past TB history, number of symptoms and signs at the clinical exam were independently associated with risk of overtreatment. Conclusion: The clinical-radiological algorithm is suboptimal to diagnose smear-negative PTB. Culture increases significantly the proportion of confirmed TB cases started on treatment. Better access to rapid MTB culture and development of new diagnostic tests is necessary.	[Huerga, Helena; Bastard, Mathieu; Bonnet, Maryline] Epictr, Dept Clin Res, Paris, France; [Varaine, Francis; Ardizzoni, Elisa] Med Sans Frontieres, Dept Med, Paris, France; [Okwaro, Eric] Med Sans Frontieres, Dist Hosp Lab, Homa Bay, Kenya; [Ardizzoni, Elisa] Inst Trop Med, Mycobacteriol Unit, B-2000 Antwerp, Belgium; [Sitienei, Joseph] Minist Hlth, Div Leprosy TB & Lung Dis, Nairobi, Kenya; [Chakaya, Jeremiah] Kenya Govt Med Res Ctr, Ctr Resp Dis Res, Nairobi, Kenya	Doctors Without Borders; Sanofi-Aventis; Sanofi France; Institute of Tropical Medicine (ITM); Kenya Medical Research Institute	Huerga, H (corresponding author), Epictr, Dept Clin Res, Paris, France.	helena.huerga@epicentre.msf.org			Medecins Sans Frontieres	Medecins Sans Frontieres	This work was supported by Medecins Sans Frontieres. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. However, some of the co-investigators and authors of this study work for this institution.	Bah B, 2002, INT J TUBERC LUNG D, V6, P592; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488; Cattamanchi A, 2009, INT J TUBERC LUNG D, V13, P1130; Chihota VN, 2010, INT J TUBERC LUNG D, V14, P1024; Colebunders R, 2000, INT J TUBERC LUNG D, V4, P97; Davis JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009859; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Hepple P, 2011, INT J TUBERC LUNG D, V15, P405; Kivihya-Ndugga LEA, 2003, INT J TUBERC LUNG D, V7, P1163; Koole O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018502; Kudjawu Y, 2006, INT J TUBERC LUNG D, V10, P441; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Martin A, 2009, J CLIN MICROBIOL, V47, P2632, DOI 10.1128/JCM.00264-09; Martin A, 2009, J MICROBIOL METH, V78, P107, DOI 10.1016/j.mimet.2009.05.001; Mejia GI, 1999, INT J TUBERC LUNG D, V3, P138; Mejía Gloria Isabel, 2004, Biomed., V24, P52; Ministry of Public Health and Sanitation, 2009, GUID MAN LEPR TUB; Mueller DH, 2008, INT J TUBERC LUNG D, V12, P1196; Nackers F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032140; Pardini M, 2007, J CLIN MICROBIOL, V45, P575, DOI 10.1128/JCM.01985-06; Rishi S, 2007, Indian J Med Microbiol, V25, P383; Robledo JA, 2006, INT J TUBERC LUNG D, V10, P613; Saranchuk P, 2007, SAMJ S AFR MED J, V97, P517; Satti L, 2010, INT J TUBERC LUNG D, V14, P1354; Siddiqi K, 2006, TROP MED INT HEALTH, V11, P323, DOI 10.1111/j.1365-3156.2006.01559.x; Soto A, 2009, INT J INFECT DIS, V13, P40, DOI 10.1016/j.ijid.2008.03.023; Soto A, 2011, TROP MED INT HEALTH, V16, P424, DOI 10.1111/j.1365-3156.2010.02715.x; Swai Hedwiga F, 2011, BMC Res Notes, V4, P475, DOI 10.1186/1756-0500-4-475; Tamhane A, 2009, INT J TUBERC LUNG D, V13, P347; van Cleeff MRA, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-111; Walley J, 2011, JAIDS-J ACQ IMM DEF, V57, pE93, DOI 10.1097/QAI.0b013e3182243a8c; WHO, 1998, LAB SERV TUB CONTR 2; WHO, 2012, TUB DIAGN XPERT MTB; WHO, 2007, IMPR DIAGN TREATM SM; Wilkinson D, 2000, INT J TUBERC LUNG D, V4, P513; Wilson D, 2011, INT J TUBERC LUNG D, V15, P919, DOI 10.5588/ijtld.10.0440; World Health Organization, 2010, REP CONCL REC STRAT	38	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51336	10.1371/journal.pone.0051336	http://dx.doi.org/10.1371/journal.pone.0051336			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284681	Green Submitted, Green Published, gold			2022-12-27	WOS:000312694300019
J	O'Gorman, EJ; Hone, DWE				O'Gorman, Eoin J.; Hone, David W. E.			Body Size Distribution of the Dinosaurs	PLOS ONE			English	Article							GROWTH-RATES; EVOLUTION; SAUROPOD; MASS; MAMMALS; WEIGHT; LENGTH; ALLOMETRIES; DIVERSITY; PATTERNS	The distribution of species body size is critically important for determining resource use within a group or clade. It is widely known that non-avian dinosaurs were the largest creatures to roam the Earth. There is, however, little understanding of how maximum species body size was distributed among the dinosaurs. Do they share a similar distribution to modern day vertebrate groups in spite of their large size, or did they exhibit fundamentally different distributions due to unique evolutionary pressures and adaptations? Here, we address this question by comparing the distribution of maximum species body size for dinosaurs to an extensive set of extant and extinct vertebrate groups. We also examine the body size distribution of dinosaurs by various sub-groups, time periods and formations. We find that dinosaurs exhibit a strong skew towards larger species, in direct contrast to modern day vertebrates. This pattern is not solely an artefact of bias in the fossil record, as demonstrated by contrasting distributions in two major extinct groups and supports the hypothesis that dinosaurs exhibited a fundamentally different life history strategy to other terrestrial vertebrates. A disparity in the size distribution of the herbivorous Ornithischia and Sauropodomorpha and the largely carnivorous Theropoda suggests that this pattern may have been a product of a divergence in evolutionary strategies: herbivorous dinosaurs rapidly evolved large size to escape predation by carnivores and maximise digestive efficiency; carnivores had sufficient resources among juvenile dinosaurs and non-dinosaurian prey to achieve optimal success at smaller body size.	[O'Gorman, Eoin J.; Hone, David W. E.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [O'Gorman, Eoin J.; Hone, David W. E.] Univ Coll Dublin, Sch Biol & Environm Sci, Sci Ctr W, Dublin 2, Ireland	University of London; Queen Mary University London; University College Dublin	O'Gorman, EJ (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	e.ogorman@qmul.ac.uk; d.hone@qmul.ac.uk	O'Gorman, Eoin J/I-6744-2012; Benton, Michael J/A-5639-2008	O'Gorman, Eoin J/0000-0003-4507-5690; Benton, Michael J/0000-0002-4323-1824	North American Electric Reliability Corporation [NE/I009280/1]	North American Electric Reliability Corporation	EJO was funded by the Irish Research Council for Science Engineering and Technology's EMPOWER initiative when this work was carried out and is now a North American Electric Reliability Corporation funded Postdoctoral Research Fellow on grant NE/I009280/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RM, 1998, PALAEONTOLOGY, V41, P1231; ALROY J, 2008, PALEOBIOLOGY DATABAS, V3; ANDERSON JF, 1985, J ZOOL, V207, P53, DOI 10.1111/j.1469-7998.1985.tb04915.x; Bakker VJ, 2000, ECOLOGY, V81, P3530, DOI 10.1890/0012-9658(2000)081[3530:SDPIBS]2.0.CO;2; BARTHOLOMAI A, 1981, Memoirs of the Queensland Museum, V20, P319; Bates KT, 2009, PALAEONTOL ELECTRON, V12; BLACKBURN TM, 1994, OIKOS, V70, P127, DOI 10.2307/3545707; Bonaparte J.F., 1990, NATURAL HIST MUSEUM, V416, P1; Borsuk-Biatynicka M., 1977, Palaeontologia Polonica, V37, P5; Brochu CA, 2003, J VERTEBR PALEONTOL, V22; Brown CM, PALAEOGEOGRAPHY PALA; BROWN JH, 1993, AM NAT, V142, P573, DOI 10.1086/285558; Buffetaut E, 2002, C R PALEVOL, V1, P103, DOI 10.1016/S1631-0683(02)00019-2; Burness GP, 2001, P NATL ACAD SCI USA, V98, P14518, DOI 10.1073/pnas.251548698; Campione NE, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-60; CARPENTER K, 1984, CAN J EARTH SCI, V21, P1491, DOI 10.1139/e84-154; Carrano MT, 2001, J ZOOL, V254, P41, DOI 10.1017/S0952836901000541; Carrano MT, 2005, AMNIOTE PALEOBIOLOGY, P225; CAUGHLEY G, 1987, OECOLOGIA, V74, P319, DOI 10.1007/BF00379377; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Christiansen P., 2004, Historical Biology, V16, P85, DOI 10.1080/08912960412331284313; Chrtstiansen P, 1999, J VERTEBR PALEONTOL, V19, P666, DOI 10.1080/02724634.1999.10011180; Clauset A, 2008, SCIENCE, V321, P399, DOI 10.1126/science.1157534; Codron D, 2012, BIOL LETTERS, V8, P620, DOI 10.1098/rsbl.2012.0240; Cooper LN, 2008, P ROY SOC B-BIOL SCI, V275, P2609, DOI 10.1098/rspb.2008.0912; CORIA RA, 1995, NATURE, V377, P224, DOI 10.1038/377224a0; Coria RA, 1996, J VERTEBR PALEONTOL, V16, P445, DOI 10.1080/02724634.1996.10011333; Currie PJ, 1993, PEOPLES REPUBLIC CHI, V30, P2037; DEMMENT MW, 1982, AFR J ECOL, V20, P43, DOI 10.1111/j.1365-2028.1982.tb01082.x; DEMMENT MW, 1985, AM NAT, V125, P641, DOI 10.1086/284369; Dong Zhiming, 1990, P255; Dunning J., 2008, CRC HDB AVIAN BODY M, V2nd; Elgin RA, PTEROSAURIA IN PRESS; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Farlow JO, 2005, J VERTEBR PALEONTOL, V25, P354, DOI 10.1671/0272-4634(2005)025[0354:FDABSO]2.0.CO;2; Froese R., 2012, FISHBASE; Galton P. M., 1997, COMPLETE DINOSAUR, P291; Galton PM., 1974, B BRIT MUS NAT HIS A, V25, P1; Gardezi T, 1999, AM NAT, V153, P110, DOI 10.1086/303150; Gaston K.J., 2000, PATTERN PROCESS MACR, DOI [10.1002/9780470999592, DOI 10.1002/9780470999592]; GASTON KJ, 1995, IBIS, V137, P237, DOI 10.1111/j.1474-919X.1995.tb03245.x; Gatton P. M., 1970, J. Paleont., V44, P464; Gilmore CW., 1920, B US NATL MUSEUM, V110, P1, DOI [10.5479/si.03629236.110.i, DOI 10.5479/SI.03629236.110.I]; Godefroit Pascal, 1998, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V68, P3; Greer AE, 2001, J HERPETOL, V35, P383, DOI 10.2307/1565956; Guyer C., 2011, COSAM COLLECTIONS RE; Hatcher JB., 1901, MEM CARNEGIE MUS, V1, P1, DOI [10.5962/p.234818, DOI 10.5962/P.234818]; Henderson DM, 2004, P ROY SOC B-BIOL SCI, V271, pS180, DOI 10.1098/rsbl.2003.0136; Henderson DM, 1999, PALEOBIOLOGY, V25, P88; Henderson DM, 2006, J VERTEBR PALEONTOL, V26, P907, DOI 10.1671/0272-4634(2006)26[907:BGCOMS]2.0.CO;2; Hoare JM, 2006, ANIM CONSERV, V9, P456, DOI 10.1111/j.1469-1795.2006.00061.x; HOLLING CS, 1992, ECOL MONOGR, V62, P447, DOI 10.2307/2937313; Hone DWE, 2010, LETHAIA, V43, P232, DOI 10.1111/j.1502-3931.2009.00187.x; Hone DWE, 2005, TRENDS ECOL EVOL, V20, P4, DOI 10.1016/j.tree.2004.10.012; Horner JR, 2000, ANNU REV EARTH PL SC, V28, P19, DOI 10.1146/annurev.earth.28.1.19; Hummel J, 2008, P ROY SOC B-BIOL SCI, V275, P1015, DOI 10.1098/rspb.2007.1728; Joanes DN, 1998, J ROY STAT SOC D-STA, V47, P183; Jones KE, 1997, FUNCT ECOL, V11, P751, DOI 10.1046/j.1365-2435.1997.00149.x; Kindlmann P, 1999, AM NAT, V153, P445, DOI 10.1086/303180; KLEIBER M, 1947, PHYSIOL REV, V27, P511, DOI 10.1152/physrev.1947.27.4.511; KOCH CF, 1978, PALEOBIOLOGY, V4, P367, DOI 10.1017/S0094837300006060; Kozlowski J, 2002, FUNCT ECOL, V16, P419, DOI 10.1046/j.1365-2435.2002.00646.x; Kozlowski J, 1997, AM NAT, V149, P352; Kurzanov S.M., 1987, T SOVMESTNOI SOVETSK, V31, P1; Lehman TM, 2008, PALEOBIOLOGY, V34, P264, DOI 10.1666/0094-8373(2008)034[0264:MGRFSD]2.0.CO;2; Mallison H, 2010, SWISS J GEOSCIENCE, V103; Manly BFJ, 1996, ECOLOGY, V77, P81, DOI 10.2307/2265657; MAURER BA, 1992, EVOLUTION, V46, P939, DOI 10.1111/j.1558-5646.1992.tb00611.x; Maurer BA, 1998, EVOL ECOL, V12, P925, DOI 10.1023/A:1006512121434; MAURER BA, 1988, ECOLOGY, V69, P1923, DOI 10.2307/1941169; MAZZETTA G. V., 2004, HIST BIOL, V16, P1; McIntosh John S., 1997, P264; McKinney M.L., 1990, P75; Meiri S, 2010, J ZOOL, V281, P218, DOI 10.1111/j.1469-7998.2010.00696.x; Meiri S, 2008, GLOBAL ECOL BIOGEOGR, V17, P724, DOI 10.1111/j.1466-8238.2008.00414.x; Moore JA, 2007, BIOL CONSERV, V135, P181, DOI 10.1016/j.biocon.2006.10.029; MORSE DR, 1985, NATURE, V314, P731, DOI 10.1038/314731a0; NORMAN D B, 1980, Institut Royal des Sciences Naturelles de Belgique Memoires, P1; Ostrom J.H., 1986, Zitteliana, V14, P111; Paul G., 1988, PREDATORY DINOSAURS; Paul Gregory S., 1997, P129; Paul GS, 1990, ENCY DINOSAURS, P58; PECZKIS J, 1994, J VERTEBR PALEONTOL, V14, P520; Petchey OL, 2008, P NATL ACAD SCI USA, V105, P4191, DOI 10.1073/pnas.0710672105; POUGH FH, 1980, AM NAT, V115, P92, DOI 10.1086/283547; Riggs ES, 1903, AM J SCI, V15, P299; SALGADO L, 1991, Ameghiniana, V28, P333; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Seebacher F, 2001, J VERTEBR PALEONTOL, V21, P51, DOI 10.1671/0272-4634(2001)021[0051:ANMTCA]2.0.CO;2; Sereno P.C., 1990, P203, DOI 10.1017/CBO9780511608377.018; Sereno PC, 1999, SCIENCE, V286, P1342, DOI 10.1126/science.286.5443.1342; SERENO PC, 1993, NATURE, V361, P64, DOI 10.1038/361064a0; SERENO PC, 1994, SCIENCE, V266, P267, DOI 10.1126/science.266.5183.267; Sereno PC, 1996, SCIENCE, V272, P986, DOI 10.1126/science.272.5264.986; Siemann E, 1999, ECOLOGY, V80, P2788, DOI 10.2307/177258; SILVERMAN BW, 1981, J ROY STAT SOC B MET, V43, P97; Smith FA, 2003, ECOLOGY, V84, P3403, DOI 10.1890/02-9003; Sookias RB, P ROYAL SOC LONDON B; Speakman JR, 2011, INTEGR COMP BIOL, V51, pE130; Symonds MRE, 1999, FUNCT ECOL, V13, P508, DOI 10.1046/j.1365-2435.1999.00340.x; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Van Heerden J, 1997, COMPLETE DINOSAUR, P330; Varricchio DJ, 2011, HIST BIOL, V23, P91, DOI 10.1080/08912963.2010.500379; Witton Mark P., 2008, Zitteliana Reihe B, V28, P143; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005; Yates Adam M., 2004, Postilla, V230, P1; Zhou S.W, 1984, MIDDLE JURASSIC DINO	108	55	56	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51925	10.1371/journal.pone.0051925	http://dx.doi.org/10.1371/journal.pone.0051925			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284818	Green Published, gold, Green Accepted			2022-12-27	WOS:000312694300058
J	Pena-Gomez, C; Sole-Padulles, C; Clemente, IC; Junque, C; Bargallo, N; Bosch, B; Molinuevo, JL; Valls-Sole, J; Pascual-Leone, A; Bartres-Faz, D				Pena-Gomez, Cleofe; Sole-Padulles, Cristina; Clemente, Imma C.; Junque, Carme; Bargallo, Nuria; Bosch, Beatriz; Luis Molinuevo, Jose; Valls-Sole, Josep; Pascual-Leone, Alvaro; Bartres-Faz, David			APOE Status Modulates the Changes in Network Connectivity Induced by Brain Stimulation in Non-Demented Elders	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; INDEPENDENT COMPONENT ANALYSIS; DEFAULT-MODE NETWORK; ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; LIFE-SPAN; CEREBRAL-CORTEX; FUNCTIONAL MRI; CORTICAL PLASTICITY; MEMORY DYSFUNCTION	Behavioral consequences of a brain insult represent an interaction between the injury and the capacity of the rest of the brain to adapt to it. We provide experimental support for the notion that genetic factors play a critical role in such adaptation. We induced a controlled brain disruption using repetitive transcranial magnetic stimulation (rTMS) and show that APOE status determines its impact on distributed brain networks as assessed by functional MRI (fMRI). Twenty non-demented elders exhibiting mild memory dysfunction underwent two fMRI studies during face-name encoding tasks (before and after rTMS). Baseline task performance was associated with activation of a network of brain regions in prefrontal, parietal, medial temporal and visual associative areas. APOE epsilon 4 bearers exhibited this pattern in two separate independent components, whereas epsilon 4-non carriers presented a single partially overlapping network. Following rTMS all subjects showed slight ameliorations in memory performance, regardless of APOE status. However, after rTMS APOE epsilon 4-carriers showed significant changes in brain network activation, expressing strikingly similar spatial configuration as the one observed in the non-carrier group prior to stimulation. Similarly, activity in areas of the default-mode network (DMN) was found in a single component among the epsilon 4-non bearers, whereas among carriers it appeared disaggregated in three distinct spatiotemporal components that changed to an integrated single component after rTMS. Our findings demonstrate that genetic background play a fundamental role in the brain responses to focal insults, conditioning expression of distinct brain networks to sustain similar cognitive performance.	[Pena-Gomez, Cleofe; Clemente, Imma C.; Junque, Carme; Bartres-Faz, David] Univ Barcelona, Dept Psiquiatria & Psicobiol Clin, Barcelona, Catalonia, Spain; [Sole-Padulles, Cristina; Bosch, Beatriz; Luis Molinuevo, Jose] Hosp Clin Barcelona, Serv Neurol, Unitat Alzheimer & Altres Trastorns Cognitius, Barcelona, Catalonia, Spain; [Clemente, Imma C.; Bartres-Faz, David] Inst Recerca Cervell Cognicio & Conducta, Barcelona, Catalonia, Spain; [Junque, Carme; Bargallo, Nuria; Bosch, Beatriz; Luis Molinuevo, Jose] Inst Invest Biomed August Pi & Sunyer, Barcelona, Catalonia, Spain; [Bargallo, Nuria] Ctr Diagnost Imatge, Serv Radiol, Seccio Neuroradiol, Barcelona, Catalonia, Spain; [Valls-Sole, Josep] Hosp Clin Barcelona, Serv Neuroradiol, Lab Explorac Neurofunc, Barcelona, Catalonia, Spain; [Pascual-Leone, Alvaro] Beth Israel Deaconess Med Ctr, Berenson Allen Ctr Noninvas Brain Stimulat, Boston, MA 02215 USA; [Pascual-Leone, Alvaro] Harvard Univ, Sch Med, Boston, MA USA	University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Bartres-Faz, D (corresponding author), Univ Barcelona, Dept Psiquiatria & Psicobiol Clin, Barcelona, Catalonia, Spain.	dbartres@ub.edu	Solé-Padullés, Cristina/K-6984-2017; Bartres-Faz, David/C-8997-2011; Clemente, I Concepcion/H-5399-2013; Bargallo, Nuria/G-6854-2016; Junque, Carme/B-4400-2011; Pascual-Leone, Alvaro/AAC-5101-2019; Molinuevo, Jose Luis/HCH-3881-2022	Solé-Padullés, Cristina/0000-0002-6653-1053; Bartres-Faz, David/0000-0001-6020-4118; Clemente, I Concepcion/0000-0003-0728-0925; Bargallo, Nuria/0000-0001-6284-5402; Junque, Carme/0000-0002-6381-3063; Pascual-Leone, Alvaro/0000-0001-8975-0382; Molinuevo, Jose Luis/0000-0003-0485-6001; Bosch, Beatriz/0000-0002-6094-0024	Spanish Ministerio de Educacion y Ciencia [SAF2007-66270]; Spanish Ministerio de Ciencia e Innovacion [SAF2009-07489]; Generalitat de Catalunya [2009SGR941]; Ajuts al Personal Investigador en Formacio APIF-UB grant from the University of Barcelona; CONSOLIDER-Ingenio program [CSD2010-00045]; National Institutes of Health [K24 RR018875, RO1-NS 20068, R01-EB 005047]; Harvard Clinical and Translational Science Center, from the National Center for Research Resources [UL1 RR025758-]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758, K24RR018875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005047] Funding Source: NIH RePORTER	Spanish Ministerio de Educacion y Ciencia(Spanish Government); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Ajuts al Personal Investigador en Formacio APIF-UB grant from the University of Barcelona; CONSOLIDER-Ingenio program(Spanish Government); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Clinical and Translational Science Center, from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Partially funded by a Spanish Ministerio de Educacion y Ciencia research project award (SAF2007-66270) and the Spanish Ministerio de Ciencia e Innovacion (SAF2009-07489) to DB-F and fundings from the Generalitat de Catalunya to the Neuropsychology Research Group (2009SGR941). CP-G was funded by a Ajuts al Personal Investigador en Formacio APIF-UB grant from the University of Barcelona. JLM was funded through a CONSOLIDER-Ingenio program 2010: CSD2010-00045). APL was supported in part by grants from the National Institutes of Health (K24 RR018875, RO1-NS 20068, R01-EB 005047), and Grant Number UL1 RR025758- Harvard Clinical and Translational Science Center, from the National Center for Research Resources. The funders had no role in study design, data colllection and analysis, decision to publish, or preparation of the manuscript.	Abele M, 1997, BRAIN, V120, P2141, DOI 10.1093/brain/120.12.2141; Adamson MM, 2011, NEUROPSYCHOLOGIA, V49, P2448, DOI 10.1016/j.neuropsychologia.2011.04.022; Bartres-Faz D, 2008, NEUROBIOL AGING, V29, P1644, DOI 10.1016/j.neurobiolaging.2007.04.021; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bero AW, 2011, NAT NEUROSCI, V14, P750, DOI 10.1038/nn.2801; Bondi MW, 2005, NEUROLOGY, V64, P501, DOI 10.1212/01.WNL.0000150885.00929.7E; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Cheeran B, 2008, J PHYSIOL-LONDON, V586, P5717, DOI 10.1113/jphysiol.2008.159905; Chen Y, 2010, P NATL ACAD SCI USA, V107, P12011, DOI 10.1073/pnas.0914984107; Dennis NA, 2010, ALZHEIMERS DEMENT, V6, P303, DOI 10.1016/j.jalz.2009.07.003; Filippini N, 2011, NEUROIMAGE, V54, P602, DOI 10.1016/j.neuroimage.2010.08.009; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fleisher AS, 2005, ARCH NEUROL-CHICAGO, V62, P1881, DOI 10.1001/archneur.62.12.1881; Fox MD, 2012, NEUROIMAGE; Glahn DC, 2010, P NATL ACAD SCI USA, V107, P1223, DOI 10.1073/pnas.0909969107; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Han SD, 2008, ALZHEIMERS DEMENT, V4, P251, DOI 10.1016/j.jalz.2008.02.006; Han SD, 2007, NEUROBIOL AGING, V28, P238, DOI 10.1016/j.neurobiolaging.2005.12.013; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; He BJ, 2007, CURR OPIN NEUROL, V20, P655, DOI 10.1097/WCO.0b013e3282f1c720; Jones DT, 2011, NEUROLOGY, V77, P1524, DOI 10.1212/WNL.0b013e318233b33d; Kleim JA, 2006, NAT NEUROSCI, V9, P735, DOI 10.1038/nn1699; Lind J, 2006, BRAIN, V129, P1240, DOI 10.1093/brain/awl054; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Meyer-Lindenberg A, 2009, HUM BRAIN MAPP, V30, P1938, DOI 10.1002/hbm.20639; Morris JC, 2010, ANN NEUROL, V67, P122, DOI 10.1002/ana.21843; Palop JJ, 2010, NEUROMOL MED, V12, P48, DOI 10.1007/s12017-009-8097-7; Park DC, 2004, P NATL ACAD SCI USA, V101, P13091, DOI 10.1073/pnas.0405148101; Park J, 2012, J NEUROSCI, V32, P2154, DOI 10.1523/JNEUROSCI.4494-11.2012; Pascual-Leone A, 1999, PHILOS T R SOC B, V354, P1229, DOI 10.1098/rstb.1999.0476; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; Pascual-Leone A, 2011, BRAIN TOPOGR, V24, P302, DOI 10.1007/s10548-011-0196-8; Persson J, 2008, NEUROPSYCHOLOGIA, V46, P1679, DOI 10.1016/j.neuropsychologia.2008.01.026; Petrella JR, 2008, RADIOLOGY, V246, P20, DOI 10.1148/radiol.2461061994; Pihlajamaki M, 2010, ALZ DIS ASSOC DIS, V24, P28, DOI 10.1097/WAD.0b013e3181a785c9; Popp J, 2010, J ALZHEIMERS DIS, V22, P459, DOI 10.3233/JAD-2010-100561; Prakash RS, 2012, BEHAV BRAIN RES, V230, P192, DOI 10.1016/j.bbr.2012.01.058; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rami L, 2012, J ALZHEIMERS DIS; Rasetti R, 2011, CURR OPIN GENET DEV, V21, P340, DOI 10.1016/j.gde.2011.02.003; RISSANEN J, 1983, ANN STAT, V11, P416, DOI 10.1214/aos/1176346150; Rosas HD, 2002, NEUROLOGY, V58, P695, DOI 10.1212/WNL.58.5.695; Sala-Llonch R, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00152; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Schwenkreis P, 2002, BRAIN, V125, P301, DOI 10.1093/brain/awf023; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Sheline YI, 2010, BIOL PSYCHIAT, V67, P584, DOI 10.1016/j.biopsych.2009.08.024; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Smith CD, 2002, NEUROLOGY, V58, P1197, DOI 10.1212/WNL.58.8.1197; Sole-Padulles C, 2006, CEREB CORTEX, V16, P1487, DOI 10.1093/cercor/bhj083; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Sperling RA, 2003, J NEUROL NEUROSUR PS, V74, P44, DOI 10.1136/jnnp.74.1.44; Sperling RA, 2001, HUM BRAIN MAPP, V14, P129, DOI 10.1002/hbm.1047; Sperling RA, 2009, NEURON, V63, P178, DOI 10.1016/j.neuron.2009.07.003; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Stagg CJ, 2010, RESTOR NEUROL NEUROS, V28, P425, DOI 10.3233/RNN-2010-0553; Sternang O, 2011, BIOL PSYCHIAT, V70, P109, DOI 10.1016/j.biopsych.2011.05.023; Trachtenberg AJ, 2012, NEUROBIOL AGING, V33, P323, DOI 10.1016/j.neurobiolaging.2010.03.009; Vaishnavi SN, 2010, P NATL ACAD SCI USA, V107, P17757, DOI 10.1073/pnas.1010459107; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; Walsh V, 2003, TMS COGNITIVE SCI NE; WENHAM PR, 1991, LANCET, V337, P1158, DOI 10.1016/0140-6736(91)92823-K; Wierenga CE, 2010, NEUROIMAGE, V51, P1222, DOI 10.1016/j.neuroimage.2010.03.021; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028; Winner B, 2004, ARCH NEUROL-CHICAGO, V61, P117, DOI 10.1001/archneur.61.1.117; Zanardi R, 2007, EUR NEUROPSYCHOPHARM, V17, P651, DOI 10.1016/j.euroneuro.2007.03.008; Zhou J, 2012, NEURON, V73, P1216, DOI 10.1016/j.neuron.2012.03.004	77	32	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51833	10.1371/journal.pone.0051833	http://dx.doi.org/10.1371/journal.pone.0051833			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284783	gold, Green Submitted, Green Published			2022-12-27	WOS:000312694300049
J	Shechter, A; Lesperance, P; Kin, NMKNY; Boivin, DB				Shechter, Ari; Lesperance, Paul; Kin, N. M. K. Ng Ying; Boivin, Diane B.			Pilot Investigation of the Circadian Plasma Melatonin Rhythm across the Menstrual Cycle in a Small Group of Women with Premenstrual Dysphoric Disorder	PLOS ONE			English	Article							BRIGHT-LIGHT; SLEEP-DEPRIVATION; CLOCK GENES; PHASE; MOOD; SEROTONIN; THERAPY; AMPLITUDE; CORTISOL; RECEPTOR	Women with premenstrual dysphoric disorder (PMDD) experience mood deterioration and altered circadian rhythms during the luteal phase (LP) of their menstrual cycles. Disturbed circadian rhythms may be involved in the development of clinical mood states, though this relationship is not fully characterized in PMDD. We therefore conducted an extensive chronobiological characterization of the melatonin rhythm in a small group of PMDD women and female controls. In this pilot study, participants included five women with PMDD and five age-matched controls with no evidence of menstrual-related mood disorders. Participants underwent two 24-hour laboratory visits, during the follicular phase (FP) and LP of the menstrual cycle, consisting of intensive physiological monitoring under "unmasked", time-isolation conditions. Measures included visual analogue scale for mood, ovarian hormones, and 24-hour plasma melatonin. Mood significantly (P <=.03) worsened during LP in PMDD compared to FP and controls. Progesterone was significantly (P=.025) increased during LP compared to FP, with no between-group differences. Compared to controls, PMDD women had significantly (P<.05) decreased melatonin at circadian phases spanning the biological night during both menstrual phases and reduced amplitude of its circadian rhythm during LP. PMDD women also had reduced area under the curve of melatonin during LP compared to FP. PMDD women showed affected circadian melatonin rhythms, with reduced nocturnal secretion and amplitude during the symptomatic phase compared to controls. Despite our small sample size, these pilot findings support a role for disturbed circadian rhythms in affective disorders. Possible associations with disrupted serotonergic transmission are proposed.	[Shechter, Ari; Boivin, Diane B.] McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Ctr Study & Treatment Circadian Rhythms, Montreal, PQ, Canada; [Lesperance, Paul] Univ Montreal, Dept Psychiat, Ctr Hosp Univ Montre, Montreal, PQ H3C 3J7, Canada; [Kin, N. M. K. Ng Ying] McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Div Clin Res, Montreal, PQ, Canada	McGill University; Universite de Montreal; McGill University	Boivin, DB (corresponding author), McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Ctr Study & Treatment Circadian Rhythms, Montreal, PQ, Canada.	diane.boivin@douglas.mcgill.ca	Shechter, Ari/GXM-8324-2022	Shechter, Ari/0000-0001-8243-0247	Canadian Institutes of Health Research; Fonds de la recherche en sante du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This study was supported by an operating grant from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html). DBB was supported by a scholarship from the Fonds de la recherche en sante du Quebec (http://www.frsq.gouv.qc.ca/en/index.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDEGUNDE M, 1985, INT J NEUROSCI, V26, P9, DOI 10.3109/00207458508985598; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; ARMITAGE R, 2005, PRINCIPLES PRACTICE, P1266; ASHBY CR, 1988, BIOL PSYCHIAT, V24, P225, DOI 10.1016/0006-3223(88)90277-6; AXELROD J, 1974, SCIENCE, V184, P1341, DOI 10.1126/science.184.4144.1341; Baker FC, 2007, SLEEP, V30, P1283, DOI 10.1093/sleep/30.10.1283; Boivin DB, 1997, ARCH GEN PSYCHIAT, V54, P145; Boivin DB, 2000, J PSYCHIATR NEUROSCI, V25, P446; BROWN EN, 1992, J BIOL RHYTHM, V7, P177, DOI 10.1177/074873049200700301; BRZEZINSKI AA, 1990, OBSTET GYNECOL, V76, P296; Cain SW, 2010, J BIOL RHYTHM, V25, P288, DOI 10.1177/0748730410374943; CHILDS PA, 1995, BRIT J PSYCHIAT, V166, P196, DOI 10.1192/bjp.166.2.196; Clemett DA, 2000, NEUROPHARMACOLOGY, V39, P123, DOI 10.1016/S0028-3908(99)00086-6; De Berardis Domenico, 2007, Ther Clin Risk Manag, V3, P585; de Bodinat C, 2010, NAT REV DRUG DISCOV, V9, P628, DOI 10.1038/nrd3140; DEACON S, 1994, NEUROSCI LETT, V167, P191, DOI 10.1016/0304-3940(94)91059-6; Duffy JE, 2002, J BIOL RHYTHM, V17, P4, DOI 10.1177/074873002129002294; Germain A, 2008, HUM PSYCHOPHARM CLIN, V23, P571, DOI 10.1002/hup.964; GOLDEN RN, 1988, ARCH GEN PSYCHIAT, V45, P150; HARDIN TA, 1991, J PSYCHIAT RES, V25, P75, DOI 10.1016/0022-3956(91)90001-Q; Harris JA, 1918, P NATL ACAD SCI USA, V4, P370, DOI 10.1073/pnas.4.12.370; James FO, 2007, CHRONOBIOL INT, V24, P1009, DOI 10.1080/07420520701800736; James FO, 2007, SLEEP, V30, P1427, DOI 10.1093/sleep/30.11.1427; JEWETT ME, 1994, J BIOL RHYTHM, V9, P295, DOI 10.1177/074873049400900310; Jockers R, 2008, BRIT J PHARMACOL, V154, P1182, DOI 10.1038/bjp.2008.184; Kessler RC, 2003, J AFFECT DISORDERS, V74, P5, DOI 10.1016/S0165-0327(02)00426-3; Kripke Daniel F, 2009, J Circadian Rhythms, V7, P2, DOI 10.1186/1740-3391-7-2; Kruijver FPM, 2002, NEUROENDOCRINOLOGY, V75, P296, DOI 10.1159/000057339; Lam RW, 1999, PSYCHIAT RES, V86, P185, DOI 10.1016/S0165-1781(99)00043-8; Lamont EW, 2010, ISR J PSYCHIATR REL, V47, P27; Landen M, 2003, DEPRESS ANXIETY, V17, P122, DOI 10.1002/da.10089; Lopez-Gimenez JF, 2001, SYNAPSE, V42, P12, DOI 10.1002/syn.1095; McClung CA, 2007, PHARMACOL THERAPEUT, V114, P222, DOI 10.1016/j.pharmthera.2007.02.003; Miguez JM, 1995, J NEUROENDOCRINOL, V7, P949, DOI 10.1111/j.1365-2826.1995.tb00740.x; Parry BL, 2008, PSYCHIAT RES, V161, P76, DOI 10.1016/j.psychres.2007.11.017; PARRY BL, 1987, AM J PSYCHIAT, V144, P808; PARRY BL, 1989, AM J PSYCHIAT, V146, P1215; Parry BL, 1997, J BIOL RHYTHM, V12, P47, DOI 10.1177/074873049701200107; PARRY BL, 1995, AM J PSYCHIAT, V152, P404; PARRY BL, 1993, AM J PSYCHIAT, V150, P1417; Parry BL, 1997, J BIOL RHYTHM, V12, P443, DOI 10.1177/074873049701200506; PARRY BL, 1990, ARCH GEN PSYCHIAT, V47, P1139; Parry BL, 2001, CNS DRUGS, V15, P277, DOI 10.2165/00023210-200115040-00003; Parry BL, 2001, NEUROPSYCHOPHARMACOL, V25, pS102, DOI 10.1016/S0893-133X(01)00340-2; Rahman SA, 2010, EUR ARCH PSY CLIN N, V260, P327, DOI 10.1007/s00406-009-0080-7; RAPKIN AJ, 1987, OBSTET GYNECOL, V70, P533; Rapkin AJ, 1997, OBSTET GYNECOL, V90, P709, DOI 10.1016/S0029-7844(97)00417-1; Shah NR, 2008, OBSTET GYNECOL, V111, P1175, DOI 10.1097/AOG.0b013e31816fd73b; Shanahan TL, 1999, J BIOL RHYTHM, V14, P237, DOI 10.1177/074873099129000560; SHANAHAN TL, 1991, J CLIN ENDOCR METAB, V73, P227, DOI 10.1210/jcem-73-2-227; Shechter A, 2012, SLEEP MED, V13, P1071, DOI 10.1016/j.sleep.2012.05.012; Shechter A, 2010, SLEEP, V33, P647, DOI 10.1093/sleep/33.5.647; Shechter A, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/259345; SKENE DJ, 1994, BRIT J CLIN PHARMACO, V37, P181, DOI 10.1111/j.1365-2125.1994.tb04258.x; Steinberg S, 1999, BIOL PSYCHIAT, V45, P313, DOI 10.1016/S0006-3223(98)00005-5; Steiner M, 1999, J AFFECT DISORDERS, V53, P269, DOI 10.1016/S0165-0327(98)00121-9; STEINER M, 1995, NEW ENGL J MED, V332, P1529, DOI 10.1056/NEJM199506083322301; Steiner M, 2000, J PSYCHIATR NEUROSCI, V25, P459; THOMPSON C, 1985, BRIT J PSYCHIAT, V147, P389, DOI 10.1192/bjp.147.4.389; VACAS MI, 1979, NEUROENDOCRINOLOGY, V29, P84, DOI 10.1159/000122909	60	17	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51929	10.1371/journal.pone.0051929	http://dx.doi.org/10.1371/journal.pone.0051929			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284821	Green Published, gold, Green Submitted			2022-12-27	WOS:000312694300061
J	Basu, D; Reyes-Mugica, M; Rebbaa, A				Basu, Dipanjan; Reyes-Mugica, Miguel; Rebbaa, Abdelhadi			Role of the Beta Catenin Destruction Complex in Mediating Chemotherapy-Induced Senescence-Associated Secretory Phenotype	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; DRUG-RESISTANCE; ANTITUMOR-ACTIVITY; CANCER-TREATMENT; TUMOR-CELLS; INHIBITION; WNT; ACTIVATION; EXPRESSION; PROLIFERATION	Cellular senescence is considered as a tumor suppressive mechanism. Recent evidence indicates however that senescent cells secrete various growth factors and cytokines, some of which may paradoxically promote cancer progression. This phenomenon termed senescence-associated secretory phenotype (SASP) must be inhibited in order for anti-proliferative agents to be effective. The present study was designed to determine whether the beta-catenin destruction complex (BCDC), known to integrate the action of various growth factors and cytokines, would represent a suitable target to inhibit the activity of SASP components. For this, we carried out experiments to determine the effect of drug-induced senescence on secretion of SASP, beta-catenin transactivation, and the relationship between these processes. Moreover, genetic and pharmacological approaches were used to define the implication of BCDC in mediating the effects of SASP components on cell migration and resistance to drugs. The findings indicate that drug-induced senescence was associated with expression of various Wnt ligands in addition to previously known SASP components. Beta catenin transactivation and expression of genes implicated in epithelial-mesenchymal transition (EMT) also increased in response to drug-induced SASP. These effects were prevented by Pyrvinium, a recently described activator of BCDC. Pyrvinium also suppressed the effects of SASP on cell migration and resistance to doxorubicin. Together, these findings provide insights on the potential role of BCDC in mediating the effects of drug-induced SASP on cancer cell invasion and resistance to therapy, and suggest that targeting this pathway may represent an effective approach to enhance the activity of current and prospective anti-cancer therapeutics.	[Rebbaa, Abdelhadi] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA; UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rebbaa, A (corresponding author), Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA.	abr25@pitt.edu	Basu, Dipanjan/J-8043-2019; Reyes-Mugica, Miguel/C-2483-2008	Basu, Dipanjan/0000-0002-3083-2954; Reyes-Mugica, Miguel/0000-0001-5698-3702	University of Pittsburgh	University of Pittsburgh(University of Pittsburgh)	This work was supported by startup funds from the University of Pittsburgh. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiri-Kordestani L, 2012, DRUG RESIST UPDATE, V15, P50, DOI 10.1016/j.drup.2012.02.002; Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Canino C, 2011, ONCOGENE; Chang BD, 2002, P NATL ACAD SCI USA, V99, P389, DOI 10.1073/pnas.012602599; Chang BD, 1999, CANCER RES, V59, P3761; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Doble BW, 2007, CELLS TISSUES ORGANS, V185, P73, DOI 10.1159/000101306; Esumi H, 2004, CANCER SCI, V95, P685, DOI 10.1111/j.1349-7006.2004.tb03330.x; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Ji HT, 2009, MOL CELL, V36, P547, DOI 10.1016/j.molcel.2009.09.034; Jin TR, 2008, CELL SIGNAL, V20, P1697, DOI 10.1016/j.cellsig.2008.04.014; Kendziorra E, 2011, CARCINOGENESIS, V32, P1824, DOI 10.1093/carcin/bgr222; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Laberge RM, 2012, CANCER MICROENVIRON, V5, P39, DOI 10.1007/s12307-011-0069-4; Laberge RM, 2012, AGING CELL; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lim JC, 2008, J NEUROCHEM, V106, P1855, DOI 10.1111/j.1471-4159.2008.05537.x; Lyden D, 2011, CANC METASTASIS BIOL; Mirkin BL, 2005, ONCOGENE, V24, P4965, DOI 10.1038/sj.onc.1208671; Pazolli E, 2012, CANCER RES, V72, P2251, DOI 10.1158/0008-5472.CAN-11-3386; Rebbaa A, 2003, ONCOGENE, V22, P2805, DOI 10.1038/sj.onc.1206366; Rebbaa A, 2001, MOL MED, V7, P393, DOI 10.1007/BF03402185; Robles SJ, 1998, ONCOGENE, V16, P1113, DOI 10.1038/sj.onc.1201862; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Roninson IB, 2003, CANCER RES, V63, P2705; Sanchez-Tillo E, 2011, P NATL ACAD SCI USA, V108, P19204, DOI 10.1073/pnas.1108977108; Schmitt CA, 2007, BBA-REV CANCER, V1775, P5, DOI 10.1016/j.bbcan.2006.08.005; Shay JW, 2004, ONCOGENE, V23, P2919, DOI 10.1038/sj.onc.1207518; Tenbaum SP, 2012, NAT MED; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; Valvezan AJ, 2012, J BIOL CHEM, V287, P3823, DOI 10.1074/jbc.M111.323337; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; Yu DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003951; Zheng X, 2004, CANCER RES, V64, P1773, DOI 10.1158/0008-5472.CAN-03-0820	40	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52188	10.1371/journal.pone.0052188	http://dx.doi.org/10.1371/journal.pone.0052188			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272224	Green Published, Green Submitted, gold			2022-12-27	WOS:000312483300068
J	Lee, S; Lee, I; Jung, Y; McConkey, D; Czerniak, B				Lee, Sangkyou; Lee, Ilkyun; Jung, Yoonsuh; McConkey, David; Czerniak, Bogdan			In-Frame cDNA Library Combined with Protein Complementation Assay Identifies ARL11-Binding Partners	PLOS ONE			English	Article							PHOSPHOGLYCERATE MUTASE; BLADDER CARCINOGENESIS; 13-CIS-RETINOIC ACID; 2-HYBRID SYSTEM; FLUORESCENT PROTEINS; MESSENGER-RNAS; INTERACTOME; INHIBITION; CARCINOMA; CANCER	The cDNA expression libraries that produce correct proteins are essential in facilitating the identification of protein-protein interactions. The 5'-untranslated regions (UTRs) that are present in the majority of mammalian and non-mammalian genes are predicted to alter the expression of correct proteins from cDNA libraries. We developed a novel cDNA expression library from which 5'-UTRs were removed using a mixture of polymerase chain reaction primers that complement the Kozak sequences we refer to as an "in-frame cDNA library.'' We used this library with the protein complementation assay to identify two novel binding partners for ras-related ADP-ribosylation factor-like 11 (ARL11), cellular retinoic acid binding protein 2 (CRABP2), and phosphoglycerate mutase 1 (PGAM1). Thus, the in-frame cDNA library without 5'-UTRs we describe here increases the chance of correctly identifying protein interactions and will have wide applications in both mammalian and non-mammalian detection systems.	[Lee, Sangkyou; Lee, Ilkyun; Czerniak, Bogdan] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Jung, Yoonsuh] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [McConkey, David] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Czerniak, B (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA.	bczernia@mdanderson.org	Jung, Yoonsuh/A-1782-2015	Jung, Yoonsuh/0000-0002-1743-5049	National Institute of Health [R01 CA 151489]; GU SPORE Grant [P50 CA91846]; NATIONAL CANCER INSTITUTE [R01CA151489, P30CA016672, P50CA091846] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GU SPORE Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institute of Health Grants R01 CA 151489 (BC) and GU SPORE Grant P50 CA91846 (Project 1, BC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; BARTEL P, 1993, BIOTECHNIQUES, V14, P920; BECCI PJ, 1978, CANCER RES, V38, P4463; Bonetta L, 2010, NATURE, V468, P851, DOI [10.1038/468851a, 10.1038/468854a, 10.1038/468852a]; Burd CG, 2004, TRENDS CELL BIOL, V14, P687, DOI 10.1016/j.tcb.2004.10.004; Chen GA, 2003, P NATL ACAD SCI USA, V100, P13537, DOI 10.1073/pnas.2233850100; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; Dube DH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015648; Durany N, 2000, BRIT J CANCER, V82, P20; Evans DRH, 2004, BIOTECHNIQUES, V37, P840, DOI 10.2144/04375PT02; Fang MZ, 2004, CARCINOGENESIS, V25, P865, DOI 10.1093/carcin/bgh097; GRUBBS CJ, 1977, SCIENCE, V198, P743, DOI 10.1126/science.910158; Gupta A, 2006, CANCER RES, V66, P8100, DOI 10.1158/0008-5472.CAN-05-4519; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Huang H, 2007, PLOS COMPUT BIOL, V3, P2155, DOI 10.1371/journal.pcbi.0030214; Huang WD, 2001, BIOTECHNIQUES, V30, P94, DOI 10.2144/01301st06; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Lee S, 2007, P NATL ACAD SCI USA, V104, P13732, DOI 10.1073/pnas.0701771104; Lemmens I, 2010, J PROTEOMICS, V73, P1415, DOI 10.1016/j.jprot.2010.02.001; LIPPMAN SM, 1987, CANCER TREAT REP, V71, P391; Majewski T, 2008, LAB INVEST, V88, P694, DOI 10.1038/labinvest.2008.27; Michnick SW, 2007, NAT REV DRUG DISCOV, V6, P569, DOI 10.1038/nrd2311; Nguyen AW, 2005, NAT BIOTECHNOL, V23, P355, DOI 10.1038/nbt1066; Ren FL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-81; Sabichi Anita L., 1998, Current Opinion in Oncology, V10, P479, DOI 10.1097/00001622-199809000-00019; Sessler RJ, 2005, MOL CELL, V18, P343, DOI 10.1016/j.molcel.2005.03.026; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; SPORN MB, 1977, SCIENCE, V195, P487, DOI 10.1126/science.835006; Stellberger Thorsten, 2010, Proteome Sci, V8, P8, DOI 10.1186/1477-5956-8-8; THOMPSON HJ, 1981, CANCER RES, V41, P933; Turhani D, 2006, ELECTROPHORESIS, V27, P1417, DOI 10.1002/elps.200500510; Tyagi S, 2000, BIOCHEM BIOPH RES CO, V277, P589, DOI 10.1006/bbrc.2000.3720; Usuba T, 2001, INT J CANCER, V94, P662, DOI 10.1002/ijc.1524; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	36	2	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52290	10.1371/journal.pone.0052290	http://dx.doi.org/10.1371/journal.pone.0052290			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272234	gold, Green Published, Green Submitted			2022-12-27	WOS:000312483300076
J	Schemann, M; Kugler, EM; Buhner, S; Eastwood, C; Donovan, J; Jiang, W; Grundy, D				Schemann, Michael; Kugler, Eva Maria; Buhner, Sabine; Eastwood, Christopher; Donovan, Jemma; Jiang, Wen; Grundy, David			The Mast Cell Degranulator Compound 48/80 Directly Activates Neurons	PLOS ONE			English	Article							HISTAMINE-RELEASE; ENTERIC NEURONS; RAT-BRAIN; IN-VIVO; RECEPTORS; CALCIUM; AXIS; H-1	Background: Compound 48/80 is widely used in animal and tissue models as a "selective'' mast cell activator. With this study we demonstrate that compound 48/80 also directly activates enteric neurons and visceral afferents. Methodology/Principal Findings: We used in vivo recordings from extrinsic intestinal afferents together with Ca++ imaging from primary cultures of DRG and nodose neurons. Enteric neuronal activation was examined by Ca++ and voltage sensitive dye imaging in isolated gut preparations and primary cultures of enteric neurons. Intraluminal application of compound 48/80 evoked marked afferent firing which desensitized on subsequent administration. In egg albumen-sensitized animals, intraluminal antigen evoked a similar pattern of afferent activation which also desensitized on subsequent exposure to antigen. In cross-desensitization experiments prior administration of compound 48/80 failed to influence the mast cell mediated response. Application of 1 and 10 mu g/ml compound 48/80 evoked spike discharge and Ca++ transients in enteric neurons. The same nerve activating effect was observed in primary cultures of DRG and nodose ganglion cells. Enteric neuron cultures were devoid of mast cells confirmed by negative staining for c-kit or toluidine blue. In addition, in cultured enteric neurons the excitatory action of compound 48/80 was preserved in the presence of histamine H-1 and H-2 antagonists. The mast cell stabilizer cromolyn attenuated compound 48/80 and nicotine evoked Ca++ transients in mast cell-free enteric neuron cultures. Conclusions/Significance: The results showed direct excitatory action of compound 48/80 on enteric neurons and visceral afferents. Therefore, functional changes measured in tissue or animal models may involve a mast cell independent effect of compound 48/80 and cromolyn.	[Schemann, Michael; Kugler, Eva Maria; Buhner, Sabine] Tech Univ Munich, Freising Weihenstephan, Germany; [Eastwood, Christopher; Donovan, Jemma; Jiang, Wen; Grundy, David] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England	Technical University of Munich; University of Sheffield	Schemann, M (corresponding author), Tech Univ Munich, Freising Weihenstephan, Germany.	schemann@wzw.tum.de		Grundy, David/0000-0003-3974-7390; Schemann, Michael/0000-0003-1007-9843	DFG [Sche 267/9-1]	DFG(German Research Foundation (DFG))	This study was supported by DFG grant Sche 267/9-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbara G, 2007, GASTROENTEROLOGY, V132, P26, DOI 10.1053/j.gastro.2006.11.039; Bischoff SC, 2009, SEMIN IMMUNOPATHOL, V31, P185, DOI 10.1007/s00281-009-0165-4; Breunig E, 2007, J PHYSIOL-LONDON, V583, P731, DOI 10.1113/jphysiol.2007.139352; Buhner S, 2012, BBA-MOL BASIS DIS, V1822, P85, DOI 10.1016/j.bbadis.2011.06.004; Chiang G, 2000, J UROLOGY, V164, P2119, DOI 10.1016/S0022-5347(05)66981-9; De Jonge F, 2004, AM J PHYSIOL-GASTR L, V287, pG178, DOI 10.1152/ajpgi.00528.2003; DJALDETTI M, 1979, NOUV REV FR HEMATOL, V21, P185; EGLEZOS A, 1992, ARCH INT PHARMACOD T, V315, P96; Giebel J, 1995, EUR J MORPHOL, V33, P359; Gilfillan AM, 2011, CRIT REV IMMUNOL, V31, P475, DOI 10.1615/CritRevImmunol.v31.i6.30; HEPPNER TJ, 1992, EUR J PHARMACOL, V213, P427, DOI 10.1016/0014-2999(92)90632-E; JANISZEWSKI J, 1990, BRAIN BEHAV IMMUN, V4, P139, DOI 10.1016/0889-1591(90)90016-J; Janssen LJ, 1998, EUR RESPIR J, V12, P50, DOI 10.1183/09031936.98.12010050; Jiang W, 2000, GASTROENTEROLOGY, V119, P1267, DOI 10.1053/gast.2000.19461; Kashem SW, 2011, EUR J PHARMACOL, V668, P299, DOI 10.1016/j.ejphar.2011.06.027; Katayama G, 2005, INFLAMM RES, V54, P370, DOI 10.1007/s00011-005-1369-2; Kaur R, 2009, ARCH PHARM RES, V32, P1775, DOI 10.1007/s12272-009-2216-8; Koszegi Z, 2006, J BIOCHEM BIOPH METH, V69, P227, DOI 10.1016/j.jbbm.2006.03.009; Kovacs P, 2006, J NEUROIMMUNOL, V171, P1, DOI 10.1016/j.jneuroim.2005.07.026; Kubes P, 1996, CARDIOVASC RES, V32, P699, DOI 10.1016/S0008-6363(96)00118-6; Kugler EM, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00133; Law JKY, 2011, BBA-GEN SUBJECTS, V1810, P867, DOI 10.1016/j.bbagen.2011.05.007; Levy D, 2012, BRAIN BEHAV IMMUN, V26, P311, DOI 10.1016/j.bbi.2011.09.016; LOVENBERG TW, 1988, J PHARMACOL EXP THER, V247, P562; Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461; Michel K, 2011, J PHYSIOL-LONDON, V589, P5941, DOI 10.1113/jphysiol.2011.219550; MOUSLI M, 1990, TRENDS PHARMACOL SCI, V11, P358, DOI 10.1016/0165-6147(90)90179-C; Palomaki VAB, 2006, BRIT J PHARMACOL, V147, P596, DOI 10.1038/sj.bjp.0706671; Paterson WG, 2007, GUT, V56, P1347, DOI 10.1136/gut.2006.115881; PATON WDM, 1951, BRIT J PHARM CHEMOTH, V6, P499, DOI 10.1111/j.1476-5381.1951.tb00661.x; Quinson N, 2001, CELL TISSUE RES, V305, P3, DOI 10.1007/s004410100395; ROTHSCHILD AM, 1970, BRIT J PHARMACOL, V38, P253, DOI 10.1111/j.1476-5381.1970.tb10354.x; TAKEUCHI K, 1985, AGENTS ACTIONS, V17, P10, DOI 10.1007/BF01966673; Theoharides TC, 2000, BRIT J PHARMACOL, V131, P1039, DOI 10.1038/sj.bjp.0703672	34	46	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52104	10.1371/journal.pone.0052104	http://dx.doi.org/10.1371/journal.pone.0052104			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272218	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000312483300064
J	Smith, SJ; Wilson, M; Ward, JH; Rahman, CV; Peet, AC; Macarthur, DC; Rose, FRAJ; Grundy, RG; Rahman, R				Smith, Stuart J.; Wilson, Martin; Ward, Jennifer H.; Rahman, Cheryl V.; Peet, Andrew C.; Macarthur, Donald C.; Rose, Felicity R. A. J.; Grundy, Richard G.; Rahman, Ruman			Recapitulation of Tumor Heterogeneity and Molecular Signatures in a 3D Brain Cancer Model with Decreased Sensitivity to Histone Deacetylase Inhibition	PLOS ONE			English	Article							ROTATING-WALL VESSEL; GLIOBLASTOMA STEM-CELLS; IN-VITRO; ENDOTHELIAL-CELLS; INITIATING CELLS; PEDIATRIC GLIOBLASTOMA; CYTOSINE-ARABINOSIDE; MALIGNANT GLIOMAS; DRUG-EVALUATION; TISSUE MODELS	Introduction: Physiologically relevant pre-clinical ex vivo models recapitulating CNS tumor micro-environmental complexity will aid development of biologically-targeted agents. We present comprehensive characterization of tumor aggregates generated using the 3D Rotary Cell Culture System (RCCS). Methods: CNS cancer cell lines were grown in conventional 2D cultures and the RCCS and comparison with a cohort of 53 pediatric high grade gliomas conducted by genome wide gene expression and microRNA arrays, coupled with immunohistochemistry, ex vivo magnetic resonance spectroscopy and drug sensitivity evaluation using the histone deacetylase inhibitor, Vorinostat. Results: Macroscopic RCCS aggregates recapitulated the heterogeneous morphology of brain tumors with a distinct proliferating rim, necrotic core and oxygen tension gradient. Gene expression and microRNA analyses revealed significant differences with 3D expression intermediate to 2D cultures and primary brain tumors. Metabolic profiling revealed differential profiles, with an increase in tumor specific metabolites in 3D. To evaluate the potential of the RCCS as a drug testing tool, we determined the efficacy of Vorinostat against aggregates of U87 and KNS42 glioblastoma cells. Both lines demonstrated markedly reduced sensitivity when assaying in 3D culture conditions compared to classical 2D drug screen approaches. Conclusions: Our comprehensive characterization demonstrates that 3D RCCS culture of high grade brain tumor cells has profound effects on the genetic, epigenetic and metabolic profiles of cultured cells, with these cells residing as an intermediate phenotype between that of 2D cultures and primary tumors. There is a discrepancy between 2D culture and tumor molecular profiles, and RCCS partially re-capitulates tissue specific features, allowing drug testing in a more relevant ex vivo system.	[Smith, Stuart J.; Ward, Jennifer H.; Grundy, Richard G.; Rahman, Ruman] Univ Nottingham, Sch Clin Sci, Childrens Brain Tumour Res Ctr, Nottingham NG7 2RD, England; [Wilson, Martin; Peet, Andrew C.] Univ Birmingham, Sch Med, Div Reprod & Child Hlth, Birmingham, W Midlands, England; [Rahman, Cheryl V.; Rose, Felicity R. A. J.] Univ Nottingham, Sch Pharm, Div Drug Delivery & Tissue Engn, Ctr Biomol Sci, Nottingham NG7 2RD, England; [Macarthur, Donald C.] Univ Nottingham Hosp, Dept Neurosurg, Nottingham NG7 2UH, England	University of Nottingham; University of Birmingham; University of Nottingham; University of Nottingham	Grundy, RG (corresponding author), Univ Nottingham, Sch Clin Sci, Childrens Brain Tumour Res Ctr, Nottingham NG7 2RD, England.	richard.grundy@nottingham.ac.uk; ruman.rahman@nottingham.ac.uk	Rahman, Ruman/FFR-5799-2022; Wilson, Martin/ABA-7210-2021	Rahman, Ruman/0000-0002-6541-9983; Wilson, Martin/0000-0002-2089-3956; Ward, Jennifer/0000-0002-3906-0858; Smith, Stuart/0000-0002-4556-2707; Rose, Felicity/0000-0001-6640-8840; Peet, Andrew/0000-0002-4846-5152	Samantha Dickson Brain Tumor Trust; Gentleman's Night Out Charity; Joseph Foote Brain Tumour Trust; The Brain Tumour Charity [17/86] Funding Source: researchfish	Samantha Dickson Brain Tumor Trust; Gentleman's Night Out Charity; Joseph Foote Brain Tumour Trust; The Brain Tumour Charity	This work was supported by the Samantha Dickson Brain Tumor Trust, the Gentleman's Night Out Charity and the Joseph Foote Brain Tumour Trust. RR is a Nottingham Advanced Research Fellow and SJS is a National Institute for Health Research/UoN Clinical Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKER H, 1987, BRIT J CANCER, V56, P325, DOI 10.1038/bjc.1987.197; Atkinson JM, 2011, CANCER CELL, V20, P384, DOI 10.1016/j.ccr.2011.08.013; Bar EE, 2010, AM J PATHOL, V177, P1491, DOI 10.2353/ajpath.2010.091021; Barrila J, 2010, NAT REV MICROBIOL, V8, P791, DOI 10.1038/nrmicro2423; Bates RC, 2000, CRIT REV ONCOL HEMAT, V36, P61, DOI 10.1016/S1040-8428(00)00077-9; Bibby MC, 2004, EUR J CANCER, V40, P852, DOI 10.1016/j.ejca.2003.11.021; Bielen A, 2011, MOL CANCER THER, V10, P1407, DOI 10.1158/1535-7163.MCT-11-0205; Biggs T, 2011, J BIOMOL SCREEN, V16, P805, DOI 10.1177/1087057111414895; Birgersdotter A, 2005, SEMIN CANCER BIOL, V15, P405, DOI 10.1016/j.semcancer.2005.06.009; Buchwald M, 2009, CANCER LETT, V280, P160, DOI 10.1016/j.canlet.2009.02.028; Buffa FM, 2001, INT J RADIAT ONCOL, V49, P1109, DOI 10.1016/S0360-3016(00)01533-9; Burdett E, 2010, TISSUE ENG PART B-RE, V16, P351, DOI [10.1089/ten.teb.2009.0676, 10.1089/ten.TEB.2009.0676]; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Campbell JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025661; Charles NA, 2012, GLIA, V60, P502, DOI 10.1002/glia.21264; Cooper LAD, 2012, AM J PATHOL, V180, P2108, DOI 10.1016/j.ajpath.2012.01.040; Davies NP, 2010, NMR BIOMED, V23, P80, DOI 10.1002/nbm.1432; de Antonellis P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024584; Elliott NT, 2011, J PHARM SCI-US, V100, P59, DOI 10.1002/jps.22257; Ernst A, 2009, CLIN CANCER RES, V15, P6541, DOI 10.1158/1078-0432.CCR-09-0695; Evans SM, 2004, CLIN CANCER RES, V10, P8177, DOI 10.1158/1078-0432.CCR-04-1081; Faute MAD, 2002, CLIN EXP METASTAS, V19, P161, DOI 10.1023/A:1014594825502; Fiebig HH, 2004, EUR J CANCER, V40, P802, DOI 10.1016/j.ejca.2004.01.009; Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085; Fotovati A, 2011, CANCER RES, V71, P5569, DOI 10.1158/0008-5472.CAN-10-2805; Fouladi M, 2010, J CLIN ONCOL, V28, P3623, DOI 10.1200/JCO.2009.25.9119; Frankel A, 1997, CANCER RES, V57, P2388; Galan-Moya EM, 2011, EMBO REP, V12, P470, DOI 10.1038/embor.2011.39; Galanis E, 2009, J CLIN ONCOL, V27, P2052, DOI 10.1200/JCO.2008.19.0694; Gaspar N, 2010, CANCER RES, V70, P9243, DOI 10.1158/0008-5472.CAN-10-1250; Gatenby RA, 2007, BRIT J CANCER, V97, P646, DOI 10.1038/sj.bjc.6603922; Gierse JK, 2005, J PHARMACOL EXP THER, V312, P1206, DOI 10.1124/jpet.104.076877; GRANT DS, 1992, J CELL PHYSIOL, V153, P614, DOI 10.1002/jcp.1041530324; Hamer PCDW, 2008, ONCOGENE, V27, P2091, DOI 10.1038/sj.onc.1210850; Hammond TG, 2001, AM J PHYSIOL-RENAL, V281, pF12, DOI 10.1152/ajprenal.2001.281.1.F12; Harma V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010431; Hassan SB, 2001, ANTI-CANCER DRUG, V12, P33, DOI 10.1097/00001813-200101000-00005; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Hicks KO, 2001, J PHARMACOL EXP THER, V297, P1088; Hutmacher DW, 2009, J CELL MOL MED, V13, P1417, DOI 10.1111/j.1582-4934.2009.00853.x; Ingthorsson Saevar, 2010, BMC Res Notes, V3, P184, DOI 10.1186/1756-0500-3-184; Johnson JI, 2001, BRIT J CANCER, V84, P1424, DOI 10.1054/bjoc.2001.1796; Kim C, 2012, LAB CHIP, V12, P4135, DOI 10.1039/c2lc40570a; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Laguinge LM, 2004, CANCER RES, V64, P2643, DOI 10.1158/0008-5472.CAN-03-3663; Lamfers ML, 2004, CURR OPIN MOL THER, V6, P403; Lathia JD, 2011, CELL STEM CELL, V8, P482, DOI 10.1016/j.stem.2011.04.013; Lee C, 2012, STEM CELLS, V30, P1064, DOI 10.1002/stem.1081; Li Q, 2011, J BIOMOL SCREEN, V16, P141, DOI 10.1177/1087057110392995; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Loessner D, 2010, BIOMATERIALS, V31, P8494, DOI 10.1016/j.biomaterials.2010.07.064; Marian CO, 2010, CLIN CANCER RES, V16, P154, DOI 10.1158/1078-0432.CCR-09-2850; Milde T, 2011, ACTA NEUROPATHOL, V122, P637, DOI 10.1007/s00401-011-0866-3; Nicholson KM, 1997, EUR J CANCER, V33, P1291, DOI 10.1016/S0959-8049(97)00114-7; Nyga A, 2011, J CELL COMMUN SIGNAL, V5, P239, DOI 10.1007/s12079-011-0132-4; Olin MR, 2011, CANCER RES, V71, P6583, DOI 10.1158/0008-5472.CAN-11-1166; Oshiro S, 2007, ANTICANCER RES, V27, P3757; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Paugh BS, 2010, J CLIN ONCOL, V28, P3061, DOI 10.1200/JCO.2009.26.7252; Pellegrini M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009064; Perche F, 2012, CANCER BIOL THER, V13, P1205, DOI 10.4161/cbt.21353; Phillips WT, 2012, NEURO-ONCOLOGY, V14, P416, DOI 10.1093/neuonc/nos060; Rahman R, 2010, MOL CANCER THER, V9, P2568, DOI 10.1158/1535-7163.MCT-10-0272; Richon VM, 2002, CLIN CANCER RES, V8, P662; Schnell O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030429; Schwarz R P, 1992, J Tissue Cult Methods, V14, P51, DOI 10.1007/BF01404744; Schwerk C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030069; Seidel S, 2010, BRAIN, V133, P983, DOI 10.1093/brain/awq042; Silvestrini F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031567; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Skardal A, 2010, BIOMATERIALS, V31, P8426, DOI 10.1016/j.biomaterials.2010.07.047; Smith BH, 2011, CANCER RES, V71, P716, DOI 10.1158/0008-5472.CAN-10-2254; Smith SJ, 2012, ACTA NEUROPATHOL, V124, P99, DOI 10.1007/s00401-012-0952-1; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; Sodek KL, 2009, INT J CANCER, V124, P2060, DOI 10.1002/ijc.24188; Sos ML, 2009, J CLIN INVEST, V119, P1727, DOI 10.1172/JCI37127; STEWART DJ, 1984, J NEURO-ONCOL, V2, P29, DOI 10.1007/BF00165155; Suggitt M, 2005, CLIN CANCER RES, V11, P971; Sung SY, 2008, CANCER RES, V68, P9996, DOI 10.1158/0008-5472.CAN-08-2492; Svensson KJ, 2011, P NATL ACAD SCI USA, V108, P13147, DOI 10.1073/pnas.1104261108; Swinnen LJ, 2008, J NEURO-ONCOL, V86, P353, DOI 10.1007/s11060-007-9483-3; Tung YC, 2011, ANALYST, V136, P473, DOI 10.1039/c0an00609b; Venkatesh HS, 2012, NEURO-ONCOLOGY, V14, P315, DOI 10.1093/neuonc/nor209; Vinci M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-29; Weinstein JN, 2002, CURR OPIN PHARMACOL, V2, P361, DOI 10.1016/S1471-4892(02)00185-6; Wilson M, 2011, MAGN RESON MED, V65, P1, DOI 10.1002/mrm.22579; YUHAS JM, 1977, CANCER RES, V37, P3639	87	33	34	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52335	10.1371/journal.pone.0052335	http://dx.doi.org/10.1371/journal.pone.0052335			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272238	Green Published, Green Submitted, gold			2022-12-27	WOS:000312483300080
J	Di Luca, M; Bottai, D; Batoni, G; Orgeur, M; Aulicino, A; Counoupas, C; Campa, M; Brosch, R; Esin, S				Di Luca, Mariagrazia; Bottai, Daria; Batoni, Giovanna; Orgeur, Mickael; Aulicino, Anna; Counoupas, Claudio; Campa, Mario; Brosch, Roland; Esin, Semih			The ESX-5 Associated eccB(5)-eccC(5) Locus Is Essential for Mycobacterium tuberculosis Viability	PLOS ONE			English	Article							PE-PGRS PROTEINS; COMPLETE GENOME SEQUENCE; SECRETION SYSTEM; PPE; VIRULENCE; MARINUM; SURFACE; INSIGHTS; GENE	The recently described ESX-5 secretion system of Mycobacterium tuberculosis is one of the most important modulators of host-pathogen interactions due to its crucial impact on PPE protein secretion, cell wall stability and virulence. Although various components of the ESX-5 secretion machinery have been defined, other ESX-5 core components still remain to be characterized. In this study, we focused on EccB(5) and EccC(5), a transmembrane protein (EccB(5)) and a membrane-bound ATPase (EccC(5)), both predicted to be building blocks of the M. tuberculosis ESX-5 membrane-associated complex. In vitro expression studies demonstrated that EccB(5) and EccC(5) encoding genes constitute an operon. The expression of this operon is essential for M. tuberculosis, since the deletion of the eccB(5)-eccC(5) genomic segment at the ESX-5 locus is possible only after the integration of a second functional copy of eccB(5)-eccC(5) genes into the M. tuberculosis chromosome. The characterization of two M. tuberculosis conditional mutant strains (Mtb(Pptr)eccB(5) and Mtb(Pptr)eccC(5)), in which the eccB(5)-eccC(5) operon or the eccC(5) gene, respectively, were expressed under the control of an anhydrotetracycline-repressible promoter, confirmed that the repression of eccB(5)-eccC(5) genes is detrimental for growth of M. tuberculosis both in vitro and in THP-1 human macrophage cell line. Moreover, analysis of the secretome of Mtb(Pptr)eccB(5)-eccC(5) and Mtb(Pptr)eccC(5) strains revealed that both EccB(5) and EccC(5) are required for secretion of ESX-5 specific substrates, thus confirming that they are indeed components of the ESX-5 secretion machinery. Taken together these findings demonstrate the importance of an intact and functional ESX-5 system for viability of M. tuberculosis, thus opening new interesting options for alternative antimycobacterial control strategies.	[Di Luca, Mariagrazia; Bottai, Daria; Batoni, Giovanna; Aulicino, Anna; Counoupas, Claudio; Campa, Mario; Esin, Semih] Univ Pisa, Dipartimento Patol Sperimentale Biotecnol Med Inf, Pisa, Italy; [Di Luca, Mariagrazia; Bottai, Daria; Batoni, Giovanna; Aulicino, Anna; Campa, Mario; Esin, Semih] Univ Pisa, Dipartimento Ric Traslaz & Nuove Tecnol Med & Chi, Pisa, Italy; [Orgeur, Mickael; Brosch, Roland] Inst Pasteur, Unit Integrated Mycobacterial Pathogenom, Paris, France	University of Pisa; University of Pisa; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Bottai, D (corresponding author), Univ Pisa, Dipartimento Patol Sperimentale Biotecnol Med Inf, Pisa, Italy.	d.bottai@biomed.unipi.it	Counoupas, Claudio/AAH-6664-2019; Brosch, Roland/ABB-4108-2021; Brosch, Roland/AAZ-3850-2021; Esin, Semih/B-7566-2013; Bottai, Daria/HFZ-9009-2022; Batoni, Giovanna/ABF-9668-2020	Brosch, Roland/0000-0003-2587-3863; Esin, Semih/0000-0002-4358-5294; Batoni, Giovanna/0000-0002-4448-2385; Di Luca, Mariagrazia/0000-0002-0688-034X; Counoupas, Claudio/0000-0002-0283-4004; Aulicino, Anna/0000-0002-3407-2796	European Community [201762, 260872]; Progetti P.R.I.N., Rome, Italy [2008WY739B]	European Community(European Commission); Progetti P.R.I.N., Rome, Italy	This work received the financial support from the European Community's Seventh Framework Programme ([FP7/2007-2013]) under grant agreement numbers 201762 and 260872, and Progetti P.R.I.N. protocol number 2008WY739B, Rome, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x; Abdallah AM, 2008, J IMMUNOL, V181, P7166, DOI 10.4049/jimmunol.181.10.7166; Abdallah AM, 2006, MOL MICROBIOL, V62, P667, DOI 10.1111/j.1365-2958.2006.05409.x; Banu S, 2002, MOL MICROBIOL, V44, P9, DOI 10.1046/j.1365-2958.2002.02813.x; Bitter W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000507; Blasco B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002621; Boldrin F, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq235; Bottai D, 2012, MOL MICROBIOL, V83, P1195, DOI 10.1111/j.1365-2958.2012.08001.x; Bottai D, 2011, J INFECT DIS, V203, P1155, DOI 10.1093/infdis/jiq089; Bottai D, 2009, MOL MICROBIOL, V73, P325, DOI 10.1111/j.1365-2958.2009.06784.x; Brodin P, 2004, TRENDS MICROBIOL, V12, P500, DOI 10.1016/j.tim.2004.09.007; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Coros A, 2008, MOL MICROBIOL, V69, P794, DOI 10.1111/j.1365-2958.2008.06299.x; Daleke MH, 2012, P NATL ACAD SCI USA, V109, P11342, DOI 10.1073/pnas.1119453109; Daleke MH, 2011, J BIOL CHEM, V286, P19024, DOI 10.1074/jbc.M110.204966; Delogu G, 2006, MICROBES INFECT, V8, P2061, DOI 10.1016/j.micinf.2006.03.015; Fernandez P, 2006, J BACTERIOL, V188, P7778, DOI 10.1128/JB.00963-06; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Houben EN, 2012, MOL MICROBIOL; Iantomasi R, 2012, CELL MICROBIOL, V14, P356, DOI 10.1111/j.1462-5822.2011.01721.x; Ioerger TR, 2010, J BACTERIOL, V192, P3645, DOI 10.1128/JB.00166-10; Joshi SA, 2012, CHEM BIOL, V19, P372, DOI 10.1016/j.chembiol.2012.01.008; Lamichhane G, 2005, INFECT IMMUN, V73, P2533, DOI 10.1128/IAI.73.4.2533-2540.2005; Li YJ, 2005, CELL MICROBIOL, V7, P539, DOI 10.1111/j.1462-5822.2004.00484.x; Pelicic V, 1997, P NATL ACAD SCI USA, V94, P10955, DOI 10.1073/pnas.94.20.10955; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sayes F, 2012, CELL HOST MICROBE, V11, P352, DOI 10.1016/j.chom.2012.03.003; Schneewind O, 2012, PHILOS T R SOC B, V367, P1123, DOI 10.1098/rstb.2011.0210; Serafini A, 2009, J BACTERIOL, V191, P6340, DOI 10.1128/JB.00756-09; Siegrist MS, 2009, P NATL ACAD SCI USA, V106, P18792, DOI 10.1073/pnas.0900589106; Simeone R, 2009, CURR OPIN MICROBIOL, V12, P4, DOI 10.1016/j.mib.2008.11.003; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Stoop EJM, 2012, TRENDS MICROBIOL, V20, P477, DOI 10.1016/j.tim.2012.07.001; Tekaia F., 1999, Tubercle and Lung Disease, V79, P329, DOI 10.1054/tuld.1999.0220; VANPITTIUS NCG, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-10-RESEARCH0044; Weerdenburg EM, 2012, CELL MICROBIOL, V14, P728, DOI 10.1111/j.1462-5822.2012.01755.x	39	34	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52059	10.1371/journal.pone.0052059	http://dx.doi.org/10.1371/journal.pone.0052059			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284869	Green Submitted, Green Published, gold			2022-12-27	WOS:000312435900073
J	Shukla, M; Minda, R; Singh, H; Tirumani, S; Chary, KVR; Rao, BJ				Shukla, Manish; Minda, Renu; Singh, Himanshu; Tirumani, Srikanth; Chary, Kandala V. R.; Rao, Basuthkar J.			UVI31+Is a DNA Endonuclease That Dynamically Localizes to Chloroplast Pyrenoids in C. reinhardtii	PLOS ONE			English	Article							UV-INDUCIBLE GENE; CHLAMYDOMONAS-REINHARDTII; SCHIZOSACCHAROMYCES-POMBE; ESCHERICHIA-COLI; CELL-DIVISION; GREEN-ALGAE; BOLA; PROTEIN; IDENTIFICATION; EXPRESSION	UVI31+ is an evolutionarily conserved BolA family protein. In this study we examine the presence, localization and possible functions of this protein in the context of a unicellular alga, Chlamydomonas reinhardtii. UVI31+ in C. reinhardtii exhibits DNA endonuclease activity and is induced upon UV stress. Further, UVI31+ that normally localizes to the cell wall and pyrenoid regions gets redistributed into punctate foci within the whole chloroplast, away from the pyrenoid, upon UV stress. The observed induction upon UV-stress as well as the endonuclease activity suggests plausible role of this protein in DNA repair. We have also observed that UV31+ is induced in C. reinhardtii grown in dark conditions, whereby the protein localization is enhanced in the pyrenoid. Biomolecular interaction between the purified pyrenoids and UVI31+ studied by NMR demonstrates the involvement of the disordered loop domain of the protein in its interaction.	[Shukla, Manish; Minda, Renu; Tirumani, Srikanth; Rao, Basuthkar J.] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India; [Singh, Himanshu; Chary, Kandala V. R.] Tata Inst Fundamental Res, Dept Chem Sci, Bombay 400005, Maharashtra, India	Tata Institute of Fundamental Research (TIFR); Tata Institute of Fundamental Research (TIFR)	Rao, BJ (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	bjrao@tifr.res.in	Singh, Himanshu/M-6619-2019; Minda, Renu/M-5476-2016	Singh, Himanshu/0000-0002-2819-6282; Minda, Renu/0000-0002-2359-9146	Department of Atomic Energy at TIFR; Department of Science and Technology (DST); Department of Biotechnology (DBT); Council of Scientific and Industrial Research (CSIR); Tata Institute of Fundamental Research, Mumbai, India	Department of Atomic Energy at TIFR; Department of Science and Technology (DST)(Department of Science & Technology (India)); Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Tata Institute of Fundamental Research, Mumbai, India	This work was funded by Department of Atomic Energy at TIFR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The facilities provided by National Facility for High Field NMR at TIFR supported by Department of Science and Technology (DST), Department of Biotechnology (DBT), Council of Scientific and Industrial Research (CSIR) and Tata Institute of Fundamental Research, Mumbai, India are gratefully acknowledged. We also acknowledge Dr. Ishita Mehta for a critical reading of the manuscript. BJR and KVRC thank DST for their JC Bose Fellowships.	Adnan M, 2010, MOL CELL BIOCHEM, V342, P207, DOI 10.1007/s11010-010-0485-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruce BD, 2000, TRENDS CELL BIOL, V10, P440, DOI 10.1016/S0962-8924(00)01833-X; Silva WLD, 2005, GENET MOL BIOL, V28, P814, DOI 10.1590/S1415-47572005000500025; Freire P, 2009, J MOL BIOL, V385, P1345, DOI 10.1016/j.jmb.2008.12.026; GIBBS SP, 1962, J ULTRA MOL STRUCT R, V7, P247, DOI 10.1016/S0022-5320(62)90021-7; Grafi G, 1995, PLANT MOL BIOL, V29, P703, DOI 10.1007/BF00041161; Harris EH, 2009, CHLAMYDOMONAS LAB; Hsia KC, 2005, CURR OPIN STRUC BIOL, V15, P126, DOI 10.1016/j.sbi.2005.01.015; IMAM SH, 1985, J CELL BIOL, V101, P1599, DOI 10.1083/jcb.101.4.1599; Kasai T, 2004, PROTEIN SCI, V13, P545, DOI 10.1110/ps.03401004; Kim MJ, 2002, MOL CELLS, V14, P425; Kim SH, 1997, ENVIRON MOL MUTAGEN, V30, P72, DOI 10.1002/(SICI)1098-2280(1997)30:1<72::AID-EM10>3.0.CO;2-N; Koch B, 2006, FEMS MICROBIOL LETT, V262, P48, DOI 10.1111/j.1574-6968.2006.00359.x; KUCHITSU K, 1988, PROTOPLASMA, V144, P17, DOI 10.1007/BF01320276; LEE JK, 1994, BIOCHEM BIOPH RES CO, V202, P1113, DOI 10.1006/bbrc.1994.2043; Lin S, 1997, MAR BIOL, V127, P521, DOI 10.1007/s002270050041; Lou YC, 2009, NUCLEIC ACIDS RES, V37, P2381, DOI 10.1093/nar/gkp097; MIYAMURA S, 1991, PROTOPLASMA, V161, P192, DOI 10.1007/BF01322731; Moharikar S, 2006, J PHYCOL, V42, P423, DOI 10.1111/j.1529-8817.2006.00207.x; Moharikar S, 2007, J BIOSCIENCES, V32, P261, DOI 10.1007/s12038-007-0026-z; Nikaido SS, 2000, PHOTOCHEM PHOTOBIOL, V71, P758, DOI 10.1562/0031-8655(2000)071<0758:DACVIS>2.0.CO;2; Rangarajan ES, 2001, FEMS MICROBIOL REV, V25, P583, DOI 10.1111/j.1574-6976.2001.tb00593.x; Rout AK, 2010, BIOMOL NMR ASSIGN, V4, P171, DOI 10.1007/s12104-010-9239-4; SANDERS MA, 1995, METHOD CELL BIOL, V47, P163, DOI 10.1016/S0091-679X(08)60805-5; Santos JM, 1999, MOL MICROBIOL, V32, P789, DOI 10.1046/j.1365-2958.1999.01397.x; Schafer P, 2004, J MOL BIOL, V338, P217, DOI 10.1016/j.jmb.2004.02.069; Selenko P, 2007, J STRUCT BIOL, V158, P244, DOI 10.1016/j.jsb.2007.04.001; Uniacke J, 2008, J CELL BIOL, V182, P641, DOI 10.1083/jcb.200805125; WITMAN GB, 1972, J CELL BIOL, V54, P507, DOI 10.1083/jcb.54.3.507; Zhou YB, 2008, MOL CELL BIOCHEM, V317, P61, DOI 10.1007/s11010-008-9809-2	31	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51913	10.1371/journal.pone.0051913	http://dx.doi.org/10.1371/journal.pone.0051913			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284814	Green Submitted, Green Published, gold			2022-12-27	WOS:000312435900064
J	van Helden, MJG; Zaiss, DMW; Sijts, AJAM				van Helden, Mary J. G.; Zaiss, Dietmar M. W.; Sijts, Alice J. A. M.			CCR2 Defines a Distinct Population of NK Cells and Mediates Their Migration during Influenza Virus Infection in Mice	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; BACTERIAL-INFECTION; CHEMOKINE RECEPTORS; BONE-MARROW; IN-VIVO; IMMUNE-RESPONSES; DENDRITIC CELLS; LYMPH-NODES; EXPRESSION; TRAFFICKING	Natural killer (NK) cells are innate lymphocytes that play an important role in control of viral infections. We recently showed that intranasal infection of mice with influenza virus induced the accumulation of NK cells in the airways. NK cells however did not proliferate in the airways or in the draining lymph node, but in the bone marrow mainly. As also monocyte-precursors undergo vigorous proliferation in the bone marrow (BM) during infections and then egress CCR2-dependently, we decided to determine the role of CCR2 in NK cell migration during intranasal influenza virus infection. We show that a unique population of NK cells in the BM expressed CCR2 and that monocyte chemotactic protein-1 (MCP-1), one of the CCR2 ligands, was produced in the airways of influenza virus infected mice. Analysis of BM chimeric mice reconstituted with a mix of wild-type (wt) and CCR2-deficient BM cells showed that upon influenza virus infection, a significantly lower proportion of CCR2-deficient than wt NK cells was recovered from the bronchoalveolar lavage (BAL). Taken together, our data demonstrate that during influenza virus infection a proportion of NK cells migrate in a CCR2-dependent fashion. Citation: van Helden MJG, Zaiss DMW, Sijts AJAM (2012) CCR2 Defines a Distinct Population of NK Cells and Mediates Their Migration during Influenza Virus Infection in Mice. PLoS ONE 7(12): e52027. doi:10.1371/journal.pone.0052027	[van Helden, Mary J. G.; Zaiss, Dietmar M. W.; Sijts, Alice J. A. M.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands	Utrecht University	Zaiss, DMW (corresponding author), Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands.	d.zaiss@uu.nl; e.j.a.m.sijts@uu.nl		Sijts, Alice/0000-0003-3815-4788; Zaiss, Dietmar M.W./0000-0003-3596-7062	Top Institute Pharma grant [T4-214]; Wellcome Trust grant [WT085733MA]	Top Institute Pharma grant; Wellcome Trust grant(Wellcome Trust)	Top Institute Pharma grant T4-214, URL: http://www.tipharma.com/and Wellcome Trust grant WT085733MA, URL: http://www.wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge JR, 2009, P NATL ACAD SCI USA, V106, P5306, DOI 10.1073/pnas.0900655106; Andrews DM, 2010, IMMUNOL CELL BIOL, V88, P107, DOI 10.1038/icb.2009.94; Babic M, 2010, J EXP MED, V207, P2663, DOI 10.1084/jem.20100921; Bernardini G, 2008, BLOOD, V111, P3626, DOI 10.1182/blood-2007-08-106203; Bernardini G, 2012, IMMUNOL LETT, V145, P39, DOI 10.1016/j.imlet.2012.04.014; Brandstadter JD, 2011, J INNATE IMMUN, V3, P274, DOI 10.1159/000324176; Campbell JJ, 2001, J IMMUNOL, V166, P6477, DOI 10.4049/jimmunol.166.11.6477; Champsaur M, 2010, IMMUNOL REV, V235, P267, DOI 10.1111/j.0105-2896.2010.00893.x; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Freud AG, 2005, IMMUNITY, V22, P295, DOI 10.1016/j.immuni.2005.01.013; Gregoire C, 2007, IMMUNOL REV, V220, P169, DOI 10.1111/j.1600-065X.2007.00563.x; Hanna J, 2005, BLOOD, V106, P3465, DOI 10.1182/blood-2005-03-0855; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Hokeness KL, 2005, J IMMUNOL, V174, P1549, DOI 10.4049/jimmunol.174.3.1549; Huntington ND, 2007, NAT REV IMMUNOL, V7, P703, DOI 10.1038/nri2154; Huntington ND, 2007, J IMMUNOL, V178, P4764, DOI 10.4049/jimmunol.178.8.4764; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Inngjerdingen M, 2000, J IMMUNOL, V164, P4048, DOI 10.4049/jimmunol.164.8.4048; Inngjerdingen M, 2001, BLOOD, V97, P367, DOI 10.1182/blood.V97.2.367; Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796; Lanier LL, 2008, NAT REV IMMUNOL, V8, P259, DOI 10.1038/nri2276; Mack M, 2001, J IMMUNOL, V166, P4697, DOI 10.4049/jimmunol.166.7.4697; MAGHAZACHI AA, 1994, J IMMUNOL, V153, P4969; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Morrison BE, 2003, J CLIN INVEST, V112, P1862, DOI 10.1172/JCI200318125; Polakos NK, 2007, J IMMUNOL, V179, P201, DOI 10.4049/jimmunol.179.1.201; Polentarutti N, 1997, J IMMUNOL, V158, P2689; Salazar-Mather TP, 2002, J CLIN INVEST, V110, P321, DOI 10.1172/JCI200215376; Salazar-Mather TP, 1998, J EXP MED, V187, P1, DOI 10.1084/jem.187.1.1; Sciume G, 2011, BLOOD, V117, P4467, DOI 10.1182/blood-2010-07-297101; Serbina NV, 2009, J IMMUNOL, V183, P1900, DOI 10.4049/jimmunol.0900612; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shi C, 2010, J IMMUNOL, V184, P6266, DOI 10.4049/jimmunol.0904160; Takeda K, 2005, BLOOD, V105, P2082, DOI 10.1182/blood-2004-08-3262; van Helden MJG, 2012, J IMMUNOL, V189, P2333, DOI 10.4049/jimmunol.1200008; Vosshenrich CAJ, 2006, NAT IMMUNOL, V7, P1217, DOI 10.1038/ni1395; Walzer T, 2007, NAT IMMUNOL, V8, P1337, DOI 10.1038/ni1523; Walzer T, 2011, TRENDS IMMUNOL, V32, P486, DOI 10.1016/j.it.2011.05.002; Zaiss DMW, 2008, INFECT IMMUN, V76, P1207, DOI 10.1128/IAI.01134-07	40	39	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e52027	10.1371/journal.pone.0052027	http://dx.doi.org/10.1371/journal.pone.0052027			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272202	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386600053
J	Benedetti, IM; de Lorenzo, V; Silva-Rocha, R				Maria Benedetti, Ilaria; de Lorenzo, Victor; Silva-Rocha, Rafael			Quantitative, Non-Disruptive Monitoring of Transcription in Single Cells with a Broad-Host Range GFP-luxCDABE Dual Reporter System	PLOS ONE			English	Article							STOCHASTIC GENE-EXPRESSION; COPY-NUMBER; ESCHERICHIA-COLI; PROMOTER; VECTORS; PLASMID; CLONING; NOISE; TECHNOLOGIES; NETWORKS	A dual promoter probe system based on a tandem bi-cistronic GFP-luxCDABE reporter cassette is described and implemented. This system is assembled in two synthetic, modular, broad-host range plasmids based on pBBR1 and RK2 origins of replication, allowing its utilization in an extensive number of gram-negative bacteria. We analyze the performance of this dual cassette in two hosts, Escherichia coli and Pseudomonas putida, by examining the induction properties of the lacI(9)-Ptrc expression system in the first host and the Pb promoter of the benzoate degradation pathway in the second host. By quantifying the bioluminescence signal produced through the expression of the lux genes, we explore the dynamic range of induction for the two systems (Ptrc-based and Pb-based) in response to the two inducers. In addition, by quantifying the fluorescence signals produced by GFP expression, we were able to monitor the single-cell expression profile and to explore stochasticity of the same two promoters by flow cytometry. The results provided here demonstrate the power of the dual GFP-luxCDABE cassette as a new, single-step tool to assess promoter properties at both the population and single-cell levels in gram-negative bacteria.	[Maria Benedetti, Ilaria; de Lorenzo, Victor; Silva-Rocha, Rafael] CSIC, Ctr Nacl Biotecnol, Syst Biol Program, Canto Blanco, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	de Lorenzo, V (corresponding author), CSIC, Ctr Nacl Biotecnol, Syst Biol Program, Canto Blanco, Spain.	vdlorenzo@cnb.csic.es	Silva-Rocha, Rafael/H-4929-2012	Silva-Rocha, Rafael/0000-0001-6319-631X; de Lorenzo, Victor/0000-0002-6041-2731	BIO program of the Spanish Ministry of Economy and Competitiveness; FEDER CONSOLIDER-INGENIO program of the Spanish Ministry of Economy and Competitiveness; MICROME Contract of the EU; ST-FLOW Contract of the EU; ERANET-IB Program; Autonomous Community of Madrid (PROMPT); La-Caixa International PhD fellowship; MCINN [BES-2008-009823]	BIO program of the Spanish Ministry of Economy and Competitiveness; FEDER CONSOLIDER-INGENIO program of the Spanish Ministry of Economy and Competitiveness; MICROME Contract of the EU; ST-FLOW Contract of the EU; ERANET-IB Program; Autonomous Community of Madrid (PROMPT); La-Caixa International PhD fellowship(La Caixa Foundation); MCINN(European Commission)	This work was supported by the BIO and FEDER CONSOLIDER-INGENIO programs of the Spanish Ministry of Economy and Competitiveness, the MICROME and ST-FLOW Contracts of the EU, the ERANET-IB Program and funding from the Autonomous Community of Madrid (PROMPT). IB was supported by La-Caixa International PhD fellowship. RS-R was the holder of FPI PhD stipend BES-2008-009823) of the MCINN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; ANTOINE R, 1992, MOL MICROBIOL, V6, P1785, DOI 10.1111/j.1365-2958.1992.tb01351.x; BAGDASARIAN M, 1981, GENE, V16, P237, DOI 10.1016/0378-1119(81)90080-9; Balleza E, 2009, FEMS MICROBIOL REV, V33, P133, DOI 10.1111/j.1574-6976.2008.00145.x; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; Brehm-Stecher BF, 2004, MICROBIOL MOL BIOL R, V68, P538, DOI 10.1128/MMBR.68.3.538-559.2004; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; Cases I, 2003, TRENDS MICROBIOL, V11, P248, DOI 10.1016/S0966-842X(03)00103-3; Cowles CE, 2000, J BACTERIOL, V182, P6339, DOI 10.1128/JB.182.22.6339-6346.2000; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Dublanche Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100081; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Hermsen R, 2006, PLOS COMPUT BIOL, V2, P1552, DOI 10.1371/journal.pcbi.0020164; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; Keasling JD, 1999, TRENDS BIOTECHNOL, V17, P452, DOI 10.1016/S0167-7799(99)01376-1; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Khlebnikov A, 2002, BIOTECHNOL PROGR, V18, P672, DOI 10.1021/bp010141k; Khlebnikov A, 2001, MICROBIOL-SGM, V147, P3241, DOI 10.1099/00221287-147-12-3241; Kinkhabwala A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002030; Lale R, 2011, METHODS MOL BIOL, V765, P327, DOI 10.1007/978-1-61779-197-0_19; Lin B, 2012, CURR OPIN CHEM BIOL, V16, P307, DOI 10.1016/j.cbpa.2012.04.012; McAdams HH, 1999, TRENDS GENET, V15, P65, DOI 10.1016/S0168-9525(98)01659-X; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; MEIGHEN EA, 1991, MICROBIOL REV, V55, P123, DOI 10.1128/MMBR.55.1.123-142.1991; Meyer JM, 2000, ARCH MICROBIOL, V174, P135, DOI 10.1007/s002030000188; Miller WG, 1997, GENE, V191, P149, DOI 10.1016/S0378-1119(97)00051-6; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Qazi SNA, 2001, INFECT IMMUN, V69, P7074, DOI 10.1128/IAI.69.11.7074-7082.2001; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Silva-Rocha R, 2013, NUCLEIC ACIDS RES, V41, pD666, DOI 10.1093/nar/gks1119; Silva-Rocha R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034675; Silva-Rocha R, 2012, MOL BIOSYST, V8, P1950, DOI 10.1039/c2mb25030f; Silva-Rocha R, 2011, MOL BIOSYST, V7, P2389, DOI 10.1039/c1mb05094j; Silva-Rocha R, 2010, ANNU REV MICROBIOL, V64, P257, DOI 10.1146/annurev.micro.091208.073229; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; THOMAS CM, 1984, EMBO J, V3, P57, DOI 10.1002/j.1460-2075.1984.tb01761.x; TWIGG AJ, 1980, NATURE, V283, P216, DOI 10.1038/283216a0; Unge A, 1999, APPL ENVIRON MICROB, V65, P813; Unge A, 2001, MICROBIAL ECOL, V41, P290; Winson MK, 1998, FEMS MICROBIOL LETT, V163, P193, DOI 10.1111/j.1574-6968.1998.tb13045.x	50	20	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52000	10.1371/journal.pone.0052000	http://dx.doi.org/10.1371/journal.pone.0052000			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23284849	Green Published, gold, Green Submitted			2022-12-27	WOS:000313051500019
J	Ballou, B; Andreko, SK; Osuna-Highley, E; McRaven, M; Catalone, T; Bruchez, MP; Hope, TJ; Labib, ME				Ballou, Byron; Andreko, Susan K.; Osuna-Highley, Elvira; McRaven, Michael; Catalone, Tina; Bruchez, Marcel P.; Hope, Thomas J.; Labib, Mohamed E.			Nanoparticle Transport from Mouse Vagina to Adjacent Lymph Nodes	PLOS ONE			English	Article							BIODEGRADABLE POLYMER NANOPARTICLES; QUANTUM DOTS; HUMAN MUCUS; IN-VITRO; MICROBICIDES; DELIVERY; TRANSMISSION; MICE; INFLAMMATION; IMMUNIZATION	To test the feasibility of localized intravaginal therapy directed to neighboring lymph nodes, the transport of quantum dots across the vaginal wall was investigated. Quantum dots instilled into the mouse vagina were transported across the vaginal mucosa into draining lymph nodes, but not into distant nodes. Most of the particles were transported to the lumbar nodes; far fewer were transported to the inguinal nodes. A low level of transport was evident at 4 hr after intravaginal instillation, and transport peaked at about 36 hr after instillation. Transport was greatly enhanced by prior vaginal instillation of Nonoxynol-9. Hundreds of micrograms of nanoparticles/kg tissue (ppb) were found in the lumbar lymph nodes at 36 hr post-instillation. Our results imply that targeted transport of microbicides or immunogens from the vagina to local lymph organs is feasible. They also offer an in vivo model for assessing the toxicity of compounds intended for intravaginal use.	[Ballou, Byron; Andreko, Susan K.; Osuna-Highley, Elvira; Bruchez, Marcel P.] Carnegie Mellon Univ, MBIC, Pittsburgh, PA 15213 USA; [Osuna-Highley, Elvira] Carnegie Mellon Univ, ICES, Pittsburgh, PA 15213 USA; [McRaven, Michael; Hope, Thomas J.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Catalone, Tina] De Sales Univ, Dept Nat Sci, Ctr Valley, Pittsburgh, PA USA; [Bruchez, Marcel P.] Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA; [Bruchez, Marcel P.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Labib, Mohamed E.] Adv Biodevices, Princeton, NJ USA	Carnegie Mellon University; Carnegie Mellon University; Northwestern University; Feinberg School of Medicine; Carnegie Mellon University; Carnegie Mellon University	Ballou, B (corresponding author), Carnegie Mellon Univ, MBIC, Pittsburgh, PA 15213 USA.	bbal@andrew.cmu.edu	Bruchez, Marcel P/C-2271-2009	Bruchez, Marcel P/0000-0002-7370-4848	National Institutes of Health [R21 AI82738, R33-AI082738-03]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI082738, R21AI082738] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institutes of Health awards R21 AI82738 and R33-AI082738-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Ayehunie S, 2011, TOXICOLOGY, V279, P130, DOI 10.1016/j.tox.2010.10.001; Ballou B, 2004, BIOCONJUGATE CHEM, V15, P79, DOI 10.1021/bc034153y; Ballou B, 2007, BIOCONJUGATE CHEM, V18, P389, DOI 10.1021/bc060261j; Bostick Roberd M, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P3313; Catalone BJ, 2004, ANTIMICROB AGENTS CH, V48, P1837, DOI 10.1128/AAC.48.5.1837-1847.2004; Chakraborty SK, 2007, NANO LETT, V7, P2618, DOI 10.1021/nl0709930; Cone RA, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-90; Cone RA, 2009, ADV DRUG DELIVER REV, V61, P75, DOI 10.1016/j.addr.2008.09.008; Cu Y, 2011, J CONTROL RELEASE, V156, P258, DOI 10.1016/j.jconrel.2011.06.036; Cummins JE, 2009, SEX TRANSM DIS, V36, pS84, DOI 10.1097/OLQ.0b013e3181994191; Czerkinsky C, 2012, CURR TOP MICROBIOL, V354, P1, DOI 10.1007/82_2010_112; Czerkinsky C, 2010, MUCOSAL IMMUNOL, V3, P545, DOI 10.1038/mi.2010.55; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Efimova OI, 2009, B EXP BIOL MED+, V147, P3, DOI 10.1007/s10517-009-0463-9; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; Fogel P, 2009, EVALUATION UNMIXING, P1; Fraillery D, 2009, VACCINE, V27, P2326, DOI 10.1016/j.vaccine.2009.02.029; Genovesio A, 2006, IEEE T IMAGE PROCESS, V15, P1062, DOI 10.1109/TIP.2006.872323; Grant RM, 2008, SCIENCE, V321, P532, DOI 10.1126/science.1160355; Ham AS, 2009, PHARM RES-DORDR, V26, P502, DOI 10.1007/s11095-008-9765-2; Hama Y, 2007, J INVEST DERMATOL, V127, P2351, DOI 10.1038/sj.jid.5700892; Hama Y, 2007, BREAST CANCER RES TR, V103, P23, DOI 10.1007/s10549-006-9347-0; Hillier SL, 2005, JAIDS-J ACQ IMM DEF, V39, P1, DOI 10.1097/01.qai.0000159671.25950.74; Hladik Florian, 2009, Curr HIV/AIDS Rep, V6, P20, DOI 10.1007/s11904-009-0004-1; Ibata B, 1997, BIOL REPROD, V56, P537, DOI 10.1095/biolreprod56.2.537; Inoue Y, 2010, J FLUORESC, V20, P599, DOI 10.1007/s10895-009-0593-5; Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920; King NJC, 1998, J IMMUNOL, V160, P1173; Lagerholm B Christoffer, 2007, Methods Mol Biol, V374, P105; Lagerholm BC, 2004, NANO LETT, V4, P2019, DOI 10.1021/nl049295v; Lai SK, 2007, P NATL ACAD SCI USA, V104, P1482, DOI 10.1073/pnas.0608611104; Lai SK, 2010, P NATL ACAD SCI USA, V107, P598, DOI 10.1073/pnas.0911748107; Lai SK, 2009, J VIROL, V83, P11196, DOI 10.1128/JVI.01899-08; Lai SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004294; Lindqvist M, 2010, MUCOSAL ADJUVANTS TH; Mallipeddi R, 2010, EXPERT OPIN DRUG DEL, V7, P37, DOI 10.1517/17425240903338055; Milligan GN, 2002, SEX TRANSM DIS, V29, P597, DOI 10.1097/00007435-200210000-00006; Moench TR, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-331; PARR MB, 1990, J REPROD IMMUNOL, V17, P101, DOI 10.1016/0165-0378(90)90029-6; Parungo CP, 2007, ANN SURG ONCOL, V14, P286, DOI 10.1245/s10434-006-9044-6; Parungo CP, 2005, CHEST, V127, P1799, DOI 10.1378/chest.127.5.1799; Parungo CP, 2005, J THORAC CARDIOV SUR, V129, P844, DOI 10.1016/j.jtcvs.2004.08.001; Paskaleva BS, 2010, INT GEOSCI REMOTE SE, P2198, DOI 10.1109/IGARSS.2010.5648869; Robe A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-111; SALTZMAN WM, 1994, BIOPHYS J, V66, P508, DOI 10.1016/S0006-3495(94)80802-1; Sherwood JK, 1996, BIOL REPROD, V54, P264, DOI 10.1095/biolreprod54.1.264; Soltesz EG, 2005, ANN THORAC SURG, V79, P269, DOI 10.1016/j.athoracsur.2004.06.055; Tang BC, 2009, P NATL ACAD SCI USA, V106, P19268, DOI 10.1073/pnas.0905998106; Vargas G, 2009, J INFECT DIS, V199, P1546, DOI 10.1086/598221; Vieira OV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002913; Vinegoni C, 2009, OPT LETT, V34, P319, DOI 10.1364/OL.34.000319; Whaley KJ, 2010, ANTIVIR RES, V88, pS55, DOI 10.1016/j.antiviral.2010.09.006; Woodrow KA, 2009, NAT MATER, V8, P526, DOI [10.1038/NMAT2444, 10.1038/nmat2444]	54	20	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e51995	10.1371/journal.pone.0051995	http://dx.doi.org/10.1371/journal.pone.0051995			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284844	gold, Green Submitted, Green Published			2022-12-27	WOS:000313158800019
J	Russell, JA; Funaro, CF; Giraldo, YM; Goldman-Huertas, B; Suh, D; Kronauer, DJC; Moreau, CS; Pierce, NE				Russell, Jacob A.; Funaro, Colin F.; Giraldo, Ysabel M.; Goldman-Huertas, Benjamin; Suh, David; Kronauer, Daniel J. C.; Moreau, Corrie S.; Pierce, Naomi E.			A Veritable Menagerie of Heritable Bacteria from Ants, Butterflies, and Beyond: Broad Molecular Surveys and a Systematic Review	PLOS ONE			English	Article							WOLBACHIA INFECTION; SEX-RATIO; CYTOPLASMIC INCOMPATIBILITY; HORIZONTAL TRANSMISSION; INTRODUCED POPULATIONS; PHYLOGENETIC ANALYSIS; SYMBIONT INFECTION; INDEPENDENT SURVEY; NITROGEN-FIXATION; GUT SYMBIONTS	Maternally transmitted bacteria have been important players in the evolution of insects and other arthropods, affecting their nutrition, defense, development, and reproduction. Wolbachia are the best studied among these and typically the most prevalent. While several other bacteria have independently evolved a heritable lifestyle, less is known about their host ranges. Moreover, most groups of insects have not had their heritable microflora systematically surveyed across a broad range of their taxonomic diversity. To help remedy these shortcomings we used diagnostic PCR to screen for five groups of heritable symbionts-Arsenophonus spp., Cardinium hertigii, Hamiltonella defensa, Spiroplasma spp., and Wolbachia spp.-across the ants and lepidopterans (focusing, in the latter case, on two butterfly families-the Lycaenidae and Nymphalidae). We did not detect Cardinium or Hamiltonella in any host. Wolbachia were the most widespread, while Spiroplasma (ants and lepidopterans) and Arsenophonus (ants only) were present at low levels. Co-infections with different Wolbachia strains appeared especially common in ants and less so in lepidopterans. While no additional facultative heritable symbionts were found among ants using universal bacterial primers, microbes related to heritable enteric bacteria were detected in several hosts. In summary, our findings show that Wolbachia are the dominant heritable symbionts of ants and at least some lepidopterans. However, a systematic review of symbiont frequencies across host taxa revealed that this is not always the case across other arthropods. Furthermore, comparisons of symbiont frequencies revealed that the prevalence of Wolbachia and other heritable symbionts varies substantially across lower-level arthropod taxa. We discuss the correlates, potential causes, and implications of these patterns, providing hypotheses on host attributes that may shape the distributions of these influential bacteria.	[Russell, Jacob A.; Funaro, Colin F.; Suh, David] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Giraldo, Ysabel M.; Goldman-Huertas, Benjamin; Kronauer, Daniel J. C.; Pierce, Naomi E.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Moreau, Corrie S.] Field Museum Nat Hist, Dept Zool, Chicago, IL 60605 USA	Drexel University; Harvard University; Field Museum of Natural History (Chicago)	Russell, JA (corresponding author), Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA.	jar337@drexel.edu	Russell, Jacob A./H-7996-2015	Moreau, Corrie/0000-0003-1139-5792; Goldman-Huertas, Benjamin/0000-0002-6741-5193	National Science Foundation (NSF) [0400889, 1050360]; NSF [1050243]; Division Of Environmental Biology [1050243] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by National Science Foundation (NSF) grants 0400889 and 1050360 to JAR and NSF grant 1050243 to CSM (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KE, 2012, MOL ECOL, V21, P2282, DOI 10.1111/j.1365-294X.2011.05464.x; [Anonymous], 2006, THESIS U TEXAS AUSTI; Baldo L, 2008, MOL ECOL, V17, P557, DOI 10.1111/j.1365-294X.2007.03608.x; Baldo L, 2007, CURR MICROBIOL, V55, P367, DOI 10.1007/s00284-007-9009-4; Bandi C, 1998, P ROY SOC B-BIOL SCI, V265, P2407, DOI 10.1098/rspb.1998.0591; BENEMANN JR, 1973, SCIENCE, V181, P164, DOI 10.1126/science.181.4095.164; Bouwma AM, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.0111; Bressan A, 2012, MICROB ECOL, V63, P628, DOI 10.1007/s00248-011-9933-5; BREZNAK JA, 1973, NATURE, V244, P577, DOI 10.1038/244577a0; Broderick NA, 2004, APPL ENVIRON MICROB, V70, P293, DOI 10.1128/AEM.70.1.293-300.2004; Cafaro MJ, 2005, CAN J MICROBIOL, V51, P441, DOI 10.1139/W05-023; Charlat S, 2003, TRENDS GENET, V19, P217, DOI 10.1016/S0168-9525(03)00024-6; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; Czarnetzki AB, 2004, FEMS MICROBIOL ECOL, V49, P217, DOI 10.1016/j.femsec.2004.03.007; Dedeine F, 2005, MOL ECOL, V14, P1543, DOI 10.1111/j.1365-294X.2005.02499.x; Degnan PH, 2005, GENOME RES, V15, P1023, DOI 10.1101/gr.3771305; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Duron O, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-27; Duron O, 2008, MOL ECOL, V17, P1427, DOI 10.1111/j.1365-294X.2008.03689.x; Duron O, 2010, ECOL LETT, V13, P1139, DOI 10.1111/j.1461-0248.2010.01502.x; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; Engelstadter J, 2009, ANNU REV ECOL EVOL S, V40, P127, DOI 10.1146/annurev.ecolsys.110308.120206; Feldhaar H, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-48; Feldhaar H, 2011, ECOL ENTOMOL, V36, P533, DOI 10.1111/j.1365-2311.2011.01318.x; Funaro CF, 2011, APPL ENVIRON MICROB, V77, P346, DOI 10.1128/AEM.01896-10; Grindle N, 2003, J INVERTEBR PATHOL, V83, P264, DOI 10.1016/S0022-2011(03)00080-6; Hail D, 2011, ENVIRON ENTOMOL, V40, P23, DOI 10.1603/EN10115; Hansen AK, 2007, APPL ENVIRON MICROB, V73, P7531, DOI 10.1128/AEM.01672-07; Haselkorn TS, 2009, MOL ECOL, V18, P1294, DOI 10.1111/j.1365-294X.2009.04085.x; He H, 2011, ENVIRON ENTOMOL, V40, P1405, DOI 10.1603/EN11157; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Hiroki M, 2002, NATURWISSENSCHAFTEN, V89, P167, DOI 10.1007/s00114-002-0303-5; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Hurst GDD, 1999, P ROY SOC B-BIOL SCI, V266, P735, DOI 10.1098/rspb.1999.0698; Ishak HD, 2011, MICROB ECOL, V61, P821, DOI 10.1007/s00248-010-9793-4; Jaenike J, 2010, SCIENCE, V329, P212, DOI 10.1126/science.1188235; Jiggins FM, 2000, PARASITOLOGY, V120, P439, DOI 10.1017/S0031182099005867; Jiggins FM, 2001, P ROY SOC B-BIOL SCI, V268, P1123, DOI 10.1098/rspb.2001.1632; Jones RT, 2011, APPL ENVIRON MICROB, V77, P8345, DOI 10.1128/AEM.05974-11; Keller L, 2001, HEREDITY, V87, P227, DOI 10.1046/j.1365-2540.2001.00918.x; Kikuchi Y, 2012, P NATL ACAD SCI USA, V109, P8618, DOI 10.1073/pnas.1200231109; Kittayapong P, 2003, MOL ECOL, V12, P1049, DOI 10.1046/j.1365-294X.2003.01793.x; Kyei-Poku GK, 2005, MOL ECOL, V14, P285, DOI 10.1111/j.1365-294X.2004.02409.x; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li HW, 2005, J INVERTEBR PATHOL, V89, P203, DOI 10.1016/j.jip.2005.05.008; MADDISON WP, 2003, MACCLADE ANAL PHYLOG; Martin OY, 2009, J ARACHNOL, V37, P106, DOI 10.1636/SH08-05.1; Mateos M, 2006, GENETICS, V174, P363, DOI 10.1534/genetics.106.058818; Medina F, 2009, CURR MICROBIOL, V58, P478, DOI 10.1007/s00284-008-9350-2; Miller M.A., 2011, CIPRES PORTALS; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Moreau CS, 2009, MYRMECOL NEWS, V12, P201; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Mueller UG, 2008, EVOLUTION, V62, P2894, DOI 10.1111/j.1558-5646.2008.00501.x; Novakova E, 2007, FEMS MICROBIOL LETT, V269, P131, DOI 10.1111/j.1574-6968.2006.00620.x; Novakova E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-143; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; ONEILL SL, 1992, P NATL ACAD SCI USA, V89, P2699, DOI 10.1073/pnas.89.7.2699; Perlman SJ, 2006, P ROY SOC B-BIOL SCI, V273, P2097, DOI 10.1098/rspb.2006.3541; Perlman SJ, 2010, J INVERTEBR PATHOL, V103, P150, DOI 10.1016/j.jip.2009.12.009; Pinto-Tomas AA, 2011, ENVIRON ENTOMOL, V40, P1111, DOI 10.1603/EN11083; Reuter M, 2003, MOL BIOL EVOL, V20, P748, DOI 10.1093/molbev/msg082; Riegler M, 2002, MOL ECOL, V11, P2425, DOI 10.1046/j.1365-294X.2002.01614.x; Rokas A, 2002, MOL ECOL, V11, P1815, DOI 10.1046/j.1365-294X.2002.01556.x; ROUSSET F, 1992, P ROY SOC B-BIOL SCI, V250, P91, DOI 10.1098/rspb.1992.0135; Russell JA, 2006, P ROY SOC B-BIOL SCI, V273, P603, DOI 10.1098/rspb.2005.3348; Russell JA, 2003, MOL ECOL, V12, P1061, DOI 10.1046/j.1365-294X.2003.01780.x; Russell JA, 2012, MYRMECOL NEWS, V16, P7; Russell JA, 2009, P NATL ACAD SCI USA, V106, P21236, DOI 10.1073/pnas.0907926106; Russell JA, 2009, EVOLUTION, V63, P624, DOI 10.1111/j.1558-5646.2008.00579.x; Sasaki T, 1999, ZOOL SCI, V16, P739, DOI 10.2108/zsj.16.739; Sauer C, 2000, INT J SYST EVOL MICR, V50, P1877, DOI 10.1099/00207713-50-5-1877; Schilthuizen M, 1997, P ROY SOC B-BIOL SCI, V264, P361, DOI 10.1098/rspb.1997.0052; Sebastien A, 2012, INSECT SOC, V59, P33, DOI 10.1007/s00040-011-0184-8; Shoemaker DD, 2000, INSECT MOL BIOL, V9, P661, DOI 10.1046/j.1365-2583.2000.00233.x; Sirvio A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-335; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stoll S, 2007, BIOL J LINN SOC, V90, P399, DOI 10.1111/j.1095-8312.2006.00730.x; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; SWOFFORD DL, 2001, PAUP; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Tsutsui ND, 2003, MOL ECOL, V12, P3057, DOI 10.1046/j.1365-294X.2003.01979.x; Tufts DM, 2009, ENVIRON ENTOMOL, V38, P1360, DOI 10.1603/022.038.0502; van Borm S, 2002, P ROY SOC B-BIOL SCI, V269, P2023, DOI 10.1098/rspb.2002.2101; Van Borm S, 2001, J EVOLUTION BIOL, V14, P805, DOI 10.1046/j.1420-9101.2001.00321.x; Vavre F, 1999, MOL BIOL EVOL, V16, P1711, DOI 10.1093/oxfordjournals.molbev.a026084; Weeks AR, 2003, P ROY SOC B-BIOL SCI, V270, P1857, DOI 10.1098/rspb.2003.2425; Weinert LA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-6; Wenseleers T, 1998, P ROY SOC B-BIOL SCI, V265, P1447, DOI 10.1098/rspb.1998.0456; Wenseleers T, 2002, P ROY SOC B-BIOL SCI, V269, P623, DOI 10.1098/rspb.2001.1927; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V262, P197, DOI 10.1098/rspb.1995.0196; West SA, 1998, MOL ECOL, V7, P1457, DOI 10.1046/j.1365-294x.1998.00467.x; Woyke T, 2006, NATURE, V443, P950, DOI 10.1038/nature05192; Xie JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012149; Zaspel JM, 2008, ANN ENTOMOL SOC AM, V101, P1050, DOI 10.1603/0013-8746-101.6.1050; Zchori-Fein E, 2004, MOL ECOL, V13, P2009, DOI 10.1111/j.1365-294X.2004.02203.x; Zchori-Fein E, 2002, ANN ENTOMOL SOC AM, V95, P711, DOI 10.1603/0013-8746(2002)095[0711:DOPAWB]2.0.CO;2	102	88	89	1	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51027	10.1371/journal.pone.0051027	http://dx.doi.org/10.1371/journal.pone.0051027			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284655	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500019
J	Schwender, H; Selinski, S; Blaszkewicz, M; Marchan, R; Ickstadt, K; Golka, K; Hengstler, JG				Schwender, Holger; Selinski, Silvia; Blaszkewicz, Meinolf; Marchan, Rosemarie; Ickstadt, Katja; Golka, Klaus; Hengstler, Jan G.			Distinct SNP Combinations Confer Susceptibility to Urinary Bladder Cancer in Smokers and Non-Smokers	PLOS ONE			English	Article							C802T HIS(268)TYR POLYMORPHISM; GLUTATHIONE S-TRANSFERASES; OCCUPATIONAL RISK-FACTORS; GENOME-WIDE ASSOCIATION; NAT2 SLOW ACETYLATION; POOLED ANALYSIS; UDP-GLUCURONOSYLTRANSFERASES; CIGARETTE-SMOKING; UROTHELIAL CANCER; SEQUENCE VARIANT	Recently, genome-wide association studies have identified and validated genetic variations associated with urinary bladder cancer (UBC). However, it is still unknown whether the high-risk alleles of several SNPs interact with one another, leading to an even higher disease risk. Additionally, there is no information available on how the UBC risk due to these SNPs compare to the risk of cigarette smoking and to occupational exposure to urinary bladder carcinogens, and whether the same or different SNP combinations are relevant in smokers and non-smokers. To address these questions, we analyzed the genotypes of six SNPs, previously found to be associated with UBC, together with the GSTM1 deletion, in 1,595 UBC cases and 1,760 controls, stratified for smoking habits. We identified the strongest interactions of different orders and tested the stability of their effect by bootstrapping. We found that different SNP combinations were relevant in smokers and nonsmokers. In smokers, polymorphisms involved in detoxification of cigarette smoke carcinogens were most relevant (GSTM1, rs11892031), in contrast to those in non-smokers with MYC and APOBEC3A near polymorphisms (rs9642880, rs1014971) being the most influential. Stable combinations of up to three high-risk alleles resulted in higher odds ratios (OR) than the individual SNPs, although the interaction effect was less than additive. The highest stable combination effects resulted in an OR of about 2.0, which is still lower than the ORs of cigarette smoking (here, current smokers' OR: 3.28) and comparable to occupational carcinogen exposure risks which, depending on the workplace, show mostly ORs up to 2.0.	[Schwender, Holger] Univ Dusseldorf, Math Inst, D-40225 Dusseldorf, Germany; [Selinski, Silvia; Blaszkewicz, Meinolf; Marchan, Rosemarie; Golka, Klaus; Hengstler, Jan G.] Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany; [Ickstadt, Katja] TU Dortmund Univ, Fac Stat, Dortmund, Germany	Heinrich Heine University Dusseldorf; Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); Dortmund University of Technology	Schwender, H (corresponding author), Univ Dusseldorf, Math Inst, D-40225 Dusseldorf, Germany.	schwender@math.uni-duesseldorf.de	Hengstler, Jan G./O-1415-2013	Marchan, Rosemarie/0000-0003-4414-1633; Hengstler, Jan/0000-0002-1427-5246	Deutsche Forschungsgemeinschaft [C4, SCHW 1508/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Project C4 of the SFB 876 "Providing Information by Resource-Constrained Data Analysis" to KI and grant SCHW 1508/3-1 to HS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arand M, 1996, ANAL BIOCHEM, V236, P184, DOI 10.1006/abio.1996.0153; BELL DA, 1993, J NATL CANCER I, V85, P1159, DOI 10.1093/jnci/85.14.1159; Bolm-Audorff U, 1993, REPORT SERIES FEDERA; Bolt HM, 2006, CURR DRUG METAB, V7, P613, DOI 10.2174/138920006778017786; Brennan P, 2000, INT J CANCER, V86, P289, DOI 10.1002/(SICI)1097-0215(20000415)86:2<289::AID-IJC21>3.0.CO;2-M; Brennan P, 2001, CANCER CAUSE CONTROL, V12, P411, DOI 10.1023/A:1011214222810; Carreon T, 2006, FRONT BIOSCI-LANDMRK, V11, P2889, DOI 10.2741/2017; CARTWRIGHT RA, 1982, LANCET, V2, P842; Colt JS, 2004, CANCER CAUSE CONTROL, V15, P759, DOI 10.1023/B:CACO.0000043426.28741.a2; CORDIER S, 1993, INT J EPIDEMIOL, V22, P403, DOI 10.1093/ije/22.3.403; Delclos GL, 2008, SCAND J UROL NEPHROL, V42, P58, DOI 10.1080/03008880802284423; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Engel LS, 2002, AM J EPIDEMIOL, V156, P95, DOI 10.1093/aje/kwf018; Federico A, 2009, CANCER RES, V69, P7079, DOI 10.1158/0008-5472.CAN-09-1542; Gandini S, 2008, INT J CANCER, V122, P155, DOI 10.1002/ijc.23033; Garcia-Closas M, 2005, LANCET, V366, P649, DOI 10.1016/S0140-6736(05)67137-1; Garcia-Closas M, 2011, PHARMACOGENET GENOM, V21, P231, DOI 10.1097/FPC.0b013e32833e1b54; Giuliani L, 2005, ONCOL REP, V13, P185; Giuliani L, 2001, INT J CANCER, V91, P141, DOI 10.1002/1097-0215(20010101)91:1<141::AID-IJC1005>3.0.CO;2-H; Golka, 1997, Int J Occup Environ Health, V3, P105; Golka K, 1999, UROLOGE A, V38, P358, DOI 10.1007/s001200050298; Golka K, 2004, WORLD J UROL, V21, P382, DOI 10.1007/s00345-003-0377-5; Golka K, 2002, TOXICOL LETT, V128, P229, DOI 10.1016/S0378-4274(01)00544-6; Golka K, 1998, Int J Occup Environ Health, V4, P79; Golka K, 1996, SCAND J WORK ENV HEA, V22, P332, DOI 10.5271/sjweh.150; Golka K, 2007, DTSCH ARZTEBL INT, V104, pA719; Golka Klaus, 2012, Front Biosci (Elite Ed), V4, P2709; Golka K, 2011, ARCH TOXICOL, V85, P539, DOI 10.1007/s00204-011-0676-3; Golka K, 2009, PHARMACOGENET GENOM, V19, P903, DOI 10.1097/FPC.0b013e328331b554; Guha N, 2010, OCCUP ENVIRON MED, V67, P568, DOI 10.1136/oem.2009.051565; Hengstler JG, 1998, RECENT RES CANCER, V154, P47; Hengstler JG, 2000, DRUG METAB REV, V32, P81, DOI 10.1081/DMR-100100564; Kempkes M, 1996, ARCH TOXICOL, V71, P123, DOI 10.1007/s002040050366; KETTERER B, 1992, ENVIRON HEALTH PERSP, V98, P87, DOI 10.2307/3431252; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Kiemeney LA, 2010, NAT GENET, V42, P415, DOI 10.1038/ng.558; KOFF A, 1991, CELL, V66, P1217, DOI 10.1016/0092-8674(91)90044-Y; Krause G, 2004, ANAL HAZARDOUS SUBST, V9, P183; Lee KH, 2002, J TOXICOL ENV HEAL A, V65, P355, DOI 10.1080/15287390252808028; Lefkimmiatis K, 2009, CANCER RES, V69, P8563, DOI 10.1158/0008-5472.CAN-09-0259; Lehmann ML, 2010, ARCH TOXICOL, V84, P967, DOI 10.1007/s00204-010-0617-6; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lin GF, 2005, TOXICOL SCI, V85, P502, DOI 10.1093/toxsci/kfi068; Moore LE, 2011, CARCINOGENESIS, V32, P182, DOI 10.1093/carcin/bgq223; MYSLAK ZW, 1991, AM J IND MED, V19, P705, DOI 10.1002/ajim.4700190604; Ovsiannikov D, 2012, J TOXICOL ENV HEAL A, V75, P557, DOI 10.1080/15287394.2012.675308; Puente D, 2006, CANCER CAUSE CONTROL, V17, P71, DOI 10.1007/s10552-005-0389-0; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Rafnar T, 2011, HUM MOL GENET, V20, P4268, DOI 10.1093/hmg/ddr303; Reulen RC, 2008, SCAND J UROL NEPHROL, V42, P64, DOI 10.1080/03008880802325192; Rothman N, 2010, NAT GENET, V42, P978, DOI 10.1038/ng.687; Rushton L, 2010, BRIT J CANCER, V102, P1428, DOI 10.1038/sj.bjc.6605637; Sayan BS, 2007, P NATL ACAD SCI USA, V104, P10871, DOI 10.1073/pnas.0700761104; SCHIFFLERS E, 1987, INT J CANCER, V39, P287, DOI 10.1002/ijc.2910390304; Selinski S, 2012, ARCH TOXICOL, V86, P195, DOI 10.1007/s00204-011-0747-5; Selinski S, 2011, PHARMACOGENET GENOM, V21, P673, DOI 10.1097/FPC.0b013e3283493a23; SILVERMAN DT, 1989, JNCI-J NATL CANCER I, V81, P1472, DOI 10.1093/jnci/81.19.1472; Steenland K, 2006, EPIDEMIOLOGY, V17, P512, DOI 10.1097/01.ede.0000229155.05644.43; Strassburg CP, 2008, ARCH TOXICOL, V82, P415, DOI 10.1007/s00204-008-0314-x; Tang W, 2012, HUM MOL GENET, V21, P1918, DOI 10.1093/hmg/ddr619; THERIAULT G, 1984, LANCET, V1, P947; Vartanian JP, 2008, SCIENCE, V320, P230, DOI 10.1126/science.1153201; Vineis P, 1997, CANCER CAUSE CONTROL, V8, P346, DOI 10.1023/A:1018453104303; Vineis P, 2001, CANCER EPIDEM BIOMAR, V10, P1249; Vineis P, 2002, TOXICOLOGY, V181, P457, DOI 10.1016/S0300-483X(02)00450-X; Wu XF, 2009, NAT GENET, V41, P991, DOI 10.1038/ng.421; Yu MC, 2002, MUTAT RES-FUND MOL M, V506, P21, DOI 10.1016/S0027-5107(02)00148-3; Zenser TV, 2002, MUTAT RES-FUND MOL M, V506, P29, DOI 10.1016/S0027-5107(02)00149-5; Zhang RG, 2011, MOL BIOL REP, V38, P2491, DOI 10.1007/s11033-010-0386-6; Zimmermann A, 2008, J TOXICOL ENV HEAL A, V71, P911, DOI 10.1080/15287390801988772	71	31	31	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51880	10.1371/journal.pone.0051880	http://dx.doi.org/10.1371/journal.pone.0051880			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284801	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500060
J	Simister, R; Taylor, MW; Tsai, P; Webster, N				Simister, Rachel; Taylor, Michael W.; Tsai, Peter; Webster, Nicole			Sponge-Microbe Associations Survive High Nutrients and Temperatures	PLOS ONE			English	Article							GREAT-BARRIER-REEF; AMMONIA-OXIDIZING ARCHAEA; 16S RIBOSOMAL-RNA; WATER-QUALITY; CORAL-REEFS; RHOPALOEIDES-ODORABILE; BACTERIAL COMMUNITIES; SUSPENDED SEDIMENTS; NITROGEN-FIXATION; ORGANIC-MATTER	Coral reefs are under considerable pressure from global stressors such as elevated sea surface temperature and ocean acidification, as well as local factors including eutrophication and poor water quality. Marine sponges are diverse, abundant and ecologically important components of coral reefs in both coastal and offshore environments. Due to their exceptionally high filtration rates, sponges also form a crucial coupling point between benthic and pelagic habitats. Sponges harbor extensive microbial communities, with many microbial phylotypes found exclusively in sponges and thought to contribute to the health and survival of their hosts. Manipulative experiments were undertaken to ascertain the impact of elevated nutrients and seawater temperature on health and microbial community dynamics in the Great Barrier Reef sponge Rhopaloeides odorabile. R. odorabile exposed to elevated nutrient levels including 10 mu mol/L total nitrogen at 31 degrees C appeared visually similar to those maintained under ambient seawater conditions after 7 days. The symbiotic microbial community, analyzed by 16S rRNA gene pyrotag sequencing, was highly conserved for the duration of the experiment at both phylum and operational taxonomic unit (OTU) (97% sequence similarity) levels with 19 bacterial phyla and 1743 OTUs identified across all samples. Additionally, elevated nutrients and temperatures did not alter the archaeal associations in R. odorabile, with sequencing of 16S rRNA gene libraries revealing similar Thaumarchaeota diversity and denaturing gradient gel electrophoresis (DGGE) revealing consistent amoA gene patterns, across all experimental treatments. A conserved eukaryotic community was also identified across all nutrient and temperature treatments by DGGE. The highly stable microbial associations indicate that R. odorabile symbionts are capable of withstanding short-term exposure to elevated nutrient concentrations and sub-lethal temperatures.	[Webster, Nicole] Australian Inst Marine Sci, Townsville Mail Ctr, Townsville, Qld 4810, Australia; [Simister, Rachel; Taylor, Michael W.] Univ Auckland, Ctr Microbial Innovat, Auckland 1, New Zealand; [Tsai, Peter] Univ Auckland, Sch Biol Sci, Bioinformat Inst, Auckland 1, New Zealand	Australian Institute of Marine Science; University of Auckland; University of Auckland	Webster, N (corresponding author), Australian Inst Marine Sci, Townsville Mail Ctr, PMB 3, Townsville, Qld 4810, Australia.	n.webster@aims.gov.au	Webster, Nicole S/G-4980-2011	Webster, Nicole S/0000-0002-4753-5278; Taylor, Michael/0000-0002-0463-7813; Tsai, Peter/0000-0002-9930-9029	University of Auckland Doctoral Scholarship; University of Auckland [3622989]	University of Auckland Doctoral Scholarship; University of Auckland	Research was supported by a University of Auckland Doctoral Scholarship to RLS and University of Auckland grant 3622989 to MWT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2001, GBRMPA RES PUBLICATI; Bainbridge ZT, 2012, MAR POLLUT BULL, V65, P236, DOI 10.1016/j.marpolbul.2012.01.043; Bannister R, 2008, THESIS JCU TOWNSVILL; Bannister RJ, 2012, CONT SHELF RES, V32, P86, DOI 10.1016/j.csr.2011.10.018; Bannister RJ, 2010, MAR FRESHWATER RES, V61, P389, DOI 10.1071/MF09067; Bayer K, 2008, ENVIRON MICROBIOL, V10, P2942, DOI 10.1111/j.1462-2920.2008.01582.x; Bell JJ, 2008, ESTUAR COAST SHELF S, V79, P341, DOI 10.1016/j.ecss.2008.05.002; BRODIE J, 1996, DOWNSTREAM EFFECTS L, P367; Brodie JE, 2012, MAR POLLUT BULL, V65, P81, DOI 10.1016/j.marpolbul.2011.12.012; Brodie JE, 2011, BIOGEOCHEMISTRY, V106, P281, DOI 10.1007/s10533-010-9542-2; Brodie JE, 2005, MAR FRESHWATER RES, V56, P279, DOI 10.1071/MF04081; Brodie J, 2012, ESTUAR COAST SHELF S, V104, P1, DOI 10.1016/j.ecss.2012.03.012; Brodie J, 2010, MAR FRESHWATER RES, V61, P651, DOI 10.1071/MF08030; Bruno JF, 2003, ECOL LETT, V6, P1056, DOI 10.1046/j.1461-0248.2003.00544.x; Carlson CA, 2002, AQUAT MICROB ECOL, V30, P19, DOI 10.3354/ame030019; Carlson CA, 2009, ISME J, V3, P283, DOI 10.1038/ismej.2008.117; Caron DA, 2000, AQUAT MICROB ECOL, V22, P175, DOI 10.3354/ame022175; Cebrian E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020211; Cervino JM, 2006, MAR ECOL PROG SER, V324, P139, DOI 10.3354/meps324139; Chen YW, 2003, J PLANKTON RES, V25, P445, DOI 10.1093/plankt/25.4.445; Crow JM, 2011, NATURE, DOI [10.1038/news.2011.21, DOI 10.1038/NEWS.2011.21]; Crump BC, 2007, APPL ENVIRON MICROB, V73, P6802, DOI 10.1128/AEM.00648-07; De'ath G, 2010, ECOL APPL, V20, P840, DOI 10.1890/08-2023.1; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Devlin MJ, 2005, MAR POLLUT BULL, V51, P9, DOI 10.1016/j.marpolbul.2004.10.037; Diaz MC, 2004, B MUS I BIOL U GEN, V68, P279; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Ferrier-Pages C, 2000, CORAL REEFS, V19, P103, DOI 10.1007/s003380000078; Ferris MJ, 1996, APPL ENVIRON MICROB, V62, P340, DOI 10.1128/AEM.62.2.340-346.1996; Fiore CL, 2010, TRENDS MICROBIOL, V18, P455, DOI 10.1016/j.tim.2010.07.001; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; Garren M, 2012, ISME J, V6, P1159, DOI 10.1038/ismej.2011.180; Garren M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007319; GERRODETTE T, 1979, MAR BIOL, V55, P103, DOI 10.1007/BF00397305; Gochfeld DJ, 2012, MAR ECOL PROG SER, V456, P101, DOI 10.3354/meps09716; Hentschel U, 2002, APPL ENVIRON MICROB, V68, P4431, DOI 10.1128/AEM.68.9.4431-4440.2002; Hentschel U, 2012, NAT REV MICROBIOL, V10, P641, DOI 10.1038/nrmicro2839; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoffmann F, 2009, ENVIRON MICROBIOL, V11, P2228, DOI 10.1111/j.1462-2920.2009.01944.x; Humphrey C, 2008, CORAL REEFS, V27, P837, DOI 10.1007/s00338-008-0408-1; Hyde KD, 1998, BIODIVERS CONSERV, V7, P1147, DOI 10.1023/A:1008823515157; IPCC, 2007, CLIM CHANG 2007 PHYS; Joachimiak MP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-225; Kaczmarsky L, 2011, CORAL REEFS, V30, P253, DOI 10.1007/s00338-010-0686-2; Kim K, 2002, ASPERGILLOSIS SEA FA, P813; Kline DI, 2006, MAR ECOL PROG SER, V314, P119, DOI 10.3354/meps314119; Klotzbach PJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025881; Koop K, 2001, MAR POLLUT BULL, V42, P91, DOI 10.1016/S0025-326X(00)00181-8; Kroon FJ, 2012, MAR POLLUT BULL, V65, P167, DOI 10.1016/j.marpolbul.2011.10.018; Kroon FJ, 2012, MAR POLLUT BULL, V65, P261, DOI 10.1016/j.marpolbul.2011.10.030; Lee OO, 2011, ISME J, V5, P650, DOI 10.1038/ismej.2010.165; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Lemoine N, 2007, PORIFERA RES BIODIVE; Looney EE, 2010, ENVIRON MICROBIOL, V12, P2479, DOI 10.1111/j.1462-2920.2010.02221.x; Lopez-Legentil S, 2008, MOL ECOL, V17, P1840, DOI 10.1111/j.1365-294X.2008.03667.x; Lopez-Legentil S, 2010, MICROB ECOL, V60, P561, DOI 10.1007/s00248-010-9662-1; Louden D, 2007, AQUACULTURE, V270, P57, DOI 10.1016/j.aquaculture.2007.02.038; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MARTINEZMURCIA AJ, 1995, FEMS MICROBIOL ECOL, V17, P247, DOI 10.1111/j.1574-6941.1995.tb00149.x; Maso M, 2006, MAR POLLUT BULL, V53, P620, DOI 10.1016/j.marpolbul.2006.08.006; Massaro AJ, 2012, J EXP MAR BIOL ECOL, V416, P55, DOI 10.1016/j.jembe.2012.02.008; Meyer B, 2008, MICROB ECOL, V56, P306, DOI 10.1007/s00248-007-9348-5; Meyer-Reil LA, 2000, MAR POLLUT BULL, V41, P255, DOI 10.1016/S0025-326X(00)00114-4; Mincer TJ, 2007, ENVIRON MICROBIOL, V9, P1162, DOI 10.1111/j.1462-2920.2007.01239.x; Mohamed NM, 2008, ENVIRON MICROBIOL, V10, P2910, DOI 10.1111/j.1462-2920.2008.01704.x; Mohamed NM, 2010, ISME J, V4, P38, DOI 10.1038/ismej.2009.84; Morris RM, 2005, LIMNOL OCEANOGR, V50, P1687, DOI 10.4319/lo.2005.50.5.1687; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Negri AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019703; Nogales B, 2011, FEMS MICROBIOL REV, V35, P275, DOI 10.1111/j.1574-6976.2010.00248.x; Off S, 2010, APPL ENVIRON MICROB, V76, P4640, DOI 10.1128/AEM.00320-10; Ovreas L, 2003, AQUAT MICROB ECOL, V31, P109, DOI 10.3354/ame031109; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Pantile R, 2011, MAR ECOL PROG SER, V431, P97, DOI 10.3354/meps09128; Preston CM, 1996, P NATL ACAD SCI USA, V93, P6241, DOI 10.1073/pnas.93.13.6241; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Radax R, 2012, ENVIRON MICROBIOL, V14, P909, DOI 10.1111/j.1462-2920.2011.02661.x; Riegman R, 1995, WATER SCI TECHNOL, V32, P63, DOI 10.1016/0273-1223(95)00682-6; Roberts DE, 2006, MAR ECOL PROG SER, V307, P143, DOI 10.3354/meps307143; RYLE VD, 1981, AIMS OCEANOGRAPHY SE, V3; Schafer H, 2001, FEMS MICROBIOL ECOL, V34, P243, DOI 10.1016/S0168-6496(00)00102-1; Schaffelke B, 2012, MAR POLLUT BULL, V65, P249, DOI 10.1016/j.marpolbul.2011.10.031; Schlappy ML, 2010, MAR BIOL, V157, P593, DOI 10.1007/s00227-009-1344-5; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmitt S, 2012, HYDROBIOLOGIA, V687, P341, DOI 10.1007/s10750-011-0799-9; Schmitt S, 2012, ISME J, V6, P564, DOI 10.1038/ismej.2011.116; Shi YM, 2012, ENVIRON MICROBIOL, V14, P191, DOI 10.1111/j.1462-2920.2011.02598.x; Simister R, 2012, ENVIRON MICROBIOL, V14, P3232, DOI 10.1111/1462-2920.12010; Simister RL, 2012, ENVIRON MICROBIOL, V14, P517, DOI 10.1111/j.1462-2920.2011.02664.x; Simister RL, 2011, J EXP MAR BIOL ECOL, V397, P38, DOI 10.1016/j.jembe.2010.11.004; Sipura J, 2005, J PLANKTON RES, V27, P1261, DOI 10.1093/plankt/fbi092; Smit E, 1997, FEMS MICROBIOL ECOL, V23, P249, DOI 10.1111/j.1574-6941.1997.tb00407.x; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Steger D, 2008, ENVIRON MICROBIOL, V10, P1087, DOI 10.1111/j.1462-2920.2007.01515.x; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Taylor MW, 2013, ISME J, V7, P438, DOI 10.1038/ismej.2012.111; Teira E, 2010, AQUAT MICROB ECOL, V60, P299, DOI 10.3354/ame01435; Thurber RV, 2009, ENVIRON MICROBIOL, V11, P2148, DOI 10.1111/j.1462-2920.2009.01935.x; Uthicke S, 2012, CORAL REEFS, V31, P401, DOI 10.1007/s00338-011-0851-2; Voss JD, 2006, CORAL REEFS, V25, P569, DOI 10.1007/s00338-006-0131-8; Webster AJ, 2012, MAR POLLUT BULL, V65, P128, DOI 10.1016/j.marpolbul.2012.02.023; Webster NS, 2008, ISME J, V2, P830, DOI 10.1038/ismej.2008.42; Webster NS, 2011, ENV MICROBIOL REP, V3, P756, DOI 10.1111/j.1758-2229.2011.00296.x; Webster NS, 2011, MAR BIOTECHNOL, V13, P296, DOI 10.1007/s10126-010-9300-4; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x; Webster NS, 2001, MAR BIOTECHNOL, V3, P600, DOI 10.1007/s10126-001-0065-7; Weisz JB, 2007, MAR BIOL, V152, P475, DOI 10.1007/s00227-007-0708-y; Whalan S, 2007, MAR BIOL, V153, P163, DOI 10.1007/s00227-007-0792-z; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wiedenmann J, 2013, NAT CLIM CHANGE, V3, P160, DOI 10.1038/NCLIMATE1661; Wilkinson Clive R., 1992, P111; WILKINSON CR, 1979, NATURE, V279, P527, DOI 10.1038/279527a0; Witt V, 2012, AQUAT MICROB ECOL, V66, P117, DOI 10.3354/ame01562; Wooldridge SA, 2009, MAR POLLUT BULL, V58, P745, DOI 10.1016/j.marpolbul.2008.12.013; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103	121	52	52	1	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52220	10.1371/journal.pone.0052220	http://dx.doi.org/10.1371/journal.pone.0052220			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284943	gold, Green Published, Green Submitted			2022-12-27	WOS:000312794500118
J	Steiner, CF				Steiner, Christopher F.			Environmental Noise, Genetic Diversity and the Evolution of Evolvability and Robustness in Model Gene Networks	PLOS ONE			English	Article							HETEROGENEOUS ENVIRONMENT; DELETERIOUS MUTATIONS; CANALIZATION; VARIABILITY; EPISTASIS; FITNESS; POLYMORPHISM; MODULARITY; COLOR	The ability of organisms to adapt and persist in the face of environmental change is accepted as a fundamental feature of natural systems. More contentious is whether the capacity of organisms to adapt (or "evolvability") can itself evolve and the mechanisms underlying such responses. Using model gene networks, I provide evidence that evolvability emerges more readily when populations experience positively autocorrelated environmental noise (red noise) compared to populations in stable or randomly varying (white noise) environments. Evolvability was correlated with increasing genetic robustness to effects on network viability and decreasing robustness to effects on phenotypic expression; populations whose networks displayed greater viability robustness and lower phenotypic robustness produced more additive genetic variation and adapted more rapidly in novel environments. Patterns of selection for robustness varied antagonistically with epistatic effects of mutations on viability and phenotypic expression, suggesting that trade-offs between these properties may constrain their evolutionary responses. Evolution of evolvability and robustness was stronger in sexual populations compared to asexual populations indicating that enhanced genetic variation under fluctuating selection combined with recombination load is a primary driver of the emergence of evolvability. These results provide insight into the mechanisms potentially underlying rapid adaptation as well as the environmental conditions that drive the evolution of genetic interactions.	Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA	Wayne State University	Steiner, CF (corresponding author), Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.	csteiner@wayne.edu			National Science Foundation [DEB-0610532]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation, nsf.gov, (grant DEB-0610532). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, MATLAB VERS 7 10; Azevedo RBR, 2006, NATURE, V440, P87, DOI 10.1038/nature04488; Bergman A, 2003, NATURE, V424, P549, DOI 10.1038/nature01765; Carrascal LM, 2009, OIKOS, V118, P681, DOI 10.1111/j.1600-0706.2008.16881.x; Ciliberti S, 2007, P NATL ACAD SCI USA, V104, P13591, DOI 10.1073/pnas.0705396104; Ciliberti S, 2007, PLOS COMPUT BIOL, V3, P164, DOI 10.1371/journal.pcbi.0030015; Crombach A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000112; Cuddington KM, 1999, P ROY SOC B-BIOL SCI, V266, P969, DOI 10.1098/rspb.1999.0731; Davidson EH, 2006, REG GEN GEN REG; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; Draghi J, 2009, J EVOLUTION BIOL, V22, P599, DOI 10.1111/j.1420-9101.2008.01663.x; Drake JW, 1998, GENETICS, V148, P1667; Earl DJ, 2004, P NATL ACAD SCI USA, V101, P11531, DOI 10.1073/pnas.0404656101; Elena SF, 2007, EVOLUTION, V61, P666, DOI 10.1111/j.1558-5646.2007.00064.x; Elena SF, 1997, NATURE, V390, P395, DOI 10.1038/37108; Emlen J., 1973, ECOLOGY EVOLUTIONARY; Erwin DH, 2009, NAT REV GENET, V10, P141, DOI 10.1038/nrg2499; Halley JM, 1996, TRENDS ECOL EVOL, V11, P33, DOI 10.1016/0169-5347(96)81067-6; HEDRICK PW, 1976, GENETICS, V84, P145; HEDRICK PW, 1986, ANNU REV ECOL SYST, V17, P535; HOEKSTRA RF, 1985, GENET RES, V45, P299, DOI 10.1017/S001667230002228X; Inchausti P, 2002, EVOL ECOL RES, V4, P1033; Kashtan N, 2005, P NATL ACAD SCI USA, V102, P13773, DOI 10.1073/pnas.0503610102; Kassen R, 2002, J EVOLUTION BIOL, V15, P173, DOI 10.1046/j.1420-9101.2002.00377.x; Kawecki TJ, 2000, EVOLUTION, V54, P1, DOI 10.1111/j.0014-3820.2000.tb00001.x; Kawecki TJ, 2000, P ROY SOC B-BIOL SCI, V267, P1315, DOI 10.1098/rspb.2000.1144; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kondrashov AS, 1996, GENET RES, V68, P157, DOI 10.1017/S0016672300034042; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; Lenski RE, 1999, NATURE, V400, P661, DOI 10.1038/23245; Lenski RE, 2006, PLOS BIOL, V4, P2190, DOI 10.1371/journal.pbio.0040428; LEVINS R, 1967, GENETICS, V56, P163; Lynch M, 2007, NAT REV GENET, V8, P803, DOI 10.1038/nrg2192; Lynch M, 2007, P NATL ACAD SCI USA, V104, P8597, DOI 10.1073/pnas.0702207104; Parter M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-169; Petchey OL, 2000, P ROY SOC B-BIOL SCI, V267, P747, DOI 10.1098/rspb.2000.1066; Phillips PC., 2000, EPISTASIS EVOLUTIONA, P20; Proulx SR, 2005, AM NAT, V165, P147, DOI 10.1086/426873; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ranta E, 2008, EVOL ECOL RES, V10, P1; Sanjuan R, 2006, P NATL ACAD SCI USA, V103, P14402, DOI 10.1073/pnas.0604543103; Siegal ML, 2002, P NATL ACAD SCI USA, V99, P10528, DOI 10.1073/pnas.102303999; STEELE JH, 1985, NATURE, V313, P355, DOI 10.1038/313355a0; Wagner A, 1996, EVOLUTION, V50, P1008, DOI 10.1111/j.1558-5646.1996.tb02342.x; Wagner A., 2005, ROBUSTNESS EVOLVABIL; Wagner GP, 1997, EVOLUTION, V51, P329, DOI [10.2307/2411105, 10.1111/j.1558-5646.1997.tb02420.x]; WHITLOCK MC, 1995, ANNU REV ECOL SYST, V26, P601, DOI 10.1146/annurev.es.26.110195.003125; Wigley TML, 1998, SCIENCE, V282, P1676, DOI 10.1126/science.282.5394.1676; Wilke CO, 2001, P ROY SOC B-BIOL SCI, V268, P1469, DOI 10.1098/rspb.2001.1690	50	13	13	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52204	10.1371/journal.pone.0052204	http://dx.doi.org/10.1371/journal.pone.0052204			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284934	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500111
J	Xu, HF; Bihan, D; Chang, F; Huang, PH; Farndale, RW; Leitinger, B				Xu, Huifang; Bihan, Dominique; Chang, Francis; Huang, Paul H.; Farndale, Richard W.; Leitinger, Birgit			Discoidin Domain Receptors Promote alpha 1 beta 1-and alpha 2 beta 1-Integrin Mediated Cell Adhesion to Collagen by Enhancing Integrin Activation	PLOS ONE			English	Article							TYROSINE KINASE DDR1; STRUCTURAL BASIS; GLYCOPROTEIN-VI; MIMETIC PEPTIDE; MATRIX METALLOPROTEINASE-2; EXTRACELLULAR-MATRIX; THROMBUS FORMATION; PLATELET-ADHESION; AFFINITY BINDING; CANCER CELLS	The discoidin domain receptors, DDR1 and DDR2, are receptor tyrosine kinases that bind to and are activated by collagens. Similar to collagen-binding beta 1 integrins, the DDRs bind to specific motifs within the collagen triple helix. However, these two types of collagen receptors recognize distinct collagen sequences. While GVMGFO (O is hydroxyproline) functions as a major DDR binding motif in fibrillar collagens, integrins bind to sequences containing Gxx'GEx ''. The DDRs are thought to regulate cell adhesion, but their roles have hitherto only been studied indirectly. In this study we used synthetic triple-helical collagen-derived peptides that incorporate either the DDR-selective GVMGFO motif or integrin-selective motifs, such as GxOGER and GLOGEN, in order to selectively target either type of receptor and resolve their contributions to cell adhesion. Our data using HEK293 cells show that while cell adhesion to collagen I was completely inhibited by anti-integrin blocking antibodies, the DDRs could mediate cell attachment to the GVMGFO motif in an integrin-independent manner. Cell binding to GVMGFO was independent of DDR receptor signalling and occurred with limited cell spreading, indicating that the DDRs do not mediate firm adhesion. However, blocking the interaction of DDR-expressing cells with collagen I via the GVMGFO site diminished cell adhesion, suggesting that the DDRs positively modulate integrin-mediated cell adhesion. Indeed, overexpression of the DDRs or activation of the DDRs by the GVMGFO ligand promoted alpha 1 beta 1 and alpha 2 beta 1 integrin-mediated cell adhesion to medium-and low-affinity integrin ligands without regulating the cell surface expression levels of alpha 1 beta 1 or alpha 2 beta 1. Our data thus demonstrate an adhesion-promoting role of the DDRs, whereby overexpression and/or activation of the DDRs leads to enhanced integrin-mediated cell adhesion as a result of higher integrin activation state.	[Xu, Huifang; Leitinger, Birgit] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Bihan, Dominique; Farndale, Richard W.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Chang, Francis; Huang, Paul H.] Inst Canc Res, Div Canc Biol, London SW3 6JB, England	Imperial College London; University of Cambridge; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Leitinger, B (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England.	b.leitinger@imperial.ac.uk	Huang, Paul H./H-8591-2015	Huang, Paul H./0000-0003-3972-5087	Medical Research Council United Kingdom; BBSRC UK; Wellcome Trust; MRC [G0701121, G0500707]; BBSRC [BB/I011226/1, BB/I014276/1, WT089028]; Biotechnology and Biological Sciences Research Council [BB/I014276/1, BB/I011226/1] Funding Source: researchfish; Medical Research Council [G0500707, G0701121] Funding Source: researchfish	Medical Research Council United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the following grants from the Medical Research Council United Kingdom (www.mrc.ac.uk), BBSRC UK (www.bbsrc.ac.uk) and the Wellcome Trust (www.wellcome.ac.uk): MRC G0701121 (to BL and RWF), MRC G0500707 (to RWF), BBSRC BB/I011226/1 (to BL), BB/I014276/1 (to PHH) and WT089028 (to PHH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali BR, 2010, HUM MOL GENET, V19, P2239, DOI 10.1093/hmg/ddq103; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Bargal R, 2009, AM J HUM GENET, V84, P80, DOI 10.1016/j.ajhg.2008.12.004; Bazzoni G, 1998, J BIOL CHEM, V273, P6670, DOI 10.1074/jbc.273.12.6670; Byron A, 2009, J CELL SCI, V122, P4009, DOI 10.1242/jcs.056770; Carafoli F, 2012, STRUCTURE, V20, P688, DOI 10.1016/j.str.2012.02.011; Carafoli F, 2009, STRUCTURE, V17, P1573, DOI 10.1016/j.str.2009.10.012; Chen JC, 2002, AM J PATHOL, V161, P337, DOI 10.1016/S0002-9440(10)64185-5; Chetoui N, 2011, J CELL BIOCHEM, V112, P3666, DOI 10.1002/jcb.23300; Curat CA, 2002, J AM SOC NEPHROL, V13, P2648, DOI 10.1097/01.ASN.0000032419.13208.0C; Day E, 2008, EUR J PHARMACOL, V599, P44, DOI 10.1016/j.ejphar.2008.10.014; Emsley J, 1997, J BIOL CHEM, V272, P28512, DOI 10.1074/jbc.272.45.28512; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Farndale RW, 2008, BIOCHEM SOC T, V36, P241, DOI 10.1042/BST0360241; Franco C, 2009, CIRC RES, V105, P1141, DOI 10.1161/CIRCRESAHA.109.207357; Fukunaga-Kalabis M, 2006, J CELL BIOL, V175, P563, DOI 10.1083/jcb.200602132; Hamaia SW, 2012, J BIOL CHEM, V287, P26019, DOI 10.1074/jbc.M112.353144; Hidalgo-Carcedo C, 2011, NAT CELL BIOL, V13, P49, DOI 10.1038/ncb2133; Honda S, 2009, BLOOD, V113, P5304, DOI 10.1182/blood-2008-07-169136; Hou GP, 2002, CIRC RES, V90, P1147, DOI 10.1161/01.RES.0000022166.74073.F8; Hou GP, 2001, J CLIN INVEST, V107, P727, DOI 10.1172/JCI10720; Hou GP, 2012, CARDIOVASC PATHOL, V21, P214, DOI 10.1016/j.carpath.2011.07.006; Huang Y, 2009, J CELL SCI, V122, P1637, DOI 10.1242/jcs.046219; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ichikawa O, 2007, EMBO J, V26, P4168, DOI 10.1038/sj.emboj.7601833; Kamohara H, 2001, FASEB J, V15, P2724, DOI 10.1096/fj.01-0359fje; Kato K, 2003, BLOOD, V102, P1701, DOI 10.1182/blood-2003-03-0717; Khew ST, 2007, TISSUE ENG, V13, P2451, DOI 10.1089/ten.2007.0063; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Knight CG, 1998, J BIOL CHEM, V273, P33287, DOI 10.1074/jbc.273.50.33287; Konitsiotis AD, 2008, J BIOL CHEM, V283, P6861, DOI 10.1074/jbc.M709290200; Labrador JP, 2001, EMBO REP, V2, P446, DOI 10.1093/embo-reports/kve094; Leitinger B, 2004, J MOL BIOL, V344, P993, DOI 10.1016/j.jmb.2004.09.089; Leitinger B, 2003, J BIOL CHEM, V278, P16761, DOI 10.1074/jbc.M301370200; Leitinger B, 2006, MATRIX BIOL, V25, P355, DOI 10.1016/j.matbio.2006.05.006; Leitinger B, 2011, ANNU REV CELL DEV BI, V27, P265, DOI 10.1146/annurev-cellbio-092910-154013; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Mihai C, 2009, J MOL BIOL, V385, P432, DOI 10.1016/j.jmb.2008.10.067; MOROI M, 1989, J CLIN INVEST, V84, P1440, DOI 10.1172/JCI114318; MORTON LF, 1989, BIOCHEM J, V258, P157, DOI 10.1042/bj2580157; Munnix ICA, 2008, J THROMB HAEMOST, V6, P2132, DOI 10.1111/j.1538-7836.2008.03167.x; Nam S, 2005, CANCER RES, V65, P9185, DOI 10.1158/0008-5472.CAN-05-1731; NIEUWENHUIS HK, 1985, NATURE, V318, P470, DOI 10.1038/318470a0; Nilsson S, 2006, EXP CELL RES, V312, P844, DOI 10.1016/j.yexcr.2005.12.001; Noordeen NA, 2006, J BIOL CHEM, V281, P22744, DOI 10.1074/jbc.M603233200; Olaso E, 2002, J BIOL CHEM, V277, P3606, DOI 10.1074/jbc.M107571200; Popova SN, 2007, ACTA PHYSIOL, V190, P179, DOI 10.1111/j.1748-1716.2007.01718.x; Pugh N, 2010, BLOOD, V115, P5069, DOI 10.1182/blood-2010-01-260778; Ram R, 2006, J NEURO-ONCOL, V76, P239, DOI 10.1007/s11060-005-6874-1; Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200; Reyes CD, 2003, J BIOMED MATER RES A, V65A, P511, DOI 10.1002/jbm.a.10550; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; Sabri S, 2004, BLOOD, V104, P3117, DOI 10.1182/blood-2003-12-4398; SANTORO SA, 1991, CELL REGUL, V2, P905, DOI 10.1091/mbc.2.11.905; Shintani Y, 2008, J CELL BIOL, V180, P1277, DOI 10.1083/jcb.200708137; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Shrivastava A, 1997, MOL CELL, V1, P25, DOI 10.1016/S1097-2765(00)80004-0; Siljander PRM, 2004, J BIOL CHEM, V279, P47763, DOI 10.1074/jbc.M404685200; Suh HN, 2011, J CELL PHYSIOL, V226, P3422, DOI 10.1002/jcp.22697; Taherian A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-293; Valencia K, 2012, CLIN CANCER RES, V18, P969, DOI 10.1158/1078-0432.CCR-11-1686; Valiathan RR, 2012, CANCER METAST REV, V31, P295, DOI 10.1007/s10555-012-9346-z; Vogel W, 2000, J BIOL CHEM, V275, P5779, DOI 10.1074/jbc.275.8.5779; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Vogel WF, 2001, MOL CELL BIOL, V21, P2906, DOI 10.1128/MCB.21.8.2906-2917.2001; Vogel WF, 2006, CELL SIGNAL, V18, P1108, DOI 10.1016/j.cellsig.2006.02.012; Vonk LA, 2011, RHEUMATOLOGY, V50, P463, DOI 10.1093/rheumatology/keq305; Wang CZ, 2006, MOL BIOL CELL, V17, P2839, DOI 10.1091/mbc.E05-11-1068; Xu HF, 2011, MATRIX BIOL, V30, P16, DOI 10.1016/j.matbio.2010.10.004; Xu Y, 2000, J BIOL CHEM, V275, P38981, DOI 10.1074/jbc.M007668200; Yeh YC, 2009, J CELL PHYSIOL, V218, P146, DOI 10.1002/jcp.21578; Yoshida D, 2007, J NEURO-ONCOL, V82, P29, DOI 10.1007/s11060-006-9246-6	72	171	172	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52209	10.1371/journal.pone.0052209	http://dx.doi.org/10.1371/journal.pone.0052209			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284937	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500114
J	Oldham, AL; Duncan, KE				Oldham, Athenia L.; Duncan, Kathleen E.			Similar Gene Estimates from Circular and Linear Standards in Quantitative PCR Analyses Using the Prokaryotic 16S rRNA Gene as a Model	PLOS ONE			English	Article							REAL-TIME PCR; MICROBIAL-COMMUNITIES; AMPLIFICATION; SAMPLES; QUANTIFICATION; COPY	Quantitative PCR (qPCR) is one of the most widely used tools for quantifying absolute numbers of microbial gene copies in test samples. A recent publication showed that circular plasmid DNA standards grossly overestimated numbers of a target gene by as much as 8-fold in a eukaryotic system using quantitative PCR (qPCR) analysis. Overestimation of microbial numbers is a serious concern in industrial settings where qPCR estimates form the basis for quality control or mitigation decisions. Unlike eukaryotes, bacteria and archaea most commonly have circular genomes and plasmids and therefore may not be subject to the same levels of overestimation. Therefore, the feasibility of using circular DNA plasmids as standards for 16S rRNA gene estimates was assayed using these two prokaryotic systems, with the practical advantage being rapid standard preparation for ongoing qPCR analyses. Full-length 16S rRNA gene sequences from Thermovirga lienii and Archaeoglobus fulgidus were cloned and used to generate standards for bacterial and archaeal qPCR reactions, respectively. Estimates of 16S rRNA gene copies were made based on circular and linearized DNA conformations using two genomes from each domain: Desulfovibrio vulgaris, Pseudomonas aeruginosa, Archaeoglobus fulgidus, and Methanocaldocococcus jannaschii. The ratio of estimated to predicted 16S rRNA gene copies ranged from 0.5 to 2.2-fold in bacterial systems and 0.5 to 1.0-fold in archaeal systems, demonstrating that circular plasmid standards did not lead to the gross over-estimates previously reported for eukaryotic systems.	[Oldham, Athenia L.; Duncan, Kathleen E.] Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA; [Oldham, Athenia L.; Duncan, Kathleen E.] Univ Oklahoma, Inst Energy & Environm, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman	Duncan, KE (corresponding author), Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA.	kathleen.e.duncan-1@ou.edu			Office of Naval Research [N000141010946]	Office of Naval Research(Office of Naval Research)	This study was supported by grant N000141010946 from the Office of Naval Research (www.onr.navy.mil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2009, FEMS MICROBIOL ECOL, V69, P301, DOI 10.1111/j.1574-6941.2009.00714.x; Duncan KE, 2009, ENVIRON SCI TECHNOL, V43, P7977, DOI 10.1021/es9013932; Filion M, 2012, QUANTITATIVE REAL-TIME PCR IN APPLIED MICROBIOLOGY, P1; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hays F, 2003, METHOD MOL BIOL, P1; Hou YB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009545; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; Lin CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029101; Lloyd KG, 2006, APPL ENVIRON MICROB, V72, P7218, DOI 10.1128/AEM.00886-06; McKew BA, 2010, HDB HYDROCARBON LIPI, P3995, DOI [10.1007/978-3-540-77587-4_311, DOI 10.1007/978-3-540-77587-4_311]; Pei AY, 2010, APPL ENVIRON MICROB, V76, P3886, DOI 10.1128/AEM.02953-09; Smith CJ, 2009, FEMS MICROBIOL ECOL, V67, P6, DOI 10.1111/j.1574-6941.2008.00629.x; Smith CJ, 2006, ENVIRON MICROBIOL, V8, P804, DOI 10.1111/j.1462-2920.2005.00963.x; Smits THM, 2004, J MICROBIOL METH, V57, P369, DOI 10.1016/j.mimet.2004.02.003; Stevenson BS, 2011, ENVIRON MICROBIOL, V13, P1078, DOI 10.1111/j.1462-2920.2010.02413.x; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; VandePeer Y, 1996, NUCLEIC ACIDS RES, V24, P3381, DOI 10.1093/nar/24.17.3381; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997	19	16	16	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51931	10.1371/journal.pone.0051931	http://dx.doi.org/10.1371/journal.pone.0051931			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284822	Green Published, gold, Green Submitted			2022-12-27	WOS:000312694300062
J	Kaur, S; Prabha, V				Kaur, Siftjit; Prabha, Vijay			Infertility as a Consequence of Spermagglutinating Staphylococcus aureus Colonization in Genital Tract of Female Mice	PLOS ONE			English	Article							MICROBICIDES; CHEMOKINES; INFECTION	Various studies have shown Staphylococcus aureus to be one of the most prevalent organism in male and female genital tract but most practitioners dismiss it as mere contamination which is assumed to be of no significance. However, it is now suggested that the presence of this organism should not be ignored, as incubation of spermatozoa with S. aureus results in reduced sperm motility. Although S. aureus has been reported to cause immobilization of spermatozoa, however, its role in infertility has yet to be elucidated. The present study was designed to establish a spermagglutinating strain of S. aureus isolated from the cervix of a woman with unexplained infertility, in mouse and evaluate its effect on fertility outcome. Female Balb/c mice were inoculated intravaginally with different doses of S. aureus (10(4), 10(6) or 10(8) cfu/20 mu l) for 10 consecutive days. Microbial colonization monitored every 3rd day by vaginal cultures, revealed that strain could efficiently colonize mouse vagina. Mating on day 12, with proven breeder males led to 100% decrease in fertility as compared to control. Even a single dose of 10(6) or 10(8) cfu could lead to vaginal colonization which persisted for 10 days followed by gradual clearing till 21 days, vaginal cultures were negative thereafter. Female mice mated on day 7 (culture positive), were rendered infertile, however, the mice mated on day 22 (culture negative), retained fertility and delivered pups indicating its role in provoking infertility. Further, except infertility, no other clinical manifestation could be seen apparently or histologically. However, when a non-spermagglutinating/immobilizing standard strain of S. aureus MTCC6625 was inoculated intravaginally at 10(8) cfu for 10 days followed by mating on day 12, fertility was observed in all the female mice. This supports the hypothesis that infertility observed in the former groups was as a result of colonization with spermagglutinating strain of S. aureus.	[Kaur, Siftjit; Prabha, Vijay] Panjab Univ, Dept Microbiol, Chandigarh 160014, India	Panjab University	Prabha, V (corresponding author), Panjab Univ, Dept Microbiol, Chandigarh 160014, India.	satishvijay11@yahoo.com		Prabha, Vijay/0000-0002-7654-2215	University Grants Commission, New Delhi, India	University Grants Commission, New Delhi, India(University Grants Commission, India)	The present work was funded by University Grants Commission, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranha CC, 2008, CYTOKINE, V43, P63, DOI 10.1016/j.cyto.2008.04.005; Cone RA, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-90; Cunningham KA, 2008, BIOL REPROD, V79, P180, DOI 10.1095/biolreprod.108.067835; Ekhaise FO, 2008, WORLD J MED SCI, V3, P28; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; Gdoura R, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-129; Golshani M, 2006, IRAN J PUBLIC HEALTH, V35, P81; Ibadin OK, 2008, MALAYS J MICROBIOL, V4, P65, DOI 10.21161/mjm.12108; Jiang J., 1996, CHIN J ANDROL, V10, P196; Kaur S, 2010, AM J BIOMED SCI, V2, P91; MILLER MD, 1992, CRIT REV IMMUNOL, V12, P17; Milligan GN, 2002, SEX TRANSM DIS, V29, P597, DOI 10.1097/00007435-200210000-00006; Momoh A, 2012, E3 J MED RES, V1, P17; Momoh A. R. M., 2011, Journal of Microbiology and Biotechnology Research, V1, P66; Moretti E, 2009, J ASSIST REPROD GEN, V26, P47, DOI 10.1007/s10815-008-9283-5; Ohri M, 2005, FERTIL STERIL, V84, P1539, DOI 10.1016/j.fertnstert.2005.05.030; Saavedra M, 1999, INFECT IMMUN, V67, P5820, DOI 10.1128/IAI.67.11.5820-5826.1999; Shalika S, 1996, HUM REPROD, V11, P2789; Villegas J, 2005, APOPTOSIS, V10, P105, DOI 10.1007/s10495-005-6065-8	19	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52325	10.1371/journal.pone.0052325	http://dx.doi.org/10.1371/journal.pone.0052325			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272237	Green Published, gold, Green Submitted			2022-12-27	WOS:000312483300079
J	Lin, S; Kim, J; Lee, MJ; Roche, L; Yang, NL; Tsao, PS; Rockson, SG				Lin, Shin; Kim, Jeanna; Lee, Mi-Joung; Roche, Leslie; Yang, Nancy L.; Tsao, Philip S.; Rockson, Stanley G.			Prospective Transcriptomic Pathway Analysis of Human Lymphatic Vascular Insufficiency: Identification and Validation of a Circulating Biomarker Panel	PLOS ONE			English	Article							GENE-EXPRESSION; LYMPHEDEMA; LYMPHANGIOGENESIS; PATTERNS; CELL; ATHEROSCLEROSIS; ADIPOGENESIS; REGENERATION; DIAGNOSIS; FIBROSIS	Background: In our previous transcriptional profiling of a murine model, we have identified a remarkably small number of specific pathways with altered expression in lymphedema. In this investigation, we utilized microarray-based transcriptomics of human skin for an unbiased a priori prospective candidate identification, with subsequent validation of these candidates through direct serum assay. The resulting multi-analyte biomarker panel sensitively should sensitively discriminate human lymphedema subjects from normal individuals. Methods and Findings: We enrolled 63 lymphedema subjects and 27 normals in our attempt to discover protein analytes that can distinguish diseased individuals from controls. To minimize technical and biologically irrelevant variation, we first identified potential candidates by performing transcriptional microarray analysis on paired diseased and normal skin specimens sampled from the same individuals. We focused our attention on genes with corresponding protein products that are secreted and took these candidates forward to a protein multiplex assay applied to diseased and normal subjects. We developed a logistic regression-based model on an eventual group of six proteins and validated our system on a separate cohort of study subjects. The area under the receiver operating characteristic curve was calculated to be 0.87 (95% CI : 0.75 to 0.97). Conclusions: We have developed an accurate bioassay utilizing proteins representing four central pathogenetic modalities of the disease: lymphangiogenesis, inflammation, fibrosis, and lipid metabolism, suggesting that these proteins are directly related to the pathogenesis of the tissue pathology in lymphatic vascular insufficiency. Further studies are warranted to determine whether this newly-identified biomarker panel will possess utility as an instrument for in vitro diagnosis of early and latent disease; the ultimate applicability to risk stratification, quantitation of disease burden, and response to therapy can easily be envisioned.	[Lin, Shin; Kim, Jeanna; Lee, Mi-Joung; Roche, Leslie; Yang, Nancy L.; Tsao, Philip S.; Rockson, Stanley G.] Stanford Univ, Stanford Ctr Lymphat & Venous Disorders, Div Cardiovasc Med, Sch Med, Stanford, CA 94305 USA	Stanford University	Rockson, SG (corresponding author), Stanford Univ, Stanford Ctr Lymphat & Venous Disorders, Div Cardiovasc Med, Sch Med, Stanford, CA 94305 USA.	rockson@stanford.edu		Lin, Shin/0000-0003-0118-0413; rockson, stanley/0000-0003-1253-474X	NIH [1RC1HL100344-01, 1F32HL110473-01]; University of Sydney; Cancer Institute NSW; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL110473, RC1HL100344] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Sydney(University of Sydney); Cancer Institute NSW; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by an NIH grant (1RC1HL100344-01) to S. G. R. S. L. is supported by NIH grant 1F32HL110473-01. M.J.L. was a postdoctoral research fellow funded by the University of Sydney and the Cancer Institute NSW. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, Lymphat Res Biol, V5, P217, DOI 10.1089/lrb.2007.5401; Ardigo D, 2007, PHYSIOL GENOMICS, V31, P402, DOI 10.1152/physiolgenomics.00104.2007; Aschen S, 2012, PLAST RECONSTR SURG, V129, P838, DOI 10.1097/PRS.0b013e3182450b47; Avraham T, 2010, AM J PATHOL, V177, P3202, DOI 10.2353/ajpath.2010.100594; Avraham T, 2009, PLAST RECONSTR SURG, V124, P438, DOI 10.1097/PRS.0b013e3181adcf4b; Boschetti E, 2012, PROTEOM CLIN APPL, V6, P22, DOI 10.1002/prca.201100039; Chen MM, 2003, CIRCULATION, V108, P1432, DOI 10.1161/01.CIR.0000091235.94914.75; Cheung L, 2006, BIODRUGS, V20, P363, DOI 10.2165/00063030-200620060-00007; Choi I, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006445; Choi I, 2012, CIRCULATION, V125, P872, DOI 10.1161/CIRCULATIONAHA.111.030296; Cooke JP, 2012, CIRCULATION, V125, P853, DOI 10.1161/CIRCULATIONAHA.111.083477; de Boer T, 2007, GENESPRING GENESPRIN; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Gergich NLS, 2008, CANCER-AM CANCER SOC, V112, P2809, DOI 10.1002/cncr.23494; Herd-Smith A, 2001, CANCER-AM CANCER SOC, V92, P1783, DOI 10.1002/1097-0142(20011001)92:7<1783::AID-CNCR1694>3.0.CO;2-G; Ho M, 2003, PHYSIOL GENOMICS, V13, P249, DOI 10.1152/physiolgenomics.00186.2002; Hwang JH, 2011, BIOMATERIALS, V32, P4415, DOI 10.1016/j.biomaterials.2011.02.051; Jin Da Pan, 2009, Lymphatic Research and Biology, V7, P47, DOI 10.1089/lrb.2009.0002; King JY, 2005, PHYSIOL GENOMICS, V23, P103, DOI 10.1152/physiolgenomics.00101.2005; Lahteenvuo M, 2011, CIRCULATION, V123, P613, DOI 10.1161/CIRCULATIONAHA.110.965384; Lopez E, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-35; Nakamura K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008380; National Heart Lung and Blood Institute, 2007, NIH WORK GROUP M LYM; OLSZEWSKI WL, 1993, TROP MED PARASITOL, V44, P40; Paquet A, 2010, ARRAYWUALITY ASSESSI; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rockson S G, 2008, Lymphat Res Biol, V6, P1, DOI 10.1089/lrb.2008.6101; Rockson SG, 1998, CANCER, V83, P2814; Rockson Stanley G., 2006, Lymphatic Research and Biology, V4, P42, DOI 10.1089/lrb.2006.4.42; Rockson SG, 2010, VASC MED, V15, P223, DOI 10.1177/1358863X10364553; Schneider M, 2006, PLOS MED, V3, P970, DOI 10.1371/journal.pmed.0030264; Shin WS, 2008, ANN NY ACAD SCI, V1131, P50, DOI 10.1196/annals.1413.005; Shin William S, 2003, Lymphat Res Biol, V1, P159, DOI 10.1089/153968503321642642; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sitzia J, 1995, Eur J Cancer Care (Engl), V4, P11; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Spin JM, 2004, PHYSIOL GENOMICS, V19, P292, DOI 10.1152/physiolgenomics.00148.2004; Tabibiazar R, 2006, PHYSIOL GENOMICS, V25, P194, DOI 10.1152/physiolgenomics.00240.2005; Tabibiazar R, 2005, PHYSIOL GENOMICS, V22, P213, DOI 10.1152/physiolgenomics.00001.2005; Tabibiazar R, 2005, ARTERIOSCL THROM VAS, V25, P302, DOI 10.1161/01.ATV.0000151372.86863.a5; Tabibiazar R, 2006, PLOS MED, V3, P1114, DOI 10.1371/journal.pmed.0030254; Team R. D. C, 2011, R LANG ENV STAT COMP; Ward LC, 2011, LYMPHAT RES BIOL, V9, P43, DOI 10.1089/lrb.2010.0024; Ward LC, 2011, LYMPHAT RES BIOL, V9, P47, DOI 10.1089/lrb.2010.0014; Ward Leigh C., 2006, Lymphatic Research and Biology, V4, P51, DOI 10.1089/lrb.2006.4.51; Yang YH, 2009, MARRAY EXPLORATORY A; Zampell JC, 2012, PLAST RECONSTR SURG, V129, P825, DOI 10.1097/PRS.0b013e3182450b2d; Zampell JC, 2012, AM J PHYSIOL-CELL PH, V302, pC392, DOI 10.1152/ajpcell.00306.2011; Zampell JC, 2011, AM J PHYSIOL-CELL PH, V300, pC1107, DOI 10.1152/ajpcell.00378.2010	49	28	32	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52021	10.1371/journal.pone.0052021	http://dx.doi.org/10.1371/journal.pone.0052021			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272198	Green Submitted, gold, Green Published			2022-12-27	WOS:000312483300046
J	Liu, J; Wang, QC; Wang, F; Duan, X; Dai, XX; Wang, T; Liu, HL; Cui, XS; Kim, NH; Sun, SC				Liu, Jun; Wang, Qiao-Chu; Wang, Fei; Duan, Xing; Dai, Xiao-Xin; Wang, Teng; Liu, Hong-Lin; Cui, Xiang-Shun; Kim, Nam-Hyung; Sun, Shao-Chen			Nucleation Promoting Factors Regulate the Expression and Localization of Arp2/3 Complex during Meiosis of Mouse Oocytes	PLOS ONE			English	Article							ACTIN-BASED MOTILITY; BINDING-ACTIVITY; WASP FAMILY; F-ACTIN; WAVE2; JMY; CORTACTIN; N-WASP/WAVE2; ACTIVATION; MEMBRANE	The actin nucleation factor Arp2/3 complex is a main regulator of actin assembly and is involved in multiple processes like cell migration and adhesion, endocytosis, and the establishment of cell polarity in mitosis. Our previous work showed that the Arp2/3 complex was involved in the actin-mediated mammalian oocyte asymmetric division. However, the regulatory mechanisms and signaling pathway of Arp2/3 complex in meiosis is still unclear. In the present work, we identified that the nucleation promoting factors (NPFs) JMY and WAVE2 were necessary for the expression and localization of Arp2/3 complex in mouse oocytes. RNAi of both caused the degradation of actin cap intensity, indicating the roles of NPFs in the formation of actin cap. Moreover, JMY and WAVE2 RNAi decreased the expression of ARP2, a key component of Arp2/3 complex. However, knock down of Arp2/3 complex by Arpc2 and Arpc3 siRNA microinjection did not affect the expression and localization of JMY and WAVE2. Our results indicate that the NPFs, JMY and WAVE2, are upstream regulators of Arp2/3 complex in mammalian oocyte asymmetric division.	[Liu, Jun; Wang, Qiao-Chu; Wang, Fei; Duan, Xing; Dai, Xiao-Xin; Wang, Teng; Liu, Hong-Lin; Sun, Shao-Chen] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Cui, Xiang-Shun; Kim, Nam-Hyung] Chungbuk Natl Univ, Dept Anim Sci, Chonju, Chungbuk, South Korea	Nanjing Agricultural University; Chungbuk National University	Sun, SC (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	sunsc@njau.edu.cn	liu, honglin/HDN-0409-2022	liu, honglin/0000-0002-1254-3163	Fundamental Research Funds for the Central Universities [KYRC201202]; Nanjing Agricultural University, China [804051]; Biogreen 21 Program, RDA, Republic of Korea [PJ0090802012, PJ009098]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Nanjing Agricultural University, China; Biogreen 21 Program, RDA, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by the Fundamental Research Funds for the Central Universities (KYRC201202) and a research grant (804051) from Nanjing Agricultural University in 2012, China; and the Biogreen 21 Program (PJ0090802012, PJ009098), RDA, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailly M, 2001, CURR BIOL, V11, P620, DOI 10.1016/S0960-9822(01)00152-X; Bompard G, 2004, J CELL BIOL, V166, P957, DOI 10.1083/jcb.200403127; Bosticardo M, 2009, BLOOD, V113, P6288, DOI 10.1182/blood-2008-12-115253; Brunet S, 2011, HUM REPROD UPDATE, V17, P68, DOI 10.1093/humupd/dmq044; Campellone KG, 2008, CELL, V134, P148, DOI 10.1016/j.cell.2008.05.032; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Carabeo RA, 2007, CELL MICROBIOL, V9, P2278, DOI 10.1111/j.1462-5822.2007.00958.x; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Chesarone MA, 2009, CURR OPIN CELL BIOL, V21, P28, DOI 10.1016/j.ceb.2008.12.001; Dahl JP, 2003, J NEUROSCI, V23, P3343; Deng MQ, 2003, DEV BIOL, V257, P166, DOI 10.1016/S0012-1606(03)00045-9; Firat-Karalar EN, 2011, MOL BIOL CELL, V22, P4563, DOI 10.1091/mbc.E11-06-0585; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Goode BL, 2001, J CELL BIOL, V153, P627, DOI 10.1083/jcb.153.3.627; Kutsuna H, 2004, AM J PHYSIOL-CELL PH, V286, pC55, DOI 10.1152/ajpcell.00131.2003; Linardopoulou EV, 2007, PLOS GENET, V3, P2477, DOI 10.1371/journal.pgen.0030237; Lommel S, 2001, EMBO REP, V2, P850, DOI 10.1093/embo-reports/kve197; LONGO FJ, 1985, DEV BIOL, V107, P382, DOI 10.1016/0012-1606(85)90320-3; Machesky LM, 1999, J CELL BIOL, V146, P267, DOI 10.1083/jcb.146.2.267; Machesky LM, 1999, CURR OPIN CELL BIOL, V11, P117, DOI 10.1016/S0955-0674(99)80014-3; Maro B, 2002, NAT CELL BIOL, V4, pE281, DOI 10.1038/ncb1202-e281; Moreau V, 1997, MOL BIOL CELL, V8, P1361, DOI 10.1091/mbc.8.7.1361; Renault L, 2008, TRENDS CELL BIOL, V18, P494, DOI 10.1016/j.tcb.2008.07.008; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Rottner K, 2010, TRENDS CELL BIOL, V20, P650, DOI 10.1016/j.tcb.2010.08.014; Rouiller I, 2008, J CELL BIOL, V180, P887, DOI 10.1083/jcb.200709092; Schaerer-Brodbeck C, 2000, MOL BIOL CELL, V11, P1113, DOI 10.1091/mbc.11.4.1113; Shikama N, 1999, MOL CELL, V4, P365, DOI 10.1016/S1097-2765(00)80338-X; Snapper SB, 2001, NAT CELL BIOL, V3, P897, DOI 10.1038/ncb1001-897; Soderling SH, 2003, P NATL ACAD SCI USA, V100, P1723, DOI 10.1073/pnas.0438033100; Steffen A, 2006, MOL BIOL CELL, V17, P2581, DOI 10.1091/mbc.E05-11-1088; Suetsugu S, 2001, J CELL SCI, V114, P4533; Suetsugu S, 2001, BIOCHEM BIOPH RES CO, V282, P739, DOI 10.1006/bbrc.2001.4619; Sun QY, 2006, REPRODUCTION, V131, P193, DOI 10.1530/rep.1.00847; Sun SC, 2011, CELL CYCLE, V10, P1853, DOI 10.4161/cc.10.11.15796; Sun SC, 2011, MOL HUM REPROD, V17, P296, DOI 10.1093/molehr/gar006; Sun SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018392; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; VANBLERKOM J, 1986, J EMBRYOL EXP MORPH, V93, P213; Veltman DM, 2010, MOL BIOL CELL, V21, P2880, DOI 10.1091/mbc.E10-04-0372; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; Yamazaki D, 2003, NATURE, V424, P452, DOI 10.1038/nature01770; Yan C, 2003, EMBO J, V22, P3602, DOI 10.1093/emboj/cdg350; Yi K, 2011, NAT CELL BIOL, V13, P1252, DOI 10.1038/ncb2320; Zuchero JB, 2009, NAT CELL BIOL, V11, P451, DOI 10.1038/ncb1852	47	10	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52277	10.1371/journal.pone.0052277	http://dx.doi.org/10.1371/journal.pone.0052277			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272233	Green Submitted, gold, Green Published			2022-12-27	WOS:000312483300075
J	Makarova, O; Contaldo, N; Paltrinieri, S; Kawube, G; Bertaccini, A; Nicolaisen, M				Makarova, Olga; Contaldo, Nicoletta; Paltrinieri, Samanta; Kawube, Geofrey; Bertaccini, Assunta; Nicolaisen, Mogens			DNA Barcoding for Identification of 'Candidatus Phytoplasmas' Using a Fragment of the Elongation Factor Tu Gene	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; ASTER YELLOWS; NUCLEOTIDE SUBSTITUTIONS; FINER DIFFERENTIATION; X-DISEASE; SEQUENCE; CLASSIFICATION; STRAINS; DIVERSITY; GRAPEVINE	Background: Phytoplasmas are bacterial phytopathogens responsible for significant losses in agricultural production worldwide. Several molecular markers are available for identification of groups or strains of phytoplasmas. However, they often cannot be used for identification of phytoplasmas from different groups simultaneously or are too long for routine diagnostics. DNA barcoding recently emerged as a convenient tool for species identification. Here, the development of a universal DNA barcode based on the elongation factor Tu (tuf) gene for phytoplasma identification is reported. Methodology/Principal Findings: We designed a new set of primers and amplified a 420-444 bp fragment of tuf from all 91 phytoplasmas strains tested (16S rRNA groups -I through -VII, -IX through -XII, -XV, and -XX). Comparison of NJ trees constructed from the tuf barcode and a 1.2 kbp fragment of the 16S ribosomal gene revealed that the tuf tree is highly congruent with the 16S rRNA tree and had higher inter-and intra-group sequence divergence. Mean K2P inter-/intra-group divergences of the tuf barcode did not overlap and had approximately one order of magnitude difference for most groups, suggesting the presence of a DNA barcoding gap. The use of the tuf barcode allowed separation of main ribosomal groups and most of their subgroups. Phytoplasma tuf barcodes were deposited in the NCBI GenBank and Q-bank databases. Conclusions/Significance: This study demonstrates that DNA barcoding principles can be applied for identification of phytoplasmas. Our findings suggest that the tuf barcode performs as well or better than a 1.2 kbp fragment of the 16S rRNA gene and thus provides an easy procedure for phytoplasma identification. The obtained sequences were used to create a publicly available reference database that can be used by plant health services and researchers for online phytoplasma identification.	[Makarova, Olga; Kawube, Geofrey; Nicolaisen, Mogens] Aarhus Univ, AU Sci & Technol, Dept Agroecol, Slagelse, Denmark; [Contaldo, Nicoletta; Paltrinieri, Samanta; Bertaccini, Assunta] Univ Bologna, DipSA Plant Pathol, Bologna, Italy	Aarhus University; University of Bologna	Makarova, O (corresponding author), Free Univ Berlin, Inst Biol, Berlin, Germany.	olga.makarova@fu-berlin.de; mogens.nicolaisen@agrsci.dk	Nicolaisen, Mogens/B-6896-2008; Contaldo, Nicoletta/GRJ-0150-2022	Nicolaisen, Mogens/0000-0002-0407-2488; CONTALDO, NICOLETTA/0000-0003-2398-4850; Bertaccini, Assunta/0000-0002-5650-1512; Makarova, Olga/0000-0003-4767-9711	7th Framework Program project "Development of a new diagnostic tool using DNA barcoding to identify quarantine organisms in support of plant health'' [FP7-KBBE-2008-2B]	7th Framework Program project "Development of a new diagnostic tool using DNA barcoding to identify quarantine organisms in support of plant health''	This project was financially supported by the 7th Framework Program project "Development of a new diagnostic tool using DNA barcoding to identify quarantine organisms in support of plant health'' FP7-KBBE-2008-2B (http://cordis.europa.eu/projects/rcn/91249_en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud G, 2007, APPL ENVIRON MICROB, V73, P4001, DOI 10.1128/AEM.02323-06; Bai XD, 2006, J BACTERIOL, V188, P3682, DOI 10.1128/JB.188.10.3682-3696.2006; Bertaccini A, 2010, PHYTOPLASMA COLLECTI; Bertaccini A, 2007, FRONT BIOSCI-LANDMRK, V12, P673, DOI 10.2741/2092; Besansky NJ, 2003, TRENDS PARASITOL, V19, P545, DOI 10.1016/j.pt.2003.09.015; Bonants P., 2010, Bulletin OEPP, V40, P30, DOI 10.1111/j.1365-2338.2009.02350.x; Botti S, 2003, J APPL MICROBIOL, V94, P103, DOI 10.1046/j.1365-2672.2003.01809.x; Casiraghi M, 2010, BRIEF BIOINFORM, V11, P440, DOI 10.1093/bib/bbq003; DENG SJ, 1991, J MICROBIOL METH, V14, P53, DOI 10.1016/0167-7012(91)90007-D; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FENG DF, 1987, J MOL EVOL, V25, P351, DOI 10.1007/BF02603120; GIBB KS, 1995, PHYTOPATHOLOGY, V85, P169, DOI 10.1094/Phyto-85-169; Gundersen D. E., 1996, Phytopathologia Mediterranea, V35, P144; Gundersen DE, 1996, INT J SYST BACTERIOL, V46, P64, DOI 10.1099/00207713-46-1-64; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hodgetts J, 2008, INT J SYST EVOL MICR, V58, P1826, DOI 10.1099/ijs.0.65668-0; Hogenhout SA, 2008, MOL PLANT PATHOL, V9, P403, DOI 10.1111/J.1364-3703.2008.00472.X; Khan AJ, 2002, PHYTOPATHOLOGY, V92, P1038, DOI 10.1094/PHYTO.2002.92.10.1038; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Kube M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-306; Lee IM, 2010, INT J SYST EVOL MICR, V60, P2887, DOI 10.1099/ijs.0.019695-0; Lee IM, 2006, MOL CELL PROBE, V20, P87, DOI 10.1016/j.mcp.2005.10.001; Lee IM, 1998, INT J SYST BACTERIOL, V48, P1153, DOI 10.1099/00207713-48-4-1153; Liefting LW, 1996, APPL ENVIRON MICROB, V62, P3133, DOI 10.1128/AEM.62.9.3133-3139.1996; Marcone C, 2000, INT J SYST EVOL MICR, V50, P1703, DOI 10.1099/00207713-50-5-1703; Martini M, 2007, INT J SYST EVOL MICR, V57, P2037, DOI 10.1099/ijs.0.65013-0; Martini M, 2002, MOL CELL PROBE, V16, P197, DOI 10.1006/mcpr.2002.0410; Mitrovic J, 2011, B INSECTOL, V64, pS17; Oshima K, 2004, NAT GENET, V36, P27, DOI 10.1038/ng1277; PRINCE JP, 1993, PHYTOPATHOLOGY, V83, P1130, DOI 10.1094/Phyto-83-1130; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schneider Bernd, 1995, P369, DOI 10.1016/B978-012583805-4/50040-6; Streten C, 2005, PLANT PATHOL, V54, P8, DOI 10.1111/j.1365-3059.2005.01113.x; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; The International Research Programme for Comparative Mycoplasmology Phytoplasma/Spiroplasma Working Team - Phytoplasma Taxonomy Group, 2004, International Journal of Systematic and Evolutionary Microbiology, V54, P1243, DOI 10.1099/ijs.0.02854-0; Tran-Nguyen LTT, 2008, J BACTERIOL, V190, P3979, DOI 10.1128/JB.01301-07; Vernooy R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000417; Wei W, 2007, INT J SYST EVOL MICR, V57, P1855, DOI 10.1099/ijs.0.65000-0	43	44	48	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52092	10.1371/journal.pone.0052092	http://dx.doi.org/10.1371/journal.pone.0052092			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272216	Green Submitted, gold, Green Published			2022-12-27	WOS:000312483300062
J	Liu, YC; Han, YH; Zhang, H; Nie, LP; Jiang, ZM; Fa, PP; Gui, YT; Cai, ZM				Liu, Yuchen; Han, Yonghua; Zhang, Hu; Nie, Liping; Jiang, Zhimao; Fa, Pingping; Gui, Yaoting; Cai, Zhiming			Synthetic miRNA-Mowers Targeting miR-183-96-182 Cluster or miR-210 Inhibit Growth and Migration and Induce Apoptosis in Bladder Cancer Cells	PLOS ONE			English	Article							DOWN-REGULATION; HYPOXIA; EXPRESSION; MICRORNA; PROLIFERATION; SURVIVAL; IDENTIFICATION; ASSAY; GENE	Background: MicroRNAs (miRNAs) function as endogenous regulators of biological behaviors of human cancers. Several natural non-coding RNAs are reported to inhibit miRNAs by base-pairing interactions. These phenomena raise questions about the ability of artificial device to regulate miRNAs. The purpose of this study is to create synthetic devices that target a single miRNA or a miRNA cluster and to ascertain their therapeutic effects on the phenotypes of bladder cancer cells. Methodology/Principal Findings: Tandem bulged miRNA binding sites were inserted into the 39 untranslated region (UTR) of the SV-40 promoter-driven Renilla luciferase gene to construct two "miRNA-mowers" for suppression of miR-183-96-182 cluster or miR-210. A third device with tandem repeat sequences not complementary to any known miRNA was generated as an untargeted-control. In functional analyses, bladder cancer T24 and UM-UC-3 cells were transfected with each of the three devices, followed by assays for detection of their impacts. Luciferase assays indicated that the activities of the luciferase reporters in the miRNA-mowers were decreased to 30-50% of the untargeted-control. Using Real-Time qPCR, the expression levels of the target miRNAs were shown to be reduced 2-3-fold by the corresponding miRNA-mower. Cell growth, apoptosis, and migration were tested by MTT assay, flow cytometry assay, and in vitro scratch assay, respectively. Cell growth inhibition, increased apoptosis, and decreased motility were observed in miRNA-mowers-transfected bladder cancer cells. Conclusions/Significance: Not only a single target miRNA but also the whole members of a target miRNA cluster can be blocked using this modular design strategy. Anti-cancer effects are induced by the synthetic miRNA-mowers in the bladder cancer cell lines. miR-183/96/182 cluster and miR-210 are shown to play oncogenic roles in bladder cancer. A potentially useful synthetic biology platform for miRNA loss-of-function study and cancer treatment has been established in this work.	[Liu, Yuchen; Han, Yonghua; Zhang, Hu; Jiang, Zhimao; Fa, Pingping; Gui, Yaoting; Cai, Zhiming] Peking Univ, Shenzhen Hosp, Shenzhen PKU HKUST Med Ctr,Inst Urol, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Shenzhen, Peoples R China; [Liu, Yuchen; Zhang, Hu] Anhui Med Univ, Hefei, Peoples R China; [Liu, Yuchen; Han, Yonghua; Cai, Zhiming] Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Shenzhen Key Lab Genitourinary Tumor, Shenzhen, Peoples R China; [Nie, Liping] Peking Univ, Shenzhen Hosp, Dept Clin Lab, Shenzhen, Peoples R China	Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center; Anhui Medical University; Shenzhen University; Peking University	Gui, YT (corresponding author), Peking Univ, Shenzhen Hosp, Shenzhen PKU HKUST Med Ctr,Inst Urol, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Shenzhen, Peoples R China.	guiyaoting2007@yahoo.com.cn; caizhiming2000@yahoo.com.cn	gui, yaoting/GLT-3684-2022; liu, yuchen/GYQ-6286-2022		Ph.D. Programs Foundation of Ministry of Education of China [20100001110100]; promotion Program for Shenzhen Key Laboratory, Shenzhen, People's Republic of China [CXB201005250016A]	Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); promotion Program for Shenzhen Key Laboratory, Shenzhen, People's Republic of China	This work was funded by the Ph.D. Programs Foundation of Ministry of Education of China(20100001110100 to ZC); the promotion Program for Shenzhen Key Laboratory, Shenzhen, People's Republic of China (CXB201005250016A to ZC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Carradori S, 2012, ANTI-CANCER AGENT ME, V12, P589, DOI 10.2174/187152012800617768; Catto JWF, 2011, EUR UROL, V59, P671, DOI 10.1016/j.eururo.2011.01.044; Cazalla D, 2010, SCIENCE, V328, P1563, DOI 10.1126/science.1187197; Cho WCS, 2012, EXPERT OPIN THER TAR, V16, P747, DOI 10.1517/14728222.2012.696102; Cho WCS, 2012, EXPERT OPIN THER TAR, V16, P345, DOI 10.1517/14728222.2012.663354; Culler SJ, 2010, SCIENCE, V330, P1251, DOI 10.1126/science.1192128; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Giannakakis A, 2008, CANCER BIOL THER, V7, P255, DOI 10.4161/cbt.7.2.5297; Han YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018286; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Iorio MV, 2012, CARCINOGENESIS, V33, P1126, DOI 10.1093/carcin/bgs140; Karlsson M, 2012, CURR OPIN BIOTECH, V23, P1; Kim HW, 2009, J BIOL CHEM, V284, P33161, DOI 10.1074/jbc.M109.020925; Lehmann U, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-109; Lei AQ, 2011, EXPERT REV ANTICANC, V11, P1851, DOI [10.1586/ERA.11.181, 10.1586/era.11.181]; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lin HX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015797; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Marta GN, 2012, INT BRAZ J UROL, V38, P144, DOI 10.1590/S1677-55382012000200002; Mihelich BL, 2011, J BIOL CHEM, V286, P44503, DOI 10.1074/jbc.M111.262915; Montironi R, 2005, INT J SURG PATHOL, V13, P143, DOI 10.1177/106689690501300203; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muro EM, 2011, BIOCHIMIE, V93, P1916, DOI 10.1016/j.biochi.2011.07.024; Nardinocchi L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015048; Nissim L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.99; Noman MZ, 2012, CANCER RES, V72, P4629, DOI 10.1158/0008-5472.CAN-12-1383; Parekh DJ, 2006, J CLIN ONCOL, V24, P5519, DOI 10.1200/JCO.2006.08.5431; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Racioppi M, 2012, UROL INT, V88, P249, DOI 10.1159/000335556; Saetrom P, 2007, NUCLEIC ACIDS RES, V35, P2333, DOI 10.1093/nar/gkm133; Sarver AL, 2010, CANCER RES, V70, P9570, DOI 10.1158/0008-5472.CAN-10-2074; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Shankar S, 2011, MOL BIOSYST, V7, P1802, DOI 10.1039/c1mb05016h; Weeraratne SD, 2012, ACTA NEUROPATHOL, V123, P539, DOI 10.1007/s00401-012-0969-5; Wu P, 2010, CURR MED CHEM, V17, P4326, DOI 10.2174/092986710793361234; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527; Yamada Y, 2011, CANCER SCI, V102, P522, DOI 10.1111/j.1349-7006.2010.01816.x; Yang W, 2012, EXP CELL RES, V318, P944, DOI 10.1016/j.yexcr.2012.02.010; Zhu WY, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-393	41	79	89	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52280	10.1371/journal.pone.0052280	http://dx.doi.org/10.1371/journal.pone.0052280			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284967	gold, Green Published, Green Submitted			2022-12-27	WOS:000312435900086
J	Song, YN; Geng, JS; Liu, T; Zhong, ZB; Liu, Y; Xia, BS; Ji, HF; Li, XM; Zhang, GQ; Ren, YL; Li, ZG; Pang, D				Song, Yan-Ni; Geng, Jing-Shu; Liu, Tong; Zhong, Zhen-Bin; Liu, Yang; Xia, Bing-Shu; Ji, Hong-Fei; Li, Xiao-Mei; Zhang, Guo-Qiang; Ren, Yan-Lv; Li, Zhi-Gao; Pang, Da			Long CAG Repeat Sequence and Protein Expression of Androgen Receptor Considered as Prognostic Indicators in Male Breast Carcinoma	PLOS ONE			English	Article							CANCER; GENE	Background: The androgen receptor (AR) expression and the CAG repeat length within the AR gene appear to be involved in the carcinogenesis of male breast carcinoma (MBC). Although phenotypic differences have been observed between MBC and normal control group in AR gene, there is lack of correlation analysis between AR expression and CAG repeat length in MBC. The purpose of the study was to investigate the prognostic value of CAG repeat lengths and AR protein expression. Methods: 81 tumor tissues were used for immunostaining for AR expression and CAG repeat length determination and 80 normal controls were analyzed with CAG repeat length in AR gene. The CAG repeat length and AR expression were analyzed in relation to clinicopathological factors and prognostic indicators. Results: AR gene in many MBCs has long CAG repeat sequence compared with that in control group (P = 0.001) and controls are more likely to exhibit short CAG repeat sequence than MBCs. There was statistically significant difference in long CAG repeat sequence between AR status for MBC patients (P = 0.004). The presence of long CAG repeat sequence and AR-positive expression were associated with shorter survival of MBC patients (CAG repeat: P = 0.050 for 5y-OS; P = 0.035 for 5yDFS AR status: P = 0.048 for 5y-OS; P = 0.029 for 5y-DFS, respectively). Conclusion: The CAG repeat length within the AR gene might be one useful molecular biomarker to identify males at increased risk of breast cancer development. The presence of long CAG repeat sequence and AR protein expression were in relation to survival of MBC patients. The CAG repeat length and AR expression were two independent prognostic indicators in MBC patients.	[Song, Yan-Ni; Liu, Tong; Zhong, Zhen-Bin; Liu, Yang; Xia, Bing-Shu; Zhang, Guo-Qiang; Ren, Yan-Lv; Li, Zhi-Gao; Pang, Da] Harbin Med Univ, Affiliated Hosp 3, Dept Breast Surg, Harbin, Peoples R China; [Geng, Jing-Shu; Li, Xiao-Mei] Harbin Med Univ, Affiliated Hosp 3, Dept Pathol, Harbin, Peoples R China; [Ji, Hong-Fei; Pang, Da] Heilongjiang Inst Canc Res, Dept Genom, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Li, ZG (corresponding author), Harbin Med Univ, Affiliated Hosp 3, Dept Breast Surg, Harbin, Peoples R China.	drzhigaoli@126.com; pangdasir@163.com		LIU, TONG/0000-0001-9234-1328; LI, ZHIGAO/0000-0002-4169-143X				Anderson WF, 2010, J CLIN ONCOL, V28, P232, DOI 10.1200/JCO.2009.23.8162; Choong CS, 1996, MOL ENDOCRINOL, V10, P1527, DOI 10.1210/me.10.12.1527; Cox DG, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1602; de Toro MMM, 1998, J STEROID BIOCHEM, V67, P333, DOI 10.1016/S0960-0760(98)00124-1; Ferro P, 2002, MOL CELL ENDOCRINOL, V193, P109, DOI 10.1016/S0303-7207(02)00104-1; Gilbert SF, 2011, BREAST CANCER RES TR, V129, P575, DOI 10.1007/s10549-011-1510-6; Giordano SH, 2002, ANN INTERN MED, V137, P678, DOI 10.7326/0003-4819-137-8-200210150-00013; Kidwai N, 2004, BREAST CANCER RES, V6, pR18, DOI 10.1186/bcr733; LOBACCARO JM, 1993, HUM MOL GENET, V2, P1799, DOI 10.1093/hmg/2.11.1799; MacLean HE, 2004, BREAST CANCER RES TR, V88, P239, DOI 10.1007/s10549-004-0781-6; SOREIDE JA, 1992, EUR J SURG ONCOL, V18, P112; Syrjakoski K, 2003, BREAST CANCER RES TR, V77, P167, DOI 10.1023/A:1021369508561; Wang-Rodriguez J, 2002, MODERN PATHOL, V15, P853, DOI 10.1097/01.MP.0000022251.61944.1D; Young IE, 2000, J MED GENET, V37, P139, DOI 10.1136/jmg.37.2.139	14	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e52271	10.1371/journal.pone.0052271	http://dx.doi.org/10.1371/journal.pone.0052271			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23272232	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386800157
J	Camp, E; Dietrich, S; Munsterberg, A				Camp, Esther; Dietrich, Susanne; Muensterberg, Andrea			Fate Mapping Identifies the Origin of SHF/AHF Progenitors in the Chick Primitive Streak	PLOS ONE			English	Article							HEART FIELD; PHARYNGEAL MESODERM; MOVEMENT PATTERNS; EMBRYONIC ORIGINS; OUTFLOW TRACT; MOUSE HEART; CELLS; MUSCLES; TUBE; DIFFERENTIATION	Heart development depends on the spatio-temporally regulated contribution of progenitor cells from the primary, secondary and anterior heart fields. Primary heart field (PHF) cells are first recruited to form a linear heart tube; later, they contribute to the inflow myocardium of the four-chambered heart. Subsequently cells from the secondary (SHF) and anterior heart fields (AHF) are added to the heart tube and contribute to both the inflow and outflow myocardium. In amniotes, progenitors of the linear heart tube have been mapped to the anterior-middle region of the early primitive streak. After ingression, these cells are located within bilateral heart fields in the lateral plate mesoderm. On the other hand SHF/AHF field progenitors are situated anterior to the linear heart tube, however, the origin and location of these progenitors prior to the development of the heart tube remains elusive. Thus, an unresolved question in the process of cardiac development is where SHF/AHF progenitors originate from during gastrulation and whether they come from a region in the primitive streak distinct from that which generates the PHF. To determine the origin and location of SHF/AHF progenitors we used vital dye injection and tissue grafting experiments to map the location and ingression site of outflow myocardium progenitors in early primitive streak stage chicken embryos. Cells giving rise to the AHF ingressed from a rostral region of the primitive streak, termed region 'A'. During development these cells were located in the cranial paraxial mesoderm and in the pharyngeal mesoderm. Furthermore we identified region 'B', located posterior to 'A', which gave rise to progenitors that contributed to the primary heart tube and the outflow tract. Our studies identify two regions in the early primitive streak, one which generates cells of the AHF and a second from which cardiac progenitors of the PHF and SHF emerge. Citation: Camp E, Dietrich S, Munsterberg A (2012) Fate Mapping Identifies the Origin of SHF/AHF Progenitors in the Chick Primitive Streak. PLoS ONE 7(12): e51948. doi:10.1371/journal.pone.0051948	[Camp, Esther; Muensterberg, Andrea] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Dietrich, Susanne] Univ Portsmouth, Inst Biomed & Biomol Sci, Portsmouth, Hants, England	University of East Anglia; University of Portsmouth	Munsterberg, A (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	a.munsterberg@uea.ac.uk	Munsterberg, Andrea E/E-2205-2011; Dietrich, Susanne/M-6515-2015	Munsterberg, Andrea E/0000-0002-4577-4240; Dietrich, Susanne/0000-0001-8688-8992	British Heart Foundation [PG/08/105/26150]	British Heart Foundation(British Heart Foundation)	EC was funded by a British Heart Foundation project grant (PG/08/105/26150) http://www.bhf.org.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Issa R, 2004, DEV BIOL, V272, P281, DOI 10.1016/j.ydbio.2004.05.016; Abu-Issa R, 2008, DEV BIOL, V319, P223, DOI 10.1016/j.ydbio.2008.04.014; Abu-Issa R, 2007, ANNU REV CELL DEV BI, V23, P45, DOI 10.1146/annurev.cellbio.23.090506.123331; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Camp E, 2012, FRONTIERS BIOSCIENCE, V17, P2416; Chapman SC, 2001, DEV DYNAM, V220, P284, DOI 10.1002/1097-0177(20010301)220:3<284::AID-DVDY1102>3.0.CO;2-5; Cohen ED, 2012, DEVELOPMENT, V139, P1931, DOI 10.1242/dev.069377; Cui C, 2009, DEV BIOL, V332, P212, DOI 10.1016/j.ydbio.2009.05.570; de Pater E, 2009, DEVELOPMENT, V136, P1633, DOI 10.1242/dev.030924; DEHAAN R. L., 1965, ORGANOGENESIS, P377; DELACRUZ MV, 1989, J ANAT, V165, P121; DELACRUZ MV, 1977, J ANAT, V123, P661; GARCIAMARTINEZ V, 1993, DEV BIOL, V159, P706, DOI 10.1006/dbio.1993.1276; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Hochgreb T, 2003, DEVELOPMENT, V130, P5363, DOI 10.1242/dev.00750; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Lescroart F, 2010, DEVELOPMENT, V137, P3269, DOI 10.1242/dev.050674; LINASK KK, 1992, DEV BIOL, V151, P213, DOI 10.1016/0012-1606(92)90228-9; LITTLE CD, 1995, EXPERIENTIA, V51, P873, DOI 10.1007/BF01921738; Lopez-Sanchez C, 2005, J MORPHOL, V264, P105, DOI 10.1002/jmor.10323; Lopez-Sanchez C, 2009, INT J DEV BIOL, V53, P1445, DOI 10.1387/ijdb.072417cl; McGrew MJ, 2008, DEVELOPMENT, V135, P2289, DOI 10.1242/dev.022020; Meilhac SM, 2004, DEV CELL, V6, P685, DOI 10.1016/S1534-5807(04)00133-9; Mjaatvedt CH, 2001, DEV BIOL, V238, P97, DOI 10.1006/dbio.2001.0409; Nagai H, 2011, GENESIS, V49, P46, DOI 10.1002/dvg.20690; Nathan E, 2008, DEVELOPMENT, V135, P647, DOI 10.1242/dev.007989; NODEN DM, 1983, AM J ANAT, V168, P257, DOI 10.1002/aja.1001680302; Psychoyos D, 1996, DEVELOPMENT, V122, P1523; Rawles Mary E., 1943, PHYSIOL ZOOL, V16, P22; Redkar A, 2001, DEVELOPMENT, V128, P2269; Rochais F, 2009, CIRC RES, V104, P933, DOI 10.1161/CIRCRESAHA.109.194464; ROSENQUIST GC, 1970, DEV BIOL, V22, P461, DOI 10.1016/0012-1606(70)90163-6; Scott IC, 2012, CURR TOP DEV BIOL, V100, P1, DOI 10.1016/B978-0-12-387786-4.00001-4; STALSBERG H, 1969, DEV BIOL, V19, P128, DOI 10.1016/0012-1606(69)90052-9; Sun YF, 2007, DEV BIOL, V304, P286, DOI 10.1016/j.ydbio.2006.12.048; Tam P.P.L., 1999, HEART DEV, DOI [10.1016/b978-012329860-7/50003-9, DOI 10.1016/B978-012329860-7/50003-9]; Tirosh-Finkel L, 2006, DEVELOPMENT, V133, P1943, DOI 10.1242/dev.02365; Tzahor E, 2003, GENE DEV, V17, P3087, DOI 10.1101/gad.1154103; Tzahor E, 2011, CARDIOVASC RES, V91, P196, DOI 10.1093/cvr/cvr116; Varner VD, 2012, DEVELOPMENT, V139, P1680, DOI 10.1242/dev.073486; Wachtler F, 1986, Bibl Anat, P24; Waldo KL, 2001, DEVELOPMENT, V128, P3179; Xavier-Neto J, 2001, GENESIS, V31, P97, DOI 10.1002/gene.10009; Yang XS, 2002, DEV CELL, V3, P425, DOI 10.1016/S1534-5807(02)00256-3; Yuan SP, 2000, ANAT REC, V260, P204, DOI 10.1002/1097-0185(20001001)260:2<204::AID-AR90>3.0.CO;2-5; Yue Q, 2008, DEVELOPMENT, V135, P1029, DOI 10.1242/dev.015321	46	19	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51948	10.1371/journal.pone.0051948	http://dx.doi.org/10.1371/journal.pone.0051948			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272192	gold, Green Published, Green Submitted			2022-12-27	WOS:000312386600051
J	Armeni, T; Ercolani, L; Urbanelli, L; Magini, A; Magherini, F; Pugnaloni, A; Piva, F; Modesti, A; Emiliani, C; Principato, G				Armeni, Tatiana; Ercolani, Luisa; Urbanelli, Lorena; Magini, Alessandro; Magherini, Francesca; Pugnaloni, Armanda; Piva, Francesco; Modesti, Alessandra; Emiliani, Carla; Principato, Giovanni			Cellular Redox Imbalance and Changes of Protein S-glutathionylation Patterns Are Associated with Senescence Induced by Oncogenic H-Ras	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; IDENTIFICATION; QUANTITATION; ANTIOXIDANTS; INVOLVEMENT; ACTIVATION; PROTEOMICS; MIGRATION; REQUIRES; PATHWAYS	H-Ras oncogene requires deregulation of additional oncogenes or inactivation of tumor suppressor proteins to increase cell proliferation rate and transform cells. In fact, the expression of the constitutively activated H-RasV12 induces cell growth arrest and premature senescence, which act like barriers in pre-neoplastic lesions. In our experimental model, human fibroblasts transfected with H-RasV12 show a dramatic modification of morphology. H-RasV12 expressing cells also show premature senescence followed by cell death, induced by autophagy and apoptosis. In this context, we provide evidence that in H-RasV12 expressing cells, the premature senescence is associated with cellular redox imbalance as well as with altered post-translation protein modification. In particular, redox imbalance is due to a strong reduction of total antioxidant capacity, and significant decrease of glutathione level. As the reversible addition of glutathione to cysteinyl residues of proteins is an important post-translational regulative modification, we investigated S-glutathionylation in cells expressing active H-Ras. In this contest we observed different S-glutathionylation patterns in control and H-RasV12 expressing cells. Particularly, the GAPDH enzyme showed S-glutathionylation increase and significant enzyme activity depletion in H-Ras V12 cells. In conclusion, we proposed that antioxidant defense reduction, glutathione depletion and subsequent modification of S-glutathionylation of target proteins contribute to arrest cell growth, leading to death of fibroblasts expressing constitutively active H-Ras oncogene, thus acting as oncogenic barriers that obstacle the progression of cell transformation.	[Armeni, Tatiana; Ercolani, Luisa; Piva, Francesco; Principato, Giovanni] Univ Politecn Marche, Dept Clin Sci, Biochem Sect, Ancona, Italy; [Urbanelli, Lorena; Magini, Alessandro; Emiliani, Carla] Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy; [Magherini, Francesca; Modesti, Alessandra] Univ Florence, Dept Biochem, Florence, Italy; [Pugnaloni, Armanda] Univ Politecn Marche, Dept Mol & Clin Sci, Ancona, Italy	Marche Polytechnic University; University of Perugia; University of Florence; Marche Polytechnic University	Armeni, T (corresponding author), Univ Politecn Marche, Dept Clin Sci, Biochem Sect, Ancona, Italy.	t.armeni@univpm.it	Emiliani, Carla/G-3738-2010; Armeni, Tatiana/J-8228-2013; magherini, francesca/A-2991-2014; Magini, Alessandro/L-9175-2015; Modesti, Alessandra/L-3276-2017; Magini, Alessandro/P-1201-2019; Pugnaloni, Armanda/AAE-9049-2020	Emiliani, Carla/0000-0002-6368-1515; Armeni, Tatiana/0000-0003-0931-1342; magherini, francesca/0000-0001-8388-0952; Magini, Alessandro/0000-0002-2750-6226; Modesti, Alessandra/0000-0002-1290-2285; Ercolani, Luisa/0000-0002-0418-3460; PRINCIPATO, Giovanni/0000-0001-8800-0301; Urbanelli, Lorena/0000-0003-0621-8476; PIVA, Francesco/0000-0003-1850-2482	Universita Politecnica delle Marche; "Fondazione Cassa di Risparmio di Perugia" [2008.021.375]	Universita Politecnica delle Marche; "Fondazione Cassa di Risparmio di Perugia"(Fondazione Cassa Risparmio Perugia)	This work was supported by Universita Politecnica delle Marche and by "Fondazione Cassa di Risparmio di Perugia" (2008.021.375) grants to C. E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2004, J BIOL CHEM, V279, P29857, DOI 10.1074/jbc.M313320200; Andrei D, 2008, J MED CHEM, V51, P7944, DOI 10.1021/jm800831y; Balendiran GK, 2004, CELL BIOCHEM FUNCT, V22, P343, DOI 10.1002/cbf.1149; Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033; Banerjee P, 2011, J BIOL CHEM, V286, P33580, DOI 10.1074/jbc.M111.248401; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Bartkova J, 2010, ONCOGENE, V29, P5095, DOI 10.1038/onc.2010.249; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bergmeyer HU, 1974, METHOD ENZYMAT AN, P466; Biswas S, 2006, BIOCHEM PHARMACOL, V71, P551, DOI 10.1016/j.bcp.2005.10.044; Borras C, 2004, J BIOL CHEM, V279, P34332, DOI 10.1074/jbc.M402425200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRIGELIUS R, 1983, BIOCHEM PHARMACOL, V32, P2529, DOI 10.1016/0006-2952(83)90014-X; Burhans WC, 2009, FREE RADICAL BIO MED, V47, P1282, DOI 10.1016/j.freeradbiomed.2009.05.026; CARLBERG I, 1975, J BIOL CHEM, V250, P5475; Collado M, 2005, CELL CYCLE, V4, P1722, DOI 10.4161/cc.4.12.2260; Dalle-Donne I, 2008, ANTIOXID REDOX SIGN, V10, P445, DOI 10.1089/ars.2007.1716; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Duan HM, 2005, INT J BIOCHEM CELL B, V37, P1407, DOI 10.1016/j.biocel.2005.01.010; Elgendy M, 2011, MOL CELL, V42, P23, DOI 10.1016/j.molcel.2011.02.009; Estrela JM, 2006, CRIT REV CL LAB SCI, V43, P143, DOI 10.1080/10408360500523878; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; Fratelli M, 2002, P NATL ACAD SCI USA, V99, P3505, DOI 10.1073/pnas.052592699; Garcia J, 2010, J BIOL CHEM, V285, P39646, DOI 10.1074/jbc.M110.164160; Ghezzi P, 2007, CURR OPIN PHARMACOL, V7, P398, DOI 10.1016/j.coph.2007.04.006; Giles GI, 2006, CURR PHARM DESIGN, V12, P4427, DOI 10.2174/138161206779010549; Gilge JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004015; Giustarini D, 2004, J CELL MOL MED, V8, P201, DOI 10.1111/j.1582-4934.2004.tb00275.x; HABIG WH, 1974, P NATL ACAD SCI USA, V71, P3879, DOI 10.1073/pnas.71.10.3879; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Hole PS, 2010, BLOOD, V115, P1238, DOI 10.1182/blood-2009-06-222869; Itahana Koji, 2007, Methods Mol Biol, V371, P21; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Kagawa Y, 1997, BIOSCIENCE REP, V17, P115, DOI 10.1023/A:1027329328504; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Lee JJ, 2010, ONCOGENE, V29, P561, DOI 10.1038/onc.2009.355; Liu RG, 2001, ONCOGENE, V20, P1486, DOI 10.1038/sj.onc.1204214; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Magherini F, 2009, CELL MOL LIFE SCI, V66, P933, DOI 10.1007/s00018-009-8574-z; Markovic J, 2010, FREE RADICAL RES, V44, P721, DOI 10.3109/10715762.2010.485989; Martinez-Ruiz A, 2007, CARDIOVASC RES, V75, P220, DOI 10.1016/j.cardiores.2007.03.016; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Mohr S, 1999, J BIOL CHEM, V274, P9427, DOI 10.1074/jbc.274.14.9427; Nicke B, 2005, MOL CELL, V20, P673, DOI 10.1016/j.molcel.2005.10.038; Perluigi M, 2010, J NEUROSCI RES, V88, P3498, DOI 10.1002/jnr.22500; Ralph SJ, 2010, MOL ASPECTS MED, V31, P145, DOI 10.1016/j.mam.2010.02.008; Regoli F, 1999, TOXICOL APPL PHARM, V156, P96, DOI 10.1006/taap.1999.8637; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Seru R, 2004, J NEUROCHEM, V91, P613, DOI 10.1111/j.1471-4159.2004.02754.x; Shlush LI, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-16; Tew KD, 2011, CURR OPIN CHEM BIOL, V15, P156, DOI 10.1016/j.cbpa.2010.10.016; Thamsen M, 2011, CURR OPIN CHEM BIOL, V15, P113, DOI 10.1016/j.cbpa.2010.11.013; Townsend DM, 2006, MOL PHARMACOL, V69, P501, DOI 10.1124/mol.105.018523; Tu SH, 2010, BREAST CANCER RES TR, V121, P539, DOI 10.1007/s10549-009-0492-0; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Vayalil PK, 2007, AM J PHYSIOL-LUNG C, V293, pL1281, DOI 10.1152/ajplung.00128.2007; Xiong Y, 2011, ANTIOXID REDOX SIGN, V15, P233, DOI 10.1089/ars.2010.3540; Yusuf MA, 2010, FREE RADICAL BIO MED, V49, P908, DOI 10.1016/j.freeradbiomed.2010.06.020	60	23	24	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52151	10.1371/journal.pone.0052151	http://dx.doi.org/10.1371/journal.pone.0052151			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284910	Green Published, gold			2022-12-27	WOS:000312794500103
J	Fan, JY; Song, YQ; Wang, YY; Hui, RT; Zhang, WL				Fan, Jingyao; Song, Yiqing; Wang, Yuyao; Hui, Rutai; Zhang, Weili			Dietary Glycemic Index, Glycemic Load, and Risk of Coronary Heart Disease, Stroke, and Stroke Mortality: A Systematic Review with Meta-Analysis	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; OBESE YOUNG-ADULTS; MIDDLE-AGED WOMEN; CARDIOVASCULAR-DISEASE; CARBOHYDRATE INTAKE; MYOCARDIAL-INFARCTION; LIPID PROFILE; SWEDISH MEN; OVERWEIGHT; AMERICANS	Background: The relationship between dietary glycemic index, glycemic load and risk of coronary heart disease (CHD), stroke, and stroke-related mortality is inconsistent. Methods: We systematically searched the MEDLINE, EMBASE, and Science Citation Index Expanded databases using glycemic index, glycemic load, and cardiovascular disease and reference lists of retrieved articles up to April 30, 2012. We included prospective studies with glycemic index and glycemic load as the exposure and incidence of fatal and nonfatal CHD, stroke, and stroke-related mortality as the outcome variable. Pooled relative risks (RR) and 95% confidence intervals (CI) were calculated using random-effects models. Results: Fifteen prospective studies with a total of 438,073 participants and 9,424 CHD cases, 2,123 stroke cases, and 342 deaths from stroke were included in the meta-analysis. Gender significantly modified the effects of glycemic index and glycemic load on CHD risk, and high glycemic load level was associated with higher risk of CHD in women (RR = 1.49, 95% CI 1.27-1.73), but not in men (RR = 1.08, 95% CI 0.91-1.27). Stratified meta-analysis by body mass index indicated that among overweight and obese subjects, dietary glycemic load level were associated with increased risk of CHD (RR = 1.49, 95% CI 1.27-1.76; P for interaction = 0.003). Higher dietary glycemic load, but not glycemic index, was positively associated with stroke (RR = 1.19, 95% CI 1.00-1.43). There is a linear dose-response relationship between dietary glycemic load and increased risk of CHD, with pooled RR of 1.05 (95% CI 1.02-1.08) per 50-unit increment in glycemic load level. Conclusion: High dietary glycemic load is associated with a higher risk of CHD and stroke, and there is a linear dose-response relationship between glycemic load and CHD risk. Dietary glycemic index is slightly associated with risk of CHD, but not with stroke and stroke-related death. Further studies are needed to verify the effects of gender and body weight on cardiovascular diseases.	[Fan, Jingyao; Wang, Yuyao; Hui, Rutai; Zhang, Weili] Peking Union Med Coll, Sino German Lab Mol Med, State Key Lab Cardiovasc Dis, FuWai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100021, Peoples R China; [Fan, Jingyao; Wang, Yuyao; Hui, Rutai; Zhang, Weili] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Song, Yiqing] Peking Univ, Inst Vasc Med, Hosp 3, Minist Hlth, Beijing 100871, Peoples R China; [Song, Yiqing] Harvard Univ, Brigham & Womens Hosp, Dept Med, Div Prevent Med,Med Sch, Boston, MA 02115 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Zhang, WL (corresponding author), Peking Union Med Coll, Sino German Lab Mol Med, State Key Lab Cardiovasc Dis, FuWai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100021, Peoples R China.	zhangwl1747@yahoo.com.cn			Ministry of Science and Technology of China [2011CB503901]; National Natural Science of China [81070172]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Ministry of Science and Technology of China (2011CB503901 to R. Hui) and from the National Natural Science of China (81070172 to W. Zhang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beulens JWJ, 2007, J AM COLL CARDIOL, V50, P14, DOI 10.1016/j.jacc.2007.02.068; Bouche C, 2002, DIABETES CARE, V25, P822, DOI 10.2337/diacare.25.5.822; Burger KNJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025955; CHOI ESK, 1990, ARCH INTERN MED, V150, P413, DOI 10.1001/archinte.150.2.413; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dickinson S, 2005, CURR OPIN LIPIDOL, V16, P69, DOI 10.1097/00041433-200502000-00012; Dong JY, 2012, AM J CARDIOL, V109, P1608, DOI 10.1016/j.amjcard.2012.01.385; Ebbeling CB, 2007, JAMA-J AM MED ASSOC, V297, P2092, DOI 10.1001/jama.297.19.2092; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ford ES, 2001, ARCH INTERN MED, V161, P572, DOI 10.1001/archinte.161.4.572; FOSTERPOWELL K, 1995, AM J CLIN NUTR, V62, p871S, DOI 10.1093/ajcn/62.4.871S; Frost G, 1999, LANCET, V353, P1045, DOI 10.1016/S0140-6736(98)07164-5; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Grau K, 2011, PUBLIC HEALTH NUTR, V14, P109, DOI 10.1017/S136898001000176X; Halton TL, 2006, NEW ENGL J MED, V355, P1991, DOI 10.1056/NEJMoa055317; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Hardy DS, 2010, ANN EPIDEMIOL, V20, P610, DOI 10.1016/j.annepidem.2010.05.008; JENKINS DJA, 1981, AM J CLIN NUTR, V34, P362, DOI 10.1093/ajcn/34.3.362; Kaushik S, 2009, STROKE, V40, P206, DOI 10.1161/STROKEAHA.108.513812; Knopp Robert H, 2005, Curr Atheroscler Rep, V7, P472, DOI 10.1007/s11883-005-0065-6; Levitan EB, 2007, AM J CLIN NUTR, V85, P1521, DOI 10.1093/ajcn/85.6.1521; Levitan EB, 2007, AM J CLIN NUTR, V85, P548, DOI 10.1093/ajcn/85.2.548; Levitan EB, 2010, BRIT J NUTR, V103, P1049, DOI 10.1017/S0007114509992674; Liu SM, 2002, AM J CLIN NUTR, V75, P492, DOI 10.1093/ajcn/75.3.492; Liu SM, 2000, AM J CLIN NUTR, V71, P1455; Liu SM, 2001, AM J CLIN NUTR, V73, P560; Ludwig DS, 2001, JAMA-J AM MED ASSOC, V287, P2414; Maki KC, 2007, AM J CLIN NUTR, V85, P724, DOI 10.1093/ajcn/85.3.724; McMillan-Price J, 2006, ARCH INTERN MED, V166, P1466, DOI 10.1001/archinte.166.14.1466; Mursu J, 2011, NUTR METAB CARDIOVAS, V21, P144, DOI 10.1016/j.numecd.2009.08.001; Oba S, 2010, METABOLISM, V59, P1574, DOI 10.1016/j.metabol.2010.02.004; Oh K, 2005, AM J EPIDEMIOL, V161, P161, DOI 10.1093/aje/kwi026; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Pierucci P, 2012, NUTR METAB CARDIOVAS, V22, P727, DOI 10.1016/j.numecd.2010.12.002; REED DM, 1990, AM J EPIDEMIOL, V131, P579, DOI 10.1093/oxfordjournals.aje.a115542; Rizkalla SW, 2004, DIABETES CARE, V27, P1866, DOI 10.2337/diacare.27.8.1866; Rucker G, 2008, STAT MED, V27, P746, DOI 10.1002/sim.2971; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; SHIMAMOTO T, 1989, CIRCULATION, V79, P503, DOI 10.1161/01.CIR.79.3.503; Sieri S, 2010, ARCH INTERN MED, V170, P640, DOI 10.1001/archinternmed.2010.15; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sutton AJAK, 2000, METHODS METAANALYSIS; van Dam RM, 2000, EUR J CLIN NUTR, V54, P726, DOI 10.1038/sj.ejcn.1601086; Willett W, 2002, AM J CLIN NUTR, V76, p274S, DOI 10.1093/ajcn/76.1.274S	45	88	93	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52182	10.1371/journal.pone.0052182	http://dx.doi.org/10.1371/journal.pone.0052182			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284926	gold, Green Published, Green Submitted			2022-12-27	WOS:000312794500107
J	Hou, EQ; Chen, CR; McGroddy, ME; Wen, DZ				Hou, Enqing; Chen, Chengrong; McGroddy, Megan E.; Wen, Dazhi			Nutrient Limitation on Ecosystem Productivity and Processes of Mature and Old-Growth Subtropical Forests in China	PLOS ONE			English	Article							N-P RATIOS; LEAF-LITTER DECOMPOSITION; NET PRIMARY PRODUCTIVITY; TROPICAL RAIN-FOREST; PHOSPHORUS LIMITATION; MINERAL-NUTRITION; ORGANIC-MATTER; NITROGEN; BIOMASS; CLIMATE	Nitrogen (N) is considered the dominant limiting nutrient in temperate regions, while phosphorus (P) limitation frequently occurs in tropical regions, but in subtropical regions nutrient limitation is poorly understood. In this study, we investigated N and P contents and N: P ratios of foliage, forest floors, fine roots and mineral soils, and their relationships with community biomass, litterfall C, N and P productions, forest floor turnover rate, and microbial processes in eight mature and old-growth subtropical forests (stand age >80 yr) at Dinghushan Biosphere Reserve, China. Average N: P ratios (mass based) in foliage, litter (L) layer and mixture of fermentation and humus (F/H) layer, and fine roots were 28.3, 42.3, 32.0 and 32.7, respectively. These values are higher than the critical N: P ratios for P limitation proposed (16-20 for foliage, ca. 25 for forest floors). The markedly high N: P ratios were mainly attributed to the high N concentrations of these plant materials. Community biomass, litterfall C, N and P productions, forest floor turnover rate and microbial properties were more strongly related to measures of P than N and frequently negatively related to the N: P ratios, suggesting a significant role of P availability in determining ecosystem production and productivity and nutrient cycling at all the study sites except for one prescribed disturbed site where N availability may also be important. We propose that N enrichment is probably a significant driver of the potential P limitation in the study area. Low P parent material may also contribute to the potential P limitation. In general, our results provided strong evidence supporting a significant role for P availability, rather than N availability, in determining ecosystem primary productivity and ecosystem processes in subtropical forests of China.	[Hou, Enqing; Chen, Chengrong] Griffith Univ, Griffith Sch Environm, Environm Futures Ctr, Nathan, Qld 4111, Australia; [Hou, Enqing; Wen, Dazhi] Chinese Acad Sci, S China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [McGroddy, Megan E.] Univ Virginia, Dept Environm Sci, NASA, Charlottesville, VA 22903 USA; [Hou, Enqing; Wen, Dazhi] Univ Chinese Acad Sci, Beijing, Peoples R China	Griffith University; Chinese Academy of Sciences; South China Botanical Garden, CAS; National Aeronautics & Space Administration (NASA); University of Virginia; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Chen, CR (corresponding author), Griffith Univ, Griffith Sch Environm, Environm Futures Ctr, Nathan, Qld 4111, Australia.	c.chen@griffith.edu.au; dzwen@scbg.ac.cn	Chen, Chengrong/B-3814-2009; Hou, Enqing/A-2056-2016; chen, chengrong/K-8188-2019; , Enqing/G-4629-2013	Chen, Chengrong/0000-0001-6377-4001; Hou, Enqing/0000-0003-4864-2347; chen, chengrong/0000-0001-6377-4001; , Enqing/0000-0002-5162-488X	National Natural Science Foundation of China [31070409]; Strategic Priority Research Program - Climate Change: Carbon Budget and Relevant Issues of the Chinese Academy of Sciences [XDA05050205]; Australian Research Council [FT0990547]; China Scholarship Council	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program - Climate Change: Carbon Budget and Relevant Issues of the Chinese Academy of Sciences(Chinese Academy of Sciences); Australian Research Council(Australian Research Council); China Scholarship Council(China Scholarship Council)	This study was supported by National Natural Science Foundation of China (No. 31070409), Strategic Priority Research Program - Climate Change: Carbon Budget and Relevant Issues of the Chinese Academy of Sciences (No. XDA05050205 and the Australian Research Council (FT0990547). The support from China Scholarship Council through an overseas joint doctoral fellowship to Enqing Hou is also kindly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aber JD, 2003, BIOSCIENCE, V53, P375, DOI 10.1641/0006-3568(2003)053[0375:INDATN]2.0.CO;2; AERTS R, 1989, OECOLOGIA, V78, P115, DOI 10.1007/BF00377206; Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Aerts R, 1996, J ECOL, V84, P597, DOI 10.2307/2261481; Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Campo J, 2003, J TROP ECOL, V19, P525, DOI 10.1017/S0266467403003572; CHAPIN FS, 1986, AM NAT, V127, P48, DOI 10.1086/284466; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; Chen CR, 2005, AUST J SOIL RES, V43, P515, DOI 10.1071/SR04132; Cleveland CC, 2002, ECOSYSTEMS, V5, P680, DOI 10.1007/s10021-002-0202-9; Cleveland CC, 2011, ECOL LETT, V14, P939, DOI 10.1111/j.1461-0248.2011.01658.x; CREWS TE, 1995, ECOLOGY, V76, P1407, DOI 10.2307/1938144; Curtin D, 2006, SOIL SCI SOC AM J, V70, P1512, DOI 10.2136/sssaj2005.0338; DELAUNE RD, 1979, ESTUAR COAST MAR SCI, V8, P477, DOI 10.1016/0302-3524(79)90063-X; EDWARDS PJ, 1982, J ECOL, V70, P807, DOI 10.2307/2260106; Eivazi F., 1995, METHODS APPL SOIL MI, V1st ed., P350; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Elser JJ, 2009, SCIENCE, V326, P835, DOI 10.1126/science.1176199; Fang YT, 2008, BIOGEOSCIENCES, V5, P339, DOI 10.5194/bg-5-339-2008; [方运霆 Fang Yunting], 2002, [广西植物, Guihaia], V22, P305; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Gusewell S, 2006, PLANT SOIL, V287, P131, DOI 10.1007/s11104-006-9050-2; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Gusewell S, 2002, PERSPECT PLANT ECOL, V5, P37, DOI 10.1078/1433-8319-0000022; HERBERT DA, 1995, BIOGEOCHEMISTRY, V29, P223, DOI 10.1007/BF02186049; Hobbie SE, 2000, ECOLOGY, V81, P1867, DOI 10.1890/0012-9658(2000)081[1867:NLODIH]2.0.CO;2; Huang WJ, 2011, ACTA OECOLOGICA INT, DOI DOI 10.1016/J.ACTA0; JENNY H, 1949, SOIL SCI, V68, P419, DOI 10.1097/00010694-194912000-00001; KENK G, 1988, ENVIRON POLLUT, V54, P199, DOI 10.1016/0269-7491(88)90112-1; Kerkhoff AJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P585, DOI 10.1111/j.1466-822x.2005.00187.x; Koerselman W, 1996, J APPL ECOL, V33, P1441, DOI 10.2307/2404783; Laurance WF, 1999, FOREST ECOL MANAG, V118, P127, DOI 10.1016/S0378-1127(98)00494-0; Lipson DA, 1996, ECOLOGY, V77, P1277, DOI 10.2307/2265597; Liu JC, 2007, ENVIRON SCI POLLUT R, V14, P123, DOI 10.1065/espr2006.07.325; Liu JX, 2002, TROPICAL SUBTROPICAL, P125; Liu L, 2012, SOIL BIOL BIOCHEM, V44, P31, DOI 10.1016/j.soilbio.2011.08.017; [刘申 LIU Shen], 2007, [生态科学, Ecologic Science], V26, P387; Liu XJ, 2011, ENVIRON POLLUT, V159, P2251, DOI 10.1016/j.envpol.2010.08.002; Lu XK, 2009, PEDOSPHERE, V19, P189, DOI 10.1016/S1002-0160(09)60108-9; Lu XK, 2011, ENVIRON POLLUT, V159, P2228, DOI 10.1016/j.envpol.2010.10.037; Lu XK, 2010, GLOBAL CHANGE BIOL, V16, P2688, DOI 10.1111/j.1365-2486.2010.02174.x; MacDonald JA, 2002, GLOBAL CHANGE BIOL, V8, P1028, DOI 10.1046/j.1365-2486.2002.00532.x; McDowell RW, 2000, NUTR CYCL AGROECOSYS, V57, P225, DOI 10.1023/A:1009838424935; McGroddy ME, 2004, ECOLOGY, V85, P2390, DOI 10.1890/03-0351; Mo J, 2008, GLOBAL CHANGE BIOL, V14, P403, DOI 10.1111/j.1365-2486.2007.01503.x; Mo JM, 2006, PLANT SOIL, V282, P135, DOI 10.1007/s11104-005-5446-7; MO JM, 1995, BIOTROPICA, V27, P290, DOI 10.2307/2388915; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; OHNO T, 1991, SOIL SCI SOC AM J, V55, P892, DOI 10.2136/sssaj1991.03615995005500030046x; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; PENG SL, 1995, SCI CHINA SER B, V38, P67; Penuelas J, 2012, GLOBAL CHANGE BIOL, V18, P3, DOI 10.1111/j.1365-2486.2011.02568.x; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; Schuur EAG, 2001, OECOLOGIA, V128, P431, DOI 10.1007/s004420100671; Schuur EAG, 2003, ECOLOGY, V84, P1165, DOI 10.1890/0012-9658(2003)084[1165:PAGCRT]2.0.CO;2; Shen CD, 2001, RADIOCARBON, V43, P671; Sparling G, 1998, SOIL BIOL BIOCHEM, V30, P1469, DOI 10.1016/S0038-0717(98)00040-6; Sundareshwar PV, 2003, SCIENCE, V299, P563, DOI 10.1126/science.1079100; Tanner EVJ, 1998, ECOLOGY, V79, P10, DOI 10.1890/0012-9658(1998)079[0010:EIONLO]2.0.CO;2; Tian HQ, 2010, BIOGEOCHEMISTRY, V98, P139, DOI 10.1007/s10533-009-9382-0; Townsend AR, 2007, ECOLOGY, V88, P107, DOI 10.1890/0012-9658(2007)88[107:COFNRI]2.0.CO;2; Van Duren IC, 2000, PLANT SOIL, V220, P35, DOI 10.1023/A:1004735618905; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; VERMEER JG, 1983, VEGETATIO, V53, P121, DOI 10.1007/BF00043032; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; VITOUSEK PM, 1975, BIOSCIENCE, V25, P376, DOI 10.2307/1297148; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; VITOUSEK PM, 1986, ANNU REV ECOL SYST, V17, P137, DOI 10.1146/annurev.es.17.110186.001033; Vitousek PM, 1997, BIOGEOCHEMISTRY, V37, P63, DOI 10.1023/A:1005757218475; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; VITOUSEK PM, 1984, ECOLOGY, V65, P285, DOI 10.2307/1939481; von Oheimb G, 2010, ECOSYSTEMS, V13, P317, DOI 10.1007/s10021-010-9320-y; WALKER TW, 1976, GEODERMA, V15, P1, DOI 10.1016/0016-7061(76)90066-5; Wang SQ, 2011, J ENVIRON MANAGE, V92, P1651, DOI 10.1016/j.jenvman.2011.01.024; Wang Z. H., 1982, Tropical and Subtropical Forest Ecosystem, Ding Hu Shan Forest Ecosystem Reserve, China, P77; Wieder WR, 2009, ECOLOGY, V90, P3333, DOI 10.1890/08-2294.1; Wood TE, 2006, ECOSYSTEMS, V9, P700, DOI 10.1007/s10021-005-0016-7; Wood TE, 2009, ECOLOGY, V90, P109, DOI 10.1890/07-1146.1; Wright SJ, 2011, ECOLOGY, V92, P1616, DOI 10.1890/10-1558.1; Yan JH, 2009, SOIL BIOL BIOCHEM, V41, P991, DOI 10.1016/j.soilbio.2008.12.018; [赵同谦 Zhao Tongqian], 2004, [自然资源学报, Journal of Natural Resources], V19, P480; Zhou GY, 2007, PLANT ECOL, V188, P77, DOI 10.1007/s11258-006-9149-9; Zhou GY, 2011, GLOBAL CHANGE BIOL, V17, P3736, DOI 10.1111/j.1365-2486.2011.02499.x	85	29	37	6	138	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52071	10.1371/journal.pone.0052071	http://dx.doi.org/10.1371/journal.pone.0052071			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284873	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500083
J	Nava, S; Dossena, M; Pogliani, S; Pellegatta, S; Antozzi, C; Baggi, F; Gellera, C; Pollo, B; Parati, EA; Finocchiaro, G; Frigerio, S				Nava, Sara; Dossena, Marta; Pogliani, Simona; Pellegatta, Serena; Antozzi, Carlo; Baggi, Fulvio; Gellera, Cinzia; Pollo, Bianca; Parati, Eugenio A.; Finocchiaro, Gaetano; Frigerio, Simona			An Optimized Method for Manufacturing a Clinical Scale Dendritic Cell-Based Vaccine for the Treatment of Glioblastoma	PLOS ONE			English	Article							ANTITUMOR IMMUNITY; MALIGNANT GLIOMAS; TUMOR; CANCER; GENERATION; IMMUNOTHERAPY; ANTIGEN; INDUCE; MICE; VIVO	Immune-based treatments represent a promising new class of therapy designed to boost the immune system to specifically eradicate malignant cells. Immunotherapy may generate specific anti-tumor immune responses, and dendritic cells (DC), professional antigen-presenting cells, are widely used in experimental cancer immunotherapy. Several reports describe methods for the generation of mature, antigen-pulsed DC for clinical use. Improved quality and standardization are desirable to obtain GMP-compliant protocols. In this study we describe the generation of DC from 31 Glioblastoma (GB) patients starting from their monocytes isolated by immunomagnetic CD14 selection using the CliniMACS (R) device. Upon differentiation of CD14+ with IL-4 and GM-CSF, DC were induced to maturation with TNF-alpha, PGE(2), IL-1 beta, and IL-6. Whole tumor lysate was obtained, for the first time, in a closed system using the semi-automated dissociator GentleMACS (R). The yield of proteins improved by 130% compared to the manual dissociation method. Interestingly the Mean Fluorescence Intensity for CD83 increased significantly in DC pulsed with "new method" lysate compared to DC pulsed with "classical method" lysate. Our results indicate that immunomagnetic isolation of CD14(+) monocytes using the CliniMACS (R) device and their pulsing with whole tumor lysate proteins is a suitable method for clinical-scale generation of high quality, functional DC under GMP-grade conditions.	[Nava, Sara; Dossena, Marta; Pogliani, Simona; Parati, Eugenio A.; Frigerio, Simona] Fdn IRCCS Ist Neurol Carlo Besta, Cell Therapy Prod Unit UPTC, Milan, Italy; [Pellegatta, Serena; Finocchiaro, Gaetano] Fdn IRCCS Ist Neurol Carlo Besta, Unit Mol Neurooncol, Milan, Italy; [Gellera, Cinzia] Fdn IRCCS Ist Neurol Carlo Besta, Dept Genet Neurodegenerat & Metab Dis, Milan, Italy; [Pollo, Bianca] Fdn IRCCS Ist Neurol Carlo Besta, Neuropathol Unit, Milan, Italy	IRCCS Istituto Neurologico Besta; IRCCS Istituto Neurologico Besta; IRCCS Istituto Neurologico Besta; IRCCS Istituto Neurologico Besta	Frigerio, S (corresponding author), Fdn IRCCS Ist Neurol Carlo Besta, Cell Therapy Prod Unit UPTC, Milan, Italy.	uptc@istituto-besta.it	Frigerio, Simona/AAI-3264-2021; Parati, Eugenio Agostino/AAN-5893-2021; Pellegatta, Serena/AAL-3693-2021; Nava, Sara/J-8740-2016; Antozzi, Carlo/AAB-8787-2019; Gellera, Cinzia/J-7887-2016; Pogliani, Simona/AAQ-4826-2021; Baggi, Fulvio/AAX-4132-2020; Pollo, Bianca/K-5347-2018; Dossena, Marta/I-2125-2012; Finocchiaro, Gaetano/B-6898-2013	Frigerio, Simona/0000-0001-7078-075X; Parati, Eugenio Agostino/0000-0001-5020-6523; Pellegatta, Serena/0000-0001-7804-9486; Nava, Sara/0000-0001-9912-8255; Antozzi, Carlo/0000-0001-9270-5224; Gellera, Cinzia/0000-0002-3582-665X; Pogliani, Simona/0000-0002-5714-6225; Baggi, Fulvio/0000-0002-4618-0102; Pollo, Bianca/0000-0002-5523-4256; Finocchiaro, Gaetano/0000-0003-3583-4040; Dossena, Marta/0000-0003-1717-8350	Italian Ministry of Health; Regione Lombardia; "il Fondo di Gio", a charity affiliated to the International Brain Tumor Alliance	Italian Ministry of Health(Ministry of Health, Italy); Regione Lombardia(Regione Lombardia); "il Fondo di Gio", a charity affiliated to the International Brain Tumor Alliance	This work was supported by the Italian Ministry of Health, by Regione Lombardia and by a grant from "il Fondo di Gio", a charity affiliated to the International Brain Tumor Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardeshna KM, 2000, VOX SANG, V79, P46; Ardon H, 2012, CANC IMMUNOL IMMUNOT; Ashley DM, 1997, J EXP MED, V186, P1177, DOI 10.1084/jem.186.7.1177; Babatz J, 2003, J HEMATOTH STEM CELL, V12, P515, DOI 10.1089/152581603322448222; Bauer C, 2011, CANCER IMMUNOL IMMUN, V60, P1097, DOI 10.1007/s00262-011-1023-5; Bohnenkamp HR, 2003, CYTOTECHNOLOGY, V42, P121, DOI 10.1023/B:CYTO.0000015833.34696.03; Daga A, 2011, CURR PHARM DESIGN, V17, P2439, DOI 10.2174/138161211797249206; Dauer M, 2008, J IMMUNOL METHODS, V337, P97, DOI 10.1016/j.jim.2008.07.003; de Heusch M, 2004, EUR J IMMUNOL, V34, P1861, DOI 10.1002/eji.200424878; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; Gilboa E, 2007, J CLIN INVEST, V117, P1195, DOI 10.1172/JCI31205; Holtl L, 1998, LANCET, V352, P1358, DOI 10.1016/S0140-6736(05)60748-9; Iwamoto M, 2003, INT J CANCER, V104, P92, DOI 10.1002/ijc.10915; Kim W, 2010, NEUROSURG CLIN N AM, V21, P139, DOI 10.1016/j.nec.2009.09.005; Lee JJ, 2008, J LEUKOCYTE BIOL, V84, P319, DOI 10.1189/jlb.1107737; Liau L M, 2000, Neurosurg Focus, V9, pe8; Liau LM, 2005, CLIN CANCER RES, V11, P5515, DOI 10.1158/1078-0432.CCR-05-0464; MAYORDOMO JI, 1995, NAT MED, V1, P1297, DOI 10.1038/nm1295-1297; Pellegatta S, 2006, NEUROL RES, V28, P527, DOI 10.1179/016164106X116809; Pellegatta S, 2006, CANCER RES, V66, P10247, DOI 10.1158/0008-5472.CAN-06-2048; Pellegatta S, 2009, METHODS MOL BIOL, V568, P233, DOI 10.1007/978-1-59745-280-9_15; Reardon DA, 2006, J CLIN ONCOL, V24, P1253, DOI 10.1200/JCO.2005.04.5302; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Shakar G, 2004, J IMMUNOL METHODS, V285, P293; STEINMAN RM, 1978, P NATL ACAD SCI USA, V75, P5132, DOI 10.1073/pnas.75.10.5132; Tan JKH, 2005, J LEUKOCYTE BIOL, V78, P319, DOI 10.1189/jlb.1104664; Thurner B, 1999, J IMMUNOL METHODS, V223, P1, DOI 10.1016/S0022-1759(98)00208-7; Tittarelli A, 2012, CANC IMMUNOL IMMUNOT; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wheeler Christopher J, 2004, Clin Neurosurg, V51, P132; Yamanaka R, 2008, TRENDS MOL MED, V14, P228, DOI 10.1016/j.molmed.2008.03.003	31	29	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52301	10.1371/journal.pone.0052301	http://dx.doi.org/10.1371/journal.pone.0052301			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284979	Green Submitted, Green Published, gold			2022-12-27	WOS:000312794500140
J	Perveen, S; Patel, H; Arif, A; Younis, S; Codipilly, CN; Ahmed, M				Perveen, Shahana; Patel, Hardik; Arif, Arslan; Younis, Sharif; Codipilly, Champa N.; Ahmed, Mohamed			Role of EC-SOD Overexpression in Preserving Pulmonary Angiogenesis Inhibited by Oxidative Stress	PLOS ONE			English	Article							EXTRACELLULAR-SUPEROXIDE-DISMUTASE; HUMAN-ENDOTHELIAL-CELLS; INDUCED LUNG INJURY; NITRIC-OXIDE; BRONCHOPULMONARY DYSPLASIA; IMPAIRS ALVEOLARIZATION; DEFICIENT MICE; FREE-RADICALS; NEWBORN MICE; RAT LUNG	Angiogenesis is one of the most important processes for normal lung development. Oxidative stress can impair the pulmonary angiogenesis, leading to chronic lung disease or Bronchopulmonary dysplasia (BPD). Objective: To investigate the protective effects of EC-SOD overexpression on pulmonary angiogenesis on neonates following exposure to acute hyperoxia. Design/Methods: Transgenic (TG) and wild-type (WT) neonatal mice (10 mice per group) were exposed either to air (control group) or 95% O-2 for 7 days starting at birth. After exposure, all animals were sacrificed. ROS concentration was measured in lung homogenates using OxiSelect ROS assay kit. Mean vascular density (MVD) was measured using anti CD34 staining. RNA was extracted and the angiogenesis markers, VEGF, VEGFR1 and VEGFR2 and PECAM-1 were analyzed by RT-q PCR. VGEF protein was measured using Western blots. Endothelial progenitor cells (EPCs) was assayed by flow cytometer. Results: There was a significant reduction of ROS in TG hyperoxic neonate group (156 +/- 14.2) compared to WT hyperoxic animals (255 +/- 35.1). Evaluation of MVD, using anti-CD34, showed marked significant increase of MVD in the TG group following hyperoxic exposure (85 +/- 12) in comparison to the WT hyperoxic group (62 +/- 8.4), (P < 0.05). Among the hyperoxic groups, both RNA and protein of VEGF expression were significantly reduced in the WT animals compared to the TG group (P < 0.05). The same trend was found in VEGFR 1 and 2 which were significantly reduced in WT group compared to the TG group (P < 0.05). There was no significant difference between hyperoxia TG and control group (P > 0.05). PECAM expression was significantly reduced in both hyperoxic compared to normoxic groups (P < 0.05). EPC's showed significant reduction in WT hyperoxic group compared to others (P > 0.05). Conclusions: EC-SOD plays a key role in preserving angiogenesis by scavenging free radicals which has an inhibitory effect on angiogenesis process in neonatal mice lung following exposure to hyperoxia.	[Ahmed, Mohamed] Cohen Childrens Med Ctr New York, Div Neonatal Perinatal Med, Manhasset, NY 11030 USA; N Shore Long Isl Jewish Hlth Syst, Lilling Family Res Lab, Feinstein Inst Med Res, Manhasset, NY USA	Northwell Health; North Shore University Hospital; Steven & Alexandra Cohen Children's Medical Center of New York; Northwell Health	Ahmed, M (corresponding author), Cohen Childrens Med Ctr New York, Div Neonatal Perinatal Med, Manhasset, NY 11030 USA.	mahmed2@nshs.edu	Patel, Hardik/L-9000-2013; Perveen, Shahana/Q-2935-2019	Patel, Hardik/0000-0003-3819-4691; PERVEEN, SHAHANA/0000-0001-5750-1787	Department of Pediatrics at Cohen Children's Medical Center NY	Department of Pediatrics at Cohen Children's Medical Center NY	Department of Pediatrics at Cohen Children's Medical Center NY have supported the research work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MN, 2003, AM J RESP CRIT CARE, V167, P400, DOI 10.1164/rccm.200202-108OC; Ahmed MN, 2011, EXP LUNG RES, V37, P10, DOI 10.3109/01902148.2010.497893; Balasubramaniam V, 2003, AM J PHYSIOL-LUNG C, V284, pL964, DOI 10.1152/ajplung.00421.2002; Balasubramaniam V, 2007, AM J PHYSIOL-LUNG C, V292, pL1073, DOI 10.1152/ajplung.00347.2006; Balasubramaniam V, 2006, AM J PHYSIOL-LUNG C, V291, pL119, DOI 10.1152/ajplung.00395.2005; Brown KA, 2006, AM J PHYSIOL-HEART C, V290, pH2600, DOI 10.1152/ajpheart.00676.2005; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chakrabarti S, 2010, VASC PHARMACOL, V53, P130, DOI 10.1016/j.vph.2010.05.003; Chen EP, 1996, CIRCULATION, V94, P412; COALSON JJ, 2000, LUNG BIOL HEALTH DIS, V137, P85; CONNOR HD, 1992, TRANSPLANTATION, V54, P199, DOI 10.1097/00007890-199208000-00002; D'Angio CT, 2002, FRONT BIOSCI-LANDMRK, V7, pD1609, DOI 10.2741/angio; DeLisser HM, 2006, J BIOL CHEM, V281, P8724, DOI 10.1074/jbc.M511798200; Ellis LM, 1996, EUR J CANCER, V32A, P2451, DOI 10.1016/S0959-8049(96)00389-9; Fattman CL, 2006, FREE RADICAL BIO MED, V40, P601, DOI 10.1016/j.freeradbiomed.2005.09.030; Fattman CL, 2003, FREE RADICAL BIO MED, V35, P236, DOI 10.1016/S0891-5849(03)00275-2; Fidler IJ, 1998, CANCER J SCI AM, V4, pS58; FOLZ RJ, 1994, GENOMICS, V22, P162, DOI 10.1006/geno.1994.1357; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Gao F, 2008, J BIOL CHEM, V283, P6058, DOI 10.1074/jbc.M709273200; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Ghio AJ, 2002, AM J PHYSIOL-LUNG C, V283, pL211, DOI 10.1152/ajplung.00409.2001; Heistad DD, 2006, ARTERIOSCL THROM VAS, V26, P689, DOI 10.1161/01.ATV.0000203525.62147.28; Hosford GE, 2003, AM J PHYSIOL-LUNG C, V285, pL161, DOI 10.1152/ajplung.00285.2002; Husain AN, 1998, HUM PATHOL, V29, P710, DOI 10.1016/S0046-8177(98)90280-5; Jakkula M, 2000, AM J PHYSIOL-LUNG C, V279, pL600, DOI 10.1152/ajplung.2000.279.3.L600; Jun S, 2010, FREE RADICAL BIO MED, V48, P590, DOI 10.1016/j.freeradbiomed.2009.12.003; Jung O, 2003, CIRC RES, V93, P622, DOI 10.1161/01.RES.0000092140.81594.A8; Kim HW, 2007, CIRC RES, V101, P409, DOI 10.1161/CIRCRESAHA.107.153791; Kliment CR, 2008, ANTIOXID REDOX SIGN, V10, P261, DOI 10.1089/ars.2007.1906; Kliment CR, 2009, J BIOL CHEM, V284, P3537, DOI 10.1074/jbc.M807001200; Le Cras TD, 2002, AM J PHYSIOL-LUNG C, V283, pL555, DOI 10.1152/ajplung.00408.2001; Levin Edward D., 2005, Current Alzheimer Research, V2, P191; MALMSTROM BG, 1982, ANNU REV BIOCHEM, V51, P21, DOI 10.1146/annurev.bi.51.070182.000321; MARKLUND SL, 1982, P NATL ACAD SCI-BIOL, V79, P7634, DOI 10.1073/pnas.79.24.7634; MATSUBARA T, 1986, J IMMUNOL, V137, P3295; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; McGrath-Morrow SA, 2005, AM J RESP CELL MOL, V32, P420, DOI 10.1165/rcmb.2004-0287OC; Mokres LM, 2010, AM J PHYSIOL-LUNG C, V298, pL23, DOI 10.1152/ajplung.00251.2009; Oshikawa J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010189; OURY TD, 1992, P NATL ACAD SCI USA, V89, P9715, DOI 10.1073/pnas.89.20.9715; Rabinovitch M, 2002, NAT MED, V8, P664, DOI 10.1038/nm0702-664; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Sheng H, 2000, EXP NEUROL, V163, P392, DOI 10.1006/exnr.2000.7363; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; TERADA LS, 1991, J CELL PHYSIOL, V148, P191, DOI 10.1002/jcp.1041480202; Terada LS, 1996, AM J PHYSIOL-HEART C, V270, pH945, DOI 10.1152/ajpheart.1996.270.3.H945; Thebaud B, 2005, CIRCULATION, V112, P2477, DOI 10.1161/CIRCULATIONAHA.105.541524; Ushio-Fukai M, 2006, CARDIOVASC RES, V71, P226, DOI 10.1016/j.cardiores.2006.04.015; WEIDNER N, 1995, BREAST CANCER RES TR, V36, P169, DOI 10.1007/BF00666038; ZWEIER JL, 1994, AM J PHYSIOL, V266, pC700, DOI 10.1152/ajpcell.1994.266.3.C700	51	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51945	10.1371/journal.pone.0051945	http://dx.doi.org/10.1371/journal.pone.0051945			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284826	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500068
J	Takamura, H; Koyama, Y; Matsuzaki, S; Yamada, K; Hattori, T; Miyata, S; Takemoto, K; Tohyama, M; Katayama, T				Takamura, Hironori; Koyama, Yoshihisa; Matsuzaki, Shinsuke; Yamada, Kohei; Hattori, Tsuyoshi; Miyata, Shingo; Takemoto, Kana; Tohyama, Masaya; Katayama, Taiichi			TRAP1 Controls Mitochondrial Fusion/Fission Balance through Drp1 and Mff Expression	PLOS ONE			English	Article							NECROSIS-FACTOR RECEPTOR; OXIDATIVE STRESS; MAMMALIAN-CELLS; PEROXISOMAL FISSION; PARKINSONS-DISEASE; PROTEIN-1 TRAP-1; PROTECTS CELLS; APOPTOSIS; DYNAMICS; FUSION	Mitochondria are dynamic organelles that change in response to extracellular stimuli. These changes are essential for normal mitochondrial/cellular function and are controlled by a tight balance between two antagonistic pathways that promote fusion and fission. Although some molecules have been identified to mediate the mitochondrial fusion and fission process, the underlying mechanisms remain unclear. Tumor necrosis factor receptor-associated protein 1 (TRAP1) is a mitochondrial molecule that regulates a variety of mitochondrial functions. Here, we examined the role of TRAP1 in the regulation of morphology. Stable TRAP1 knockdown cells showed abnormal mitochondrial morphology, and we observed significant decreases in dynamin-related protein 1 (Drp1) and mitochondrial fission factor (Mff), mitochondrial fission proteins. Similar results were obtained by transient knockdown of TRAP1 in two different cell lines, SH-SY5Y neuroblastoma cells and KNS-42 glioma cells. However, TRAP1 knockdown did not affect expression levels of fusion proteins. The reduction in Drp1 and Mff protein levels was rescued following treatment with the proteasome inhibitor MG132. These results suggest that TRAP1 regulates the expression of fission proteins and controls mitochondrial fusion/fission, which affects mitochondrial/cellular function.	[Takamura, Hironori; Matsuzaki, Shinsuke; Yamada, Kohei; Miyata, Shingo; Tohyama, Masaya] Osaka Univ, Mol Res Ctr Childrens Mental Dev, United Grad Sch Child Dev, Suita, Osaka, Japan; [Takamura, Hironori; Matsuzaki, Shinsuke; Yamada, Kohei; Tohyama, Masaya; Katayama, Taiichi] Osaka Univ, Dept Child Dev & Mol Brain Sci, United Grad Sch Child Dev, Suita, Osaka, Japan; [Koyama, Yoshihisa; Matsuzaki, Shinsuke; Miyata, Shingo; Takemoto, Kana; Tohyama, Masaya] Osaka Univ, Grad Sch Med, Dept Anat & Neurosci, Suita, Osaka, Japan; [Hattori, Tsuyoshi] Osaka Univ, Grad Sch Med, Dept Mol Neuropsychiat, Suita, Osaka, Japan; [Miyata, Shingo; Tohyama, Masaya] Kinki Univ, Div Mol Brain Sci, Res Inst Tradit Oriental Med, Sayama, Osaka, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Kindai University (Kinki University)	Takamura, H (corresponding author), Osaka Univ, Mol Res Ctr Childrens Mental Dev, United Grad Sch Child Dev, Suita, Osaka, Japan.	takamura@ugscd.osaka-u.ac.jp			Sakamoto Research Institute of Psychopathology; Japan Society for the Promotion of Science [23791332, 23790224]	Sakamoto Research Institute of Psychopathology; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partially supported by the Sakamoto Research Institute of Psychopathology to HT, and by the Grant-in-Aid for Young Scientists (B) from Japan Society for the Promotion of Science to HT (No.23791332) and to SM. (No.23790224). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Amoroso MR, 2012, CELL DEATH DIFFER, V19, P592, DOI 10.1038/cdd.2011.128; Arnoult D, 2007, TRENDS CELL BIOL, V17, P6, DOI 10.1016/j.tcb.2006.11.001; Benard G, 2009, SEMIN CELL DEV BIOL, V20, P365, DOI 10.1016/j.semcdb.2008.12.012; Bueler H, 2009, EXP NEUROL, V218, P235, DOI 10.1016/j.expneurol.2009.03.006; Butler EK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002488; Carette J, 2002, INT J RADIAT BIOL, V78, P183, DOI 10.1080/09553000110097208; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Cechetto JD, 2000, EXP CELL RES, V260, P30, DOI 10.1006/excr.2000.4983; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Chien WL, 2011, J NEUROCHEM, V117, P643, DOI 10.1111/j.1471-4159.2011.07229.x; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Felts SJ, 2000, J BIOL CHEM, V275, P3305, DOI 10.1074/jbc.275.5.3305; Figueroa-Romero C, 2009, FASEB J, V23, P3917, DOI 10.1096/fj.09-136630; Filosto M, 2011, J NEUROL, V258, P1763, DOI 10.1007/s00415-011-6104-z; Finkel T, 2009, P NATL ACAD SCI USA, V106, P11825, DOI 10.1073/pnas.0906430106; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Gesualdi NM, 2007, STRESS, V10, P342, DOI 10.1080/10253890701314863; Hadari YR, 1997, J BIOL CHEM, V272, P657; Harder Z, 2004, CURR BIOL, V14, P340, DOI 10.1016/j.cub.2004.02.004; Hua GQ, 2007, J BIOL CHEM, V282, P20553, DOI 10.1074/jbc.M703196200; Im CN, 2007, J CELL BIOCHEM, V100, P474, DOI 10.1002/jcb.21064; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200; Karbowski M, 2007, J CELL BIOL, V178, P71, DOI 10.1083/jcb.200611064; Knott AB, 2008, ANN NY ACAD SCI, V1147, P283, DOI 10.1196/annals.1427.030; Kubota K, 2009, J NEUROCHEM, V110, P496, DOI 10.1111/j.1471-4159.2009.06099.x; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774; Masuda Y, 2004, J BIOL CHEM, V279, P42503, DOI 10.1074/jbc.M404256200; Mitsumoto A, 2002, FREE RADICAL BIO MED, V32, P22, DOI 10.1016/S0891-5849(01)00755-9; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; Nakamura N, 2006, EMBO REP, V7, P1019, DOI 10.1038/sj.embor.7400790; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Otera H, 2011, J BIOCHEM, V149, P241, DOI 10.1093/jb/mvr002; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Palmer CS, 2011, EMBO REP, V12, P565, DOI 10.1038/embor.2011.54; Park YY, 2010, J CELL SCI, V123, P619, DOI 10.1242/jcs.061481; Parone PA, 2006, BBA-MOL CELL RES, V1763, P522, DOI 10.1016/j.bbamcr.2006.04.005; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156; Siegelin MD, 2011, J CLIN INVEST, V121, P1349, DOI 10.1172/JCI44855; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; SONG HY, 1995, J BIOL CHEM, V270, P3574, DOI 10.1074/jbc.270.8.3574; Stojanovski D, 2004, J CELL SCI, V117, P1201, DOI 10.1242/jcs.01058; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Takemoto K, 2011, NEUROCHEM INT, V58, P880, DOI 10.1016/j.neuint.2011.02.015; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Voloboueva LA, 2008, J CEREBR BLOOD F MET, V28, P1009, DOI 10.1038/sj.jcbfm.9600600; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; Wang HX, 2011, J BIOL CHEM, V286, P11649, DOI 10.1074/jbc.M110.144238; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Williamson CL, 2008, AM J PHYSIOL-HEART C, V294, pH249, DOI 10.1152/ajpheart.00775.2007; Xu LJ, 2009, J CEREBR BLOOD F MET, V29, P365, DOI 10.1038/jcbfm.2008.125; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Yonashiro R, 2006, EMBO J, V25, P3618, DOI 10.1038/sj.emboj.7601249; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Yu WD, 2011, HUM MOL GENET, V20, P3227, DOI 10.1093/hmg/ddr235; Zhao J, 2011, EMBO J, V30, P2762, DOI 10.1038/emboj.2011.198; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107; Zunino R, 2007, J CELL SCI, V120, P1178, DOI 10.1242/jcs.03418; Zunino R, 2009, J BIOL CHEM, V284, P17783, DOI 10.1074/jbc.M901902200	70	27	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51912	10.1371/journal.pone.0051912	http://dx.doi.org/10.1371/journal.pone.0051912			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284813	gold, Green Published, Green Submitted			2022-12-27	WOS:000312794500065
J	Yu, LP; Qian, WW; Yin, GY; Ren, YX; Hu, ZY				Yu, Li-Peng; Qian, Wen-Wu; Yin, Guo-Yong; Ren, Yong-Xin; Hu, Zhi-Yi			MRI Assessment of Lumbar Intervertebral Disc Degeneration with Lumbar Degenerative Disease Using the Pfirrmann Grading Systems	PLOS ONE			English	Article							LOW-BACK-PAIN; SIGNAL MODIC CHANGES; MARROW CHANGES; TYPE-2 CHANGES; END-PLATES	Background: To evaluate by MRI intervertebral disc degeneration in patients with lumbar degenerative disease using the Pfirrmann grading system and to determine whether Modic changes correlated with the Pfirrmann grades and modified Pfirrmann grades of disc degeneration. Methods: The clinical data of 108 surgical patients with lumbar degenerative disease were reviewed and their preoperative MR images were analyzed. Disc degeneration was evaluated using the Pfirrmann grading system. Patients were followed up and low back pain was evaluated using the visual analog scale (VAS) and the effect of back pain on the daily quality of life was assessed using Oswestry disability index (ODI). Results: Forty-four cases had normal anatomical appearance (Modic type 0) and their Pfirrmann grades were 3.77 +/- 0.480 and their modified Pfirrmann grades were of 5.81 +/- 1.006. Twenty-seven cases had Modic type I changes and their Pfirrmann grades were 4.79 +/- 0.557 and their modified Pfirrmann grades were 7.00 +/- 0.832. Thirty-six cases exhibited Modic type II changes and their Pfirrmann grades and modified Pfirrmann grades were 4.11 +/- 0.398 and 6.64 +/- 0.867, respectively. One case had Modic type III changes. Kruskal-Wallis test revealed significant difference in modified Pfirrmann grade among Modic type 0, I and II changes (P<0.01) but no significant difference between Modic type I and II changes (P>0.05). Binary regression analysis showed that Modic changes correlated most strongly with disc degeneration. Follow up studies indicated that the VAS and ODI scores were markedly improved postoperatively. However, no difference was noted in VAS and ODI scores among patients with different Modic types. Conclusion: Modic changes correlate with the Pfirrmann and modified Pfirrmann grades of disc degeneration in lumbar degenerative disease. There is no significant correlation between Modic types and surgical outcomes. Citation: Yu L-P, Qian W-W, Yin G-Y, Ren Y-X, Hu Z-Y (2012) MRI Assessment of Lumbar Intervertebral Disc Degeneration with Lumbar Degenerative Disease Using the Pfirrmann Grading Systems. PLoS ONE 7(12): e48074. doi:10.1371/journal.pone.0048074	[Yu, Li-Peng; Yin, Guo-Yong; Ren, Yong-Xin; Hu, Zhi-Yi] Nanjing Med Univ, Affiliated Hosp 1, Dept Spine Surg, Nanjing, Jiangsu, Peoples R China; [Qian, Wen-Wu] Peoples Hosp, Dept Orthoped Surg, Gaochun, Jiangsu, Peoples R China	Nanjing Medical University	Yin, GY (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Spine Surg, Nanjing, Jiangsu, Peoples R China.	guoyong_submit@sina.com			National Natural and Science Foundation [81071481]	National Natural and Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural and Science Foundation (81071481). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert HB, 2008, MED HYPOTHESES, V70, P361, DOI 10.1016/j.mehy.2007.05.014; Burke JG, 2002, J BONE JOINT SURG BR, V84B, P196, DOI 10.1302/0301-620X.84B2.12511; CROCK HV, 1986, SPINE, V11, P650, DOI 10.1097/00007632-198607000-00028; DEROOS A, 1987, AM J ROENTGENOL, V149, P531, DOI 10.2214/ajr.149.3.531; Djurasovic M, 2012, EUR SPINE J, V21, P1616, DOI 10.1007/s00586-012-2244-9; Emch TM, 2011, SKELETAL RADIOL, V40, P1175, DOI 10.1007/s00256-011-1163-x; Esposito P, 2006, NEUROCHIRURGIE, V52, P315, DOI 10.1016/S0028-3770(06)71225-5; Griffith JF, 2007, SPINE, V32, pE708, DOI 10.1097/BRS.0b013e31815a59a0; Jensen RK, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-183; Jensen TS, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-81; Jensen TS, 2010, EUR SPINE J, V19, P129, DOI 10.1007/s00586-009-1184-5; Karchevsky M, 2005, SKELETAL RADIOL, V34, P125, DOI 10.1007/s00256-004-0886-3; Kjaer P, 2005, SPINE, V30, P1173, DOI 10.1097/01.brs.0000162396.97739.76; Kokkonen SM, 2002, SPINE, V27, P2274, DOI 10.1097/00007632-200210150-00017; Marshman LAG, 2007, J NEUROSURG-SPINE, V6, P152, DOI 10.3171/spi.2007.6.2.152; MODIC MT, 1988, RADIOLOGY, V168, P177, DOI 10.1148/radiology.168.1.3289089; MODIC MT, 1988, RADIOLOGY, V166, P193, DOI 10.1148/radiology.166.1.3336678; Ohtori S, 2006, SPINE, V31, P1026, DOI 10.1097/01.brs.0000215027.87102.7c; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; THOMPSON JP, 1990, SPINE, V15, P411, DOI 10.1097/00007632-199005000-00012; TOYONE T, 1994, J BONE JOINT SURG BR, V76B, P757, DOI 10.1302/0301-620X.76B5.8083266; Vital JM, 2003, SPINE, V28, P715; Weishaupt D, 2001, RADIOLOGY, V218, P420, DOI 10.1148/radiology.218.2.r01fe15420	23	49	56	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e48074	10.1371/journal.pone.0048074	http://dx.doi.org/10.1371/journal.pone.0048074			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284612	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500003
J	Verrel, J; Lovden, M; Lindenberger, U				Verrel, Julius; Lovden, Martin; Lindenberger, Ulman			Older Adults Show Preserved Equilibrium but Impaired Step Length Control in Motor-Equivalent Stabilization of Gait	PLOS ONE			English	Article							LOCAL DYNAMIC STABILITY; KINEMATIC VARIABILITY; FOOT PLACEMENT; HUMAN WALKING; COORDINATION; AGE; COVARIATION; PERFORMANCE; TREADMILL; TASKS	Stable walking depends on the coordination of multiple biomechanical degrees of freedom to ensure the dynamic maintenance of whole-body equilibrium as well as continuous forward progression. We investigated adult age-related differences in whole-body coordination underlying stabilization of center of mass (CoM) position and step pattern during locomotion. Sixteen younger (20-30 years) and 16 healthy older men (65-80 years) walked on a motorized treadmill at 80%, 100% and 120% of their self-selected preferred speed. Preferred speeds did not differ between the age groups. Motor-equivalent stabilization of step parameters (step length and width) and CoM position relative to the support (back and front foot) was examined using a generalized covariation analysis. Across age groups, covariation indices were highest for CoM position relative to the front foot, the measure most directly related to body equilibrium. Compared to younger adults, older adults showed lower covariation indices with respect to step length, extending previous findings of age-related differences in motor-equivalent coordination. In contrast, no reliable age differences were found regarding stabilization of step width or any of the CoM parameters. The observed pattern of results may reflect robust prioritization of balance over step pattern regularity, which may be adaptive in the face of age-associated sensorimotor losses and decline of coordinative capacities.	[Verrel, Julius; Lovden, Martin; Lindenberger, Ulman] Max Planck Inst Human Dev, Ctr Lifespan Psychol, Berlin, Germany; [Lovden, Martin] Lund Univ, Dept Psychol, Lund, Sweden; [Lovden, Martin] Karolinska Inst, Aging Res Ctr, Stockholm, Sweden; [Lovden, Martin] Lund Univ, Dept Psychol, Lund, Sweden; [Lovden, Martin] Karolinska Inst, Aging Res Ctr, Stockholm, Sweden	Max Planck Society; Lund University; Karolinska Institutet; Lund University; Karolinska Institutet	Verrel, J (corresponding author), Max Planck Inst Human Dev, Ctr Lifespan Psychol, Berlin, Germany.	verrel@mpib-berlin.mpg.de	Lindenberger, Ulman/A-5846-2013	Lindenberger, Ulman/0000-0001-8428-6453; Verrel, Julius/0000-0001-5850-5202	International Max Planck Research School LIFE (The Life Course: Evolutionary and Ontogenetic Dynamics)	International Max Planck Research School LIFE (The Life Course: Evolutionary and Ontogenetic Dynamics)	During this research, JV was supported by a scholarship from the International Max Planck Research School LIFE (The Life Course: Evolutionary and Ontogenetic Dynamics). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Bauby CE, 2000, J BIOMECH, V33, P1433, DOI 10.1016/S0021-9290(00)00101-9; Bernstein N, 1967, COORDINATION REGULAT; Buzzi UH, 2003, CLIN BIOMECH, V18, P435, DOI 10.1016/S0268-0033(03)00029-9; Cusumano JP, 2008, EVIDENCE GOAL EQUIVA; Decker LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041306; Dingwell JB, 2001, J BIOMECH ENG-T ASME, V123, P27, DOI 10.1115/1.1336798; Dingwell JB, 2000, CHAOS, V10, P848, DOI 10.1063/1.1324008; England SA, 2007, GAIT POSTURE, V25, P172, DOI 10.1016/j.gaitpost.2006.03.003; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GABELL A, 1984, J GERONTOL, V39, P662, DOI 10.1093/geronj/39.6.662; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; HOLM S, 1979, SCAND J STAT, V6, P65; Kang HG, 2008, J BIOMECH, V41, P2899, DOI 10.1016/j.jbiomech.2008.08.002; Latash ML, 2007, MOTOR CONTROL, V11, P276, DOI 10.1123/mcj.11.3.276; Lawrence M. A., 2011, EZ EASY ANAL VISUALI; Muller H, 2003, BIOL CYBERN, V89, P22, DOI 10.1007/s00422-003-0399-5; Owings TM, 2003, J BIOMECH, V36, P1215, DOI 10.1016/S0021-9290(03)00108-8; R Core Team, 2018, R LANG ENV STAT COMP; REDFERN MS, 1994, J BIOMECH, V27, P1339, DOI 10.1016/0021-9290(94)90043-4; Schellenbach M, 2010, GAIT POSTURE, V31, P295, DOI 10.1016/j.gaitpost.2009.11.008; Scholz JP, 2007, EXP BRAIN RES, V180, P163, DOI 10.1007/s00221-006-0848-1; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; Schoner G, 1995, ECOL PSYCHOL, V7, P291, DOI 10.1207/s15326969eco0704_5; Seidler RD, 2002, MOTOR CONTROL, V6, P19, DOI 10.1123/mcj.6.1.19; Shim JK, 2004, J APPL PHYSIOL, V97, P213, DOI 10.1152/japplphysiol.00045.2004; Shinohara M, 2004, EXP BRAIN RES, V156, P282, DOI 10.1007/s00221-003-1786-9; Sternad D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000751; Tang PF, 1998, J GERONTOL A-BIOL, V53, pM471, DOI 10.1093/gerona/53A.6.M471; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; TOWNSEND MA, 1985, J BIOMECH, V18, P21, DOI 10.1016/0021-9290(85)90042-9; Tseng YW, 2002, MOTOR CONTROL, V6, P183, DOI 10.1123/mcj.6.2.183; Verrel J, 2010, NEUROSCIENCE METHODS, V191, P166; Verrel J, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.07.006; Verrel J, 2011, J NEUROSCI METH, V200, P199, DOI 10.1016/j.jneumeth.2011.04.006; Verrel J, 2010, EXP BRAIN RES, V207, P13, DOI 10.1007/s00221-010-2424-y; Yen JT, 2010, J R SOC INTERFACE, V7, P801, DOI 10.1098/rsif.2009.0296	37	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52024	10.1371/journal.pone.0052024	http://dx.doi.org/10.1371/journal.pone.0052024			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272200	Green Published, Green Submitted, gold			2022-12-27	WOS:000312483300048
J	Abbasi, A; Bakker, SJL; Corpeleijn, E; van der A, DL; Gansevoort, RT; Gans, ROB; Peelen, LM; van der Schouw, YT; Stolk, RP; Navis, G; Spijkerman, AMW; Beulens, JWJ				Abbasi, Ali; Bakker, Stephan J. L.; Corpeleijn, Eva; van der A, Daphne L.; Gansevoort, Ron T.; Gans, Rijk O. B.; Peelen, Linda M.; van der Schouw, Yvonne T.; Stolk, Ronald P.; Navis, Gerjan; Spijkerman, Annemieke M. W.; Beulens, Joline W. J.			Liver Function Tests and Risk Prediction of Incident Type 2 Diabetes: Evaluation in Two Independent Cohorts	PLOS ONE			English	Article							GAMMA-GLUTAMYL-TRANSFERASE; CARDIOVASCULAR RISK; METABOLIC SYNDROME; MODELS; BIOMARKERS; VALIDATION; ENZYMES; MARKERS; MEN	Background: Liver function tests might predict the risk of type 2 diabetes. An independent study evaluating utility of these markers compared with an existing prediction model is yet lacking. Methods and Findings: We performed a case-cohort study, including random subcohort (6.5%) from 38,379 participants with 924 incident diabetes cases (the Dutch contribution to the European Prospective Investigation Into Cancer and Nutrition, EPIC-NL, the Netherlands), and another population-based cohort study including 7,952 participants with 503 incident cases (the Prevention of Renal and Vascular End-stage Disease, PREVEND, Groningen, the Netherlands). We examined predictive value of combination of the Liver function tests (gamma-glutamyltransferase, alanine aminotransferase, aspartate aminotransferase and albumin) above validated models for 7.5-year risk of diabetes (the Cooperative Health Research in the Region of Augsburg, the KORA study). Basic model includes age, sex, BMI, smoking, hypertension and parental diabetes. Clinical models additionally include glucose and uric acid (model1) and HbA1c (model2). In both studies, addition of Liver function tests to the basic model improved the prediction (C-statistic by similar to 0.020; NRI by similar to 9.0%; P<0.001). In the EPIC-NL case-cohort study, addition to clinical model1 resulted in statistically significant improvement in the overall population (C-statistic = +0.009; P<0.001; NRI = 8.8%; P<0.001), while addition to clinical model 2 yielded marginal improvement limited to men (C-statistic = +0.007; P = 0.06; NRI = 3.3%; P = 0.04). In the PREVEND cohort study, addition to clinical model 1 resulted in significant improvement in the overall population (C-statistic change = 0.008; P = 0.003; NRI = 3.6%; P = 0.03), with largest improvement in men (C-statistic change = 0.013; P = 0.01; NRI = 5.4%; P = 0.04). In PREVEND, improvement compared to clinical model 2 could not be tested because of lack of HbA1c data. Conclusions: Liver function tests modestly improve prediction for medium-term risk of incident diabetes above basic and extended clinical prediction models, only if no HbA1c is incorporated. If data on HbA1c are available, Liver function tests have little incremental predictive value, although a small benefit may be present in men.	[Abbasi, Ali; Corpeleijn, Eva; Stolk, Ronald P.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Abbasi, Ali; Bakker, Stephan J. L.; Gansevoort, Ron T.; Gans, Rijk O. B.; Navis, Gerjan] Univ Groningen, Dept Internal Med, Univ Med Ctr Groningen, Groningen, Netherlands; [Abbasi, Ali; Peelen, Linda M.; van der Schouw, Yvonne T.; Beulens, Joline W. J.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [van der A, Daphne L.] Natl Inst Publ Hlth & Environm RIVM, Ctr Nutr & Hlth, Bilthoven, Netherlands; [Spijkerman, Annemieke M. W.] Natl Inst Publ Hlth & Environm RIVM, Ctr Prevent & Hlth Serv Res, Bilthoven, Netherlands	University of Groningen; University of Groningen; Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment	Abbasi, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.	a.abbasi@umcg.nl	Bakker, Stephan J. L./J-4023-2015; Stolk, Ronald P/B-2341-2013; Abbasi, Ali/N-7707-2013; van der Schouw, Yvonne T./F-8327-2014	Bakker, Stephan J. L./0000-0003-3356-6791; Stolk, Ronald P/0000-0002-0518-1205; van der Schouw, Yvonne T./0000-0002-4605-435X; Beulens, Joline/0000-0002-4181-0937; ABBASI, ALI/0000-0002-6452-4765; Corpeleijn, Eva/0000-0002-2974-3305; Gans, Reinold/0000-0001-5481-2387	Netherlands Heart Foundation; Dutch Diabetes Research Foundation; Dutch Kidney Foundation; project PREDICCt [01C-104-07]; "Europe against Cancer" Programme of the European Commission (SANCO); Dutch Ministry of Health; Dutch Cancer Society; Netherlands Organization for Health Research and Development (ZonMW); World Cancer Research Fund (WCRF)	Netherlands Heart Foundation(Netherlands Heart Foundation); Dutch Diabetes Research Foundation; Dutch Kidney Foundation; project PREDICCt; "Europe against Cancer" Programme of the European Commission (SANCO)(European CommissionEuropean Commission Joint Research Centre); Dutch Ministry of Health; Dutch Cancer Society(KWF Kankerbestrijding); Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); World Cancer Research Fund (WCRF)(World Cancer Research Fund International (WCRF))	This work was supported by the Netherlands Heart Foundation, the Dutch Diabetes Research Foundation and the Dutch Kidney Foundation. This research was performed within the framework of the Center for Translational Molecular Medicine (CTMM; www.ctmm.nl); project PREDICCt (grant 01C-104-07). The EPIC-NL study was funded by "Europe against Cancer" Programme of the European Commission (SANCO), the Dutch Ministry of Health, the Dutch Cancer Society, the Netherlands Organization for Health Research and Development (ZonMW), and World Cancer Research Fund (WCRF). The authors thank Statistics Netherlands and the PHARMO Institute for follow-up data on cancer, cardiovascular disease and vital status. None of the study sponsors had a role in the study design, data collection, analysis or interpretation, report writing, or the decision to submit the report for publication.	Abbasi A, 2012, DIABETOLOGIA, V55, P1963, DOI 10.1007/s00125-012-2545-x; Abbasi A, 2011, DIABETOLOGIA, V54, P2463, DOI 10.1007/s00125-011-2216-3; Abbasi A, 2012, EUR J EPIDEMIOL; Abbasi A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5900; Balkau B, 2008, DIABETES CARE, V31, P2056, DOI 10.2337/dc08-0368; Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; Beulens JWJ, 2010, INT J EPIDEMIOL, V39, P1170, DOI 10.1093/ije/dyp217; Buijsse B, 2011, EPIDEMIOL REV, V33, P46, DOI 10.1093/epirev/mxq019; Chao C, 2010, ARCH INTERN MED, V170, P1557, DOI 10.1001/archinternmed.2010.312; Cook NR, 2009, ANN INTERN MED, V150, P795, DOI 10.7326/0003-4819-150-11-200906020-00007; Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001/jama.295.11.1288; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Fraser A, 2009, DIABETES CARE, V32, P741, DOI 10.2337/dc08-1870; Ghouri N, 2010, HEPATOLOGY, V52, P1156, DOI 10.1002/hep.23789; Hanley AJG, 2004, DIABETES, V53, P2623, DOI 10.2337/diabetes.53.10.2623; Herder C, 2011, CLIN PHARMACOL THER, V90, P52, DOI 10.1038/clpt.2011.93; Herder C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019852; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Lambers Heerspink HJ, 2008, AM J EPIDEMIOL, V168, P897, DOI 10.1093/aje/kwn209; McGeechan K, 2008, ARCH INTERN MED, V168, P2304, DOI 10.1001/archinte.168.21.2304; Moons KGM, 2010, CLIN CHEM, V56, P537, DOI 10.1373/clinchem.2009.134155; Nakanishi N, 2004, DIABETES CARE, V27, P1427, DOI 10.2337/diacare.27.6.1427; Paynter NP, 2011, ARCH INTERN MED, V171, P1712, DOI 10.1001/archinternmed.2011.351; Rathmann W, 2010, DIABETIC MED, V27, P1116, DOI 10.1111/j.1464-5491.2010.03065.x; Schulze MB, 2009, DIABETES CARE, V32, P2116, DOI 10.2337/dc09-0197; Shafizadeh TB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022863; Sluijs I, 2010, NETH J MED, V68, P333; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; van Houwelingen HC, 2000, STAT MED, V19, P3401, DOI 10.1002/1097-0258(20001230)19:24<3401::AID-SIM554>3.0.CO;2-2; Vergouwe Y, 2010, AM J EPIDEMIOL, V172, P971, DOI 10.1093/aje/kwq223; Volovics A, 1997, BIOMETRICAL J, V39, P195, DOI 10.1002/bimj.4710390208; Wannamethee SG, 2011, DIABETIC MED, V28, P23, DOI 10.1111/j.1464-5491.2010.03171.x; Wannamethee SG, 2005, DIABETES CARE, V28, P2913, DOI 10.2337/diacare.28.12.2913	33	27	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51496	10.1371/journal.pone.0051496	http://dx.doi.org/10.1371/journal.pone.0051496			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284703	gold, Green Published, Green Submitted			2022-12-27	WOS:000312435900024
J	Oliveira, ID; Franke, FA; Hering, L; Schaffer, S; Rowell, DM; Weck-Heimann, A; Monge-Najera, J; Morera-Brenes, B; Mayer, G				Oliveira, Ivo de Sena; Franke, Franziska Anni; Hering, Lars; Schaffer, Stefan; Rowell, David M.; Weck-Heimann, Andreas; Monge-Najera, Julian; Morera-Brenes, Bernal; Mayer, Georg			Unexplored Character Diversity in Onychophora (Velvet Worms): A Comparative Study of Three Peripatid Species	PLOS ONE			English	Article							EPIPERIPATUS; BIOLOGY; GENOME; PERIPATOPSIDAE; PLANIPAPILLUS; SYSTEMATICS; AUSTRALIA; EVOLUTION; PROVIDES; SENSILLA	Low character variation among onychophoran species has been an obstacle for taxonomic and phylogenetic studies in the past, however we have identified a number of new and informative characters using morphological, molecular, and chromosomal techniques. Our analyses involved a detailed examination of Epiperipatus biolleyi from Costa Rica, Eoperipatus sp. from Thailand, and a new onychophoran species and genus from Costa Rica, Principapillatus hitoyensis gen. et sp. nov.. Scanning electron microscopy on embryos and specimens of varying age revealed novel morphological characters and character states, including the distribution of different receptor types along the antennae, the arrangement and form of papillae on the head, body and legs, the presence and shape of interpedal structures and fields of modified scales on the ventral body surface, the arrangement of lips around the mouth, the number, position and structure of crural tubercles and anal gland openings, and the presence and shape of embryonic foot projections. Karyotypic analyses revealed differences in the number and size of chromosomes among the species studied. The results of our phylogenetic analyses using mitochondrial COI and 12S rRNA gene sequences are in line with morphological and karyotype data. However, our data show a large number of unexplored, albeit informative, characters in the Peripatidae. We suggest that analysing these characters in additional species would help unravel species diversity and phylogeny in the Onychophora, and that inconsistencies among most diagnostic features used for the peripatid genera in the literature could be addressed by identifying a suite of characters common to all peripatids.	[Oliveira, Ivo de Sena; Franke, Franziska Anni; Hering, Lars; Schaffer, Stefan; Mayer, Georg] Univ Leipzig, Inst Biol, Leipzig, Germany; [Rowell, David M.] Australian Natl Univ, Res Sch Biol, Div Evolut Ecol & Genet, Canberra, ACT, Australia; [Weck-Heimann, Andreas] Museum Zool, Senckenberg Nat Hist Collect, Dresden, Germany; [Monge-Najera, Julian] Univ Costa Rica, San Jose, Costa Rica; [Morera-Brenes, Bernal] Univ Nacl, Escuela Ciencias Biol, Lab Genet Evolut, Heredia, Costa Rica; [Morera-Brenes, Bernal] Univ Costa Rica, Ctr Invest Estruct Microscop CIENic, San Jose, Costa Rica	Leipzig University; Australian National University; Senckenberg Gesellschaft fur Naturforschung (SGN); Universidad Costa Rica; Universidad Nacional Costa Rica; Universidad Costa Rica	Oliveira, ID (corresponding author), Univ Leipzig, Inst Biol, Leipzig, Germany.	ivo.de_sena_oliveira@uni-leipzig.de	Morera, Bernal/B-3227-2013; Rowell, David/C-9751-2009; Oliveira, Ivo S./H-3727-2013; Mayer, Georg/Y-9581-2018; Morera, Bernal/B-8671-2012	Rowell, David/0000-0002-2077-9774; Oliveira, Ivo S./0000-0002-8340-7660; Mayer, Georg/0000-0003-0737-2440; Morera, Bernal/0000-0001-8042-4265; Monge-Najera, Julian/0000-0001-7764-2966; Hering, Lars/0000-0003-4469-991X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq: 290029/2010-4]; SYNTHESYS grant; European Community Research Infrastructure Action - FP7 Integrating Activities Programme); Emmy Noether Programme of the German Research Foundation [DFG: Ma 4147/3-1]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); SYNTHESYS grant; European Community Research Infrastructure Action - FP7 Integrating Activities Programme); Emmy Noether Programme of the German Research Foundation(German Research Foundation (DFG))	This study was supported by a Ph.D. fellowship of the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq: 290029/2010-4) and by a SYNTHESYS grant (financed by the European Community Research Infrastructure Action - FP7 Integrating Activities Programme: http://www.synthesys.info/) to ISO. GM is a Research Group Leader supported by the Emmy Noether Programme of the German Research Foundation (DFG: Ma 4147/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Altincicek B, 2008, DEV COMP IMMUNOL, V32, P1416, DOI 10.1016/j.dci.2008.06.004; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baer A, 2012, J MORPHOL, V273, P1079, DOI 10.1002/jmor.20044; Barclay SD, 2000, J ZOOL, V250, P437; Bittner K, 1998, ACTA ZOOL-STOCKHOLM, V79, P267, DOI 10.1111/j.1463-6395.1998.tb01278.x; Bouvier E. L., 1905, Ann Sci nat (n s), Vii, P1; Braband A, 2010, MOL PHYLOGENET EVOL, V57, P293, DOI 10.1016/j.ympev.2010.05.012; Braband A, 2010, MOL PHYLOGENET EVOL, V57, P285, DOI 10.1016/j.ympev.2010.05.011; Clark Austin Hobart, 1913, Proceedings of the Biological Society of Washington, V26; Daniels SR, 2009, BIOL J LINN SOC, V97, P200, DOI 10.1111/j.1095-8312.2009.01205.x; Oliveira ID, 2012, ZOOKEYS, P1, DOI 10.3897/zookeys.211.3463; Evans R, 1901, Q J MICROSC SCI, V44, P473; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gaffron E., 1885, ZOOL BEITR, V1, P33; Gleeson DM, 1998, MOL PHYLOGENET EVOL, V10, P237, DOI 10.1006/mpev.1998.0512; Grabham M., 1892, Nature, Vxlvi, P514; Haug JT, 2012, CURRENT BIO IN PRESS, DOI [10.1016/j.cub.2012.06.066, DOI 10.1016/J.CUB.2012.06.066)]; Hering L, 2012, MOL BIOL EVOL, V29, P3451, DOI 10.1093/molbev/mss148; ICZN, 1999, INT CODE ZOOLOGICAL; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; KEMP S, 1914, REC INDIAN MUS, V8, P471; Kemp Stanley, 1913, Records of the Indian Museum, V9; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Kircher M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-382; Kircher M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r83; Lacorte GA, 2011, ZOOTAXA, P57; LAVALLARD R, 1975, Zoologischer Anzeiger, V195, P338; Mayer G, 2005, ARTHROPOD STRUCT DEV, V34, P471, DOI 10.1016/j.asd.2005.03.004; Mayer G, 2010, BMC EVOL BIOL, V10, P1, DOI DOI 10.1186/1471-2148-10-255); Mayer G, 2006, ARTHROPOD STRUCT DEV, V35, P231, DOI 10.1016/j.asd.2006.06.003; Mayer G, 2009, DEV BIOL, V335, P263, DOI 10.1016/j.ydbio.2009.08.011; Mayer G, 2009, P ROY SOC B-BIOL SCI, V276, P3571, DOI 10.1098/rspb.2009.0950; Mayer G, 2009, ZOOL J LINN SOC-LOND, V157, P17, DOI 10.1111/j.1096-3642.2009.00523.x; Meyer M, 2010, COLD SPRING HARBOR P; MONGENAJERA J, 1995, ZOOL J LINN SOC-LOND, V114, P21, DOI 10.1111/j.1096-3642.1995.tb00111.x; MONGENAJERA J, 1994, REV BIOL TROP, V42, P181; Mora M, 1996, REV BIOL TROP, V44, P153; Morera-Brenes B, 2010, REV BIOL TROP, V58, P1127; Oliveira ID, 2010, ZOOTAXA, P16; Oliveira IS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019973; PECK S B, 1975, Psyche (Cambridge), V82, P341, DOI 10.1155/1975/98614; Podsiadlowski L, 2008, MOL BIOL EVOL, V25, P42, DOI 10.1093/molbev/msm223; READ VMS, 1988, ZOOL J LINN SOC-LOND, V93, P187, DOI 10.1111/j.1096-3642.1988.tb01361.x; READ VMS, 1988, ZOOL J LINN SOC-LOND, V93, P225, DOI 10.1111/j.1096-3642.1988.tb01362.x; Reid AL, 1996, INVERTEBR TAXON, V10, P663, DOI 10.1071/IT9960663; REID AL, 1995, ZOOL J LINN SOC-LOND, V114, P115, DOI 10.1006/zjls.1995.0020; ROBSON EA, 1966, NATURE, V209, P533, DOI 10.1038/209533a0; Rockman MV, 2001, MOL PHYLOGENET EVOL, V21, P103, DOI 10.1006/mpev.2001.0990; Rota-Stabelli O, 2010, GENOME BIOL EVOL, V2, P425, DOI 10.1093/gbe/evq030; Rowell DM, 2011, METHODS MOL BIOL, V772, P13, DOI 10.1007/978-1-61779-228-1_2; Rowell DM, 2002, J ZOOL, V257, P171, DOI 10.1017/S0952836902000778; ROWELL DM, 1995, ZOOL J LINN SOC-LOND, V114, P139, DOI 10.1111/j.1096-3642.1995.tb00117.x; Rucker A., 1900, Biol Bull, Vi, P251; Ruhberg H, 1996, MEMOIR MUS NATL HIST, V169, P139; Sakamoto Y, 2009, LEVAN TUTORIAL STEB; SCOTT IAW, 1991, AUST J ZOOL, V39, P499, DOI 10.1071/ZO9910499; Sedgwick A, 1888, Q J MICROSCOPICAL SC, V28, P431; Segovia R, 2011, MOL BIOL EVOL, V28, P2873, DOI 10.1093/molbev/msr113; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STORCH V, 1977, CELL TISSUE RES, V177, P539; Sunnucks P, 2000, J ZOOL, V250, P447, DOI 10.1111/j.1469-7998.2000.tb00788.x; von Kennel J., 1885, ARB ZOOL ZOOTOM I W, V7, P95; Walker M., 1990, P449; WALKER M, 1988, J MORPHOL, V195, P123, DOI 10.1002/jmor.1051950202; Whitington PM, 2011, ARTHROPOD STRUCT DEV, V40, P193, DOI 10.1016/j.asd.2011.01.006; WRIGHT JC, 1989, TISSUE CELL, V21, P605, DOI 10.1016/0040-8166(89)90012-8; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Zilch A., 1954, Senckenbergiana Biologica, V35, P147	72	44	48	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51220	10.1371/journal.pone.0051220	http://dx.doi.org/10.1371/journal.pone.0051220			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284667	Green Submitted, Green Published, gold			2022-12-27	WOS:000312435900015
J	Saeed, M; Ijaz, M; Javed, K; Babri, HA				Saeed, Mehreen; Ijaz, Maliha; Javed, Kashif; Babri, Haroon Atique			Reverse Engineering Boolean Networks: From Bernoulli Mixture Models to Rule Based Systems	PLOS ONE			English	Article								A Boolean network is a graphical model for representing and analyzing the behavior of gene regulatory networks (GRN). In this context, the accurate and efficient reconstruction of a Boolean network is essential for understanding the gene regulation mechanism and the complex relations that exist therein. In this paper we introduce an elegant and efficient algorithm for the reverse engineering of Boolean networks from a time series of multivariate binary data corresponding to gene expression data. We call our method ReBMM, i.e., reverse engineering based on Bernoulli mixture models. The time complexity of most of the existing reverse engineering techniques is quite high and depends upon the indegree of a node in the network. Due to the high complexity of these methods, they can only be applied to sparsely connected networks of small sizes. ReBMM has a time complexity factor, which is independent of the indegree of a node and is quadratic in the number of nodes in the network, a big improvement over other techniques and yet there is little or no compromise in accuracy. We have tested ReBMM on a number of artificial datasets along with simulated data derived from a plant signaling network. We also used this method to reconstruct a network from real experimental observations of microarray data of the yeast cell cycle. Our method provides a natural framework for generating rules from a probabilistic model. It is simple, intuitive and illustrates excellent empirical results.	[Saeed, Mehreen] Natl Univ Comp & Emerging Sci, FAST, Dept Comp Sci, Lahore, Pakistan; [Javed, Kashif; Babri, Haroon Atique] Univ Engn & Technol, Dept Elect Engn, Lahore, Pakistan	University of Engineering & Technology Lahore	Saeed, M (corresponding author), Natl Univ Comp & Emerging Sci, FAST, Dept Comp Sci, Lahore, Pakistan.	mehreen.saeed@nu.edu.pk						Akutsu T, 1999, Pac Symp Biocomput, P17; Akutsu T, 2000, J COMPUT BIOL, V7, P331, DOI 10.1089/106652700750050817; Alpaydin E, 2005, INTRO MACHINE LEARNI; Bishop C. M, 2006, PATTERN RECOGNITION; Bornholdt S, 2005, SCIENCE, V310, P449, DOI 10.1126/science.1119959; Carreira-Perpinan MA, 2000, NEURAL COMPUT, V12, P141, DOI 10.1162/089976600300015925; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; D'haeseleer P, 1999, PACIFIC S BIOCOMPUTI; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dimitrova E, 2011, THEOR COMPUT SCI, V412, P2816, DOI 10.1016/j.tcs.2010.04.034; Duda R.O., 2000, PATTERN CLASSIFICATI; Figueiredo MAT, 2002, IEEE T PATTERN ANAL, V24, P381, DOI 10.1109/34.990138; Friedman N, 2000, P 4 ANN INT C COMP M; Fuente ADL, 2001, 2 INT C SYST BIOL, P213; Guyon I, 2010, JMLR WORKSH C P CAN; Han ZM, 2009, 2009 2ND IEEE INTERNATIONAL CONFERENCE ON COMPUTER SCIENCE AND INFORMATION TECHNOLOGY, VOL 3, P194, DOI 10.1109/ICCSIT.2009.5234743; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Hopfensitz M, 2011, IEEE ACM T COMPUTATI; Ideker T. E., 2000, PAC S BIOC, V5, P302; Jenkins J, 2010, JMLR WORKSH C P CAN; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Lahdesmaki H, 2003, MACH LEARN, V52, P147, DOI 10.1023/A:1023905711304; Li H., 1999, P 20 NAT C ART INT, V20, P807; Li S, 2006, PLOS BIOL, V4, P1732, DOI 10.1371/journal.pbio.0040312; Liang S, 1998, Pac Symp Biocomput, P18; Maucher M, 2011, BIOINFORMATICS, V27, P1529, DOI 10.1093/bioinformatics/btr166; McLachlan G., 2000, WILEY SER PROB STAT; Mordelet F, 2008, BIOINFORMATICS, V24, pI76, DOI 10.1093/bioinformatics/btn273; Nam D, 2006, MACH LEARN, V65, P229, DOI 10.1007/s10994-006-9014-z; Orlando DA, 2008, NATURE, V453, P944, DOI 10.1038/nature06955; Pramila T, 2006, GENE DEV, V20; Saeed M, 2010, JMLR WORKSH C P CAN, V6; Shmulevich I, 2002, BIOINFORMATICS, V18, P555, DOI 10.1093/bioinformatics/18.4.555; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Weaver D C, 1999, Pac Symp Biocomput, P112	35	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51006	10.1371/journal.pone.0051006	http://dx.doi.org/10.1371/journal.pone.0051006			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284654	Green Published, gold, Green Submitted			2022-12-27	WOS:000312435900010
J	Wang, X; Jiang, CM; Wan, HY; Wu, JL; Quan, WQ; Bals, R; Wu, KY; Li, D				Wang, Xuan; Jiang, Cui-Min; Wan, Hai-Ying; Wu, Jun-Lu; Quan, Wen-Qiang; Bals, Robert; Wu, Kai-Yin; Li, Dong			CDA-2, a Urinary Preparation, Inhibits Lung Cancer Development through the Suppression of NF-kappaB Activation in Myeloid Cell	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; INNATE IMMUNITY; INFLAMMATORY CYTOKINES; MOUSE MODEL; IKK-BETA; TUMORIGENESIS; ANGIOGENESIS; APOPTOSIS; EXTRACT; TARGETS	CDA-2 (cell differentiation agent 2), a urinary preparation, has potent anti-proliferative and pro-apoptotic properties in cancer cells. However, the mechanisms of tumor inhibitory action of CDA-2 are far from clear, and especially there was no report on lung cancer. Here we demonstrate that CDA-2 and its main component phenylacetylglutamine (PG) reduce the metastatic lung tumor growth, and increases survival time after inoculation with Lewis lung carcinoma (LLC) cells in a dose-dependent manner in C57BL6 mice. Proliferative program analysis in cancer cells revealed a fundamental impact of CDA-2 and PG on proliferation and apoptosis, including Bcl-2, Bcl-XL, cIAP1, Survivin, PCNA, Ki-67 proteins and TUNEL assays. CDA-2 and PG significantly reduced NF-kappa B DNA-binding activity in lung cancer cells and in alveolar macrophages of tumor bearing mice and especially decreased the release of inflammatory factors including TNF alpha, IL-6, and KC. Furthermore, CDA-2 and PG decrease the expressions of TLR2, TLR6, and CD14, but not TLR1, TLR3, TLR4, and TLR9 in bone-marrow-derived macrophages (BMDM) of mice stimulated by LLC-conditioned medium (LLC-CM). Over-expressing TLR2 in BMDM prevented CDA-2 and PG from inhibiting NF-kappa B activation, as well as induction of TNF alpha and IL-6. TLR2: TLR6 complexes mediate the effect of NF-kappa B inactivation by CDA-2. In conclusion, CDA-2 potently inhibits lung tumor development by reduction of the inflammation in lung through suppression of NF-kappa B activation in myeloid cells, associating with modulation of TLR2 signaling.	[Wan, Hai-Ying; Wu, Jun-Lu; Quan, Wen-Qiang; Li, Dong] Tongji Univ, Tongji Hosp, Dept Clin Lab, Shanghai 200092, Peoples R China; [Wang, Xuan; Jiang, Cui-Min] Putuo Peoples Hosp, Dept Pharm, Shanghai, Peoples R China; [Bals, Robert] Saarland Univ Hosp, Dept Internal Med Pulmonol 5, Homburg, Germany; [Wu, Kai-Yin] Charite, Inst Pathol, Berlin, Germany	Tongji University; Universitatsklinikum des Saarlandes; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Li, D (corresponding author), Tongji Univ, Tongji Hosp, Dept Clin Lab, Shanghai 200092, Peoples R China.	186ld@163.com			Research Program of the Committee of Science and Technology of Putuo District, Shanghai [PTKW09-B02]	Research Program of the Committee of Science and Technology of Putuo District, Shanghai	This work was supported by the Research Program of the Committee of Science and Technology of Putuo District, Shanghai (PTKW09-B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Chen JJW, 2005, J CLIN ONCOL, V23, P953, DOI 10.1200/JCO.2005.12.172; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov SI, 2011, ANN RHEUM DIS, V70, pI104, DOI 10.1136/ard.2010.140145; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Grivennikov SI, 2010, CURR OPIN GENET DEV, V20, P65, DOI 10.1016/j.gde.2009.11.004; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hess C, 2010, EUR RESPIR J, V35, P343, DOI 10.1183/09031936.00196408; Huang J, 2008, ACTA PHARMACOL SIN, V29, P951, DOI 10.1111/j.1745-7254.2008.00826.x; Huang J, 2009, FOOD CHEM TOXICOL, V47, P40, DOI 10.1016/j.fct.2008.08.001; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545; Li D, MYELOID CEL IN PRESS; Lin CL, 2009, J NEURO-ONCOL, V95, P29, DOI 10.1007/s11060-009-9900-x; Lin WC, 2006, FOOD CHEM TOXICOL, V44, P546, DOI 10.1016/j.fct.2005.08.029; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Ono M, 2008, CANCER SCI, V99, P1501, DOI 10.1111/j.1349-7006.2008.00853.x; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Roy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038113; Smolinska MJ, 2011, J IMMUNOL, V187, P6043, DOI 10.4049/jimmunol.1100967; SOLTYSIAKPAWLUCZUK D, 1995, CANCER LETT, V88, P107, DOI 10.1016/0304-3835(94)03621-O; Stathopoulos GT, 2007, P NATL ACAD SCI USA, V104, P18514, DOI 10.1073/pnas.0705316104; Takahashi H, 2010, CANCER CELL, V17, P89, DOI 10.1016/j.ccr.2009.12.008; Takanami I, 1999, ONCOLOGY-BASEL, V57, P138, DOI 10.1159/000012021; Vlahos R, 2006, AM J PHYSIOL-LUNG C, V290, pL931, DOI 10.1152/ajplung.00201.2005; von Haussen J, 2008, LUNG CANCER, V59, P12, DOI 10.1016/j.lungcan.2007.07.014; Xia YF, 2012, NAT CELL BIOL, V14, P257, DOI 10.1038/ncb2428; Xiao S, 2006, P NATL ACAD SCI USA, V103, P16448, DOI 10.1073/pnas.0607830103; Yao CJ, 2005, J ALTERN COMPLEM MED, V11, P903, DOI 10.1089/acm.2005.11.903; Yoshimura A, 2006, CANCER SCI, V97, P439, DOI 10.1111/j.1349-7006.2006.00197.x; Zaynagetdinov R, 2012, ONCOGENE, V31, P3164, DOI 10.1038/onc.2011.480	43	2	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52117	10.1371/journal.pone.0052117	http://dx.doi.org/10.1371/journal.pone.0052117			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284890	Green Submitted, Green Published, gold			2022-12-27	WOS:000312435900076
J	Fujita, H; Hamazaki, Y; Noda, Y; Oshima, M; Minato, N				Fujita, Harumi; Hamazaki, Yoko; Noda, Yumi; Oshima, Masanobu; Minato, Nagahiro			Claudin-4 Deficiency Results in Urothelial Hyperplasia and Lethal Hydronephrosis	PLOS ONE			English	Article							NEPHROGENIC DIABETES-INSIPIDUS; RECESSIVE DEAFNESS DFNB29; TIGHT JUNCTIONS; CHLORIDE CHANNEL; GROWTH-FACTOR; RAT-KIDNEY; WATER CHANNEL; MICE; EXPRESSION; CELLS	Claudin (Cld)-4 is one of the dominant Clds expressed in the kidney and urinary tract, including selective segments of renal nephrons and the entire urothelium from the pelvis to the bladder. We generated Cldn4(-/-) mice and found that these mice had increased mortality due to hydronephrosis of relatively late onset. While the renal nephrons of Cldn4(-/-) mice showed a concomitant diminution of Cld8 expression at tight junction (TJ), accumulation of Cld3 at TJ was markedly enhanced in compensation and the overall TJ structure was unaffected. Nonetheless, Cldn4(-/-) mice showed slightly yet significantly increased fractional excretion of Ca2+ and Cl-, suggesting a role of Cld4 in the specific reabsorption of these ions via a paracellular route. Although the urine volume tended to be increased concordantly, Cldn4(-/-) mice were capable of concentrating urine normally on dehydration, with no evidence of diabetes insipidus. In the urothelium, the formation of TJs and uroplaques as well as the gross barrier function were also unaffected. However, intravenous pyelography analysis indicated retarded urine flow prior to hydronephrosis. Histological examination revealed diffuse hyperplasia and a thickening of pelvic and ureteral urothelial layers with markedly increased BrdU uptake in vivo. These results suggest that progressive hydronephrosis in Cldn4(-/-) mice arises from urinary tract obstruction due to urothelial hyperplasia, and that Cld4 plays an important role in maintaining the homeostatic integrity of normal urothelium.	[Fujita, Harumi; Minato, Nagahiro] Kyoto Univ, Grad Sch Biostudies, Dept Immunol & Cell Biol, Kyoto, Japan; [Fujita, Harumi; Hamazaki, Yoko; Minato, Nagahiro] Kyoto Univ, Grad Sch Med, Kyoto, Japan; [Noda, Yumi] Tokyo Med & Dent Univ, Dept Nephrol, Tokyo, Japan; [Oshima, Masanobu] Kanazawa Univ, Canc Res Inst, Div Genet, Kanazawa, Ishikawa 920, Japan	Kyoto University; Kyoto University; Tokyo Medical & Dental University (TMDU); Kanazawa University	Hamazaki, Y (corresponding author), Kyoto Univ, Grad Sch Med, Kyoto, Japan.	hamazaki@imm.med.kyoto-u.ac.jp	Oshima, Masanobu/F-9958-2014; Hamazaki, Y*/Q-3076-2019	Oshima, Masanobu/0000-0002-3304-0004; Hamazaki, Y*/0000-0001-5866-7340; Fujita, Harumi/0000-0003-2133-845X	Ministry of Education, Culture, Science, Sports and Technology of the Japanese Government	Ministry of Education, Culture, Science, Sports and Technology of the Japanese Government	This work was supported by grants from the Ministry of Education, Culture, Science, Sports and Technology of the Japanese Government to Y.H. and N.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya P, 2004, AM J PHYSIOL-RENAL, V287, pF305, DOI 10.1152/ajprenal.00341.2003; Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Angelow S, 2008, AM J PHYSIOL-RENAL, V295, pF867, DOI 10.1152/ajprenal.90264.2008; Ben-Yosef T, 2003, HUM MOL GENET, V12, P2049, DOI 10.1093/hmg/ddg210; Buchert M, 2010, P NATL ACAD SCI USA, V107, P2628, DOI 10.1073/pnas.0903747107; Dhawan P, 2011, ONCOGENE, V30, P3234, DOI 10.1038/onc.2011.43; Freeman MR, 1997, J CLIN INVEST, V99, P1028, DOI 10.1172/JCI119230; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Furuse M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002907; FUSHIMI K, 1993, NATURE, V361, P549, DOI 10.1038/361549a0; Gow A, 1999, CELL, V99, P649, DOI 10.1016/S0092-8674(00)81553-6; Hamazaki Y, 2002, J BIOL CHEM, V277, P455, DOI 10.1074/jbc.M109005200; Hamazaki Y, 2007, NAT IMMUNOL, V8, P304, DOI 10.1038/ni1438; Hayashi D, 2012, GASTROENTEROLOGY, V142, P292, DOI 10.1053/j.gastro.2011.10.040; HESSION C, 1987, SCIENCE, V237, P1479, DOI 10.1126/science.3498215; Hou JH, 2010, P NATL ACAD SCI USA, V107, P18010, DOI 10.1073/pnas.1009399107; Hou JH, 2010, CURR OPIN NEPHROL HY, V19, P483, DOI 10.1097/MNH.0b013e32833b7125; Hou JH, 2009, P NATL ACAD SCI USA, V106, P15350, DOI 10.1073/pnas.0907724106; Hu P, 2000, J CELL BIOL, V151, P961, DOI 10.1083/jcb.151.5.961; Kawai Y, 2011, P NATL ACAD SCI USA, V108, P4075, DOI 10.1073/pnas.1014178108; Khandelwal P, 2009, AM J PHYSIOL-RENAL, V297, pF1477, DOI 10.1152/ajprenal.00327.2009; Kiuchi-Saishin Y, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134875; Kong XT, 2004, J CELL BIOL, V167, P1195, DOI 10.1083/jcb.200406025; Lanaspa MA, 2008, P NATL ACAD SCI USA, V105, P15797, DOI 10.1073/pnas.0805761105; Lloyd DJ, 2005, PLOS GENET, V1, P171, DOI 10.1371/journal.pgen.0010020; Loffing J, 2001, AM J PHYSIOL-RENAL, V281, pF1021, DOI 10.1152/ajprenal.0085.2001; Matsumura Y, 1999, NAT GENET, V21, P95, DOI 10.1038/5036; McDill BW, 2006, P NATL ACAD SCI USA, V103, P6952, DOI 10.1073/pnas.0602087103; Milatz S, 2010, BBA-BIOMEMBRANES, V1798, P2048, DOI 10.1016/j.bbamem.2010.07.014; Muto S, 2012, CLIN EXP NEPHROL, V16, P61, DOI 10.1007/s10157-011-0491-4; Muto S, 2010, P NATL ACAD SCI USA, V107, P8011, DOI 10.1073/pnas.0912901107; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; PARRIES G, 1995, J BIOL CHEM, V270, P27954, DOI 10.1074/jbc.270.46.27954; SABOLIC I, 1992, AM J PHYSIOL, V263, pC1225, DOI 10.1152/ajpcell.1992.263.6.C1225; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Shimatani K, 2009, P NATL ACAD SCI USA, V106, P15807, DOI 10.1073/pnas.0908805106; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Swisshelm K, 2005, ADV DRUG DELIVER REV, V57, P919, DOI 10.1016/j.addr.2005.01.006; Tamura A, 2008, GASTROENTEROLOGY, V134, P523, DOI 10.1053/j.gastro.2007.11.040; Tamura A, 2011, GASTROENTEROLOGY, V140, P913, DOI 10.1053/j.gastro.2010.08.006; Tatum R, 2010, AM J PHYSIOL-RENAL, V298, pF24, DOI 10.1152/ajprenal.00450.2009; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Tsukita S, 2008, ONCOGENE, V27, P6930, DOI 10.1038/onc.2008.344; UCHIDA S, 1995, J CLIN INVEST, V95, P104, DOI 10.1172/JCI117626; Van Itallie C, 2001, J CLIN INVEST, V107, P1319, DOI 10.1172/JCI12464; Varley CL, 2006, J CELL PHYSIOL, V208, P407, DOI 10.1002/jcp.20676; Wilcox ER, 2001, CELL, V104, P165, DOI 10.1016/S0092-8674(01)00200-8; Wu XR, 2009, KIDNEY INT, V75, P1153, DOI 10.1038/ki.2009.73; Yang BX, 2006, AM J PHYSIOL-RENAL, V291, pF465, DOI 10.1152/ajprenal.00494.2005	49	59	59	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52272	10.1371/journal.pone.0052272	http://dx.doi.org/10.1371/journal.pone.0052272			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284964	Green Submitted, Green Published, gold			2022-12-27	WOS:000313158800041
J	Vendra, VPR; Chandani, S; Balasubramanian, D				Vendra, Venkata Pulla Rao; Chandani, Sushil; Balasubramanian, Dorairajan			The Mutation V42M Distorts the Compact Packing of the Human Gamma-S-Crystallin Molecule, Resulting in Congenital Cataract	PLOS ONE			English	Article							EYE LENS; AGGREGATION; PROTEINS; STABILITY; BINDING; BOVINE; MUTANT; INTERMEDIATE; SIMULATION; FAMILIES	Background: Human gamma S-crystallin is an important component of the human eye lens nucleus and cortex. The mutation V42M in the molecule causes severe congenital cataract in children. We compare the structure of the mutant protein with that of the wild type in order to understand how structural changes in the mutant relate to the mechanism of opacification. Methods: Both proteins were made using conventional cloning and expression procedures. Secondary and tertiary structural features of the proteins were analyzed using spectral methods. Structural stabilities of the proteins were analyzed using chemical and thermal denaturation methods. Self-aggregation was monitored using extrinsic spectral probes. Molecular modeling was used to compare the structural features of the two proteins. Results: While the wild type and mutant have the same secondary structure, molecular modeling and fluorescence analysis suggest the mutant to have a more open tertiary structure, with a larger hydrophobic surface. Experiments using extrinsic probes reveal that the mutant readily self-aggregates, with the suggestion that the aggregates might be similar to amyloidogenic fibrils. Chemical denaturation indicates that while the wild type exhibits the classic two-state transition, V42M goes through an intermediate state, and has a distinctly lower stability than the wild type. The temperature of thermal unfolding of the mutant is also distinctly lower. Further, the mutant readily precipitates and scatters light more easily than the wild type. Conclusion: The replacement of valine in position 42 by the longer and bulkier methionine in human gamma S-crystallin perturbs the compact beta-sheet core packing topology in the N-terminal domain of the molecule, exposes nonpolar residues thereby increasing the surface hydrophobicity and weakens the stability of the protein, thus promoting self-aggregation leading to light scattering particles. This set of changes in the properties of the mutant offers a molecular insight into the mechanism of opacification.	[Vendra, Venkata Pulla Rao; Balasubramanian, Dorairajan] Hyderabad Eye Res Fdn, Prof Brien Holden Eye Res Ctr, LV Prasad Eye Inst Hyderabad, Hyderabad, Andhra Pradesh, India; [Chandani, Sushil] Novarus Discoveries Pvt Ltd, Hyderabad, Andhra Pradesh, India	L. V. Prasad Eye Institute	Balasubramanian, D (corresponding author), Hyderabad Eye Res Fdn, Prof Brien Holden Eye Res Ctr, LV Prasad Eye Inst Hyderabad, Hyderabad, Andhra Pradesh, India.	dbala@lvpei.org		Alimchandani, Sushil/0000-0001-8036-5584	Department of Biotechnology, India [BT/01/COE/06/02/10]; Champalimaud Foundation, Portugal; Hyderabad Eye Research Foundation, India	Department of Biotechnology, India(Department of Biotechnology (DBT) India); Champalimaud Foundation, Portugal; Hyderabad Eye Research Foundation, India	This research was funded by grants from the Department of Biotechnology, India, (grant number BT/01/COE/06/02/10), Champalimaud Foundation, Portugal, (2008-12) and in-house funding from the Hyderabad Eye Research Foundation, India. The authors have no commercial interests or any financial disclosure to make. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; AUGUSTEYN RC, 1994, BBA-PROTEIN STRUCT M, V1205, P89, DOI 10.1016/0167-4838(94)90096-5; Augusteyn RC, 2010, EXP EYE RES, V90, P643, DOI 10.1016/j.exer.2010.01.013; BRAKENHOFF RH, 1990, J MOL BIOL, V216, P519, DOI 10.1016/0022-2836(90)90380-5; BRITTAIN HG, 1976, J AM CHEM SOC, V98, P8255, DOI 10.1021/ja00441a060; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Brubaker WD, 2012, BIOMOL NMR ASSIGN, V6, P63, DOI 10.1007/s12104-011-9326-1; Brubaker WD, 2011, BIOPHYS J, V100, P498, DOI 10.1016/j.bpj.2010.12.3691; CLARK AC, 1993, J BIOL CHEM, V268, P10773; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; Devi RR, 2008, MOL VIS, V14, P1157; Foster A, 1997, J CATARACT REFR SURG, V23, P601, DOI 10.1016/S0886-3350(97)80040-5; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; GREENE RF, 1974, J BIOL CHEM, V249, P5388; HEMMINGSEN JM, 1994, PROTEIN SCI, V3, P1927, DOI 10.1002/pro.5560031104; Lee S, 2010, J MOL BIOL, V399, P320, DOI 10.1016/j.jmb.2010.04.003; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Ma ZW, 2009, BIOCHEMISTRY-US, V48, P7334, DOI 10.1021/bi900467a; Macdonald JT, 2005, PROTEIN SCI, V14, P1282, DOI 10.1110/ps.041227805; Mahler B, 2011, J MOL BIOL, V405, P840, DOI 10.1016/j.jmb.2010.11.005; Meehan S, 2004, J BIOL CHEM, V279, P3413, DOI 10.1074/jbc.M308203200; Mills IA, 2007, PROTEIN SCI, V16, P2427, DOI 10.1110/ps.072970207; Mishra A, 2012, J MOL BIOL, V415, P75, DOI 10.1016/j.jmb.2011.10.037; Purkiss AG, 2002, J BIOL CHEM, V277, P4199, DOI 10.1074/jbc.M110083200; Rajini B, 2001, J BIOL CHEM, V276, P38464, DOI 10.1074/jbc.M102164200; ROSEN CG, 1969, BIOCHEMISTRY-US, V8, P3915, DOI 10.1021/bi00838a006; Sandilands A, 2002, EMBO J, V21, P6005, DOI 10.1093/emboj/cdf609; Shiels A, 2010, MOL VIS, V16, P2007; Sinha D, 1998, Mol Vis, V4, P8; Sinha D, 2001, J BIOL CHEM, V276, P9308, DOI 10.1074/jbc.M010583200; Suman SK, 2011, J BIOL CHEM, V286, P43891, DOI 10.1074/jbc.M111.247890; Sun H, 2005, J MED GENET, V42, P706, DOI 10.1136/jmg.2004.028274; Sun WM, 2011, MOL VIS, V17, P2197; Sutter M, 2007, J FLUORESC, V17, P181, DOI 10.1007/s10895-007-0156-6; Talla V, 2008, INVEST OPHTH VIS SCI, V49, P3483, DOI 10.1167/iovs.07-1114; TARDIEU A, 1988, ANNU REV BIOPHYS BIO, V17, P47; Vanita V, 2009, MOL VIS, V15, P476; Vendra VPR, 2010, MOL VIS, V16, P2822; Wenk M, 2000, BIOPHYS CHEM, V86, P95, DOI 10.1016/S0301-4622(00)00161-7; Wu ZR, 2005, PROTEIN SCI, V14, P3101, DOI 10.1110/ps.051635205	41	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e51401	10.1371/journal.pone.0051401	http://dx.doi.org/10.1371/journal.pone.0051401			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284690	Green Published, gold, Green Submitted			2022-12-27	WOS:000313158800010
J	Yu, RJ; Guo, XL; Zhong, JP; Li, M; Zeng, ZX; Zhang, HH				Yu, Rongjie; Guo, Xiaoling; Zhong, Jiaping; Li, Mei; Zeng, Zhixing; Zhang, Huahua			The N-Terminal HSDCIF Motif Is Required for Cell Surface Trafficking and Dimerization of Family B G Protein Coupled Receptor PAC1	PLOS ONE			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; VASOACTIVE-INTESTINAL-PEPTIDE; SECRETIN RECEPTOR; PHARMACOLOGY; EXPRESSION; OLIGOMERIZATION; RESIDUES; CYSTEINE; VIP	PAC1 is PACAP (pituitary adenylate cyclase-activating polypeptide) preferring receptor belonging to class B G protein coupled receptor (GPCR) mediating the most effects of PACAP. The important role of G protein coupled receptor homo/heteromerization in receptor folding, maturation, trafficking, and cell surface expression has become increasingly evident. The bimolecular fluorescence complementation (BiFC) and bioluminescence resonance energy transfer (BRET) assay were used in this research to confirm the dimerization of PAC1 for the first time. The structure-activity relationship focused on the N-terminal HSDCIF motif, which locates behind the signal sequence and has high homology with PACAP (1-6), was assayed using a receptor mutant with the deletion of the HSDCIF motif. The fluorescence confocal microscope observation showed that the deletion of the HSDCIF motif impaired the cell delivery of PAC1. The results of BiFC, BRET and westernblot indicated that the deletion of HSDCIF motif and the replacement of the Cys residue with Ala in HSDCIF motif resulted in the disruption of receptor dimerization. And the exogenous chemically synthesized oligopeptide HSDCIF (100 nmol/L) not only down-regulated the dimerization of PAC1, induced the internalization of PAC1, but also inhibited the proliferation of CHO cells expressing PAC1 stably and decreased the activity of PACAP on the cell viability. All these data suggested that the N-terminal HSDCIF motif played key role in the trafficking and the dimerization of PAC1, and the exogenous oligopeptide HSDCIF had effects on the cell signaling, trafficking and the dimerization of PAC1.	[Yu, Rongjie; Guo, Xiaoling; Zhong, Jiaping; Li, Mei; Zeng, Zhixing] Jinan Univ, Dept Cell Biol, Inst Cell Biol, Guangzhou, Guangdong, Peoples R China; [Zhang, Huahua] Guangdong Med Coll, Med Genet Lab, Dongguan, Guangdong, Peoples R China	Jinan University; Guangdong Medical University	Yu, RJ (corresponding author), Jinan Univ, Dept Cell Biol, Inst Cell Biol, Guangzhou, Guangdong, Peoples R China.	rongjie_yu1123@163.com	Guo, Xiaoling/AAJ-2958-2020	Yu, Rongjie/0000-0001-9285-5783	National Natural Science Foundation of China [31100545]; Science and Technology Bureau of Guangdong Province [2011B090400024]; Natural Science Foundation of Guangdong Province [S2011010002931]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Bureau of Guangdong Province; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Science Foundation of China (No. 31100545), the Science and Technology Bureau of Guangdong Province (2011B090400024) and the Natural Science Foundation of Guangdong Province (S2011010002931). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINO H, 1995, GENE, V164, P301, DOI 10.1016/0378-1119(95)00391-I; Asmann YW, 2000, MOL PHARMACOL, V58, P911, DOI 10.1124/mol.58.5.911; Boronkai A, 2009, ANN NY ACAD SCI, V1163, P353, DOI 10.1111/j.1749-6632.2008.03630.x; Bourgault S, 2009, CURR MED CHEM, V16, P4462, DOI 10.2174/092986709789712899; Bourgault S, 2009, J MED CHEM, V52, P3308, DOI 10.1021/jm900291j; Couvineau A, 2004, REGUL PEPTIDES, V123, P181, DOI 10.1016/j.regpep.2004.06.025; Dickson L, 2009, PHARMACOL THERAPEUT, V121, P294, DOI 10.1016/j.pharmthera.2008.11.006; Gao F, 2009, MOL PHARMACOL, V76, P264, DOI 10.1124/mol.109.055756; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Harikumar KG, 2007, J BIOL CHEM, V282, P30363, DOI 10.1074/jbc.M702325200; Harikumar KG, 2006, MOL PHARMACOL, V69, P363, DOI 10.1124/mol.105.015776; Harmar AJ, 2012, BRIT J PHARMACOL, V166, P4, DOI 10.1111/j.1476-5381.2012.01871.x; Hawtin SR, 2006, J BIOL CHEM, V281, P38478, DOI 10.1074/jbc.M607639200; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Laburthe M, 1996, ANN NY ACAD SCI, V805, P94; Laburthe M, 2007, PEPTIDES, V28, P1631, DOI 10.1016/j.peptides.2007.04.026; Langer I, 2008, BBA-MOL CELL RES, V1783, P1663, DOI 10.1016/j.bbamcr.2008.03.013; Langer I, 2006, BRIT J PHARMACOL, V148, P1051, DOI 10.1038/sj.bjp.0706816; Lee JC, 2010, BRAIN RES, V1351, P32, DOI 10.1016/j.brainres.2010.06.048; Lieu SN, 2006, ANN NY ACAD SCI, V1070, P399, DOI 10.1196/annals.1317.052; Lisenbee CS, 2005, J BIOL CHEM, V280, P12330, DOI 10.1074/jbc.M414016200; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.; OKAZAKI K, 1992, FEBS LETT, V298, P49, DOI 10.1016/0014-5793(92)80020-H; Prinster SC, 2005, PHARMACOL REV, V57, P289, DOI 10.1124/pr.57.3.1; Ressler KJ, 2011, NATURE, V470, P492, DOI 10.1038/nature09856; ROBBERECHT P, 1992, EUR J BIOCHEM, V207, P239, DOI 10.1111/j.1432-1033.1992.tb17043.x; Roed Sarah Norklit, 2012, Front Endocrinol (Lausanne), V3, P62, DOI 10.3389/fendo.2012.00062; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; Szidonya L, 2008, J ENDOCRINOL, V196, P435, DOI 10.1677/JOE-07-0573; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; Vaudry D, 2000, PHARMACOL REV, V52, P269; Yu RJ, 2006, PEPTIDES, V27, P1359, DOI 10.1016/j.peptides.2005.11.026; Yu RJ, 2010, NEUROSCI LETT, V480, P73, DOI 10.1016/j.neulet.2010.06.007; Yu RJ, 2010, PEPTIDES, V31, P1062, DOI 10.1016/j.peptides.2010.03.008	34	12	13	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e51811	10.1371/journal.pone.0051811	http://dx.doi.org/10.1371/journal.pone.0051811			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284775	Green Submitted, gold, Green Published			2022-12-27	WOS:000313158800015
J	Chen, RX; Barphagha, IK; Karki, HS; Ham, JH				Chen, Ruoxi; Barphagha, Inderjit K.; Karki, Hari S.; Ham, Jong Hyun			Dissection of Quorum-Sensing Genes in Burkholderia glumae Reveals Non-Canonical Regulation and the New Regulatory Gene tofM for Toxoflavin Production	PLOS ONE			English	Article							CLONING; CONSTRUCTION; MUTAGENESIS; INHIBITION; INSERTION; PATHOGEN; BACTERIA; VECTOR; SYSTEM	Burkholderia glumae causes bacterial panicle blight of rice and produces major virulence factors, including toxoflavin, under the control of the quorum-sensing (QS) system mediated by the luxI homolog, tofI, and the luxR homolog, tofR. In this study, a series of markerless deletion mutants of B. glumae for tofI and tofR were generated using the suicide vector system, pKKSacB, for comprehensive characterization of the QS system of this pathogen. Consistent with the previous studies by other research groups, Delta tofI and Delta tofR strains of B. glumae did not produce toxoflavin in Luria-Bertani (LB) broth. However, these mutants produced high levels of toxoflavin when grown in a highly dense bacterial inoculum (similar to 10(11) CFU/ml) on solid media, including LB agar and King's B (KB) agar media. The Delta tofI/Delta tofR strain of B. glumae, LSUPB201, also produced toxoflavin on LB agar medium. These results indicate the presence of previously unknown regulatory pathways for the production of toxoflavin that are independent of tofI and/or tofR. Notably, the conserved open reading frame (locus tag: bglu_2g14480) located in the intergenic region between tofI and tofR was found to be essential for the production of toxoflavin by tofI and tofR mutants on solid media. This novel regulatory factor of B. glumae was named tofM after its homolog, rsaM, which was recently identified as a novel negative regulatory gene for the QS system of another rice pathogenic bacterium, Pseudomonas fuscovaginae. The Delta tofM strain of B. glumae, LSUPB286, produced a less amount of toxoflavin and showed attenuated virulence when compared with its wild type parental strain, 336gr-1, suggesting that tofM plays a positive role in toxoflavin production and virulence. In addition, the observed growth defect of the Delta tofI strain, LSUPB145, was restored by 1 mu M N-octanoyl homoserine lactone (C8-HSL).	[Chen, Ruoxi; Barphagha, Inderjit K.; Karki, Hari S.; Ham, Jong Hyun] Louisiana State Univ, Ctr Agr, Dept Plant Pathol & Crop Physiol, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Ham, JH (corresponding author), Louisiana State Univ, Ctr Agr, Dept Plant Pathol & Crop Physiol, Baton Rouge, LA 70803 USA.	jham@agcenter.lsu.edu	Karki, Hari Sharan/AAB-5819-2020		Louisiana State University Agricultural Center; Research and Development Program of the Louisiana Board of Regents Support Fund [LEQSF(2008-11)-RD-A-02]; Pilot Funding for New Research (Pfund) Program of the National Science Foundation; Louisiana Board of Regents [NSF(2010)-PFUND-194]; Louisiana Board of Regents	Louisiana State University Agricultural Center; Research and Development Program of the Louisiana Board of Regents Support Fund; Pilot Funding for New Research (Pfund) Program of the National Science Foundation; Louisiana Board of Regents; Louisiana Board of Regents	This work was supported by the Louisiana State University Agricultural Center, the Research and Development Program of the Louisiana Board of Regents Support Fund (Grant number: LEQSF(2008-11)-RD-A-02), and the Pilot Funding for New Research (Pfund) Program of the National Science Foundation and the Louisiana Board of Regents (Grant number: NSF(2010)-PFUND-194). RC was supported by the Economic Development Assistantship of the Louisiana Board of Regents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeyev MF, 1999, BIOTECHNIQUES, V26, P824, DOI 10.2144/99265bm05; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; Devescovi G, 2007, APPL ENVIRON MICROB, V73, P4950, DOI 10.1128/AEM.00105-07; DITTA G, 1980, P NATL ACAD SCI-BIOL, V77, P7347, DOI 10.1073/pnas.77.12.7347; Dunlap Paul V., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P5; EBERHARD A, 1972, J BACTERIOL, V109, P1101, DOI 10.1128/JB.109.3.1101-1105.1972; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Fuqua C, 2001, ANNU REV GENET, V35, P439, DOI 10.1146/annurev.genet.35.102401.090913; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Ham JH, 2011, MOL PLANT PATHOL, V12, P329, DOI 10.1111/j.1364-3703.2010.00676.x; Iiyama Kazuhiro, 1995, Annals of the Phytopathological Society of Japan, V61, P470, DOI 10.3186/jjphytopath.61.470; Jacobs JL, 2008, APPL ENVIRON MICROB, V74, P3121, DOI 10.1128/AEM.01941-07; Jung WS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022443; Karki HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045376; Karki HS, 2012, MOL PLANT PATHOL; Kim J, 2004, MOL MICROBIOL, V54, P921, DOI 10.1111/j.1365-2958.2004.04338.x; Kim J, 2007, MOL MICROBIOL, V64, P165, DOI 10.1111/j.1365-2958.2007.05646.x; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Mattiuzzo M, 2011, ENVIRON MICROBIOL, V13, P145, DOI 10.1111/j.1462-2920.2010.02316.x; McClean KH, 1997, MICROBIOL-UK, V143, P3703, DOI 10.1099/00221287-143-12-3703; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Nagamatsu T, 2002, CHEM INFORM, V33, P261; Nandakumar R, 2009, PLANT DIS, V93, P896, DOI 10.1094/PDIS-93-9-0896; PENFOLD RJ, 1992, GENE, V118, P145, DOI 10.1016/0378-1119(92)90263-O; Sambrook J., 2001, MOL CLONING LAB MANU; Schaad N. W., 2001, LAB GUIDE IDENTIFICA, V3rd, P1; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Suzuki Fumihiko, 2004, Journal of General Plant Pathology, V70, P97, DOI 10.1007/s10327-003-0096-1; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Venturi V, 2011, MOL MICROBIOL, V82, P1060, DOI 10.1111/j.1365-2958.2011.07890.x	32	26	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52150	10.1371/journal.pone.0052150	http://dx.doi.org/10.1371/journal.pone.0052150			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284909	gold, Green Submitted, Green Published			2022-12-27	WOS:000312794500102
J	Curtis, AJ; Marshall, CS; Spelman, T; Greig, J; Elliot, JH; Shanks, L; Du Cros, P; Casas, EC; Da Fonseca, MS; O'Brien, DP				Curtis, Andrea J.; Marshall, Catherine S.; Spelman, Tim; Greig, Jane; Elliot, Julian H.; Shanks, Leslie; Du Cros, Philipp; Casas, Esther C.; Da Fonseca, Marcio Silveria; O'Brien, Daniel P.			Incidence of WHO Stage 3 and 4 Conditions following Initiation of Anti-Retroviral Therapy in Resource Limited Settings	PLOS ONE			English	Article							HIV-INFECTED ADULTS; COTRIMOXAZOLE PROPHYLAXIS; OPPORTUNISTIC ILLNESSES; SOUTH-AFRICA; RISK-FACTORS; MORTALITY; COHORT; AIDS; TUBERCULOSIS; CRYPTOCOCCOSIS	Objectives: To determine the incidence of WHO clinical stage 3 and 4 conditions during early anti-retroviral therapy (ART) in resource limited settings (RLS). Design/Setting: A descriptive analysis of routine program data collected prospectively from 25 Medecins Sans Frontieres supported HIV treatment programs in eight countries between 2002 and 2010. Subjects/Participants: 35,349 study participants with median follow-up on ART of 1.33 years (IQR 0.51-2.41). Outcome Measures: Incidence in 100 person-years of WHO stage 3 or 4 conditions during 5 periods after ART initiation. Diagnoses of conditions were made according to WHO criteria and relied upon clinical assessments supported by basic laboratory investigations. Results: The incidence of any WHO clinical stage 3 or 4 condition over 3 years was 40.02 per 100 person-years (31.77 for stage 3 and 8.25 for stage 4). The incidence of stage 3 and 4 conditions fell by over 97% between months 0-3 and months 25-36 (77.81 to 2.40 for stage 3 and 28.70 to 0.64 for stage 4). During months 0-3 pulmonary tuberculosis was the most common condition diagnosed in adults (incidence 22.24 per 100 person-years) and children aged 5-14 years (25.76) and oral candidiasis was the most common in children <5 years (25.79). Overall incidences were higher in Africa compared with Asia (43.98 versus 12.97 for stage 3 and 8.98 versus 7.05 for stage 4 conditions, p < 0.001). Pulmonary tuberculosis, weight loss, oral and oesophageal candidiasis, chronic diarrhoea, HIV wasting syndrome and severe bacterial infections were more common in Africa. Extra-pulmonary tuberculosis, non-tuberculous mycobacterial infection, cryptococcosis, penicilliosis and toxoplasmosis were more common in Asia. Conclusions: The incidence of WHO stage 3 and 4 conditions during the early period after ART initiation in RLS is high, but greatly reduces over time. This is likely due to both the benefits of ART and deaths of the sickest patients occurring shortly after ART initiation. Access to appropriate disease prevention tools prior to ART, and early initiation of ART, are important for their prevention.	[Greig, Jane; Du Cros, Philipp; O'Brien, Daniel P.] Medecins Sans Frontieres, Manson Unit, London, England; [Curtis, Andrea J.; Spelman, Tim; Elliot, Julian H.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Marshall, Catherine S.; Elliot, Julian H.] Alfred Hosp, Infect Dis Unit, Melbourne, Vic, Australia; [Spelman, Tim; Elliot, Julian H.] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia; [Shanks, Leslie; Casas, Esther C.; Da Fonseca, Marcio Silveria] Medecins Sans Frontieres, Dept Publ Hlth, Amsterdam, Netherlands; [O'Brien, Daniel P.] Geelong Hosp, Dept Infect Dis, Geelong, Vic, Australia; [O'Brien, Daniel P.] Univ Melbourne, Royal Melbourne Hosp, Dept Med & Infect Dis, Melbourne, Vic 3050, Australia	Doctors Without Borders; Monash University; Florey Institute of Neuroscience & Mental Health; Burnet Institute; Doctors Without Borders; Geelong Hospital; Royal Melbourne Hospital; University of Melbourne	O'Brien, DP (corresponding author), Medecins Sans Frontieres, Manson Unit, London, England.	daniel.obrien@amsterdam.msf.org	O'Brien, Daniel/ABE-9658-2020	O'Brien, Daniel/0000-0001-5418-3330; du Cros, Philipp/0000-0002-3599-029X; Curtis, Andrea/0000-0003-2407-770X; Greig, Jane/0000-0003-2732-0023	M�decins Sans Fronti�res [OCA_pilot_00_Greig, OCA_ERB_009_20_OBrien] Funding Source: researchfish	M�decins Sans Fronti�res		Abadi J, 1999, CLIN INFECT DIS, V28, P309, DOI 10.1086/515130; [Anonymous], 2011, GUIDELINES FOR INTEN; Buchacz K, 2010, AIDS, V24, P1549, DOI 10.1097/QAD.0b013e32833a3967; Castelnuovo B, 2009, CLIN INFECT DIS, V49, P965, DOI 10.1086/605500; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Fielding K, 2012, 19TH CONFERENCE ON R; Golub JE, 2009, AIDS, V23, P631, DOI 10.1097/QAD.0b013e328327964f; Gonzalez CE, 1996, PEDIATR INFECT DIS J, V15, P796, DOI 10.1097/00006454-199609000-00012; HOOVER DR, 1991, STAT MED, V10, P1993, DOI 10.1002/sim.4780101212; Ives NJ, 2001, J INFECTION, V42, P134, DOI 10.1053/jinf.2001.0810; Kaplan JE, 2000, CLIN INFECT DIS, V30, pS5, DOI 10.1086/313843; Kasprowicz VO, 2011, J INFECT DIS, V204, pS1099, DOI 10.1093/infdis/jir414; Lawn SD, 2010, CURR OPIN HIV AIDS, V5, P18, DOI 10.1097/COH.0b013e328333850f; Ledergerber B, 1999, JAMA-J AM MED ASSOC, V282, P2220, DOI 10.1001/jama.282.23.2220; Lynen L, 2006, CLINICAL HIV AIDS CA; Manosuthi W, 2006, JAIDS-J ACQ IMM DEF, V43, P42, DOI 10.1097/01.qai.0000230521.86964.86; Mermin J, 2004, LANCET, V364, P1428, DOI 10.1016/S0140-6736(04)17225-5; Miranda A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000826; Monforte AD, 2005, ARCH INTERN MED, V165, P416; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Sloan DJ, 2009, CURR OPIN INFECT DIS, V22, P455, DOI 10.1097/QCO.0b013e32832fa214; [UNICEF WHO], 2006, PNEUMONIA THE FORGOT; Walker AS, 2010, LANCET, V375, P1278, DOI 10.1016/S0140-6736(10)60057-8; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2004, SCALING UP ANTIRETRO; World Health Organization, 2006, ANTIRETROVIRAL THERA; World Health Organization, 2011, RAPID ADVICE DIAGNOS; World Health Organization, 2010, ANTIRETROVIRAL THERA; Zachariah R, 2006, AIDS, V20, P2355, DOI 10.1097/QAD.0b013e32801086b0	29	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52019	10.1371/journal.pone.0052019	http://dx.doi.org/10.1371/journal.pone.0052019			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284857	gold, Green Published, Green Submitted			2022-12-27	WOS:000312794500078
J	Okumura, M; Kijima, A; Kadota, K; Yokoyama, K; Suzuki, H; Yamamoto, Y				Okumura, Motoki; Kijima, Akifumi; Kadota, Koji; Yokoyama, Keiko; Suzuki, Hiroo; Yamamoto, Yuji			A Critical Interpersonal Distance Switches between Two Coordination Modes in Kendo Matches	PLOS ONE			English	Article							TEAM SPORTS; INSTANTANEOUS FREQUENCY; ECOLOGICAL DYNAMICS; VISUAL COORDINATION; FRACTAL TRANSITION; PHASE-TRANSITIONS; JOINT ACTION; MOVEMENTS; SYSTEMS; CONSTRAINTS	In many competitive sports, players need to quickly and continuously execute movements that co-adapt to various movements executed by their opponents and physical objects. In a martial art such as kendo, players must be able to skillfully change interpersonal distance in order to win. However, very little information about the task and expertise properties of the maneuvers affecting interpersonal distance is available. This study investigated behavioral dynamics underlying opponent tasks by analyzing changes in interpersonal distance made by expert players in kendo matches. Analysis of preferred interpersonal distances indicated that players tended to step toward and away from their opponents based on two distances. The most preferred distance enabled the players to execute both striking and defensive movements immediately. The relative phase analysis of the velocities at which players executed steps toward and away revealed that players developed anti-phase synchronizations at near distances to maintain safe distances from their opponents. Alternatively, players shifted to in-phase synchronization to approach their opponents from far distances. This abrupt phase-transition phenomenon constitutes a characteristic bifurcation dynamics that regularly and instantaneously occurs between in- and anti-phase synchronizations at a critical interpersonal distance. These dynamics are profoundly affected by the task constraints of kendo and the physical constraints of the players. Thus, the current study identifies the clear behavioral dynamics that emerge in a sport setting.	[Okumura, Motoki] Shizuoka Univ, Fac Educ, Shizuoka 4228529, Japan; [Okumura, Motoki] Shizuoka Univ, Grad Sch Educ, Shizuoka 4228529, Japan; [Kijima, Akifumi] Univ Yamanashi, Grad Sch Educ, Kofu, Yamanashi, Japan; [Kadota, Koji] Osaka Univ, Dept Hlth & Sport Sci, Grad Sch Med, Osaka, Japan; [Yokoyama, Keiko] Hokkaido Univ, Div Appl Phys, Fac Engn, Sapporo, Hokkaido 060, Japan; [Yokoyama, Keiko] Japan Soc Promot Sci, Tokyo, Japan; [Suzuki, Hiroo] Nagoya Univ, Grad Sch Educ & Human Dev, Nagoya, Aichi 4648601, Japan; [Yamamoto, Yuji] Nagoya Univ, Res Ctr Hlth Phys Fitness & Sports, Nagoya, Aichi 4648601, Japan; [Yamamoto, Yuji] Nagoya Univ, Dept Psychol & Human Dev Sci, Nagoya, Aichi 4648601, Japan	Shizuoka University; Shizuoka University; University of Yamanashi; Osaka University; Hokkaido University; Japan Society for the Promotion of Science; Nagoya University; Nagoya University; Nagoya University	Okumura, M (corresponding author), Shizuoka Univ, Fac Educ, Shizuoka 4228529, Japan.	emuokumu@ipc.shizuoka.ac.jp			Japan Society for the Promotion of Science [20240060]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The work has been supported in part by Grant-in-Aid for Scientific Research (A) 20240060 from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Araujo D, 2004, SKILL ACQUISITION SP, P409; Araujo D, 2006, PSYCHOL SPORT EXERC, V7, P653, DOI 10.1016/j.psychsport.2006.07.002; Bardy BG, 2002, J EXP PSYCHOL HUMAN, V28, P499, DOI 10.1037//0096-1523.28.3.499; Beek P. J., 2003, EXPERT PERFORMANCE S, P321; BOASHASH B, 1992, P IEEE, V80, P540, DOI 10.1109/5.135378; BOASHASH B, 1992, P IEEE, V80, P520, DOI 10.1109/5.135376; Bourbousson J, 2010, J SPORT SCI, V28, P349, DOI 10.1080/02640410903503640; Bourbousson J, 2010, J SPORT SCI, V28, P339, DOI 10.1080/02640410903503632; Davids K, 2008, DYNAMICS SKILL ACQUI; Dietrich G, 2010, MOTOR CONTROL, V14, P509, DOI 10.1123/mcj.14.4.509; Gohara K, 1999, FRACTALS, V7, P205, DOI 10.1142/S0218348X99000220; Gohara K, 1999, FRACTALS, V7, P313, DOI 10.1142/S0218348X99000311; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Haken H, 1978, SYNERGETICS INTRO NO, DOI [10.1007/978-3-642-96469-5, DOI 10.1007/978-3-642-96469-5]; Haken H., 1983, ADV SYNERGETICS INST; Hall E.T., 1966, HIDDEN DIMENSION, V609; Hediger HP, 1962, SOCIAL LIFE EARLY MA, P34; Higuchi T, 2011, HUM MOVEMENT SCI, V30, P534, DOI 10.1016/j.humov.2010.08.003; Hristovski Robert, 2006, Nonlinear Dynamics Psychol Life Sci, V10, P409; INGLE D, 1977, VISION RES, V17, P1009, DOI 10.1016/0042-6989(77)90003-7; Kelso J, 1984, AM J PHYSIOL-REG I, V15, pR1000, DOI DOI 10.1152/ajpregu.1984.246.6.R1000; KELSO JAS, 1981, B PSYCHONOMIC SOC, V18, P63; Kelso S., 1995, DYNAMIC PATTERNS SEL; Kijima A, PLOS ONE IN PRESS; Lames M, 2006, J SPORT SCI MED, V5, P556; LEE DN, 1982, J EXPT PSYCHOL HUMAN, V8, P448, DOI DOI 10.1037/0096-1523.8.3.448; McGarry T, 1999, J SPORT SCI, V17, P297, DOI 10.1080/026404199366019; McGarry T, 2002, J SPORT SCI, V20, P771, DOI 10.1080/026404102320675620; Nishikawa J, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036210; Oullier O, 2002, HUM MOVEMENT SCI, V21, P147, DOI 10.1016/S0167-9457(02)00093-3; Palut Y, 2005, J SPORT SCI, V23, P1021, DOI 10.1080/02640410400021682; Passos P, 2006, BEHAV RES METHODS, V38, P683, DOI 10.3758/BF03193901; Passos P, 2011, J MOTOR BEHAV, V43, P155, DOI 10.1080/00222895.2011.552078; Passos P, 2009, J MOTOR BEHAV, V41, P445, DOI 10.3200/35-08-061; Raab, 2009, PERSPECTIVES COGNITI, P157; Ramenzoni VC, 2011, EXP BRAIN RES, V211, P447, DOI 10.1007/s00221-011-2653-8; Rand MK, 2007, EXP BRAIN RES, V181, P447, DOI 10.1007/s00221-007-0945-9; Richardson MJ, 2007, HUM MOVEMENT SCI, V26, P867, DOI 10.1016/j.humov.2007.07.002; Riley MA, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00038; Schmidt R, 2010, INT J SPORT PSYCHOL, V41, P105; Schmidt RC, 2011, HUM MOVEMENT SCI, V30, P834, DOI 10.1016/j.humov.2010.05.014; SCHMIDT RC, 1990, J EXP PSYCHOL HUMAN, V16, P227, DOI 10.1037/0096-1523.16.2.227; Schmidt RC, 1997, ECOL PSYCHOL, V9, P189, DOI 10.1207/s15326969eco0903_2; SCHMIDT RC, 1994, ECOL PSYCHOL, V6, P159, DOI 10.1207/s15326969eco0603_1; Schmidt RC, 1999, INT J SPORT PSYCHOL, V30, P558; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Shockley K, 2003, J EXP PSYCHOL HUMAN, V29, P326, DOI 10.1037/0096-1523.29.2.326; Travassos B, 2012, PSYCHOL SPORT EXERC, V13, P216, DOI 10.1016/j.psychsport.2011.11.009; Travassos B, 2011, HUM MOVEMENT SCI, V30, P1245, DOI 10.1016/j.humov.2011.04.003; Vilar L, 2012, SPORTS MED, V42, P1, DOI 10.2165/11596520-000000000-00000; WARREN WH, 1984, J EXP PSYCHOL HUMAN, V10, P683, DOI 10.1037/0096-1523.10.5.683; WARREN WH, 1987, J EXP PSYCHOL HUMAN, V13, P371, DOI 10.1037/0096-1523.13.3.371; Yamamoto Y, 2000, HUM MOVEMENT SCI, V19, P341, DOI 10.1016/S0167-9457(00)00018-X; Yokoyama K, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002181	55	27	27	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51877	10.1371/journal.pone.0051877	http://dx.doi.org/10.1371/journal.pone.0051877			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	060RA	23284799	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500059
J	Park, C; Rubchinsky, LL				Park, Choongseok; Rubchinsky, Leonid L.			Potential Mechanisms for Imperfect Synchronization in Parkinsonian Basal Ganglia	PLOS ONE			English	Article							EXTERNAL GLOBUS-PALLIDUS; SUBTHALAMIC NUCLEUS; PATHOLOGICAL SYNCHRONIZATION; NEURONAL OSCILLATIONS; BETA OSCILLATIONS; DOPAMINE; PATTERNS; DISEASE	Neural activity in the brain of parkinsonian patients is characterized by the intermittently synchronized oscillatory dynamics. This imperfect synchronization, observed in the beta frequency band, is believed to be related to the hypokinetic motor symptoms of the disorder. Our study explores potential mechanisms behind this intermittent synchrony. We study the response of a bursting pallidal neuron to different patterns of synaptic input from subthalamic nucleus (STN) neuron. We show how external globus pallidus (GPe) neuron is sensitive to the phase of the input from the STN cell and can exhibit intermittent phase-locking with the input in the beta band. The temporal properties of this intermittent phase-locking show similarities to the intermittent synchronization observed in experiments. We also study the synchronization of GPe cells to synaptic input from the STN cell with dependence on the dopamine-modulated parameters. Earlier studies showed how the strengthening of dopamine-modulated coupling may lead to transitions from non-synchronized to partially synchronized dynamics, typical in Parkinson's disease. However, dopamine also affects the cellular properties of neurons. We show how the changes in firing patterns of STN neuron due to the lack of dopamine may lead to transition from a lower to a higher coherent state, roughly matching the synchrony levels observed in basal ganglia in normal and parkinsonian states. The intermittent nature of the neural beta band synchrony in Parkinson's disease is achieved in the model due to the interplay of the timing of STN input to pallidum and pallidal neuronal dynamics, resulting in sensitivity of pallidal output to the phase of the arriving STN input. Thus the mechanism considered here (the change in firing pattern of subthalamic neurons through the dopamine-induced change of membrane properties) may be one of the potential mechanisms responsible for the generation of the intermittent synchronization observed in Parkinson's disease.	[Park, Choongseok; Rubchinsky, Leonid L.] Indiana Univ Purdue Univ Indianapolis, Dept Math Sci, Indianapolis, IN USA; [Park, Choongseok; Rubchinsky, Leonid L.] Indiana Univ Purdue Univ Indianapolis, Ctr Math Biosci, Indianapolis, IN USA; [Rubchinsky, Leonid L.] Indiana Univ, Sch Med, Stark Neurosci Res Inst, Indianapolis, IN USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Park, C (corresponding author), Univ Pittsburgh, Dept Math, Pittsburgh, PA 15260 USA.	21cspark@gmail.com	Rubchinsky, Leonid/L-1896-2017	Rubchinsky, Leonid/0000-0002-6596-4594	National Institutes of Health [R01NS067200]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by National Institutes of Health grant R01NS067200 (NSF/NIH CRCNS program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016201; Baufreton J, 2005, FASEB J, V19, P1771, DOI 10.1096/fj.04-3401hyp; Baufreton J, 2003, J NEUROSCI, V23, P816; Best J, 2007, J COMPUT NEUROSCI, V23, P217, DOI 10.1007/s10827-007-0029-7; Bevan MD, 2002, TRENDS NEUROSCI, V25, P525, DOI 10.1016/S0166-2236(02)02235-X; Bezard E, 2003, FASEB J, V17, P2337, DOI 10.1096/fj.03-0291fje; Brown P, 2007, CURR OPIN NEUROBIOL, V17, P656, DOI 10.1016/j.conb.2007.12.001; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cragg SJ, 2004, EUR J NEUROSCI, V20, P1788, DOI 10.1111/j.1460-9568.2004.03629.x; Eusebio A, 2009, EXP NEUROL, V217, P1, DOI 10.1016/j.expneurol.2009.02.003; Hammond C, 2007, TRENDS NEUROSCI, V30, P357, DOI 10.1016/j.tins.2007.05.004; Hegger R, 1999, CHAOS, V9, P413, DOI 10.1063/1.166424; Hurtado JA, 2005, J NEUROPHYSIOL, V93, P1569, DOI 10.1152/jn.00829.2004; Hurtado JM, 2004, J NEUROPHYSIOL, V91, P1883, DOI 10.1152/jn.00853.2003; Hutchison WD, 2004, J NEUROSCI, V24, P9240, DOI 10.1523/JNEUROSCI.3366-04.2004; Kuhn AA, 2009, EXP NEUROL, V215, P380, DOI 10.1016/j.expneurol.2008.11.008; Loucif AJC, 2008, NEUROPHARMACOLOGY, V55, P94, DOI 10.1016/j.neuropharm.2008.04.025; Mallet N, 2008, J NEUROSCI, V28, P14245, DOI 10.1523/JNEUROSCI.4199-08.2008; Maran SK, 2011, J COMPUT NEUROSCI; Park C, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.042901; Park C, 2010, J NEUROPHYSIOL, V103, P2707, DOI 10.1152/jn.00724.2009; Park G, 2012, INTERMITTEN IN PRESS; Schnitzler A, 2005, NAT REV NEUROSCI, V6, P285, DOI 10.1038/nrn1650; Terman D, 2002, J NEUROSCI, V22, P2963, DOI 10.1523/JNEUROSCI.22-07-02963.2002; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020	26	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51530	10.1371/journal.pone.0051530	http://dx.doi.org/10.1371/journal.pone.0051530			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284707	Green Published, Green Submitted, gold			2022-12-27	WOS:000312694300029
J	Sreeramareddy, CT; Sathyanarayana, TN; Kumar, HNH				Sreeramareddy, Chandrashekhar T.; Sathyanarayana, T. N.; Kumar, H. N. Harsha			Utilization of Health Care Services for Childhood Morbidity and Associated Factors in India: A National Cross-Sectional Household Survey	PLOS ONE			English	Article							SEEKING BEHAVIOR; DEVELOPING-COUNTRIES; RESPIRATORY ILLNESS; CHILDREN; DIARRHEA; MORTALITY; POOR; DETERMINANTS; GUATEMALA; STRATEGY	Background: Information about utilization of health services and associated factors are useful for improving service delivery to achieve universal health coverage. Methods: Data on a sample of ever-married women from India Demographic and Health survey 2005-06 was used. Mothers of children aged 0-59 months were asked about child's illnesses and type of health facilities where treatment was given during 15 days prior to the survey date. Type of health facilities were grouped as informal provider, public provider and private provider. Factors associated with utilization of health services for diarrhea and fever/cough was assessed according to Andersen's health behavior model. Multinomial logistic regression analyses were done considering sampling weights for complex sampling design. Results: A total of 48,679 of ever-married women reported that 9.1% 14.8% and 17.67% of their children had diarrhea, fever and cough respectively. Nearly one-third of the children with diarrhea and fever/cough did not receive any treatment. Two-thirds of children who received treatment were from private health care providers (HCPs). Among predisposing factors, children aged 1-2 years and those born at health facility (public/private) were more likely to be taken to any type of HCP during illness. Among enabling factors, as compared to poorer household, wealthier households were 2.5 times more likely to choose private HCPs for any illness. Children in rural areas were likely to be taken to any type of HCP for diarrhea but rural children were less likely to utilize private HCP for fever/cough. 'Need' factors i.e. children having severe symptoms were 2-3 times more likely to be taken to any type of HCP. Conclusion: Private HCPs were preferred for treatment of childhood illnesses. Involvement of private HCPs may be considered while planning child health programs. Health insurance scheme for childhood illnesses may to protect economically weaker sections from out-of-pocket health expenditure during child illness.	[Sreeramareddy, Chandrashekhar T.] Univ Tunku Abdul Rahman, Fac Med & Hlth Sci, Dept Clin Sci, Sungai Long, Malaysia; [Sathyanarayana, T. N.] Publ Hlth Fdn India, Indian Inst Publ Hlth, Bangalore, Karnataka, India; [Kumar, H. N. Harsha] Kasturba Med Coll & Hosp, Dept Community Med, Mangalore, India	Public Health Foundation of India; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Mangalore	Sreeramareddy, CT (corresponding author), Univ Tunku Abdul Rahman, Fac Med & Hlth Sci, Dept Clin Sci, Sungai Long, Malaysia.	chandrashekharats@yahoo.com	CT, Sreeramareddy/I-1203-2019; Sreeramareddy, Chandrashekhar/C-5433-2014	CT, Sreeramareddy/0000-0002-5693-7631; Sreeramareddy, Chandrashekhar/0000-0002-5693-7631				ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Aremu O, 2011, ITAL J PEDIATR, V37, DOI 10.1186/1824-7288-37-13; Bhutta ZA, 2006, BMJ-BRIT MED J, V333, P612, DOI 10.1136/bmj.38975.602836.BE; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Bryce J, 2006, LANCET, V368, P817, DOI 10.1016/S0140-6736(06)69299-4; Central Bureau of Health Intelligence, 2012, HLTH INF IND; de Silva MWA, 2001, SOC SCI MED, V53, P1363, DOI 10.1016/S0277-9536(00)00425-1; Deogaonkar M, 2004, ELECT J SOCIOLOGY; Forsberg BC, 2007, B WORLD HEALTH ORGAN, V85, P42, DOI 10.2471/BLT.06.030866; FOSU GB, 1994, SOC SCI MED, V38, P1209, DOI 10.1016/0277-9536(94)90186-4; Ghosh R, 2012, WORLD J PEDIATR, V8, P11, DOI 10.1007/s12519-012-0331-y; Goldman N, 2000, TROP MED INT HEALTH, V5, P145, DOI 10.1046/j.1365-3156.2000.00527.x; Goldman N, 2002, SOC SCI MED, V55, P1693, DOI 10.1016/S0277-9536(01)00260-X; Government of India, 2012, NAT HLTH ACC 2004 05, P2004; Herman E, 1994, Int J Health Plann Manage, V9, P235, DOI 10.1002/hpm.4740090304; Hill Z, 2003, TROP MED INT HEALTH, V8, P668, DOI 10.1046/j.1365-3156.2003.01058.x; Horton R, 2006, LANCET, V368, P1041, DOI 10.1016/S0140-6736(06)69331-8; International Institute for Population Sciences MI, 2005, NAT FAM HLTH SURV NF; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Keusch GT, 2006, DIARRHEAL DIS; KHALLAF N, 1991, LANCET, V338, P248, DOI 10.1016/0140-6736(91)90380-8; Makinen M, 2000, B WORLD HEALTH ORGAN, V78, P55; Ministry of Health and Family Welfare, 2000, NAT POP POL 2000; Ministry of Health and Family Welfare, 2012, REP NAT COMM MACR HL; Moisi JC, 2011, B WORLD HEALTH ORGAN, V89, P102, DOI 10.2471/BLT.10.080796; Murray CJL, 2007, LANCET, V370, P1040, DOI 10.1016/S0140-6736(07)61478-0; Nuruddin R, 2009, J PUBLIC HEALTH-UK, V31, P389, DOI 10.1093/pubmed/fdp038; Office of Registrar General ISRSS, 2011, MAT CHILD MORT TOT F; Pillai R, 2003, SOC SCI MED, V57, P783, DOI 10.1016/S0277-9536(02)00448-3; Pokhrel S, 2005, HEALTH POLICY, V74, P100, DOI 10.1016/j.healthpol.2004.12.013; Ramiji S, 2006, INDIAN PEDIATR, V43, P1029; Rudan I, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001099; Selvaraj SKA, 2012, EC POLIT WKLY, VXLIV, P55; Shahrawat R, 2012, HEALTH POLICY PLANN, V27, P213, DOI 10.1093/heapol/czr029; Sreeramareddy Chandrashekhar T, 2006, BMC Int Health Hum Rights, V6, P7, DOI 10.1186/1472-698X-6-7; Srivastava NM, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-61; Thind A, 2005, J BIOSOC SCI, V37, P129, DOI 10.1017/S002193200300645X; Thind A, 2004, J TROP PEDIATRICS, V50, P137, DOI 10.1093/tropej/50.3.137; Thind A, 2003, J TROP PEDIATRICS, V49, P269, DOI 10.1093/tropej/49.5.269; Thind A, 2003, SOC SCI MED, V56, P1173, DOI 10.1016/S0277-9536(02)00116-8; Tinuade O, 2010, J PAEDIATR CHILD H, V46, P238, DOI 10.1111/j.1440-1754.2009.01677.x; United Nations Children's Fund, 2012, LEV TRENDS CHILD MOR; Uzochukwu BSC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001788; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; World Health Organisation, 2012, COUNS MOTH MAN CHILD; World Health Organization, 2012, TECHN BAS WHO REC MA; YODER PS, 1994, J TROP MED HYG, V97, P1; Zaidi S Shujaat H, 2006, J Coll Physicians Surg Pak, V16, P245	49	32	32	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51904	10.1371/journal.pone.0051904	http://dx.doi.org/10.1371/journal.pone.0051904			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	059HF	23284810	Green Published, gold, Green Submitted			2022-12-27	WOS:000312694300054
J	Takahashi, DY; Sato, JR; Ferreira, CE; Fujita, A				Takahashi, Daniel Yasumasa; Sato, Joao Ricardo; Ferreira, Carlos Eduardo; Fujita, Andre			Discriminating Different Classes of Biological Networks by Analyzing the Graphs Spectra Distribution	PLOS ONE			English	Article							SCALE-FREE; TOPOLOGY; DYNAMICS; BRAIN	The brain's structural and functional systems, protein-protein interaction, and gene networks are examples of biological systems that share some features of complex networks, such as highly connected nodes, modularity, and small-world topology. Recent studies indicate that some pathologies present topological network alterations relative to norms seen in the general population. Therefore, methods to discriminate the processes that generate the different classes of networks (e. g., normal and disease) might be crucial for the diagnosis, prognosis, and treatment of the disease. It is known that several topological properties of a network (graph) can be described by the distribution of the spectrum of its adjacency matrix. Moreover, large networks generated by the same random process have the same spectrum distribution, allowing us to use it as a "fingerprint". Based on this relationship, we introduce and propose the entropy of a graph spectrum to measure the "uncertainty" of a random graph and the Kullback-Leibler and Jensen-Shannon divergences between graph spectra to compare networks. We also introduce general methods for model selection and network model parameter estimation, as well as a statistical procedure to test the nullity of divergence between two classes of complex networks. Finally, we demonstrate the usefulness of the proposed methods by applying them to (1) protein-protein interaction networks of different species and (2) on networks derived from children diagnosed with Attention Deficit Hyperactivity Disorder (ADHD) and typically developing children. We conclude that scale-free networks best describe all the protein-protein interactions. Also, we show that our proposed measures succeeded in the identification of topological changes in the network while other commonly used measures (number of edges, clustering coefficient, average path length) failed.	[Ferreira, Carlos Eduardo; Fujita, Andre] Univ Sao Paulo, Dept Comp Sci, Inst Math & Stat, Santo Andre, SP, Brazil; [Takahashi, Daniel Yasumasa] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Takahashi, Daniel Yasumasa] Princeton Univ, Inst Neurosci, Princeton, NJ 08544 USA; [Sato, Joao Ricardo] Fed Univ ABC, Ctr Math Computat & Cognit, Sao Paulo, Brazil	Universidade de Sao Paulo; Princeton University; Princeton University; Universidade Federal do ABC (UFABC)	Fujita, A (corresponding author), Univ Sao Paulo, Dept Comp Sci, Inst Math & Stat, Santo Andre, SP, Brazil.	fujita@ime.usp.br	Fujita, Andre/Q-1271-2019; Ferreira, Carlos/A-1156-2010	Fujita, Andre/0000-0002-7756-7051; Sato, Joao Ricardo/0000-0002-7503-9781; Ferreira, Carlos/0000-0003-4804-5788	FAPESP [11/07762-8, 10/01394-4]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [302736/2010-7]; Pew Latin American Fellowship	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Pew Latin American Fellowship	AF and JRS were partially supported by FAPESP grants 11/07762-8 and 10/01394-4, respectively. CEF was partially supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico grant 302736/2010-7 and DYT was partially supported by Pew Latin American Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No other current external funding sources for this study.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bollobas B, 2004, COMBINATORICA, V24, P5, DOI 10.1007/s00493-004-0002-2; COVER T. M., 2012, ELEMENTS INFORM THEO, DOI 10.1002/0471200611; Dorogovtsev SN, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.046109; Efron B, 1993, INTRO BOOTSTRAP, DOI [DOI 10.1007/978-1-4899-4541-9, 10.1007/978-1-4899-4541-9]; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Guimera R, 2009, P NATL ACAD SCI USA, V106, P22073, DOI 10.1073/pnas.0908366106; Han JDJ, 2005, NAT BIOTECHNOL, V23, P839, DOI 10.1038/nbt1116; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Huberman BA, 1999, NATURE, V401, P131, DOI 10.1038/43604; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Khanin R, 2006, J COMPUT BIOL, V13, P810, DOI 10.1089/cmb.2006.13.810; Lima-Mendez G, 2009, MOL BIOSYST, V5, P1482; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mieghem P. V., 2011, GRAPH SPECTRA COMPLE; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Nadaraya E.A., 1964, THEOR PROBAB APPL+, V9, P141, DOI [10.1137/1110024, DOI 10.1137/1109020]; Newman MEJ, 1999, PHYS LETT A, V263, P341, DOI 10.1016/S0375-9601(99)00757-4; R Core Team, 2021, R LANGUAGE ENV STAT; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Sain SR, 1996, J AM STAT ASSOC, V91, P1525, DOI 10.2307/2291578; Singh I, 2008, NAT REV NEUROSCI, V9, P957, DOI 10.1038/nrn2514; Sturges HA, 1926, J AM STAT ASSOC, V21, P65, DOI 10.1080/01621459.1926.10502161; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Whittle P., 1953, ARK F R MATEMATIK, V2, P423, DOI [https://doi.org/10.1007/BF02590998, DOI 10.1007/BF02590998]; WIGNER EP, 1958, ANN MATH, V67, P325, DOI 10.2307/1970008	34	28	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e49949	10.1371/journal.pone.0049949	http://dx.doi.org/10.1371/journal.pone.0049949			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284629	gold, Green Published, Green Submitted			2022-12-27	WOS:000312694300009
J	Sotton, B; Guillard, J; Bony, S; Devaux, A; Domaizon, I; Givaudan, N; Crespeau, F; Huet, H; Anneville, O				Sotton, Benoit; Guillard, Jean; Bony, Sylvie; Devaux, Alain; Domaizon, Isabelle; Givaudan, Nicolas; Crespeau, Francois; Huet, Helene; Anneville, Orlane			Impact of Toxic Cyanobacterial Blooms on Eurasian Perch (Perca fluviatilis): Experimental Study and In Situ Observations in a Peri-Alpine Lake	PLOS ONE			English	Article							PLANKTOTHRIX-RUBESCENS; MICROCYSTIN-LR; BIOCHEMICAL-CHARACTERIZATION; MOLECULAR-MECHANISMS; SUBCHRONIC EXPOSURE; OXIDATIVE STRESS; PEPTIDE TOXIN; COMET ASSAY; FISH; WHITEFISH	Due to the importance of young-of-the-year (YOY) perch in the peri-alpine regions where they are consumed, the microcystin (MC) contamination of YOY perch was analysed both in field (Lake Bourget, France) and experimentally using force-feeding protocols with pure MCs. In-situ, schools of YOY perch present in the epilimnion of the lake were never found in direct contact with the P. rubescens blooms that were present in the metalimnion. However, MCs were detected in the muscles and liver of the fish and were thus assumed to reach YOY perch through dietary routes, particularly via the consumption of MC-containing Daphnia. Force-feeding experiment demonstrates the existence of MC detoxification/excretion processes and suggests that in situ, YOY perch could partly detoxify and excrete ingested MCs, thereby limiting the potential negative effects on perch populations under bloom conditions. However, because of chronic exposure these processes could not allow for the complete elimination of MCs. In both experimental and in situ studies, no histological change was observed in YOY perch, indicating that MC concentrations that occurred in Lake Bourget in 2009 were too low to cause histological damage prone to induce mortality. However, Deoxyribonucleic acid (DNA) damages were observed for both the high and low experimental MC doses, suggesting that similar effects could occur in situ and potentially result in perch population disturbance during cyanobacterial blooms. Our results indicate the presence of MCs in wild perch, the consumption of this species coming from Lake Bourget is not contested but more analyses are needed to quantify the risk.	[Sotton, Benoit; Guillard, Jean; Domaizon, Isabelle; Givaudan, Nicolas; Anneville, Orlane] INRA, UMR CARRTEL, Thonon Les Bains, France; [Bony, Sylvie; Devaux, Alain] Univ Lyon, LEHNA, UMR 5023, ENTPE, Vaulx En Velin, France; [Givaudan, Nicolas] Univ Rennes 1, UMR CNRS Ecobio 6553, Rennes, France; [Crespeau, Francois; Huet, Helene] Ecole Natl Vet, Anat Pathol Lab, F-94704 Maisons Alfort, France; [Bony, Sylvie; Devaux, Alain] INRA, USC IGH, ENTPE, Vaulx En Velin, France	INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE	Sotton, B (corresponding author), INRA, UMR CARRTEL, Thonon Les Bains, France.	benoit.sotton@thonon.inra.fr	GUILLARD, Jean/A-2577-2011; Domaizon, Isabelle/A-2517-2011; Guillard, Jean/AAP-9870-2020	GUILLARD, Jean/0000-0003-0116-1167; Domaizon, Isabelle/0000-0001-9785-3082; Guillard, Jean/0000-0003-0116-1167; HUET, Helene/0000-0003-1910-5825	Rhone-Alpes region; ONEMA (Office National de l'Eau et des Milieux Aquatiques); department "Ecologie des forets, Prairies et milieux Aquatiques'' (EFPA) of the "Institut National de la Recherche agronomique'' (INRA)	Rhone-Alpes region(Region Auvergne-Rhone-Alpes); ONEMA (Office National de l'Eau et des Milieux Aquatiques); department "Ecologie des forets, Prairies et milieux Aquatiques'' (EFPA) of the "Institut National de la Recherche agronomique'' (INRA)	B.S.'s PhD is a CIBLE project funded by the Rhone-Alpes region. N.G.'s CDD and experiments were financed by ONEMA (Office National de l'Eau et des Milieux Aquatiques). The in-situ sampling and data analyses were part of "Projet innovant'' funded by the department "Ecologie des forets, Prairies et milieux Aquatiques'' (EFPA) of the "Institut National de la Recherche agronomique'' (INRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anneville O, 2004, FRESHWATER BIOL, V49, P98, DOI 10.1046/j.1365-2426.2003.01167.x; Azevedo SMFO, 2002, TOXICOLOGY, V181, P441, DOI 10.1016/S0300-483X(02)00491-2; Baganz D, 2004, ENVIRON TOXICOL, V19, P564, DOI 10.1002/tox.20063; BOYSE E A, 1964, Methods Med Res, V10, P39; Brancroft JD, 2008, THEORY PRACTICE HIST; Briand JF, 2005, MICROB ECOL, V50, P418, DOI 10.1007/s00248-005-0186-z; Campos A, 2010, INT J MOL SCI, V11, P268, DOI 10.3390/ijms11010268; Carbis CR, 1996, J FISH DIS, V19, P199, DOI 10.1111/j.1365-2761.1996.tb00126.x; CARMICHAEL WW, 1992, J APPL BACTERIOL, V72, P445, DOI 10.1111/j.1365-2672.1992.tb01858.x; Codd GA, 2005, TOXICOL APPL PHARM, V203, P264, DOI 10.1016/j.taap.2004.02.016; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; Craig M, 1996, BIOCHEM CELL BIOL, V74, P569, DOI 10.1139/o96-061; Cuypers Y, 2011, ISME J, V5, P580, DOI 10.1038/ismej.2010.154; D'Alelio D, 2011, FRESHWATER BIOL, V56, P1481, DOI 10.1111/j.1365-2427.2011.02584.x; David J, 1967, B FR PISCIC, V224, P81, DOI DOI 10.1051/KMAE:1967009; Dawson RM, 1998, TOXICON, V36, P953, DOI 10.1016/S0041-0101(97)00102-5; Ernst B, 2005, ENVIRON TOXICOL, V20, P449, DOI 10.1002/tox.20131; Ernst B, 2001, ENVIRON TOXICOL, V16, P483, DOI 10.1002/tox.10006.abs; Ernst B, 2007, AQUAT TOXICOL, V82, P15, DOI 10.1016/j.aquatox.2007.01.007; Ernst B, 2006, AQUAT TOXICOL, V79, P31, DOI 10.1016/j.aquatox.2006.04.013; FAIRBAIRN DW, 1995, MUTAT RES-REV GENET, V339, P37, DOI 10.1016/0165-1110(94)00013-3; Feuillade J., 1994, ARCH HYDROBIOL, V41, P77; Fischer WJ, 2000, TOXICOL APPL PHARM, V164, P73, DOI 10.1006/taap.1999.8861; Gkelis S, 2006, AQUAT TOXICOL, V78, P32, DOI 10.1016/j.aquatox.2006.02.001; Guillard J, 2006, FISHERIES MANAG ECOL, V13, P319, DOI 10.1111/j.1365-2400.2006.00508.x; Guillard J, 2011, LIMNOL OCEANOGR-METH, V9, P322, DOI 10.4319/lom.2011.9.322; Hays GC, 2003, HYDROBIOLOGIA, V503, P163, DOI 10.1023/B:HYDR.0000008476.23617.b0; Ibelings BW, 2005, MICROB ECOL, V49, P487, DOI 10.1007/s00248-004-0014-x; Jacquet S, 2005, HARMFUL ALGAE, V4, P651, DOI 10.1016/j.hal.2003.12.006; Jann-Para G, 2004, TOXICON, V43, P279, DOI 10.1016/j.toxicon.2003.12.005; Jos A, 2005, AQUAT TOXICOL, V72, P261, DOI 10.1016/j.aquatox.2005.01.003; KARAS P, 1992, J FISH BIOL, V41, P217, DOI 10.1111/j.1095-8649.1992.tb02652.x; Leboulanger C, 2002, AQUAT MICROB ECOL, V30, P83, DOI 10.3354/ame030083; Li XY, 2003, TOXICON, V42, P85, DOI 10.1016/S0041-0101(03)00104-1; MACKINTOSH RW, 1995, FEBS LETT, V371, P236, DOI 10.1016/0014-5793(95)00888-G; Malbrouck C, 2003, COMP BIOCHEM PHYS C, V135, P39, DOI 10.1016/S1532-0456(03)00047-4; Malbrouck C, 2006, ENVIRON TOXICOL CHEM, V25, P72, DOI 10.1897/05-029R.1; Mankiewicz-Boczek J, 2011, HARMFUL ALGAE, V10, P356, DOI 10.1016/j.hal.2011.01.001; Masson S, 2001, J PLANKTON RES, V23, P1041, DOI 10.1093/plankt/23.10.1041; McElhiney J, 2005, TOXICOL APPL PHARM, V203, P219, DOI 10.1016/j.taap.2004.06.002; Metcalf JS, 2000, FEMS MICROBIOL LETT, V189, P155, DOI 10.1111/j.1574-6968.2000.tb09222.x; Neffling MR, 2010, ENVIRON POLLUT, V158, P948, DOI 10.1016/j.envpol.2009.10.023; Oberhaus L, 2007, J PHYCOL, V43, P1191, DOI 10.1111/j.1529-8817.2007.00414.x; OLIVE PL, 1993, RADIAT RES, V136, P130, DOI 10.2307/3578650; Paulino S, 2009, HYDROBIOLOGIA, V621, P207, DOI 10.1007/s10750-008-9640-5; Prieto AI, 2006, AQUAT TOXICOL, V77, P314, DOI 10.1016/j.aquatox.2005.12.012; Probst WN, 2009, FISH RES, V96, P133, DOI 10.1016/j.fishres.2008.10.009; RABERGH CMI, 1991, AQUAT TOXICOL, V20, P131, DOI 10.1016/0166-445X(91)90012-X; Repka S, 1997, FRESHWATER BIOL, V38, P675, DOI 10.1046/j.1365-2427.1997.00236.x; Sahin A, 1996, TOXICOLOGY, V106, P123, DOI 10.1016/0300-483X(95)03173-D; Simmonds J., 2005, FISHERIES ACOUSTICS; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Smith JL, 2010, ECOTOX ENVIRON SAFE, V73, P757, DOI 10.1016/j.ecoenv.2009.12.003; Smith JL, 2009, TOXICON, V53, P238, DOI 10.1016/j.toxicon.2008.11.007; Sotton B, 2012, ECOTOXICOLOGY, V21, P1788, DOI 10.1007/s10646-012-0913-4; Sotton B, 2011, HARMFUL ALGAE, V10, P749, DOI 10.1016/j.hal.2011.06.006; STRASKRABA M, 1964, LIMNOL OCEANOGR, V9, P268, DOI 10.4319/lo.1964.9.2.0268; Tencalla F, 1997, TOXICON, V35, P583, DOI 10.1016/S0041-0101(96)00153-5; TENCALLA FG, 1994, AQUAT TOXICOL, V30, P215, DOI 10.1016/0166-445X(94)90059-0; Trinchet I, 2011, REPROD TOXICOL, V32, P329, DOI 10.1016/j.reprotox.2011.07.006; van der Oost R, 2003, ENVIRON TOXICOL PHAR, V13, P57, DOI 10.1016/S1382-6689(02)00126-6; Walsby AE, 2006, NEW PHYTOL, V169, P109, DOI 10.1111/j.1469-8137.2005.01567.x; WANG N, 1994, HYDROBIOLOGIA, V277, P135, DOI 10.1007/BF00007295; Welker M, 2006, FEMS MICROBIOL REV, V30, P530, DOI 10.1111/j.1574-6976.2006.00022.x; Williams DE, 1997, TOXICON, V35, P985, DOI 10.1016/S0041-0101(96)00196-1; Williams DE, 1997, CHEM RES TOXICOL, V10, P463, DOI 10.1021/tx9601519; Wilson AE, 2008, CAN J FISH AQUAT SCI, V65, P1487, DOI 10.1139/F08-067; Zhang DW, 2012, ECOTOXICOLOGY, V21, P244, DOI 10.1007/s10646-011-0783-1; Zhang DW, 2009, SCI TOTAL ENVIRON, V407, P2191, DOI 10.1016/j.scitotenv.2008.12.039	70	11	11	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52243	10.1371/journal.pone.0052243	http://dx.doi.org/10.1371/journal.pone.0052243			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272228	Green Submitted, Green Published, gold			2022-12-27	WOS:000312483300071
J	Chao, HH; He, XP; Parker, JS; Zhao, W; Perou, CM				Chao, Hann-Hsiang; He, Xiaping; Parker, Joel S.; Zhao, Wei; Perou, Charles M.			Micro-Scale Genomic DNA Copy Number Aberrations as Another Means of Mutagenesis in Breast Cancer	PLOS ONE			English	Article							GENE-EXPRESSION PATTERNS; MAMMARY EPITHELIAL-CELLS; ONCOGENE AMPLIFICATION; MOLECULAR PORTRAITS; TUMOR-SUPPRESSOR; BASAL-LIKE; INSTABILITY; MUTATIONS; SUBTYPES; BRCA1	Introduction: In breast cancer, the basal-like subtype has high levels of genomic instability relative to other breast cancer subtypes with many basal-like-specific regions of aberration. There is evidence that this genomic instability extends to smaller scale genomic aberrations, as shown by a previously described micro-deletion event in the PTEN gene in the Basal-like SUM149 breast cancer cell line. Methods: We sought to identify if small regions of genomic DNA copy number changes exist by using a high density, gene-centric Comparative Genomic Hybridizations (CGH) array on cell lines and primary tumors. A custom tiling array for CGH (244,000 probes, 200 bp tiling resolution) was created to identify small regions of genomic change, which was focused on previously identified basal-like-specific, and general cancer genes. Tumor genomic DNA from 94 patients and 2 breast cancer cell lines was labeled and hybridized to these arrays. Aberrations were called using SWITCHdna and the smallest 25% of SWITCHdna-defined genomic segments were called micro-aberrations (<64 contiguous probes, similar to 15 kb). Results: Our data showed that primary tumor breast cancer genomes frequently contained many small-scale copy number gains and losses, termed micro-aberrations, most of which are undetectable using typical-density genome-wide aCGH arrays. The basal-like subtype exhibited the highest incidence of these events. These micro-aberrations sometimes altered expression of the involved gene. We confirmed the presence of the PTEN micro-amplification in SUM149 and by mRNA-seq showed that this resulted in loss of expression of all exons downstream of this event. Micro-aberrations disproportionately affected the 59 regions of the affected genes, including the promoter region, and high frequency of micro-aberrations was associated with poor survival. Conclusion: Using a high-probe-density, gene-centric aCGH microarray, we present evidence of small-scale genomic aberrations that can contribute to gene inactivation. These events may contribute to tumor formation through mechanisms not detected using conventional DNA copy number analyses.	[Chao, Hann-Hsiang; He, Xiaping; Parker, Joel S.; Zhao, Wei; Perou, Charles M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Chao, Hann-Hsiang] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC USA; [He, Xiaping; Parker, Joel S.; Perou, Charles M.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Zhao, Wei] Univ N Carolina, Curriculum Bioinformat & Computat Biol, Chapel Hill, NC USA; [Perou, Charles M.] Univ N Carolina, Carolina Genome Sci Ctr, Chapel Hill, NC USA; [Perou, Charles M.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Perou, CM (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	cperou@med.unc.edu	Parker, Joel/AAG-1108-2019; Perou, Charles M/H-9934-2014	Perou, Charles M/0000-0001-9827-2247	National Cancer Insitute Breast SPORE program [P50-CA58223-09A1]; Breast Cancer Research Foundation;  [RO1-CA138255];  [RO1-CA148761];  [T32-GM008719];  [F30-ES018038]; NATIONAL CANCER INSTITUTE [P30CA016086, R01CA148761, R01CA138255, P50CA058223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126, F30ES018038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008719] Funding Source: NIH RePORTER	National Cancer Insitute Breast SPORE program; Breast Cancer Research Foundation; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funds from the National Cancer Insitute Breast SPORE program (P50-CA58223-09A1), by RO1-CA138255, RO1-CA148761, T32-GM008719, F30-ES018038, and by the Breast Cancer Research Foundation (http://www.bcrfcure.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajay SS, 2011, GENOME RES, V21, P1498, DOI 10.1101/gr.123638.111; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Benito M, 2004, BIOINFORMATICS, V20, P105, DOI 10.1093/bioinformatics/btg385; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; ETHIER SP, 1993, CANCER RES, V53, P627; Fedele CG, 2010, P NATL ACAD SCI US; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hatakeyama H, 2009, J CLIN ONCOL, V27; Herschkowitz JI, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2142; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Jarvinen AK, 2008, GENE CHROMOSOME CANC, V47, P500, DOI 10.1002/gcc.20551; Jiang Z, 2010, J CLIN INVEST; Johannsdottir HK, 2006, INT J CANCER, V119, P1052, DOI 10.1002/ijc.21934; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kristensen GB, 2003, ANN ONCOL, V14, P1494, DOI 10.1093/annonc/mdg403; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pinkel D, 2005, NAT GENET, V37, pS11, DOI 10.1038/ng1569; R Core Team, 2020, R LANG ENV STAT COMP; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Russnes HG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000611; Saal LH, 2008, NAT GENET, V40, P102, DOI 10.1038/ng.2007.39; Sakakura C, 1999, GENE CHROMOSOME CANC, V24, P299, DOI 10.1002/(SICI)1098-2264(199904)24:4<299::AID-GCC2>3.0.CO;2-U; SESHADRI R, 1993, J CLIN ONCOL, V11, P1936, DOI 10.1200/JCO.1993.11.10.1936; SESHADRI R, 1989, INT J CANCER, V43, P270, DOI 10.1002/ijc.2910430218; Shen ZY, 2011, J MOL CELL BIOL, V3, P1, DOI 10.1093/jmcb/mjq057; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tran LM, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-121; Trope C, 2000, ANN ONCOL, V11, P281, DOI 10.1023/A:1008399414923; Van Loo P, 2010, P NATL ACAD SCI US; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Weigman VJ, 2012, BREAST CANC RES TREA; Wood LD, 2007, SCIENCE; Xing F, 2012, ONCOGENE, V31, P446, DOI 10.1038/onc.2011.250	43	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51719	10.1371/journal.pone.0051719	http://dx.doi.org/10.1371/journal.pone.0051719			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284754	Green Published, gold, Green Submitted			2022-12-27	WOS:000312435900050
J	Distler, MG; Opal, MD; Dulawa, SC; Palmer, AA				Distler, Margaret G.; Opal, Mark D.; Dulawa, Stephanie C.; Palmer, Abraham A.			Assessment of Behaviors Modeling Aspects of Schizophrenia in Csmd1 Mutant Mice	PLOS ONE			English	Article							STARCH SYNTHESIS; ANTISENSE REPRESSION; POTATO PLANTS; PHOSPHOGLUCOMUTASE; CARBON; YIELD	Schizophrenia is a debilitating psychotic disorder that affects up to 1.5% of the population worldwide. Two recent studies in humans identified genome-wide significant associations between schizophrenia and single-nucleotide polymorphisms (SNPs) in an intron of CSMD1. The effect of deleting CSMD1 on mouse behavior is unknown. The present study utilized mice with a mutant Csmd1 allele in which the first exon had been ablated (KO mice). All Csmd1 transcripts that included the first exon were absent in the brains of KO mice, but there was persistent expression of at least one other transcript that does not include the first exon. Wild type (WT), heterozygous (HET), and KO mice were assessed using several well-established behavioral paradigms that model aspects of schizophrenia. Csmd1 KO mice did not differ from wild-type littermates for sensorimotor gating (measured as prepulse inhibition), social interaction, anhedonia (measured by sucrose preference), or sensitivity to the locomotor stimulant effects of the dopaminergic agent d-amphetamine. These data demonstrate that loss of Csmd1 transcripts that include the first exon does not alter multiple well-established behaviors that model aspects of schizophrenia. The SNP most strongly associated with schizophrenia in humans is between exons 3 and 4; therefore, ablation of exon 1 appeared to be a logical animal model. Nevertheless, future studies should consider alternative mouse models including gain-of-function mutations, and loss-of-function mutations that target alternative transcripts of Csmd1.	[Dulawa, Stephanie C.; Palmer, Abraham A.] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA; [Distler, Margaret G.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Opal, Mark D.] Univ Chicago, Comm Neurobiol, Chicago, IL 60637 USA; [Palmer, Abraham A.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago	Palmer, AA (corresponding author), Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA.	aap@uchicago.edu	Palmer, Abraham/L-2158-2014; Dulawa, Stephanie/M-8070-2016	Palmer, Abraham/0000-0003-3634-0747; Dulawa, Stephanie/0000-0003-1281-782X	NIH [GM07281, GM07839, MH079424, MH079103, DA021336]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007281, T32GM007839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079424, R01MH079103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021336] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants GM07281 (M. G. D.), GM07839 (M.D.O.), MH079424 (S. C. D.), MH079103 (A. A. P.) and DA021336 (A. A. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fernie AR, 2002, PLANT PHYSIOL BIOCH, V40, P921, DOI 10.1016/S0981-9428(02)01457-2; Fernie AR, 2002, PLANTA, V214, P510, DOI 10.1007/s004250100644; Fettke J, 2010, NEW PHYTOL, V185, P663, DOI 10.1111/j.1469-8137.2009.03126.x; Geigenberger P, 2001, PLANT PHYSIOL, V125, P1667, DOI 10.1104/pp.125.4.1667; James MG, 2003, CURR OPIN PLANT BIOL, V6, P215, DOI 10.1016/S1369-5266(03)00042-6; Jeong JS, 2007, J CHROMATOGR A, V1164, P167, DOI 10.1016/j.chroma.2007.07.007; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Lytovchenko A, 2007, CURR OPIN PLANT BIOL, V10, P227, DOI 10.1016/j.pbi.2007.04.002; Nielsen Kare Lehmann, 2008, V387, P81; Nielsen KL, 2008, NEXT GENERATION SEQU, P229; Regierer B, 2002, NAT BIOTECHNOL, V20, P1256, DOI 10.1038/nbt760; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; STARK DM, 1992, SCIENCE, V258, P287, DOI 10.1126/science.258.5080.287; Streb S, 2009, PLANT PHYSIOL, V151, P1769, DOI 10.1104/pp.109.144931; Sweetlove LJ, 1999, PLANTA, V209, P330, DOI 10.1007/s004250050640; Tauberger E, 2000, PLANT J, V23, P43, DOI 10.1046/j.1365-313x.2000.00783.x; Tjaden J, 1998, PLANT J, V16, P531, DOI 10.1046/j.1365-313X.1998.00317.x; Vreugdenhil Dick, 2007, pV, DOI 10.1016/B978-044451018-1/50040-3; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158	20	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51235	10.1371/journal.pone.0051235	http://dx.doi.org/10.1371/journal.pone.0051235			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284669	gold, Green Published			2022-12-27	WOS:000312435900016
J	Li, QX; Wu, HL; Chen, B; Hu, GY; Huang, L; Qin, K; Chen, Y; Yuan, XL; Liao, ZX				Li, Qianxia; Wu, Huanlei; Chen, Bei; Hu, Guangyuan; Huang, Liu; Qin, Kai; Chen, Yu; Yuan, Xianglin; Liao, Zhongxing			SNPs in the TGF-beta Signaling Pathway Are Associated with Increased Risk of Brain Metastasis in Patients with Non-Small-Cell Lung Cancer	PLOS ONE			English	Article							PROPHYLACTIC CRANIAL IRRADIATION; THERAPY-ONCOLOGY-GROUP; GROWTH-FACTOR-BETA; RADIATION-THERAPY; GENETIC-VARIATIONS; ACTIVIN-A; CARCINOMA; CHEMORADIOTHERAPY; FOLLISTATIN; EXPRESSION	Purpose: Brain metastasis (BM) from non-small cell lung cancer (NSCLC) is relatively common, but identifying which patients will develop brain metastasis has been problematic. We hypothesized that genotype variants in the TGF-beta signaling pathway could be a predictive biomarker of brain metastasis. Patients and Methods: We genotyped 33 SNPs from 13 genes in the TGF-beta signaling pathway and evaluated their associations with brain metastasis risk by using DNA from blood samples from 161 patients with NSCLC. Kaplan-Meier analysis was used to assess brain metastasis risk; Cox hazard analyses were used to evaluate the effects of various patient and disease characteristics on the risk of brain metastasis. Results: The median age of the 116 men and 45 women in the study was 58 years; 62 (39%) had stage IIIB or IV disease. Within 24 months after initial diagnosis of lung cancer, brain metastasis was found in 60 patients (37%). Of these 60 patients, 16 had presented with BM at diagnosis. Multivariate analysis showed the GG genotype of SMAD6: rs12913975 and TT genotype of INHBC: rs4760259 to be associated with a significantly higher risk of brain metastasis at 24 months follow-up (hazard ratio [HR] 2.540, 95% confidence interval [CI] 1.204-5.359, P = 0.014; and HR 1.885, 95% CI 1.086-3.273, P = 0.024), compared with the GA or CT/CC genotypes, respectively. When we analyzed combined subgroups, these rates showed higher for those having both the GG genotype of SMAD6: rs12913975 and the TT genotype of INHBC: rs4760259 (HR 2.353, 95% CI 1.390-3.985, P = 0.001). Conclusions: We found the GG genotype of SMAD6: rs12913975 and TT genotype of INHBC: rs4760259 to be associated with risk of brain metastasis in patients with NSCLC. This finding, if confirmed, can help to identify patients at high risk of brain metastasis.	[Li, Qianxia; Wu, Huanlei; Hu, Guangyuan; Huang, Liu; Qin, Kai; Chen, Yu; Yuan, Xianglin] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Oncol, Wuhan 430074, Hubei Province, Peoples R China; [Liao, Zhongxing] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Chen, Bei] Hubei Prov Tumor Hosp, Dept Electrocardiog Room, Wuhan, Hubei Province, Peoples R China	Huazhong University of Science & Technology; University of Texas System; UTMD Anderson Cancer Center	Yuan, XL (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Dept Oncol, Wuhan 430074, Hubei Province, Peoples R China.	yxl@medmail.com.cn			National Natural Science Foundation [81071832]; Hubei Provincial Health Office [JX5A01]; Wuhan Planning Project of Science and Technology [201161038339-07]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Hubei Provincial Health Office; Wuhan Planning Project of Science and Technology	This study was funded by the National Natural Science Foundation ( grant 81071832), a Key Project of Hubei Provincial Health Office grant (JX5A01), and a Wuhan Planning Project of Science and Technology grant (201161038339-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auperin A, 1999, NEW ENGL J MED, V341, P476, DOI 10.1056/NEJM199908123410703; Ball EMA, 2001, DEV BIOL, V238, P1, DOI 10.1006/dbio.2001.0399; Bovi JA, 2012, CURR ONCOL REP, V14, P55, DOI 10.1007/s11912-011-0208-6; Butler CM, 2005, CYTOKINE GROWTH F R, V16, P377, DOI 10.1016/j.cytogfr.2005.04.005; Ceresoli GL, 2002, CANCER, V95, P605, DOI 10.1002/cncr.10687; Cox JD, 1999, INT J RADIAT ONCOL, V43, P505, DOI 10.1016/S0360-3016(98)00429-5; COX JD, 1981, JAMA-J AM MED ASSOC, V245, P469, DOI 10.1001/jama.245.5.469; de Kretser DM, 2002, HUM REPROD UPDATE, V8, P529, DOI 10.1093/humupd/8.6.529; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Gaspar LE, 2000, INT J RADIAT ONCOL, V47, P1001, DOI 10.1016/S0360-3016(00)00547-2; Gore EM, 2011, J CLIN ONCOL, V29, P272, DOI 10.1200/JCO.2010.29.1609; Grinberg-Rashi H, 2009, CLIN CANCER RES, V15, P1755, DOI 10.1158/1078-0432.CCR-08-2124; Hildebrandt MAT, 2009, J CLIN ONCOL, V27, P857, DOI 10.1200/JCO.2008.17.6297; HULLY JR, 1994, HEPATOLOGY, V20, P854, DOI 10.1002/hep.1840200413; Javelaud D, 2008, PIGM CELL MELANOMA R, V21, P123, DOI 10.1111/j.1755-148X.2008.00450.x; Javelaud D, 2011, CANCER RES, V71, P5606, DOI 10.1158/0008-5472.CAN-11-1194; Jones KL, 2004, MOL CELL ENDOCRINOL, V225, P119, DOI 10.1016/j.mce.2004.07.010; Khuri FR, 2001, CANCER EPIDEM BIOMAR, V10, P823; Le Page C, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-4; Lin MB, 2011, CARCINOGENESIS, V32, P1050, DOI 10.1093/carcin/bgr067; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; McDowell N, 1999, SEMIN CELL DEV BIOL, V10, P311, DOI 10.1006/scdb.1999.0307; Meert AP, 2001, BMC CANCER, V1, DOI 10.1186/1471-2407-1-5; Mellor SL, 2003, ENDOCRINOLOGY, V144, P4410, DOI 10.1210/en.2003-0225; Meulmeester E, 2011, J PATHOL, V223, P205, DOI 10.1002/path.2785; Nathoo N, 2005, J CLIN PATHOL, V58, P237, DOI 10.1136/jcp.2003.013623; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Pui Ching-Hon, 2006, Hematology Am Soc Hematol Educ Program, P142; Robnett TJ, 2001, J CLIN ONCOL, V19, P1344, DOI 10.1200/JCO.2001.19.5.1344; RUSSELL AH, 1991, INT J RADIAT ONCOL, V21, P637, DOI 10.1016/0360-3016(91)90681-S; Slotman B, 2007, NEW ENGL J MED, V357, P664, DOI 10.1056/NEJMoa071780; Subramanian A, 2002, LANCET ONCOL, V3, P498, DOI 10.1016/S1470-2045(02)00819-7; UMSAWASDI T, 1984, J NEURO-ONCOL, V2, P253; Vejda S, 2003, CARCINOGENESIS, V24, P1801, DOI 10.1093/carcin/bgg154; Xia Y, 2009, J ENDOCRINOL, V202, P1, DOI 10.1677/JOE-08-0549; Yin JK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025559; Yuan XL, 2009, J CLIN ONCOL, V27, P3370, DOI 10.1200/JCO.2008.20.6763	37	19	20	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51713	10.1371/journal.pone.0051713	http://dx.doi.org/10.1371/journal.pone.0051713			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284751	Green Submitted, Green Published, gold			2022-12-27	WOS:000312435900049
J	McLean, D; Cooke, MJ; Wang, YF; Green, D; Fraser, PE; St George-Hyslop, P; Shoichet, MS				McLean, Daniel; Cooke, Michael J.; Wang, Yuanfei; Green, David; Fraser, Paul E.; St George-Hyslop, Peter; Shoichet, Molly S.			Anti-Amyloid-beta-Mediated Positron Emission Tomography Imaging in Alzheimer's Disease Mouse Brains	PLOS ONE			English	Article							IN-VIVO; NANOPARTICLES; IMMUNIZATION; DEPOSITION; TRANSPORT; DELIVERY; BARRIER	Antibody-mediated imaging of amyloid beta (A beta) in Alzheimer's disease (AD) offers a promising strategy to detect and monitor specific A beta species, such as oligomers, that have important pathological and therapeutic relevance. The major current limitation of antibodies as a diagnostic and imaging device is poor blood-brain-barrier permeability. A classical anti-A beta antibody, 6E10, is modified with 10 kDa polyethylene glycol (PEG) and a positron emitting isotope, Copper-64 (t(1/2) = 12.7 h), and intravenously delivered to the TgCRND8 mouse model of Alzheimer's disease. Modification of 6E10 with PEG (6E10-PEG) increases accumulation of 6E10 in brain tissue in both TgCRND8 and wild type control animals. 6E10-PEG differentiates TgCRND8 animals from wild type controls using positron emission tomography (PET) and provides a framework for using antibodies to detect pathology using non-invasive medical imaging techniques.	[McLean, Daniel; Cooke, Michael J.; Wang, Yuanfei; Shoichet, Molly S.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada; [McLean, Daniel; Wang, Yuanfei; Shoichet, Molly S.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Green, David] Princess Margaret Hosp, Ctr Spatio & Temporal Targeting & Amplificat Radi, Toronto, ON M4X 1K9, Canada; [Fraser, Paul E.; St George-Hyslop, Peter] Univ Toronto, Dept Med Neurol, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; [Fraser, Paul E.; St George-Hyslop, Peter] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [St George-Hyslop, Peter] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Shoichet, Molly S.] Univ Toronto, Dept Chem, Toronto, ON M5S 1A1, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University of Cambridge; University of Toronto	Shoichet, MS (corresponding author), Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada.	molly.shoichet@utoronto.ca			Firefly Foundation Grant; Canadian Institutes for Health Research [MOP-115056]; Natural Sciences and Engineering Research Council of Canada	Firefly Foundation Grant; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Work was funded by a Firefly Foundation Grant (to PSGH, PEF), Canadian Institutes for Health Research (MOP-115056; PEF) and the Natural Sciences and Engineering Research Council of Canada (to MSS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beffert U, 1998, BRAIN RES REV, V27, P119, DOI 10.1016/S0165-0173(98)00008-3; Bilbul M, 2011, CAN J NEUROL SCI, V38, P580, DOI 10.1017/S0317167100012129; Bjugstad KB, 2008, CELL TRANSPLANT, V17, P409; Boado RJ, 2007, BIOCONJUGATE CHEM, V18, P447, DOI 10.1021/bc060349x; Boche D, 2008, BRAIN, V131, P3299, DOI 10.1093/brain/awn261; Bryan JN, 2011, CANCER BIOL THER, V11, P1001, DOI 10.4161/cbt.11.12.15528; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Chua TC, 2008, CURR OPIN NEUROL, V21, P83, DOI 10.1097/WCO.0b013e3282f4594b; Frisoni GB, 2012, NEUROBIOL AGING, V33, P1021, DOI 10.1016/j.neurobiolaging.2010.09.007; Galvin JE, 2012, J AM BOARD FAM MED, V25, P367, DOI 10.3122/jabfm.2012.03.100181; Hampel H, 2011, PROG NEUROBIOL, V95, P718, DOI 10.1016/j.pneurobio.2011.11.008; Jordao JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010549; Kim HR, 2007, CELL MOL LIFE SCI, V64, P356, DOI 10.1007/s00018-007-6390-x; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Koffie RM, 2011, P NATL ACAD SCI USA, V108, P18837, DOI 10.1073/pnas.1111405108; Liu R, 2005, GENE THER, V12, P647, DOI 10.1038/sj.gt.3302445; McLean D, 2012, J CONTROL RELEASE, V159, P302, DOI 10.1016/j.jconrel.2011.12.036; Michaelis K, 2006, J PHARMACOL EXP THER, V317, P1246, DOI 10.1124/jpet.105.097139; Paul J, 2007, J EXP MED, V204, P1999, DOI 10.1084/jem.20070304; PODUSLO JF, 1994, P NATL ACAD SCI USA, V91, P5705, DOI 10.1073/pnas.91.12.5705; Ramakrishnan M, 2008, PHARM RES-DORDR, V25, P1861, DOI 10.1007/s11095-008-9600-9; Reiman EM, 2012, NEUROIMAGE, V61, P505, DOI 10.1016/j.neuroimage.2011.11.075; Sair HI, 2004, NEURORADIOLOGY, V46, P93, DOI 10.1007/s00234-003-1034-9; Selkoe Dennis J, 2008, Handb Clin Neurol, V89, P245, DOI 10.1016/S0072-9752(07)01223-7; SKARLATOS S, 1995, J DRUG TARGET, V3, P9, DOI 10.3109/10611869509015927; Tam JHK, 2012, CAN J NEUROL SCI, V39, P286, DOI 10.1017/S0317167100013408; Veronese FM, 2001, BIOMATERIALS, V22, P405, DOI 10.1016/S0142-9612(00)00193-9; Wang YF, 2011, J CONTROL RELEASE, V149, P225, DOI 10.1016/j.jconrel.2010.10.022; Wisniewski T, 2008, LANCET NEUROL, V7, P805, DOI 10.1016/S1474-4422(08)70170-4; Zhang Y, 2008, PHARM RES-DORD, V25, P400, DOI 10.1007/s11095-007-9357-6	31	10	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e51958	10.1371/journal.pone.0051958	http://dx.doi.org/10.1371/journal.pone.0051958			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284831	Green Submitted, Green Published, gold			2022-12-27	WOS:000313158800016
J	Rouault, A; Banneau, G; MacGrogan, G; Jones, N; Elarouci, N; Barouk-Simonet, E; Venat, L; Coupier, I; Letouze, E; de Reynies, A; Bonnet, F; Iggo, R; Sevenet, N; Longy, M				Rouault, Audrey; Banneau, Guillaume; MacGrogan, Gaetan; Jones, Natalie; Elarouci, Nabila; Barouk-Simonet, Emmanuelle; Venat, Laurence; Coupier, Isabelle; Letouze, Eric; de Reynies, Aurelien; Bonnet, Francoise; Iggo, Richard; Sevenet, Nicolas; Longy, Michel			Deletion of Chromosomes 13q and 14q Is a Common Feature of Tumors with BRCA2 Mutations	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; BREAST-CANCER; EXPRESSION PROFILES; GENE; PATTERNS; CARRIERS; DISPLAY	Introduction: Germline BRCA1 or BRCA2 mutations account for 20-30% of familial clustering of breast cancer. The main indication for BRCA2 screening is currently the family history but the yield of mutations identified in patients selected this way is low. Methods: To develop more efficient approaches to screening we have compared the gene expression and genomic profiles of BRCA2-mutant breast tumors with those of breast tumors lacking BRCA1 or BRCA2 mutations. Results: We identified a group of 66 genes showing differential expression in our training set of 7 BRCA2-mutant tumors and in an independent validation set of 19 BRCA2-mutant tumors. The differentially expressed genes include a prominent cluster of genes from chromosomes 13 and 14 whose expression is reduced. Gene set enrichment analysis confirmed that genes in specific bands on 13q and 14q showed significantly reduced expression, suggesting that the affected bands may be preferentially deleted in BRCA2-mutant tumors. Genomic profiling showed that the BRCA2-mutant tumors indeed harbor deletions on chromosomes 13q and 14q. To exploit this information we have created a simple fluorescence in situ hybridization (FISH) test and shown that it detects tumors with deletions on chromosomes 13q and 14q. Conclusion: Together with previous reports, this establishes that deletions on chromosomes 13q and 14q are a hallmark of BRCA2-mutant tumors. We propose that FISH to detect these deletions would be an efficient and cost-effective first screening step to identify potential BRCA2-mutation carriers among breast cancer patients without a family history of breast cancer.	[Rouault, Audrey; Banneau, Guillaume; MacGrogan, Gaetan; Jones, Natalie; Bonnet, Francoise; Iggo, Richard; Sevenet, Nicolas; Longy, Michel] Univ Bordeaux, Bergonie Canc Inst, French Natl Inst Hlth & Med Res INSERM, U916, Bordeaux, France; [MacGrogan, Gaetan] Bergonie Canc Inst, Dept Pathol, Bordeaux, France; [Elarouci, Nabila; Letouze, Eric; de Reynies, Aurelien] Ligue Natl Canc, Cartes Ident Tumeurs CIT Program, Paris, France; [Barouk-Simonet, Emmanuelle; Bonnet, Francoise; Sevenet, Nicolas; Longy, Michel] Bergonie Canc Inst, Canc Genet Unit, Bordeaux, France; [Venat, Laurence] Dupuytren Univ Hosp, Dept Med Oncol, Limoges, France; [Coupier, Isabelle] Val dAurelle Reg Canc Ctr, Canc Genet Unit, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UNICANCER; Institut Bergonie; UNICANCER; Institut Bergonie; UNICANCER; Institut Bergonie; CHU Limoges	Iggo, R (corresponding author), Univ Bordeaux, Bergonie Canc Inst, French Natl Inst Hlth & Med Res INSERM, U916, Bordeaux, France.	r.iggo@bordeaux.unicancer.fr	Jones, Natalie/L-2455-2014; Iggo, Richard/G-3546-2014; Letouzé, Eric/AAP-9924-2020; Feillet, Francois/A-3648-2017; de Reyniès, Aurélien/Q-8640-2017	Letouzé, Eric/0000-0002-6369-2839; Feillet, Francois/0000-0002-8717-469X; de Reyniès, Aurélien/0000-0002-1328-5290; MacGrogan, Gaetan/0000-0002-3483-9758	Charente-Maritime committee of the French Cancer League; Pyrenees-Atlantiques committee of the French Cancer League; Bergerac Lions Club; French National Research Agency (ANR); French National Cancer League program grant; Ligue nationale contre le cancer	Charente-Maritime committee of the French Cancer League; Pyrenees-Atlantiques committee of the French Cancer League; Bergerac Lions Club; French National Research Agency (ANR)(French National Research Agency (ANR)); French National Cancer League program grant; Ligue nationale contre le cancer(Ligue nationale contre le cancer)	The work was funded by grants from the Charente-Maritime and Pyrenees-Atlantiques committees of the French Cancer League and the Bergerac Lions Club to M. L.; the French National Research Agency (ANR) to R. I.; and a French National Cancer League program grant to M. L. and R. I. This work is part of the national program Cartes d'Identite des Tumeurs (CIT) [http://cit.ligue-cancer.net/] funded and developed by the Ligue nationale contre le cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banneau G, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2626; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Boulton SJ, 2006, BIOCHEM SOC T, V34, P633, DOI 10.1042/BST0340633; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; CAPweb, COP NUMB ARR AN PLAT; COLLINS N, 1995, ONCOGENE, V10, P1673; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fackenthal JD, 2007, NAT REV CANCER, V7, P937, DOI 10.1038/nrc2054; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jonsson G, 2005, CANCER RES, V65, P7612, DOI 10.1158/0008-5472.CAN-05-0570; Jonsson G, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2596; Joosse SA, 2012, BREAST CANCER RES TR, V132, P379, DOI 10.1007/s10549-010-1016-7; Moller P, 2007, EUR J CANCER, V43, P1713, DOI 10.1016/j.ejca.2007.04.023; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; R Core Team, 2012, R LANG ENV STAT COMP; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stefansson OA, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2334; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tirkkonen M, 1997, CANCER RES, V57, P1222; Tischkowitz M, 2007, P NATL ACAD SCI USA, V104, P6788, DOI 10.1073/pnas.0701724104; Waddell N, 2010, BREAST CANCER RES TR, V123, P661, DOI 10.1007/s10549-009-0653-1; Walsh T, 2007, CANCER CELL, V11, P103, DOI 10.1016/j.ccr.2007.01.010; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234	28	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52079	10.1371/journal.pone.0052079	http://dx.doi.org/10.1371/journal.pone.0052079			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284877	gold, Green Published, Green Submitted			2022-12-27	WOS:000313158800028
J	Laddha, NC; Dwivedi, M; Begum, R				Laddha, Naresh C.; Dwivedi, Mitesh; Begum, Rasheedunnisa			Increased Tumor Necrosis Factor (TNF)-alpha and Its Promoter Polymorphisms Correlate with Disease Progression and Higher Susceptibility towards Vitiligo	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; TNF-ALPHA POLYMORPHISMS; GENERALIZED VITILIGO; AUTOIMMUNE-DISEASES; LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; MONOCLONAL-ANTIBODY; GUJARAT POPULATION; ANTIOXIDANT STATUS; CLASS-II	Tumor Necrosis Factor (TNF)-alpha, is a paracrine inhibitor of melanocytes, which plays a critical role in the pathogenesis of several autoimmune diseases including vitiligo, as abnormal immune responses have frequently been observed in vitiligo patients. Moreover, vitiligo patients show higher lesion levels of TNF-alpha. Genetic polymorphisms in the promoter region of TNF-alpha are involved in the regulation of its expression. The present study explores TNF-alpha promoter polymorphisms and correlates them with TNF-alpha transcript and protein levels in vitiligo patients and controls of Gujarat along with its effect on disease onset and progression. PCR-RFLP technique was used for genotyping of these polymorphisms in 977 vitiligo patients and 990 controls. TNF-alpha transcript and protein levels were measured by Real time PCR and ELISA respectively. The genotype and allele frequencies for the investigated polymorphisms were significantly associated with vitiligo patients. The study revealed significant increase in TNF-alpha transcript and protein levels in vitiligo patients compared to controls. In particular, haplotypes: AATCC, AACCT, AGTCT, GATCT, GATCC and AGCCT were found to increase the TNF-alpha levels in vitiligo patients. Analysis of TNF-alpha levels based on the gender and disease progression suggests that female patients and patients with active vitiligo had higher levels of TNF-alpha. Also, the TNF-alpha levels were high in patients with generalized vitiligo as compared to localized vitiligo. Age of onset analysis of the disease suggests that the haplotypes: AACAT, AACCT, AATCC and AATCT had a profound effect in the early onset of the disease. Moreover, the analysis suggests that female patients had an early onset of vitiligo. Overall, our results suggest that TNF-alpha promoter polymorphisms may be genetic risk factors for susceptibility and progression of the disease. The up-regulation of TNF-alpha transcript and protein levels in individuals with susceptible haplotypes advocates the crucial role of TNF-alpha in autoimmune pathogenesis of vitiligo.	[Laddha, Naresh C.; Dwivedi, Mitesh; Begum, Rasheedunnisa] Maharaja Sayajirao Univ Baroda, Dept Biochem, Fac Sci, Vadodara, Gujarat, India	Maharaja Sayajirao University Baroda	Begum, R (corresponding author), Maharaja Sayajirao Univ Baroda, Dept Biochem, Fac Sci, Vadodara, Gujarat, India.	rasheedunnisab@yahoo.co.in	Begum, Rasheedunnisa/AAF-2981-2020; Dwivedi, Mitesh/Q-1276-2019	Dwivedi, Mitesh/0000-0001-8497-0765; BEGUM, RASHEEDUNNISA/0000-0003-3446-0980	UGC, New Delhi, India [36-158/2008(SR)]; DBT, New Delhi, India [BT/PR9024/MED/12/332/2007]; Council of Scientific and Industrial Research (New Delhi)	UGC, New Delhi, India(University Grants Commission, India); DBT, New Delhi, India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (New Delhi)(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants to RB ("F. No. 36-158/2008(SR)"), UGC, New Delhi, India and RB ("BT/PR9024/MED/12/332/2007") DBT, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all vitiligo patients and control subjects for their participation in this study. NCL thanks the Council of Scientific and Industrial Research (New Delhi) for awarding SRF.	Afshan G, 2012, CLIN LAB, V58, P567; Agrawal D, 2004, PIGM CELL RES, V17, P289, DOI 10.1111/j.1600-0749.2004.00149.x; ALBADRI AMT, 1993, J PATHOL, V169, P203, DOI 10.1002/path.1711690205; Alkhateeb A, 2003, PIGM CELL RES, V16, P208, DOI 10.1034/j.1600-0749.2003.00032.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bayley JP, 2001, CYTOKINE, V14, P316, DOI 10.1006/cyto.2001.0902; CABRERA M, 1995, J EXP MED, V182, P1259, DOI 10.1084/jem.182.5.1259; DAS S K, 1985, Genetic Epidemiology, V2, P71; Dwivedi M, 2009, BRIT J DERMATOL, V161, P63, DOI 10.1111/j.1365-2133.2009.09140.x; Dwivedi M, 2008, PIGM CELL MELANOMA R, V21, P407, DOI 10.1111/j.1755-148X.2008.00462.x; Dwivedi M, 2011, PIGM CELL MELANOMA R, V24, P737, DOI 10.1111/j.1755-148X.2011.00892.x; ELLIOTT MJ, 1994, LANCET, V344, P1125, DOI 10.1016/S0140-6736(94)90632-7; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Feldmann M, 1998, Int Rev Immunol, V17, P217, DOI 10.3109/08830189809084493; Ferguson LR, 2008, WORLD J GASTROENTERO, V14, P4652, DOI 10.3748/wjg.14.4652; FONG CLW, 1994, NUCLEIC ACIDS RES, V22, P1108, DOI 10.1093/nar/22.6.1108; Grimes PE, 2004, J AM ACAD DERMATOL, V51, P52, DOI 10.1016/j.jaad.2003.12.031; Gupta S, 2006, AUTOIMMUN REV, V5, P264, DOI 10.1016/j.autrev.2005.09.007; Huang Carol L, 2002, Am J Clin Dermatol, V3, P301, DOI 10.2165/00128071-200203050-00001; Imran M, 2012, BRIT J DERMATOL, V167, P314, DOI 10.1111/j.1365-2133.2012.11000.x; JACOB CO, 1990, P NATL ACAD SCI USA, V87, P1233, DOI 10.1073/pnas.87.3.1233; Kamali-Sarvestani E, 2007, J INVEST ALLERG CLIN, V17, P361; Kemp E H, 2001, Expert Rev Mol Med, V3, P1, DOI 10.1017/S1462399401003362; Kim JJ, 2010, CELL DEATH DIFFER, V17, P1420, DOI 10.1038/cdd.2010.19; Kim SM, 1998, INT J DERMATOL, V37, P908, DOI 10.1046/j.1365-4362.1998.00549.x; Kroeger KM, 1997, MOL IMMUNOL, V34, P391, DOI 10.1016/S0161-5890(97)00052-7; Kumar R, 2007, TISSUE ANTIGENS, V69, P557, DOI 10.1111/j.1399-0039.2007.00817.x; Laberge G, 2005, PIGM CELL RES, V18, P300, DOI 10.1111/j.1600-0749.2005.00242.x; Laddha NC, 2008, J DERMATOL SCI, V49, P260, DOI 10.1016/j.jdermsci.2007.10.002; Li CY, 2007, J INVEST DERMATOL, V127, P1886, DOI 10.1038/sj.jid.5700822; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Martinez-Esparza M, 1998, EUR J BIOCHEM, V255, P139, DOI 10.1046/j.1432-1327.1998.2550139.x; MCGUIRE W, 1994, NATURE, V371, P508, DOI 10.1038/371508a0; MORELLI JG, 1993, J INVEST DERMATOL, V100, pS191; Moretti S, 2002, PIGM CELL RES, V15, P87, DOI 10.1034/j.1600-0749.2002.1o049.x; Namian AM, 2009, ARCH DERMATOL RES, V301, P21, DOI 10.1007/s00403-008-0904-8; Noble JA, 2006, HUM IMMUNOL, V67, P999, DOI 10.1016/j.humimm.2006.10.002; Nordlund JJ, 1997, CLIN DERMATOL, V15, P875, DOI 10.1016/S0738-081X(97)00128-4; Panchanathan R, 2013, MOL IMMUNOL, V53, P15, DOI 10.1016/j.molimm.2012.06.013; Rahman P, 2006, ANN RHEUM DIS, V65, P919, DOI 10.1136/ard.2005.039164; Rosenberg SA, 1997, IMMUNOL TODAY, V18, P175, DOI 10.1016/S0167-5699(97)84664-6; SCHALLREUTER KU, 1991, J INVEST DERMATOL, V97, P1081, DOI 10.1111/1523-1747.ep12492612; Shajil E. M., 2006, Indian Journal of Dermatology, V51, P100; Shajil E. M., 2006, Indian Journal of Experimental Biology, V44, P526; Shajil EM, 2006, PIGM CELL RES, V19, P179, DOI 10.1111/j.1600-0749.2006.00299.x; Shajil EM, 2007, THESIS MS U BARODA V; Sharma S, 2008, CLIN EXP IMMUNOL, V151, P251, DOI 10.1111/j.1365-2249.2007.03564.x; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Simmonds MJ, 2004, GENES IMMUN, V5, P267, DOI 10.1038/sj.gene.6364066; Simon JA, 2008, DERMATOLOGY, V216, P234, DOI 10.1159/000112932; Singh A, 2012, J INVEST DERMATOL, V132, P124, DOI 10.1038/jid.2011.240; Skoog T, 1999, HUM MOL GENET, V8, P1443, DOI 10.1093/hmg/8.8.1443; Spritz Richard A., 2008, V10, P244, DOI 10.1159/000131501; Spritz RA, 2007, PIGM CELL RES, V20, P271, DOI 10.1111/j.1600-0749.2007.00384.x; Spritz RA, 2011, J GENET GENOMICS, V38, P271, DOI 10.1016/j.jgg.2011.05.005; Spritz RA, 2010, GENOME MED, V2, DOI 10.1186/gm199; Suarez A, 2005, ANN RHEUM DIS, V64, P1605, DOI 10.1136/ard.2004.035048; Taieb A, 2009, NEW ENGL J MED, V360, P160, DOI 10.1056/NEJMcp0804388; VANDULLEMEN HM, 1995, GASTROENTEROLOGY, V109, P129, DOI 10.1016/0016-5085(95)90277-5; Wankowicz-Kalinska A, 2003, LAB INVEST, V83, P683, DOI 10.1097/01.LAB.0000069521.42488.1B; Whitacre CC, 2001, NAT IMMUNOL, V2, P777, DOI 10.1038/ni0901-777; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195; Yazici AC, 2006, ARCH DERMATOL RES, V298, P46, DOI 10.1007/s00403-006-0664-2; YOHN JJ, 1990, J INVEST DERMATOL, V95, P233, DOI 10.1111/1523-1747.ep12478093	64	72	73	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52298	10.1371/journal.pone.0052298	http://dx.doi.org/10.1371/journal.pone.0052298			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284977	Green Submitted, Green Published, gold			2022-12-27	WOS:000312794500138
J	Morise, H; Miyazaki, E; Yoshimitsu, S; Eki, T				Morise, Hisashi; Miyazaki, Erika; Yoshimitsu, Shoko; Eki, Toshihiko			Profiling Nematode Communities in Unmanaged Flowerbed and Agricultural Field Soils in Japan by DNA Barcode Sequencing	PLOS ONE			English	Article							GEL-ELECTROPHORESIS DGGE; PHYLOGENETIC-RELATIONSHIPS; LIVING NEMATODES; BIODIVERSITY; EXTRACTION; INDICATORS; DIVERSITY; MONONCHIDA; MANAGEMENT; TILLAGE	Soil nematodes play crucial roles in the soil food web and are a suitable indicator for assessing soil environments and ecosystems. Previous nematode community analyses based on nematode morphology classification have been shown to be useful for assessing various soil environments. Here we have conducted DNA barcode analysis for soil nematode community analyses in Japanese soils. We isolated nematodes from two different environmental soils of an unmanaged flowerbed and an agricultural field using the improved flotation-sieving method. Small subunit (SSU) rDNA fragments were directly amplified from each of 68 (flowerbed samples) and 48 (field samples) isolated nematodes to determine the nucleotide sequence. Sixteen and thirteen operational taxonomic units (OTUs) were obtained by multiple sequence alignment from the flowerbed and agricultural field nematodes, respectively. All 29 SSU rDNA-derived OTUs (rOTUs) were further mapped onto a phylogenetic tree with 107 known nematode species. Interestingly, the two nematode communities examined were clearly distinct from each other in terms of trophic groups: Animal predators and plant feeders were markedly abundant in the flowerbed soils, in contrast, bacterial feeders were dominantly observed in the agricultural field soils. The data from the flowerbed nematodes suggests a possible food web among two different trophic nematode groups and plants (weeds) in the closed soil environment. Finally, DNA sequences derived from the mitochondrial cytochrome oxidase c subunit 1 (COI) gene were determined as a DNA barcode from 43 agricultural field soil nematodes. These nematodes were assigned to 13 rDNA-derived OTUs, but in the COI gene analysis were assigned to 23 COI gene-derived OTUs (cOTUs), indicating that COI gene-based barcoding may provide higher taxonomic resolution than conventional SSU rDNA-barcoding in soil nematode community analysis.	[Morise, Hisashi; Miyazaki, Erika; Yoshimitsu, Shoko; Eki, Toshihiko] Toyohashi Univ Technol, Dept Environm & Life Sci, Div Biosci & Biotechnol, Mol Genet Lab, Toyohashi, Aichi, Japan	Toyohashi University of Technology	Eki, T (corresponding author), Toyohashi Univ Technol, Dept Environm & Life Sci, Div Biosci & Biotechnol, Mol Genet Lab, Tempaku Cho, Toyohashi, Aichi, Japan.	eki@ens.tut.ac.jp			Toyohashi University of Technology	Toyohashi University of Technology	This work was supported in part by grants from the research program of Toyohashi University of Technology (to TE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abebe E, 2011, AFR J BIOTECHNOL, V10, P312; Baermann G., 1917, Geneeskundig Tijdschrift voor Nederlandsch-Indie Batavia, V57; BAIRD SM, 1984, J NEMATOL, V16, P379; Barthes BG, 2011, SOIL BIOL BIOCHEM, V43, P1649, DOI 10.1016/j.soilbio.2011.03.023; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Blaxter ML, 2004, PHILOS T R SOC B, V359, P669, DOI 10.1098/rstb.2003.1447; Boag B, 1998, BIODIVERS CONSERV, V7, P617, DOI 10.1023/A:1008852301349; Bongers T, 1999, TRENDS ECOL EVOL, V14, P224, DOI 10.1016/S0169-5347(98)01583-3; Brown D.J.F., 1988, Nematologia Mediterranea, V16, P93; Carta LK, 2000, J NEMATOL, V32, P362; Coolen W.A, 1977, Nematologia Mediterranea, V5, P195; Derycke S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013716; Eki T, 2011, ECOTOXICOLOGY GROBE, P1; Ferris H, 2004, APPL SOIL ECOL, V25, P19, DOI 10.1016/j.apsoil.2003.07.001; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Foucher ALJL, 2004, SOIL BIOL BIOCHEM, V36, P2027, DOI 10.1016/j.soilbio.2004.05.021; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Griffiths BS, 2006, APPL SOIL ECOL, V32, P325, DOI 10.1016/j.apsoil.2005.07.006; GRIFFITHS BS, 1994, SOIL USE MANAGE, V10, P20, DOI 10.1111/j.1475-2743.1994.tb00452.x; GRIFFITHS BS, 1990, NEMATOLOGICA, V36, P465, DOI 10.1163/002925990X00437; Hamilton HC, 2009, SOIL BIOL BIOCHEM, V41, P1311, DOI 10.1016/j.soilbio.2009.03.021; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heininger P, 2007, ENVIRON POLLUT, V146, P64, DOI 10.1016/j.envpol.2006.06.023; Holterman M, 2008, MOL PHYLOGENET EVOL, V48, P758, DOI 10.1016/j.ympev.2008.04.033; Holterman M, 2006, MOL BIOL EVOL, V23, P1792, DOI 10.1093/molbev/msl044; Jairajpuri M.S., 1978, Nematologia Mediterranea, V6, P205; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liang WJ, 2005, APPL SOIL ECOL, V29, P185, DOI 10.1016/j.apsoil.2004.10.004; MCSORLEY R, 1987, NEMATROPICA, V17, P147; McSorley R, 2004, APPL SOIL ECOL, V27, P55, DOI 10.1016/j.apsoil.2004.02.005; Nassonova E, 2010, PROTIST, V161, P102, DOI 10.1016/j.protis.2009.07.003; Neher DA, 2001, J NEMATOL, V33, P161; Neher DA, 2005, APPL SOIL ECOL, V30, P47, DOI 10.1016/j.apsoil.2005.01.002; Neher DA, 2010, ANNU REV PHYTOPATHOL, V48, P371, DOI 10.1146/annurev-phyto-073009-114439; Okada H, 2007, APPL SOIL ECOL, V35, P582, DOI 10.1016/j.apsoil.2006.09.008; Okada H, 2008, NEMATOLOGY, V10, P689, DOI 10.1163/156854108785787280; Olia M, 2009, NEMATOLOGY, V11, P337, DOI 10.1163/156854109X446935; Olia Majid, 2008, Japanese Journal of Nematology, V38, P57, DOI 10.3725/jjn.38.57; Oliveira CMG, 2004, J NEMATOL, V36, P153; Porazinska DL, 2010, MOL ECOL, V19, P5521, DOI 10.1111/j.1365-294X.2010.04891.x; Porazinska DL, 2010, MOL ECOL RESOUR, V10, P666, DOI 10.1111/j.1755-0998.2009.02819.x; Porazinska DL, 2009, MOL ECOL RESOUR, V9, P1439, DOI 10.1111/j.1755-0998.2009.02611.x; Powers TO, 2009, MOL ECOL, V18, P985, DOI 10.1111/j.1365-294X.2008.04075.x; PROCTER DLC, 1990, J NEMATOL, V22, P1; Ritz K, 1999, PLANT SOIL, V212, P1, DOI 10.1023/A:1004673027625; RODRIGUEZ-KABANA R, 1981, Nematropica, V11, P175; Sakai H, 2011, ZOOKEYS, P21, DOI 10.3897/zookeys.135.1716; Sochova I, 2006, ENVIRON INT, V32, P374, DOI 10.1016/j.envint.2005.08.031; Taylor HR, 2012, MOL ECOL RESOUR, V12, P377, DOI 10.1111/j.1755-0998.2012.03119.x; Timmermans MJTN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq807; Urzelai A, 2000, SCI TOTAL ENVIRON, V247, P253, DOI 10.1016/S0048-9697(99)00494-5; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Vanreusel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012449; Waite IS, 2003, SOIL BIOL BIOCHEM, V35, P1165, DOI 10.1016/S0038-0717(03)00177-9; WARDLE DA, 1995, OIKOS, V73, P155, DOI 10.2307/3545904; Wu TH, 2009, SOIL BIOL BIOCHEM, V41, P849, DOI 10.1016/j.soilbio.2009.02.003; Yeates GW, 2003, BIOL FERT SOILS, V37, P199, DOI 10.1007/s00374-003-0586-5; YEATES GW, 1993, J NEMATOL, V25, P315; Yeates GW, 1997, PEDOBIOLOGIA, V41, P526; Yeates GW, 1999, AGR ECOSYST ENVIRON, V74, P113, DOI 10.1016/S0167-8809(99)00033-X	61	29	31	3	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51785	10.1371/journal.pone.0051785	http://dx.doi.org/10.1371/journal.pone.0051785			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284767	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500046
J	Schaffner, U; Alewell, C; Eschen, R; Matthies, D; Spiegelberger, T; Hegg, O				Schaffner, Urs; Alewell, Christine; Eschen, Rene; Matthies, Diethart; Spiegelberger, Thomas; Hegg, Otto			Calcium Induces Long-Term Legacy Effects in a Subalpine Ecosystem	PLOS ONE			English	Article							SPECIES COMPOSITION; GRASSLAND; CARBON; SOIL; BONFERRONI; DIVERSITY	Human activities have transformed a significant proportion of the world's land surface, with profound effects on ecosystem processes. Soil applications of macronutrients such as nitrate, phosphorus, potassium or calcium are routinely used in the management of croplands, grasslands and forests to improve plant health or increase productivity. However, while the effects of continuous fertilization and liming on terrestrial ecosystems are well documented, remarkably little is known about the legacy effect of historical fertilization and liming events in terrestrial ecosystems and of the mechanisms involved. Here, we show that more than 70 years after the last application of lime on a subalpine grassland, all major soil and plant calcium pools were still significantly larger in limed than in unlimed plots, and that the resulting shift in the soil calcium/aluminium ratio continues to affect ecosystem services such as primary production. The difference in the calcium content of the vegetation and the topmost 10 cm of the soil in limed vs. unlimed plots amounts to approximately 19.5 g m(-2), equivalent to 16.3% of the amount that was added to the plots some 70 years ago. In contrast, plots that were treated with nitrogen-phosphorus-potassium fertilizer in the 1930s did not differ from unfertilized plots in any of the soil and vegetation characteristics measured. Our findings suggest that the long-term legacy effect of historical liming is due to long-term storage of added calcium in stable soil pools, rather than a general increase in nutrient availability. Our results demonstrate that single applications of calcium in its carbonated form can profoundly and persistently alter ecosystem processes and services in mountain ecosystems.	[Schaffner, Urs; Eschen, Rene; Spiegelberger, Thomas] CABI, Delemont, Switzerland; [Alewell, Christine] Univ Basel, Dept Environm Sci, Basel, Switzerland; [Matthies, Diethart] Univ Marburg, Dept Biol, Marburg, Germany; [Spiegelberger, Thomas] Inst Natl Rech Sci & Technol Environm & Agr, Ecosystemes Montagnards, St Martin Dheres, France; [Hegg, Otto] Univ Bern, Dept Biol, Bern, Switzerland	University of Basel; Philipps University Marburg; INRAE; University of Bern	Schaffner, U (corresponding author), CABI, Delemont, Switzerland.	U.Schaffner@cabi.org	Spiegelberger, Thomas/B-9513-2009; Alewell, Christine/K-5104-2016	Spiegelberger, Thomas/0000-0002-0979-1043; Alewell, Christine/0000-0001-9295-9806; Matthies, Diethart/0000-0003-2439-0501	Bristol Stiftung; Bristol Foundation	Bristol Stiftung; Bristol Foundation	The work was funded by the Bristol Stiftung (http://www.bristol-stiftung.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank the Geschaftsleitung of the Alpengarten Schynige Platte for allowing us to work on the Ludi plots, Franz Conen and Heinz Hurlimann for technical support, Franz Conen and Richard Bardgett for valuable comments on an earlier version of the manuscript and the Bristol Foundation for financial support.	Alewell C, 2000, NATURE, V407, P856, DOI 10.1038/35038158; Blum JD, 2002, NATURE, V417, P729, DOI 10.1038/nature00793; Bossew P, 2004, J ENVIRON RADIOACTIV, V73, P87, DOI 10.1016/j.jenvrad.2003.08.004; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; CRONAN CS, 1995, J ENVIRON QUAL, V24, P209, DOI 10.2134/jeq1995.00472425002400020002x; Dahler W, 1993, GEOBOTANICA HELVETIC, V71, P1; DEANGELIS DL, 1989, AM NAT, V134, P778, DOI 10.1086/285011; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Folke C, 2002, AMBIO, V31, P437, DOI 10.1639/0044-7447(2002)031[0437:RASDBA]2.0.CO;2; Fornara DA, 2011, GLOBAL CHANGE BIOL, V17, P1925, DOI 10.1111/j.1365-2486.2010.02328.x; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Garcia LV, 2004, OIKOS, V105, P657, DOI 10.1111/j.0030-1299.2004.13046.x; Hamilton SK, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002738; HERBEN T, 1993, J VEG SCI, V4, P163, DOI 10.2307/3236101; Hrevusova Z, 2009, AGR ECOSYST ENVIRON, V130, P123, DOI 10.1016/j.agee.2008.12.008; Isselstein J, 2005, GRASSLAND SCI EUR, V10, P211; Jandl R, 2004, SOIL SCI SOC AM J, V68, P588, DOI 10.2136/sssaj2004.0588; Leifeld J, 2009, GLOBAL CHANGE BIOL, V15, P668, DOI 10.1111/j.1365-2486.2008.01782.x; Ludi W, 1959, VERSUCHE ALPWEIDENVE; McLaughlin SB, 1999, NEW PHYTOL, V142, P373, DOI 10.1046/j.1469-8137.1999.00420.x; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Pierik M, 2011, ECOLOGY, V92, P1393, DOI 10.1890/10-0210.1; Ray J. G., 2010, Journal of Agronomy, V9, P70, DOI 10.3923/ja.2010.70.74; RORISON IH, 1984, PLANT CELL ENVIRON, V7, P381, DOI 10.1111/j.1365-3040.1984.tb01427.x; Ross DS, 2008, EUR J SOIL SCI, V59, P1141, DOI 10.1111/j.1365-2389.2008.01069.x; Schaberg PG, 2001, ECOSYST HEALTH, V7, P214, DOI 10.1046/j.1526-0992.2001.01046.x; Schlesinger WH, 2003, TREATISE GEOCHEMISTR, V8; SHORTLE WC, 1988, SCIENCE, V240, P1017, DOI 10.1126/science.240.4855.1017; Silvertown J, 2006, J ECOL, V94, P801, DOI 10.1111/j.1365-2745.2006.01145.x; Spiegelberger T, 2006, ECOLOGY, V87, P1939, DOI 10.1890/0012-9658(2006)87[1939:LEOSPI]2.0.CO;2; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; TILMAN D, 1994, LONG-TERM EXPERIMENTS IN AGRICULTURAL AND ECOLOGICAL SCIENCES, P287; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; van Breemen N, 2000, GEODERMA, V94, P163, DOI 10.1016/S0016-7061(99)00050-6; Vanguelova EI, 2007, PLANT BIOSYST, V141, P460, DOI 10.1080/11263500701626192; Wedin DA, 1996, SCIENCE, V274, P1720, DOI 10.1126/science.274.5293.1720; West TO, 2005, AGR ECOSYST ENVIRON, V108, P145, DOI 10.1016/j.agee.2005.01.002; Whitehead D.C, 2000, NUTR ELEMENTS GRASSL	40	6	6	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51818	10.1371/journal.pone.0051818	http://dx.doi.org/10.1371/journal.pone.0051818			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284779	gold, Green Published			2022-12-27	WOS:000312794500050
J	Wootton, JT				Wootton, J. Timothy			River Food Web Response to Large-Scale Riparian Zone Manipulations	PLOS ONE			English	Article							LARGE WOODY DEBRIS; SALMON ONCORHYNCHUS-KISUTCH; BRITISH-COLUMBIA; COHO SALMON; JUVENILE SALMONIDS; BENTHIC COMMUNITY; CARNATION CREEK; STREAM; ECOSYSTEM; USA	Conservation programs often focus on select species, leading to management plans based on the autecology of the focal species, but multiple ecosystem components can be affected both by the environmental factors impacting, and the management targeting, focal species. These broader effects can have indirect impacts on target species through the web of interactions within ecosystems. For example, human activity can strongly alter riparian vegetation, potentially impacting both economically-important salmonids and their associated river food web. In an Olympic Peninsula river, Washington state, USA, replicated large-scale riparian vegetation manipulations implemented with the long-term (>40 yr) goal of improving salmon habitat did not affect water temperature, nutrient limitation or habitat characteristics, but reduced canopy cover, causing reduced energy input via leaf litter, increased incident solar radiation (UV and PAR) and increased algal production compared to controls. In response, benthic algae, most insect taxa, and juvenile salmonids increased in manipulated areas. Stable isotope analysis revealed a predominant contribution of algal-derived energy to salmonid diets in manipulated reaches. The experiment demonstrates that riparian management targeting salmonids strongly affects river food webs via changes in the energy base, illustrates how species-based management strategies can have unanticipated indirect effects on the target species via the associated food web, and supports ecosystem-based management approaches for restoring depleted salmonid stocks.	Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago	Wootton, JT (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	twootton@uchicago.edu	Wootton, J. Timothy/F-3191-2015	Wootton, J. Timothy/0000-0002-7715-0344	Howard Hughes Foundation; National Science Foundation [DEB 93-17980, OCE 01-17801, OCE 04-52687, DEB 09-19420]; Andrew W. Mellon Foundation; Olympic Natural Resources Center; United States Environmental Protection Agency (University of Chicago Center for Integrating Statistics and the Environmental Sciences); Division Of Environmental Biology [0919420] Funding Source: National Science Foundation	Howard Hughes Foundation(Howard Hughes Medical Institute); National Science Foundation(National Science Foundation (NSF)); Andrew W. Mellon Foundation; Olympic Natural Resources Center; United States Environmental Protection Agency (University of Chicago Center for Integrating Statistics and the Environmental Sciences)(United States Environmental Protection Agency); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The research was partially supported by grants from the Howard Hughes Foundation, National Science Foundation (DEB 93-17980, OCE 01-17801, OCE 04-52687, DEB 09-19420), Andrew W. Mellon Foundation, Olympic Natural Resources Center, and United States Environmental Protection Agency (University of Chicago Center for Integrating Statistics and the Environmental Sciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumsteiger J, 2005, T AM FISH SOC, V134, P829, DOI 10.1577/T04-114.1; BERG DR, 1995, ECOL APPL, V5, P87, DOI 10.2307/1942054; BILBY RE, 1992, CAN J FISH AQUAT SCI, V49, P540, DOI 10.1139/f92-064; Bilby RE, 1998, CAN J FISH AQUAT SCI, V55, P1909, DOI 10.1139/cjfas-55-8-1909; BOTHWELL ML, 1994, SCIENCE, V265, P97, DOI 10.1126/science.265.5168.97; Crowder LB, 2008, ANNU REV ECOL EVOL S, V39, P259, DOI 10.1146/annurev.ecolsys.39.110707.173406; EMLEN JM, 1990, CAN J FISH AQUAT SCI, V47, P1765, DOI 10.1139/f90-200; ESSEEN PA, 1994, BIOL CONSERV, V68, P19, DOI 10.1016/0006-3207(94)90542-8; FAUSCH KD, 1992, CAN J FISH AQUAT SCI, V49, P682, DOI 10.1139/f92-077; Findlay J.C., 1999, LIMNOL OCEANOGR, V44, P1198; Finlay JC, 2011, ECOLOGY, V92, P140, DOI 10.1890/09-2243.1; GIBEAU GG, 1989, J FRESHWATER ECOL, V5, P171, DOI 10.1080/02705060.1989.9665226; GREGORY SV, 1991, BIOSCIENCE, V41, P540, DOI 10.2307/1311607; Harpole WS, 2011, ECOL LETT, V14, P852, DOI 10.1111/j.1461-0248.2011.01651.x; Hartman G.F., 1990, Canadian Bulletin of Fisheries and Aquatic Sciences, V223, P1; HARTMAN GF, 1987, CAN J FISH AQUAT SCI, V44, P262, DOI 10.1139/f87-035; HEIFETZ J, 1986, North American Journal of Fisheries Management, V6, P52, DOI 10.1577/1548-8659(1986)6<52:EOLOWH>2.0.CO;2; HOLTBY LB, 1988, CAN J FISH AQUAT SCI, V45, P502, DOI 10.1139/f88-060; Hyatt TL, 2001, ECOL APPL, V11, P191, DOI 10.1890/1051-0761(2001)011[0191:TRTOLW]2.0.CO;2; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Janisch JE, 2012, FOREST ECOL MANAG, V270, P302, DOI 10.1016/j.foreco.2011.12.035; JOHNSTON NT, 1990, CAN J FISH AQUAT SCI, V47, P862, DOI 10.1139/f90-099; Kareiva P, 2000, SCIENCE, V290, P977, DOI 10.1126/science.290.5493.977; Kiffney PM, 1997, J N AM BENTHOL SOC, V16, P520, DOI 10.2307/1468141; Kiffney PM, 2003, J APPL ECOL, V40, P1060, DOI 10.1111/j.1365-2664.2003.00855.x; LAJTHA K, 1994, STABLE ISOTOPES ECOL; LAMBERTI GA, 1985, FRESHWATER BIOL, V15, P21, DOI 10.1111/j.1365-2427.1985.tb00693.x; Levin PS, 2009, PLOS BIOL, V7, P23, DOI 10.1371/journal.pbio.1000014; Li Hiram W., 1996, P391; LIKENS GE, 1970, ECOL MONOGR, V40, P23, DOI 10.2307/1942440; LIN BH, 1988, FISH B-NOAA, V86, P655; MacLeod NA, 1998, CAN J FISH AQUAT SCI, V55, P1919, DOI 10.1139/cjfas-55-8-1919; Mangel M, 2005, PHILOS T R SOC B, V360, P95, DOI 10.1098/rstb.2004.1571; Marks JC, 2000, OIKOS, V90, P20, DOI 10.1034/j.1600-0706.2000.900103.x; McHenry ML, 1998, CAN J FISH AQUAT SCI, V55, P1395, DOI 10.1139/cjfas-55-6-1395; Montgomery DR, 1996, NATURE, V381, P587, DOI 10.1038/381587a0; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Moring J.R., 1975, 9 OR DEP FISH WILDL; MURPHY ML, 1981, T AM FISH SOC, V110, P469, DOI 10.1577/1548-8659(1981)110<469:EOCMAA>2.0.CO;2; Nakano S, 2001, P NATL ACAD SCI USA, V98, P166, DOI 10.1073/pnas.98.1.166; Nickelson TE, 1998, CAN J FISH AQUAT SCI, V55, P2383, DOI 10.1139/cjfas-55-11-2383; PERRIN CJ, 1987, CAN J FISH AQUAT SCI, V44, P1247, DOI 10.1139/f87-147; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Pollard W.R., 1997, FIELD IDENTIFICATION; RALPH SC, 1994, CAN J FISH AQUAT SCI, V51, P37, DOI 10.1139/f94-006; Roni P, 2002, N AM J FISH MANAGE, V22, P1, DOI 10.1577/1548-8675(2002)022&lt;0001:AROSRT&gt;2.0.CO;2; Roni P, 2001, CAN J FISH AQUAT SCI, V58, P282, DOI 10.1139/cjfas-58-2-282; Rosemond AD, 2000, CAN J FISH AQUAT SCI, V57, P66, DOI 10.1139/cjfas-57-1-66; Rosenfeld JS, 1997, ARCH HYDROBIOL, V139, P301; Sedell J. R., 1984, Verhandlungen der Internationalen Vereinigung fur Theoretische und Angewandte Limnologie, V22, P1828; SEDELL JR, 1990, ENVIRON MANAGE, V14, P711, DOI 10.1007/BF02394720; SLANEY PA, 1994, B MAR SCI, V55, P1160; TUCHMAN ML, 1980, HYDROBIOLOGIA, V75, P73, DOI 10.1007/BF00006564; UNESCO, 1994, PROT JOINT GLOB OC F, V29; Wallace JB, 1997, SCIENCE, V277, P102, DOI 10.1126/science.277.5322.102; Walters CJ, 2005, ICES J MAR SCI, V62, P558, DOI 10.1016/j.icesjms.2004.12.005; WEBSTER JR, 1986, ANNU REV ECOL SYST, V17, P567, DOI 10.1146/annurev.es.17.110186.003031; Whitledge GW, 2000, HYDROBIOLOGIA, V437, P165, DOI 10.1023/A:1026559008308; Wigington PJ, 1998, J AM WATER RESOUR AS, V34, P1035, DOI 10.1111/j.1752-1688.1998.tb04152.x; Wilzbach MA, 2005, CAN J FISH AQUAT SCI, V62, P58, DOI 10.1139/F04-177; Wootton JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043561; WOOTTON JT, 1993, P NATL ACAD SCI USA, V90, P1384, DOI 10.1073/pnas.90.4.1384; Wootton JT, 1996, SCIENCE, V273, P1558, DOI 10.1126/science.273.5281.1558; Wydoski R.S., 1979, INLAND FISHES WASHIN; YEAKLEY JA, 1994, WATER AIR SOIL POLL, V77, P229, DOI 10.1007/BF00478421	65	30	31	0	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51839	10.1371/journal.pone.0051839	http://dx.doi.org/10.1371/journal.pone.0051839			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284786	Green Submitted, Green Published, gold			2022-12-27	WOS:000312794500052
J	Zhai, WG; Zhang, DN; Mai, C; Choy, J; Jian, G; Sra, K; Galinski, MS				Zhai, Weiguo; Zhang, Dan Ning; Mai, Cecilia; Choy, Justin; Jian, Gary; Sra, Kuldip; Galinski, Mark S.			Comparison of Different Cell Substrates on the Measurement of Human Influenza Virus Neutralizing Antibodies	PLOS ONE			English	Article							RESPIRATORY VIRUSES; ENZYME-IMMUNOASSAY; EPITHELIAL-CELLS; LINES; MDCK; SUSCEPTIBILITY; REPLICATION; APOPTOSIS; VACCINES; SYSTEM	Eight cell lines were systematically compared for their permissivity to primary infection, replication, and spread of seven human influenza viruses. Cell lines were of human origin (Caco-2, A549, HEp-2, and NCI-H292), monkey (Vero, LLC-MK2), mink (Mv1 Lu), and canine (MDCK). The influenza viruses included seasonal types and subtypes and a pandemic virus. The MDCK, Caco-2, and Mv1 Lu cells were subsequently compared for their capacity to report neutralization titers at day one, three and six post-infection. A gradient of sensitivity to primary infection across the eight cell lines was observed. Relative to MDCK cells, Mv1 Lu reported higher titers and the remaining six cell lines reported lower titers. The replication and spread of the seven influenza viruses in the eight cell substrates was determined using hemagglutinin expression, cytopathic effect, and neuraminidase activity. Virus growth was generally concordant with primary infection, with a gradient in virus replication and spread. However, Mv1 Lu cells poorly supported virus growth, despite a higher sensitivity to primary infection. Comparison of MDCK, Caco-2, and Mv1 Lu in neutralization assays using defined animal antiserum confirmed MDCK cells as the preferred cell substrate for influenza virus testing. The results observed for neutralization at one day post-infection showed MDCK cells were similar (<1 log(2) lower) or superior (>1 log(2) higher) for all seven viruses. Relative to Caco-2 and Mv1 Lu cells, MDCK generally reported the highest titers at three and six days post-infection for the type A viruses and lower titers for the type B viruses and the pandemic H9N2 virus. The reduction in B virus titer was attributed to the complete growth of type B viruses in MDCK cells before day three post-infection, resulting in the systematic underestimation of neutralization titers. This phenomenon was also observed with Caco-2 cells.	[Galinski, Mark S.] MedImmune, Vaccine Analyt Sci, Mountain View, CA 94089 USA; [Zhai, Weiguo; Zhang, Dan Ning; Mai, Cecilia; Choy, Justin; Jian, Gary; Sra, Kuldip] MedImmune, Analyt Biochem, Mountain View, CA USA	AstraZeneca; Medimmune; AstraZeneca; Medimmune	Galinski, MS (corresponding author), MedImmune, Vaccine Analyt Sci, Mountain View, CA 94089 USA.	GalinskiM@Medimmune.com						Andrewes CH, 1933, BRIT J EXP PATHOL, V14, P367; Barenfanger J, 2001, J CLIN VIROL, V22, P101, DOI 10.1016/S1386-6532(01)00171-8; BENNE CA, 1994, J CLIN MICROBIOL, V32, P987, DOI 10.1128/JCM.32.4.987-990.1994; Chiapponi C, 2010, J VIROL METHODS, V163, P162, DOI 10.1016/j.jviromet.2009.09.017; El Ahmer OR, 1999, FEMS IMMUNOL MED MIC, V23, P331, DOI 10.1016/S0928-8244(98)00153-9; European Medicines Agency, 2010, EMA7328062010; FRANK AL, 1980, J CLIN MICROBIOL, V12, P426, DOI 10.1128/JCM.12.3.426-432.1980; Genzel Y, 2009, EXPERT REV VACCINES, V8, P1681, DOI [10.1586/erv.09.128, 10.1586/ERV.09.128]; Govorkova EA, 1996, J VIROL, V70, P5519, DOI 10.1128/JVI.70.8.5519-5524.1996; Granstrom M, 2011, VACCINE, V29, P7572, DOI 10.1016/j.vaccine.2011.08.017; Hamilton SB, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-66; Hassantoufighi A, 2010, VACCINE, V28, P790, DOI 10.1016/j.vaccine.2009.10.066; HIERHOLZER JC, 1993, J CLIN MICROBIOL, V31, P1504, DOI 10.1128/JCM.31.6.1504-1510.1993; Hussain AI, 2010, VACCINE, V28, P3848, DOI 10.1016/j.vaccine.2010.03.005; Kim JS, 2008, J CLIN VIROL, V42, P264, DOI 10.1016/j.jcv.2008.03.015; Lam WY, 2008, J VIROL, V82, P2741, DOI 10.1128/JVI.01712-07; Li IWS, 2009, J CLIN VIROL, V46, P325, DOI 10.1016/j.jcv.2009.09.013; ORSTAVIK I, 1981, ACTA PATH MICRO IM B, V89, P179; SCHEPETIUK SK, 1993, J VIROL METHODS, V42, P241, DOI 10.1016/0166-0934(93)90036-Q; Schultz-Cherry S, 1998, J CLIN MICROBIOL, V36, P3718, DOI 10.1128/JCM.36.12.3718-3720.1998; USUBA O, 1990, Viral Immunology, V3, P237, DOI 10.1089/vim.1990.3.237; WHO, 2011, MAN LAB DIAGN VIR SU; Zhirnov O, 2003, VIROLOGY, V313, P198, DOI 10.1016/S0042-6822(03)00264-2; Zhirnov OP, 2009, J CLIN VIROL, V45, P322, DOI 10.1016/j.jcv.2009.05.030	24	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52327	10.1371/journal.pone.0052327	http://dx.doi.org/10.1371/journal.pone.0052327			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284988	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500144
J	Fang, P; Hu, JH; Cheng, ZG; Liu, ZF; Wang, JL; Jiao, SC				Fang, Ping; Hu, Jin-hua; Cheng, Zhi-gang; Liu, Zhe-feng; Wang, Jin-liang; Jiao, Shun-chang			Efficacy and Safety of Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma: A Systematic Review of Phase II Trials	PLOS ONE			English	Article							PLUS ERLOTINIB; THERAPY; CANCER; COMBINATION; CHEMOTHERAPY; PERSPECTIVES; CHALLENGES; MANAGEMENT	Background: Hepatocellular carcinoma (HCC) is a common cancer associated with a poor prognosis. Bevacizumab is a monoclonal antibody that binds vascular endothelial growth factor, a mediator of tumor angiogenesis. Bevacizumab is currently under investigation as treatment for HCC. We performed a systematic review of the efficacy and safety of bevacizumab for the treatment of advanced HCC. Methods: PubMed, the Cochrane Library, and Google Scholar were searched using the terms "bevacizumab AND hepatocellular carcinoma AND (advanced OR unresectable)". Phase II trials of bevacizumab for the treatment of advanced HCC were included. Outcomes of interest included progression-free and overall survival (PFS and OS), tumor response, and toxicities. Results: A total of 26 records were identified. Of these, 18 were excluded. Hence, eight trials involving 300 patients were included. Bevacizumab was given as monotherapy (n = 1 trial) or in combination with erlotinib (n = 4 trials), capecitabine (n = 1 trial), capecitabine+oxaliplatin (n = 1 trial), or gemcitabine+oxaliplatin (n = 1 trial). Most trials (five of eight) reported median PFS and OS between 5.3 months and 9.0 months and 5.9 and 13.7 months, respectively. The disease control rate was consistent in five of eight trials, ranging from 51.1% to 76.9%. The response and partial response rates ranged from 0 to 23.7%, but were around 20% in four trials. Only one patient had a complete response. Frequently reported Grade 3/4 toxicities were increased aspartate transaminase/alanine transaminase (13%), fatigue (12%), hypertension (10%), diarrhea (8%), and neutropenia (5%). Thirty patients experienced gastrointestinal bleeding (grade 1/2 = 18, grade 3/4 = 12), typically due to esophageal varices. Conclusions: Bevacizumab shows promise as an effective and tolerable treatment for advanced HCC. The reported efficacy of bevacizumab appears to compare favorably with that of sorafenib, the only currently approved treatment for unresectable HCC. Phase III trials are warranted to comprehensively examine the efficacy and safety of bevacizumab for treatment of advanced HCC.	[Fang, Ping; Liu, Zhe-feng; Wang, Jin-liang; Jiao, Shun-chang] Peoples Liberat Army Gen Hosp, Inst Canc, Dept Oncol, Beijing, Peoples R China; [Hu, Jin-hua] Shandong Prov Hosp, Dept Digest, Jinan, Peoples R China; [Cheng, Zhi-gang] Peoples Liberat Army Gen Hosp, Inst Canc, Dept Ultrasound Intervent, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Shandong First Medical University & Shandong Academy of Medical Sciences; Chinese People's Liberation Army General Hospital	Jiao, SC (corresponding author), Peoples Liberat Army Gen Hosp, Inst Canc, Dept Oncol, Beijing, Peoples R China.	fangping301@sina.com						Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Di Fiore F, 2009, BEST PRACT RES CL GA, V23, P113, DOI 10.1016/j.bpg.2008.11.016; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Frenette C, 2012, WORLD J GASTROENTERO, V18, P498, DOI 10.3748/wjg.v18.i6.498; Han KH, 2011, ONCOLOGY-BASEL, V81, P158, DOI 10.1159/000333280; Hsu CH, 2010, BRIT J CANCER, V102, P981, DOI 10.1038/sj.bjc.6605580; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kaseb AO, 2012, ONCOLOGY-BASEL, V82, P67, DOI 10.1159/000335963; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; McGlynn KA, 2001, INT J CANCER, V94, P290, DOI 10.1002/ijc.1456; Philip PA, 2005, J CLIN ONCOL, V23, P6657, DOI 10.1200/JCO.2005.14.696; Philip PA, 2012, CANCER-AM CANCER SOC, V118, P2424, DOI 10.1002/cncr.26556; Presta LG, 1997, CANCER RES, V57, P4593; Randall LM, 2010, GYNECOL ONCOL, V117, P497, DOI 10.1016/j.ygyno.2010.02.021; Rossi L, 2010, WORLD J GASTRO ONCOL, V2, P348, DOI 10.4251/wjgo.v2.i9.348; Saad ED, 2009, ANN ONCOL, V20, P460, DOI 10.1093/annonc/mdn670; Shojaei F, 2012, CANCER LETT, V320, P130, DOI 10.1016/j.canlet.2012.03.008; Sia D, 2011, ONCOLOGY-BASEL, V81, P18, DOI 10.1159/000333254; Siegel AB, 2008, J CLIN ONCOL, V26, P2992, DOI 10.1200/JCO.2007.15.9947; Sun WJ, 2011, CANCER-AM CANCER SOC, V117, P3187, DOI 10.1002/cncr.25889; Thomas MB, 2005, J CLIN ONCOL, V23, P2892, DOI 10.1200/JCO.2005.03.196; Thomas MB, 2007, CANCER-AM CANCER SOC, V110, P1059, DOI 10.1002/cncr.22886; Thomas MB, 2009, J CLIN ONCOL, V27, P843, DOI 10.1200/JCO.2008.18.3301; Woodburn JR, 1999, PHARMACOL THERAPEUT, V82, P241, DOI 10.1016/S0163-7258(98)00045-X; Yau T, 2012, INVEST NEW DRUGS; Yeo W, 2005, JNCI-J NATL CANCER I, V97, P1532, DOI 10.1093/jnci/dji315; Zhu AX, 2006, J CLIN ONCOL, V24, P1898, DOI 10.1200/JCO.2005.04.9130	29	60	61	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e49717	10.1371/journal.pone.0049717	http://dx.doi.org/10.1371/journal.pone.0049717			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284624	Green Published, Green Submitted, gold			2022-12-27	WOS:000312694300008
J	Wang, QD; Hu, C; Short, LA; Fu, GY				Wang, Qiandong; Hu, Chao; Short, Lindsey A.; Fu, Genyue			The Influence of Shyness on the Scanning of Own- and Other-Race Faces in Adults	PLOS ONE			English	Article							EYE-TO-EYE; SOCIAL ANXIETY; FACIAL EXPRESSIONS; INDIVIDUAL-DIFFERENCES; GAZE; ATTENTION; DISORDER; BEHAVIOR; CHILDREN; AREA	The current study explored the relationship between shyness and face scanning patterns for own- and other-race faces in adults. Participants completed a shyness inventory and a face recognition task in which their eye movements were recorded by a Tobii 1750 eye tracker. We found that: (1) Participants' shyness scores were negatively correlated with the fixation proportion on the eyes, regardless of the race of face they viewed. The shyer the participants were, the less time they spent fixating on the eye region; (2) High shyness participants tended to fixate significantly more than low shyness participants on the regions just below the eyes as if to avoid direct eye contact; (3) When participants were recognizing own-race faces, their shyness scores were positively correlated with the normalized criterion. The shyer they were, the more apt they were to judge the faces as novel, regardless of whether they were target or foil faces. The present results support an avoidance hypothesis of shyness, suggesting that shy individuals tend to avoid directly fixating on others' eyes, regardless of face race.	[Wang, Qiandong; Hu, Chao; Fu, Genyue] Zhejiang Normal Univ, Dept Psychol, Jinhua, Zhejiang, Peoples R China; [Hu, Chao] Univ Toronto, Dept Human Dev & Appl Psychol, Toronto, ON, Canada; [Short, Lindsey A.] Brock Univ, Dept Psychol, St Catharines, ON L2S 3A1, Canada; [Fu, Genyue] Zhejiang Normal Univ, Hangzhou Coll Kindergarten Teachers, Hangzhou, Zhejiang, Peoples R China	Zhejiang Normal University; University of Toronto; Brock University; Zhejiang Normal University	Fu, GY (corresponding author), Zhejiang Normal Univ, Dept Psychol, Jinhua, Zhejiang, Peoples R China.	fugy@zjnu.cn	Hu, Chao S./I-2666-2019	Hu, Chao S./0000-0003-3315-9651	National Natural Science Foundation of China [31070894]; Program for Innovative Research Team in Zhejiang Normal University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Innovative Research Team in Zhejiang Normal University	This research was funded by National Natural Science Foundation of China, No. 31070894 (http://www.nsfc.gov.cn/Portal0/default152.htm) and Program for Innovative Research Team in Zhejiang Normal University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIEN JL, 1993, J AM ACAD CHILD PSY, V32, P617, DOI 10.1097/00004583-199305000-00019; Battaglia M, 2004, J AM ACAD CHILD PSY, V43, P358, DOI 10.1097/00004583-200403000-00019; Blais C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003022; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Brunet PM, 2009, J ANXIETY DISORD, V23, P909, DOI 10.1016/j.janxdis.2009.05.009; BUITELAAR JK, 1991, J CHILD PSYCHOL PSYC, V32, P995, DOI 10.1111/j.1469-7610.1991.tb01925.x; Caldara R, 2005, J COGNITIVE NEUROSCI, V17, P1652, DOI 10.1162/089892905774597254; Caldara R, 2011, BEHAV RES METHODS, V43, P864, DOI 10.3758/s13428-011-0092-x; Cheek J.M., 1990, HDB SOCIAL EVALUATIO, P47; Cheek J.M, 1983, REVISED CHEEK BUSS S; Chen YP, 2002, BEHAV RES THER, V40, P677, DOI 10.1016/S0005-7967(01)00086-9; Clark D. M., 1995, SOCIALPHOBIA DIAGNOS, P69, DOI DOI 10.1017/S1352465808004487; DALY S, 1978, BRIT J SOC CLIN PSYC, V17, P117, DOI 10.1111/j.2044-8260.1978.tb00252.x; FARABEE DJ, 1993, J RES PERS, V27, P365, DOI 10.1006/jrpe.1993.1025; Fu GY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037688; Garner M, 2006, J ABNORM PSYCHOL, V115, P760, DOI 10.1037/0021-843X.115.4.760; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Hofmann SG, 1997, J ANXIETY DISORD, V11, P573, DOI 10.1016/S0887-6185(97)00040-6; Horley K, 2003, J ANXIETY DISORD, V17, P33, DOI 10.1016/S0887-6185(02)00180-9; Jack RE, 2009, CURR BIOL, V19, P1543, DOI 10.1016/j.cub.2009.07.051; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kelly DJ, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00006; Mansell W, 1999, COGNITION EMOTION, V13, P673, DOI 10.1080/026999399379032; Mogg K, 2000, J ABNORM PSYCHOL, V109, P695, DOI 10.1037/0021-843X.109.4.695; Mondloch CJ, 2010, PERCEPTION, V39, P819, DOI 10.1068/p6584; Perlman SB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005952; PILKONIS PA, 1977, J PERS, V45, P596, DOI 10.1111/j.1467-6494.1977.tb00174.x; Rosenthal MZ, 2011, PERSONAL DISORD, V2, P327, DOI 10.1037/a0023672; Rubin K. H., 1993, SOCIAL WITHDRAWAL IN; Schmidt L. A., 2010, DEV SHYNESS SOCIAL W, P23; Strand PS, 2008, INFANT CHILD DEV, V17, P109, DOI 10.1002/icd.534; Thomas KM, 2001, BIOL PSYCHIAT, V49, P309, DOI 10.1016/S0006-3223(00)01066-0; Wang X., 1993, RATING SCALES MENTAL; Wieser MJ, 2009, J ANXIETY DISORD, V23, P93, DOI 10.1016/j.janxdis.2008.04.004; Willenbockel V, 2010, BEHAV RES METHODS, V42, P671, DOI 10.3758/BRM.42.3.671	35	3	3	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52203	10.1371/journal.pone.0052203	http://dx.doi.org/10.1371/journal.pone.0052203			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	059HF	23284933	gold, Green Published, Green Submitted			2022-12-27	WOS:000312694300080
J	Dumesnil, H; Cortaredona, S; Verdoux, H; Sebbah, R; Paraponaris, A; Verger, P				Dumesnil, Helene; Cortaredona, Sebastien; Verdoux, Helene; Sebbah, Remy; Paraponaris, Alain; Verger, Pierre			General Practitioners' Choices and Their Determinants When Starting Treatment for Major Depression: A Cross Sectional, Randomized Case-Vignette Survey	PLOS ONE			English	Article							PRIMARY-CARE PHYSICIANS; MANAGEMENT; GUIDELINES; DISORDERS; ANTIDEPRESSANTS; RECOMMENDATIONS; EPIDEMIOLOGY; DECISIONS; QUALITY; GENDER	Background: In developed countries, primary care physicians manage most patients with depression. Relatively few studies allow a comprehensive assessment of the decisions these doctors make in these cases and the factors associated with these decisions. We studied how general practitioners (GPs) manage the acute phase of a new episode of non-comorbid major depression (MD) and the factors associated with their decisions. Methodology/Principal Findings: In this cross-sectional telephone survey, professional investigators interviewed an existing panel of randomly selected GPs (1249/1431, response rate: 87.3%). We used case-vignettes about new MD episodes in 8 versions differing by patient gender and socioeconomic status (blue/white collar) and disease intensity (mild/severe). GPs were randomized to receive one of these 8 versions. Overall, 82.6% chose pharmacotherapy; among them GPs chose either an antidepressant (79.8%) or an anxiolytic/hypnotic alone (18.5%). They rarely recommended referral for psychotherapy alone, regardless of severity, but 38.2% chose it in combination with pharmacotherapy. Antidepressant prescription was associated with severity of depression (OR = 1.74; 95% CI = 1.33-2.27), patient gender (female, OR = 0.75; 95% CI = 0.58-0.98), GP personal characteristics (e.g. history of antidepressant treatment: OR = 2.31; 95% CI = 1.41-3.81) and GP belief that antidepressants are overprescribed in France (OR = 0.63; 95% CI = 0.48-0.82). The combination of antidepressants and psychotherapy was associated with severity of depression (OR = 1.82; 95% CI = 1.31-2.52), patient's white-collar status (OR = 1.58; 95% CI = 1.14-2.18), and GPs' dissatisfaction with cooperation with mental health specialists (OR = 0.63; 95% CI = 0.45-0.89). These choices were not associated with either GPs' professional characteristics or psychiatrist density in the GP's practice areas. Conclusions/Significance: GPs' choices for treating severe MD complied with clinical guidelines better than those for mild MD; GPs rarely recommended psychotherapy alone but rather as a complement to pharmacotherapy. Their decisions were mainly influenced by personal life experience and attitudes regarding treatment more than by professional characteristics. These results call into question the methods and content of continuing medical education in France about MD management. Citation: Dumesnil H, Cortaredona S, Verdoux H, Sebbah R, Paraponaris A, et al. (2012) General Practitioners' Choices and Their Determinants When Starting Treatment for Major Depression: A Cross Sectional, Randomized Case-Vignette Survey. PLoS ONE 7(12): e52429. doi:10.1371/journal.pone. 0052429	[Dumesnil, Helene; Cortaredona, Sebastien; Paraponaris, Alain; Verger, Pierre] INSERM, SESSTIM, UMR912, F-13258 Marseille, France; [Dumesnil, Helene; Cortaredona, Sebastien; Paraponaris, Alain; Verger, Pierre] Aix Marseille Univ, IRD, UMR S912, Marseille, France; [Dumesnil, Helene; Cortaredona, Sebastien; Paraponaris, Alain; Verger, Pierre] ORS Paca, Marseille, France; [Verdoux, Helene] Univ Bordeaux, U657, Bordeaux, France; [Verdoux, Helene] INSERM, U657, Bordeaux, France; [Sebbah, Remy] Union Reg Profess Sante Med Liberaux Prov Alpes C, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Verger, P (corresponding author), INSERM, SESSTIM, UMR912, F-13258 Marseille, France.	pierre.verger@inserm.fr	Verdoux, Helene/T-1996-2019	Verdoux, Helene/0000-0003-2948-3782; Paraponaris, Alain/0000-0001-8281-8305; Dumesnil, Helene/0000-0002-4214-8949; Cortaredona, Sebastien/0000-0003-3523-7158	Direction de la Recherche, des Etudes, de l'Evaluation et des Statistiques (DREES) - Ministere du travail, des relations sociales, de la famille, de la solidarite et de la ville/Ministere de la Sante et des Sports; Observatoire Regional de la Sante Provence-Alpes-Cote d'Azur; Institut de la Recherche en Sante Publique (IReSP) in the frame of the Research Program "Sante mentale, prevention, prospective, thematiques generales de l'IReSP"	Direction de la Recherche, des Etudes, de l'Evaluation et des Statistiques (DREES) - Ministere du travail, des relations sociales, de la famille, de la solidarite et de la ville/Ministere de la Sante et des Sports; Observatoire Regional de la Sante Provence-Alpes-Cote d'Azur; Institut de la Recherche en Sante Publique (IReSP) in the frame of the Research Program "Sante mentale, prevention, prospective, thematiques generales de l'IReSP"	The French Regional Panel of General Practices received funding from: 1) the Direction de la Recherche, des Etudes, de l'Evaluation et des Statistiques (DREES) - Ministere du travail, des relations sociales, de la famille, de la solidarite et de la ville/Ministere de la Sante et des Sports as part of the 2010-2012 contract with the Observatoire Regional de la Sante Provence-Alpes-Cote d'Azur; 2) the Institut de la Recherche en Sante Publique (IReSP) in the frame of the Research Program 2011 "Sante mentale, prevention, prospective, thematiques generales de l'IReSP''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P47; American Psychiatric Association, 2010, PRACT GUID TREATM PA; Andersson SJ, 2001, FAM PRACT, V18, P64, DOI 10.1093/fampra/18.1.64; Andersson Stig J, 2005, BMC Fam Pract, V6, P21, DOI 10.1186/1471-2296-6-21; Backenstrass M, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-190; Barley EA, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-47; Bartels SJ, 1997, INT J PSYCHIAT MED, V27, P215, DOI 10.2190/VKBR-1AR6-9NBD-0N25; Bauer M, 2007, WORLD J BIOL PSYCHIA, V8, P66, DOI 10.1080/15622970701308413; Bernheim SM, 2008, ANN FAM MED, V6, P53, DOI 10.1370/afm.749; Briffault X, 2008, SOC PSYCH PSYCH EPID, V43, P165, DOI 10.1007/s00127-007-0281-1; Dumesnil H, 2011, STRATEGIES PRISE CHA; Epstein SA, 2008, MED CARE RES REV, V65, P674, DOI 10.1177/1077558708320987; Frayne SM, 2004, J WOMENS HEALTH, V13, P919, DOI 10.1089/jwh.2004.13.919; Hyde J, 2005, BRIT J GEN PRACT, V55, P755; Johnston O, 2004, BR J GEN PRACT, V57, P872; Kendrick T, 2005, BRIT J GEN PRACT, V55, P280; Kennedy SH, 2003, CAN FAM PHYSICIAN, V49, P489; Kilbourne AM, 2007, CURR OPIN PSYCHIATR, V20, P626, DOI 10.1097/YCO.0b013e3282f0c4d3; Kirby M, 1999, INT J GERIATR PSYCH, V14, P280, DOI 10.1002/(SICI)1099-1166(199904)14:4<280::AID-GPS898>3.3.CO;2-F; Kisely S, 2000, PSYCHOL MED, V30, P1217, DOI 10.1017/S0033291799002743; Kosteniuk J, 2012, CAN FAM PHYSICIAN, V58, pE152; Kovess-Masfety V, 2007, PSYCHIAT SERV, V58, P213, DOI 10.1176/appi.ps.58.2.213; Kravitz RL, 2006, J GEN INTERN MED, V21, P584, DOI 10.1111/j.1525-1497.2006.00411.x; Martin-Agueda B, 2005, GEN HOSP PSYCHIAT, V27, P305, DOI 10.1016/j.genhosppsych.2005.05.002; Mercier A, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-99; Meredith LS, 2007, PSYCHIAT SERV, V58, P72, DOI 10.1176/appi.ps.58.1.72; Mitchell AJ, 2009, LANCET, V374, P609, DOI 10.1016/S0140-6736(09)60879-5; [National Agency for Health Accreditation and Evaluation] Agence Nationale d'Accreditation et d'Evaluation en Sante, 2002, OUTP MAN IS DEPR EP; National Collaborating Centre for Mental Health, 2009, DEPR TREATM MAN DEPR; National Health Insurance Fund] Caisse Nationale d'Assurance Maladie (2011) [Medication Use and Expenditures in France and Europe. Trends 2006-2009, 2006, CONS DEP MED FRANC E; Ogden J, 2004, FAM PRACT, V21, P479, DOI 10.1093/fampra/cmh502; Patten SB, 2008, CAN J PSYCHIAT, V53, P689, DOI 10.1177/070674370805301008; Peabody JW, 2004, ANN INTERN MED, V141, P771, DOI 10.7326/0003-4819-141-10-200411160-00008; POTTHOFF RF, 1994, AM J EPIDEMIOL, V139, P967, DOI 10.1093/oxfordjournals.aje.a116946; Ross S, 1999, BRIT J GEN PRACT, V49, P17; Sicart D, 2008, MED EST LER JENV 200; Stafford Randall S., 2001, Prim Care Companion J Clin Psychiatry, V3, P232; Tarricone R, 2000, PHARMACOECONOMICS, V17, P167, DOI 10.2165/00019053-200017020-00005; Timonen M, 2008, BMJ-BRIT MED J, V336, P435, DOI 10.1136/bmj.39478.609097.BE; Vasiliadis HM, 2005, CAN J PSYCHIAT, V50, P614, DOI 10.1177/070674370505001007; Verger P, 2008, OCCUP ENVIRON MED, V65, P392, DOI 10.1136/oem.2007.035808; Verger P, 2008, CAN J PSYCHIAT, V53, P94, DOI 10.1177/070674370805300204; Verger P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041837; WILLIAMS JBW, 1995, AM J OBSTET GYNECOL, V173, P654, DOI 10.1016/0002-9378(95)90298-8; WRIGHT AF, 1988, J ROY COLL GEN PRACT, V38, P542	45	28	30	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52429	10.1371/journal.pone.0052429	http://dx.doi.org/10.1371/journal.pone.0052429			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	056JC	23272243	Green Published, Green Submitted, gold			2022-12-27	WOS:000312483300085
J	Nie, K; Qi, SX; Zhang, Y; Luo, L; Xie, Y; Yang, MJ; Zhang, Y; Li, J; Shen, HW; Li, Q; Ma, XJ				Nie, Kai; Qi, Shun-xiang; Zhang, Yong; Luo, Le; Xie, Yun; Yang, Meng-jie; Zhang, Yi; Li, Jin; Shen, Hongwei; Li, Qi; Ma, Xue-jun			Evaluation of a Direct Reverse Transcription Loop-Mediated Isothermal Amplification Method without RNA Extraction for the Detection of Human Enterovirus 71 Subgenotype C4 in Nasopharyngeal Swab Specimens	PLOS ONE			English	Article							HYDROXYNAPHTHOL BLUE-DYE; RAPID DETECTION; VISUAL DETECTION; CEREBROSPINAL-FLUID; RT-PCR; DNA; VIRUS; ASSAY; BLOOD; SERUM	Human enterovirus 71 (EV71) is the major causative agent of hand, foot, and mouth disease (HFMD) worldwide and has been associated with neurological complications which resulted in fatalities during recent outbreak in Asia pacific region. A direct reverse transcription loop-mediated isothermal amplification (direct RT-LAMP) assay using heat-treated samples without RNA extraction was developed and evaluated for the detection of EV71 subgenotype C4 in nasopharyngeal swab specimens. The analytical sensitivity and specificity of the direct RT-LAMP assay were examined. The detection limit of the direct RT-LAMP assays was 1.6 of a 50% tissue culture infective dose (TCID50) per reaction and no cross-reaction was observed with control viruses including Cosackievirus A (CVA) viruses (CVA2,4,5,7,9,10,14,16, and 24), Coxsackievirus B (CVB) viruses (CVB1,2,3,4, and 5) or ECHO viruses (ECHO3,6,11, and 19). The direct RT-LAMP assay was evaluated and compared to both RT-LAMP and quantitative real-time PCR (qRT-PCR) in detecting EV71 infection with 145 nasopharyngeal swab specimens. The clinical performance demonstrated the sensitivity and specificity of direct RT-LAMP was reported to be 90.3% and 100% respectively, compared to RT-LAMP, and 86.83% and 100% respectively, compared to qRT-PCR. These data demonstrated that the direct RT-LAMP assay can potentially be developed for the point of care screening of EV71 infection in China.	[Qi, Shun-xiang; Xie, Yun; Li, Qi] Ctr Dis Control & Prevent Hebei, Inst Viral Dis Control & Prevent, Shijiazhuang, Hebei, Peoples R China; [Nie, Kai; Zhang, Yong; Luo, Le; Yang, Meng-jie; Zhang, Yi; Li, Jin; Shen, Hongwei; Ma, Xue-jun] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Li, Q (corresponding author), Ctr Dis Control & Prevent Hebei, Inst Viral Dis Control & Prevent, Shijiazhuang, Hebei, Peoples R China.	liqinew@yahoo.com.cn; maxj2004@yahoo.com.cn	Nie, Kai/L-5389-2019	Zhang, Yong/0000-0002-2692-5437	China Mega-Project for Infectious Disease [2011ZX10004-001, 2012ZX10004-215]; State Key Laboratory for Genetic Engineering and Molecular Virology	China Mega-Project for Infectious Disease; State Key Laboratory for Genetic Engineering and Molecular Virology	This work was supported by the China Mega-Project for Infectious Disease (2011ZX10004-001, 2012ZX10004-215) and a research grant from the State Key Laboratory for Genetic Engineering and Molecular Virology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baethgen LF, 2003, J MED MICROBIOL, V52, P793, DOI 10.1099/jmm.0.05192-0; Bista BR, 2007, J CLIN MICROBIOL, V45, P1581, DOI 10.1128/JCM.01024-06; Cardoso MA, 2009, ZOONOSES PUBLIC HLTH, V56, P465, DOI 10.1111/j.1863-2378.2008.01199.x; Enomoto Y, 2005, J CLIN MICROBIOL, V43, P951, DOI 10.1128/JCM.43.2.951-955.2005; Fujimoto T, 2008, JPN J INFECT DIS, V61, P497; Haridas DV, 2010, J VIROL METHODS, V167, P61, DOI 10.1016/j.jviromet.2010.03.011; Ihira M, 2007, J CLIN VIROL, V39, P22, DOI 10.1016/j.jcv.2007.02.001; Ihira M, 2010, J VIROL METHODS, V167, P103, DOI 10.1016/j.jviromet.2010.01.025; Jiang T, 2011, J CLIN MICROBIOL, V49, P870, DOI 10.1128/JCM.02045-10; Kuan CP, 2010, J VIROL METHODS, V169, P61, DOI 10.1016/j.jviromet.2010.06.017; Luo L, 2011, J CLIN MICROBIOL, V49, P3545, DOI 10.1128/JCM.00930-11; Ma XJ, 2010, J VIROL METHODS, V167, P214, DOI 10.1016/j.jviromet.2010.03.027; Nakamichi K, 2011, JPN J INFECT DIS, V64, P211; Nemoto M, 2011, J VET MED SCI, V73, P1225, DOI 10.1292/jvms.11-0065; Nie K, 2011, J VIROL METHODS, V175, P283, DOI 10.1016/j.jviromet.2011.05.020; Nishimura N, 2010, J VIROL METHODS, V163, P282, DOI 10.1016/j.jviromet.2009.10.011; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Parida M, 2005, J CLIN MICROBIOL, V43, P2895, DOI 10.1128/JCM.43.6.2895-2903.2005; Poon LLM, 2006, CLIN CHEM, V52, P303; RUWAIDA ASA, 1976, EUR J APPL MICROBIOL, V2, P73, DOI 10.1007/BF00942349; Saitou Y, 2010, J VIROL METHODS, V168, P13, DOI 10.1016/j.jviromet.2010.04.008; Sarmiento PL, 2000, REV CUBANA MED TROP, V52, P15; Shi WF, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-197; Tan EL, 2008, J CLIN VIROL, V42, P203, DOI 10.1016/j.jcv.2008.01.001; Victor ST, 2009, MOL DIAGN THER, V13, P383, DOI 10.2165/11317520-000000000-00000; Xia JF, 2011, DIAGN MICR INFEC DIS, V71, P244, DOI 10.1016/j.diagmicrobio.2011.07.014; Xiao XL, 2009, ARCH VIROL, V154, P121, DOI 10.1007/s00705-008-0266-8	27	34	41	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52486	10.1371/journal.pone.0052486	http://dx.doi.org/10.1371/journal.pone.0052486			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272248	Green Published, gold, Green Submitted			2022-12-27	WOS:000312483300090
J	Sekiguchi, S; Kimura, K; Chiyo, T; Ohtsuki, T; Tobita, Y; Tokunaga, Y; Yasui, F; Tsukiyama-Kohara, K; Wakita, T; Tanaka, T; Miyasaka, M; Mizuno, K; Hayashi, Y; Hishima, T; Matsushima, K; Kohara, M				Sekiguchi, Satoshi; Kimura, Kiminori; Chiyo, Tomoko; Ohtsuki, Takahiro; Tobita, Yoshimi; Tokunaga, Yuko; Yasui, Fumihiko; Tsukiyama-Kohara, Kyoko; Wakita, Takaji; Tanaka, Toshiyuki; Miyasaka, Masayuki; Mizuno, Kyosuke; Hayashi, Yukiko; Hishima, Tsunekazu; Matsushima, Kouji; Kohara, Michinori			Immunization with a Recombinant Vaccinia Virus That Encodes Nonstructural Proteins of the Hepatitis C Virus Suppresses Viral Protein Levels in Mouse Liver	PLOS ONE			English	Article							TRANSGENIC MICE; STRUCTURAL PROTEINS; CRE/LOXP SYSTEM; IMMUNE-RESPONSE; CORE PROTEIN; SARS-COV; INFECTION; EXPRESSION; CHIMPANZEES; INTERFERON	Chronic hepatitis C, which is caused by infection with the hepatitis C virus (HCV), is a global health problem. Using a mouse model of hepatitis C, we examined the therapeutic effects of a recombinant vaccinia virus (rVV) that encodes an HCV protein. We generated immunocompetent mice that each expressed multiple HCV proteins via a Cre/loxP switching system and established several distinct attenuated rVV strains. The HCV core protein was expressed consistently in the liver after polyinosinic acid-polycytidylic acid injection, and these mice showed chronic hepatitis C-related pathological findings (hepatocyte abnormalities, accumulation of glycogen, steatosis), liver fibrosis, and hepatocellular carcinoma. Immunization with one rVV strain (rVV-N25), which encoded nonstructural HCV proteins, suppressed serum inflammatory cytokine levels and alleviated the symptoms of pathological chronic hepatitis C within 7 days after injection. Furthermore, HCV protein levels in liver tissue also decreased in a CD4 and CD8 T-cell-dependent manner. Consistent with these results, we showed that rVV-N25 immunization induced a robust CD8 T-cell immune response that was specific to the HCV nonstructural protein 2. We also demonstrated that the onset of chronic hepatitis in CN2-29((+/-))/MxCre((+/-)) mice was mainly attributable to inflammatory cytokines, (tumor necrosis factor) TNF-alpha and (interleukin) IL-6. Thus, our generated mice model should be useful for further investigation of the immunological processes associated with persistent expression of HCV proteins because these mice had not developed immune tolerance to the HCV antigen. In addition, we propose that rVV-N25 could be developed as an effective therapeutic vaccine.	[Sekiguchi, Satoshi; Chiyo, Tomoko; Ohtsuki, Takahiro; Tobita, Yoshimi; Tokunaga, Yuko; Yasui, Fumihiko; Kohara, Michinori] Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Setagaya Ku, Tokyo 113, Japan; [Kimura, Kiminori] Tokyo Metropolitan Komagome Hosp, Div Hepatol, Bunkyo Ku, Tokyo, Japan; [Tsukiyama-Kohara, Kyoko] Kagoshima Univ, Transboundary Anim Dis Ctr, Joint Fac Vet Med, Kagoshima 890, Japan; [Wakita, Takaji] Natl Inst Infect Dis, Dept Virol 2, Shinjuku Ku, Tokyo, Japan; [Tanaka, Toshiyuki] Hyogo Univ Hlth Sci, Sch Pharm, Dept Pharm, Immunobiol Lab,Chuo Ku, Kobe, Hyogo, Japan; [Miyasaka, Masayuki] Osaka Univ, Grad Sch Med, Dept Microbiol & Immunol, Lab Immunodynam, Suita, Osaka, Japan; [Mizuno, Kyosuke] Chemoserotherapeut Res Inst, Kumamoto, Japan; [Hayashi, Yukiko; Hishima, Tsunekazu] Tokyo Metropolitan Komagome Hosp, Dept Pathol, Bunkyo Ku, Tokyo, Japan; [Matsushima, Kouji] Univ Tokyo, Sch Med, Dept Mol Prevent Med, Bunkyo Ku, Tokyo 113, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Cancer & Infectious Diseases Center Komagome Hospital; Kagoshima University; National Institute of Infectious Diseases (NIID); Immuno-Biological Laboratories Co. Ltd.; Osaka University; Tokyo Metropolitan Cancer & Infectious Diseases Center Komagome Hospital; University of Tokyo	Kohara, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Setagaya Ku, Bunkyo Ku, Tokyo 113, Japan.	kohara-mc@igakuken.or.jp	kimura, kiminori/H-6186-2019; Kimura, Kiminori/W-3108-2019; Miyasaka, Masayuki/AAM-6343-2020	kimura, kiminori/0000-0002-9352-4721; Kimura, Kiminori/0000-0002-9352-4721; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Program for Promotion of Fundamental Studies in Health Sciences of the Pharmaceuticals and Medical Devices Agency of Japan; Ministry of Health, Labor, and Welfare of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Fundamental Studies in Health Sciences of the Pharmaceuticals and Medical Devices Agency of Japan; Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; the Program for Promotion of Fundamental Studies in Health Sciences of the Pharmaceuticals and Medical Devices Agency of Japan; and the Ministry of Health, Labor, and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTER MJ, 1995, SEMIN LIVER DIS, V15, P5, DOI 10.1055/s-2007-1007259; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; Burkett MW, 2005, J IMMUNOTHER, V28, P396, DOI 10.1097/01.cji.0000165357.11548.6d; Chisari FV, 2005, NATURE, V436, P930, DOI 10.1038/nature04076; CHISARI FV, 1995, SPRINGER SEMIN IMMUN, V17, P261, DOI 10.1007/BF00196169; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629; Dustin LB, 2007, ANNU REV IMMUNOL, V25, P71, DOI 10.1146/annurev.immunol.25.022106.141602; Elmowalid GA, 2007, P NATL ACAD SCI USA, V104, P8427, DOI 10.1073/pnas.0702162104; Folgori A, 2006, NAT MED, V12, P190, DOI 10.1038/nm1353; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; Humlova Z, 2002, J GEN VIROL, V83, P2821, DOI 10.1099/0022-1317-83-11-2821; Jasani B, 2009, VACCINE, V27, P3401, DOI 10.1016/j.vaccine.2009.01.071; Kawamura T, 1997, HEPATOLOGY, V25, P1014, DOI 10.1002/hep.510250437; Kitabatake M, 2007, VACCINE, V25, P630, DOI 10.1016/j.vaccine.2006.08.039; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lang KS, 2006, J CLIN INVEST, V116, P2456, DOI 10.1172/JCI28349; Large MK, 1999, J IMMUNOL, V162, P931; Larrea E, 1996, HEPATOLOGY, V23, P210, DOI 10.1002/hep.510230203; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lerat H, 2002, GASTROENTEROLOGY, V122, P352, DOI 10.1053/gast.2002.31001; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; Machida K, 2001, J BIOL CHEM, V276, P12140, DOI 10.1074/jbc.M010137200; Malaguarnera M, 1997, INT J CLIN PHARM TH, V35, P385; Moriya K, 1998, NAT MED, V4, P1065, DOI 10.1038/2053; Nishimura T, 2009, J BIOL CHEM, V284, P36442, DOI 10.1074/jbc.M109.043232; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Pasquinelli C, 1997, HEPATOLOGY, V25, P719, DOI 10.1002/hep.510250338; Saito T, 1997, GASTROENTEROLOGY, V112, P1321, DOI 10.1016/S0016-5085(97)70146-X; Samuelsson C, 2008, J CLIN INVEST, V118, P1776, DOI 10.1172/JCI33940; Satoi J, 2001, J VIROL, V75, P12121, DOI 10.1128/JVI.75.24.12121-12127.2001; Sheikh MY, 2008, HEPATOLOGY, V47, P2127, DOI 10.1002/hep.22269; SHIMIZU YK, 1993, P NATL ACAD SCI USA, V90, P6037, DOI 10.1073/pnas.90.13.6037; SUGIMOTO M, 1994, VACCINE, V12, P675, DOI 10.1016/0264-410X(94)90215-1; Tilg H, 2008, GUT, V57, P684, DOI 10.1136/gut.2006.117382; Tsukiyama-Kohara K, 2004, J BIOL CHEM, V279, P14531, DOI 10.1074/jbc.M312822200; Wakita T, 1998, J BIOL CHEM, V273, P9001, DOI 10.1074/jbc.273.15.9001; Wakita T, 2000, J MED VIROL, V62, P308, DOI 10.1002/1096-9071(200011)62:3<308::AID-JMV2>3.0.CO;2-6; Yasui F, 2008, J IMMUNOL, V181, P6337, DOI 10.4049/jimmunol.181.9.6337; Youn JW, 2008, J VIROL, V82, P10896, DOI 10.1128/JVI.01179-08; Zhu JG, 2007, BLOOD, V109, P619, DOI 10.1182/blood-2006-06-027136	42	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51656	10.1371/journal.pone.0051656	http://dx.doi.org/10.1371/journal.pone.0051656			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284733	Green Submitted, Green Published, gold			2022-12-27	WOS:000312435900038
J	Whitley, E; Deary, IJ; Der, G; Batty, GD; Benzeval, M				Whitley, Elise; Deary, Ian J.; Der, Geoff; Batty, G. David; Benzeval, Michaela			Paternal Age in Relation to Offspring Intelligence in the West of Scotland Twenty-07 Prospective Cohort Study	PLOS ONE			English	Article							ALL-CAUSE-MORTALITY; REACTION-TIME; PARENTAL AGE; RISK; IQ; SCHIZOPHRENIA; HEALTH; YOUTH; DEATH; OLD	Background: The adverse effects of advancing maternal age on offspring's health and development are well understood. Much less is known about the impact of paternal age. Methods: We explored paternal age-offspring cognition associations in 772 participants from the West of Scotland Twenty-07 study. Offspring cognitive ability was assessed using Part 1 of the Alice Heim 4 (AH4) test of General Intelligence and by reaction time (RT). Results: There was no evidence of a parental age association with offspring RT. However, we observed an inverse U-shaped association between paternal age and offspring AH4 score with the lowest scores observed for the youngest and oldest fathers. Adjustment for parental education and socioeconomic status somewhat attenuated this association. Adjustment for number of, particularly older, siblings further reduced the scores of children of younger fathers and appeared to account for the lower offspring scores in the oldest paternal age group. Conclusion: We observed a paternal age association with AH4 but not RT, a measure of cognition largely independent of social and educational experiences. Factors such as parental education, socioeconomic status and number of, particularly older, siblings may play an important role in accounting for paternal age-AH4 associations. Future studies should include parental intelligence. Citation: Whitley E, Deary IJ, Der G, Batty GD, Benzeval M (2012) Paternal Age in Relation to Offspring Intelligence in the West of Scotland Twenty-07 Prospective Cohort Study. PLoS ONE 7(12): e52112. doi:10.1371/journal.pone.0052112	[Whitley, Elise; Der, Geoff; Benzeval, Michaela] MRC, CSO Social & Publ Hlth Serv Unit, Glasgow, Lanark, Scotland; [Deary, Ian J.; Batty, G. David] Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Batty, G. David] UCL, Dept Epidemiol & Publ Hlth, London, England	University of Edinburgh; University of London; University College London	Whitley, E (corresponding author), MRC, CSO Social & Publ Hlth Serv Unit, Glasgow, Lanark, Scotland.	elise.whitley@bristol.ac.uk	Benzeval, Michaela/J-3163-2015; Batty, GD/Y-4401-2018; Deary, Ian J/C-6297-2009	Benzeval, Michaela/0000-0002-0372-2098; Batty, GD/0000-0003-1822-5753; Deary, Ian J/0000-0002-1733-263X; Whitley, Elise/0000-0002-0297-9078; Der, Geoff/0000-0002-8677-073X	UK Medical Research Council (MRC) [MC_US_A540_53462, MC_US_A540_5TK10, MC_US_A540_5TK30]; Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council; Economic and Social Research Council; MRC; University of Edinburgh as part of the cross-council Lifelong Health and Wellbeing initiative; Medical Research Council [G0700704, MC_U130059823] Funding Source: researchfish; Chief Scientist Office [SPHSU2] Funding Source: researchfish; MRC [MC_U130059823, G0700704] Funding Source: UKRI	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Edinburgh as part of the cross-council Lifelong Health and Wellbeing initiative; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The West of Scotland Twenty-07 Study is funded by the UK Medical Research Council (MRC) (MC_US_A540_53462). E Whitley, M Benzeval (MC_US_A540_5TK10) and G Der (MC_US_A540_5TK30) are funded by the MRC. The Centre for Cognitive Ageing and Cognitive Epidemiology is supported by the Biotechnology and Biological Sciences Research Council, the Engineering and Physical Sciences Research Council, the Economic and Social Research Council, the MRC, and the University of Edinburgh as part of the cross-council Lifelong Health and Wellbeing initiative. GD Batty is a Wellcome Trust Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RJ, 2004, NATURE, V432, P48, DOI 10.1038/432048a; Andersen AMN, 2004, AM J EPIDEMIOL, V160, P1214, DOI 10.1093/aje/kwh332; AUROUX M, 1983, TERATOLOGY, V27, P141, DOI 10.1002/tera.1420270202; AUROUX MR, 1989, HUM REPROD, V4, P794, DOI 10.1093/oxfordjournals.humrep.a136988; Batty GD, 2007, ANN EPIDEMIOL, V17, P278, DOI 10.1016/j.annepidem.2006.07.010; Benzeval M, 2009, INT J EPIDEMIOL, V38, P1215, DOI 10.1093/ije/dyn213; Botting B, 2003, NATL STAT POPUL TREN, V100, P32; Bray I, 2006, J EPIDEMIOL COMMUN H, V60, P851, DOI 10.1136/jech.2005.045179; Calvin CM, 2011, INT J EPIDEMIOL, V40, P626, DOI 10.1093/ije/dyq190; Coleman DA, 2000, INT ST DEMOG, P29; Cox BD, 1993, HLTH LIFESTYLE SURVE; Deary IJ, 2010, PSYCHOL AGING, V25, P219, DOI 10.1037/a0017750; Deary IJ, 2005, PSYCHOL SCI, V16, P64, DOI 10.1111/j.0956-7976.2005.00781.x; Deary IJ, 2005, AGING NEUROPSYCHOL C, V12, P187, DOI 10.1080/13825580590969235; Deary IJ, 2001, INTELLIGENCE, V29, P389, DOI 10.1016/S0160-2896(01)00062-9; Deary IJ, 2006, HUMAN ABILITY GENETI; Der G, 2003, INTELLIGENCE, V31, P491, DOI 10.1016/S0160-2896(02)00189-7; Der G, 1998, COMP W SCOTLAND 2 07; Downey DB, 2001, AM PSYCHOL, V56, P497, DOI 10.1037//0003-066X.56.6-7.497; Edwards RD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012157; El-Saadi O, 2004, SCHIZOPHR RES, V67, P227, DOI 10.1016/S0920-9964(03)00100-2; Heim A, 1970, MANUAL AII4 GROUP TE; Hultman CM, 2011, MOL PSYCHIATR, V16, P1203, DOI 10.1038/mp.2010.121; Malaspina D, 2005, PSYCHIAT GENET, V15, P117, DOI 10.1097/00041444-200506000-00008; Mathews T, 2009, DELAYED CHILDBEARING; Neiss M, 2002, J BIOSOC SCI, V34, P259, DOI 10.1017/S0021932002002596; ONS, 2009, PATT FATH ENGL WAL 1, P103; Perrin MC, 2007, SCHIZOPHRENIA BULL, V33, P1270, DOI 10.1093/schbul/sbm093; Powell B, 2006, SOC FORCES, V84, P1359, DOI 10.1353/sof.2006.0064; Reichenberg A, 2006, ARCH GEN PSYCHIAT, V63, P1026, DOI 10.1001/archpsyc.63.9.1026; Roberts J, 1974, VITAL HLTH STAT, V11, P1; Saha S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000040; Schmidt L, 2012, HUM REPROD UPDATE, V18, P29, DOI 10.1093/humupd/dmr040; Shaw P, 2012, CEREB CORTEX, V22, P1256, DOI 10.1093/cercor/bhr194; Shipley BA, 2006, PSYCHOSOM MED, V68, P17, DOI 10.1097/01.psy.0000195867.66643.0f; Wohl M, 2007, EUR PSYCHIAT, V22, P22, DOI 10.1016/j.eurpsy.2006.08.007	37	12	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e52112	10.1371/journal.pone.0052112	http://dx.doi.org/10.1371/journal.pone.0052112			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055AH	23272219	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000312386600055
J	Kondo, A; Saiki, J				Kondo, Aki; Saiki, Jun			Feature-Specific Encoding Flexibility in Visual Working Memory	PLOS ONE			English	Article							ORIENTING ATTENTION; FEATURE BINDING; CONJUNCTIONS; REPRESENTATIONS; OBJECTS	The current study examined selective encoding in visual working memory by systematically investigating interference from task-irrelevant features. The stimuli were objects defined by three features (color, shape, and location), and during a delay period, any of the features could switch between two objects. Additionally, single- and whole-probe trials were randomized within experimental blocks to investigate effects of memory retrieval. A series of relevant-feature switch detection tasks, where one feature was task-irrelevant, showed that interference from the task-irrelevant feature was only observed in the color-shape task, suggesting that color and shape information could be successfully filtered out, but location information could not, even when location was a task-irrelevant feature. Therefore, although location information is added to object representations independent of task demands in a relatively automatic manner, other features (e.g., color, shape) can be flexibly added to object representations.	[Kondo, Aki] Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo, Japan; [Saiki, Jun] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto, Japan	University of Tokyo; Kyoto University	Kondo, A (corresponding author), Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo, Japan.	aki.kon10@gmail.com	Saiki, Jun/GXA-1822-2022	Saiki, Jun/0000-0002-3480-4336	Hokuriku Innovation Cluster for Health Science (Ministry of Education, Culture, Sports, Science and Technology Program for Fostering Regional Innovation); Japan Society for the Promotion of Science [21300103]; Ministry of Education, Culture, Sports, Science and Technology	Hokuriku Innovation Cluster for Health Science (Ministry of Education, Culture, Sports, Science and Technology Program for Fostering Regional Innovation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by the Hokuriku Innovation Cluster for Health Science (Ministry of Education, Culture, Sports, Science and Technology Program for Fostering Regional Innovation) to AK, and Grants-in-Aid from the Japan Society for the Promotion of Science (#21300103) and the global COE Program "Revitalizing Education for Dynamic Hearts and Minds'' from Ministry of Education, Culture, Sports, Science and Technology to JS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	GRIER JB, 1971, PSYCHOL BULL, V75, P424, DOI 10.1037/h0031246; Griffin IC, 2003, J COGNITIVE NEUROSCI, V15, P1176, DOI 10.1162/089892903322598139; Johnson JS, 2008, J EXP PSYCHOL HUMAN, V34, P41, DOI 10.1037/0096-1523.34.1.41; Kahneman D, 1992, COGNITIVE PSYCHOL, V24, P174, DOI DOI 10.1016/0010-0285(92)90007-0; Li Q, 2010, C OBJ PERC ATT MEM S; Logie RH, 2011, MEM COGNITION, V39, P24, DOI 10.3758/s13421-010-0001-z; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Makovski T, 2008, J EXP PSYCHOL LEARN, V34, P369, DOI 10.1037/0278-7393.34.2.369; Robertson LC, 2003, NAT REV NEUROSCI, V4, P93, DOI 10.1038/nrn1030; Saiki J, 2003, J VISION, V3, P6, DOI 10.1167/3.1.2; Saiki J, 2003, VISION RES, V43, P2107, DOI 10.1016/S0042-6989(03)00331-6; TREISMAN A, 1982, COGNITIVE PSYCHOL, V14, P107, DOI 10.1016/0010-0285(82)90006-8; Treisman A, 2006, MEM COGNITION, V34, P1704, DOI 10.3758/BF03195932; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Vogel EK, 2001, J EXP PSYCHOL HUMAN, V27, P92, DOI 10.1037/0096-1523.27.1.92; Wheeler ME, 2002, J EXP PSYCHOL GEN, V131, P48, DOI 10.1037//0096-3445.131.1.48	16	18	18	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e50962	10.1371/journal.pone.0050962	http://dx.doi.org/10.1371/journal.pone.0050962			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	064DQ	23284652	Green Submitted, gold, Green Published			2022-12-27	WOS:000313051500007
J	Lambert, SL; Yang, CF; Liu, Z; Sweetwood, R; Zhao, J; Cheng, LL; Jin, H; Woo, J				Lambert, Stacie L.; Yang, Chin-Fen; Liu, Zheng; Sweetwood, Rosemary; Zhao, Jackie; Cheng, Lily; Jin, Hong; Woo, Jennifer			Molecular and Cellular Response Profiles Induced by the TLR4 Agonist-Based Adjuvant Glucopyranosyl Lipid A	PLOS ONE			English	Article							ACTIVATION; CELLS	Background: Toll-like receptor (TLR) 4 agonists are known potent immunostimulatory compounds. These compounds can be formulated as part of novel adjuvants to enhance vaccine medicated immune responses. However, the contribution of the formulation to the innate in vivo activity of TLR4 agonist compounds is not well understood. Methodology and Principal Findings: We evaluated synthetic TLR4 agonist Glucopyranosyl Lipid A (GLA) for its effects on molecular and cellular innate immune responses in the murine model. Microarray techniques were used to compare the responses to GLA in an aqueous formulation or in an oil-in-water Stable Emulsion formulation (GLA-SE) versus either SE alone or the mineral salt aluminum hydroxide (alum) at the muscle injection site over multiple timepoints. In contrast to the minimal gene upregulation induced by SE and alum, both GLA and GLA-SE triggered MyD88- and TRIF-dependent gene expression. Genes for chemokines, cytokine receptors, signaling molecules, complement, and antigen presentation were also strongly upregulated by GLA and GLA-SE. These included chemokines for TH1-type T cells (CXCL9 and CXCL10) and mononuclear leukocytes (CCL2, CCL3) among others. GLA-SE induced stronger and more sustained gene upregulation than GLA in the muscle; GLA-SE induced genes were also detected in local draining lymph nodes and at lower levels in peripheral blood. Both GLA and GLA-SE resulted in increased cellular trafficking to the draining lymph nodes and upregulated MHC molecules and ICAM1 on local dendritic cells. GLA and GLA-SE transiently upregulated circulating MCP-1, TNF alpha, IFN gamma and IP-10 in blood. Conclusions/Significance: While GLA and GLA-SE activate a large number of shared innate genes and proteins, GLA-SE induces a quantitatively and qualitatively stronger response than GLA, SE or alum. The genes and proteins upregulated could be used to facilitate selection of appropriate adjuvant doses in vaccine formulations.	[Lambert, Stacie L.; Yang, Chin-Fen; Liu, Zheng; Sweetwood, Rosemary; Zhao, Jackie; Cheng, Lily; Jin, Hong; Woo, Jennifer] MedImmune LLC, Mountain View, CA USA	AstraZeneca; Medimmune	Jin, H (corresponding author), MedImmune LLC, Mountain View, CA USA.	jinh@medimmune.com; wooj@medimmune.com						Ahmed SS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002302; Anderson RC, 2010, COLLOID SURFACE B, V75, P123, DOI 10.1016/j.colsurfb.2009.08.022; Baldwin SL, 2009, VACCINE, V27, P5956, DOI 10.1016/j.vaccine.2009.07.081; Calabro S, 2011, VACCINE, V29, P1812, DOI 10.1016/j.vaccine.2010.12.090; Coler RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016333; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; Eddahri F, 2009, BLOOD, V113, P2426, DOI 10.1182/blood-2008-04-154682; Eskay R L, 1990, Adv Exp Med Biol, V274, P331; Fruh K, 1999, CURR OPIN IMMUNOL, V11, P76, DOI 10.1016/S0952-7915(99)80014-4; Garcon N, 2007, EXPERT REV VACCINES, V6, P723, DOI 10.1586/14760584.6.5.723; Kang Suk-Jo, 2009, F1000 Biol Rep, V1, P15, DOI 10.3410/B1-15; Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004; Le YY, 2004, CELL MOL IMMUNOL, V1, P95; Marino M, 2011, GENE THER, V18, P109, DOI 10.1038/gt.2010.124; Martin M, 2003, INFECT IMMUN, V71, P2498, DOI 10.1128/IAI.71.5.2498-2507.2003; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Morel S, 2011, VACCINE, V29, P2461, DOI 10.1016/j.vaccine.2011.01.011; Mosca F, 2008, P NATL ACAD SCI USA, V105, P10501, DOI 10.1073/pnas.0804699105; Rallabhandi P, 2008, J IMMUNOL, V180, P1139, DOI 10.4049/jimmunol.180.2.1139; Raman VS, 2010, J IMMUNOL, V185, P1701, DOI 10.4049/jimmunol.1000238; Ramanathan S, 2008, ARCH IMMUNOL THER EX, V56, P311, DOI 10.1007/s00005-008-0033-2; Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006; Renkl AC, 2005, BLOOD, V106, P946, DOI 10.1182/blood-2004-08-3228; Ryman B E, 1978, Ann N Y Acad Sci, V308, P281, DOI 10.1111/j.1749-6632.1978.tb22031.x; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x	25	35	42	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e51618	10.1371/journal.pone.0051618	http://dx.doi.org/10.1371/journal.pone.0051618			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23284726	gold, Green Published, Green Submitted			2022-12-27	WOS:000313051500013
J	Mostafavi, S; Goldenberg, A; Morris, Q				Mostafavi, Sara; Goldenberg, Anna; Morris, Quaid			Labeling Nodes Using Three Degrees of Propagation	PLOS ONE			English	Article							LANDSCAPE; NETWORK	The properties (or labels) of nodes in networks can often be predicted based on their proximity and their connections to other labeled nodes. So-called "label propagation algorithms" predict the labels of unlabeled nodes by propagating information about local label density iteratively through the network. These algorithms are fast, simple and scale to large networks but nonetheless regularly perform better than slower and much more complex algorithms on benchmark problems. We show here, however, that these algorithms have an intrinsic limitation that prevents them from adapting to some common patterns of network node labeling; we introduce a new algorithm, 3Prop, that retains all their advantages but is much more adaptive. As we show, 3Prop performs very well on node labeling problems ill-suited to label propagation, including predicting gene function in protein and genetic interaction networks and gender in friendship networks, and also performs slightly better on problems already well-suited to label propagation such as labeling blogs and patents based on their citation networks. 3Prop gains its adaptability by assigning separate weights to label information from different steps of the propagation. Surprisingly, we found that for many networks, the third iteration of label propagation receives a negative weight.	[Mostafavi, Sara] Stanford Univ, Dept Comp Sci, Palo Alto, CA 94304 USA; [Goldenberg, Anna] Univ Toronto, Sick Kids Res Inst, Toronto, ON, Canada; [Morris, Quaid] Univ Toronto, Dept Comp Sci, Dept Mol Genet, Toronto, ON, Canada; [Morris, Quaid] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada	Stanford University; University of Toronto; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Mostafavi, S (corresponding author), Stanford Univ, Dept Comp Sci, Palo Alto, CA 94304 USA.	saram@cs.stanford.edu; quaid.morris@utoronto.ca	Morris, Quaid/ABE-8343-2020	Morris, Quaid/0000-0002-2760-6999; Mostafavi, Sara/0000-0003-4698-1177	NSERC operating grant	NSERC operating grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	SM, AG, and QM gratefully acknowledge the support from an NSERC operating grant to QM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic L. A., 2005, P WWW 2005 WORKSH WE; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bengio Y., 2006, SEMISUPERVISED LEARN, P193, DOI [10.7551/mitpress/9780262033589.003.0011, DOI 10.7551/MITPRESS/9780262033589.003.0011]; Bishop C. M, 2006, PATTERN RECOGNITION; Brun C, 2004, GENOME BIOL, V5; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Chua HN, 2006, BIOINFORMATICS, V22, P1623, DOI 10.1093/bioinformatics/btl145; Chung F. R. K., 1997, CBMS REGIONAL C SERI; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Davis J., 2006, P INT C MACH LEARN; Fowler J, 2008, BRIT MED J, V357, P370; Gallagher B., 2008, INT C KNOWL DISC DAT; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Ghahramani Z., 2003, INT C MACH LEARN, P912, DOI DOI 10.1/1/14/4312; Gillis J, 2010, MULTIFUNCTIONA UNPUB; Goh K, 2001, PHYS REV LETT, P87; Hall Bronwyn H., 2001, 8498 NBER; Haveliwala TH, 2002, P 11 INT WORLD WID W, P526; Hess DC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000407; Kondor R, 2009, INT C MACH LEARN; Koutis I, 2010, FOCS; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lanckriet GRG, 2004, BIOINFORMATICS, V20, P2626, DOI 10.1093/bioinformatics/bth294; Lee I, 2011, GENOME RES; Leskovec J, 2006, PAC AS C KNOWL DISC; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Min R, 2009, LEARNING RANDOM WALK; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Myers CL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-187; Newman M, 2006, P NATL ACAD SCI US; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Page Lawrence, 1999, 199966 STANF INFOLAB; Park JY, 2007, P NATL ACAD SCI USA, V104, P17916, DOI 10.1073/pnas.0705081104; Pena-Castillo L, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s2; Qi Y, 2008, GENOME RES, V18, P1991, DOI 10.1101/gr.077693.108; Richardson M, 2002, INT C KNOWL DISC DAT; Smola A, 2003, C LEARN THEOR COLT; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Tong HH, 2008, KNOWL INF SYST, V14, P327, DOI 10.1007/s10115-007-0094-2; Traud A, 2008, 08090690 ARXIV; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wang PI, 2010, J PROTEOMICS, V73, P2277, DOI 10.1016/j.jprot.2010.07.005; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weston J, 2004, P NATL ACAD SCI USA, V101, P6559, DOI 10.1073/pnas.0308067101; Zhou DY, 2004, ADV NEUR IN, V16, P321; Zhou X, P NATL ACAD SCI US, V99, P12783; Zhou X, 2011, INT C ART INT STAT A	47	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e51947	10.1371/journal.pone.0051947	http://dx.doi.org/10.1371/journal.pone.0051947			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23284828	gold, Green Published, Green Submitted			2022-12-27	WOS:000313051500018
J	Betts, G; Poyntz, H; Stylianou, E; Reyes-Sandoval, A; Cottingham, M; Hill, A; McShane, H				Betts, Gareth; Poyntz, Hazel; Stylianou, Elena; Reyes-Sandoval, Arturo; Cottingham, Matthew; Hill, Adrian; McShane, Helen			Optimising Immunogenicity with Viral Vectors: Mixing MVA and HAdV-5 Expressing the Mycobacterial Antigen Ag85A in a Single Injection	PLOS ONE			English	Article							VACCINIA VIRUS ANKARA; PROTECTIVE EFFICACY; ENHANCED IMMUNOGENICITY; TUBERCULOSIS INFECTION; ADENOVIRUS VECTORS; T-CELLS; BCG; IMMUNITY; MICE; IMMUNIZATION	The Bacillus Calmette - Guerin (BCG) vaccine provides a critical but limited defense against Mycobacterium tuberculosis (M.tb). More than 60 years after the widespread introduction of BCG, there is an urgent need for a better vaccine. A large body of pre-clinical research continues to support ongoing clinical trials to assess whether viral vectors expressing M. tb antigens that are shared by BCG and M. tb, can be used alongside BCG to enhance protection. A major focus involves using multiple unique viral vectors to limit anti-vector immunity and thereby enhance responses to the insert antigen delivered. The successful introduction of viral vector vaccines to target M. tb and other pathogens will be reliant on reducing the costs when using multiple vectors and inhibiting the development of unwanted anti-vector responses that interfere with the response to insert antigen. This study examines methods to reduce the logistical costs of vaccination by mixing different viral vectors that share the same insert antigen in one vaccine; and whether combining different viral vectors reduces anti-vector immunity to improve immunogenicity to the insert antigen. Here we show that a homologous prime-boost regimen with a mixture of MVA (Modified Vaccinia virus Ankara) and Ad5 (human adenovirus type 5) vectors both expressing Ag85A in a single vaccine preparation is able to reduce anti-vector immunity, compared with a homologous prime-boost regimen with either vector alone. However, the level of immunogenicity induced by the homologous mixture remained comparable to that induced with single viral vectors and was less immunogenic than a heterologous Ad5 prime-MVA-boost regimen. These findings advance the understanding of how anti-vector immunity maybe reduced in viral vector vaccination regimens. Furthermore, an insight is provided to the impact on vaccine immunogenicity from altering vaccination methods to reduce the logistical demands of using separate vaccine preparations in the field.	[Betts, Gareth; Poyntz, Hazel; Stylianou, Elena; Reyes-Sandoval, Arturo; Cottingham, Matthew; Hill, Adrian; McShane, Helen] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg, Oxford OX3 9DU, England; [Betts, Gareth] Univ Oxford, Jenner Inst, Oxford, England	University of Oxford; University of Oxford; Jenner Institute	Betts, G (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg, Oxford OX3 9DU, England.	Gareth.Betts@nds.ox.ac.uk	Reyes-Sandoval, Arturo/B-4264-2011	Cottingham, Matthew/0000-0003-0766-6465; McShane, Helen/0000-0002-2126-5142; Reyes-Sandoval, Arturo/0000-0002-2648-1696	NEWTBVAC (EC FP7); Wellcome Trust [WT076943MA, 097395]	NEWTBVAC (EC FP7); Wellcome Trust(Wellcome TrustEuropean Commission)	Funding was provided by NEWTBVAC (EC FP7). HM is a Wellcome Trust Senior Research Fellow (www.wellcome.ac.uk; WT076943MA). HM, AH and AR-S are Jenner Institute Investigators. AR-S is a Wellcome Trust Career Development Fellow (097395). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel B, 2010, AM J RESP CRIT CARE, V181, P1407, DOI 10.1164/rccm.200910-1484OC; Beveridge NER, 2007, EUR J IMMUNOL, V37, P3089, DOI 10.1002/eji.200737504; Caruso AM, 1999, J IMMUNOL, V162, P5407; Corbett EL, 1996, BRIT J HOSP MED, V56, P200; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Dorman SE, 2004, LANCET, V364, P2113, DOI 10.1016/S0140-6736(04)17552-1; Draper SJ, 2010, NAT REV MICROBIOL, V8, P62, DOI 10.1038/nrmicro2240; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Gardam MA, 2003, LANCET INFECT DIS, V3, P148, DOI 10.1016/S1473-3099(03)00545-0; Gilbert SC, 2002, VACCINE, V20, P1039, DOI 10.1016/S0264-410X(01)00450-9; Goonetilleke NP, 2003, J IMMUNOL, V171, P1602, DOI 10.4049/jimmunol.171.3.1602; Hill AVS, 2010, HUM VACCINES, V6, P78, DOI 10.4161/hv.6.1.10116; Kaufmann SHE, 2010, IMMUNITY, V33, P567, DOI 10.1016/j.immuni.2010.09.015; McCoy K, 2007, J VIROL, V81, P6594, DOI 10.1128/JVI.02497-06; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; McShane H, 2002, INFECT IMMUN, V70, P1623, DOI 10.1128/IAI.70.3.1623-1626.2002; McShane H, 2009, SWISS MED WKLY, V139, P156, DOI smw-12374; Oseroff C, 2005, P NATL ACAD SCI USA, V102, P13980, DOI 10.1073/pnas.0506768102; Reyes-Sandoval A, 2008, EUR J IMMUNOL, V38, P732, DOI 10.1002/eji.200737672; Reyes-Sandoval A, 2012, MOL THER, V20, P1633, DOI 10.1038/mt.2012.25; Reyes-Sandoval A, 2010, INFECT IMMUN, V78, P145, DOI 10.1128/IAI.00740-09; RODRIGUES LC, 1993, INT J EPIDEMIOL, V22, P1154, DOI 10.1093/ije/22.6.1154; Roederer M, 2011, CYTOMETRY A; Santosuosso M, 2006, INFECT IMMUN, V74, P4634, DOI 10.1128/IAI.00517-06; Schirmbeck R, 2008, MOL THER, V16, P1609, DOI 10.1038/mt.2008.141; Schneider J, 1998, NAT MED, V4, P397, DOI 10.1038/nm0498-397; Sousa AO, 2000, P NATL ACAD SCI USA, V97, P4204, DOI 10.1073/pnas.97.8.4204; Tscharke DC, 2006, J VIROL, V80, P6318, DOI 10.1128/JVI.00427-06; Verreck FAW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005264; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09	32	18	19	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e50447	10.1371/journal.pone.0050447	http://dx.doi.org/10.1371/journal.pone.0050447			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284637	Green Published, Green Submitted, gold			2022-12-27	WOS:000313158800004
J	Gonzalez, G; Vituret, C; Di Pietro, A; Chanson, M; Boulanger, P; Hong, SS				Gonzalez, Gaelle; Vituret, Cyrielle; Di Pietro, Attilio; Chanson, Marc; Boulanger, Pierre; Hong, Saw-See			Microparticle-Mediated Transfer of the Viral Receptors CAR and CD46, and the CFTR Channel in a CHO Cell Model Confers New Functions to Target Cells	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; STOMATITIS-VIRUS GLYCOPROTEIN; RETROVIRUS-LIKE PARTICLES; CYSTIC-FIBROSIS; MEASLES-VIRUS; IN-VITRO; ENDOTHELIAL MICROPARTICLES; MEMBRANE MICROPARTICLES; HORIZONTAL TRANSFER; EPITHELIAL-CELLS	Cell microparticles (MPs) released in the extracellular milieu can embark plasma membrane and intracellular components which are specific of their cellular origin, and transfer them to target cells. The MP-mediated, cell-to-cell transfer of three human membrane glycoproteins of different degrees of complexity was investigated in the present study, using a CHO cell model system. We first tested the delivery of CAR and CD46, two monospanins which act as adenovirus receptors, to target CHO cells. CHO cells lack CAR and CD46, high affinity receptors for human adenovirus serotype 5 (HAdV5), and serotype 35 (HAdV35), respectively. We found that MPs derived from CHO cells (MP-donor cells) constitutively expressing CAR (MP-CAR) or CD46 (MP-CD46) were able to transfer CAR and CD46 to target CHO cells, and conferred selective permissiveness to HAdV5 and HAdV35. In addition, target CHO cells incubated with MP-CD46 acquired the CD46-associated function in complement regulation. We also explored the MP-mediated delivery of a dodecaspanin membrane glycoprotein, the CFTR to target CHO cells. CFTR functions as a chloride channel in human cells and is implicated in the genetic disease cystic fibrosis. Target CHO cells incubated with MPs produced by CHO cells constitutively expressing GFP-tagged CFTR (MP-GFP-CFTR) were found to gain a new cellular function, the chloride channel activity associated to CFTR. Time-course analysis of the appearance of GFP-CFTR in target cells suggested that MPs could achieve the delivery of CFTR to target cells via two mechanisms: the transfer of mature, membrane-inserted CFTR glycoprotein, and the transfer of CFTR-encoding mRNA. These results confirmed that cell-derived MPs represent a new class of promising therapeutic vehicles for the delivery of bioactive macromolecules, proteins or mRNAs, the latter exerting the desired therapeutic effect in target cells via de novo synthesis of their encoded proteins.	[Gonzalez, Gaelle; Vituret, Cyrielle; Boulanger, Pierre; Hong, Saw-See] Univ Lyon 1, UCBL INRA EPHE, UMR Retrovirus & Comparat Pathol 754, F-69365 Lyon, France; [Vituret, Cyrielle; Di Pietro, Attilio] Univ Lyon 1, Equipe Labellise Ligue 2009, Inst Biol & Chim Prot FR 3302, CNRS,UMR 5086, F-69365 Lyon, France; [Chanson, Marc] Univ Hosp Geneva, Fac Med, Dept Pediat, Lab Clin Invest 3, Geneva, Switzerland; [Chanson, Marc] Univ Geneva, Fdn Med Res, Geneva, Switzerland; [Hong, Saw-See] Inst Natl Sante & Rech Med, Paris, France	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Geneva; University of Geneva; Institut National de la Sante et de la Recherche Medicale (Inserm)	Hong, SS (corresponding author), Univ Lyon 1, UCBL INRA EPHE, UMR Retrovirus & Comparat Pathol 754, F-69365 Lyon, France.	saw-see.hong@univ-lyon1.fr	Boulanger, Pierre/AFV-2750-2022; Hong, Saw See/M-9818-2017	Hong, Saw See/0000-0001-8871-0901; Chanson, Marc/0000-0001-8104-2090	Cystic Fibrosis French Association [GT2009-2010-2011]; Swiss Science Foundation [310030_134907/1]	Cystic Fibrosis French Association; Swiss Science Foundation(Swiss National Science Foundation (SNSF))	The work in Lyon was financed by the Cystic Fibrosis French Association (VLM Contract GT2009-2010-2011). The work in Geneva was supported by grant #310030_134907/1 from the Swiss Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 1998, J VIROL, V72, P6159, DOI 10.1128/JVI.72.7.6159-6163.1998; Ahn YS, 2008, THROMB HAEMOSTASIS, V99, P657, DOI 10.1160/TH08-03-0135; Arnberg N, 2009, REV MED VIROL, V19, P165, DOI 10.1002/rmv.612; Baj-Krzyworzeka M, 2002, EXP HEMATOL, V30, P450, DOI 10.1016/S0301-472X(02)00791-9; Baj-Krzyworzeka M, 2007, IMMUNOL LETT, V113, P76, DOI 10.1016/j.imlet.2007.07.014; Bartoszewski R, 2008, J BIOL CHEM, V283, P12154, DOI 10.1074/jbc.M707610200; Bebawy M, 2009, LEUKEMIA, V23, P1643, DOI 10.1038/leu.2009.76; Benameur T, 2009, PHARMACOL REP, V61, P49, DOI 10.1016/S1734-1140(09)70006-4; Benharouga M, 2001, J CELL BIOL, V153, P957, DOI 10.1083/jcb.153.5.957; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Beyer C, 2010, NAT REV RHEUMATOL, V6, P21, DOI 10.1038/nrrheum.2009.229; Boulanger CM, 2006, HYPERTENSION, V48, P180, DOI 10.1161/01.HYP.0000231507.00962.b5; Boulanger CM, 2010, CURR OPIN NEPHROL HY, V19, P177, DOI 10.1097/MNH.0b013e32833640fd; Bradbury Neil A., 1999, Physiological Reviews, V79, pS175; Buchholz CJ, 1997, J BIOL CHEM, V272, P22072, DOI 10.1074/jbc.272.35.22072; Chaput N, 2005, BLOOD CELL MOL DIS, V35, P111, DOI 10.1016/j.bcmd.2005.05.009; Chow YH, 2000, MOL THER, V2, P359, DOI 10.1006/mthe.2000.0135; Christiansen D, 2000, J VIROL, V74, P4672, DOI 10.1128/JVI.74.10.4672-4678.2000; Coclet-Ninin J, 2002, EXP LUNG RES, V28, P181, DOI 10.1080/019021402753570491; Collino F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011803; Combes V, 1999, J CLIN INVEST, V104, P93, DOI 10.1172/JCI4985; Corjon S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018205; D'Souza-Schorey C, 2012, GENE DEV, V26, P1287, DOI 10.1101/gad.192351.112; DaFonseca S, 2007, ANTIVIR THER, V12, P1185; DAINIAK N, 1988, BLOOD, V72, P165; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Devaux P, 1996, J GEN VIROL, V77, P1477, DOI 10.1099/0022-1317-77-7-1477; DHALLUIN JC, 1980, NUCLEIC ACIDS RES, V8, P1625, DOI 10.1093/nar/8.7.1625; Diamant M, 2004, EUR J CLIN INVEST, V34, P392, DOI 10.1111/j.1365-2362.2004.01355.x; Eldh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015353; Farley DC, 2007, J GENE MED, V9, P345, DOI 10.1002/jgm.1022; Franqueville L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002894; GAGGAR A, 2003, NAT MED, V8, P746; Gerlier D, 2009, CURR TOP MICROBIOL, V329, P163; Granio O, 2007, AM J RESP CELL MOL, V37, P631, DOI 10.1165/rcmb.2007-0026TE; Granio O, 2010, HUM GENE THER, V21, P251, DOI 10.1089/hum.2009.056; Granio O, 2009, J VIROL, V83, P6048, DOI 10.1128/JVI.00012-09; Grumelli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018785; Guibinga GH, 2002, MOL THER, V5, P538, DOI 10.1006/mthe.2002.0578; Guibinga GH, 2005, MOL THER, V11, P645, DOI 10.1016/j.ymthe.2004.12.002; Guo Y, 2009, J HISTOCHEM CYTOCHEM, V57, P1113, DOI 10.1369/jhc.2009.953455; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Heda GD, 2001, AM J PHYSIOL-CELL PH, V280, pC166, DOI 10.1152/ajpcell.2001.280.1.C166; Hudrisier D, 2002, FASEB J, V16, P477, DOI 10.1096/fj.01-0933rev; Hudrisier D, 2009, J IMMUNOL, V183, P6102, DOI 10.4049/jimmunol.0900821; Hugel B, 2005, PHYSIOLOGY, V20, P22, DOI 10.1152/physiol.00029.2004; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Jimenez JJ, 2005, ADV CLIN CHEM, V39, P131, DOI 10.1016/S0065-2423(04)39005-0; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; Kesimer M, 2009, FASEB J, V23, P1858, DOI 10.1096/fj.08-119131; Koppler B, 2006, EUR J IMMUNOL, V36, P648, DOI 10.1002/eji.200535435; Kowalski MP, 2004, J IMMUNOL, V172, P418, DOI 10.4049/jimmunol.172.1.418; Law LK, 2005, MOL THER, V12, P599, DOI 10.1016/j.ymthe.2005.05.017; Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x; Liu R, 2009, EUR J HAEMATOL, V83, P220, DOI 10.1111/j.1600-0609.2009.01271.x; Mack M, 2000, NAT MED, V6, P769, DOI 10.1038/77498; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mause SF, 2010, CIRC RES, V107, P1047, DOI 10.1161/CIRCRESAHA.110.226456; Meckes DG, 2011, J VIROL, V85, P12844, DOI 10.1128/JVI.05853-11; Mohamed A, 1997, BIOCHEM J, V322, P259, DOI 10.1042/bj3220259; Muratori C, 2009, CELL HOST MICROBE, V6, P218, DOI 10.1016/j.chom.2009.06.009; Okimoto T, 2001, MOL THER, V4, P232, DOI 10.1006/mthe.2001.0443; Pap E, 2009, INFLAMM RES, V58, P1, DOI 10.1007/s00011-008-8210-7; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; Riley-Vargas RC, 2004, TRENDS IMMUNOL, V25, P496, DOI 10.1016/j.it.2004.07.004; Roche S, 2008, CELL MOL LIFE SCI, V65, P1716, DOI 10.1007/s00018-008-7534-3; Roche S, 2007, SCIENCE, V315, P843, DOI 10.1126/science.1135710; Sandrin V, 2005, J GEN VIROL, V86, P3189, DOI 10.1099/vir.0.81428-0; Segerman A, 2003, J VIROL, V77, P9183, DOI 10.1128/JVI.77.17.9183-9191.2003; Sheppard David N., 1999, Physiological Reviews, V79, pS23; Shet AS, 2008, VASC HEALTH RISK MAN, V4, P769, DOI 10.2147/VHRM.S955; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Stepien E, 2012, EXPERT OPIN THER TAR, V16, P677, DOI 10.1517/14728222.2012.691471; TABCHARANI JA, 1991, NATURE, V352, P628, DOI 10.1038/352628a0; Taieb J, 2005, CRIT REV IMMUNOL, V25, P215, DOI 10.1615/CritRevImmunol.v25.i3.30; Thomas GM, 2009, J EXP MED, V206, P1913, DOI 10.1084/jem.20082297; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vickers KC, 2012, CURR OPIN LIPIDOL, V23, P91, DOI 10.1097/MOL.0b013e328350a425; Walters RW, 1999, J BIOL CHEM, V274, P10219, DOI 10.1074/jbc.274.15.10219; Yanagi Y, 2006, J GEN VIROL, V87, P2767, DOI 10.1099/vir.0.82221-0; Yuan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004722	82	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52326	10.1371/journal.pone.0052326	http://dx.doi.org/10.1371/journal.pone.0052326			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284987	gold, Green Published, Green Accepted			2022-12-27	WOS:000312794500143
J	Abell, GCJ; Robert, SS; Frampton, DMF; Volkman, JK; Rizwi, F; Csontos, J; Bodrossy, L				Abell, Guy C. J.; Robert, Stan S.; Frampton, Dion M. F.; Volkman, John K.; Rizwi, Farhan; Csontos, Jozsef; Bodrossy, Levente			High-Throughput Analysis of Ammonia Oxidiser Community Composition via a Novel, amoA-Based Functional Gene Array	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; DIAGNOSTIC MICROARRAY; OLIGONUCLEOTIDE MICROARRAYS; ENVIRONMENTAL GRADIENTS; BACTERIAL COMMUNITIES; NITROGEN-CYCLE; DIVERSITY; ARCHAEA; ESTUARY; SOIL	Advances in microbial ecology research are more often than not limited by the capabilities of available methodologies. Aerobic autotrophic nitrification is one of the most important and well studied microbiological processes in terrestrial and aquatic ecosystems. We have developed and validated a microbial diagnostic microarray based on the ammonia-monooxygenase subunit A (amoA) gene, enabling the in-depth analysis of the community structure of bacterial and archaeal ammonia oxidisers. The amoA microarray has been successfully applied to analyse nitrifier diversity in marine, estuarine, soil and wastewater treatment plant environments. The microarray has moderate costs for labour and consumables and enables the analysis of hundreds of environmental DNA or RNA samples per week per person. The array has been thoroughly validated with a range of individual and complex targets (amoA clones and environmental samples, respectively), combined with parallel analysis using traditional sequencing methods. The moderate cost and high throughput of the microarray makes it possible to adequately address broader questions of the ecology of microbial ammonia oxidation requiring high sample numbers and high resolution of the community composition.	[Abell, Guy C. J.; Robert, Stan S.; Frampton, Dion M. F.; Volkman, John K.; Rizwi, Farhan; Bodrossy, Levente] CSIRO Marine & Atmospher Res & Wealth Oceans Natl, Hobart, Tas, Australia; [Csontos, Jozsef] Budapest Univ Technol & Econ, Dept Phys Chem & Mat Sci, Budapest, Hungary	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Budapest University of Technology & Economics	Bodrossy, L (corresponding author), CSIRO Marine & Atmospher Res & Wealth Oceans Natl, Hobart, Tas, Australia.	lev.bodrossy@csiro.au	Csontos, Jozsef/H-5688-2012; Bodrossy, Levente/B-8054-2009; Frampton, Dion/D-3310-2012; Abell, Guy C J/A-1767-2010	Csontos, Jozsef/0000-0003-4732-9703; Bodrossy, Levente/0000-0001-6940-452X; 	Theme 'Our Resilient Coastal Australia' of the CSIRO Wealth from Oceans National Research Flagship	Theme 'Our Resilient Coastal Australia' of the CSIRO Wealth from Oceans National Research Flagship	The present work was funded by the Theme 'Our Resilient Coastal Australia' of the CSIRO Wealth from Oceans National Research Flagship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell GCJ, 2005, FEMS MICROBIOL ECOL, V51, P265, DOI 10.1016/j.femsec.2004.09.001; Abell GCJ, 2011, FEMS MICROBIOL ECOL, V75, P111, DOI 10.1111/j.1574-6941.2010.00988.x; Abell GCJ, 2010, ISME J, V4, P286, DOI 10.1038/ismej.2009.105; Blainey PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016626; Bodrossy L, 2004, CURR OPIN MICROBIOL, V7, P245, DOI 10.1016/j.mib.2004.04.005; Bodrossy L, 2006, APPL ENVIRON MICROB, V72, P1672, DOI 10.1128/AEM.72.2.1672-1676.2006; Bodrossy L, 2003, ENVIRON MICROBIOL, V5, P566, DOI 10.1046/j.1462-2920.2003.00450.x; Bouskill N.J., 2011, ENV MICROBIOL; Cabezas A, 2009, APPL MICROBIOL BIOT, V84, P1191, DOI 10.1007/s00253-009-2138-x; Canfield DE, 2010, SCIENCE, V330, P192, DOI 10.1126/science.1186120; Casciotti KL, 2003, GEOMICROBIOL J, V20, P335, DOI 10.1080/01490450303895; Cebron A, 2003, APPL ENVIRON MICROB, V69, P7091, DOI 10.1128/AEM.69.12.7091-7100.2003; Chu HY, 2007, APPL ENVIRON MICROB, V73, P485, DOI 10.1128/AEM.01536-06; Cloern JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024465; Daebeler A, 2010, FRONTIERS MICROBIOLO, V3; Dang HY, 2008, MICROBIOL-SGM, V154, P2084, DOI 10.1099/mic.0.2007/013581-0; de la Torre JR, 2008, ENVIRON MICROBIOL, V10, P810, DOI 10.1111/j.1462-2920.2007.01506.x; El Fantroussi S, 2003, APPL ENVIRON MICROB, V69, P2377, DOI 10.1128/AEM.69.4.2377-2382.2003; Erguder TH, 2009, FEMS MICROBIOL REV, V33, P855, DOI 10.1111/j.1574-6976.2009.00179.x; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Francis CA, 2003, GEOBIOLOGY, V1, P129, DOI 10.1046/j.1472-4669.2003.00010.x; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Hallam SJ, 2006, PLOS BIOL, V4, P520, DOI 10.1371/journal.pbio.0040095; Hatzenpichler R, 2008, P NATL ACAD SCI USA, V105, P2134, DOI 10.1073/pnas.0708857105; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; He Z, 2010, ISME J, DOI 101038/ismej201046; HOLMES AJ, 1995, FEMS MICROBIOL LETT, V132, P203, DOI 10.1016/0378-1097(95)00311-R; Horz HP, 2000, J MICROBIOL METH, V39, P197, DOI 10.1016/S0167-7012(99)00119-0; Jin T, 2010, APPL MICROBIOL BIOT, V87, P1167, DOI 10.1007/s00253-010-2595-2; Junier P, 2010, APPL MICROBIOL BIOT, V85, P425, DOI 10.1007/s00253-009-2228-9; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Kowalchuk GA, 2001, ANNU REV MICROBIOL, V55, P485, DOI 10.1146/annurev.micro.55.1.485; Kumaresan D, 2011, RES MICROBIOL, V162, P1027, DOI 10.1016/j.resmic.2011.08.002; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Loy A, 2002, APPL ENVIRON MICROB, V68, P5064, DOI 10.1128/AEM.68.10.5064-5081.2002; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Mertens J, 2009, ISME J, V3, P916, DOI 10.1038/ismej.2009.39; Microarrays, 2003, BEGINNERS GUIDE MICR, P43; Moin NS, 2009, APPL ENVIRON MICROB, V75, P7461, DOI 10.1128/AEM.01001-09; Mosier AC, 2008, ENVIRON MICROBIOL, V10, P3002, DOI 10.1111/j.1462-2920.2008.01764.x; Nicol GW, 2008, ENVIRON MICROBIOL, V10, P2966, DOI 10.1111/j.1462-2920.2008.01701.x; Nicolaisen MH, 2002, J MICROBIOL METH, V50, P189, DOI 10.1016/S0167-7012(02)00026-X; Onodera Y, 2010, MICROBES ENVIRON, V25, P28, DOI 10.1264/jsme2.ME09179; Park HD, 2004, WATER RES, V38, P3275, DOI 10.1016/j.watres.2004.04.047; Pester M, 2012, ENVIRON MICROBIOL, V14, P525, DOI 10.1111/j.1462-2920.2011.02666.x; Pester M, 2011, CURR OPIN MICROBIOL, V14, P300, DOI 10.1016/j.mib.2011.04.007; Purkhold U, 2000, APPL ENVIRON MICROB, V66, P5368, DOI 10.1128/AEM.66.12.5368-5382.2000; Reed DW, 2010, APPL ENVIRON MICROB, V76, P2517, DOI 10.1128/AEM.02436-09; Ritz K, 2009, ECOL INDIC, V9, P1212, DOI 10.1016/j.ecolind.2009.02.009; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Roh SW, 2010, TRENDS BIOTECHNOL, V28, P291, DOI 10.1016/j.tibtech.2010.03.001; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Sahan E, 2008, FEMS MICROBIOL ECOL, V64, P175, DOI 10.1111/j.1574-6941.2008.00462.x; Sanguin H, 2006, APPL ENVIRON MICROB, V72, P4302, DOI 10.1128/AEM.02686-05; Siljanen HMP, 2011, FEMS MICROBIOL ECOL, V75, P430, DOI 10.1111/j.1574-6941.2010.01015.x; STEHR G, 1995, FEMS MICROBIOL ECOL, V17, P177, DOI 10.1016/0168-6496(95)00022-3; Steward GF, 2004, APPL ENVIRON MICROB, V70, P1455, DOI 10.1128/AEM.70.3.1455-1465.2004; Stralis-Pavese N, 2004, ENVIRON MICROBIOL, V6, P347, DOI 10.1111/j.1462-2920.2004.00582.x; Stralis-Pavese N, 2011, NAT PROTOC, V6, P609, DOI 10.1038/nprot.2010.191; Tavormina PL, 2011, ENV MICROBIOL REP, V3, P91, DOI 10.1111/j.1758-2229.2010.00192.x; Tourna M, 2011, P NATL ACAD SCI USA, V108, P8420, DOI 10.1073/pnas.1013488108; Treusch AH, 2005, ENVIRON MICROBIOL, V7, P1985, DOI 10.1111/j.1462-2920.2005.00906.x; Trias R, 2012, APPL ENVIRON MICROB, V78, P318, DOI 10.1128/AEM.05904-11; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Ward BB, 2007, ENVIRON MICROBIOL, V9, P2522, DOI 10.1111/j.1462-2920.2007.01371.x; Ye L, 2011, BIOTECHNOL BIOENG, V108, P2544, DOI 10.1002/bit.23211; Zhang L, 2006, MICROB ECOL; Zhang LM, 2009, FEMS MICROBIOL ECOL, V70, P208, DOI 10.1111/j.1574-6941.2009.00775.x	69	23	23	0	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51542	10.1371/journal.pone.0051542	http://dx.doi.org/10.1371/journal.pone.0051542			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284709	Green Published, Green Submitted, gold			2022-12-27	WOS:000312694300030
J	Kouwenberg, M; Rieffe, C; Theunissen, SCPM; de Rooij, M				Kouwenberg, Maartje; Rieffe, Carolien; Theunissen, Stephanie C. P. M.; de Rooij, Mark			Peer Victimization Experienced by Children and Adolescents Who Are Deaf or Hard of Hearing	PLOS ONE			English	Article							MENTAL-HEALTH; PARENTING PRACTICES; BEHAVIOR PROBLEMS; EMOTION; BULLIES; ANGER; COMMUNICATION; DYSREGULATION; PRESCHOOLERS; TEMPERAMENT	Victimization is a relatively common, yet serious problem, with potentially severe consequences for children's psychosocial and academic functioning. Children who are Deaf or Hard of Hearing (DHH) may be at a higher risk for victimization than hearing children. The aims of the present study were to compare DHH and hearing children on i) self-reported experiences of victimization and ii) associations between victimization, parental- and child variables. In total 188 children (mean age 11;11 years) from the Netherlands and Dutch-speaking part of Belgium participated in the study. No difference between DHH and hearing children were found on general experiences of victimization. However, differences between the groups were found on specific forms of experienced victimization and on the associations between victimization and parental variables. For DHH children, parental sensitivity and parents who challenge their DHH children to become competent in the practical, emotional, cognitive and social domain is associated with them being less victimized. For hearing children at this age these relations were reversed, absent or more complex. Finally, DHH children in special schools were more victimized than DHH children in regular schools. It can be concluded that parents can play an important role in reducing social problems experienced by DHH children and young adolescents.	[Kouwenberg, Maartje; Rieffe, Carolien; de Rooij, Mark] Leiden Univ, Inst Psychol, Leiden, Netherlands; [Rieffe, Carolien] Dutch Fdn Deaf & Hard Hearing Child, Amsterdam, Netherlands; [Theunissen, Stephanie C. P. M.] Leiden Univ, Med Ctr, Dept Otorhinolaryngol & Head & Neck Surg, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Kouwenberg, M (corresponding author), Leiden Univ, Inst Psychol, Leiden, Netherlands.	kouwenbergm@fsw.leidenuniv.nl	De Rooij, Mark/C-7047-2015	De Rooij, Mark/0000-0001-7308-6210; Rieffe, Carolien/0000-0002-7584-6698	Innovational Research Incentives Scheme (a VIDI grant); The Netherlands Organisation for Scientific Research (NWO) [452-07-004]	Innovational Research Incentives Scheme (a VIDI grant); The Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was supported by the Innovational Research Incentives Scheme (a VIDI grant) by The Netherlands Organisation for Scientific Research (NWO), no. 452-07-004 to Carolien Rieffe. Funder's website: http://www.nwo.nl/nwohome.nsf/pages/SPPD_5R2QE7_Eng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L. S., 1991, MULTIPLE REGRESSION; Bagwell CL, 1998, CHILD DEV, V69, P140, DOI 10.1111/j.1467-8624.1998.tb06139.x; Bandura Albert, 1977, SOCIAL LEARNING THEO; Barker DH, 2009, DEV PSYCHOPATHOL, V21, P373, DOI 10.1017/S0954579409000212; Bauman S, 2011, J DEAF STUD DEAF EDU, V16, P236, DOI 10.1093/deafed/enq043; Betts J, 2009, BRIT J DEV PSYCHOL, V27, P473, DOI 10.1348/026151008X314900; BOIVIN M, 1995, DEV PSYCHOPATHOL, V7, P765, DOI 10.1017/S0954579400006830; Bond L, 2001, BRIT MED J, V323, P480, DOI 10.1136/bmj.323.7311.480; BOWERS L, 1994, J SOC PERS RELAT, V11, P215, DOI 10.1177/0265407594112004; Brubaker RG, 2000, CHILD FAM BEHAV THER, V22, P13, DOI 10.1300/J019v22n04_02; Camodeca M, 2005, J CHILD PSYCHOL PSYC, V46, P186, DOI 10.1111/j.1469-7610.2004.00347.x; Card NA, 2008, SCHOOL PSYCHOL QUART, V23, P451, DOI 10.1037/a0012769; CRICK NR, 1995, DEV PSYCHOPATHOL, V7, P313, DOI 10.1017/S0954579400006520; Cummings E. Mark, 2020, DEV PSYCHOPATHOL; Denham SA, 1997, MOTIV EMOTION, V21, P65, DOI 10.1023/A:1024426431247; DENHAM SA, 1994, MERRILL PALMER QUART, V40, P488; Eisenberg N, 1998, PSYCHOL INQ, V9, P317, DOI 10.1207/s15327965pli0904_1; Espelage DL, 2004, BULLYING IN AMERICAN SCHOOLS: A SOCIAL-ECOLOGICAL PERSPECTIVE ON PREVENTION AND INTERVENTION, P37; Fellinger J, 2009, ACTA PSYCHIAT SCAND, V120, P153, DOI 10.1111/j.1600-0447.2009.01350.x; Fellinger J, 2012, LANCET, V379, P1037, DOI 10.1016/S0140-6736(11)61143-4; Flynt S., 2004, J INSTRUCTIONAL PSYC, V31, P330; Frick P.J., 1991, ALABAMA PARENTING QU; Gerris J.M., 1993, PARENTING DUTCH FAMI; Hermans D, 2010, J DEAF STUD DEAF EDU, V15, P107, DOI 10.1093/deafed/enp030; Hintermair M, 2006, J DEAF STUD DEAF EDU, V11, P493, DOI 10.1093/deafed/enl005; Holmbeck GN, 2002, J CONSULT CLIN PSYCH, V70, P96, DOI 10.1037//0022-006X.70.1.96; Hoover J. H., 1996, BULLYING PREVENTION; Hosie JA, 2000, J CHILD PSYCHOL PSYC, V41, P389, DOI 10.1017/S0021963099005405; Kent B A, 2003, J Deaf Stud Deaf Educ, V8, P315, DOI 10.1093/deafed/eng017; Kochenderfer-Ladd B, 2004, SOC DEV, V13, P329, DOI 10.1111/j.1467-9507.2004.00271.x; Kort W., 2002, WISC 3 NL; Kort W., 2008, CELF4NL PEARS ASS IN; Kouwenberg M., 2011, INT J MENTAL HLTH DE, V1, P46; Ladd GW, 1998, DEV PSYCHOL, V34, P1450, DOI 10.1037/0012-1649.34.6.1450; LEDERBERG AR, 1990, CHILD DEV, V61, P1596; Leigh IW, 2009, J DEAF STUD DEAF EDU, V14, P244, DOI 10.1093/deafed/enn038; Mavroveli S, 2007, BRIT J DEV PSYCHOL, V25, P263, DOI 10.1348/026151006X118577; McCrone W.P., 2004, ODYSSEY NEW DIRECTIO, V5, P4; Meadow-Orlans K.P., 1993, J APPL DEV PSYCHOL, V14, P407, DOI [10.1016/0193-3973(93)90017-P, DOI 10.1016/0193-3973(93)90017-P]; Mitchell R. E., 2004, SIGN LANG STUD, V4, P138, DOI DOI 10.1353/SLS.2004.0005; Nunes T., 2001, DEAF EDUC INT, P123, DOI DOI 10.1179/146431501790560972; OLWEUS D, 1989, OLWEUS BULLY V UNPUB; Olweus D., 1993, AGGRESSIVE BEHAV CUR; Percy-Smith L, 2008, INT J PEDIATR OTORHI, V72, P1113, DOI 10.1016/j.ijporl.2008.03.028; Perry DG, 2001, PEER HARASSMENT IN SCHOOL, P73; Petrides K.V., 2004, TECHNICAL MANUAL TRA; Preisler G, 2002, CHILD CARE HLTH DEV, V28, P403, DOI 10.1046/j.1365-2214.2002.00291.x; Pressman L, 1999, J Deaf Stud Deaf Educ, V4, P294, DOI 10.1093/deafed/4.4.294; Rieffe C, 2007, COGNITION EMOTION, V21, P1630, DOI 10.1080/02699930701238495; Rieffe C, 2006, COGNITION EMOTION, V20, P1261, DOI 10.1080/02699930500513502; Rieffe C, 2004, EUR J DEV PSYCHOL, V1, P31, DOI 10.1080/17405620344000013; Rieffe C, 2012, BRIT J DEV PSYCHOL, V30, P477, DOI 10.1111/j.2044-835X.2011.02057.x; Rieffe C, 2012, EUR J DEV PSYCHOL, V9, P351, DOI 10.1080/17405629.2012.680302; SEMEL EM, 1987, CELF CLIN EVALUATION; Morris AS, 2007, SOC DEV, V16, P361, DOI 10.1111/j.1467-9507.2007.00389.x; Shelton KK, 1996, J CLIN CHILD PSYCHOL, V25, P317, DOI 10.1207/s15374424jccp2503_8; Slot N, 1996, JEUGD SAMENLEVING, V1, P3; Spence SH, 2009, AUST J PSYCHOL, V61, P145, DOI 10.1080/00049530802259076; Stevenson J, 2011, DEV MED CHILD NEUROL, V53, P269, DOI 10.1111/j.1469-8749.2010.03839.x; Swearer SM, 2004, BULLYING IN AMERICAN SCHOOLS: A SOCIAL-ECOLOGICAL PERSPECTIVE ON PREVENTION AND INTERVENTION, P1; Sweeting H., 2001, RES PAPERS ED, V16, P225, DOI [DOI 10.1080/02671520110058679, 10.1080/02671520110058679]; Tellegen P., 1993, EUROPEAN J PSYCHOL A, V9, P147, DOI DOI 10.1016/J.AJHG.2016.01.016; Theunissen SCPM, 2012, LARYNGOSCOPE, V122, P654, DOI 10.1002/lary.22502; Traxler C B, 2000, J Deaf Stud Deaf Educ, V5, P337; Tresh J., 2004, ODYSSEY, V5, P36; van Aken C, 2007, INFANT CHILD DEV, V16, P553, DOI 10.1002/icd.529; Van Eldik T, 2005, AM ANN DEAF, V150, P11, DOI 10.1353/aad.2005.0024; Veenstra R, 2005, DEV PSYCHOL, V41, P672, DOI 10.1037/0012-1649.41.4.672; Wauters LN, 2008, J DEAF STUD DEAF EDU, V13, P21, DOI 10.1093/deafed/enm028; Wechsler D., 1991, WISC 3 WECHSLER INTE; Weiner MT, 2006, AM ANN DEAF, V151, P61, DOI 10.1353/aad.2006.0021; Wolters N, 2012, J DEAF STUD DEAF EDU, V17, P463, DOI 10.1093/deafed/ens021; Wolters N, 2011, RES DEV DISABIL, V32, P2553, DOI 10.1016/j.ridd.2011.07.003	73	37	38	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52174	10.1371/journal.pone.0052174	http://dx.doi.org/10.1371/journal.pone.0052174			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	059HF	23284923	Green Published, gold			2022-12-27	WOS:000312694300078
J	Lucas, TM; Janaka, SK; Stephens, EB; Johnson, MC				Lucas, Tiffany M.; Janaka, Sanath K.; Stephens, Edward B.; Johnson, Marc C.			Vpu Downmodulates Two Distinct Targets, Tetherin and Gibbon Ape Leukemia Virus Envelope, through Shared Features in the Vpu Cytoplasmic Tail	PLOS ONE			English	Article							HIV-1 VPU; TRANSMEMBRANE DOMAIN; BETA-TRCP; CONFER SENSITIVITY; RAPID DEGRADATION; PARTICLE RELEASE; INHIBITS HIV-1; CELL-SURFACE; PROTEIN; CD4	During human immunodeficiency virus-1 (HIV-1) assembly, the host proteins CD4 (the HIV-1 receptor) and tetherin (an interferon stimulated anti-viral protein) both reduce viral fitness. The HIV-1 accessory gene Vpu counteracts both of these proteins, but it is thought to do so through two distinct mechanisms. Modulation of CD4 likely occurs through proteasomal degradation from the endoplasmic reticulum. The exact mechanism of tetherin modulation is less clear, with possible roles for degradation and alteration of protein transport to the plasma membrane. Most investigations of Vpu function have used different assays for CD4 and tetherin. In addition, many of these investigations used exogenously expressed Vpu, which could result in variable expression levels. Thus, few studies have investigated these two Vpu functions in parallel assays, making direct comparisons difficult. Here, we present results from a rapid assay used to simultaneously investigate Vpu-targeting of both tetherin and a viral glycoprotein, gibbon ape leukemia virus envelope (GaLV Env). We previously reported that Vpu modulates GaLV Env and prevents its incorporation into HIV-1 particles through a recognition motif similar to that found in CD4. Using this assay, we performed a comprehensive mutagenic scan of Vpu in its native proviral context to identify features required for both types of activity. We observed considerable overlap in the Vpu sequences required to modulate tetherin and GaLV Env. We found that features in the cytoplasmic tail of Vpu, specifically within the cytoplasmic tail hinge region, were required for modulation of both tetherin and GaLV Env. Interestingly, these same regions features have been determined to be critical for CD4 downmodulation. We also observed a role for the transmembrane domain in the restriction of tetherin, as previously reported, but not of GaLV Env. We propose that Vpu may target both proteins in a mechanistically similar manner, albeit in different cellular locations.	[Lucas, Tiffany M.; Janaka, Sanath K.; Johnson, Marc C.] Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Christopher S Bond Life Sci Ctr, Columbia, MO 65212 USA; [Stephens, Edward B.] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66103 USA	University of Missouri System; University of Missouri Columbia; University of Kansas; University of Kansas Medical Center	Johnson, MC (corresponding author), Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Christopher S Bond Life Sci Ctr, Columbia, MO 65212 USA.	marcjohnson@missouri.edu	Janaka, Sanath Kumar/AAE-8500-2021	Janaka, Sanath Kumar/0000-0003-2341-1526	NIH-NIAID [R21 AI087448-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI087448] Funding Source: NIH RePORTER	NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial aid for this study was funded by NIH-NIAID, in the form of a grant to M. C. J. (R21 AI087448-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binette J, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-75; BOUR S, 1995, J VIROL, V69, P1510, DOI 10.1128/JVI.69.3.1510-1520.1995; Bour S, 2003, MICROBES INFECT, V5, P1029, DOI 10.1016/S1286-4579(03)00191-6; Bour S, 2001, J BIOL CHEM, V276, P15920, DOI 10.1074/jbc.M010533200; CHEN MY, 1993, J VIROL, V67, P3877, DOI 10.1128/JVI.67.7.3877-3884.1993; Christodoulopoulos I, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-4; Douglas JL, 2009, J VIROL, V83, P7931, DOI 10.1128/JVI.00242-09; Dube M, 2011, TRAFFIC, V12, P1714, DOI 10.1111/j.1600-0854.2011.01277.x; Dube M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000856; Dube M, 2009, J VIROL, V83, P4574, DOI 10.1128/JVI.01800-08; Fujita K, 1997, J GEN VIROL, V78, P619, DOI 10.1099/0022-1317-78-3-619; Guatelli JC, 2009, CURR TOP MICROBIOL, V339, P27, DOI 10.1007/978-3-642-02175-6_2; Gustin JK, 2012, J BIOL CHEM, V287, P14837, DOI 10.1074/jbc.M112.349928; Hauser H, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-51; Hill MS, 2010, VIROLOGY, V397, P104, DOI 10.1016/j.virol.2009.10.048; Hout DR, 2005, VIROLOGY, V339, P56, DOI 10.1016/j.virol.2005.04.038; Hussain A, 2008, J VIROL, V82, P893, DOI 10.1128/JVI.01373-07; Iwabu Y, 2009, J BIOL CHEM, V284, P35060, DOI 10.1074/jbc.M109.058305; Janaka SK, 2011, J VIROL, V85, P11945, DOI 10.1128/JVI.05171-11; Jorgenson RL, 2009, J VIROL, V83, P4060, DOI 10.1128/JVI.02425-08; Kobayashi T, 2011, J VIROL, V85, P932, DOI 10.1128/JVI.01668-10; Kueck T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002609; Lewis BC, 2001, J VIROL, V75, P9339, DOI 10.1128/JVI.75.19.9339-9344.2001; Lucas TM, 2010, J VIROL, V84, P2666, DOI 10.1128/JVI.01562-09; Magadan JG, 2012, J VIROL, V86, P757, DOI 10.1128/JVI.05933-11; Magadan JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000869; Mangeat B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000574; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Mitchell RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000450; Miyagi E, 2009, P NATL ACAD SCI USA, V106, P2868, DOI 10.1073/pnas.0813223106; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neil SJD, 2007, CELL HOST MICROBE, V2, P193, DOI 10.1016/j.chom.2007.08.001; Nomaguchi M, 2008, MICROBES INFECT, V10, P960, DOI 10.1016/j.micinf.2008.07.006; Pardieu C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000843; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Rong LW, 2009, J VIROL, V83, P7536, DOI 10.1128/JVI.00620-09; Ruiz A, 2008, VIROLOGY, V378, P58, DOI 10.1016/j.virol.2008.05.022; Ruiz A, 2010, CURR HIV RES, V8, P240, DOI 10.2174/157016210791111124; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Schmidt S, 2011, MBIO, V2, DOI 10.1128/mBio.00036-11; SCHUBERT U, 1994, J MOL BIOL, V236, P16, DOI 10.1006/jmbi.1994.1114; SCHUBERT U, 1994, J VIROL, V68, P2260, DOI 10.1128/JVI.68.4.2260-2271.1994; Schubert U, 1998, J VIROL, V72, P2280, DOI 10.1128/JVI.72.3.2280-2288.1998; Schubert U, 1996, J VIROL, V70, P809, DOI 10.1128/JVI.70.2.809-819.1996; Shah AH, 2010, CELL HOST MICROBE, V8, P397, DOI 10.1016/j.chom.2010.10.008; Skasko M, 2012, J BIOL CHEM, V287, P58, DOI 10.1074/jbc.M111.296772; Skasko M, 2011, VIROLOGY, V411, P65, DOI 10.1016/j.virol.2010.12.038; Tiganos E, 1998, VIROLOGY, V251, P96, DOI 10.1006/viro.1998.9368; Tokarev AA, 2011, J VIROL, V85, P51, DOI 10.1128/JVI.01795-10; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Vigan R, 2011, J VIROL, V85, P9737, DOI 10.1128/JVI.00479-11; Vigan R, 2010, J VIROL, V84, P12958, DOI 10.1128/JVI.01699-10; Watanabe R, 2011, VIROLOGY, V417, P50, DOI 10.1016/j.virol.2011.05.006; WILLEY RL, 1994, J VIROL, V68, P1207, DOI 10.1128/JVI.68.2.1207-1212.1994; WILLEY RL, 1992, J VIROL, V66, P7193, DOI 10.1128/JVI.66.12.7193-7200.1992	55	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51741	10.1371/journal.pone.0051741	http://dx.doi.org/10.1371/journal.pone.0051741			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284757	gold, Green Published, Green Submitted			2022-12-27	WOS:000312694300038
J	Raap, AK; Tafrechi, RSJ; van de Rijke, FM; Pyle, A; Wahlby, C; Szuhai, K; Ravelli, RBG; de Coo, RFM; Rajasimha, HK; Nilsson, M; Chinnery, PF; Samuels, DC; Janssen, GMC				Raap, Anton K.; Tafrechi, Roshan S. Jahangir; van de Rijke, Frans M.; Pyle, Angela; Waehlby, Carolina; Szuhai, Karoly; Ravelli, Raimond B. G.; de Coo, Rene F. M.; Rajasimha, Harsha K.; Nilsson, Mats; Chinnery, Patrick F.; Samuels, David C.; Janssen, George M. C.			Non-Random mtDNA Segregation Patterns Indicate a Metastable Heteroplasmic Segregation Unit in m.3243A > G Cybrid Cells	PLOS ONE			English	Article							MITOCHONDRIAL-DNA DELETIONS; FUNCTIONAL-ORGANIZATION; TRNA(LEU(UUR)) MUTATION; GENETIC AUTONOMY; DEAFNESS MIDD; FIBER-FISH; MUTANT; EXPRESSION; NUCLEOIDS; REPLICATION	Many pathogenic mitochondrial DNA mutations are heteroplasmic, with a mixture of mutated and wild-type mtDNA present within individual cells. The severity and extent of the clinical phenotype is largely due to the distribution of mutated molecules between cells in different tissues, but mechanisms underpinning segregation are not fully understood. To facilitate mtDNA segregation studies we developed assays that measure m.3243A>G point mutation loads directly in hundreds of individual cells to determine the mechanisms of segregation over time. In the first study of this size, we observed a number of discrete shifts in cellular heteroplasmy between periods of stable heteroplasmy. The observed patterns could not be parsimoniously explained by random mitotic drift of individual mtDNAs. Instead, a genetically metastable, heteroplasmic mtDNA segregation unit provides the likely explanation, where stable heteroplasmy is maintained through the faithful replication of segregating units with a fixed wild-type/m.3243A>G mutant ratio, and shifts occur through the temporary disruption and re-organization of the segregation units. While the nature of the physical equivalent of the segregation unit remains uncertain, the factors regulating its organization are of major importance for the pathogenesis of mtDNA diseases.	[Raap, Anton K.; Tafrechi, Roshan S. Jahangir; van de Rijke, Frans M.; Szuhai, Karoly; Ravelli, Raimond B. G.; Janssen, George M. C.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands; [Pyle, Angela; Chinnery, Patrick F.] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Waehlby, Carolina] Broad Inst MIT & Harvard, Cambridge, MA USA; [Waehlby, Carolina] Uppsala Univ, Ctr Image Anal, Uppsala, Sweden; [de Coo, Rene F. M.] Erasmus MC, Dept Neurol, Rotterdam, Netherlands; [Rajasimha, Harsha K.; Samuels, David C.] Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN USA; [Nilsson, Mats] Uppsala Univ, Dept Genet & Pathol, Uppsala, Sweden	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Newcastle University - UK; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Uppsala University; Erasmus University Rotterdam; Erasmus MC; Vanderbilt University; Uppsala University	Janssen, GMC (corresponding author), Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands.	g.m.c.janssen@lumc.nl	Samuels, David C/A-5393-2008; Szuhai, Karoly/A-1100-2008; Samuels, David/AHC-8381-2022	Samuels, David C/0000-0003-3529-7791; Szuhai, Karoly/0000-0002-1228-4245; Samuels, David/0000-0003-3529-7791; de Coo, Irenaeus/0000-0003-0533-7422; Wahlby, Carolina/0000-0002-4139-7003; Raap, Anton Klaas/0000-0003-1483-7816; Chinnery, Patrick/0000-0002-7065-6617; Ravelli, Raimond/0000-0001-6056-5888	National Institute for Health Research [NF-SI-0509-10011] Funding Source: researchfish; Wellcome Trust [096919] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission)		Allalou A, 2007, IMAGE ANAL LECT NOTE, V4522, P632; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132; Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311; Chinnery PF, 2002, TRENDS GENET, V18, P173, DOI 10.1016/S0168-9525(01)02636-1; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562; Durham SE, 2007, AM J HUM GENET, V81, P189, DOI 10.1086/518901; El Meziane A, 1998, NAT GENET, V18, P350; Enriquez JA, 2000, J BIOL CHEM, V275, P11207, DOI 10.1074/jbc.275.15.11207; Enriquez JA, 2003, GENETICS MITOCHONDRI, P279; Finsterer J, 2007, ACTA NEUROL SCAND, V116, P1, DOI 10.1111/j.1600-0404.2007.00836.x; Florijn RJ, 1996, GENOMICS, V38, P277, DOI 10.1006/geno.1996.0629; Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399; Gilkerson RW, 2008, J CELL BIOL, V181, P1117, DOI 10.1083/jcb.200712101; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; Greaves LC, 2009, BBA-GEN SUBJECTS, V1790, P1015, DOI 10.1016/j.bbagen.2009.04.018; He JY, 2007, J CELL BIOL, V176, P141, DOI 10.1083/jcb.200609158; Holt IJ, 2007, MITOCHONDRION, V7, P311, DOI 10.1016/j.mito.2007.06.004; Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9; Jacobs HT, 2000, BIOESSAYS, V22, P564, DOI 10.1002/(SICI)1521-1878(200006)22:6<564::AID-BIES9>3.0.CO;2-4; Janssen GMC, 2007, HUM MOL GENET, V16, P2472, DOI 10.1093/hmg/ddm203; Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404; Khrapko K, 2008, NAT GENET, V40, P134, DOI 10.1038/ng0208-134; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Knijnenburg J, 2005, AM J MED GENET A, V132A, P36, DOI 10.1002/ajmg.a.30378; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Krishnan KJ, 2007, NUCLEIC ACIDS RES, V35, P7399, DOI 10.1093/nar/gkm635; Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108; Larsson C, 2004, NAT METHODS, V1, P227, DOI 10.1038/NMETH723; Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; Lehtinen SK, 2000, GENETICS, V154, P363; Malena A, 2009, HUM MOL GENET, V18, P3407, DOI 10.1093/hmg/ddp281; Malka F, 2005, EMBO REP, V6, P853, DOI 10.1038/sj.embor.7400488; Malka F, 2006, BBA-MOL CELL RES, V1763, P463, DOI 10.1016/j.bbamcr.2006.04.001; Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897; Moslemi AR, 1998, NEUROMUSCULAR DISORD, V8, P345, DOI 10.1016/S0960-8966(98)00029-7; Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x; Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863; Pohjoismaki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600; Rajasimha HK, 2008, AM J HUM GENET, V82, P333, DOI 10.1016/j.ajhg.2007.10.007; Spelbrink JN, 2010, IUBMB LIFE, V62, P19, DOI 10.1002/iub.282; Szuhai K, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.3.e13; Tafrechi RSJ, 2007, J HISTOCHEM CYTOCHEM, V55, P1159, DOI 10.1369/jhc.7A7282.2007; Tafrechi RSJ, 2005, MUTAT RES-FUND MOL M, V578, P43, DOI 10.1016/j.mrfmmm.2005.02.002; Takai D, 1999, J BIOL CHEM, V274, P11199, DOI 10.1074/jbc.274.16.11199; Tanke HJ, 1999, EUR J HUM GENET, V7, P2, DOI 10.1038/sj.ejhg.5200265; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Turner CJ, 2005, GENETICS, V170, P1879, DOI 10.1534/genetics.105.043653; van de Rijke FM, 2000, J HISTOCHEM CYTOCHEM, V48, P743, DOI 10.1177/002215540004800602; van den Ouweland JMW, 1999, DIABETOLOGIA, V42, P485, DOI 10.1007/s001250051183; VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368; Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258; Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200; YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164; YONEDA M, 1994, MOL CELL BIOL, V14, P2699, DOI 10.1128/MCB.14.4.2699	59	15	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52080	10.1371/journal.pone.0052080	http://dx.doi.org/10.1371/journal.pone.0052080			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272214	Green Submitted, Green Published, gold			2022-12-27	WOS:000312483300060
J	Zurovac, D; Larson, BA; Sudoi, RK; Snow, RW				Zurovac, Dejan; Larson, Bruce A.; Sudoi, Raymond K.; Snow, Robert W.			Costs and Cost-Effectiveness of a Mobile Phone Text-Message Reminder Programmes to Improve Health Workers' Adherence to Malaria Guidelines in Kenya	PLOS ONE			English	Article							MEDICINE RETAILERS; FACILITIES; QUALITY; MANAGEMENT	Background: Simple interventions for improving health workers' adherence to malaria case-management guidelines are urgently required across Africa. A recent trial in Kenya showed that text-message reminders sent to health workers' mobile phones improved management of pediatric outpatients by 25 percentage points. In this paper we examine costs and cost-effectiveness of this intervention. Methods/Findings: We evaluate costs and cost-effectiveness in 2010 USD under three implementation scenarios: (1) as implemented under study conditions in study areas; (2) if the intervention was routinely implemented by the Ministry of Health (MoH) in the same areas; and (3) if the intervention was scaled up nationally. Under study conditions, intervention costs were 19,342 USD, of which 45% were for developing and pretesting text-messages, 12% for developing text-message distribution system, 29% for collecting health workers' phone numbers, and 13% were costs of sending text-messages and monitoring of the system. If the intervention was implemented in the same areas by the MoH, the costs would be 28% lower (13,920 USD) due to lower costs of collecting health workers' numbers. The cost of national scale-up would be 97,350 USD, and the majority of these costs (66%) would be for sending text-messages. The cost per additional child correctly managed was 0.50 USD under study conditions, 0.36 USD if implemented by the MoH in the same area, and estimated at only 0.03 USD if implemented nationally. Even if the effect size was only 5% or the cost on the national scale was 400% higher than estimated, the cost per additional child correctly managed would be only 0.16 USD. Conclusions: A simple text-messaging intervention improving health worker adherence to malaria guidelines is effective and inexpensive. Further research is justified to optimize delivery of the intervention and expand targets beyond children and malaria disease.	[Zurovac, Dejan; Sudoi, Raymond K.; Snow, Robert W.] KEMRI Wellcome Trust Univ Oxford Collaborat Progr, Malaria Publ Hlth Cluster, Nairobi, Kenya; [Zurovac, Dejan; Snow, Robert W.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Zurovac, Dejan; Larson, Bruce A.] Boston Univ, Dept Int Hlth, Ctr Global Hlth & Dev, Boston, MA 02215 USA	University of Oxford; Boston University	Zurovac, D (corresponding author), KEMRI Wellcome Trust Univ Oxford Collaborat Progr, Malaria Publ Hlth Cluster, Nairobi, Kenya.	dzurovac@nairobi.kemri-wellcome.org	Snow, Robert William/AFR-1436-2022	Snow, Robert William/0000-0003-3725-6088; Larson, Bruce/0000-0002-9322-2387	Wellcome Trust, UK [084253]; Wellcome Trust [084253, 079080, 092654]	Wellcome Trust, UK(Wellcome Trust); Wellcome Trust(Wellcome TrustEuropean Commission)	This study was funded by the Wellcome Trust, UK (#084253). RWS is supported by the Wellcome Trust as Principal Research Fellow [#079080]. DZ and RKS are supported by the Welcome Trust project grant [#084253]. All authors acknowledge support of the Wellcome Trust to the Kenyan Major Overseas Programme [#092654]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazin D., 2009, EC ANAL, V42, P7; Gething PW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000301; Goodman CA, 2006, HEALTH POLICY PLANN, V21, P275, DOI 10.1093/heapol/czl011; Jones COH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038636; Lubell Y, 2008, BMJ-BRIT MED J, V336, P202, DOI 10.1136/bmj.39395.696065.47; Mangham LJ, 2012, TROP MED INT HEALTH, V17, P330, DOI 10.1111/j.1365-3156.2011.02918.x; Mangham LJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-155; Ministry of Health, 2009, TRAIN GUID 2006 NAT; Ministry of Health, 2008, NAT GUID DIAGN TREAT; Nyandigisi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024781; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Rowe AK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-275; Thirumurthy H, 2012, B WORLD HEALTH ORGAN, V90, P390, DOI 10.2471/BLT.11.099317; White MT, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-337; Whitty CJM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S7; Zurovac D, 2006, ANN TROP MED PARASIT, V100, P283, DOI 10.1179/136485906X105633; Zurovac D, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001176; Zurovac D, 2011, LANCET, V378, P795, DOI 10.1016/S0140-6736(11)60783-6	18	42	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52045	10.1371/journal.pone.0052045	http://dx.doi.org/10.1371/journal.pone.0052045			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272206	Green Submitted, Green Published, gold			2022-12-27	WOS:000312483300052
J	Blount, RJ; Jarlsberg, LG; Daly, KR; Worodria, W; Davis, JL; Cattamanchi, A; Djawe, K; Andama, A; Koch, J; Walzer, PD; Huang, L				Blount, Robert J.; Jarlsberg, Leah G.; Daly, Kieran R.; Worodria, William; Davis, J. Lucian; Cattamanchi, Adithya; Djawe, Kpandja; Andama, Alfred; Koch, Judith; Walzer, Peter D.; Huang, Laurence		Int HIV-Associated Opportunistic P	Serologic Responses to Recombinant Pneumocystis jirovecii Major Surface Glycoprotein among Ugandan Patients with Respiratory Symptoms	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; IMMUNODEFICIENCY-VIRUS-INFECTION; B-CELLS; ANTIBODY-RESPONSE; HUMORAL IMMUNITY; CARINII INFECTION; IGG ANTIBODIES; TB SUSPECTS; EXPRESSION; ANTIGEN	Background: Little is known about the serologic responses to Pneumocystis jirovecii major surface glycoprotein (Msg) antigen in African cohorts, or the IgM responses to Msg in HIV-positive and HIV-negative persons with respiratory symptoms. Methods: We conducted a prospective study of 550 patients, both HIV-positive (n = 467) and HIV-negative (n = 83), hospitalized with cough >= 2 weeks in Kampala, Uganda, to evaluate the association between HIV status, CD4 cell count, and other clinical predictors and antibody responses to P. jirovecii. We utilized ELISA to measure the IgM and IgG serologic responses to three overlapping recombinant fragments that span the P. jirovecii major surface glycoprotein: MsgA (amino terminus), MsgB (middle portion) and MsgC1 (carboxyl terminus), and to three variations of MsgC1 (MsgC3, MsgC8 and MsgC9). Results: HIV-positive patients demonstrated significantly lower IgM antibody responses to MsgC1, MsgC3, MsgC8 and MsgC9 compared to HIV-negative patients. We found the same pattern of low IgM antibody responses to MsgC1, MsgC3, MsgC8 and MsgC9 among HIV-positive patients with a CD4 cell count <200 cells/mu l compared to those with a CD4 cell count >= 200 cells/mu l. HIV-positive patients on PCP prophylaxis had significantly lower IgM responses to MsgC3 and MsgC9, and lower IgG responses to MsgA, MsgC1, MsgC3, and MsgC8. In contrast, cigarette smoking was associated with increased IgM antibody responses to MsgC1 and MsgC3 but was not associated with IgG responses. We evaluated IgM and IgG as predictors of mortality. Lower IgM responses to MsgC3 and MsgC8 were both associated with increased in-hospital mortality. Conclusions: HIV infection and degree of immunosuppression are associated with reduced IgM responses to Msg. In addition, low IgM responses to MsgC3 and MsgC8 are associated with increased mortality.	[Blount, Robert J.; Huang, Laurence] Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; [Daly, Kieran R.; Koch, Judith; Walzer, Peter D.] Univ Cincinnati, Dept Internal Med, Div Infect Dis, Cincinnati, OH USA; [Daly, Kieran R.; Djawe, Kpandja; Koch, Judith; Walzer, Peter D.] Vet Adm Med Ctr, Cincinnati, OH 45220 USA; [Worodria, William; Davis, J. Lucian; Cattamanchi, Adithya; Andama, Alfred; Huang, Laurence] MU UCSF, Res Collaborat, Kampala, Uganda; [Worodria, William; Andama, Alfred] Mulago Hosp, Dept Med, Kampala, Uganda; [Djawe, Kpandja; Walzer, Peter D.] Univ Cincinnati, Dept Environm Hlth, Div Epidemiol & Biostat, Cincinnati, OH USA; [Huang, Laurence] Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA 94143 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; Mulago National Referral Hospital; University System of Ohio; University of Cincinnati; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Blount, RJ (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA.	robert.blount@ucsf.edu	Huang, Laurence/AAZ-7120-2021; Davis, J. Lucian/AAC-8376-2019; blount, robert/ABI-5978-2020; Huang, Laurence/AAE-1590-2019	Huang, Laurence/0000-0003-3888-2195; Davis, J. Lucian/0000-0002-8629-9992; Blount, Robert/0000-0001-6177-7436; Jarlsberg, Leah/0000-0001-6548-6337	National Heart, Lung and Blood Institute (NHLBI) [K24HL087713, R01HL090335, K23HL094141]; National Institute of Allergy and Infectious Diseases (NIAID) [K23AI080147]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL087713, T32HL007185, K23HL094141, R01HL090335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI080147] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Heart, Lung and Blood Institute (NHLBI) K24HL087713 (LH), R01HL090335 (LH), K23HL094141 (AC), and National Institute of Allergy and Infectious Diseases (NIAID) K23AI080147 (JLD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMANN AJ, 1984, JAMA-J AM MED ASSOC, V251, P1447, DOI 10.1001/jama.251.11.1447; ATZORI C, 1993, T ROY SOC TROP MED H, V87, P55, DOI 10.1016/0035-9203(93)90418-P; Bishop LR, 2003, J INFECT DIS, V187, P1844, DOI 10.1086/375354; BURNS SM, 1990, J INFECTION, V20, P33, DOI 10.1016/S0163-4453(90)92280-X; Cattamanchi A, 2009, INT J TUBERC LUNG D, V13, P1130; Crothers K, 2011, CLIN VACCINE IMMUNOL, V18, P380, DOI 10.1128/CVI.00421-10; Crum-Cianflone NF, 2010, J INFECT DIS, V202, P1114, DOI 10.1086/656147; Daley CL, 1996, AM J RESP CRIT CARE, V154, P105, DOI 10.1164/ajrccm.154.1.8680664; Daly K, 2009, CLIN MICROBIOL INFEC, V15, P937, DOI 10.1111/j.1469-0691.2009.02716.x; Daly KR, 2006, CLIN VACCINE IMMUNOL, V13, P1071, DOI 10.1128/CVI.00140-06; Daly KR, 2006, EMERG INFECT DIS, V12, P1231, DOI 10.3201/eid1708.060230; Daly KR, 2004, EMERG INFECT DIS, V10, P848, DOI 10.3201/eid1005.030497; Daly KR, 2002, J INFECT DIS, V186, P644, DOI 10.1086/341565; De Milito A, 2004, BLOOD, V103, P2180, DOI 10.1182/blood-2003-07-2375; Deok-Jong Yoo S, 2010, J ACQUIRED IMMUNE DE; Djawe K, 2010, INT J INFECT DIS IJI; Djawe K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014259; ELVIN K, 1994, SCAND J INFECT DIS, V26, P33, DOI 10.3109/00365549409008588; GARBE TR, 1994, INFECT IMMUN, V62, P3092, DOI 10.1128/IAI.62.8.3092-3101.1994; GIGLIOTTI F, 1988, J CLIN INVEST, V81, P1666, DOI 10.1172/JCI113503; Gigliotti F, 1996, INFECT IMMUN, V64, P1892, DOI 10.1128/IAI.64.6.1892-1899.1996; Hart M, 2007, J IMMUNOL, V178, P8212, DOI 10.4049/jimmunol.178.12.8212; HOFMANN B, 1985, J INFECT DIS, V152, P838, DOI 10.1093/infdis/152.4.838; HOFMANN B, 1988, SCAND J INFECT DIS, V20, P389, DOI 10.3109/00365548809032473; JANOFF EN, 1988, J INFECT DIS, V158, P983, DOI 10.1093/infdis/158.5.983; JANOFF EN, 1993, J INFECT DIS, V167, P49, DOI 10.1093/infdis/167.1.49; JANOFF EN, 1988, J INFECT DIS, V157, P798, DOI 10.1093/infdis/157.4.798; KOVACS JA, 1993, J BIOL CHEM, V268, P6034; Kroon FP, 1997, CLIN INFECT DIS, V25, P600, DOI 10.1086/513750; Kyeyune R, 2010, JAIDS-J ACQ IMM DEF, V55, P446, DOI 10.1097/QAI.0b013e3181eb611a; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; Laursen AL, 1998, SCAND J INFECT DIS, V30, P495, DOI 10.1080/00365549850161511; LUCAS S, 1989, AIDS, V3, P47, DOI 10.1097/00002030-198903010-00012; LUNDGREN B, 1993, SCAND J INFECT DIS, V25, P515, DOI 10.3109/00365549309008535; LUNDGREN B, 1992, J INFECT DIS, V165, P1151, DOI 10.1093/infdis/165.6.1151; MARTINEZMAZA O, 1987, J IMMUNOL, V138, P3720; Mei Q, 1998, INFECT IMMUN, V66, P4268; Moir S, 2001, P NATL ACAD SCI USA, V98, P10362, DOI 10.1073/pnas.181347898; Moir S, 2004, J EXP MED, V200, P587, DOI 10.1084/jem.20032236; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Mount AM, 2004, LANCET, V363, P1860, DOI 10.1016/S0140-6736(04)16354-X; Muller F, 1998, BLOOD, V92, P3721, DOI 10.1182/blood.V92.10.3721.422k11_3721_3729; Notermans DW, 2001, AIDS RES HUM RETROV, V17, P1003, DOI 10.1089/088922201300343681; PEGLOW SL, 1990, J INFECT DIS, V161, P296, DOI 10.1093/infdis/161.2.296; PERLMAN DM, 1988, ANN INTERN MED, V108, P540, DOI 10.7326/0003-4819-108-4-540; PIFER LLW, 1987, J CLIN MICROBIOL, V25, P991, DOI 10.1128/JCM.25.6.991-995.1987; SHIRAI A, 1992, J CLIN INVEST, V89, P561, DOI 10.1172/JCI115621; Srikantiah P, 2007, INT J TUBERC LUNG D, V11, P168; Stringer JR, 2007, J EUKARYOT MICROBIOL, V54, P8, DOI 10.1111/j.1550-7408.2006.00225.x; Stringer JR, 2001, INFECT IMMUN, V69, P627, DOI 10.1128/IAI.69.2.627-639.2001; Taylor SM, 2012, DIAGN MICR INFEC DIS, V72, P139, DOI 10.1016/j.diagmicrobio.2011.10.009; THEUS SA, 1995, J CLIN INVEST, V95, P2587, DOI 10.1172/JCI117960; Theus SA, 1998, VACCINE, V16, P1149, DOI 10.1016/S0264-410X(98)80113-8; Tipirneni R, 2009, EMERG INFECT DIS, V15, P1590, DOI 10.3201/eid1510.090207; Titanji K, 2006, BLOOD, V108, P1580, DOI 10.1182/blood-2005-11-013383; van Oosterhout JJG, 2007, EMERG INFECT DIS, V13, P325, DOI 10.3201/eid1302.060462; Vargas SL, 2001, CLIN INFECT DIS, V32, P855, DOI 10.1086/319340; WABWIREMANGEN F, 1989, AM J TROP MED HYG, V41, P504, DOI 10.4269/ajtmh.1989.41.504; Walzer PD, 1999, CLIN DIAGN LAB IMMUN, V6, P149, DOI 10.1128/CDLI.6.2.149-155.1999; Walzer PD, 2009, J INFECT DIS, V199, P1335, DOI 10.1086/597803	61	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e51545	10.1371/journal.pone.0051545	http://dx.doi.org/10.1371/journal.pone.0051545			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284710	Green Published, gold			2022-12-27	WOS:000313158800012
J	Datta, R; Lee, J; Duda, J; Avants, BB; Vite, CH; Tseng, B; Gee, JC; Aguirre, GD; Aguirre, GK				Datta, Ritobrato; Lee, Jongho; Duda, Jeffrey; Avants, Brian B.; Vite, Charles H.; Tseng, Ben; Gee, James C.; Aguirre, Gustavo D.; Aguirre, Geoffrey K.			A Digital Atlas of the Dog Brain	PLOS ONE			English	Article							LYSOSOMAL STORAGE DISEASES; LEBER CONGENITAL AMAUROSIS; SURFACE-BASED ANALYSIS; GENE-THERAPY; CANINE BRAIN; ANIMAL-MODELS; DOMESTIC DOG; IMAGE REGISTRATION; CEREBRAL ASYMMETRY; STANDARD POODLES	There is a long history and a growing interest in the canine as a subject of study in neuroscience research and in translational neurology. In the last few years, anatomical and functional magnetic resonance imaging (MRI) studies of awake and anesthetized dogs have been reported. Such efforts can be enhanced by a population atlas of canine brain anatomy to implement group analyses. Here we present a canine brain atlas derived as the diffeomorphic average of a population of fifteen mesaticephalic dogs. The atlas includes: 1) A brain template derived from in-vivo, T1-weighted imaging at 1 mm isotropic resolution at 3 Tesla (with and without the soft tissues of the head); 2) A co-registered, high-resolution (0.33 mm isotropic) template created from imaging of ex-vivo brains at 7 Tesla; 3) A surface representation of the gray matter/white matter boundary of the high-resolution atlas (including labeling of gyral and sulcal features). The properties of the atlas are considered in relation to historical nomenclature and the evolutionary taxonomy of the Canini tribe. The atlas is available for download (https://cfn.upenn.edu/aguirre/wiki/public:data_plosone_2012_datta).	[Datta, Ritobrato; Tseng, Ben; Aguirre, Geoffrey K.] Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Lee, Jongho; Duda, Jeffrey; Avants, Brian B.; Gee, James C.] Univ Penn, Sch Med, Dept Radiol, Philadelphia, PA 19104 USA; [Vite, Charles H.] Univ Penn, Sch Vet Med, Dept Clin Studies, Neurol Sect, Philadelphia, PA 19104 USA; [Aguirre, Gustavo D.] Univ Penn, Sch Vet Med, Dept Clin Studies, Sect Ophthalmol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Aguirre, GK (corresponding author), Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA.	aguirreg@mail.med.upenn.edu		Aguirre, Geoffrey/0000-0002-4028-3100; Aguirre, Gustavo/0000-0002-5228-256X; avants, brian/0000-0002-4212-3362	Burroughs-Wellcome Career development award; Hope for Vision foundation; Pennsylvania Lion's Foundation; National Eye Institute (NEI) / National Institutes of Health (NIH) [EY020516, -06855, -14579]; Foundation Fighting Blindness; ONCE International Price for R&D in Biomedicine and New Technologies for the Blind; NATIONAL EYE INSTITUTE [R01EY020516, R01EY017549] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010939] Funding Source: NIH RePORTER	Burroughs-Wellcome Career development award(Burroughs Wellcome Fund); Hope for Vision foundation; Pennsylvania Lion's Foundation; National Eye Institute (NEI) / National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Foundation Fighting Blindness(European Commission); ONCE International Price for R&D in Biomedicine and New Technologies for the Blind; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a Burroughs-Wellcome Career development award to GKA, grants from the Hope for Vision foundation to GDA and GKA, a grant from the Pennsylvania Lion's Foundation to GKA, National Eye Institute (NEI) / National Institutes of Health (NIH) grants EY020516 (GKA), -06855 (GDA), and -14579 (GDA), Foundation Fighting Blindness (GDA), and the ONCE International Price for R&D in Biomedicine and New Technologies for the Blind (GDA, GKA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Aguirre GD, 2007, DOG ITS GENOME; Aguirre GK, 2007, PLOS MED, V4, P1117, DOI 10.1371/journal.pmed.0040230; Ashburner J, 2009, NEUROIMAGE, V45, P333, DOI 10.1016/j.neuroimage.2008.12.008; Atkins DL, 1978, COYOTES BEHAVIOR BIO; Avants B, 2004, NEUROIMAGE, V23, pS139, DOI 10.1016/j.neuroimage.2004.07.010; Avants B, 2008, UNBIASED DIFFEOMORPH; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Beltran WA, 2012, P NATL ACAD SCI USA, V109, P2132, DOI 10.1073/pnas.1118847109; Berns GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038027; Bisazza A, 1998, NEUROSCI BIOBEHAV R, V22, P411, DOI 10.1016/S0149-7634(97)00050-X; BLACK AH, 1972, J COMP PHYSIOL PSYCH, V79, P128, DOI 10.1037/h0032535; Bonin von G, 1960, SOME PAPERS ON THE C, Vxxiv; Budras K., 2007, ANATOMY OF THE DOG; Buxton DF, 1986, THE CANINE BRAIN BAS; Cahill LS, 2012, NEUROIMAGE, V60, P933, DOI 10.1016/j.neuroimage.2012.01.100; CLARKE PGH, 1976, J PHYSIOL-LONDON, V256, P497, DOI 10.1113/jphysiol.1976.sp011335; COHN HAROLD A., 1933, JOUR COMP NEUROL, V58, P593, DOI 10.1002/cne.900580304; Cotman CW, 2008, J ALZHEIMERS DIS, V15, P685; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Ellinwood NM, 2004, J GENE MED, V6, P481, DOI 10.1002/jgm.581; Ellis JL, 2009, J ANAT, V214, P362, DOI 10.1111/j.1469-7580.2008.01042.x; Evans HE, 1993, MILLERS ANATOMY OF T; Ferrier D, 1886, THE FUNCTIONS OF THE; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2008, CEREB CORTEX, V18, P1973, DOI 10.1093/cercor/bhm225; Fritsch GT, 1870, ARCH ANAT PHYSL WISS, P300; Ghosh SS, 2010, NEUROIMAGE, V53, P85, DOI 10.1016/j.neuroimage.2010.05.075; Gonzalez-Martinez A, 2011, EXP GERONTOL, V46, P590, DOI 10.1016/j.exger.2011.02.013; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Greve DN, 2011, AUTOMATIC SURFACE BA; HAMEL CP, 1993, J NEUROSCI RES, V34, P414, DOI 10.1002/jnr.490340406; Hasegawa D, 2005, VET RADIOL ULTRASOUN, V46, P452, DOI 10.1111/j.1740-8261.2005.00083.x; Hasegawa D, 2012, SCI WORLD J, DOI 10.1100/2012/250197; Haskins M, 2009, ILAR J, V50, P112, DOI 10.1093/ilar.50.2.112; Helton WS, 2009, BEHAV PROCESS, V82, P355, DOI 10.1016/j.beproc.2009.08.004; Hernandez M, 2010, INVEST OPHTH VIS SCI, V51, P6793, DOI 10.1167/iovs.10-5213; HOERLEIN BF, 1978, CANINE NEUROLOGY DIA; Horsley V, 1915, BRIT MED J, V1915, P321; Huxley T.H., 1880, P ZOOL SOC LOND, V48, P238, DOI DOI 10.1111/J.1469-7998.1880.TB06558.X; Jiang JF, 2009, J NEUROSCI, V29, P2205, DOI 10.1523/JNEUROSCI.5451-08.2009; Jurney C, 2009, J VET INTERN MED, V23, P871, DOI 10.1111/j.1939-1676.2009.0338.x; Kaminski J, 2004, SCIENCE, V304, P1682, DOI 10.1126/science.1097859; Kang BT, 2009, VET RADIOL ULTRASOUN, V50, P615, DOI 10.1111/j.1740-8261.2009.01591.x; Klein A, 2010, NEUROIMAGE, V51, P214, DOI 10.1016/j.neuroimage.2010.01.091; Komaromy AM, 2010, HUM MOL GENET, V19, P2581, DOI 10.1093/hmg/ddq136; KRAFT SL, 1989, VET RADIOLOGY, V30, P147, DOI 10.1111/j.1740-8261.1989.tb00767.x; Kuwabara T, 2010, VET RADIOL ULTRASOUN, V51, P485, DOI 10.1111/j.1740-8261.2010.01700.x; Langley JN, 1883, J PHYSIOL-LONDON, V4, P248; Lee KI, 2011, J VET MED SCI, V73, P1385, DOI 10.1292/jvms.11-0117; Leigh EJ, 2008, VET RADIOL ULTRASOUN, V49, P113, DOI 10.1111/j.1740-8261.2008.00336.x; Lim R. K. S., 1960, STEREOTAXIC ATLAS DO; Luders E, 2004, NEUROIMAGE, V22, P656, DOI 10.1016/j.neuroimage.2004.01.032; Lyras GA, 2003, ZOOL J LINN SOC-LOND, V138, P505, DOI 10.1046/j.1096-3642.2003.00067.x; Lyras GA, 2009, SCRIPTA GEOLOGICA, V139; MacKillop E, 2011, VET RADIOL ULTRASOUN, V52, pS42, DOI 10.1111/j.1740-8261.2010.01784.x; Martin-Vaquero P, 2011, VET RADIOL ULTRASOUN, V52, P25, DOI 10.1111/j.1740-8261.2010.01747.x; McGowan JC, 2000, J COMPUT ASSIST TOMO, V24, P316, DOI 10.1097/00004728-200003000-00025; McGreevy P, 2004, BRAIN BEHAV EVOLUT, V63, P13, DOI 10.1159/000073756; McGreevy PD, 2010, J VET BEHAV, V5, P318, DOI 10.1016/j.jveb.2010.05.001; Miklosi A, 2006, ANIM COGN, V9, P81, DOI 10.1007/s10071-005-0008-1; Miller ME, 1965, REPRINT; Miyadera K, 2012, MAMM GENOME, V23, P40, DOI 10.1007/s00335-011-9361-3; Mogicato G, 2011, REV MED VET-TOULOUSE, V162, P400; Munk H, 1878, ARCH ANATOMY PHYSL, V2, P161; Natchev S, 2000, COMPTES RENDUS DE LA, V53, P121; Ofri R, 1993, THESIS, V1993; Palazzi X, 2011, THE BEAGLE BRAIN IN; Park HJ, 2009, NEUROIMAGE, V47, P98, DOI 10.1016/j.neuroimage.2009.03.076; Pavlov IP, 1995, LECTURES ON CONDITIO; Pellegrino FC, 2004, CLIN NEUROPHYSIOL, V115, P477, DOI 10.1016/S1388-2457(03)00347-X; RADINSKY L, 1973, BRAIN BEHAV EVOLUT, V7, P169, DOI 10.1159/000124409; Razran HS, 1929, PSYCHOL BULL, V26, P202, DOI 10.1037/h0073189; Roberts T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011946; Sarasa M, 2009, CURR ALZHEIMER RES, V6, P171, DOI 10.2174/156720509787602834; Sereno MI, 1991, THE NEURAL BASIS OF; Stein L, 2011, EXPERT OPIN BIOL TH, V11, P429, DOI 10.1517/14712598.2011.557358; TAN U, 1987, INT J NEUROSCI, V32, P943, DOI 10.3109/00207458709043351; Tapp PD, 2006, NEUROIMAGE, V29, P234, DOI 10.1016/j.neuroimage.2005.07.043; Teglas E, 2012, CURR BIOL, V22, P209, DOI 10.1016/j.cub.2011.12.018; VANWINKLE TJ, 1994, PROG VET NEUROL, V5, P66; Vite CH, 2001, VET RADIOL ULTRASOUN, V42, P5, DOI 10.1111/j.1740-8261.2001.tb00896.x; Vite CH, 2011, VET RADIOL ULTRASOUN, V52, pS23, DOI 10.1111/j.1740-8261.2010.01782.x; Wang P, 2010, THE OPEN MEDICAL IMA, V4, P1; Wells DL, 2003, BEHAV PROCESS, V61, P27, DOI 10.1016/S0376-6357(02)00161-4; Willis CKR, 2001, VET OPHTHALMOL, V4, P243, DOI 10.1046/j.1463-5216.2001.00183.x; Willis CKR, 2001, CAN J VET RES, V65, P188; Wolff CA, 2012, J VET INTERN MED, V26, P589, DOI 10.1111/j.1939-1676.2012.00899.x; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	89	60	60	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52140	10.1371/journal.pone.0052140	http://dx.doi.org/10.1371/journal.pone.0052140			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284904	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500099
J	Pavli, OI; Tampakaki, AP; Skaracis, GN				Pavli, Ourania I.; Tampakaki, Anastasia P.; Skaracis, George N.			High Level Resistance against Rhizomania Disease by Simultaneously Integrating Two Distinct Defense Mechanisms	PLOS ONE			English	Article							YELLOW-VEIN-VIRUS; SUGAR-BEET; MEDIATED RESISTANCE; BNYVV; PROTEIN; RICE; PATHOGENICITY; INFECTIONS; BREAKING; FRAGMENT	With the aim of achieving durable resistance against rhizomania disease of sugar beet, the employment of different sources of resistance to Beet necrotic yellow vein virus was pursued. To this purpose, Nicotiana benthamiana transgenic plants that simultaneously produce dsRNA originating from a conserved region of the BNYVV replicase gene and the HrpZ(Psph) protein in a secreted form (SP/HrpZ(Psph)) were produced. The integration and expression of both transgenes as well as proper production of the harpin protein were verified in all primary transformants and selfed progeny (T1, T2). Transgenic resistance was assessed by BNYVV-challenge inoculation on T2 progeny by scoring disease symptoms and DAS-ELISA at 20 and 30 dpi. Transgenic lines possessing single transformation events for both transgenes as well as wild type plants were included in inoculation experiments. Transgenic plants were highly resistant to virus infection, whereas in some cases immunity was achieved. In all cases, the resistant phenotype of transgenic plants carrying both transgenes was superior in comparison with the ones carrying a single transgene. Collectively, our findings demonstrate, for a first time, that the combination of two entirely different resistance mechanisms provide high level resistance or even immunity against the virus. Such a novel approach is anticipated to prevent a rapid virus adaptation that could potentially lead to the emergence of isolates with resistance breaking properties.	[Pavli, Ourania I.; Skaracis, George N.] Agr Univ Athens, Dept Crop Sci, Athens, Greece; [Tampakaki, Anastasia P.] Agr Univ Athens, Dept Agr Biotechnol, Athens, Greece	Agricultural University of Athens; Agricultural University of Athens	Pavli, OI (corresponding author), Agr Univ Athens, Dept Crop Sci, Athens, Greece.	raniapavli@yahoo.gr; gskaracis@aua.gr	Tampakaki, Anastasia/ABF-8966-2021	Tampakaki, Anastasia/0000-0003-4439-0920; Pavli, Ourania/0000-0002-5276-2184	Laboratory of Plant Breeding and Biometry; Laboratory of General and Agricultural Microbiology	Laboratory of Plant Breeding and Biometry; Laboratory of General and Agricultural Microbiology	The study was funded by the Laboratory of Plant Breeding and Biometry and the Laboratory of General and Agricultural Microbiology. No other funders supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Leal R, 2007, PHYTOPATHOLOGY, V97, P325, DOI 10.1094/PHYTO-97-3-0325; Acosta-Leal R, 2008, VIROLOGY, V376, P60, DOI 10.1016/j.virol.2008.03.008; Acosta-Leal R, 2010, PHYTOPATHOLOGY, V100, P127, DOI 10.1094/PHYTO-100-2-0127; Andika IB, 2005, MOL PLANT MICROBE IN, V18, P194, DOI 10.1094/MPMI-18-0194; Biancardi E, 2002, EUPHYTICA, V127, P383, DOI 10.1023/A:1020310718166; Casarini B, 1999, BARBABIETOLA NEGLI A, P273; Chen L, 2008, PHYTOPATHOLOGY, V98, P792, DOI 10.1094/PHYTO-98-7-0792; Chiba S, 2008, J GEN VIROL, V89, P1314, DOI 10.1099/vir.0.83624-0; Chiba S, 2011, MOL PLANT MICROBE IN, V24, P207, DOI 10.1094/MPMI-10-10-0241; Conrath U, 2006, MOL PLANT MICROBE IN, V19, P1062, DOI 10.1094/MPMI-19-1062; Dong HP, 2005, PLANTA, V221, P313, DOI 10.1007/s00425-004-1444-x; Fecker LF, 1997, ARCH VIROL, V142, P1857, DOI 10.1007/s007050050203; Grimmer MK, 2007, THEOR APPL GENET, V114, P1151, DOI 10.1007/s00122-007-0507-3; Heijbroek W, 1999, EUR J PLANT PATHOL, V105, P397, DOI 10.1023/A:1008705111232; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Huo R, 2010, TRANSGENIC RES, V19, P841, DOI 10.1007/s11248-010-9365-x; Kiguchi T, 1996, J GEN VIROL, V77, P575, DOI 10.1099/0022-1317-77-4-575; Koenig R, 2009, J GEN VIROL, V90, P759, DOI 10.1099/vir.0.007112-0; KOENIG R, 1995, J GEN VIROL, V76, P2051, DOI 10.1099/0022-1317-76-8-2051; Koenig R, 1997, ARCH VIROL, V142, P1499, DOI 10.1007/s007050050176; Koenig R, 2000, ARCH VIROL, V145, P1561, DOI 10.1007/s007050070076; KRUSE M, 1994, J GEN VIROL, V75, P1835, DOI 10.1099/0022-1317-75-8-1835; Lennefors BL, 2006, MOL BREEDING, V18, P313, DOI 10.1007/s11032-006-9030-5; LEWELLEN RT, 1990, P 53 C IIRB, P79; Lewer R. P., 1987, Proceedings of the the Sixth Conference, Australian Association of Animal Breeding and Genetics, University of Western Australia, Perth, WA, Australia, 9-11 February 1987., P139; Mannerlof M, 1996, EUPHYTICA, V90, P293, DOI 10.1007/BF00027479; Oh CS, 2007, PLANT PHYSIOL, V145, P426, DOI 10.1104/pp.107.103432; Pavli O, 2011, EUR J PLANT PATHOL, V130, P133, DOI 10.1007/s10658-010-9639-4; Pavli OI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017306; Pavli OI, 2010, TRANSGENIC RES, V19, P915, DOI 10.1007/s11248-010-9364-y; Ren HY, 2006, ANN MICROBIOL, V56, P281, DOI 10.1007/BF03175019; Rush CM, 2006, PLANT DIS, V90, P4, DOI 10.1094/PD-90-0004; Rush CM, 2003, ANNU REV PHYTOPATHOL, V41, P567, DOI 10.1146/annurev.phyto.41.052002.095705; Schirmer A, 2005, J GEN VIROL, V86, P2897, DOI 10.1099/vir.0.81167-0; Scholten OE, 1996, EUPHYTICA, V91, P331, DOI 10.1007/BF00033095; Shao M, 2008, PLANT BIOTECHNOL J, V6, P73, DOI 10.1111/j.1467-7652.2007.00304.x; TAMADA T, 1989, J GEN VIROL, V70, P3399, DOI 10.1099/0022-1317-70-12-3399; Tamada T., 1996, Proceedings of the Third Symposium of the International Working Group on Plant Viruses with Fungal Vectors, West Park Conference Centre, Dundee, Scotland, 6-7 August, 1996, P49; Tamada T, 2002, P 5 S INT WORK GROUP, P13; Tamada T, 1999, ENCY VIROLOGY, P154; Tampakaki AP, 2000, MOL PLANT MICROBE IN, V13, P1366, DOI 10.1094/MPMI.2000.13.12.1366	41	1	1	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51414	10.1371/journal.pone.0051414	http://dx.doi.org/10.1371/journal.pone.0051414			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284692	gold, Green Submitted, Green Published			2022-12-27	WOS:000312794500028
J	Peace, C; Bassil, N; Main, D; Ficklin, S; Rosyara, UR; Stegmeir, T; Sebolt, A; Gilmore, B; Lawley, C; Mockler, TC; Bryant, DW; Wilhelm, L; Iezzoni, A				Peace, Cameron; Bassil, Nahla; Main, Dorrie; Ficklin, Stephen; Rosyara, Umesh R.; Stegmeir, Travis; Sebolt, Audrey; Gilmore, Barbara; Lawley, Cindy; Mockler, Todd C.; Bryant, Douglas W.; Wilhelm, Larry; Iezzoni, Amy			Development and Evaluation of a Genome-Wide 6K SNP Array for Diploid Sweet Cherry and Tetraploid Sour Cherry	PLOS ONE			English	Article							PRUNUS-AVIUM; ROSACEAE; INHERITANCE; RESISTANCE; HAPLOTYPE; DATABASE; MAP	High-throughput genome scans are important tools for genetic studies and breeding applications. Here, a 6K SNP array for use with the Illumina Infinium (R) system was developed for diploid sweet cherry (Prunus avium) and allotetraploid sour cherry (P. cerasus). This effort was led by RosBREED, a community initiative to enable marker-assisted breeding for rosaceous crops. Next-generation sequencing in diverse breeding germplasm provided 25 billion basepairs (Gb) of cherry DNA sequence from which were identified genome-wide SNPs for sweet cherry and for the two sour cherry subgenomes derived from sweet cherry (avium subgenome) and P. fruticosa (fruticosa subgenome). Anchoring to the peach genome sequence, recently released by the International Peach Genome Initiative, predicted relative physical locations of the 1.9 million putative SNPs detected, preliminarily filtered to 368,943 SNPs. Further filtering was guided by results of a 144-SNP subset examined with the Illumina GoldenGate (R) assay on 160 accessions. A 6K Infinium (R) II array was designed with SNPs evenly spaced genetically across the sweet and sour cherry genomes. SNPs were developed for each sour cherry subgenome by using minor allele frequency in the sour cherry detection panel to enrich for subgenome-specific SNPs followed by targeting to either subgenome according to alleles observed in sweet cherry. The array was evaluated using panels of sweet (n = 269) and sour (n = 330) cherry breeding germplasm. Approximately one third of array SNPs were informative for each crop. A total of 1825 polymorphic SNPs were verified in sweet cherry, 13% of these originally developed for sour cherry. Allele dosage was resolved for 2058 polymorphic SNPs in sour cherry, one third of these being originally developed for sweet cherry. This publicly available genomics resource represents a significant advance in cherry genome-scanning capability that will accelerate marker-locus-trait association discovery, genome structure investigation, and genetic diversity assessment in this diploid-tetraploid crop group. Citation: Peace C, Bassil N, Main D, Ficklin S, Rosyara UR, et al. (2012) Development and Evaluation of a Genome-Wide 6K SNP Array for Diploid Sweet Cherry and Tetraploid Sour Cherry. PLoS ONE 7(12): e48305. doi:10.1371/journal.pone.0048305	[Peace, Cameron; Main, Dorrie; Ficklin, Stephen] Washington State Univ, Dept Hort, Pullman, WA 99164 USA; [Bassil, Nahla; Gilmore, Barbara] ARS, USDA, Corvallis, OR USA; [Rosyara, Umesh R.; Stegmeir, Travis; Sebolt, Audrey; Iezzoni, Amy] Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA; [Lawley, Cindy] Illumina Inc, Hayward, CA USA; [Mockler, Todd C.; Bryant, Douglas W.] Donald Danforth Plant Sci Ctr, St Louis, MO USA; [Bryant, Douglas W.] Intuit Genom Inc, St Louis, MO USA; [Wilhelm, Larry] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Washington State University; United States Department of Agriculture (USDA); Michigan State University; Illumina; Donald Danforth Plant Science Center; Oregon Health & Science University	Peace, C (corresponding author), Washington State Univ, Dept Hort, Pullman, WA 99164 USA.	cpeace@wsu.edu	Mockler, Todd C/L-2609-2013; Ficklin, Stephen/L-4324-2019	Mockler, Todd C/0000-0002-0462-5775; Ficklin, Stephen/0000-0001-9138-6292; Lawley, Cynthia/0000-0001-7001-4705	USDA's National Institute of Food and Agriculture - Specialty Crop Research Initiative project, "RosBREED: Enabling marker-assisted breeding in Rosaceae'' [2009-51181-05808]	USDA's National Institute of Food and Agriculture - Specialty Crop Research Initiative project, "RosBREED: Enabling marker-assisted breeding in Rosaceae''	This work was partially funded by the USDA's National Institute of Food and Agriculture - Specialty Crop Research Initiative project, "RosBREED: Enabling marker-assisted breeding in Rosaceae'' (2009-51181-05808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Akhunov E, 2009, THEOR APPL GENET, V119, P507, DOI 10.1007/s00122-009-1059-5; BEAVER JA, 1995, THEOR APPL GENET, V90, P847, DOI 10.1007/BF00222021; BEAVER JA, 1993, J AM SOC HORTIC SCI, V118, P873, DOI 10.21273/JASHS.118.6.873; Boskovic R, 2001, THEOR APPL GENET, V103, P475, DOI 10.1007/PL00002906; Cabrera A, 2012, TREE GENET GENOMES, V8, P237, DOI 10.1007/s11295-011-0436-9; Chagne D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031745; Clarke JB, 2009, TREE GENET GENOMES, V5, P41, DOI 10.1007/s11295-008-0166-9; Dirlewanger E, 2004, P NATL ACAD SCI USA, V101, P9891, DOI 10.1073/pnas.0307937101; Dirlewanger E., 2007, Fruits and nuts, P103; Felcher K, 2012, PLOS ONE IN PRESS; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Hamilton JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-302; Hauck NR, 2006, J HERED, V97, P514, DOI 10.1093/jhered/esl029; Iezzoni A, 2010, ACTA HORTIC, V859, P389; Illumina, 2008, GENOMESTUDIO GEN MOD; Illumina, 2006, TOP BOT STRAND AB AL; Illumina I, 2010, INF GEN DAT AN GUID; Illumina Inc, 2011, CALL POL GEN GENOMES; Illumina Inc, 2010, IMPR CLUST GEN GENTR; Wen J, 2008, J SYST EVOL, V46, P322, DOI 10.3724/SP.J.1002.2008.08050; Jung S, 2008, NUCLEIC ACIDS RES, V36, pD1034, DOI 10.1093/nar/gkm803; Klagges C, 2012, PLOS ONE UNPUB; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; OLDEN EJ, 1968, HEREDITAS-GENETISK A, V59, P327; Olmstead JW, 2008, TREE GENET GENOMES, V4, P897, DOI 10.1007/s11295-008-0161-1; Olmstead JW, 2001, HORTSCIENCE, V36, P337, DOI 10.21273/HORTSCI.36.2.337; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Tavaud M, 2004, HEREDITY, V93, P631, DOI 10.1038/sj.hdy.6800589; Tsukamoto T, 2006, PLANT MOL BIOL, V62, P371, DOI 10.1007/s11103-006-9026-x; Tsukamoto T, 2010, GENETICS, V184, P411, DOI 10.1534/genetics.109.109728; Verde I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035668; Wharton PS, 2003, PLANT DIS, V87, P471, DOI 10.1094/PDIS.2003.87.5.471; Zhang GR, 2010, TREE GENET GENOMES, V6, P25, DOI 10.1007/s11295-009-0225-x	34	98	101	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e48305	10.1371/journal.pone.0048305	http://dx.doi.org/10.1371/journal.pone.0048305			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284615	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500005
J	Ye, ZX; Wang, YQ; Quan, X; Li, J; Hu, XY; Huang, JH; Luo, ZJ				Ye, Zhengxu; Wang, Yuqing; Quan, Xin; Li, Jing; Hu, Xueyu; Huang, Jinghui; Luo, Zhuojing			Effects of Mechanical Force on Cytoskeleton Structure and Calpain-Induced Apoptosis in Rat Dorsal Root Ganglion Neurons In Vitro	PLOS ONE			English	Article							SPINAL-CORD-INJURY; COLCHICINE-INDUCED APOPTOSIS; OXIDATIVE STRESS; EXPRESSION; INHIBITOR; PROTEASE; CALCIUM; CELLS; INVOLVEMENT; ACTIVATION	Background: A sudden mechanical insult to the spinal cord is usually caused by changing pressure on the surface of the spinal cord. Most of these insults are mechanical force injuries, and their mechanism of injury to the spinal cord is largely unknown. Methods: Using a compression-driven instrument to simulate mechanical force, we applied mechanical pressure of 0.5 MPa to rat dorsal root ganglion (DRG) neurons for 10 min to investigate cytoskeletal alterations and calpain-induced apoptosis after the mechanical force injury. Results: The results indicated that mechanical forces affect the structure of the cytoskeleton and cell viability, induce early apoptosis, and affect the cell cycle of DRG neurons. In addition, the calpain inhibitor PD150606 reduced cytoskeletal degradation and the rate of apoptosis after mechanical force injury. Conclusion: Thus, calpain may play an important role in DRG neurons in the regulation of apoptosis and cytoskeletal alterations induced by mechanical force. Moreover, cytoskeletal alterations may be substantially involved in the mechanotransduction process in DRG neurons after mechanical injury and may be induced by activated calpain. To our knowledge, this is the first report to demonstrate a relationship between cytoskeletal degradation and apoptosis in DRG neurons.	[Ye, Zhengxu; Wang, Yuqing; Quan, Xin; Hu, Xueyu; Huang, Jinghui; Luo, Zhuojing] Fourth Mil Med Univ, Dept Orthoped, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China; [Li, Jing] Fourth Mil Med Univ, Dept Pathol, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Luo, ZJ (corresponding author), Fourth Mil Med Univ, Dept Orthoped, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China.	yzengx@fmmu.edu.cn	Wang, yuqing/HIR-1604-2022	Huang, Jinghui/0000-0002-0991-0591; xin, quan/0000-0003-2295-350X	National Natural Science Foundation of China [30901510]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant (No. 30901510) from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrozaitis Kazys Vytautas, 2006, Medicina (Kaunas), V42, P255; Banik N.L, 1999, CALPAIN PHARM TOXICO, P211; Bareyre FM, 2008, J NEUROL SCI, V265, P63, DOI 10.1016/j.jns.2007.05.004; BARTUS RT, 1994, STROKE, V25, P2265, DOI 10.1161/01.STR.25.11.2265; BELOUSSOV LV, 1980, ROUX ARCH DEV BIOL, V188, P1, DOI 10.1007/BF00848603; Blomgren K, 1999, J BIOL CHEM, V274, P14046, DOI 10.1074/jbc.274.20.14046; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Corsini E, 2011, TOXICOL APPL PHARM, V250, P108, DOI 10.1016/j.taap.2010.11.004; CROALL DE, 1991, PHYSIOL REV, V71, P813, DOI 10.1152/physrev.1991.71.3.813; Dare E, 2001, NEUROTOX RES, V3, P501, DOI 10.1007/BF03033206; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; Friedlander R.M., 2003, NEW ENGL J MED, V348, P1365; Guttman R. P, 1999, CALPAIN PHARM TOXICO, P229; JOHNSON P, 1990, INT J BIOCHEM, V22, P811, DOI 10.1016/0020-711X(90)90284-A; Jorda EG, 2005, BIOCHEM PHARMACOL, V70, P470, DOI 10.1016/j.bcp.2005.04.036; Jorda EG, 2003, NEUROPHARMACOLOGY, V45, P672, DOI 10.1016/S0028-3908(03)00204-1; Jorda EG, 2004, BIPOLAR DISORD, V6, P144, DOI 10.1046/j.1399-5618.2003.00090.x; Lee JSH, 2005, MOL BIOL CELL, V16, P871, DOI 10.1091/mbc.e03-12-0910; LI ZH, 1995, NEUROCHEM INT, V27, P425, DOI 10.1016/0197-0186(95)00024-3; Martinac B, 2004, J CELL SCI, V117, P2449, DOI 10.1242/jcs.01232; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nath R, 1996, BIOCHEM J, V319, P683, DOI 10.1042/bj3190683; Nath R, 1996, NEUROREPORT, V8, P249, DOI 10.1097/00001756-199612200-00050; Nicotera P, 1998, CELL CALCIUM, V23, P173, DOI 10.1016/S0143-4160(98)90116-6; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; Ray SK, 2000, BRAIN RES, V852, P326, DOI 10.1016/S0006-8993(99)02148-4; Ray SK, 2000, NEUROCHEM RES, V25, P1191, DOI 10.1023/A:1007631826160; Ray SK, 1999, BRAIN RES, V829, P18, DOI 10.1016/S0006-8993(99)01290-1; Ray SK, 2003, BRAIN RES REV, V42, P169, DOI 10.1016/S0165-0173(03)00152-8; Ray SK, 2002, J NEUROSCI RES, V70, P561, DOI 10.1002/jnr.10414; Ray SK, 2001, BRAIN RES, V916, P115, DOI 10.1016/S0006-8993(01)02874-8; Ray SK, 2000, BRAIN RES, V867, P80, DOI 10.1016/S0006-8993(00)02260-5; Roth KA, 2001, J NEUROPATH EXP NEUR, V60, P829, DOI 10.1093/jnen/60.9.829; SAIDO TC, 1994, FASEB J, V8, P814, DOI 10.1096/fasebj.8.11.8070630; SANCES A, 1984, CRIT REV BIOMED ENG, V11, P1; Schotte P, 1998, BIOCHEM BIOPH RES CO, V251, P379, DOI 10.1006/bbrc.1998.9425; Schumacher PA, 2000, J NEUROCHEM, V74, P1646, DOI 10.1046/j.1471-4159.2000.0741646.x; Slee EA, 1999, CELL DEATH DIFFER, V6, P1067, DOI 10.1038/sj.cdd.4400601; Stefanis L, 2005, NEUROSCIENTIST, V11, P50, DOI 10.1177/1073858404271087; Storch A, 2000, J NEUROCHEM, V75, P2259, DOI 10.1046/j.1471-4159.2000.0752259.x; Sui F, 2010, J ASIAN NAT PROD RES, V12, P76, DOI 10.1080/10286020903451732; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; TRUMP BF, 1995, FASEB J, V9, P219, DOI 10.1096/fasebj.9.2.7781924; YOUSEFIAN J, 1995, AM J ORTHOD DENTOFAC, V108, P402, DOI 10.1016/S0889-5406(95)70038-2	46	19	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52183	10.1371/journal.pone.0052183	http://dx.doi.org/10.1371/journal.pone.0052183			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284927	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500108
J	Zhang, H; Chen, YL; Chen, Y				Zhang, Hui; Chen, Yueling; Chen, Yong			Noise Propagation in Gene Regulation Networks Involving Interlinked Positive and Negative Feedback Loops	PLOS ONE			English	Article							CELL-CYCLE OSCILLATOR; MAP KINASE; MEMORY; FATE; DIFFERENTIATION; STOCHASTICITY; FLUCTUATIONS; VARIABILITY; SIMULATION; EXPRESSION	It is well known that noise is inevitable in gene regulatory networks due to the low-copy numbers of molecules and local environmental fluctuations. The prediction of noise effects is a key issue in ensuring reliable transmission of information. Interlinked positive and negative feedback loops are essential signal transduction motifs in biological networks. Positive feedback loops are generally believed to induce a switch-like behavior, whereas negative feedback loops are thought to suppress noise effects. Here, by using the signal sensitivity (susceptibility) and noise amplification to quantify noise propagation, we analyze an abstract model of the Myc/E2F/MiR-17-92 network that is composed of a coupling between the E2F/Myc positive feedback loop and the E2F/Myc/miR-17-92 negative feedback loop. The role of the feedback loop on noise effects is found to depend on the dynamic properties of the system. When the system is in monostability or bistability with high protein concentrations, noise is consistently suppressed. However, the negative feedback loop reduces this suppression ability (or improves the noise propagation) and enhances signal sensitivity. In the case of excitability, bistability, or monostability, noise is enhanced at low protein concentrations. The negative feedback loop reduces this noise enhancement as well as the signal sensitivity. In all cases, the positive feedback loop acts contrary to the negative feedback loop. We also found that increasing the time scale of the protein module or decreasing the noise autocorrelation time can enhance noise suppression; however, the systems sensitivity remains unchanged. Taken together, our results suggest that the negative/positive feedback mechanisms in coupled feedback loop dynamically buffer noise effects rather than only suppressing or amplifying the noise.	[Zhang, Hui; Chen, Yueling; Chen, Yong] Lanzhou Univ, Inst Theoret Phys, Lanzhou 730000, Peoples R China; [Chen, Yueling] Gansu Coll Tradit Chinese Med, Dept Phys, Lanzhou, Peoples R China; [Chen, Yong] Kings Coll London, Dept Math, London WC2R 2LS, England	Lanzhou University; Gansu University of Chinese Medicine; University of London; King's College London	Chen, Y (corresponding author), Lanzhou Univ, Inst Theoret Phys, Lanzhou 730000, Peoples R China.	ychen@lzu.edu.cn	Chen, Yong/B-9051-2008	Chen, Yong/0000-0003-2580-5895	National Natural Science Foundation of China [10975063]; Fundamental Research Funds for the Central Universities [lzujbky-2012-17]; Program for New Century Excellent Talents in University [NCET-11-0206]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Natural Science Foundation of China (Grants No. 10975063), the Fundamental Research Funds for the Central Universities (Grant No. lzujbky-2012-17), and the Program for New Century Excellent Talents in University (Grant No. NCET-11-0206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrieu A, 2001, J CELL SCI, V114, P257; Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Berridge MJ, 2001, NOVART FDN SYMP, V239, P52; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Bratsun D, 2005, P NATL ACAD SCI USA, V102, P14593, DOI 10.1073/pnas.0503858102; Cheng Z, 2008, FEBS LETT, V582, P3776, DOI 10.1016/j.febslet.2008.10.005; Cole F, 2004, DEV CELL, V7, P843, DOI 10.1016/j.devcel.2004.10.009; Dublanche Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100081; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; Hooshangi S, 2006, CHAOS, V16, DOI 10.1063/1.2208927; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Hornung G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040008; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; KASDIN NJ, 1995, J GUID CONTROL DYNAM, V18, P114, DOI 10.2514/3.56665; Kaufmann BB, 2007, PLOS BIOL, V5, P1973, DOI 10.1371/journal.pbio.0050239; KEIZER J, 1995, MOL BIOL CELL, V6, P945, DOI 10.1091/mbc.6.8.945; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kim D, 2007, BIOESSAYS, V29, P85, DOI 10.1002/bies.20511; Kim JR, 2008, BIOPHYS J, V94, P359, DOI 10.1529/biophysj.107.105106; KLOSEKDYGAS MM, 1988, SIAM J APPL MATH, V48, P425, DOI 10.1137/0148023; Korobkova E, 2004, NATURE, V428, P574, DOI 10.1038/nature02404; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Li Y, 2011, PLOS ONE, V6, DOI DOI 10.1371/journal.pone.0026302; Lindner B, 2004, PHYS REP, V392, P321, DOI 10.1016/j.physrep.2003.10.015; Ma J, 2008, CHAOS, V18, DOI 10.1063/1.3013178; MCADAMS HH, 1995, SCIENCE, V269, P650, DOI 10.1126/science.7624793; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Mitrophanov AY, 2008, BIOESSAYS, V30, P542, DOI 10.1002/bies.20769; Nevozhay D, 2009, P NATL ACAD SCI USA, V106, P5123, DOI 10.1073/pnas.0809901106; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Papoulis A., 1991, PROBABILITY RANDOM V; Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Paulsson J, 2005, PHYS LIFE REV, V2, P157, DOI 10.1016/j.plrev.2005.03.003; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Pedraza JM, 2008, SCIENCE, V319, P339, DOI 10.1126/science.1144331; Pfeuty B, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046013; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Pulikkan JA, 2010, BLOOD, V115, P1768, DOI 10.1182/blood-2009-08-240101; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Shahrezaei V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.31; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Simpson ML, 2003, P NATL ACAD SCI USA, V100, P4551, DOI 10.1073/pnas.0736140100; SINGH P, 1994, EMBO J, V13, P3329, DOI 10.1002/j.1460-2075.1994.tb06635.x; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Tian XJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.011926; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Ueda M, 2001, SCIENCE, V294, P864, DOI 10.1126/science.1063951; Wedlich-Soldner R, 2004, J CELL BIOL, V166, P889, DOI 10.1083/jcb.200405061; Wee KB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004407; Wolf DM, 2003, CURR OPIN MICROBIOL, V6, P125, DOI 10.1016/S1369-5274(03)00033-X; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Zhao HW, 2009, BLOOD, V113, P505, DOI 10.1182/blood-2008-01-136218	70	29	29	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51840	10.1371/journal.pone.0051840	http://dx.doi.org/10.1371/journal.pone.0051840			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284787	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500053
J	Bosch, X; Hernandez, C; Pericas, JM; Doti, P; Marusic, A				Bosch, Xavier; Hernandez, Cristina; Pericas, Juan M.; Doti, Pamela; Marusic, Ana			Misconduct Policies in High-Impact Biomedical Journals	PLOS ONE			English	Article							PUBLICATION ETHICS; MEDICAL LITERATURE; INTEGRITY; RETRACTIONS; STANDARDS; SCIENCE	Background: It is not clear which research misconduct policies are adopted by biomedical journals. This study assessed the prevalence and content policies of the most influential biomedical journals on misconduct and procedures for handling and responding to allegations of misconduct. Methods: We conducted a cross-sectional study of misconduct policies of 399 high-impact biomedical journals in 27 biomedical categories of the Journal Citation Reports in December 2011. Journal websites were reviewed for information relevant to misconduct policies. Results: Of 399 journals, 140 (35.1%) provided explicit definitions of misconduct. Falsification was explicitly mentioned by 113 (28.3%) journals, fabrication by 104 (26.1%), plagiarism by 224 (56.1%), duplication by 242 (60.7%) and image manipulation by 154 (38.6%). Procedures for responding to misconduct were described in 179 (44.9%) websites, including retraction, (30.8%) and expression of concern (16.3%). Plagiarism-checking services were used by 112 (28.1%) journals. The prevalences of all types of misconduct policies were higher in journals that endorsed any policy from editors' associations, Office of Research Integrity or professional societies compared to those that did not state adherence to these policy-producing bodies. Elsevier and Wiley-Blackwell had the most journals included (22.6% and 14.8%, respectively), with Wiley journals having greater a prevalence of misconduct definition and policies on falsification, fabrication and expression of concern and Elsevier of plagiarism-checking services. Conclusions: Only a third of top-ranking peer-reviewed journals had publicly-available definitions of misconduct and less than a half described procedures for handling allegations of misconduct. As endorsement of international policies from policy-producing bodies was positively associated with implementation of policies and procedures, journals and their publishers should standardize their policies globally in order to increase public trust in the integrity of the published record in biomedicine.	[Bosch, Xavier; Hernandez, Cristina; Pericas, Juan M.; Doti, Pamela] Univ Barcelona, Dept Internal Med, Inst Invest Biomed, Hosp Clin, Barcelona, Spain; [Marusic, Ana] Univ Split, Sch Med, Dept Res Biomed & Hlth, Split, Croatia	University of Barcelona; University of Split	Bosch, X (corresponding author), Univ Barcelona, Dept Internal Med, Inst Invest Biomed, Hosp Clin, Barcelona, Spain.	xavbosch@clinic.ub.es	Pericàs, Juan M/N-5674-2019; Marusic, Ana/E-7683-2013	Pericàs, Juan M/0000-0002-3645-3293; Marusic, Ana/0000-0001-6272-0917				[Anonymous], 2011, NAT MED, V17, P1523, DOI 10.1038/nm.2611; [Anonymous], 2008, ALL ELS J BEC COPE M; [Anonymous], 2000, MAN ALL SCI MISC GUI; [Anonymous], 2011, DIABETES PUBLICATION; Barrett Kirsten A, 2005, Account Res, V12, P193, DOI 10.1080/08989620500217321; Benninger MS, 2005, ARCH OTOLARYNGOL, V131, P381, DOI 10.1001/archotol.131.5.381; Bosch X, 2012, ARCH INTERN MED, V172, P70, DOI 10.1001/archinternmed.2011.600; COPE flowcharts, WHAT DO YOU SUSP RED, V16; Drazen JM, 2009, NEW ENGL J MED, V361, P1896, DOI [10.1056/NEJMe0909052, 10.1503/cmaj.091691]; Fanelli Daniele, 2009, PLoS One, V4, pe5738, DOI 10.1371/journal.pone.0005738; Fang FC, 2012, P NATL ACAD SCI USA, V109, P17028, DOI 10.1073/pnas.1212247109; Fang FC, 2011, INFECT IMMUN, V79, P3855, DOI 10.1128/IAI.05661-11; Graf Chris, 2007, Int J Clin Pract Suppl, P1; Hall RI, 2012, J CARDIOTHOR VASC AN, V26, P181, DOI 10.1053/j.jvca.2011.12.003; International Committee of Medical Journal Editors, UN REQ MAN SUB BIOM; Kohler CS, 2012, DIABETES, V61, P38, DOI 10.2337/db11-1432; Martinson BC, 2005, NATURE, V435, P737, DOI 10.1038/435737a; Miano JM, 2010, ARTERIOSCL THROM VAS, V30, P1, DOI 10.1161/ATVBAHA.109.200204; Redman Barbara K, 2006, Account Res, V13, P247, DOI 10.1080/08989620600848199; Resnik DB, 2013, J MED ETHICS, V39, P46, DOI 10.1136/medethics-2012-100766; Resnik DB, 2010, ACCOUNT RES, V17, P79, DOI 10.1080/08989621003641181; Resnik DB, 2009, ACCOUNT RES, V16, P254, DOI 10.1080/08989620903190299; Roberts J, 2009, HEADACHE, V49, P578, DOI 10.1111/j.1526-4610.2009.01379.x; Rossner M, 2004, J CELL BIOL, V166, P11, DOI 10.1083/jcb.200406019; Scheetz MD, 2000, P 1 ORI RES C RES IN, P285; Sox HC, 2006, ANN INTERN MED, V144, P609, DOI 10.7326/0003-4819-144-8-200604180-00123; Steen RG, 2011, J MED ETHICS, V37, P688, DOI 10.1136/jme.2011.043133; Steneck NH, 2006, SCI ENG ETHICS, V12, P53, DOI 10.1007/PL00022268; Thomson Reuters, J CIT REP; Trikalinos NA, 2008, J CLIN EPIDEMIOL, V61, P464, DOI 10.1016/j.jclinepi.2007.11.019; Wager E, 2012, MATURITAS, V72, P165, DOI [10.5455/aim.2012.20.136-140, 10.1016/j.maturitas.2012.03.011]; Wager E, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6586; Wager E, 2011, J MED ETHICS, V37, P567, DOI 10.1136/jme.2010.040964	33	60	60	2	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51928	10.1371/journal.pone.0051928	http://dx.doi.org/10.1371/journal.pone.0051928			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284820	Green Submitted, Green Published, gold			2022-12-27	WOS:000312694300060
J	Pan, FG; Zhao, YY; Zhu, S; Sun, CJ; Lei, LC; Feng, X; Han, WY				Pan, Fengguang; Zhao, Yaya; Zhu, Seng; Sun, Changjiang; Lei, Liancheng; Feng, Xin; Han, Wen Yu			Different Transcriptional Profiles of RAW264.7 Infected with Mycobacterium tuberculosis H37Rv and BCG Identified via Deep Sequencing	PLOS ONE			English	Article							ACTIN-FILAMENT NETWORK; INNATE IMMUNITY; PATHOGENIC MYCOBACTERIA; MACROPHAGE RESPONSES; DEFENSE-MECHANISM; AUTOPHAGY; EXPRESSION; PHAGOSOMES; PATHWAYS; CELLS	Background: The Mycobacterium tuberculosis H37Rv and BCG effects on the host cell transcriptional profile consider a main research point. In the present study the transcriptome profiling analysis of RAW264.7 either infected with Mycobacterium tuberculosis H37Rv or BCG have been reported using Solexa/Illumina digital gene expression (DGE). Results: The DGE analysis showed 1,917 different expressed genes between the BCG and H37Rv group. In addition, approximately 5% of the transcripts appeared to be predicted genes that have never been described before. KEGG Orthology (KO) annotations showed more than 71% of these transcripts are possibly involved in approximately 210 known metabolic or signaling pathways. The gene of the 28 pathways about pathogen recognition receptors and Mycobacterium tuberculosis interaction with macrophages were analyzed using the CLUSTER 3.0 available, the Tree View tool and Gene Orthology (GO). Some genes were randomly selected to confirm their altered expression levels by quantitative real-time PCR (qRT-PCR). Conclusion: The present study used DGE from pathogen recognition receptors and Mycobacterium tuberculosis interaction with macrophages to understand the interplay between Mycobacterium tuberculosis and RAW264.7. Meanwhile find some important host protein which was affected by Mycobacterium tuberculosis to provide evidence for the further improvement of the present efficacy of existing Mycobacterium tuberculosis therapy and vaccine.	[Pan, Fengguang; Zhu, Seng; Sun, Changjiang; Lei, Liancheng; Feng, Xin; Han, Wen Yu] Jilin Univ, Coll Anim Sci & Vet Med, Changchun 130023, Jilin, Peoples R China; [Pan, Fengguang; Zhao, Yaya] Jilin Univ, Lab Food Safety & Hyg Inspect, Changchun 130023, Jilin, Peoples R China	Jilin University; Jilin University	Sun, CJ (corresponding author), Jilin Univ, Coll Anim Sci & Vet Med, Changchun 130023, Jilin, Peoples R China.	schangjiang@126.com; jluhwy@sohu.com	SUN, CHANG/GXM-3680-2022	ZHAO, YAYA/0000-0001-6424-8687	National Science and Technology Major Project [2009ZX08009-163B]; National Natural Science Foundation of China [31101813]; Jilin Province Science and Technology Developing Project [20076013]	National Science and Technology Major Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jilin Province Science and Technology Developing Project	This work was supported by National Science and Technology Major Project (2009ZX08009-163B, http://www.nmp.gov.cn/), National Natural Science Foundation of China (Key Program, No. 31101813, http://www.nsfc.gov.cn) and Jilin Province Science and Technology Developing Project (20076013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimov SV, 2008, CURR PHARM BIOTECHNO, V9, P338, DOI 10.2174/138920108785915148; Ansari MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022889; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bulut Y, 2005, J BIOL CHEM, V280, P20961, DOI 10.1074/jbc.M411379200; Chang YY, 2009, MOL BIOL CELL, V20, P2004, DOI 10.1091/mbc.E08-12-1250; Chin MP, 2010, CHEM RES TOXICOL, V23, P778, DOI 10.1021/tx900415k; Christophe T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000645; Coler RN, 2009, VACCINE, V27, P223, DOI 10.1016/j.vaccine.2008.10.056; Deb C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006077; Deretic V, 2006, CELL MICROBIOL, V8, P719, DOI 10.1111/j.1462-5822.2006.00705.x; Deretic V, 2009, CURR TOP MICROBIOL, V335, P169, DOI 10.1007/978-3-642-00302-8_8; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; ESPOSITO MS, 1969, J BACTERIOL, V100, P180, DOI 10.1128/JB.100.1.180-186.1969; Fader CM, 2009, CELL DEATH DIFFER, V16, P70, DOI 10.1038/cdd.2008.168; Friberg IM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020070; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Guerin I, 2000, EUR J CELL BIOL, V79, P735, DOI 10.1078/0171-9335-00092; Guerin I, 2000, INFECT IMMUN, V68, P2655, DOI 10.1128/IAI.68.5.2655-2662.2000; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Harrison RE, 2003, MOL CELL BIOL, V23, P6494, DOI 10.1128/MCB.23.18.6494-6506.2003; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Hestvik ALK, 2005, FEMS MICROBIOL REV, V29, P1041, DOI 10.1016/j.femsre.2005.04.013; Jones BW, 2001, J LEUKOCYTE BIOL, V69, P1036; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kissner TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015985; Korbel DS, 2008, MICROBES INFECT, V10, P995, DOI 10.1016/j.micinf.2008.07.039; Kozak RA, 2011, INFECT IMMUN, V79, P59, DOI 10.1128/IAI.00824-10; Lee J, 2009, YONSEI MED J, V50, P1, DOI 10.3349/ymj.2009.50.1.1; Means TK, 2001, J IMMUNOL, V166, P4074, DOI 10.4049/jimmunol.166.6.4074; Noel S, 2007, TOXICOLOGY, V239, P96, DOI 10.1016/j.tox.2007.06.098; Oliveira Helenice Bosco de, 2011, Rev Soc Bras Med Trop, V44, P627; Perskvist N, 2002, J CELL SCI, V115, P1321; Rohde K, 2007, IMMUNOL REV, V219, P37, DOI 10.1111/j.1600-065X.2007.00547.x; Sanarico N, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/741051; Stewart GR, 2005, PLOS PATHOG, V1, P269, DOI 10.1371/journal.ppat.0010033; Stockhammer OW, 2009, J IMMUNOL, V182, P5641, DOI 10.4049/jimmunol.0900082; Thoma-Uszynski S, 2001, SCIENCE, V291, P1544, DOI 10.1126/science.291.5508.1544; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015; Wang B, 2010, NUCLEIC ACIDS RES, V38, P5075, DOI 10.1093/nar/gkq256; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Ward SK, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00121; Warner DF, 2006, CLIN MICROBIOL REV, V19, P558, DOI 10.1128/CMR.00060-05; Weber SS, 2009, MOL MICROBIOL, V71, P1341, DOI 10.1111/j.1365-2958.2009.06608.x; Weigelt K, 2007, J LEUKOCYTE BIOL, V82, P1564, DOI 10.1189/jlb.0707447; Xiang LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-472; Xiao SQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011377; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233	49	10	11	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51988	10.1371/journal.pone.0051988	http://dx.doi.org/10.1371/journal.pone.0051988			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284841	Green Published, Green Submitted, gold			2022-12-27	WOS:000312694300068
J	Srikiatkhachorn, A; Wichit, S; Gibbons, RV; Green, S; Libraty, DH; Endy, TP; Ennis, FA; Kalayanarooj, S; Rothman, AL				Srikiatkhachorn, Anon; Wichit, Sineewanlaya; Gibbons, Robert V.; Green, Sharone; Libraty, Daniel H.; Endy, Timothy P.; Ennis, Francis A.; Kalayanarooj, Siripen; Rothman, Alan L.			Dengue Viral RNA Levels in Peripheral Blood Mononuclear Cells Are Associated with Disease Severity and Preexisting Dengue Immune Status	PLOS ONE			English	Article							VIRUS-INFECTION; CYTOKINE PRODUCTION; ANTIBODY; REPLICATION; ENHANCEMENT; LYMPHOCYTES; ACTIVATION; LEUKOCYTES; ILLNESS; HUMANS	Background: Infection with dengue viruses (DENV) causes a wide range of manifestations from asymptomatic infection to a febrile illness called dengue fever (DF), to dengue hemorrhagic fever (DHF). The in vivo targets of DENV and the relation between the viral burden in these cells and disease severity are not known. Method: The levels of positive and negative strand viral RNA in peripheral blood monocytes, T/NK cells, and B cells and in plasma of DF and DHF cases were measured by quantitative RT-PCR. Results: Positive strand viral RNA was detected in monocytes, T/NK cells and B cells with the highest amounts found in B cells. Viral RNA levels in CD14+ cells and plasma were significantly higher in DHF compared to DF, and in cases with a secondary infection compared to those undergoing a primary infection. The distribution of viral RNA among cell subpopulations was similar in DF and DHF cases. Small amounts of negative strand RNA were found in a few cases only. The severity of plasma leakage correlated with viral RNA levels in plasma and in CD14+ cells. Conclusions: B cells were the principal cells containing DENV RNA in peripheral blood, but overall there was little active DENV RNA replication detectable in peripheral blood mononuclear cells (PBMC). Secondary infection and DHF were associated with higher viral burden in PBMC populations, especially CD14+ monocytes, suggesting that viral infection of these cells may be involved in disease pathogenesis.	[Srikiatkhachorn, Anon; Green, Sharone; Libraty, Daniel H.; Ennis, Francis A.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA; [Wichit, Sineewanlaya; Gibbons, Robert V.] Armed Forces Res Inst Med Sci, Dept Virol, Bangkok 10400, Thailand; [Endy, Timothy P.] SUNY Syracuse, Dept Med, Upstate Med Univ, Syracuse, NY USA; [Kalayanarooj, Siripen] Queen Sirikit Natl Inst Child Hlth, Bangkok, Thailand; [Rothman, Alan L.] Univ Rhode Isl, Inst Immunol & Informat, Providence, RI 02908 USA	University of Massachusetts System; University of Massachusetts Worcester; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Rhode Island	Srikiatkhachorn, A (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA.	anon.srikiatkhachorn@umassmed.edu		Rothman, Alan/0000-0002-4064-6848; Kalayanarooj, Siripen/0000-0002-3568-0929	National Institutes of Health [NIH-P01AI34533]; Military Infectious Disease Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057319, P01AI034533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Military Infectious Disease Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant [NIH-P01AI34533] and the Military Infectious Disease Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baclig MO, 2010, SE ASIAN J TROP MED, V41, P1352; Balsitis SJ, 2009, AM J TROP MED HYG, V80, P416, DOI 10.4269/ajtmh.2009.80.416; Chareonsirisuthigul T, 2007, J GEN VIROL, V88, P365, DOI 10.1099/vir.0.82537-0; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cyster JG, 2003, IMMUNOL REV, V194, P48, DOI 10.1034/j.1600-065X.2003.00041.x; Durbin AP, 2008, VIROLOGY, V376, P429, DOI 10.1016/j.virol.2008.03.028; HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0; HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527; INNIS BL, 1989, AM J TROP MED HYG, V40, P418, DOI 10.4269/ajtmh.1989.40.418; Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043; Kalayanarooj S, 1997, J INFECT DIS, V176, P313, DOI 10.1086/514047; King Alan D., 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P718; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Libraty DH, 2002, J INFECT DIS, V185, P1213, DOI 10.1086/340365; Lin YW, 2002, J VIROL, V76, P12242, DOI 10.1128/JVI.76.23.12242-12249.2002; Mentor NA, 1997, ACTA VIROL, V41, P175; Mota J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020762; Peyrefitte CN, 2003, J VIROL METHODS, V113, P19, DOI 10.1016/S0166-0934(03)00218-0; Ubol S, 2010, J INFECT DIS, V201, P923, DOI 10.1086/651018; Wang WK, 2002, J CLIN MICROBIOL, V40, P4472, DOI 10.1128/JCM.40.12.4472-4478.2002; WATERMAN SH, 1985, AM J TROP MED HYG, V34, P380, DOI 10.4269/ajtmh.1985.34.380; World Health Organization, 2009, DENGUE GUIDELINES DI; World Health Organization, 1997, DENG HEM FEV DIAGN T, V2nd; Wrammert J, 2012, J VIROL, V86, P2911, DOI 10.1128/JVI.06075-11	25	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51335	10.1371/journal.pone.0051335	http://dx.doi.org/10.1371/journal.pone.0051335			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284680	Green Published, Green Submitted, gold			2022-12-27	WOS:000312694300018
J	Wahl, K; Rosenberg, W; Vaske, B; Manns, MP; Schulze-Osthoff, K; Bahr, MJ; Bantel, H				Wahl, Kristin; Rosenberg, William; Vaske, Bernhard; Manns, Michael P.; Schulze-Osthoff, Klaus; Bahr, Matthias J.; Bantel, Heike			Biopsy-Controlled Liver Fibrosis Staging Using the Enhanced Liver Fibrosis (ELF) Score Compared to Transient Elastography	PLOS ONE			English	Article							SERUM MARKERS; NONINVASIVE ASSESSMENT; STIFFNESS MEASUREMENT; HEPATITIS-C; CIRRHOSIS; DIAGNOSIS; CELLS; VARIABILITY; PERFORMANCE; REGRESSION	Background and Aims: Chronic liver diseases are characterized by inflammatory and fibrotic liver injuries that often result in liver cirrhosis with its associated complications such as portal hypertension and hepatocellular carcinoma. Liver biopsy still represents the reference standard for fibrosis staging, although transient elastography is increasingly used for non-invasive monitoring of fibrosis progression. However, this method is not generally available and is associated with technical limitations emphasizing the need for serological biomarkers staging of liver fibrosis. The enhanced liver fibrosis (ELF) score was shown to accurately predict significant liver fibrosis in different liver diseases, although extracellular matrix components detected by this score may not only mirror the extent of liver fibrosis but also inflammatory processes. Methods: In this prospective biopsy-controlled study we evaluated the utility of the ELF score in comparison to transient elastography to predict different stages of fibrosis in 102 patients with chronic liver diseases. Results: Both techniques revealed similar area under receiver operating characteristic curve values for prediction of advanced fibrosis stages. Compared to transient elastography, the ELF score showed a broader overlap between low and moderate fibrosis stages and a stronger correlation with inflammatory liver injury. Conclusions: Both the ELF score as well as transient elastography allowed for high quality fibrosis staging. However, the ELF score was less discriminative in low and moderate fibrosis stages and appeared more strongly influenced by inflammatory liver injury. This should be considered when making clinical interpretations on the basis of ELF score values.	[Wahl, Kristin; Manns, Michael P.; Bantel, Heike] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-3000 Hannover, Germany; [Rosenberg, William] UCL, Ctr Hepatol, Inst Liver & Digest Hlth, Div Med, London, England; [Vaske, Bernhard] Hannover Med Sch, Inst Biometry, D-3000 Hannover, Germany; [Schulze-Osthoff, Klaus] Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany; [Bahr, Matthias J.] Sana Kliniken, Lubeck, Germany	Hannover Medical School; University of London; University College London; Hannover Medical School; Eberhard Karls University of Tubingen	Bantel, H (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-3000 Hannover, Germany.	Bantel.Heike@mh-hannover.de	Schulze-Osthoff, Klaus/N-9025-2013; Rosenberg, William/ABA-1071-2021	Schulze-Osthoff, Klaus/0000-0003-1443-2720; Rosenberg, William/0000-0002-2732-2304; Bahr, Matthias J./0000-0001-6242-5299	Deutsche Forschungsgemeinschaft [SFB Transregio 77, SFB 685, BA 2092/9-1]; Siemens Healthcare Diagnostics Inc.	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Siemens Healthcare Diagnostics Inc.	This study was supported by the Deutsche Forschungsgemeinschaft (SFB Transregio 77, SFB 685, BA 2092/9-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; WR is an inventor of the ELF test and has received support for research studies and speaking events from Siemens Healthcare Diagnostics Inc. The proprietary assays developed for the ELF test by Siemens Healthcare Diagnostics Inc. (Tarrytown, New York, United States of America) were used and analyses were performed on an Immuno-1 auto-analyser (Siemens Healthcare Diagnostics Inc., Tarrytown, New York, United States of America). There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Afdhal NH, 2003, HEPATOLOGY, V37, P972, DOI 10.1053/jhep.2003.50223; Arena U, 2008, HEPATOLOGY, V47, P380, DOI 10.1002/hep.22007; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Canbay A, 2002, GASTROENTEROLOGY, V123, P1323, DOI 10.1053/gast.2002.35953; Cao Q, 2004, J BIOL CHEM, V279, P4292, DOI 10.1074/jbc.M308351200; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Castera L, 1999, HEPATOLOGY, V30, P1529, DOI 10.1002/hep.510300624; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Castera L, 2010, HEPATOLOGY, V51, P828, DOI 10.1002/hep.23425; Coco B, 2007, J VIRAL HEPATITIS, V14, P360, DOI 10.1111/j.1365-2893.2006.00811.x; Crespo G, 2012, J HEPATOL, V57, P281, DOI 10.1016/j.jhep.2012.03.016; Dechene A, 2010, HEPATOLOGY, V52, P1008, DOI 10.1002/hep.23754; Ellis EL, 2012, J HEPATOL, V56, P1171, DOI 10.1016/j.jhep.2011.09.024; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Foucher J, 2006, GUT, V55, P403, DOI 10.1136/gut.2005.069153; Fraquelli M, 2007, GUT, V56, P968, DOI 10.1136/gut.2006.111302; Friedrich-Rust M, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-103; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Kim BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041964; Kisseleva T, 2011, BEST PRACT RES CL GA, V25, P305, DOI 10.1016/j.bpg.2011.02.011; Kong XN, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00069; Lebensztejn DM, 2005, EUR J GASTROEN HEPAT, V17, P843, DOI 10.1097/00042737-200508000-00011; Lee MH, 2010, DIGEST DIS SCI, V55, P3552, DOI 10.1007/s10620-010-1219-0; Lichtinghagen R, 2004, EXPERT REV MOL DIAGN, V4, P715, DOI 10.1586/14737159.4.5.715; Lichtinghagen R, 2000, CLIN CHEM, V46, P183; Martinez SM, 2011, HEPATOLOGY, V53, P325, DOI 10.1002/hep.24013; Mayo MJ, 2008, HEPATOLOGY, V48, P1549, DOI 10.1002/hep.22517; McHutchison JG, 2000, J GASTROEN HEPATOL, V15, P945, DOI 10.1046/j.1440-1746.2000.02233.x; Nahon P, 2008, J HEPATOL, V49, P1062, DOI 10.1016/j.jhep.2008.08.011; Nobili V, 2009, GASTROENTEROLOGY, V136, P160, DOI 10.1053/j.gastro.2008.09.013; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Parkes J, 2006, J HEPATOL, V44, P462, DOI 10.1016/j.jhep.2005.10.019; Parkes J, 2011, J VIRAL HEPATITIS, V18, P23, DOI 10.1111/j.1365-2893.2009.01263.x; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Rosenberg WMC, 2004, GASTROENTEROLOGY, V127, P1704, DOI 10.1053/j.gastro.2004.08.052; Roulot D, 2008, J HEPATOL, V48, P606, DOI 10.1016/j.jhep.2007.11.020; Rousselet MC, 2005, HEPATOLOGY, V41, P257, DOI 10.1002/hep.20535; Sagir A, 2008, HEPATOLOGY, V47, P592, DOI 10.1002/hep.22056; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Sebastiani G, 2006, WORLD J GASTROENTERO, V12, P3682, DOI 10.3748/wjg.v12.i23.3682; Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347; Wong VWS, 2010, HEPATOLOGY, V51, P454, DOI 10.1002/hep.23312; Ziol M, 2005, HEPATOLOGY, V41, P48, DOI 10.1002/hep.20506	48	28	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51906	10.1371/journal.pone.0051906	http://dx.doi.org/10.1371/journal.pone.0051906			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284811	gold, Green Published, Green Submitted			2022-12-27	WOS:000312694300055
J	Yang, XF; Tan, MZ; Qiu, AQ				Yang, Xianfeng; Tan, Ming Zhen; Qiu, Anqi			CSF and Brain Structural Imaging Markers of the Alzheimer's Pathological Cascade	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; HIPPOCAMPAL ATROPHY; DISEASE; MRI; RECOMMENDATIONS; BIOMARKERS; DEMENTIA	Cerebral spinal fluid (CSF) and structural imaging markers are suggested as biomarkers amended to existing diagnostic criteria of mild cognitive impairment (MCI) and Alzheimer's disease (AD). But there is no clear instruction on which markers should be used at which stage of dementia. This study aimed to first investigate associations of the CSF markers as well as volumes and shapes of the hippocampus and lateral ventricles with MCI and AD at the baseline and secondly apply these baseline markers to predict MCI conversion in a two-year time using the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort. Our results suggested that the CSF markers, including A beta 42, t-tau, and p-tau, distinguished MCI or AD from NC, while the A beta 42 CSF marker contributed to the differentiation between MCI and AD. The hippocampal shapes performed better than the hippocampal volumes in classifying NC and MCI, NC and AD, as well as MCI and AD. Interestingly, the ventricular volumes were better than the ventricular shapes to distinguish MCI or AD from NC, while the ventricular shapes showed better accuracy than the ventricular volumes in classifying MCI and AD. As the CSF markers and the structural markers are complementary, the combination of them showed great improvements in the classification accuracies of MCI and AD. Moreover, the combination of these markers showed high sensitivity but low specificity for predicting conversion from MCI to AD in two years. Hence, it is feasible to employ a cross-sectional sample to investigate dynamic associations of the CSF and imaging markers with MCI and AD and to predict future MCI conversion. In particular, the volumetric information may be good for the early stage of AD, while morphological shapes should be considered as markers in the prediction of MCI conversion to AD together with the CSF markers.	[Yang, Xianfeng; Tan, Ming Zhen; Qiu, Anqi] Natl Univ Singapore, Dept Bioengn, Singapore 117548, Singapore; [Qiu, Anqi] Natl Univ Singapore, Clin Imaging Res Ctr, Singapore 117548, Singapore; [Qiu, Anqi] Singapore Inst Clin Sci, Agcy Sci Technol & Res, Singapore, Singapore	National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS)	Qiu, AQ (corresponding author), Natl Univ Singapore, Dept Bioengn, Singapore 117548, Singapore.	bieqa@nus.edu.sg	Qiu, Anqi/H-2267-2011	Qiu, Anqi/0000-0002-0215-6338	National Medical Research Council (NMRC/CG/NUHS/2010); Young Investigator Award at the National University of Singapore [NUSYIA FY10 P07]; National University of Singapore MOE AcRF	National Medical Research Council (NMRC/CG/NUHS/2010)(National Medical Research Council, Singapore); Young Investigator Award at the National University of Singapore(National University of Singapore); National University of Singapore MOE AcRF(Ministry of Education, SingaporeNational University of Singapore)	The work was supported by grants: a centre grant from the National Medical Research Council (NMRC/CG/NUHS/2010), the Young Investigator Award at the National University of Singapore (NUSYIA FY10 P07), and the National University of Singapore MOE AcRF Tier 1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Alves FD, 2008, PSYCHOPHARMACOL BULL, V41, P121; Apostolova LG, 2006, BRAIN, V129, P2867, DOI 10.1093/brain/awl274; Apostolova LG, 2006, ARCH NEUROL-CHICAGO, V63, P693, DOI 10.1001/archneur.63.5.693; Cardenas VA, 2003, NEUROBIOL AGING, V24, P537, DOI 10.1016/S0197-4580(02)00130-6; Chetelat G, 2002, NEUROREPORT, V13, P1939; Costafreda SG, 2011, NEUROIMAGE, V56, P212, DOI 10.1016/j.neuroimage.2011.01.050; Cui Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021896; Davatzikos C, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.023; Ewers M, 2010, NEUROBIOL AGING; Ferrarini L, 2008, MAGN RESON MED, V59, P260, DOI 10.1002/mrm.21471; Ferrarini L, 2009, J ALZHEIMERS DIS, V17, P643, DOI 10.3233/JAD-2009-1082; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fox NC, 1996, BRAIN, V119, P2001, DOI 10.1093/brain/119.6.2001; Jack CR, 2011, ALZHEIMERS DEMENT, V7, P257, DOI 10.1016/j.jalz.2011.03.004; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062; Kantarci K, 2009, NEUROLOGY, V72, P1519, DOI 10.1212/WNL.0b013e3181a2e864; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Miller MI, 2009, NEUROIMAGE, V45, pS16, DOI 10.1016/j.neuroimage.2008.10.044; Qiu AQ, 2008, NEUROIMAGE, V42, P1430, DOI 10.1016/j.neuroimage.2008.04.257; Qiu A, 2008, NEUROIMAGE, V40, P68, DOI 10.1016/j.neuroimage.2007.11.041; Qiu AQ, 2010, IEEE T IMAGE PROCESS, V19, P1539, DOI 10.1109/TIP.2010.2042099; Qiu AQ, 2009, NEUROIMAGE, V45, P656, DOI 10.1016/j.neuroimage.2009.01.013; Ridha BH, 2006, LANCET NEUROL, V5, P828, DOI 10.1016/S1474-4422(06)70550-6; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Vapnik V., 2013, NATURE STAT LAERNING; Vemuri P, 2010, NEUROLOGY, V75, P143, DOI 10.1212/WNL.0b013e3181e7ca82; Vemuri P, 2009, NEUROLOGY, V73, P294, DOI 10.1212/WNL.0b013e3181af79fb; Wang L, 2003, NEUROIMAGE, V20, P667, DOI 10.1016/S1053-8119(03)00361-6; Westman E, 2012, NEUROIMAGE; Yang XF, 2011, NEUROIMAGE, V56, P149, DOI 10.1016/j.neuroimage.2011.01.069; Zhang DQ, 2011, NEUROIMAGE, V55, P856, DOI 10.1016/j.neuroimage.2011.01.008	35	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e47406	10.1371/journal.pone.0047406	http://dx.doi.org/10.1371/journal.pone.0047406			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284610	gold, Green Published, Green Submitted			2022-12-27	WOS:000312694300003
J	Kweka, EJ; Zhou, GF; Munga, S; Lee, MC; Atieli, HE; Nyindo, M; Githeko, AK; Yan, GY				Kweka, Eliningaya J.; Zhou, Guofa; Munga, Stephen; Lee, Ming-Chieh; Atieli, Harrysone E.; Nyindo, Mramba; Githeko, Andrew K.; Yan, Guiyun			Anopheline Larval Habitats Seasonality and Species Distribution: A Prerequisite for Effective Targeted Larval Habitats Control Programmes	PLOS ONE			English	Article							WESTERN KENYA HIGHLANDS; GAMBIAE COMPLEX MOSQUITOS; INSECTICIDE-TREATED NETS; DAR-ES-SALAAM; RICE FIELDS; LAND-COVER; MALARIA TRANSMISSION; MICROBIAL LARVICIDES; USAMBARA MOUNTAINS; IMMATURE STAGES	Background: Larval control is of paramount importance in the reduction of malaria vector abundance and subsequent disease transmission reduction. Understanding larval habitat succession and its ecology in different land use managements and cropping systems can give an insight for effective larval source management practices. This study investigated larval habitat succession and ecological parameters which influence larval abundance in malaria epidemic prone areas of western Kenya. Methods and Findings: A total of 51 aquatic habitats positive for anopheline larvae were surveyed and visited once a week for a period of 85 weeks in succession. Habitats were selected and identified. Mosquito larval species, physico-chemical parameters, habitat size, grass cover, crop cycle and distance to nearest house were recorded. Polymerase chain reaction revealed that An. gambiae s.l was the most dominant vector species comprised of An. gambiae s.s (77.60%) and An.arabiensis (18.34%), the remaining 4.06% had no amplification by polymerase chain reaction. Physico-chemical parameters and habitat size significantly influenced abundance of An. gambiae s.s (P = 0.024) and An. arabiensis (P = 0.002) larvae. Further, larval species abundance was influenced by crop cycle (P <= 0.001), grass cover (P <= 0.001), while distance to nearest houses significantly influenced the abundance of mosquito species larvae (r = 0.920; P <= 0.001). The number of predator species influenced mosquito larval abundance in different habitat types. Crop weeding significantly influenced with the abundance of An. gambiae s.l (P <= 0.001) when preceded with fertilizer application. Significantly higher anopheline larval abundance was recorded in habitats in pasture compared to farmland (P = 0.002). When habitat stability and habitat types were considered, hoof print were the most productive followed by disused goldmines. Conclusion: These findings suggest that implementation of effective larval control programme should be targeted with larval habitats succession information when larval habitats are fewer and manageable. Crop cycles and distance from habitats to household should be considered as effective information in planning larval control.	[Kweka, Eliningaya J.; Munga, Stephen; Atieli, Harrysone E.; Githeko, Andrew K.] Kenya Govt Med Res Ctr, Climate & Human Hlth Res Unit, Kisumu, Kenya; [Kweka, Eliningaya J.; Nyindo, Mramba] Tumaini Univ Makumira, Kilimanjaro Christian Med Univ Coll, Moshi, Tanzania; [Zhou, Guofa; Lee, Ming-Chieh; Yan, Guiyun] Univ Calif Irvine, Coll Hlth Sci, Program Publ Hlth, Irvine, CA USA	Kenya Medical Research Institute; University of California System; University of California Irvine	Kweka, EJ (corresponding author), Trop Pesticides Res Inst, Div Livestock & Human Dis Vector Control, Mosquito Sect, Arusha, Tanzania.	pat.kweka@gmail.com	Lee, Ming-Chieh/ABE-8421-2021	Lee, Ming-Chieh/0000-0002-2462-6089; Kweka, Eliningaya/0000-0002-8891-758X	American National Institute of Health [D43 TW01505, R01 AI-50243]; FOGARTY INTERNATIONAL CENTER [D43TW001505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050243] Funding Source: NIH RePORTER	American National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work received financial support from American National Institute of Health (D43 TW01505 and R01 AI-50243 to GY). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrane YA, 2005, J MED ENTOMOL, V42, P974, DOI 10.1603/0022-2585(2005)042[0974:EOMCCB]2.0.CO;2; Afrane YA, 2006, AM J TROP MED HYG, V74, P772, DOI 10.4269/ajtmh.2006.74.772; ALATALO R, 1977, ECOLOGY, V58, P900, DOI 10.2307/1936226; Balls MJ, 2004, T ROY SOC TROP MED H, V98, P400, DOI 10.1016/j.trstmh.2003.11.005; Baolin L, 1998, PARSITOL TODAY, V4, P328; Blaustein L, 2007, ANNU REV ENTOMOL, V52, P489, DOI 10.1146/annurev.ento.52.110405.091431; Bodker R, 2003, J MED ENTOMOL, V40, P706, DOI 10.1603/0022-2585-40.5.706; Bodker R, 2006, AM J TROP MED HYG, V74, P716; Chaki PP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-311; Chuma J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-144; Coetzee M, 2000, PARASITOL TODAY, V16, P74, DOI 10.1016/S0169-4758(99)01563-X; Fillinger U, 2004, TROP MED INT HEALTH, V9, P1274, DOI 10.1111/j.1365-3156.2004.01335.x; Fillinger Ulrike, 2006, Trop Med Int Health, V11, P1629, DOI 10.1111/j.1365-3156.2006.01733.x; Fillinger U, 2009, B WORLD HEALTH ORGAN, V87, P655, DOI 10.2471/BLT.08.055632; Geissbuhler Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005107; Gillies TM, 1987, ANOPHELES AFRICAN S; Gimnig JE, 2002, J MED ENTOMOL, V39, P162, DOI 10.1603/0022-2585-39.1.162; Gimnig JE, 2001, J MED ENTOMOL, V38, P282, DOI 10.1603/0022-2585-38.2.282; Githeko A.K., 2001, GLOB CHANGE HUM HLTH, V2, P54, DOI [10.1023/A:1011943131643, DOI 10.1023/A:1011943131643]; Githeko AK, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-107; Greenwood B, 2002, NATURE, V415, P670, DOI 10.1038/415670a; Himeidan YE, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-234; Kebede A, 2005, AM J TROP MED HYG, V73, P676, DOI 10.4269/ajtmh.2005.73.676; KHAEMBA BM, 1994, E AFR MED J, V71, P159; Kweka EJ, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-128; Kweka EJ, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-110; Lindsay SW, 2000, LANCET, V355, P989, DOI 10.1016/S0140-6736(00)90022-9; Mala AO, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-25; MCCRAE AWR, 1984, ANN TROP MED PARASIT, V78, P307, DOI 10.1080/00034983.1984.11811821; Minakawa N, 2002, J MED ENTOMOL, V39, P833, DOI 10.1603/0022-2585-39.6.833; Minakawa N, 2005, J MED ENTOMOL, V42, P295, DOI 10.1603/0022-2585(2005)042[0295:RBOOAG]2.0.CO;2; Minakawa N, 2004, MED VET ENTOMOL, V18, P301, DOI 10.1111/j.0269-283X.2004.00503.x; Minakawa N, 2002, AM J TROP MED HYG, V67, P32, DOI 10.4269/ajtmh.2002.67.32; Minakawa N, 1999, AM J TROP MED HYG, V61, P1010, DOI 10.4269/ajtmh.1999.61.1010; Minakawa N, 2001, J MED ENTOMOL, V38, P388, DOI 10.1603/0022-2585-38.3.388; Minakawa N, 2006, AM J TROP MED HYG, V75, P448, DOI 10.4269/ajtmh.2006.75.448; MOGI M, 1986, J MED ENTOMOL, V23, P244, DOI 10.1093/jmedent/23.3.244; Munga S, 2006, J MED ENTOMOL, V43, P221, DOI 10.1603/0022-2585(2006)043[0221:EOLCAP]2.0.CO;2; Munga S, 2006, AM J TROP MED HYG, V74, P69, DOI 10.4269/ajtmh.2006.74.69; Munga S, 2005, J MED ENTOMOL, V42, P993, DOI 10.1603/0022-2585(2005)042[0993:OSPAEH]2.0.CO;2; Munga S, 2007, J MED ENTOMOL, V44, P758, DOI 10.1603/0022-2585(2007)44[758:SOISOA]2.0.CO;2; Munga S, 2009, AM J TROP MED HYG, V81, P1079, DOI 10.4269/ajtmh.2009.09-0156; Mutero CM, 2000, ACTA TROP, V76, P253, DOI 10.1016/S0001-706X(00)00109-1; Mutero CM, 2004, ACTA TROP, V89, P187, DOI 10.1016/j.actatropica.2003.08.006; Mutuku FM, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-19; Mutuku FM, 2006, AM J TROP MED HYG, V74, P54, DOI 10.4269/ajtmh.2006.74.54; Muturi EJ, 2007, J MED ENTOMOL, V44, P336, DOI 10.1603/0022-2585(2007)44[336:MSSAPF]2.0.CO;2; Mwangangi J, 2006, J VECTOR ECOL, V31, P245, DOI 10.3376/1081-1710(2006)31[245:DOISOA]2.0.CO;2; Mwangangi JM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-114; Mwangangi JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-228; Mwingira V S, 2009, Tanzan J Health Res, V11, P17; Ndenga B, 2006, J MED ENTOMOL, V43, P200, DOI 10.1603/0022-2585(2006)043[0200:PDOMVI]2.0.CO;2; Ndenga BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019473; Norris JL, 1998, ENVIRON ECOL STAT, V5, P391, DOI 10.1023/A:1009659922745; Paaijmans KP, 2008, INT J BIOMETEOROL, V52, P747, DOI 10.1007/s00484-008-0167-2; Paaijmans KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001146; Palmquist KR, 2008, ENVIRON TOXICOL CHEM, V27, P1728, DOI 10.1897/07-499.1; RAJENDRAN R, 1991, MED VET ENTOMOL, V5, P299, DOI 10.1111/j.1365-2915.1991.tb00556.x; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; SERVICE MW, 1977, J MED ENTOMOL, V13, P535, DOI 10.1093/jmedent/13.4-5.535; Shililu J, 2003, J MED ENTOMOL, V40, P921, DOI 10.1603/0022-2585-40.6.921; Shililu JI, 1998, TROP MED INT HEALTH, V3, P706; Shililu J, 2007, AM J TROP MED HYG, V76, P103, DOI 10.4269/ajtmh.2007.76.103; Silberbush A, 2010, ECOL LETT, V13, P1129, DOI 10.1111/j.1461-0248.2010.01501.x; Tuno N, 2005, J MED ENTOMOL, V42, P270, DOI 10.1603/0022-2585(2005)042[0270:SOAGSS]2.0.CO;2; Victor TJ, 2000, MED VET ENTOMOL, V14, P361, DOI 10.1046/j.1365-2915.2000.00255.x; Wanjala CL, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-81; Wellborn GA, 1996, ANNU REV ECOL SYST, V27, P337, DOI 10.1146/annurev.ecolsys.27.1.337; Yakob L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006921; Yasuoka J, 2007, AM J TROP MED HYG, V76, P450, DOI 10.4269/ajtmh.2007.76.450; Ye-Ebiyo Y, 2003, J MED ENTOMOL, V40, P860, DOI 10.1603/0022-2585-40.6.860; Ye-Ebiyo Y, 2003, AM J TROP MED HYG, V68, P748, DOI 10.4269/ajtmh.2003.68.748; Ye-Ebiyo Y, 2000, AM J TROP MED HYG, V63, P90, DOI 10.4269/ajtmh.2000.63.90; Zhou GF, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-67	74	50	52	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52084	10.1371/journal.pone.0052084	http://dx.doi.org/10.1371/journal.pone.0052084			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272215	Green Published, gold			2022-12-27	WOS:000312483300061
J	Starzengruber, P; Swoboda, P; Fuehrer, HP; Khan, WA; Hofecker, V; Siedl, A; Fally, M; Graf, O; Teja-Isavadharm, P; Haque, R; Ringwald, P; Noedl, H				Starzengruber, Peter; Swoboda, Paul; Fuehrer, Hans-Peter; Khan, Wasif A.; Hofecker, Verena; Siedl, Anja; Fally, Markus; Graf, Oliver; Teja-Isavadharm, Paktiya; Haque, Rashidul; Ringwald, Pascal; Noedl, Harald			Current Status of Artemisinin-Resistant falciparum Malaria in South Asia: A Randomized Controlled Artesunate Monotherapy Trial in Bangladesh	PLOS ONE			English	Article							THERAPEUTIC-EFFICACY; CLINICAL-TRIAL; PLASMODIUM; SPREAD; CAMBODIA; ASSAY	Objective: Recent reports indicate that first cases of genuine artemisinin resistance have already emerged along the Thai-Cambodian border. The main objective of this trial was to track the potential emergence of artemisinin resistance in Bangladesh, which in terms of drug resistance forms a gateway to the Indian subcontinent. Methods: We conducted an open-label, randomized, controlled 42-day clinical trial in Southeastern Bangladesh to investigate the potential spread of clinical artemisinin resistance from Southeast Asia. A total of 126 uncomplicated falciparum malaria patients were randomized to one of 3 treatment arms (artesunate monotherapy with 2 or 4 mg/kg/day once daily or quinine plus doxycycline TID for 7 days). Only cases fulfilling a stringent set of criteria were considered as being artemisinin-resistant. Findings: The 28-day and 42-day cure rates in the artesunate monotherapy (2 and 4 mg/kg) and quinine/doxycyline arms were 97.8% (95% confidence interval, CI: 87.8-99.8%), 100% (95% CI: 91.1-100%), and 100% (95% CI: 83.4-100%), respectively. One case of re-infection was seen in the artesunate high dose arm, and a single case of recrudescence was observed in the low dose group on day 26. No differences in median parasite and fever clearance times were found between the 2 artesunate arms (29.8 h and 17.9 h vs. 29.5 h and 19.1 h). Not a single case fulfilled our criteria of artemisinin resistance. Parasite clearance times were considerably shorter and ex vivo results indicate significantly higher susceptibility (50% inhibitory concentration for dihydroartemisinin was 1.10 nM; 95% CI: 0.95-1.28 nM) to artemisinins as compared to SE-Asia. Conclusion: There is currently no indication that artemisinin resistance has reached Bangladesh. However, the fact that resistance has recently been reported from nearby Myanmar indicates an urgent need for close monitoring of artemisinin resistance in the region.	[Starzengruber, Peter; Swoboda, Paul; Fuehrer, Hans-Peter; Hofecker, Verena; Siedl, Anja; Fally, Markus; Graf, Oliver; Noedl, Harald] Med Univ Vienna, Inst Specif Prophylaxis & Trop Med, Vienna, Austria; [Starzengruber, Peter; Swoboda, Paul; Fuehrer, Hans-Peter; Hofecker, Verena; Siedl, Anja; Fally, Markus; Graf, Oliver; Noedl, Harald] Malaria Res Initiat Bandarban, MARIB, Bandarban, Bangladesh; [Khan, Wasif A.; Haque, Rashidul] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Teja-Isavadharm, Paktiya] US Army Med Component Armed Forces Res Inst Med S, Dept Immunol & Med, Bangkok, Thailand; [Ringwald, Pascal] WHO, Global Malaria Programme, CH-1211 Geneva, Switzerland	Medical University of Vienna; International Centre for Diarrhoeal Disease Research (ICDDR); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); World Health Organization	Noedl, H (corresponding author), Med Univ Vienna, Inst Specif Prophylaxis & Trop Med, Vienna, Austria.	harald.noedl@meduniwien.ac.at	Fally, Markus/GYV-3933-2022; Fuehrer, Hans-Peter/J-9055-2019	Fally, Markus/0000-0002-1339-2918; Fuehrer, Hans-Peter/0000-0002-4178-0133	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This trial was funded by the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Haque R, 2007, AM J TROP MED HYG, V76, P39, DOI 10.4269/ajtmh.2007.76.39; Krishna S, 2006, TRENDS MOL MED, V12, P200, DOI 10.1016/j.molmed.2006.03.005; Mita T, 2009, PARASITOL INT, V58, P201, DOI 10.1016/j.parint.2009.04.004; Noedl H, 2004, AM J TROP MED HYG, V71, P711, DOI 10.4269/ajtmh.2004.71.711; Noedl H, 2005, TRENDS PARASITOL, V21, P404, DOI 10.1016/j.pt.2005.06.012; Noedl H, 2005, ANTIMICROB AGENTS CH, V49, P3575, DOI 10.1128/AAC.49.8.3575-3577.2005; Noedl H, 2003, AM J TROP MED HYG, V68, P140, DOI 10.4269/ajtmh.2003.68.140; Noedl H, 2010, CLIN INFECT DIS, V51, pE82, DOI 10.1086/657120; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Noedl H, 2009, NEW ENGL J MED, V361, P540, DOI 10.1056/NEJMc0900231; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Siriyanoda D, 2005, 54 ANN M AM SOC TROP; Snounou Georges, 2002, Methods Mol Med, V72, P103, DOI 10.1385/1-59259-271-6:103; Stepniewska K, 2010, J INFECT DIS, V201, P570, DOI 10.1086/650301; Thriemer K, 2006, AM J TROP MED HYG, V75, P645, DOI 10.4269/ajtmh.2006.75.645; Thriemer K, 2010, J INFECT DIS, V202, P392, DOI 10.1086/653710; VERDRAGER J, 1986, J TROP MED HYG, V89, P277; Vijaykadga S, 2006, TROP MED INT HEALTH, V11, P211, DOI 10.1111/j.1365-3156.2005.01557.x; WHO, 2003, ASS MON ANT DRUG EFF; WHO, 2010, GUID TREATM MAL, V2nd; WHO, 2000, PRACT HDB; World Health Organization, 2001, WHOCDSRBM200133	23	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52236	10.1371/journal.pone.0052236	http://dx.doi.org/10.1371/journal.pone.0052236			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272227	Green Published, gold			2022-12-27	WOS:000312483300070
J	Apfelbeck, B; Kiefer, S; Mortega, KG; Goymann, W; Kipper, S				Apfelbeck, Beate; Kiefer, Sarah; Mortega, Kim G.; Goymann, Wolfgang; Kipper, Silke			Testosterone Affects Song Modulation during Simulated Territorial Intrusions in Male Black Redstarts (Phoenicurus ochruros)	PLOS ONE			English	Article							EXPERIMENTALLY ELEVATED TESTOSTERONE; ESTROGEN-RECEPTOR-ALPHA; MEDIAL PREOPTIC AREA; VOCAL PERFORMANCE; ZEBRA FINCH; PLASMA TESTOSTERONE; ANDROGEN RECEPTOR; SINGING BEHAVIOR; SEASONAL-CHANGES; FEMALE RESPONSE	Although it has been suggested that testosterone plays an important role in resource allocation for competitive behavior, details of the interplay between testosterone, territorial aggression and signal plasticity are largely unknown. Therefore, we investigated if testosterone acts specifically on signals that communicate the motivation or ability of individuals to engage in competitive situations in a natural context. We studied the black redstart, a territorial songbird species, during two different life-cycle stages, the early breeding phase in spring and the non-breeding phase in fall. Male territory holders were implanted with the androgen receptor blocker flutamide (Flut) and the aromatase inhibitor letrozole (Let) to inhibit the action of testosterone and its estrogenic metabolites. Controls received a placebo treatment. Three days after implantation birds were challenged with a simulated territorial intrusion (STI). Song was recorded before, during and after the challenge. In spring, both treatment groups increased the number of elements sung in parts of their song in response to the STI. However, Flut/Let-implanted males reacted to the STI with a decreased maximum acoustic frequency of one song part, while placebo-implanted males did not. Instead, placebo-implanted males sang the atonal part of their song with a broader frequency range. Furthermore, placebo-, but not Flut/Let-implanted males, sang shorter songs with shorter pauses between parts in the STIs. During simulated intrusions in fall, when testosterone levels are naturally low in this species, males of both treatment groups sang similar to Flut/Let-implanted males during breeding. The results suggest that song sung during a territorial encounter is of higher competitive value than song sung in an undisturbed situation and may, therefore, convey information about the motivation or quality of the territory holder. We conclude that testosterone facilitates context-dependent changes in song structures that may be honest signals of male quality in black redstarts.	[Apfelbeck, Beate; Goymann, Wolfgang] Max Planck Inst Ornithol, Abt Verhaltensneurobiol, Seewiesen, Germany; [Kiefer, Sarah; Mortega, Kim G.; Kipper, Silke] Free Univ Berlin, Inst Biol, AG Verhaltensbiol, Berlin, Germany; [Mortega, Kim G.] Univ Konstanz, Abt Ornithol, Constance, Germany	Max Planck Society; Free University of Berlin; University of Konstanz	Apfelbeck, B (corresponding author), Max Planck Inst Ornithol, Abt Verhaltensneurobiol, Seewiesen, Germany.	apfelbeck@orn.mpg.de	Goymann, Wolfgang/E-4854-2010	Goymann, Wolfgang/0000-0002-7553-5910; Apfelbeck, Beate/0000-0001-7605-7060; Mortega, Kim Geraldine/0000-0002-2645-6677	Max-Planck Gesellschaft; 'Berliner Programm' of the Freie Universitat Berlin	Max-Planck Gesellschaft(Max Planck Society); 'Berliner Programm' of the Freie Universitat Berlin	The study was kindly funded by the Max-Planck Gesellschaft and the 'Berliner Programm' of the Freie Universitat Berlin (research travel grants to S. Kiefer and KGM). Novartis kindly provided the authors with letrozole. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins-Regan E., 2005, HORMONES ANIMAL SOCI; Apfelbeck B, 2011, HORM BEHAV, V60, P565, DOI 10.1016/j.yhbeh.2011.08.005; Apfelbeck B, 2011, P ROY SOC B-BIOL SCI, V278, P3233, DOI 10.1098/rspb.2011.0098; Ballentine B, 2004, BEHAV ECOL, V15, P163, DOI 10.1093/beheco/arg090; Ballentine B, 2009, ANIM BEHAV, V77, P973, DOI 10.1016/j.anbehav.2008.12.027; Balthazart J, 1997, J STEROID BIOCHEM, V61, P323; Balthazart J, 2010, EUR J NEUROSCI, V32, P2116, DOI 10.1111/j.1460-9568.2010.07518.x; Bartsch C, 2012, ETHOLOGY, V118, P876, DOI 10.1111/j.1439-0310.2012.02081.x; Beckett MD, 2010, WILSON J ORNITHOL, V122, P655, DOI 10.1676/09-204.1; Bee MA, 1996, BEHAVIOUR, V133, P283, DOI 10.1163/156853996X00152; Boseret G, 2006, J NEUROBIOL, V66, P1044, DOI 10.1002/neu.20268; Botero CA, 2009, ANIM BEHAV, V77, P701, DOI 10.1016/j.anbehav.2008.11.020; Cheshenko K, 2008, GEN COMP ENDOCR, V155, P31, DOI 10.1016/j.ygcen.2007.03.005; Cucco M, 1999, CONDOR, V101, P689, DOI 10.2307/1370203; Cynx J, 2005, HORM BEHAV, V47, P446, DOI 10.1016/j.yhbeh.2004.11.018; DEWOLFE BB, 1974, BIRD BANDING, V45, P224, DOI 10.2307/4512046; Draganoiu T, 2006, J ORNITHOL, V147, P158; Draganoiu TI, 2002, P ROY SOC B-BIOL SCI, V269, P2525, DOI 10.1098/rspb.2002.2192; DuBois AL, 2011, BEHAV ECOL SOCIOBIOL, V65, P717, DOI 10.1007/s00265-010-1073-2; DuBois AL, 2009, BIOL LETTERS, V5, P163, DOI 10.1098/rsbl.2008.0626; Edler R, 2011, IBIS, V153, P46, DOI 10.1111/j.1474-919X.2010.01075.x; Fusani L, 2008, GEN COMP ENDOCR, V157, P249, DOI 10.1016/j.ygcen.2008.04.016; Gahr M, 1997, BRAIN RES BULL, V44, P509, DOI 10.1016/S0361-9230(97)00233-5; Galeotti P, 1997, ANIM BEHAV, V53, P687, DOI 10.1006/anbe.1996.0304; Garamszegi LZ, 2004, BEHAV ECOL, V15, P148, DOI 10.1093/beheco/arg108; Gil D, 2002, TRENDS ECOL EVOL, V17, P133, DOI 10.1016/S0169-5347(02)02410-2; Goymann W, 2007, HORM BEHAV, V51, P463, DOI 10.1016/j.yhbeh.2007.01.007; Goymann W, 2009, GEN COMP ENDOCR, V163, P149, DOI 10.1016/j.ygcen.2008.11.027; Halupka K, 2006, BEHAVIOUR, V143, P1, DOI 10.1163/156853906775133614; Harding CF, 2004, ANN NY ACAD SCI, V1016, P524, DOI 10.1196/annals.1298.030; Hau M, 2000, GEN COMP ENDOCR, V117, P20, DOI 10.1006/gcen.1999.7390; Hau M, 2007, BIOESSAYS, V29, P133, DOI 10.1002/bies.20524; Hoese WJ, 2000, J EXP BIOL, V203, P1845; Hurd PL, 2005, ANIM BEHAV, V70, P1155, DOI 10.1016/j.anbehav.2005.02.014; Illes AE, 2006, P ROY SOC B-BIOL SCI, V273, P1907, DOI 10.1098/rspb.2006.3535; KETTERSON ED, 1992, AM NAT, V140, P980, DOI 10.1086/285451; Kipper S, 2010, ADV STUD BEHAV, V41, P77, DOI 10.1016/S0065-3454(10)41003-7; Kunc HP, 2006, ETHOLOGY, V112, P984, DOI 10.1111/j.1439-0310.2006.01254.x; LANDMANN A, 1995, ETHOL ECOL EVOL, V7, P147, DOI 10.1080/08927014.1995.9522962; Landmann A., 1996, HAUSROTSCHWANZ FELS; Landys MM, 2010, HORM BEHAV, V58, P317, DOI 10.1016/j.yhbeh.2010.02.013; Leitner S, 2001, HORM BEHAV, V40, P160, DOI 10.1006/hbeh.2001.1700; LOGAN CA, 1990, HORM BEHAV, V24, P568, DOI 10.1016/0018-506X(90)90042-V; LOGAN CA, 1984, J COMP PSYCHOL, V98, P3, DOI 10.1037/0735-7036.98.1.3; MONAGHAN E P, 1992, P261; Oyegbile TO, 2005, HORM BEHAV, V48, P259, DOI 10.1016/j.yhbeh.2005.04.007; Pasch B, 2011, ANIM BEHAV, V82, P177, DOI 10.1016/j.anbehav.2011.04.018; Pasch B, 2011, HORM BEHAV, V59, P90, DOI 10.1016/j.yhbeh.2010.10.011; Podos J, 2009, ADV STUD BEHAV, V40, P159, DOI 10.1016/S0065-3454(09)40005-6; Price JJ, 2006, ANIM BEHAV, V71, P799, DOI 10.1016/j.anbehav.2005.05.025; R Core Team, 2020, R LANG ENV STAT COMP; Riede T, 2010, BRAIN LANG, V115, P69, DOI 10.1016/j.bandl.2009.11.003; Riters LV, 2000, HORM BEHAV, V38, P250, DOI 10.1006/hbeh.2000.1623; Riters LV, 1999, HORM BEHAV, V36, P276, DOI 10.1006/hbeh.1999.1549; Ritschard M, 2011, PHYSIOL BEHAV, V102, P30, DOI 10.1016/j.physbeh.2010.10.005; Schlinger BA, 2006, J EXP ZOOL PART A, V305A, P743, DOI 10.1002/jez.a.303; SCHWABL H, 1992, ORNIS SCAND, V23, P271, DOI 10.2307/3676649; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; Searcy WA, 2010, BEHAV ECOL SOCIOBIOL, V64, P1343, DOI 10.1007/s00265-010-0949-5; Searcy WA, 2009, ANIM BEHAV, V78, P1281, DOI 10.1016/j.anbehav.2009.08.011; SILVERIN B, 1980, ANIM BEHAV, V28, P906, DOI 10.1016/S0003-3472(80)80152-7; Smith GT, 1997, J NEUROSCI, V17, P6001; Thompson CK, 2007, P NATL ACAD SCI USA, V104, P15520, DOI 10.1073/pnas.0707239104; Thompson CK, 2010, J COMP NEUROL, V518, P4760, DOI 10.1002/cne.22486; Vallet E, 1998, ANIM BEHAV, V55, P291, DOI 10.1006/anbe.1997.0631; Van Duyse E, 2005, HORM BEHAV, V48, P243, DOI 10.1016/j.yhbeh.2005.02.013; Veney SL, 2005, J COMP PHYSIOL A, V191, P97, DOI 10.1007/s00359-004-0577-5; Veney SL, 2004, GEN COMP ENDOCR, V136, P192, DOI 10.1016/j.ygcen.2003.12.017; Voigt C, 2008, HORM BEHAV, V54, P373, DOI 10.1016/j.yhbeh.2008.05.001; Wade J, 2000, J COMP NEUROL, V426, P154; WEATHERHEAD PJ, 1993, BEHAV ECOL SOCIOBIOL, V33, P13, DOI 10.1007/BF00164342; Weggler M, 2000, AUK, V117, P65, DOI 10.1642/0004-8038(2000)117[0065:RCOASI]2.0.CO;2; Weiss M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045057; Wingfield J.C., 2006, BIOL AGGRESSION, P179, DOI DOI 10.1093/ACPRO6OSO/9780195168261.0030008; WINGFIELD JC, 1994, HORM BEHAV, V28, P1, DOI 10.1006/hbeh.1994.1001; WINGFIELD JC, 1994, PSYCHONEUROENDOCRINO, V19, P709, DOI 10.1016/0306-4530(94)90052-3	76	24	24	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52009	10.1371/journal.pone.0052009	http://dx.doi.org/10.1371/journal.pone.0052009			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284852	gold, Green Published, Green Accepted			2022-12-27	WOS:000312435900069
J	Rasmuson, A; Segerstrom, L; Nethander, M; Finnman, J; Elfman, LHM; Javanmardi, N; Nilsson, S; Johnsen, JI; Martinsson, T; Kogner, P				Rasmuson, Agnes; Segerstrom, Lova; Nethander, Maria; Finnman, Jennie; Elfman, Lotta H. M.; Javanmardi, Niloufar; Nilsson, Staffan; Johnsen, John Inge; Martinsson, Tommy; Kogner, Per			Tumor Development, Growth Characteristics and Spectrum of Genetic Aberrations in the TH-MYCN Mouse Model of Neuroblastoma	PLOS ONE			English	Article							N-MYC; MALIGNANT PROGRESSION; TRANSGENIC MODEL; AMPLIFICATION; EXPRESSION; INHIBITION; ONCOGENE; PROTEIN; TARGET; DNA	Background: The TH-MYCN transgenic neuroblastoma model, with targeted MYCN expression to the developing neural crest, has been used to study neuroblastoma development and evaluate novel targeted tumor therapies. Methods: We followed tumor development in 395 TH-MYCN (129X1/SvJ) mice (125 negative, 206 hemizygous and 64 homozygous mice) by abdominal palpations up to 40 weeks of age. DNA sequencing of MYCN in the original plasmid construct and mouse genomic DNA was done to verify the accuracy. Copy number analysis with Affymetrix(R) Mouse Diversity Genotyping Arrays was used to characterize acquired genetic aberrations. Results: DNA sequencing confirmed presence of human MYCN cDNA in genomic TH-MYCN DNA corresponding to the original plasmid construct. Tumor incidence and growth correlated significantly to transgene status with event-free survival for hemizygous mice at 50%, and 0% for homozygous mice. Hemizygous mice developed tumors at 5.6-19 weeks (median 9.1) and homozygous mice at 4.0-6.9 weeks (5.4). The mean treatment window, time from palpable tumor to sacrifice, for hemizygous and homozygous mice was 15 and 5.2 days, respectively. Hemizygous mice developing tumors as early as homozygous mice had a longer treatment window. Age at tumor development did not influence treatment window for hemizygous mice, whereas treatment window in homozygous mice decreased significantly with increasing age. Seven out of 10 analysed tumors had a flat DNA profile with neither segmental nor numerical chromosomal aberrations. Only three tumors from hemizygous mice showed acquired genetic features with one or more numerical aberrations. Of these, one event corresponded to gain on the mouse equivalent of human chromosome 17. Conclusion: Hemizygous and homozygous TH-MYCN mice have significantly different neuroblastoma incidence, tumor growth characteristics and treatment windows but overlap in age at tumor development making correct early genotyping essential to evaluate therapeutic interventions. Contrasting previous studies, our data show that TH-MYCN tumors have few genetic aberrations.	[Rasmuson, Agnes; Segerstrom, Lova; Elfman, Lotta H. M.; Johnsen, John Inge; Kogner, Per] Karolinska Inst, Childhood Canc Res Unit, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Finnman, Jennie; Javanmardi, Niloufar; Martinsson, Tommy] Univ Gothenburg, Sahlgrenska Univ Hosp, Dept Clin Genet, Inst Biomed, Gothenburg, Sweden; [Nethander, Maria] Gothenburg Univ, Genom Core Facil, Gothenburg, Sweden; [Nilsson, Staffan] Chalmers, Dept Math Stat, S-41296 Gothenburg, Sweden	Karolinska Institutet; Sahlgrenska University Hospital; University of Gothenburg; University of Gothenburg; Chalmers University of Technology	Rasmuson, A (corresponding author), Karolinska Inst, Childhood Canc Res Unit, Dept Womens & Childrens Hlth, Stockholm, Sweden.	Agnes.Rasmuson@ki.se; Per.Kogner@ki.se	Martinsson, Tommy/J-4140-2013	Martinsson, Tommy/0000-0002-9403-3123; Johnsen, John Inge/0000-0003-1277-812X; Kogner, Per/0000-0002-2202-9694; Nethander, Maria/0000-0003-3688-906X; Nilsson, Staffan/0000-0003-4748-0446	Swedish Children's Cancer Foundation; Swedish Cancer Society; Swedish Research Council; Robert Lundberg Memorial Foundation; ACT! thematic centre; Karolinska Institutet	Swedish Children's Cancer Foundation; Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Robert Lundberg Memorial Foundation; ACT! thematic centre; Karolinska Institutet(Karolinska Institutet)	This work was supported by grants from the Swedish Children's Cancer Foundation (http://www.barncancerfonden.se/), the Swedish Cancer Society (http://www.cancerfonden.se/), the Swedish Research Council (http://www.vr.se/), and the Robert Lundberg Memorial Foundation (http://www.ki.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors would like to thank KIGene and Visual Sonics for expert assistance and advice in performing the sequencing and high-resolution ultrasound imaging, respectively. We acknowledge the support and collaboration within the ACT! thematic centre and the INTENT collaboration within the Karolinska Institutet.	Balamuth NJ, 2010, CANCER RES, V70, P2749, DOI 10.1158/0008-5472.CAN-09-3844; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Caren H, 2010, P NATL ACAD SCI USA, V107, P4323, DOI 10.1073/pnas.0910684107; Caren H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-353; Chesler L, 2008, NEOPLASIA, V10, P1268, DOI 10.1593/neo.08778; Chesler L, 2007, CANCER RES, V67, P9435, DOI 10.1158/0008-5472.CAN-07-1316; Chesler L, 2006, CANCER RES, V66, P8139, DOI 10.1158/0008-5472.CAN-05-2769; Chesler L, 2011, SEMIN CANCER BIOL, V21, P245, DOI 10.1016/j.semcancer.2011.09.011; Hackett CS, 2003, CANCER RES, V63, P5266; Hansford LM, 2004, P NATL ACAD SCI USA, V101, P12664, DOI 10.1073/pnas.0401083101; Haraguchi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006902; Hogarty MD, 2008, CANCER RES, V68, P9735, DOI 10.1158/0008-5472.CAN-07-6866; Johnsen J, 2009, APOPTOSIS, V14, P424, DOI 10.1007/s10495-009-0325-y; Morowitz MJ, 2005, CLIN CANCER RES, V11, P2680, DOI 10.1158/1078-0432.CCR-04-1917; Norris MD, 2000, MED PEDIATR ONCOL, V35, P585, DOI 10.1002/1096-911X(20001201)35:6<585::AID-MPO20>3.3.CO;2-G; RAMSAY G, 1986, MOL CELL BIOL, V6, P4450, DOI 10.1128/MCB.6.12.4450; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Teitz T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019133; Weiss WA, 2000, CANCER RES, V60, P2483; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985	22	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51297	10.1371/journal.pone.0051297	http://dx.doi.org/10.1371/journal.pone.0051297			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284678	Green Submitted, Green Published, gold			2022-12-27	WOS:000312435900019
J	Naito, M; Hirai, S; Mihara, M; Terayama, H; Hatayama, N; Hayashi, S; Matsushita, M; Itoh, M				Naito, Munekazu; Hirai, Shuichi; Mihara, Makoto; Terayama, Hayato; Hatayama, Naoyuki; Hayashi, Shogo; Matsushita, Masayuki; Itoh, Masahiro			Effect of a Magnetic Field on Drosophila under Supercooled Conditions	PLOS ONE			English	Article							PRESERVATION; CRYOPRESERVATION; EXPRESSION; EXPOSURE; LIVERS; CELLS	Under subzero degree conditions, free water contained in biological cells tends to freeze and then most living things die due to low temperatures. We examined the effect of a variable magnetic field on Drosophila under supercooled conditions (a state in which freezing is not caused even below the freezing point). Under such supercooled conditions with the magnetic field at 0 degrees C for 72 hours, -4 degrees C for 24 hours and -8 degrees C for 1 hour, the Drosophila all survived, while all conversely died under the supercooled conditions without the magnetic field. This result indicates a possibility that the magnetic field can reduce cell damage caused due to low temperatures in living things.	[Naito, Munekazu; Hirai, Shuichi; Terayama, Hayato; Hatayama, Naoyuki; Itoh, Masahiro] Tokyo Med Univ, Dept Anat, Tokyo, Japan; [Mihara, Makoto] Univ Tokyo, Grad Sch Med, Dept Plast & Reconstruct Surg, Tokyo, Japan; [Hayashi, Shogo] Aichi Med Univ, Med Educ Ctr, Sch Med, Aichi, Japan; [Matsushita, Masayuki] Univ Ryukyus, Nishihara, Okinawa 90301, Japan	Tokyo Medical University; University of Tokyo; Aichi Medical University; University of the Ryukyus	Hirai, S (corresponding author), Tokyo Med Univ, Dept Anat, Tokyo, Japan.	shinamon611@gmail.com	HIRAI, SHUICHI/AAQ-6081-2020; Hayashi, Shogo/K-7268-2015	Hayashi, Shogo/0000-0003-0302-7658	Ministry of Education, Science, Sports, and Culture, Japan	Ministry of Education, Science, Sports, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by a Grant-in-Aid for General Science Research from the Ministry of Education, Science, Sports, and Culture, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSETT CAL, 1981, J BONE JOINT SURG AM, V63, P511, DOI 10.2106/00004623-198163040-00001; Belova N. A., 2010, Biofizika, V55, P657; Boyer BB, 1999, BIOSCIENCE, V49, P713, DOI 10.2307/1313595; Cho MH, 2012, NAT MAT IN PRESS; Delhaye C, 2012, J AM COLL CARDIOL, V59, P197, DOI 10.1016/j.jacc.2011.06.077; Feeney R E, 1978, Adv Protein Chem, V32, P191, DOI 10.1016/S0065-3233(08)60576-8; Gavish Z, 2008, REJUV RES, V11, P765, DOI 10.1089/rej.2008.0706; Iwasaka M, 2010, J APPL PHYS, V107, DOI 10.1063/1.3357348; Kostal V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025025; McCann J, 1998, MUTAT RES-REV MUTAT, V411, P45, DOI 10.1016/S1383-5742(98)00006-4; Mevissen M, 1998, J TOXICOL ENV HEAL A, V53, P401; Monzen K, 2005, BIOCHEM BIOPH RES CO, V337, P534, DOI 10.1016/j.bbrc.2005.09.082; Nakagawa T, 2012, ACSC IN PRESS; OHTSU S, 1995, BIOCHEM BIOPH RES CO, V212, P104, DOI 10.1006/bbrc.1995.1942; Okamoto T, 2008, J HEART LUNG TRANSPL, V27, P1150, DOI 10.1016/j.healun.2008.07.008; Oshibuchi H, 1975, NIPPON GEKA GAKKAI Z, V76, P432; Silber SJ, 2012, MOL HUM REPROD, V18, P59, DOI 10.1093/molehr/gar082; Sputtek Andreas, 2007, Methods Mol Biol, V368, P283; Strachan LA, 2011, PHYSIOL BIOCHEM ZOOL, V84, P43, DOI 10.1086/657147; Takahashi T, 2001, TRANSPL P, V33, P916, DOI 10.1016/S0041-1345(00)02268-5; Valavanidis A, 2005, REDOX REP, V10, P37, DOI 10.1179/135100005X21606; WERTHEIMER N, 1979, AM J EPIDEMIOL, V109, P273, DOI 10.1093/oxfordjournals.aje.a112681; Woods EJ, 2004, CRYOBIOLOGY, V48, P146, DOI 10.1016/j.cryobiol.2004.03.002; [No title captured]	24	19	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e51902	10.1371/journal.pone.0051902	http://dx.doi.org/10.1371/journal.pone.0051902			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23284809	gold, Green Submitted, Green Published			2022-12-27	WOS:000313051500017
J	Murugan, S; Hung, HC				Murugan, Sujithkumar; Hung, Hui-Chih			Biophysical Characterization of the Dimer and Tetramer Interface Interactions of the Human Cytosolic Malic Enzyme	PLOS ONE			English	Article							NICOTINAMIDE ADENINE-DINUCLEOTIDE; OXIDATIVE DECARBOXYLASES; CATALYTIC MECHANISM; CRYSTAL-STRUCTURE; TUMOR-CELLS; OBESE MICE; LIVER; PURIFICATION; EXPRESSION; IDENTIFICATION	The cytosolic NADP(+)-dependent malic enzyme (c-NADP-ME) has a dimer-dimer quaternary structure in which the dimer interface associates more tightly than the tetramer interface. In this study, the urea-induced unfolding process of the c-NADP-ME interface mutants was monitored using fluorescence and circular dichroism spectroscopy, analytical ultracentrifugation and enzyme activities. Here, we demonstrate the differential protein stability between dimer and tetramer interface interactions of human c-NADP-ME. Our data clearly demonstrate that the protein stability of c-NADP-ME is affected predominantly by disruptions at the dimer interface rather than at the tetramer interface. First, during thermal stability experiments, the melting temperatures of the wild-type and tetramer interface mutants are 8-10 degrees C higher than those of the dimer interface mutants. Second, during urea denaturation experiments, the thermodynamic parameters of the wild-type and tetramer interface mutants are almost identical. However, for the dimer interface mutants, the first transition of the urea unfolding curves shift towards a lower urea concentration, and the unfolding intermediate exist at a lower urea concentration. Third, for tetrameric WT c-NADP-ME, the enzyme is first dissociated from a tetramer to dimers before the 2 M urea treatment, and the dimers then dissociated into monomers before the 2.5 M urea treatment. With a dimeric tetramer interface mutant (H142A/D568A), the dimer completely dissociated into monomers after a 2.5 M urea treatment, while for a dimeric dimer interface mutant (H51A/D90A), the dimer completely dissociated into monomers after a 1.5 M urea treatment, indicating that the interactions of c-NADP-ME at the dimer interface are truly stronger than at the tetramer interface. Thus, this study provides a reasonable explanation for why malic enzymes need to assemble as a dimer of dimers.	[Murugan, Sujithkumar; Hung, Hui-Chih] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Hung, Hui-Chih] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 40227, Taiwan; [Hung, Hui-Chih] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan	National Chung Hsing University; National Chung Hsing University; National Chung Hsing University	Hung, HC (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan.	hchung@dragon.nchu.edu.tw	Hung, Hui-Chih/L-8061-2019; Hung, Hui-Chih/G-4485-2013	Hung, Hui-Chih/0000-0003-0180-1822; Hung, Hui-Chih/0000-0003-0180-1822	National Science Council, Republic of China [NSC-101-2311-B-005-005-MY3]; Ministry of Education, Taiwan, Republic of China	National Science Council, Republic of China(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan, Republic of China(Ministry of Education, Taiwan)	This work was supported by the National Science Council, Republic of China (NSC-101-2311-B-005-005-MY3 to H-CH) and in part by the Ministry of Education, Taiwan, Republic of China under the ATU plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYALA A, 1986, FEBS LETT, V202, P102, DOI 10.1016/0014-5793(86)80657-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHANG GG, 1991, EUR J BIOCHEM, V202, P681, DOI 10.1111/j.1432-1033.1991.tb16423.x; Chang GG, 2003, BIOCHEMISTRY-US, V42, P12721, DOI 10.1021/bi035251+; Cohen P T, 1972, Biochem Genet, V7, P303, DOI 10.1007/BF00484830; Coleman DE, 2002, BIOCHEMISTRY-US, V41, P6928, DOI 10.1021/bi0255120; CROZIER G, 1987, METABOLISM, V36, P807, DOI 10.1016/0026-0495(87)90122-3; Edens WA, 1997, BIOCHEMISTRY-US, V36, P1141, DOI 10.1021/bi962128s; FITCH WM, 1960, J BIOL CHEM, V235, P554; Frenkel R, 1975, Curr Top Cell Regul, V9, P157; Hsieh JY, 2009, J BIOL CHEM, V284, P18096, DOI 10.1074/jbc.M109.005082; HSU RY, 1982, MOL CELL BIOCHEM, V43, P3; HUUPPONEN R, 1989, DIABETES RES CLIN EX, V10, P143; KAM PL, 1988, MOL CELL BIOCHEM, V79, P171, DOI 10.1007/BF02424560; LOEBER G, 1994, BIOCHEM J, V304, P687, DOI 10.1042/bj3040687; LOEBER G, 1994, FEBS LETT, V344, P181, DOI 10.1016/0014-5793(94)00386-6; Pace C N, 1986, Methods Enzymol, V131, P266; POVEY S, 1975, ANN HUM GENET, V39, P203, DOI 10.1111/j.1469-1809.1975.tb00123.x; Rao GSJ, 2003, J BIOL CHEM, V278, P38051, DOI 10.1074/jbc.M305145200; Sanz N, 1997, BRIT J CANCER, V75, P487, DOI 10.1038/bjc.1997.85; SAUER LA, 1980, J BIOL CHEM, V255, P3844; SAUER LA, 1978, CANCER RES, V38, P1751; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Tao X, 2003, STRUCTURE, V11, P1141, DOI 10.1016/S0969-2126(03)00168-0; van Schothorst EM, 2006, OBESITY, V14, P974, DOI 10.1038/oby.2006.111; WISE EM, 1964, P NATL ACAD SCI USA, V52, P1255, DOI 10.1073/pnas.52.5.1255; Xu YW, 1999, STRUCT FOLD DES, V7, P877, DOI 10.1016/S0969-2126(99)80115-4; Yang ZR, 2000, NAT STRUCT BIOL, V7, P251; Yang ZR, 2002, PROTEIN SCI, V11, P332, DOI 10.1110/ps.38002; Yang ZR, 2002, STRUCTURE, V10, P951, DOI 10.1016/S0969-2126(02)00788-8; YEN TT, 1976, HORM METAB RES, V8, P159, DOI 10.1055/s-0028-1093672; ZELEWSKI M, 1991, EUR J BIOCHEM, V201, P339, DOI 10.1111/j.1432-1033.1991.tb16291.x; Zhang YJ, 2006, BIOORG MED CHEM LETT, V16, P525, DOI 10.1016/j.bmcl.2005.10.065	34	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e50143	10.1371/journal.pone.0050143	http://dx.doi.org/10.1371/journal.pone.0050143			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284632	Green Submitted, gold, Green Published			2022-12-27	WOS:000313158800003
J	Dube, ALN; Baschieri, A; Cleland, J; Floyd, S; Molesworth, A; Parrott, F; French, N; Glynn, JR				Dube, Albert L. N.; Baschieri, Angela; Cleland, John; Floyd, Sian; Molesworth, Anna; Parrott, Fiona; French, Neil; Glynn, Judith R.			Fertility Intentions and Use of Contraception among Monogamous Couples in Northern Malawi in the Context of HIV Testing: A Cross-Sectional Analysis	PLOS ONE			English	Article							POSITIVE WOMEN; ANTIRETROVIRAL THERAPY; REPRODUCTIVE HEALTH; SOUTH-AFRICA; DESIRES; MEN; PREFERENCES; INFECTION; PREGNANCY; HIV/AIDS	Context: Knowledge of HIV status may influence fertility desires of married men and women. There is little knowledge about the importance of this influence among monogamously married couples and how knowledge of HIV status influences use of contraception among these couples. Methodology: We carried out a cross-sectional analysis of interview data collected between October 2008 and September 2009 on men aged 15-59 years and women aged 15-49 years who formed 1766 monogamously married couples within the Karonga Prevention Study demographic surveillance study in northern Malawi. Results: 5% of men and 4% of women knew that they were HIV positive at the time of interview and 81% of men and 89% of women knew that they were HIV negative. 73% of men and 83% of women who knew that they were HIV positive stated that they did not want more children, compared to 35% of men and 38% of women who knew they were HIV negative. Concordant HIV positive couples were more likely than concordant negative couples to desire to stop child bearing (odds ratio 11.5, 95%CI 4.3-30.7, after adjusting for other factors) but only slightly more likely to use contraceptives (adjusted odds ratio 1.5 (95%CI 0.8-3.3). Conclusion: Knowledge of HIV positive status is associated with an increase in the reported desire to cease childbearing but there was limited evidence that this desire led to higher use of contraception. More efforts directed towards assisting HIV positive couples to access and use reproductive health services and limit HIV transmission among couples are recommended.	[Dube, Albert L. N.; Molesworth, Anna; Parrott, Fiona; French, Neil] London Sch Hyg & Trop Med, Karonga Prevent Study, Karonga, Malawi; [Baschieri, Angela; Cleland, John; French, Neil] London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1, England; [Floyd, Sian; Glynn, Judith R.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [French, Neil] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England	Malawi Epidemiology and Intervention Research Unit; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Liverpool	Dube, ALN (corresponding author), London Sch Hyg & Trop Med, Karonga Prevent Study, Karonga, Malawi.	ankhata@gmail.com	Cleland, John G./AAZ-4185-2020	Cleland, John G./0000-0002-1471-7016; Houben, Fiona/0000-0002-5630-3516; Dube, Albert/0000-0002-6392-0475; French, Neil/0000-0003-4814-8293	Wellcome Trust; Joint Hewlett; Economic and Social Research Council; ESRC [ES/F038437/1] Funding Source: UKRI; Economic and Social Research Council [ES/F038437/2, ES/F038437/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Joint Hewlett; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by The Wellcome Trust, Joint Hewlett and Economic and Social Research Council. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglewicz P, 2011, AIDS CARE, V23, P998, DOI 10.1080/09540121.2010.542130; [Anonymous], 2002, N INDIA HUMAN DEV RE, P1; [Anonymous], 2010, MAL DEM HLTH SURV 20; Bankole A, 1998, INT FAM PLAN PERSPEC, V24, P15, DOI 10.2307/2991915; Becker S, 1996, STUD FAMILY PLANN, V27, P291, DOI 10.2307/2138025; Becker S, 2007, J BIOSOC SCI, V39, P137, DOI 10.1017/S0021932006001283; Blanc AK, 2001, STUD FAMILY PLANN, V32, P189, DOI 10.1111/j.1728-4465.2001.00189.x; Chimbiri AM, 2007, SOC SCI MED, V64, P1102, DOI 10.1016/j.socscimed.2006.10.012; Cooper D, 2007, SOC SCI MED, V65, P274, DOI 10.1016/j.socscimed.2007.03.019; Cooper D, 2009, AIDS BEHAV, V13, pS38, DOI 10.1007/s10461-009-9550-1; Dodoo FNA, 1998, DEMOGRAPHY, V35, P229, DOI 10.2307/3004054; Floyd S, 2010, PLOS ONE, V10; Heys J, 2009, AIDS, V23, pS37, DOI 10.1097/01.aids.0000363776.76129.fd; Hoffman IF, 2008, JAIDS-J ACQ IMM DEF, V47, P477, DOI 10.1097/QAI.0b013e318165dc52; Jahn A, 2007, DEMOGR RES, V16, P219, DOI 10.4054/DemRes.2007.16.8; Laher F, 2009, AIDS BEHAV, V13, pS47, DOI 10.1007/s10461-009-9544-z; Loutfy MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007925; Magadi MA, 2010, SOC SCI MED, V71, P335, DOI 10.1016/j.socscimed.2010.03.040; Maier M, 2009, AIDS BEHAV, V13, pS28, DOI 10.1007/s10461-008-9371-7; Molesworth AM, 2010, JAIDS-J ACQ IMM DEF, V55, P625, DOI 10.1097/QAI.0b013e3181f98628; Myer L, 2007, AIDS PATIENT CARE ST, V21, P278, DOI 10.1089/apc.2006.0108; Nattabi B, 2009, AIDS BEHAV, V13, P949, DOI 10.1007/s10461-009-9537-y; Nduna M, 2009, AIDS BEHAV, V13, pS62, DOI 10.1007/s10461-009-9545-y; Panozzo L, 2003, SWISS MED WKLY, V133, P124; Setel P, 1995, Health Transit Rev, V5 Suppl, P179; Taulo F, 2009, AIDS BEHAV, V13, pS20, DOI 10.1007/s10461-009-9547-9; Yeatman S, 2009, STUD FAMILY PLANN, V40, P261, DOI 10.1111/j.1728-4465.2009.00210.x; Yeatman SE, 2009, AIDS BEHAV, V13, pS12, DOI 10.1007/s10461-009-9534-1; Zaba B, 1998, AIDS, V12, pS41	29	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51861	10.1371/journal.pone.0051861	http://dx.doi.org/10.1371/journal.pone.0051861			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	060RA	23284791	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000312794500054
J	Qiao, M; Jindrich, DL				Qiao, Mu; Jindrich, Devin L.			Task-Level Strategies for Human Sagittal-Plane Running Maneuvers Are Consistent with Robotic Control Policies	PLOS ONE			English	Article							DYNAMIC STABILITY; ROUGH TERRAIN; LEG STIFFNESS; LOCOMOTION; MUSCLE; TEMPLATES; MECHANICS; BALANCE; WALKING; ANCHORS	The strategies that humans use to control unsteady locomotion are not well understood. A "spring-mass" template comprised of a point mass bouncing on a sprung leg can approximate both center of mass movements and ground reaction forces during running in humans and other animals. Legged robots that operate as bouncing, "spring-mass" systems can maintain stable motion using relatively simple, distributed feedback rules. We tested whether the changes to sagittal-plane movements during five running tasks involving active changes to running height, speed, and orientation were consistent with the rules used by bouncing robots to maintain stability. Changes to running height were associated with changes to leg force but not stance duration. To change speed, humans primarily used a "pogo stick" strategy, where speed changes were associated with adjustments to fore-aft foot placement, and not a "unicycle" strategy involving systematic changes to stance leg hip moment. However, hip moments were related to changes to body orientation and angular speed. Hip moments could be described with first order proportional-derivative relationship to trunk pitch. Overall, the task-level strategies used for body control in humans were consistent with the strategies employed by bouncing robots. Identification of these behavioral strategies could lead to a better understanding of the sensorimotor mechanisms that allow for effective unsteady locomotion.	[Jindrich, Devin L.] Calif State Univ San Marcos, Dept Kinesiol, San Marcos, CA 92078 USA; [Qiao, Mu] Arizona State Univ, Kinesiol Program, Sch Nutr & Hlth Promot, Tempe, AZ USA	California State University System; California State University San Marcos; Arizona State University; Arizona State University-Tempe	Jindrich, DL (corresponding author), Calif State Univ San Marcos, Dept Kinesiol, San Marcos, CA 92078 USA.	djindrich@csusm.edu	Qiao, Mu/H-6877-2019	Qiao, Mu/0000-0002-7110-4830	Kinesiology Department, Arizona State University	Kinesiology Department, Arizona State University	This study was supported by the 2008 Douglas L. Conley Memorial Scholarship, Kinesiology Department, Arizona State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah ME, 2009, ROBOTICA, V27, P789, DOI 10.1017/S0263574708005134; ALEXANDER RM, 1991, J EXP BIOL, V160, P55; Biewener AA, 2007, J EXP BIOL, V210, P2949, DOI 10.1242/jeb.005801; BIZZI E, 1991, SCIENCE, V253, P287, DOI 10.1126/science.1857964; Blickhan R, 2007, PHILOS T R SOC A, V365, P199, DOI 10.1098/rsta.2006.1911; Bullimore SR, 2008, J THEOR BIOL, V250, P339, DOI 10.1016/j.jtbi.2007.09.038; Cavagna GA, 2009, P R SOC B, V276, P4279, DOI 10.1098/rspb.2009.1317; Cham JG, 2007, J DYN SYST-T ASME, V129, P275, DOI 10.1115/1.2718237; Cowan NJ, 2006, J EXP BIOL, V209, P1617, DOI 10.1242/jeb.02166; Daley MA, 2007, J EXP BIOL, V210, P383, DOI 10.1242/jeb.02668; Daley MA, 2006, J EXP BIOL, V209, P171, DOI 10.1242/jeb.01986; Daley MA, 2006, P NATL ACAD SCI USA, V103, P15681, DOI 10.1073/pnas.0601473103; DIETZ V, 1987, J PHYSIOL-LONDON, V386, P149, DOI 10.1113/jphysiol.1987.sp016527; Edgerton VR, 2009, EXERC SPORT SCI REV, V37, P171, DOI 10.1097/JES.0b013e3181b7b932; FARLEY CT, 1993, J EXP BIOL, V185, P71; Ferris DP, 1998, P ROY SOC B-BIOL SCI, V265, P989, DOI 10.1098/rspb.1998.0388; Full RJ, 2002, INTEGR COMP BIOL, V42, P149, DOI 10.1093/icb/42.1.149; Full RJ, 1999, J EXP BIOL, V202, P3325; Geyer H, 2006, P R SOC B, V273, P2861, DOI 10.1098/rspb.2006.3637; Grimmer S, 2008, J EXP BIOL, V211, P2989, DOI 10.1242/jeb.014357; Hamner SR, 2010, J BIOMECH, V43, P2709, DOI 10.1016/j.jbiomech.2010.06.025; Hasan Z, 2005, J MOTOR BEHAV, V37, P484, DOI 10.3200/JMBR.37.6.484-493; Hof AL, 2008, HUM MOVEMENT SCI, V27, P112, DOI 10.1016/j.humov.2007.08.003; Huston RL, 1982, HUMAN BODY DYNAMICS, P203; Jindrich DL, 2009, CHAOS, V19, DOI 10.1063/1.3143031; Jindrich DL, 2002, J EXP BIOL, V205, P2803; Jindrich DL, 2006, J BIOMECH, V39, P1611, DOI 10.1016/j.jbiomech.2005.05.007; Keppel G, 2004, DESIGN ANAL RES HDB, P401; Khatib O, 2009, J PHYSIOL-PARIS, V103, P211, DOI 10.1016/j.jphysparis.2009.08.004; Kuo AD, 2010, PHYS THER, V90, P157, DOI 10.2522/ptj.20090125; Latash M.L., 2008, NEUROPHYSIOLOGICAL B, V3rd ed.; Lee J, 2008, IEEE T ROBOT, V24, P130, DOI 10.1109/TRO.2007.913981; McGowan CP, 2005, J EXP BIOL, V208, P2741, DOI 10.1242/jeb.01702; McGowan CP, 2012, J R SOC INTERFACE, V9, P1975, DOI 10.1098/rsif.2011.0877; Millard M, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.4000193; Muller R, 2010, HUM MOVEMENT SCI, V29, P578, DOI 10.1016/j.humov.2010.04.007; Pratt J., 2006, CAPTURE POINT STEP H, P200; RACK PMH, 1974, J PHYSIOL-LONDON, V240, P331, DOI 10.1113/jphysiol.1974.sp010613; Raibert MH., 1986, IEEE INTELL SYST APP, DOI [10.1109/MEX.1986.4307016, DOI 10.1109/MEX.1986.4307016]; Reisman DS, 2010, PHYS THER, V90, P187, DOI 10.2522/ptj.20090073; Ringrose R, 1997, IEEE INT CONF ROBOT, P487, DOI 10.1109/ROBOT.1997.620084; Ristroph L, 2010, P NATL ACAD SCI USA, V107, P4820, DOI 10.1073/pnas.1000615107; Roberts TJ, 2005, J EXP BIOL, V208, P1963, DOI 10.1242/jeb.01555; Rummel J, 2008, INT J ROBOT RES, V27, P919, DOI 10.1177/0278364908095136; Seyfarth A, 1999, J BIOMECH, V32, P1259, DOI 10.1016/S0021-9290(99)00137-2; Seyfarth A, 2003, J EXP BIOL, V206, P2547, DOI 10.1242/jeb.00463; Tresch MC, 2009, CURR OPIN NEUROBIOL, V19, P601, DOI 10.1016/j.conb.2009.09.002; Williams GN, 2001, J ORTHOP SPORT PHYS, V31, P546, DOI 10.2519/jospt.2001.31.10.546; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9	49	17	17	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51888	10.1371/journal.pone.0051888	http://dx.doi.org/10.1371/journal.pone.0051888			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284804	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500062
J	Bedrosian, B; Craighead, D; Crandall, R				Bedrosian, Bryan; Craighead, Derek; Crandall, Ross			Lead Exposure in Bald Eagles from Big Game Hunting, the Continental Implications and Successful Mitigation Efforts	PLOS ONE			English	Article							CALIFORNIA CONDORS; AMMUNITION; GOLDEN; PERFORMANCE; HAZARDS	Studies suggest hunter discarded viscera of big game animals (i.e., offal) is a source of lead available to scavengers. We investigated the incidence of lead exposure in bald eagles in Wyoming during the big game hunting season, the influx of eagles into our study area during the hunt, the geographic origins of eagles exposed to lead, and the efficacy of using non-lead rifle ammunition to reduce lead in eagles. We tested 81 blood samples from bald eagles before, during and after the big game hunting seasons in 2005-2010, excluding 2008, and found eagles had significantly higher lead levels during the hunt. We found 24% of eagles tested had levels indicating at least clinical exposure (. 60 ug/dL) during the hunt while no birds did during the non-hunting seasons. We performed driving surveys from 2009-2010 to measure eagle abundance and found evidence to suggest that eagles are attracted to the study area during the hunt. We fitted 10 eagles with satellite transmitters captured during the hunt and all migrated south after the cessation of the hunt. One returned to our study area while the remaining nine traveled north to summer/breed in Canada. The following fall, 80% returned to our study area for the hunting season, indicating that offal provides a seasonal attractant for eagles. We fitted three local breeding eagles with satellite transmitters and none left their breeding territories to feed on offal during the hunt, indicating that lead ingestion may be affecting migrants to a greater degree. During the 2009 and 2010 hunting seasons we provided non-lead rifle ammunition to local hunters and recorded that 24% and 31% of successful hunters used non-lead ammunition, respectively. We found the use of non-lead ammunition significantly reduced lead exposure in eagles, suggesting this is a viable solution to reduce lead exposure in eagles.	[Bedrosian, Bryan; Craighead, Derek; Crandall, Ross] Craighead Beringia S, Kelly, WY USA		Bedrosian, B (corresponding author), Craighead Beringia S, Kelly, WY USA.	bryan@beringiasouth.org			1% for the Tetons; Engelhard Foundation; Community Foundation of Jackson Hole; Hewlett Foundation; Peregrine Fund; Packard Foundation	1% for the Tetons; Engelhard Foundation; Community Foundation of Jackson Hole; Hewlett Foundation; Peregrine Fund; Packard Foundation(The David & Lucile Packard Foundation)	Funding was provided by 1% for the Tetons, Engelhard Foundation, Community Foundation of Jackson Hole, the Hewlett Foundation, the Peregrine Fund, the Packard Foundation, R. and L. Haberfeld, Y. and M. Chouinard, A. and B. Hirschfield, H. Luther, G. Ordway, and P. Van Roijen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedrosian Bryan, 2007, Northwestern Naturalist, V88, P1, DOI 10.1898/1051-1733(2007)88[1:EOTFAT]2.0.CO;2; BORTOLOTTI GR, 1984, J FIELD ORNITHOL, V55, P54; Britten MW, 1999, J WILDLIFE MANAGE, V63, P1349, DOI 10.2307/3802854; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cade TJ, 2007, J WILDLIFE MANAGE, V71, P2125, DOI 10.2193/2007-084; CAIN S L, 1989, Journal of Raptor Research, V23, P10; Church ME, 2006, ENVIRON SCI TECHNOL, V40, P6143, DOI 10.1021/es060765s; CRAIG TH, 1990, WILSON BULL, V102, P130; Craighead D, 2008, P ING SPENT AMM IMPL, P202; Craighead D, 2008, J WILDLIFE MANAGE, V72, P240, DOI 10.2193/2007-120; Cruz-Martinez Luis, 2012, Human-Wildlife Interactions, V6, P94; Fisher IJ, 2006, BIOL CONSERV, V131, P421, DOI 10.1016/j.biocon.2006.02.018; Fry D.M., 2003, ASSESSMENT LEAD CONT; Fuller M.R., 1981, Studies in Avian Biology, P235; Grantham J, 2010, SO CENTRAL CAL UNPUB; Green RE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004022; Harmata A. R., 1995, INTERMT J SCI, V1, P1; Harmata AR, 2011, J RAPTOR RES, V45, P119, DOI 10.3356/JRR-10-37.1; Harmata AR, 1992, BALD EAGLES GREATER; Hunt WG, 2006, WILDLIFE SOC B, V34, P167, DOI 10.2193/0091-7648(2006)34[167:BFIDRI]2.0.CO;2; Hunt WG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005330; Kelly TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017656; Kelly TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015350; Knopper LD, 2006, J WILDLIFE MANAGE, V70, P295, DOI 10.2193/0022-541X(2006)70[295:COSRGS]2.0.CO;2; Kramer JL, 1997, J RAPTOR RES, V31, P327; Krone O., 2009, INGESTION LEAD SPENT; Lambertucci SA, 2011, BIOL CONSERV, V144, P1464, DOI 10.1016/j.biocon.2011.01.015; Longmire JL, 1988, GENOMICS, V2, P14, DOI 10.1016/0888-7543(88)90104-8; MCCOLLOUGH MA, 1989, WILSON BULL, V101, P1; Miller MJR, 1998, J WILDLIFE DIS, V34, P704, DOI 10.7589/0090-3558-34.4.704; Pain DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010315; Pain DJ, 1997, BIOL CONSERV, V81, P1, DOI 10.1016/S0006-3207(96)00132-2; Parish Christopher N., 2009, P259, DOI 10.4080/ilsa.2009.0217; Parish CN, 2007, CALIFORNIA CONDORS 2; PATTEE OH, 1990, CONDOR, V92, P931, DOI 10.2307/1368729; Pauli JN, 2007, J WILDLIFE MANAGE, V71, P103, DOI 10.2193/2005-620; RABINOWITZ MB, 1991, ENVIRON HEALTH PERSP, V91, P33, DOI 10.2307/3430979; Redig P, 2008, P ING SPENT AMM IMPL, P208; Redig PT, 1984, INVESTIGATION EFFECT; Seng PT, 2006, NONLEAD AMMUNITION P; Smith B., 2004, IMPERFECT PASTURE CE; Stauber E, 2010, J AVIAN MED SURG, V24, P279, DOI 10.1647/2009-006.1; Tranel Molly A., 2009, P318, DOI 10.4080/ilsa.2009.0307; Wayland M, 2003, J RAPTOR RES, V37, P8; Weisskopf MG, 2007, EPIDEMIOLOGY, V18, P59, DOI 10.1097/01.ede.0000248237.35363.29	45	46	46	2	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51978	10.1371/journal.pone.0051978	http://dx.doi.org/10.1371/journal.pone.0051978			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284837	gold, Green Published, Green Submitted			2022-12-27	WOS:000312694300067
J	Bowers, JE; Nambeesan, S; Corbi, J; Barker, MS; Rieseberg, LH; Knapp, SJ; Burke, JM				Bowers, John E.; Nambeesan, Savithri; Corbi, Jonathan; Barker, Michael S.; Rieseberg, Loren H.; Knapp, Steven J.; Burke, John M.			Development of an Ultra-Dense Genetic Map of the Sunflower Genome Based on Single-Feature Polymorphisms	PLOS ONE			English	Article							CULTIVATED SUNFLOWER; RFLP MAP; IDENTIFICATION	The development of ultra-dense genetic maps has the potential to facilitate detailed comparative genomic analyses and whole genome sequence assemblies. Here we describe the use of a custom Affymetrix GeneChip containing nearly 2.4 million features (25 bp sequences) targeting 86,023 unigenes from sunflower (Helianthus annuus L.) and related species to test for single-feature polymorphisms (SFPs) in a recombinant inbred line (RIL) mapping population derived from a cross between confectionery and oilseed sunflower lines (RHA280xRHA801). We then employed an existing genetic map derived from this same population to rigorously filter out low quality data and place 67,486 features corresponding to 22,481 unigenes on the sunflower genetic map. The resulting map contains a substantial fraction of all sunflower genes and will thus facilitate a number of downstream applications, including genome assembly and the identification of candidate genes underlying QTL or traits of interest.	[Bowers, John E.; Nambeesan, Savithri; Corbi, Jonathan; Burke, John M.] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Barker, Michael S.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Rieseberg, Loren H.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Rieseberg, Loren H.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Knapp, Steven J.] Univ Georgia, Ctr Appl Genet Technol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University of Arizona; University of British Columbia; Indiana University System; Indiana University Bloomington; University System of Georgia; University of Georgia	Burke, JM (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.	jmburke@uga.edu	Burke, John M/A-3502-2013; Bowers, John/B-9245-2009; Barker, Mike/AAE-7891-2019; Bowers, John/AAD-7601-2019; Rieseberg, Loren H/B-3591-2013	Burke, John M/0000-0002-1412-5539; Bowers, John/0000-0001-8984-9796; Barker, Mike/0000-0001-7173-1319; Rieseberg, Loren H/0000-0002-2712-2417; Bowers, John/0000-0001-5693-2796	National Science Foundation Plant Genome Research Program [DBI-0820451]; Genome Canada; Genome British Columbia; INRA; Syngenta; Biogemma; Georgia Research Alliance	National Science Foundation Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD)); Genome Canada(Genome Canada); Genome British Columbia; INRA; Syngenta(Syngenta); Biogemma; Georgia Research Alliance	This work was supported by funding from the National Science Foundation Plant Genome Research Program (DBI-0820451), Genome Canada, Genome British Columbia, INRA, Syngenta, Biogemma, and the Georgia Research Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachlava E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029814; Barker MS, 2008, MOL BIOL EVOL, V25, P2445, DOI 10.1093/molbev/msn187; Borevitz JO, 2003, GENOME RES, V13, P513, DOI 10.1101/gr.541303; Bowers JE, 2012, G3-GENES GENOM GENET, V2, P721, DOI 10.1534/g3.112.002659; Burke JM, 2002, GENETICS, V161, P1257; Doyle J. J., 1987, PHYTOCHEM B, P11; FICK GN, 1974, CROP SCI, V14, P912, DOI 10.2135/cropsci1974.0011183X001400060061x; GARDINER JM, 1993, GENETICS, V134, P917; GENTZBITTEL L, 1995, THEOR APPL GENET, V90, P1079, DOI 10.1007/BF00222925; Lai Z, 2005, THEOR APPL GENET, V111, P1532, DOI 10.1007/s00122-005-0082-4; Mester D, 2003, GENETICS, V165, P2269; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Roath WW, 1981, CROP SCI, V21, P1; Tang S, 2002, THEOR APPL GENET, V105, P1124, DOI 10.1007/s00122-002-0989-y; Tang SX, 2006, CROP SCI, V46, P721, DOI 10.2135/cropsci2005.0006-7; Yu JK, 2003, CROP SCI, V43, P367, DOI 10.2135/cropsci2003.0367	17	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51360	10.1371/journal.pone.0051360	http://dx.doi.org/10.1371/journal.pone.0051360			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284684	Green Published, gold, Green Submitted			2022-12-27	WOS:000312694300020
J	Ha, N; Polychronidou, M; Lohmann, I				Ha, Nati; Polychronidou, Maria; Lohmann, Ingrid			COPS: Detecting Co-Occurrence and Spatial Arrangement of Transcription Factor Binding Motifs in Genome-Wide Datasets	PLOS ONE			English	Article							REGULATORY CODE; DROSOPHILA; ENHANCERS; DORSAL; ORGANIZATION; SPECIFICITY; TWIST; INTEGRATION; NETWORKS; CLUSTERS	In multi-cellular organisms, spatiotemporal activity of cis-regulatory DNA elements depends on their occupancy by different transcription factors (TFs). In recent years, genome-wide ChIP-on-Chip, ChIP-Seq and DamID assays have been extensively used to unravel the combinatorial interaction of TFs with cis-regulatory modules (CRMs) in the genome. Even though genome-wide binding profiles are increasingly becoming available for different TFs, single TF binding profiles are in most cases not sufficient for dissecting complex regulatory networks. Thus, potent computational tools detecting statistically significant and biologically relevant TF-motif co-occurrences in genome-wide datasets are essential for analyzing context-dependent transcriptional regulation. We have developed COPS (Co-Occurrence Pattern Search), a new bioinformatics tool based on a combination of association rules and Markov chain models, which detects co-occurring TF binding sites (BSs) on genomic regions of interest. COPS scans DNA sequences for frequent motif patterns using a Frequent-Pattern tree based data mining approach, which allows efficient performance of the software with respect to both data structure and implementation speed, in particular when mining large datasets. Since transcriptional gene regulation very often relies on the formation of regulatory protein complexes mediated by closely adjoining TF binding sites on CRMs, COPS additionally detects preferred short distance between co-occurring TF motifs. The performance of our software with respect to biological significance was evaluated using three published datasets containing genomic regions that are independently bound by several TFs involved in a defined biological process. In sum, COPS is a fast, efficient and user-friendly tool mining statistically and biologically significant TFBS co-occurrences and therefore allows the identification of TFs that combinatorially regulate gene expression.	[Ha, Nati; Polychronidou, Maria; Lohmann, Ingrid] Heidelberg Univ, Ctr Organismal Studies COS Heidelberg, Heidelberg & CellNetworks Cluster Excellence Germ, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Lohmann, I (corresponding author), Heidelberg Univ, Ctr Organismal Studies COS Heidelberg, Heidelberg & CellNetworks Cluster Excellence Germ, Heidelberg, Germany.	ilohmann@flydev.org			Cluster of Excellence "Cellular Networks''	Cluster of Excellence "Cellular Networks''	Funding for this project provided by Cluster of Excellence "Cellular Networks''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R., 1994, P 20 INT C VER LARG, P487; Ambrosetti DC, 1997, MOL CELL BIOL, V17, P6321, DOI 10.1128/MCB.17.11.6321; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Arnone MI, 1997, DEVELOPMENT, V124, P1851; Baylies MK, 1996, SCIENCE, V272, P1481, DOI 10.1126/science.272.5267.1481; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Choksi SP, 2006, DEV CELL, V11, P775, DOI 10.1016/j.devcel.2006.09.015; Down TA, 2007, PLOS COMPUT BIOL, V3, P95, DOI 10.1371/journal.pcbi.0030007; Fakhouri WD, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.97; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Frith MC, 2003, NUCLEIC ACIDS RES, V31, P3666, DOI 10.1093/nar/gkg540; Frith MC, 2001, BIOINFORMATICS, V17, P878, DOI 10.1093/bioinformatics/17.10.878; Ghazi A, 2000, NATURE, V408, P419, DOI 10.1038/35044174; Halfon MS, 2000, CELL, V103, P63, DOI 10.1016/S0092-8674(00)00105-7; Han JW, 2007, DATA MIN KNOWL DISC, V15, P55, DOI 10.1007/s10618-006-0059-1; Han JW, 2000, SIGMOD RECORD, V29, P1; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Jakobsen JS, 2007, GENE DEV, V21, P2448, DOI 10.1101/gad.437607; JUANG BH, 1985, IEEE T ACOUST SPEECH, V33, P1404, DOI 10.1109/TASSP.1985.1164727; Kolesov G, 2007, P NATL ACAD SCI USA, V104, P13948, DOI 10.1073/pnas.0700672104; Kulakovskiy I. V., 2011, Biophysics, V56, P114, DOI 10.1134/S0006350911010155; Kulakovskiy IV, 2011, BIOINFORMATICS, V27, P2621, DOI 10.1093/bioinformatics/btr453; Makeev VJ, 2003, NUCLEIC ACIDS RES, V31, P6016, DOI 10.1093/nar/gkg799; Mann RS, 2009, CURR TOP DEV BIOL, V88, P63, DOI 10.1016/S0070-2153(09)88003-4; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; Papatsenko D, 2009, NUCLEIC ACIDS RES, V37, P5665, DOI 10.1093/nar/gkp619; Remenyi A, 2004, NAT STRUCT MOL BIOL, V11, P812, DOI 10.1038/nsmb820; Sandve GK, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-527; Schlesinger J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001313; Slattery M, 2011, CELL, V147, P1270, DOI 10.1016/j.cell.2011.10.053; Southall TD, 2009, EMBO J, V28, P3799, DOI 10.1038/emboj.2009.309; Stathopoulos A, 2002, DEVELOPMENT, V129, P3411; Stathopoulos A, 2002, DEV BIOL, V246, P57, DOI 10.1006/dbio.2002.0652; Sun H, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks237; Sun H, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S30; SZYMANSKI P, 1995, EMBO J, V14, P2229, DOI 10.1002/j.1460-2075.1995.tb07217.x; Touzet H, 2007, ALGORITHM MOL BIOL, V2, DOI 10.1186/1748-7188-2-15; Van Loo P, 2009, BRIEF BIOINFORM, V10, P509, DOI 10.1093/bib/bbp025; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Zeitlinger J, 2007, GENE DEV, V21, P385, DOI 10.1101/gad.1509607; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	46	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52055	10.1371/journal.pone.0052055	http://dx.doi.org/10.1371/journal.pone.0052055			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272209	Green Published, gold, Green Submitted			2022-12-27	WOS:000312483300055
J	Redondo, N; Sanz, MA; Steinberger, J; Skern, T; Kusov, Y; Carrasco, L				Redondo, Natalia; Angel Sanz, Miguel; Steinberger, Jutta; Skern, Tim; Kusov, Yuri; Carrasco, Luis			Translation Directed by Hepatitis A Virus IRES in the Absence of Active eIF4F Complex and eIF2	PLOS ONE			English	Article							INITIATION-FACTOR 4G; CAP-INDEPENDENT TRANSLATION; RIBOSOME ENTRY SEGMENTS; DEPENDENT TRANSLATION; INTERNAL INITIATION; BINDING-PROTEIN; RNA HELICASE; PHOSPHORYLATION; SITE; REPLICATION	Translation directed by several picornavirus IRES elements can usually take place after cleavage of eIF4G by picornavirus proteases 2A(pro) or L-pro. The hepatitis A virus (HAV) IRES is thought to be an exception to this rule because it requires intact eIF4F complex for translation. In line with previous results we report that poliovirus (PV) 2A(pro) strongly blocks protein synthesis directed by HAV IRES. However, in contrast to previous findings we now demonstrate that eIF4G cleavage by foot-and-mouth disease virus (FMDV) L-pro strongly stimulates HAV IRES-driven translation. Thus, this is the first observation that 2A(pro) and L-pro exhibit opposite effects to what was previously thought to be the case in HAV IRES. This effect has been observed both in hamster BHK and human hepatoma Huh7 cells. In addition, this stimulation of translation is also observed in cell free systems after addition of purified L-pro. Notably, in presence of this FMDV protease, translation directed by HAV IRES takes place when eIF2 alpha has been inactivated by phosphorylation. Our present findings clearly demonstrate that protein synthesis directed by HAV IRES can occur when eIF4G has been cleaved and after inactivation of eIF2. Therefore, translation directed by HAV IRES without intact eIF4G and active eIF2 is similar to that observed with other picornavirus IRESs.	[Redondo, Natalia; Angel Sanz, Miguel; Carrasco, Luis] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Steinberger, Jutta; Skern, Tim] Med Univ Vienna, Max F Perutz Labs, Vienna, Austria; [Kusov, Yuri] Med Univ Lubeck, Ctr Struct & Cell Biol Med, Inst Biochem, D-23538 Lubeck, Germany; [Kusov, Yuri] Med Univ Lubeck, German Ctr Infect Res, D-23538 Lubeck, Germany	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Lubeck; German Center for Infection Research; University of Lubeck	Redondo, N (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain.	nsevillano@cbm.uam.es	sanz-gomez, miguel/Y-6244-2019; Skern, Tim/AAC-1732-2022; Sanz, Miguel A/H-1914-2015; Carrasco, Luis/E-2435-2012; Carrasco, Luis/H-3001-2017	sanz-gomez, miguel/0000-0002-5761-9010; Skern, Tim/0000-0001-8865-5500; Sanz, Miguel A/0000-0001-6573-883X; Carrasco, Luis/0000-0003-3833-8835; REDONDO, NATALIA/0000-0001-9356-8102	DGICYT (Direccion General de Investigacion Cientifica y Tecnica) [BFU2009-07352]; Fundacion Ramon Areces; FWF Austrian Science Fund [P24038]; Austrian Science Fund (FWF) [P 24038] Funding Source: researchfish	DGICYT (Direccion General de Investigacion Cientifica y Tecnica); Fundacion Ramon Areces; FWF Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by a DGICYT (Direccion General de Investigacion Cientifica y Tecnica) project BFU2009-07352. The Institutional Grant was awarded to the Centro de Biologia Molecular "Severo Ochoa'' (CSIC-UAM) by the Fundacion Ramon Areces. This project was funded by the FWF Austrian Science Fund, grant P24038, to TS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDABE R, 1995, BIOCHEM BIOPH RES CO, V215, P928, DOI 10.1006/bbrc.1995.2553; Ali IK, 2001, J VIROL, V75, P7854, DOI 10.1128/JVI.75.17.7854-7863.2001; Ali IK, 2001, EMBO J, V20, P4233, DOI 10.1093/emboj/20.15.4233; Alvarez E, 2003, J VIROL, V77, P12392, DOI 10.1128/JVI.77.23.12392-12400.2003; Sanz MA, 2010, J MOL BIOL, V402, P101, DOI 10.1016/j.jmb.2010.07.014; Appel N, 2005, J VIROL, V79, P3187, DOI 10.1128/JVI.79.5.3187-3194.2005; BARCO A, 1995, EMBO J, V14, P3349, DOI 10.1002/j.1460-2075.1995.tb07341.x; Belsham GJ, 2009, VIRUS RES, V139, P183, DOI 10.1016/j.virusres.2008.07.001; Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776; Borman AM, 1997, VIROLOGY, V237, P129, DOI 10.1006/viro.1997.8761; BORMAN AM, 1995, NUCLEIC ACIDS RES, V23, P3656, DOI 10.1093/nar/23.18.3656; Borman AM, 2001, J VIROL, V75, P7864, DOI 10.1128/JVI.75.17.7864-7871.2001; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Castello A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/369648; Cordes S, 2008, BIOCHEM BIOPH RES CO, V368, P1014, DOI 10.1016/j.bbrc.2008.01.163; Fernandez J, 2002, J BIOL CHEM, V277, P2050, DOI 10.1074/jbc.M109199200; Gauss-Muller V, 2002, J GEN VIROL, V83, P2183, DOI 10.1099/0022-1317-83-9-2183; Junemann C, 2007, J BIOL CHEM, V282, P132, DOI 10.1074/jbc.M608750200; Kanda T, 2010, J VIRAL HEPATITIS, V17, P618, DOI 10.1111/j.1365-2893.2009.01221.x; KIRCHWEGER R, 1994, J VIROL, V68, P5677, DOI 10.1128/JVI.68.9.5677-5684.1994; Lindqvist L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001583; Lindqvist L, 2009, FUTURE MED CHEM, V1, P1709, DOI 10.4155/FMC.09.122; Lomakin IB, 2000, MOL CELL BIOL, V20, P6019, DOI 10.1128/MCB.20.16.6019-6029.2000; McEwen E, 2005, J BIOL CHEM, V280, P16925, DOI 10.1074/jbc.M412882200; MEEROVITCH K, 1993, J VIROL, V67, P3798, DOI 10.1128/JVI.67.7.3798-3807.1993; Merrick WC, 2004, GENE, V332, P1, DOI 10.1016/j.gene.2004.02.051; Niepmann M, 2009, BBA-GENE REGUL MECH, V1789, P529, DOI 10.1016/j.bbagrm.2009.05.002; Parsyan A, 2011, NAT REV MOL CELL BIO, V12, P235, DOI 10.1038/nrm3083; Paulous S, 2003, NUCLEIC ACIDS RES, V31, P722, DOI 10.1093/nar/gkf695; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Redondo N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025699; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Terenin IM, 2008, NAT STRUCT MOL BIOL, V15, P836, DOI 10.1038/nsmb.1445; Ventoso I, 2001, P NATL ACAD SCI USA, V98, P12966, DOI 10.1073/pnas.231343498; Wehner KA, 2010, MOL CELL BIOL, V30, P2006, DOI 10.1128/MCB.01350-09; Welnowska E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022230; WHETTER LE, 1994, J VIROL, V68, P5253, DOI 10.1128/JVI.68.8.5253-5263.1994; Zhang B, 2007, NUCLEIC ACIDS RES, V35, P5975, DOI 10.1093/nar/gkm645	38	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52065	10.1371/journal.pone.0052065	http://dx.doi.org/10.1371/journal.pone.0052065			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272212	gold, Green Published, Green Submitted			2022-12-27	WOS:000312483300058
J	Conte, A; Brancati, F; Garaci, F; Toschi, N; Bologna, M; Fabbrini, G; Falla, M; Dallapiccola, B; Bollero, P; Floris, R; Berardelli, A				Conte, Antonella; Brancati, Francesco; Garaci, Francesco; Toschi, Nicola; Bologna, Matteo; Fabbrini, Giovanni; Falla, Marika; Dallapiccola, Bruno; Bollero, Patrizio; Floris, Roberto; Berardelli, Alfredo			Kinematic and Diffusion Tensor Imaging Definition of Familial Marcus Gunn Jaw-Winking Synkinesis	PLOS ONE			English	Article							REFLEX BLINKING; VOLUNTARY; DYSTONIA	Background: Marcus Gunn jaw-winking synkinesis (MGJWS) is characterized by eyelid ptosis, which disappears during jaw movement. Familial MGJWS is an extremely rare condition. Some authors suggested that MGJWS is due to neural misdirection in the brainstem whereas others suggested that aberrant reinnervation or ephapse may be responsible for synkinetic activity. Pathogenesis of this condition is therefore still unclear. Methodology/Principal Findings: To investigate pathogenetic mechanism in familial MGJWS we performed neurophysiological (EMG, Blink Reflex, Recovery cycle of the R2 component of the blink reflex, Masseter inhibitory reflex, BAEPS and kinematic analysis) and neuroradiological (MRI, Diffusion Tensor Imaging) investigations in a member of a multigenerational family with autosomal dominant Marcus Gunn jaw-winking synkinesis (MGJWS). Kinematic analysis of eyelid and jaw movements disclosed a similar onset and offset of the eyelid and jaw in both the opening and closing phases. The excitability of brainstem circuits, as assessed by the blink reflex recovery cycle and recovery index, was normal. Diffusion Tensor Imaging revealed reduced fractional anisotropy within the midbrain tegmentum. Conclusions/Significance: Kinematic and MRI findings point to a brainstem structural abnormality in our familial MGJWS patient thus supporting the hypothesis of a neural misdirection of trigeminal motor axons to the elevator palpebralis muscle.	[Conte, Antonella; Bologna, Matteo; Fabbrini, Giovanni; Berardelli, Alfredo] IRCCS Neuromed, Pozzilli, Isernia, Italy; [Brancati, Francesco] Gabriele dAnnunzio Univ Chieti Pescara, Chieti, Italy; [Brancati, Francesco] IRCCS Casa Sollievo Sofferenza, Mendel Inst, Rome, Italy; [Garaci, Francesco; Floris, Roberto] Univ Roma Tor Vergata, Dept Diagnost Imaging Mol Imaging Intervent Radio, Rome, Italy; [Garaci, Francesco] IRCCS San Raffaele, Rome, Italy; [Toschi, Nicola] Univ Roma Tor Vergata, Fac Med, Med Phys Sect, Rome, Italy; [Fabbrini, Giovanni; Falla, Marika; Berardelli, Alfredo] Univ Roma La Sapienza, Dept Neurol & Psychiat, Rome, Italy; [Dallapiccola, Bruno] IRCCS Bambino Gesu Hosp, Rome, Italy; [Bollero, Patrizio] Univ Roma Tor Vergata, Oral Pathol Unit, Rome, Italy	IRCCS Neuromed; G d'Annunzio University of Chieti-Pescara; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; University of Rome Tor Vergata; IRCCS San Raffaele Pisana; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Rome Tor Vergata; Sapienza University Rome; IRCCS Bambino Gesu; University of Rome Tor Vergata	Berardelli, A (corresponding author), IRCCS Neuromed, Pozzilli, Isernia, Italy.	alfredo.berardelli@uniroma1.it	Conte, Antonella/J-4508-2012; Floris, Roberto/AAC-4594-2022; Bologna, Matteo/K-7886-2016; Brancati, Francesco/AAC-3778-2022; floris, roberto/AAC-2396-2019; Garaci, Francesco/AAC-3433-2022; Toschi, Nicola/J-2555-2012; Fabbrini, Giovanni/AAC-1875-2020; Dallapiccola, Bruno/K-8692-2016	Floris, Roberto/0000-0002-6098-2232; Bologna, Matteo/0000-0003-0165-0833; Brancati, Francesco/0000-0003-3624-2354; Garaci, Francesco/0000-0003-1499-5718; Toschi, Nicola/0000-0003-1929-5833; BOLLERO, Patrizio/0000-0003-2430-2057; Conte, Antonella/0000-0002-6338-2961; BERARDELLI, Alfredo/0000-0003-3598-3142; Dallapiccola, Bruno/0000-0002-5031-1013; Fabbrini, Giovanni/0000-0001-7614-8771				Agostino R, 2008, MOVEMENT DISORD, V23, P669, DOI 10.1002/mds.21887; Alexander DC, 2005, NEUROIMAGE, V27, P357, DOI 10.1016/j.neuroimage.2005.04.008; Aramideh M, 2002, MUSCLE NERVE, V26, P14, DOI 10.1002/mus.10120; Bolacchi F, 2012, INVEST OPHTH VIS SCI, V53, P4191, DOI 10.1167/iovs.11-9345; Bologna M, 2009, BRAIN, V132, P502, DOI 10.1093/brain/awn317; Brodsky MC, 2010, PEDIATRIC NEURO-OPHTHALMOLOGY, SECOND EDITION, P1, DOI 10.1007/978-0-387-69069-8; Conte A, 2010, EUR J NEUROL, V17, P449, DOI 10.1111/j.1468-1331.2009.02840.x; Della Nave R, 2011, NEURORADIOLOGY, V53, P367, DOI 10.1007/s00234-010-0807-1; Engle EC, 2007, ARCH NEUROL-CHICAGO, V64, P633, DOI 10.1001/archneur.64.5.633; Glenn Orit, 2011, Top Magn Reson Imaging, V22, P3, DOI 10.1097/RMR.0b013e31823e614c; HEPLER RS, 1968, ARCH NEUROL-CHICAGO, V18, P416, DOI 10.1001/archneur.1968.00470340102009; KIRKHAM TH, 1969, BRIT J OPHTHALMOL, V53, P282, DOI 10.1136/bjo.53.4.282; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; NAKASHIMA K, 1990, ARCH NEUROL-CHICAGO, V47, P413, DOI 10.1001/archneur.1990.00530040055019; PAULETTI G, 1993, MOVEMENT DISORD, V8, P495, DOI 10.1002/mds.870080414; RANA PVS, 1985, J NEUROL NEUROSUR PS, V48, P939, DOI 10.1136/jnnp.48.9.939; RASMINSKY M, 1980, J PHYSIOL-LONDON, V305, P151, DOI 10.1113/jphysiol.1980.sp013356; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Tischfield MA, 2010, CELL, V140, P74, DOI 10.1016/j.cell.2009.12.011	21	13	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51749	10.1371/journal.pone.0051749	http://dx.doi.org/10.1371/journal.pone.0051749			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284759	Green Published, Green Submitted, gold			2022-12-27	WOS:000312435900052
J	Hediger, MR; De Vico, L; Svendsen, A; Besenmatter, W; Jensen, JH				Hediger, Martin R.; De Vico, Luca; Svendsen, Allan; Besenmatter, Werner; Jensen, Jan H.			A Computational Methodology to Screen Activities of Enzyme Variants	PLOS ONE			English	Article							SEMIEMPIRICAL METHODS; PARAMETERS; MECHANISM; APPROXIMATIONS; OPTIMIZATION; CATALYSIS; ENERGY; AM1	We present a fast computational method to efficiently screen enzyme activity. In the presented method, the effect of mutations on the barrier height of an enzyme-catalysed reaction can be computed within 24 hours on roughly 10 processors. The methodology is based on the PM6 and MOZYME methods as implemented in MOPAC2009, and is tested on the first step of the amide hydrolysis reaction catalyzed by the Candida Antarctica lipase B (CalB) enzyme. The barrier heights are estimated using adiabatic mapping and shown to give barrier heights to within 3 kcal/mol of B3LYP/6-31G(d)//RHF/3-21G results for a small model system. Relatively strict convergence criteria (0.5 kcal/(mol angstrom)), long NDDO cutoff distances within the MOZYME method (15 angstrom) and single point evaluations using conventional PM6 are needed for reliable results. The generation of mutant structures and subsequent setup of the semiempirical calculations are automated so that the effect on barrier heights can be estimated for hundreds of mutants in a matter of weeks using high performance computing.	[Hediger, Martin R.; De Vico, Luca; Jensen, Jan H.] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark; [Svendsen, Allan; Besenmatter, Werner] Novozymes AS, Bagsvaerd, Denmark	University of Copenhagen; Novozymes	Jensen, JH (corresponding author), Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark.	jhjensen@chem.ku.dk	Jensen, Jan Halborg/G-4338-2010; De Vico, Luca/D-2267-2009; De Vico, Luca/HFZ-7775-2022	Jensen, Jan Halborg/0000-0002-1465-1010; De Vico, Luca/0000-0002-2821-5711; De Vico, Luca/0000-0002-2821-5711	In Silico Rational Engineering of Novel Enzymes FP7 project	In Silico Rational Engineering of Novel Enzymes FP7 project	The authors acknowledge the In Silico Rational Engineering of Novel Enzymes FP7 project for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altarsha M, 2010, J BIOL INORG CHEM, V15, P361, DOI 10.1007/s00775-009-0608-3; Claeyssens F, 2006, ANGEW CHEM, V118, P7010, DOI [10.1002/ange.200602711, DOI 10.1002/ANGE.200602711]; DEWAR MJS, 1977, J AM CHEM SOC, V99, P4899, DOI 10.1021/ja00457a004; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Friesner RA, 2005, ANNU REV PHYS CHEM, V56, P389, DOI 10.1146/annurev.physchem.55.091602.094410; Hermann JC, 2009, J PHYS CHEM A, V113, P11984, DOI 10.1021/jp9037254; Klamt A., 1993, J CHEM SOC P2, V2, P799, DOI DOI 10.1039/P29930000799; Li H, 2002, THEOR CHEM ACC, V107, P211, DOI 10.1007/s00214-001-0317-7; Noodleman L, 2004, CHEM REV, V104, P459, DOI 10.1021/cr020625a; Parks JM, 2009, J PHYS CHEM B, V113, P5217, DOI 10.1021/jp805137x; Pople JA., 1970, APPROXIMATE MOL ORBI; Rocha GB, 2006, J COMPUT CHEM, V27, P1101, DOI 10.1002/jcc.20425; Schenker S, 2011, J CHEM THEORY COMPUT; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Schrodinger, 2010, PYMOL MOL GRAPHICS S; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Stewart JJP, 2007, J MOL MODEL, V13, P1173, DOI 10.1007/s00894-007-0233-4; Stewart JJP, 2009, J MOL MODEL, V15, P765, DOI 10.1007/s00894-008-0420-y; STEWART JJP, 1990, J COMPUT AID MOL DES, V4, P1, DOI 10.1007/BF00128336; Stewart JJP, 1996, INT J QUANTUM CHEM, V58, P133, DOI 10.1002/(SICI)1097-461X(1996)58:2<133::AID-QUA2>3.0.CO;2-Z; STEWART JJP, 1989, J COMPUT CHEM, V10, P209, DOI 10.1002/jcc.540100208; Syren PO, 2011, CHEMCATCHEM, V3, P853, DOI 10.1002/cctc.201000448; Tian L, 2009, J CHEM THEORY COMPUT, V5, P1421, DOI 10.1021/ct900040n; Uppenberg J, 1995, BIOCHEMISTRY-US, V34, P16838, DOI 10.1021/bi00051a035	26	12	13	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e49849	10.1371/journal.pone.0049849	http://dx.doi.org/10.1371/journal.pone.0049849			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284627	Green Submitted, Green Published, gold			2022-12-27	WOS:000312435900004
J	Liu, Q; Zhou, RL; Chen, SG; Tan, C				Liu, Qing; Zhou, Renlai; Chen, Shanguang; Tan, Cheng			Effects of Head-Down Bed Rest on the Executive Functions and Emotional Response	PLOS ONE			English	Article							RATE-VARIABILITY; COGNITIVE PERFORMANCE; STRESS	Prolonged bed rest may cause changes in the autonomic nervous system that are related to cognition and emotion. This study adopted an emotional flanker task to evaluate the effect of 45 days -6 degrees head-down bed rest (HDBR) on executive functioning in 16 healthy young men at each of six time points: the second-to-last day before the bed rest period, the eleventh, twentieth, thirty-second and fortieth day during the bed rest period, and the eighth day after the bed rest period. In addition, self-report inventories (Beck Anxiety Inventory, BAI; Beck Depression Inventory, BDI; Positive Affect and Negative Affect Scale, PANAS) were conducted to record emotional changes, and the participants' galvanic skin response (GSR), heart rate (HR) and heart rate variability (HRV) were assessed as measures of physiological activity. The results showed that the participants' reaction time on the flanker task increased significantly relative to their responses on the second-to-last day before the period of bed rest, their galvanic skin response weakened and their degrees of positive affect declined during the bed rest period. Our results provide some evidence for a detrimental effect of prolonged bed rest on executive functioning and positive affect. Whether this stems from a lack of aerobic physical activity and/or the effect of HDBR itself remains to be determined.	[Liu, Qing; Zhou, Renlai] Beijing Normal Univ, Sch Psychol, Beijing Key Lab Appl Expt Psychol, Beijing 100875, Peoples R China; [Zhou, Renlai] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Chen, Shanguang; Tan, Cheng] China Astronaut Res & Training Ctr, Beijing, Peoples R China	Beijing Normal University; Beijing Normal University	Zhou, RL (corresponding author), Beijing Normal Univ, Sch Psychol, Beijing Key Lab Appl Expt Psychol, Beijing 100875, Peoples R China.	rlzhou@bnu.edu.cn; tigercsg@163.com	liu, qingqing/HHD-0360-2022; Liu, Qing/GWC-9222-2022; Zhou, Renlai/ABA-1226-2021	Zhou, Renlai/0000-0001-7035-7097	National Basic Research Program of China [2011CB7110001]	National Basic Research Program of China(National Basic Research Program of China)	This work was funded by the National Basic Research Program of China (2011CB7110001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[陈思佚 CHEN Siyi], 2011, [航天医学与医学工程, Space Medicine & Medical Engineering], V24, P253; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Crucian BE, 2009, AVIAT SPACE ENVIR MD, V80, pA37, DOI 10.3357/ASEM.BR05.2009; Hansen AL, 2004, EUR J APPL PHYSIOL, V93, P263, DOI 10.1007/s00421-004-1208-0; Hirayanagi K, 2004, EUR J APPL PHYSIOL, V92, P160, DOI 10.1007/s00421-004-1067-8; Hockey GRJ, 1997, BIOL PSYCHOL, V45, P73; Ishizaki Y, 2002, ACTA ASTRONAUT, V50, P453, DOI 10.1016/S0094-5765(01)00189-8; Ishizaki Y, 2009, ACTA ASTRONAUT, V64, P864, DOI 10.1016/j.actaastro.2008.10.006; Jo NY, 2012, LECT NOTES ARTIF INT, V7198, P19, DOI 10.1007/978-3-642-28493-9_3; Lane RD, 2009, NEUROIMAGE, V44, P213, DOI 10.1016/j.neuroimage.2008.07.056; Leon GR, 2011, J ENVIRON PSYCHOL, V31, P353, DOI 10.1016/j.jenvp.2011.08.001; Lipnicki DM, 2009, AVIAT SPACE ENVIR MD, V80, P1018, DOI 10.3357/ASEM.2581.2009; Lipnicki DM, 2009, EUR J APPL PHYSIOL, V105, P27, DOI 10.1007/s00421-008-0869-5; Messerotti Benvenuti S, 2011, PHYSIOL BEHAV, V104, P503, DOI 10.1016/j.physbeh.2011.05.019; Moore ST, 2010, EXP BRAIN RES, V204, P617, DOI 10.1007/s00221-010-2317-0; PAVYLETRAON A, 1994, ACTA ASTRONAUT, V32, P319, DOI 10.1016/0094-5765(94)90083-3; [秦海波 Qin Haibo], 2010, [航天医学与医学工程, Space Medicine & Medical Engineering], V23, P163; Qiu L., 2008, APPL PSYCHOL, P249, DOI 10.1093/molbev/msx285/4596561; Richard LH, 2009, RESP PHYSIOL NEUROBI, V169, P38; Shehab RL, 1998, ACTA ASTRONAUT, V43, P223, DOI 10.1016/S0094-5765(98)00156-8; Svensson EAI, 2002, INT J AVIAT PSYCHOL, V12, P95, DOI 10.1207/S15327108IJAP1201_8; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; Traon APL, 2007, EUR J APPL PHYSIOL, V101, P143, DOI 10.1007/s00421-007-0474-z; Wang XD, 1999, MENTAL HLTH ASSESS S, P91; [王妍 Wang Yan], 2005, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V13, P396; Zhao X, 2011, ACTA ASTRONAUT, V69, P969, DOI 10.1016/j.actaastro.2011.07.003	26	13	17	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52160	10.1371/journal.pone.0052160	http://dx.doi.org/10.1371/journal.pone.0052160			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055RZ	23284916	Green Published, Green Submitted, gold			2022-12-27	WOS:000312435900082
J	Mendez-Villanueva, A; Edge, J; Suriano, R; Hamer, P; Bishop, D				Mendez-Villanueva, Alberto; Edge, Johann; Suriano, Rob; Hamer, Peter; Bishop, David			The Recovery of Repeated-Sprint Exercise Is Associated with PCr Resynthesis, while Muscle pH and EMG Amplitude Remain Depressed	PLOS ONE			English	Article							MAXIMAL VOLUNTARY CONTRACTIONS; INTERMITTENT CYCLING SPRINTS; SKELETAL-MUSCLE; POWER OUTPUT; SURFACE ELECTROMYOGRAM; NEUROMUSCULAR ACTIVITY; HIGH-INTENSITY; FATIGUE; METABOLISM; HUMANS	The physiological equivalents of power output maintenance and recovery during repeated-sprint exercise (RSE) remain to be fully elucidated. In an attempt to improve our understanding of the determinants of RSE performance we therefore aimed to determine its recovery following exhaustive exercise (which affected intramuscular and neural factors) concomitantly with those of intramuscular concentrations of adenosine triphosphate [ATP], phosphocreatine [PCr] and pH values and electromyography (EMG) activity (a proxy for net motor unit activity) changes. Eight young men performed 10, 6-s all-out sprints on a cycle ergometer, interspersed with 30 s of recovery, followed, after 6 min of passive recovery, by five 6-s sprints, again interspersed by 30 s of passive recovery. Biopsies of the vastus lateralis were obtained at rest, immediately after the first 10 sprints and after 6 min of recovery. EMG activity of the vastus lateralis was obtained from surface electrodes throughout exercise. Total work (TW), [ATP], [PCr], pH and EMG amplitude decreased significantly throughout the first ten sprints (P<0.05). After 6 min of recovery, TW during sprint 11 recovered to 86.3 +/- 7.7% of sprint 1. ATP and PCr were resynthesized to 92.6 +/- 6.0% and 85.3 +/- 10.3% of the resting value, respectively, but muscle pH and EMG amplitude remained depressed. PCr resynthesis was correlated with TW done in sprint 11 (r = 0.79, P<0.05) and TW done during sprints 11 to 15 (r = 0.67, P<0.05). There was a similar to 2-fold greater decrease in the TW/EMG ratio in the last five sprints (sprint 11 to 15) than in the first five sprints (sprint 1 to 5) resulting in a disproportionate decrease in mechanical power (i.e., TW) in relation to EMG. Thus, we conclude that the inability to produce power output during repeated sprints is mostly mediated by intramuscular fatigue signals probably related with the control of PCr metabolism.	[Mendez-Villanueva, Alberto] ASPIRE Acad Sports Excellence, Football Performance & Sci Dept, Doha, Qatar; [Mendez-Villanueva, Alberto; Edge, Johann; Suriano, Rob; Hamer, Peter; Bishop, David] Univ Western Australia, Sch Human Movement & Exercise Sci, Perth, WA 6009, Australia; [Hamer, Peter] Univ Notre Dame Australia, Sch Physiotherapy, Perth, WA, Australia; [Bishop, David] Victoria Univ, Sch Sport & Exercise Sci, ISEAL, Melbourne, Vic 8001, Australia	Aspire Academy for Sports Excellence; University of Western Australia; University of Notre Dame Australia; Victoria University	Mendez-Villanueva, A (corresponding author), ASPIRE Acad Sports Excellence, Football Performance & Sci Dept, Doha, Qatar.	amendezvillanueva@yahoo.com	Bishop, David John/X-9826-2019	Bishop, David John/0000-0002-6956-9188	Gatorade Sports Science Institute	Gatorade Sports Science Institute	This work was partly supported by a grant from the Gatorade Sports Science Institute to AMV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Akima H, 2005, INT J SPORTS MED, V26, P245, DOI 10.1055/s-2004-821000; Amann M, 2008, J PHYSIOL-LONDON, V586, P161, DOI 10.1113/jphysiol.2007.141838; ARTHUR PG, 1995, ANAL BIOCHEM, V227, P281, DOI 10.1006/abio.1995.1281; BIGLANDRITCHIE B, 1984, MUSCLE NERVE, V7, P691, DOI 10.1002/mus.880070902; BIGLANDRITCHIE B, 1983, J PHYSIOL-LONDON, V340, P335, DOI 10.1113/jphysiol.1983.sp014765; Billaut F, 2006, INT J SPORTS MED, V27, P25, DOI 10.1055/s-2005-837488; Billaut F, 2005, NEUROSCI LETT, V380, P265, DOI 10.1016/j.neulet.2005.01.048; Bishop D, 2004, MED SCI SPORT EXER, V36, P807, DOI 10.1249/01.MSS.0000126392.20025.17; Bishop D, 2011, SPORTS MED, V41, P741, DOI 10.2165/11590560-000000000-00000; Bogdanis GC, 1996, J APPL PHYSIOL, V80, P876, DOI 10.1152/jappl.1996.80.3.876; BOGDANIS GC, 1995, J PHYSIOL-LONDON, V482, P467, DOI 10.1113/jphysiol.1995.sp020533; Bogdanis GC, 1998, ACTA PHYSIOL SCAND, V163, P261, DOI 10.1046/j.1365-201x.1998.00378.x; Bruton JD, 1998, J APPL PHYSIOL, V85, P478, DOI 10.1152/jappl.1998.85.2.478; Day SJ, 2001, J NEUROPHYSIOL, V86, P2144, DOI 10.1152/jn.2001.86.5.2144; De Luca CJ, 1996, J NEUROPHYSIOL, V76, P1503, DOI 10.1152/jn.1996.76.3.1503; Deschenes MR, 2002, AM J PHYSIOL-REG I, V282, pR578, DOI 10.1152/ajpregu.00386.2001; Duchateau J, 2006, J APPL PHYSIOL, V101, P1766, DOI 10.1152/japplphysiol.00543.2006; Edge J, 2005, MED SCI SPORT EXER, V37, P1975, DOI 10.1249/01.mss.0000175855.35403.4c; ENOKA RM, 1992, MUSCLE NERVE, V15, P138, DOI 10.1002/mus.880150204; Farina D, 2006, EXERC SPORT SCI REV, V34, P121, DOI 10.1249/00003677-200607000-00006; Fuglevand AJ, 2003, J PHYSIOL-LONDON, V549, P865, DOI 10.1113/jphysiol.2003.038836; GAITANOS GC, 1993, J APPL PHYSIOL, V75, P712, DOI 10.1152/jappl.1993.75.2.712; Girard O, 2011, SPORTS MED, V41, P673, DOI 10.2165/11590550-000000000-00000; Glaister M, 2005, SPORTS MED, V35, P757, DOI 10.2165/00007256-200535090-00003; Gray SR, 2006, AM J PHYSIOL-REG I, V290, pR376, DOI 10.1152/ajpregu.00291.2005; Kalmar JM, 2006, J APPL PHYSIOL, V100, P1757, DOI 10.1152/japplphysiol.01347.2005; Karatzaferi C, 2001, PFLUG ARCH EUR J PHY, V442, P467, DOI 10.1007/s004240100552; Keenan KG, 2005, J APPL PHYSIOL, V98, P120, DOI 10.1152/japplphysiol.00894.2004; Kinugasa R, 2004, EUR J APPL PHYSIOL, V91, P230, DOI 10.1007/s00421-003-0970-8; Klein CS, 2001, NEUROSCI LETT, V316, P153, DOI 10.1016/S0304-3940(01)02389-8; Krustrup P, 2004, PFLUG ARCH EUR J PHY, V449, P56, DOI 10.1007/s00424-004-1304-3; Maxwell BF, 1998, EUR J APPL PHYSIOL O, V78, P346, DOI 10.1007/s004210050430; MCCARTNEY N, 1986, J APPL PHYSIOL, V60, P1164, DOI 10.1152/jappl.1986.60.4.1164; McGawley K, 2006, EUR J APPL PHYSIOL, V98, P383, DOI 10.1007/s00421-006-0284-8; McGawley K., 2008, COACHING SPORT SCI J, V3, P52; Mendez-Villanueva A, 2008, EUR J APPL PHYSIOL, V103, P411, DOI 10.1007/s00421-008-0723-9; Mendez-Villanueva A, 2007, MED SCI SPORT EXER, V39, P2219, DOI 10.1249/mss.0b013e31815669dc; Mendez-Villanueva A, 2007, J SCI MED SPORT, V10, P323, DOI 10.1016/j.jsams.2006.07.017; Parolin ML, 1999, AM J PHYSIOL-ENDOC M, V277, pE890, DOI 10.1152/ajpendo.1999.277.5.E890; Posterino GS, 2001, PFLUG ARCH EUR J PHY, V442, P197, DOI 10.1007/s004240100528; Racinais S, 2007, MED SCI SPORT EXER, V39, P268, DOI 10.1249/01.mss.0000251775.46460.cb; SAHLIN K, 1989, J APPL PHYSIOL, V67, P648, DOI 10.1152/jappl.1989.67.2.648; Sargeant AJ, 2007, EXP PHYSIOL, V92, P323, DOI 10.1113/expphysiol.2006.034322; Spencer M, 2005, SPORTS MED, V35, P1025, DOI 10.2165/00007256-200535120-00003; Spencer M, 2006, MED SCI SPORT EXER, V38, P1492, DOI 10.1249/01.mss.0000228944.62776.a7; Taylor JL, 2008, J APPL PHYSIOL, V104, P542, DOI 10.1152/japplphysiol.01053.2007; Thomas C, 2004, J APPL PHYSIOL, V97, P2132, DOI 10.1152/japplphysiol.00387.2004; Westerblad H, 2002, NEWS PHYSIOL SCI, V17, P17; Zhang SJ, 2006, J PHYSIOL-LONDON, V572, P551, DOI 10.1113/jphysiol.2005.104521	49	69	69	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51977	10.1371/journal.pone.0051977	http://dx.doi.org/10.1371/journal.pone.0051977			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284836	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000312435900067
J	Navarro-Gonzalez, N; Mentaberre, G; Porrero, CM; Serrano, E; Mateos, A; Lopez-Martin, JM; Lavin, S; Dominguez, L				Navarro-Gonzalez, Nora; Mentaberre, Gregorio; Porrero, Concepcion M.; Serrano, Emmanuel; Mateos, Ana; Lopez-Martin, Jose M.; Lavin, Santiago; Dominguez, Lucas			Effect of Cattle on Salmonella Carriage, Diversity and Antimicrobial Resistance in Free-Ranging Wild Boar (Sus scrofa) in Northeastern Spain	PLOS ONE			English	Article							INFECTIOUS-DISEASES; ESCHERICHIA-COLI; ENTERITIDIS; INTEGRONS; ENVIRONMENTS; TYPHIMURIUM; PREVALENCE; LIVESTOCK; OUTBREAK; VECTORS	Salmonella is distributed worldwide and is a pathogen of economic and public health importance. As a multi-host pathogen with a long environmental persistence, it is a suitable model for the study of wildlife-livestock interactions. In this work, we aim to explore the spill-over of Salmonella between free-ranging wild boar and livestock in a protected natural area in NE Spain and the presence of antimicrobial resistance. Salmonella prevalence, serotypes and diversity were compared between wild boars, sympatric cattle and wild boars from cattle-free areas. The effect of age, sex, cattle presence and cattle herd size on Salmonella probability of infection in wild boars was explored by means of Generalized Linear Models and a model selection based on the Akaike's Information Criterion. Prevalence was higher in wild boars co-habiting with cattle (35.67%, CI 95% 28.19-43.70) than in wild boar from cattle-free areas (17.54%, CI 95% 8.74-29.91). Probability of a wild boar being a Salmonella carrier increased with cattle herd size but decreased with the host age. Serotypes Meleagridis, Anatum and Othmarschen were isolated concurrently from cattle and sympatric wild boars. Apart from serotypes shared with cattle, wild boars appear to have their own serotypes, which are also found in wild boars from cattle-free areas (Enteritidis, Mikawasima, 4:b:- and 35:r:z35). Serotype richness (diversity) was higher in wild boars co-habiting with cattle, but evenness was not altered by the introduction of serotypes from cattle. The finding of a S. Mbandaka strain resistant to sulfamethoxazole, streptomycin and chloramphenicol and a S. Enteritidis strain resistant to ciprofloxacin and nalidixic acid in wild boars is cause for public health concern.	[Navarro-Gonzalez, Nora; Mentaberre, Gregorio; Serrano, Emmanuel; Lopez-Martin, Jose M.; Lavin, Santiago] UAB, Dept Med & Cirurgia Anim, Serv Ecopatol Fauna Salvatge SEFaS, Barcelona, Spain; [Porrero, Concepcion M.; Mateos, Ana; Dominguez, Lucas] Univ Complutense UCM, Fac Vet Med, Ctr Vigilancia Sanitaria Vet VISAVET, Madrid, Spain; [Serrano, Emmanuel] Univ Lleida UdL, Dept Matemat, Lleida, Spain; [Lopez-Martin, Jose M.] Generalitat Catalunya, Direccio Gen Med Nat & Biodiversitat, Area Activitats Cineget, Barcelona, Spain	Autonomous University of Barcelona; Complutense University of Madrid; Universitat de Lleida	Navarro-Gonzalez, N (corresponding author), UAB, Dept Med & Cirurgia Anim, Serv Ecopatol Fauna Salvatge SEFaS, Barcelona, Spain.	norit85@gmail.com	Navarro-Gonzalez, Nora/GYD-6516-2022; SERRANO-FERRON, Emmanuel/J-4489-2013; Martin, Josep Maria Lopez/H-8392-2015; Navarro-Gonzalez, Nora/N-9799-2017; Lavín, Santiago/L-5975-2014; Mentaberre, Gregorio A/H-4629-2015; Rodríguez, Lucas Domínguez/B-9668-2014; studies, IT VISAVET Account for bibliometric/C-3115-2014; Mentaberre, Gregorio/AAB-5912-2020	SERRANO-FERRON, Emmanuel/0000-0002-9799-9804; Martin, Josep Maria Lopez/0000-0001-8162-3960; Navarro-Gonzalez, Nora/0000-0002-1878-1242; Lavín, Santiago/0000-0001-5655-588X; Mentaberre, Gregorio A/0000-0001-9542-7514; Rodríguez, Lucas Domínguez/0000-0001-8843-0010; studies, IT VISAVET Account for bibliometric/0000-0003-3319-0050; Mentaberre, Gregorio/0000-0001-9542-7514; MATEOS GARCIA, ANA ISABEL/0000-0002-5008-9053	Spanish Ministry of Science and Innovation [FAU2006-00011, FAU2008-00021]; Ministerio de Educacion (MEC, Spain); Catalan Science and Technology System (Spain); Comunidad de Madrid (Vigilancia Sanitaria) [S2009/AGR-1489]; Departament d'Agricultura, Ramaderia, Pesca, Alimentacio i Medi Natural of the Generalitat de Catalunya	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Educacion (MEC, Spain)(Spanish Government); Catalan Science and Technology System (Spain); Comunidad de Madrid (Vigilancia Sanitaria)(Comunidad de Madrid); Departament d'Agricultura, Ramaderia, Pesca, Alimentacio i Medi Natural of the Generalitat de Catalunya(Generalitat de Catalunya)	This work has been partially funded by the Spanish Ministry of Science and Innovation within the Program of Interaction between wild animals and livestock (FAU2006-00011 and FAU2008-00021). N. Navarro-Gonzalez was supported by the FPU programme of the Ministerio de Educacion (MEC, Spain) and E. Serrano by the Beatriu de Pinos programme (BP-DGR 2011) of the Catalan Science and Technology System (Spain). Phage Typing was performed in the Centro Nacional de Microbiologia, Instituto de Salud Carlos III, Madrid, Spain) within a collaborative project funded by the Comunidad de Madrid (Vigilancia Sanitaria, S2009/AGR-1489). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We express our gratitude to the Departament d'Agricultura, Ramaderia, Pesca, Alimentacio i Medi Natural of the Generalitat de Catalunya for supporting our research activity. We also are very grateful to the staff of the Natural Park and the National Game Reserve "Els Ports" for their big help in the sampling and the information about livestock, especially Xavier Olive and Josep Maria Forcadell.	Anderson DR, 2001, WILDLIFE SOC B, V29, P1260; Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; ANDERSON ES, 1977, J HYG-CAMBRIDGE, V78, P297, DOI 10.1017/S0022172400056187; [Anonymous], 2002, MODEL SELECTION MULT; Bohm M, 2007, VET J, V174, P260, DOI 10.1016/j.tvjl.2006.11.003; BOITANI L, 1992, ONGULES / UNGULATES 91, P419; Caleja C, 2011, INT MICROBIOL, V14, P19, DOI 10.2436/20.1501.01.131; Carlson JC, 2011, J APPL ECOL, V48, P479, DOI 10.1111/j.1365-2664.2010.01935.x; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Davies RH, 2003, ENVIRON MICROBIOL, V5, P79, DOI 10.1046/j.1462-2920.2003.00387.x; Dolejska M, 2007, J APPL MICROBIOL, V103, P11, DOI 10.1111/j.1365-2672.2006.03241.x; EFSA, 2010, EFSA J, V8, P1309, DOI [10.2903/j.efsa.2010.1309, DOI 10.2903/J.EFSA.2010.1309]; European Environment Agency, 2007, 172007 EEA; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2597; FEDORKACRAY PJ, 1995, INFECT IMMUN, V63, P2658, DOI 10.1128/IAI.63.7.2658-2664.1995; Foley S L, 2008, J Anim Sci, V86, pE173; Garber L, 2003, AVIAN DIS, V47, P134, DOI 10.1637/0005-2086(2003)047[0134:SESEIT]2.0.CO;2; Glawischnig W, 2000, WIEN TIERARZTL MONAT, V87, P21; Gorski L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034722; Gortazar C, 2007, EUR J WILDLIFE RES, V53, P241, DOI 10.1007/s10344-007-0098-y; Gotelli NJ, ECOSIM 7 72 ACQ INT; Grimont P. A. D., 2007, ANTIGENIC FORMULAS S; Hilbert F, 2012, FOOD RES INT, V45, P603, DOI 10.1016/j.foodres.2011.08.015; Hudson P., 2002, ECOLOGY WILDLIFE DIS; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; International Organization for Standardization, 2007, 65792002 INT ORG STA; Johnson DH, 2002, J WILDLIFE MANAGE, V66, P272, DOI 10.2307/3803159; Lankau EW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037302; Liebana E, 2003, J APPL MICROBIOL, V94, P1024, DOI 10.1046/j.1365-2672.2003.01924.x; Literak I, 2010, J APPL MICROBIOL, V108, P1702, DOI 10.1111/j.1365-2672.2009.04572.x; Meng XJ, 2009, PHILOS T R SOC B, V364, P2697, DOI 10.1098/rstb.2009.0086; Mentaberre G, ZOONOSES PU IN PRESS; Methner U, 2010, EUR J WILDLIFE RES, V56, P493, DOI 10.1007/s10344-009-0339-3; Millan J, 2004, REV SCI TECH OIE, V23, P905, DOI 10.20506/rst.23.3.1529; Murray C.J., 1991, Revue Scientifique et Technique Office International des Epizooties, V10, P765; Navarro-Gonzalez N, TRANSBOUND IN PRESS; Patton TG, 2009, VET MICROBIOL, V136, P285, DOI 10.1016/j.vetmic.2008.10.032; Paulsen P, 2012, FOOD RES INT, V45, P609, DOI 10.1016/j.foodres.2011.06.055; Perron GG, 2007, INFECT GENET EVOL, V7, P223, DOI 10.1016/j.meegid.2006.09.003; R Development Core Team, 2011, LANG ENV STAT COMP; Santos FBO, 2007, J APPL POULTRY RES, V16, P563, DOI 10.3382/japr.2006-00105; Schley L, 2003, MAMMAL REV, V33, P43, DOI 10.1046/j.1365-2907.2003.00010.x; Singer RS, 2009, J FOOD PROTECT, V72, P707, DOI 10.4315/0362-028X-72.4.707; Skov MN, 2008, J APPL MICROBIOL, V105, P1558, DOI 10.1111/j.1365-2672.2008.03914.x; Skurnik D, 2006, J ANTIMICROB CHEMOTH, V57, P1215, DOI 10.1093/jac/dkl122; Stevenson M, 2012, EPIR R PACK AN EP DA; Thulke HH, 2009, J WILDLIFE DIS, V45, P1089, DOI 10.7589/0090-3558-45.4.1089; Uzzau S, 2000, EPIDEMIOL INFECT, V125, P229, DOI 10.1017/S0950268899004379; VAV, 2005, RED VIG VET RES ANT; Vieira-Pinto M, 2011, FOODBORNE PATHOG DIS, V8, P739, DOI 10.1089/fpd.2010.0742; Wacheck S, 2010, FOODBORNE PATHOG DIS, V7, P307, DOI 10.1089/fpd.2009.0367; Winfield MD, 2003, APPL ENVIRON MICROB, V69, P3687, DOI 10.1128/AEM.69.7.3687-3694.2003; Zuur AF, 2007, STAT BIOL HEALTH, P1; Zuur Alain F., 2009, P1	54	32	32	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51614	10.1371/journal.pone.0051614	http://dx.doi.org/10.1371/journal.pone.0051614			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284725	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000312435900034
J	Patel, R; Tsan, A; Tam, R; Desai, R; Schoenbrunner, N; Myers, TW; Bauer, K; Smith, E; Raja, R				Patel, Rajesh; Tsan, Alison; Tam, Rachel; Desai, Rupal; Schoenbrunner, Nancy; Myers, Thomas W.; Bauer, Keith; Smith, Edward; Raja, Rajiv			Mutation Scanning Using MUT-MAP, a High-Throughput, Microfluidic Chip-Based, Multi-Analyte Panel	PLOS ONE			English	Article							LUNG-CANCER; DNA; THERAPY; GENOME	Targeted anticancer therapies rely on the identification of patient subgroups most likely to respond to treatment. Predictive biomarkers play a key role in patient selection, while diagnostic and prognostic biomarkers expand our understanding of tumor biology, suggest treatment combinations, and facilitate discovery of novel drug targets. We have developed a high-throughput microfluidics method for mutation detection (MUT-MAP, mutation multi-analyte panel) based on TaqMan or allele-specific PCR (AS-PCR) assays. We analyzed a set of 71 mutations across six genes of therapeutic interest. The six-gene mutation panel was designed to detect the most common mutations in the EGFR, KRAS, PIK3CA, NRAS, BRAF, and AKT1 oncogenes. The DNA was preamplified using custom-designed primer sets before the TaqMan/AS-PCR assays were carried out using the Biomark microfluidics system (Fluidigm; South San Francisco, CA). A cross-reactivity analysis enabled the generation of a robust automated mutation-calling algorithm which was then validated in a series of 51 cell lines and 33 FFPE clinical samples. All detected mutations were confirmed by other means. Sample input titrations confirmed the assay sensitivity with as little as 2 ng gDNA, and demonstrated excellent inter-and intra-chip reproducibility. Parallel analysis of 92 clinical trial samples was carried out using 2-100 ng genomic DNA (gDNA), allowing the simultaneous detection of multiple mutations. DNA prepared from both fresh frozen and formalin-fixed, paraffin-embedded (FFPE) samples were used, and the analysis was routinely completed in 2-3 days: traditional assays require 0.5-1 mu g high-quality DNA, and take significantly longer to analyze. This assay can detect a wide range of mutations in therapeutically relevant genes from very small amounts of sample DNA. As such, the mutation assay developed is a valuable tool for high-throughput biomarker discovery and validation in personalized medicine and cancer drug development.	[Patel, Rajesh; Tam, Rachel; Desai, Rupal; Raja, Rajiv] Genentech Inc, Oncol Biomarker Dev, San Francisco, CA 94080 USA; [Myers, Thomas W.; Bauer, Keith; Smith, Edward] Roche Mol Syst Inc, Program Core Res, Pleasanton, CA USA	Roche Holding; Genentech; Roche Holding	Patel, R (corresponding author), Genentech Inc, Oncol Biomarker Dev, San Francisco, CA 94080 USA.	rajeshdp@gene.com			Genentech Inc.	Genentech Inc.(Roche HoldingGenentech)	This study was funded by Genentech Inc. The funders were responsible for the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Cronin M, 2011, BIOMARK MED, V5, P293, DOI [10.2217/BMM.11.37, 10.2217/bmm.11.37]; Denkert C, 2011, BREAST CARE, V6, P265, DOI 10.1159/000331696; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Jakobsen JN, 2011, CANCER CHEMOTH PHARM, V68, P1, DOI 10.1007/s00280-011-1655-3; Kuan CT, 2001, ENDOCR-RELAT CANCER, V8, P83, DOI 10.1677/erc.0.0080083; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mani Vigneshwaran, 2011, Expert Opin Med Diagn, V5, P381; Mittempergher L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017163; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; O'Brien C, 2010, CLIN CANCER RES, V16, P3670, DOI 10.1158/1078-0432.CCR-09-2828; O'Dwyer D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027718; OKAYAMA H, 1989, J LAB CLIN MED, V114, P105; Prat A, 2012, NAT REV CLIN ONCOL, V9, P48, DOI 10.1038/nrclinonc.2011.178; Reichert F, 2012, U.S. Patents, Patent No. [US-2012-0009628 A1, 20120009628]; Reichert F, 2011, U.S. Patents, Patent No. [US 2011-0312038 A1, 20110312038]; Reichert F, 2011, U.S. Patents, Patent No. [US 2011-0318786 A1, 20110318786]; Reichert F, 2011, U.S. Patents, Patent No. [US 2011-0318785 A1, 20110318785]; Reichert F, 2012, U.S. Patents, Patent No. [US-2012-0015405 A1, 20120015405]; Reichert F, 2011, U.S. Patents, Patent No. [US 2011-0312037 A1, 20110312037]; Reichert F, 2011, U.S. Patents, Patent No. [US 2011-0312039 A1, 20110312039]; Reichert F, 2012, U.S. Patent, Patent No. [2011/0312041A1, 20110312041]; Sawyers CL, 2008, NATURE, V452, P548, DOI 10.1038/nature06913; Shi MM, 2000, METH MOLEC MED, V49, P459, DOI 10.1385/1-59259-081-0:459; Sozzi G, 2001, CANCER RES, V61, P4675; Weberpals JI, 2011, CANCER GENET-NY, V204, P525, DOI 10.1016/j.cancergen.2011.09.004; Will SG, 2011, US Patent, Patent No. [2010/0099110A1, 20100099110]; Wistuba II, 2011, NAT REV CLIN ONCOL, V8, P135, DOI 10.1038/nrclinonc.2011.2	32	14	14	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51153	10.1371/journal.pone.0051153	http://dx.doi.org/10.1371/journal.pone.0051153			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284662	gold, Green Submitted, Green Published			2022-12-27	WOS:000312435900013
J	Vu, BV; Anthony, KL; Strych, U; Willson, RC				Vu, Binh V.; Anthony, Kim L.; Strych, Ulrich; Willson, Richard C.			Recovery of Small DNA Fragments from Serum Using Compaction Precipitation	PLOS ONE			English	Article							CIRCULATING DNA; SELECTIVE PRECIPITATION; CANCER-PATIENTS; PLASMA; QUANTIFICATION	Background: While most nucleic acids are intracellular, trace amounts of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), including micro RNAs, can also be found in peripheral blood. Many studies have suggested the potential utility of these circulating nucleic acids in prenatal diagnosis, early cancer detection, and the diagnosis of infectious diseases. However, DNA circulating in blood is usually present at very low concentrations (ng/ml), and is in the form of relatively small fragments (<1,000 bp), making its isolation challenging. Methods: Here we report an improved method for the isolation of small DNA fragments from serum using selective precipitation by quaternary ammonium compaction agents. A 151 bp fragment of double-stranded DNA from the Escherichia coli bacteriophage lambda served as the model DNA in our experiments. DNA was serially diluted in serum until undetectable by conventional polymerase chain reaction (PCR), before being enriched by compaction precipitation. Results: Starting with concentrations two to three orders of magnitude lower than the PCR-detectable level (0.01 ng/ml), we were able to enrich the DNA to a detectable level using a novel compaction precipitation protocol. The isolated DNA product after compaction precipitation was largely free of serum contaminants and was suitable for downstream applications. Conclusions: Using compaction precipitation, we were able to isolate and concentrate small DNA from serum, and increase the sensitivity of detection by more than four orders of magnitude. We were able to recover and detect very low levels (0.01 ng/ml) of a small DNA fragment in serum. In addition to being very sensitive, the method is fast, simple, inexpensive, and avoids the use of toxic chemicals.	[Vu, Binh V.; Anthony, Kim L.; Willson, Richard C.] Univ Houston, Dept Chem & Biomol Engn, Houston, TX 77204 USA; [Strych, Ulrich; Willson, Richard C.] Univ Houston, Dept Biol & Biochem, Houston, TX USA	University of Houston System; University of Houston; University of Houston System; University of Houston	Willson, RC (corresponding author), Univ Houston, Dept Chem & Biomol Engn, Houston, TX 77204 USA.	willson@uh.edu	Willson, richard/AAD-4832-2019	Strych, Ulrich/0000-0001-9455-7683	Welch Foundation	Welch Foundation(The Welch Foundation)	Funded by the Welch Foundation (http://www.welch1.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Al-Soud W, 2000, J CLIN MICROBIOL, V38, P345; Abu al-Soud W, 2001, J CLIN MICROBIOL, V39, P485, DOI 10.1128/JCM.39.2.485-493.2001; Anez-Lingerfelt M, 2009, ANAL BIOCHEM, V384, P79, DOI 10.1016/j.ab.2008.09.009; [Anonymous], 2010, CIRCULATING DNA PLAS; [Anonymous], 2009, QIAAMP CIRCULATING N; Gal S, 2004, BRIT J CANCER, V90, P1211, DOI 10.1038/sj.bjc.6601609; Goebel G, 2005, DIS MARKERS, V21, P105, DOI 10.1155/2005/218759; GOSULE LC, 1976, NATURE, V259, P333, DOI 10.1038/259333a0; Hahn SH, 2001, CLIN CHEM, V47, P1577; HOOPES BC, 1981, NUCLEIC ACIDS RES, V9, P5493, DOI 10.1093/nar/9.20.5493; Jung M, 2003, CLIN CHEM, V49, P1028, DOI 10.1373/49.6.1028; Kirsch C, 2008, ANN NY ACAD SCI, V1137, P135, DOI 10.1196/annals.1448.035; LEON SA, 1977, CANCER RES, V37, P646; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; Mourich DV, 2003, J IMMUNOL METHODS, V274, P257, DOI 10.1016/S0022-1759(02)00516-1; Murphy JC, 1999, NAT BIOTECHNOL, V17, P822, DOI 10.1038/11777; RAZIN S, 1959, ARCH BIOCHEM BIOPHYS, V81, P36, DOI 10.1016/0003-9861(59)90173-0; Schmidt B, 2005, CLIN CHEM, V51, P1561, DOI 10.1373/clinchem.2005.051003; Sozzi G, 2003, J CLIN ONCOL, V21, P3902, DOI 10.1200/JCO.2003.02.006; STROUN M, 1987, EUR J CANCER CLIN ON, V23, P707, DOI 10.1016/0277-5379(87)90266-5; Tamkovich SN, 2008, B EXP BIOL MED+, V146, P89, DOI 10.1007/s10517-008-0213-4	21	3	3	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51863	10.1371/journal.pone.0051863	http://dx.doi.org/10.1371/journal.pone.0051863			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284792	Green Published, Green Submitted, gold			2022-12-27	WOS:000312435900059
J	Thomson, RL; Tomas, G; Forsman, JT; Monkkonen, M				Thomson, Robert L.; Tomas, Gustavo; Forsman, Jukka T.; Monkkonen, Mikko			Manipulating Individual Decisions and Environmental Conditions Reveal Individual Quality in Decision-Making and Non-Lethal Costs of Predation Risk	PLOS ONE			English	Article							STRESS-PROTEIN-LEVELS; BREEDING HABITAT SELECTION; NEST-SITE SELECTION; CLUTCH SIZE; HSP70 EXPRESSION; PIED-FLYCATCHER; INFORMATION USE; HEAT-STRESS; BLUE TITS; EXPOSURE	Habitat selection is a crucial decision for any organism. Selecting a high quality site will positively impact survival and reproductive output. Predation risk is an important component of habitat quality that is known to impact reproductive success and individual condition. However, separating the breeding consequences of decision-making of wild animals from individual quality is difficult. Individuals face reproductive decisions that often vary with quality such that low quality individuals invest less. This reduced reproductive performance could appear a cost of increased risk but may simply reflect lower quality. Thus, teasing apart the effects of individual quality and the effect of predation risk is vital to understand the physiological and reproductive costs of predation risk alone on breeding animals. In this study we alter the actual territory location decisions of pied flycatchers by moving active nests relative to breeding sparrowhawks, the main predators of adult flycatchers. We experimentally measure the non-lethal effects of predation on adults and offspring while controlling for effects of parental quality, individual territory choice and initiation of breeding. We found that chicks from high predation risk nests (<50 m of hawk) were significantly smaller than chicks from low risk nests (>200 m from hawk). However, in contrast to correlative results, females in manipulated high risk nests did not suffer decreased body condition or increased stress response (HSP60 and HSP70). Our results suggest that territory location decisions relative to breeding avian predators cause spatial gradients in individual quality. Small adjustments in territory location decisions have crucial consequences and our results confirm non-lethal costs of predation risk that were expressed in terms of smaller offspring produced. However, females did not show costs in physiological condition which suggests that part of the costs incurred by adults exposed to predation risk are quality determined. Citation: Thomson RL, Tomas G, Forsman JT, Monkkonen M (2012) Manipulating Individual Decisions and Environmental Conditions Reveal Individual Quality in Decision-Making and Non-Lethal Costs of Predation Risk. PLoS ONE 7(12): e52226. doi:10.1371/journal.pone.0052226	[Thomson, Robert L.] Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland; [Tomas, Gustavo] CSIC, Museo Nacl Ciencias Nat, Dept Evolutionary Ecol, E-28006 Madrid, Spain; [Forsman, Jukka T.] Univ Oulu, Dept Biol, Oulu, Finland; [Monkkonen, Mikko] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland	University of Turku; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); University of Oulu; University of Jyvaskyla	Thomson, RL (corresponding author), Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland.	robtho@utu.fi	Thomson, Robert L/B-9637-2012; Forsman, Jukka/H-5345-2012; Tomas, Gustavo/J-7559-2012	Thomson, Robert L/0000-0002-6958-1259; Tomas, Gustavo/0000-0001-6701-2055; Monkkonen, Mikko/0000-0001-8897-3314	Oskar Oflund's foundation; Ella and Georg Ehrnrooth foundation; Academy of Finland [138049, 122665, 125720]; Programme Juan de la Cierva from Ministerio de Educacion y Ciencia; Ministerio de Educacion y Ciencia [BOS 2003-05724]	Oskar Oflund's foundation; Ella and Georg Ehrnrooth foundation; Academy of Finland(Academy of Finland); Programme Juan de la Cierva from Ministerio de Educacion y Ciencia; Ministerio de Educacion y Ciencia(Spanish Government)	This work was supported by: Oskar Oflund's foundation, Ella and Georg Ehrnrooth foundation and the Academy of Finland (project number 138049) to RT; Academy of Finland (project numbers: 122665 and 125720) to JF; Programme Juan de la Cierva and Grant BOS 2003-05724 from Ministerio de Educacion y Ciencia to GT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALATALO RV, 1986, EVOLUTION, V40, P574, DOI 10.1111/j.1558-5646.1986.tb00508.x; Arlt D, 2007, ECOLOGY, V88, P792, DOI 10.1890/06-0574; Blaustein L, 2004, OECOLOGIA, V138, P300, DOI 10.1007/s00442-003-1398-x; Buchanan KL, 2000, TRENDS ECOL EVOL, V15, P156, DOI 10.1016/S0169-5347(99)01812-1; Creel S, 2005, ECOLOGY, V86, P3387, DOI 10.1890/05-0032; Creel S, 2007, SCIENCE, V315, P960, DOI 10.1126/science.1135918; Cresswell W, 2008, IBIS, V150, P3, DOI 10.1111/j.1474-919X.2007.00793.x; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; Doligez B, 2002, SCIENCE, V297, P1168, DOI 10.1126/science.1072838; Doligez B, 2003, ECOLOGY, V84, P2582, DOI 10.1890/02-3116; Eggers S, 2006, P ROY SOC B-BIOL SCI, V273, P701, DOI 10.1098/rspb.2005.3373; Fleshner M, 2004, PSYCHONEUROENDOCRINO, V29, P1142, DOI 10.1016/j.psyneuen.2004.01.007; Fontaine JJ, 2006, AM NAT, V168, P811, DOI 10.1086/508297; Fontaine JJ, 2006, ECOL LETT, V9, P428, DOI 10.1111/j.1461-0248.2006.00892.x; Fontaine JJ, 2011, CONDOR, V113, P825, DOI 10.1525/cond.2011.110027; Forsman JT, 2007, BEHAV ECOL, V18, P888, DOI 10.1093/beheco/arm048; Forstmeier W, 2004, OIKOS, V104, P487, DOI 10.1111/j.0030-1299.1999.12698.x; Herring G, 2007, THESCIENTIFICWORLDJO, V7, P1596, DOI 10.1100/tsw.2007.242; Huhta E, 1999, AUK, V116, P528, DOI 10.2307/4089385; Kessler A, 2002, ECOLOGY, V83, P2346, DOI 10.1890/0012-9658(2002)083[2346:MQSOOI]2.0.CO;2; Kokko H, 1999, J ANIM ECOL, V68, P940, DOI 10.1046/j.1365-2656.1999.00343.x; Kristensen TN, 2005, GENETICS, V171, P157, DOI 10.1534/genetics.104.039610; Kristensen TN, 2003, J GENET, V82, P89, DOI 10.1007/BF02715811; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; Lima SL, 2009, BIOL REV, V84, P485, DOI 10.1111/j.1469-185X.2009.00085.x; MARTIN TE, 1993, BIOSCIENCE, V43, P523, DOI 10.2307/1311947; Martinez-Padilla J, 2004, FUNCT ECOL, V18, P426, DOI 10.1111/j.0269-8463.2004.00874.x; Merino S, 1998, OECOLOGIA, V116, P343, DOI 10.1007/s004420050596; Merino S, 2002, ECOSCIENCE, V9, P300, DOI 10.1080/11956860.2002.11682716; Merino S, 2006, J ANIM ECOL, V75, P1147, DOI 10.1111/j.1365-2656.2006.01135.x; Monkkonen M, 2007, J ANIM ECOL, V76, P619, DOI 10.1111/j.1365-2656.2007.01233.x; Morosinotto C, 2010, J ANIM ECOL, V79, P327, DOI 10.1111/j.1365-2656.2009.01638.x; Pauwels K, 2005, J EVOLUTION BIOL, V18, P867, DOI 10.1111/j.1420-9101.2005.00890.x; PETTIFOR RA, 1988, NATURE, V336, P160, DOI 10.1038/336160a0; Resetarits WJ, 2005, ECOL LETT, V8, P480, DOI 10.1111/j.1461-0248.2005.00747.x; Scheuerlein A, 2001, P ROY SOC B-BIOL SCI, V268, P1575, DOI 10.1098/rspb.2001.1691; Seppanen JT, 2007, ECOLOGY, V88, P1622, DOI 10.1890/06-1757.1; SIIKAMAKI P, 1995, ECOLOGY, V76, P308, DOI 10.2307/1940652; Slos S, 2008, FUNCT ECOL, V22, P637, DOI 10.1111/j.1365-2435.2008.01424.x; Sorensen JG, 2011, CAN J ZOOL, V89, P1249, DOI 10.1139/Z11-105; Sorensen JG, 2004, J THERM BIOL, V29, P195, DOI 10.1016/j.jtherbio.2004.02.004; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Thomson RL, 2006, OIKOS, V113, P325, DOI 10.1111/j.2006.0030-1299.14376.x; Thomson RL, 2006, ECOGRAPHY, V29, P507; Thomson RL, 2011, ANIM BEHAV, V82, P1443, DOI 10.1016/j.anbehav.2011.09.029; Thomson RL, 2010, ECOLOGY, V91, P1832, DOI 10.1890/09-0989.1; Tomas G, 2005, ANN ZOOL FENN, V42, P45; Tomas G, 2004, J FIELD ORNITHOL, V75, P281, DOI 10.1648/0273-8570-75.3.281; Trnka A, 2011, ORNIS FENNICA, V88, P179; Valeix M, 2009, ECOLOGY, V90, P23, DOI 10.1890/08-0606.1; Wisenden BD, 2000, PHILOS T ROY SOC B, V355, P1205, DOI 10.1098/rstb.2000.0668	51	9	9	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e52226	10.1371/journal.pone.0052226	http://dx.doi.org/10.1371/journal.pone.0052226			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272226	Green Submitted, Green Published, gold			2022-12-27	WOS:000312386600057
J	Critselis, E; Nastos, PT; Theodoridou, K; Theodoridou, M; Tsolia, MN; Hadjichristodoulou, C; Papaevangelou, V				Critselis, Elena; Nastos, Panagiotis T.; Theodoridou, Kalliopi; Theodoridou, Maria; Tsolia, Maria N.; Hadjichristodoulou, Christos; Papaevangelou, Vassiliki			Time Trends in Pediatric Hospitalizations for Varicella Infection Are Associated with Climatic Changes: A 22-Year Retrospective Study in a Tertiary Greek Referral Center	PLOS ONE			English	Article							ZOSTER-VIRUS; CHICKENPOX INCIDENCE; SEROPREVALENCE; EPIDEMIOLOGY; POPULATION; CHILDREN; TRANSMISSION; TEMPERATURE; VACCINATION; ANTIBODIES	Background/Aims: The transmission rate of air-borne infectious diseases may vary secondary to climate conditions. The study assessed time trends in the seasonality of hospitalized varicella cases in a temperate region in relation to climatic parameters prior to the implementation of universal varicella immunization. Methods: A retrospective descriptive study was conducted among all pediatric and adolescent varicella patients (n = 2366) hospitalized at the "Aghia Sophia" Children's Hospital during 1982-2003 in Athens, Greece. Date of infection was computed based on hospital admission date. Seasonal and monthly trends in the epidemiology of varicella infection were assessed with time series analysis (ARIMA modeling procedure). The correlation between the frequency of varicella patients and the meteorological parameters was examined by the application of Generalized Linear Models with Gamma distribution. Results: During 1982-2003, the occurrence of hospitalized varicella cases increased during summer (p = 0.025) and decreased during autumn (p = 0.021), and particularly in September (p = 0.003). The frequency of hospitalized varicella cases was inversely associated with air temperature (p<0.001). In contrast, the occurrence of hospitalized varicella cases was positively associated with wind speed (p = 0.009). Conclusions: Pediatric hospitalizations for varicella infection rates have increased during summer and decreased during autumn in the examined temperate region. Time trends in hospitalized varicella cases are associated with climatic variables.	[Critselis, Elena; Tsolia, Maria N.; Papaevangelou, Vassiliki] Univ Athens, Sch Med, P&A Kyriakou Childrens Hosp, Univ Dept Pediat 2, Athens 11528, Greece; [Nastos, Panagiotis T.] Univ Athens, Dept Geol & Geoenvironm, Lab Climatol & Atmospher Environm, Athens 11528, Greece; [Theodoridou, Kalliopi; Theodoridou, Maria] Univ Athens, Sch Med, Aghia Sophia Childrens Hosp, Univ Dept Pediat 1, Athens 11528, Greece; [Hadjichristodoulou, Christos] Univ Thessaly, Sch Med, Dept Hyg & Epidemiol, Thessaly, Greece	Athens Medical School; National & Kapodistrian University of Athens; National & Kapodistrian University of Athens; Athens Medical School; National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital; University of Thessaly	Papaevangelou, V (corresponding author), Univ Athens, Sch Med, P&A Kyriakou Childrens Hosp, Univ Dept Pediat 2, Athens 11528, Greece.	vpapaev@med.uoa.gr	Nastos, Panagiotis T/E-7455-2015; Nastos, Panagiotis/Q-5419-2019	Nastos, Panagiotis T/0000-0001-9336-6586; Nastos, Panagiotis/0000-0001-9336-6586; Hadjichristodoulou, Christos/0000-0002-4769-8376	Second University Department of Pediatrics, "P. & A. Kyriakou" Children's Hospital, of the National and Kapodistrian University of Athens School of Medicine	Second University Department of Pediatrics, "P. & A. Kyriakou" Children's Hospital, of the National and Kapodistrian University of Athens School of Medicine	The present work was funded by the Second University Department of Pediatrics, "P. & A. Kyriakou" Children's Hospital, of the National and Kapodistrian University of Athens School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, MMWR Recomm Rep, V45, P1; Bonanni P, 2009, BMC MED, V7, P26, DOI DOI 10.1186/1741-7015-7-26; Chan JYC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-366; de Melker H, 2006, VACCINE, V24, P3946, DOI 10.1016/j.vaccine.2006.02.017; GARNETT GP, 1993, EPIDEMIOL INFECT, V110, P361, DOI 10.1017/S0950268800068308; Gustin KM, 2011, P NATL ACAD SCI USA, V108, P8432, DOI 10.1073/pnas.1100768108; Katsafadou A, 2008, EUR J CLIN MICROBIOL, V27, P223, DOI 10.1007/s10096-007-0418-x; Khoshnood B, 2006, PEDIATR INFECT DIS J, V25, P41, DOI 10.1097/01.inf.0000195636.43584.bb; Knibbs LD, 2012, EPIDEMIOL INFECT, V140, P474, DOI 10.1017/S0950268811000835; Kokaze A, 2001, EPIDEMIOL INFECT, V126, P269, DOI 10.1017/S0950268801005246; Lee BW, 1998, TROP MED INT HEALTH, V3, P886; Liyanage N P M, 2007, Indian J Med Sci, V61, P128; Lolekha S, 2001, AM J TROP MED HYG, V64, P131, DOI 10.4269/ajtmh.2001.64.131; Mandal BK, 1998, J INFECT DIS, V178, pS52, DOI 10.1086/514262; McGullagh P., 1997, GEN LINEAR MODELS; Nastos PT, 2011, INT J REMOTE SENS, V32, P737, DOI 10.1080/01431161.2010.517796; NEDLER JA, 1972, J ROY STAT SOC A STA, V135, P370; O'Grady KA, 2000, TROP MED INT HEALTH, V5, P732, DOI 10.1046/j.1365-3156.2000.00622.x; Red Book, 2009, RED BOOK; Sauerbrei Andreas, 2007, Indian J Med Sci, V61, P123; Teunis PFM, 2010, EPIDEMICS-NETH, V2, P215, DOI 10.1016/j.epidem.2010.10.001; Theodoridou M, 2006, EUR J PEDIATR, V165, P273, DOI 10.1007/s00431-005-0043-6; Tseng H. F., 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P1201; VENKITARAMAN AR, 1984, J CLIN MICROBIOL, V20, P582, DOI 10.1128/JCM.20.3.582-583.1984; Vyse AJ, 2004, EPIDEMIOL INFECT, V132, P1129, DOI 10.1017/S0950268804003140; Wu PY, 2007, INT J DERMATOL, V46, P362, DOI 10.1111/j.1365-4632.2006.03050.x; Yang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021481; Yawn BP, 1997, J PEDIATR-US, V130, P759, DOI 10.1016/S0022-3476(97)80019-4; Zak-Prelich M, 2002, EPIDEMIOL INFECT, V129, P593, DOI 10.1017/S0950268802007793	29	21	22	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52016	10.1371/journal.pone.0052016	http://dx.doi.org/10.1371/journal.pone.0052016			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23284855	Green Submitted, gold, Green Published			2022-12-27	WOS:000313051500020
J	Alwis, DS; Yan, EB; Morganti-Kossmann, MC; Rajan, R				Alwis, Dasuni S.; Yan, Edwin B.; Morganti-Kossmann, Maria-Cristina; Rajan, Ramesh			Sensory Cortex Underpinnings of Traumatic Brain Injury Deficits	PLOS ONE			English	Article							RAT BARREL CORTEX; VISUAL PROCESSING DEFICITS; DIFFUSE AXONAL INJURY; WHISKER VIBRATION; HIPPOCAMPAL CA1; CORTICAL INJURY; COMPLEX SOUNDS; LATE-ONSET; NEURONS; HYPEREXCITABILITY	Traumatic brain injury (TBI) can result in persistent sensorimotor and cognitive deficits including long-term altered sensory processing. The few animal models of sensory cortical processing effects of TBI have been limited to examination of effects immediately after TBI and only in some layers of cortex. We have now used the rat whisker tactile system and the cortex processing whisker-derived input to provide a highly detailed description of TBI-induced long-term changes in neuronal responses across the entire columnar network in primary sensory cortex. Brain injury (n = 19) was induced using an impact acceleration method and sham controls received surgery only (n = 15). Animals were tested in a range of sensorimotor behaviour tasks prior to and up to 6 weeks post-injury when there were still significant sensorimotor behaviour deficits. At 8-10 weeks post-trauma, in terminal experiments, extracellular recordings were obtained from barrel cortex neurons in response to whisker motion, including motion that mimicked whisker motion observed in awake animals undertaking different tasks. In cortex, there were lamina-specific neuronal response alterations that appeared to reflect local circuit changes. Hyper-excitation was found only in supragranular layers involved in intra-areal processing and long-range integration, and only for stimulation with complex, naturalistic whisker motion patterns and not for stimulation with simple trapezoidal whisker motion. Thus TBI induces long-term directional changes in integrative sensory cortical layers that depend on the complexity of the incoming sensory information. The nature of these changes allow predictions as to what types of sensory processes may be affected in TBI and contribute to post-trauma sensorimotor deficits.	[Alwis, Dasuni S.; Rajan, Ramesh] Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia; [Alwis, Dasuni S.; Yan, Edwin B.; Morganti-Kossmann, Maria-Cristina] Alfred Hosp, Natl Trauma Res Inst, Prahran, Vic 3181, Australia	Monash University; Florey Institute of Neuroscience & Mental Health	Rajan, R (corresponding author), Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia.	Ramesh.Rajan@monash.edu	rajan, ramesh/L-4842-2019	Rajan, Ramesh/0000-0001-9862-0520; Morganti-Kossmann, Cristina/0000-0002-0807-2063	NHMRC of Australia [APP 1029311]	NHMRC of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by the NHMRC of Australia Grant No. APP 1029311. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock RA, 2009, SCHIZOPHRENIA BULL, V35, P1132, DOI 10.1093/schbul/sbp068; Akasu T, 2002, NEUROSCI LETT, V329, P305, DOI 10.1016/S0304-3940(02)00707-3; Andermann ML, 2004, NEURON, V42, P451, DOI 10.1016/S0896-6273(04)00198-9; Arabzadeh E, 2004, J NEUROSCI, V24, P6011, DOI 10.1523/JNEUROSCI.1389-04.2004; Arabzadeh E, 2003, J NEUROSCI, V23, P9146; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Arundine M, 2004, J NEUROSCI, V24, P8106, DOI 10.1523/JNEUROSCI.1362-04.2004; Arundine M, 2003, J NEUROTRAUM, V20, P1377, DOI 10.1089/089771503322686166; Boddaert N, 2004, AM J PSYCHIAT, V161, P2117, DOI 10.1176/appi.ajp.161.11.2117; Boddaert N, 2003, AM J PSYCHIAT, V160, P2057, DOI 10.1176/appi.ajp.160.11.2057; BOHNEN N, 1991, J NEUROL, V238, P443, DOI 10.1007/BF00314651; Bonislawski DP, 2007, NEUROBIOL DIS, V25, P163, DOI 10.1016/j.nbd.2006.09.002; Brosseau-Lachaine O, 2008, BRAIN INJURY, V22, P657, DOI 10.1080/02699050802203353; Butler PD, 2009, SCHIZOPHRENIA BULL, V35, P1095, DOI 10.1093/schbul/sbp109; Bye N, 2011, J NEUROSCI RES, V89, P986, DOI 10.1002/jnr.22635; Caeyenberghs K, 2009, BRAIN, V132, P684, DOI 10.1093/brain/awn344; Carmichael ST, 2012, ARCH NEUROL-CHICAGO, V69, P161, DOI 10.1001/archneurol.2011.1175; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; Cook NL, 2010, J MOL NEUROSCI, V42, P192, DOI 10.1007/s12031-010-9347-8; Corbo J, 2004, ANN EMERG MED, V44, P57, DOI 10.1016/j.annemergmed.2003.11.010; Davis AS, 2010, APPL NEUROPSYCHOL, V17, P104, DOI 10.1080/09084281003708951; Ding MC, 2008, NEUROSCIENCE, V154, P551, DOI 10.1016/j.neuroscience.2008.03.088; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; Donkin JJ, 2011, J NEUROTRAUM, V28, P217, DOI 10.1089/neu.2010.1632; DOSTER SK, 1991, NEURON, V6, P635, DOI 10.1016/0896-6273(91)90066-9; Draper K, 2009, NEUROPSYCHOL REHABIL, V19, P645, DOI 10.1080/17405620802613935; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Folmer RL, 2011, INT J PSYCHOPHYSIOL, V82, P4, DOI 10.1016/j.ijpsycho.2011.03.005; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Galvin J, 2009, AM J OCCUP THER, V63, P701, DOI 10.5014/ajot.63.6.701; Gao PH, 2001, J NEUROSCI, V21, P5374, DOI 10.1523/JNEUROSCI.21-14-05374.2001; Gibson JR, 2008, J NEUROPHYSIOL, V100, P2615, DOI 10.1152/jn.90752.2008; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Griesemer D, 2007, J NEUROTRAUM, V24, P1823, DOI 10.1089/neu.2006.0237; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; Hartmann MJ, 2003, J NEUROSCI, V23, P6510; Heath DL, 2001, J NEUROTRAUM, V18, P465, DOI 10.1089/089771501750171074; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Higley MJ, 2003, J NEUROSCI, V23, P10190; Hoane MR, 2008, OXID MED CELL LONGEV, V1, P46, DOI 10.4161/oxim.1.1.6694; Horton HK, 2011, SCHIZOPHRENIA BULL, V37, P716, DOI 10.1093/schbul/sbr055; Hulsebosch CE, 1998, NEUROSCI LETT, V255, P83, DOI 10.1016/S0304-3940(98)00712-5; Imbrosci B, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/614329; Kalauzi Aleksandar, 2009, Nonlinear Biomed Phys, V3, P8, DOI 10.1186/1753-4631-3-8; Kim D, 2006, SCHIZOPHR RES, V82, P1, DOI 10.1016/j.schres.2005.10.008; Korostenskaja M, 2010, EPILEPSY RES, V92, P63, DOI 10.1016/j.eplepsyres.2010.08.008; Learoyd AE, 2012, BEHAV BRAIN RES, V226, P197, DOI 10.1016/j.bbr.2011.09.016; Leitman DI, 2007, AM J PSYCHIAT, V164, P474, DOI 10.1176/appi.ajp.164.3.474; Leitman DI, 2005, BIOL PSYCHIAT, V58, P56, DOI 10.1016/j.biopsych.2005.02.034; Lew HL, 2010, NEUROREHABILITATION, V26, P213, DOI 10.3233/NRE-2010-0557; Lew HL, 2009, J REHABIL RES DEV, V46, P819, DOI 10.1682/JRRD.2008.09.0129; Lew HL, 2004, AM J PHYS MED REHAB, V83, P428, DOI 10.1097/00002060-200406000-00004; Lewis DA, 2012, TRENDS NEUROSCI, V35, P57, DOI 10.1016/j.tins.2011.10.004; Li HF, 2002, J NEUROPHYSIOL, V88, P2, DOI 10.1152/jn.00507.2001; Li Y, 2011, J NEUROTRAUM, V28, P1767, DOI 10.1089/neu.2010.1687; Lifshitz J, 2007, J NEUROPATH EXP NEUR, V66, P218, DOI 10.1097/01.jnen.0000248558.75950.4d; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MANDELBROT BB, 1991, P ROY SOC LOND A MAT, V434, P79, DOI 10.1098/rspa.1991.0081; Marco EJ, 2011, PEDIATR RES, V69, p48R, DOI [10.1203/PDR.0b013e3182130c54, 10.1109/SPL.2011.5782616]; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McNamara KCS, 2010, J NEUROTRAUM, V27, P695, DOI 10.1089/neu.2009.1237; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Paluszkiewicz SM, 2011, DEV NEUROSCI-BASEL, V33, P349, DOI 10.1159/000329420; Patel R, 2011, OPTOMETRY, V82, P284, DOI 10.1016/j.optm.2010.10.012; Pinto DJ, 2000, J NEUROPHYSIOL, V83, P1158, DOI 10.1152/jn.2000.83.3.1158; Prince DA, 2009, EPILEPSIA, V50, P30, DOI 10.1111/j.1528-1167.2008.02008.x; Rafols JA, 2007, NEUROL RES, V29, P348, DOI 10.1179/016164107X204657; Raghavendra BS, 2009, PHYSIOL MEAS, V30, P795, DOI 10.1088/0967-3334/30/8/005; Rajan R, 1998, NAT NEUROSCI, V1, P138, DOI 10.1038/388; Rajan R, 2007, EUR J NEUROSCI, V25, P2383, DOI 10.1111/j.1460-9568.2007.05481.x; Rajan R, 2006, J NEUROSCI METH, V157, P103, DOI 10.1016/j.jneumeth.2006.04.008; Rajan R, 2001, CEREB CORTEX, V11, P171, DOI 10.1093/cercor/11.2.171; Rancan M, 2001, J NEUROSCI RES, V63, P438, DOI 10.1002/1097-4547(20010301)63:5<438::AID-JNR1039>3.0.CO;2-P; Raymond MJ, 1996, NEUROREHABILITATION, V6, P229, DOI 10.3233/NRE-1996-6309; Ritt JT, 2008, NEURON, V57, P599, DOI 10.1016/j.neuron.2007.12.024; Russo NM, 2008, CLIN NEUROPHYSIOL, V119, P1720, DOI 10.1016/j.clinph.2008.01.108; Schiene K, 1996, J CEREBR BLOOD F MET, V16, P906, DOI 10.1097/00004647-199609000-00014; Schmanke T, 1997, J NEUROTRAUM, V14, P459, DOI 10.1089/neu.1997.14.459; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Thomas TC, 2012, J NEUROTRAUM, V29, P187, DOI 10.1089/neu.2011.2091; Vink R, 2003, NEUROSCI LETT, V336, P41, DOI 10.1016/S0304-3940(02)01244-2; WADDELL PA, 1984, ACTA NEUROL SCAND, V69, P270, DOI 10.1111/j.1600-0404.1984.tb07812.x; Wang JH, 2003, BRAIN RES BULL, V60, P53, DOI 10.1016/S0361-9230(03)00026-1; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Wolf DH, 2008, BRAIN IMAGING BEHAV, V2, P132, DOI 10.1007/s11682-008-9022-7; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; Yang L, 2010, J NEUROTRAUM, V27, P1541, DOI 10.1089/neu.2009.1244; YU Z, 2009, EMBC 2009 ANN INT C, P1135	96	48	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52169	10.1371/journal.pone.0052169	http://dx.doi.org/10.1371/journal.pone.0052169			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284921	Green Published, Green Submitted, gold			2022-12-27	WOS:000313158800036
J	Mondini, A; Sassone, F; Civello, DA; Garavaglia, ML; Bazzini, C; Rodighiero, S; Vezzoli, V; Conti, F; Torielli, L; Capasso, G; Paulmichl, M; Meyer, G				Mondini, Anna; Sassone, Francesca; Civello, Davide Antonio; Garavaglia, Maria Lisa; Bazzini, Claudia; Rodighiero, Simona; Vezzoli, Valeria; Conti, Fabio; Torielli, Lucia; Capasso, Giovanbattista; Paulmichl, Markus; Meyer, Giuliano			Hypertension-Linked Mutation of alpha-Adducin Increases CFTR Surface Expression and Activity in HEK and Cultured Rat Distal Convoluted Tubule Cells	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; SALT-SENSITIVE HYPERTENSION; SODIUM-CHANNEL ACTIVITY; EPITHELIAL NA+ CHANNEL; CYSTIC-FIBROSIS; PLASMA-MEMBRANE; BLOOD-PRESSURE; GENETIC-HYPERTENSION; CHLORIDE CHANNELS; CL-CHANNELS	The CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) activity and localization are influenced by the cytoskeleton, in particular by actin and its polymerization state. In this study we investigated whether the expression of the hypertensive mutations of alpha-adducin (G460W-S586C in humans, F316Y in rats), an actin capping protein, led to a functional modification of CFTR activity and surface expression. The experiments were performed on HEK293 T cells cotransfected with CFTR and the human wild type (WT) or G460W mutated alpha-adducin. In whole-cell patch-clamp experiments, both the CFTR chloride current and the slope of current activation after forskolin addition were significantly higher in HEK cells overexpressing the G460W adducin. A higher plasma membrane density of active CFTR channels was confirmed by cell-attached patch-clamp experiments, both in HEK cells and in cultured primary DCT cells, isolated from MHS (Milan Hypertensive Strain, a Wistar rat (Rattus norvegicus) hypertensive model carrying the F316Y adducin mutation), compared to MNS (Milan Normotensive Strain) rats. Western blot experiments demonstrated an increase of the plasma membrane CFTR protein expression, with a modification of the channel glycosylation state, in the presence of the mutated adducin. A higher retention of CFTR protein in the plasma membrane was confirmed both by FRAP (Fluorescence Recovery After Photobleaching) and photoactivation experiments. The present data indicate that in HEK cells and in isolated DCT cells the presence of the G460W-S586C hypertensive variant of adducin increases CFTR channel activity, possibly by altering its membrane turnover and inducing a retention of the channel in the plasmamembrane. Since CFTR is known to modulate the activity of many others transport systems, the increased surface expression of the channel could have consequences on the whole network of transport in kidney cells.	[Mondini, Anna; Sassone, Francesca; Civello, Davide Antonio; Garavaglia, Maria Lisa; Bazzini, Claudia; Vezzoli, Valeria; Meyer, Giuliano] Univ Milan, Dept Life Sci, Milan, Italy; [Rodighiero, Simona] Fdn Filarete, Milan, Italy; [Rodighiero, Simona] Prassis Res Inst, Sigma Tau, Settimo Mse, Italy; [Capasso, Giovanbattista] Univ Naples Federico II, Dept Internal Med, Naples, Italy; [Paulmichl, Markus] Paracelsus Med Univ, Inst Pharmacol & Toxicol, Salzburg, Austria	University of Milan; University of Naples Federico II; Paracelsus Private Medical University	Meyer, G (corresponding author), Univ Milan, Dept Life Sci, Milan, Italy.	giuliano.meyer@unimi.it	Garavaglia, Maria Lisa/AFV-3214-2022; Rodighiero, Simona/AAP-9816-2020; Meyer, Giuliano/G-8062-2011	Rodighiero, Simona/0000-0003-4236-7823; Vezzoli, Valeria/0000-0001-6396-7284; CIVELLO, DAVIDE ANTONIO/0000-0003-4133-8211; Capasso, Giovambattista/0000-0003-3469-8614; Mondini, Anna/0000-0002-3219-0684	Italian MIUR (Ministero Istruzione Universita Ricerca) [2008W5AZEC_002]	Italian MIUR (Ministero Istruzione Universita Ricerca)(Ministry of Education, Universities and Research (MIUR))	This paper was supported by grant #2008W5AZEC_002 (PRIN 2008; prin.miur.it) from the Italian MIUR (Ministero Istruzione Universita Ricerca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker EH, 1999, HYPERTENSION, V33, P1031, DOI 10.1161/01.HYP.33.4.1031; Ban H, 2007, GENE THER, V14, P1688, DOI 10.1038/sj.gt.3303032; Barriere H, 2004, J MEMBRANE BIOL, V198, P113, DOI 10.1007/s00232-004-0665-z; Bates IR, 2006, BIOPHYS J, V91, P1046, DOI 10.1529/biophysj.106.084830; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bernstein PL, 2011, SEMIN NEPHROL, V31, P475, DOI 10.1016/j.semnephrol.2011.09.002; BIANCHI G, 1975, CIRC RES, V36, P153, DOI 10.1161/01.RES.36.6.153; Bianchi G, 2005, AM J PHYSIOL-REG I, V289, pR1536, DOI 10.1152/ajpregu.00441.2005; BIANCHI G, 1994, P NATL ACAD SCI USA, V91, P3999, DOI 10.1073/pnas.91.9.3999; Cantiello HF, 2001, PFLUG ARCH EUR J PHY, V443, pS75; Capasso G, 2005, AM J PHYSIOL-RENAL, V288, pF1173, DOI 10.1152/ajprenal.00228.2004; Capasso G, 2008, AM J PHYSIOL-RENAL, V295, pF556, DOI 10.1152/ajprenal.00340.2007; Carmosino M, 2011, PFLUG ARCH EUR J PHY, V462, P281, DOI 10.1007/s00424-011-0967-9; Chang CT, 2005, J PHYSIOL-LONDON, V562, P271, DOI 10.1113/jphysiol.2004.077933; Chang XB, 2008, J CELL SCI, V121, P2814, DOI 10.1242/jcs.028951; Pinto ACOD, 2007, CELL PHYSIOL BIOCHEM, V20, P83, DOI 10.1159/000104156; Efendiev R, 2004, CIRC RES, V95, P1100, DOI 10.1161/01.RES.0000149570.20845.89; Ferrandi M, 1996, HYPERTENSION, V28, P1018, DOI 10.1161/01.HYP.28.6.1018; Ferrandi M, 1999, AM J PHYSIOL-HEART C, V277, pH1338, DOI 10.1152/ajpheart.1999.277.4.H1338; Ferrandi M, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001815; Ganeshan R, 2007, BBA-MOL CELL RES, V1773, P192, DOI 10.1016/j.bbamcr.2006.09.031; GARDNER K, 1987, NATURE, V328, P359, DOI 10.1038/328359a0; Glozman R, 2009, J CELL BIOL, V184, P847, DOI 10.1083/jcb.200808124; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Haggie PM, 2006, MOL BIOL CELL, V17, P4937, DOI 10.1091/mbc.E06-08-0670; Haggie PM, 2004, J BIOL CHEM, V279, P5494, DOI 10.1074/jbc.M312445200; Hubberstey AV, 2002, FASEB J, V16, P487, DOI 10.1096/fj.01-0659rev; Jin S, 2007, BIOPHYS J, V93, P1079, DOI 10.1529/biophysj.106.102244; Jouret F, 2011, METHODS MOL BIOL, V741, P285, DOI 10.1007/978-1-61779-117-8_19; Jouret F, 2009, PFLUG ARCH EUR J PHY, V457, P1227, DOI 10.1007/s00424-008-0594-2; KAISER HW, 1989, J CELL BIOL, V109, P557, DOI 10.1083/jcb.109.2.557; Karpushev AV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008827; Kuhlman PA, 1996, J BIOL CHEM, V271, P7986, DOI 10.1074/jbc.271.14.7986; Kunzelmann K, 2003, PFLUG ARCH EUR J PHY, V445, P504, DOI 10.1007/s00424-002-0958-y; Kunzelmann K, 2002, CELL BIOCHEM BIOPHYS, V36, P209, DOI 10.1385/CBB:36:2-3:209; Lansdell KA, 1998, J PHYSIOL-LONDON, V508, P379, DOI 10.1111/j.1469-7793.1998.379bq.x; Lazrak A, 2011, AM J PHYSIOL-LUNG C, V301, pL557, DOI 10.1152/ajplung.00094.2011; Li CY, 2010, INTEGR BIOL-UK, V2, P161, DOI [10.1039/B924455G, 10.1039/b924455g]; Li CY, 2004, J BIOL CHEM, V279, P24673, DOI 10.1074/jbc.M400688200; Li XL, 1998, J BIOL CHEM, V273, P19329, DOI 10.1074/jbc.273.30.19329; LIEBERMAN J, 1975, ANN INTERN MED, V82, P806, DOI 10.7326/0003-4819-82-6-806; Liedtke CM, 2002, J BIOL CHEM, V277, P22925, DOI 10.1074/jbc.M201917200; Lu M, 2010, P NATL ACAD SCI USA, V107, P6082, DOI 10.1073/pnas.0902661107; Luo TC, 2001, J VIROL, V75, P2488, DOI 10.1128/JVI.75.5.2488-2492.2001; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Mall M, 1998, J CLIN INVEST, V102, P15, DOI 10.1172/JCI2729; MISCHE SM, 1987, J CELL BIOL, V105, P2837, DOI 10.1083/jcb.105.6.2837; Monterisi S, 2012, J CELL SCI; Morales MM, 2000, AN ACAD BRAS CIENC, V72, P399, DOI 10.1590/S0001-37652000000300013; Morales MM, 2001, PFLUG ARCH EUR J PHY, V443, P202, DOI 10.1007/s004240100671; Moscatelli A, 2007, J CELL SCI, V120, P3804, DOI 10.1242/jcs.012138; Naydenov NG, 2010, MOL BIOL CELL, V21, P3506, DOI 10.1091/mbc.E10-03-0259; O'Riordan CR, 2000, GLYCOBIOLOGY, V10, P1225, DOI 10.1093/glycob/10.11.1225; Penmatsa H, 2010, MOL BIOL CELL, V21, P1097, DOI 10.1091/mbc.E09-08-0655; Pera A, 2008, P NATL ACAD SCI USA, V105, P18608, DOI 10.1073/pnas.0805831105; Procino G, 2011, AM J HYPERTENS, V24, P822, DOI 10.1038/ajh.2011.47; Qualmann B, 2002, INT REV CYTOL, V220, P93; Reddy MM, 1999, NATURE, V402, P301, DOI 10.1038/46297; Scanlin TF, 2001, RESP RES, V2, P276, DOI 10.1186/rr69; Stanton BA, 1997, WIEN KLIN WOCHENSCHR, V109, P457; Sun F, 2000, J BIOL CHEM, V275, P29539, DOI 10.1074/jbc.M004961200; Super M, 2004, HYPERTENSION, V44, P878, DOI 10.1161/01.HYP.0000145901.81989.46; Super M, 2000, LANCET, V355, P1840, DOI 10.1016/S0140-6736(00)02282-0; Swiatecka-Urban A, 2004, J BIOL CHEM, V279, P38025, DOI 10.1074/jbc.M403141200; Thelin WR, 2007, J CLIN INVEST, V117, P364, DOI 10.1172/JCI30376; Torielli L, 2008, AM J PHYSIOL-RENAL, V295, pF478, DOI 10.1152/ajprenal.90226.2008; Tripodi G, 1996, J CLIN INVEST, V97, P2815, DOI 10.1172/JCI118737; Vandewalle Alain, 2007, Chang Gung Med J, V30, P17; Veizis IE, 2007, PEDIATR NEPHROL, V22, P770, DOI 10.1007/s00467-006-0355-4; Weixel KM, 2001, J BIOL CHEM, V276, P46251, DOI 10.1074/jbc.M104545200; Won S, 2011, FEBS LETT, V585, P2323, DOI 10.1016/j.febslet.2011.05.069; Xie Y, 2004, AM J PHYSIOL-RENAL, V287, pF722, DOI 10.1152/ajprenal.00135.2004	72	4	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52014	10.1371/journal.pone.0052014	http://dx.doi.org/10.1371/journal.pone.0052014			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284854	Green Published, Green Submitted, gold			2022-12-27	WOS:000313158800023
J	Muxel, SM; Pires-Lapa, MA; Monteiro, AWA; Cecon, E; Tamura, EK; Floeter-Winter, LM; Markus, RP				Muxel, Sandra Marcia; Pires-Lapa, Marco Antonio; Arantes Monteiro, Alex Willian; Cecon, Erika; Tamura, Eduardo Koji; Floeter-Winter, Lucile Maria; Markus, Regina P.			NF-kappa B Drives the Synthesis of Melatonin in RAW 264.7 Macrophages by Inducing the Transcription of the Arylalkylamine-N-Acetyltransferase (AA-NAT) Gene	PLOS ONE			English	Article							PINEAL-GLAND; RESPONSE ELEMENT; C-REL; ACTIVATION; CELLS; EXPRESSION; RECEPTORS; ENDOCRINE; KB; INHIBITION	We demonstrate that during inflammatory responses the nuclear factor kappa B (NF-kappa B) induces the synthesis of melatonin by macrophages and that macrophage-synthesized melatonin modulates the function of these professional phagocytes in an autocrine manner. Expression of a DsRed2 fluorescent reporter driven by regions of the aa-nat promoter, that encodes the key enzyme involved in melatonin synthesis (arylalkylamine-N-acetyltransferase), containing one or two upstream kappa B binding sites in RAW 264.7 macrophage cell lines was repressed when NF-kappa B activity was inhibited by blocking its nuclear translocation or its DNA binding activity or by silencing the transcription of the RelA or c-Rel NF-kappa B subunits. Therefore, transcription of aa-nat driven by NF-kappa B dimers containing RelA or c-Rel subunits mediates pathogen-associated molecular patterns (PAMPs) or pro-inflammatory cytokine-induced melatonin synthesis in macrophages. Furthermore, melatonin acts in an autocrine manner to potentiate macrophage phagocytic activity, whereas luzindole, a competitive antagonist of melatonin receptors, decreases macrophage phagocytic activity. The opposing functions of NF-kappa B in the modulation of AA-NAT expression in pinealocytes and macrophages may represent the key mechanism for the switch in the source of melatonin from the pineal gland to immune-competent cells during the development of an inflammatory response.	[Muxel, Sandra Marcia; Pires-Lapa, Marco Antonio; Arantes Monteiro, Alex Willian; Cecon, Erika; Tamura, Eduardo Koji; Floeter-Winter, Lucile Maria; Markus, Regina P.] Univ Sao Paulo, Inst Biosci, Dept Physiol, Sao Paulo, Brazil	Universidade de Sao Paulo	Markus, RP (corresponding author), Univ Sao Paulo, Inst Biosci, Dept Physiol, Sao Paulo, Brazil.	rpmarkus@usp.br	Tamura, Eduardo Koji/L-4360-2019; Markus, Regina P./AAC-1505-2021; Cecon, Erika/AAG-9413-2020; Markus, Regina P/K-2954-2012; Cecon, Erika/B-3444-2016; Cecon, Erika/F-9842-2014; Tamura, Eduardo Koji/F-7068-2012; Floeter-Winter, Lucile Maria/K-2618-2012; Muxel, Sandra/F-7464-2012; Floeter-Winter, Lucile Maria/AAE-7629-2019	Tamura, Eduardo Koji/0000-0002-6105-7452; Markus, Regina P./0000-0003-4606-6120; Cecon, Erika/0000-0003-2387-9313; Markus, Regina P/0000-0003-4606-6120; Cecon, Erika/0000-0003-2387-9313; Cecon, Erika/0000-0003-2387-9313; Tamura, Eduardo Koji/0000-0002-6105-7452; Floeter-Winter, Lucile Maria/0000-0002-8954-8704; Muxel, Sandra/0000-0003-0118-5361; Floeter-Winter, Lucile Maria/0000-0002-8954-8704; Lapa, Marco/0000-0003-4451-3169	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [07/7871-6]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, 07/7871-6) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baler R, 1997, J BIOL CHEM, V272, P6979, DOI 10.1074/jbc.272.11.6979; Carrillo-Vico A, 2005, J CLIN ENDOCR METAB, V90, P992, DOI 10.1210/jc.2004-1429; CARVALHOSOUSA CE, 2011, FR ENDOCRINOL, V2, P1, DOI DOI 10.3389/FENDO.2011.00010; Cecon E, 2010, CHRONOBIOL INT, V27, P52, DOI 10.3109/07420521003661615; Cruz-Machado SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040142; Cruz-Machado SD, 2010, J PINEAL RES, V49, P183, DOI 10.1111/j.1600-079X.2010.00785.x; Dubocovich ML, 2005, ENDOCRINE, V27, P101, DOI 10.1385/ENDO:27:2:101; Fernandes PACM, 2006, J PINEAL RES, V41, P344, DOI 10.1111/j.1600-079X.2006.00373.x; Ferreira ZS, 2005, J PINEAL RES, V38, P182, DOI 10.1111/j.1600-079X.2004.00191.x; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Gilad E, 1998, FASEB J, V12, P685, DOI 10.1096/fasebj.12.9.685; Hardeland R, 2009, BIOFACTORS, V35, P183, DOI 10.1002/biof.23; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Huang DB, 2001, STRUCTURE, V9, P669, DOI 10.1016/S0969-2126(01)00635-9; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; Lezoualc'h F, 1998, J NEUROSCI, V18, P3224; Lotufo CMC, 2006, EUR J PHARMACOL, V534, P258, DOI 10.1016/j.ejphar.2006.01.050; Lotufo CMC, 2001, EUR J PHARMACOL, V430, P351, DOI 10.1016/S0014-2999(01)01369-3; Luchetti F, 2010, FASEB J, V24, P3603, DOI 10.1096/fj.10-154450; Majewski P, 2005, LIFE SCI, V76, P1907, DOI 10.1016/j.lfs.2004.04.062; Marcola M, 2012, J PINEAL RES; Markus RP, 2007, NEUROIMMUNOMODULAT, V14, P126, DOI 10.1159/000110635; Markus RP, 2011, ADV NEUROIMMUNE BIOL, V1, P95, DOI 10.3233/NIB-2011-009; Martins E, 2004, J LEUKOCYTE BIOL, V75, P1116, DOI 10.1189/jlb.1203614; Min KJ, 2012, J PINEAL RES, V52, P296, DOI 10.1111/j.1600-079X.2011.00943.x; Mohan N, 1995, BIOCHEM MOL BIOL INT, V37, P1063; Murakami Y, 2011, IN VIVO, V25, P641; Pontes GN, 2006, J PINEAL RES, V41, P136, DOI 10.1111/j.1600-079X.2006.00345.x; RALPH P, 1981, CANCER RES, V41, P3546; Rao P, 2010, NATURE, V466, P1115, DOI 10.1038/nature09283; Sanjabi S, 2000, P NATL ACAD SCI USA, V97, P12705, DOI 10.1073/pnas.230436397; Shi DB, 2012, J PINEAL RES, V53, P154, DOI 10.1111/j.1600-079X.2012.00982.x; Shishodia S, 2004, BIOCHEM PHARMACOL, V68, P1071, DOI 10.1016/j.bcp.2004.04.026; Shiu SY, 2012, J PINEAL RES; Siggers T, 2012, NAT IMMUNOL, V13, P95, DOI 10.1038/ni.2151; Simonneaux V, 2003, PHARMACOL REV, V55, P325, DOI 10.1124/pr.55.2.2; Skwarlo-Sonta K, 2003, CAN J PHYSIOL PHARM, V81, P342, DOI 10.1139/Y03-026; Tamura EK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013958; Tan DX, 2007, J PINEAL RES, V43, P317, DOI 10.1111/j.1600-079X.2007.00513.x; Tan DX, 2010, BIOL REV, V85, P607, DOI 10.1111/j.1469-185X.2009.00118.x; VERWEIJ CL, 1991, J BIOL CHEM, V266, P14179; Xia MZ, 2012, J PINEAL RES	45	96	100	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52010	10.1371/journal.pone.0052010	http://dx.doi.org/10.1371/journal.pone.0052010			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284853	Green Submitted, gold, Green Published			2022-12-27	WOS:000313158800022
J	Forrest, MD; Wall, MJ; Press, DA; Feng, JF				Forrest, Michael D.; Wall, Mark J.; Press, Daniel A.; Feng, Jianfeng			The Sodium-Potassium Pump Controls the Intrinsic Firing of the Cerebellar Purkinje Neuron	PLOS ONE			English	Article							ACTIVE MEMBRANE MODEL; CALCIUM EXCHANGE; ELECTROPHYSIOLOGICAL PROPERTIES; FUZZY SPACE; K+ CHANNELS; CELL SOMATA; ATPASE; MODULATION; SIMULATION; DENDRITES	In vitro, cerebellar Purkinje cells can intrinsically fire action potentials in a repeating trimodal or bimodal pattern. The trimodal pattern consists of tonic spiking, bursting, and quiescence. The bimodal pattern consists of tonic spiking and quiescence. It is unclear how these firing patterns are generated and what determines which firing pattern is selected. We have constructed a realistic biophysical Purkinje cell model that can replicate these patterns. In this model, Na+/K+ pump activity sets the Purkinje cell's operating mode. From rat cerebellar slices we present Purkinje whole cell recordings in the presence of ouabain, which irreversibly blocks the Na+/K+ pump. The model can replicate these recordings. We propose that Na+/K+ pump activity controls the intrinsic firing mode of cerbellar Purkinje cells.	[Forrest, Michael D.; Feng, Jianfeng] Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England; [Wall, Mark J.; Press, Daniel A.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Feng, Jianfeng] Fudan Univ, Computat Syst Biol Ctr, Shanghai 200433, Peoples R China	University of Warwick; University of Warwick; Fudan University	Forrest, MD (corresponding author), Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England.	mikeforrest@hotmail.com		feng, jianfeng/0000-0002-9328-5732; Forrest, Michael/0000-0002-0648-7468; wall, mark/0000-0002-7014-1867	Medical Research Council (MRC) of the UK	Medical Research Council (MRC) of the UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Michael Forrest conducted the majority of this work and conducted it as a component of his Ph.D. research, which was funded by the Medical Research Council (MRC) of the UK, http://www.mrc.ac.uk/index.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; Akemann W, 2006, J NEUROSCI, V26, P4602, DOI 10.1523/JNEUROSCI.5204-05.2006; Amzica F, 2002, J NEUROSCI, V22, P1042, DOI 10.1523/JNEUROSCI.22-03-01042.2002; Arganda S, 2007, NAT NEUROSCI, V10, P1467, DOI 10.1038/nn1982; Baccus SA, 1998, P NATL ACAD SCI USA, V95, P8345, DOI 10.1073/pnas.95.14.8345; Bazhenov M, 2004, J NEUROPHYSIOL, V92, P1116, DOI 10.1152/jn.00529.2003; Blaustein MP, 2007, CIRC RES, V101, P959, DOI 10.1161/CIRCRESAHA.107.164459; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Brent R, 1976, NEW ALGORITHM MINIMI; Burke RE, 2000, J COMPUT NEUROSCI, V9, P31, DOI 10.1023/A:1008934327204; BUSH PC, 1993, J NEUROSCI METH, V46, P159, DOI 10.1016/0165-0270(93)90151-G; Canavier CC, 1999, J COMPUT NEUROSCI, V6, P49, DOI 10.1023/A:1008809000182; Cannon SC, 2004, NEURON, V43, P153, DOI 10.1016/j.neuron.2004.07.002; CHANG W, 1993, BRAIN RES, V614, P335, DOI 10.1016/0006-8993(93)91052-T; Colley B, 2004, RECEPTOR CHANNEL, V10, P25, DOI 10.1080/10606820490270870; Courtemanche M, 1998, AM J PHYSIOL-HEART C, V275, pH301, DOI 10.1152/ajpheart.1998.275.1.H301; Delmas P, 2002, NEURON, V36, P787, DOI 10.1016/S0896-6273(02)01097-8; DESCHUTTER E, 1994, J NEUROPHYSIOL, V71, P401, DOI 10.1152/jn.1994.71.1.401; DESCHUTTER E, 1994, J NEUROPHYSIOL, V71, P375, DOI 10.1152/jn.1994.71.1.375; Despa S, 2003, BIOPHYS J, V84, P4157, DOI 10.1016/S0006-3495(03)75140-6; Destexhe A, 1998, J NEUROSCI, V18, P3574, DOI 10.1523/jneurosci.18-10-03574.1998; Durstewitz D, 2000, J NEUROPHYSIOL, V83, P1733, DOI 10.1152/jn.2000.83.3.1733; Edgerton JR, 2003, J PHYSIOL-LONDON, V548, P53, DOI 10.1113/jphysiol.2002.027854; Fierro L, 1998, J PHYSIOL-LONDON, V510, P499, DOI 10.1111/j.1469-7793.1998.499bk.x; Frohlich F, 2006, J NEUROSCI, V26, P6153, DOI 10.1523/JNEUROSCI.5509-05.2006; Genet S, 1997, PFLUG ARCH EUR J PHY, V434, P559, DOI 10.1007/s004240050436; Glitsch HG, 2001, PHYSIOL REV, V81, P1791, DOI 10.1152/physrev.2001.81.4.1791; GUSTAFSSON B, 1983, BRAIN RES, V275, P159, DOI 10.1016/0006-8993(83)90429-8; HEINEMANN U, 1977, BRAIN RES, V120, P231, DOI 10.1016/0006-8993(77)90903-9; HENKART M, 1976, J CELL BIOL, V70, P338, DOI 10.1083/jcb.70.2.338; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HUANG XY, 1993, CELL, V75, P1145, DOI 10.1016/0092-8674(93)90324-J; Ito M, 1984, CEREBELLUM NEURAL CO; Johnston D., 1995, FDN CELLULAR NEUROPH; Kager H, 2007, J COMPUT NEUROSCI, V22, P105, DOI 10.1007/s10827-006-0001-y; Khaliq ZM, 2003, J NEUROSCI, V23, P4899, DOI 10.1523/jneurosci.23-12-04899.2003; Kofuji P, 2004, NEUROSCIENCE, V129, P1045, DOI 10.1016/j.neurscience.2004.06.008; Komendantov AO, 2004, J NEUROPHYSIOL, V91, P346, DOI 10.1152/jn.00062.2003; LEDERER WJ, 1990, SCIENCE, V248, P283, DOI 10.1126/science.2326638; Lindblad DS, 1996, AM J PHYSIOL-HEART C, V271, pH1666, DOI 10.1152/ajpheart.1996.271.4.H1666; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P171, DOI 10.1113/jphysiol.1980.sp013357; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; Loewenstein Y, 2005, NAT NEUROSCI, V8, P202, DOI 10.1038/nn1393; McKay BE, 2005, J PHYSIOL-LONDON, V567, P829, DOI 10.1113/jphysiol.2005.089383; McKay BE, 2005, J NEUROSCI, V25, P1481, DOI 10.1523/JNEUROSCI.3523-04.2005; Mckay BE, 2007, J NEUROPHYSIOL, V97, P2590, DOI 10.1152/jn.00627.2006; Miyasho T, 2001, BRAIN RES, V891, P106, DOI 10.1016/S0006-8993(00)03206-6; MOODY WJ, 1974, EXP NEUROL, V42, P248, DOI 10.1016/0014-4886(74)90023-5; PHILIPSON KD, 1985, ANNU REV PHYSIOL, V47, P561; Prinz A., 2006, SCHOLARPEDIA, V2, P1903, DOI [10.4249/scholarpedia.l903, DOI 10.4249/SCHOLARPEDIA.1903]; Pulver SR, 2010, NAT NEUROSCI, V13, P53, DOI 10.1038/nn.2444; RAPP M, 1994, J PHYSIOL-LONDON, V474, P101, DOI 10.1113/jphysiol.1994.sp020006; Saraga F, 2003, J PHYSIOL-LONDON, V552, P673, DOI 10.1113/jphysiol.2003.046177; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; Sawczuk A, 1997, J NEUROPHYSIOL, V78, P2246, DOI 10.1152/jn.1997.78.5.2246; Scuri R, 2007, EUR J NEUROSCI, V25, P159, DOI 10.1111/j.1460-9568.2006.05257.x; Semb SO, 1996, ACTA PHYSIOL SCAND, V156, P213, DOI 10.1046/j.1365-201X.1996.211000.x; SHELTON DP, 1985, NEUROSCIENCE, V14, P111, DOI 10.1016/0306-4522(85)90168-X; Silverman BDZ, 2003, CARDIOVASC RES, V57, P1025, DOI 10.1016/S0008-6363(02)00645-4; Stryer L, 2002, BIOCHEMISTRY; Su Z, 1998, AM J PHYSIOL-HEART C, V275, pH1808, DOI 10.1152/ajpheart.1998.275.5.H1808; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; Verdonck F, 2004, CELL CALCIUM, V35, P603, DOI 10.1016/j.ceca.2004.01.014; Wall MJ, 1997, EUR J NEUROSCI, V9, P533, DOI 10.1111/j.1460-9568.1997.tb01630.x; WENDTGALLITELLI MF, 1993, J PHYSIOL-LONDON, V472, P33, DOI 10.1113/jphysiol.1993.sp019934; Winklhofer A, 2003, NEUROPHARMACOLOGY, V44, P829, DOI 10.1016/S0028-3908(03)00070-4; WIT AL, 1981, CIRC RES, V49, P1029, DOI 10.1161/01.RES.49.4.1029; Womack M, 2002, J NEUROSCI, V22, P10603; Womack MD, 2004, J NEUROSCI, V24, P3511, DOI 10.1523/JNEUROSCI.0290-04.2004; Womack MD, 2003, J NEUROSCI, V23, P2600; Zhang HY, 2012, CURR BIOL, V22, P526, DOI 10.1016/j.cub.2012.01.058	71	40	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51169	10.1371/journal.pone.0051169	http://dx.doi.org/10.1371/journal.pone.0051169			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284664	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500021
J	Qu, ZP; Adelson, DL				Qu, Zhipeng; Adelson, David L.			Identification and Comparative Analysis of ncRNAs in Human, Mouse and Zebrafish Indicate a Conserved Role in Regulation of Genes Expressed in Brain	PLOS ONE			English	Article							LONG NONCODING RNAS; INTERGENIC TRANSCRIPTION; DARK-MATTER; GENOME; REVEALS; PLURIPOTENCY; ARCHITECTURE; COMPLEXITY; SEQUENCES; REPRESS	ncRNAs (non-coding RNAs), in particular long ncRNAs, represent a significant proportion of the vertebrate transcriptome and probably regulate many biological processes. We used publically available ESTs (Expressed Sequence Tags) from human, mouse and zebrafish and a previously published analysis pipeline to annotate and analyze the vertebrate non-protein-coding transcriptome. Comparative analysis confirmed some previously described features of intergenic ncRNAs, such as a positionally biased distribution with respect to regulatory or development related protein-coding genes, and weak but clear sequence conservation across species. Significantly, comparative analysis of developmental and regulatory genes proximate to long ncRNAs indicated that the only conserved relationship of these genes to neighbor long ncRNAs was with respect to genes expressed in human brain, suggesting a conserved, ncRNA cis-regulatory network in vertebrate nervous system development. Most of the relationships between long ncRNAs and proximate coding genes were not conserved, providing evidence for the rapid evolution of species-specific gene associated long ncRNAs. We have reconstructed and annotated over 130,000 long ncRNAs in these three species, providing a significantly expanded number of candidates for functional testing by the research community.	[Qu, Zhipeng; Adelson, David L.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia	University of Adelaide	Adelson, DL (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia.	david.adelson@adelaide.edu.au	Adelson, David L/E-5506-2011	Adelson, David L/0000-0003-2404-5636; Qu, Zhipeng/0000-0002-6841-0773	University of Adelaide; China Scholarship Council	University of Adelaide; China Scholarship Council(China Scholarship Council)	Funding from the University of Adelaide and a PhD scholarship to ZQ from the China Scholarship Council supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Braidotti G, 2004, COLD SPRING HARB SYM, V69, P55, DOI 10.1101/sqb.2004.69.55; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Carninci P, 2006, TRENDS GENET, V22, P501, DOI 10.1016/j.tig.2006.07.003; Chodroff RA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r72; Clark MB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000625; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; Dinger Marcel E., 2009, Briefings in Functional Genomics & Proteomics, V8, P407, DOI 10.1093/bfgp/elp038; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Frith MC, 2005, EUR J HUM GENET, V13, P894, DOI 10.1038/sj.ejhg.5201459; Fu XQ, 2006, DNA CELL BIOL, V25, P135, DOI 10.1089/dna.2006.25.135; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gustincich S, 2006, J PHYSIOL-LONDON, V575, P321, DOI 10.1113/jphysiol.2006.115568; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hirota K, 2008, NATURE, V456, P130, DOI 10.1038/nature07348; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Johnson JM, 2005, TRENDS GENET, V21, P93, DOI 10.1016/j.tig.2004.12.009; Kapranov P, 2005, GENOME RES, V15, P987, DOI 10.1101/gr.3455305; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kurokawa R, 2011, ADV EXP MED BIOL, V722, P196, DOI 10.1007/978-1-4614-0332-6_12; Lee JT, 2009, GENE DEV, V23, P1831, DOI 10.1101/gad.1811209; Managadze D, 2011, GENOME BIOL EVOL, V3, P1390, DOI 10.1093/gbe/evr116; Mancini-DiNardo D, 2006, GENE DEV, V20, P1268, DOI 10.1101/gad.1416906; Marques AC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r124; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Mercer TR, 2011, NUCLEIC ACIDS RES, V39, P2393, DOI 10.1093/nar/gkq1158; Mercer TR, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-14; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Numata K, 2003, GENOME RES, V13, P1301, DOI 10.1101/gr.1011603; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Petruk S, 2006, CELL, V127, P1209, DOI 10.1016/j.cell.2006.10.039; Ponjavic J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000617; Ponting CP, 2010, HUM MOL GENET, V19, pR162, DOI 10.1093/hmg/ddq362; Qu ZP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042638; Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020; Sasaki YTF, 2007, BIOCHEM BIOPH RES CO, V357, P991, DOI 10.1016/j.bbrc.2007.04.034; Schmitt S, 2005, GENE DEV, V19, P697, DOI 10.1101/gad.326205; Shabalina SA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-105; Song XY, 2012, METHODS MOL BIOL, V809, P609, DOI 10.1007/978-1-61779-376-9_39; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; Uhler JP, 2007, P NATL ACAD SCI USA, V104, P8011, DOI 10.1073/pnas.0702431104; Washietl S, 2007, GENOME RES, V17, P852, DOI 10.1101/gr.5650707	57	21	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52275	10.1371/journal.pone.0052275	http://dx.doi.org/10.1371/journal.pone.0052275			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284966	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500133
J	Tegge, AN; Caldwell, CW; Xu, D				Tegge, Allison N.; Caldwell, Charles W.; Xu, Dong			Pathway Correlation Profile of Gene-Gene Co-Expression for Identifying Pathway Perturbation	PLOS ONE			English	Article							SET ENRICHMENT; DIFFERENTIAL COEXPRESSION; ESCHERICHIA-COLI; EXPRESSION; DIAGNOSIS; RELAPSE; BIOTIN	Identifying perturbed or dysregulated pathways is critical to understanding the biological processes that change within an experiment. Previous methods identified important pathways that are significantly enriched among differentially expressed genes; however, these methods cannot account for small, coordinated changes in gene expression that amass across a whole pathway. In order to overcome this limitation, we use microarray gene expression data to identify pathway perturbation based on pathway correlation profiles. By identifying the distribution of gene-gene pair correlations within a pathway, we can rank the pathways based on the level of perturbation and dysregulation. We have shown this successfully for differences between two experimental conditions in Escherichia coli and changes within time series data in Saccharomyces cerevisiae, as well as two estrogen receptor response classes of breast cancer. Overall, our method made significant predictions as to the pathway perturbations that are involved in the experimental conditions.	[Tegge, Allison N.; Xu, Dong] Univ Missouri, Inst Informat, Columbia, MO 65211 USA; [Caldwell, Charles W.] Univ Missouri, Dept Pathol & Anat Sci, Columbia, MO USA; [Xu, Dong] Univ Missouri, Dept Comp Sci, Columbia, MO USA; [Xu, Dong] Univ Missouri, CS Bond Life Sci Ctr, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Xu, D (corresponding author), Univ Missouri, Inst Informat, Columbia, MO 65211 USA.	xudong@missouri.edu			National Library of Medicine Biomedical and Health Informatics Research Training Program [T15-LM07089]; NATIONAL LIBRARY OF MEDICINE [T15LM007089] Funding Source: NIH RePORTER	National Library of Medicine Biomedical and Health Informatics Research Training Program; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the National Library of Medicine Biomedical and Health Informatics Research Training Program T15-LM07089. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-47; Adewale AJ, 2008, J COMPUT BIOL, V15, P269, DOI 10.1089/cmb.2008.0002; Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Childs KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022196; Cho SB, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-109; CRONAN JE, 1988, J BIOL CHEM, V263, P10332; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Freudenberg JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-234; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Keller A, 2009, BIOINFORMATICS, V25, P2787, DOI 10.1093/bioinformatics/btp510; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Krull M, 2006, NUCLEIC ACIDS RES, V34, pD546, DOI 10.1093/nar/gkj107; Lai YL, 2004, BIOINFORMATICS, V20, P3146, DOI 10.1093/bioinformatics/bth379; Li KC, 2002, P NATL ACAD SCI USA, V99, P16875, DOI 10.1073/pnas.252466999; Maurer LM, 2005, J BACTERIOL, V187, P304, DOI 10.1128/JB.187.1.304-319.2005; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Novak BA, 2006, BIOINFORMATICS, V22, P233, DOI 10.1093/bioinformatics/bti764; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Singh J, 2005, APPL ENVIRON MICROB, V71, P8752, DOI 10.1128/AEM.71.12.8752-8763.2005; Song S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-502; Staal FJT, 2003, LEUKEMIA, V17, P1324, DOI 10.1038/sj.leu.2402974; Streit WR, 2003, APPL MICROBIOL BIOT, V61, P21, DOI 10.1007/s00253-002-1186-2; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sybesma W, 2003, APPL ENVIRON MICROB, V69, P4542, DOI 10.1128/AEM.69.8.4542-4548.2003; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Yang JJ, 2008, BLOOD, V112, P4178, DOI 10.1182/blood-2008-06-165027	33	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52127	10.1371/journal.pone.0052127	http://dx.doi.org/10.1371/journal.pone.0052127			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284898	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500097
J	Zhu, XJ; Yang, ZF; Chen, YY; Wang, JL; Rosmarin, AG				Zhu, Xue-Jun; Yang, Zhong-Fa; Chen, Yaoyu; Wang, Junling; Rosmarin, Alan G.			PU.1 Is Essential for CD11c Expression in CD8(+)/CD8(-) Lymphoid and Monocyte-Derived Dendritic Cells during GM-CSF or FLT3L-Induced Differentiation	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; TRANSCRIPTION FACTOR E2-2; REGULATORY FACTOR-4; CUTTING EDGE; MOUSE; GENERATION; ANTIGEN; LIGAND	Dendritic cells (DCs) regulate innate and acquired immunity through their roles as antigen-presenting cells. Specific subsets of mature DCs, including monocyte-derived and lymphoid-derived DCs, can be distinguished based on distinct immunophenotypes and functional properties. The leukocyte integrin, CD11c, is considered a specific marker for DCs and it is expressed by all DC subsets. We created a strain of mice in which DCs and their progenitors could be lineage traced based on activity of the CD11c proximal promoter. Surprisingly, we observed levels of CD11c promoter activity that were similar in DCs and in other mature leukocytes, including monocytes, granulocytes, and lymphocytes. We sought to identify DNA elements and transcription factors that regulate DC-associated expression of CD11c. The ets transcription factor, PU.1, is a key regulator of DC development, and expression of PU.1 varies in different DC subsets. GM-CSF increased monocyte-derived DCs in mice and from mouse bone marrow cultured in vitro, but it did not increase CD8(+) lymphoid-derived DCs or B220(+) plasmacytoid DCs. FLT3L increased both monocyte-derived DCs and lymphoid-derived DCs from mouse bone marrow cultured in vitro. GM-CSF increased the 5.3 Kb CD11c proximal promoter activity in monocyte-derived DCs and CD8(+) lymphoid-derived DCs, but not in B220(+) plasmacytoid DCs. In contrast, FLT3L increased the CD11c proximal promoter activity in both monocyte-derived DCs and B220(+) plasmacytoid DCs. We used shRNA gene knockdown and chromatin immunoprecipitation to demonstrate that PU.1 is required for the effects of GM-CSF or FLT3L on monocyte-derived DCs. We conclude that both GM-CSF and FLT3L act through PU.1 to activate the 5.3 Kb CD11c proximal promoter in DCs and to induce differentiation of monocyte-derived DCs. We also confirm that the CD11c proximal promoter is not sufficient to direct lineage specificity of CD11c expression, and that additional DNA elements are required for lineage-specific CD11c expression.	[Zhu, Xue-Jun] Jiangsu Prov Tradit Chinese Med Hosp, Cell & Mol Biol Lab, Div Hematol, Dept Med, Nanjing, Jiangsu, Peoples R China; [Zhu, Xue-Jun; Yang, Zhong-Fa; Chen, Yaoyu; Wang, Junling; Rosmarin, Alan G.] Univ Massachusetts, Sch Med, Dept Med, Div Hematol Oncol, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester	Zhu, XJ (corresponding author), Jiangsu Prov Tradit Chinese Med Hosp, Cell & Mol Biol Lab, Div Hematol, Dept Med, Nanjing, Jiangsu, Peoples R China.	Zhuxj2@hotmail.com; Alan.Rosmarin@umassmed.edu			Top Six Elite Scholar Program of Jiangsu Province China [2010-WS-012]; University of Massachusetts Medical School; Jiangsu Province Triditional Chinese Medicine Hospital scholar exchange fund	Top Six Elite Scholar Program of Jiangsu Province China; University of Massachusetts Medical School; Jiangsu Province Triditional Chinese Medicine Hospital scholar exchange fund	The Top Six Elite Scholar Program of Jiangsu Province China #2010-WS-012. University of Massachusetts Medical School startup funding; and Jiangsu Province Triditional Chinese Medicine Hospital scholar exchange fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belz GT, 2012, NAT REV IMMUNOL, V12, P101, DOI 10.1038/nri3149; Brasel K, 2000, BLOOD, V96, P3029, DOI 10.1182/blood.V96.9.3029.h8003029_3029_3039; Carotta S, 2010, IMMUNITY, V32, P628, DOI 10.1016/j.immuni.2010.05.005; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Ghosh HS, 2010, IMMUNITY, V33, P905, DOI 10.1016/j.immuni.2010.11.023; Gilliet M, 2002, J EXP MED, V195, P953, DOI 10.1084/jem.20020045; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Satpathy AT, 2011, SEMIN IMMUNOL, V23, P388, DOI 10.1016/j.smim.2011.08.009; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Steinman RM, 2003, APMIS, V111, P675, DOI 10.1034/j.1600-0463.2003.11107802.x; Stranges PB, 2007, IMMUNITY, V26, P629, DOI 10.1016/j.immuni.2007.03.016; Suzuki S, 2004, P NATL ACAD SCI USA, V101, P8981, DOI 10.1073/pnas.0402139101; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Tsujimura H, 2003, J IMMUNOL, V170, P1131, DOI 10.4049/jimmunol.170.3.1131; Vremec D, 1997, EUR J IMMUNOL, V27, P40, DOI 10.1002/eji.1830270107	23	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52141	10.1371/journal.pone.0052141	http://dx.doi.org/10.1371/journal.pone.0052141			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284905	gold, Green Published, Green Submitted			2022-12-27	WOS:000312794500100
J	Fujiwara, T; Kubzansky, LD; Matsumoto, K; Kawachi, I				Fujiwara, Takeo; Kubzansky, Laura D.; Matsumoto, Kenji; Kawachi, Ichiro			The Association between Oxytocin and Social Capital	PLOS ONE			English	Article							SELF-RATED HEALTH; PLASMA OXYTOCIN; PARTICIPATION; NEIGHBORHOOD; TRUST; COMMUNITY; EMOTION; STRESS	Background: Oxytocin is known to be related to social behaviors, including trust. However, few studies have investigated the association between oxytocin levels and social capital. Thus, we tested the hypothesis that endogenous oxytocin levels are positively associated with social capital. We also considered whether the association differed across gender because previous studies have shown differential effects of OT on social behaviors depending on gender. Methods: We recruited a convenience sample of 50 women and 31 men in Japan via community sampling from whom we obtained urine sample with which to measure oxytocin levels. Individual-level cognitive social capital (social trust and mutual aid) and structural social capital (community participation) were assessed using a questionnaire. We used multivariate regression, adjusted for covariates (age, number of children, self-rated health, and education), and stratified by gender to consider associations between oxytocin and social capital. Results: Among women, oxytocin was inversely associated with social trust and mutual aid (p<0.05). However, women participating in only 1 organization in the community showed higher oxytocin than women who participated in either no organizations (p<0.05) or 2 or more organization (i.e. inverse-U shape association). Among men, no association was observed between oxytocin and either form of cognitive and structural social capital. Conclusion: Women who perceived low cognitive social capital showed higher oxytocin levels, while structural social capital showed inverse-U shape association with oxytocin. No association between oxytocin and social capital was found among men. Further study is needed to elucidate why oxytocin was inversely associated with cognitive social capital only among women.	[Fujiwara, Takeo] Natl Res Inst Child Hlth & Dev, Dept Social Med, Tokyo, Japan; [Kubzansky, Laura D.; Kawachi, Ichiro] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Cambridge, MA 02138 USA; [Matsumoto, Kenji] Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, Tokyo, Japan	National Center for Child Health & Development - Japan; Harvard University; Harvard T.H. Chan School of Public Health; National Center for Child Health & Development - Japan	Fujiwara, T (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Social Med, Tokyo, Japan.	fujiwara-tk@ncchd.go.jp			Research Development Grant for Child Health and Development from National Center for Child Health and Development [21 shi -10]	Research Development Grant for Child Health and Development from National Center for Child Health and Development	This research was supported by Research Development Grant for Child Health and Development from National Center for Child Health and Development (21 shi -10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMICO JA, 1987, J CLIN ENDOCR METAB, V64, P340, DOI 10.1210/jcem-64-2-340; Aneshensel CS, 1996, J HEALTH SOC BEHAV, V37, P293, DOI 10.2307/2137258; Baumgartner T, 2008, NEURON, V58, P639, DOI 10.1016/j.neuron.2008.04.009; Bolin K, 2003, SOC SCI MED, V56, P2379, DOI 10.1016/S0277-9536(02)00242-3; Carlson P, 2004, SOC SCI MED, V59, P1985, DOI 10.1016/j.socscimed.2004.03.003; CARTER CS, 1992, ANN NY ACAD SCI, V652, P204, DOI 10.1111/j.1749-6632.1992.tb34356.x; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Ellaway A, 2001, URBAN STUD, V38, P2299, DOI 10.1080/00420980120087171; Feldman R, 2007, PSYCHOL SCI, V18, P965, DOI 10.1111/j.1467-9280.2007.02010.x; Feldman R, 2011, DEVELOPMENTAL SCI, V14, P752, DOI 10.1111/j.1467-7687.2010.01021.x; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Fujiwara T, 2008, J EPIDEMIOL COMMUN H, V62, P627, DOI 10.1136/jech.2007.064261; Fujiwara T, J EPIDEMIOL IN PRESS; Fujiwara T, 2008, AM J PREV MED, V35, P139, DOI 10.1016/j.amepre.2008.04.015; Fujiwara T, 2012, ACTA MED OKAYAMA, V66, P343; Fukuyama F, 1995, TRUST SOCIAL VIRTURE; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Glei DA, 2012, SOC SCI MED; Gonzaga GC, 2006, EMOTION, V6, P163, DOI 10.1037/1528-3542.6.2.163; Grewen KM, 2005, PSYCHOSOM MED, V67, P531, DOI 10.1097/01.psy.0000170341.88395.47; Harpham T, 2002, HEALTH POLICY PLANN, V17, P106, DOI 10.1093/heapol/17.1.106; Heim C, 2009, MOL PSYCHIATR, V14, P954, DOI 10.1038/mp.2008.112; Hyyppa MT, 2003, HEALTH EDUC RES, V18, P770, DOI 10.1093/her/cyf044; Hyyppa MT, 2001, PREV MED, V32, P148, DOI 10.1006/pmed.2000.0782; Kawachi I, 1997, AM J PUBLIC HEALTH, V87, P1491, DOI 10.2105/AJPH.87.9.1491; KEVERNE EB, 1992, ANN NY ACAD SCI, V652, P83, DOI 10.1111/j.1749-6632.1992.tb34348.x; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Lai JCL, 2012, SCI WORLD J, P1, DOI 10.1100/2012/929067; Lindstrom M, 2004, SOC SCI MED, V59, P595, DOI 10.1016/j.socscimed.2003.11.006; Lindstrom M, 2001, SOC SCI MED, V52, P441, DOI 10.1016/S0277-9536(00)00153-2; Lindstrom M, 2003, TOB CONTROL, V12, P274, DOI 10.1136/tc.12.3.274; McCulloch A, 2001, BRIT MED J, V323, P208, DOI 10.1136/bmj.323.7306.208; Mitchell C. U., 2002, CITY COMMUNITY, V1, P199, DOI DOI 10.1111/1540-6040.00017; Mitsui S, 2011, HORM BEHAV, V60, P239, DOI 10.1016/j.yhbeh.2011.05.012; Murayama H, 2012, J EPIDEMIOL, V22, P179, DOI 10.2188/jea.JE20110128; Oksanen T, 2012, J HYPERTENS, V30, P1129, DOI 10.1097/HJH.0b013e32835377ed; Rose R, 2000, SOC SCI MED, V51, P1421, DOI 10.1016/S0277-9536(00)00106-4; Steptoe A, 2001, ANN BEHAV MED, V23, P177, DOI 10.1207/S15324796ABM2303_5; Subramanian SV, 2002, J URBAN HEALTH, V79, pS21, DOI 10.1093/jurban/79.suppl_1.S21; Sudo T, 1978, Horumon To Rinsho, V26, P179; Taylor SE, 2006, PSYCHOSOM MED, V68, P238, DOI 10.1097/01.psy.0000203242.95990.74; Turner RA, 1999, PSYCHIATRY, V62, P97, DOI 10.1080/00332747.1999.11024859; Ueshima K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012135; Uphoff N, 1999, UNDERSTANDING SOCIAL, P215; Veenstra G, 2005, SOC SCI MED, V60, P2799, DOI 10.1016/j.socscimed.2004.11.013; Veenstra G, 2000, SOC SCI MED, V50, P619, DOI 10.1016/S0277-9536(99)00307-X; Zak PJ, 2005, HORM BEHAV, V48, P522, DOI 10.1016/j.yhbeh.2005.07.009; Ziersch AM, 2004, J EPIDEMIOL COMMUN H, V58, P493, DOI 10.1136/jech.2003.009084	48	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52018	10.1371/journal.pone.0052018	http://dx.doi.org/10.1371/journal.pone.0052018			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	059HF	23284856	gold, Green Published, Green Submitted			2022-12-27	WOS:000312694300069
J	Godsey, B; Heiser, D; Civin, C				Godsey, Brian; Heiser, Diane; Civin, Curt			Inferring MicroRNA Regulation of mRNA with Partially Ordered Samples of Paired Expression Data and Exogenous Prediction Algorithms	PLOS ONE			English	Article							GENE-EXPRESSION; DOWN-REGULATION; TARGETS; IDENTIFICATION; GENECODIS; MIRBASE	MicroRNAs (miRs) are known to play an important role in mRNA regulation, often by binding to complementary sequences in "target" mRNAs. Recently, several methods have been developed by which existing sequence-based target predictions can be combined with miR and mRNA expression data to infer true miR-mRNA targeting relationships. It has been shown that the combination of these two approaches gives more reliable results than either by itself. While a few such algorithms give excellent results, none fully addresses expression data sets with a natural ordering of the samples. If the samples in an experiment can be ordered or partially ordered by their expected similarity to one another, such as for time-series or studies of development processes, stages, or types, (e. g. cell type, disease, growth, aging), there are unique opportunities to infer miR-mRNA interactions that may be specific to the underlying processes, and existing methods do not exploit this. We propose an algorithm which specifically addresses [partially] ordered expression data and takes advantage of sample similarities based on the ordering structure. This is done within a Bayesian framework which specifies posterior distributions and therefore statistical significance for each model parameter and latent variable. We apply our model to a previously published expression data set of paired miR and mRNA arrays in five partially ordered conditions, with biological replicates, related to multiple myeloma, and we show how considering potential orderings can improve the inference of miR-mRNA interactions, as measured by existing knowledge about the involved transcripts.	[Godsey, Brian] Vienna Univ Technol, Dept Stat & Probabil, A-1040 Vienna, Austria; [Godsey, Brian] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Heiser, Diane] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA; [Heiser, Diane; Civin, Curt] Univ Maryland, Sch Med, Ctr Stem Cell Biol & Regenerat Med, Baltimore, MD 21201 USA; [Civin, Curt] Univ Maryland, Sch Med, Dept Physiol, Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Civin, Curt] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA	Technische Universitat Wien; University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Johns Hopkins Medicine; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Godsey, B (corresponding author), Vienna Univ Technol, Dept Stat & Probabil, A-1040 Vienna, Austria.	briangodsey@gmail.com		Pellegrini, Matteo/0000-0001-9355-9564	National Foundation for Cancer Research; National Institutes of Health [PO1CA70970, CA70970, DK080750]; Maryland Stem Cell Research Foundation/TEDCO [2007-MSCRFII-0114, 2008-MSCRF-303524, 2010-MSCRFII-0065]; National Institutes of Health; NATIONAL CANCER INSTITUTE [P01CA070970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080750] Funding Source: NIH RePORTER	National Foundation for Cancer Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Stem Cell Research Foundation/TEDCO; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants to C.I.C. from the National Foundation for Cancer Research (Fellow Award), the National Institutes of Health (PO1CA70970, CA70970, and DK080750), and the Maryland Stem Cell Research Foundation/TEDCO (2007-MSCRFII-0114, 2008-MSCRF-303524, and 2010-MSCRFII-0065). Funding for open access charge: National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Beal M.J., 2003, VARIATIONAL ALGORITH; Beal MJ, 2005, BIOINFORMATICS, V21, P349, DOI 10.1093/bioinformatics/bti014; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Chen LJ, 2011, CANCER LETT, V309, P62, DOI 10.1016/j.canlet.2011.05.017; Cheng C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001989; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Heuck C, 2012, CLIN CANC RES; Huang J C, 2008, Pac Symp Biocomput, P52; Huang JC, 2007, J COMPUT BIOL, V14, P550, DOI 10.1089/cmb.2007.R002; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Jayaswal V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp153; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Jopling CL, 2006, COLD SH Q B, V71, P369; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lionetti M, 2009, BLOOD, V114, pE20, DOI 10.1182/blood-2009-08-237495; Muniategui A, 2012, BRIEFINGS BIOINFORMA; Muniategui A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030766; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Pichiorri F, 2010, CANCER CELL, V18, P367, DOI 10.1016/j.ccr.2010.09.005; R Core Team, 2020, R LANG ENV STAT COMP; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Stingo FC, 2010, ANN APPL STAT, V4, P2024, DOI 10.1214/10-AOAS360; Teschendorff AE, 2005, BIOINFORMATICS, V21, P3025, DOI 10.1093/bioinformatics/bti466; Tokumoto M, 2011, J TOXICOL SCI, V36, P191, DOI 10.2131/jts.36.191; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Welling M, 2006, SIAM PROC S, P474; Winn JM, 2003, THESIS ST JOHNS COLL	39	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51480	10.1371/journal.pone.0051480	http://dx.doi.org/10.1371/journal.pone.0051480			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284698	gold, Green Published, Green Submitted			2022-12-27	WOS:000312694300027
J	Slekovec, C; Plantin, J; Cholley, P; Thouverez, M; Talon, D; Bertrand, X; Hocquet, D				Slekovec, Celine; Plantin, Julie; Cholley, Pascal; Thouverez, Michelle; Talon, Daniel; Bertrand, Xavier; Hocquet, Didier			Tracking Down Antibiotic-Resistant Pseudomonas aeruginosa Isolates in a Wastewater Network	PLOS ONE			English	Article							EXTENDED-SPECTRUM OXACILLINASES; FIELD GEL-ELECTROPHORESIS; METALLO-BETA-LACTAMASE; STRAINS; INDUCTION; PATTERNS; REVEALS	The Pseudomonas aeruginosa-containing wastewater released by hospitals is treated by wastewater treatment plants (WWTPs), generating sludge, which is used as a fertilizer, and effluent, which is discharged into rivers. We evaluated the risk of dissemination of antibiotic-resistant P. aeruginosa (AR-PA) from the hospital to the environment via the wastewater network. Over a 10-week period, we sampled weekly 11 points (hospital and urban wastewater, untreated and treated water, sludge) of the wastewater network and the river upstream and downstream of the WWTP of a city in eastern France. We quantified the P. aeruginosa load by colony counting. We determined the susceptibility to 16 antibiotics of 225 isolates, which we sorted into three categories (wild-type, antibiotic-resistant and multidrug-resistant). Extended-spectrum beta-lactamases (ESBLs) and metallo-beta-lactamases (MBLs) were identified by gene sequencing. All non-wild-type isolates (n = 56) and a similar number of wild-type isolates (n = 54) were genotyped by pulsed-field gel electrophoresis and multilocus sequence typing. Almost all the samples (105/110, 95.5%) contained P. aeruginosa, with high loads in hospital wastewater and sludge (>= 3 x 10(6) CFU/l or/kg). Most of the multidrug-resistant isolates belonged to ST235, CC111 and ST395. They were found in hospital wastewater and some produced ESBLs such as PER-1 and MBLs such as IMP-29. The WWTP greatly reduced P. aeruginosa counts in effluent, but the P. aeruginosa load in the river was nonetheless higher downstream than upstream from the WWTP. We conclude that the antibiotic-resistant P. aeruginosa released by hospitals is found in the water downstream from the WWTP and in sludge, constituting a potential risk of environmental contamination.	[Slekovec, Celine; Plantin, Julie; Cholley, Pascal; Thouverez, Michelle; Talon, Daniel; Bertrand, Xavier; Hocquet, Didier] CHU Besancon, Serv Hyg Hosp, F-25030 Besancon, France; [Slekovec, Celine; Plantin, Julie; Cholley, Pascal; Thouverez, Michelle; Talon, Daniel; Bertrand, Xavier; Hocquet, Didier] Univ Franche Comte, Unite Mixte Rech Chronoenvironm 6249, F-25030 Besancon, France	Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte	Hocquet, D (corresponding author), CHU Besancon, Serv Hyg Hosp, F-25030 Besancon, France.	dhocquet@univ-fcomte.fr	Bertrand, Xavier/AAK-3270-2021; Bertrand, Xavier/AAL-3809-2021; Hocquet, Didier/AAK-9107-2020	Bertrand, Xavier/0000-0002-8028-1396; Hocquet, Didier/0000-0002-4192-7238	University Hospital of Besancon	University Hospital of Besancon	The study was funded by the University Hospital of Besancon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BMR-Raisin network, 2010, MULT RES BACT SURV F; Cholley P, 2011, J CLIN MICROBIOL, V49, P2578, DOI 10.1128/JCM.00102-11; Curran B, 2004, J CLIN MICROBIOL, V42, P5644, DOI 10.1128/JCM.42.12.5644-5649.2004; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Hocquet D, 2003, ANTIMICROB AGENTS CH, V47, P1887, DOI 10.1128/AAC.47.6.1887-1894.2003; Hocquet D, 2007, ANTIMICROB AGENTS CH, V51, P3531, DOI 10.1128/AAC.00503-07; Hocquet D, 2011, J CLIN MICROBIOL, V49, P2262, DOI 10.1128/JCM.02585-10; Hocquet D, 2010, ANTIMICROB AGENTS CH, V54, P3512, DOI 10.1128/AAC.01646-09; Jeannot K, 2012, ANTIMICROB AGENTS CH, V56, P2187, DOI 10.1128/AAC.05838-11; Kerr KG, 2009, J HOSP INFECT, V73, P338, DOI 10.1016/j.jhin.2009.04.020; Khodursky AB, 1998, J BIOL CHEM, V273, P27668, DOI 10.1074/jbc.273.42.27668; LIAO XW, 1995, ANTIMICROB AGENTS CH, V39, P1871, DOI 10.1128/AAC.39.8.1871; Maatallah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025617; MACH PA, 1982, APPL ENVIRON MICROB, V44, P1395, DOI 10.1128/AEM.44.6.1395-1403.1982; Mesaros N, 2007, CLIN MICROBIOL INFEC, V13, P560, DOI 10.1111/j.1469-0691.2007.01681.x; Morita Y, 2003, J ANTIMICROB CHEMOTH, V51, P991, DOI 10.1093/jac/dkg173; Normark S, 1995, MICROB DRUG RESIST, V1, P111, DOI 10.1089/mdr.1995.1.111; Prado T, 2008, LETT APPL MICROBIOL, V46, P136, DOI 10.1111/j.1472-765X.2007.02275.x; Quinteira S, 2006, APPL ENVIRON MICROB, V72, P3743, DOI 10.1128/AEM.72.5.3743-3745.2006; Dinh QT, 2011, TALANTA, V85, P1238, DOI 10.1016/j.talanta.2011.05.013; Schouls LM, 2004, J BACTERIOL, V186, P5496, DOI 10.1128/JB.186.16.5496-5505.2004; Schwartz T, 2006, FEMS MICROBIOL ECOL, V57, P158, DOI 10.1111/j.1574-6941.2006.00100.x; Scotta C, 2011, ANTIMICROB AGENTS CH, V55, P5376, DOI 10.1128/AAC.00716-11; Strateva T, 2009, J MED MICROBIOL, V58, P1133, DOI 10.1099/jmm.0.009142-0; Talon D, 1996, J HOSP INFECT, V32, P135, DOI 10.1016/S0195-6701(96)90055-9; Tamtam F, 2009, ANAL BIOANAL CHEM, V393, P1709, DOI 10.1007/s00216-008-2576-9; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tumeo E, 2008, INT J HYG ENVIR HEAL, V211, P200, DOI 10.1016/j.ijheh.2007.02.010; Van Mansfeld R, 2009, J CLIN MICROBIOL, V47, P4096, DOI 10.1128/JCM.01462-09; Vettoretti L, 2009, EUR J CLIN MICROBIOL, V28, P1217, DOI 10.1007/s10096-009-0767-8; Yang CM, 2009, LETT APPL MICROBIOL, V48, P560, DOI 10.1111/j.1472-765X.2009.02572.x; YOSHIDA H, 1990, ANTIMICROB AGENTS CH, V34, P1273, DOI 10.1128/AAC.34.6.1273	32	62	62	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e49300	10.1371/journal.pone.0049300	http://dx.doi.org/10.1371/journal.pone.0049300			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284623	Green Published, Green Submitted, gold			2022-12-27	WOS:000312694300007
J	Reif, R; Qin, J; Shi, L; Dziennis, S; Zhi, ZW; Nuttall, AL; Wang, RK				Reif, Roberto; Qin, Jia; Shi, Lei; Dziennis, Suzan; Zhi, Zhongwei; Nuttall, Alfred L.; Wang, Ruikang K.			Monitoring Hypoxia Induced Changes in Cochlear Blood Flow and Hemoglobin Concentration Using a Combined Dual-Wavelength Laser Speckle Contrast Imaging and Doppler Optical Microangiography System	PLOS ONE			English	Article							CEREBRAL-ISCHEMIA; OXYGENATION; NOISE; MODEL; PERFUSION; VELOCITY	A synchronized dual-wavelength laser speckle contrast imaging (DWLSCI) system and a Doppler optical microangiography (DOMAG) system was developed to determine several ischemic parameters in the cochlea due to a systemic hypoxic challenge. DWLSCI can obtain two-dimensional data, and was used to determine the relative changes in cochlear blood flow, and change in the concentrations of oxyhemoglobin (HbO), deoxyhemoglobin (Hb) and total hemoglobin (HbT) in mice. DOMAG can obtain three-dimensional data, and was used to determine the changes in cochlear blood flow with single vessel resolution. It was demonstrated that during a hypoxic challenge there was an increase in the concentrations of Hb, a decrease in the concentrations of HbO and cochlear blood flow, and a slight decrease in the concentration of HbT. Also, the rate of change in the concentrations of Hb and HbO was quantified during and after the hypoxic challenge. The ability to simultaneously measure these ischemic parameters with high spatio-temporal resolution will allow the detailed quantitative analysis of several hearing disorders, and will be useful for diagnosing and developing treatments.	[Reif, Roberto; Qin, Jia; Shi, Lei; Dziennis, Suzan; Zhi, Zhongwei; Wang, Ruikang K.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Nuttall, Alfred L.] Oregon Hlth & Sci Univ, Sch Med, Oregon Hearing Res Ctr, Portland, OR 97201 USA	University of Washington; University of Washington Seattle; Oregon Health & Science University	Wang, RK (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.	wangrk@uw.edu	Wang, Ruikang/L-3889-2019; An, Lin/C-9923-2016; Zhi, Zhongwei/H-4175-2015	Wang, Ruikang/0000-0001-5169-8822; Zhi, Zhongwei/0000-0001-8995-7287	NIDCD [R01 DC010201, R01 DC000105, P30 DC005983]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010201, K23DC000105, P30DC005983, R01DC000105] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported in part by research grants from the NIDCD R01 DC010201 (RKW), R01 DC000105 (ALN) and P30 DC005983 (ALN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boas DA, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3285504; BONNER R, 1981, APPL OPTICS, V20, P2097, DOI 10.1364/AO.20.002097; Briers J D, 1996, J Biomed Opt, V1, P174, DOI 10.1117/12.231359; Cantos R, 2000, P NATL ACAD SCI USA, V97, P11707, DOI 10.1073/pnas.97.22.11707; Cheng HY, 2008, OPT EXPRESS, V16, P10214, DOI 10.1364/OE.16.010214; Choudhury N, 2010, IEEE J SEL TOP QUANT, V16, P524, DOI 10.1109/JSTQE.2009.2032671; Du CW, 2005, J CEREBR BLOOD F MET, V25, P1078, DOI 10.1038/sj.jcbfm.9600102; Duncan DD, 2008, J OPT SOC AM A, V25, P2088, DOI 10.1364/JOSAA.25.002088; Dunn AK, 2001, J CEREBR BLOOD F MET, V21, P195, DOI 10.1097/00004647-200103000-00002; Dunn AK, 2003, OPT LETT, V28, P28, DOI 10.1364/OL.28.000028; Dziennis S, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.10.106003; Fercher AF, 2003, REP PROG PHYS, V66, P239, DOI [10.1088/0034-4885/66/2/204, 10.2184/lsj.31.635]; HAWKINS JE, 1971, ANN OTO RHINOL LARYN, V80, P903, DOI 10.1177/000348947108000617; HULTCRANTZ E, 1979, ARCH OTO-RHINO-LARYN, V224, P103, DOI 10.1007/BF00455231; HULTCRANTZ E, 1979, ACTA PHYSIOL SCAND, V106, P29, DOI 10.1111/j.1748-1716.1979.tb06366.x; Jero J, 2001, HEARING RES, V151, P106, DOI 10.1016/S0378-5955(00)00216-1; Jones PB, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2950312; Kusaka T, 2003, OPT REV, V10, P466, DOI 10.1007/s10043-003-0466-0; Lamm K, 1996, Audiol Neurootol, V1, P148; Luo ZC, 2009, OPT LETT, V34, P1480, DOI 10.1364/OL.34.001480; MILLER JM, 1983, HEARING RES, V11, P385, DOI 10.1016/0378-5955(83)90069-2; MILLER JM, 1995, OTOLARYNG HEAD NECK, V112, P101, DOI 10.1016/S0194-5998(95)70308-X; Mom T, 2001, J ACOUST SOC AM, V110, P1477, DOI 10.1121/1.1390337; Mom T, 2005, FR ORL, V88, P81; NUTTALL AL, 1987, HEARING RES, V27, P111, DOI 10.1016/0378-5955(87)90012-8; Nuttall Alfred L., 1999, Noise Health, V2, P17; PERLMAN H B, 1959, Laryngoscope, V69, P591; PRAZMA J, 1983, ARCH OTOLARYNGOL, V109, P611; Qin J, 2012, OPT LETT, V37, P4005, DOI 10.1364/OL.37.004005; Qin J, 2012, BIOMED OPT EXPRESS, V3, P455, DOI 10.1364/BOE.3.000455; Ramirez-San-Juan JC, 2008, OPT EXPRESS, V16, P3197, DOI 10.1364/OE.16.003197; Ren TY, 1995, HEARING RES, V92, P30, DOI 10.1016/0378-5955(95)00192-1; Rosenberg M E, 1992, Br J Sports Med, V26, P161; SANTI PA, 1978, OTOLARYNG HEAD NECK, V86, P354, DOI 10.1177/019459987808600229; Shi XR, 2011, HEARING RES, V282, P10, DOI 10.1016/j.heares.2011.08.006; SINGH D, 1976, J LARYNGOL OTOL, V90, P1113, DOI 10.1017/S0022215100083201; Subhash HM, 2011, IEEE T MED IMAGING, V30, P224, DOI 10.1109/TMI.2010.2072934; THALMANN R, 1972, LARYNGOSCOPE, V82, P2249, DOI 10.1288/00005537-197212000-00013; THORNE PR, 1987, HEARING RES, V27, P1, DOI 10.1016/0378-5955(87)90021-9; Tominaga M, 2006, ACTA OTO-LARYNGOL, V126, P232, DOI 10.1080/00016480500316803; Wang RKK, 2010, IEEE J SEL TOP QUANT, V16, P545, DOI 10.1109/JSTQE.2009.2033609; Wang RK, 2009, OPT EXPRESS, V17, P8926, DOI 10.1364/OE.17.008926; Zhi ZW, 2011, BIOMED OPT EXPRESS, V2, P579, DOI 10.1364/BOE.2.000579	43	19	19	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52041	10.1371/journal.pone.0052041	http://dx.doi.org/10.1371/journal.pone.0052041			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272205	Green Published, gold, Green Submitted			2022-12-27	WOS:000312483300051
J	Zhang, X; Ung, CY; Lam, SH; Ma, J; Chen, YZ; Zhang, LX; Gong, ZY; Li, BW				Zhang, Xun; Ung, Choong Yong; Lam, Siew Hong; Ma, Jing; Chen, Yu Zong; Zhang, Louxin; Gong, Zhiyuan; Li, Baowen			Toxicogenomic Analysis Suggests Chemical-Induced Sexual Dimorphism in the Expression of Metabolic Genes in Zebrafish Liver	PLOS ONE			English	Article							GENDER-DIFFERENCES; SPOTTED-MICROARRAY; ACID-METABOLISM; BRAIN; DIFFERENTIATION; TESTOSTERONE; HORMONES; DRUGS; MICE	Differential gene expression in two sexes is widespread throughout the animal kingdom, giving rise to sex-dimorphic gene activities and sex-dependent adaptability to environmental cues, diets, growth and development as well as susceptibility to diseases. Here, we present a study using a toxicogenomic approach to investigate metabolic genes that show sex-dimorphic expression in the zebrafish liver triggered by several chemicals. Our analysis revealed that, besides the known genes for xenobiotic metabolism, many functionally diverse metabolic genes, such as ELOVL fatty acid elongase, DNA-directed RNA polymerase, and hydroxysteroid dehydrogenase, were also sex-dimorphic in their response to chemical treatments. Moreover, sex-dimorphic responses were also observed at the pathway level. Pathways belonging to xenobiotic metabolism, lipid metabolism, and nucleotide metabolism were enriched with sex-dimorphically expressed genes. We also observed temporal differences of the sex-dimorphic responses, suggesting that both genes and pathways are differently correlated during different periods of chemical perturbation. The ubiquity of sex-dimorphic activities at different biological hierarchies indicate the importance and the need of considering the sex factor in many areas of biological researches, especially in toxicology and pathology.	[Zhang, Xun; Ma, Jing; Chen, Yu Zong; Zhang, Louxin; Gong, Zhiyuan; Li, Baowen] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Zhang, Xun; Ma, Jing; Chen, Yu Zong; Li, Baowen] Natl Univ Singapore, Ctr Computat Sci & Engn, Singapore 117548, Singapore; [Ung, Choong Yong; Lam, Siew Hong; Gong, Zhiyuan] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Ung, Choong Yong; Zhang, Louxin] Natl Univ Singapore, Dept Math, Singapore 117548, Singapore; [Chen, Yu Zong] Natl Univ Singapore, Dept Pharm, Singapore 117548, Singapore; [Li, Baowen] Natl Univ Singapore, Dept Phys, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Zhang, X (corresponding author), Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore.	g0801800@nus.edu.sg; dbsgzy@nus.edu.sg	Zhang, Louxin/M-4865-2016; Lam, Siew Hong/H-8483-2012; Gong, Zhiyuan/H-8794-2012; Li, Baowen/G-3003-2011	Zhang, Louxin/0000-0003-0260-824X; Gong, Zhiyuan/0000-0002-9660-5260; Li, Baowen/0000-0002-8728-520X; Chen, Yu Zong/0000-0002-5473-8022	Singapore National Research Foundation; Environment & Water Industry Programme Office (EWI) of the PUB [R-154-000-328-272]; Ministry of Education of Singapore [MOE2009-T2-2-064]	Singapore National Research Foundation(National Research Foundation, Singapore); Environment & Water Industry Programme Office (EWI) of the PUB; Ministry of Education of Singapore(Ministry of Education, Singapore)	This work was supported by the Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research Programme and administered by the Environment & Water Industry Programme Office (EWI) of the PUB, grant number R-154-000-328-272. CYU is currently supported by Ministry of Education of Singapore Grant MOE2009-T2-2-064. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold AP, 2004, NAT REV NEUROSCI, V5, P701, DOI 10.1038/nrn1494; Bakker J, 2006, NAT NEUROSCI, V9, P220, DOI 10.1038/nn1624; BARDIN CW, 1981, SCIENCE, V211, P1285, DOI 10.1126/science.7010603; Begriche K, 2011, J HEPATOL, V54, P773, DOI 10.1016/j.jhep.2010.11.006; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Davies W, 2006, BRAIN RES, V1126, P36, DOI 10.1016/j.brainres.2006.09.105; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; De Leon-Nava MA, 2009, J STEROID BIOCHEM, V113, P57, DOI 10.1016/j.jsbmb.2008.11.003; Decsi T, 2011, AM J CLIN NUTR, V94, p1914S, DOI 10.3945/ajcn.110.000893; Dennis C, 2004, NATURE, V427, P390, DOI 10.1038/427390a; Enserink M, 2005, SCIENCE, V308, P1578, DOI 10.1126/science.308.5728.1578; Gochfeld M, 2007, ENVIRON RES, V104, P4, DOI 10.1016/j.envres.2005.12.005; Han E, 2009, INT J OBESITY, V33, P249, DOI 10.1038/ijo.2008.193; Holden C, 2005, SCIENCE, V308, P1574, DOI 10.1126/science.308.5728.1574; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; Horiuchi H, 2000, LIFE SCI, V66, P2051, DOI 10.1016/S0024-3205(00)00532-4; JOST A, 1970, PHILOS T ROY SOC B, V259, P119, DOI 10.1098/rstb.1970.0052; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Lam SH, 2006, NAT BIOTECHNOL, V24, P73, DOI 10.1038/nbt1169; Lam Siew Hong, 2009, V546, P175, DOI 10.1007/978-1-60327-977-2_12; Lam Siew Hong, 2009, V546, P197, DOI 10.1007/978-1-60327-977-2_13; Li ZB, 2007, PLOS BIOL, V5, P212, DOI 10.1371/journal.pbio.0050035; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Mittendorfer B, 2005, J NUTR, V135, P681, DOI 10.1093/jn/135.4.681; Mugford CA, 1998, DRUG METAB REV, V30, P441, DOI 10.3109/03602539808996322; Nicolson TJ, 2010, TRENDS PHARMACOL SCI, V31, P108, DOI 10.1016/j.tips.2009.12.001; NISHIDA Y, 1975, EXPERIENTIA, V31, P1134, DOI 10.1007/BF02326752; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; PHOENIX CH, 1959, ENDOCRINOLOGY, V65, P369, DOI 10.1210/endo-65-3-369; Robison BD, 2008, COMP BIOCHEM PHYS D, V3, P141, DOI 10.1016/j.cbd.2008.01.001; Santos EM, 2008, COMP BIOCHEM PHYS A, V149, P314, DOI 10.1016/j.cbpa.2008.01.010; Sreenivasan R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001791; Stromberg Anna, 2003, Eur J Cardiovasc Nurs, V2, P7; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Waxman D J, 2000, Novartis Found Symp, V227, P61; Waxman DJ, 2006, MOL ENDOCRINOL, V20, P2613, DOI 10.1210/me.2006-0007; Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705; Waxman DJ., 2000, NOVART FDN SYMP, V227, P75; Woods SC, 2003, EXP BIOL MED, V228, P1175; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Yang X, 2010, GENOME RES, V20, P1020, DOI 10.1101/gr.103341.109; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	42	4	4	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51971	10.1371/journal.pone.0051971	http://dx.doi.org/10.1371/journal.pone.0051971			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272195	gold, Green Submitted, Green Published			2022-12-27	WOS:000312483300044
J	Firnberg, E; Ostermeier, M				Firnberg, Elad; Ostermeier, Marc			PFunkel: Efficient, Expansive, User-Defined Mutagenesis	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; SCANNING MUTAGENESIS; PHENOTYPIC SELECTION; ESCHERICHIA-COLI; DNA; MUTATION; GALAXY; SCALE; GENE	We introduce PFunkel, a versatile method for extensive, researcher-defined DNA mutagenesis using a ssDNA or dsDNA template. Once the template DNA is prepared, the method can be completed in a single day in a single tube, and requires no intermediate DNA purification or sub-cloning. PFunkel can be used for site-directed mutagenesis at an efficiency approaching 100%. More importantly, PFunkel allows researchers the unparalleled ability to efficiently construct user-defined libraries. We demonstrate the creation of a library with site-saturation at four distal sites simultaneously at 70% efficiency. We also employ PFunkel to create a comprehensive codon mutagenesis library of the TEM-1 beta-lactamase gene. We designed this library to contain 18,081 members, one for each possible codon substitution in the gene (287 positions in TEM-1 x 63 possible codon substitutions). Deep sequencing revealed that similar to 97% of the designed single codon substitutions are present in the library. From such a library we identified 18 previously unreported adaptive mutations that each confer resistance to the beta-lactamase inhibitor tazobactam. Three of these mutations confer resistance equal to or higher than that of the most resistant reported TEM-1 allele and have the potential to emerge clinically.	[Firnberg, Elad; Ostermeier, Marc] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA	Johns Hopkins University	Ostermeier, M (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.	oster@jhu.edu	Ostermeier, Marc/A-2697-2010	Ostermeier, Marc/0000-0003-0900-3665	National Science Foundation [CBET-0828724, DEB-0950939]; Division Of Environmental Biology [0950939] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by funding from the National Science Foundation [CBET-0828724 and DEB-0950939 to M.O.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBLER RP, 1991, BIOCHEM J, V276, P269, DOI 10.1042/bj2760269; [Anonymous], QUIKCHANGE MULT DIR; [Anonymous], 2009, PFUTURBO CX HOTST DN; Araya CL, 2011, TRENDS BIOTECHNOL, V29, P435, DOI 10.1016/j.tibtech.2011.04.003; Baldwin AJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn358; Bi WL, 1998, ANAL BIOCHEM, V256, P137, DOI 10.1006/abio.1997.2516; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Denbigh KG, 1944, T FARADAY SOC, V40, P0352, DOI 10.1039/tf9444000352; Dominy Clifford N, 2003, Methods Mol Biol, V235, P209; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hames C, 2005, APPL ENVIRON MICROB, V71, P4097, DOI 10.1128/AEM.71.7.4097-4100.2005; Hogrefe HH, 2001, METHOD ENZYMOL, V334, P91; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Leung DW, 1989, TECHNIQUE, V1, P11; Liu J, 2012, PROTEIN ENG DES SEL, V25, P67, DOI 10.1093/protein/gzr060; Murakami H, 2002, NAT BIOTECHNOL, V20, P76, DOI 10.1038/nbt0102-76; Norholm MHH, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-21; Robin F, 2011, J ANTIMICROB CHEMOTH, V66, P1052, DOI 10.1093/jac/dkr045; Rogers S G, 1980, Methods Enzymol, V65, P201; Sambrook J., 2001, MOL CLONING LAB MANU; Scholle MD, 2005, COMB CHEM HIGH T SCR, V8, P545, DOI 10.2174/1386207054867337; Sohka T, 2009, P NATL ACAD SCI USA, V106, P10135, DOI 10.1073/pnas.0901246106; Stratagene, QUIKCHANGE SIT DIR M; TAYLOR AF, 1982, J BACTERIOL, V151, P351, DOI 10.1128/JB.151.1.351-357.1982; Trower M K, 1994, Methods Mol Biol, V31, P67; Vakulenko SB, 1998, ANTIMICROB AGENTS CH, V42, P1542, DOI 10.1128/AAC.42.7.1542; Wassman CD, 2004, NUCLEIC ACIDS RES, V32, P6407, DOI 10.1093/nar/gkh977; Weiss GA, 2000, P NATL ACAD SCI USA, V97, P8950, DOI 10.1073/pnas.160252097	34	80	86	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52031	10.1371/journal.pone.0052031	http://dx.doi.org/10.1371/journal.pone.0052031			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284860	gold, Green Submitted, Green Published			2022-12-27	WOS:000312435900070
J	Spinelli, KJ; Gillespie, PG				Spinelli, Kateri J.; Gillespie, Peter G.			Monitoring Intracellular Calcium Ion Dynamics in Hair Cell Populations with Fluo-4 AM	PLOS ONE			English	Article							MECHANOTRANSDUCER CHANNEL; MECHANICAL TRANSDUCTION; MAMMALIAN COCHLEA; TURTLE; RESTORATION; ADAPTATION; CA2+; RAT	We optimized Fluo-4 AM loading of chicken cochlea to report hair-bundle Ca2+ signals in populations of hair cells. The bundle Ca2+ signal reported the physiological state of the bundle and cell; extruding cells had very high bundle Fluo-4 fluorescence, cells with intact bundles and tip links had intermediate fluorescence, and damaged cells with broken tip links had low fluorescence. Moreover, Fluo-4 fluorescence in the bundle correlated with Ca2+ entry through transduction channels; mechanically activating transduction channels increased the Fluo-4 signal, while breaking tip links with Ca2+ chelators or blocking Ca2+ entry through transduction channels each caused bundle and cell-body Fluo-4 fluorescence to decrease. These results show that when tip links break, bundle and soma Ca2+ decrease, which could serve to stimulate the hair cell's tip-link regeneration process. Measurement of bundle Ca2+ with Fluo-4 AM is therefore a simple method for assessing mechanotransduction in hair cells and permits an increased understanding of the interplay of tip links, transduction channels, and Ca2+ signaling in the hair cell.	[Gillespie, Peter G.] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Gillespie, PG (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA.	gillespp@ohsu.edu		Spinelli, Kateri/0000-0002-6290-0886; Barr-Gillespie, Peter/0000-0002-9787-5860	National Institutes of Health [F31 DC10107, R01 DC002368, P30 DC005983]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005983, R01DC002368, F31DC010107] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health grants F31 DC10107 (to KJS), R01 DC002368 (to PGG), and P30 DC005983 (to PGG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; Auer M, 2008, JARO-J ASSOC RES OTO, V9, P215, DOI 10.1007/s10162-008-0114-2; Beurg M, 2010, J NEUROPHYSIOL, V104, P18, DOI 10.1152/jn.00019.2010; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; Bortolozzi M, 2010, J BIOL CHEM, V285, P37693, DOI 10.1074/jbc.M110.170092; COREY DP, 1983, J NEUROSCI, V3, P962; COREY DP, 1979, NATURE, V281, P675, DOI 10.1038/281675a0; CRAWFORD AC, 1991, J PHYSIOL-LONDON, V434, P369, DOI 10.1113/jphysiol.1991.sp018475; Crumling MA, 2009, NEUROSCIENCE, V161, P1144, DOI 10.1016/j.neuroscience.2009.02.076; EATOCK RA, 1987, J NEUROSCI, V7, P2821; Farris HE, 2004, J PHYSIOL-LONDON, V558, P769, DOI 10.1113/jphysiol.2004.061267; Fettiplace R, 1999, ANNU REV PHYSIOL, V61, P809, DOI 10.1146/annurev.physiol.61.1.809; Ficarella R, 2007, P NATL ACAD SCI USA, V104, P1516, DOI 10.1073/pnas.0609775104; Frolenkov Gregory I., 2009, V493, P381, DOI 10.1007/978-1-59745-523-7_23; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; Glowatzki E, 2008, CURR OPIN NEUROBIOL, V18, P389, DOI 10.1016/j.conb.2008.09.006; Griesinger CB, 2004, EUR J NEUROSCI, V20, P41, DOI 10.1111/j.0953-816X.2004.03452.x; Griesinger CB, 2002, J NEUROSCI, V22, P3939, DOI 10.1523/JNEUROSCI.22-10-03939.2002; Johnson SL, 2011, NEURON, V70, P1143, DOI 10.1016/j.neuron.2011.04.024; Kennedy HJ, 2003, NAT NEUROSCI, V6, P832, DOI 10.1038/nn1089; Lumpkin EA, 1998, J NEUROSCI, V18, P6300; Meyers JR, 2003, J NEUROSCI, V23, P4054; Raybould NP, 2007, J PHYSIOL-LONDON, V579, P101, DOI 10.1113/jphysiol.2006.122929; Ricci AJ, 1998, J PHYSIOL-LONDON, V506, P159, DOI 10.1111/j.1469-7793.1998.159bx.x; Schwander M, 2010, J CELL BIOL, V190, P9, DOI 10.1083/jcb.201001138; Shin JB, 2007, NEURON, V53, P371, DOI 10.1016/j.neuron.2006.12.021; Spinelli KJ, 2012, P NATL ACAD SCI USA, V109, pE268, DOI 10.1073/pnas.1115866109; Yuan T, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3290799; Zhao YD, 1996, P NATL ACAD SCI USA, V93, P15469, DOI 10.1073/pnas.93.26.15469	29	25	25	5	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51874	10.1371/journal.pone.0051874	http://dx.doi.org/10.1371/journal.pone.0051874			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284798	Green Published, gold, Green Submitted			2022-12-27	WOS:000312435900061
J	Wallner, B; Fieder, M; Seidler, H				Wallner, Bernard; Fieder, Martin; Seidler, Horst			Ownership of Dwelling Affects the Sex Ratio at Birth in Uganda	PLOS ONE			English	Article							TRIVERS-WILLARD; MATERNAL AGE; MOTHERS; DETERMINANTS; ASSOCIATION; FERTILITY; POLYGYNY; PARITY; ORDER; TIME	Background: Socio-economic conditions can affect the secondary sex ratio in humans. Mothers under good environmental conditions are predicted to increase the birth rates of sons according to the Trivers-Willard hypothesis (TWH). This study analyzed the effects of ownership and non-ownership of dwellings on the sex ratio at birth (SRB) on a Ugandan sample. Methodology/Principal Findings: Our investigation included 438,640 mothers aged between 12 and 54 years. The overall average SRB was 0.5008. Mothers who live in owned dwellings gave increased births to sons (0.5019) compared to those who live in non-owned dwellings (0.458). Multivariate statistics revealed the strongest effects of dwelling ownership when controlling for demographic and social variables such as marital status, type of marriage, mothers' age, mothers' education, parity and others. Conclusions/Significance: The results are discussed in the framework of recent plausible models dealing with the adjustment of the sex ratio. We conclude that the aspect of dwelling status could represent an important socio-economic parameter in relation to SRB variations in humans if further studies are able to analyze it between different countries in a comparative way.	[Wallner, Bernard; Fieder, Martin; Seidler, Horst] Univ Vienna, Dept Anthropol, Vienna, Austria; [Wallner, Bernard] Univ Vienna, Dept Behav Biol, Vienna, Austria; [Wallner, Bernard] Univ Vienna, Cognit Sci Res Platform, Vienna, Austria	University of Vienna; University of Vienna; University of Vienna	Wallner, B (corresponding author), Univ Vienna, Dept Anthropol, Vienna, Austria.	bernard.wallner@univie.ac.at	Wallner, Bernard/B-1089-2009	wallner, bernard/0000-0002-1089-7443				Almond D, 2007, P ROY SOC B-BIOL SCI, V274, P2491, DOI 10.1098/rspb.2007.0524; Barber N, 2004, SOC BIOL, V51, P71; Cameron EZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004195; Catalano R, 2005, INT J EPIDEMIOL, V34, P944, DOI 10.1093/ije/dyi081; Catalano RA, 2003, HUM REPROD, V18, P1972, DOI 10.1093/humrep/deg370; ChaconPuignau GC, 1996, SOC BIOL, V43, P257; CHAHNAZARIAN A, 1988, SOC BIOL, V35, P214; ChartsBin statistics collector team, 2011, WORLDW HUM SEX RAT B; Curtis MA, 2010, SOC SCI MED, V71, P2049, DOI 10.1016/j.socscimed.2010.09.034; ERICKSON JD, 1976, ANN HUM GENET, V40, P205, DOI 10.1111/j.1469-1809.1976.tb00182.x; Fukuda M, 1998, HUM REPROD, V13, P2321, DOI 10.1093/humrep/13.8.2321; Garenne M, 2008, HUM BIOL, V80, P473, DOI 10.3378/1534-6617-80.5.473; Garenne M, 2009, J BIOSOC SCI, V41, P399, DOI 10.1017/S0021932008003106; Gibson MA, 2003, P ROY SOC B-BIOL SCI, V270, pS108, DOI 10.1098/rsbl.2003.0031; Grant V. J., 2003, EVOL PSYCHOL, V1, P96, DOI [10.1177/147470490300100106, DOI 10.1177/147470490300100106, DOI 10.1177/]; Grant V. J., 1998, MATERNAL PERSONALITY; Grant VJ, 2011, ANIM BEHAV, V82, P893, DOI 10.1016/j.anbehav.2011.07.029; GUERRERO R, 1974, NEW ENGL J MED, V291, P1056, DOI 10.1056/NEJM197411142912004; Helle S, 2002, SCIENCE, V296, P1085, DOI 10.1126/science.1070106; Helle S, 2008, BIOL LETTERS, V4, P60, DOI 10.1098/rsbl.2007.0482; IMAIZUMI Y, 1979, ANN HUM GENET, V42, P457, DOI 10.1111/j.1469-1809.1979.tb00679.x; Jacobsen R, 1999, HUM REPROD, V14, P3120, DOI 10.1093/humrep/14.12.3120; JAMES WH, 1985, J BIOSOC SCI, V17, P47, DOI 10.1017/S0021932000015467; JAMES WH, 1987, HUM BIOL, V59, P721; James WH, 2001, HUM REPROD, V16, P2246, DOI 10.1093/humrep/16.10.2246; James WH, 2010, J BIOSOC SCI, V42, P587, DOI 10.1017/S002193201000012X; JOHNSON NE, 1984, J BIOSOC SCI, V16, P531, DOI 10.1017/S0021932000015352; Kulu H, 2007, DEMOGR RES, V17, P775, DOI 10.4054/DemRes.2007.17.26; Lazarus J, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P287, DOI 10.1017/CBO9780511542053.015; MACKEY WC, 1987, ETHOL SOCIOBIOL, V8, P49, DOI 10.1016/0162-3095(87)90057-4; Martina John F, 2008, Biodemography Soc Biol, V54, P141, DOI 10.1080/19485565.2008.9989139; Mulder CH, 2001, EUR J POPUL, V17, P137, DOI 10.1023/A:1010706308868; Norton HW, 1940, J HERED, V31, P29, DOI 10.1093/oxfordjournals.jhered.a104788; Owen D, 2003, ENDOCRINOLOGY, V144, P2775, DOI 10.1210/en.2002-0145; Pollet TV, 2009, BIOL LETTERS, V5, P765, DOI 10.1098/rsbl.2009.0394; Ruckstuhl KE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-269; Scahfer K, 1999, COLLEGIUM ANTROPOL, V23, P369; Stein AD, 2004, P ROY SOC B-BIOL SCI, V271, pS37, DOI 10.1098/rsbl.2003.0086; TEITELBAUM MS, 1971, J BIOSOC SCI, V3, P23, DOI 10.1017/S0021932000007793; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Wallner B, 2005, NEUROENDOCRINOL LETT, V26, P759; WHITING JWM, 1993, AM ANTHROPOL, V95, P435, DOI 10.1525/aa.1993.95.2.02a00090; Wilson K, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P48, DOI 10.1017/CBO9780511542053.004; ZALDIVAR ME, 1991, HUM ECOL, V19, P469, DOI 10.1007/BF00889791	44	7	7	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51463	10.1371/journal.pone.0051463	http://dx.doi.org/10.1371/journal.pone.0051463			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055RZ	23284697	Green Submitted, gold, Green Published			2022-12-27	WOS:000312435900021
J	Vezzi, F; Narzisi, G; Mishra, B				Vezzi, Francesco; Narzisi, Giuseppe; Mishra, Bud			Reevaluating Assembly Evaluations with Feature Response Curves: GAGE and Assemblathons	PLOS ONE			English	Article							READ ALIGNMENT	In just the last decade, a multitude of bio-technologies and software pipelines have emerged to revolutionize genomics. To further their central goal, they aim to accelerate and improve the quality of de novo whole-genome assembly starting from short DNA sequences/reads. However, the performance of each of these tools is contingent on the length and quality of the sequencing data, the structure and complexity of the genome sequence, and the resolution and quality of long-range information. Furthermore, in the absence of any metric that captures the most fundamental "features'' of a high-quality assembly, there is no obvious recipe for users to select the most desirable assembler/assembly. This situation has prompted the scientific community to rely on crowd-sourcing through international competitions, such as Assemblathons or GAGE, with the intention of identifying the best assembler(s) and their features. Somewhat circuitously, the only available approach to gauge de novo assemblies and assemblers relies solely on the availability of a high-quality fully assembled reference genome sequence. Still worse, reference-guided evaluations are often both difficult to analyze, leading to conclusions that are difficult to interpret. In this paper, we circumvent many of these issues by relying upon a tool, dubbed FRCbam, which is capable of evaluating de novo assemblies from the read-layouts even when no reference exists. We extend the FRCurve approach to cases where lay-out information may have been obscured, as is true in many deBruijn-graph-based algorithms. As a by-product, FRCurve now expands its applicability to a much wider class of assemblers - thus, identifying higher-quality members of this group, their inter-relations as well as sensitivity to carefully selected features, with or without the support of a reference sequence or layout for the reads. The paper concludes by reevaluating several recently conducted assembly competitions and the datasets that have resulted from them.	[Vezzi, Francesco] KTH Royal Inst Technol, Sci Life Lab, Sch Comp Sci & Commun, Solna, Sweden; [Narzisi, Giuseppe; Mishra, Bud] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Mishra, Bud] NYU, Courant Inst Math Sci, New York, NY USA; [Mishra, Bud] NYU, Sch Med, New York, NY USA	Royal Institute of Technology; Cold Spring Harbor Laboratory; New York University; New York University	Vezzi, F (corresponding author), KTH Royal Inst Technol, Sci Life Lab, Sch Comp Sci & Commun, Solna, Sweden.	francesco.vezzi@scilifelab.se			Knut and Alice Wallenberg Foundation; National Science Foundation (NSF) Cyber-Enabled Discovery and Innovation (CDI) grant; NSF CDI grant; NSF Expedition in Computing grant	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); National Science Foundation (NSF) Cyber-Enabled Discovery and Innovation (CDI) grant(National Science Foundation (NSF)); NSF CDI grant; NSF Expedition in Computing grant	The work was partially supported by Knut and Alice Wallenberg Foundation and by a National Science Foundation (NSF) Cyber-Enabled Discovery and Innovation (CDI) grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank all the Spruce Assembly Project, in particular Prof. Lars Arvestad, Bjorn Nystedt and Nathaniel Street for their constant feedback and advice. We also wish to thank Vadim Sapiro of OpGen, LLC., Mike Schatz of Cold Spring Harbor Lab, Mihai Pop of of JohnsHopkins University and Adam Phillipy of National Biodefense Analysis and Countermeasures Center for many useful comments on an initial draft of the paper. Moreover, FV would like to thank Knut and Alice Wallenberg Foundation for their support. The research reported in this paper was partially supported by NSF CDI and Expedition in Computing grants.	Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Anantharaman TS, 1997, J COMPUT BIOL, V4, P91, DOI 10.1089/cmb.1997.4.91; Anantharaman TS., 1997, GENOMICS VIA OPTICAL, P18; BRODY H, 1991, NUCLEIC ACIDS RES, V19, P3105, DOI 10.1093/nar/19.11.3105; Earl DA., 2011, GENOME RES; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Miller Jim Wayne, 2010, GENOMICS, P1; Nagarajan N, 2009, J COMPUT BIOL, V16, P897, DOI 10.1089/cmb.2009.0005; Narzisi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019175; Narzisi G, 2011, BIOINFORMATICS, V27, P153, DOI 10.1093/bioinformatics/btq646; Phillippy AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r55; Reinhardt J, 2008, GENOME; Salzberg SL, 2011, GENOME RES; Semple CAM, 2003, ASSEMBLING VIEW HUMA, P93, DOI [10.1002/0470867302.ch5, DOI 10.1002/0470867302.CH5]; Vezzi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031002; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zimin AV, 2008, BIOINFORMATICS, V24, P42, DOI 10.1093/bioinformatics/btm542	19	65	65	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52210	10.1371/journal.pone.0052210	http://dx.doi.org/10.1371/journal.pone.0052210			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23284938	Green Submitted, Green Published, gold			2022-12-27	WOS:000313051500024
J	Zhang, QW; Liu, L; Gong, CY; Shi, HS; Zeng, YH; Wang, XZ; Zhao, YW; Wei, YW				Zhang, Qiong-wen; Liu, Lei; Gong, Chang-yang; Shi, Hua-shan; Zeng, Yun-hui; Wang, Xiao-ze; Zhao, Yu-wei; Wei, Yu-quan			Prognostic Significance of Tumor-Associated Macrophages in Solid Tumor: A Meta-Analysis of the Literature	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; ENDOTHELIAL GROWTH-FACTOR; HUMAN PROSTATE-CANCER; INFILTRATING MACROPHAGES; HEPATOCELLULAR-CARCINOMA; THYMIDINE PHOSPHORYLASE; FAVORABLE PROGNOSIS; GASTRIC-CANCER; CHEMOATTRACTANT PROTEIN-1; SIGNIFICANT PREDICTOR	Purpose: Tumor associated macrophages (TAMs) are considered with the capacity to have both negative and positive effects on tumor growth. The prognostic value of TAM for survival in patients with solid tumor remains controversial. Experimental Design: We conducted a meta-analysis of 55 studies (n = 8,692 patients) that evaluated the correlation between TAM (detected by immunohistochemistry) and clinical staging, overall survival (OS) and disease free survival (DFS). The impact of M1 and M2 type TAM (n = 5) on survival was also examined. Results: High density of TAM was significantly associated with late clinical staging in patients with breast cancer [risk ratio (RR) = 1.20 (95% confidence interval (CI), 1.14-1.28)] and bladder cancer [RR = 3.30 (95% CI, 1.56-6.96)] and with early clinical staging in patients with ovarian cancer [RR = 0.52 (95% CI, 0.35-0.77)]. Negative effects of TAM on OS was shown in patients with gastric cancer [RR = 1.64 (95% CI, 1.24-2.16)], breast cancer [RR = 8.62 (95% CI, 3.10-23.95)], bladder cancer [RR = 5.00 (95% CI, 1.98-12.63)], ovarian cancer [RR = 2.55 (95% CI, 1.60-4.06)], oral cancer [RR = 2.03 (95% CI, 1.47-2.80)] and thyroid cancer [RR = 2.72 (95% CI, 1.26-5.86)], and positive effects was displayed in patients with colorectal cancer [RR = 0.64 (95% CI, 0.43-0.96)]. No significant effect was showed between TAM and DFS. There was also no significant effect of two phenotypes of TAM on survival. Conclusions: Although some modest bias cannot be excluded, high density of TAM seems to be associated with worse OS in patients with gastric cancer, urogenital cancer and head and neck cancer, with better OS in patients with colorectal cancer.	[Zhang, Qiong-wen; Liu, Lei; Gong, Chang-yang; Shi, Hua-shan; Zeng, Yun-hui; Wang, Xiao-ze; Zhao, Yu-wei; Wei, Yu-quan] Sichuan Univ, W China Hosp, Ctr Canc, Dept Med Oncol,State Key Lab Biotherapy, Chengdu 610064, Peoples R China	Sichuan University	Liu, L (corresponding author), Sichuan Univ, W China Hosp, Ctr Canc, Dept Med Oncol,State Key Lab Biotherapy, Chengdu 610064, Peoples R China.	liuleiliulei2012@gmail.com		Zhang, Qiongwen/0000-0003-2033-6663; Shi, Hua-shan/0000-0002-9958-9892	National Natural Science Foundation of China [NSFC 81101729]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by National Natural Science Foundation of China (NSFC 81101729). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSHIBLI IK, 2009, VIRCHOWS ARCH S1, V455, P85; Avila-Moreno F, 2006, CANCER IMMUNOL IMMUN, V55, P598, DOI 10.1007/s00262-005-0060-3; Bacman D, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-156; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Bolat F, 2006, J EXP CLIN CANC RES, V25, P365; BONTA IL, 1993, J LEUKOCYTE BIOL, V54, P613, DOI 10.1002/jlb.54.6.613; Burt BM, 2011, CANCER-AM CANCER SOC, V117, P5234, DOI 10.1002/cncr.26143; Chai CY, 2008, J CLIN PATHOL, V61, P658, DOI 10.1136/jcp.2007.050666; Chen JJW, 2005, J CLIN ONCOL, V23, P953, DOI 10.1200/JCO.2005.12.172; Ding T, 2009, HUM PATHOL, V40, P381, DOI 10.1016/j.humpath.2008.08.011; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Espinosa I, 2011, AM J PATHOL, V179, P2100, DOI 10.1016/j.ajpath.2011.06.021; Espinosa I, 2010, AM J SURG PATHOL, V34, P1708, DOI 10.1097/PAS.0b013e3181f32168; Forssell J, 2007, CLIN CANCER RES, V13, P1472, DOI 10.1158/1078-0432.CCR-06-2073; Fujii N, 2012, J ORAL PATHOL MED; Fujimoto H, 2009, INT J CANCER, V125, P1276, DOI 10.1002/ijc.24378; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Haas M, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-65; Hanada T, 2000, INT J UROL, V7, P263, DOI 10.1046/j.1442-2042.2000.00190.x; Hashimoto I, 2000, ANTICANCER RES, V20, P4853; Hasita H, 2010, CANCER SCI, V101, P1913, DOI 10.1111/j.1349-7006.2010.01614.x; Heller DS, 2003, INT J GYNECOL CANCER, V13, P67, DOI 10.1046/j.1525-1438.2003.13035.x; Heusinkveld M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-216; Ishigami S, 2003, ANTICANCER RES, V23, P4079; Ju MJ, 2009, AM J CLIN PATHOL, V131, P498, DOI 10.1309/AJCP86PPBNGOHNNL; Kawahara A, 2010, ONCOL REP, V24, P405, DOI 10.3892/or_00000873; Kawai O, 2008, CANCER-AM CANCER SOC, V113, P1387, DOI 10.1002/cncr.23712; Kawanaka T, 2008, J MED INVESTIG, V55, P78, DOI 10.2152/jmi.55.78; Khorana AA, 2003, CANCER, V97, P960, DOI 10.1002/cncr.11152; Koide N, 2002, DIS ESOPHAGUS, V15, P67, DOI 10.1046/j.1442-2050.2002.00223.x; Kuang DM, 2009, J EXP MED, V206, P1327, DOI 10.1084/jem.20082173; Kurahara H, 2012, ANN SURG ONCOL; Leek RD, 1996, CANCER RES, V56, P4625; Li YW, 2009, J CANCER RES CLIN, V135, P439, DOI 10.1007/s00432-008-0469-0; Liguori Manuela, 2011, Cancers (Basel), V3, P3740, DOI 10.3390/cancers3043740; Lin Jia-Ying, 2011, Chin J Cancer, V30, P280; Lissbrant IF, 2000, INT J ONCOL, V17, P445; Liu SY, 2008, ORAL ONCOL, V44, P277, DOI 10.1016/j.oraloncology.2007.02.007; Ma JL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-112; Mahmoud SMA, 2012, J CLIN PATHOL, V65, P159, DOI 10.1136/jclinpath-2011-200355; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; MANTOVANI A, 1994, LAB INVEST, V71, P5; Mantovuni BB, 1992, IMMUNOL TODAY, V13, P2; Marcus B, 2004, CANCER-AM CANCER SOC, V101, P2779, DOI 10.1002/cncr.20701; Nesbit M, 2001, J IMMUNOL, V166, P6483, DOI 10.4049/jimmunol.166.11.6483; Nonomura N, 2011, BJU INT, V107, P1918, DOI 10.1111/j.1464-410X.2010.09804.x; Ohba K, 2005, J UROLOGY, V174, P461, DOI 10.1097/01.ju.0000165150.46006.92; Ohno S, 2004, ANTICANCER RES, V24, P3335; Ohno S, 2003, ANTICANCER RES, V23, P5015; Ohri CM, 2009, EUR RESPIR J, V33, P118, DOI 10.1183/09031936.00065708; Ohtaki Y, 2010, J THORAC ONCOL, V5, P1507, DOI 10.1097/JTO.0b013e3181eba692; Oosterling SJ, 2005, J PATHOL, V207, P147, DOI 10.1002/path.1830; Osinsky S, 2011, CLIN TRANSL ONCOL, V13, P133, DOI 10.1007/s12094-011-0630-0; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Peng Juan, 2006, Ai Zheng, V25, P1340; Ryder M, 2008, ENDOCR-RELAT CANCER, V15, P1069, DOI 10.1677/ERC-08-0036; Guo SJ, 2007, DIS ESOPHAGUS, V20, P107, DOI 10.1111/j.1442-2050.2007.00655.x; Salvesen HB, 1999, INT J CANCER, V84, P539; Shimura S, 2000, CANCER RES, V60, P5857; Sickert D, 2005, HISTOPATHOLOGY, V46, P515, DOI 10.1111/j.1365-2559.2005.02129.x; SIMON R, 1994, BRIT J CANCER, V69, P979, DOI 10.1038/bjc.1994.192; Siveen KS, 2009, IMMUNOL LETT, V123, P97, DOI 10.1016/j.imlet.2009.02.011; Soeda S, 2008, GYNECOL ONCOL, V109, P122, DOI 10.1016/j.ygyno.2007.12.033; STEWART LA, 1993, LANCET, V341, P418, DOI 10.1016/0140-6736(93)93004-K; Takanami I, 1999, ONCOLOGY-BASEL, V57, P138, DOI 10.1159/000012021; Takayama H, 2009, J UROLOGY, V181, P1894, DOI 10.1016/j.juro.2008.11.090; Tan SY, 2005, WORLD J GASTROENTERO, V11, P1210, DOI 10.3748/wjg.v11.i8.1210; Tanaka Y, 2004, GYNECOL ONCOL, V94, P725, DOI 10.1016/j.ygyno.2004.06.012; Toi M, 1999, CLIN CANCER RES, V5, P1131; Ueno T, 2000, CLIN CANCER RES, V6, P3282; Umemura N, 2008, J LEUKOCYTE BIOL, V83, P1136, DOI 10.1189/jlb.0907611; Valkovic T, 1998, PATHOL RES PRACT, V194, P335, DOI 10.1016/S0344-0338(98)80057-5; Valkovic T, 2002, VIRCHOWS ARCH, V440, P583, DOI 10.1007/s004280100458; Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015; Virchow R., 1863, KRANKHAFTEN GESCHWUL, P57; Wan Ting, 2009, Ai Zheng, V28, P323; Wang R, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-62; Welsh TJ, 2005, J CLIN ONCOL, V23, P8959, DOI 10.1200/JCO.2005.01.4910; XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522; Zeni E, 2007, EUR RESPIR J, V30, P627, DOI 10.1183/09031936.00129306; Zhang BC, 2011, MED ONCOL, V28, P1447, DOI 10.1007/s12032-010-9638-5; Zhou Q, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-13; Zhu XD, 2008, J CLIN ONCOL, V26, P2707, DOI 10.1200/JCO.2007.15.6521	84	590	602	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e50946	10.1371/journal.pone.0050946	http://dx.doi.org/10.1371/journal.pone.0050946			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23284651	Green Submitted, gold, Green Published			2022-12-27	WOS:000313051500006
J	Le Gall, SM; Legrand, J; Benbijja, M; Safya, H; Benihoud, K; Kanellopoulos, JM; Bobe, P				Le Gall, Sylvain M.; Legrand, Julie; Benbijja, Mohcine; Safya, Hanaa; Benihoud, Karim; Kanellopoulos, Jean M.; Bobe, Pierre			Loss of P2X7 Receptor Plasma Membrane Expression and Function in Pathogenic B220(+) Double-Negative T Lymphocytes of Autoimmune MRL/lpr Mice	PLOS ONE			English	Article							MRL HEMATOPOIETIC CHIMERAS; P2X(7) RECEPTOR; CELL-ACTIVATION; L-SELECTIN; IMMUNE SUPPRESSION; CUTTING EDGE; ATP RELEASE; IN-VIVO; FAS; APOPTOSIS	Lupus is a chronic inflammatory autoimmune disease influenced by multiple genetic loci including Fas Ligand (FasL) and P2X7 receptor (P2X7R). The Fas/Fas Ligand apoptotic pathway is critical for immune homeostasis and peripheral tolerance. Normal effector T lymphocytes up-regulate the transmembrane tyrosine phosphatase B220 before undergoing apoptosis. Fas-deficient MRL/lpr mice (lpr mutation) exhibit lupus and lymphoproliferative syndromes due to the massive accumulation of B220(+) CD4(-)CD8(-) (DN) T lymphocytes. The precise ontogeny of B220(+) DN T cells is unknown. B220(+) DN T lymphocytes could be derived from effector CD4(+) and CD8(+) T lymphocytes, which have not undergone activation-induced cell death due to inactivation of Fas, or from a special cell lineage. P2X7R is an extracellular ATP-gated cell membrane receptor involved in the release of proinflammatory cytokines and TNFR1/Fas-independent cell death. P2X7R also regulate early signaling events involved in T-cell activation. We show herein that MRL/lpr mice carry a P2X7R allele, which confers a high sensitivity to ATP. However, during aging, the MRL/lpr T-cell population exhibits a drastically reduced sensitivity to ATP- or NAD-mediated stimulation of P2X7R, which parallels the increase in B220(+) DN T-cell numbers in lymphoid organs. Importantly, we found that this B220(+) DN T-cell subpopulation has a defect in P2X7R-mediated responses. The few B220(+) T cells observed in normal MRL+/+ and C57BL/6 mice are also resistant to ATP or NAD treatment. Unexpectedly, while P2X7R mRNA and proteins are present inside of B220(+) T cells, P2X7R are undetectable on the plasma membrane of these T cells. Our results prompt the conclusion that cell surface expression of B220 strongly correlates with the negative regulation of the P2X7R pathway in T cells.	[Le Gall, Sylvain M.; Benbijja, Mohcine; Safya, Hanaa; Bobe, Pierre] Univ Paris Diderot, CNRS, Inst Jacques Monod, Paris, France; [Legrand, Julie; Benbijja, Mohcine; Bobe, Pierre] Univ Paris 11, CNRS, Inst Andre Lwoff, Villejuif, France; [Benihoud, Karim] Univ Paris 11, CNRS, Inst Gustave Roussy, UMR 8203, Villejuif, France; [Kanellopoulos, Jean M.] Univ Paris 11, CNRS, Inst Biochim & Biophys Mol & Cellulaire, UMR 8619, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Bobe, P (corresponding author), Univ Paris Diderot, CNRS, Inst Jacques Monod, Paris, France.	pierre.bobe@u-psud.fr	, BENIHOUD/O-4334-2019	Bobe, Pierre/0000-0002-8835-6786	Centre Nationale de la Recherche Scientifique; Agence Nationale de la Recherche [ANR-07-BLAN-0089-02]	Centre Nationale de la Recherche Scientifique; Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was funded by the Centre Nationale de la Recherche Scientifique and grants from Agence Nationale de la Recherche (ANR-07-BLAN-0089-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI M, 1995, NAT GENET, V11, P294, DOI 10.1038/ng1195-294; Adriouch S, 2002, J IMMUNOL, V169, P4108, DOI 10.4049/jimmunol.169.8.4108; Aswad F, 2005, J IMMUNOL, V175, P3075, DOI 10.4049/jimmunol.175.5.3075; Auger R, 2005, J BIOL CHEM, V280, P28142, DOI 10.1074/jbc.M501290200; Benihoud K, 2002, ONCOGENE, V21, P5593, DOI 10.1038/sj.onc.1205730; Benihoud K, 1997, EUR J IMMUNOL, V27, P415, DOI 10.1002/eji.1830270211; Bidere N, 2006, ANNU REV IMMUNOL, V24, P321, DOI 10.1146/annurev.immunol.24.021605.090513; Bleesing JJH, 2001, CELL IMMUNOL, V213, P72, DOI 10.1006/cimm.2001.1865; Bobe P, 1997, J IMMUNOL, V159, P4197; Bobe P, 2006, BLOOD, V108, P3967, DOI 10.1182/blood-2006-04-020610; Bonardelle D, 2005, J LEUKOCYTE BIOL, V78, P1052, DOI 10.1189/jlb.0904536; Bonardelle D, 2001, J RHEUMATOL, V28, P956; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Brooks WP, 2001, CELL IMMUNOL, V212, P24, DOI 10.1006/cimm.2001.1845; Colomar A, 2003, J BIOL CHEM, V278, P30732, DOI 10.1074/jbc.M304534200; Coutinho-Silva R, 2003, IMMUNITY, V19, P403, DOI 10.1016/S1074-7613(03)00235-8; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Elliott JI, 2005, ARTHRITIS RES THER, V7, pR468, DOI 10.1186/ar1699; Elliott JI, 2005, NAT CELL BIOL, V7, P808, DOI 10.1038/ncb1279; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Ford MS, 2002, J EXP MED, V196, P261, DOI 10.1084/jem.20020029; GIESE T, 1992, J IMMUNOL, V149, P3097; Gonnord P, 2009, FASEB J, V23, P795, DOI 10.1096/fj.08-114637; Gu B, 1998, BLOOD, V92, P946; Hamad ARA, 2003, J IMMUNOL, V171, P2421, DOI 10.4049/jimmunol.171.5.2421; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Holmes N, 2006, IMMUNOLOGY, V117, P145, DOI 10.1111/j.1365-2567.2005.02265.x; Hubert S, 2010, J EXP MED, V207, P2561, DOI 10.1084/jem.20091154; IZUI S, 1984, J IMMUNOL, V133, P227; Jiang H, 2006, NEW ENGL J MED, V354, P1166, DOI 10.1056/NEJMra055446; Khakh BS, 2001, PHARMACOL REV, V53, P107; Kinjyo I, 2010, J IMMUNOL, V185, P7151, DOI 10.4049/jimmunol.1003193; Labasi JM, 2002, J IMMUNOL, V168, P6436, DOI 10.4049/jimmunol.168.12.6436; Lammas DA, 1997, IMMUNITY, V7, P433, DOI 10.1016/S1074-7613(00)80364-7; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Loomis WH, 2003, J BIOL CHEM, V278, P4590, DOI 10.1074/jbc.M207868200; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Mohamood AS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003465; Morel L, 2010, NAT REV RHEUMATOL, V6, P348, DOI 10.1038/nrrheum.2010.63; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Portales-Cervantes L, 2010, HUM IMMUNOL, V71, P818, DOI 10.1016/j.humimm.2010.05.008; Renno T, 1998, EUR J IMMUNOL, V28, P540, DOI 10.1002/(SICI)1521-4141(199802)28:02<540::AID-IMMU540>3.3.CO;2-P; Renno T, 1996, J EXP MED, V183, P431, DOI 10.1084/jem.183.2.431; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; Seman M, 2003, IMMUNITY, V19, P571, DOI 10.1016/S1074-7613(03)00266-8; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Suri-Payer E, 1998, J IMMUNOL, V160, P1212; Taylor SRJ, 2007, J IMMUNOL, V178, P3474, DOI 10.4049/jimmunol.178.6.3474; Thomson CW, 2006, IMMUNOL RES, V35, P163, DOI 10.1385/IR:35:1:163; Tsukimoto M, 2006, J IMMUNOL, V177, P2842, DOI 10.4049/jimmunol.177.5.2842; Venturi GM, 2003, IMMUNITY, V19, P713, DOI 10.1016/S1074-7613(03)00295-4; Virginio C, 1999, J PHYSIOL-LONDON, V519, P335, DOI 10.1111/j.1469-7793.1999.0335m.x; Yip L, 2009, FASEB J, V23, P1685, DOI 10.1096/fj.08-126458	53	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52161	10.1371/journal.pone.0052161	http://dx.doi.org/10.1371/journal.pone.0052161			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284917	Green Submitted, Green Published, gold			2022-12-27	WOS:000313158800033
J	Bueno-Orovio, A; Hanson, BM; Gill, JS; Taggart, P; Rodriguez, B				Bueno-Orovio, Alfonso; Hanson, Ben M.; Gill, Jaswinder S.; Taggart, Peter; Rodriguez, Blanca			In Vivo Human Left-to-Right Ventricular Differences in Rate Adaptation Transiently Increase Pro-Arrhythmic Risk following Rate Acceleration	PLOS ONE			English	Article							ACTION-POTENTIAL DURATION; ACUTE MYOCARDIAL-INFARCTION; ONE-DIMENSIONAL CABLE; SHORT-TERM; HEART-RATE; RESTITUTION PROPERTIES; VULNERABLE WINDOW; POTASSIUM CURRENT; CONDUCTION BLOCK; CARDIAC-CELLS	Left-to-right ventricular (LV/RV) differences in repolarization have been implicated in lethal arrhythmias in animal models. Our goal is to quantify LV/RV differences in action potential duration (APD) and APD rate adaptation and their contribution to arrhythmogenic substrates in the in vivo human heart using combined in vivo and in silico studies. Electrograms were acquired from 10 LV and 10 RV endocardial sites in 15 patients with normal ventricles. APD and APD adaptation were measured during an increase in heart rate. Analysis of in vivo electrograms revealed longer APD in LV than RV (207.8 +/- 21.5 vs 196.7 +/- 20.1 ms; P<0.05), and slower APD adaptation in LV than RV (time constant tau(s) = 47.0 +/- 14.3 vs 35.6 +/- 6.5 s; P<0.05). Following rate acceleration, LV/RV APD dispersion experienced an increase of up to 91% in 12 patients, showing a strong correlation (r(2) = 0.90) with both initial dispersion and LV/RV difference in slow adaptation. Pro-arrhythmic implications of measured LV/RV functional differences were studied using in silico simulations. Results show that LV/RV APD and APD adaptation heterogeneities promote unidirectional block following rate acceleration, albeit being insufficient for establishment of reentry in normal hearts. However, in the presence of an ischemic region at the LV/RV junction, LV/RV heterogeneity in APD and APD rate adaptation promotes reentrant activity and its degeneration into fibrillatory activity. Our results suggest that LV/RV heterogeneities in APD adaptation cause a transient increase in APD dispersion in the human ventricles following rate acceleration, which promotes unidirectional block and wave-break at the LV/RV junction, and may potentiate the arrhythmogenic substrate, particularly in patients with ischemic heart disease.	[Bueno-Orovio, Alfonso; Rodriguez, Blanca] Univ Oxford, Dept Comp Sci, Computat Biol Grp, Oxford, England; [Hanson, Ben M.] UCL, Dept Mech Engn, London, England; [Gill, Jaswinder S.] Guys & St Thomas Hosp, London SE1 9RT, England; [Taggart, Peter] Univ Coll London Hosp, Neurocardiol Res Unit, London, England	University of Oxford; University of London; University College London; Guy's & St Thomas' NHS Foundation Trust; University College London Hospitals NHS Foundation Trust; University of London; University College London	Bueno-Orovio, A (corresponding author), Univ Oxford, Dept Comp Sci, Computat Biol Grp, Oxford, England.	alfonso.bueno@cs.ox.ac.uk	Bueno-Orovio, Alfonso/K-7225-2013	Bueno-Orovio, Alfonso/0000-0002-1634-3601; Hanson, Benjamin/0000-0003-4661-6778; Rodriguez, Blanca/0000-0001-6361-3339	European Commission [DG-INFSO-224381]; United Kingdom Medical Research Council; Medical Research Council (MRC) [G0901819]; MRC [G0700278, G0901819] Funding Source: UKRI; Medical Research Council [G0901819, G0700278] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was financially supported by European Commission preDiCT Grant DG-INFSO-224381; United Kingdom Medical Research Council Career Development award to BR; and Medical Research Council (MRC) grant G0901819 to BH and PT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD L, 1982, CARDIOVASC RES, V16, P547, DOI 10.1093/cvr/16.10.547; Baher A, 2007, AM J PHYSIOL-HEART C, V292, pH180, DOI 10.1152/ajpheart.00944.2005; Bueno-Orovio A, 2008, J THEOR BIOL, V253, P544, DOI 10.1016/j.jtbi.2008.03.029; Bueno-Orovio A, 2006, SIAM J SCI COMPUT, V28, P886, DOI 10.1137/040607575; Clayton RH, 2005, BIOMED ENG ONLINE, V20, P4; Coronel R, 2006, HEART RHYTHM, V3, P1043, DOI 10.1016/j.hrthm.2006.05.027; Coronel R, 2009, HEART RHYTHM, V6, P537, DOI 10.1016/j.hrthm.2009.01.013; DiDiego JM, 1996, AM J PHYSIOL-HEART C, V271, pH548, DOI 10.1152/ajpheart.1996.271.2.H548; EISENBERG SJ, 1995, AM J CARDIOL, V75, P687, DOI 10.1016/S0002-9149(99)80654-7; Fenton FH, 1999, PHYS REV LETT, V83, P3964, DOI 10.1103/PhysRevLett.83.3964; FRANZ MR, 1988, J CLIN INVEST, V82, P972, DOI 10.1172/JCI113706; Ghanem RN, 2001, CIRCULATION, V104, P1306, DOI 10.1161/hc3601.094277; GILL JS, 1993, AM HEART J, V126, P1357, DOI 10.1016/0002-8703(93)90534-G; Haim M, 1997, AM J CARDIOL, V79, P717, DOI 10.1016/S0002-9149(96)00856-9; Hanson B, 2009, CIRC-ARRHYTHMIA ELEC, V2, P162, DOI 10.1161/CIRCEP.108.785352; Jiang Y, 2009, COMPUT CARDIOL, V36, P293; Komniski MS, 2011, AM J PHYSIOL-HEART C, V300, pH1645, DOI 10.1152/ajpheart.00220.2010; Kop WJ, 2001, J AM COLL CARDIOL, V38, P742, DOI 10.1016/S0735-1097(01)01451-6; KUO CS, 1983, CIRCULATION, V67, P1356, DOI 10.1161/01.CIR.67.6.1356; LEE KL, 1995, CIRCULATION, V91, P1659, DOI 10.1161/01.CIR.91.6.1659; Lerma C, 2008, MED BIOL ENG COMPUT, V46, P715, DOI 10.1007/s11517-008-0326-y; Lysaker M, 2006, INT J NUMER ANAL MOD, V3, P377; Minchole A, 2011, IEEE T BIO-MED ENG, V58, P1172, DOI 10.1109/TBME.2010.2097597; Mironov S, 2008, CIRCULATION, V118, P17, DOI 10.1161/CIRCULATIONAHA.107.737254; MORGAN JM, 1992, J AM COLL CARDIOL, V19, P1244, DOI 10.1016/0735-1097(92)90331-G; Nash MP, 2006, EXP PHYSIOL, V91, P339, DOI 10.1113/expphysiol.2005.031070; Pandit SV, 2011, HEART RHYTHM, V8, P1732, DOI 10.1016/j.hrthm.2011.06.028; Pitruzzello AM, 2007, AM J PHYSIOL-HEART C, V292, pH1568, DOI 10.1152/ajpheart.00619.2006; Pitt-Francis J, 2009, COMPUT PHYS COMMUN, V180, P2452, DOI 10.1016/j.cpc.2009.07.019; Pueyo E, 2004, IEEE T BIO-MED ENG, V51, P1511, DOI 10.1109/TBME.2004.828050; Pueyo E, 2010, AM J PHYSIOL-HEART C, V298, pH1577, DOI 10.1152/ajpheart.00936.2009; Qu ZL, 2006, BIOPHYS J, V91, P793, DOI 10.1529/biophysj.106.080945; Qu ZL, 2006, BIOPHYS J, V91, P805, DOI 10.1529/biophysj.106.080952; Ramanathan C, 2006, P NATL ACAD SCI USA, V103, P6309, DOI 10.1073/pnas.0601533103; Rodriguez B, 2005, CIRC RES, V97, P168, DOI 10.1161/01.RES.0000174429.00987.17; Romero L, 2009, AM J PHYSIOL-HEART C, V297, pH1436, DOI 10.1152/ajpheart.00263.2009; Samie FH, 2001, CIRC RES, V89, P1216, DOI 10.1161/hh2401.100818; STEINHAUS BM, 1989, CIRC RES, V64, P449, DOI 10.1161/01.RES.64.3.449; Szentadrassy N, 2005, CARDIOVASC RES, V65, P851, DOI 10.1016/j.cardiores.2004.11.022; Taggart P, 2000, J MOL CELL CARDIOL, V32, P621, DOI 10.1006/jmcc.2000.1105; Taggart P, 1999, PROG BIOPHYS MOL BIO, V71, P139, DOI 10.1016/S0079-6107(98)00039-X; Tolkacheva EG, 2006, BIOPHYS J, V91, P2735, DOI 10.1529/biophysj.106.083865; UDELNOV MG, 1961, CIRCULATION, V24, P110, DOI 10.1161/01.CIR.24.1.110; Volders PGA, 1999, CIRCULATION, V99, P206, DOI 10.1161/01.CIR.99.2.206; Warren M, 2003, J CARDIOVASC ELECTR, V14, P621, DOI 10.1046/j.1540-8167.2003.03006.x; Western D, 2010, IEEE ENG MED BIO, P114, DOI 10.1109/IEMBS.2010.5626087; YUAN S, 1995, EUR HEART J, V16, P68, DOI 10.1093/eurheartj/16.1.68; Yuan SW, 2001, PACE, V24, P1479, DOI 10.1046/j.1460-9592.2001.01479.x; Yue AM, 2004, CIRCULATION, V110, P1343, DOI 10.1161/01.CIR.0000141734.43393.BE	49	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52234	10.1371/journal.pone.0052234	http://dx.doi.org/10.1371/journal.pone.0052234			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284948	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500121
J	Carneiro, MW; Santos, DM; Fukutani, KF; Clarencio, J; Miranda, JC; Brodskyn, C; Barral, A; Barral-Netto, M; Soto, M; de Oliveira, CI				Carneiro, Marcia W.; Santos, Diego M.; Fukutani, Kiyoshi F.; Clarencio, Jorge; Miranda, Jose Carlos; Brodskyn, Claudia; Barral, Aldina; Barral-Netto, Manoel; Soto, Manuel; de Oliveira, Camila I.			Vaccination with L. infantum chagasi Nucleosomal Histones Confers Protection against New World Cutaneous Leishmaniasis Caused by Leishmania braziliensis	PLOS ONE			English	Article							MURINE VISCERAL LEISHMANIASIS; PRIME-BOOST VACCINATION; SAND FLY SALIVA; IMMUNE-RESPONSE; BALB/C MICE; ANTIGENIC DETERMINANTS; LUTZOMYIA-LONGIPALPIS; DENDRITIC CELLS; CONSERVED PROTEINS; GLAND LYSATE	Background: Nucleosomal histones are intracellular proteins that are highly conserved among Leishmania species. After parasite destruction or spontaneous lysis, exposure to these proteins elicits a strong host immune response. In the present study, we analyzed the protective capability of Leishmania infantum chagasi nucleosomal histones against L. braziliensis infection using different immunization strategies. Methodology/Principal Findings: BALB/c mice were immunized with either a plasmid DNA cocktail (DNA) containing four Leishmania nucleosomal histones or with the DNA cocktail followed by the corresponding recombinant proteins plus CpG (DNA/Protein). Mice were later challenged with L. braziliensis, in the presence of sand fly saliva. Lesion development, parasite load and the cellular immune response were analyzed five weeks after challenge. Immunization with either DNA alone or with DNA/Protein was able to inhibit lesion development. This finding was highlighted by the absence of infected macrophages in tissue sections. Further, parasite load at the infection site and in the draining lymph nodes was also significantly lower in vaccinated animals. This outcome was associated with increased expression of IFN-gamma and down regulation of IL-4 at the infection site. Conclusion: The data presented here demonstrate the potential use of L. infantum chagasi nucleosomal histones as targets for the development of vaccines against infection with L. braziliensis, as shown by the significant inhibition of disease development following a live challenge.	[Carneiro, Marcia W.; Santos, Diego M.; Fukutani, Kiyoshi F.; Clarencio, Jorge; Miranda, Jose Carlos; Brodskyn, Claudia; Barral, Aldina; Barral-Netto, Manoel; de Oliveira, Camila I.] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil; [Brodskyn, Claudia; Barral, Aldina; Barral-Netto, Manoel; de Oliveira, Camila I.] Inst Invest Imunol, Salvador, BA, Brazil; [Soto, Manuel] Univ Autonoma Madrid, Dept Biol Mol, Ctr Biol Mol Severo Ochoa, Consejo Super Invest Cient, Madrid, Spain	Fundacao Oswaldo Cruz; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	de Oliveira, CI (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.	camila@bahia.fiocruz.br	Barral-Netto, Manoel/B-3904-2009; Brodskyn, Cláudia/AAO-3288-2021; Barral, Aldina/B-4191-2009; Miranda, Jose/HCI-6099-2022; Fukutani, Kiyoshi/T-1630-2019; Fukutani, Kiyoshi/N-7905-2016; de Oliveira, Camila I/B-4358-2009; Álvarez, Manuel Soto/Q-5234-2018	Barral-Netto, Manoel/0000-0002-5823-7903; Brodskyn, Cláudia/0000-0003-3367-5365; Barral, Aldina/0000-0002-7177-464X; Fukutani, Kiyoshi/0000-0003-2223-0918; de Oliveira, Camila I/0000-0002-7868-5164; Álvarez, Manuel Soto/0000-0001-6825-841X; Weber Carneiro, Marcia/0000-0002-4220-5085; Clarencio, Jorge/0000-0002-4289-5450	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; CYTED; CAPES	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CYTED; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico and CYTED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr Almerio Noronha for help with histopathology analysis and documentation. MWC, DMS and KFF were supported by CAPES fellowships. MBN, AB, CB and CIO are senior investigators from CNPq.	Abdian N, 2011, EXP PARASITOL, V127, P627, DOI 10.1016/j.exppara.2010.12.007; Agallou M, 2012, VACCINE, V30, P5086, DOI 10.1016/j.vaccine.2012.05.075; Andrade BB, 2007, SCAND J IMMUNOL, V66, P122, DOI 10.1111/j.1365-3083.2007.01964.x; Belkaid Y, 2001, J EXP MED, V194, P1497, DOI 10.1084/jem.194.10.1497; Bittencourt Achiléa, 2003, Braz J Infect Dis, V7, P229, DOI 10.1590/S1413-86702003000300009; Carmelo E, 2006, PARASITE, V13, P231, DOI 10.1051/parasite/2006133231; Carmelo E, 2002, CLIN DIAGN LAB IMMUN, V9, P808, DOI 10.1128/CDLI.9.4.808-811.2002; Carrion J, 2008, VACCINE, V26, P1155, DOI 10.1016/j.vaccine.2007.12.051; Carrion J, 2008, VACCINE, V26, P2537, DOI 10.1016/j.vaccine.2008.03.003; Carrion J, 2007, MICROBES INFECT, V9, P735, DOI 10.1016/j.micinf.2007.02.018; Cerna P, 2002, INSECT BIOCHEM MOLEC, V32, P1691, DOI 10.1016/S0965-1748(02)00109-1; Charlab R, 1999, P NATL ACAD SCI USA, V96, P15155, DOI 10.1073/pnas.96.26.15155; Chenik M, 2006, VACCINE, V24, P2521, DOI 10.1016/j.vaccine.2005.12.027; Costa DL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000965; de Carvalho LP, 2003, MICROBES INFECT, V5, P7, DOI 10.1016/S1286-4579(02)00051-5; de Moura TR, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000084; de Moura TR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000712; de Moura TR, 2005, INFECT IMMUN, V73, P5827, DOI 10.1128/IAI.73.9.5827-5834.2005; de Oliveira CI, 2009, PARASITOL INT, V58, P319, DOI 10.1016/j.parint.2009.07.013; Dondji B, 2005, INFECT IMMUN, V73, P5286, DOI 10.1128/IAI.73.8.5286-5289.2005; Donnelly KB, 1998, J PARASITOL, V84, P97, DOI 10.2307/3284537; Falcao SC, 2012, INT J PARASITOL, V42, P771, DOI 10.1016/j.ijpara.2012.05.006; Galanti N, 1998, PARASITOL TODAY, V14, P64, DOI 10.1016/S0169-4758(97)01162-9; Gomes R, 2008, P NATL ACAD SCI USA, V105, P7845, DOI 10.1073/pnas.0712153105; Gomes R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001610; Gonzalo RM, 2002, VACCINE, V20, P1226, DOI 10.1016/S0264-410X(01)00427-3; Goto Y, 2011, CLIN VACCINE IMMUNOL, V18, P1118, DOI 10.1128/CVI.05024-11; Iborra S, 2004, VACCINE, V22, P3865, DOI 10.1016/j.vaccine.2004.04.015; Klinman DM, 1997, J IMMUNOL, V158, P3635; Klinman DM, 2000, SPRINGER SEMIN IMMUN, V22, P173, DOI 10.1007/s002810050027; Launois P, 2008, EXPERT REV VACCINES, V7, P1277, DOI 10.1586/14760584.7.8.1277; LERNER EA, 1991, J BIOL CHEM, V266, P11234; LIEW FY, 1990, J IMMUNOL, V145, P4306; Lima HC, 1996, INFECT IMMUN, V64, P5442, DOI 10.1128/IAI.64.12.5442-5445.1996; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masina S, 2003, J INFECT DIS, V188, P1250, DOI 10.1086/378677; Mazumder S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014644; Meddeb-Garnaoui A, 2010, VACCINE, V28, P1881, DOI 10.1016/j.vaccine.2009.11.075; Costa CHN, 2011, PLOS NEGLECT TROP D, V5, DOI [10.1371/journal.pntd.0000965, 10.1371/journal.pntd.0000943]; Norsworthy NB, 2004, INFECT IMMUN, V72, P1240, DOI 10.1128/IAI.72.3.1240-1247.2004; Okwor I, 2009, HUM VACCINES, V5, P291, DOI 10.4161/hv.5.5.7607; Peters NC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000484; Probst P, 2001, J IMMUNOL, V166, P498, DOI 10.4049/jimmunol.166.1.498; Rafati S, 2006, VACCINE, V24, P2169, DOI 10.1016/j.vaccine.2005.11.011; Ramshaw IA, 2000, IMMUNOL TODAY, V21, P163, DOI 10.1016/S0167-5699(00)01612-1; Requena JM, 2000, PARASITOL TODAY, V16, P246, DOI 10.1016/S0169-4758(00)01651-3; Rohousova I, 2005, PARASITE IMMUNOL, V27, P469, DOI 10.1111/j.1365-3024.2005.00787.x; Salay G, 2007, CLIN VACCINE IMMUNOL, V14, P1173, DOI 10.1128/CVI.00060-07; SAMUELSON J, 1991, J EXP MED, V173, P49, DOI 10.1084/jem.173.1.49; Santarem N, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/85154; Shi PY, 1997, BIOTECHNIQUES, V23, P1036, DOI 10.2144/97236bm15; Solioz N, 1999, VACCINE, V18, P850, DOI 10.1016/S0264-410X(99)00340-0; Soto M, 1996, CLIN EXP IMMUNOL, V106, P454, DOI 10.1046/j.1365-2249.1996.d01-865.x; Soto M, 1999, CLIN EXP IMMUNOL, V115, P342, DOI 10.1046/j.1365-2249.1999.00796.x; Soto M, 1995, IMMUNOL LETT, V48, P209, DOI 10.1016/0165-2478(95)02473-5; Tapia E, 2003, MICROBES INFECT, V5, P73, DOI 10.1016/S1286-4579(02)00077-1; Tavares NM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001169; Tewary P, 2005, J INFECT DIS, V191, P2130, DOI 10.1086/430348; TITUS RG, 1985, PARASITE IMMUNOL, V7, P545, DOI 10.1111/j.1365-3024.1985.tb00098.x; Valenzuela JG, 2001, J EXP MED, V194, P331, DOI 10.1084/jem.194.3.331	60	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52296	10.1371/journal.pone.0052296	http://dx.doi.org/10.1371/journal.pone.0052296			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284976	Green Submitted, Green Published, gold			2022-12-27	WOS:000312794500137
J	Defang, GN; Martin, NJ; Burgess, TH; Millar, EV; Pecenka, LA; Danko, JR; Arnold, JC; Kochel, TJ; Luke, TC				Defang, Gabriel N.; Martin, Nicholas J.; Burgess, Timothy H.; Millar, Eugene V.; Pecenka, LeNae A.; Danko, Janine R.; Arnold, John C.; Kochel, Tadeusz J.; Luke, Thomas C.			Comparative Analysis of Hemagglutination Inhibition Titers Generated Using Temporally Matched Serum and Plasma Samples	PLOS ONE			English	Article							INFLUENZA-VIRUS; IMMUNOGENICITY; ANTIBODIES; VACCINE	Influenza-specific hemaggluitination inhibition (HAI) antibody titer, an indicator of immunity to influenza, is often used to measure exposure to influenza in surveillance and immunogenicity studies. Traditionally, serum has been the specimen of choice for HAI assays, but a desire to reduce the amount of blood collected during studies and the availability of plasma in archived sample collections warrant the evaluation of plasma for HAI titer. Therefore, the relationship between serum and plasma HAI titer values is of great interest. Here, we compare HAI titers determined on temporally matched serum and plasma (citrated and heparinized) using influenza A and B viruses. Bland-Altman plots, McNemar's test, and geometric coefficient of variation were used respectively for evaluating agreement, correlation and variability in the serum-plasma titer results. We observed a high degree of agreement (80.5%-98.8%) and correlation (r = 0.796-0.964)in the serum and matched plasma titer values although plasma titers were generally lower than corresponding serum titers. Calculated seropositive (HAI >= 40) rates were higher using serum titers than with plasma titers, but seroconversion rates were unaffected by sample type. Stronger agreement and decreased variability in titers were seen between serum and citrated plasma than between serum and heparinized plasma. Overall, these data suggest that serum or plasma can be used in serodiagnostic HAI assays, but seropositive rates may be underestimated using plasma HAI titers. The type of anticoagulant present in plasma may affect HAI titer values and warrants further investigation. Citation: Defang GN, Martin NJ, Burgess TH, Millar EV, Pecenka LA, et al. (2012) Comparative Analysis of Hemagglutination Inhibition Titers Generated Using Temporally Matched Serum and Plasma Samples. PLoS ONE 7(12): e48229. doi:10.1371/journal.pone.0048229	[Defang, Gabriel N.; Martin, Nicholas J.; Pecenka, LeNae A.; Danko, Janine R.; Kochel, Tadeusz J.; Luke, Thomas C.] USN, Med Res Ctr, Viral & Rickettsial Dis Dept, Silver Spring, MD USA; [Burgess, Timothy H.; Millar, Eugene V.] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Infect Dis Clin Res Program, Bethesda, MD 20814 USA; [Arnold, John C.] USN, Med Ctr, San Diego, CA 92152 USA	United States Department of Defense; United States Navy; Uniformed Services University of the Health Sciences - USA; United States Department of Defense; United States Navy	Martin, NJ (corresponding author), USN, Med Res Ctr, Viral & Rickettsial Dis Dept, Silver Spring, MD USA.	nicholas.martin@med.navy.mil			Armed Forces Health Surveillance Center Global Emerging Infections Surveillance and Response System project [I0279_11_NM]; Navy Bureau of Medicine Defense Health Program [0000188D.0000.000.A0312]	Armed Forces Health Surveillance Center Global Emerging Infections Surveillance and Response System project; Navy Bureau of Medicine Defense Health Program	This work was supported by Armed Forces Health Surveillance Center Global Emerging Infections Surveillance and Response System project I0279_11_NM and Navy Bureau of Medicine Defense Health Program award# 0000188D.0000.000.A0312. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bland MJ, 1986, LANCET, V327, P307; Boon ACM, 2004, J IMMUNOL, V172, P2453, DOI 10.4049/jimmunol.172.4.2453; CLEMENTS ML, 1986, J CLIN MICROBIOL, V24, P157, DOI 10.1128/JCM.24.1.157-160.1986; Couch R B, 1975, Dev Biol Stand, V28, P295; COUCH RB, 1983, ANNU REV MICROBIOL, V37, P529, DOI 10.1146/annurev.mi.37.100183.002525; Crum-Cianflone NF, 2011, CLIN INFECT DIS, V52, P138, DOI 10.1093/cid/ciq019; Hirst GK, 1942, J EXP MED, V75, P49, DOI 10.1084/jem.75.1.49; Jones AM, 2006, CLIN ENDOCRINOL, V64, P234, DOI 10.1111/j.1365-2265.2006.02439.x; Kendal AP, 1982, CONCEPTS PROCEDURES; King JC, 2001, PEDIATR INFECT DIS J, V20, P1124, DOI 10.1097/00006454-200112000-00006; Kirkwood TBL, 1979, BIOMETRICS, V35, P908; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Salk JE, 1944, J IMMUNOL, V49, P87; SHORTRIDGE KF, 1972, MICROBIOS, V6, P213; *US FDA, 2008, GUID IND CLIN DAT NE; Wilde C., 2005, IMMUNOASSAY HDB, P443	17	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e48229	10.1371/journal.pone.0048229	http://dx.doi.org/10.1371/journal.pone.0048229			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284613	gold, Green Published, Green Submitted			2022-12-27	WOS:000312794500004
J	Di Franco, A; Coppini, G; Pujolar, JM; De Leo, GA; Gatto, M; Lyubartsev, V; Melia, P; Zane, L; Guidetti, P				Di Franco, Antonio; Coppini, Giovanni; Pujolar, Jose Martin; De Leo, Giulio A.; Gatto, Marino; Lyubartsev, Vladyslav; Melia, Paco; Zane, Lorenzo; Guidetti, Paolo			Assessing Dispersal Patterns of Fish Propagules from an Effective Mediterranean Marine Protected Area	PLOS ONE			English	Article							DIPLODUS-SARGUS-SARGUS; ADRIATIC SEA; LARVAL DISPERSAL; POPULATION CONNECTIVITY; REEF; RESERVES; RETENTION; SCALE; REPLENISHMENT; VARIABILITY	Successfully enforced marine protected areas (MPAs) have been widely demonstrated to allow, within their boundaries, the recovery of exploited species and beyond their boundaries, the spillover of juvenile and adult fish. Little evidence is available about the so-called 'recruitment subsidy', the augmented production of propagules (i.e. eggs and larvae) due to the increased abundance of large-sized spawners hosted within effective MPAs. Once emitted, propagules can be locally retained and/or exported elsewhere. Patterns of propagule retention and/or export from MPAs have been little investigated, especially in the Mediterranean. This study investigated the potential for propagule production and retention/export from a Mediterranean MPA (Torre Guaceto, SW Adriatic Sea) using the white sea bream, Diplodus sargus sargus, as a model species. A multidisciplinary approach was used combining 1) spatial distribution patterns of individuals (post-settlers and adults) assessed through visual census within Torre Guaceto MPA and in northern and southern unprotected areas, 2) Lagrangian simulations of dispersal based on an oceanographic model of the region and data on early life-history traits of the species (spawning date, pelagic larval duration) and 3) a preliminary genetic study using microsatellite loci. Results show that the MPA hosts higher densities of larger-sized spawners than outside areas, potentially guaranteeing higher propagule production. Model simulations and field observation suggest that larval retention within and long-distance dispersal across MPA boundaries allow the replenishment of the MPA and of exploited populations up to 100 km down-current (southward) from the MPA. This pattern partially agrees with the high genetic homogeneity found in the entire study area (no differences in genetic composition and diversity indices), suggesting a high gene flow. By contributing to a better understanding of propagule dispersal patterns, these findings provide crucial information for the design of MPAs and MPA networks effective to replenish fish stocks and enhance fisheries in unprotected areas.	[Di Franco, Antonio; Guidetti, Paolo] Univ Salento, Lab Conservat & Management Marine & Coastal Resou, Dipartimento Sci & Tecnol Biol & Ambientali, Consorzio Nazl Interuniv Sci Mare, Lecce, Italy; [Di Franco, Antonio; Guidetti, Paolo] Univ Nice Sophia Antipolis, Lab ECOMERS, Fac Sci, Nice, France; [Coppini, Giovanni] Ist Nazl Geofis & Vulcanol, Bologna, Italy; [Pujolar, Jose Martin; Zane, Lorenzo] Univ Padua, Dept Biol, Padua, Italy; [De Leo, Giulio A.] Univ Parma, Dept Environm Sci, I-43100 Parma, Italy; [De Leo, Giulio A.] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [Gatto, Marino; Melia, Paco] Politecn Milan, Dipartimento Elettron & Informaz, I-20133 Milan, Italy; [Lyubartsev, Vladyslav] Ctr Euromediterraneo & Cambiamenti Climat, Bologna, Italy	University of Salento; UDICE-French Research Universities; Universite Cote d'Azur; Istituto Nazionale Geofisica e Vulcanologia (INGV); University of Padua; University of Parma; Stanford University; Polytechnic University of Milan	Di Franco, A (corresponding author), Univ Salento, Lab Conservat & Management Marine & Coastal Resou, Dipartimento Sci & Tecnol Biol & Ambientali, Consorzio Nazl Interuniv Sci Mare, Lecce, Italy.	difry@libero.it	Zane, Lorenzo/G-6249-2010; Melià, Paco/E-8844-2012; De Leo, Giulio/AAC-5098-2019; Gatto, Marino/D-9531-2012; Di Franco, Antonio/A-8796-2010	Zane, Lorenzo/0000-0002-6963-2132; Melià, Paco/0000-0002-7763-9836; De Leo, Giulio/0000-0002-4186-3369; Guidetti, Paolo/0000-0002-7983-8775; pujolar, marti/0000-0002-5037-8840; Gatto, Marino/0000-0001-8063-9178; Di Franco, Antonio/0000-0003-3411-7015	Italian Ministero dell'Istruzione e dell'Universita [2008E7KBAE]	Italian Ministero dell'Istruzione e dell'Universita	This research was funded by the Italian Ministero dell'Istruzione e dell'Universita (PRIN Project: protocol no. 2008E7KBAE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardy T, 2011, MAR POLICY, V35, P226, DOI 10.1016/j.marpol.2010.10.006; Almany GR, 2009, CORAL REEFS, V28, P339, DOI 10.1007/s00338-009-0484-x; Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; [Anonymous], 2002, FSTAT VERSION 2 9 3; Artegiani A, 1997, J PHYS OCEANOGR, V27, P1515, DOI 10.1175/1520-0485(1997)027<1515:TASGCP>2.0.CO;2; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; BAYLESEMPERE JT, 2002, ECOCEN V1 00 00 APPL; BELKHIR K, 2005, GENETIX 4 05 LOGICIE; Botsford LW, 2009, CORAL REEFS, V28, P327, DOI 10.1007/s00338-009-0466-z; Bradbury IR, 2008, MOL ECOL, V17, P1438, DOI 10.1111/j.1365-294X.2008.03694.x; Branch GM, 2003, BIOL CONSERV, V114, P255, DOI 10.1016/S0006-3207(03)00045-4; Bussotti S, 2011, ITAL J ZOOL, V78, P243, DOI 10.1080/11250001003774652; Butler MJ, 2011, MAR ECOL PROG SER, V422, P223, DOI 10.3354/meps08878; Cheminee A, 2011, SCI MAR, V75, P181, DOI 10.3989/scimar.2011.75n1181; Christie MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015715; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Claudet Joachim, 2011, P37; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Crec'hriou R, 2010, FISH OCEANOGR, V19, P135, DOI 10.1111/j.1365-2419.2010.00533.x; Cudney-Bueno R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004140; D'Anna G, 2011, ITAL J ZOOL, V78, P255, DOI 10.1080/11250000903464059; Di Franco A, 2011, ITAL J ZOOL, V78, P182, DOI 10.1080/11250003.2011.566227; Di Franco A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031681; Di Franco A, 2011, BIOL LETTERS, V7, P454, DOI 10.1098/rsbl.2010.1149; Di Franco A, 2009, MAR ECOL PROG SER, V387, P275, DOI 10.3354/meps08051; Diaz D, 2011, MAR ECOL PROG SER, V433, P149, DOI 10.3354/meps09182; Dobricic S, 2008, OCEAN MODEL, V22, P89, DOI 10.1016/j.ocemod.2008.01.004; Engie K, 2007, ESTUAR COAST, V30, P201, DOI 10.1007/BF02700164; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Evans RD, 2008, CORAL REEFS, V27, P179, DOI 10.1007/s00338-007-0309-8; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fenberg PB, 2012, MAR POLICY, V36, P1012, DOI 10.1016/j.marpol.2012.02.021; Fisher R, 2005, MAR BIOL, V147, P1201, DOI 10.1007/s00227-005-0001-x; Franch R, 2006, GENETICS, V174, P851, DOI 10.1534/genetics.106.059014; GAINES S, 1985, OECOLOGIA, V67, P267, DOI 10.1007/BF00384297; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Gerlach G, 2007, P NATL ACAD SCI USA, V104, P858, DOI 10.1073/pnas.0606777104; GOTELLI NJ, 1991, AM NAT, V138, P768, DOI 10.1086/285249; Gruss A, 2011, BIOL CONSERV, V144, P692, DOI 10.1016/j.biocon.2010.12.015; Guarnieri A, 2010, COASTAL GLOBAL OPERA, V28, p[20, 184]; Guarnieri G, 2012, J GEOPHYS R IN PRESS; Guidetti P, 2012, DESIGNING NETWORKS M; Guidetti P, 2008, BIOL CONSERV, V141, P699, DOI 10.1016/j.biocon.2007.12.013; Guidetti P, 2007, MAR ECOL PROG SER, V335, P43, DOI 10.3354/meps335043; Guidetti P, 2006, ECOL APPL, V16, P963, DOI 10.1890/1051-0761(2006)016[0963:MRRLPI]2.0.CO;2; Halpern BS, 2009, ENVIRON CONSERV, V36, P268, DOI 10.1017/S0376892910000032; Halpern BS, 2003, ECOL APPL, V13, pS117; Halpern BS, 2003, P ROY SOC B-BIOL SCI, V270, P1871, DOI 10.1098/rspb.2003.2405; Halpern BS, 2002, ECOL LETT, V5, P361, DOI 10.1046/j.1461-0248.2002.00326.x; HARMELINVIVIEN ML, 1985, REV ECOL-TERRE VIE, V40, P466; HARMELINVIVIEN ML, 1995, HYDROBIOLOGIA, V300, P309, DOI 10.1007/BF00024471; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Jones GP, 2009, CORAL REEFS, V28, P307, DOI 10.1007/s00338-009-0469-9; Jones GP, 2005, CURR BIOL, V15, P1314, DOI 10.1016/j.cub.2005.06.061; Kingsford MJ, 2011, CORAL REEFS, V30, P203, DOI 10.1007/s00338-010-0692-4; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; Le Quesne WJF, 2009, ICES J MAR SCI, V66, P122, DOI 10.1093/icesjms/fsn202; Leis JM, 2011, INTEGR COMP BIOL, V51, P826, DOI 10.1093/icb/icr004; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Lloret J, 2008, FISH RES, V91, P252, DOI 10.1016/j.fishres.2007.12.002; Lopez-Sanz A, 2011, ESTUAR COAST SHELF S, V92, P521, DOI 10.1016/j.ecss.2011.02.006; Lopez-Sanz A, 2009, J PLANKTON RES, V31, P763, DOI 10.1093/plankt/fbp024; MacPherson E, 1998, J EXP MAR BIOL ECOL, V220, P127, DOI 10.1016/S0022-0981(97)00086-5; Marinaro JY, 2005, CYBIUM, V29, P198; Massault C, 2011, ANIM GENET, V42, P191, DOI 10.1111/j.1365-2052.2010.02110.x; Mora C, 2002, TRENDS ECOL EVOL, V17, P422, DOI 10.1016/S0169-5347(02)02584-3; Mouine N, 2007, SCI MAR, V71, P461, DOI 10.3989/scimar.2007.71n3461; Oddo P, 2005, SCI TOTAL ENVIRON, V353, P39, DOI 10.1016/j.scitotenv.2005.09.061; Olivar MP, 1997, MAR BIOL, V129, P289, DOI 10.1007/s002270050169; ORLIC M, 1994, CONT SHELF RES, V14, P91, DOI 10.1016/0278-4343(94)90007-8; Palumbi SR, 2003, SCIENCE, V299, P51, DOI 10.1126/science.1080775; Paris CB, 2005, MAR ECOL PROG SER, V296, P93, DOI 10.3354/meps296093; Paris CB, 2004, LIMNOL OCEANOGR, V49, P1964, DOI 10.4319/lo.2004.49.6.1964; Paris CB, 2007, MAR ECOL PROG SER, V347, P285, DOI 10.3354/meps06985; Pelc RA, 2010, P NATL ACAD SCI USA, V107, P18266, DOI 10.1073/pnas.0907368107; Pelc RA, 2009, MAR ECOL PROG SER, V394, P65, DOI 10.3354/meps08326; Pinardi N, 2010, OCEAN SCI, V6, P263, DOI 10.5194/os-6-263-2010; Pinsky ML, 2010, EVOLUTION, V64, P2688, DOI 10.1111/j.1558-5646.2010.01003.x; PISCO, 2011, SCI MAR RES; PISCO Partnership for Interdisciplinary Studies of Coastal Oceans, 2007, SCI MAR RES; Planes S, 2000, ENVIRON CONSERV, V27, P126, DOI 10.1017/S0376892900000175; Planes S, 2009, P NATL ACAD SCI USA, V106, P5693, DOI 10.1073/pnas.0808007106; Poulain PM, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019121; Poulain PM, 2001, J MARINE SYST, V29, P3, DOI 10.1016/S0924-7963(01)00007-0; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Roberts C.M., 1991, Reviews in Fish Biology and Fisheries, V1, P65, DOI 10.1007/BF00042662; Ryman N, 2006, MOL ECOL NOTES, V6, P600, DOI 10.1111/j.1471-8286.2006.01378.x; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Shanks AL, 2003, ECOL APPL, V13, pS159; Simpson SD, 2005, SCIENCE, V308, P221, DOI 10.1126/science.1107406; Sundelof A, 2012, MAR ECOL-EVOL PERSP, V33, P183, DOI 10.1111/j.1439-0485.2011.00485.x; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Taylor MS, 2003, SCIENCE, V299, P107, DOI 10.1126/science.1079365; Tonani M, 2008, OCEAN SCI, V4, P1, DOI 10.5194/os-4-1-2008; Tortonese E., 1965, RAPPORTS COMMISSION, P189; Treml EA, 2008, LANDSCAPE ECOL, V23, P19, DOI 10.1007/s10980-007-9138-y; Valles H, 2001, J FISH BIOL, V59, P152, DOI 10.1006/jfbi.2001.1763; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vigliola L., 1998, THESIS U AIX MARSEIL THESIS U AIX MARSEIL; Watson JR, 2010, MAR ECOL PROG SER, V401, P31, DOI 10.3354/meps08376; Williamson DH, 2009, MAR BIOL, V156, P2517, DOI 10.1007/s00227-009-1276-0; Zavatarelli M, 2003, ANN GEOPHYS-GERMANY, V21, P345, DOI 10.5194/angeo-21-345-2003	104	38	38	0	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52108	10.1371/journal.pone.0052108	http://dx.doi.org/10.1371/journal.pone.0052108			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284887	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500092
J	Hershberg, R; Petrov, DA				Hershberg, Ruth; Petrov, Dmitri A.			On the Limitations of Using Ribosomal Genes as References for the Study of Codon Usage: A Rebuttal	PLOS ONE			English	Article							ESCHERICHIA-COLI; SELECTION	In a recent paper published in PLOS ONE, Wang et al. challenge our finding that the identity of optimal codons in different genomes follows a set of clear rules. Here we provide a rebuttal of their paper and demonstrate that the results of our original PLOS Genetics paper stand. This provides us with an opportunity to bring up an aspect of how codon usage has been studied that should be of general interest. The Wang et al. study, as well as many other studies, used ribosomal genes as a reference set for the study of patterns of codon usage. We discuss here the assumptions that are made in order to justify using ribosomal genes to study codon bias, suggest that this practice can at times be problematic, and discuss its limitations.	[Hershberg, Ruth] Technion Israel Inst Technol, Fac Med, Rachel & Menachem Mendelovitch Evolutionary Proce, Dept Genet, Haifa, Israel; [Petrov, Dmitri A.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Stanford University	Hershberg, R (corresponding author), Technion Israel Inst Technol, Fac Med, Rachel & Menachem Mendelovitch Evolutionary Proce, Dept Genet, Haifa, Israel.	ruthersh@tx.technion.ac.il		Petrov, Dmitri/0000-0002-3664-9130	National Institutes of Health [RO1GM100366, RO1GM097415]; ERC FP7 CIG grant; Yigal Allon Fellowship; Israeli Council for Higher Education; Robert J. Shillman Career Advancement Chair; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097415, R01GM100366] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERC FP7 CIG grant; Yigal Allon Fellowship; Israeli Council for Higher Education; Robert J. Shillman Career Advancement Chair; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	DAP was supported by National Institutes of Health grants RO1GM100366 and RO1GM097415. RH was supported by an ERC FP7 CIG grant, by a Yigal Allon Fellowship awarded by the Israeli Council for Higher Education, and by the Robert J. Shillman Career Advancement Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKASHI H, 1994, GENETICS, V136, P927; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Ermolaeva M D, 2001, Curr Issues Mol Biol, V3, P91; Hershberg R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001115; Hershberg R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000556; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Hildebrand F., 2010, PLOS GENET, V6; Lin K, 2002, NUCLEIC ACIDS RES, V30, P2599, DOI 10.1093/nar/30.11.2599; Marais G, 2001, J MOL EVOL, V52, P275, DOI 10.1007/s002390010155; Novembre JA, 2002, MOL BIOL EVOL, V19, P1390, DOI 10.1093/oxfordjournals.molbev.a004201; Parmley JL, 2007, MOL BIOL EVOL, V24, P1600, DOI 10.1093/molbev/msm104; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Sharp PM, 2010, PHILOS T R SOC B, V365, P1203, DOI 10.1098/rstb.2009.0305; Sharp PM, 2005, NUCLEIC ACIDS RES, V33, P1141, DOI 10.1093/nar/gki242; Stoletzki N, 2007, MOL BIOL EVOL, V24, P374, DOI 10.1093/molbev/msl166; Supek F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001004; Wang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022714; Warnecke T, 2007, MOL BIOL EVOL, V24, P2755, DOI 10.1093/molbev/msm210; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9	19	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e49060	10.1371/journal.pone.0049060	http://dx.doi.org/10.1371/journal.pone.0049060			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284622	Green Submitted, Green Published, gold			2022-12-27	WOS:000312794500008
J	La Rosa, PS; Brooks, JP; Deych, E; Boone, EL; Edwards, DJ; Wang, Q; Sodergren, E; Weinstock, G; Shannon, WD				La Rosa, Patricio S.; Brooks, J. Paul; Deych, Elena; Boone, Edward L.; Edwards, David J.; Wang, Qin; Sodergren, Erica; Weinstock, George; Shannon, William D.			Hypothesis Testing and Power Calculations for Taxonomic-Based Human Microbiome Data	PLOS ONE			English	Article							NONPARAMETRIC MULTIVARIATE-ANALYSIS; COMMUNITIES; PROJECT; PROPORTIONS; INTEGRATION; STATISTICS; LIBRARIES; DIVERSITY; SAMPLES	This paper presents new biostatistical methods for the analysis of microbiome data based on a fully parametric approach using all the data. The Dirichlet-multinomial distribution allows the analyst to calculate power and sample sizes for experimental design, perform tests of hypotheses (e. g., compare microbiomes across groups), and to estimate parameters describing microbiome properties. The use of a fully parametric model for these data has the benefit over alternative non-parametric approaches such as bootstrapping and permutation testing, in that this model is able to retain more information contained in the data. This paper details the statistical approaches for several tests of hypothesis and power/sample size calculations, and applies them for illustration to taxonomic abundance distribution and rank abundance distribution data using HMP Jumpstart data on 24 subjects for saliva, subgingival, and supragingival samples. Software for running these analyses is available.	[La Rosa, Patricio S.; Deych, Elena; Shannon, William D.] Washington Univ, Sch Med, Dept Med, Div Gen Med Sci, St Louis, MO 63110 USA; [Brooks, J. Paul; Boone, Edward L.; Edwards, David J.; Wang, Qin] Virginia Commonwealth Univ, Dept Stat Sci & Operat Res, Richmond, VA USA; [Sodergren, Erica; Weinstock, George] Washington Univ, Sch Med, Genome Inst, St Louis, MO USA	Washington University (WUSTL); Virginia Commonwealth University; Washington University (WUSTL)	Shannon, WD (corresponding author), Washington Univ, Sch Med, Dept Med, Div Gen Med Sci, St Louis, MO 63110 USA.	wshannon@wustl.edu	Weinstock, George M/C-6314-2013	Weinstock, George M/0000-0002-2997-4592	National Institutes of Health (NIH) [U54 HG004968, 1UH2AI083265]; St. Louis Children's Hospital and Children Discovery Institute Grant; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UH2AI083265] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. Louis Children's Hospital and Children Discovery Institute Grant; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) Grant U54 HG004968 "Human Microbiome Project Consortium Sequencing of Healthy People", NIH Grant 1UH2AI083265 "The Neonatal Microbiome and Necrotizing Enterocolotis", and St. Louis Children's Hospital and Children Discovery Institute Grant "The St. Louis Neonatal Gut Microbiome Initiative". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], HUM MICR PROJ 16S RR; BRIER SS, 1980, BIOMETRIKA, V67, P591; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; COX DR, 1983, BIOMETRIKA, V70, P269, DOI 10.1093/biomet/70.1.269; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Holmes I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030126; KIM BS, 1992, BIOMETRICS, V48, P711, DOI 10.2307/2532338; Kirk RE, 1968, EXPT DESIGN; KOEHLER KJ, 1986, COMMUN STAT-THEOR M, V15, P2977, DOI 10.1080/03610928608829290; La Rosa P, 2011, HMP HYPOTHESIS TESTI; Legendre P., 1998, DEV ENV MODELLING; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; MANTEL N, 1970, BIOMETRICS, V26, P547, DOI 10.2307/2529108; MANTEL N, 1967, CANCER RES, V27, P209; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Schloss PD, 2006, APPL ENVIRON MICROB, V72, P6773, DOI 10.1128/AEM.00474-06; Schloss PD, 2006, APPL ENVIRON MICROB, V72, P2379, DOI 10.1128/AEM.72.4.2379-2384.2006; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Schloss PD, 2004, APPL ENVIRON MICROB, V70, P5485, DOI 10.1128/AEM.70.9.5485-5492.2004; Singleton DR, 2001, APPL ENVIRON MICROB, V67, P4374, DOI 10.1128/AEM.67.9.4374-4376.2001; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Vilo C, 2012, METAGENOMICS; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; WHITTAKER RH, 1965, SCIENCE, V147, P250, DOI 10.1126/science.147.3655.250; Wilson JR, 1984, P JOINT STAT ASS M S; Wooley JC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000667	34	176	181	4	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52078	10.1371/journal.pone.0052078	http://dx.doi.org/10.1371/journal.pone.0052078			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284876	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500086
J	Novak, P; Stampfer, MR; Munoz-Rodriguez, JL; Garbe, JC; Ehrich, M; Futscher, BW; Jensen, TJ				Novak, Petr; Stampfer, Martha R.; Munoz-Rodriguez, Jose L.; Garbe, James C.; Ehrich, Mathias; Futscher, Bernard W.; Jensen, Taylor J.			Cell-Type Specific DNA Methylation Patterns Define Human Breast Cellular Identity	PLOS ONE			English	Article							MAMMARY EPITHELIAL-CELLS; DIFFERENTIAL METHYLATION; EPIGENETIC INACTIVATION; HYPERMETHYLATION; PLURIPOTENT; EXPRESSION; GROWTH; GENES; BARRIERS; CLUSTER	DNA methylation plays a role in a variety of biological processes including embryonic development, imprinting, X-chromosome inactivation, and stem cell differentiation. Tissue specific differential methylation has also been well characterized. We sought to extend these studies to create a map of differential DNA methylation between different cell types derived from a single tissue. Using three pairs of isogenic human mammary epithelial and fibroblast cells, promoter region DNA methylation was characterized using MeDIP coupled to microarray analysis. Comparison of DNA methylation between these cell types revealed nearly three thousand cell-type specific differentially methylated regions (ctDMRs). MassARRAY was performed upon 87 ctDMRs to confirm and quantify differential DNA methylation. Each of the examined regions exhibited statistically significant differences ranging from 10-70%. Gene ontology analysis revealed the overrepresentation of many transcription factors involved in developmental processes. Additionally, we have shown that ctDMRs are associated with histone related epigenetic marks and are often aberrantly methylated in breast cancer. Overall, our data suggest that there are thousands of ctDMRs which consistently exhibit differential DNA methylation and may underlie cell type specificity in human breast tissue. In addition, we describe the pathways affected by these differences and provide insight into the molecular mechanisms and physiological overlap between normal cellular differentiation and breast carcinogenesis.	[Novak, Petr; Stampfer, Martha R.; Munoz-Rodriguez, Jose L.; Futscher, Bernard W.; Jensen, Taylor J.] Univ Arizona, Arizona Canc Ctr, Tucson, AZ 85721 USA; [Munoz-Rodriguez, Jose L.; Futscher, Bernard W.; Jensen, Taylor J.] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA; [Stampfer, Martha R.; Garbe, James C.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Novak, Petr] Acad Sci Czech Republ, Inst Plant Mol Biol, Vvi, Biol Ctr ASCR, CR-37005 Ceske Budejovice, Czech Republic; [Ehrich, Mathias] Sequenom Inc, San Diego, CA USA; [Jensen, Taylor J.] John Hopkins Ct, Sequenom Ctr Mol Med, San Diego, CA USA	Arizona Center Cancer Care; University of Arizona; University of Arizona; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Sequenom; Sequenom	Novak, P (corresponding author), Univ Arizona, Arizona Canc Ctr, Tucson, AZ 85721 USA.	petr@umbr.cas.cz	Novak, Petr/A-3059-2013; Rodríguez, Jose Manuel JMMR Muñoz/A-7323-2016	Novak, Petr/0000-0002-5068-9681; Rodríguez, Jose Manuel JMMR Muñoz/0000-0002-4688-6420	BIO5 interdisciplinary biotechnology center at the UA; DOD [BCRP BC060444]; National Institutes of Health [U54 CA112970]; Office of Energy Research, Office of Health and Biological Research, U.S. Department of Energy [DE-AC03-76SF00098]; NIEHS [ES06694]; Academy of Sciences of the Czech Republic [AVOZ50510513];  [R01CA65662];  [R33CA091351];  [P30ES06694];  [P30CA023074];  [CA09213]; NATIONAL CANCER INSTITUTE [R01CA065662, U54CA112970, T32CA009213, R33CA091351, P30CA023074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER	BIO5 interdisciplinary biotechnology center at the UA; DOD(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Energy Research, Office of Health and Biological Research, U.S. Department of Energy(United States Department of Energy (DOE)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Grants R01CA65662 and R33CA091351 to BWF supported this work. Center Grants P30ES06694 and P30CA023074, and the BIO5 interdisciplinary biotechnology center at the UA supported the Genomics Shared Service. Training grant CA09213 helped support TJJ. JCG and MRS were supported by DOD BCRP BC060444, National Institutes of Health U54 CA112970, and the Office of Energy Research, Office of Health and Biological Research, U.S. Department of Energy under Contract No. DE-AC03-76SF00098. NIEHS Grant ES06694 and Grant AVOZ50510513 from the Academy of Sciences of the Czech Republic support PN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Alves G, 1996, GENE, V176, P39, DOI 10.1016/0378-1119(96)00205-3; BAYLIN SB, 1991, CANCER CELL-MON REV, V3, P383; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; BEARD C, 1995, GENE DEV, V9, P2325, DOI 10.1101/gad.9.19.2325; Bernardino T, 1997, CANCER GENET CYTOGEN, V97, P83, DOI 10.1016/S0165-4608(96)00385-8; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bloushtain-Qimron N, 2008, P NATL ACAD SCI USA, V105, P14076, DOI 10.1073/pnas.0805206105; Brenner AJ, 1998, ONCOGENE, V17, P199, DOI 10.1038/sj.onc.1201919; De Carvalho DD, 2012, CANCER CELL, V21, P655, DOI 10.1016/j.ccr.2012.03.045; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fang F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001875; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Frigola J, 2006, NAT GENET, V38, P540, DOI 10.1038/ng1781; Futscher BW, 2002, NAT GENET, V31, P175, DOI 10.1038/ng886; Garbe JC, 2007, CELL CYCLE, V6, P1927, DOI 10.4161/cc.6.15.4519; Garbe JC, 2012, CANCER RES, V72, P3687, DOI 10.1158/0008-5472.CAN-12-0157; Garbe JC, 2009, CANCER RES, V69, P7557, DOI 10.1158/0008-5472.CAN-09-0270; HAMMOND SL, 1984, P NATL ACAD SCI-BIOL, V81, P5435, DOI 10.1073/pnas.81.17.5435; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hitchins MP, 2007, CANCER RES, V67, P9107, DOI 10.1158/0008-5472.CAN-07-0869; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jensen TJ, 2008, CARCINOGENESIS, V29, P1500, DOI 10.1093/carcin/bgn102; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Keller PJ, 2012, P NATL ACAD SCI USA, V109, P2772, DOI 10.1073/pnas.1017626108; LaBarge MA, 2012, J VISUALIZE IN PRESS; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Li YZ, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-7; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; MAKOS M, 1993, CANCER RES, V53, P2715; MAKOS M, 1992, P NATL ACAD SCI USA, V89, P1929, DOI 10.1073/pnas.89.5.1929; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Novak P, 2008, CANCER RES, V68, P8616, DOI 10.1158/0008-5472.CAN-08-1419; Novak P, 2006, CANCER RES, V66, P10664, DOI 10.1158/0008-5472.CAN-06-2761; Novak P, 2009, CANCER RES, V69, P5251, DOI 10.1158/0008-5472.CAN-08-4977; Ordway JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001314; Oshiro MM, 2005, NEOPLASIA, V7, P799, DOI 10.1593/neo.05274; Rauch T, 2007, P NATL ACAD SCI USA, V104, P5527, DOI 10.1073/pnas.0701059104; Sproul D, 2011, P NATL ACAD SCI USA, V108, P4364, DOI 10.1073/pnas.1013224108; STAMPFER M, 1980, IN VITRO CELL DEV B, V16, P415; Strathdee G, 2007, CLIN CANCER RES, V13, P5048, DOI 10.1158/1078-0432.CCR-07-0919; Vrba L, 2011, GENOME RES, V21, P2026, DOI 10.1101/gr.123935.111; Vrba L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008697; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Zhang JM, 2006, CANCER RES, V66, P10325, DOI 10.1158/0008-5472.CAN-06-1594	50	17	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52299	10.1371/journal.pone.0052299	http://dx.doi.org/10.1371/journal.pone.0052299			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284978	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500139
J	Ouelaa, W; Ghouzali, I; Langlois, L; Fetissov, S; Dechelotte, P; Ducrotte, P; Leroi, AM; Gourcerol, G				Ouelaa, Wassila; Ghouzali, Ibtissem; Langlois, Ludovic; Fetissov, Serguei; Dechelotte, Pierre; Ducrotte, Philippe; Leroi, Anne Marie; Gourcerol, Guillaume			Gastric Electrical Stimulation Decreases Gastric Distension-Induced Central Nociception Response through Direct Action on Primary Afferents	PLOS ONE			English	Article							COLORECTAL DISTENSION; VISCERAL PAIN; NEURONS; GASTROPARESIS; ACTIVATION; MECHANISMS; OUTCOMES; STRESS	Background & Aims: Gastric electrical stimulation (GES) is an effective therapy to treat patients with chronic dyspepsia refractory to medical management. However, its mechanisms of action remain poorly understood. Methods: Gastric pain was induced by performing gastric distension (GD) in anesthetized rats. Pain response was monitored by measuring the pseudo-affective reflex (e.g., blood pressure variation), while neuronal activation was determined using c-fos immunochemistry in the central nervous system. Involvement of primary afferents was assessed by measuring phosphorylation of ERK1/2 in dorsal root ganglia. Results: GES decreased blood pressure variation induced by GD, and prevented GD-induced neuronal activation in the dorsal horn of the spinal cord (T9-T10), the nucleus of the solitary tract and in CRF neurons of the hypothalamic paraventricular nucleus. This effect remained unaltered within the spinal cord when sectioning the medulla at the T5 level. Furthermore, GES prevented GD-induced phosphorylation of ERK1/2 in dorsal root ganglia. Conclusions: GES decreases GD-induced pain and/or discomfort likely through a direct modulation of gastric spinal afferents reducing central processing of visceral nociception. Citation: Ouelaa W, Ghouzali I, Langlois L, Fetissov S, Dechelotte P, et al. (2012) Gastric Electrical Stimulation Decreases Gastric Distension-Induced Central Nociception Response through Direct Action on Primary Afferents. PLoS ONE 7(12): e47849. doi:10.1371/journal.pone.0047849	[Ouelaa, Wassila; Ghouzali, Ibtissem; Langlois, Ludovic; Fetissov, Serguei; Dechelotte, Pierre; Ducrotte, Philippe; Leroi, Anne Marie; Gourcerol, Guillaume] Univ Rouen, Nutr Gut & Brain Unit, ADEN INSERM U1073, Inst Biomed Res & Innovat, Rouen, France; [Dechelotte, Pierre; Ducrotte, Philippe; Leroi, Anne Marie; Gourcerol, Guillaume] Rouen Univ Hosp, Dept Nutr, Rouen, France; [Ducrotte, Philippe; Leroi, Anne Marie; Gourcerol, Guillaume] Rouen Univ Hosp, Dept Gastroenterol, Rouen, France; [Leroi, Anne Marie; Gourcerol, Guillaume] Rouen Univ Hosp, Dept Physiol, Rouen, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; CHU de Rouen; CHU de Rouen; CHU de Rouen	Gourcerol, G (corresponding author), Univ Rouen, Nutr Gut & Brain Unit, ADEN INSERM U1073, Inst Biomed Res & Innovat, Rouen, France.	Gourcerol.Guillaume@chu-rouen.fr	Fetissov, Sergueï O/H-6023-2016	Fetissov, Sergueï O/0000-0002-2491-4945; Gourcerol, Guillaume/0000-0001-8220-9155	University of Rouen, Institute for Research and Innovation in Biomedicine (IRIB); French Ministry of Health Grants for therapeutic innovation (STIC); French Society of Gastroenterology (SNFGE)	University of Rouen, Institute for Research and Innovation in Biomedicine (IRIB); French Ministry of Health Grants for therapeutic innovation (STIC); French Society of Gastroenterology (SNFGE)	This work was supported by the University of Rouen, Institute for Research and Innovation in Biomedicine (IRIB), by the French Ministry of Health Grants for therapeutic innovation (STIC). WO was the recipient of a fellowship from the French Society of Gastroenterology (SNFGE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell T, 2003, JPEN-PARENTER ENTER, V27, P277, DOI 10.1177/0148607103027004277; Abell T, 2003, GASTROENTEROLOGY, V125, P421, DOI 10.1016/S0016-5085(03)00878-3; Chen JDZ, 2003, GASTROENTEROLOGY, V124, P401, DOI 10.1053/gast.2003.50048; Derrey S, 2011, NEUROSCIENCE, V195, P89, DOI 10.1016/j.neuroscience.2011.08.004; Erriquez J, 2009, CELL CALCIUM, V46, P197, DOI 10.1016/j.ceca.2009.07.003; Familoni BO, 1997, DIGEST DIS SCI, V42, P885, DOI 10.1023/A:1018852011857; Gallas S, 2011, EUR J NEUROSCI, V33, P276, DOI 10.1111/j.1460-9568.2010.07474.x; Gourcerol G, 2007, NEUROSCIENCE, V148, P775, DOI 10.1016/j.neuroscience.2007.07.001; Gourcerol G, 2007, EUR J GASTROEN HEPAT, V19, P29, DOI 10.1097/01.meg.0000250584.15490.b4; Gourcerol G, 2009, J AM COLL SURGEONS, V209, P215, DOI 10.1016/j.jamcollsurg.2009.04.009; Larauche M, 2008, AM J PHYSIOL-GASTR L, V294, pG1033, DOI 10.1152/ajpgi.00507.2007; Lin Z, 2006, NEUROGASTROENT MOTIL, V18, P18, DOI 10.1111/j.1365-2982.2005.00732.x; Lin Z, 2004, NEUROGASTROENT MOTIL, V16, P205, DOI 10.1111/j.1365-2982.2004.00503.x; Lin ZY, 2004, DIABETES CARE, V27, P1071, DOI 10.2337/diacare.27.5.1071; Marion R, 2006, INFECT IMMUN, V74, P4387, DOI 10.1128/IAI.02055-05; McCallum R, 2005, CLIN GASTROENTEROL H, V3, P49, DOI 10.1016/S1542-3565(04)00605-6; McCallum RW, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2009.01389.x; McCallum RW, 2011, CLIN GASTROENTEROL H, V9, P314, DOI 10.1016/j.cgh.2010.12.013; Million M, 2006, GUT, V55, P172, DOI 10.1136/gut.2004.051391; NESS TJ, 1988, BRAIN RES, V450, P153, DOI 10.1016/0006-8993(88)91555-7; Peng YB, 2003, J NEUROSCI, V23, P4766; Reddymasu SC, 2010, DIGEST DIS SCI, V55, P983, DOI 10.1007/s10620-009-0818-0; Sakurai J, 2008, GASTROENTEROLOGY, V134, P1094, DOI 10.1053/j.gastro.2008.01.031; Stengel A, 2009, ANNU REV PHYSIOL, V71, P219, DOI 10.1146/annurev.physiol.010908.163221; Tache Yvette, 2009, Curr Gastroenterol Rep, V11, P270; Tang M, 2006, OBES SURG, V16, P344, DOI 10.1381/096089206776116372; Vergnano AM, 2008, ENDOCRINOLOGY, V149, P2306, DOI 10.1210/en.2007-1164	27	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e47849	10.1371/journal.pone.0047849	http://dx.doi.org/10.1371/journal.pone.0047849			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284611	gold, Green Submitted, Green Published			2022-12-27	WOS:000312794500002
J	Raz, T; Avni, R; Addadi, Y; Cohen, Y; Jaffa, AJ; Hemmings, B; Garbow, JR; Neeman, M				Raz, Tal; Avni, Reut; Addadi, Yoseph; Cohen, Yoni; Jaffa, Ariel J.; Hemmings, Brian; Garbow, Joel R.; Neeman, Michal			The Hemodynamic Basis for Positional- and Inter-Fetal Dependent Effects in Dual Arterial Supply of Mouse Pregnancies	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; INTRAUTERINE POSITION; GROWTH-RETARDATION; MICE; MRI; EMBRYO; AKT1; PREECLAMPSIA; RESTRICTION; INHIBITION	In mammalian pregnancy, maternal cardiovascular adaptations must match the requirements of the growing fetus(es), and respond to physiologic and pathologic conditions. Such adaptations are particularly demanding for mammals bearing large-litter pregnancies, with their inherent conflict between the interests of each individual fetus and the welfare of the entire progeny. The mouse is the most common animal model used to study development and genetics, as well as pregnancy-related diseases. Previous studies suggested that in mice, maternal blood flow to the placentas occurs via a single arterial uterine loop generated by arterial-arterial anastomosis of the uterine artery to the uterine branch of the ovarian artery, resulting in counter bi-directional blood flow. However, we provide here experimental evidence that each placenta is actually supplied by two distinct arterial inputs stemming from the uterine artery and from the uterine branch of the ovarian artery, with position-dependent contribution of flow from each source. Moreover, we report significant positional- and inter-fetal dependent alteration of placental perfusion, which were detected by in vivo MRI and fluorescence imaging. Maternal blood flow to the placentas was dependent on litter size and was attenuated for placentas located centrally along the uterine horn. Distinctive apposing, inter-fetal hemodynamic effects of either reduced or elevated maternal blood flow, were measured for placenta of normal fetuses that are positioned adjacent to either pathological, or to hypovascular Akt1-deficient placentas, respectively. The results reported here underscore the critical importance of confounding local and systemic in utero effects on phenotype presentation, in general and in the setting of genetically modified mice. The unique robustness and plasticity of the uterine vasculature architecture, as reported in this study, can explain the ability to accommodate varying litter sizes, sustain large-litter pregnancies and overcome pathologic challenges. Remarkably, the dual arterial supply is evolutionary conserved in mammals bearing a single offspring, including primates.	[Raz, Tal; Avni, Reut; Addadi, Yoseph; Cohen, Yoni; Neeman, Michal] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Jaffa, Ariel J.] Lis Matern Hosp, Tel Aviv Souraski Med Ctr, Tel Aviv, Israel; [Hemmings, Brian] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Garbow, Joel R.] Washington Univ, Mallinckrodt Inst Radiol, Biomed MR Lab, St Louis, MO USA	Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Friedrich Miescher Institute for Biomedical Research; Washington University (WUSTL)	Neeman, M (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.	michal.neeman@weizmann.ac.il	Neeman, Michal/A-8264-2008; Neeman, Michal/AAH-9602-2019	Neeman, Michal/0000-0002-6296-816X; Neeman, Michal/0000-0002-6296-816X; Addadi, Sefi/0000-0001-9827-0436	7th Framework European Research Council [232640-IMAGO]; United States - Israel Binational Science Foundation [2011405]; STFC [ST/H005234/1] Funding Source: UKRI	7th Framework European Research Council(European Commission); United States - Israel Binational Science Foundation(US-Israel Binational Science Foundation); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This work was supported by the 7th Framework European Research Council Advanced grant 232640-IMAGO (to MN), and by the United States - Israel Binational Science Foundation grant 2011405 (BSF to MN, JRG and TR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avni R, 2012, MAGN RESON MED, V68, P560, DOI 10.1002/mrm.23246; BARKER DJP, 1989, LANCET, V2, P577; Barker DJP, 1999, ANN MED, V31, P3, DOI 10.1080/07853890.1999.11904392; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Berkane N, 2010, CURR OPIN OBSTET GYN, V22, P242, DOI 10.1097/GCO.0b013e328338c179; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cicinelli E, 2004, ANN NY ACAD SCI, V1034, P19, DOI 10.1196/annals.1335.002; Cohen B, 2007, NAT MED, V13, P498, DOI 10.1038/nm1497; DeBosch B, 2006, CIRCULATION, V113, P2097, DOI 10.1161/CIRCULATIONAHA.105.595231; Dickinson ME, 2006, DEV DYNAM, V235, P2386, DOI 10.1002/dvdy.20889; Eghbali M, 2005, CIRC RES, V96, P1208, DOI 10.1161/01.RES.0000170652.71414.16; GINTHER OJ, 1974, J ANIM SCI, V39, P550, DOI 10.2527/jas1974.393550x; Girsh E, 2007, NMR BIOMED, V20, P28, DOI 10.1002/nbm.1087; GROENENBERG IAL, 1989, CIRCULATION, V80, P1711, DOI 10.1161/01.CIR.80.6.1711; Jayet PY, 2010, CIRCULATION, V122, P488, DOI 10.1161/CIRCULATIONAHA.110.941203; Kent LN, 2012, INT J DEV BIOL, V56, P255, DOI 10.1387/ijdb.113407lk; Khankin EV, 2010, SEMIN THROMB HEMOST, V36, P309, DOI 10.1055/s-0030-1253453; Kulandavelu S, 2006, HYPERTENSION, V47, P1175, DOI 10.1161/01.HYP.0000218440.71846.db; Magness RR, 1998, AM J PHYSIOL-HEART C, V275, pH731, DOI 10.1152/ajpheart.1998.275.3.H731; MCGRATH CJ, 1984, MOD VET PRACT, V65, P522; MCLAREN A, 1960, NATURE, V187, P363, DOI 10.1038/187363a0; Meyer KM, 2010, BIOL REPROD, V83, P799, DOI 10.1095/biolreprod.110.085381; Nagao T, 2004, REPROD TOXICOL, V18, P109, DOI 10.1016/j.reprotox.2003.10.009; Nieman BJ, 2010, METHOD ENZYMOL, V476, P379, DOI 10.1016/S0076-6879(10)76021-3; Noori M, 2010, CIRCULATION, V122, P478, DOI 10.1161/CIRCULATIONAHA.109.895458; O'Leary-Moore SK, 2011, NEUROPSYCHOL REV, V21, P167, DOI 10.1007/s11065-011-9164-z; Orita J, 1996, EXP ANIM TOKYO, V45, P171, DOI 10.1538/expanim.45.171; Osol G, 2009, PHYSIOLOGY, V24, P58, DOI 10.1152/physiol.00033.2008; Plaks V, 2006, MAGN RESON MED, V55, P1013, DOI 10.1002/mrm.20881; Plaks V, 2011, MOL IMAGING BIOL, V13, P481, DOI 10.1007/s11307-010-0390-1; Plaks V, 2011, BIOL REPROD, V84, P537, DOI 10.1095/biolreprod.110.085951; Poppas A, 1997, CIRCULATION, V95, P2407, DOI 10.1161/01.CIR.95.10.2407; RAMSEY EM, 1979, AM J OBSTET GYNECOL, V135, P247, DOI 10.1016/0002-9378(79)90353-3; Riesterer O, 2004, ONCOGENE, V23, P4624, DOI 10.1038/sj.onc.1207596; Riley JK, 2005, DEV BIOL, V284, P377, DOI 10.1016/j.ydbio.2005.05.033; Ryan BC, 2002, NEUROSCI BIOBEHAV R, V26, P665, DOI 10.1016/S0149-7634(02)00038-6; SAAL FSV, 1992, PHYSIOL BEHAV, V52, P163, DOI 10.1016/0031-9384(92)90447-A; Salomon LJ, 2005, RADIOLOGY, V235, P73, DOI 10.1148/radiol.2351040192; Shen Y, 2005, PHYSIOL GENOMICS, V24, P23, DOI 10.1152/physiolgenomics.00129.2005; Spurney CF, 2006, ECHOCARDIOGR-J CARD, V23, P891, DOI 10.1111/j.1540-8175.2006.00335.x; Tobita K, 2010, BIRTH DEFECTS RES C, V90, P176, DOI 10.1002/bdrc.20187; Tomlinson TM, 2010, AM J PHYSIOL-REG I, V298, pR312, DOI 10.1152/ajpregu.00425.2009; Valdes G, 2011, INTEGR BLOOD PRESS C, V4, P45, DOI 10.2147/IBPC.S8393; VOMSAAL FS, 1981, J REPROD FERTIL, V62, P633, DOI [10.1530/jrf.0.0620633, 10.1530/jrf.0.0620033]; Walls JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002853; Wong AYH, 2002, AM J PHYSIOL-HEART C, V282, pH918, DOI 10.1152/ajpheart.00641.2001; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200; Yung HW, 2008, AM J PATHOL, V173, P451, DOI 10.2353/ajpath.2008.071193	48	14	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52273	10.1371/journal.pone.0052273	http://dx.doi.org/10.1371/journal.pone.0052273			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284965	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500132
J	Zhang, JY; Tong, W; Wu, F; Bi, SH; Xu, M; Jin, ZX; Yang, Y; Jiang, XF; Zhou, JJ				Zhang, Jian-Ying; Tong, Wei; Wu, Feng; Bi, Sheng-Hui; Xu, Ming; Jin, Zhen-Xiao; Yang, Yang; Jiang, Xiao-Fan; Zhou, Jing-Jun			Different Roles for Contracture and Calpain in Calcium Paradox-Induced Heart Injury	PLOS ONE			English	Article							RAT-HEART; MYOCARDIAL ISCHEMIA/REPERFUSION; VENTRICULAR MYOCYTES; NA+/CA2+ EXCHANGER; REVERSE MODE; REPERFUSION; ACTIVATION; ISCHEMIA; SODIUM; SYSTEM	The Ca2+ paradox represents a good model to study Ca2+ overload injury in ischemic heart diseases. We and others have demonstrated that contracture and calpain are involved in the Ca2+ paradox-induced injury. This study aimed to elucidate their roles in this model. The Ca2+ paradox was elicited by perfusing isolated rat hearts with Ca2+-free KH media for 3 min or 5 min followed by 30 min of Ca2+ repletion. The LVDP was measured to reflect contractile function, and the LVEDP was measured to indicate contracture. TTC staining and the quantification of LDH release were used to define cell death. Calpain activity and troponin I release were measured after Ca2+ repletion. Ca2+ repletion of the once 3-min Ca2+ depleted hearts resulted in almost no viable tissues and the disappearance of contractile function. Compared to the effects of the calpain inhibitor MDL28170, KB-R7943, an inhibitor of the Na+/Ca2+ exchanger, reduced the LVEDP level to a greater extent, which was well correlated with improved contractile function recovery and tissue survival. The depletion of Ca2+ for 5 min had the same effects on injury as the 3-min Ca2+ depletion, except that the LVEDP in the 5-min Ca2+ depletion group was lower than the level in the 3-min Ca2+ depletion group. KB-R7943 failed to reduce the level of LVEDP, with no improvement in the LVDP recovery in the hearts subjected to the 5-min Ca2+ depletion treatment; however, KB-R7943 preserved its protective effects in surviving tissue. Both KB-R7943 and MDL28170 attenuated the Ca2+ repletion-induced increase in calpain activity in 3 min or 5 min Ca2+ depleted hearts. However, only KB-R7943 reduced the release of troponin I from the Ca2+ paradoxic heart. These results provide evidence suggesting that contracture is the main cause for contractile dysfunction, while activation of calpain mediates cell death in the Ca2+ paradox.	[Jiang, Xiao-Fan] Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Peoples R China; [Zhang, Jian-Ying; Xu, Ming; Zhou, Jing-Jun] Fourth Mil Med Univ, Xijing Hosp, Dept Physiol, Xian 710032, Peoples R China; [Tong, Wei] Fourth Mil Med Univ, Xijing Hosp, Dept Out Patient Clin, Xian 710032, Peoples R China; [Wu, Feng] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Peoples R China; [Bi, Sheng-Hui; Jin, Zhen-Xiao; Yang, Yang] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiovasc Surg, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Jiang, XF (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Peoples R China.	jiangxf@fmmu.edu.cn; jjzhou71@yahoo.com	Jin, Zhenxiao/AAJ-5777-2020	xu, ming/0000-0001-5234-2203	Natural Science Foundation of China [30971196, 81100082]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of China (grant no. 30971196 and 81100082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolakis EE, 2009, J CARDIOTHORAC SURG, V4, DOI 10.1186/1749-8090-4-67; BARRY WH, 1987, CIRC RES, V61, P726, DOI 10.1161/01.RES.61.5.726; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bi SH, 2012, CLIN EXP PHARMACOL P, V39, P385, DOI 10.1111/j.1440-1681.2012.05683.x; Chatamra KR, 1996, EXP PHYSIOL, V81, P203, DOI 10.1113/expphysiol.1996.sp003925; Chen M, 2001, J BIOL CHEM, V276, P30724, DOI 10.1074/jbc.M103701200; DALY MJ, 1987, CIRC RES, V61, P560, DOI 10.1161/01.RES.61.4.560; Donkor IO, 2000, CURR MED CHEM, V7, P1171, DOI 10.2174/0929867003374129; Fozzard HA, 2002, CARDIOVASC RES, V55, P1, DOI 10.1016/S0008-6363(02)00407-8; Gaitanaki C, 2003, CELL PHYSIOL BIOCHEM, V13, P173, DOI 10.1159/000071868; Galvez AS, 2007, CIRC RES, V100, P1071, DOI 10.1161/01.RES.0000261938.28365.11; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hernando V, 2010, J MOL CELL CARDIOL, V49, P271, DOI 10.1016/j.yjmcc.2010.02.024; Inserte J, 2005, CIRC RES, V97, P465, DOI 10.1161/01.RES.0000181170.87738.f3; Inserte J, 2009, CARDIOVASC RES, V81, P116, DOI 10.1093/cvr/cvn260; Iwamoto T, 1996, J BIOL CHEM, V271, P22391, DOI 10.1074/jbc.271.37.22391; Jin ZX, 2007, ANN THORAC SURG, V83, P2066, DOI 10.1016/j.athoracsur.2006.12.031; Kojima A, 2010, BRIT J PHARMACOL, V161, P1734, DOI 10.1111/j.1476-5381.2010.00986.x; Leloup L, 2010, J BIOL CHEM, V285, P33549, DOI 10.1074/jbc.M110.123604; Lompre AM, 2010, CIRCULATION, V121, P822, DOI 10.1161/CIRCULATIONAHA.109.890954; MacGowan GA, 2001, AM J PHYSIOL-HEART C, V280, pH835, DOI 10.1152/ajpheart.2001.280.2.H835; Makazan Z, 2009, CAN J PHYSIOL PHARM, V87, P789, DOI 10.1139/Y09-050; Mani SK, 2009, AM J PHYSIOL-HEART C, V297, pH1744, DOI 10.1152/ajpheart.00338.2009; Murgia M, 2009, J MOL CELL CARDIOL, V46, P781, DOI 10.1016/j.yjmcc.2009.03.003; NAYLER WG, 1984, CIRC RES, V55, P227, DOI 10.1161/01.RES.55.2.227; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Piper HM, 2000, CARDIOVASC RES, V45, P123, DOI 10.1016/S0008-6363(99)00304-1; Sapia L, 2010, J MOL CELL CARDIOL, V49, P459, DOI 10.1016/j.yjmcc.2010.04.013; Satoh H, 2000, CIRCULATION, V101, P1441, DOI 10.1161/01.CIR.101.12.1441; Schafer C, 2001, CARDIOVASC RES, V51, P241, DOI 10.1016/S0008-6363(01)00282-6; Shan LM, 2010, FREE RADICAL BIO MED, V49, P1804, DOI 10.1016/j.freeradbiomed.2010.09.018; SINGAL PK, 1979, BRIT J EXP PATHOL, V60, P96; Suzuki K, 2004, DIABETES, V53, pS12, DOI 10.2337/diabetes.53.2007.S12; Takahashi K, 2003, EUR J PHARMACOL, V458, P155, DOI 10.1016/S0014-2999(02)02732-2; Talukder MAH, 2009, CARDIOVASC RES, V84, P345, DOI 10.1093/cvr/cvp264; VANDERHEIDE RS, 1986, AM J PATHOL, V123, P351; VANDERHEIDE RS, 1986, AM J PATHOL, V125, P55; Venge P, 2001, CLIN CHEM, V47, P959; Villars PS, 2004, AM J CRIT CARE, V13, P394, DOI 10.4037/ajcc2004.13.5.394; Wada T, 2010, AM J PHYSIOL-ENDOC M, V298, pE881, DOI 10.1152/ajpendo.00649.2009; Willis MS, 2009, CARDIOVASC RES, V81, P439, DOI 10.1093/cvr/cvn289; YOSHIDA K, 1995, CIRC RES, V77, P603, DOI 10.1161/01.RES.77.3.603; ZIMMERMAN AN, 1966, NATURE, V211, P646, DOI 10.1038/211646a0	43	7	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52270	10.1371/journal.pone.0052270	http://dx.doi.org/10.1371/journal.pone.0052270			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284963	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500131
J	Chamorro-Garcia, R; Cervera, M; Arredondo, JJ				Chamorro-Garcia, Raquel; Cervera, Margarita; Arredondo, Juan J.			AF10 Plays a Key Role in the Survival of Uncommitted Hematopoietic Cells	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; STEM-CELLS; T(10-11) TRANSLOCATION; CALM/AF10 FUSION; SELF-RENEWAL; LINE; MLL; DIFFERENTIATION; TRANSFORMATION; GENES	Hematopoiesis is a complex process regulated by both cell intrinsic and cell extrinsic factors. Alterations in the expression of critical genes during hematopoiesis can modify the balance between stem cell differentiation and proliferation, and may ultimately give rise to leukemia and other diseases. AF10 is a transcription factor that has been implicated in the development of leukemia following chromosomal rearrangements between the AF10 gene and one of at least two other genes, MLL and CALM. The link between AF10 and leukemia, together with the known interactions between AF10 and hematopoietic regulators, suggests that AF10 may be important in hematopoiesis and in leukemic transformation. Here we show that AF10 is important for proper hematopoietic differentiation. The induction of hematopoietic differentiation in both human hematopoietic cell lines and murine total bone marrow cells triggers a decrease of AF10 mRNA and protein levels, particularly in stem cells and multipotent progenitors. Gain-and loss-of-function studies demonstrate that over-or under-expression of AF10 leads to apoptotic cell death in stem cells and multipotent progenitors. We conclude that AF10 plays a key role in the maintenance of multipotent hematopoietic cells.	Autonomous Univ Madrid, Consejo Super Invest Cient, Dept Bioquim, E-28049 Madrid, Spain; Autonomous Univ Madrid, Consejo Super Invest Cient, Inst Invest Biomed, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC)	Chamorro-Garcia, R (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA.	rchamorr@uci.edu; juan.arredondo@uam.es	Arredondo, Juan/L-2404-2013	Arredondo, Juan/0000-0002-6784-0990	Autonomous University of Madrid-CAM [06/CSB/004, CCG06-UAM/BIO-0322]; Fundacion MMA	Autonomous University of Madrid-CAM; Fundacion MMA	Work supported by grants 06/CSB/004 and CCG06-UAM/BIO-0322 from The Autonomous University of Madrid-CAM and by Fundacion MMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai F, 2007, ADV EXP MED BIOL, V602, P61; Arco PGD, 2005, MOL CELL BIOL, V25, P2688, DOI 10.1128/MCB.25.7.2688-2697.2005; Argiropoulos B, 2007, ONCOGENE, V26, P6766, DOI 10.1038/sj.onc.1210760; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; Barry ER, 2009, STEM CELLS, V27, P1538, DOI 10.1002/stem.86; Biondi A, 2000, BLOOD, V96, P24, DOI 10.1182/blood.V96.1.24; Bodine PVN, 2008, CELL RES, V18, P248, DOI 10.1038/cr.2008.13; Bohlander SK, 2000, LEUKEMIA, V14, P93, DOI 10.1038/sj.leu.2401614; BOLTZNITULESCU G, 1987, J LEUKOCYTE BIOL, V41, P83, DOI 10.1002/jlb.41.1.83; CHAPLIN T, 1995, BLOOD, V86, P2073, DOI 10.1182/blood.V86.6.2073.bloodjournal8662073; CHAPLIN T, 1995, BLOOD, V85, P1435, DOI 10.1182/blood.V85.6.1435.bloodjournal8561435; COLLINS SJ, 1987, BLOOD, V70, P1233; Daser A, 2004, GENE DEV, V18, P965, DOI 10.1101/gad.1195504; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Deshpande AJ, 2011, LEUKEMIA, V25, P1718, DOI 10.1038/leu.2011.153; Dreyling MH, 1996, P NATL ACAD SCI USA, V93, P4804, DOI 10.1073/pnas.93.10.4804; Ernst P, 2004, DEV CELL, V6, P437, DOI 10.1016/S1534-5807(04)00061-9; Felix CA, 1998, BBA-GENE STRUCT EXPR, V1400, P233, DOI 10.1016/S0167-4781(98)00139-0; Feng Y, 2010, BLOOD, V116, P4483, DOI 10.1182/blood-2010-03-276501; FitzGerald J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014714; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Forissier S, 2007, BIOL CELL, V99, P563, DOI 10.1042/BC20060131; GEORGOPOULOS K, 1992, SCIENCE, V258, P808, DOI 10.1126/science.1439790; Gomez-del Arco P, 2004, MOL CELL BIOL, V24, P2797, DOI 10.1128/MCB.24.7.2797-2807.2004; Greif PA, 2008, ONCOGENE, V27, P2886, DOI 10.1038/sj.onc.1210945; Hess JL, 2004, CRIT REV EUKAR GENE, V14, P235, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i4.10; Jones B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000190; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Lessard J, 2003, EXP HEMATOL, V31, P567, DOI 10.1016/S0301-472X(03)00081-X; LONG MW, 1990, J CLIN INVEST, V85, P1072, DOI 10.1172/JCI114538; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Luis TC, 2009, BLOOD, V113, P546, DOI 10.1182/blood-2008-06-163774; Maguer-Satta W, 2004, MOL CELL ENDOCRINOL, V225, P109, DOI 10.1016/j.mce.2004.07.009; Mahmoudi T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000539; Mohan M, GENES DEV, V24, P574; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Okada Y, 2006, NAT CELL BIOL, V8, P1017, DOI 10.1038/ncb1464; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; SATO T, 1989, BRIT J HAEMATOL, V72, P184, DOI 10.1111/j.1365-2141.1989.tb07681.x; Slany RK, 2009, HAEMATOL-HEMATOL J, V94, P984, DOI 10.3324/haematol.2008.002436; You L, 2006, DRUG NEWS PERSPECT, V19, P27, DOI 10.1358/dnp.2006.19.1.965871; Yu BD, 1998, P NATL ACAD SCI USA, V95, P10632, DOI 10.1073/pnas.95.18.10632; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0	48	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51626	10.1371/journal.pone.0051626	http://dx.doi.org/10.1371/journal.pone.0051626			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284727	Green Published, Green Accepted, gold			2022-12-27	WOS:000312694300033
J	Prowse, ABJ; Chong, F; Elliott, DA; Elefanty, AG; Stanley, EG; Gray, PP; Munro, TP; Osborne, GW				Prowse, Andrew B. J.; Chong, Fenny; Elliott, David A.; Elefanty, Andrew G.; Stanley, Edouard G.; Gray, Peter P.; Munro, Trent P.; Osborne, Geoffrey W.			Analysis of Mitochondrial Function and Localisation during Human Embryonic Stem Cell Differentiation In Vitro	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; RECOMBINANT VITRONECTIN; ANTIOXIDANT ENZYMES; BIOGENESIS; DNA; LINES; PCR; QUANTIFICATION; MECHANISMS	Human embryonic stem cell (hESC) derivatives show promise as viable cell therapy options for multiple disorders in different tissues. Recent advances in stem cell biology have lead to the reliable production and detailed molecular characterisation of a range of cell-types. However, the role of mitochondria during differentiation has yet to be fully elucidated. Mitochondria mediate a cells response to altered energy requirements (e.g. cardiomyocyte contraction) and, as such, the mitochondrial phenotype is likely to change during the dynamic process of hESC differentiation. We demonstrate that manipulating mitochondrial biogenesis alters mesendoderm commitment. To investigate mitochondrial localisation during early lineage specification of hESCs we developed a mitochondrial reporter line, KMEL2, in which sequences encoding the green fluorescent protein (GFP) are targeted to the mitochondria. Differentiation of KMEL2 lines into the three germ layers showed that the mitochondria in these differentiated progeny are GFP positive. Therefore, KMEL2 hESCs facilitate the study of mitochondria in a range of cell types and, importantly, permit real-time analysis of mitochondria via the GFP tag.	[Prowse, Andrew B. J.; Chong, Fenny; Gray, Peter P.; Munro, Trent P.; Osborne, Geoffrey W.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld, Australia; [Elliott, David A.; Elefanty, Andrew G.; Stanley, Edouard G.] Monash Univ, Monash Immunol & Stem Cell Labs, Clayton, Vic, Australia; [Osborne, Geoffrey W.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia; [Elefanty, Andrew G.; Stanley, Edouard G.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia	University of Queensland; Monash University; University of Queensland; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Prowse, ABJ (corresponding author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld, Australia.	a.prowse@uq.edu.au	Elliott, David/H-3334-2012; Gray, Peter/AAC-3737-2019; Munro, Trent/AAC-1129-2020; Elefanty, Andrew G/A-6066-2008; Stanley, Ed G/A-2985-2013; Osborne, Geoffrey/G-4873-2010	Elliott, David/0000-0003-1052-7407; Munro, Trent/0000-0003-1987-2020; Stanley, Ed G/0000-0002-6389-3665; Osborne, Geoffrey/0000-0003-0472-6610; Elefanty, Andrew/0000-0001-6448-8314	The Australian Research Council; Australian Institute for Bioengineering and Nanotechnology; National Health and Medical Research Council (NHMRC) of Australia; Qatar National Research Fund	The Australian Research Council(Australian Research Council); Australian Institute for Bioengineering and Nanotechnology; National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Qatar National Research Fund(Qatar National Research Fund (QNRF))	The authors would like to thank The Australian Research Council (A.B.J.P., P.P.G., A.G.E., E.G.S.), the Australian Institute for Bioengineering and Nanotechnology (http://www.aibn.uq.edu.au/), the National Health and Medical Research Council (NHMRC) of Australia (D.A.E., A.G.E., E.G.S.) and the Qatar National Research Fund (D.A.E., A.G.E., E.G.S.) for funding. A.G.E. and E.G.S. are Senior Research Fellows of the NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit M, 2003, BIOL REPROD, V68, P2150, DOI 10.1095/biolreprod.102.012583; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Armstrong L, 2010, STEM CELLS, V28, P661, DOI 10.1002/stem.307; Bez A, 2003, BRAIN RES, V993, P18, DOI 10.1016/j.brainres.2003.08.061; Borniquel S, 2006, FASEB J, V20, P1889, DOI 10.1096/fj.05-5189fje; Braam SR, 2008, STEM CELLS, V26, P2257, DOI 10.1634/stemcells.2008-0291; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509; Cho YM, 2006, BIOCHEM BIOPH RES CO, V348, P1472, DOI 10.1016/j.bbrc.2006.08.020; Chung Susan, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS60, DOI 10.1038/ncpcardio0766; Collins TJ, 2002, EMBO J, V21, P1616, DOI 10.1093/emboj/21.7.1616; Davis RP, 2008, BLOOD, V111, P1876, DOI 10.1182/blood-2007-06-093609; Elliott DA, 2011, NAT METHODS; Facucho-Oliveira JM, 2009, STEM CELL REV REP, V5, P140, DOI 10.1007/s12015-009-9058-0; FREY T, 1995, CYTOMETRY, V21, P265, DOI 10.1002/cyto.990210307; Fujisawa K, 2009, BIOCHEM BIOPH RES CO, V379, P43, DOI 10.1016/j.bbrc.2008.11.141; Gahan ME, 2001, J CLIN VIROL, V22, P241, DOI 10.1016/S1386-6532(01)00195-0; Gibson TC, 2006, REPROD BIOMED ONLINE, V12, P101, DOI 10.1016/S1472-6483(10)60987-X; Hattori F, 2010, NAT METHODS, V7, P61, DOI [10.1038/NMETH.1403, 10.1038/nmeth.1403]; Kanazawa M, 1997, BIOCHEM BIOPH RES CO, V239, P580, DOI 10.1006/bbrc.1997.7448; Kanno S, 2004, P NATL ACAD SCI USA, V101, P12277, DOI 10.1073/pnas.0401557101; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943; Larsson NG, 1997, HUM MOL GENET, V6, P185, DOI 10.1093/hmg/6.2.185; Lonergan T, 2007, MITOCHONDRION, V7, P289, DOI 10.1016/j.mito.2007.05.002; Lopez MF, 2000, ELECTROPHORESIS, V21, P3427, DOI 10.1002/1522-2683(20001001)21:16<3427::AID-ELPS3427>3.0.CO;2-L; Mandal S, 2011, STEM CELLS, V29, P486, DOI 10.1002/stem.590; Marmolino D, 2011, BRAIN RES REV, V67, P311, DOI 10.1016/j.brainresrev.2011.04.001; Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060; Narendra DP, 2012, NATURE, V483, P418, DOI 10.1038/nature10952; Nesti C, 2007, BIOSCIENCE REP, V27, P165, DOI 10.1007/s10540-007-9044-1; Ng ES, 2008, NAT PROTOC, V3, P768, DOI 10.1038/nprot.2008.42; Ng Elizabeth S, 2008, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01d03s4; Oh SK, 2005, STEM CELLS, V23, P211, DOI 10.1634/stemcells.2004-0122; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pietila M, 2010, TISSUE ENG PART C-ME, V16, P435, DOI 10.1089/ten.tec.2009.0247; Prigione A, 2010, STEM CELLS, V28, P721, DOI 10.1002/stem.404; Prowse ABJ, 2010, BIOMATERIALS, V31, P8281, DOI 10.1016/j.biomaterials.2010.07.037; Prowse ABJ, 2009, STEM CELLS DEV, V18, P1135, DOI 10.1089/scd.2009.0080; Rehman J, 2010, J MOL MED, V88, P981, DOI 10.1007/s00109-010-0678-2; RIZZUTO R, 1995, CURR BIOL, V5, P635, DOI 10.1016/S0960-9822(95)00128-X; San Martin N, 2011, STEM CELLS, V29, P1064, DOI 10.1002/stem.654; Sharma NS, 2009, TISSUE ENG PART C-ME, V15, P297, DOI 10.1089/ten.tec.2008.0303; Snyder DS, 2001, J IMMUNOL METHODS, V257, P35, DOI 10.1016/S0022-1759(01)00440-9; St John JC, 2005, CLONING STEM CELLS, V7, P141, DOI 10.1089/clo.2005.7.141; St John JC, 2006, METH MOL B, V331, P347; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Varum S, 2009, STEM CELL RES, V3, P142, DOI 10.1016/j.scr.2009.07.002; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	50	34	36	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52214	10.1371/journal.pone.0052214	http://dx.doi.org/10.1371/journal.pone.0052214			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284940	Green Published, Green Submitted, gold			2022-12-27	WOS:000312694300081
J	Valdes-Mas, R; Bea, S; Puente, DA; Lopez-Otin, C; Puente, XS				Valdes-Mas, Rafael; Bea, Silvia; Puente, Diana A.; Lopez-Otin, Carlos; Puente, Xose S.			Estimation of Copy Number Alterations from Exome Sequencing Data	PLOS ONE			English	Article							FREQUENT MUTATION; HYBRID SELECTION; CANCER GENOME; IDENTIFICATION; DISCOVERY; VARIANTS; PATIENT	Exome sequencing constitutes an important technology for the study of human hereditary diseases and cancer. However, the ability of this approach to identify copy number alterations in primary tumor samples has not been fully addressed. Here we show that somatic copy number alterations can be reliably estimated using exome sequencing data through a strategy that we have termed exome2cnv. Using data from 86 paired normal and primary tumor samples, we identified losses and gains of complete chromosomes or large genomic regions, as well as smaller regions affecting a minimum of one gene. Comparison with high-resolution comparative genomic hybridization (CGH) arrays revealed a high sensitivity and a low number of false positives in the copy number estimation between both approaches. We explore the main factors affecting sensitivity and false positives with real data, and provide a side by side comparison with CGH arrays. Together, these results underscore the utility of exome sequencing to study cancer samples by allowing not only the identification of substitutions and indels, but also the accurate estimation of copy number alterations.	[Valdes-Mas, Rafael; Puente, Diana A.; Lopez-Otin, Carlos; Puente, Xose S.] Univ Oviedo, Inst Univ Oncol IUOPA, Dept Bioquim & Biol Mol, Oviedo, Spain; [Bea, Silvia] Hosp Clin Barcelona, Hematopathol Unit, IDIBAPS, Barcelona, Spain	University of Oviedo; Instituto Universitario de Oncologia de Asturias; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Puente, XS (corresponding author), Univ Oviedo, Inst Univ Oncol IUOPA, Dept Bioquim & Biol Mol, Oviedo, Spain.	xspuente@uniovi.es	bea, silvia/K-7699-2014; Valdés-Mas, Rafael/AAC-2879-2021; Puente, Xosé S./ADB-0672-2022; López-Otín, Carlos/AAB-2106-2020	bea, silvia/0000-0001-7192-2385; Valdés-Mas, Rafael/0000-0002-0737-5425; Puente, Xosé S./0000-0001-9525-1483; López-Otín, Carlos/0000-0001-6964-1904; Wang, Pei/0000-0002-6890-6453	Ministerio de Ciencia e Innovacion-Spain; Fundacion "M.Botin"; European Union (FP7 MicroEnviMet); Instituto de Salud Carlos III (ISCIII); Red Tematica de Investigacion del Cancer (RTICC) del ISCIII	Ministerio de Ciencia e Innovacion-Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion "M.Botin"; European Union (FP7 MicroEnviMet); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Red Tematica de Investigacion del Cancer (RTICC) del ISCIII	This work was supported by grants from Ministerio de Ciencia e Innovacion-Spain, Fundacion "M.Botin", European Union (FP7 MicroEnviMet), Instituto de Salud Carlos III (ISCIII) and Red Tematica de Investigacion del Cancer (RTICC) del ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akavia UD, 2010, CELL, V143, P1005, DOI 10.1016/j.cell.2010.11.013; Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Gilissen C, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-228; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Hodges E, 2009, NAT PROTOC, V4, P960, DOI 10.1038/nprot.2009.68; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Krumm N, 2012, GENOME RES, V22, P1525, DOI 10.1101/gr.138115.112; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2012, BIOINFORMATICS, V28, P1307, DOI 10.1093/bioinformatics/bts146; Link DC, 2011, JAMA-J AM MED ASSOC, V305, P1568, DOI 10.1001/jama.2011.473; Lonigro RJ, 2011, NEOPLASIA, V13, P1019, DOI 10.1593/neo.111252; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Mefford HC, 2009, GENOME RES, V19, P1579, DOI 10.1101/gr.094987.109; Merla G, 2010, HUM GENET, V128, P3, DOI 10.1007/s00439-010-0827-2; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Puente XS, 2011, AM J HUM GENET, V88, P650, DOI 10.1016/j.ajhg.2011.04.010; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Robbins CM, 2011, GENOME RES, V21, P47, DOI 10.1101/gr.107961.110; Sathirapongsasuti JF, 2011, BIOINFORMATICS, V27, P2648, DOI 10.1093/bioinformatics/btr462; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wang Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033673, 10.1371/journal.pone.0041830]; Zenz T, 2010, NAT REV CANCER, V10, P37, DOI 10.1038/nrc2764	42	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51422	10.1371/journal.pone.0051422	http://dx.doi.org/10.1371/journal.pone.0051422			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284693	Green Published, Green Submitted, gold			2022-12-27	WOS:000312694300026
J	Buckley, CD				Buckley, Christopher D.			Investigating Cultural Evolution Using Phylogenetic Analysis: The Origins and Descent of the Southeast Asian Tradition of Warp Ikat Weaving	PLOS ONE			English	Article							HUMAN HISTORY; TREES; POPULATIONS; POLYNESIANS; MTDNA	The warp ikat method of making decorated textiles is one of the most geographically widespread in southeast Asia, being used by Austronesian peoples in Indonesia, Malaysia and the Philippines, and Daic peoples on the Asian mainland. In this study a dataset consisting of the decorative characters of 36 of these warp ikat weaving traditions is investigated using Bayesian and Neighbornet techniques, and the results are used to construct a phylogenetic tree and taxonomy for warp ikat weaving in southeast Asia. The results and analysis show that these diverse traditions have a common ancestor amongst neolithic cultures the Asian mainland, and parallels exist between the patterns of textile weaving descent and linguistic phylogeny for the Austronesian group. Ancestral state analysis is used to reconstruct some of the features of the ancestral weaving tradition. The widely held theory that weaving motifs originated in the late Bronze Age Dong-Son culture is shown to be inconsistent with the data.				chrisbuckley888@hotmail.com		Buckley, Christopher/0000-0002-5059-1668				Adams M, 1972, NEEDLE BOBBIN B NEW, V55, P1; Barnes Ruth., 1989, IKAT TEXTILES LAMALE; Barrkman J, 2009, ART FUTUS; Barrkman J, 2006, THESIS C DARWIN U; Bellwood P, 2005, J AUSTR STUDIES, V1; Bellwood Peter, 1997, PREHISTORY INDOMALAY; Bezemer TJ, 1931, ARTS METIERS INDONES; Blust R, 1995, AUSTRONESIAN COMP DI; Blust Robert, 2009, AUSTRONESIAN LANGUAG; Brow JR, 2007, ART ASIA, V37, P54; Bullough N, 1981, WOVEN TREASURES INSU; Capelli C, 2001, AM J HUM GENET, V68, P432, DOI 10.1086/318205; Cheesman P., 2004, LAO TAI TEXTILES TEX; Collard M, 2006, EVOL HUM BEHAV, V27, P169, DOI 10.1016/j.evolhumbehav.2005.07.003; Crill R, 1998, INDIAN IKAT TEXTILES; Dijk T. van., 2010, 5 CENTURIES INDONESI; Duggan Genevieve, 2004, HALI, V134, P110; FARRIS JS, 1989, CLADISTICS, V5, P417, DOI 10.1111/j.1096-0031.1989.tb00573.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fischer J, 1979, THREADS TRADITION TE; Fraser-Lu Sylvia, 1989, HANDWOVEN TEXTILES S; Gavin T, 1996, WOMENS WARPATH IBAN; Gavin Traude, 2004, IBAN RITUAL TEXTILES; Gittinger M, 1979, SPLENDID SYMBOLS TEX; Gray RD, 2000, NATURE, V405, P1052, DOI 10.1038/35016575; Gray RD, 2011, PHILOS T R SOC B, V366, P1090, DOI 10.1098/rstb.2010.0378; Gray RD, 2010, PHILOS T R SOC B, V365, P3923, DOI 10.1098/rstb.2010.0162; Gray Russell D., 2007, Biological Theory, V2, P360, DOI 10.1162/biot.2007.2.4.360; Green RC, 1979, EXPLORING VISUAL ART, P13; Greenhill SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009573; Greenhill SJ, 2009, P ROY SOC B-BIOL SCI, V276, P2299, DOI 10.1098/rspb.2008.1944; Guy J, 1988, INDIAN TEXTILES E; Haddon Alfred C., 1936, IBAN SEA DAYAK FABRI; Hamilton, 1998, RAINBOWS VARIED HUE; Heine-Geldern R, 1937, REV ARTS ASIATIQUES, VXI, P4; Heine-Geldern R, 1948, INDONESIAN ART; Heringa Rens., 1989, SPEAK CLOTH STUDIES, P107; Holland BR, 2002, MOL BIOL EVOL, V19, P2051, DOI 10.1093/oxfordjournals.molbev.a004030; Holmgren Robert J, 1989, EARLY INDONESIAN TEX; Hose Charles, 1912, PAGAN TRIBES BORNEO; Howard MC, 2002, TEXTILES DAIC PEOPLE; Howard MC, 2010, DASHES DRAGONS IKAT; Howard MC, 2006, BARK CLOTH SE ASIA; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hunt Kahlenberg M, 1977, TEXTILE TRADITIONS I; Hunt-Kahlenberg M, 2010, 5 CENTURIES INDONESI; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jonge Nico de, 1995, VERGETEN EILANDEN KU; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kayser M, 2008, AM J HUM GENET, V82, P194, DOI 10.1016/j.ajhg.2007.09.010; Kayser M, 2006, MOL BIOL EVOL, V23, P2234, DOI 10.1093/molbev/msl093; Khan Majlis B, 2007, ART INDONESIAN TEXTI; Khan Majlis B., 1984, INDONESISCHE TEXTILI; Khan Majlis Brigitte, 1991, WOVEN MESSAGES INDON; Langewis Laurens., 1964, DECORATIVE ART INDON; Larsen AW, 2011, J ANTHROPOL ARCHAEOL, V30, P116, DOI 10.1016/j.jaa.2010.12.004; Larssen JL, 1976, DYERS ART IKAT BATIK; Leedom Lefferts, 1992, TEXTILES TAI EXPERIE; Leigh-Theisen H, 1995, LEBENSMUSTER TEXTILE; Lewis ED, 1994, GIFT COTTON MAIDEN T; Lewis M. P., 2009, ETHNOLOGUE LANGUAGES; Linggi M., 2001, TIES BIND IBAN IKAT; Maddison WP, 2011, MESQUITE MODULAR SYS; Matthews LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014810; Maxwell Robyn, 2010, LIFE DEATH MAGIC 200; Maxwell Robyn, 2003, TEXTILES SE ASIA TRA; Niessen Sandra A., 2009, LEGACY CLOTH BATAK T; Oppeheimer S, 2006, UNC SE AS 10 INT C E; Oppenheimer Stephen, 2001, Science Progress, V84, P157, DOI 10.3184/003685001783238989; Reyes, 1992, TEXTILES SO PHILIPPI; Richards M, 1998, AM J HUM GENET, V63, P1234, DOI 10.1086/302043; Saunders K. J., 1997, CONT TIE DYE TEXTILE; Shennan S, 2009, ORIG HUM BEHAV, V2, P1; Soares P, 2008, MOL BIOL EVOL, V25, P1209, DOI 10.1093/molbev/msn068; Solyom B, 1984, FABRIC TRADITIONS IN; Steele J, 2010, PHILOS T R SOC B, V365, P3781, DOI 10.1098/rstb.2010.0202; Sumner G, 2001, ARTS SE ASIA; Tehrani J, 2002, J ANTHROPOL ARCHAEOL, V21, P443, DOI 10.1016/S0278-4165(02)00002-8; Tehrani JJ, 2010, PHILOS T R SOC B, V365, P3865, DOI 10.1098/rstb.2010.0020; Thurgood G., 1999, ANCIENT CHAM MODERN; Tolstoy P, 2008, J POLYNESIAN SOC, V117, P15; Totton Mary-Louise, 2009, WEARING WEALTH STYLI; van Vuuren M, 2001, IKAT TANIMBAR; Vanderstraete A, 2012, MAGIE VROUWE; Voelger G, 1991, IND TEXT S; Whiten A, 2011, PHILOS T R SOC B, V366, P938, DOI 10.1098/rstb.2010.0372; Yaeger RM, 2002, TEXTILES W TIMOR; Zahorka H, 2007, P 2 INT TEXT C NAT M, P79; [No title captured]	89	24	25	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52064	10.1371/journal.pone.0052064	http://dx.doi.org/10.1371/journal.pone.0052064			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272211	gold, Green Published, Green Submitted			2022-12-27	WOS:000312483300057
J	Liu, H; Patil, HP; de Vries-Idema, J; Wilschut, J; Huckriede, A				Liu, Heng; Patil, Harshad P.; de Vries-Idema, Jacqueline; Wilschut, Jan; Huckriede, Anke			Enhancement of the Immunogenicity and Protective Efficacy of a Mucosal Influenza Subunit Vaccine by the Saponin Adjuvant GPI-0100	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; PULMONARY DELIVERY; BELLS-PALSY; IMMUNITY; INFECTION; RESPONSES; ANTIBODY; PROTEIN; CELLS; TRACT	Identification of safe and effective adjuvants remains an urgent need for the development of inactivated influenza vaccines for mucosal administration. Here, we used a murine challenge model to evaluate the adjuvant activity of GPI-0100, a saponin-derived adjuvant, on influenza subunit vaccine administered via the intranasal or the intrapulmonary route. Balb/c mice were immunized with 1 mu g A/PR/8 (H1N1) subunit antigen alone or in combination with varying doses of GPI-0100. The addition of GPI-0100 was required for induction of mucosal and systemic antibody responses to intranasally administered influenza vaccine and significantly enhanced the immunogenicity of vaccine administered via the intrapulmonary route. Remarkably, GPI-0100-adjuvanted influenza vaccine given at a low dose of 2x1 mu g either in the nares or directly into the lungs provided complete protection against homologous influenza virus infection.	[Liu, Heng; Patil, Harshad P.; de Vries-Idema, Jacqueline; Wilschut, Jan; Huckriede, Anke] Univ Groningen, Univ Med Ctr Groningen, Mol Virol Sect, Dept Med Microbiol, Groningen, Netherlands	University of Groningen	Huckriede, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Mol Virol Sect, Dept Med Microbiol, Groningen, Netherlands.	a.l.w.huckriede@med.umcg.nl	Huckriede, Anke/P-3558-2019	Huckriede, Anke/0000-0002-2646-5143	Netherlands Influenza Vaccine Research Centre (NIVAREC); Netherlands Organisation for Health Research and Development (ZonMw); Jan Kornelis de cock stichting	Netherlands Influenza Vaccine Research Centre (NIVAREC); Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Jan Kornelis de cock stichting	This study was conducted under the auspices of the Netherlands Influenza Vaccine Research Centre (NIVAREC), financially supported by the Netherlands Organisation for Health Research and Development (ZonMw). The study received a subsidy from Jan Kornelis de cock stichting (http://www.decockstichting.nl/subsidies.html). None of the funder had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorij JP, 2010, LANCET INFECT DIS, V10, P699, DOI 10.1016/S1473-3099(10)70157-2; Asahi Y, 2002, J IMMUNOL, V168, P2930, DOI 10.4049/jimmunol.168.6.2930; Atmar RL, 2007, VACCINE, V25, P5367, DOI 10.1016/j.vaccine.2007.05.002; Belshe Robert, 2004, Expert Rev Vaccines, V3, P643, DOI 10.1586/14760584.3.6.643; Bienenstock J, 2005, IMMUNOL REV, V206, P22, DOI 10.1111/j.0105-2896.2005.00299.x; Block Stan L, 2004, Paediatr Drugs, V6, P199, DOI 10.2165/00148581-200406040-00001; Boyce TG, 2000, VACCINE, V19, P217, DOI 10.1016/S0264-410X(00)00171-7; Brandt C, 1997, J INFECT DIS, V176, P884, DOI 10.1086/516503; Brandtzaeg P, 1999, IMMUNOL REV, V171, P45, DOI 10.1111/j.1600-065X.1999.tb01342.x; Brandtzaeg P, 2009, SCAND J IMMUNOL, V70, P505, DOI 10.1111/j.1365-3083.2009.02319.x; Brandtzaeg P, 1999, IMMUNOL TODAY, V20, P267, DOI 10.1016/S0167-5699(99)01468-1; Bungener L, 2008, VACCINE, V26, P2350, DOI 10.1016/j.vaccine.2008.02.063; Constant SL, 2000, EUR J IMMUNOL, V30, P840, DOI 10.1002/1521-4141(200003)30:3<840::AID-IMMU840>3.0.CO;2-L; Constant SL, 2002, J CLIN INVEST, V110, P1441, DOI 10.1172/JCI200216109; Couch RB, 2004, NEW ENGL J MED, V350, P860, DOI 10.1056/NEJMp048006; Coulter A, 2003, VACCINE, V21, P946, DOI 10.1016/S0264-410X(02)00545-5; Hagiwara Y, 1999, VACCINE, V17, P2918, DOI 10.1016/S0264-410X(99)00135-8; Hasegawa H, 2005, J MED VIROL, V75, P130, DOI 10.1002/jmv.20247; Jabbal-Gill I, 2010, J DRUG TARGET, V18, P771, DOI 10.3109/1061186X.2010.523790; Kistner O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009349; Lawson LB, 2011, CURR OPIN IMMUNOL, V23, P414, DOI 10.1016/j.coi.2011.03.009; Liu H, 2011, VACCINE, V29, P2037, DOI 10.1016/j.vaccine.2011.01.012; Lycke N, 2012, NAT REV IMMUNOL, V12, P592, DOI 10.1038/nri3251; Marciani DJ, 2000, VACCINE, V18, P3141, DOI 10.1016/S0264-410X(00)00118-3; Marciani DJ, 2003, VACCINE, V21, P3961, DOI 10.1016/S0264-410X(03)00298-6; Mbawuike IN, 1999, J IMMUNOL, V162, P2530; Minne A, 2007, IMMUNOLOGY, V122, P316, DOI 10.1111/j.1365-2567.2007.02641.x; Mutsch M, 2004, NEW ENGL J MED, V350, P896, DOI 10.1056/NEJMoa030595; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Pavot V, 2012, VACCINE, V30, P142, DOI 10.1016/j.vaccine.2011.11.003; Persson CGA, 1998, SCAND J IMMUNOL, V47, P302; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Plotnicky-Gilquin H, 1999, J VIROL, V73, P5637, DOI 10.1128/JVI.73.7.5637-5645.1999; Ragupathi G, 2008, VACCINE, V26, P4860, DOI 10.1016/j.vaccine.2008.06.098; Sanders MT, 2009, VACCINE, V27, P2475, DOI 10.1016/j.vaccine.2009.02.054; Sharma S, 2009, J PHARM SCI-US, V98, P812, DOI 10.1002/jps.21493; Slovin SF, 2005, VACCINE, V23, P3114, DOI 10.1016/j.vaccine.2005.01.072; Southam DS, 2002, AM J PHYSIOL-LUNG C, V282, pL833, DOI 10.1152/ajplung.00173.2001; Vujanic A, 2012, VET IMMUNOL IMMUNOP, V148, P172, DOI 10.1016/j.vetimm.2011.03.004; Vujanic A, 2012, CLIN VACCINE IMMUNOL, V19, P79, DOI 10.1128/CVI.05265-11; Vujanic A, 2010, VACCINE, V28, P2593, DOI 10.1016/j.vaccine.2010.01.018; Wee JLK, 2008, MUCOSAL IMMUNOL, V1, P489, DOI 10.1038/mi.2008.59; Yamamoto M, 1996, ANN NY ACAD SCI, V778, P64, DOI 10.1111/j.1749-6632.1996.tb21115.x; Zhang P, 2003, VACCINE, V21, P4459, DOI 10.1016/S0264-410X(03)00438-9	45	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52135	10.1371/journal.pone.0052135	http://dx.doi.org/10.1371/journal.pone.0052135			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284901	gold, Green Published, Green Submitted			2022-12-27	WOS:000312435900079
J	Bobermin, LD; Quincozes-Santos, A; Guerra, MC; Leite, MC; Souza, DO; Goncalves, CA; Gottfried, C				Bobermin, Larissa Daniele; Quincozes-Santos, Andre; Guerra, Maria Cristina; Leite, Marina Concli; Souza, Diogo Onofre; Goncalves, Carlos-Alberto; Gottfried, Carmem			Resveratrol Prevents Ammonia Toxicity in Astroglial Cells	PLOS ONE			English	Article							C6 GLIOMA-CELLS; CORTICAL ASTROCYTE CULTURES; INCREASES GLUTAMATE UPTAKE; SYRUP-URINE-DISEASE; OXIDATIVE STRESS; S100B SECRETION; GLIAL-CELLS; LIVER-FAILURE; NITRIC-OXIDE; CYCLIC-AMP	Ammonia is implicated as a neurotoxin in brain metabolic disorders associated with hyperammonemia. Acute ammonia toxicity can be mediated by an excitotoxic mechanism, oxidative stress and nitric oxide (NO) production. Astrocytes interact with neurons, providing metabolic support and protecting against oxidative stress and excitotoxicity. Astrocytes also convert excess ammonia and glutamate into glutamine via glutamine synthetase (GS). Resveratrol, a polyphenol found in grapes and red wines, exhibits antioxidant and anti-inflammatory properties and modulates glial functions, such as glutamate metabolism. We investigated the effect of resveratrol on the production of reactive oxygen species (ROS), GS activity, S100B secretion, TNF-alpha, IL-1 beta and IL-6 levels in astroglial cells exposed to ammonia. Ammonia induced oxidative stress, decreased GS activity and increased cytokines release, probably by a mechanism dependent on protein kinase A (PKA) and extracellular signal-regulated kinase (ERK) pathways. Resveratrol prevented ammonia toxicity by modulating oxidative stress, glial and inflammatory responses. The ERK and nuclear factor-kappa B (NF-kappa B) are involved in the protective effect of resveratrol on cytokines proinflammatory release. In contrast, other antioxidants (e. g., ascorbic acid and trolox) were not effective against hyperammonemia. Thus, resveratrol could be used to protect against ammonia-induced neurotoxicity.	[Bobermin, Larissa Daniele; Quincozes-Santos, Andre; Guerra, Maria Cristina; Leite, Marina Concli; Souza, Diogo Onofre; Goncalves, Carlos-Alberto; Gottfried, Carmem] Univ Fed Rio Grande do Sul, Inst Basic Hlth Sci, Dept Biochem, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	Quincozes-Santos, A (corresponding author), Univ Fed Rio Grande do Sul, Inst Basic Hlth Sci, Dept Biochem, Porto Alegre, RS, Brazil.	andrequincozes@yahoo.com.br	Souza, Diogo O/J-8894-2014; Quincozes-Santos, André/AAO-2714-2020; Bobermin, Larissa/AGN-9475-2022; Goncalves, Carlos Alberto/K-1851-2014; Gottfried, Carmem/AAG-2355-2019	Souza, Diogo O/0000-0002-4322-0404; Gottfried, Carmem/0000-0001-8838-1300; /0000-0002-1907-6051; Quincozes-Santos, Andre/0000-0001-8611-4890	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); FINEP/Rede IBN [01.06.0842-00]; INCTEN National Institute of Science and Technology for Excitotoxicity and Neuroprotection	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FINEP/Rede IBN(Financiadora de Inovacao e Pesquisa (Finep)); INCTEN National Institute of Science and Technology for Excitotoxicity and Neuroprotection	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), FINEP/Rede IBN 01.06.0842-00 and INCTEN National Institute of Science and Technology for Excitotoxicity and Neuroprotection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht J, 1999, J NEUROL SCI, V170, P138, DOI 10.1016/S0022-510X(99)00169-0; Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Baltimore D, 2011, NAT IMMUNOL, V12, P683, DOI 10.1038/ni.2072; Barbeito LH, 2004, BRAIN RES REV, V47, P263, DOI 10.1016/j.brainresrev.2004.05.003; Bastianetto S, 2010, EXP NEUROL, V225, P237, DOI 10.1016/j.expneurol.2010.06.019; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; BENDA P, 1968, SCIENCE, V161, P370, DOI 10.1126/science.161.3839.370; Butterworth RF, 2011, NEUROCHEM INT, V59, P830, DOI 10.1016/j.neuint.2011.07.014; Butterworth RF, 2011, HEPATOLOGY, V53, P1372, DOI 10.1002/hep.24228; Buzanska L, 2000, NEUROCHEM INT, V37, P287, DOI 10.1016/S0197-0186(00)00030-9; Csiszar A, 2011, ANN NY ACAD SCI, V1215, P117, DOI 10.1111/j.1749-6632.2010.05848.x; Davey GE, 2001, J BIOL CHEM, V276, P30819, DOI 10.1074/jbc.M103541200; Delmas D, 2005, MOL NUTR FOOD RES, V49, P377, DOI 10.1002/mnfr.200400098; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; dos Santos AQ, 2006, ARCH BIOCHEM BIOPHYS, V453, P161, DOI 10.1016/j.abb.2006.06.025; Dringen R, 2003, BIOL CHEM, V384, P505, DOI 10.1515/BC.2003.059; Escartin C, 2011, J NEUROSCI, V31, P7392, DOI 10.1523/JNEUROSCI.6577-10.2011; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Felipo V, 2002, PROG NEUROBIOL, V67, P259, DOI 10.1016/S0301-0082(02)00019-9; Felipo V, 1998, NEUROTOXICOLOGY, V19, P675; Fernandes A, 2007, EUR J NEUROSCI, V25, P1058, DOI 10.1111/j.1460-9568.2007.05340.x; Fukui M, 2010, FREE RADICAL BIO MED, V49, P800, DOI 10.1016/j.freeradbiomed.2010.06.002; Funchal C, 2007, J NEUROL SCI, V260, P87, DOI 10.1016/j.jns.2007.04.011; Funchal C, 2006, NEUROCHEM INT, V49, P640, DOI 10.1016/j.neuint.2006.05.007; Gerlo S, 2011, CELL MOL LIFE SCI, V68, P3823, DOI 10.1007/s00018-011-0757-8; Gorg B, 2008, HEPATOLOGY, V48, P567, DOI 10.1002/hep.22345; Goncalves D, 2002, NEUROREPORT, V13, P1533; Guerra MC, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-128; Gutteridge JMC, 2010, BIOCHEM BIOPH RES CO, V393, P561, DOI 10.1016/j.bbrc.2010.02.071; Haussinger D, 2010, CURR OPIN CLIN NUTR, V13, P87, DOI 10.1097/MCO.0b013e328333b829; Haghighat N, 2000, NEUROCHEM RES, V25, P277, DOI 10.1023/A:1007535922977; Hamby ME, 2008, NEUROCHEM INT, V52, P962, DOI 10.1016/j.neuint.2007.10.010; He F, 2007, INT J BIOCHEM CELL B, V39, P661, DOI 10.1016/j.biocel.2006.10.022; Hertz L, 2004, TRENDS NEUROSCI, V27, P735, DOI 10.1016/j.tins.2004.10.008; Hillmann P, 2008, TOXICOL APPL PHARM, V227, P36, DOI 10.1016/j.taap.2007.10.012; Hu JG, 1996, J BIOL CHEM, V271, P2543, DOI 10.1074/jbc.271.5.2543; Huang TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029102; Jayakumar AR, 2006, NEUROCHEM INT, V48, P623, DOI 10.1016/j.neuint.2005.11.017; Jayakumar AR, 2006, J NEUROSCI, V26, P4774, DOI 10.1523/JNEUROSCI.0120-06.2006; King CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018713; Kosenko E, 1997, METAB BRAIN DIS, V12, P69, DOI 10.1007/BF02676355; Kosenko E, 1997, FREE RADICAL RES, V27, P637, DOI 10.3109/10715769709097867; Kwon KJ, 2011, J PINEAL RES, V50, P110, DOI 10.1111/j.1600-079X.2010.00820.x; Lee EO, 2010, J NEUROCHEM, V112, P1477, DOI 10.1111/j.1471-4159.2009.06564.x; Leite MC, 2008, J NEUROSCI METH, V169, P93, DOI 10.1016/j.jneumeth.2007.11.021; Leite MC, 2006, BRAIN RES BULL, V70, P179, DOI 10.1016/j.brainresbull.2006.05.003; Leite MC, 2009, J NEUROSCI RES, V87, P2439, DOI 10.1002/jnr.22083; Lemberg A, 2009, ANN HEPATOL, V8, P95, DOI 10.1016/S1665-2681(19)31785-5; LISKOWSKY DR, 1986, BRAIN RES, V386, P386, DOI 10.1016/0006-8993(86)90176-9; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Markiewicz I, 2006, ACTA NEUROBIOL EXP, V66, P343; Mates JM, 2002, INT J BIOCHEM CELL B, V34, P439, DOI 10.1016/S1357-2725(01)00143-1; McKenna MC, 2007, J NEUROSCI RES, V85, P3347, DOI 10.1002/jnr.21444; Monfort P, 2002, METAB BRAIN DIS, V17, P237, DOI 10.1023/A:1021993431443; Monfort P, 2002, NEUROCHEM INT, V41, P95, DOI 10.1016/S0197-0186(02)00029-3; Nardin P, 2007, NEUROCHEM INT, V50, P774, DOI 10.1016/j.neuint.2007.01.013; Norenberg MD, 2009, METAB BRAIN DIS, V24, P103, DOI 10.1007/s11011-008-9113-6; Norenberg MD, 2003, HEPATOLOGY, V37, P245, DOI 10.1053/jhep.2003.50087; Pellerin L, 2002, DIABETES NUTR METAB, V15, P268; Quincozes-Santos A, 2011, GLIA, V59, pS80; Quincozes-Santos A, 2007, NEUROTOXICOLOGY, V28, P886, DOI 10.1016/j.neuro.2007.03.008; Quincozes-Santos A, 2011, ANN NY ACAD SCI, V1215, P72, DOI 10.1111/j.1749-6632.2010.05857.x; Quincozes-Santos A, 2010, METAB BRAIN DIS, V25, P191, DOI 10.1007/s11011-010-9203-0; Quincozes-Santos A, 2010, TOXICOL IN VITRO, V24, P916, DOI 10.1016/j.tiv.2009.11.016; Quincozes-Santos A, 2009, NEUROTOX RES, V16, P30, DOI 10.1007/s12640-009-9042-0; Rose C, 2005, METAB BRAIN DIS, V20, P275, DOI 10.1007/s11011-005-7906-4; Rose C, 2005, J BIOL CHEM, V280, P20937, DOI 10.1074/jbc.M412448200; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Sakata Y, 2010, EXP NEUROL, V224, P325, DOI 10.1016/j.expneurol.2010.03.032; Santello M, 2011, NEURON, V69, P988, DOI 10.1016/j.neuron.2011.02.003; Schliess F, 2009, METAB BRAIN DIS, V24, P119, DOI 10.1007/s11011-008-9125-2; Schroeter ML, 2011, J AFFECT DISORDERS, V134, P32, DOI 10.1016/j.jad.2010.11.008; Shen HM, 2006, FASEB J, V20, P1589, DOI 10.1096/fj.05-5603rev; Steiner J, 2010, NEUROSCIENCE, V167, P1025, DOI 10.1016/j.neuroscience.2010.03.010; Svoboda N, 2007, EUR J NEUROSCI, V25, P2285, DOI 10.1111/j.1460-9568.2007.05452.x; Tanabe K, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-68; Tanabe K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-16; Tiwari V, 2011, J NEUROCHEM, V117, P678, DOI 10.1111/j.1471-4159.2011.07236.x; Van Eldik LJ, 2003, RESTOR NEUROL NEUROS, V21, P97; Vang O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019881; de Almeida LMV, 2008, ARCH BIOCHEM BIOPHYS, V480, P27, DOI 10.1016/j.abb.2008.09.006; de Almeida LMV, 2008, NEUROCHEM RES, V33, P8, DOI 10.1007/s11064-007-9399-5; de Almeida LMV, 2007, CELL MOL NEUROBIOL, V27, P661, DOI 10.1007/s10571-007-9152-2; Wakabayashi N., 2010, ANTIOXID REDOX SIGNA; WESTERGAARD N, 1995, DEV NEUROSCI-BASEL, V17, P203, DOI 10.1159/000111288; Wiltfang J, 1999, METAB BRAIN DIS, V14, P239, DOI 10.1023/A:1020785009005; Zielinska M, 2005, NEUROCHEM RES, V30, P349, DOI 10.1007/s11064-005-2608-1	88	58	65	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52164	10.1371/journal.pone.0052164	http://dx.doi.org/10.1371/journal.pone.0052164			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284918	Green Published, Green Submitted, gold			2022-12-27	WOS:000313158800034
J	Bajaj, D; Batra, JK				Bajaj, Divya; Batra, Janendra K.			The C-Terminus of ClpC1 of Mycobacterium tuberculosis Is Crucial for Its Oligomerization and Function	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; ESCHERICHIA-COLI; STRESS-RESPONSE; PROTEASE; VIRULENCE; CHAPERONE; DOMAINS; COMPLEX; PROTEOLYSIS; COMPETENCE	Mycobacterium tuberculosis ClpC1 is a member of the Hsp100/Clp AAA+ family of ATPases. The primary sequence of ClpC1 contains two N-terminal domains and two nucleotide binding domains (NBD). The second NBD has a long C-terminal subdomain containing several motifs important for substrate interaction. Generally, ClpC proteins are highly conserved, however presence of C-terminal domains of variable lengths is a remarkable difference in ClpC from different species. In this study, we constructed deletion mutants at the C-terminus of M. tuberculosis ClpC1 to determine its role in the structure and function of the protein. In addition, a deletion mutant having the two conserved N-terminal domains deleted was also constructed to investigate the role of these domains in M. tuberculosis ClpC1 function. The N-terminal domains were found to be dispensable for the formation of oligomeric structure, and ATPase and chaperone activities. However, deletions beyond a specific region in the C-terminus of the ClpC1 resulted in oligomerization defects and loss of chaperonic activity of the protein without affecting its ATPase activity. The truncated mutants, defective in oligomerization were also found to have lost the chaperonic activity, showing the formation of oligomer to be required for the chaperonic activity of M. tuberculosis ClpC1. The current study has identified a region in the C-terminus of M. tuberculosis ClpC1 which is essential for its oligomerization and in turn its function.	[Bajaj, Divya; Batra, Janendra K.] Natl Inst Immunol, Immunochem Lab, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Batra, JK (corresponding author), Natl Inst Immunol, Immunochem Lab, Aruna Asaf Ali Marg, New Delhi 110067, India.	janendra@nii.res.in	Batra, Janendra/GWQ-8031-2022	Batra, Janendra/0000-0003-2206-3398	National Institute of Immunology; Department of Biotechnology, Government of India [BT-TF-10-BRB-2010]	National Institute of Immunology; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by core grants to the National Institute of Immunology and a grant No. BT-TF-10-BRB-2010 to JKB from the Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian T, 2012, EMBO J, V31, P1529, DOI 10.1038/emboj.2012.5; Barik S, 2010, MOL MICROBIOL, V75, P592, DOI 10.1111/j.1365-2958.2009.07008.x; Barnett ME, 2000, J BIOL CHEM, V275, P37565, DOI 10.1074/jbc.M005211200; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Carroll P, 2011, APPL ENVIRON MICROB, V77, P5040, DOI 10.1128/AEM.02880-10; Feldman DE, 2000, CURR OPIN STRUC BIOL, V10, P26, DOI 10.1016/S0959-440X(99)00044-5; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; Guenther B, 1997, CELL, V91, P335, DOI 10.1016/S0092-8674(00)80417-1; Kar NP, 2008, FEBS J, V275, P6149, DOI 10.1111/j.1742-4658.2008.06738.x; Kwon HY, 2004, INFECT IMMUN, V72, P5646, DOI 10.1128/IAI.72.10.5646-5653.2004; Lanneau D, 2010, THESCIENTIFICWORLDJO, V10, P1543, DOI 10.1100/tsw.2010.152; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Luong TT, 2011, J BACTERIOL, V193, P686, DOI 10.1128/JB.00987-10; Michel A, 2006, J BACTERIOL, V188, P5783, DOI 10.1128/JB.00074-06; Mogk A, 2003, J BIOL CHEM, V278, P17615, DOI 10.1074/jbc.M209686200; de Oliveira NEM, 2011, MICROBIOL-SGM, V157, P656, DOI 10.1099/mic.0.041897-0; Neuwald AF, 1999, GENOME RES, V9, P27; Raju RM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002511; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Rouquette C, 1998, MOL MICROBIOL, V27, P1235, DOI 10.1046/j.1365-2958.1998.00775.x; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/0968-0004(96)10038-4; Schmitt EK, 2011, ANGEW CHEM INT EDIT, V50, P5889, DOI 10.1002/anie.201101740; Sherrid AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011622; Smith CK, 1999, P NATL ACAD SCI USA, V96, P6678, DOI 10.1073/pnas.96.12.6678; Sousa MC, 2000, CELL, V103, P633, DOI 10.1016/S0092-8674(00)00166-5; Stewart GR, 2001, NAT MED, V7, P732, DOI 10.1038/89113; Turgay K, 1997, GENE DEV, V11, P119, DOI 10.1101/gad.11.1.119; Turgay K, 2001, MOL MICROBIOL, V42, P717, DOI 10.1046/j.1365-2958.2001.02623.x; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Yu AYH, 2007, FEBS LETT, V581, P3749, DOI 10.1016/j.febslet.2007.04.076	33	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51261	10.1371/journal.pone.0051261	http://dx.doi.org/10.1371/journal.pone.0051261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284674	Green Submitted, gold, Green Published			2022-12-27	WOS:000312794500024
J	Brown, JVE; Moe-Byrne, T; Harden, M; McGuire, W				Brown, Jennifer V. E.; Moe-Byrne, Thirimon; Harden, Melissa; McGuire, William			Lower versus Higher Oxygen Concentration for Delivery Room Stabilisation of Preterm Neonates: Systematic Review	PLOS ONE			English	Article							NEWBORN-INFANTS; RESUSCITATION; AIR; BIRTH; SATURATION; CONSENSUS; SURVIVAL	Background: Emerging evidence suggests that initiating delivery room respiratory support or resuscitation for term infants using lower rather than higher concentrations of oxygen reduces mortality and the risk of serious morbidity. Uncertainty exists with regard to applicability of this strategy for preterm infants who have different underlying reasons for respiratory distress and risks for harm at birth than term infants. Methods: We performed a systematic review and meta-analysis of randomised controlled trials to determine the effect on mortality and morbidity of using lower (21-50%) versus higher (>50%) oxygen concentrations for delivery room transition support of preterm infants. Results: We identified six randomised controlled trials in which a total of 484 infants participated. Most participants were preterm infants born before 32 weeks' gestation. One trial was quasi-randomised and in one trial allocation concealment was not described. Clinicians and investigators were aware of the interventions in all but one trial. Meta-analyses found a statistically significant reduction in the risk of death pooled risk ratio 0.65 (95% confidence interval 0.43, 0.98), but this effect disappeared when only the four trials with adequate allocation concealment were included [pooled risk ratio 1.0 (95% confidence interval 0.45, 2.24)]. None of the trials has evaluated any neuro-developmental outcomes. Conclusions: The available trial data do not provide strong evidence that using lower versus higher oxygen concentrations for delivery room transition support for preterm infants confers important benefits or harms. Lack of allocation concealment and blinding of clinicians and assessors are the major sources of bias in the existing trials. Further, large, good-quality trials are needed to resolve on-going uncertainties and inform clinical practice.	[Brown, Jennifer V. E.; Moe-Byrne, Thirimon; Harden, Melissa; McGuire, William] Univ York, Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England; [McGuire, William] Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England	University of York - UK; University of Hull; University of York - UK	McGuire, W (corresponding author), Univ York, Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England.	William.McGuire@hyms.ac.uk	Brown, Jennifer V E/C-6947-2019; Moe-Byrne, Thirimon/AAY-8744-2021	Brown, Jennifer V E/0000-0003-0943-5177; McGuire, William/0000-0001-8572-3467; Byrne, Thirimon Moe/0000-0002-2827-9715	National Institute for Health Research (NIHR) [RP-PG-0609-10107]	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR))	This paper presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme (RP-PG-0609-10107). The views expressed in this paper are those of the authors and not necessarily those of the National Health Service, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhola K, 2012, J PAEDIATR CHILD H, V48, P828, DOI 10.1111/j.1440-1754.2012.02545.x; CRD, 2008, CRDS GUID UND REV HL; Dawson JA, 2009, ARCH DIS CHILD-FETAL, V94, pF87, DOI 10.1136/adc.2008.141341; Dawson JA, 2012, J PEDIATR-US, V160, P158, DOI 10.1016/j.jpeds.2011.07.045; Harling AE, 2005, ARCH DIS CHILD-FETAL, V90, pF401, DOI 10.1136/adc.2004.059287; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Koh J, 2012, EARLY HUM DEV, V88, P631, DOI 10.1016/j.earlhumdev.2012.01.005; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; LUNDSTROM KE, 1995, ARCH DIS CHILD-FETAL, V73, pF81, DOI 10.1136/fn.73.2.F81; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mann C, 2012, RESUSCITATION, V83, P607, DOI 10.1016/j.resuscitation.2012.01.002; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; O'Donnell CPF, 2008, SEMIN FETAL NEONAT M, V13, P401, DOI 10.1016/j.siny.2008.04.010; O'Donnell CPF, 2007, ARCH DIS CHILD-FETAL, V92, P465, DOI 10.1136/adc.2007.120634; O'Donnell CPF, 2006, J PEDIATR-US, V149, P486, DOI 10.1016/j.jpeds.2006.05.040; O'Donnell CPF, 2010, J PEDIATR-US, V156, P846, DOI 10.1016/j.jpeds.2010.01.007; Odgaard-Jensen J, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000012.pub3; Rabi Y, 2007, RESUSCITATION, V72, P353, DOI 10.1016/j.resuscitation.2006.06.134; Rabi Y, 2011, PEDIATRICS, V128, pE374, DOI 10.1542/peds.2010-3130; Rook D, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-65; Saugstad OD, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.1.e1; Saugstad OD, 2008, NEONATOLOGY, V94, P176, DOI 10.1159/000143397; Saugstad OD, 2012, NEONATOLOGY, V101, P315, DOI 10.1159/000337345; Stenson B, 2011, NEW ENGL J MED, V364, P1680, DOI 10.1056/NEJMc1101319; Sweet DG, 2010, NEONATOLOGY, V97, P402, DOI 10.1159/000297773; Tan A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002273.pub3; Vento M, 2009, PEDIATRICS, V124, pE439, DOI 10.1542/peds.2009-0434; Wang CL, 2008, PEDIATRICS, V121, P1083, DOI 10.1542/peds.2007-1460; Wyllie J, 2010, RESUSCITATION, V81, pE260, DOI 10.1016/j.resuscitation.2010.08.029; Zhu Jia-Jun, 2007, Zhonghua Er Ke Za Zhi, V45, P644	31	5	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52033	10.1371/journal.pone.0052033	http://dx.doi.org/10.1371/journal.pone.0052033			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284861	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500080
J	Hare, JA; Wuenschel, MJ; Kimball, ME				Hare, Jonathan A.; Wuenschel, Mark J.; Kimball, Matthew E.			Projecting Range Limits with Coupled Thermal Tolerance - Climate Change Models: An Example Based on Gray Snapper (Lutjanus griseus) along the US East Coast	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; COD GADUS-MORHUA; MARINE FISH; POPULATION-STRUCTURE; IMPACTS; RESPONSES; FISHERIES; DYNAMICS; BIODIVERSITY; BIOGEOGRAPHY	We couple a species range limit hypothesis with the output of an ensemble of general circulation models to project the poleward range limit of gray snapper. Using laboratory-derived thermal limits and statistical downscaling from IPCC AR4 general circulation models, we project that gray snapper will shift northwards; the magnitude of this shift is dependent on the magnitude of climate change. We also evaluate the uncertainty in our projection and find that statistical uncertainty associated with the experimentally-derived thermal limits is the largest contributor (similar to 65%) to overall quantified uncertainty. This finding argues for more experimental work aimed at understanding and parameterizing the effects of climate change and variability on marine species.	[Hare, Jonathan A.] NOAA NMFS Narragansett Lab, Narragansett, RI 02882 USA; [Wuenschel, Mark J.] NOAA NMFS Woods Hole Lab, Woods Hole, MA USA; [Kimball, Matthew E.] GTM Natl Estuarine Res Reserve, Ponte Vedra Beach, FL USA; [Kimball, Matthew E.] Univ N Florida, Dept Biol, Jacksonville, FL USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; State University System of Florida; University of North Florida	Hare, JA (corresponding author), NOAA NMFS Narragansett Lab, Narragansett, RI 02882 USA.	jon.hare@noaa.gov		Wuenschel, Mark/0000-0002-9307-7319				Able K. W., 2010, ECOLOGY ESTUARINE FI; AVISE JC, 1992, OIKOS, V63, P62, DOI 10.2307/3545516; Berg MP, 2010, GLOBAL CHANGE BIOL, V16, P587, DOI 10.1111/j.1365-2486.2009.02014.x; Brander K, 2003, ICES MARINE SCI S, V219, P261; Brett JR, 1979, FISH PHYSIOL, V8, P599, DOI DOI 10.1016/S1546-5098(08)60033-3; Cheung WWL, 2011, ICES J MAR SCI, V68, P1008, DOI 10.1093/icesjms/fsr012; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Cheung WW., 2008, MODELLING PRESENT CL; DelSole T, 2010, J CLIMATE, V23, P4794, DOI 10.1175/2010JCLI3164.1; Drinkwater KF, 2005, ICES J MAR SCI, V62, P1327, DOI 10.1016/j.icesjms.2005.05.015; Faunce CH, 2007, B MAR SCI, V80, P473; Figueira WF, 2010, GLOBAL CHANGE BIOL, V16, P506, DOI 10.1111/j.1365-2486.2009.01934.x; Fodrie FJ, 2010, GLOBAL CHANGE BIOL, V16, P48, DOI 10.1111/j.1365-2486.2009.01889.x; FRANK KT, 1990, T AM FISH SOC, V119, P353, DOI 10.1577/1548-8659(1990)119<0353:PRONAI>2.3.CO;2; Fry F.E.J., 1971, P1; Furrer R, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027754; Gold JR, 2009, COPEIA, P277, DOI 10.1643/CI-08-071; Gold JR, 1998, J HERED, V89, P404, DOI 10.1093/jhered/89.5.404; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hare JA, 2007, FISH OCEANOGR, V16, P31, DOI 10.1111/j.1365-2419.2006.00407.x; Hare JA, 2010, ECOL APPL, V20, P452, DOI 10.1890/08-1863.1; Helmuth B, 2006, ANNU REV ECOL EVOL S, V37, P373, DOI 10.1146/annurev.ecolsys.37.091305.110149; Helmuth B, 2009, J EXP BIOL, V212, P753, DOI 10.1242/jeb.023861; HETTLER WF, 1982, FISH B-NOAA, V80, P761; Hof C, 2011, GLOBAL CHANGE BIOL, V17, P2987, DOI 10.1111/j.1365-2486.2011.02418.x; Hollowed AB, 2009, ICES J MAR SCI, V66, P1584, DOI 10.1093/icesjms/fsp057; HUBBS CL, 1948, J MAR RES, V7, P459; Hurst TP, 2007, J FISH BIOL, V71, P315, DOI 10.1111/j.1095-8649.2007.01596.x; Hurst TP, 2002, CAN J FISH AQUAT SCI, V59, P787, DOI 10.1139/F02-051; HUTCHINS LW, 1947, ECOL MONOGR, V17, P325, DOI 10.2307/1948663; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jamison N, 2010, J CLIMATE, V23, P4619, DOI 10.1175/2010JCLI3598.1; Jones DL, 2010, MAR ECOL PROG SER, V401, P245, DOI 10.3354/meps08404; Joyce TM, 2002, J CLIMATE, V15, P1076, DOI 10.1175/1520-0442(2002)015<1076:OHPYOW>2.0.CO;2; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; KERR SR, 1980, T AM FISH SOC, V109, P254, DOI 10.1577/1548-8659(1980)109<254:NTIFE>2.0.CO;2; Knutson TR, 2006, J CLIMATE, V19, P1624, DOI 10.1175/JCLI3709.1; Lehodey P, 2010, PROG OCEANOGR, V86, P302, DOI 10.1016/j.pocean.2010.04.021; Lenoir S, 2011, GLOBAL CHANGE BIOL, V17, P115, DOI 10.1111/j.1365-2486.2010.02229.x; Luo JG, 2009, MAR ECOL PROG SER, V380, P255, DOI 10.3354/meps07911; Madeira D, 2012, J SEA RES, V70, P32, DOI 10.1016/j.seares.2012.03.002; Magnuson J. J., 1997, THERMAL NICHE FISHES, P377; Manderson JP, 2002, MAR ECOL PROG SER, V228, P227, DOI 10.3354/meps228227; Maul GA, 2001, GEOPHYS RES LETT, V28, P3935, DOI 10.1029/2001GL013458; McAfee SA, 2011, CLIM DYNAM, V37, P2271, DOI 10.1007/s00382-011-1136-8; McBride RS, 2000, FISH B-NOAA, V98, P528; Mueter FJ, 2008, ECOL APPL, V18, P309, DOI 10.1890/07-0564.1; MURAWSKI SA, 1993, T AM FISH SOC, V122, P647, DOI 10.1577/1548-8659(1993)122<0647:CCAMFD>2.3.CO;2; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; Parker RO, 1998, T AM FISH SOC, V127, P908, DOI 10.1577/1548-8659(1998)127<0908:CIANCR>2.0.CO;2; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Planque B, 2011, ICES J MAR SCI, V68, P1045, DOI 10.1093/icesjms/fsr007; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Portner HO, 2001, CONT SHELF RES, V21, P1975, DOI 10.1016/S0278-4343(01)00038-3; Robins C.R., 1999, FIELD GUIDE ATLANTIC; ROELOFS E. W., 1953, BULL MARINE SCI GULF AND CARIBBEAN, V3, P181; Sette O. E., 1950, Fishery Bulletin United States, V51, P251; SHANNON LV, 1988, J CONSEIL, V45, P5; Shearman RK, 2010, J PHYS OCEANOGR, V40, P1004, DOI 10.1175/2009JPO4300.1; Sims DW, 2004, J ANIM ECOL, V73, P333, DOI 10.1111/j.0021-8790.2004.00810.x; Solomon S., 2007, PHYS SCI BASIS WORKI; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Sorte CJB, 2010, GLOBAL ECOL BIOGEOGR, V19, P303, DOI 10.1111/j.1466-8238.2009.00519.x; Starck WA II, 1971, STUD TROP OCEANOGR, V10, P1; Stock CA, 2011, PROG OCEANOGR, V88, P1, DOI 10.1016/j.pocean.2010.09.001; Taylor C. C., 1957, Fishery Bulletin United States, V57, P293; Teal LR, 2012, GLOBAL CHANGE BIOL, V18, P3291, DOI 10.1111/j.1365-2486.2012.02795.x; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Tolan JM, 2009, FISH B-NOAA, V107, P36; Torgersen CE, 1999, ECOL APPL, V9, P301, DOI 10.1890/1051-0761(1999)009[0301:MTRASH]2.0.CO;2; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wright DG, 1986, CANADIAN TECHNICAL R, P78; Wuenschel MJ, 2012, J EXP MAR BIOL ECOL, V436, P19, DOI 10.1016/j.jembe.2012.08.012	76	33	34	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52294	10.1371/journal.pone.0052294	http://dx.doi.org/10.1371/journal.pone.0052294			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284974	Green Submitted, Green Published, gold			2022-12-27	WOS:000312794500136
J	Montag, C; Brockmann, EM; Lehmann, A; Muller, DJ; Rujescu, D; Gallinat, J				Montag, Christiane; Brockmann, Eva-Maria; Lehmann, Anja; Mueller, Daniel J.; Rujescu, Dan; Gallinat, Juergen			Association between Oxytocin Receptor Gene Polymorphisms and Self-Rated 'Empathic Concern' in Schizophrenia	PLOS ONE			English	Article							HEALTHY CAUCASIAN ADULTS; EXTENDED LIMBIC SYSTEM; SOCIAL-BEHAVIOR; AFFILIATIVE BEHAVIOR; OXTR GENE; CENTRAL VASOPRESSIN; NEURAL CIRCUITRY; CENTRAL AMYGDALA; BRAIN OXYTOCIN; HUMANS	The nonapeptide oxytocin (OXT) and its receptor (OXTR) have been implicated in social cognition, empathy, emotion and stress regulation in humans. Previous studies reported associations between OXT and OXTR genetic polymorphisms and risk for disorders characterized by impaired socio-emotional functioning, such as schizophrenia and autism. Here we investigate the influence of two single nucleotide polymorphisms (SNPs) within the OXTR gene on a measure of socio-emotional functioning in schizophrenic patients. OXTR SNPs that were previously investigated in other studies were genotyped in 145 patients diagnosed with schizophrenia according to DSM-IV and 145 healthy controls matched for age and gender. The Interpersonal Reactivity Index (IRI) was used to assess cognitive ('perspective taking'), affective ('empathic concern') and self-related ('personal distress') dimensions of empathy. No group differences in genotype frequencies were observed. MANCOVA revealed a significant main (F [1,282] = 10.464; p < 0.01) and interaction effect (genotype by diagnosis: F [1,282] = 4.329; p < 0.05) of OXTR SNP rs2254298(A>GG) with 'empathic concern'. Within the schizophrenia group, linear regression analysis determined OXTR rs2254298 genotype, PANSS negative and general symptom score, and age of disease onset as being significantly associated with 'empathic concern'. OXTR rs2254298 significantly impacted PANSS general psychopathology scores. No associations were found for OXTR rs53576, IRI 'perspective taking' or 'personal distress' ratings. Our preliminary findings support hypotheses about an involvement of OXTR rs2254298 in emotional empathy in schizophrenic and healthy individuals, warranting independent replication.	[Montag, Christiane; Brockmann, Eva-Maria; Lehmann, Anja; Gallinat, Juergen] Charite, Dept Psychiat & Psychotherapy, Charite Campus Mitte, D-13353 Berlin, Germany; [Mueller, Daniel J.] Univ Toronto, Dept Psychiat, Neurogenet Sect, Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Rujescu, Dan] Univ Munich, Dept Psychiat, D-8000 Munich, Germany; [Rujescu, Dan] Univ Halle Wittenberg, Dept Psychiat, Halle, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Munich; Martin Luther University Halle Wittenberg	Montag, C (corresponding author), Charite, Dept Psychiat & Psychotherapy, Charite Campus Mitte, D-13353 Berlin, Germany.	christiane.montag@charite.de	Müller, Daniel J./L-4159-2016; Mueller, Daniel Josef/GVT-7899-2022; Rujescu, Dan/GRS-3875-2022	Müller, Daniel J./0000-0003-4978-4400; Mueller, Daniel Josef/0000-0003-4978-4400; Montag, Christiane/0000-0002-3307-276X	Canadian Institues of Health Research; Ontario Mental Health Foundation	Canadian Institues of Health Research; Ontario Mental Health Foundation	This work was supported by Canadian Institues of Health Research Michael Smith New Investigator Salary Prize for Research in Schizophrenia to DJM, and Ontario Mental Health Foundation New Investigator Fellowship to DJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Achim AM, 2011, PSYCHIAT RES, V190, P3, DOI 10.1016/j.psychres.2010.10.030; Averbeck BB, 2011, PSYCHOL MED, P1; Bakermans-Kranenburg MJ, 2008, SOC COGN AFFECT NEUR, V3, P128, DOI 10.1093/scan/nsn004; Bale TL, 2001, J NEUROSCI, V21, P2546, DOI 10.1523/JNEUROSCI.21-07-02546.2001; Bartz JA, 2006, HORM BEHAV, V50, P518, DOI 10.1016/j.yhbeh.2006.06.018; Bartz JA, 2011, TRENDS COGN SCI, V15, P301, DOI 10.1016/j.tics.2011.05.002; Bartz JA, 2010, P NATL ACAD SCI USA, V107, P21371, DOI 10.1073/pnas.1012669107; Bartz JA, 2010, PSYCHOL SCI, V21, P1426, DOI 10.1177/0956797610383439; Baskerville TA, 2010, CNS NEUROSCI THER, V16, pe92, DOI 10.1111/j.1755-5949.2010.00154.x; Baumgartner T, 2008, NEURON, V58, P639, DOI 10.1016/j.neuron.2008.04.009; Bora E, 2009, ACTA PSYCHIAT SCAND, V120, P253, DOI 10.1111/j.1600-0447.2009.01414.x; Brune M, 2007, SCHIZOPHR RES, V92, P151, DOI 10.1016/J.SCHRES.2007.01.006; Brune M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-38; Brune M, 2005, SCHIZOPHRENIA BULL, V31, P21, DOI 10.1093/schbul/sbi002; Buchheim A, 2009, PSYCHONEUROENDOCRINO, V34, P1417, DOI 10.1016/j.psyneuen.2009.04.002; BUJANOW W, 1974, CAN PSYCHIAT ASSOC J, V19, P323, DOI 10.1177/070674377401900323; Campbell DB, 2011, J NEURODEV DISORD, V3, P101, DOI 10.1007/s11689-010-9071-2; Campbell P, 2009, J COMP NEUROL, V516, P321, DOI 10.1002/cne.22116; Carter CS, 2007, BEHAV BRAIN RES, V176, P170, DOI 10.1016/j.bbr.2006.08.025; Chan RCK, 2010, PSYCHIAT RES, V178, P381, DOI 10.1016/j.psychres.2009.03.035; Chen FS, 2011, P NATL ACAD SCI USA, V108, P19937, DOI 10.1073/pnas.1113079108; Chen FS, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00200; Churchland PS, 2012, HORM BEHAV, V61, P392, DOI 10.1016/j.yhbeh.2011.12.003; Cohen AS, 2010, SCHIZOPHRENIA BULL, V36, P143, DOI 10.1093/schbul/sbn061; Costa B, 2009, PSYCHONEUROENDOCRINO, V34, P1506, DOI 10.1016/j.psyneuen.2009.05.006; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Derntl B, 2012, SCHIZOPHR RES, V136, P70, DOI 10.1016/j.schres.2011.12.018; Derntl B, 2009, SCHIZOPHR RES, V108, P197, DOI 10.1016/j.schres.2008.11.009; Domes G, 2007, BIOL PSYCHIAT, V62, P1187, DOI 10.1016/j.biopsych.2007.03.025; Domes G, 2007, BIOL PSYCHIAT, V61, P731, DOI 10.1016/j.biopsych.2006.07.015; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Feifel D, 1999, PSYCHOPHARMACOLOGY, V141, P93, DOI 10.1007/s002130050811; Feifel D, 2012, SCHIZOPHR RES, V139, P207, DOI 10.1016/j.schres.2012.05.018; Feifel D, 2010, BIOL PSYCHIAT, V68, P678, DOI 10.1016/j.biopsych.2010.04.039; Feldman R, 2012, BIOL PSYCHIAT, V72, P175, DOI 10.1016/j.biopsych.2011.12.025; Ferguson JN, 2001, J NEUROSCI, V21, P8278; Frith CD, 2004, PSYCHOL MED, V34, P385, DOI 10.1017/S0033291703001326; Furman DJ, 2011, PSYCHONEUROENDOCRINO, V36, P891, DOI 10.1016/j.psyneuen.2010.12.004; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Goldman M, 2008, SCHIZOPHR RES, V98, P247, DOI 10.1016/j.schres.2007.09.019; Goldman MB, 2011, PSYCHOPHARMACOLOGY, V216, P101, DOI 10.1007/s00213-011-2193-8; Gregory SG, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-62; Heinrichs M, 2003, BIOL PSYCHIAT, V54, P1389, DOI 10.1016/S0006-3223(03)00465-7; Heinrichs M, 2008, PROG BRAIN RES, V170, P337, DOI 10.1016/S0079-6123(08)00428-7; HELMCHEN H, 1995, NERVENARZT, V66, P231; Huber D, 2005, SCIENCE, V308, P245, DOI 10.1126/science.1105636; Inoue H, 2010, BIOL PSYCHIAT, V68, P1066, DOI 10.1016/j.biopsych.2010.07.019; Jacob S, 2007, NEUROSCI LETT, V417, P6, DOI 10.1016/j.neulet.2007.02.001; Kawamura Y, 2010, J AFFECT DISORDERS, V127, P31, DOI 10.1016/j.jad.2010.04.014; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Keri S, 2011, PHYSIOL BEHAV, V102, P221, DOI 10.1016/j.physbeh.2010.11.011; Keri S, 2009, COGN AFFECT BEHAV NE, V9, P237, DOI 10.3758/CABN.9.3.237; Keri S, 2009, SOC NEUROSCI-UK, V4, P287, DOI 10.1080/17470910802319710; Kim HS, 2010, P NATL ACAD SCI USA, V107, P15717, DOI 10.1073/pnas.1010830107; Kimura T, 2003, J MOL ENDOCRINOL, V30, P109, DOI 10.1677/jme.0.0300109; Kirsch P, 2005, J NEUROSCI, V25, P11489, DOI 10.1523/JNEUROSCI.3984-05.2005; Kiss A, 2010, J NEUROSCI RES, V88, P677, DOI 10.1002/jnr.22226; Knobloch HS, 2012, NEURON, V73, P553, DOI 10.1016/j.neuron.2011.11.030; Kogan A, 2011, P NATL ACAD SCI USA, V108, P19189, DOI 10.1073/pnas.1112658108; Krueger F, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00004; Landgraf R, 2004, FRONT NEUROENDOCRIN, V25, P150, DOI 10.1016/j.yfrne.2004.05.001; Lee PR, 2007, BRAIN RES, V1156, P152, DOI 10.1016/j.brainres.2007.04.042; Lee PR, 2005, NEUROPSYCHOPHARMACOL, V30, P1883, DOI 10.1038/sj.npp.1300722; LEHRL S, 1995, ACTA NEUROL SCAND, V91, P335, DOI 10.1111/j.1600-0404.1995.tb07018.x; Lerer E, 2008, MOL PSYCHIATR, V13, P980, DOI 10.1038/sj.mp.4002087; Lim MM, 2006, HORM BEHAV, V50, P506, DOI 10.1016/j.yhbeh.2006.06.028; Liu XX, 2010, J HUM GENET, V55, P137, DOI 10.1038/jhg.2009.140; Lucht MJ, 2009, PROG NEURO-PSYCHOPH, V33, P860, DOI 10.1016/j.pnpbp.2009.04.004; MacDonald K, 2012, ACTA NEUROPSYCHIATR, V24, P130, DOI 10.1111/j.1601-5215.2011.00634.x; MacDonald K, 2010, HARVARD REV PSYCHIAT, V18, P1, DOI 10.3109/10673220903523615; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Montag C, 2007, SCHIZOPHR RES, V92, P85, DOI 10.1016/j.schres.2007.01.024; Montag C, 2013, WORLD J BIOL PSYCHIA, V14, P500, DOI 10.3109/15622975.2012.677547; Montag C, 2011, PSYCHIAT RES, V186, P203, DOI 10.1016/j.psychres.2010.09.006; Murakami G, 2011, EUR J NEUROSCI, V34, P469, DOI 10.1111/j.1460-9568.2011.07761.x; Neumann ID, 2008, J NEUROENDOCRINOL, V20, P858, DOI 10.1111/j.1365-2826.2008.01726.x; Neumann ID, 2002, PROG BRAIN RES, V139, P147; Norman GJ, 2012, HORM BEHAV, V61, P134, DOI 10.1016/j.yhbeh.2011.11.006; Ochsner KN, 2008, BIOL PSYCHIAT, V64, P48, DOI 10.1016/j.biopsych.2008.04.024; PAULUS C, 1992, EMPATHIE KOMPETENZ A; Pedersen CA, 2011, SCHIZOPHR RES, V132, P50, DOI 10.1016/j.schres.2011.07.027; Petrovic P, 2008, J NEUROSCI, V28, P6607, DOI 10.1523/JNEUROSCI.4572-07.2008; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Riem MME, 2012, NEUROPSYCHOPHARMACOL, V37, P1257, DOI 10.1038/npp.2011.313; Riem MME, 2011, BIOL PSYCHIAT, V70, P291, DOI 10.1016/j.biopsych.2011.02.006; Rodrigues SM, 2009, P NATL ACAD SCI USA, V106, P21437, DOI 10.1073/pnas.0909579106; Rogers K, 2007, J AUTISM DEV DISORD, V37, P709, DOI 10.1007/s10803-006-0197-8; Rosenfeld AJ, 2011, SCHIZOPHRENIA BULL, V37, P1077, DOI 10.1093/schbul/sbq015; Ross HE, 2009, NEUROSCIENCE, V162, P892, DOI 10.1016/j.neuroscience.2009.05.055; Rubin LH, 2011, SCHIZOPHR RES, V130, P266, DOI 10.1016/j.schres.2011.06.002; Ruble LH, 2010, SCHIZOPHR RES, V124, P13, DOI 10.1016/j.schres.2010.09.014; Sasayama D, 2012, SCHIZOPHR RES, V139, P201, DOI 10.1016/j.schres.2012.06.016; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Skuse DH, 2011, PEDIATR RES, V69, p85R, DOI 10.1203/PDR.0b013e318212f562; Skuse DH, 2009, TRENDS COGN SCI, V13, P27, DOI 10.1016/j.tics.2008.09.007; Smith MJ, 2012, SCHIZOPHR RES, V137, P196, DOI 10.1016/j.schres.2012.01.012; Souza RP, 2010, SCHIZOPHR RES, V121, P279, DOI 10.1016/j.schres.2010.04.019; Souza RP, 2010, INT J NEUROPSYCHOPH, V13, P793, DOI 10.1017/S1461145710000167; Sprong M, 2007, BRIT J PSYCHIAT, V191, P5, DOI 10.1192/bjp.bp.107.035899; Striepens N, 2011, FRONT NEUROENDOCRIN, V32, P426, DOI 10.1016/j.yfrne.2011.07.001; Tansey KE, 2010, NEUROSCI LETT, V474, P163, DOI 10.1016/j.neulet.2010.03.035; Teltsh O, 2012, INT J NEUROPSYCHOPH, V15, P309, DOI 10.1017/S1461145711001374; Thompson RJ, 2011, PSYCHONEUROENDOCRINO, V36, P144, DOI 10.1016/j.psyneuen.2010.07.003; Tomasino B, 2011, PSYCHOL MED, V41, P301, DOI 10.1017/S0033291710000875; Tost H, 2011, BIOL PSYCHIAT, V70, pE37, DOI 10.1016/j.biopsych.2011.06.034; Tost H, 2010, P NATL ACAD SCI USA, V107, P13936, DOI 10.1073/pnas.1003296107; UVNASMOBERG K, 1992, PSYCHOPHARMACOLOGY, V109, P473, DOI 10.1007/BF02247726; Veenema AH, 2008, PROG BRAIN RES, V170, P261, DOI 10.1016/S0079-6123(08)00422-6; Wermter AK, 2010, AM J MED GENET B, V153B, P629, DOI 10.1002/ajmg.b.31032; Wittchen H.U., 1997, SKID 1 SCID 2 STRUKT; Wright IC, 2000, AM J PSYCHIAT, V157, P16, DOI 10.1176/ajp.157.1.16; Wu N, 2012, J AFFECT DISORDERS, V138, P468, DOI 10.1016/j.jad.2012.01.009; Wu SP, 2005, BIOL PSYCHIAT, V58, P74, DOI 10.1016/j.biopsych.2005.03.013; Yamasue H, 2011, BIOL PSYCHIAT, V70, pE41, DOI 10.1016/j.biopsych.2011.07.021; Ylisaukko-oja T, 2006, ANN NEUROL, V59, P145, DOI 10.1002/ana.20722; Yrigollen CM, 2008, BIOL PSYCHIAT, V63, P911, DOI 10.1016/j.biopsych.2007.11.015; Zak PJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001128	119	57	60	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51882	10.1371/journal.pone.0051882	http://dx.doi.org/10.1371/journal.pone.0051882			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284802	Green Submitted, Green Published, gold			2022-12-27	WOS:000312794500061
J	Nasir, A; Norton, JD; Baou, M; Zekavati, A; Bijlmakers, MJ; Thompson, S; Murphy, JJ				Nasir, Asghar; Norton, John D.; Baou, Maria; Zekavati, Anna; Bijlmakers, Marie-Jose; Thompson, Steve; Murphy, John J.			ZFP36L1 Negatively Regulates Plasmacytoid Differentiation of BCL1 Cells by Targeting BLIMP1 mRNA	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; EARLY RESPONSE GENE; ZINC-FINGER PROTEINS; B-CELLS; TRISTETRAPROLIN FAMILY; LYMPHOBLASTIC-LEUKEMIA; BINDING PROTEINS; EXPRESSION; TURNOVER; MYELOMA	The ZFP36/Tis11 family of zinc-finger proteins regulate cellular processes by binding to adenine uridine rich elements in the 3' untranslated regions of various mRNAs and promoting their degradation. We show here that ZFP36L1 expression is largely extinguished during the transition from B cells to plasma cells, in a reciprocal pattern to that of ZFP36 and the plasma cell transcription factor, BLIMP1. Enforced expression of ZFP36L1 in the mouse BCL1 cell line blocked cytokine-induced differentiation while shRNA-mediated knock-down enhanced differentiation. Reconstruction of regulatory networks from microarray gene expression data using the ARACNe algorithm identified candidate mRNA targets for ZFP36L1 including BLIMP1. Genes that displayed down-regulation in plasma cells were significantly over-represented (P = <0.0001) in a set of previously validated ZFP36 targets suggesting that ZFP36L1 and ZFP36 target distinct sets of mRNAs during plasmacytoid differentiation. ShRNA-mediated knock-down of ZFP36L1 in BCL1 cells led to an increase in levels of BLIMP1 mRNA and protein, but not for mRNAs of other transcription factors that regulate plasmacytoid differentiation (xbp1, irf4, bcl6). Finally, ZFP36L1 significantly reduced the activity of a BLIMP1 39 untranslated region-driven luciferase reporter. Taken together, these findings suggest that ZFP36L1 negatively regulates plasmacytoid differentiation, at least in part, by targeting the expression of BLIMP1.	[Nasir, Asghar; Zekavati, Anna; Bijlmakers, Marie-Jose; Thompson, Steve; Murphy, John J.] Kings Coll London, Div Immunol Infect & Inflammatory Dis, London WC2R 2LS, England; [Norton, John D.; Baou, Maria] Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England; [Murphy, John J.] Univ Westminster, Dept Biomed Sci, London W1R 8AL, England	University of London; King's College London; University of Essex; University of Westminster	Murphy, JJ (corresponding author), Kings Coll London, Div Immunol Infect & Inflammatory Dis, London WC2R 2LS, England.	j.murphy@westminster.ac.uk	bijlmakers, marie-jose/N-5369-2014; Baou, Maria/AAX-4674-2020	bijlmakers, marie-jose/0000-0001-6762-1168; 	government of Pakistan PhD. Scholarship; Leukaemia and Lymphoma Research United Kingdom	government of Pakistan PhD. Scholarship; Leukaemia and Lymphoma Research United Kingdom	The work was supported by a government of Pakistan PhD. Scholarship awarded to AN. This work was supported in part by Leukaemia and Lymphoma Research United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakheet T, 2003, NUCLEIC ACIDS RES, V31, P421, DOI 10.1093/nar/gkg023; Baou M, 2009, LEUKEMIA, V23, P986, DOI 10.1038/leu.2008.340; Baou M, 2011, BLOOD, V118, P5732, DOI 10.1182/blood-2011-07-347237; Baou M, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/634520; Basso K, 2010, BLOOD, V115, P975, DOI 10.1182/blood-2009-06-227017; Bell SE, 2006, DEV DYNAM, V235, P3144, DOI 10.1002/dvdy.20949; Bernard MP, 2010, IMMUNOLOGY, V129, P87, DOI 10.1111/j.1365-2567.2009.03152.x; BLACKMAN MA, 1986, CELL, V47, P609, DOI 10.1016/0092-8674(86)90625-2; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Blackshear PJ, 2005, BIOL REPROD, V73, P297, DOI 10.1095/biolreprod.105.040527; Borset M, 1996, J BIOL CHEM, V271, P24655, DOI 10.1074/jbc.271.40.24655; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Doody GM, 2010, NUCLEIC ACIDS RES, V38, P5336, DOI 10.1093/nar/gkq268; Emmons J, 2008, RNA, V14, P888, DOI 10.1261/rna.748408; Gould J, 2006, BIOINFORMATICS, V22, P1924, DOI 10.1093/bioinformatics/btl196; GREIL J, 1994, BRIT J HAEMATOL, V86, P275, DOI 10.1111/j.1365-2141.1994.tb04726.x; Gutierrez NC, 2007, LEUKEMIA, V21, P541, DOI 10.1038/sj.leu.2404520; Hodson DJ, 2010, NAT IMMUNOL, V11, P717, DOI 10.1038/ni.1901; HURWITZ R, 1979, INT J CANCER, V23, P174, DOI 10.1002/ijc.2910230206; Igarashi K, 2007, J BIOCHEM, V141, P783, DOI 10.1093/jb/mvm106; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Johnson BA, 2000, ONCOGENE, V19, P1657, DOI 10.1038/sj.onc.1203474; Lai WS, 2006, MOL CELL BIOL, V26, P9196, DOI 10.1128/MCB.00945-06; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Margolin AA, 2006, NAT PROTOC, V1, P663, DOI 10.1038/nprot.2006.106; MURPHY JJ, 1990, BIOCHIM BIOPHYS ACTA, V1049, P261; NAMBA M, 1989, IN VITRO CELL DEV B, V25, P723; Ning ZQ, 1996, EUR J IMMUNOL, V26, P2356, DOI 10.1002/eji.1830261013; Ning ZQ, 1996, BIOCHEM J, V319, P59, DOI 10.1042/bj3190059; Ogilvie RL, 2005, J IMMUNOL, V174, P953, DOI 10.4049/jimmunol.174.2.953; Ohkubo Y, 2005, J IMMUNOL, V174, P7703, DOI 10.4049/jimmunol.174.12.7703; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Shaffer AL, 2006, IMMUNOL REV, V210, P67, DOI 10.1111/j.0105-2896.2006.00373.x; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shimada H, 2000, BLOOD, V96, P655; SNAPPER CM, 1995, J IMMUNOL, V154, P5842; Stoecklin G, 2000, MOL CELL BIOL, V20, P3753, DOI 10.1128/MCB.20.11.3753-3763.2000; Stoecklin G, 2002, EMBO J, V21, P4709, DOI 10.1093/emboj/cdf444; Stoecklin G, 2008, J BIOL CHEM, V283, P11689, DOI 10.1074/jbc.M709657200; Stumpo DJ, 2004, MOL CELL BIOL, V24, P6445, DOI 10.1128/MCB.24.14.6445-6455.2004; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TOGAWA A, 1982, INT J CANCER, V29, P495, DOI 10.1002/ijc.2910290502; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Vignudelli T, 2010, MOL BIOL CELL, V21, P3340, DOI 10.1091/mbc.E10-01-0040; Wegmuller D, 2007, STEM CELLS, V25, P1178, DOI 10.1634/stemcells.2006-0106; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025	49	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52187	10.1371/journal.pone.0052187	http://dx.doi.org/10.1371/journal.pone.0052187			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284928	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000312794500109
J	Saxena, R; Ganguly, S; Chattopadhyay, A				Saxena, Roopali; Ganguly, Sourav; Chattopadhyay, Amitabha			Comparative Analysis of Calcium Spikes upon Activation of Serotonin(1A) and Purinergic Receptors	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; CA2+ SIGNALS; CELLS; 5-HT1A-RECEPTORS; OSCILLATIONS; SPECIFICITY; EXPRESSION; DYNAMICS; KINETICS; DRUG	Calcium signaling represents one of the most important signaling cascades in cells and regulates diverse processes such as exocytosis, muscle contraction and relaxation, gene expression and cell growth. G protein-coupled receptors (GPCRs) are the most important family of receptors that activate calcium signaling. Since calcium signaling regulates a large number of physiological responses, it is intriguing that how changes in cytosolic calcium levels by a wide range of stimuli lead to signal-specific physiological responses in the cellular interior. In order to address this issue, we have analyzed temporal calcium profiles induced by two GPCRs, the serotonin(1A) and purinergic receptors. In this work, we have described a set of parameters for the analysis of calcium transients that could provide novel insight into mechanisms responsible for maintaining signal specificity by shaping calcium transients. An interesting feature of calcium signaling that has emerged from our analysis is that the profile of individual transients in a calcium response could play an important role in maintaining downstream signal specificity. In summary, our analysis offers a novel approach to identify differences in calcium response patterns induced by various stimuli.	[Saxena, Roopali; Ganguly, Sourav; Chattopadhyay, Amitabha] Ctr Cellular & Mol Biol, Council Sci & Ind Res, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Chattopadhyay, A (corresponding author), Ctr Cellular & Mol Biol, Council Sci & Ind Res, Hyderabad 500007, Andhra Pradesh, India.	amit@ccmb.res.in	Ganguly, Sourav/A-8931-2011; Chattopadhyay, Amitabha/C-9882-2013	Ganguly, Sourav/0000-0003-1002-9002; 	Council of Scientific and Industrial Research, Govt. of India; Council of Scientific and Industrial Research	Council of Scientific and Industrial Research, Govt. of India(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Council of Scientific and Industrial Research, Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; R.S. and S. G. thank the Council of Scientific and Industrial Research for the award of Senior Research Fellowships. A. C. is an Adjunct Professor at the Special Centre for Molecular Medicine of Jawaharlal Nehru University (New Delhi, India) and Indian Institute of Science Education and Research (Mohali, India), and Honorary Professor at the Jawaharlal Nehru Centre for Advanced Scientific Research (Bangalore, India). A. C. gratefully acknowledges J.C. Bose Fellowship (Department of Science and Technology, Govt. of India). We thank Nandini Rangaraj for valuable suggestions and technical help, and members of our laboratory for critically reading the manuscript.	Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Bruce JIE, 2003, CELL CALCIUM, V34, P431, DOI 10.1016/S0143-4160(03)00150-7; Carafoli E, 2005, FEBS J, V272, P1073, DOI 10.1111/j.1742-4658.2005.04546.x; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cornelisse LN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001073; Dargan SL, 2003, J PHYSIOL-LONDON, V553, P775, DOI 10.1113/jphysiol.2003.054247; Dawson AP, 1997, CURR BIOL, V7, pR544, DOI 10.1016/S0960-9822(06)00277-6; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Dupont G, 2007, INT REV CYTOL, V261, P193, DOI 10.1016/S0074-7696(07)61005-5; Heilker R, 2009, DRUG DISCOV TODAY, V14, P231, DOI 10.1016/j.drudis.2008.11.011; HOSEY MM, 1988, J MEMBRANE BIOL, V104, P81, DOI 10.1007/BF01870922; Iradale PA, 1993, BRIT J PHARMACOL, V110, P1305; James LR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026889; Kiselyov K, 2003, CELL SIGNAL, V15, P243, DOI 10.1016/S0898-6568(02)00074-8; Lin SH, 2004, ANN MED, V36, P204, DOI 10.1080/07853890310024668; Marcet B, 2004, J PHARMACOL EXP THER, V309, P533, DOI 10.1124/jpet.103.063396; MILLARD PJ, 1988, P NATL ACAD SCI USA, V85, P1854, DOI 10.1073/pnas.85.6.1854; MINTA A, 1989, J BIOL CHEM, V264, P8171; Muller CP, 2007, PROG NEUROBIOL, V81, P133, DOI 10.1016/j.pneurobio.2007.01.001; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; Parekh AB, 2011, TRENDS BIOCHEM SCI, V36, P78, DOI 10.1016/j.tibs.2010.07.013; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pucadyil TJ, 2005, CELL MOL NEUROBIOL, V25, P553, DOI 10.1007/s10571-005-3969-3; Ralevic V, 1998, PHARMACOL REV, V50, P413; RAYMOND JR, 1992, N-S ARCH PHARMACOL, V346, P127, DOI 10.1007/BF00165293; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Schlyer S, 2006, DRUG DISCOV TODAY, V11, P481, DOI 10.1016/j.drudis.2006.04.008; Schuster S, 2002, EUR J BIOCHEM, V269, P1333, DOI 10.1046/j.0014-2956.2001.02720.x; Unal H, 2012, TRENDS PHARMACOL SCI, V33, P79, DOI 10.1016/j.tips.2011.09.007; Vermassen E, 2004, BIOL CELL, V96, P3, DOI 10.1016/j.biolcel.2003.11.004; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200	36	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51857	10.1371/journal.pone.0051857	http://dx.doi.org/10.1371/journal.pone.0051857			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284790	Green Published, Green Submitted, gold			2022-12-27	WOS:000312694300051
J	Thorsen, VC; Sundby, J; Malata, A				Thorsen, Viva Combs; Sundby, Johanne; Malata, Address			Piecing Together the Maternal Death Puzzle through Narratives: The Three Delays Model Revisited	PLOS ONE			English	Article							TRADITIONAL BIRTH ATTENDANTS; HEALTH-CARE; MORTALITY; WOMEN; PREGNANCY; SYSTEMS; PREPAREDNESS; FRAMEWORK	Background: In Malawi maternal mortality continues to be a major public health challenge. Going beyond the numbers to form a more complete view of why women die is critical to improving access to and quality of emergency obstetric care. The objective of the current study was to identify the socio-cultural and facility-based factors that contributed to maternal deaths in the district of Lilongwe, Malawi. Methods: Retrospectively, 32 maternal death cases that occurred between January 1, 2011 and June 30, 2011 were reviewed independently by two gynecologists/obstetricians. Interviews were conducted with healthcare staff, family members, neighbors, and traditional birth attendants. Guided by the grounded theory approach, interview transcripts were analyzed manually and continuously. Emerging, recurring themes were identified and excerpts from the transcripts were categorized according to the Three Delays Model (3Ds). Results: Sixteen deaths were due to direct obstetric complications, sepsis and hemorrhage being most common. Sixteen deaths were due to indirect causes with the main cause being anemia, followed by HIV and heart disease. Lack of recognizing signs, symptoms, and severity of the situation; using traditional Birth Attendant services; low female literacy level; delayed access to transport; hardship of long distance and physical terrain; delayed prompt quality emergency obstetric care; and delayed care while at the hospital due to patient refusal or concealment were observed. According to the 3Ds, the most common delay observed was in receiving treatment upon reaching the facility due to referral delays, missed diagnoses, lack of blood, lack of drugs, or inadequate care, and severe mismanagement.	[Thorsen, Viva Combs; Sundby, Johanne] Univ Oslo, Dept Community Med, Oslo, Norway; [Malata, Address] Univ Malawi, Kamuzu Coll Nursing, Dept Maternal & Child Hlth, Lilongwe, Malawi	University of Oslo; University of Malawi	Thorsen, VC (corresponding author), Univ Oslo, Dept Community Med, Oslo, Norway.	v.c.thorsen@medisin.uio.no			Norwegian Research Council [177643]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This research was funded by the Norwegian Research Council (Project #177643). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeleke N, 2011, NIGER MED PRACT, V59, P68; Agarwal S, 2010, J HEALTH POPUL NUTR, V28, P383; Baby H, 2010, J BANGLADESH COLL PH, V28, P5; Barnes-Josiah D, 1998, SOC SCI MED, V46, P981, DOI 10.1016/S0277-9536(97)10018-1; Bisika Thomas, 2008, East Afr J Public Health, V5, P103; Cannoodt L, 2012, INT J HEALTH PLAN M, V27, pe104, DOI 10.1002/hpm.1098; Cham Mamady, 2005, Reprod Health, V2, P3, DOI 10.1186/1742-4755-2-3; CIA, 2009, WORLD FACTB 2009; Ebuehi OM, 2012, INT J WOMENS HEALTH, V4, P25, DOI 10.2147/IJWH.S23173; Essendi H, 2011, J URBAN HEALTH, V88, P356, DOI 10.1007/s11524-010-9481-1; Freedman LP, 2005, LANCET, V365, P997, DOI 10.1016/S0140-6736(05)71090-4; Friis R, 2009, EPIDEMIOLOGY PUBLIC, P49; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Ghebrehiwet B., 2007, J ERITREAN MED ASS, V2, P8; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hesse-Biber S, 2006, PRACTICE QUALITATIVE, P229; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Huntington D, 2012, B WORLD HEALTH ORGAN, V90, P104, DOI 10.2471/BLT.11.092825; Jammeh Abdou, 2011, ISRN Obstet Gynecol, V2011, P981096, DOI 10.5402/2011/981096; JHPIEGO/MNH Program, 2004, MON BIRTH PREP COMPL; KHAN AA, 1994, EVAL HEALTH PROF, V17, P60, DOI 10.1177/016327879401700104; Kongnyuy EJ, 2009, WOMEN HEALTH ISS, V19, P14, DOI 10.1016/j.whi.2008.09.008; Lewis G, 2003, BRIT MED BULL, V67, P27, DOI 10.1093/bmb/ldg009; Lewis G, 2008, BEST PRACT RES CL OB, V22, P447, DOI 10.1016/j.bpobgyn.2007.10.007; Lonkhujizen L, 2009, COCHRANE DATABASE SY, P3; Malawi Health Workforce Observatory, 2010, HUM RES HLTH COUNTR; Malawi Ministry of Development Planning and Cooperation, 2010, 2010 MAL MILL DEV GO; Mason M, 2010, FORUMQUALITATIVE SOZ, V11; Mayring P., 2000, FORUM QUALITATIVE SO, V1, P1, DOI [10.17169/fqs-1.2.1089, DOI 10.17169/FQS-22.2.3826]; Moran AC, 2006, J HEALTH POPUL NUTR, V24, P489; National Statistical Office, 2011, MAL DEM HLTH SURV 20; Prata N, 2011, J HEALTH POPUL NUTR, V29, P81; Seljeskog Line, 2006, Afr J Reprod Health, V10, P66; Shah N, 2007, RAWAL MED J, V32, P163; Smit J J, 1994, Curationis, V17, P25; Stanton C, 2008, B WORLD HEALTH ORGAN, V86, P241; SUNDARI TK, 1992, INT J HEALTH SERV, V22, P513, DOI 10.2190/91YH-A52T-AFBB-1LEA; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Titaley CR, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-43; UNICEF, 2012, COUNTR STAT MAL; United Nations Development Program, 2010, HUM DEV REP 2010 REA; Urassa E, 1997, HEALTH POLICY PLANN, V12, P50, DOI 10.1093/heapol/12.1.50; van den Akker T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020776; White PM, 2002, J MIDWIFERY WOM HEAL, V47, P239, DOI 10.1016/S1526-9523(02)00266-0; WHO, 1996, MAT WAIT HOM REV EXP; WHO, 2010, TRENDS MAT MORT 1990; WHO UNFPA UNICEF and World Bank, 1999, RED MAT MORT JOINT S; WHO UNICEF and The World Bank, 2012, TRENDS MAT MORT 1990; World Health Organization, 2004, NUMB REV MAT DEATHS; World Health Organization, 2011, WORLD HLTH STAT 2011	50	65	65	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52090	10.1371/journal.pone.0052090	http://dx.doi.org/10.1371/journal.pone.0052090			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	059HF	23284882	Green Submitted, Green Published, gold			2022-12-27	WOS:000312694300072
J	Tsui, H; Lau, JTF; Xiang, WN; Gu, J; Wang, ZX				Tsui, Hiyi; Lau, Joseph T. F.; Xiang, Weina; Gu, Jing; Wang, Zixin			Should Associations between HIV-Related Risk Perceptions and Behaviors or Intentions Be Positive or Negative?	PLOS ONE			English	Article							INJECTION-DRUG USERS; SELF-PERCEIVED RISK; SEXUAL-BEHAVIOR; PROTECTIVE BEHAVIOR; CHINA; PREVALENCE; PARTNER; TRANSMISSION; INFECTION; POPULATION	Risk perceptions are important in HIV research and interventions; mixed results were found between HIV-related perceptions and behaviors. We interviewed 377 sexually active injecting drug users in China, finding mixed associations between HIV-related risk perception assessed by two general measures and two previous risk behaviors (syringe sharing: p<.05; unprotected sex: p>.05) - partially supporting the 'reflective hypothesis' that reflection on previous behaviors increases risk perceptions. When we use specific measures for risk perceptions (HIV transmission via unprotected sex with specific types of sex partner and via syringe sharing) and use behavioral intention to adopt protective risk behaviors (condom use and avoid syringe sharing totally) as dependent variables, positive significant associations were observed - supporting the motivational hypothesis that risk perceptions motivate one to adopt protective behaviors. The direction and significance of the associations of concern depends on types of measures used. It has important implications on research design, data interpretation and services.	[Tsui, Hiyi; Lau, Joseph T. F.; Wang, Zixin] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Fac Med, Ctr Hlth Behav Res, Hong Kong, Hong Kong, Peoples R China; [Lau, Joseph T. F.; Gu, Jing] Sun Yat Sen Univ, Ctr Med Anthropol & Behav Hlth, Guangzhou 510275, Guangdong, Peoples R China; [Xiang, Weina] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Gu, Jing] Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China	Chinese University of Hong Kong; Sun Yat Sen University; Emory University; Rollins School Public Health; Sun Yat Sen University	Lau, JTF (corresponding author), Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Fac Med, Ctr Hlth Behav Res, Hong Kong, Hong Kong, Peoples R China.	jlau@cuhk.edu.hk	Wang, Zhiquan/HHS-6768-2022					AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Bailey SL, 2007, DRUG ALCOHOL DEPEN, V91, pS18, DOI 10.1016/j.drugalcdep.2007.02.014; Bang-Ping J, 2009, J SEX MED, V6, P1072, DOI 10.1111/j.1743-6109.2007.00707.x; CRISP BR, 1993, DRUG ALCOHOL DEPEN, V33, P73, DOI 10.1016/0376-8716(93)90035-O; Do M, 2009, AIDS CARE, V21, P1211, DOI 10.1080/09540120902730047; Ellen JM, 2002, J APPL SOC PSYCHOL, V32, P648, DOI 10.1111/j.1559-1816.2002.tb00235.x; Essien EJ, 2008, PUBLIC HEALTH, V122, P397, DOI 10.1016/j.puhe.2007.07.023; Fotopoulou A, 2007, NEUROCASE, V13, P6, DOI 10.1080/13554790601160566; Fraile JS, 1997, ACTAS LUSO-ESP NEUR, V25, P17; Gerrard M, 1996, PSYCHOL BULL, V119, P390, DOI 10.1037/0033-2909.119.3.390; Go VF, 2006, JAIDS-J ACQ IMM DEF, V42, P108, DOI 10.1097/01.qai.0000199354.88607.2f; Gu J, 2008, DRUG ALCOHOL DEPEN, V97, P257, DOI 10.1016/j.drugalcdep.2008.03.029; Gu J, 2009, AIDS CARE, V21, P31, DOI 10.1080/09540120802068787; HERSHEY JC, 1980, ORGAN BEHAV HUM PERF, V25, P395, DOI 10.1016/0030-5073(80)90037-9; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Khawcharoenporn T, 2012, AIDS PATIENT CARE ST, V26, P222, DOI 10.1089/apc.2011.0202; Kowalewski MR, 1997, HEALTH EDUC BEHAV, V24, P313, DOI 10.1177/109019819702400305; Lau J. T., 2012, AIDS BEHAV, DOI 10.1007/s10461-012-0244-8; Lau JTF, 2007, SEX TRANSM DIS, V34, P574, DOI 10.1097/01.olq.0000253339.49181.f9; Lau JTF, 2011, SEX TRANSM DIS, V38, P788, DOI 10.1097/OLQ.0b013e318218cc66; Lau JTF, 2009, AIDS CARE, V21, P909, DOI 10.1080/09540120802612790; Lau JTF, 2005, AIDS CARE, V17, P166, DOI 10.1080/09540120512331325662; Lawan U M, 2012, Afr J Reprod Health, V16, P61; Lin DH, 2010, AIDS EDUC PREV, V22, P344, DOI 10.1521/aeap.2010.22.4.344; Liu HJ, 2006, SEX TRANSM DIS, V33, P111, DOI 10.1097/01.olq.0000199762.28231.ee; LOXLEY W, 2000, SEX RELATSH THER, V15, P297, DOI DOI 10.1080/14681990050109872; Ma Y, 1990, ZHONGHUA LIU XING BI, V11, P184; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Mehrotra P, 2009, AIDS EDUC PREV, V21, P39, DOI 10.1521/aeap.2009.21.1.39; Mills HL, 2012, DRUG ALCOHOL DEPEND; Ministry of Health of the People's Republic of China, 2012, 2012 CHIN AIDS RESP; Mitchell MM, 2009, AIDS CARE, V21, P221, DOI 10.1080/09540120801982897; Nunn A, 2011, AIDS PATIENT CARE ST, V25, P229, DOI 10.1089/apc.2010.0313; Pan Xiao-hong, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P499; Pang L, 2007, AIDS, V21, pS103, DOI 10.1097/01.aids.0000304704.71917.64; Pisani E, 2003, JAIDS-J ACQ IMM DEF, V34, P403, DOI 10.1097/00126334-200312010-00007; Poppen PJ, 1997, AIDS EDUC PREV, V9, P373; PROHASKA TR, 1990, J HEALTH SOC BEHAV, V31, P384, DOI 10.2307/2136821; Reisen CA, 1999, J APPL SOC PSYCHOL, V29, P667, DOI 10.1111/j.1559-1816.1999.tb02018.x; ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P328, DOI 10.1177/109019817400200403; Ruan YH, 2004, SEX TRANSM DIS, V31, P623; Schwarzer R, 1999, J Health Psychol, V4, P115, DOI 10.1177/135910539900400208; Schwarzer R., 1992, SELF EFFICACY THOUGH, P217; SINGH K, 1992, SMJ Singapore Medical Journal, V33, P58; Teng Y, 2011, HEALTH PSYCHOL, V30, P119, DOI 10.1037/a0022023; Tenkorang EY, 2009, AIDS BEHAV, V13, P234, DOI 10.1007/s10461-008-9470-5; VanDerVelde FW, 1996, PSYCHOL HEALTH, V12, P87, DOI 10.1080/08870449608406924; WEINSTEIN ND, 1993, HEALTH PSYCHOL, V12, P324, DOI 10.1037/0278-6133.12.4.324; WEINSTEIN ND, 1993, HEALTH PSYCHOL, V12, P235, DOI 10.1037/0278-6133.12.3.235; *WHO, 2001, HIV AIDS AS PAC REG; Wood E, 2005, INT J EPIDEMIOL, V34, P152, DOI 10.1093/ije/dyh357; Wright PB, 2009, J DRUG ISSUES, V39, P577, DOI 10.1177/002204260903900306; Wu ZY, 1996, AIDS, V10, P1017, DOI 10.1097/00002030-199610090-00013; Yang HM, 2005, SEX TRANSM DIS, V32, P270, DOI 10.1097/01.olq.0000162360.11910.5a; Yao Y, 2009, INT J INFECT DIS, V13, P154, DOI 10.1016/j.ijid.2008.05.1228; Yin L., 2007, CHINA HARM REDUCTION, V4, P6; Yin WY, 2010, INT J EPIDEMIOL, V39, pII29, DOI 10.1093/ije/dyq210; Zhang CY, 2002, J ACQ IMMUN DEF SYND, V29, P191, DOI 10.1097/00042560-200202010-00014	58	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52124	10.1371/journal.pone.0052124	http://dx.doi.org/10.1371/journal.pone.0052124			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	059HF	23284896	Green Published, Green Submitted, gold			2022-12-27	WOS:000312694300073
J	Han, ZC; Conley, SM; Makkia, R; Guo, JJ; Cooper, MJ; Naash, MI				Han, Zongchao; Conley, Shannon M.; Makkia, Rasha; Guo, Junjing; Cooper, Mark J.; Naash, Muna I.			Comparative Analysis of DNA Nanoparticles and AAVs for Ocular Gene Delivery	PLOS ONE			English	Article							ADENOASSOCIATED VIRUS; IN-VIVO; OPTIC-NERVE; EXPRESSION; THERAPY; MOUSE; TRANSDUCTION; VECTORS; INTEGRATION; PROMOTER	Gene therapy is a critical tool for the treatment of monogenic retinal diseases. However, the limited vector capacity of the current benchmark delivery strategy, adeno-associated virus (AAV), makes development of larger capacity alternatives, such as compacted DNA nanoparticles (NPs), critical. Here we conduct a side-by-side comparison of self-complementary AAV and CK30PEG NPs using matched ITR plasmids. We report that although AAVs are more efficient per vector genome (vg) than NPs, NPs can drive gene expression on a comparable scale and longevity to AAV. We show that subretinally injected NPs do not leave the eye while some of the AAV-injected animals exhibited vector DNA and GFP expression in the visual pathways of the brain from PI-60 onward. As a result, these NPs have the potential to become a successful alternative for ocular gene therapy, especially for the multitude of genes too large for AAV vectors.	[Han, Zongchao; Conley, Shannon M.; Makkia, Rasha; Guo, Junjing; Naash, Muna I.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK USA; [Cooper, Mark J.] Copernicus Therapeut Inc, Cleveland, OH USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Naash, MI (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK USA.	Muna-Naash@ouhsc.edu		Han, Zongchao/0000-0002-1287-1810; Han, Zongchao/0000-0002-2019-395X	National Eye Institute [EY10609-MIN, EY018656-MIN, EY018512-SMC]; Foundation Fighting Blindness; Oklahoma Center for the Advancement of Science and Technology; state of Ohio Biomedical Research Commercialization Program; Dr. William "Bill'' W. Talley II Research Award; NATIONAL EYE INSTITUTE [R55EY010609, R56EY010609, R01EY018656, F32EY018512, R01EY010609] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Foundation Fighting Blindness(European Commission); Oklahoma Center for the Advancement of Science and Technology; state of Ohio Biomedical Research Commercialization Program; Dr. William "Bill'' W. Talley II Research Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding provided by National Eye Institute (EY10609-MIN, EY018656-MIN, EY018512-SMC, http://www.nei.nih.gov/), the Foundation Fighting Blindness (MIN, http://www.blindness.org/), the Oklahoma Center for the Advancement of Science and Technology (ZH, SMC, and MIN, http://www.ok.gov/ocast/), the state of Ohio Biomedical Research Commercialization Program (MJC), and Dr. William "Bill'' W. Talley II Research Award ( ZH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland GM, 2005, MOL THER, V12, P1072, DOI 10.1016/j.ymthe.2005.08.008; Allocca M, 2008, J CLIN INVEST, V118, P1955, DOI 10.1172/JCI34316; Amado D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000659; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Buch PK, 2008, GENE THER, V15, P849, DOI 10.1038/gt.2008.66; Cai X, 2010, FASEB J, V24, P1178, DOI 10.1096/fj.09-139147; Cai X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005290; Chen X, 2008, MOL THER, V16, P333, DOI 10.1038/sj.mt.6300365; Chen ZY, 2004, GENE THER, V11, P856, DOI 10.1038/sj.gt.3302231; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Dinculescu A, 2005, HUM GENE THER, V16, P649, DOI 10.1089/hum.2005.16.649; Ding XQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007410; Donsante A, 2001, GENE THER, V8, P1343, DOI 10.1038/sj.gt.3301541; Donsante A, 2007, SCIENCE, V317, P477, DOI 10.1126/science.1142658; Dudus L, 1999, VISION RES, V39, P2545, DOI 10.1016/S0042-6989(98)00308-3; Esumi N, 2004, J BIOL CHEM, V279, P19064, DOI 10.1074/jbc.M309881200; Farjo R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000038; Fink TL, 2006, GENE THER, V13, P1048, DOI 10.1038/sj.gt.3302761; Flannery JG, 1997, P NATL ACAD SCI USA, V94, P6916, DOI 10.1073/pnas.94.13.6916; Glushakova LG, 2006, MOL VIS, V12, P298; Glushakova LG, 2006, INVEST OPHTH VIS SCI, V47, P3505, DOI 10.1167/iovs.05-1670; Gray SJ, 2011, HUM GENE THER, V22, P1143, DOI 10.1089/hum.2010.245; Guy J, 1999, ARCH OPHTHALMOL-CHIC, V117, P929; Han Z, 2008, MOL GENET METAB, V93, P381, DOI 10.1016/j.ymgme.2007.10.131; Han ZC, 2008, HUM GENE THER, V19, P267, DOI 10.1089/hum.2007.161; Han ZC, 2012, NANOMEDICINE-UK, V7, P521, DOI [10.2217/NNM.11.158, 10.2217/nnm.11.158]; Hasbrouck NC, 2008, GENE THER, V15, P870, DOI 10.1038/gt.2008.71; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Hennig AK, 2003, J NEUROSCI, V23, P3302; Jacobson SG, 2006, HUM GENE THER, V17, P845, DOI 10.1089/hum.2006.17.845; Jacobson SG, 2006, MOL THER, V13, P1074, DOI 10.1016/j.ymthe.2006.03.005; Koirala A, 2011, BIOMATERIALS, V32, P9483, DOI 10.1016/j.biomaterials.2011.08.062; Konstan MW, 2004, HUM GENE THER, V15, P1255, DOI 10.1089/hum.2004.15.1255; Lai Y, 2010, MOL THER, V18, P75, DOI 10.1038/mt.2009.256; Lei B, 2009, MOL VIS, V15, P1374; Liu G, 2003, J BIOL CHEM, V278, P32578, DOI 10.1074/jbc.M305776200; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Mao HY, 2011, HUM GENE THER, V22, P567, DOI 10.1089/hum.2010.140; McCarty DM, 2004, ANNU REV GENET, V38, P819, DOI 10.1146/annurev.genet.37.110801.143717; Padegimas L, 2012, MOL THER, V20, P63, DOI 10.1038/mt.2011.196; Provost N, 2005, MOL THER, V11, P275, DOI 10.1016/j.ymthe.2004.09.022; Rhee JM, 2006, GENESIS, V44, P202, DOI 10.1002/dvg.20203; Rocha EM, 2011, INVEST OPHTH VIS SCI, V52, P9567, DOI 10.1167/iovs.11-8171; Sarra GM, 2001, HUM MOL GENET, V10, P2353, DOI 10.1093/hmg/10.21.2353; Shen WY, 2003, J GENE MED, V5, P576, DOI 10.1002/jgm.375; Voutetakis A, 2004, P NATL ACAD SCI USA, V101, P3053, DOI 10.1073/pnas.0400136101; Yang GS, 2002, J VIROL, V76, P7651, DOI 10.1128/JVI.76.15.7651-7660.2002; Yurek DM, 2011, MOL IMAGING, V10, P327, DOI 10.2310/7290.2010.00053; Ziady AG, 2003, MOL THER, V8, P936, DOI 10.1016/j.ymthe.2003.07.007; Ziady AG, 2003, MOL THER, V8, P948, DOI 10.1016/j.ymthe.2003.09.002	50	59	61	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52189	10.1371/journal.pone.0052189	http://dx.doi.org/10.1371/journal.pone.0052189			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272225	gold, Green Published, Green Submitted			2022-12-27	WOS:000312483300069
J	Weiland, T; Klein, K; Zimmermann, M; Speicher, T; Venturelli, S; Berger, A; Bantel, H; Konigsrainer, A; Schenk, M; Weiss, TS; Wendel, A; Schwab, M; Bitzer, M; Lauer, UM				Weiland, Timo; Klein, Kathrin; Zimmermann, Martina; Speicher, Tobias; Venturelli, Sascha; Berger, Alexander; Bantel, Heike; Koenigsrainer, Alfred; Schenk, Martin; Weiss, Thomas S.; Wendel, Albrecht; Schwab, Matthias; Bitzer, Michael; Lauer, Ulrich M.			Selective Protection of Human Liver Tissue in TNF-Targeting of Cancers of the Liver by Transient Depletion of Adenosine Triphosphate	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; ISOLATED HEPATIC PERFUSION; NECROSIS-FACTOR-ALPHA; PHASE-I; INTRAVENOUS FRUCTOSE; METABOLIC DEPLETION; TUMOR; APOPTOSIS; HEPATOCYTES; ATP	Background: Tumor necrosis factor alpha (TNF) is able to kill cancer cells via receptor-mediated cell death requiring adenosine triphosphate (ATP). Clinical usage of TNF so far is largely limited by its profound hepatotoxicity. Recently, it was found in the murine system that specific protection of hepatocytes against TNF's detrimental effects can be achieved by fructose-mediated ATP depletion therein. Before employing this quite attractive selection principle in a first clinical trial, we here comprehensively investigated the interdependence between ATP depletion and TNF hepatotoxicity in both in vitro and ex vivo experiments based on usage of primary patient tissue materials. Methods: Primary human hepatocytes, and both non-tumorous and tumorous patient-derived primary liver tissue slices were used to elucidate fructose-induced ATP depletion and TNF-induced cytotoxicity. Results: PHH as well as tissue slices prepared from non-malignant human liver specimen undergoing a fructose-mediated ATP depletion were both demonstrated to be protected against TNF-induced cell death. In contrast, due to tumor-specific overexpression of hexokinase II, which imposes a profound bypass on hepatocytic-specific fructose catabolism, this was not the case for human tumorous liver tissues. Conclusion: Normal human liver tissues can be protected transiently against TNF-induced cell death by systemic pretreatment with fructose used in non-toxic/physiologic concentrations. Selective TNF-targeting of primary and secondary tumors of the liver by transient and specific depletion of hepatocytic ATP opens up a new clinical avenue for the TNF-based treatment of liver cancers.	[Weiland, Timo; Zimmermann, Martina; Venturelli, Sascha; Berger, Alexander; Bitzer, Michael; Lauer, Ulrich M.] Med Univ Hosp, Dept Internal Med 1, Tubingen, Germany; [Klein, Kathrin; Schwab, Matthias] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-7000 Stuttgart, Germany; [Speicher, Tobias] ETH, Dept Biol, Inst Cell Biol, Zurich, Switzerland; [Bantel, Heike] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-3000 Hannover, Germany; [Koenigsrainer, Alfred; Schenk, Martin] Univ Tubingen Hosp, Dept Gen Visceral & Transplant Surg, Tubingen, Germany; [Weiss, Thomas S.] Univ Hosp, Ctr Liver Cell Res, Regensburg, Germany; [Wendel, Albrecht] Univ Tubingen, Interfac Ctr Pharmacogen & Drug Res ICEPHA, D-72074 Tubingen, Germany; [Schwab, Matthias] Med Univ Hosp, Dept Clin Pharmacol, Inst Expt & Clin Pharmacol & Toxicol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; Hannover Medical School; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Regensburg; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf	Lauer, UM (corresponding author), Med Univ Hosp, Dept Internal Med 1, Tubingen, Germany.	ulrich.lauer@uni-tuebingen.de	Schwab, Matthias/ABH-7449-2020; Weiss, Thomas S./G-3989-2012	Weiss, Thomas S./0000-0003-0336-0581; Venturelli, Sascha/0000-0001-5585-6701	ICEPHA grant [2009-09]; Deutsche Forschungsgemeinschaft [SFB/TRR77]; Federal Ministry for Education and Research (BMBF) [0315755]; Robert Bosch Foundation, Stuttgart, Germany	ICEPHA grant; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Robert Bosch Foundation, Stuttgart, Germany	This work was supported by ICEPHA grant 2009-09, the Deutsche Forschungsgemeinschaft (SFB/TRR77), the Federal Ministry for Education and Research (BMBF, #0315755) and the Robert Bosch Foundation, Stuttgart, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander HR, 1998, CLIN CANCER RES, V4, P2357; Boesch C, 1997, MAGN RESON IMAGING, V15, P1067, DOI 10.1016/S0730-725X(97)00163-X; BOESIGER P, 1994, PEDIATR RES, V36, P436, DOI 10.1203/00006450-199410000-00004; Christoforidis D, 2002, EUR J SURG ONCOL, V28, P875, DOI 10.1053/ejso.2002.1328; Cortez-Pinto H, 1999, JAMA-J AM MED ASSOC, V282, P1659, DOI 10.1001/jama.282.17.1659; de Vries MR, 1998, RECENT RES CANCER, V147, P107; Hentze H, 2004, HEPATOLOGY, V39, P1311, DOI 10.1002/hep.20174; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Latta M, 2000, J EXP MED, V191, P1975, DOI 10.1084/jem.191.11.1975; LEIST M, 1994, J IMMUNOL, V153, P1778; LEJEUNE F, 1994, J CELL BIOCHEM, V56, P52, DOI 10.1002/jcb.240560110; LIENARD D, 1992, J CLIN ONCOL, V10, P52, DOI 10.1200/JCO.1992.10.1.52; OBERHAENSLI RD, 1986, BRIT J RADIOL, V59, P695, DOI 10.1259/0007-1285-59-703-695; SHERMAN ML, 1988, J CLIN ONCOL, V6, P344, DOI 10.1200/JCO.1988.6.2.344; Speicher T, 2012, J BIOL CHEM, V287, P1837, DOI 10.1074/jbc.M111.266742; Speicher T, 2010, J HEPATOL, V53, P896, DOI 10.1016/j.jhep.2010.05.024; SPRIGGS DR, 1988, J NATL CANCER I, V80, P1039, DOI 10.1093/jnci/80.13.1039; TERRIER F, 1989, RADIOLOGY, V171, P557, DOI 10.1148/radiology.171.2.2704824; Weinreich DM, 2002, SEMIN ONCOL, V29, P136, DOI 10.1053/sonc.2002.31681; WOODS HG, 1970, BIOCHEM J, V119, P501, DOI 10.1042/bj1190501; Zimmermann M, 2009, INT J ONCOL, V34, P1247, DOI 10.3892/ijo_00000253	21	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52496	10.1371/journal.pone.0052496	http://dx.doi.org/10.1371/journal.pone.0052496			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272249	Green Published, gold, Green Submitted			2022-12-27	WOS:000312483300091
J	Gotoh, H; Ono, K; Nomura, T; Takebayashi, H; Harada, H; Nakamura, H; Ikenaka, K				Gotoh, Hitoshi; Ono, Katsuhiko; Nomura, Tadashi; Takebayashi, Hirohide; Harada, Hidekiyo; Nakamura, Harukazu; Ikenaka, Kazuhiro			Nkx2.2+Progenitors Generate Somatic Motoneurons in the Chick Spinal Cord	PLOS ONE			English	Article							MOTOR-NEURON DIVERSITY; TRANSCRIPTION FACTORS; PROGENITOR DISPERSAL; OLIG2; ORIGIN; IDENTITY; NKX2.2; OLIGODENDROCYTES; SPECIFICATION; PROTEINS	Heterogeneous classes of neurons are present in the spinal cord and are essential for its function. Expression patterns of transcription factors in neural progenitor cells determine neuron subtypes during development. Nkx2.2 is expressed in the progenitor cell pool located just ventrally to the Olig2-positive pool and is indispensable for V3 interneuron generation in the spinal cord and also for visceral motoneuron generation in the hindbrain. However, whether Nkx2.2-positive progenitor cells generate diverse classes of neuron is not fully understood. Using a chick lineage tracing method in a genetically-defined manner, we found that Nkx2.2-expressing progenitor cells differentiate into general visceral motoneurons as well as sim1-positive V3 interneurons. Surprisingly, we further observed that Nkx2.2-expressing progenitors differentiate into somatic motoneuron. Our findings suggest that the different classes of motoneurons are derived from more complex sources than were previously expected in the chick spinal cord.	[Gotoh, Hitoshi; Ono, Katsuhiko; Nomura, Tadashi] Kyoto Prefectural Univ Med, Dept Biol, Kyoto, Japan; [Takebayashi, Hirohide] Niigata Univ, Grad Sch Med & Dent Sci, Div Neurobiol & Anat, Niigata, Japan; [Nomura, Tadashi; Takebayashi, Hirohide] Japan Sci & Technol Agcy JST, PRESTO, Saitama, Japan; [Harada, Hidekiyo; Nakamura, Harukazu] Tohoku Univ, Grad Sch Life Sci, Inst Dev Aging & Canc, Dept Mol Neurobiol, Sendai, Miyagi 980, Japan; [Ikenaka, Kazuhiro] Grad Univ Adv Studies Sokendai, Sch Life Sci, Dept Physiol Sci, Hayama, Kanagawa, Japan	Kyoto Prefectural University of Medicine; Niigata University; Japan Science & Technology Agency (JST); Tohoku University; Graduate University for Advanced Studies - Japan	Gotoh, H (corresponding author), Kyoto Prefectural Univ Med, Dept Biol, Kyoto, Japan.	hgotoh@koto.kpu-m.ac.jp; ikenaka@nips.ac.jp	Harada, Hidekiyo/X-2704-2019; Takebayashi, Hirohide/AAO-1693-2020	Harada, Hidekiyo/0000-0001-6758-4141; 	JSPS [22500295, 24657158]; MEXT [23523124]; Kyoto Prefectural University of Medicine; National Institute for Physiological Sciences; Astellas Foundation for Research on Metabolic Disorders; JST, PRESTO; Naito foundation	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kyoto Prefectural University of Medicine; National Institute for Physiological Sciences(National Institutes of Natural Sciences (NINS) - JapanNational Institute for Physiological Sciences (NIPS)); Astellas Foundation for Research on Metabolic Disorders; JST, PRESTO(Japan Science & Technology Agency (JST)); Naito foundation(Naito Memorial Foundation)	This work was supported by Grant-in-Aid for Scientific Research (A) and (C)(22500295), for Challenging Exploratory Research (24657158) provided by JSPS, by Grant-in-Aid for Scientific Research on Innovative Areas (23523124) provided by MEXT, by Project Research Grants from Kyoto Prefectural University of Medicine, and by Cooperative Study Program of the National Institute for Physiological Sciences. TN was supported by Astellas Foundation for Research on Metabolic Disorders, and JST, PRESTO. HG was supported by the Naito foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalliu D, 2009, NEURON, V61, P708, DOI 10.1016/j.neuron.2008.12.026; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Cajal Ramon y S, 1911, HISTOLOGY NERVOUS SY, VI; Clarke JDW, 1998, DEV DYNAM, V212, P14, DOI 10.1002/(SICI)1097-0177(199805)212:1<14::AID-AJA2>3.0.CO;2-5; Dasen JS, 2008, CELL, V134, P304, DOI 10.1016/j.cell.2008.06.019; di Sanguinetto SADT, 2008, CURR OPIN NEUROBIOL, V18, P36, DOI 10.1016/j.conb.2008.04.002; Erskine L, 1998, DEV BIOL, V199, P26, DOI 10.1006/dbio.1998.8912; Fu H, 2002, DEVELOPMENT, V129, P681; Gotoh H, 2011, DEV BIOL, V349, P504, DOI 10.1016/j.ydbio.2010.10.007; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HOLLYDAY M, 1977, BRAIN RES, V132, P197, DOI 10.1016/0006-8993(77)90416-4; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; LEBER SM, 1995, J NEUROSCI, V15, P1236; Lee SK, 2004, DEVELOPMENT, V131, P3295, DOI 10.1242/dev.01179; Lei QB, 2006, DEV CELL, V11, P325, DOI 10.1016/j.devcel.2006.06.013; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Masahira N, 2006, DEV BIOL, V293, P358, DOI 10.1016/j.ydbio.2006.02.029; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Nanmoku K, 2003, DEV NEUROSCI-BASEL, V25, P152, DOI 10.1159/000072264; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Pattyn A, 2003, GENE DEV, V17, P729, DOI 10.1101/gad.255803; PRASAD A, 1991, J COMP NEUROL, V307, P237, DOI 10.1002/cne.903070207; Richardson WD, 2000, GLIA, V29, P136, DOI 10.1002/(SICI)1098-1136(20000115)29:2<136::AID-GLIA6>3.0.CO;2-G; Richardson WD, 2006, NAT REV NEUROSCI, V7, P11, DOI 10.1038/nrn1826; Rousso DL, 2008, NEURON, V59, P226, DOI 10.1016/j.neuron.2008.06.025; Soula C, 2001, DEVELOPMENT, V128, P1369; Sun T, 2003, J NEUROSCI, V23, P9547; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3; Zinyk DL, 1998, CURR BIOL, V8, P665, DOI 10.1016/S0960-9822(98)70255-6	32	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51581	10.1371/journal.pone.0051581	http://dx.doi.org/10.1371/journal.pone.0051581			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284718	Green Published, gold, Green Submitted			2022-12-27	WOS:000312435900030
J	Kim, HL; Jeon, JH; Koo, TH; Lee, UY; Jeong, E; Chun, MH; Moon, JI; Massey, SC; Kim, IB				Kim, Hong-Lim; Jeon, Ji Hyun; Koo, Tae-Hyung; Lee, U-Young; Jeong, Eojin; Chun, Myung-Hoon; Moon, Jung-Il; Massey, Stephen C.; Kim, In-Beom			Axonal Synapses Utilize Multiple Synaptic Ribbons in the Mammalian Retina	PLOS ONE			English	Article							DOPAMINERGIC AMACRINE CELLS; INNER PLEXIFORM LAYER; EXPRESSING GANGLION-CELLS; CONE BIPOLAR CELLS; PRIMATE RETINA; RABBIT RETINA; CAT RETINA; MOUSE RETINA; ON-CENTER; FUNCTIONAL-ORGANIZATION	In the mammalian retina, bipolar cells and ganglion cells which stratify in sublamina a of the inner plexiform layer (IPL) show OFF responses to light stimuli while those that stratify in sublamina b show ON responses. This functional relationship between anatomy and physiology is a key principle of retinal organization. However, there are at least three types of retinal neurons, including intrinsically photosensitive retinal ganglion cells (ipRGCs) and dopaminergic amacrine cells, which violate this principle. These cell types have light-driven ON responses, but their dendrites mainly stratify in sublamina a of the IPL, the OFF sublayer. Recent anatomical studies suggested that certain ON cone bipolar cells make axonal or ectopic synapses as they descend through sublamina a, thus providing ON input to cells which stratify in the OFF sublayer. Using immunoelectron microscopy with 3-dimensional reconstruction, we have identified axonal synapses of ON cone bipolar cells in the rabbit retina. Ten calbindin ON cone bipolar axons made en passant ribbon synapses onto amacrine or ganglion dendrites in sublamina a of the IPL. Compared to the ribbon synapses made by bipolar terminals, these axonal ribbon synapses were characterized by a broad postsynaptic element that appeared as a monad and by the presence of multiple short synaptic ribbons. These findings confirm that certain ON cone bipolar cells can provide ON input to amacrine and ganglion cells whose dendrites stratify in the OFF sublayer via axonal synapses. The monadic synapse with multiple ribbons may be a diagnostic feature of the ON cone bipolar axonal synapse in sublamina a. The presence of multiple ribbons and a broad postsynaptic density suggest these structures may be very efficient synapses. We also identified axonal inputs to ipRGCs with the architecture described above.	[Kim, Hong-Lim; Jeon, Ji Hyun; Lee, U-Young; Jeong, Eojin; Chun, Myung-Hoon; Kim, In-Beom] Catholic Univ Korea, Coll Med, Dept Anat, Seoul, South Korea; [Kim, Hong-Lim] Catholic Univ Korea, Coll Med, Integrat Res Support Ctr, Seoul, South Korea; [Koo, Tae-Hyung; Moon, Jung-Il] Catholic Univ Korea, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Lee, U-Young] Catholic Univ Korea, Coll Med, Catholic Inst Appl Anat, Seoul, South Korea; [Massey, Stephen C.] Univ Texas Hlth Sci Ctr Houston, Dept Ophthalmol & Visual Sci, Houston, TX USA	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; University of Texas System; University of Texas Health Science Center Houston	Kim, IB (corresponding author), Catholic Univ Korea, Coll Med, Dept Anat, Seoul, South Korea.	ibkimmd@catholic.ac.kr	Kim, In-Beom/A-6728-2011		National Research Foundation of Korea [20100022317]; Scientific Research Center; National Institutes of Health [EY06515, EY10608]; NATIONAL EYE INSTITUTE [R55EY006515, P30EY010608, R01EY006515] Funding Source: NIH RePORTER	National Research Foundation of Korea(National Research Foundation of Korea); Scientific Research Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Research Foundation of Korea grant # 20100022317 (I-BK), a Scientific Research Center grant (I-BK), and National Institutes of Health grants EY06515 and EY10608 (SCM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baver SB, 2008, EUR J NEUROSCI, V27, P1763, DOI 10.1111/j.1460-9568.2008.06149.x; Berson DM, 2010, J COMP NEUROL, V518, P2405, DOI 10.1002/cne.22381; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Berson DM, 2003, TRENDS NEUROSCI, V26, P314, DOI 10.1016/S0166-2236(03)00130-9; BLOOMFIELD SA, 1986, J NEUROSCI, V6, P1; Boelen MK, 1998, VISUAL NEUROSCI, V15, P97, DOI 10.1017/S0952523898151040; Boycott B, 1999, INVEST OPHTH VIS SCI, V40, P1313; BOYCOTT BB, 1991, EUR J NEUROSCI, V3, P1069, DOI 10.1111/j.1460-9568.1991.tb00043.x; Calkins DJ, 1998, J NEUROSCI, V18, P3373; Contini M, 2010, J COMP NEUROL, V518, P2035, DOI 10.1002/cne.22320; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; DUBIN MW, 1970, J COMP NEUROL, V140, P479, DOI 10.1002/cne.901400406; Dumitrescu ON, 2009, J COMP NEUROL, V517, P226, DOI 10.1002/cne.22158; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; EULER T, 1995, J COMP NEUROL, V361, P461, DOI 10.1002/cne.903610310; FAMIGLIETTI EV, 1976, SCIENCE, V194, P193, DOI 10.1126/science.959847; Fu YB, 2005, CURR OPIN NEUROBIOL, V15, P415, DOI 10.1016/j.conb.2005.06.011; Ghosh KK, 2004, J COMP NEUROL, V469, P70, DOI 10.1002/cne.10985; Goz D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003153; Grunert U, 2011, VISUAL NEUROSCI, V28, P39, DOI 10.1017/S095252381000026X; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Gustincich S, 1997, NEURON, V18, P723, DOI 10.1016/S0896-6273(00)80313-X; Hartveit E, 1997, J NEUROPHYSIOL, V77, P1716, DOI 10.1152/jn.1997.77.4.1716; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Haverkamp S, 2003, J COMP NEUROL, V455, P463, DOI 10.1002/cne.10491; HOKOC JN, 1988, BRAIN RES, V461, P17, DOI 10.1016/0006-8993(88)90721-4; HOKOC JN, 1987, J NEUROSCI, V7, P2785; Hoshi H, 2009, J NEUROSCI, V29, P8875, DOI 10.1523/JNEUROSCI.0912-09.2009; Hoshi H, 2009, J COMP NEUROL, V513, P69, DOI 10.1002/cne.21941; Kim SA, 2010, CELL TISSUE RES, V339, P311, DOI 10.1007/s00441-009-0895-6; KOLB H, 1979, J NEUROCYTOL, V8, P295, DOI 10.1007/BF01236124; Lauritzen JS, 2013, J COMP NEUROL, V521, P977, DOI 10.1002/cne.23244; MacNeil MA, 2004, J COMP NEUROL, V472, P73, DOI 10.1002/cne.20063; Massey SC, 1996, J COMP NEUROL, V366, P15; MCGUIRE BA, 1984, J NEUROSCI, V4, P2920; MCGUIRE BA, 1986, J NEUROSCI, V6, P907; NELSON R, 1983, VISION RES, V23, P1183, DOI 10.1016/0042-6989(83)90032-9; NELSON R, 1978, J NEUROPHYSIOL, V41, P472, DOI 10.1152/jn.1978.41.2.472; PEICHL L, 1981, PROC R SOC SER B-BIO, V212, P139, DOI 10.1098/rspb.1981.0030; Pickard GE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004984; Schmidt TM, 2008, J NEUROPHYSIOL, V100, P371, DOI 10.1152/jn.00062.2008; Schmidt TM, 2009, J NEUROSCI, V29, P476, DOI 10.1523/JNEUROSCI.4117-08.2009; Shinohara Y, 2012, HIPPOCAMPUS, V22, P942, DOI 10.1002/hipo.20950; Sterling P, 2005, TRENDS NEUROSCI, V28, P20, DOI 10.1016/j.tins.2004.11.009; Sterling P, 1995, FUNCTIONAL ARCHITECT; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; Viney TJ, 2007, CURR BIOL, V17, P981, DOI 10.1016/j.cub.2007.04.058; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Witkovsky P, 2004, DOC OPHTHALMOL, V108, P17, DOI 10.1023/B:DOOP.0000019487.88486.0a; Wong KY, 2007, J PHYSIOL-LONDON, V582, P279, DOI 10.1113/jphysiol.2007.133751; Zhang J, 2005, VISUAL NEUROSCI, V22, P535, DOI 10.1017/S0952523805224148	54	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52295	10.1371/journal.pone.0052295	http://dx.doi.org/10.1371/journal.pone.0052295			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284975	gold, Green Submitted, Green Published			2022-12-27	WOS:000312435900088
J	Ma, Y; Wen, XZ; Peng, J; Lu, Y; Guo, ZM; Lu, JH				Ma, Yu; Wen, Xiaozhong; Peng, Jing; Lu, Yi; Guo, Zhongmin; Lu, Jiahai			Systematic Review and Meta-Analysis on the Association between Outpatient Statins Use and Infectious Disease-Related Mortality	PLOS ONE			English	Review							POPULATION-BASED COHORT; SEVERE SEPSIS; CARDIAC OUTCOMES; ACE-INHIBITORS; PNEUMONIA; THERAPY; ROSUVASTATIN; IMPACT; INFLUENZA; TRIAL	Background: To update and refine systematic literature review on the association between outpatient statins use and mortality in patients with infectious disease. Materials and Methods: We searched articles published before September 31, 2012, on the association between statins and infectious disease-related mortality through electronic databases. Eligible articles were analyzed in Review Manager 5.1. We conducted stratification analysis by study design, infection types, clinical outcomes and study locations. Results: The pooled odds ratio (OR) for death (statins use vs. no use) across the 41 included studies was 0.71 (95% confidence interval: 0.64, 0.78). The corresponding pooled ORs were 0.58 (0.38, 0.90), 0.66 (0.57, 0.75), 0.71 (0.57, 0.89) and 0.83 (0.67, 1.04) for the case-control study, retrospective cohort studies, prospective cohort studies and RCTs; 0.40 (0.20, 0.78), 0.61 (0.41, 0.90), 0.69 (0.62, 0.78) and 0.86 (0.68, 1.09) for bacteremia, sepsis, pneumonia and other infections; 0.62 (0.534, 0.72), 0.68 (0.53, 0.89), 0.71 (0.61, 0.83) and 0.86 (0.70, 1.07) for 30-day, 90-day, in-hospital and long-term (>1 year) mortality, respectively. Conclusions: Outpatient statins use is associated with a lower risk of death in patients with infectious disease in observational studies, but in a less extent in clinical trials. This association also varies considerably by infection types and clinical outcomes. Citation: Ma Y, Wen X, Peng J, Lu Y, Guo Z, et al. (2012) Systematic Review and Meta-Analysis on the Association between Outpatient Statins Use and Infectious Disease-Related Mortality. PLoS ONE 7(12): e51548. doi:10.1371/journal.pone.0051548	[Guo, Zhongmin] Sun Yat Sen Univ, Lab Anim Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Ma, Yu; Lu, Jiahai] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control Res, Sch Publ Hlth,Dept Epidemiol & Biostat, Guangzhou 510275, Guangdong, Peoples R China; [Wen, Xiaozhong] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA USA; [Wen, Xiaozhong] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Peng, Jing] Sun Yat Sen Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Guangzhou 510275, Guangdong, Peoples R China; [Lu, Yi] So Med Univ, Sch Publ Hlth & Trop Med, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Sun Yat Sen University; Southern Medical University - China	Guo, ZM (corresponding author), Sun Yat Sen Univ, Lab Anim Ctr, Guangzhou 510275, Guangdong, Peoples R China.	zhongminguo@yahoo.com.cn; jiahailu@yahoo.com.cn			Natural Science Foundation of China (NSFC) [81172735]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This project was supported by the Natural Science Foundation of China (NSFC) [grant No. 81172735] (http://159.226.244.22/portal/Proj_List.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almog Y, 2007, CRIT CARE MED, V35, P372, DOI 10.1097/01.CCM.0000253397.42079.D5; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; [Anonymous], PRAV VENT ASS PNEUM; [Anonymous], STAT THER TREATM SEP; [Anonymous], STAT EARL TREATM SEP; [Anonymous], STAT AC INJ LUNGS SE; [Anonymous], NEWC OTT SCAL NOS AS; Bjorkhem-Bergman L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010702; Brett SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018120; Chalmers JD, 2008, AM J MED, V121, P1002, DOI 10.1016/j.amjmed.2008.06.030; de Saint Martin Luc, 2010, Presse Med, V39, pe52, DOI 10.1016/j.lpm.2009.09.022; DETSKY AS, 1985, ARCH INTERN MED, V145, P709, DOI 10.1001/archinte.145.4.709; Dobesh PP, 2009, PHARMACOTHERAPY, V29, P621, DOI 10.1592/phco.29.6.621; Donnino MW, 2009, ACAD EMERG MED, V16, P230, DOI 10.1111/j.1553-2712.2009.00350.x; Douglas I, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1642; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Falagas ME, 2008, J ANTIMICROB CHEMOTH, V61, P774, DOI 10.1093/jac/dkn019; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Fernandez R, 2006, INTENS CARE MED, V32, P160, DOI 10.1007/s00134-005-2743-9; Frost FJ, 2007, CHEST, V131, P1006, DOI 10.1378/chest.06-1997; Hackam DG, 2006, LANCET, V367, P413, DOI 10.1016/S0140-6736(06)68041-0; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holdaas H, 2005, AM J TRANSPLANT, V5, P2929, DOI 10.1111/j.1600-6143.2005.01105.x; Hsu J, 2009, EUR J CLIN MICROBIOL, V28, P1343, DOI 10.1007/s10096-009-0787-4; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Janda Surinder, 2010, J Crit Care, V25, DOI 10.1016/j.jcrc.2010.02.013; Kjekshus J, 2007, NEW ENGL J MED, V357, P2248, DOI 10.1056/NEJMoa0706201; Kopterides P, 2009, CLIN MICROBIOL INFEC, V15, P325, DOI 10.1111/j.1469-0691.2009.02750.x; Kruger P, 2006, INTENS CARE MED, V32, P75, DOI 10.1007/s00134-005-2859-y; Kwong JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008087; Leung S, 2012, CRIT CARE MED; Liappis AP, 2001, CLIN INFECT DIS, V33, P1352, DOI 10.1086/323334; Link A, 2006, EUR HEART J, V27, P2945, DOI 10.1093/eurheartj/ehl277; Majumdar SR, 2006, BMJ-BRIT MED J, V333, P999, DOI 10.1136/BMJ.38992.565972.7C; Makris D, 2011, CRIT CARE MED, V39, P2440, DOI 10.1097/CCM.0b013e318225742c; Martin CP, 2007, PHARMACOTHERAPY, V27, P20, DOI 10.1592/phco.27.1.20; McGown CC, 2007, BRIT J ANAESTH, V98, P163, DOI 10.1093/bja/ael358; Merx MW, 2006, CURR OPIN CRIT CARE, V12, P309, DOI 10.1097/01.ccx.0000235207.00322.96; Mortensen EM, 2008, EUR RESPIR J, V31, P611, DOI 10.1183/09031936.00162006; Mortensen EM, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-82; Mortensen EM, 2007, PHARMACOTHERAPY, V27, P1619, DOI 10.1592/phco.27.12.1619; Mortensen EM, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-45; Myles PR, 2009, PHARMACOEPIDEM DR S, V18, P697, DOI 10.1002/pds.1769; Nielsen AG, 2012, CRIT CARE, V16, DOI 10.1186/cc11418; Novack V, 2006, CRIT CARE, V10, DOI 10.1186/cc3972; O'Neal HR, 2011, CRIT CARE MED, V39, P1343, DOI 10.1097/CCM.0b013e3182120992; Rothberg MB, 2012, J GEN INTERN MED, V27, P280, DOI 10.1007/s11606-011-1826-2; Schlienger RG, 2007, PHARMACOTHERAPY, V27, P325, DOI 10.1592/phco.27.3.325; Schmidt H, 2006, INTENS CARE MED, V32, P1248, DOI 10.1007/s00134-006-0246-y; Serruys PWJC, 2002, JAMA-J AM MED ASSOC, V287, P3215, DOI 10.1001/jama.287.24.3215; Sever PS, 2011, EUR HEART J, V32, P2525, DOI 10.1093/eurheartj/ehr333; Speizer FE, 2006, RESP DIS ADULTS; Stegmayr BG, 2005, SCAND J UROL NEPHROL, V39, P489, DOI 10.1080/00365590500329304; Tavazzi L, 2008, LANCET, V372, P1231, DOI 10.1016/S0140-6736(08)61240-4; Thomsen RW, 2008, ARCH INTERN MED, V168, P2081, DOI 10.1001/archinte.168.19.2081; Thomsen RW, 2006, CRIT CARE MED, V34, P1080, DOI 10.1097/01.CCM.0000207345.92928.E4; Tleyjeh IM, 2009, ARCH INTERN MED, V169, P1658, DOI 10.1001/archinternmed.2009.286; Tseng MY, 2007, STROKE, V38, P1545, DOI 10.1161/STROKEAHA.106.475905; Vandermeer ML, 2012, J INFECT DIS, V205, P13, DOI 10.1093/infdis/jir695; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Weitz-Schmidt G, 2001, NAT MED, V7, P687, DOI 10.1038/89058; Yang KC, 2007, AM J EMERG MED, V25, P494, DOI 10.1016/j.ajem.2006.09.011; Yende S, 2011, CRIT CARE MED, V39, P1871, DOI 10.1097/CCM.0b013e31821b8290	63	31	31	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51548	10.1371/journal.pone.0051548	http://dx.doi.org/10.1371/journal.pone.0051548			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284711	Green Published, gold, Green Submitted			2022-12-27	WOS:000312435900026
J	Zheng, YB; Xiao, YY; Tan, P; Zhang, Q; Xu, PL				Zheng, Yuan-Bin; Xiao, Ying-Ying; Tan, Peng; Zhang, Qing; Xu, Peilin			Live-Cell Visualization of Intracellular Interaction between a Nuclear Migration Protein (hNUDC) and the Thrombopoietin Receptor (Mpl)	PLOS ONE			English	Article							MOVEMENT PROTEIN; GENE NUDC; ASPERGILLUS-NIDULANS; EXTRACELLULAR DOMAIN; MOLECULAR-CLONING; HUMAN HOMOLOG; DYNEIN; LIS1; IDENTIFICATION; DIFFERENTIATION	We previously demonstrated that endogenous hNUDC and Mpl co-localized in the perinuclear and cytoplasmic regions of megakaryocyte cells by indirect immunofluorescence. We further reported that hNUDC accumulated in the Golgi when NIH 3T3 cells were transfected with an hNUDC expression vector alone. However, co-transfection with hNUDC and Mpl expression vectors caused both proteins to co-localize predominantly in the cytosol. These observations led us to hypothesize that a complex containing hNUDC and Mpl may alter hNUDC subcellular location and induce its secretion. In the present study, we test this hypothesis by employing bimolecular fluorescence complementation (BiFC) to detect and visualize the complex formation of hNUDC/Mpl in living cells. We further examined in detail the subcellular locations of the hNUDC/Mpl complex by co-transfection of BiFC chimeras with known subcellular markers. The distribution of hNUDC/Mpl in the endoplasmic reticulum (ER), Golgi and cell surface was determined. Furthermore, the N-terminal 159 amino acids of hNUDC, but not C-terminal half, bound to Mpl in vivo and exhibited a similar localization pattern to that of full-length hNUDC in Cos-1 cells. Adenovirus-mediated overexpression of hNUDC or its N-terminal 159 residues in a human megakaryocyte cell line (Dami) resulted in increased levels of hNUDC or hNUDC(1-159) secretion. In contrast, depletion of Mpl by transfecting Dami cells with adenovirus bearing Mpl-targeting siRNA significantly blocked hNUDC secretion. Thus, we provide the first evidence that the N-terminal region of hNUDC contains all of the necessary information to complex with Mpl and traffic through the secretory pathway.	[Zheng, Yuan-Bin; Xiao, Ying-Ying; Tan, Peng; Zhang, Qing; Xu, Peilin] Zhongshan Univ, Educ Minist, Key Lab Gene Engn, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Zhang, Q (corresponding author), Zhongshan Univ, Educ Minist, Key Lab Gene Engn, Guangzhou, Guangdong, Peoples R China.	lsszq@mail.sysu.edu.cn; xupeilin@hotmail.com	Tan, Peng/P-3856-2015; Tan, Peng/HGD-6812-2022; Tan, Peng/P-3825-2015; Tan, Peng/ABD-8190-2020	Tan, Peng/0000-0001-6992-9000; Tan, Peng/0000-0002-7005-1896; ZHANG, QING/0000-0003-3522-1471	National Natural Science Foundation of China [31271230, 30770923]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 31271230 and 30770923. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander WS, 1996, EMBO J, V15, P6531, DOI 10.1002/j.1460-2075.1996.tb01044.x; Aumais JP, 2003, J CELL SCI, V116, P1991, DOI 10.1242/jcs.00412; Aumais JP, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0002.2001; Chen WM, 2010, J BIOL CHEM, V285, P26697, DOI 10.1074/jbc.M110.120956; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Gocke CD, 2000, LEUKEMIA LYMPHOMA, V39, P447, DOI 10.3109/10428190009113375; Helmstaedt K, 2008, EUKARYOT CELL, V7, P1041, DOI 10.1128/EC.00071-07; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Karpova T., 2006, CURR PROTOC CYTOM, V35, P12; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Kerppola TK, 2009, CHEM SOC REV, V38, P2876, DOI 10.1039/b909638h; MASIBAY AS, 1993, J BIOL CHEM, V268, P9908; Matsumoto N, 1999, HUM GENET, V104, P498, DOI 10.1007/s004390050994; MEIER UT, 1992, CELL, V70, P127; Miller BA, 1999, EXP HEMATOL, V27, P742, DOI 10.1016/S0301-472X(98)00074-5; Morris SM, 1997, MOL ENDOCRINOL, V11, P229, DOI 10.1210/me.11.2.229; Morris SM, 1998, CURR BIOL, V8, P603, DOI 10.1016/S0960-9822(98)70232-5; Pan RM, 2005, J CELL BIOCHEM, V96, P741, DOI 10.1002/jcb.20573; Pang SF, 2009, EXP CELL RES, V125, P1352; Riera J, 2007, FEBS LETT, V581, P3057, DOI 10.1016/j.febslet.2007.05.065; Riera J, 2009, CELL MOL LIFE SCI, V66, P2383, DOI 10.1007/s00018-009-0025-3; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; TANG BL, 1992, J BIOL CHEM, V267, P7072; Tang YS, 2008, LEUKEMIA, V22, P1018, DOI 10.1038/leu.2008.20; VIGON I, 1992, P NATL ACAD SCI USA, V89, P5640, DOI 10.1073/pnas.89.12.5640; Wei MX, 2006, J CELL BIOCHEM, V98, P429, DOI 10.1002/jcb.20803; XIANG X, 1995, MOL BIOL CELL, V6, P297, DOI 10.1091/mbc.6.3.297; Zhang MY, 2002, EXP CELL RES, V273, P73, DOI 10.1006/excr.2001.5414; Zhang YP, 2007, EXP CELL RES, V313, P3210, DOI 10.1016/j.yexcr.2007.06.021; Zhou TH, 2006, P NATL ACAD SCI USA, V103, P9039, DOI 10.1073/pnas.0602916103; Zhu XJ, 2010, J BIOL CHEM, V285, P29903, DOI 10.1074/jbc.M110.105494	32	2	2	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51849	10.1371/journal.pone.0051849	http://dx.doi.org/10.1371/journal.pone.0051849			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284788	Green Published, Green Submitted, gold			2022-12-27	WOS:000312435900058
J	Nakao, R; Ramstedt, M; Wai, SN; Uhlin, BE				Nakao, Ryoma; Ramstedt, Madeleine; Wai, Sun Nyunt; Uhlin, Bernt Eric			Enhanced Biofilm Formation by Escherichia coli LPS Mutants Defective in Hep Biosynthesis	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA PAO1; O-ANTIGEN LIPOPOLYSACCHARIDE; NEGATIVE ANTIVIRULENCE DRUGS; EXTRACELLULAR DNA; PORPHYROMONAS-GINGIVALIS; SALMONELLA-TYPHIMURIUM; MONOCLONAL-ANTIBODY; MEMBRANE-VESICLES; IN-VIVO; CORE	Lipopolysaccharide (LPS) is the major component of the surface of Gram-negative bacteria and its polysaccharide portion is situated at the outermost region. We investigated the relationship between the polysaccharide portion of LPS and biofilm formation using a series of Escherichia coli mutants defective in genes earlier shown to affect the LPS sugar compositions. Biofilm formation by a deep rough LPS mutant, the hldE strain, was strongly enhanced in comparison with the parental strain and other LPS mutants. The hldE strain also showed a phenotype of increased auto-aggregation and stronger cell surface hydrophobicity compared to the wild-type. Similar results were obtained with another deep rough LPS mutant, the waaC strain whose LPS showed same molecular mass as that of the hldE strain. Confocal laser scanning microscopy (CLSM) analysis and biofilm formation assay using DNase I revealed that biofilm formation by the hldE strain was dependent on extracellular DNA. Furthermore, a loss of flagella and an increase in amount of outer membrane vesicles in case of the hldE strain were also observed by transmission electron microscopy and atomic force microscopy, respectively. In addition, we demonstrated that a mutation in the hldE locus, which alters the LPS structure, caused changes in both expression and properties of several surface bacterial factors involved in biofilm formation and virulence. We suggest that the implication of these results should be considered in the context of biofilm formation on abiotic surfaces, which is frequently associated with nosocominal infections such as the catheter-associated infections.	[Nakao, Ryoma; Wai, Sun Nyunt; Uhlin, Bernt Eric] Umea Univ, UCMR, Dept Mol Biol, Umea, Sweden; [Nakao, Ryoma; Wai, Sun Nyunt; Uhlin, Bernt Eric] Umea Univ, UCMR, Lab Mol Infect Med Sweden MIMS, Umea, Sweden; [Ramstedt, Madeleine] Umea Univ, Dept Chem, Umea, Sweden; [Nakao, Ryoma] Natl Inst Infect Dis, Dept Bacteriol, Tokyo, Japan	Umea University; Umea University; Umea University; National Institute of Infectious Diseases (NIID)	Uhlin, BE (corresponding author), Umea Univ, UCMR, Dept Mol Biol, Umea, Sweden.	bernt.eric.uhlin@molbiol.umu.se	Uhlin, Bernt Eric/AAO-6292-2021; Ramstedt, Madeleine/E-7852-2011	Uhlin, Bernt Eric/0000-0002-2991-8072; Ramstedt, Madeleine/0000-0003-2646-8501; Wai, Sun Nyunt/0000-0003-4793-4671	Swedish Research Council; Naito Foundation; Waksman Foundation of Japan; Scandinavia-Japan Sasakawa Foundation; Curth Nilson Foundation for Scientific Research; Miyata Cardiac Research Promotion Foundation; JSPS KAKENHI [22791822]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Naito Foundation(Naito Memorial Foundation); Waksman Foundation of Japan(Waksman Foundation of Japan Inc.); Scandinavia-Japan Sasakawa Foundation; Curth Nilson Foundation for Scientific Research; Miyata Cardiac Research Promotion Foundation; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Swedish Research Council, The Naito Foundation, The Waksman Foundation of Japan, The Scandinavia-Japan Sasakawa Foundation, The Curth Nilson Foundation for Scientific Research, Miyata Cardiac Research Promotion Foundation, and JSPS KAKENHI (22791822). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA Y, 1992, J BIOL CHEM, V267, P22440; Bahrami S, 1997, CRIT CARE MED, V25, P1030, DOI 10.1097/00003246-199706000-00021; Beloin C, 2008, CURR TOP MICROBIOL, V322, P249; Beloin C, 2006, J BACTERIOL, V188, P1316, DOI 10.1128/JB.188.4.1316-1331.2006; Bennett-Guerrero E, 2000, INFECT IMMUN, V68, P6202, DOI 10.1128/IAI.68.11.6202-6208.2000; Bouchet V, 2003, P NATL ACAD SCI USA, V100, P8898, DOI 10.1073/pnas.1432026100; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAMPRUBI S, 1993, FEMS MICROBIOL LETT, V111, P9; CAMPRUBI S, 1993, MICROB PATHOGENESIS, V14, P433, DOI 10.1006/mpat.1993.1042; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Danese PN, 2000, J BACTERIOL, V182, P3593, DOI 10.1128/JB.182.12.3593-3596.2000; Das T, 2010, APPL ENVIRON MICROB, V76, P3405, DOI 10.1128/AEM.03119-09; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Desroy N, 2009, BIOORGAN MED CHEM, V17, P1276, DOI 10.1016/j.bmc.2008.12.021; DIPADOVA FE, 1993, INFECT IMMUN, V61, P3863, DOI 10.1128/IAI.61.9.3863-3872.1993; Dissanayake DRA, 2010, J MED MICROBIOL, V59, P100, DOI 10.1099/jmm.0.014720-0; Feldman MF, 1999, J BIOL CHEM, V274, P35129, DOI 10.1074/jbc.274.49.35129; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; Ghigo JM, 2001, NATURE, V412, P442, DOI 10.1038/35086581; Harmsen M, 2010, APPL ENVIRON MICROB, V76, P2271, DOI 10.1128/AEM.02361-09; Harvill ET, 2000, INFECT IMMUN, V68, P6720, DOI 10.1128/IAI.68.12.6720-6728.2000; Hoshino K, 1999, J IMMUNOL, V162, P3749; Kaplan JB, 2012, MBIO, P3; Kong QK, 2011, INFECT IMMUN, V79, P4227, DOI 10.1128/IAI.05398-11; Lappann M, 2010, MOL MICROBIOL; Leone L, 2006, SURF INTERFACE ANAL, V38, P202, DOI 10.1002/sia.2184; Lindhout T, 2009, MICROBIOL-SGM, V155, P3449, DOI 10.1099/mic.0.030510-0; Moller AK, 2003, INFECT IMMUN, V71, P2142, DOI 10.1128/IAI.71.4.2142-2152.2003; Moreau F, 2008, BIOORG MED CHEM LETT, V18, P4022, DOI 10.1016/j.bmcl.2008.05.117; Muller-Loennies S, 2003, J BIOL CHEM, V278, P34090, DOI 10.1074/jbc.M303985200; Nagy G, 2005, FEMS MICROBIOL LETT, V244, P173, DOI 10.1016/j.femsle.2005.01.038; Nakao R, 2008, BIOCHEM BIOPH RES CO, V365, P784, DOI 10.1016/j.bbrc.2007.11.035; Nakao R, 2006, INFECT IMMUN, V74, P6145, DOI 10.1128/IAI.00261-06; Nakao R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026163; Nakao Ryoma, 2009, P129; Nesper J, 2001, INFECT IMMUN, V69, P435, DOI 10.1128/IAI.69.1.435-445.2001; NEVOLA JJ, 1987, INFECT IMMUN, V55, P2884, DOI 10.1128/IAI.55.12.2884-2890.1987; NEVOLA JJ, 1985, INFECT IMMUN, V50, P152, DOI 10.1128/IAI.50.1.152-159.1985; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Petersen FC, 2005, J BACTERIOL, V187, P4392, DOI 10.1128/JB.187.13.4392-4400.2005; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pouttu R, 2001, J BACTERIOL, V183, P4727, DOI 10.1128/JB.183.16.4727-4736.2001; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ramstedt M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.209536; Renelli M, 2004, MICROBIOL-SGM, V150, P2161, DOI 10.1099/mic.0.26841-0; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; ROSENBERG M, 1991, J BACTERIOL, V173, P2581, DOI 10.1128/jb.173.8.2581-2589.1991; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; Sambrook J., 2001, MOL CLONING LAB MANU; Schleheck D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005513; Schooling SR, 2006, J BACTERIOL, V188, P5945, DOI 10.1128/JB.00257-06; Seper A, 2011, MOL MICROBIOL, V82, P1015, DOI 10.1111/j.1365-2958.2011.07867.x; Tetz VV, 2010, DNA CELL BIOL, V29, P399, DOI 10.1089/dna.2009.1011; Valvano MA, 2000, J BACTERIOL, V182, P488, DOI 10.1128/JB.182.2.488-497.2000; Wai SN, 2003, CELL, V115, P25, DOI 10.1016/S0092-8674(03)00754-2; Westerlund-Wikstrom B, 1997, PROTEIN ENG, V10, P1319, DOI 10.1093/protein/10.11.1319; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; WILLETTS NS, 1969, J BACTERIOL, V97, P244, DOI 10.1128/JB.97.1.244-249.1969; Yethon JA, 1998, J BIOL CHEM, V273, P26310, DOI 10.1074/jbc.273.41.26310	60	81	83	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e51241	10.1371/journal.pone.0051241	http://dx.doi.org/10.1371/journal.pone.0051241			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23284671	Green Submitted, Green Published, gold			2022-12-27	WOS:000313051500008
J	Beebe, SJ; Chen, YJ; Sain, NM; Schoenbach, KH; Xiao, S				Beebe, Stephen J.; Chen, Yeong-Jer; Sain, Nova M.; Schoenbach, Karl H.; Xiao, Shu			Transient Features in Nanosecond Pulsed Electric Fields Differentially Modulate Mitochondria and Viability	PLOS ONE			English	Article							CELL-DEATH; MEMBRANE PERMEABILIZATION; CALCIUM UNIPORTER; ELECTROPORATION; APOPTOSIS; NECROSIS; INHIBITION; ACTIVATION; MECHANISMS; ABLATION	It is hypothesized that high frequency components of nanosecond pulsed electric fields (nsPEFs), determined by transient pulse features, are important for maximizing electric field interactions with intracellular structures. For monopolar square wave pulses, these transient features are determined by the rapid rise and fall of the pulsed electric fields. To determine effects on mitochondria membranes and plasma membranes, N1-S1 hepatocellular carcinoma cells were exposed to single 600 ns pulses with varying electric fields (0-80 kV/cm) and short (15 ns) or long (150 ns) rise and fall times. Plasma membrane effects were evaluated using Fluo-4 to determine calcium influx, the only measurable source of increases in intracellular calcium. Mitochondria membrane effects were evaluated using tetramethylrhodamine ethyl ester (TMRE) to determine mitochondria membrane potentials (DYm). Single pulses with short rise and fall times caused electric field-dependent increases in calcium influx, dissipation of DYm and cell death. Pulses with long rise and fall times exhibited electric field-dependent increases in calcium influx, but diminished effects on dissipation of DYm and viability. Results indicate that high frequency components have significant differential impact on mitochondria membranes, which determines cell death, but lesser variances on plasma membranes, which allows calcium influxes, a primary determinant for dissipation of DYm and cell death.	[Beebe, Stephen J.; Chen, Yeong-Jer; Sain, Nova M.; Schoenbach, Karl H.; Xiao, Shu] Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA 23529 USA; [Schoenbach, Karl H.; Xiao, Shu] Old Dominion Univ, Dept Elect & Comp Engn, Norfolk, VA USA	Old Dominion University; Old Dominion University	Beebe, SJ (corresponding author), Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA 23529 USA.	sbeebe@odu.edu						Andre FM, 2010, BIOELECTROCHEMISTRY, V79, P95, DOI 10.1016/j.bioelechem.2009.12.007; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Beebe SJ, 2003, FASEB J, V17, P1493, DOI 10.1096/fj.02-0859fje; Beebe SJ, 2002, IEEE T PLASMA SCI, V30, P286, DOI 10.1109/TPS.2002.1003872; Bowman AM, 2010, J MEMBRANE BIOL, V236, P15, DOI 10.1007/s00232-010-9269-y; Buescher ES, 2004, IEEE T PLASMA SCI, V32, P1563, DOI 10.1109/TPS.2004.832643; Chen X, 2012, TECHNOL CANCER RES T, V11, P83, DOI 10.7785/tcrt.2012.500237; Chen XH, 2010, PIGM CELL MELANOMA R, V23, P554, DOI 10.1111/j.1755-148X.2010.00704.x; Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; Eguchi Y, 1997, CANCER RES, V57, P1835; Festjens N, 2006, BBA-BIOENERGETICS, V1757, P1371, DOI 10.1016/j.bbabio.2006.06.014; Ford WE, 2010, ARCH BIOCHEM BIOPHYS, V497, P82, DOI 10.1016/j.abb.2010.03.008; Foster HR, 1995, HDB BIOL EFFECTS ELE; Galluzzi L, 2008, CELL, V135, P1161, DOI 10.1016/j.cell.2008.12.004; Gowrishankar TR, 2006, BIOCHEM BIOPH RES CO, V341, P1266, DOI 10.1016/j.bbrc.2006.01.094; Grimm S, 2012, BBA-MOL CELL RES, V1823, P327, DOI 10.1016/j.bbamcr.2011.11.018; Kotnik T, 2006, BIOPHYS J, V90, P480, DOI 10.1529/biophysj.105.070771; Long G., 2011, IEEE T BIOMED ENG, V99, P1; Napotnik TB, 2012, BIOELECTROMAGNETICS, V33, P257, DOI 10.1002/bem.20707; Nicotera P, 1998, CELL CALCIUM, V23, P173, DOI 10.1016/S0143-4160(98)90116-6; Pakhomov AG, 2007, BIOELECTROMAGNETICS, V28, P655, DOI 10.1002/bem.20354; Pakhomov AG, 2009, BIOCHEM BIOPH RES CO, V385, P181, DOI 10.1016/j.bbrc.2009.05.035; Pakhomova ON, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017100; Ren W, 2011, APOPTOSIS, V16, P382, DOI 10.1007/s10495-010-0572-y; Schoenbach KH, 2001, BIOELECTROMAGNETICS, V22, P440, DOI 10.1002/bem.71; Schoenbach KH., 2010, ADV ELECTROPORATION, P19; Stewart DA, 2004, IEEE T PLASMA SCI, V32, P1696, DOI 10.1109/TPS.2004.832639; Vernier PT, 2003, IEEE T DIELECT EL IN, V10, P795, DOI 10.1109/TDEI.2003.1237329; Vernier PT, 2003, BIOCHEM BIOPH RES CO, V310, P286, DOI 10.1016/j.bbrc.2003.08.140; Wang SF, 2009, BIOPHYS J, V96, P1640, DOI 10.1016/j.bpj.2008.11.011; Weaver JC, 2012, BIOELECTROCHEMISTRY, V87, P236, DOI 10.1016/j.bioelechem.2012.02.007; Weaver JC, 2003, IEEE T DIELECT EL IN, V10, P754, DOI 10.1109/TDEI.2003.1237325; White JA, 2004, J BIOL CHEM, V279, P22964, DOI 10.1074/jbc.M311135200; Zhang J, 2008, ARCH BIOCHEM BIOPHYS, V471, P240, DOI 10.1016/j.abb.2007.12.009; Zhivotovsky B, 2011, CELL CALCIUM, V50, P211, DOI 10.1016/j.ceca.2011.03.003	37	48	49	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e51349	10.1371/journal.pone.0051349	http://dx.doi.org/10.1371/journal.pone.0051349			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284682	Green Published, gold, Green Submitted			2022-12-27	WOS:000313158800009
J	Belardinelli, P; Ortiz, E; Barnes, G; Noppeney, U; Preissl, H				Belardinelli, Paolo; Ortiz, Erick; Barnes, Gareth; Noppeney, Uta; Preissl, Hubert			Source Reconstruction Accuracy of MEG and EEG Bayesian Inversion Approaches	PLOS ONE			English	Article							SOURCE LOCALIZATION; MAXIMUM-LIKELIHOOD; MOTOR CONTROL; BRAIN; BEAMFORMER; MODEL; SYNCHRONIZATION; PERFORMANCE; RESOLUTION; FREQUENCY	Electro- and magnetoencephalography allow for non-invasive investigation of human brain activation and corresponding networks with high temporal resolution. Still, no correct network detection is possible without reliable source localization. In this paper, we examine four different source localization schemes under a common Variational Bayesian framework. A Bayesian approach to the Minimum Norm Model (MNM), an Empirical Bayesian Beamformer (EBB) and two iterative Bayesian schemes (Automatic Relevance Determination (ARD) and Greedy Search (GS)) are quantitatively compared. While EBB and MNM each use a single empirical prior, ARD and GS employ a library of anatomical priors that define possible source configurations. The localization performance was investigated as a function of (i) the number of sources (one vs. two vs. three), (ii) the signal to noise ratio (SNR; 5 levels) and (iii) the temporal correlation of source time courses (for the cases of two or three sources). We also tested whether the use of additional bilateral priors specifying source covariance for ARD and GS algorithms improved performance. Our results show that MNM proves effective only with single source configurations. EBB shows a spatial accuracy of few millimeters with high SNRs and low correlation between sources. In contrast, ARD and GS are more robust to noise and less affected by temporal correlations between sources. However, the spatial accuracy of ARD and GS is generally limited to the order of one centimeter. We found that the use of correlated covariance priors made no difference to ARD/GS performance.	[Belardinelli, Paolo; Ortiz, Erick; Preissl, Hubert] Univ Tubingen, MEG Ctr, Tubingen, Germany; [Barnes, Gareth] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Noppeney, Uta] Max Planck Inst Biol Cybernet, Cognit Neuroimaging Grp, D-72076 Tubingen, Germany; [Preissl, Hubert] Univ Arkansas Med Sci, Dept Obstet & Gynecol, Little Rock, AR 72205 USA; [Preissl, Hubert] Univ Tubingen, Werner Reichardt Ctr Integrat Neurosci CIN, Tubingen, Germany	Eberhard Karls University of Tubingen; University of London; University College London; Max Planck Society; University of Arkansas System; University of Arkansas Medical Sciences; Eberhard Karls University of Tubingen	Belardinelli, P (corresponding author), Univ Tubingen, MEG Ctr, Tubingen, Germany.	paolo.belardinelli@med.uni-tuebingen.de	Barnes, Gareth/ABB-7650-2020; Belardinelli, Paolo/AAN-6304-2021; Preißl, Hubert/E-9070-2012	Barnes, Gareth/0000-0002-5396-7712; Preißl, Hubert/0000-0002-8859-4661; Noppeney, Uta/0000-0002-7697-2290	Center for Integrated Neuroscience of Tubingen (Germany) [2010 17]; Wellcome Trust	Center for Integrated Neuroscience of Tubingen (Germany); Wellcome Trust(Wellcome TrustEuropean Commission)	The present work is supported by an award from the Center for Integrated Neuroscience of Tubingen (Germany) (Pool Project nr. 2010 17). The Wellcome Trust Centre for Neuroimaging is supported by a strategic award from the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillet S, 2001, IEEE SIGNAL PROC MAG, V18, P14, DOI 10.1109/79.962275; Barnes GR, 2003, HUM BRAIN MAPP, V18, P1, DOI 10.1002/hbm.10072; Belardinelli P, 2007, NEUROIMAGE, V37, P1301, DOI 10.1016/j.neuroimage.2007.05.053; Belardinelli P, 2009, COGN PROCESS, V10, pS185, DOI 10.1007/s10339-009-0282-y; Brookes MJ, 2008, NEUROIMAGE, V40, P1090, DOI 10.1016/j.neuroimage.2007.12.030; Brookes MJ, 2007, NEUROIMAGE, V34, P1454, DOI 10.1016/j.neuroimage.2006.11.012; Buffalo EA, 2010, P NATL ACAD SCI USA, V107, P361, DOI 10.1073/pnas.0907658106; CASELLA G, 1985, AM STAT, V39, P83, DOI 10.2307/2682801; Cheyne D, 2007, CLIN NEUROPHYSIOL, V118, P1691, DOI 10.1016/j.clinph.2007.05.064; Darvas F, 2004, NEUROIMAGE, V23, pS289, DOI 10.1016/j.neuroimage.2004.07.014; Daunizeau J, 2006, IEEE T BIO-MED ENG, V53, P503, DOI 10.1109/TBME.2005.869791; de Pasquale F, 2010, P NATL ACAD SCI USA, V107, P6040, DOI 10.1073/pnas.0913863107; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Friston KJ, 2008, NEUROIMAGE, V39, P181, DOI 10.1016/j.neuroimage.2007.08.013; Friston KJ, 2008, NEUROIMAGE, V39, P1104, DOI 10.1016/j.neuroimage.2007.09.048; Friston KJ, 2007, NEUROIMAGE, V34, P220, DOI 10.1016/j.neuroimage.2006.08.035; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Gross J, 2002, P NATL ACAD SCI USA, V99, P2299, DOI 10.1073/pnas.032682099; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Hall SD, 2005, NEUROIMAGE, V26, P13, DOI 10.1016/j.neuroimage.2005.01.009; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; HARVILLE DA, 1977, J AM STAT ASSOC, V72, P320, DOI 10.2307/2286796; Henson RN, 2009, NEUROIMAGE, V46, P168, DOI 10.1016/j.neuroimage.2009.01.062; Henson RN, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00076; Hillebrand A, 2005, INT REV NEUROBIOL, V68, P149, DOI 10.1016/S0074-7742(05)68006-3; Hillebrand A, 2011, NEUROIMAGE, V54, P2732, DOI 10.1016/j.neuroimage.2010.10.036; Hipp JF, 2011, NEURON, V69, P387, DOI 10.1016/j.neuron.2010.12.027; Hoogenboom N, 2006, NEUROIMAGE, V29, P764, DOI 10.1016/j.neuroimage.2005.08.043; Hui HB, 2010, NEUROIMAGE, V49, P3161, DOI 10.1016/j.neuroimage.2009.10.078; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Kiebel SJ, 2008, NEUROIMAGE, V39, P728, DOI 10.1016/j.neuroimage.2007.09.005; Kucukaltum-Yildirim E, 2006, IEEE T BIO-MED ENG, V53, P1783, DOI 10.1109/TBME.2006.873747; Kujala J, 2007, CEREB CORTEX, V17, P1476, DOI 10.1093/cercor/bhl059; Liljestrom M, 2005, NEUROIMAGE, V25, P734, DOI 10.1016/j.neuroimage.2004.11.034; Litvak V, 2010, NEUROIMAGE, V50, P1578, DOI 10.1016/j.neuroimage.2009.12.115; Mattout J, 2006, NEUROIMAGE, V30, P753, DOI 10.1016/j.neuroimage.2005.10.037; Mosher JC, 2004, IEEE WORKSH STAT SIG, P294; Nummemnaa A, 2007, NEUROIMAGE, V35, P669, DOI 10.1016/j.neuroimage.2006.05.001; Pammer K, 2004, NEUROIMAGE, V22, P1819, DOI 10.1016/j.neuroimage.2004.05.004; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Phillips C, 2005, NEUROIMAGE, V24, P997, DOI 10.1016/j.neuroimage.2004.10.030; Robinson S.E., 1999, RECENT ADV BIOMAGNET, P302; ROMANI GL, 1987, PHYS MED BIOL, V32, P23, DOI 10.1088/0031-9155/32/1/005; Sato M, 2004, NEUROIMAGE, V23, P806, DOI 10.1016/j.neuroimage.2004.06.037; Schoffelen JM, 2009, HUM BRAIN MAPP, V30, P1857, DOI 10.1002/hbm.20745; Sekihara K, 2005, NEUROIMAGE, V25, P1056, DOI 10.1016/j.neuroimage.2004.11.051; Sekihara K, 2002, IEEE T BIO-MED ENG, V49, P1534, DOI 10.1109/TBME.2002.805485; Singh KD, 2002, NEUROIMAGE, V16, P103, DOI 10.1006/nimg.2001.1050; Stephan KE, 2009, NEUROIMAGE, V46, P1004, DOI 10.1016/j.neuroimage.2009.03.025; Tipping ME, 2001, J MACH LEARN RES, V1, P211, DOI 10.1162/15324430152748236; Toda A, 2011, NEUROIMAGE, V54, P892, DOI 10.1016/j.neuroimage.2010.09.057; Trujillo-Barreto NJ, 2004, NEUROIMAGE, V21, P1300, DOI 10.1016/j.neuroimage.2003.11.008; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Wipf D, 2007, ACM, P1023; Wipf D, 2009, NEUROIMAGE, V44, P947, DOI 10.1016/j.neuroimage.2008.02.059; Wipf DP, 2010, NEUROIMAGE, V49, P641, DOI 10.1016/j.neuroimage.2009.06.083; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Woolrich M, 2011, NEUROIMAGE, V57, P1466, DOI 10.1016/j.neuroimage.2011.04.041; ZOLTOWSKI MD, 1988, IEEE T ACOUST SPEECH, V36, P945, DOI 10.1109/29.1614	60	56	56	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e51985	10.1371/journal.pone.0051985	http://dx.doi.org/10.1371/journal.pone.0051985			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284840	Green Published, gold, Green Submitted			2022-12-27	WOS:000313158800018
J	Legros, M; Xu, CG; Okamoto, K; Scott, TW; Morrison, AC; Lloyd, AL; Gould, F				Legros, Mathieu; Xu, Chonggang; Okamoto, Kenichi; Scott, Thomas W.; Morrison, Amy C.; Lloyd, Alun L.; Gould, Fred			Assessing the Feasibility of Controlling Aedes aegypti with Transgenic Methods: A Model-Based Evaluation	PLOS ONE			English	Article							MARK-RELEASE-RECAPTURE; BORNE DISEASE-CONTROL; DENGUE CONTROL; COMMUNITY PARTICIPATION; MESOCYCLOPS COPEPODA; CULICIDAE PRODUCTION; DIPTERA-CULICIDAE; VECTOR MOSQUITOS; SOUTHERN MEXICO; GENETIC-CONTROL	Suppression of dengue and malaria through releases of genetically engineered mosquitoes might soon become feasible. Aedes aegypti mosquitoes carrying a conditionally lethal transgene have recently been used to suppress local vector populations in small-scale field releases. Prior to releases of transgenic insects on a wider scale, however, most regulatory authorities will require additional evidence that suppression will be effective in natural heterogeneous habitats. We use a spatially explicit stochastic model of an Ae. aegypti population in Iquitos, Peru, along with an uncertainty analysis of its predictions, to quantitatively assess the outcome of varied operational approaches for releases of transgenic strains with conditional death of females. We show that population elimination might be an unrealistic objective in heterogeneous populations. We demonstrate that substantial suppression can nonetheless be achieved if releases are deployed in a uniform spatial pattern using strains combining multiple lethal elements, illustrating the importance of detailed spatial models for guiding genetic mosquito control strategies.	[Legros, Mathieu; Xu, Chonggang; Okamoto, Kenichi; Gould, Fred] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Legros, Mathieu; Scott, Thomas W.; Morrison, Amy C.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Xu, Chonggang] Los Alamos Natl Lab, Div Earth & Environm Sci, Los Alamos, NM 87545 USA; [Scott, Thomas W.; Lloyd, Alun L.; Gould, Fred] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Lloyd, Alun L.] N Carolina State Univ, Grad Program, Dept Math & Biomath, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of California System; University of California Davis; United States Department of Energy (DOE); Los Alamos National Laboratory; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University of North Carolina; North Carolina State University	Legros, M (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	legros.mathieu@gmail.com	Legros, Mathieu/E-6767-2011; Lloyd, Alun/AAN-6639-2020; Morrison, Amy/AAU-6511-2020; Lloyd, Alun L/H-4944-2012; Okamoto, Kenichi/AAA-3763-2021	Legros, Mathieu/0000-0003-3807-8594; Lloyd, Alun/0000-0002-6389-6321; Okamoto, Kenichi/0000-0002-1889-4538; Xu, Chonggang/0000-0002-0937-5744; Morrison, Amy/0000-0001-6224-5984	National Institutes of Health [R01-AI54954-0IA2]; Regents of the University of California from the Foundation for the National Institutes of Health Grand Challenges in Global Health initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054954, R01AI091980] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Regents of the University of California from the Foundation for the National Institutes of Health Grand Challenges in Global Health initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institutes of Health grant R01-AI54954-0IA2, and through the Regents of the University of California from the Foundation for the National Institutes of Health Grand Challenges in Global Health initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alphey L, 2010, AM J TROP MED HYG, V83, P305; Arredondo-Jimenez JI, 2006, ANN TROP MED PARASIT, V100, pS17, DOI 10.1179/136485906X105480; ASMAN SM, 1981, ANNU REV ENTOMOL, V26, P289, DOI 10.1146/annurev.en.26.010181.001445; Benedict M, 2008, VECTOR-BORNE ZOONOT, V8, P127, DOI 10.1089/vbz.2007.0273; Benedict MQ, 2003, TRENDS PARASITOL, V19, P349, DOI 10.1016/S1471-4922(03)00144-2; BIDLINGMAYER WL, 1985, J AM MOSQUITO CONTR, V1, P328; CRAIG GB, 1967, SCIENCE, V156, P1499, DOI 10.1126/science.156.3781.1499; de Valdez MRW, 2011, P NATL ACAD SCI USA, V108, P4772, DOI 10.1073/pnas.1019295108; Enserink M, 2010, SCIENCE, V330, P1030, DOI 10.1126/science.330.6007.1030; FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003; Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11; Focks DA, 2006, TDRIRMDEN0601P WHO; Fu GL, 2010, P NATL ACAD SCI USA, V107, P4550, DOI 10.1073/pnas.1000251107; Getis A, 2003, AM J TROP MED HYG, V69, P494, DOI 10.4269/ajtmh.2003.69.494; Gilles JRL, 2011, J MED ENTOMOL, V48, P296, DOI 10.1603/ME09209; GILPIN ME, 1979, FORTS ZOOL, V25, P355; Gould F, 2004, ANNU REV ENTOMOL, V49, P193, DOI 10.1146/annurev.ento.49.061802.123344; Gubler DJ, 1996, ACTA TROP, V61, P169, DOI 10.1016/0001-706X(95)00103-L; Hanh TTT, 2009, AM J TROP MED HYG, V80, P312, DOI 10.4269/ajtmh.2009.80.312; Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209; Heintze C, 2007, T ROY SOC TROP MED H, V101, P317, DOI 10.1016/j.trstmh.2006.08.007; Kay BH, 2002, AM J TROP MED HYG, V66, P40, DOI 10.4269/ajtmh.2002.66.40; Kay BH, 2010, AM J TROP MED HYG, V82, P822, DOI 10.4269/ajtmh.2010.09-0503; Kroeger A, 2006, LANCET, V368, P2193, DOI 10.1016/S0140-6736(06)69873-5; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; Legros M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022701; Legros M, 2009, J MED ENTOMOL, V46, P409, DOI 10.1603/033.046.0301; Magori K, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000508; Marshall JM, 2010, NAT BIOTECHNOL, V28, P896, DOI 10.1038/nbt0910-896; Marshall JM, 2009, J THEOR BIOL, V258, P250, DOI 10.1016/j.jtbi.2009.01.031; Morrison AC, 2006, ANN TROP MED PARASIT, V100, pS73, DOI 10.1179/136485906X105534; Morrison AC, 2004, J MED ENTOMOL, V41, P1123, DOI 10.1603/0022-2585-41.6.1123; Nam VS, 2005, AM J TROP MED HYG, V72, P67, DOI 10.4269/ajtmh.2005.72.67; Parks W, 2004, WHOCDSWMC20042; Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11; Romani MET, 2007, SOC SCI MED, V64, P976, DOI 10.1016/j.socscimed.2006.10.033; RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892; Russell RC, 2005, MED VET ENTOMOL, V19, P451, DOI 10.1111/j.1365-2915.2005.00589.x; Schliekelman P, 2000, J ECON ENTOMOL, V93, P1543, DOI 10.1603/0022-0493-93.6.1543; Schliekelman P, 2000, J ECON ENTOMOL, V93, P1566, DOI 10.1603/0022-0493-93.6.1566; SCOTT TW, 2008, LONGITUDINAL FIELD S, P132; SERVICE MW, 1993, ANN TROP MED PARASIT, V87, P223, DOI 10.1080/00034983.1993.11812760; Subbaraman N, 2011, NAT BIOTECHNOL, V29, P9, DOI 10.1038/nbt0111-9a; Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474; Toledo ME, 2008, TROP MED INT HEALTH, V13, P728, DOI 10.1111/j.1365-3156.2008.02046.x; TRPIS M, 1995, J MED ENTOMOL, V32, P27, DOI 10.1093/jmedent/32.1.27; Valerio L, 2012, AM J TROP MED HYG, V86, P665, DOI 10.4269/ajtmh.2012.11-0513; Vanlerberghe V, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1959; White SM, 2010, J APPL ECOL, V47, P1329, DOI 10.1111/j.1365-2664.2010.01880.x; WINCH P, 1992, HEALTH POLICY PLANN, V7, P342, DOI 10.1093/heapol/7.4.342; World Health Organization, 2009, DENG DENG HAEM FEV F; Xu CG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000830; Yakob L, 2008, THEOR POPUL BIOL, V74, P324, DOI 10.1016/j.tpb.2008.09.003; Yakob L, 2008, J APPL ECOL, V45, P1258, DOI 10.1111/j.1365-2664.2008.01498.x	55	25	25	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52235	10.1371/journal.pone.0052235	http://dx.doi.org/10.1371/journal.pone.0052235			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284949	gold, Green Published, Green Submitted			2022-12-27	WOS:000313158800039
J	Li, JY; Henry, E; Wang, LM; Delelis, O; Wang, H; Simon, F; Tauc, P; Brochon, JC; Zhao, YL; Deprez, E				Li, Jiayao; Henry, Etienne; Wang, Lanmei; Delelis, Olivier; Wang, Huan; Simon, Francoise; Tauc, Patrick; Brochon, Jean-Claude; Zhao, Yunlong; Deprez, Eric			Comparative Study of the Fatty Acid Binding Process of a New FABP from Cherax quadricarinatus by Fluorescence Intensity, Lifetime and Anisotropy	PLOS ONE			English	Article							HIV-1 INTEGRASE; CONFORMATIONAL STABILITY; CRYSTAL-STRUCTURE; GENE-EXPRESSION; PROTEIN; LIVER; SPECIFICITY; MUSCLE; SHRIMP; TRANSCRIPTION	Fatty acid-binding proteins (FABPs) are small cytosolic proteins, largely distributed in invertebrates and vertebrates, which accomplish uptake and intracellular transport of hydrophobic ligands such as fatty acids. Although long chain fatty acids play multiple crucial roles in cellular functions (structural, energy metabolism, regulation of gene expression), the precise functions of FABPs, especially those of invertebrate species, remain elusive. Here, we have identified and characterized a novel FABP family member, Cq-FABP, from the hepatopancreas of red claw crayfish Cherax quadricarinatus. We report the characterization of fatty acid-binding affinity of Cq-FABP by four different competitive fluorescence-based assays. In the two first approaches, the fluorescent probe 8-Anilino-1-naphthalenesulfonate (ANS), a binder of internal cavities of protein, was used either by directly monitoring its fluorescence emission or by monitoring the fluorescence resonance energy transfer occurring between the single tryptophan residue of Cq-FABP and ANS. The third and the fourth approaches were based on the measurement of the fluorescence emission intensity of the naturally fluorescent cis-parinaric acid probe or the steady-state fluorescence anisotropy measurements of a fluorescently labeled fatty acid (BODIPY-C16), respectively. The four methodologies displayed consistent equilibrium constants for a given fatty acid but were not equivalent in terms of analysis. Indeed, the two first methods were complicated by the existence of non specific binding modes of ANS while BODIPY-C16 and cis-parinaric acid specifically targeted the fatty acid binding site. We found a relationship between the affinity and the length of the carbon chain, with the highest affinity obtained for the shortest fatty acid, suggesting that steric effects primarily influence the interaction of fatty acids in the binding cavity of Cq-FABP. Moreover, our results show that the binding affinities of several fatty acids closely parallel their prevalences in the hepatopancreas of C. quadricarinatus as measured under specific diet conditions.	[Li, Jiayao; Henry, Etienne; Delelis, Olivier; Wang, Huan; Simon, Francoise; Tauc, Patrick; Brochon, Jean-Claude; Deprez, Eric] Ecole Normale Super, Inst Alembert, CNRS, LBPA,UMR8113, Cachan, France; [Li, Jiayao; Wang, Lanmei; Zhao, Yunlong] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; East China Normal University	Deprez, E (corresponding author), Ecole Normale Super, Inst Alembert, CNRS, LBPA,UMR8113, Cachan, France.	deprez@lbpa.ens-cachan.fr	HENRY, Etienne/J-8118-2014	HENRY, Etienne/0000-0002-2547-3467	Centre National de la Recherche Scientifique (CNRS); Shanghai Science and Technology Commission; Science and Technology Support Project [12391900700]; East China Normal University (ECNU)-Shanghai	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Shanghai Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM)Shanghai Science & Technology Committee); Science and Technology Support Project; East China Normal University (ECNU)-Shanghai	This work was supported by grants from Centre National de la Recherche Scientifique (CNRS), Shanghai Science and Technology Commission, Science and Technology Support Project (12391900700) and East China Normal University (ECNU)-Shanghai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Atshaves BP, 2010, J NUTR BIOCHEM, V21, P1015, DOI 10.1016/j.jnutbio.2010.01.005; BROCHON JC, 1994, METHOD ENZYMOL, V240, P262; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Cheng Yong-Xu, 1998, Acta Zoologica Sinica, V44, P420; Chmurzynska A, 2006, J APPL GENET, V47, P39, DOI 10.1007/BF03194597; Chuang S, 2008, J MED CHEM, V51, P3755, DOI 10.1021/jm701192w; Delelis O, 2008, J BIOL CHEM; Deprez E, 2000, BIOCHEMISTRY-US, V39, P9275, DOI 10.1021/bi000397j; Deprez E, 2001, P NATL ACAD SCI USA, V98, P10090, DOI 10.1073/pnas.181024498; Di Nunzio M, 2009, LIPIDS, V44, P1073, DOI 10.1007/s11745-009-3362-y; Di Pietro SM, 1999, EUR J BIOCHEM, V259, P127, DOI 10.1046/j.1432-1327.1999.00015.x; DISTEL RJ, 1992, J BIOL CHEM, V267, P5937; Duplus E, 2002, BIOCHEM PHARMACOL, V64, P893, DOI 10.1016/S0006-2952(02)01157-7; Esteves A, 2006, COMP BIOCHEM PHYS C, V142, P262, DOI 10.1016/j.cbpc.2005.11.006; Esteves A, 2003, BBA-MOL CELL BIOL L, V1631, P26, DOI 10.1016/S1388-1981(02)00321-9; Evans JD, 1999, P NATL ACAD SCI USA, V96, P5575, DOI 10.1073/pnas.96.10.5575; Folli C, 2005, BBA-PROTEINS PROTEOM, V1747, P229, DOI 10.1016/j.bbapap.2004.11.013; GLATZ JFC, 1983, ANAL BIOCHEM, V132, P89, DOI 10.1016/0003-2697(83)90429-3; Gong YN, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-71; Gu PL, 2002, GENE, V288, P77, DOI 10.1016/S0378-1119(02)00430-4; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Guiot E, 2006, J BIOL CHEM, V281, P22707, DOI 10.1074/jbc.M602198200; Hanhoff T, 2002, MOL CELL BIOCHEM, V239, P45, DOI 10.1023/A:1020502624234; HAUNERLAND NH, 1990, BIOCHIM BIOPHYS ACTA, V1047, P233, DOI 10.1016/0005-2760(90)90521-X; Hohoff C, 1999, BIOCHEMISTRY-US, V38, P12229, DOI 10.1021/bi990305u; Huang H, 2004, BIOCHEMISTRY-US, V43, P2484, DOI 10.1021/bi0352318; Jakobsson E, 2003, BBA-PROTEINS PROTEOM, V1649, P40, DOI 10.1016/S1570-9639(03)00151-1; Jenkins AE, 2002, BIOCHEMISTRY-US, V41, P2022, DOI 10.1021/bi015769i; Jump DB, 2002, CURR OPIN LIPIDOL, V13, P155, DOI 10.1097/00041433-200204000-00007; Kane CD, 1996, ANAL BIOCHEM, V233, P197, DOI 10.1006/abio.1996.0028; Klimtchuk E, 2007, BIOPHYS CHEM, V125, P1, DOI 10.1016/j.bpc.2006.07.016; Kurian E, 1996, BIOCHEMISTRY-US, V35, P3865, DOI 10.1021/bi952589y; LAKOWICS J, 2006, PRINCIPLES FLUORESCE; Levin LB, 2010, J MOL MODEL, V16, P929, DOI 10.1007/s00894-009-0599-6; Li JY, 2011, AQUACULT NUTR, V17, pE853, DOI 10.1111/j.1365-2095.2011.00852.x; Liu RZ, 2008, GENOMICS, V92, P436, DOI 10.1016/j.ygeno.2008.08.003; MAATMAN RGHJ, 1994, BBA-LIPID LIPID MET, V1214, P1, DOI 10.1016/0005-2760(94)90002-7; Matulis D, 1998, BIOPHYS J, V74, P422, DOI 10.1016/S0006-3495(98)77799-9; Mita R, 2010, J BIOL CHEM, V285, P37005, DOI 10.1074/jbc.M110.170076; Motojima K, 2000, INT J BIOCHEM CELL B, V32, P1085, DOI 10.1016/S1357-2725(00)00046-7; Norris AW, 2002, J LIPID RES, V43, P646; OCKNER RK, 1972, SCIENCE, V177, P56, DOI 10.1126/science.177.4043.56; Pangantihon-Kuhlmann MP, 1998, AQUAT LIVING RESOUR, V11, P403, DOI 10.1016/S0990-7440(99)80006-0; Prinsen CFM, 1996, BIOCHEM J, V314, P253, DOI 10.1042/bj3140253; RICHIERI GV, 1995, J BIOL CHEM, V270, P15076, DOI 10.1074/jbc.270.25.15076; Richieri GV, 2000, BIOCHEMISTRY-US, V39, P7197, DOI 10.1021/bi000314z; Shechter A, 2005, BIOL REPROD, V73, P72, DOI 10.1095/biolreprod.104.038554; Sirangelo I, 2002, PHOTOCHEM PHOTOBIOL, V76, P381, DOI 10.1562/0031-8655(2002)076<0381:ROTAFE>2.0.CO;2; Soderhall I, 2006, FEBS J, V273, P2902, DOI 10.1111/j.1742-4658.2006.05303.x; Storch J, 2000, BBA-MOL CELL BIOL L, V1486, P28, DOI 10.1016/S1388-1981(00)00046-9; Storch J, 2009, J LIPID RES, V50, pS126, DOI 10.1194/jlr.R800084-JLR200; Thompson J, 1999, MOL CELL BIOCHEM, V192, P9, DOI 10.1023/A:1006806616963; Thumser AE, 2007, MOL CELL BIOCHEM, V299, P67, DOI 10.1007/s11010-005-9041-2; Veerkamp JH, 1999, MOL CELL BIOCHEM, V192, P137, DOI 10.1023/A:1006866119264; Velkov T, 2005, PROTEIN EXPRES PURIF, V44, P23, DOI 10.1016/j.pep.2005.04.006; Velkov T, 2005, J BIOL CHEM, V280, P17769, DOI 10.1074/jbc.M410193200; Wen XB, 2002, COMP BIOCHEM PHYS A, V131, P675, DOI 10.1016/S1095-6433(01)00515-3; Wouters R, 2001, AQUACULTURE, V202, P1, DOI 10.1016/S0044-8486(01)00570-1; Yan J, 2009, J LIPID RES, V50, P2445, DOI 10.1194/jlr.M900177-JLR200; Ying XP, 2006, AQUACULTURE, V256, P617, DOI 10.1016/j.aquaculture.2006.02.045; Zimmerman AW, 2002, CELL MOL LIFE SCI, V59, P1096, DOI 10.1007/s00018-002-8490-y; Zimmerman AW, 2001, INT J BIOCHEM CELL B, V33, P865, DOI 10.1016/S1357-2725(01)00070-X	63	6	6	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e51079	10.1371/journal.pone.0051079	http://dx.doi.org/10.1371/journal.pone.0051079			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284658	Green Published, gold			2022-12-27	WOS:000313158800008
J	Dixit, AK; Jayabaskaran, C				Dixit, Ajay Kumar; Jayabaskaran, Chelliah			Phospholipid Mediated Activation of Calcium Dependent Protein Kinase 1 (CaCDPK1) from Chickpea: A New Paradigm of Regulation	PLOS ONE			English	Article							SUCROSE SYNTHASE; SALT-STRESS; IN-VITRO; RESPONSES; PHOSPHORYLATION; GROWTH; PHOSPHATIDYLCHOLINE; IDENTIFICATION; EXPRESSION; TOLERANCE	Phospholipids, the major structural components of membranes, can also have functions in regulating signaling pathways in plants under biotic and abiotic stress. The effects of adding phospholipids on the activity of stress-induced calcium dependent protein kinase (CaCDPK1) from chickpea are reported here. Both autophosphorylation as well as phosphorylation of the added substrate were enhanced specifically by phosphatidylcholine and to a lesser extent by phosphatidic acid, but not by phosphatidylethanolamine. Diacylgylerol, the neutral lipid known to activate mammalian PKC, stimulated CaCDPK1 but at higher concentrations. Increase in V-max of the enzyme activity by these phospholipids significantly decreased the K-m indicating that phospholipids enhance the affinity towards its substrate. In the absence of calcium, addition of phospholipids had no effect on the negligible activity of the enzyme. Intrinsic fluorescence intensity of the CaCDPK1 protein was quenched on adding PA and PC. Higher binding affinity was found with PC (K-1/2 = 114 nM) compared to PA (K-1/2 = 335 nM). We also found that the concentration of PA increased in chickpea plants under salt stress. The stimulation by PA and PC suggests regulation of CaCDPK1 by these phospholipids during stress response.	[Dixit, Ajay Kumar; Jayabaskaran, Chelliah] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Jayabaskaran, C (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	cjb@biochem.iisc.ernet.in	Dixit, Ajay/AAH-7171-2021		Department of Sciences and Technology (DST), New Delhi, India [SR/SO/BB-07/2008/14.1.09]	Department of Sciences and Technology (DST), New Delhi, India	Financial supported provided by the Department of Sciences and Technology (DST), New Delhi, India (number SR/SO/BB-07/2008/14.1.09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Anthony RG, 2004, EMBO J, V23, P572, DOI 10.1038/sj.emboj.7600068; Asano T, 2012, PLANT J, V69, P26, DOI 10.1111/j.1365-313X.2011.04766.x; Benetka W, 2008, CELL CYCLE, V7, P3709, DOI 10.4161/cc.7.23.7176; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boudsocq M, 2010, NATURE, V464, P418, DOI 10.1038/nature08794; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Coca M, 2010, PLANT J, V63, P526, DOI 10.1111/j.1365-313X.2010.04255.x; Dammann C, 2003, PLANT PHYSIOL, V132, P1840, DOI 10.1104/pp.103.020008; Darwish E, 2009, PLANT CELL PHYSIOL, V50, P986, DOI 10.1093/pcp/pcp051; Dixit AK, 2013, APPL MICROBIOL BIOT, V97, P3429, DOI 10.1007/s00253-012-4215-9; Farmer PK, 1999, BBA-PROTEIN STRUCT M, V1434, P6, DOI 10.1016/S0167-4838(99)00166-1; Geiger D, 2010, P NATL ACAD SCI USA, V107, P8023, DOI 10.1073/pnas.0912030107; Ghosh S, 2003, J BIOL CHEM, V278, P45690, DOI 10.1074/jbc.M302933200; GUNDERSEN RE, 1987, J BIOL CHEM, V262, P4602; Harper JF, 2005, NAT REV MOL CELL BIO, V6, P555, DOI 10.1038/nrm1679; HARPER JF, 1993, BIOCHEMISTRY-US, V32, P3282, DOI 10.1021/bi00064a010; Hwang I, 2000, P NATL ACAD SCI USA, V97, P6224, DOI 10.1073/pnas.97.11.6224; Ishida S, 2008, PLANT CELL, V20, P3273, DOI 10.1105/tpc.107.057489; Ivashuta S, 2005, PLANT CELL, V17, P2911, DOI 10.1105/tpc.105.035394; Kieschnick H, 2001, J BIOL CHEM, V276, P12369, DOI 10.1074/jbc.M011045200; Klimecka M, 2007, ACTA BIOCHIM POL, V54, P219, DOI 10.18388/abp.2007_3242; Klimecka M, 2011, ACTA BIOCHIM POL, V58, P589; Lee S, 2001, PLANT J, V26, P479, DOI 10.1046/j.1365-313x.2001.01037.x; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Ludwig AA, 2005, P NATL ACAD SCI USA, V102, P10736, DOI 10.1073/pnas.0502954102; Ma SY, 2007, PLANT MOL BIOL, V65, P511, DOI 10.1007/s11103-007-9187-2; Mehlmer N, 2010, PLANT J, V63, P484, DOI 10.1111/j.1365-313X.2010.04257.x; Munnik T, 1998, BBA-LIPID LIPID MET, V1389, P222, DOI 10.1016/S0005-2760(97)00158-6; Myers C, 2009, PLANT J, V59, P528, DOI 10.1111/j.1365-313X.2009.03894.x; Nakai T, 1998, PLANT CELL PHYSIOL, V39, P1337, DOI 10.1093/oxfordjournals.pcp.a029339; Ogawa N, 1998, PLANT CELL PHYSIOL, V39, P1010, DOI 10.1093/oxfordjournals.pcp.a029297; Pical C, 1999, J BIOL CHEM, V274, P38232, DOI 10.1074/jbc.274.53.38232; Prakash SRS, 2006, J PLANT PHYSIOL, V163, P1135, DOI 10.1016/j.jplph.2006.04.002; Prakash SRS, 2006, J PLANT PHYSIOL, V163, P1083, DOI 10.1016/j.jplph.2006.04.005; Rietz S, 2010, MOL PLANT, V3, P524, DOI 10.1093/mp/ssp109; Saijo Y, 2000, PLANT J, V23, P319, DOI 10.1046/j.1365-313x.2000.00787.x; SCHALLER GE, 1992, BIOCHEMISTRY-US, V31, P1721, DOI 10.1021/bi00121a020; Sebastia CH, 2004, ARCH BIOCHEM BIOPHYS, V428, P81, DOI 10.1016/j.abb.2004.04.025; Szczegielniak J, 2005, PLANT PHYSIOL, V139, P1970, DOI 10.1104/pp.105.066472; Tasseva G, 2004, FEBS LETT, V566, P115, DOI 10.1016/j.febslet.2004.04.015; Testerink C, 2004, PLANT J, V39, P527, DOI 10.1111/j.1365-313X.2004.02152.x; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Zhang WH, 2004, P NATL ACAD SCI USA, V101, P9508, DOI 10.1073/pnas.0402112101; Zhang XQ, 1997, FEBS LETT, V410, P126, DOI 10.1016/S0014-5793(97)00537-1; ZHAO Y, 1994, MOL BIOCHEM PARASIT, V66, P329, DOI 10.1016/0166-6851(94)90159-7; Zhu SY, 2007, PLANT CELL, V19, P3019, DOI 10.1105/tpc.107.050666	48	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51591	10.1371/journal.pone.0051591	http://dx.doi.org/10.1371/journal.pone.0051591			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284721	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000312794500035
J	Goekoop, R; Goekoop, JG; Scholte, HS				Goekoop, Rutger; Goekoop, Jaap G.; Scholte, H. Steven			The Network Structure of Human Personality According to the NEO-PI-R: Matching Network Community Structure to Factor Structure	PLOS ONE			English	Article							DIMENSIONAL MODELS; NEGATIVE AFFECT; SMALL-WORLD; DSM-IV; DISORDER; TRAITS; EXTROVERSION; ORGANIZATION; NEUROTICISM; STABILITY	Introduction: Human personality is described preferentially in terms of factors (dimensions) found using factor analysis. An alternative and highly related method is network analysis, which may have several advantages over factor analytic methods. Aim: To directly compare the ability of network community detection (NCD) and principal component factor analysis (PCA) to examine modularity in multidimensional datasets such as the neuroticism-extraversion-openness personality inventory revised (NEO-PI-R). Methods: 434 healthy subjects were tested on the NEO-PI-R. PCA was performed to extract factor structures (FS) of the current dataset using both item scores and facet scores. Correlational network graphs were constructed from univariate correlation matrices of interactions between both items and facets. These networks were pruned in a link-by-link fashion while calculating the network community structure (NCS) of each resulting network using the Wakita Tsurumi clustering algorithm. NCSs were matched against FS and networks of best matches were kept for further analysis. Results: At facet level, NCS showed a best match (96.2%) with a 'confirmatory' 5-FS. At item level, NCS showed a best match (80%) with the standard 5-FS and involved a total of 6 network clusters. Lesser matches were found with 'confirmatory' 5-FS and 'exploratory' 6-FS of the current dataset. Network analysis did not identify facets as a separate level of organization in between items and clusters. A small-world network structure was found in both item-and facet level networks. Conclusion: We present the first optimized network graph of personality traits according to the NEO-PI-R: a 'Personality Web'. Such a web may represent the possible routes that subjects can take during personality development. NCD outperforms PCA by producing plausible modularity at item level in non-standard datasets, and can identify the key roles of individual items and clusters in the network.	[Goekoop, Rutger] PsyQ Psychomed Programs, Dept Mood Disorders, The Hague, Netherlands; [Goekoop, Jaap G.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands; [Scholte, H. Steven] Univ Amsterdam, Dept Psychol, Cognit Neurosci Grp, Amsterdam, Netherlands; [Goekoop, Rutger] Parnassia Bavo Goup, The Hague, Netherlands; [Scholte, H. Steven] Univ Amsterdam, Brain & Cognit Prior Program, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Parnassia Psychiatric Institute; University of Amsterdam	Goekoop, R (corresponding author), PsyQ Psychomed Programs, Dept Mood Disorders, The Hague, Netherlands.	R.Goekoop@PsyQ.nl	Scholte, H.Steven/ABD-1737-2020	Scholte, H.Steven/0000-0002-9839-1788	PsyQ, Psychoedical Programs in the Hague	PsyQ, Psychoedical Programs in the Hague	Research was funded by PsyQ, Psychoedical Programs in the Hague, an institution dedicated to providing specialized mental care, in the form of time reserved for research instead of health care. Data were obtained from healthy subjects without charge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Ashton MC, 2005, J PERS, V73, P1321, DOI 10.1111/j.1467-6494.2005.00351.x; Ashton MC, 2007, PERS SOC PSYCHOL REV, V11, P150, DOI 10.1177/1088868306294907; Bagby RM, 2005, J PERS DISORD, V19, P53, DOI 10.1521/pedi.19.1.53.62180; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Cloninger CR, 1997, DEV PSYCHOPATHOL, V9, P881, DOI 10.1017/S095457949700148X; Costa PT, 1997, J PERS ASSESS, V68, P86, DOI 10.1207/s15327752jpa6801_7; COSTA PT, 1995, J PERS ASSESS, V64, P21, DOI 10.1207/s15327752jpa6401_2; DIGMAN JM, 1989, J PERS, V57, P195, DOI 10.1111/j.1467-6494.1989.tb00480.x; Funder DC, 2001, ANNU REV PSYCHOL, V52, P197, DOI 10.1146/annurev.psych.52.1.197; GOLDBERG LR, 1990, J PERS SOC PSYCHOL, V59, P1216, DOI 10.1037/0022-3514.59.6.1216; Grossardt BR, 2009, PSYCHOSOM MED, V71, P491, DOI 10.1097/PSY.0b013e31819e67db; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Huprich SK, 2007, J PERS ASSESS, V89, P3, DOI 10.1080/00223890701356904; Josefsson K, 2011, J AFFECT DISORDERS, V133, P265, DOI 10.1016/j.jad.2011.03.023; Kampman O, 2011, J AFFECT DISORDERS, V135, P20, DOI 10.1016/j.jad.2010.12.021; Kim JM, 1991, INTRO FACTOR ANAL WH; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lis E, 2007, J PSYCHIATR NEUROSCI, V32, P162; Lonnqvist JE, 2012, J PERS DISORD, V26, P298, DOI 10.1521/pedi.2012.26.2.298; Lowe JR, 2009, J PERS DISORD, V23, P211, DOI 10.1521/pedi.2009.23.3.211; Lynam DR, 2012, J PERS, V80, P1593, DOI 10.1111/j.1467-6494.2012.00775.x; Markon KE, 2005, J PERS SOC PSYCHOL, V88, P139, DOI 10.1037/0022-3514.88.1.139; McCrae RR, 1997, AM PSYCHOL, V52, P509, DOI 10.1037/0003-066X.52.5.509; McCrae RR, 2005, ASSESSMENT, V12, P363, DOI 10.1177/1073191105279724; Morrongiello BA, 2010, ACCIDENT ANAL PREV, V42, P1332, DOI 10.1016/j.aap.2010.02.014; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Opsahl T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.168702; Quirk SW, 2003, PSYCHOL ASSESSMENT, V15, P311, DOI 10.1037/1040-3590.15.3.311; Roberts BW, 2000, PSYCHOL BULL, V126, P3, DOI 10.1037/0033-2909.126.1.3; Rusting CL, 1997, PERS INDIV DIFFER, V22, P607, DOI 10.1016/S0191-8869(96)00246-2; Saucier G, 1998, J PERS, V66, P495, DOI 10.1111/1467-6494.00022; Sbarra DA, 2009, PSYCHOL SCI, V20, P107, DOI 10.1111/j.1467-9280.2008.02252.x; Serrano MA, 2009, P NATL ACAD SCI USA, V106, P6483, DOI 10.1073/pnas.0808904106; Shen HW, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.016114; Smith M., 2010, NODEXL FREE OPEN NET; SVRAKIC DM, 1993, ARCH GEN PSYCHIAT, V50, P991; Trull TJ, 2005, ANNU REV CLIN PSYCHO, V1, P355, DOI 10.1146/annurev.clinpsy.1.102803.144009; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel MP, 2012, P NATL ACAD SCI USA, V109, P11372, DOI 10.1073/pnas.1203593109; Wakita K, 2007, 16 INT WORLD WIDE WE, P1275, DOI [10.1145/1242572.1242805, DOI 10.1145/1242572.1242805]; Wang L, 2009, SOC BEHAV PERSONAL, V37, P193, DOI 10.2224/sbp.2009.37.2.193; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weber S, 2008, BEHAV SCI LAW, V26, P7, DOI 10.1002/bsl.802; Whisman MA, 2007, J PERS DISORD, V21, P690, DOI 10.1521/pedi.2007.21.6.690	47	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51558	10.1371/journal.pone.0051558	http://dx.doi.org/10.1371/journal.pone.0051558			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	060RA	23284713	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500034
J	Hills, SFK; Crampton, JS; Trewick, SA; Morgan-Richards, M				Hills, Simon F. K.; Crampton, James S.; Trewick, Steven A.; Morgan-Richards, Mary			DNA and Morphology Unite Two Species and 10 Million Year Old Fossils	PLOS ONE			English	Article							CALIBRATION UNCERTAINTY; CONVERGENT EVOLUTION; GENUS; CALYPTRAEIDAE; GASTROPODA; TRAITS; SHAPE; SIZE	Species definition and delimitation is a non-trivial problem in evolutionary biology that is particularly problematic for fossil organisms. This is especially true when considering the continuity of past and present species, because species defined in the fossil record are not necessarily equivalent to species defined in the living fauna. Correctly assigned fossil species are critical for sensitive downstream analysis (e. g., diversification studies and molecular-clock calibration). The marine snail genus Alcithoe exemplifies many of the problems with species identification. The paucity of objective diagnostic characters, prevalence of morphological convergence between species and considerable variability within species that are observed in Alcithoe are typical of a broad range of fossilised organisms. Using a synthesis of molecular and morphometric approaches we show that two taxa currently recognised as distinct are morphological variants of a single species. Furthermore, we validate the fossil record for one of these morphotypes by finding a concordance between the palaeontological record and divergence time of the lineage inferred using molecular-clock analysis. This work demonstrates the utility of living species represented in the fossil record as candidates for molecular-clock calibration, as the veracity of fossil species assignment can be more rigorously tested.	[Hills, Simon F. K.; Trewick, Steven A.; Morgan-Richards, Mary] Massey Univ, Inst Nat Resources, Ecol Grp, Palmerston North, New Zealand; [Crampton, James S.] GNS Sci, Lower Hutt, New Zealand	Massey University; GNS Science - New Zealand	Hills, SFK (corresponding author), Massey Univ, Inst Nat Resources, Ecol Grp, Palmerston North, New Zealand.	s.f.hills@massey.ac.nz	Hills, Simon F K/L-3244-2016; Morgan-Richards, Mary/B-4444-2011; Crampton, James/G-1381-2012	Hills, Simon F K/0000-0002-9115-0375; Morgan-Richards, Mary/0000-0002-3913-9814; Trewick, Steven/0000-0002-4680-8457; Crampton, James/0000-0003-3270-9981	Marsden Fund [04 GNS 021]	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	This work was funded as part of the Marsden Fund contract 04 GNS 021, administered by the Royal Society of New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht C, 2004, ZOOL J LINN SOC-LOND, V140, P577, DOI 10.1111/j.1096-3642.2003.00108.x; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2002, SE AL SEQUENCE ALIGN; Bail P, 2005, THE RECENT VOLUTES O; Barraclough TG, 2010, PHILOS T R SOC B, V365, P1801, DOI 10.1098/rstb.2009.0276; Beu AG, 1990, CENOZOIC MOLLUSCA OF; Bookstein F. L, 1991, MORPHOMETRIC TOOLS F; Bookstein FL, 1996, B MATH BIOL, V58, P313, DOI 10.1016/0092-8240(95)00329-0; BOOTH CL, 1990, EVOLUTION, V44, P210, DOI 10.1111/j.1558-5646.1990.tb04291.x; Bunce M, 2003, NATURE, V425, P172, DOI 10.1038/nature01871; Chaparro OR, 1999, J EXP MAR BIOL ECOL, V232, P261, DOI 10.1016/S0022-0981(98)00115-4; Cooper R. A., 2004, I GEOLOGICAL NUCL SC, P1; Crampton JS, 2006, PALEOBIOLOGY, V32, P509, DOI 10.1666/06014.1; Crampton JS, 2010, PALEOBIOLOGY, V36, P204, DOI 10.1666/09010.1; Crampton JS, 2003, SCIENCE, V301, P358, DOI 10.1126/science.1085075; DARRAGH T A, 1988, Memoirs of the Museum of Victoria, V49, P195; Darwin C, 1859, ON THE ORIGIN OF SPE; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; DELL R K, 1978, National Museum of New Zealand Records, V1, P161; DRUMMOND A. J., 2007, GENEIOUS V3 8, P8; Foote M, 2007, PRINCIPLES OF PALEON; Foote M, 2007, SCIENCE, V318, P1131, DOI 10.1126/science.1146303; Forey PL, 2004, PHILOS T R SOC B, V359, P639, DOI 10.1098/rstb.2003.1453; Haines AJ, 2000, PALAEONTOLOGY, V43, P765, DOI 10.1111/1475-4983.00148; Hey J, 2006, TRENDS ECOL EVOL, V21, P447, DOI 10.1016/j.tree.2006.05.011; HILLIS DM, 1987, ANNU REV ECOL SYST, V18, P23, DOI 10.1146/annurev.es.18.110187.000323; Hills SFK, 2011, BIOL J LINN SOC, V104, P770, DOI 10.1111/j.1095-8312.2011.01756.x; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Holford M, 2009, MOL BIOL EVOL, V26, P15, DOI 10.1093/molbev/msn211; Lee MSY, 2009, MOL PHYLOGENET EVOL, V50, P661, DOI 10.1016/j.ympev.2008.11.024; MALLET J, 1995, TRENDS ECOL EVOL, V10, P294, DOI 10.1016/0169-5347(95)90031-4; MICHAUX B, 1987, NEW ZEAL J ZOOL, V14, P359, DOI 10.1080/03014223.1987.10423006; Miloslavich P, 2001, NAUTILUS, V115, P39; Moore J, 1997, BIOL REV, V72, P1, DOI 10.1017/S0006323196004926; Near TJ, 2005, AM NAT, V165, P137, DOI 10.1086/427734; Nolte AW, 2005, FRONTIERS ZOOLOGY, V2; Olabarria C, 2004, J MOLLUS STUD, V70, P59, DOI 10.1093/mollus/70.1.59; Parham JF, 2008, AM NAT, V171, P132, DOI 10.1086/524198; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Perez SI, 2006, J ANAT, V208, P769, DOI 10.1111/j.1469-7580.2006.00576.x; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Powell AWB, 1979, NEW ZEALAND MOLLUSCA; Reid DG, 1996, PHILOS T R SOC B, V351, P877, DOI 10.1098/rstb.1996.0082; Rohlf F. J., 2010, TPSDIG V 2 16; Rutschmann F, 2007, SYST BIOL, V56, P591, DOI 10.1080/10635150701491156; Sheets H. D., 2004, IMP INTEGRATED MORPH; Sheets H. David, 2006, Frontiers in Zoology, V3, pUnpaginated, DOI 10.1186/1742-9994-3-15; SLATKIN M, 1991, GENETICS, V129, P555; van Tuinen M, 2004, J MOL EVOL, V59, P267, DOI 10.1007/s00239-004-2624-9; Waggoner B, 2004, J PALEONTOL, V78, P51, DOI 10.1666/0022-3360(2004)078<0051:RAATTE>2.0.CO;2; Wallace AR, 1855, ANN MAGAZINE NATURAL, V16, P184, DOI DOI 10.1080/037454809495509; Webster M., 2010, PALEONTOL SOC PAP, DOI [10.1017/s1089332600001868, DOI 10.1017/S1089332600001868]; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR; [No title captured]; [No title captured]	58	9	9	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52083	10.1371/journal.pone.0052083	http://dx.doi.org/10.1371/journal.pone.0052083			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284880	Green Submitted, Green Published, gold			2022-12-27	WOS:000312794500087
J	Kong, Y; Wang, XP; Shang, YS; Schroder, PM; Liang, WH; Ling, XT; Guo, ZY; He, XS				Kong, Yuan; Wang, Xiaoping; Shang, Yushu; Schroder, Paul M.; Liang, Wenhua; Ling, Xiaoting; Guo, Zhiyong; He, Xiaoshun			Efficacy and Tolerability of Telaprevir for Chronic Hepatitis Virus C Genotype 1 Infection: A Meta-Analysis	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; PROTEASE INHIBITOR; INTERFERON-ALPHA; FOLLOW-UP; RIBAVIRIN; PEGINTERFERON; RESISTANCE; POLYMERASE; THERAPY; HEART	Background: Chronic hepatitis C virus (HCV) infection is one of the leading causes of hepatic cirrhosis and hepatocellular carcinoma, and HCV genotype 1 is the most prevalent genotype and is resistant to current standard therapy. We performed this meta-analysis to evaluate the efficacy and safety of telaprevir-based therapy for chronic HCV genotype 1 infection. Methods: We included randomized controlled trials with no year or language restriction. All data were analyzed using a random-effects model by Review Manager v5.0. The primary outcome was the proportion of patients achieving sustained virologic response (SVR), and the secondary outcomes were HCV relapse rate, incidence of severe adverse events (SAEs), and discontinuation due to adverse events. Results: The proportion of achieving SVR was significantly higher in the telaprevir group (odds ratio [OR] = 3.40 [1.92, 6.00], P<0.0001; I-2 = 87%) regardless of a patients' previous treatment status. It was also significantly higher in the 24-week and 48-week treatment groups (OR = 4.52 [2.08, 9.81], P<0.001; I-2 = 85%, and OR = 4.05 [1.56, 10.56], P = 0.004; I-2 = 92%, respectively), while it was comparable in the 12-week treatment group (OR = 1.32 [0.63, 2.75], P = 0.46; I-2 = 35%). In addition, the HCV relapse rate was significantly reduced in the telaprevir group (OR = 0.28 [0.16, 0.49], P<0.001; I-2 = 76%). However, the incidence of SAE (OR = 1.56 [1.15, 2.10], P = 0.004; I-2 = 0%) and study discontinuation due to adverse events (OR = 2.24 [1.43, 3.50], P<0.001; I-2 = 37%) were significantly higher in the telaprevir group. Conclusion: Despite its higher incidence of SAEs and discontinuation due to adverse events, telaprevir-based therapy can increase the proportion of achieving SVR in both previously treated and untreated chronic HCV-1 infected patients.	[Kong, Yuan; Wang, Xiaoping; Shang, Yushu; Liang, Wenhua; Ling, Xiaoting; Guo, Zhiyong; He, Xiaoshun] Sun Yat Sen Univ, Organ Transplant Ctr, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Schroder, Paul M.] Univ Toledo, Dept Med Microbiol & Immunol, Coll Med, Toledo, OH 43606 USA	Sun Yat Sen University; University System of Ohio; University of Toledo	Guo, ZY (corresponding author), Sun Yat Sen Univ, Organ Transplant Ctr, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China.	rockyucsf1981@126.com; gdtrc@126.com		Wenhua, Liang/0000-0002-1391-8238	Key Clinical Project from the Ministry of Health [159]; National Natural Science Foundation of China [30972951, 81102244, 81102245, 81170448]; Ministry of Health [201002004]	Key Clinical Project from the Ministry of Health; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Health	This study was supported by the Key Clinical Project from the Ministry of Health (159), National Natural Science Foundation of China (30972951, 81102244, 81102245 and 81170448) (http://www.nsfc.gov.cn/), and special fund for science research by the Ministry of Health (201002004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels DJ, 2008, J INFECT DIS, V198, P800, DOI 10.1086/591141; Bruno S, 2007, HEPATOLOGY, V45, P579, DOI 10.1002/hep.21492; Deuffic-Burban S, 2007, J VIRAL HEPATITIS, V14, P107, DOI 10.1111/j.1365-2893.2006.00785.x; Fontaine H, 2000, LANCET, V356, P41, DOI 10.1016/S0140-6736(00)02434-X; Gale M, 2005, NATURE, V436, P939, DOI 10.1038/nature04078; Gentile I, 2010, EXPERT OPIN INV DRUG, V19, P151, DOI 10.1517/13543780903501505; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Jacobson Ira M, 2010, Gastroenterol Hepatol (N Y), V6, P623; Joyce MA, 2010, MICROBES INFECT, V12, P263, DOI 10.1016/j.micinf.2009.12.012; Kieffer TL, 2007, HEPATOLOGY, V46, P631, DOI 10.1002/hep.21781; Kuntzen T, 2008, HEPATOLOGY, V48, P1769, DOI 10.1002/hep.22549; Lau DTY, 1998, HEPATOLOGY, V28, P1121, DOI 10.1002/hep.510280430; Manesis EK, 1997, HEPATOLOGY, V26, P734, DOI 10.1002/hep.510260327; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; McCown MF, 2008, ANTIMICROB AGENTS CH, V52, P1604, DOI 10.1128/AAC.01317-07; McCown MF, 2009, ANTIMICROB AGENTS CH, V53, P2129, DOI 10.1128/AAC.01598-08; McHutchison JG, 2001, J HEPATOL, V34, P140, DOI 10.1016/S0168-8278(00)00026-X; McHutchison JG, 2010, NEW ENGL J MED, V362, P1292, DOI 10.1056/NEJMoa0908014; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Russo Mark W, 2003, Cleve Clin J Med, V70 Suppl 4, pS14; Russo MW, 2003, GASTROENTEROLOGY, V124, P1711, DOI 10.1016/S0016-5085(03)00394-9; Sarrazin C, 2007, GASTROENTEROLOGY, V132, P1767, DOI 10.1053/j.gastro.2007.02.037; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; Schmidt S, 2008, TELEMED J E-HEALTH, V14, P426, DOI 10.1089/tmj.2007.0076; Seeff LB, 2001, HEPATOLOGY, V33, P455, DOI 10.1053/jhep.2001.21905; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Veldt BJ, 2007, ANN INTERN MED, V147, P677, DOI 10.7326/0003-4819-147-10-200711200-00003; Zeuzem S, 2000, NEW ENGL J MED, V343, P1666, DOI 10.1056/NEJM200012073432301; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	31	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52158	10.1371/journal.pone.0052158	http://dx.doi.org/10.1371/journal.pone.0052158			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284915	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500105
J	Schmidt, S; Hoving, JC; Horsnell, WGC; Mearns, H; Cutler, AJ; Brombacher, TM; Brombacher, F				Schmidt, Saskia; Hoving, J. Claire; Horsnell, William G. C.; Mearns, Helen; Cutler, Antony J.; Brombacher, Tiroyaone M.; Brombacher, Frank			Nippostrongylus-Induced Intestinal Hypercontractility Requires IL-4 Receptor Alpha-Responsiveness by T Cells in Mice	PLOS ONE			English	Article							ALTERNATIVE MACROPHAGE ACTIVATION; SMOOTH-MUSCLE CONTRACTILITY; STIMULATORY FACTOR-I; INFLAMMATION; INFECTION; CYTOKINE; STAT6; INTERLEUKIN-13; RESISTANCE; EXPRESSION	Gut-dwelling helminthes induce potent IL-4 and IL-13 dominated type 2 T helper cell (T(H)2) immune responses, with IL-13 production being essential for Nippostrongylus brasiliensis expulsion. This T(H)2 response results in intestinal inflammation associated with local infiltration by T cells and macrophages. The resulting increased IL-4/IL-13 intestinal milieu drives goblet cell hyperplasia, alternative macrophage activation and smooth muscle cell hypercontraction. In this study we investigated how IL-4-promoted T cells contributed to the parasite induced effects in the intestine. This was achieved using pan T cell-specific IL-4 receptor alpha-deficient mice (iLck(cre)IL-4R alpha(-/lox)) and IL-4R alpha-responsive control mice. Global IL-4R alpha(-/-) mice showed, as expected, impaired type 2 immunity to N. brasiliensis. Infected T cell-specific IL-4R alpha-deficient mice showed comparable worm expulsion, goblet cell hyperplasia and IgE responses to control mice. However, impaired IL-4-promoted T(H)2 cells in T cell-specific IL-4R alpha deficient mice led to strikingly reduced IL-4 production by mesenteric lymph node CD4(+) T cells and reduced intestinal IL-4 and IL-13 levels, compared to control mice. This reduced IL-4/IL-13 response was associated with an impaired IL-4/IL-13-mediated smooth muscle cell hypercontractility, similar to that seen in global IL-4R alpha(-/-) mice. These results demonstrate that IL-4-promoted T cell responses are not required for the resolution of a primary N. brasiliensis infection. However, they do contribute significantly to an important physiological manifestation of helminth infection; namely intestinal smooth muscle cell-driven hypercontractility.	[Brombacher, Frank] Univ Cape Town, ICGEB, ZA-7925 Cape Town, South Africa; Univ Cape Town, Div Immunol, IIDMM, Fac Hlth Sci, ZA-7925 Cape Town, South Africa	International Center for Genetic Engineering & Biotechnology (ICGEB); ICGEB Cape Town; University of Cape Town; University of Cape Town	Brombacher, F (corresponding author), Univ Cape Town, ICGEB, ZA-7925 Cape Town, South Africa.	fbrombac@mweb.co.za	Horsnell, William GC/A-9512-2013	Horsnell, William Gordon Charles/0000-0001-7172-408X; Cutler, Antony/0000-0002-9617-9994; Mearns, Helen/0000-0002-7971-1256	South African Research Chair initiative of the Department of Science and Technology (DST); National Research Foundation (NRF); South African Medical Research Council (MRC)	South African Research Chair initiative of the Department of Science and Technology (DST); National Research Foundation (NRF); South African Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the South African Research Chair initiative of the Department of Science and Technology (DST), National Research Foundation (NRF), and the South African Medical Research Council (MRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiho H, 2002, AM J PHYSIOL-GASTR L, V282, pG226, DOI 10.1152/ajpgi.2002.282.2.G226; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Barner M, 1998, CURR BIOL, V8, P669, DOI 10.1016/S0960-9822(98)70256-8; Brombacher F, 2000, BIOESSAYS, V22, P646, DOI 10.1002/1521-1878(200007)22:7&lt;646::AID-BIES7&gt;3.0.CO;2-9; Brombacher Frank, 2009, V531, P225, DOI 10.1007/978-1-59745-396-7_15; Cliffe LJ, 2005, SCIENCE, V308, P1463, DOI 10.1126/science.1108661; COFFMAN RL, 1986, J IMMUNOL, V136, P4538; Cohn L, 1997, J EXP MED, V186, P1737, DOI 10.1084/jem.186.10.1737; Cooney LA, 2011, J IMMUNOL, V187, P4440, DOI 10.4049/jimmunol.1002860; Dewals B, 2009, AM J PATHOL, V175, P706, DOI 10.2353/ajpath.2009.090137; DUNN A, 1986, J HELMINTHOL, V60, P260, DOI 10.1017/S0022149X00008464; Finkelman FD, 2004, IMMUNOL REV, V201, P139, DOI 10.1111/j.0105-2896.2004.00192.x; Galeazzi F, 2000, AM J PHYSIOL-GASTR L, V278, pG259, DOI 10.1152/ajpgi.2000.278.2.G259; Gallina G, 2006, J CLIN INVEST, V116, P2777, DOI 10.1172/JCI28828; Hasnain SZ, 2011, J EXP MED, V208, P893, DOI 10.1084/jem.20102057; Herbert DR, 2009, J EXP MED, V206, P2947, DOI 10.1084/jem.20091268; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Horsnell WGC, 2007, PLOS PATHOG, V3, P46, DOI 10.1371/journal.ppat.0030001; Inagaki-Ohara K, 2011, IMMUNOLOGY, V134, P448, DOI 10.1111/j.1365-2567.2011.03503.x; KOPF M, 1993, NATURE, V362, P245, DOI 10.1038/362245a0; MADDEN KB, 1991, J IMMUNOL, V147, P1387; Marillier RG, 2010, AM J PHYSIOL-GASTR L, V298, pG943, DOI 10.1152/ajpgi.00321.2009; McKenzie GJ, 1998, CURR BIOL, V8, P339, DOI 10.1016/S0960-9822(98)70134-4; Mearns H, 2008, INFECT IMMUN, V76, P5535, DOI 10.1128/IAI.00210-08; MILLER HRP, 1981, IMMUNOLOGY, V44, P419; Mohrs M, 1999, J IMMUNOL, V162, P7302; Moreels TG, 2004, GUT, V53, P99, DOI 10.1136/gut.53.1.99; Moreels TG, 2001, AM J PHYSIOL-GASTR L, V280, pG1030, DOI 10.1152/ajpgi.2001.280.5.G1030; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Muller U, 2007, J IMMUNOL, V179, P5367, DOI 10.4049/jimmunol.179.8.5367; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Radwanska M, 2007, PLOS PATHOG, V3, P619, DOI 10.1371/journal.ppat.0030068; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Stenzel W, 2009, AM J PATHOL, V174, P486, DOI 10.2353/ajpath.2009.080598; SVETIC A, 1993, J IMMUNOL, V150, P3434; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; URBAN JF, 1991, P NATL ACAD SCI USA, V88, P5513, DOI 10.1073/pnas.88.13.5513; Urban JF, 2001, J IMMUNOL, V167, P6078, DOI 10.4049/jimmunol.167.11.6078; Vallance BA, 1997, AM J PHYSIOL-GASTR L, V272, pG321, DOI 10.1152/ajpgi.1997.272.2.G321; Vallance BA, 1999, INFECT IMMUN, V67, P6090, DOI 10.1128/IAI.67.11.6090-6097.1999; VITETTA ES, 1985, J EXP MED, V162, P1726, DOI 10.1084/jem.162.5.1726; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; YAMAGUCHI Y, 1988, J EXP MED, V167, P43, DOI 10.1084/jem.167.1.43; Zhao AP, 2008, GASTROENTEROLOGY, V135, P217, DOI 10.1053/j.gastro.2008.03.077; Zhao AP, 2003, J IMMUNOL, V171, P948, DOI 10.4049/jimmunol.171.2.948; ZURAWSKI G, 1994, IMMUNOL TODAY, V15, P19, DOI 10.1016/0167-5699(94)90021-3	49	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52211	10.1371/journal.pone.0052211	http://dx.doi.org/10.1371/journal.pone.0052211			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284939	Green Submitted, Green Published, gold			2022-12-27	WOS:000312794500115
J	Zhou, SS; Fu, YG; Li, J; He, LY; Cai, XS; Yan, QY; Rao, XQ; Huang, SF; Li, G; Wang, YQ; Xu, AL				Zhou, Sisi; Fu, Yonggui; Li, Jie; He, Lingyu; Cai, Xingsheng; Yan, Qingyu; Rao, Xingqiang; Huang, Shengfeng; Li, Guang; Wang, Yiquan; Xu, Anlong			HTS-PEG: A Method for High Throughput Sequencing of the Paired-Ends of Genomic Libraries	PLOS ONE			English	Article							STRUCTURAL VARIATION; BAC LIBRARY; CONSTRUCTION; GENERATION; EVOLUTION; DNA	Second generation sequencing has been widely used to sequence whole genomes. Though various paired-end sequencing methods have been developed to construct the long scaffold from contigs derived from shotgun sequencing, the classical paired-end sequencing of the Bacteria Artificial Chromosome (BAC) or fosmid libraries by the Sanger method still plays an important role in genome assembly. However, sequencing libraries with the Sanger method is expensive and time-consuming. Here we report a new strategy to sequence the paired-ends of genomic libraries with parallel pyrosequencing, using a Chinese amphioxus (Branchiostoma belcheri) BAC library as an example. In total, approximately 12,670 non-redundant paired-end sequences were generated. Mapping them to the primary scaffolds of Chinese amphioxus, we obtained 413 ultra-scaffolds from 1,182 primary scaffolds, and the N50 scaffold length was increased approximately 55 kb, which is about a 10% improvement. We provide a universal and cost-effective method for sequencing the ultra-long pairedends of genomic libraries. This method can be very easily implemented in other second generation sequencing platforms.	[Zhou, Sisi; Fu, Yonggui; Li, Jie; He, Lingyu; Cai, Xingsheng; Yan, Qingyu; Rao, Xingqiang; Huang, Shengfeng; Xu, Anlong] Sun Yat Sen Univ, Guangdong Prov Key Lab Pharmaceut Funct Genes, State Key Lab Biocontrol,Dept Biochem, Higher Educ Mega Ctr,Coll Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Li, Guang; Wang, Yiquan] Xiamen Univ, Minist Educ Coastal & Wetland Ecosyst, Key Lab, Sch Life Sci, Xiamen, Peoples R China	Sun Yat Sen University; Xiamen University	Xu, AL (corresponding author), Sun Yat Sen Univ, Guangdong Prov Key Lab Pharmaceut Funct Genes, State Key Lab Biocontrol,Dept Biochem, Higher Educ Mega Ctr,Coll Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	lssxal@mail.sysu.edu.cn	yan, qing/GZN-2287-2022; Li, Jie/N-5859-2015	Li, Jie/0000-0002-8328-3274; Fu, Yonggui/0000-0001-6469-3430	National Natural Science Foundation of China [30730089, 30801012, 31171193]; National Basic Research Program of China (973 Program) [2011CB946101, 2007CB815800]; Fundamental Research Funds for the Central Universities; State High-Tech Development Project (863 Project) [2008AA092601]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); State High-Tech Development Project (863 Project)	This work was supported by the key project (No. 30730089) of the National Natural Science Foundation of China (to AX), the National Basic Research Program of China (973 Program; No. 2011CB946101 and 2007CB815800) (to AX), Fundamental Research Funds for the Central Universities (to YF), the National Natural Science Foundation of China (No. 30801012) (to YF), the State High-Tech Development Project (863 Project 2008AA092601) (to SH) and the National Natural Science Foundation of China (No. 31171193) (to SH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bovee D, 2008, NAT GENET, V40, P96, DOI 10.1038/ng.2007.34; Droege M, 2008, J BIOTECHNOL, V136, P3, DOI 10.1016/j.jbiotec.2008.03.021; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Fullwood MJ, 2009, GENOME RES, V19, P521, DOI 10.1101/gr.074906.107; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; HONG GF, 1981, BIOSCIENCE REP, V1, P243, DOI 10.1007/BF01114911; Hong YS, 2003, MOL GENET GENOMICS, V268, P720, DOI 10.1007/s00438-003-0813-7; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Nachman MW, 2000, GENETICS, V156, P297; Peng Z, 2010, LARGE GAP SIZE PAIRE; Peng Z, 2008, MODIFICATION GS LT P; Peng Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029437; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Siegel AF, 2000, GENOMICS, V68, P237, DOI 10.1006/geno.2000.6303; TAKAHATA N, 1993, MOL BIOL EVOL, V10, P2; Williams LJ, 2012, GENOME RES; Wu C-C, 2012, NAT METH, P9; Zhang Ju-Yong, 2010, Yichuan, V32, P67, DOI 10.3724/SP.J.1005.2010.00067; Zhao SY, 2001, GENOME RES, V11, P1736, DOI 10.1101/gr.179201	24	0	0	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52257	10.1371/journal.pone.0052257	http://dx.doi.org/10.1371/journal.pone.0052257			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284958	Green Submitted, gold, Green Published			2022-12-27	WOS:000312794500126
J	Kjellstrom, A; Edlund, H; Lembring, M; Ahlgren, V; Allen, M				Kjellstrom, Anna; Edlund, Hanna; Lembring, Maria; Ahlgren, Viktoria; Allen, Marie			An Analysis of the Alleged Skeletal Remains of Carin Goring	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; SEQUENCE; BONES; IDENTIFICATION; HYPEROSTOSIS; SURFACE; GENOME	In 1991, treasure hunters found skeletal remains in an area close to the destroyed country residence of former Nazi leader Hermann Goring in northeastern Berlin. The remains, which were believed to belong to Carin Goring, who was buried at the site, were examined to determine whether it was possible to make a positive identification. The anthropological analysis showed that the remains come from an adult woman. The DNA analysis of several bone elements showed female sex, and a reference sample from Carin's son revealed mtDNA sequences identical to the remains. The profile has one nucleotide difference from the Cambridge reference sequence ( rCRS), the common variant 263G. A database search resulted in a frequency of this mtDNA sequence of about 10% out of more than 7,000 European haplotypes. The mtDNA sequence found in the ulna, the cranium and the reference sample is, thus, very common among Europeans. Therefore, nuclear DNA analysis was attempted. The remains as well as a sample from Carin's son were successfully analysed for the three nuclear markers TH01, D7S820 and D8S1179. The nuclear DNA analysis of the two samples revealed one shared allele for each of the three markers, supporting a mother and son relationship. This genetic information together with anthropological and historical files provides an additional piece of circumstantial evidence in our efforts to identify the remains of Carin Goring.	[Edlund, Hanna; Lembring, Maria; Ahlgren, Viktoria; Allen, Marie] Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Kjellstrom, Anna] Stockholm Univ, Dept Archaeol & Class Studies, Osteoarchaeol Res Lab, S-10691 Stockholm, Sweden	Uppsala University; Stockholm University	Allen, M (corresponding author), Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden.	marie.allen@igp.uu.se	Kjellström, Anna/C-4343-2016	Kjellström, Anna/0000-0001-8964-3771	Beijer foundation; Carl Tryggers foundation; Kjell and Marta Beijer Foundation	Beijer foundation; Carl Tryggers foundation; Kjell and Marta Beijer Foundation	This work has been funded by The Beijer foundation and Carl Tryggers foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was generously supported by a grant from the Kjell and Marta Beijer Foundation. Likelihood ratios were kindly calculated by Dr. Andreas Tillmar at the National Board of Forensic Medicine in Linkoping.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Anton SC, 1997, AM J PHYS ANTHROPOL, V102, P111; Aufderheide A. C., 1998, HUMAN PALEOPATHOLOGY; Bar W, 2000, INT J LEGAL MED, V113, P193, DOI 10.1007/s004140000149; Buchwald G., 2004, DECLINE TUBERCULOSIS; Buikstra JE, 1994, ARKANSAS ARCHEOLOGIC, V44; Chong VFH, 2002, AM J ROENTGENOL, V178, P717, DOI 10.2214/ajr.178.3.1780717; Coble MD, 2005, J FORENSIC SCI, V50, P43; Coble MD, 2004, INT J LEGAL MED, V118, P137, DOI 10.1007/s00414-004-0427-6; Divne AM, 2010, FORENSIC SCI INT-GEN, V4, P122, DOI 10.1016/j.fsigen.2009.07.004; Fontander B, 2009, CARIN GORING SKRIVER; France DL, 1998, FORENSIC OSTEOLOGY A, P163; GILL P, 1994, NAT GENET, V6, P130, DOI 10.1038/ng0294-130; Hershkovitz I, 1999, AM J PHYS ANTHROPOL, V109, P303, DOI 10.1002/(SICI)1096-8644(199907)109:3<303::AID-AJPA3>3.0.CO;2-I; HOLLAND MM, 1993, J FORENSIC SCI, V38, P542; Irving D, 2002, GORING BIOGRAPHY; Kemp BM, 2005, FORENSIC SCI INT, V154, P53, DOI 10.1016/j.forsciint.2004.11.017; Manvell R, 1962, HERMANN GORING; Mays S, 2002, AM J PHYS ANTHROPOL, V119, P27, DOI 10.1002/ajpa.10099; MEINDL RS, 1985, AM J PHYS ANTHROPOL, V68, P57, DOI 10.1002/ajpa.1330680106; Nilsson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008986; Ortner D. J., 2003, IDENTIFICATION PATHO, DOI DOI 10.1016/B978-012528628-2/50057-0; ROBBINS SL, 1974, PATHOLOGIC BASIS DIS; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Salamon M, 2005, P NATL ACAD SCI USA, V102, P13783, DOI 10.1073/pnas.0503718102; Stewart TD., 1979, ESSENTIALS FORENSIC; SULLIVAN KM, 1993, BIOTECHNIQUES, V15, P636; Trotter M, 1952, AM J PHYS ANTHROP-NE, V10, P463, DOI 10.1002/ajpa.1330100407	29	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e44366	10.1371/journal.pone.0044366	http://dx.doi.org/10.1371/journal.pone.0044366			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284605	Green Published, gold			2022-12-27	WOS:000312694300001
J	Lautenschlager, S; Rayfield, EJ; Altangerel, P; Zanno, LE; Witmer, LM				Lautenschlager, Stephan; Rayfield, Emily J.; Altangerel, Perle; Zanno, Lindsay E.; Witmer, Lawrence M.			The Endocranial Anatomy of Therizinosauria and Its Implications for Sensory and Cognitive Function	PLOS ONE			English	Article							SEMICIRCULAR CANAL SYSTEM; COMPUTED-TOMOGRAPHY; FALCARIUS-UTAHENSIS; FOSSIL EVIDENCE; DINOSAURIA; THEROPODA; BRAIN; BIRDS; EVOLUTION; BEHAVIOR	Background: Therizinosauria is one of the most enigmatic and peculiar clades among theropod dinosaurs, exhibiting an unusual suite of characters, such as lanceolate teeth, a rostral rhamphotheca, long manual claws, and a wide, opisthopubic pelvis. This specialized anatomy has been associated with a shift in dietary preferences and an adaptation to herbivory. Despite a large number of discoveries in recent years, the fossil record for Therizinosauria is still relatively poor, and cranial remains are particularly rare. Methodology/Principal Findings: Based on computed tomographic (CT) scanning of the nearly complete and articulated skull of Erlikosaurus andrewsi, as well as partial braincases of two other therizinosaurian taxa, the endocranial anatomy is reconstructed and described. The wider phylogenetic range of the described specimens permits the evaluation of sensory and cognitive capabilities of Therizinosauria in an evolutionary context. The endocranial anatomy reveals a mosaic of plesiomorphic and derived characters in therizinosaurians. The anatomy of the olfactory apparatus and the endosseous labyrinth suggests that olfaction, hearing, and equilibrium were well-developed in therizinosaurians and might have affected or benefited from an enlarged telencephalon. Conclusion/Significance: This study presents the first appraisal of the evolution of endocranial anatomy and sensory adaptations in Therizinosauria. Despite their phylogenetically basal position among maniraptoran dinosaurs, therizinosaurians had developed the neural pathways for a well developed sensory repertoire. In particular olfaction and hearing may have played an important role in foraging, predator evasion, and/or social complexity.	[Lautenschlager, Stephan; Rayfield, Emily J.] Univ Bristol, Sch Earth Sci, Bristol, Avon, England; [Altangerel, Perle] Natl Univ Mongolia, Ulaanbaatar, Mongolia; [Zanno, Lindsay E.] NC Museum Nat Sci, Nat Res Ctr, Raleigh, NC USA; [Zanno, Lindsay E.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA; [Witmer, Lawrence M.] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA	University of Bristol; National University of Mongolia; University of North Carolina; North Carolina State University; University System of Ohio; Ohio University	Lautenschlager, S (corresponding author), Univ Bristol, Sch Earth Sci, Bristol, Avon, England.	glzsl@bristol.ac.uk	Rayfield, Emily/F-5038-2010	Rayfield, Emily/0000-0002-2618-750X; Witmer, Lawrence/0000-0002-7610-0118; Lautenschlager, Stephan/0000-0003-3472-814X; Zanno, Lindsay/0000-0002-1654-1990	Volkswagen Foundation (Volkswagen Stiftung), Hannover; United States National Science Foundation [IBN-9601174, IBN-0343744, IOB-0517257, IOS-1050154]; Ohio University Heritage College of Osteopathic Medicine; Ohio Supercomputing Center; Division Of Integrative Organismal Systems [1050154] Funding Source: National Science Foundation	Volkswagen Foundation (Volkswagen Stiftung), Hannover; United States National Science Foundation(National Science Foundation (NSF)); Ohio University Heritage College of Osteopathic Medicine; Ohio Supercomputing Center; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	SL is supported by a doctoral fellowship by the Volkswagen Foundation (Volkswagen Stiftung), Hannover. LMW acknowledges funding support from the United States National Science Foundation (IBN-9601174, IBN-0343744, IOB-0517257, IOS-1050154) and the Ohio University Heritage College of Osteopathic Medicine. The Ohio Supercomputing Center also provided support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RM, 1998, PALAEONTOLOGY, V41, P1231; Ali F, 2008, J VERTEBR PALEONTOL, V28, P123, DOI 10.1671/0272-4634(2008)28[123:HOTECO]2.0.CO;2; Alifanov VR, 2011, PALEONTOL J+, V45, P183, DOI 10.1134/S0031030111020031; ANDERSON JF, 1985, J ZOOL, V207, P53, DOI 10.1111/j.1469-7998.1985.tb04915.x; Ashwell KWS, 2008, BRAIN BEHAV EVOLUT, V71, P151, DOI 10.1159/000111461; Balanoff AM, 2009, AM MUS NOVIT, P1, DOI 10.1206/644.1; Barsbold R., 1980, Acta Palaeontologica Polonica, V25, P187; Bever GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023393; Brochu CA, 2000, J VERTEBR PALEONTOL, V20, P1, DOI 10.1671/0272-4634(2000)020[0001:ADREFT]2.0.CO;2; Christiansen P., 2004, Historical Biology, V16, P85, DOI 10.1080/08912960412331284313; Chure Daniel J., 2000, Gaia (Lisboa), V15, P233; Clark JM, 2004, DINOSAURIA, 2ND EDITION, P151; Clark James M., 1994, American Museum Novitates, V3115, P1; Clark JM, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)364<0001:CAOCOT>2.0.CO;2; Crepet WL, 2004, AM J BOT, V91, P1666, DOI 10.3732/ajb.91.10.1666; CREPET WL, 1991, PHILOS T ROY SOC B, V333, P187, DOI 10.1098/rstb.1991.0067; CURRIE PJ, 1985, CAN J EARTH SCI, V22, P1643, DOI 10.1139/e85-173; Evans DC, 2009, ANAT REC, V292, P1315, DOI 10.1002/ar.20984; Evans DC, 2005, ACTA PALAEONTOL POL, V50, P617; Franzosa J, 2005, J VERTEBR PALEONTOL, V25, P859, DOI 10.1671/0272-4634(2005)025[0859:CEOTCT]2.0.CO;2; Franzosa J.W., 2004, THESIS U TEXAS; Friis EM, 1987, ORIGINS ANGIOSPERMS, P145; Giffin E.B., 1989, Journal of Vertebrate Paleontology, V9, P67; Gleich O, 2005, NATURWISSENSCHAFTEN, V92, P595, DOI 10.1007/s00114-005-0050-5; Gleich O, 2000, SPR HDB AUD, V13, P70; Hall MI, 2007, J ZOOL, V271, P437, DOI 10.1111/j.1469-7998.2006.00227.x; HOPSON JA, 1977, ANNU REV ECOL SYST, V8, P429, DOI 10.1146/annurev.es.08.110177.002241; Hullar TE, 2006, ANAT REC PART A, V288A, P466, DOI 10.1002/ar.a.20304; Hurlburt G.R., 1996, THESIS U TORONTO; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Kirkland JI, 2005, NATURE, V435, P84, DOI 10.1038/nature03468; Kirkland JI, 2005, LIFE O PAST, P87; Kirkland JI, 2001, J VERTEBR PALEONTOL, V21, P410, DOI 10.1671/0272-4634(2001)021[0410:FDTDTF]2.0.CO;2; Knoll F, 2009, ANN PALEONTOL, V95, P165, DOI 10.1016/j.annpal.2009.06.001; Kundrat M, 2008, ACTA ZOOL-STOCKHOLM, V89, P231, DOI 10.1111/j.1463-6395.2007.00311.x; Kundrat M, 2007, NATURWISSENSCHAFTEN, V94, P499, DOI 10.1007/s00114-007-0219-1; Larsson Hans C.E., 2001, P19; Larsson HCE, 2000, J VERTEBR PALEONTOL, V20, P615, DOI 10.1671/0272-4634(2000)020[0615:FEANTD]2.0.CO;2; Makovicky Peter J., 1998, American Museum Novitates, V3247, P1; Makovicky PJ, 2003, AM MUS NOVIT, P1; MANLEY GA, 1972, EVOLUTION, V26, P608, DOI 10.1111/j.1558-5646.1972.tb01968.x; Martin Graham R., 1993, P5; Norell MA, 2009, AM MUS NOVIT, P1; Osmolska H, 2004, ACTA PALAEONTOL POL, V49, P321; Carabajal AP, 2010, NEUES JAHRB GEOL P-A, V258, P249, DOI 10.1127/0077-7749/2010/0104; Perle A., 1981, JOINT SOVIET MONGOLI, V8, P45; Rogers SW, 1998, NEURON, V21, P673, DOI 10.1016/S0896-6273(00)80585-1; Rogers SW, 1999, ANAT RECORD, V257, P162; Rozhdestvensky A.K, 1970, PALEONTOL ZH, P131; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2107, DOI 10.1139/e93-183; RUSSELL DA, 1993, RES EXPLOR, V9, P70; Sampson SD, 2007, J VERTEBR PALEONTOL, V27, P32, DOI 10.1671/0272-4634(2007)27[32:CAOMCT]2.0.CO;2; Sanders RK, 2005, ACTA PALAEONTOL POL, V50, P601; Saveliev SV, 2007, PALEONTOL J+, V41, P281, DOI 10.1134/S0031030107030070; Schmitz L, 2011, SCIENCE, V332, P705, DOI 10.1126/science.1200043; Schmitz L, 2009, J MORPHOL, V270, P759, DOI 10.1002/jmor.10720; Senter P, 2007, J SYST PALAEONTOL, V5, P429, DOI 10.1017/S1477201907002143; Senter P, 2008, HIST BIOL, V20, P255, DOI 10.1080/08912960903033327; Sipla J, 2004, J VERTEBR PALEONTOL, V24, p113A; Smith DK, 2011, J VERTEBR PALEONTOL, V31, P387, DOI 10.1080/02724634.2011.549442; Spoor F, 2003, COUR FOR SEKENBG, V243, P93; Spoor F, 2007, P NATL ACAD SCI USA, V104, P10808, DOI 10.1073/pnas.0704250104; Therrien F, 2007, J VERTEBR PALEONTOL, V27, P108, DOI 10.1671/0272-4634(2007)27[108:MTIBTY]2.0.CO;2; Walsh SA, 2009, P ROY SOC B-BIOL SCI, V276, P1355, DOI 10.1098/rspb.2008.1390; Weishampel DB, 1997, BIOSCIENCE, V47, P150, DOI 10.2307/1313034; Wharton DS, 2002, THESIS U BRISTOL; Witmer LM, 2008, ANATOMICAL IMAGING: TOWARDS A NEW MORPHOLOGY, P67, DOI 10.1007/978-4-431-76933-0_6; Witmer LM, 2009, ANAT REC, V292, P1266, DOI 10.1002/ar.20983; Witmer Lawrence M., 2008, P117; Witmer LM, 2003, NATURE, V425, P950, DOI 10.1038/nature02048; Witmer LM, 1997, J VERTEBR PALEONTOL, V17, P1, DOI 10.1080/02724634.1997.10011027; Zanno L, 2006, J VERTEBR PALEONTOL, V26, p143A; Zanno LE, 2011, P NATL ACAD SCI USA, V108, P232, DOI 10.1073/pnas.1011924108; Zanno LE, 2010, J SYST PALAEONTOL, V8, P503, DOI 10.1080/14772019.2010.488045; Zanno LE, 2010, ZOOL J LINN SOC-LOND, V158, P196, DOI 10.1111/j.1096-3642.2009.00464.x; Zanno LE, 2009, P ROY SOC B-BIOL SCI, V276, P3505, DOI 10.1098/rspb.2009.1029; Zelenitsky DK, 2011, P ROY SOC B-BIOL SCI, V278, P3625, DOI 10.1098/rspb.2011.0238; Zelenitsky DK, 2009, P ROY SOC B-BIOL SCI, V276, P667, DOI 10.1098/rspb.2008.1075; Zhou Chang-Fu, 2007, Palaeoworld, V16, P285, DOI 10.1016/j.palwor.2007.07.002	79	54	55	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52289	10.1371/journal.pone.0052289	http://dx.doi.org/10.1371/journal.pone.0052289			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284972	gold, Green Published, Green Submitted			2022-12-27	WOS:000312694300085
J	Makadi, L; Caldwell, MW; Osi, A				Makadi, Laszlo; Caldwell, Michael W.; Osi, Attila			The First Freshwater Mosasauroid (Upper Cretaceous, Hungary) and a New Clade of Basal Mosasauroids	PLOS ONE			English	Article							HUNGAROSAURUS-TORMAI; HALISAURUS; SQUAMATA; MOROCCO; LIZARD; DINOSAURIA; PHOSPHATES; PHYLOGENY; SPECIMEN; SLOVENIA	Mosasauroids are conventionally conceived of as gigantic, obligatorily aquatic marine lizards (1000s of specimens from marine deposited rocks) with a cosmopolitan distribution in the Late Cretaceous (90-65 million years ago [mya]) oceans and seas of the world. Here we report on the fossilized remains of numerous individuals (small juveniles to large adults) of a new taxon, Pannoniasaurus inexpectatus gen. et sp. nov. from the Csehbanya Formation, Hungary (Santonian, Upper Cretaceous, 85.3-83.5 mya) that represent the first known mosasauroid that lived in freshwater environments. Previous to this find, only one specimen of a marine mosasauroid, cf. Plioplatecarpus sp., is known from non-marine rocks in Western Canada. Pannoniasaurus inexpectatus gen. et sp. nov. uniquely possesses a plesiomorphic pelvic anatomy, a non-mosasauroid but pontosaur-like tail osteology, possibly limbs like a terrestrial lizard, and a flattened, crocodile-like skull. Cladistic analysis reconstructs P. inexpectatus in a new clade of mosasauroids: (Pannoniasaurus (Tethysaurus (Yaguarasaurus, Russellosaurus))). P. inexpectatus is part of a mixed terrestrial and freshwater faunal assemblage that includes fishes, amphibians turtles, terrestrial lizards, crocodiles, pterosaurs, dinosaurs and birds.	[Makadi, Laszlo] Hungarian Nat Hist Museum, Dept Geol & Paleontol, Budapest, Hungary; [Caldwell, Michael W.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Osi, Attila] Eotvos Lorand Univ, Dept Phys & Appl Geol, MTA ELTE Lendulet Dinosaur Res Grp, Budapest, Hungary	University of Alberta; Eotvos Lorand University	Makadi, L (corresponding author), Hungarian Nat Hist Museum, Dept Geol & Paleontol, Budapest, Hungary.	iharkutia@yahoo.com	Ősi, Attila/K-2414-2018; Caldwell, Michael/A-2622-2014	Ősi, Attila/0000-0003-2967-997X; Caldwell, Michael/0000-0002-2377-3925	NSERC [238458-01]; University of Alberta, Chairs Research Allowance; OTKA [T-39045, PD-73021, NF-84193]; MTA-ELTE Lendulet (Dinosaur Research Group) [95102]; National Geographic Society; Jurassic Foundation; Hantken Foundation; Department of Geology and Paleontology, Hungarian Natural History Museum	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Alberta, Chairs Research Allowance; OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); MTA-ELTE Lendulet (Dinosaur Research Group); National Geographic Society(National Geographic Society); Jurassic Foundation; Hantken Foundation; Department of Geology and Paleontology, Hungarian Natural History Museum	MWC was supported by an NSERC Discovery Grant (#238458-01) and a University of Alberta, Chairs Research Allowance. Fieldwork and the work of LM and AO were supported by the OTKA T-39045, PD-73021, NF-84193 grants; the MTA-ELTE Lendulet (Dinosaur Research Group, grant n. 95102); the National Geographic Society; the Jurassic Foundation, and the Hantken Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank N. Bardet, G. Bell, M. Polcyn, A. Palci, and T. Konishi for helpful discussions, providing literature and access to material. Members of the Iharkut Research Group, the staff of the Department of Paleontology, Eotvos University and the Department of Geology and Paleontology, Hungarian Natural History Museum, as well as the participants of the excavations are acknowledged for their support and help provided through the years. We are grateful to the Bakonyi Bauxitbanya Kft and the Geovol Kft for their assistance in the fieldworks. Nathalie Bardet and an anonymous reviewer are gratefully acknowledged for critically reading the manuscript and making useful suggestions that greatly improved our work.	Bardet N, 2005, ZOOL J LINN SOC-LOND, V143, P447, DOI 10.1111/j.1096-3642.2005.00152.x; Bardet N, 2003, CR PALEVOL, V2, P607, DOI 10.1016/j.crpv.2003.09.006; Bardet N, 2001, CR ACAD SCI II A, V332, P395, DOI 10.1016/S1251-8050(00)01486-5; Bell GL, 2005, NETH J GEOSCI, V84, P177, DOI 10.1017/S0016774600020965; Bell Gorden L. Jr, 1997, P293, DOI 10.1016/B978-012155210-7/50017-X; Caldwell M.W., 2007, 2 MOS M ABSTR BOOKL, P10; Caldwell MW, 2007, J VERTEBR PALEONTOL, V27, P863, DOI 10.1671/0272-4634(2007)27[863:ANBMFT]2.0.CO;2; Caldwell Michael W., 2006, Memorie della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale di Milano, V34, P1; Caldwell MW, 2012, B SOC GEOL FR, V183, P7, DOI 10.2113/gssgfbull.183.1.7; Caldwell MW, 2010, J VERTEBR PALEONTOL, V30, P747, DOI 10.1080/02724631003762963; Camp CL, 1923, B AM MUS NAT HIST, V48, P289; Carroll R.L., 1992, Journal of Vertebrate Paleontology, V12, P66; Cassens I, 2000, P NATL ACAD SCI USA, V97, P11343, DOI 10.1073/pnas.97.21.11343; Cuvier George, 1808, ANN MUSEUM HIST NATU, V12, P145; DEBRAGA M, 1993, EVOL BIOL, V27, P245; Dutchak AR, 2006, CAN J EARTH SCI, V43, P1821, DOI 10.1139/E06-086; Dutchak AR, 2005, NETH J GEOSCI, V84, P221, DOI 10.1017/S0016774600021004; Dyke GJ, 2010, GEOL J, V45, P434, DOI 10.1002/gj.1209; Estes R., 1983, ENCY PALEOHERPETOLOG; Evans SE, 2006, PALAEONTOLOGY, V49, P1143, DOI 10.1111/j.1475-4983.2006.00598.x; Haas J, 1977, STUDY MESOZOIC FORMA, V1975, P259; Haas J., 1992, CONTROLS DISTRIBUTIO, V267, P245; Holmes R, 1999, CAN J EARTH SCI, V36, P363, DOI 10.1139/e98-112; Holmes RB, 2000, J PALEONTOL, V74, P309, DOI 10.1666/0022-3360(2000)074<0309:APSOTB>2.0.CO;2; Houssaye A, 2011, GEOL MAG, V148, P237, DOI 10.1017/S0016756810000580; Jocha-Edelenyi E., 1988, ACTA GEOLOGICA HUNGA, V31, P19; Jocha-Edelenyi E., 1996, BASIC LITHOSTRATIGRA, P61; Knauer J, 1992, PALYNOSTRATIGRAPHIC, P463; Kocsis L, 2009, PALAEOGEOGR PALAEOCL, V280, P532, DOI 10.1016/j.palaeo.2009.07.009; Lindgren J, 2005, J PALEONTOL, V79, P763, DOI 10.1666/0022-3360(2005)079[0763:HSASMW]2.0.CO;2; Lindgren J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011998; Lingham-Soliar T, 2002, LETHAIA, V35, P187, DOI 10.1080/002411602320184033; LINGHAMSOLIAR T, 1991, PALAEONTOLOGY, V34, P653; Makadi Laszlo, 2006, Acta Geologica Hungarica, V49, P373, DOI 10.1556/AGeol.49.2006.4.5; Makadi Laszlo, 2006, Foldtani Kozlony, V136, P487; Mertens R, 1942, ABHANDLUNGEN SENCKEN, V465, P117; Norell M., 1992, AM MUS NOVIT, V3045, P1; Osi A, 2009, PALAEONTOL Z, V83, P227, DOI 10.1007/s12542-009-0017-5; Oppel M., 1811, ORDNUNGEN FAMILIEN G, p[i, 1], DOI DOI 10.5962/BHL.TITLE.4911; Osi A, 2005, ACTA PALAEONTOL POL, V50, P777; Osi A, 2005, J VERTEBR PALEONTOL, V25, P370, DOI 10.1671/0272-4634(2005)025[0370:HTANAD]2.0.CO;2; Osi A, 2009, CRETACEOUS SEDIMENTS, P51; Osi A, 2007, NEUES JAHRB GEOL P-A, V243, P169, DOI 10.1127/0077-7749/2007/0243-0169; Osi Attila, 2012, P532; Osi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044318; Osi A, 2010, CRETACEOUS RES, V31, P304, DOI 10.1016/j.cretres.2010.01.001; Osi A, 2010, NATURE, V465, P466, DOI 10.1038/nature09019; Paramo Maria Euridice, 1994, Revista de la Academia Colombiana de Ciencias Exactas Fisicas y Naturales, V19, P63; Paramo-Fonseca Maria E., 2000, Historical Biology, V14, P121; Pianka E.R., 2003, LIZARDS WINDOWS EVOL; Polcyn MJ, 2005, NETH J GEOSCI, V84, P321, DOI 10.1017/S0016774600021107; Rabi M, 2012, GEOL MAG, V149, P662, DOI 10.1017/S0016756811000756; Rage J.-C., 1984, ENCY PALEOHERPETOLOG; Russell D. A., 1967, Bulletin of the Peabody Museum of Natural History, V23, P1; Swofford D.L., 1999, PAUP PHYLOGENETIC AN; Szantner F., 1984, FOLDTANI KOZLONY, V114, P19; Szentesi Z, 2010, NEUES JAHRB GEOL P-A, V256, P291, DOI 10.1127/0077-7749/2010/0054; Tuba Gy, 2006, FOLDTANI KOZLONY, V136, P1	58	49	54	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51781	10.1371/journal.pone.0051781	http://dx.doi.org/10.1371/journal.pone.0051781			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284766	gold, Green Published, Green Accepted			2022-12-27	WOS:000312694300043
J	Oonincx, DGAB; de Boer, IJM				Oonincx, Dennis G. A. B.; de Boer, Imke J. M.			Environmental Impact of the Production of Mealworms as a Protein Source for Humans - A Life Cycle Assessment	PLOS ONE			English	Article							LIVESTOCK PRODUCTION; NUTRIENT COMPOSITION; CLIMATE-CHANGE; FOOD; INSECTS; ENERGY	The demand for animal protein is expected to rise by 70-80% between 2012 and 2050, while the current animal production sector already causes major environmental degradation. Edible insects are suggested as a more sustainable source of animal protein. However, few experimental data regarding environmental impact of insect production are available. Therefore, a lifecycle assessment for mealworm production was conducted, in which greenhouse gas production, energy use and land use were quantified and compared to conventional sources of animal protein. Production of one kg of edible protein from milk, chicken, pork or beef result in higher greenhouse gas emissions, require similar amounts of energy and require much more land. This study demonstrates that mealworms should be considered a more sustainable source of edible protein.	[Oonincx, Dennis G. A. B.] Wageningen Univ, Dept Plant Sci, Wageningen, Netherlands; [de Boer, Imke J. M.] Wageningen Univ, Anim Dept Anim Sci, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Oonincx, DGAB (corresponding author), Wageningen Univ, Dept Plant Sci, Wageningen, Netherlands.	dennis.oonincx@wur.nl	de Boer, Imke/P-7107-2014	de Boer, Imke/0000-0002-0675-7528; Oonincx, Dennis/0000-0002-6728-4859	Wageningen University, Wageningen, The Netherlands	Wageningen University, Wageningen, The Netherlands(Netherlands Government)	This study was directly funded by Wageningen University, Wageningen, The Netherlands (www.wur.nl) as part of a PhD program. Wageningen University had no other role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, than can be expected with the academic supervision of a PhD candidate.	Barker D, 1998, ZOO BIOL, V17, P123, DOI 10.1002/(SICI)1098-2361(1998)17:2&lt;123::AID-ZOO7&gt;3.0.CO;2-B; Bernard JB., 1997, NUTR ADVIS GR HDB, V25, P7; Carlsson-Kanyama A, 1998, FOOD POLICY, V23, P277, DOI 10.1016/S0306-9192(98)00037-2; de Vries M, 2010, LIVEST SCI, V128, P1, DOI 10.1016/j.livsci.2009.11.007; DeFoliart GR, 1997, ECOL FOOD NUTR, V36, P109, DOI 10.1080/03670244.1997.9991510; Ecoinvent Inventories SCfLC, 2004, EC DAT V1 1; FAO, 2007, MEAT PROC TECHN SMAL; Finke MD, 2002, ZOO BIOL, V21, P269, DOI 10.1002/zoo.10031; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Friedrich U., 2004, BREEDING FOOD ANIMAL; Godfray HCJ, 2011, SCIENCE, V331, P1013, DOI 10.1126/science.1202899; Graham-Rowe D, 2011, NATURE, V474, pS6, DOI 10.1038/474S06a; Guinee J, 2001, INT J LIFE CYCLE ASS, V6, P255, DOI 10.1007/BF02978784; IPCC, 2007, CLIM CHANG 2007 PHYS; Luske B., 2009, MILIEUEFFECTEN DIERL; McMichael AJ, 2007, LANCET, V370, P1253, DOI 10.1016/S0140-6736(07)61256-2; Meijer-Rochow VB, 1975, SEARCH, V6, P261; Mercer CWL, 1997, ECOL FOOD NUTR, V36, P151, DOI 10.1080/03670244.1997.9991512; Oonincx DGAB, 2010, COMP BIOCHEM PHYS B, V156, P122, DOI 10.1016/j.cbpb.2010.02.008; Oonincx DGAB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014445; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Pelletier N, 2010, P NATL ACAD SCI USA, V107, P18371, DOI 10.1073/pnas.1004659107; Piao SL, 2009, NATURE, V458, P1009, DOI 10.1038/nature07944; Ramos-Elorduy J, 2004, ECOLOGICAL IMPLICATIONS OF MINLIVESTOCK: POTENTIAL OF INSECTS RODENTS FROGS AND SNAILS, P263; Smil V, 2002, ENZYME MICROB TECH, V30, P305, DOI 10.1016/S0141-0229(01)00504-X; Steinfeld H., 2012, EXPL WORKSH SUST PRO; Steinfeld H., 2006, LIVESTOCKS LONG SHAD, DOI [10.1890/1540-9295(2007)5[4:D]2.0.CO;2, DOI 10.1890/1540-9295(2007)5[4:D]2.0.CO;2]; Steinfeld H, 2010, P NATL ACAD SCI USA, V107, P18237, DOI 10.1073/pnas.1012541107; Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970; van Huis A., 2003, Insect Science and its Application, V23, P163; Wilkinson JM, 2011, ANIMAL, V5, P1014, DOI 10.1017/S175173111100005X; Wise M, 2009, SCIENCE, V324, P1183, DOI 10.1126/science.1168475; WUR-Lifestock Research, 2012, LCI DAT CALC TOOL FE	33	373	385	11	259	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51145	10.1371/journal.pone.0051145	http://dx.doi.org/10.1371/journal.pone.0051145			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284661	Green Published, Green Submitted, gold			2022-12-27	WOS:000312694300014
J	Patnaik, BB; Kim, DH; Oh, SH; Song, YS; Nguyen, DMC; Kim, JS; Jung, WJ; Saha, AK; Bindroo, BB; Han, YS				Patnaik, Bharat Bhusan; Kim, Dong Hyun; Oh, Seung Han; Song, Yong-Su; Nguyen Dang Minh Chanh; Kim, Jong Sun; Jung, Woo-Jin; Saha, Atul Kumar; Bindroo, Bharat Bhushan; Han, Yeon Soo			Molecular Cloning and Characterization of Novel Morus alba Germin-Like Protein Gene Which Encodes for a Silkworm Gut Digestion-Resistant Antimicrobial Protein	PLOS ONE			English	Article							RED FLUORESCENT PROTEIN; FUNCTIONALLY DIVERSE SUPERFAMILY; SWISS-MODEL REPOSITORY; SEED STORAGE PROTEINS; BOMBYX-MORI; OXALATE OXIDASE; ANTIVIRAL SUBSTANCE; SIGNAL PEPTIDES; PREDICTION; PURIFICATION	Background: Silkworm fecal matter is considered one of the richest sources of antimicrobial and antiviral protein (substances) and such economically feasible and eco-friendly proteins acting as secondary metabolites from the insect system can be explored for their practical utility in conferring broad spectrum disease resistance against pathogenic microbial specimens. Methodology/Principal Findings: Silkworm fecal matter extracts prepared in 0.02 M phosphate buffer saline (pH 7.4), at a temperature of 60 degrees C was subjected to 40% saturated ammonium sulphate precipitation and purified by gel-filtration chromatography (GFC). SDS-PAGE under denaturing conditions showed a single band at about 21.5 kDa. The peak fraction, thus obtained by GFC wastested for homogeneityusing C18reverse-phase high performance liquid chromatography (HPLC). The activity of the purified protein was tested against selected Gram +/- bacteria and phytopathogenic Fusarium species with concentration-dependent inhibitionrelationship. The purified bioactive protein was subjected to matrix-assisted laser desorption and ionization-time of flight mass spectrometry (MALDI-TOF-MS) and N-terminal sequencing by Edman degradation towards its identification. The N-terminal first 18 amino acid sequence following the predicted signal peptide showed homology to plant germin-like proteins (Glp). In order to characterize the full-length gene sequence in detail, the partial cDNA was cloned and sequenced using degenerate primers, followed by 5'- and 3'-rapid amplification of cDNA ends (RACE-PCR). The full-length cDNA sequence composed of 630 bp encoding 209 amino acids and corresponded to germin-like proteins (Glps) involved in plant development and defense. Conclusions/Significance: The study reports, characterization of novel Glpbelonging to subfamily 3 from M. alba by the purification of mature active protein from silkworm fecal matter. The N-terminal amino acid sequence of the purified protein was found similar to the deduced amino acid sequence (without the transit peptide sequence) of the full length cDNA from M. alba.	[Patnaik, Bharat Bhusan; Kim, Dong Hyun; Oh, Seung Han; Han, Yeon Soo] Chonnam Natl Univ, Div Plant Biotechnol, Coll Agr & Life Sci, Kwangju, South Korea; [Song, Yong-Su; Nguyen Dang Minh Chanh; Jung, Woo-Jin] Chonnam Natl Univ, Inst Environm Friendly Agr, Div Appl Biosci & Biotechnol, Kwangju, South Korea; [Kim, Jong Sun] Jeonnam Agr Res & Extens Serv, Inst Insect & Sericultural Res, Jangseong, South Korea; [Saha, Atul Kumar; Bindroo, Bharat Bhushan] Cent Silk Board Govt India, Cent Sericultural Res & Training Inst, Berhampur, W Bengal, India	Chonnam National University; Chonnam National University	Patnaik, BB (corresponding author), Chonnam Natl Univ, Div Plant Biotechnol, Coll Agr & Life Sci, Kwangju, South Korea.	drbharatbhusan4@gmail.com; hanys@chonnam.ac.kr	Patnaik, Bharat Bhusan/H-2973-2019; Patnaik, Bharat Bhusan/CAG-0338-2022	Patnaik, Bharat Bhusan/0000-0003-1383-6758; Patnaik, Bharat Bhusan/0000-0003-1383-6758; Lee, Yongseok/0000-0002-8687-589X	Korea Foundation for Advanced Studies through International Scholar Exchange Fellowship; Next-Generation Bio Green 21 Program of Rural Development Administration, Republic of Korea [PJ008186032012]	Korea Foundation for Advanced Studies through International Scholar Exchange Fellowship; Next-Generation Bio Green 21 Program of Rural Development Administration, Republic of Korea	The authors would like to acknowledge the following funding organizations for their support: 1) Korea Foundation for Advanced Studies through International Scholar Exchange Fellowship to first author (www.kfas.co.kr); 2) Next-Generation Bio Green 21 Program (No. PJ008186032012) of Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIZAWA K, 1962, J INSECT PATHOL, V4, P72; Amit Kumar, 2005, Pakistan Journal of Biological Sciences, V8, P190, DOI 10.3923/pjbs.2005.190.193; Bernier F, 2001, PLANT PHYSIOL BIOCH, V39, P545, DOI 10.1016/S0981-9428(01)01285-2; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROEKAERT WF, 1990, FEMS MICROBIOL LETT, V69, P55, DOI [10.1111/j.1574-6968.1990.tb04174.x, 10.1016/S0378-1097(98)00477-7]; Carter C, 2000, J BIOL CHEM, V275, P36726, DOI 10.1074/jbc.M006461200; Chen H, 2007, PLANT PHYSIOL, V143, P1954, DOI 10.1104/pp.106.095588; Dae L, 2002, J PHOTOCHEM PHOTOBIO, V67, P149; Dunwell JM, 1998, J MOL EVOL, V46, P147, DOI 10.1007/PL00006289; El-Sharkawy I, 2010, J EXP BOT, V61, P1761, DOI 10.1093/jxb/erq043; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Evdokimov AG, 2001, J MOL BIOL, V305, P891, DOI 10.1006/jmbi.2000.4202; FINNEY D J, 1971, P333; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Godfrey D, 2007, MOL PLANT MICROBE IN, V20, P1112, DOI 10.1094/MPMI-20-9-1112; Harish BG, 2007, INT J BIOMED PHARM S, V1, P65; HAYASHIYA K, 1968, Japanese Journal of Applied Entomology and Zoology, V12, P189; HAYASHIYA K, 1978, ENTOMOL EXP APPL, V24, P428, DOI 10.1007/BF02385095; HEINTZEN C, 1994, PLANT PHYSIOL, V106, P905, DOI 10.1104/pp.106.3.905; Hiraki A, 2000, MICROBIOL IMMUNOL, V44, P669, DOI 10.1111/j.1348-0421.2000.tb02548.x; Hiraki A, 1997, BIOL PHARM BULL, V20, P547, DOI 10.1248/bpb.20.547; HIRAYAMA E, 1993, CELL STRUCT FUNCT, V18, P161, DOI 10.1247/csf.18.161; HOU RF, 1986, ENTOMOL EXP APPL, V42, P3, DOI 10.1007/BF00186151; Hwang JH, 2007, J MED FOOD, V10, P467, DOI 10.1089/jmf.2006.165; IKAI A, 1980, J BIOCHEM-TOKYO, V88, P1895; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Khuri S, 2001, MOL BIOL EVOL, V18, P593, DOI 10.1093/oxfordjournals.molbev.a003840; Kiemer L, 2005, BIOINFORMATICS, V21, P1269, DOI 10.1093/bioinformatics/bti130; Kim HJ, 2004, PLANTA, V218, P516, DOI 10.1007/s00425-003-1133-1; Knecht K, 2010, MOL PLANT MICROBE IN, V23, P446, DOI 10.1094/MPMI-23-4-0446; Kopp J, 2004, NUCLEIC ACIDS RES, V32, pD230, DOI 10.1093/nar/gkh008; Kopp J, 2006, NUCLEIC ACIDS RES, V34, pD315, DOI 10.1093/nar/gkj056; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Laboure AM, 1999, FEBS LETT, V442, P123, DOI 10.1016/S0014-5793(98)01634-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lakkappan V. J., 2007, Journal of Entomological Research, V31, P251; Lane BG, 2002, IUBMB LIFE, V53, P67, DOI 10.1080/15216540211474; Le Deunff E, 2004, PLANT J, V38, P421, DOI 10.1111/j.1365-313X.2004.02056.x; LEE M, 1990, Yonsei Medical Journal, V31, P339; Leon-Galvan F, 2011, INT J MOL SCI, V12, P7301, DOI 10.3390/ijms12117301; Lim DS, 2002, J PHOTOCH PHOTOBIO B, V67, P149, DOI 10.1016/S1011-1344(02)00318-4; Lippert D, 2007, PROTEOMICS, V7, P248, DOI 10.1002/pmic.200600525; Lou YG, 2006, PLANT PHYSIOL, V140, P1126, DOI 10.1104/PP.105.073700; Mahmood T, 2010, AFR J BIOTECHNOL, V9, P1871; Manosalva PM, 2009, PLANT PHYSIOL, V149, P286, DOI 10.1104/pp.108.128348; Markert Y, 2001, PROTEIN ENG, V14, P791, DOI 10.1093/protein/14.10.791; Matti KM, 2009, PHOTOCH PHOTOBIO SCI, V8, P1364, DOI 10.1039/b904102h; Matti KM, 2010, BIOL PHARM BULL, V33, P1143, DOI 10.1248/bpb.33.1143; Membre N, 2000, PLANTA, V211, P345, DOI 10.1007/s004250000277; MUKAI JI, 1969, AGR BIOL CHEM TOKYO, V33, P125, DOI 10.1080/00021369.1969.10859288; Nakazawa H, 2004, VIROLOGY, V321, P154, DOI 10.1016/j.virol.2003.12.011; Neelagund S. E., 2007, Caspian Journal of Environmental Sciences, V5, P77; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; NISHIKAWA K, 1986, BIOCHIM BIOPHYS ACTA, V871, P45, DOI 10.1016/0167-4838(86)90131-7; Ohmiya A, 1998, PLANT CELL PHYSIOL, V39, P492, DOI 10.1093/oxfordjournals.pcp.a029396; OHMIYA A, 1993, PLANT CELL PHYSIOL, V34, P177; Ono M, 1996, PLANT CELL PHYSIOL, V37, P855, DOI 10.1093/oxfordjournals.pcp.a029022; Pan HY, 2007, BIOCHEM BIOPH RES CO, V356, P925, DOI 10.1016/j.bbrc.2007.03.097; Pandian GN, 2010, J MEMBRANE BIOL, V237, P125, DOI 10.1007/s00232-010-9314-x; Park CJ, 2004, PLANT J, V37, P186, DOI 10.1046/j.1365-313X.2003.01951.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ponnuvel KM, 2003, J VIROL, V77, P10725, DOI 10.1128/JVI.77.19.10725-10729.2003; Priyadharshini P., 2008, Current Biotica, V2, P181; Raghavendra R, 2012, APPL BIOCHEM BIOTECH, V167, P1002, DOI 10.1007/s12010-012-9588-9; Raghavendra R, 2009, INT J BIOMED PHARM S, V3, P74; Ravi Kumar S, 2009, INT J MED SCI, V1, P184; Smeath PHA, 1973, NUMERICAL TAXONOMY; Sobhani A, 2004, ACTA MED IRANICA, V42, P46; Staiger D, 1999, PLANT MOL BIOL, V40, P873, DOI 10.1023/A:1006278030024; Sunagar SG, 2008, PHOTOCHEM PHOTOBIOL, V84, P1440, DOI 10.1111/j.1751-1097.2008.00360.x; Suzuki K, 1936, B KYOTO SERICULT COL, V1, P225; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; UCHIDA Y, 1984, J INVERTEBR PATHOL, V43, P182, DOI 10.1016/0022-2011(84)90136-8; Vallelian-Bindschedler L, 1998, PLANT MOL BIOL, V37, P297, DOI 10.1023/A:1005982715972; Woo EJ, 1998, FEBS LETT, V437, P87, DOI 10.1016/S0014-5793(98)01203-4; Woo EJ, 2000, NAT STRUCT BIOL, V7, P1036; Xu JG, 2007, PESTIC BIOCHEM PHYS, V87, P220, DOI 10.1016/j.pestbp.2006.07.013; Yan BX, 1997, J BIOL CHEM, V272, P3190, DOI 10.1074/jbc.272.6.3190; Zhang ChuanXi, 2008, Entomological Research, V38, pS38, DOI 10.1111/j.1748-5967.2008.00173.x; Zimmermann G, 2006, PLANT PHYSIOL, V142, P181, DOI 10.1104/pp.106.083824	84	6	7	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e50900	10.1371/journal.pone.0050900	http://dx.doi.org/10.1371/journal.pone.0050900			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284650	Green Published, Green Submitted, gold			2022-12-27	WOS:000312694300013
J	Qi, M; Chen, J; Sun, XX; Deng, XW; Niu, Y; Xie, P				Qi, Min; Chen, Jun; Sun, Xiaoxue; Deng, Xuwei; Niu, Yuan; Xie, Ping			Development of Models for Predicting the Predominant Taste and Odor Compounds in Taihu Lake, China	PLOS ONE			English	Article							PURGE-AND-TRAP; SOLID-PHASE MICROEXTRACTION; VOLATILE ORGANIC-COMPOUNDS; EARTHY-MUSTY ODORANTS; FENG-SHEN RESERVOIR; DRINKING-WATER; GAS-CHROMATOGRAPHY; MASS-SPECTROMETRY; SOUTH TAIWAN; BY-PRODUCTS	Taste and odor (T&O) problems, which have adversely affected the quality of water supplied to millions of residents, have repeatedly occurred in Taihu Lake (e. g., a serious odor accident occurred in 2007). Because these accidents are difficult for water resource managers to forecast in a timely manner, there is an urgent need to develop optimum models to predict these T&O problems. For this purpose, various biotic and abiotic environmental parameters were monitored monthly for one year at 30 sites across Taihu Lake. This is the first investigation of this huge lake to sample T&O compounds at the whole-lake level. Certain phytoplankton taxa were important variables in the models; for instance, the concentrations of the particle-bound 2-methylisoborneol (p-MIB) were correlated with the presence of Oscillatoria, whereas those of the p-beta-cyclocitral and p-beta-ionone were correlated with Microcystis levels. Abiotic factors such as nitrogen (TN, TDN, NO3-N, and NO2-N), pH, DO, COND, COD and Chl-a also contributed significantly to the T&O predictive models. The dissolved (d) T&O compounds were related to both the algal biomass and to certain abiotic environmental factors, whereas the particle-bound (p) T&O compounds were more strongly related to the algal presence. We also tested the validity of these models using an independent data set that was previously collected from Taihu Lake in 2008. In comparing the concentrations of the T&O compounds observed in 2008 with those concentrations predicted from our models, we found that most of the predicted data points fell within the 90% confidence intervals of the observed values. This result supported the validity of these models in the studied system. These models, basing on easily collected environmental data, will be of practical value to the water resource managers of Taihu Lake for evaluating the probability of T&O accidents.	[Qi, Min; Chen, Jun; Sun, Xiaoxue; Deng, Xuwei; Niu, Yuan; Xie, Ping] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol China, Donghu Expt Stn Lake Ecosyst, Wuhan, Hubei, Peoples R China; [Qi, Min; Sun, Xiaoxue] Huazhong Agr Univ, Coll Fisheries, Wuhan, Hubei, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Huazhong Agricultural University	Xie, P (corresponding author), Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol China, Donghu Expt Stn Lake Ecosyst, Wuhan, Hubei, Peoples R China.	xieping@ihb.ac.cn	Xie, Ping/AAL-7532-2020		National Basic Research Program of China (973 Program) [2008CB418101]; State Key Laboratory of Freshwater Ecology and Biotechnology [2008FBZ01]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); State Key Laboratory of Freshwater Ecology and Biotechnology(Chinese Academy of Sciences)	This study was jointly supported by the National Basic Research Program of China (973 Program) (2008CB418101) [http://www.973.gov.cn/AreaAppl.aspx] and State Key Laboratory of Freshwater Ecology and Biotechnology (2008FBZ01) [http://eastlake.ihb.ac.cn/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREAE MO, 1986, ROLE AIR SEA EXCHANG, P331, DOI DOI 10.1007/978-94-009-4738-2_14; BAUMANN FJ, 1974, ANAL CHEM, V46, P1336, DOI 10.1021/ac60345a039; Carmichael WW, 1997, ADV BOT RES, V27, P211; Chang DW, 2011, J HAZARD MATER, V185, P1214, DOI 10.1016/j.jhazmat.2010.10.033; Chen J, 2010, SCI TOTAL ENVIRON, V409, P314, DOI 10.1016/j.scitotenv.2010.10.010; Christensen VG, 2006, 2006509543 US GEOL S, P43; Deng XW, 2012, J CHROMATOGR A, V1219, P75, DOI 10.1016/j.chroma.2011.11.031; Deng XW, 2011, J CHROMATOGR A, V1218, P3791, DOI 10.1016/j.chroma.2011.04.041; Dzialowski AR, 2009, WATER RES, V43, P2829, DOI 10.1016/j.watres.2009.04.001; Filipiak W, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-113; GERBER NN, 1977, J CHEM ECOL, V3, P475, DOI 10.1007/BF00988190; Ginzburg B, 1998, ENVIRON SCI TECHNOL, V32, P2130, DOI 10.1021/es9709076; Grimm CC, 2001, J AGR FOOD CHEM, V49, P245, DOI 10.1021/jf0008902; Guo L, 2007, SCIENCE, V317, P1166, DOI 10.1126/science.317.5842.1166; Harada KI, 2009, J CHEM ECOL, V35, P1295, DOI 10.1007/s10886-009-9706-5; Huang WJ, 2007, SCI TOTAL ENVIRON, V377, P214, DOI 10.1016/j.scitotenv.2007.01.075; HWANG CJ, 1984, ENVIRON SCI TECHNOL, V18, P535, DOI 10.1021/es00125a010; Ikawa M, 2001, HYDROBIOLOGIA, V443, P19, DOI 10.1023/A:1017535801766; Juttner F, 1984, APPL ENVIRON MICROB, V47, P4814; KARNES HT, 1991, PHARMACEUT RES, V8, P421, DOI 10.1023/A:1015882607690; Lara-Gonzalo A, 2008, TALANTA, V74, P1455, DOI 10.1016/j.talanta.2007.09.036; Li L, 2007, WATER SCI TECHNOL, V55, P43, DOI 10.2166/wst.2007.160; Li Lin, 2007, Acta Hydrobiologica Sinica, V31, P112; [李林 LI Lin], 2007, [中国给水排水, China Water & Wastewater], V23, P102; Lin TF, 2002, SCI TOTAL ENVIRON, V289, P225, DOI 10.1016/S0048-9697(01)01049-X; Lloyd SW, 1998, WATER RES, V32, P2140, DOI 10.1016/S0043-1354(97)00444-2; LORENZEN CJ, 1967, LIMNOL OCEANOGR, V12, P343, DOI 10.4319/lo.1967.12.2.0343; Ma K, 2012, J SEP SCI, V35, P1494, DOI 10.1002/jssc.201200029; Mau DP, 2004, 2004504795 US GEOL S, P95; MCGUIRE MJ, 1981, J AM WATER WORKS ASS, V73, P530; Montenegro P, 2009, J WATER SUPPLY RES T, V58, P257, DOI 10.2166/aqua.2009.089; Nakanishi M, 1999, WATER SCI TECHNOL, V40, P179, DOI 10.2166/wst.1999.0293; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Paerl HW, 2011, WATER RES, V45, P1973, DOI 10.1016/j.watres.2010.09.018; Peter A, 2009, WATER RES, V43, P2191, DOI 10.1016/j.watres.2009.02.016; Piriou P, 2009, J WATER SUPPLY RES T, V58, P532, DOI 10.2166/aqua.2009.124; Qin BQ, 2007, HYDROBIOLOGIA, V581, P3, DOI 10.1007/s10750-006-0521-5; SAS Institute, 2008, SAS STAT US GUID; Schellin M, 2006, J CHROMATOGR A, V1103, P211, DOI 10.1016/j.chroma.2005.11.010; Shen PP, 2003, ENVIRON INT, V29, P641, DOI 10.1016/S0160-4120(03)00047-3; Smith JL, 2008, AQUACULTURE, V280, P5, DOI 10.1016/j.aquaculture.2008.05.007; Smith VH, 2002, LAKE RESERV MANAGE, V18, P319, DOI 10.1080/07438140209353938; Sommerburg O, 2003, FREE RADICAL BIO MED, V35, P1480, DOI 10.1016/j.freeradbiomed.2003.08.020; STEFELS J, 1993, MAR ECOL PROG SER, V97, P11, DOI 10.3354/meps097011; Strickland J.D.H., 1968, PRACTICAL HDB SEAWAT, P311; Suffet IH, 1999, WATER SCI TECHNOL, V40, P1; SUGIURA N, 1994, HYDROBIOLOGIA, V288, P57, DOI 10.1007/BF00006806; SUGIURA N, 1987, ENVIRON TECHNOL LETT, V8, P95, DOI 10.1080/09593338709384467; Sugiura N, 1998, WATER RES, V32, P3549, DOI 10.1016/S0043-1354(98)00153-5; Sugiura Norio, 2004, Lakes & Reservoirs Research and Management, V9, P195, DOI 10.1111/j.1440-1770.2004.00246.x; Tao M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032020; Tucker Craig S., 2000, Reviews in Fisheries Science, V8, P45, DOI 10.1080/10641260091129170; Tung SC, 2006, WA SCI TECHNOL, V6, P55, DOI 10.2166/ws.2006.050; Tung SC, 2004, WATER SCI TECHNOL, V49, P281, DOI 10.2166/wst.2004.0587; Tung SC, 2008, ENVIRON MONIT ASSESS, V145, P407, DOI 10.1007/s10661-007-0049-9; Utermohl H, 1958, MITT INT VER LIMNOL, V9, P1; Watson SB, 2007, WATER SCI TECHNOL, V55, P1, DOI 10.2166/wst.2007.155; Watson SB, 2003, PHYCOLOGIA, V42, P332, DOI 10.2216/i0031-8884-42-4-332.1; Westerhoff P, 2005, WATER RES, V39, P4899, DOI 10.1016/j.watres.2005.06.038; Yang Liu, 2011, Hupo Kexue, V23, P605; Yang M, 2008, SCIENCE, V319, P158, DOI 10.1126/science.319.5860.158a; Ye C, 2011, J ENVIRON SCI, V23, P222, DOI 10.1016/S1001-0742(10)60396-8; Zhang KJ, 2012, SEP PURIF TECHNOL, V92, P93, DOI 10.1016/j.seppur.2011.10.031; Zimba PV, 2003, AQUACULTURE, V218, P81, DOI 10.1016/S0044-8486(02)00519-7	64	18	24	3	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51976	10.1371/journal.pone.0051976	http://dx.doi.org/10.1371/journal.pone.0051976			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284835	gold, Green Published, Green Submitted			2022-12-27	WOS:000312694300066
J	Maresca, B; Cigliano, L; Spagnuolo, MS; Dal Piaz, F; Corsaro, MM; Balato, N; Nino, M; Balato, A; Ayala, F; Abrescia, P				Maresca, Bernardetta; Cigliano, Luisa; Spagnuolo, Maria Stefania; Dal Piaz, Fabrizio; Corsaro, Maria M.; Balato, Nicola; Nino, Massimiliano; Balato, Anna; Ayala, Fabio; Abrescia, Paolo			Differences between the Glycosylation Patterns of Haptoglobin Isolated from Skin Scales and Plasma of Psoriatic Patients	PLOS ONE			English	Article							CHOLESTEROL ACYLTRANSFERASE ACTIVITY; ACUTE-PHASE PROTEINS; SERUM GLYCOPROTEINS; OVARIAN-CANCER; EXPRESSION; GALECTIN-3; BINDING; CELLS; DISEASE; SITE	Improved diagnosis of psoriasis, by new biomarkers, is required for evaluating the progression rate of the disease and the response to treatment. Haptoglobin (Hpt), a glycoprotein secreted by hepatocytes and other types of cells including keratinocytes, was found with glycan changes in psoriasis and other diseases. We previously reported that Hpt isolated from plasma of psoriatic patients is more fucosylated than Hpt of healthy subjects. The aim of this study was to compare the glycosylation pattern of Hpt isolated from skin scales or plasma of patients with psoriasis with that of Hpt from cornified epidermal layer or plasma of healthy subjects. High performance liquid chromatography analysis of the glycans isolated from the protein backbone revealed that glycan patterns from skin and plasma of patients were similar, and mostly displayed quantitative rather than qualitative differences from normal pattern. Biotin-labeled lectins were used to evaluate quantitative differences in the glycoforms of Hpt from plasma and psoriatic skin scales. Hpt from skin and plasma of patients showed more fucosylated and branched glycans than Hpt from plasma of healthy subjects. Tryptic glycopeptides of Hpt were also analyzed by mass spectrometry, and a decreased amount of sialylated glycan chains was found in glycopeptides of skin Hpt, as compared with Hpt from plasma. High levels of glycans with fucosylated and tetra-antennary chains were detected on the peptide NLFLNHSENATAK from Hpt of psoriatic patients. Our data demonstrate that specific changes in glycan structures of Hpt, such as enhanced glycan branching and fucose content, are associated with psoriasis, and that differences between circulating and skin Hpt do exist. A lower extent of glycan fucosylation and branching was found in Hpt from plasma of patients in disease remission. Altered glycoforms might reflect changes of Hpt function in the skin, and could be used as markers of the disease.	[Maresca, Bernardetta; Cigliano, Luisa; Abrescia, Paolo] Univ Naples Federico II, Dipartimento Sci Biol, Naples, Italy; [Spagnuolo, Maria Stefania] CNR, Ist Sistema Prod Anim Ambiente Mediterraneo, I-80125 Naples, Italy; [Dal Piaz, Fabrizio] Univ Salerno, Dipartimento Sci Farmaceut & Biomed, I-84100 Salerno, Italy; [Corsaro, Maria M.] Complesso Univ MS Angelo, Dipartimento Chim Organ & Biochim, Univ Napoli Federico II, Naples, Italy; [Balato, Nicola; Nino, Massimiliano; Balato, Anna; Ayala, Fabio] Univ Naples Federico II, Dipartimento Patol Sistemat, Sez Dermatol, Naples, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto Per Il Sistema Produzione Animale In Ambiente Mediterraneo (ISPAAM-CNR); University of Salerno; University of Naples Federico II; University of Naples Federico II	Cigliano, L (corresponding author), Univ Naples Federico II, Dipartimento Sci Biol, Naples, Italy.	luisa.cigliano@unina.it	Dal Piaz, Fabrizio/D-1843-2010; Cigliano, Luisa/AEL-3260-2022; Corsaro, Maria Michela/T-6190-2019; Spagnuolo, Maria Stefania/B-7661-2015; Balato, Anna/K-5655-2016	Dal Piaz, Fabrizio/0000-0002-8643-5018; Corsaro, Maria Michela/0000-0002-6834-8682; Spagnuolo, Maria Stefania/0000-0001-6980-0661; Balato, Anna/0000-0001-5485-0172; Ayala, Fabio/0000-0002-2596-1268; Balato, Nicola/0000-0003-4871-2413	University of Naples Federico II [Ric. Dip. 10112/2010]	University of Naples Federico II	This work was supported by a research grant from the University of Naples Federico II (Ric. Dip. 10112/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almkvist J, 2002, GLYCOCONJUGATE J, V19, P575, DOI 10.1023/B:GLYC.0000014088.21242.e0; Azuma Y, 2000, CLIN CHIM ACTA, V294, P93, DOI 10.1016/S0009-8981(99)00248-X; BOWMAN BH, 1982, ADV HUM GENET, V12, P189; Bresalier RS, 2004, GASTROENTEROLOGY, V127, P741, DOI 10.1053/j.gastro.2004.06.016; Carlsson MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026560; Cederfur C, 2008, GLYCOBIOLOGY, V18, P384, DOI 10.1093/glycob/cwn015; Chen IJ, 2007, J BIOL CHEM, V282, P35361, DOI 10.1074/jbc.M706923200; Cigliano L, 2008, J EUR ACAD DERMATOL, V22, P417, DOI 10.1111/j.1468-3083.2007.02444.x; Cigliano L, 2003, ARCH BIOCHEM BIOPHYS, V416, P227, DOI 10.1016/S0003-9861(03)00318-7; Cigliano L, 2009, FEBS J, V276, P6158, DOI 10.1111/j.1742-4658.2009.07319.x; Comunale MA, 2006, J PROTEOME RES, V5, P308, DOI 10.1021/pr050328x; DArmiento J, 1997, GENE, V195, P19, DOI 10.1016/S0378-1119(97)00123-6; de Kleijn DPV, 2002, FASEB J, V16, P1123, DOI 10.1096/fj.02-0019fje; DOBROTINA NA, 1977, VOP MED KHIM, V23, P215; Dobryszycka W., 1997, J CLIN CHEM CLIN BIO, V35, P647; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Ferens-Sieczkowska M, 1999, GLYCOCONJUGATE J, V16, P573, DOI 10.1023/A:1007078114674; Fujimura T, 2008, INT J CANCER, V122, P39, DOI 10.1002/ijc.22958; Fukaya Y, 2008, J BIOL CHEM, V283, P18573, DOI 10.1074/jbc.M803115200; HANASAKI K, 1995, J BIOL CHEM, V270, P7543, DOI 10.1074/jbc.270.13.7543; He ZC, 2006, BIOCHEM BIOPH RES CO, V343, P496, DOI 10.1016/j.bbrc.2006.03.007; Ideo H, 2005, J BIOL CHEM, V280, P4730, DOI 10.1074/jbc.M410362200; Ishibashi Y, 2005, GLYCOCONJUGATE J, V22, P53, DOI 10.1007/s10719-005-0292-7; Kaartinen V, 1998, BIOCHIM BIOPHYS ACTA, V14, P345; KALMOVARIN N, 1991, INFLAMMATION, V15, P369, DOI 10.1007/BF00917353; Kossowska B, 2005, CLIN CHEM LAB MED, V43, P361, DOI 10.1515/CCLM.2005.066; KUROSKY A, 1980, P NATL ACAD SCI-BIOL, V77, P3388, DOI 10.1073/pnas.77.6.3388; Langlois MR, 1996, CLIN CHEM, V42, P1589; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Lim SK, 1998, BLOOD, V92, P1870, DOI 10.1182/blood.V92.6.1870.418k38_1870_1877; MANN AC, 1994, CLIN CHIM ACTA, V227, P69, DOI 10.1016/0009-8981(94)90136-8; Maresca B, 2010, BIOL CHEM, V391, P1429, DOI 10.1515/BC.2010.146; Nakano M, 2008, INT J CANCER, V122, P2301, DOI 10.1002/ijc.23364; NEMANSKY M, 1995, FEBS LETT, V363, P280, DOI 10.1016/0014-5793(95)00336-8; Park SY, 2012, INT J CANCER, V130, P2366, DOI 10.1002/ijc.26288; Piva M, 2002, GLYCOCONJUGATE J, V19, P33, DOI 10.1023/A:1022580813870; Rabinovich GA, 2007, SCAND J IMMUNOL, V66, P143, DOI 10.1111/j.1365-3083.2007.01986.x; Saegusa J, 2008, J INVEST DERMATOL, V128, P2403, DOI 10.1038/jid.2008.119; Saldova R, 2007, GLYCOBIOLOGY, V17, P1344, DOI 10.1093/glycob/cwm100; Spagnuolo MS, 2011, BIOL CHEM, V392, P371, DOI 10.1515/BC.2011.033; Spagnuolo MS, 2005, J BIOL CHEM, V280, P1193, DOI 10.1074/jbc.M411390200; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; THOMPSON S, 1992, CANCER LETT, V66, P43, DOI 10.1016/0304-3835(92)90278-4; THOMPSON S, 1993, CLIN CHIM ACTA, V220, P107, DOI 10.1016/0009-8981(93)90011-R; Varki A., 2009, ESSENTIALS GLYCOBIOL, P784; WADA T, 1970, J RETICULOENDOTH SOC, V8, P185; Wang H, 2005, BRIT J DERMATOL, V153, P894, DOI 10.1111/j.1365-2133.2005.06807.x; Xie Y, 2000, J DERMATOL SCI, V24, P25, DOI 10.1016/S0923-1811(00)00078-5; Yang FM, 2003, AM J PHYSIOL-LUNG C, V284, pL402, DOI 10.1152/ajplung.00115.2002	49	12	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52040	10.1371/journal.pone.0052040	http://dx.doi.org/10.1371/journal.pone.0052040			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272204	Green Submitted, gold, Green Published			2022-12-27	WOS:000312483300050
J	Wang, YH; Li, XC; Zhu-Ge, Q; Jiang, X; Wang, WD; Fang, WP; Chen, X; Li, XH				Wang, Yu-Hua; Li, Xiao-Cheng; Zhu-Ge, Qiang; Jiang, Xin; Wang, Wei-Dong; Fang, Wan-Ping; Chen, Xuan; Li, Xing-Hui			Nitric Oxide Participates in Cold-Inhibited Camellia sinensis Pollen Germination and Tube Growth Partly via cGMP In Vitro	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; GENE-EXPRESSION; LOW-TEMPERATURE; ABIOTIC STRESS; ABSCISIC-ACID; SALT STRESS; PLANTS; TOLERANCE; TOBACCO; NO	Nitric oxide (NO) plays essential roles in many biotic and abiotic stresses in plant development procedures, including pollen tube growth. Here, effects of NO on cold stress inhibited pollen germination and tube growth in Camellia sinensis were investigated in vitro. The NO production, NO synthase (NOS)-like activity, cGMP content and proline (Pro) accumulation upon treatment with NO scavenger cPTIO, NOS inhibitor L-NNA, NO donor DEA NONOate, guanylate cyclase (GC) inhibitor ODQ or phosphodiesterase (PDE) inhibitor Viagra at 25 degrees C (control) or 4 degrees C were analyzed. Exposure to 4 degrees C for 2 h reduced pollen germination and tube growth along with increase of NOS-like activity, NO production and cGMP content in pollen tubes. DEA NONOate treatment inhibited pollen germination and tube growth in a dose-dependent manner under control and reinforced the inhibition under cold stress, during which NO production and cGMP content promoted in pollen tubes. L-NNA and cPTIO markedly reduced the generation of NO induced by cold or NO donor along with partly reverse of cold-or NO donor-inhibited pollen germination and tube growth. Furthermore, ODQ reduced the cGMP content under cold stress and NO donor treatment in pollen tubes. Meanwhile, ODQ disrupted the reinforcement of NO donor on the inhibition of pollen germination and tube growth under cold condition. Additionally, Pro accumulation of pollen tubes was reduced by ODQ compared with that receiving NO donor under cold or control condition. Effects of cPTIO and L-NNA in improving cold-treated pollen germination and pollen tube growth could be lowered by Viagra. Moreover, the inhibitory effects of cPTIO and L-NNA on Pro accumulation were partly reversed by Viagra. These data suggest that NO production from NOS-like enzyme reaction decreased the cold-responsive pollen germination, inhibited tube growth and reduced Pro accumulation, partly via cGMP signaling pathway in C. sinensis.	[Wang, Yu-Hua; Li, Xiao-Cheng; Jiang, Xin; Wang, Wei-Dong; Fang, Wan-Ping; Chen, Xuan; Li, Xing-Hui] Nanjing Agr Univ, Tea Sci Res Inst, Nanjing, Jiangsu, Peoples R China; [Zhu-Ge, Qiang] Nanjing Forestry Univ, Forest Resources & Environm Inst, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Nanjing Forestry University	Li, XH (corresponding author), Nanjing Agr Univ, Tea Sci Res Inst, Nanjing, Jiangsu, Peoples R China.	lxh@njau.edu.cn			National Natural Science Foundation of China [31000315, 30972403]; Research Fund for the Doctoral Program of Higher Education of China [20090097120049]; China Postdoctoral Science Foundation [20100481158]; Open Project of Key Laboratory of Forest Genetics and Biotechnology (Nanjing Forestry University); Ministry of Education, China [FGB200904]; Natural Science Foundation of Jiangsu Province [BK2010451]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Open Project of Key Laboratory of Forest Genetics and Biotechnology (Nanjing Forestry University); Ministry of Education, China(Ministry of Education, China); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by National Natural Science Foundation of China (31000315, 30972403, http://www.nsfc.gov.cn/Portal0/default152.htm), Research Fund for the Doctoral Program of Higher Education of China (20090097120049, http://www.moe.edu.cn/), China Postdoctoral Science Foundation (20100481158, http://www.chinapostdoctor.org.cn/V3/Program/Main.aspx), Open Project of Key Laboratory of Forest Genetics and Biotechnology (Nanjing Forestry University), Ministry of Education, China (FGB200904, http://fgbio.njfu.edu.cn/), and Natural Science Foundation of Jiangsu Province (BK2010451, http://www.jstd.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Mamun E, 2010, CELL BIOL INT, V34, P469, DOI 10.1042/CBI20090417; Bai XG, 2011, J PROTEOME RES, V10, P4349, DOI 10.1021/pr200333f; Bouchard JN, 2008, PLANT CELL PHYSIOL, V49, P641, DOI 10.1093/pcp/pcn037; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cantrel C, 2011, NEW PHYTOL, V189, P415, DOI 10.1111/j.1469-8137.2010.03500.x; Chinnusamy V, 2006, PHYSIOL PLANTARUM, V126, P52, DOI 10.1111/j.1399-3054.2006.00596.x; Corpas FJ, 2008, PLANT CELL PHYSIOL, V49, P1711, DOI 10.1093/pcp/pcn144; Corpas FJ, 2009, NEW PHYTOL, V184, P9, DOI 10.1111/j.1469-8137.2009.02989.x; Enrich MJD, 2000, ANAL BIOCHEM, V285, P105, DOI 10.1006/abio.2000.4731; Fan QJ, 2012, PLANT CELL REP, V31, P145, DOI 10.1007/s00299-011-1148-1; Gupta KJ, 2011, TRENDS PLANT SCI, V16, P160, DOI 10.1016/j.tplants.2010.11.007; Gupta KJ, 2011, NEW PHYTOL, V189, P360, DOI 10.1111/j.1469-8137.2010.03586.x; He JM, 2007, PHYSIOL PLANTARUM, V131, P273, DOI 10.1111/j.1399-3054.2007.00955.x; Hepler PK, 2001, ANNU REV CELL DEV BI, V17, P159, DOI 10.1146/annurev.cellbio.17.1.159; Huang X, 2004, PLANTA, V218, P938, DOI 10.1007/s00425-003-1178-1; Khodakovskaya M, 2006, PLANTA, V223, P1090, DOI 10.1007/s00425-005-0161-4; Lee JY, 2003, PLANT PHYSIOL, V132, P517, DOI 10.1104/pp.103.020511; Liu YJ, 2010, PLANT PHYSIOL BIOCH, V48, P936, DOI 10.1016/j.plaphy.2010.09.001; Mur LAJ, 2011, PLANT SCI, V181, P509, DOI 10.1016/j.plantsci.2011.04.003; Neill S, 2008, J EXP BOT, V59, P165, DOI 10.1093/jxb/erm293; Newton RP, 2004, PHYTOCHEMISTRY, V65, P2423, DOI 10.1016/j.phytochem.2004.07.026; Pasqualini S, 2009, NEW PHYTOL, V181, P860, DOI 10.1111/j.1469-8137.2008.02711.x; Prado AM, 2004, DEVELOPMENT, V131, P2707, DOI 10.1242/dev.01153; Prado AM, 2008, MOL PLANT, V1, P703, DOI 10.1093/mp/ssn034; Reichler SA, 2009, J EXP BOT, V60, P2129, DOI 10.1093/jxb/erp091; Ruan HH, 2004, ACTA BOT SIN, V46, P1307; Rumer S, 2012, NITRIC OXIDE-BIOL CH, V27, P123, DOI 10.1016/j.niox.2012.05.007; Rumer S, 2009, PLANT SIGNAL BEHAV, V4, P853, DOI 10.1093/jxb/erp077; Sakaguchi M, 2007, J BIOCHEM, V141, P213, DOI 10.1093/jh/mvm025; Salmi ML, 2007, PLANT PHYSIOL, V144, P94, DOI 10.1104/pp.107.096131; SEKIYA J, 1988, AGR BIOL CHEM TOKYO, V52, P243; Shi HT, 2012, PLANT CELL PHYSIOL, V53, P344, DOI 10.1093/pcp/pcr181; Tossi V, 2022, NEW PHYTOL, DOI [10.1111/j.1469-8137.2008.02722.x, 10.1111/nph.17330]; Vyas D, 2005, PLANT PHYSIOL BIOCH, V43, P383, DOI 10.1016/j.plaphy.2005.02.016; Wang ML, 2004, PLANT CELL PHYSIOL, V45, P1519, DOI 10.1093/pcp/pch174; Wang YH, 2009, NEW PHYTOL, V182, P851, DOI 10.1111/j.1469-8137.2009.02820.x; Wilkins KA, 2011, PLANT PHYSIOL, V156, P404, DOI 10.1104/pp.110.167510; Wilson ID, 2008, PLANT CELL ENVIRON, V31, P622, DOI 10.1111/j.1365-3040.2007.01761.x; Xu YC, 2004, PHYTOPATHOLOGY, V94, P402, DOI 10.1094/PHYTO.2004.94.4.402; Zhang LP, 2008, PLANT CELL PHYSIOL, V49, P411, DOI 10.1093/pcp/pcn017; Zhao MG, 2009, PLANT PHYSIOL, V151, P755, DOI 10.1104/pp.109.140996	41	29	30	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52436	10.1371/journal.pone.0052436	http://dx.doi.org/10.1371/journal.pone.0052436			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272244	Green Published, Green Submitted, gold			2022-12-27	WOS:000312483300086
J	Brinkhuizen, T; van den Hurk, K; Winnepenninckx, VJL; de Hoon, JP; van Marion, AM; Veeck, J; van Engeland, M; van Steensel, MAM				Brinkhuizen, Tjinta; van den Hurk, Karin; Winnepenninckx, Veronique J. L.; de Hoon, Joep P.; van Marion, Arienne M.; Veeck, Juergen; van Engeland, Manon; van Steensel, Maurice A. M.			Epigenetic Changes in Basal Cell Carcinoma Affect SHH and WNT Signaling Components	PLOS ONE			English	Article							METHYLATION-SPECIFIC PCR; NONMELANOMA SKIN-CANCER; BETA-CATENIN EXPRESSION; PROMOTER METHYLATION; TUMOR-SUPPRESSOR; DNA METHYLATION; CUTANEOUS MALIGNANCIES; COLORECTAL-CANCER; BREAST-CANCER; E-CADHERIN	Background: The genetic background of Basal Cell Carcinoma (BCC) has been studied extensively, while its epigenetic makeup has received comparatively little attention. Epigenetic alterations such as promoter hypermethylation silence tumor suppressor genes (TSG) in several malignancies. Objective: We sought to analyze the promoter methylation status of ten putative (tumor suppressor) genes that are associated with Sonic Hedgehog (SHH), WNT signaling and (hair follicle) tumors in a large series of 112 BCC and 124 healthy control samples by methylation-specific PCR. Results: Gene promoters of SHH (P = 0.016), adenomatous polyposis coli (APC) (P = 0.003), secreted frizzled-related protein 5 (SFRP5) (P = 0.004) and Ras association domain family 1A (RASSF1A) (P = 0.023) showed significantly more methylation in BCC versus normal skin. mRNA levels of these four genes were reduced for APC and SFRP5 in BCC (n = 6) vs normal skin (n = 6). Down regulation of SHH, APC and RASSF1A could be confirmed on protein level as well (P < 0.001 for all genes) by immunohistochemical staining. Increased canonical WNT activity was visualized by beta-catenin staining, showing nuclear beta-catenin in only 28/101 (27.7%) of BCC. Absence of nuclear beta-catenin in some samples may be due to high levels of membranous E-cadherin (in 94.1% of the samples). Conclusions: We provide evidence that promoter hypermethylation of key players within the SHH and WNT pathways is frequent in BCC, consistent with their known constitutive activation in BCC. Epigenetic gene silencing putatively contributes to BCC tumorigenesis, indicating new venues for treatment.	[Brinkhuizen, Tjinta; van Steensel, Maurice A. M.] Maastricht Univ, Med Ctr, Dept Dermatol, Maastricht, Netherlands; [van den Hurk, Karin; Winnepenninckx, Veronique J. L.; de Hoon, Joep P.; Veeck, Juergen; van Engeland, Manon] Maastricht Univ, Med Ctr, Dept Pathol, Maastricht, Netherlands; [van Steensel, Maurice A. M.] Maastricht Univ, Med Ctr, Dept Clin Genet, Maastricht, Netherlands; [Brinkhuizen, Tjinta; van den Hurk, Karin; Winnepenninckx, Veronique J. L.; de Hoon, Joep P.; Veeck, Juergen; van Engeland, Manon; van Steensel, Maurice A. M.] Maastricht Univ, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands; [de Hoon, Joep P.; Veeck, Juergen] Maastricht Univ, Med Ctr, Div Med Oncol, Dept Internal Med, Maastricht, Netherlands; [van Marion, Arienne M.] VieCuri Med Ctr, Dept Pathol, Venlo, Netherlands; [Veeck, Juergen] Rhein Westfal TH Aachen, Univ Hosp, Inst Pathol, D-52062 Aachen, Germany	Maastricht University; Maastricht University; Maastricht University; Maastricht University; Maastricht University; VieCuri Medical Center; RWTH Aachen University; RWTH Aachen University Hospital	Brinkhuizen, T (corresponding author), Maastricht Univ, Med Ctr, Dept Dermatol, Maastricht, Netherlands.	t.brinkhuizen@mumc.nl	van Engeland, Manon/A-7479-2009; van Steensel, Maurice A.M./V-3852-2019; Veeck, Jurgen/B-9256-2008	van Engeland, Manon/0000-0002-7952-6843; Veeck, Jurgen/0000-0002-2952-6159; van Steensel, Maurice/0000-0002-7507-2442	Dutch Cancer Society [KWF UM2009-4609, KWF UM2009-4352]	Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by the Dutch Cancer Society, grants to TB (KWF UM2009-4609) and MVS (KWF UM2009-4352). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla FR, 2005, PEDIATR DERMATOL, V22, P501, DOI 10.1111/j.1525-1470.2005.00129.x; Bezdekova Michala, 2007, Biomedical Papers (Olomouc), V151, P251; BONIFAS JM, 1994, HUM MOL GENET, V3, P447, DOI 10.1093/hmg/3.3.447; Borkowska J, 2011, INT J DERMATOL, V50, P13, DOI 10.1111/j.1365-4632.2010.04727.x; Chhibber A, 2008, ANAL BIOCHEM, V377, P46, DOI 10.1016/j.ab.2008.02.026; Dahmane N, 1997, NATURE, V389, P876, DOI 10.1038/39918; Derks S, 2004, CELL ONCOL, V26, P291; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Donovan J, 2009, DERMATOL SURG, V35, P1311, DOI 10.1111/j.1524-4725.2009.01236.x; El-Bahrawy M, 2003, BRIT J DERMATOL, V148, P964, DOI 10.1046/j.1365-2133.2003.05240.x; Epstein EH, 2008, NAT REV CANCER, V8, P743, DOI 10.1038/nrc2503; Fukumaru K, 2007, J DERMATOL, V34, P746, DOI 10.1111/j.1346-8138.2007.00376.x; Gailani MR, 1996, NAT GENET, V14, P78, DOI 10.1038/ng0996-78; Giacinti L, 2008, CLIN TER, V159, P347; Goldberg M, 2006, BRIT J DERMATOL, V155, P1154, DOI 10.1111/j.1365-2133.2006.07433.x; Gort EH, 2008, CANCER EPIDEM BIOMAR, V17, P3325, DOI 10.1158/1055-9965.EPI-08-0472; Hahn H, 1999, J MOL MED-JMM, V77, P459, DOI 10.1007/s001099900018; Hatziapostolou M, 2011, CELL MOL LIFE SCI, V68, P1681, DOI 10.1007/s00018-010-0624-z; Heitzer E, 2010, EXP DERMATOL, V19, P926, DOI 10.1111/j.1600-0625.2010.01120.x; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Holterhues C, 2010, J INVEST DERMATOL, V130, P1807, DOI 10.1038/jid.2010.58; House MG, 2003, CARCINOGENESIS, V24, P193, DOI 10.1093/carcin/24.2.193; Issa JPJ, 2009, CLIN CANCER RES, V15, P3938, DOI 10.1158/1078-0432.CCR-08-2783; Kundel HL, 2003, RADIOLOGY, V228, P303, DOI 10.1148/radiol.2282011860; Lee DA, 2005, J MED GENET, V42, P811, DOI 10.1136/jmg.2004.025577; Li L, 2011, GRAEF ARCH CLIN EXP, V249, P1867, DOI 10.1007/s00417-011-1729-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Madan V, 2010, LANCET, V375, P673, DOI 10.1016/S0140-6736(09)61196-X; Mosterd K, 2009, ACTA DERM-VENEREOL, V89, P454, DOI 10.2340/00015555-0710; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nandakumar V, 2011, CARCINOGENESIS, V32, P597, DOI 10.1093/carcin/bgq282; Pourreyron C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031827; Reifenberger J, 2005, BRIT J DERMATOL, V152, P43, DOI 10.1111/J.1365-2133.2005.06353.X; Reifenberger J, 1998, CANCER RES, V58, P1798; Richter AM, 2009, BBA-REV CANCER, V1796, P114, DOI 10.1016/j.bbcan.2009.03.004; Roewert-Huber J, 2007, BRIT J DERMATOL, V157, P47, DOI 10.1111/j.1365-2133.2007.08273.x; Rosner B., 2006, FUNDAMENTALS BIOSTAT; Saldanha G, 2004, BRIT J DERMATOL, V151, P157, DOI 10.1111/j.1365-2133.2004.06048.x; Sathyanarayana UG, 2007, CANCER LETT, V245, P112, DOI 10.1016/j.canlet.2005.12.042; Schuebel KE, 2007, PLOS GENET, V3, P1709, DOI 10.1371/journal.pgen.0030157; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Smeets NWJ, 2004, LANCET, V364, P1766, DOI 10.1016/S0140-6736(04)17399-6; Szeimies RM, 2006, BRIT J DERMATOL, V154, P16, DOI 10.1111/j.1365-2133.2006.07232.x; Tian XR, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/567305; Tilli CMLJ, 2005, BRIT J DERMATOL, V152, P1108, DOI 10.1111/j.1365-2133.2005.06587.x; van Doorn R, 2005, SEMIN ONCOL, V32, P479, DOI 10.1053/j.seminoncol.2005.07.001; van Engeland M, 2002, ONCOGENE, V21, P3792, DOI 10.1038/sj.onc.1205466; van Steensel MAM, 2009, EXP DERMATOL, V18, P185, DOI 10.1111/j.1600-0625.2008.00808.x; Veeck J, 2008, CARCINOGENESIS, V29, P991, DOI 10.1093/carcin/bgn076; VONDOMARUS H, 1984, J AM ACAD DERMATOL, V10, P1043; Wu W, 2011, CLIN EXP DERMATOL, V36, P381, DOI 10.1111/j.1365-2230.2010.03968.x; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yang SH, 2008, NAT GENET, V40, P1130, DOI 10.1038/ng.192; Zedan W, 2001, J PATHOL, V194, P473, DOI 10.1002/path.940	56	31	31	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51710	10.1371/journal.pone.0051710	http://dx.doi.org/10.1371/journal.pone.0051710			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284750	gold, Green Published, Green Submitted			2022-12-27	WOS:000312435900048
J	Leistner, S; Benik, S; Laumeier, I; Ziegler, A; Nieweler, G; Nolte, CH; Heuschmann, PU; Audebert, HJ				Leistner, Stefanie; Benik, Steffen; Laumeier, Inga; Ziegler, Annerose; Nieweler, Gabriele; Nolte, Christian H.; Heuschmann, Peter U.; Audebert, Heinrich J.			Secondary Prevention after Minor Stroke and TIA - Usual Care and Development of a Support Program	PLOS ONE			English	Article							TRANSIENT ISCHEMIC ATTACK; RANDOMIZED CONTROLLED-TRIAL; CARDIOVASCULAR RISK-FACTORS; BLOOD-PRESSURE; EVENT RATES; CLINICAL-TRIAL; HYPERTENSION; DISEASE; ATHEROTHROMBOSIS; MULTIFACTORIAL	Background: Effective methods of secondary prevention after stroke or TIA are available but adherence to recommended evidence-based treatments is often poor. The study aimed to determine the quality of secondary prevention in usual care and to develop a stepwise modeled support program. Methods: Two consecutive cohorts of patients with acute minor stroke or TIA undergoing usual outpatient care versus a secondary prevention program were compared. Risk factor control and medication adherence were assessed in 6-month follow-ups (6M-FU). Usual care consisted of detailed information concerning vascular risk factor targets given at discharge and regular outpatient care by primary care physicians. The stepwise modeled support program additionally employed up to four outpatient appointments. A combination of educational and behavioral strategies was employed. Results: 168 patients in the observational cohort who stated their openness to participate in a prevention program (mean age 64.7 y, admission blood pressure (BP): 155/84 mmHg) and 173 patients participating in the support program (mean age 67.6 y, BP: 161/84 mmHg) were assessed at 6 months. Proportions of patients with BP according to guidelines were 50% in usual-care and 77% in the support program (p<0.01). LDL<100 mg/dl was measured in 62 versus 71% (p = 0.12). Proportions of patients who stopped smoking were 50 versus 79% (p<0.01). 72 versus 89% of patients with atrial fibrillation were on oral anticoagulation (p = 0.09). Conclusions: Risk factor control remains unsatisfactory in usual care. Targets of secondary prevention were met more often within the supported cohort. Effects on (cerebro-)vascular recurrence rates are going to be assessed in a multicenter randomized trial.	[Leistner, Stefanie; Benik, Steffen; Laumeier, Inga; Ziegler, Annerose; Nieweler, Gabriele; Nolte, Christian H.] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany; [Heuschmann, Peter U.] Univ Wurzburg, Inst Clin Epidemiol & Biometry, Wurzburg, Germany; [Audebert, Heinrich J.] Charite Univ Med Berlin, Ctr Stroke Res, Dept Neurol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Wurzburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Leistner, S (corresponding author), Charite Univ Med Berlin, Dept Neurol, Berlin, Germany.	stefanie.leistner@charite.de	Nolte, Christian/AAA-2651-2022	Nolte, Christian/0000-0001-5577-1775; Audebert, Heinrich J./0000-0002-4785-0366	Lundbeck Pharma; Boehringer Ingelheim Pharma; Takeda Pharma; Sanofi Synthelabo; Bayer Vital; UCB Pharma; European Union; German Stroke Foundation; Stanley Thomas Johnson Foundation	Lundbeck Pharma(Lundbeck Corporation); Boehringer Ingelheim Pharma(Boehringer Ingelheim); Takeda Pharma(Takeda Pharmaceutical Company Ltd); Sanofi Synthelabo; Bayer Vital(Bayer AG); UCB Pharma(UCB Pharma SA); European Union(European Commission); German Stroke Foundation; Stanley Thomas Johnson Foundation	HJA received honoraria payment from Lundbeck Pharma, Boehringer Ingelheim Pharma, Takeda Pharma, Sanofi Synthelabo, Bayer Vital, UCB Pharma; Dr. C. H. Nolte from Boehringer Ingelheim Pharma, Takeda Pharma. PUH received research support from the European Union, the German Stroke Foundation, the Stanley Thomas Johnson Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Alberts MJ, 2009, EUR HEART J, V30, P2318, DOI 10.1093/eurheartj/ehp355; Amarenco P, 2006, NEW ENGL J MED, V355, P549; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; Bayerische Arbeitsgemeinschaft fur Qualitatssicherung in der stationaren Versorgung, 2010, JAHRESAUSWERTUNG MOD; Bhatt DL, 2010, JAMA-J AM MED ASSOC, V304, P1350, DOI 10.1001/jama.2010.1322; Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180; Bushnell CD, 2011, NEUROLOGY, V77, P1182, DOI 10.1212/WNL.0b013e31822f0423; Chimowitz MI, 2005, NEW ENGL J MED, V352, P1305, DOI 10.1056/NEJMoa043033; Dart RA, 2003, CHEST, V123, P244, DOI 10.1378/chest.123.1.244; DiClemente C.C., 2002, MOTIVATIONAL INTERVI, V2nd ed., P201; Diener HCPN, 2008, PRIMAR UND SEKUNDARP; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Geschaftsstelle Qualitatssicherung Hessen, 2010, EXTERNE QUALITATSSIC; Green BB, 2008, JAMA-J AM MED ASSOC, V299, P2857, DOI 10.1001/jama.299.24.2857; Halkes PHA, 2006, LANCET, V367, P1665; He FJ, 2006, LANCET, V367, P320, DOI 10.1016/S0140-6736(06)68069-0; Heuschmann PU, 2011, NEUROLOGY, V76, P159, DOI 10.1212/WNL.0b013e318206ca1e; Johnston SC, 2000, JAMA-J AM MED ASSOC, V284, P2901, DOI 10.1001/jama.284.22.2901; KOUDSTAAL PJ, 1993, LANCET, V342, P1255; MacMahon S, 2001, LANCET, V358, P1033, DOI 10.1016/S0140-6736(01)06178-5; Mohan KM, 2011, STROKE, V42, P1489, DOI 10.1161/STROKEAHA.110.602615; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Palanco MAM, 2007, MED CLIN-BARCELONA, V129, P241, DOI 10.1157/13108346; Rother J, 2008, CEREBROVASC DIS, V25, P366, DOI 10.1159/000120687; Rothwell PM, 2007, LANCET, V370, P1432, DOI 10.1016/S0140-6736(07)61448-2; Rothwell PM, 2005, LANCET, V366, P29, DOI 10.1016/S0140-6736(05)66702-5; Sacco RL, 1997, NEUROLOGY S4, V49, P39; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Vale MJ, 2003, ARCH INTERN MED, V163, P2775, DOI 10.1001/archinte.163.22.2775; Wolf-Maier K, 2003, JAMA-J AM MED ASSOC, V289, P2363, DOI 10.1001/jama.289.18.2363; Zeymer U, 2008, DTSCH ARZTEBL INT, V105, P769, DOI 10.3238/arztebl.2008.0769	33	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e49985	10.1371/journal.pone.0049985	http://dx.doi.org/10.1371/journal.pone.0049985			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284630	gold, Green Submitted, Green Published			2022-12-27	WOS:000312435900005
J	Zhang, BD; Asadi, S; Weng, ZY; Sismanopoulos, N; Theoharides, TC				Zhang, Bodi; Asadi, Shahrzad; Weng, Zuyi; Sismanopoulos, Nikolaos; Theoharides, Theoharis C.			Stimulated Human Mast Cells Secrete Mitochondrial Components That Have Autocrine and Paracrine Inflammatory Actions	PLOS ONE			English	Article							ACTIVATION; DNA; DISORDERS; MECHANISM; FISSION; AUTISM; DAMPS; ATP	Mast cells are hematopoietically-derived tissue immune cells that participate in acquired and innate immunity, as well as in inflammation through release of many chemokines and cytokines, especially in response to the pro-inflammatory peptide substance P (SP). Inflammation is critical in the pathogenesis of many diseases, but the trigger(s) is often unknown. We investigated if mast cell stimulation leads to secretion of mitochondrial components and whether these could elicit autocrine and/or paracrine inflammatory effects. Here we show that human LAD2 mast cells stimulated by IgE/anti-IgE or by the SP led to secretion of mitochondrial particles, mitochondrial (mt) mtDNA and ATP without cell death. Mitochondria purified fromLAD2 cells and, when mitochondria added to mast cells trigger degranulation and release of histamine, PGD(2), IL-8, TNF, and IL-1 beta. This stimulatory effect is partially inhibited by an ATP receptor antagonist and by DNAse. These results suggest that the mitochondrial protein fraction may also contribute. Purified mitochondria also stimulate IL-8 and vascular endothelial growth factor (VEGF) release from cultured human keratinocytes, and VEGF release from primary human microvascular endothelial cells. In order to investigate if mitochondrial components could be secreted in vivo, we injected rats intraperiotoneally (ip) with compound 48/80, which mimicks the action of SP. Peritoneal mast cells degranulated and mitochondrial particles were documented by transimission electron microscopy outside the cells. We also wished to investigate if mitochondrial components secreted locally could reach the systemic circulation. Administration ip of mtDNA isolated from LAD2 cells in rats was detected in their serum within 4 hr, indicating that extravascular mtDNA could enter the systemic circulation. Secretion of mitochondrial components from stimulated live mast cells may act as "autopathogens" contributing to the pathogenesis of inflammatory diseases and may be used as targets for novel treatments.	[Zhang, Bodi; Asadi, Shahrzad; Weng, Zuyi; Sismanopoulos, Nikolaos; Theoharides, Theoharis C.] Tufts Univ, Sch Med, Dept Mol Physiol & Pharmacol, Mol Immunopharm & Drug Discovery Lab, Boston, MA 02111 USA; [Zhang, Bodi; Theoharides, Theoharis C.] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA; [Zhang, Bodi; Weng, Zuyi; Theoharides, Theoharis C.] Tufts Univ, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA; [Asadi, Shahrzad; Theoharides, Theoharis C.] Tufts Med Ctr, Dept Pharm, Boston, MA USA; [Theoharides, Theoharis C.] Tufts Univ, Sch Med, Dept Internal Med, Boston, MA 02111 USA	Tufts University; Tufts University; Tufts University; Tufts Medical Center; Tufts University	Theoharides, TC (corresponding author), Tufts Univ, Sch Med, Dept Mol Physiol & Pharmacol, Mol Immunopharm & Drug Discovery Lab, Boston, MA 02111 USA.	theoharis.theoharides@tufts.edu	weng, zuyi/J-4147-2015; Zhang, Bodi/ABI-6738-2020		National Institutes of Health [R01 AR47652]; Safe Minds; Galenica, SA (Athens, Greece); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047652] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Safe Minds; Galenica, SA (Athens, Greece); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by National Institutes of Health grant R01 AR47652 and a grant from Safe Minds to TCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. A. S. Kirshenbaum (National Institutes of Health, Bethesda, MD) for the supply of LAD2 mast cells, Dr. A Slominski (University of Tennessee, TN) for the supply of HaCaT keratinocytes, Dr. Ira Herman (Tufts University) for the supply of HMVECs, and Sweden Orphan Biovitrum AB (Stockholm, Sweden) for their kind gift of rhSCF. We also thank Mr. Steven Punzell for his expert technical support. Bodi Zhang was supported by a graduate student fellowship from Galenica, SA (Athens, Greece).	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Angelidou A, 2011, J AUTISM DEV DISORD, V41, P1579, DOI 10.1007/s10803-010-1171-z; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bischoff SC, 2007, IMMUNOL REV, V217, P329, DOI 10.1111/j.1600-065X.2007.00523.x; Campello S, 2006, J EXP MED, V203, P2879, DOI 10.1084/jem.20061877; Castells M, 2011, AM J CLIN DERMATOL, V12, P259, DOI 10.2165/11588890-000000000-00000; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Corriden R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3104re1; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; GORDON JR, 1990, NATURE, V346, P274, DOI 10.1038/346274a0; Guescini M, 2010, J NEURAL TRANSM, V117, P1, DOI 10.1007/s00702-009-0288-8; Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018; JOHNSON RG, 1980, FEBS LETT, V120, P75, DOI 10.1016/0014-5793(80)81050-7; Kempuraj D, 1999, BLOOD, V93, P3338, DOI 10.1182/blood.V93.10.3338.410k05_3338_3346; Kirshenbaum AS, 2003, LEUKEMIA RES, V27, P677, DOI 10.1016/S0145-2126(02)00343-0; Kouzaki H, 2011, J IMMUNOL, V186, P4375, DOI 10.4049/jimmunol.1003020; Lauritzen KH, 2010, MOL CELL BIOL, V30, P1357, DOI 10.1128/MCB.01149-09; Maintz L, 2011, ALLERGY, V66, P862, DOI 10.1111/j.1398-9995.2011.02550.x; Marichal T, 2011, NAT MED, V17, P996, DOI 10.1038/nm.2403; Olszewski MB, 2007, J IMMUNOL, V178, P5701, DOI 10.4049/jimmunol.178.9.5701; Quintana A, 2007, P NATL ACAD SCI USA, V104, P14418, DOI 10.1073/pnas.0703126104; Schaechter M, 2012, SCIENCE, V335, P32; Sismanopoulos N, 2012, PLOS ONE IN PRESS; Skokos D, 2001, J IMMUNOL, V166, P868, DOI 10.4049/jimmunol.166.2.868; Sudo N, 1996, J IMMUNOL, V156, P3970; Theoharides TC, 2006, ANN NY ACAD SCI, V1088, P78, DOI 10.1196/annals.1366.025; Theoharides TC, 2012, BBA-MOL BASIS DIS, V1822, P21, DOI 10.1016/j.bbadis.2010.12.014; Theoharides TC, 2009, INT J IMMUNOPATH PH, V22, P859, DOI 10.1177/039463200902200401; Theoharides TC, 2009, EXPERT OPIN PHARMACO, V10, P2127, DOI 10.1517/14656560903107789; Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001; Valent P, 2012, INT ARCH ALLERGY IMM, V157, P215, DOI 10.1159/000328760; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wedemeyer J, 2000, CURR OPIN IMMUNOL, V12, P624, DOI 10.1016/S0952-7915(00)00154-0; Weng Z, 2012, PLOS ONE IN PRESS; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Zhang B, 2012, INT ARCH AL IN PRESS; Zhang B, 2010, J IMMUNOL, V184, P11; Zhang BD, 2011, J ALLERGY CLIN IMMUN, V127, P1522, DOI 10.1016/j.jaci.2011.02.005; Zhang BD, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-80; Zhang Q, 2010, SHOCK, V34, P55, DOI 10.1097/SHK.0b013e3181cd8c08; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	41	69	70	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e49767	10.1371/journal.pone.0049767	http://dx.doi.org/10.1371/journal.pone.0049767			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284625	Green Published, gold, Green Submitted			2022-12-27	WOS:000312435900003
J	Ndirangu, J; Viljoen, J; Bland, RM; Danaviah, S; Thorne, C; Van de Perre, P; Newell, ML				Ndirangu, James; Viljoen, Johannes; Bland, Ruth M.; Danaviah, Siva; Thorne, Claire; Van de Perre, Philippe; Newell, Marie-Louise			Cell-Free (RNA) and Cell-Associated (DNA) HIV-1 and Postnatal Transmission through Breastfeeding	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; TYPE-1 RNA; NEVIRAPINE PROPHYLAXIS; VERTICAL TRANSMISSION; HIV-1-INFECTED WOMEN; INFECTED MOTHERS; P24 ANTIGEN; MILK CELLS	Introduction: Transmission through breastfeeding remains important for mother-to-child transmission (MTCT) in resource-limited settings. We quantify the relationship between cell-free (RNA) and cell-associated (DNA) shedding of HIV-1 virus in breastmilk and the risk of postnatal HIV-1 transmission in the first 6 months postpartum. Materials and Methods: Thirty-six HIV-positive mothers who transmitted HIV-1 by breastfeeding were matched to 36 non-transmitting HIV-1 infected mothers in a case-control study nested in a cohort of HIV-infected women. RNA and DNA were quantified in the same breastmilk sample taken at 6 weeks and 6 months. Cox regression analysis assessed the association between cell-free and cell-associated virus levels and risk of postnatal HIV-1 transmission. Results: There were higher median levels of cell-free than cell-associated HIV-1 virus (per ml) in breastmilk at 6 weeks and 6 months. Multivariably, adjusting for antenatal CD4 count and maternal plasma viral load, at 6 weeks, each 10-fold increase in cell-free or cell-associated levels (per ml) was significantly associated with HIV-1 transmission but stronger for cell-associated than cell-free levels [2.47 (95% CI 1.33-4.59) vs. aHR 1.52 (95% CI, 1.17-1.96), respectively]. At 6 months, cell-free and cell-associated levels (per ml) in breastmilk remained significantly associated with HIV-1 transmission but was stronger for cell-free than cell-associated levels [aHR 2.53 (95% CI 1.64-3.92) vs. 1.73 (95% CI 0.94-3.19), respectively]. Conclusions: The findings suggest that cell-associated virus level (per ml) is more important for early postpartum HIV-1 transmission (at 6 weeks) than cell-free virus. As cell-associated virus levels have been consistently detected in breastmilk despite antiretroviral therapy, this highlights a potential challenge for resource-limited settings to achieve the UNAIDS goal for 2015 of eliminating vertical transmission. More studies would further knowledge on mechanisms of HIV-1 transmission and help develop more effective drugs during lactation.	[Ndirangu, James; Viljoen, Johannes; Bland, Ruth M.; Danaviah, Siva; Newell, Marie-Louise] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Somkhele, South Africa; [Bland, Ruth M.] Univ Glasgow, Sch Med, Glasgow, Lanark, Scotland; [Thorne, Claire; Newell, Marie-Louise] UCL, Inst Child Hlth, MRC Ctr Epidemiol Child Hlth, London, England; [Van de Perre, Philippe] INSERM U, Montpellier, France; [Van de Perre, Philippe] Univ Montpellier, F-34059 Montpellier, France; [Van de Perre, Philippe] CHU Montpellier, Dept Bacteriol Virol, Montpellier, France; [Van de Perre, Philippe] CHU Montpellier, Dept Med Informat, Montpellier, France	University of Kwazulu Natal; University of Glasgow; University of London; University College London; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier	Ndirangu, J (corresponding author), Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Somkhele, South Africa.	jndirangu@africacentre.ac.za; jviljoen@africacentre.ac.za	Newell, Marie-Louise/AAE-8222-2019; Van de Perre, Philippe/B-9692-2008; Thorne, Claire/C-5943-2008	Newell, Marie-Louise/0000-0002-1074-7699; Van de Perre, Philippe/0000-0002-3912-0427; Thorne, Claire/0000-0003-0389-1956; Bland, Ruth/0000-0003-1675-9268; Ndirangu, James/0000-0002-2768-5631	Wellcome Trust; University of KwaZulu-Natal [050524];  [UK 063009/Z/00/2]; Medical Research Council [G0400546, G0400546B] Funding Source: researchfish; MRC [G0400546] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); University of KwaZulu-Natal; ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Wellcome Trust core grant to the Africa Centre for Health and Population Studies, University of KwaZulu-Natal (050524); and an additional grant to the Vertical Transmission Study (UK 063009/Z/00/2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, KWAZULU NAT PROV DEP; Antinori A, 2005, CLIN INFECT DIS, V41, P1787, DOI 10.1086/498310; Ayouba A, 2003, AM J TROP MED HYG, V69, P447, DOI 10.4269/ajtmh.2003.69.447; Becquart P, 2002, VIROLOGY, V300, P109, DOI 10.1006/viro.2002.1537; Bennetto-Hood C, 2007, CLIN INFECT DIS, V45, P391, DOI 10.1086/519427; Bland RM, 2007, CLIN INFECT DIS, V45, P1502, DOI 10.1086/523320; Bland RM, 2010, INT J EPIDEMIOL, V39, P351, DOI 10.1093/ije/dyp165; Cassol S, 1997, J CLIN MICROBIOL, V35, P2795, DOI 10.1128/JCM.35.11.2795-2801.1997; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; Chege D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013077; Chung MH, 2005, AIDS, V19, P1415, DOI 10.1097/01.aids.0000181013.70008.4d; Chung MH, 2008, ANTIVIR THER, V13, P799; Chung MH, 2007, JAIDS-J ACQ IMM DEF, V46, P472, DOI 10.1097/QAI.0b013e3181594c1c; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; Coovadia HM, 2007, LANCET, V369, P1107, DOI 10.1016/S0140-6736(07)60283-9; Department of Health, 2010, CLIN GUID PMTCT PREV; Gantt S, 2008, AIDS, V22, P1453, DOI 10.1097/QAD.0b013e32830184f2; Ghosh MK, 2003, J CLIN MICROBIOL, V41, P2465, DOI 10.1128/JCM.41.6.2465-2470.2003; Giaquinto C, 2005, CLIN INFECT DIS, V40, P458, DOI 10.1086/427287; GOLDMAN AS, 1982, J PEDIATR-US, V100, P563, DOI 10.1016/S0022-3476(82)80753-1; Guay LA, 1996, PEDIATRICS, V98, P438; Gupta A, 2011, J INFECT DIS, V203, P358, DOI [10.1093/infdis/jiq064, 10.1093/jinfdis/jiq064]; Houzet L, 2007, NUCLEIC ACIDS RES, V35, P2695, DOI 10.1093/nar/gkm153; John GC, 2001, J INFECT DIS, V183, P206, DOI 10.1086/317918; John-Stewart G, 2004, JAIDS-J ACQ IMM DEF, V35, P196, DOI 10.1097/00126334-200402010-00015; Khamduang W, 2011, JAIDS-J ACQ IMM DEF, V58, P188, DOI [10.1097/QAI.0B013E31822D0433, 10.1097/QAI.0b013e31822d0433]; Kilewo C, 2009, JAIDS-J ACQ IMM DEF, V52, P406, DOI 10.1097/QAI.0b013e3181b323ff; Koulinska IN, 2006, JAIDS-J ACQ IMM DEF, V41, P93, DOI 10.1097/01.qai.0000179424.19413.24; Lehman DA, 2008, AIDS, V22, P1475, DOI 10.1097/QAD.0b013e328302cc11; Lewis P, 1998, J INFECT DIS, V177, P34, DOI 10.1086/513816; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Mmiro FA, 2009, JAIDS-J ACQ IMM DEF, V52, P32, DOI 10.1097/QAI.0b013e3181afd352; NDUATI RW, 1995, J INFECT DIS, V172, P1461, DOI 10.1093/infdis/172.6.1461; Neveu D, 2011, CLIN INFECT DIS, V52, P819, DOI 10.1093/cid/ciq203; NEWELL ML, 1992, LANCET, V339, P1007; Newell ML, 2003, T ROY SOC TROP MED H, V97, P22, DOI 10.1016/S0035-9203(03)90009-5; Pillay K, 2000, J ACQ IMMUN DEF SYND, V24, P330, DOI 10.1097/00126334-200008010-00006; Richardson BA, 2003, J INFECT DIS, V187, P736, DOI 10.1086/374272; Rouet F, 2007, JAIDS-J ACQ IMM DEF, V45, P380, DOI 10.1097/QAI.0b013e3180640cf5; Rousseau CM, 2003, J INFECT DIS, V187, P741, DOI 10.1086/374273; Rousseau CM, 2004, J INFECT DIS, V190, P1880, DOI 10.1086/425076; RUFF AJ, 1994, J ACQ IMMUN DEF SYND, V7, P68; Semba RD, 1999, J INFECT DIS, V180, P93, DOI 10.1086/314854; Semrau K, 2008, JAIDS-J ACQ IMM DEF, V47, P320, DOI 10.1097/QAI.0b013e31815e7436; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Shapiro RL, 2005, J INFECT DIS, V192, P713, DOI 10.1086/432489; Slyker JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029777; Tasker S, 2010, J MED MICROBIOL, V59, P1285, DOI 10.1099/jmm.0.021691-0; Thomas TK, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001015; Townsend CL, 2008, AIDS, V22, P973, DOI 10.1097/QAD.0b013e3282f9b67a; UNAIDS, 2011, GLOB REP UNAIDS REP; UNAIDS, 2010, GETT ZER 2011 2015 S; Valea D, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-34; Van de Perre P, 1999, AIDS, V13, P1133, DOI 10.1097/00002030-199906180-00018; VANDEPERRE P, 1993, LANCET, V341, P914, DOI 10.1016/0140-6736(93)91210-D; WHO, 2010, WHO ANT DRUGS TREAT; Willumsen JF, 2001, AIDS, V15, P1896, DOI 10.1097/00002030-200109280-00026	57	38	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e51493	10.1371/journal.pone.0051493	http://dx.doi.org/10.1371/journal.pone.0051493			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23284701	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000313051500012
J	Chakroborty, S; Briggs, C; Miller, MB; Goussakov, I; Schneider, C; Kim, J; Wicks, J; Richardson, JC; Conklin, V; Cameransi, BG; Stutzmann, GE				Chakroborty, Shreaya; Briggs, Clark; Miller, Megan B.; Goussakov, Ivan; Schneider, Corinne; Kim, Joyce; Wicks, Jaime; Richardson, Jill C.; Conklin, Vincent; Cameransi, Benjamin G.; Stutzmann, Grace E.			Stabilizing ER Ca2+ Channel Function as an Early Preventative Strategy for Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; MEDIATED CALCIUM-RELEASE; A-BETA-DEPOSITION; RYANODINE RECEPTOR; MOUSE MODEL; NEUROPATHOLOGY; ACTIVATION; PHOSPHORYLATION; HOMEOSTASIS; HYPOTHESIS	Alzheimer's disease (AD) is a devastating neurodegenerative condition with no known cure. While current therapies target late-stage amyloid formation and cholinergic tone, to date, these strategies have proven ineffective at preventing disease progression. The reasons for this may be varied, and could reflect late intervention, or, that earlier pathogenic mechanisms have been overlooked and permitted to accelerate the disease process. One such example would include synaptic pathology, the disease component strongly associated with cognitive impairment. Dysregulated Ca2+ homeostasis may be one of the critical factors driving synaptic dysfunction. One of the earliest pathophysiological indicators in mutant presenilin (PS) AD mice is increased intracellular Ca2+ signaling, predominantly through the ER-localized inositol triphosphate (IP3) and ryanodine receptors (RyR). In particular, the RyR-mediated Ca2+ upregulation within synaptic compartments is associated with altered synaptic homeostasis and network depression at early (presymptomatic) AD stages. Here, we offer an alternative approach to AD therapeutics by stabilizing early pathogenic mechanisms associated with synaptic abnormalities. We targeted the RyR as a means to prevent disease progression, and sub-chronically treated AD mouse models (4-weeks) with a novel formulation of the RyR inhibitor, dantrolene. Using 2-photon Ca2+ imaging and patch clamp recordings, we demonstrate that dantrolene treatment fully normalizes ER Ca2+ signaling within somatic and dendritic compartments in early and later-stage AD mice in hippocampal slices. Additionally, the elevated RyR2 levels in AD mice are restored to control levels with dantrolene treatment, as are synaptic transmission and synaptic plasticity. A beta deposition within the cortex and hippocampus is also reduced in dantrolene-treated AD mice. In this study, we highlight the pivotal role of Ca2+ aberrations in AD, and propose a novel strategy to preserve synaptic function, and thereby cognitive function, in early AD patients.	[Chakroborty, Shreaya; Briggs, Clark; Schneider, Corinne; Kim, Joyce; Wicks, Jaime; Stutzmann, Grace E.] Rosalind Franklin Univ, Chicago Med Sch, Dept Neurosci, N Chicago, IL USA; [Miller, Megan B.] Univ Connecticut, Dept Neurosci, Farmington, CT USA; [Goussakov, Ivan] Univ Chicago, Neurol Sect, Chicago, IL 60637 USA; [Richardson, Jill C.] GlaxoSmithKline, United Kingdom Grp, Res & Dev China, Stevenage, Herts, England; [Conklin, Vincent; Cameransi, Benjamin G.] Lyotrop Therapeut, Ashland, VA USA	Chicago Medical School; Rosalind Franklin University Medical & Science; University of Connecticut; University of Chicago; GlaxoSmithKline	Stutzmann, GE (corresponding author), Rosalind Franklin Univ, Chicago Med Sch, Dept Neurosci, N Chicago, IL USA.	grace.stutzmann@rosalindfranklin.edu		Richardson, Jill/0000-0001-6564-3187	National Institutes of Health [AG030205]; Alzheimer's Drug Discovery Foundation; American Health Assistance Foundation; NATIONAL INSTITUTE ON AGING [R01AG030205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Drug Discovery Foundation; American Health Assistance Foundation(BrightFocus Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support to GES was provided by National Institutes of Health AG030205, the Alzheimer's Drug Discovery Foundation and the American Health Assistance Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisen PS, 2011, NEUROLOGY, V76, P280, DOI 10.1212/WNL.0b013e318207b1b9; Avila J, 2004, NEUROTOX RES, V6, P477, DOI 10.1007/BF03033284; Bruno AM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.03.011; Chakroborty S, 2012, J NEUROSCI, V32, P8341, DOI 10.1523/JNEUROSCI.0936-12.2012; Chakroborty S, 2009, J NEUROSCI, V29, P9458, DOI 10.1523/JNEUROSCI.2047-09.2009; Cheung KH, 2008, NEURON, V58, P871, DOI 10.1016/j.neuron.2008.04.015; Cheung KH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000818; Coleman PD, 2003, NEUROBIOL AGING, V24, P1023, DOI 10.1016/j.neurobiolaging.2003.09.001; Demuro A, 2011, J CELL BIOL, V195, P515, DOI 10.1083/jcb.201104133; Demuro A, 2010, J BIOL CHEM, V285, P12463, DOI 10.1074/jbc.R109.080895; Extance A, 2010, NAT REV DRUG DISCOV, V9, P749, DOI 10.1038/nrd3288; Ferreira IL, 2012, CELL CALCIUM, V51, P95, DOI 10.1016/j.ceca.2011.11.008; Filbert MLEBG, 2005, J MED CBR DEF, V3, P21; Galimberti Daniela, 2011, Ther Adv Neurol Disord, V4, P203, DOI 10.1177/1756285611404470; Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; Goldman WP, 2001, NEUROLOGY, V56, P361, DOI 10.1212/WNL.56.3.361; Goussakov I, 2011, CHANNELS, V5, P9, DOI 10.4161/chan.5.1.14124; Goussakov I, 2010, J NEUROSCI, V30, P12128, DOI 10.1523/JNEUROSCI.2474-10.2010; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003529; Howlett DR, 2008, HISTOL HISTOPATHOL, V23, P67, DOI 10.14670/HH-23.67; Howlett DR, 2004, BRAIN RES, V1017, P130, DOI 10.1016/j.brainres.2004.05.029; Itkin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018250; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kawahara Masahiro, 2011, Int J Alzheimers Dis, V2011, P304583, DOI 10.4061/2011/304583; Kelliher M, 1999, NEUROSCIENCE, V92, P499, DOI 10.1016/S0306-4522(99)00042-1; Muehlschlegel S, 2009, NEUROCRIT CARE, V10, P103, DOI 10.1007/s12028-008-9133-4; Muller M, 2011, P NATL ACAD SCI USA, V108, P13293, DOI 10.1073/pnas.1109297108; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Oules B, 2012, J NEUROSCI, V32, P11820, DOI 10.1523/JNEUROSCI.0875-12.2012; Peng J, 2012, NEUROSCI LETT, V516, P274, DOI 10.1016/j.neulet.2012.04.008; Pierrot N, 2004, J NEUROCHEM, V88, P1140, DOI 10.1046/j.1471-4159.2003.02227.x; Pierrot N, 2006, J BIOL CHEM, V281, P39907, DOI 10.1074/jbc.M606015200; Price JL, 2009, NEUROBIOL AGING, V30, P1026, DOI 10.1016/j.neurobiolaging.2009.04.002; QUERFURTH HW, 1994, BIOCHEMISTRY-US, V33, P4550, DOI 10.1021/bi00181a016; Sambamurti K, 2011, J NEUROCHEM, V117, P359, DOI 10.1111/j.1471-4159.2011.07213.x; Scheff SW, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P101; Schmitt FA, 2000, NEUROLOGY, V55, P370, DOI 10.1212/WNL.55.3.370; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Stutzmann GE, 2005, PHYSIOLOGY, V20, P15, DOI 10.1152/physiol.00028.2004; Stutzmann GE, 2004, J NEUROSCI, V24, P508, DOI 10.1523/JNEUROSCI.4386-03.2004; Stutzmann GE, 2007, ANN NY ACAD SCI, V1097, P265, DOI 10.1196/annals.1379.025; Stutzmann GE, 2007, NEUROSCIENTIST, V13, P546, DOI 10.1177/1073858407299730; Stutzmann GE, 2006, J NEUROSCI, V26, P5180, DOI 10.1523/JNEUROSCI.0739-06.2006; Supnet C, 2006, J BIOL CHEM, V281, P38440, DOI 10.1074/jbc.M606736200; Supnet C, 2010, J NEUROCHEM, V112, P356, DOI 10.1111/j.1471-4159.2009.06487.x; Zhang H, 2010, J NEUROSCI, V30, P8566, DOI 10.1523/JNEUROSCI.1554-10.2010; Zhao FY, 2001, J BIOL CHEM, V276, P13810, DOI 10.1074/jbc.M006104200	49	94	96	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52056	10.1371/journal.pone.0052056	http://dx.doi.org/10.1371/journal.pone.0052056			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284867	Green Published, gold, Green Submitted			2022-12-27	WOS:000313158800026
J	Srivastava, SK; Robins, HS				Srivastava, Santosh K.; Robins, Harlan S.			Palindromic Nucleotide Analysis in Human T Cell Receptor Rearrangements	PLOS ONE			English	Article							V(D)J RECOMBINATION; JUNCTIONAL DIVERSITY; IMMUNOGLOBULIN; COMPLEX; MECHANISM	Diversity of T cell receptor (TCR) genes is primarily generated by nucleotide insertions upon rearrangement from their germ line-encoded V, D and J segments. Nucleotide insertions at V-D and D-J junctions are random, but some small subsets of these insertions are exceptional, in that one to three base pairs inversely repeat the sequence of the germline DNA. These short complementary palindromic sequences are called P nucleotides. We apply the ImmunoSeq deep-sequencing assay to the third complementarity determining region (CDR3) of the beta chain of T cell receptors, and use the resulting data to study P nucleotides in the repertoire of naive and memory CD8(+) and CD4(+) T cells. We estimate P nucleotide distributions in a cross section of healthy adults and different T cell subtypes. We show that P nucleotide frequency in all T cell subtypes ranges from 1% to 2%, and that the distribution is highly biased with respect to the coding end of the gene segment. Classification of observed palindromic sequences into P nucleotides using a maximum conditional probability model shows that single base P nucleotides are very rare in VDJ recombination; P nucleotides are primarily two bases long. To explore the role of P nucleotides in thymic selection, we compare P nucleotides in productive and non-productive sequences of CD8(+) naive T cells. The naive CD8(+) T cell clones with P nucleotides are more highly expanded.	[Srivastava, Santosh K.] IBM Res Lab, New Delhi, India; [Robins, Harlan S.] Fred Hutchinson Canc Res Ctr, Programs Computat Biol, Seattle, WA 98104 USA	International Business Machines (IBM); Fred Hutchinson Cancer Center	Robins, HS (corresponding author), Fred Hutchinson Canc Res Ctr, Programs Computat Biol, 1124 Columbia St, Seattle, WA 98104 USA.	hrobins@fhcrc.org			Ellison Medical Foundation	Ellison Medical Foundation(Lawrence Ellison Foundation)	This study was supported by the Ellison Medical Foundation New Scholar Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gauss GH, 1996, MOL CELL BIOL, V16, P258; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; LIEBER MR, 1991, FASEB J, V5, P2934, DOI 10.1096/fasebj.5.14.1752360; Lu H, 2007, NUCLEIC ACIDS RES, V35, P6917, DOI 10.1093/nar/gkm823; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; MEIER JT, 1993, MOL CELL BIOL, V13, P1078, DOI 10.1128/MCB.13.2.1078; Monod MY, 2004, BIOINFORMATICS, V20, P379, DOI 10.1093/bioinformatics/bth945; Nadel B, 1997, MOL CELL BIOL, V17, P3768, DOI 10.1128/MCB.17.7.3768; PANDEY A, 1993, J EXP MED, V177, P329, DOI 10.1084/jem.177.2.329; Robins HS, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001442; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Tanaka H, 2009, NAT REV CANCER, V9, P215, DOI 10.1038/nrc2591	13	11	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52250	10.1371/journal.pone.0052250	http://dx.doi.org/10.1371/journal.pone.0052250			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284955	Green Published, gold, Green Submitted			2022-12-27	WOS:000313158800040
J	Benkert, TF; Dietz, L; Hartmann, EM; Leich, E; Rosenwald, A; Serfling, E; Buttmann, M; Berberich-Siebelt, F				Benkert, Thomas F.; Dietz, Lena; Hartmann, Elena M.; Leich, Ellen; Rosenwald, Andreas; Serfling, Edgar; Buttmann, Mathias; Berberich-Siebelt, Friederike			Natalizumab Exerts Direct Signaling Capacity and Supports a Pro-Inflammatory Phenotype in Some Patients with Multiple Sclerosis	PLOS ONE			English	Article							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; FOCAL ADHESION KINASE; REGULATORY T-CELLS; ALPHA-4-BETA-1 INTEGRIN; ACTIVATION; EXPRESSION; UPDATE; LYMPHOCYTES; ANTIBODIES; RESPONSES	Natalizumab is a recombinant monoclonal antibody raised against integrin alpha-4 (CD49d). It is approved for the treatment of patients with multiple sclerosis (MS), a chronic inflammatory autoimmune disease of the CNS. While having shown high therapeutic efficacy, treatment by natalizumab has been linked to progressive multifocal leukoencephalopathy (PML) as a serious adverse effect. Furthermore, drug cessation sometimes induces rebound disease activity of unknown etiology. Here we investigated whether binding of this adhesion-blocking antibody to T lymphocytes could modulate their phenotype by direct induction of intracellular signaling events. Primary CD4(+) T lymphocytes either from healthy donors and treated with natalizumab in vitro or from MS patients receiving their very first dose of natalizumab were analyzed. Natalizumab induced a mild upregulation of IL-2, IFN-gamma and IL-17 expression in activated primary human CD4(+) T cells propagated ex vivo from healthy donors, consistent with a pro-inflammatory costimulatory effect on lymphokine expression. Along with this, natalizumab binding triggered rapid MAPK/ERK phosphorylation. Furthermore, it decreased CD49d surface expression on effector cells within a few hours. Sustained CD49d downregulation could be attributed to integrin internalization and degradation. Importantly, also CD4(+) T cells from some MS patients receiving their very first dose of natalizumab produced more IL-2, IFN-gamma and IL-17 already 24 h after infusion. Together these data indicate that in addition to its adhesion-blocking mode of action natalizumab possesses mild direct signaling capacities, which can support a pro-inflammatory phenotype of peripheral blood T lymphocytes. This might explain why a rebound of disease activity or IRIS is observed in some MS patients after natalizumab cessation.	[Benkert, Thomas F.; Dietz, Lena; Serfling, Edgar; Berberich-Siebelt, Friederike] Univ Wurzburg, Dept Mol Pathol, Wurzburg, Germany; [Benkert, Thomas F.; Dietz, Lena; Hartmann, Elena M.; Leich, Ellen; Rosenwald, Andreas; Serfling, Edgar; Berberich-Siebelt, Friederike] Univ Wurzburg, Inst Pathol, D-8700 Wurzburg, Germany; [Buttmann, Mathias] Univ Wurzburg, Dept Neurol, D-8700 Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg	Berberich-Siebelt, F (corresponding author), Univ Wurzburg, Dept Mol Pathol, Wurzburg, Germany.	path230@mail.uni-wuerzburg.de	Buttmann, Mathias/R-7301-2019; Serfling, Edgar/X-7212-2019; Buttmann, Mathias/AAD-7488-2021	Buttmann, Mathias/0000-0001-8309-7685; Buttmann, Mathias/0000-0001-8309-7685	Interdisciplinary Center for Clinical Research, University of Wurzburg; Federal Ministry for Education and Research; German Research Foundation DFG [SPP1365, TRR52/A3]; German research Foundation (DFG); University of Wuerzburg; Biogen Idec; Merck Serono; Sanofi Aventis; Teva Pharmaceutical Industries Ltd.; Novartis	Interdisciplinary Center for Clinical Research, University of Wurzburg; Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation DFG(German Research Foundation (DFG)); German research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg; Biogen Idec(Biogen); Merck Serono(Merck & Company); Sanofi Aventis(Sanofi-Aventis); Teva Pharmaceutical Industries Ltd.(Teva Pharmaceutical Industries); Novartis(Novartis)	This work was mainly supported by the Interdisciplinary Center for Clinical Research, University of Wurzburg, provided by the Federal Ministry for Education and Research (T. B., E. M. H., E. L., A. R., M. B., F.B.-S.) as well as by the German Research Foundation DFG (SPP1365 and TRR52/A3 to F.B.-S.). The cost of publication were funded by the German research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing.; M.B. received a travel grant from Biogen Idec, the manufacturer of natalizumab (Tysabri (R)), which was not related to this manuscript. Furthermore, he received travel grants, speaker's fees and a research grant from Merck Serono, served on an advisory board for Almirall Hermal GmbH, and received research grants from Sanofi Aventis and Teva Pharmaceutical Industries Ltd. as well as from Novartis. The other authors declare no competing interests. Biogen Idec/Elan had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; BARON JL, 1993, J EXP MED, V177, P57, DOI 10.1084/jem.177.1.57; Beck O, 2006, BLOOD, V107, P2562, DOI 10.1182/blood-2005-04-1660; BENVENUTO R, 1992, ANN NY ACAD SCI, V650, P341; Bloomgren G, 2012, NEW ENGL J MED, V366, P1870, DOI 10.1056/NEJMoa1107829; Bonig H, 2008, BLOOD, V111, P3439, DOI 10.1182/blood-2007-09-112052; Buttmann M, 2010, EXPERT REV NEUROTHER, V10, P791, DOI [10.1586/ern.10.38, 10.1586/ERN.10.38]; Clifford DB, 2010, LANCET NEUROL, V9, P438, DOI 10.1016/S1474-4422(10)70028-4; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; DOREDUFFY P, 1993, ADV EXP MED BIOL, V331, P243; Fleming JC, 2010, INFLAMM RES, V59, P647, DOI 10.1007/s00011-010-0177-5; Frisullo G, 2011, MULT SCLER J, V17, P556, DOI 10.1177/1352458510392263; Frisullo G, 2009, IMMUNOLOGY, V127, P418, DOI 10.1111/j.1365-2567.2008.02963.x; Garron ML, 2008, J MOL BIOL, V375, P1320, DOI 10.1016/j.jmb.2007.11.040; Gomez IG, 2012, J BIOL CHEM, V287, P4581, DOI 10.1074/jbc.M111.321182; Hohlfeld R, 2001, CURR OPIN NEUROL, V14, P299, DOI 10.1097/00019052-200106000-00006; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kebir H, 2009, ANN NEUROL, V66, P390, DOI 10.1002/ana.21748; Kerbrat A, 2011, J NEUROL SCI, V308, P98, DOI 10.1016/j.jns.2011.05.043; Khademi M, 2008, EUR J NEUROL, V15, P309, DOI 10.1111/j.1468-1331.2007.02037.x; Khademi M, 2009, EUR J NEUROL, V16, P528, DOI 10.1111/j.1468-1331.2009.02532.x; Kim TK, 2010, HUM IMMUNOL, V71, P23, DOI 10.1016/j.humimm.2009.09.360; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Kivisakk P, 2009, NEUROLOGY, V72, P1922, DOI 10.1212/WNL.0b013e3181a8266f; Kleinschmidt-DeMasters BK, 2012, J NEUROPATH EXP NEUR, V71, P604, DOI 10.1097/NEN.0b013e31825caf2c; Korn T, 2008, J NEUROL, V255, P2, DOI 10.1007/s00415-008-6001-2; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lindberg RLP, 2008, J NEUROIMMUNOL, V194, P153, DOI 10.1016/j.jneuroim.2007.11.007; McCombe JA, 2009, NEUROLOGY, V72, P835, DOI 10.1212/01.wnl.0000343854.80344.69; Millonig A, 2010, J NEUROIMMUNOL, V227, P190, DOI 10.1016/j.jneuroim.2010.07.012; Miravalle A, 2011, ARCH NEUROL-CHICAGO, V68, P186, DOI 10.1001/archneurol.2010.257; Mittelbrunn M, 2004, P NATL ACAD SCI USA, V101, P11058, DOI 10.1073/pnas.0307927101; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Neumann F, 2009, EXPERT OPIN BIOL TH, V9, P1099, DOI 10.1517/14712590903055011; Nguyen K, 2008, IMMUNITY, V28, P810, DOI 10.1016/j.immuni.2008.04.019; Niino M, 2006, ANN NEUROL, V59, P748, DOI 10.1002/ana.20859; O'Connor PW, 2011, NEUROLOGY, V76, P1858, DOI 10.1212/WNL.0b013e31821e7c8a; Oreja-Guevara C, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-95; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Ramos-Cejudo J, 2011, J CLIN IMMUNOL, V31, P623, DOI 10.1007/s10875-011-9522-x; Redondo-Munoz J, 2008, BLOOD, V112, P169, DOI 10.1182/blood-2007-08-109249; Rigau V, 2012, NEUROLOGY; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Saure C, 2011, ARCH NEUROL-CHICAGO, V68, P1428, DOI 10.1001/archneurol.2011.238; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Steinman L, 2005, NAT REV DRUG DISCOV, V4, P510, DOI 10.1038/nrd1752; Tan IL, 2011, NEUROLOGY, V77, P1061, DOI 10.1212/WNL.0b013e31822e55e7; Vellinga MM, 2008, NEUROLOGY, V70, P1150, DOI 10.1212/01.wnl.0000265393.03231.e5; VOSKUHL RR, 1993, AUTOIMMUNITY, V15, P137, DOI 10.3109/08916939309043888; WASHINGTON R, 1994, ANN NEUROL, V35, P89, DOI 10.1002/ana.410350114; West TW, 2010, ANN NEUROL, V68, P395, DOI 10.1002/ana.22163; Westhoff MA, 2004, MOL CELL BIOL, V24, P8113, DOI 10.1128/MCB.24.18.8113-8133.2004; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0	54	34	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52208	10.1371/journal.pone.0052208	http://dx.doi.org/10.1371/journal.pone.0052208			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284936	Green Submitted, gold, Green Published			2022-12-27	WOS:000312794500113
J	Eijkemans, M; Mommers, M; Draaisma, JMT; Thijs, C; Prins, MH				Eijkemans, Marianne; Mommers, Monique; Draaisma, Jos M. Th; Thijs, Carel; Prins, Martin H.			Physical Activity and Asthma: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							BODY-MASS INDEX; 5TH GRADE SCHOOLCHILDREN; RISK-FACTORS; ACTIVITY PARTICIPATION; RESPIRATORY SYMPTOMS; WATCHING TIME; US ADULTS; CHILDREN; ASSOCIATIONS; ONSET	Introduction: This review aims to give an overview of available published evidence concerning the association between physical activity and asthma in children, adolescents and adults. Methods: We included all original articles in which both physical activity and asthma were assessed in case-control, cross-sectional or longitudinal (cohort) studies. Excluded were studies concerning physical fitness, studies in athletes, therapeutic or rehabilitation intervention studies such as physical training or exercise in asthma patients. Methodological quality of the included articles was assessed according to the Newcastle-Ottawa Scale (NOS). Results: A literature search was performed until June 2011 and resulted in 6,951 publications derived from PubMed and 1,978 publications from EMBASE. In total, 39 studies met the inclusion criteria: 5 longitudinal studies (total number of subjects n = 85,117) with physical activity at baseline as exposure, and asthma incidence as outcome. Thirty-four cross-sectional studies (n = 661,222) were included. Pooling of the longitudinal studies showed that subjects with higher physical activity levels had lower incidence of asthma (odds ratio 0.88 (95% CI: 0.77-1.01)). When restricting pooling to the 4 prospective studies with moderate to good study quality (defined as NOS >= 5) the pooled odds ratio only changed slightly (0.87 (95% CI: 0.77-0.99)). In the cross-sectional studies, due to large clinical variability and heterogeneity, further statistical analysis was not possible. Conclusions: The available evidence indicates that physical activity is a possible protective factor against asthma development. The heterogeneity suggests that possible relevant effects remain hidden in critical age periods, sex differences, or extremes of levels of physical activity (e. g. sedentary). Future longitudinal studies should address these issues.	[Eijkemans, Marianne; Draaisma, Jos M. Th] Radboud Univ Nijmegen Med Ctr, Dept Pediat, Nijmegen, Netherlands; [Eijkemans, Marianne; Mommers, Monique; Thijs, Carel; Prins, Martin H.] Maastricht Univ, Sch Publ Hlth & Primary Care CAPHRI, Dept Epidemiol, Maastricht, Netherlands	Radboud University Nijmegen; Maastricht University	Eijkemans, M (corresponding author), Radboud Univ Nijmegen Med Ctr, Dept Pediat, Nijmegen, Netherlands.	m.eijkemans@cukz.umcn.nl	Thijs, Carel/H-8340-2019; Draaisma, J.M.T./L-4283-2015	Thijs, Carel/0000-0001-6646-5458; Draaisma, Jos/0000-0003-4829-6173; Eijkemans, Marianne/0000-0003-4550-8628				Beckett WS, 2001, AM J RESP CRIT CARE, V164, P2045, DOI 10.1164/ajrccm.164.11.2004235; Bener A, 1996, HUM BIOL, V68, P405; Benet M, 2011, RESP MED, V105, P1104, DOI 10.1016/j.rmed.2011.03.016; Berntsen S, 2009, ALLERGY, V64, P421, DOI 10.1111/j.1398-9995.2008.01845.x; Burr ML, 2006, THORAX, V61, P296, DOI 10.1136/thx.2005.045682; Chen Y, 2001, RESP MED, V95, P13, DOI 10.1053/rmed.2000.0961; Cheng BL, 2010, WORLD J PEDIATR, V6, P238, DOI 10.1007/s12519-010-0222-z; Chiang LC, 2006, J ADV NURS, V54, P653, DOI 10.1111/j.1365-2648.2006.03873.x; Corbo GM, 2008, EPIDEMIOLOGY, V19, P747, DOI 10.1097/EDE.0b013e3181776213; DiFranza JR, 2004, PEDIATRICS, V113, P1007; Dogra S, 2008, AGE AGEING, V37, P449, DOI 10.1093/ageing/afn114; Eijkemans M, 2008, PEDIATRICS, V121, pE666, DOI 10.1542/peds.2007-1236; Firrincieli V, 2005, PEDIATR PULM, V40, P57, DOI 10.1002/ppul.20214; Flaherman V, 2006, ARCH DIS CHILD, V91, P334, DOI 10.1136/adc.2005.080390; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Ford ES, 2002, EPIDEMIOLOGY, V13, P561, DOI 10.1097/00001648-200209000-00012; Ford ES, 2003, CHEST, V124, P432, DOI 10.1378/chest.124.2.432; Gannotti Mary, 2007, Pediatr Phys Ther, V19, P301, DOI 10.1097/PEP.0b013e318157da3d; Glazebrook C, 2006, PEDIATRICS, V118, P2443, DOI 10.1542/peds.2006-1846; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huovinen E, 2003, RESP MED, V97, P273, DOI 10.1053/rmed.2003.1419; Jones SE, 2006, J COMMUN HEALTH, V31, P469, DOI 10.1007/s10900-006-9026-4; Kilpelainen M, 2006, RESP MED, V100, P1518, DOI 10.1016/j.rmed.2006.01.011; Kitsantas A, 2000, J ASTHMA, V37, P163, DOI 10.3109/02770900009055439; Lang DM, 2004, PEDIATRICS, V113, pE341, DOI 10.1542/peds.113.4.e341; Livingstone MBE, 2003, P NUTR SOC, V62, P681, DOI 10.1079/PNS2003291; Lucas SR, 2005, J ALLERGY CLIN IMMUN, V115, P928, DOI 10.1016/j.jaci.2005.01.033; Lucke J, 2007, WOMENS HEALTH, V3, P423, DOI 10.2217/17455057.3.4.423; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Malkia E, 1998, SCAND J MED SCI SPOR, V8, P27; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Nystad W, 1997, SCAND J MED SCI SPOR, V7, P331; Ownby DR, 2007, J ASTHMA, V44, P885, DOI 10.1080/02770900701752698; Priftis KN, 2007, J ASTHMA, V44, P521, DOI 10.1080/02770900701496023; Ram FSF, 2005, COCHRANE DB SYST REV, DOI [10.1002/146514858.CD004360.pub2, 10.1002/14651858.CD004360.pub3, 10.1002/14651858.CD003137.pub2]; Ritz T, 2010, CHEST, V138, P913, DOI 10.1378/chest.08-3073; Romieu I, 2004, PEDIATR PULM, V38, P31, DOI 10.1002/ppul.20042; Rundle A, 2009, J ASTHMA, V46, P803, DOI 10.3109/02770900903114564; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Strine TW, 2007, J ASTHMA, V44, P651, DOI 10.1080/02770900701554896; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Teramoto M, 2011, J ASTHMA, V48, P517, DOI 10.3109/02770903.2011.567426; Thomsen SF, 2006, ALLERGY, V61, P229, DOI 10.1111/j.1398-9995.2006.01004.x; Trzcieniecka-Green A, 2009, EUR J MED RES, V14, P147; Tsai HJ, 2007, J ASTHMA, V44, P397, DOI 10.1080/02770900701364304; Tsai HJ, 2009, J ASTHMA, V46, P9, DOI 10.1080/02770900802444229; Vahlkvist S, 2009, ALLERGY, V64, P1649, DOI 10.1111/j.1398-9995.2009.02081.x; van Gent R, 2007, PEDIATR PULM, V42, P1018, DOI 10.1002/ppul.20672; Vlaski E, 2008, ALLERGOL IMMUNOPATH, V36, P247, DOI 10.1016/S0301-0546(08)75218-2; Vogelberg C, 2007, EUR RESPIR J, V30, P672, DOI 10.1183/09031936.00152906; Vogt R, 2008, J ASTHMA, V45, P568, DOI 10.1080/02770900802005269; Walders-Abramson N, 2009, PEDIATR PULM, V44, P909, DOI 10.1002/ppul.21077; Wells G.A., NEWCASTLE OTTAWA SCA; WESTON AR, 1989, J ASTHMA, V26, P279, DOI 10.3109/02770908909073264	55	101	104	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e50775	10.1371/journal.pone.0050775	http://dx.doi.org/10.1371/journal.pone.0050775			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284646	gold, Green Published, Green Submitted			2022-12-27	WOS:000312794500016
J	Gonzalez-Recio, O; Ugarte, E; Bach, A				Gonzalez-Recio, Oscar; Ugarte, Eva; Bach, Alex			Trans-Generational Effect of Maternal Lactation during Pregnancy: A Holstein Cow Model	PLOS ONE			English	Article							BODY CONDITION SCORE; FEMALE FERTILITY; MILK-YIELD; SELECTION; NUTRITION; TRAITS; HEALTH; PERFORMANCE; PREDICTION; DISEASE	Epigenetic regulation in mammals begins in the first stages of embryogenesis. This prenatal programming determines, in part, phenotype expression in adult life. Some species, particularly dairy cattle, are conceived during the maternal lactation, which is a period of large energy and nutrient needs. Under these circumstances, embryo and fetal development compete for nutrients with the mammary gland, which may affect prenatal programming and predetermine phenotype at adulthood. Data from a specialized dairy breed were used to determine the transgenerational effect when embryo development coincides with maternal lactation. Longitudinal phenotypic data for milk yield (kg), ratio of fat-protein content in milk during first lactation, and lifespan (d) from 40,065 cows were adjusted for environmental and genetic effects using a Bayesian framework. Then, the effect of different maternal circumstances was determined on the residuals. The maternal-related circumstances were 1) presence of lactation, 2) maternal milk yield level, and 3) occurrence of mastitis during embryogenesis. Females born to mothers that were lactating while pregnant produced 52 kg (MonteCarlo standard error; MCs.e. = 0.009) less milk, lived 16 d (MCs.e. = 0.002) shorter and were metabolically less efficient (+0.42% milk fat/protein ratio; MCs.e.<0.001) than females whose fetal life developed in the absence of maternal lactation. The greater the maternal milk yield during embryogenesis, the larger the negative effects of prenatal programming, precluding the offspring born to the most productive cows to fully express their potential additive genetic merit during their adult life. Our data provide substantial evidence of transgenerational effect when pregnancy and lactation coincide. Although this effect is relatively low, it should not be ignored when formulating rations for lactating and pregnant cows. Furthermore, breeding, replacement, and management strategies should also take into account whether the individuals were conceived during maternal lactation because, otherwise, their performance may deviate from what it could be expected.	[Gonzalez-Recio, Oscar] INIA, Dept Mejora Genet Anim, Madrid, Spain; [Ugarte, Eva] NEIKER TECNALIA, Araba, Spain; [Bach, Alex] ICREA, Barcelona, Spain; [Bach, Alex] IRTA, Dept Ruminant Prod, Caldes De Montbui, Spain	ICREA; IRTA	Gonzalez-Recio, O (corresponding author), INIA, Dept Mejora Genet Anim, Madrid, Spain.	gonzalez.oscar@inia.es	Ugarte, Eva/D-9598-2019; Gonzalez-Recio, Oscar/C-8553-2016	Gonzalez-Recio, Oscar/0000-0002-9106-4063; Bach, Alex/0000-0001-6804-2002	ICREA Funding Source: Custom	ICREA(ICREA)		Bach A, 2012, J ANIM SCI, V90, P1835, DOI 10.2527/jas.2011-4516; Banos G, 2007, J DAIRY SCI, V90, P3490, DOI 10.3168/jds.2006-809; BARKER DJP, 1992, P NUTR SOC, V51, P135, DOI 10.1079/PNS19920023; Bascom SS, 1998, J DAIRY SCI, V81, P2299, DOI 10.3168/jds.S0022-0302(98)75810-2; Bell CG, 2010, BRIEF FUNCT GENOMICS, V9, P477, DOI 10.1093/bfgp/elq026; Berry DP, 2008, J DAIRY SCI, V91, P329, DOI 10.3168/jds.2007-0438; Bjornsson HT, 2004, TRENDS GENET, V20, P350, DOI 10.1016/j.tig.2004.06.009; Burdge GC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028282; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Funston RN, 2010, J ANIM SCI, V88, pE205, DOI 10.2527/jas.2009-2351; Geyer C. J., 1992, STAT SCI, V7, P473, DOI [10.1214/ss/1177011137, DOI 10.1214/SS/1177011137]; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gonzalez-Recio O, 2006, J DAIRY SCI, V89, P4438, DOI 10.3168/jds.S0022-0302(06)72492-4; Gonzalez-Recio O, 2005, J DAIRY SCI, V88, P783, DOI 10.3168/jds.S0022-0302(05)72742-9; Gonzalez-Recio O, 2004, J DAIRY SCI, V87, P3053, DOI 10.3168/jds.S0022-0302(04)73438-4; Gonzalez-Recio Oscar, 2012, Frontiers in Genetics, V2, P106, DOI 10.3389/fgene.2011.00106; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; HENDERSON CR, 1976, BIOMETRICS, V32, P69, DOI 10.2307/2529339; HENDERSON CR, 1975, BIOMETRICS, V31, P423, DOI 10.2307/2529430; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; JONES WP, 1994, J DAIRY SCI, V77, P3137, DOI 10.3168/jds.S0022-0302(94)77257-X; Kossaibati MA, 1997, VET J, V154, P41, DOI 10.1016/S1090-0233(05)80007-3; Nijland MJ, 2008, CURR OPIN OBSTET GYN, V20, P132, DOI 10.1097/GCO.0b013e3282f76753; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rauw WM, 1998, LIVEST PROD SCI, V56, P15, DOI 10.1016/S0301-6226(98)00147-X; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Robinson JJ, 1999, ANIM SCI, V68, P315, DOI 10.1017/S1357729800050323; Roxstrom A, 2002, LIVEST PROD SCI, V74, P125, DOI 10.1016/S0301-6226(01)00300-1; SORENSEN DA, 2002, LIKELIHOOD BAYESIAN, P588; Veerkamp RF, 2001, J DAIRY SCI, V84, P2327, DOI 10.3168/jds.S0022-0302(01)74681-4; Vollema AR, 1996, J DAIRY SCI, V79, P2261, DOI 10.3168/jds.S0022-0302(96)76603-1; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156; Zwald NR, 2004, J DAIRY SCI, V87, P4287, DOI 10.3168/jds.S0022-0302(04)73573-0	33	59	60	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51816	10.1371/journal.pone.0051816	http://dx.doi.org/10.1371/journal.pone.0051816			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284777	gold, Green Published, Green Submitted			2022-12-27	WOS:000312794500048
J	Mondal, S; Martinson, JA; Ghosh, S; Watson, R; Pahan, K				Mondal, Susanta; Martinson, Jeffrey A.; Ghosh, Supurna; Watson, Richard; Pahan, Kalipada			Protection of Tregs, Suppression of Th1 and Th17 Cells, and Amelioration of Experimental Allergic Encephalomyelitis by a Physically-Modified Saline	PLOS ONE			English	Article							REGULATORY T-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; INHIBITS ADOPTIVE TRANSFER; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; NITRIC-OXIDE; IL-12P40 HOMODIMER; SODIUM BENZOATE; CUTTING EDGE; FOXP3	In multiple sclerosis (MS) and other autoimmune diseases, the autoreactive T cells overcome the resistance provided by the regulatory T cells (Tregs) due to a decrease in the number of Foxp3-expressing Tregs. Therefore, upregulation and/or maintenance of Tregs during an autoimmune insult may have therapeutic efficacy in autoimmune diseases. Although several immunomodulatory drugs and molecules are available, most present significant side effects over long-term use. Here we have undertaken an innovative approach to upregulate Tregs and achieve immunomodulation. RNS60 is a 0.9% saline solution generated by subjecting normal saline to Taylor-Couette-Poiseuille (TCP) flow under elevated oxygen pressure. RNS60, but not NS (normal saline), RNS10.3 (TCP-modified saline without excess oxygen) and PNS60 (saline containing excess oxygen without TCP modification), was found to upregulate Foxp3 and enrich Tregs in MBP-primed T cells. Moreover, RNS60, but not NS, RNS10.3 and PNS60, inhibited the production of nitric oxide (NO) and the expression of iNOS in MBP-primed splenocytes. Incubation of the cells with an NO donor abrogated the RNS60-mediated upregulation of Foxp3. These results suggest that RNS60 boosts Tregs via suppression of NO production. Consistent to the suppressive activity of Tregs towards autoreactive T cells, RNS60, but not NS, RNS10.3, or PNS60, suppressed the differentiation of Th17 and Th1 cells and shifted the balance towards a Th2 response. Finally, RNS60 treatment exhibited immunomodulation and ameliorated adoptive transfer of experimental allergic encephalomyelitis, an animal model of MS, via Tregs. These results describe a novel immunomodulatory property of RNS60 and suggest its exploration for therapeutic intervention in MS and other autoimmune disorders.	[Mondal, Susanta; Pahan, Kalipada] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Martinson, Jeffrey A.] Rush Univ, Med Ctr, Dept Immunol & Microbiol, Chicago, IL 60612 USA; [Ghosh, Supurna; Watson, Richard] Revalesio Corp, Tacoma, WA USA	Rush University; Rush University	Pahan, K (corresponding author), Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA.	Kalipada_Pahan@rush.edu			Revalesio Corporation	Revalesio Corporation	This work was supported by Revalesio Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhaskar S, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-3; Brahmachari S, 2007, J IMMUNOL, V179, P275, DOI 10.4049/jimmunol.179.1.275; Brahmachari S, 2010, J IMMUNOL, V184, P1799, DOI 10.4049/jimmunol.0804394; Brahmachari S, 2009, J IMMUNOL, V183, P2045, DOI 10.4049/jimmunol.0800276; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chun J, 2010, CLIN NEUROPHARMACOL, V33, P91, DOI 10.1097/WNF.0b013e3181cbf825; Coffer PJ, 2004, NAT REV IMMUNOL, V4, P889, DOI 10.1038/nri1488; Cohen JA, 2012, LANCET NEUROL, V11, P467, DOI 10.1016/S1474-4422(12)70059-5; Dasgupta S, 2004, J IMMUNOL, V173, P1344, DOI 10.4049/jimmunol.173.2.1344; Dasgupta S, 2003, J IMMUNOL, V170, P3874, DOI 10.4049/jimmunol.170.7.3874; Dasgupta S, 2003, J BIOL CHEM, V278, P22424, DOI 10.1074/jbc.M301789200; Dasgupta S, 2007, MOL PHARMACOL, V72, P934, DOI 10.1124/mol.106.033787; El-behi M, 2010, J NEUROIMMUNE PHARM, V5, P189, DOI 10.1007/s11481-009-9188-9; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huan J, 2005, J NEUROSCI RES, V81, P45, DOI 10.1002/jnr.20522; Khasnavis S, 2012, J BIOL CHEM, V287, P29529, DOI 10.1074/jbc.M111.338012; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Kuerten S, 2011, J INTERF CYTOK RES, V31, P907, DOI 10.1089/jir.2011.0072; MARTIN R, 1992, ANNU REV IMMUNOL, V10, P153, DOI 10.1146/annurev.iy.10.040192.001101; McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025; McKee AS, 2004, J IMMUNOL, V173, P1224, DOI 10.4049/jimmunol.173.2.1224; Miller A, 1997, SOUTH MED J, V90, P367, DOI 10.1097/00007611-199704000-00001; Mondal S, 2009, J IMMUNOL, V182, P5013, DOI 10.4049/jimmunol.0801734; Niedbala W, 2007, EUR J IMMUNOL, V37, P3021, DOI 10.1002/eji.200737810; Pahan K, 1997, J CLIN INVEST, V100, P2671, DOI 10.1172/JCI119812; Pahan K, 2011, IMMUNOPHARM IMMUNOT, V33, P586, DOI 10.3109/08923973.2011.561861; Pahan K, 2010, J NEUROIMMUNE PHARM, V5, P165, DOI 10.1007/s11481-010-9219-6; Paust S, 2005, IMMUNOL REV, V204, P195, DOI 10.1111/j.0105-2896.2005.00247.x; Rapoport N, 2007, JNCI-J NATL CANCER I, V99, P1095, DOI 10.1093/jnci/djm043; Reddy J, 2005, J IMMUNOL, V175, P5591, DOI 10.4049/jimmunol.175.9.5591; Sabatino JJ, 2010, J NEUROIMMUNE PHARM, V5, P176, DOI 10.1007/s11481-009-9181-3; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sakaguchi S, 2007, SCIENCE, V317, P627, DOI 10.1126/science.1142331; Schrempf W, 2007, AUTOIMMUN REV, V6, P469, DOI 10.1016/j.autrev.2007.02.003; Shi GP, 2008, J IMMUNOL, V181, P7205, DOI 10.4049/jimmunol.181.10.7205; Sinha S, 2010, J NEUROIMMUNE PHARM, V5, P231, DOI 10.1007/s11481-009-9175-1; Venken K, 2008, IMMUNOLOGY, V123, P79, DOI 10.1111/j.1365-2567.2007.02690.x; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Xu DM, 2003, J IMMUNOL, V170, P394, DOI 10.4049/jimmunol.170.1.394; Zhu JF, 2010, IMMUNITY, V32, P11, DOI 10.1016/j.immuni.2010.01.001; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	41	45	52	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51869	10.1371/journal.pone.0051869	http://dx.doi.org/10.1371/journal.pone.0051869			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284794	Green Submitted, Green Published, gold			2022-12-27	WOS:000312794500056
J	Scheer, JM; Sandoval, W; Elliott, JM; Shao, L; Luis, E; Lewin-Koh, SC; Schaefer, G; Vandlen, R				Scheer, Justin M.; Sandoval, Wendy; Elliott, J. Michael; Shao, Lily; Luis, Elizabeth; Lewin-Koh, Sock-Cheng; Schaefer, Gabriele; Vandlen, Richard			Reorienting the Fab Domains of Trastuzumab Results in Potent HER2 Activators	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; MONOCLONAL-ANTIBODY; BISPECIFIC ANTIBODIES; STRUCTURAL-ANALYSIS; THERAPEUTIC INDEX; ESCHERICHIA-COLI; CANCER-THERAPY; BREAST-CANCER; KINASE DOMAIN; COMPLEX	The structure of the Fab region of antibodies is critical to their function. By introducing single cysteine substitutions into various positions of the heavy and light chains of the Fab region of trastuzumab, a potent antagonist of HER2, and using thiol chemistry to link the different Fabs together, we produced a variety of monospecific F(ab')(2)-like molecules with activities spanning from activation to inhibition of breast tumor cell growth. These isomers (or bis-Fabs) of trastuzumab, with varying relative spatial arrangements between the Fv-regions, were able to either promote or inhibit cell-signaling activities through the PI3K/AKT and MAPK pathways. A quantitative phosphorylation mapping of HER2 indicated that the agonistic isomers produced a distinct phosphorylation pattern associated with activation. This study suggests that antibody geometric isomers, found both in nature and during synthetic antibody development, can have profoundly different biological activities independent of their affinities for their target molecules.	[Scheer, Justin M.; Sandoval, Wendy; Elliott, J. Michael; Luis, Elizabeth; Vandlen, Richard] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Shao, Lily; Schaefer, Gabriele] Genentech Inc, Dept Res Oncol, San Francisco, CA 94080 USA; [Lewin-Koh, Sock-Cheng] Genentech Inc, Dept Biostat, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Scheer, JM (corresponding author), Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA.	scheer.justin@gene.com		Schaefer, Gabriele/0000-0001-9727-3555				[Anonymous], 2006, SAS MIXED MODELS; Carter P, 2000, Breast Dis, V11, P103; CARTER P, 1992, BIO-TECHNOL, V10, P163, DOI 10.1038/nbt0292-163; Chames P, 2009, IDRUGS, V12, P276; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Dornan D, 2009, BLOOD, V114, P2721, DOI 10.1182/blood-2009-02-205500; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Ghosh R, 2011, CANCER RES, V71, P1871, DOI 10.1158/0008-5472.CAN-10-1872; HORGAN C, 1993, J IMMUNOL, V150, P5400; Jackson JG, 2004, CANCER RES, V64, P2601, DOI 10.1158/0008-5472.CAN-03-3106; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Junutula JR, 2008, NAT BIOTECHNOL, V26, P925, DOI 10.1038/nbt.1480; Junutula JR, 2008, J IMMUNOL METHODS, V332, P41, DOI 10.1016/j.jim.2007.12.011; Junutula JR, 2010, CLIN CANCER RES, V16, P4769, DOI 10.1158/1078-0432.CCR-10-0987; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kirkpatrick DS, 2005, METHODS, V35, P265, DOI 10.1016/j.ymeth.2004.08.018; Kontermann RE, 2005, ACTA PHARMACOL SIN, V26, P1, DOI 10.1111/j.1745-7254.2005.00008.x; Kruser TJ, 2010, EXP CELL RES, V316, P1083, DOI 10.1016/j.yexcr.2010.01.009; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; Liu YD, 2008, J BIOL CHEM, V283, P29266, DOI 10.1074/jbc.M804787200; Montgomery D., 2001, DESIGN ANAL EXPT, V5th; Patel D, 2009, INT J ONCOL, V34, P25, DOI 10.3892/ijo_00000125; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Simmons LC, 2002, J IMMUNOL METHODS, V263, P133, DOI 10.1016/S0022-1759(02)00036-4; SMIGEL MD, 1981, INT J BIOMED COMPUT, V12, P189, DOI 10.1016/0020-7101(81)90009-X; STANCOVSKI I, 1991, P NATL ACAD SCI USA, V88, P8691, DOI 10.1073/pnas.88.19.8691; Takai N, 2005, CANCER-AM CANCER SOC, V104, P2701, DOI 10.1002/cncr.21533; Wieduwilt MJ, 2008, CELL MOL LIFE SCI, V65, P1566, DOI 10.1007/s00018-008-7440-8; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yip YL, 2003, INT J CANCER, V104, P303, DOI 10.1002/ijc.10951; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	33	25	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51817	10.1371/journal.pone.0051817	http://dx.doi.org/10.1371/journal.pone.0051817			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284778	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500049
J	Yagi, S; Matsuda, M; Kiyokawa, E				Yagi, Shunsuke; Matsuda, Michiyuki; Kiyokawa, Etsuko			Chimaerin Suppresses Rac1 Activation at the Apical Membrane to Maintain the Cyst Structure	PLOS ONE			English	Article							PROTEIN N-CHIMAERIN; SPINDLE ORIENTATION; RHO-GTPASES; CDC42 GEF; KINASE-C; GAP; BETA-2-CHIMAERIN; DOMAIN; PHOSPHOINOSITIDES; DIACYLGLYCEROL	Epithelial organs are made of a well-polarized monolayer of epithelial cells, and their morphology is maintained strictly for their proper functions. Previously, we showed that Rac1 activation is suppressed at the apical membrane in the mature organoid, and that such spatially biased Rac1 activity is required for the polarity maintenance. Here we identify Chimaerin, a GTPase activating protein for Rac1, as a suppressor of Rac1 activity at the apical membrane. Depletion of Chimaerin causes over-activation of Rac1 at the apical membrane in the presence of hepatocyte growth factor (HGF), followed by luminal cell accumulation. Importantly, Chimaerin depletion did not inhibit extension formation at the basal membrane. These observations suggest that Chimaerin functions as the apical-specific Rac1 GAP to maintain epithelial morphology.	[Matsuda, Michiyuki; Kiyokawa, Etsuko] Kyoto Univ, Dept Pathol & Biol Dis, Grad Sch Med, Sakyo Ku, Kyoto, Japan; [Yagi, Shunsuke; Matsuda, Michiyuki] Kyoto Univ, Grad Sch Biostudies, Lab Bioimaging & Cell Signaling, Sakyo Ku, Kyoto, Japan; [Kiyokawa, Etsuko] Kanazawa Med Univ, Dept Oncol Pathol, Uchinada, Ishikawa, Japan	Kyoto University; Kyoto University; Kanazawa Medical University	Kiyokawa, E (corresponding author), Kyoto Univ, Dept Pathol & Biol Dis, Grad Sch Med, Sakyo Ku, Yoshida Konoe Cho, Kyoto, Japan.	kiyokawa@kanazawa-med.ac.jp		Matsuda, Michiyuki/0000-0002-5876-9969	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [24112524, 22590358, 22113001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. S. Yagi was supported by research fellowships from the Japan Society for the Promotion of Science for Young Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 2005, MOL BIOL CELL, V16, P2207, DOI 10.1091/mbc.e04-10-0904; Aoki K, 2007, J CELL BIOL, V177, P817, DOI 10.1083/jcb.200609017; Burbelo PD, 1995, J BIOL CHEM, V270, P30919, DOI 10.1074/jbc.270.52.30919; Caloca MJ, 1999, P NATL ACAD SCI USA, V96, P11854, DOI 10.1073/pnas.96.21.11854; Caloca MJ, 2003, BIOCHEM J, V375, P313, DOI 10.1042/BJ20030727; Charrier C, 2012, CELL, V149, P923, DOI 10.1016/j.cell.2012.03.034; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; HALL C, 1993, MOL CELL BIOL, V13, P4986, DOI 10.1128/MCB.13.8.4986; Hall C, 2001, J NEUROSCI, V21, P5191, DOI 10.1523/JNEUROSCI.21-14-05191.2001; HALL C, 1990, J MOL BIOL, V211, P11, DOI 10.1016/0022-2836(90)90006-8; Hara S, 2008, MOL BIOL CELL, V19, P3823, DOI 10.1091/mbc.E08-03-0314; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Iwasato T, 2007, CELL, V130, P742, DOI 10.1016/j.cell.2007.07.022; Kiyokawa E, 2011, ANNU REV PHARMACOL, V51, P337, DOI 10.1146/annurev-pharmtox-010510-100234; Kogure T, 2006, NAT BIOTECHNOL, V24, P577, DOI 10.1038/nbt1207; Kozma R, 1996, MOL CELL BIOL, V16, P5069; Kumagai Y, 2011, ANAL BIOCHEM, V413, P192, DOI 10.1016/j.ab.2011.02.021; LEUNG T, 1994, J BIOL CHEM, V269, P12888; LEUNG T, 1993, J BIOL CHEM, V268, P3813; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; MONTESANO R, 1991, CELL, V67, P901, DOI 10.1016/0092-8674(91)90363-4; Nishioka T, 2008, MOL BIOL CELL, V19, P4213, DOI 10.1091/mbc.E08-03-0315; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Qin Y, 2010, J CELL BIOL, V189, P661, DOI 10.1083/jcb.201002097; Riccomagno MM, 2012, CELL, V149, P1594, DOI 10.1016/j.cell.2012.05.018; Rodriguez-Fraticelli AE, 2010, J CELL BIOL, V189, P725, DOI 10.1083/jcb.201002047; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sakurai A, 2012, J BIOL CHEM, V287, P31703, DOI 10.1074/jbc.M112.377804; Saras J, 1997, J BIOL CHEM, V272, P24333, DOI 10.1074/jbc.272.39.24333; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Yagi S, 2012, EMBO REP, V13, P237, DOI 10.1038/embor.2011.249; Yang CF, 2005, J BIOL CHEM, V280, P24363, DOI 10.1074/jbc.M411629200; Yang CF, 2007, BIOCHEM J, V403, P1, DOI 10.1042/bj20061750; Yoshizaki H, 2007, MOL BIOL CELL, V18, P119, DOI 10.1091/mbc.E06-05-0467	38	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52258	10.1371/journal.pone.0052258	http://dx.doi.org/10.1371/journal.pone.0052258			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284959	gold, Green Published, Green Submitted			2022-12-27	WOS:000312794500127
J	Dimitri, N				Dimitri, Nicola			R&D Incentives for Neglected Diseases	PLOS ONE			English	Article								Neglected diseases are typically characterized as those for which adequate drug treatment is lacking, and the potential return on effort in research and development (R&D), to produce new therapies, is too small for companies to invest significant resources in the field. In recent years various incentives schemes to stimulate R&D by pharmaceutical firms have been considered. Broadly speaking, these can be classified either as 'push' or 'pull' programs. Hybrid options, that include push and pull incentives, have also become increasingly popular. Supporters and critics of these various incentive schemes have argued in favor of their relative merits and limitations, although the view that no mechanism is a perfect fit for all situations appears to be widely held. For this reason, the debate on the advantages and disadvantages of different approaches has been important for policy decisions, but is dispersed in a variety of sources. With this in mind, the aim of this paper is to contribute to the understanding of the economic determinants behind R&D investments for neglected diseases by comparing the relative strength of different incentive schemes within a simple economic model, based on the assumption of profit maximizing firms. The analysis suggests that co-funded push programs are generally more efficient than pure pull programs. However, by setting appropriate intermediate goals hybrid incentive schemes could further improve efficiency.	[Dimitri, Nicola] Univ Siena, Dept Polit Econ & Stat, I-53100 Siena, Italy; [Dimitri, Nicola] Maastricht Sch Management, Holland, MI USA; [Dimitri, Nicola] IMT Lucca, Lucca, Italy	University of Siena; IMT School for Advanced Studies Lucca	Dimitri, N (corresponding author), Univ Siena, Dept Polit Econ & Stat, Via Laterina 8, I-53100 Siena, Italy.	dimitri@unisi.it						Acemoglu D, 2004, Q J ECON, V119, P1049, DOI 10.1162/0033553041502144; [Anonymous], 2007, OECD HIGH LEV FOR ME; Danzon PM, 2007, NATURE, V449, P176, DOI 10.1038/449176a; Glennerster R., 2006, INNOVATIONS TECHNOLO, V1, P67, DOI [10.1162/itgg.2006.1.1.67, DOI 10.1162/ITGG.2006.1.1.67]; Herrling P, 2008, MAKING DRUGS ACCESSI, P5; Herrling PL, 2009, NAT REV DRUG DISCOV, V8, P91, DOI 10.1038/nrd2818; Konrad K. A., 2009, STRATEGY DYNAMICS CO; Kremer M, 2006, STRONG MED; Love J, 2007, BIG IDEA PRIZES STIM; Maurer S, 2005, DESIGNING COST EFFEC; Maurer SM, 2006, B WORLD HEALTH ORGAN, V84, P376, DOI 10.2471/BLT.06.029835; Moran M, 2005, PLOS MED, V2, P828, DOI 10.1371/journal.pmed.0020302; Nature Outlook, 2007, NEGLECTED DIS, V449, P157; Nwaka S, 2003, NAT REV DRUG DISCOV, V2, P919, DOI 10.1038/nrd1230; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Price Waterhouse Coopers, 2007, PHARM 2020 VIS WHICH; Ropars AL, 2005, NEW LANDSCAPE NEGLEC; WHO, 2012, RES DEV MEET HLTH NE	18	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e50835	10.1371/journal.pone.0050835	http://dx.doi.org/10.1371/journal.pone.0050835			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284648	Green Submitted, gold, Green Published			2022-12-27	WOS:000312694300012
J	Fleming, JM; Shabir, S; Varley, CL; Kirkwood, LA; White, A; Holder, J; Trejdosiewicz, LK; Southgate, J				Fleming, Jonathan M.; Shabir, Saqib; Varley, Claire L.; Kirkwood, Lisa A.; White, Angela; Holder, Julie; Trejdosiewicz, Ludwik K.; Southgate, Jennifer			Differentiation-Associated Reprogramming of the Transforming Growth Factor beta Receptor Pathway Establishes the Circuitry for Epithelial Autocrine/Paracrine Repair	PLOS ONE			English	Article							HUMAN UROTHELIAL CELLS; UROPLAKIN GENE-EXPRESSION; TGF-BETA; IN-VITRO; URINARY-BLADDER; PPAR-GAMMA; PROLIFERATION	Transforming growth factor (TGF) beta has diverse and sometimes paradoxical effects on cell proliferation and differentiation, presumably reflecting a fundamental but incompletely-understood role in regulating tissue homeostasis. It is generally considered that downstream activity is modulated at the ligand: receptor axis, but microarray analysis of proliferative versus differentiating normal human bladder epithelial cell cultures identified unexpected transcriptional changes in key components of the canonical TGF beta R/activin signalling pathway associated with cytodifferentiation. Changes included upregulation of the transcriptional modulator SMAD3 and downregulation of inhibitory modulators SMURF2 and SMAD7. Functional analysis of the signalling pathway revealed that non-differentiated normal human urothelial cells responded in paracrine mode to TGF beta by growth inhibition, and that exogenous TGF beta inhibited rather than promoted differentiation. By contrast, in differentiated cell cultures, SMAD3 was activated upon scratch-wounding and was involved in promoting tissue repair. Exogenous TGF beta enhanced the repair and resulted in hyperplastic scarring, indicating a feedback loop implicit in an autocrine pathway. Thus, the machinery for autocrine activation of the SMAD3-mediated TGF beta R pathway is established during urothelial differentiation, but signalling occurs only in response to a trigger, such as wounding. Our study demonstrates that the circuitry of the TGF beta R pathway is defined transcriptionally within a tissue-specific differentiation programme. The findings provide evidence for re-evaluating the role of TGF beta R signalling in epithelial homeostasis as an autocrine-regulated pathway that suppresses differentiation and promotes tissue repair. This provides a new paradigm to help unravel the apparently diverse and paradoxical effect of TGF beta signalling on cell proliferation and differentiation.	[Fleming, Jonathan M.; Shabir, Saqib; Varley, Claire L.; Kirkwood, Lisa A.; Trejdosiewicz, Ludwik K.; Southgate, Jennifer] Univ York, Dept Biol, Jack Birch Unit Mol Carcinogenesis, York YO10 5DD, N Yorkshire, England; [White, Angela; Holder, Julie] GlaxoSmithKline R&D, Ware, Herts, England	University of York - UK; GlaxoSmithKline	Southgate, J (corresponding author), Univ York, Dept Biol, Jack Birch Unit Mol Carcinogenesis, York YO10 5DD, N Yorkshire, England.	jennifer.southgate@york.ac.uk	Southgate, Jennifer/AAJ-9089-2021	Southgate, Jennifer/0000-0002-0135-480X; Tang, Yaoliang/0000-0002-8372-1545	Biotechnology & Biological Sciences Research Council; GlaxoSmithKline; York Against Cancer	Biotechnology & Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); GlaxoSmithKline(GlaxoSmithKline); York Against Cancer	JMF was in receipt of a Biotechnology & Biological Sciences Research Council Industrial CASE studentship with GlaxoSmithKline. JS holds a research chair supported by York Against Cancer. AW and JH are employees of GlaxoSmithKline. The funders did not control the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOMBARA C, 1992, J CELL PHYSIOL, V153, P30, DOI 10.1002/jcp.1041530106; Booth C, 2002, J PATHOL, V198, P359, DOI 10.1002/path.1214; Cross WR, 2005, AM J PHYSIOL-RENAL, V289, pF459, DOI 10.1152/ajprenal.00040.2005; DEBOER WI, 1994, EXP CELL RES, V214, P510, DOI 10.1006/excr.1994.1288; Gaja L, 2012, CURR PHARM DES; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Herrera RE, 1996, MOL BIOL CELL, V7, P1335, DOI 10.1091/mbc.7.9.1335; HICKS RM, 1975, BIOL REV, V50, P215, DOI 10.1111/j.1469-185X.1975.tb01057.x; Lobban ED, 1998, AM J PATHOL, V153, P1957, DOI 10.1016/S0002-9440(10)65709-4; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Masters, 2003, CULTURE EPITHELIAL C, V8, P381, DOI DOI 10.1002/0471221201.CH12; Olsburgh J, 2003, J PATHOL, V199, P41, DOI 10.1002/path.1252; Shin K, 2011, NATURE, V472, P110, DOI 10.1038/nature09851; SHINAR DM, 1990, ENDOCRINOLOGY, V126, P3153, DOI 10.1210/endo-126-6-3153; Sillett HK, 2001, IMMUNOLOGY, V102, P310, DOI 10.1046/j.1365-2567.2001.01185.x; SOUTHGATE J, 1994, LAB INVEST, V71, P583; SOUTHGATE J, 1995, CELL ADHES COMMUN, V3, P231, DOI 10.3109/15419069509081289; Southgate J, 2007, BJU INT, V99, P1506, DOI 10.1111/j.1464-410X.2007.06795.x; Sun TT, 1999, ADV EXP MED BIOL, V462, P7; Varley C, 2005, EXP CELL RES, V306, P216, DOI 10.1016/j.yexcr.2005.02.004; Varley CL, 2004, J CELL SCI, V117, P2029, DOI 10.1242/jcs.01042; Varley CL, 2004, AM J PATHOL, V164, P1789, DOI 10.1016/S0002-9440(10)63737-6; Varley CL, 2006, J CELL PHYSIOL, V208, P407, DOI 10.1002/jcp.20676; Walker DC, 2004, IEEE T NANOBIOSCI, V3, P153, DOI 10.1109/TNB.2004.833680; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhang J, 2002, CANCER RES, V62, P3743; Zi ZK, 2012, FEBS LETT, V586, P1921, DOI 10.1016/j.febslet.2012.03.063	28	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51404	10.1371/journal.pone.0051404	http://dx.doi.org/10.1371/journal.pone.0051404			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284691	Green Published, Green Submitted, gold			2022-12-27	WOS:000312694300025
J	Gumbel, JH; Patterson, EM; Owusu, SA; Kabat, BE; Jung, DO; Simmons, J; Hopkins, T; Ellsworth, BS				Gumbel, Jason H.; Patterson, Elizabeth M.; Owusu, Sarah A.; Kabat, Brock E.; Jung, Deborah O.; Simmons, Jasmine; Hopkins, Torin; Ellsworth, Buffy S.			The Forkhead Transcription Factor, Foxd1, Is Necessary for Pituitary Luteinizing Hormone Expression in Mice	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; HOMEOBOX GENE LHX3; ANTERIOR-PITUITARY; HPG MOUSE; DISEASE; DIFFERENTIATION; PROTEIN; GROWTH; FOXL2; ORGANOGENESIS	The pituitary gland regulates numerous physiological functions including growth, reproduction, temperature and metabolic homeostasis, lactation, and response to stress. Pituitary organogenesis is dependent on signaling factors that are produced in and around the developing pituitary. The studies described in this report reveal that the forkhead transcription factor, Foxd1, is not expressed in the developing mouse pituitary gland, but rather in the mesenchyme surrounding the pituitary gland, which is an essential source of signaling factors that regulate pituitary organogenesis. Loss of Foxd1 causes a morphological defect in which the anterior lobe of the pituitary gland protrudes through the cartilage plate that is developing ventral to the pituitary at embryonic days ( e) 14.5, e16.5, and e18.5. The number of proliferating pituitary cells is increased at e14.5 and e16.5. Loss of Foxd1 also results in significantly decreased levels of Lhb expression at e18.5. This decrease in Lhb expression does not appear to be due to a change in the number of gonadotrope cells in the pituitary gland. Previous studies have shown that loss of the LIM homeodomain factor, Lhx3, which is activated by the FGF signaling pathway, results in loss of LH production. Although there is a difference in Lhb expression in Foxd1 null mice, the expression pattern of LHX3 is not altered in Foxd1 null mice. These studies suggest that Foxd1 is indirectly required for normal Lhb expression and cartilage formation.	[Gumbel, Jason H.; Patterson, Elizabeth M.; Owusu, Sarah A.; Kabat, Brock E.; Jung, Deborah O.; Simmons, Jasmine; Hopkins, Torin; Ellsworth, Buffy S.] So Illinois Univ, Dept Physiol, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University	Ellsworth, BS (corresponding author), So Illinois Univ, Dept Physiol, Carbondale, IL 62901 USA.	bellsworth@siumed.edu		Gumbel, Jason/0000-0002-2302-3657; Jung, Deborah/0000-0002-8307-8772	Southern Illinois University School of Medicine	Southern Illinois University School of Medicine	This work was supported by a REACH award (E.M.P.), startup funds (B.S.E.), and an ORDA Faculty Seed Grant (B.S.E.) from Southern Illinois University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann JC, 2001, J PEDIATR ENDOCR MET, V14, P3; Arriola DJ, 2012, J BIOL CHEM, V287, P33424, DOI 10.1074/jbc.M112.362103; Brannick KE, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100636; Brinkmeier ML, 2003, MOL ENDOCRINOL, V17, P2152, DOI 10.1210/me.2003-0225; Brinkmeler ML, 2007, DEV BIOL, V311, P396, DOI 10.1016/j.ydbio.2007.08.046; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Carninci P, 2003, GENOME RES, V13, P1273, DOI 10.1101/gr.1119703; Charles MA, 2005, MOL ENDOCRINOL, V19, P1893, DOI 10.1210/me.2005-0052; CHARLTON HM, 1983, ENDOCRINOLOGY, V113, P535, DOI 10.1210/endo-113-2-535; Cirillo LA, 2008, EMBO REP, V9, P721, DOI 10.1038/embor.2008.130; Coss D, 2010, TRENDS ENDOCRIN MET, V21, P562, DOI 10.1016/j.tem.2010.05.006; Cushman LJ, 2001, MAMM GENOME, V12, P485, DOI 10.1007/s003350040002; Dasen JS, 1999, CURR OPIN CELL BIOL, V11, P669, DOI 10.1016/S0955-0674(99)00034-4; Davis SW, 2007, DEV BIOL, V305, P145, DOI 10.1016/j.ydbio.2007.02.001; Ellsworth BS, 2003, MOL CELL ENDOCRINOL, V206, P93, DOI 10.1016/S0303-7207(03)00235-1; Ellsworth BS, 2008, DEV BIOL, V313, P118, DOI 10.1016/j.ydbio.2007.10.006; Ellsworth BS, 2006, MOL ENDOCRINOL, V20, P2796, DOI 10.1210/me.2005-0303; Ericson J, 1998, DEVELOPMENT, V125, P1005; GODFREY VL, 1991, P NATL ACAD SCI USA, V88, P5528, DOI 10.1073/pnas.88.13.5528; Hannenhalli S, 2009, NAT REV GENET, V10, P233, DOI 10.1038/nrg2523; Hatini V, 1996, GENE DEV, V10, P1467, DOI 10.1101/gad.10.12.1467; Herrera E, 2004, DEVELOPMENT, V131, P5727, DOI 10.1242/dev.01431; Jung DO, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094904; Justice NJ, 2011, MOL ENDOCRINOL, V25, P1404, DOI 10.1210/me.2011-0093; Kalinichenko VV, 2003, GENE EXPR PATTERNS, V3, P153, DOI 10.1016/S1567-133X(03)00010-3; Kelberman D, 2009, ENDOCR REV, V30, P790, DOI 10.1210/er.2009-0008; Lamba P, 2009, MOL ENDOCRINOL, V23, P1001, DOI 10.1210/me.2008-0324; Levinson RS, 2005, DEVELOPMENT, V132, P529, DOI 10.1242/dev.01604; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyon MF, 1986, MOUSE NEWS LETT, V74, P93; MASON AJ, 1986, SCIENCE, V234, P1366, DOI 10.1126/science.3024317; Norquay LD, 2006, MOL ENDOCRINOL, V20, P598, DOI 10.1210/me.2005-0221; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; Savage JJ, 2007, J CELL PHYSIOL, V212, P105, DOI 10.1002/jcp.21010; Savage JJ, 2003, GENE, V319, P1, DOI 10.1016/S0378-1119(03)00804-7; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scully KM, 2002, SCIENCE, V295, P2231, DOI 10.1126/science.1062736; Sheng HZ, 1996, SCIENCE, V272, P1004, DOI 10.1126/science.272.5264.1004; Treier M, 1998, GENE DEV, V12, P1691, DOI 10.1101/gad.12.11.1691; Watkins-Chow DE, 1998, TRENDS GENET, V14, P284, DOI 10.1016/S0168-9525(98)01476-0; Wijchers PJEC, 2006, BIOCHEM J, V397, P233, DOI 10.1042/BJ20060387; Zannini M, 1997, EMBO J, V16, P3185, DOI 10.1093/emboj/16.11.3185; Zhao YG, 2006, MECH DEVELOP, V123, P605, DOI 10.1016/j.mod.2006.06.005; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	45	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52156	10.1371/journal.pone.0052156	http://dx.doi.org/10.1371/journal.pone.0052156			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284914	gold, Green Published, Green Submitted			2022-12-27	WOS:000312694300077
J	Liu, YS; Luo, XY; Hu, HC; Wang, R; Sun, YH; Zeng, R; Chen, HQ				Liu, Yansheng; Luo, Xiaoyang; Hu, Haichuan; Wang, Rui; Sun, Yihua; Zeng, Rong; Chen, Haiquan			Integrative Proteomics and Tissue Microarray Profiling Indicate the Association between Overexpressed Serum Proteins and Non-Small Cell Lung Cancer	PLOS ONE			English	Article							MULTIDIMENSIONAL LIQUID-CHROMATOGRAPHY; DIFFERENCE GEL-ELECTROPHORESIS; LEUCINE-RICH ALPHA-2-GLYCOPROTEIN; TARGETED MASS-SPECTROMETRY; PLASMA PROTEOME; BIOMARKER DISCOVERY; PANCREATIC-CANCER; HEPATOCELLULAR-CARCINOMA; SQUAMOUS CARCINOMA; PROSTATE-CANCER	Lung cancer is the leading cause of cancer deaths worldwide. Clinically, the treatment of non-small cell lung cancer (NSCLC) can be improved by the early detection and risk screening among population. To meet this need, here we describe the application of extensive peptide level fractionation coupled with label free quantitative proteomics for the discovery of potential serum biomarkers for lung cancer, and the usage of Tissue microarray analysis (TMA) and Multiple reaction monitoring (MRM) assays for the following up validations in the verification phase. Using these state-of-art, currently available clinical proteomic approaches, in the discovery phase we confidently identified 647 serum proteins, and 101 proteins showed a statistically significant association with NSCLC in our 18 discovery samples. This serum proteomic dataset allowed us to discern the differential patterns and abnormal biological processes in the lung cancer blood. Of these proteins, Alpha-1B-glycoprotein (A1BG) and Leucine-rich alpha-2-glycoprotein (LRG1), two plasma glycoproteins with previously unknown function were selected as examples for which TMA and MRM verification were performed in a large sample set consisting about 100 patients. We revealed that A1BG and LRG1 were overexpressed in both the blood level and tumor sections, which can be referred to separate lung cancer patients from healthy cases.	[Liu, Yansheng; Zeng, Rong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Key Lab Syst Biol, Shanghai, Peoples R China; [Luo, Xiaoyang; Hu, Haichuan; Wang, Rui; Sun, Yihua; Chen, Haiquan] Fudan Univ, Shanghai Med Coll, Dept Oncol, Dept Thorac Surg,Shanghai Canc Ctr, Shanghai 200433, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University	Zeng, R (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Key Lab Syst Biol, Shanghai, Peoples R China.	zr@sibs.ac.cn; chenhq@shca.org.cn	Hu, Haichuan/U-7131-2017; Liu, Yansheng/E-4786-2018; Hu, Haichuan/O-7726-2018	Liu, Yansheng/0000-0002-2626-3912; Hu, Haichuan/0000-0003-3436-290X	Ministry of Science and Technology [2010CB912100, 2011CB910200]; National Natural Science Foundation of China [91029301, 30821065, 81101760, 81172218, 81101761]; Science and Technology Commission of Shanghai Municipality [09JC1416302]; Chinese Academy of Science [KSCX2-YW-R-106, KSCX1-YW-02]; Fudan University [09FQ78]; Fudan University Cancer Hospital [YJ200804, YJ200701]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Chinese Academy of Science(Chinese Academy of Sciences); Fudan University; Fudan University Cancer Hospital	This project was supported by grants from the Ministry of Science and Technology (2010CB912100, 2011CB910200), National Natural Science Foundation of China (91029301, 30821065, 81101760, 81172218, 81101761), Science and Technology Commission of Shanghai Municipality (09JC1416302), Chinese Academy of Science Project (KSCX2-YW-R-106, KSCX1-YW-02), Fudan University (09FQ78) and Fudan University Cancer Hospital (YJ200804, YJ200701). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson L, 2005, J PHYSIOL-LONDON, V563, P23, DOI 10.1113/jphysiol.2004.080473; Badve SS, 2008, J CLIN ONCOL, V26, P2473, DOI 10.1200/JCO.2007.13.6424; Bharti A, 2007, MASS SPECTROM REV, V26, P451, DOI 10.1002/mas.20125; Chatterji B, 2007, PROTEOMICS, V7, P3980, DOI 10.1002/pmic.200700290; Chatterji B, 2009, PROTEOMICS, V9, P1044, DOI 10.1002/pmic.200701135; Cheng AJ, 2005, CLIN CHEM, V51, P2236, DOI 10.1373/clinchem.2005.052324; Cima I, 2011, P NATL ACAD SCI USA, V108, P3342, DOI 10.1073/pnas.1013699108; Colantonio DA, 2005, PROTEOMICS, V5, P3831, DOI 10.1002/pmic.200401235; Cummings C, 2006, APOPTOSIS, V11, P1121, DOI 10.1007/s10495-006-8159-3; Dai J, 2005, ANAL CHEM, V77, P5793, DOI 10.1021/ac050251w; DeSouza L, 2005, J PROTEOME RES, V4, P377, DOI 10.1021/pr049821j; Dowling P, 2007, ELECTROPHORESIS, V28, P4302, DOI 10.1002/elps.200700246; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Faca V, 2006, J PROTEOME RES, V5, P2009, DOI 10.1021/pr060102+; Fiedler GM, 2009, CLIN CANCER RES, V15, P3812, DOI 10.1158/1078-0432.CCR-08-2701; Fu Q, 2005, PROTEOMICS, V5, P2656, DOI 10.1002/pmic.200402048; Fujii K, 2005, PROTEOMICS, V5, P1150, DOI 10.1002/pmic.200401145; Goncalves A, 2008, MOL CELL PROTEOMICS, V7, P1420, DOI 10.1074/mcp.M700487-MCP200; Hanash SM, 2008, NATURE, V452, P571, DOI 10.1038/nature06916; Hebbar V, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-124; Heo SH, 2007, PROTEOMICS, V7, P4292, DOI 10.1002/pmic.200700433; Hong QY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005755; Howard BA, 2003, PROTEOMICS, V3, P1720, DOI 10.1002/pmic.200300514; Huttenhain R, 2009, CURR OPIN CHEM BIOL, V13, P518, DOI 10.1016/j.cbpa.2009.09.014; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kakisaka T, 2007, J CHROMATOGR B, V852, P257, DOI 10.1016/j.jchromb.2007.01.029; Kassis ES, 2009, J THORAC CARDIOV SUR, V138, P412, DOI 10.1016/j.jtcvs.2009.01.033; Kawakami T, 2005, PROTEOMICS, V5, P4287, DOI 10.1002/pmic.200401287; Keshishian H, 2007, MOL CELL PROTEOMICS, V6, P2212, DOI 10.1074/mcp.M700354-MCP200; Kreunin P, 2007, J PROTEOME RES, V6, P2631, DOI 10.1021/pr0700807; Kuzyk MA, 2009, MOL CELL PROTEOMICS, V8, P1860, DOI 10.1074/mcp.M800540-MCP200; Lee HJ, 2006, CURR OPIN CHEM BIOL, V10, P42, DOI 10.1016/j.cbpa.2006.01.007; Li C, 2006, PROTEOMICS, V6, P547, DOI 10.1002/pmic.200500256; Li C, 2003, BIOCHEM BIOPH RES CO, V309, P253, DOI 10.1016/j.bbrc.2003.08.001; Li C, 2011, ELECTROPHORESIS, V32, P2028, DOI 10.1002/elps.201000693; Liu YS, 2010, FEBS J, V277, P4039, DOI 10.1111/j.1742-4658.2010.07795.x; Maciel CM, 2005, J EXP THER ONCOL, V5, P31; Morrissey ER, 2009, NUCLEIC ACIDS RES, V37, pW581, DOI 10.1093/nar/gkp366; Nakagawa T, 2004, LUNG CANCER, V43, P145, DOI 10.1016/j.lungcan.2003.09.004; Nedelkov D, 2005, P NATL ACAD SCI USA, V102, P10852, DOI 10.1073/pnas.0500426102; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; O'Byrne KJ, 2007, J CLIN ONCOL, V25, P3266, DOI 10.1200/JCO.2006.09.2791; O'Donnell LC, 2002, J LEUKOCYTE BIOL, V72, P478; Okano T, 2006, PROTEOMICS, V6, P3938, DOI 10.1002/pmic.200500883; Pan S, 2009, OMICS, V13, P345, DOI 10.1089/omi.2009.0008; Patz EF, 2007, J CLIN ONCOL, V25, P5578, DOI 10.1200/JCO.2007.13.5392; Reiter L, 2009, MOL CELL PROTEOMICS, V8, P2405, DOI 10.1074/mcp.M900317-MCP200; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Sheng QH, 2012, J PROTEOME RES, V11, P1494, DOI 10.1021/pr200194p; States DJ, 2006, NAT BIOTECHNOL, V24, P333, DOI 10.1038/nbt1183; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Tian M, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-241; Ueda K, 2007, J PROTEOME RES, V6, P3475, DOI 10.1021/pr070103h; Weivoda S, 2008, J IMMUNOL METHODS, V336, P22, DOI 10.1016/j.jim.2008.03.004; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; Zeng Z, 2010, J CHROMATOGR A, V1217, P3307, DOI 10.1016/j.chroma.2009.09.029; Zhu WL, 2009, ANTICANCER RES, V29, P2531	59	43	45	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51748	10.1371/journal.pone.0051748	http://dx.doi.org/10.1371/journal.pone.0051748			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284758	gold, Green Submitted, Green Published			2022-12-27	WOS:000312694300039
J	Reichen, M; Macown, RJ; Jaccard, N; Super, A; Ruban, L; Griffin, LD; Veraitch, FS; Szita, N				Reichen, Marcel; Macown, Rhys J.; Jaccard, Nicolas; Super, Alexandre; Ruban, Ludmila; Griffin, Lewis D.; Veraitch, Farlan S.; Szita, Nicolas			Microfabricated Modular Scale-Down Device for Regenerative Medicine Process Development	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; MICROCHANNEL BIOREACTORS; MICROFLUIDIC CULTURE; GREEN LIGHT; PERFUSION; EXPANSION; MICROBIOREACTOR; SELECTION; DESIGN; FUTURE	The capacity of milli and micro litre bioreactors to accelerate process development has been successfully demonstrated in traditional biotechnology. However, for regenerative medicine present smaller scale culture methods cannot cope with the wide range of processing variables that need to be evaluated. Existing microfabricated culture devices, which could test different culture variables with a minimum amount of resources (e. g. expensive culture medium), are typically not designed with process development in mind. We present a novel, autoclavable, and microfabricated scale-down device designed for regenerative medicine process development. The microfabricated device contains a re-sealable culture chamber that facilitates use of standard culture protocols, creating a link with traditional small-scale culture devices for validation and scale-up studies. Further, the modular design can easily accommodate investigation of different culture substrate/extracellular matrix combinations. Inactivated mouse embryonic fibroblasts (iMEF) and human embryonic stem cell (hESC) colonies were successfully seeded on gelatine-coated tissue culture polystyrene (TC-PS) using standard static seeding protocols. The microfluidic chip included in the device offers precise and accurate control over the culture medium flow rate and resulting shear stresses in the device. Cells were cultured for two days with media perfused at 300 mu l.h(-1) resulting in a modelled shear stress of 1.1x10(-4) Pa. Following perfusion, hESC colonies stained positively for different pluripotency markers and retained an undifferentiated morphology. An image processing algorithm was developed which permits quantification of co-cultured colony-forming cells from phase contrast microscope images. hESC colony sizes were quantified against the background of the feeder cells (iMEF) in less than 45 seconds for high-resolution images, which will permit real-time monitoring of culture progress in future experiments. The presented device is a first step to harness the advantages of microfluidics for regenerative medicine process development.	[Reichen, Marcel; Macown, Rhys J.; Jaccard, Nicolas; Super, Alexandre; Ruban, Ludmila; Veraitch, Farlan S.; Szita, Nicolas] UCL, Dept Biochem Engn, London, England; [Jaccard, Nicolas; Griffin, Lewis D.] UCL, Ctr Math & Phys, London, England; [Griffin, Lewis D.] UCL, Dept Comp Sci, London, England	University of London; University College London; University of London; University College London; University of London; University College London	Szita, N (corresponding author), UCL, Dept Biochem Engn, London, England.	n.szita@ucl.ac.uk	Super, Alexandre SM/I-4571-2014	Super, Alexandre/0000-0002-5779-7140	Engineering and Physical Sciences Research Council EPSRC [EP/I005471/1]; Department of Biochemical Engineering, UCL; Peter Dunnill Scholarship; UCL's Engineering Sciences Faculty; British Heart Foundation [BHF SP/08/004]; UCL's Centre for Mathematics and Physics in the Life Sciences and Experimental Biology; EPSRC [EP/I005471/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I005471/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Department of Biochemical Engineering, UCL; Peter Dunnill Scholarship; UCL's Engineering Sciences Faculty; British Heart Foundation(British Heart Foundation); UCL's Centre for Mathematics and Physics in the Life Sciences and Experimental Biology; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors gratefully acknowledge the Engineering and Physical Sciences Research Council EPSRC ('First Grant', EP/I005471/1); the Department of Biochemical Engineering, UCL, for providing funding during Marcel Reichen's PhD studentship; the Peter Dunnill Scholarship, UCL's Engineering Sciences Faculty and UCL's Overseas Research Scholarship for the funding of Rhys J. Macown's PhD studentship; the British Heart Foundation (BHF SP/08/004) and UCL's Centre for Mathematics and Physics in the Life Sciences and Experimental Biology for funding Nicolas Jaccard's PhD studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper J, 2009, NAT BIOTECHNOL, V27, P213, DOI 10.1038/nbt0309-213a; Aunins JG, 2003, BIOTECHNOL PROGR, V19, P2, DOI 10.1021/bp0256521; Berthier E, 2012, LAB CHIP, V12, P1224, DOI 10.1039/c2lc20982a; Betts JI, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-21; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Crosier M, 2010, INT J COMPUT VISION, V88, P447, DOI 10.1007/s11263-009-0315-0; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063; Figallo E, 2007, LAB CHIP, V7, P710, DOI 10.1039/b700063d; Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736; Fong WJ, 2005, BIOPROC BIOSYST ENG, V27, P381, DOI 10.1007/s00449-005-0421-5; Fredrickson CK, 2004, LAB CHIP, V4, P526, DOI 10.1039/b410720a; Gorba T, 2003, PHARMACOL RES, V47, P269, DOI 10.1016/S1043-6618(03)00036-7; Haeberle S, 2007, LAB CHIP, V7, P1094, DOI 10.1039/b706364b; Heng BC, 2012, STEM CELLS DEV, V21, P1701, DOI 10.1089/scd.2011.0509; Hung PJ, 2005, LAB CHIP, V5, P44, DOI 10.1039/b410743h; Jaiantilal A, 2009, CLASSIFICATION REGRE; Kamei KI, 2009, LAB CHIP, V9, P555, DOI 10.1039/b809105f; Kang LF, 2008, DRUG DISCOV TODAY, V13, P1, DOI 10.1016/j.drudis.2007.10.003; Kim L, 2007, LAB CHIP, V7, P681, DOI 10.1039/b704602b; Kirouac DC, 2008, CELL STEM CELL, V3, P369, DOI 10.1016/j.stem.2008.09.001; KOLLER MR, 1993, BLOOD, V82, P378; Korin N, 2006, SPIE P, V6416; Korin N, 2009, BIOMED MICRODEVICES, V11, P87, DOI 10.1007/s10544-008-9212-5; Korin N, 2009, BIOTECHNOL BIOENG, V102, P1222, DOI 10.1002/bit.22153; Kostov Y, 2001, BIOTECHNOL BIOENG, V72, P346, DOI 10.1002/1097-0290(20010205)72:3<346::AID-BIT12>3.0.CO;2-X; Lemon EW, 2009, CRC HDB CHEM PHYS; Mack GS, 2011, NAT BIOTECHNOL, V29, P95, DOI 10.1038/nbt0211-95; Marques Marco P C, 2009, Recent Pat Biotechnol, V3, P124, DOI 10.2174/187220809788700193; Mason C, 2008, REGEN MED, V3, P1, DOI 10.2217/17460751.3.1.1; Mason C, 2007, TISSUE ENG, V13, P301, DOI 10.1089/ten.2006.0177; Mason C, 2009, REGEN MED, V4, P153, DOI 10.2217/17460751.4.2.153; McKernan R, 2010, CELL STEM CELL, V6, P517, DOI 10.1016/j.stem.2010.05.012; Micheletti M, 2006, CURR OPIN BIOTECH, V17, P611, DOI 10.1016/j.copbio.2006.10.006; Oh SK, 2005, STEM CELLS, V23, P605, DOI 10.1634/stemcells.2004-0297; Oh SKW, 2005, BIOTECHNOL BIOENG, V91, P523, DOI 10.1002/bit.20650; Petronis S, 2006, BIOTECHNIQUES, V40, P368, DOI 10.2144/000112122; Placzek MR, 2009, J R SOC INTERFACE, V6, P209, DOI 10.1098/rsif.2008.0442; Rao G, 2009, BIOTECHNOL BIOENG, V102, P348, DOI 10.1002/bit.22192; SANDSTROM CE, 1995, BLOOD, V86, P958; Schapper D, 2009, ANAL BIOANAL CHEM, V395, P679, DOI 10.1007/s00216-009-2955-x; Terstegge S, 2007, BIOTECHNOL BIOENG, V96, P195, DOI 10.1002/bit.21061; Thomson H, 2007, TRENDS BIOTECHNOL, V25, P224, DOI 10.1016/j.tibtech.2007.03.003; Titmarsh D, 2011, BIOTECHNOL BIOENG, V108, P2894, DOI 10.1002/bit.23260; Tkachenko E, 2009, LAB CHIP, V9, P1085, DOI 10.1039/b812184b; Toh YC, 2011, FASEB J, V25, P1208, DOI 10.1096/fj.10-168971; van Heeren H, 2012, LAB CHIP, V12, P1022, DOI 10.1039/c2lc20937c; van Noort D, 2009, BIOTECHNOL PROGR, V25, P52, DOI 10.1002/btpr.171; Veraitch FS, 2008, BIOTECHNOL BIOENG, V99, P1216, DOI 10.1002/bit.21673; Villa-Diaz LG, 2009, LAB CHIP, V9, P1749, DOI 10.1039/b820380f; Young EWK, 2010, CHEM SOC REV, V39, P1036, DOI 10.1039/b909900j; Zanzotto A, 2004, BIOTECHNOL BIOENG, V87, P243, DOI 10.1002/bit.20140	52	24	24	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52246	10.1371/journal.pone.0052246	http://dx.doi.org/10.1371/journal.pone.0052246			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284952	Green Published, gold, Green Submitted			2022-12-27	WOS:000312694300082
J	Aluru, SV; Agarwal, S; Srinivasan, B; Iyer, GK; Rajappa, SM; Tatu, U; Padmanabhan, P; Subramanian, N; Narayanasamy, A				Aluru, Saijyothi Venkata; Agarwal, Shweta; Srinivasan, Bhaskar; Iyer, Geetha Krishnan; Rajappa, Sivakumar M.; Tatu, Utpal; Padmanabhan, Prema; Subramanian, Nirmala; Narayanasamy, Angayarkanni			Lacrimal Proline Rich 4 (LPRR4) Protein in the Tear Fluid Is a Potential Biomarker of Dry Eye Syndrome	PLOS ONE			English	Article							OCULAR SURFACE; SECRETORY IGA; PATTERNS; LACRITIN; DISEASE	Dry eye syndrome (DES) is a complex, multifactorial, immune-associated disorder of the tear and ocular surface. DES with a high prevalence world over needs identification of potential biomarkers so as to understand not only the disease mechanism but also to identify drug targets. In this study we looked for differentially expressed proteins in tear samples of DES to arrive at characteristic biomarkers. As part of a prospective case-control study, tear specimen were collected using Schirmer strips from 129 dry eye cases and 73 age matched controls. 2D electrophoresis (2DE) and Differential gel electrophoresis (DIGE) was done to identify differentially expressed proteins. One of the differentially expressed protein in DES is lacrimal proline rich 4 protein (LPRR4). LPRR4 protein expression was quantified by enzyme immune sorbent assay (ELISA). LPRR4 was down regulated significantly in all types of dry eye cases, correlating with the disease severity as measured by clinical investigations. Further characterization of the protein is required to assess its therapeutic potential in DES.	[Aluru, Saijyothi Venkata; Narayanasamy, Angayarkanni] Sankara Nethralaya, Biochem & Cell Biol Dept, Vis Res Fdn, Madras, Tamil Nadu, India; [Agarwal, Shweta; Srinivasan, Bhaskar; Iyer, Geetha Krishnan; Padmanabhan, Prema] Sankara Nethralaya, Ocular Surface Clin, Med Res Fdn, Madras, Tamil Nadu, India; [Rajappa, Sivakumar M.] Cerebrovasc & Vasculitis Res Fdn, Madras, Tamil Nadu, India; [Tatu, Utpal] Indian Inst Sci IISc, Dept Biochem, Bangalore, Karnataka, India; [Subramanian, Nirmala] Sankara Nethralaya, Med Res Fdn, Oculoplasty Dept, Madras, Tamil Nadu, India	Indian Institute of Science (IISC) - Bangalore	Narayanasamy, A (corresponding author), Sankara Nethralaya, Biochem & Cell Biol Dept, Vis Res Fdn, Madras, Tamil Nadu, India.	drak@snmail.org	Iyer, Geetha/GZA-6085-2022; Narayanasamy, Angayarkanni/ABD-8584-2020	Iyer, Geetha/0000-0002-7903-9500; Tatu, Utpal/0000-0003-0404-8872	Department of Biotechnology (DBT), India [BT/PR/0412/Med/30/82/2008]	Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India)	This work is funded by Department of Biotechnology (DBT), No. BT/PR/0412/Med/30/82/2008, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthi S, 2008, MOL VIS, V14, P500; Assouti M, 2006, BBA-MOL BASIS DIS, V1762, P54, DOI 10.1016/j.bbadis.2005.09.005; Baldini C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-188; BENNICK A, 1971, BIOCHEM J, V123, P455, DOI 10.1042/bj1230455; Boehm N, 2011, INVEST OPHTH VIS SCI, V52, P7725, DOI 10.1167/iovs.11-7266; CARLSON DM, 1993, CRIT REV ORAL BIOL M, V4, P495, DOI 10.1177/10454411930040033401; Choy CKM, 2001, INVEST OPHTH VIS SCI, V42, P3130; DICKINSON DP, 1995, INVEST OPHTH VIS SCI, V36, P2020; Fung KYC, 2004, PROTEOMICS, V4, P3953, DOI 10.1002/pmic.200300849; Galor A, 2011, AM J OPHTHALMOL, V152, P377, DOI 10.1016/j.ajo.2011.02.026; Graham Joanna E, 2007, Invest Ophthalmol Vis Sci, V48, P5616; Gupta N, 2010, ANN TROP MED PARASIT, V104, P247, DOI 10.1179/136485910X12647085215859; Ham BM, 2007, ANAL BIOANAL CHEM, V387, P889, DOI 10.1007/s00216-006-1018-9; HAY DI, 1988, BIOCHEM J, V255, P15, DOI 10.1042/bj2550015; Herber S, 2001, ELECTROPHORESIS, V22, P1838, DOI 10.1002/1522-2683(200105)22:9<1838::AID-ELPS1838>3.0.CO;2-7; Hjelmervik TOR, 2009, ORAL DIS, V15, P342, DOI 10.1111/j.1601-0825.2009.01531.x; HOLLY FJ, 1977, SURV OPHTHALMOL, V22, P69, DOI 10.1016/0039-6257(77)90087-X; Hoshino Mai, 2006, Nippon Ganka Gakkai Zasshi, V110, P276; Jeong JH, 2011, CORNEA; Kawai S, 2002, ANN CLIN BIOCHEM, V39, P56, DOI 10.1258/0004563021901748; Knop E, 2003, OPHTHALMOLOGE, V100, P917, DOI 10.1007/s00347-003-0935-7; Knop E, 2008, INVEST OPHTH VIS SCI, V49, P2322, DOI 10.1167/iovs.07-0691; Koo BS, 2005, J PROTEOME RES, V4, P719, DOI 10.1021/pr0498133; Lehrer RI, 1998, FEBS LETT, V432, P163, DOI 10.1016/S0014-5793(98)00852-7; Lembach M, 2001, CURR EYE RES, V22, P286, DOI 10.1076/ceyr.22.4.286.5502; Lemp MA, 2007, OCUL SURF, V5, P75; McKown RL, 2009, EXP EYE RES, V88, P848, DOI 10.1016/j.exer.2008.09.002; MORENO EC, 1982, J BIOL CHEM, V257, P2981; OPPENHEIM FG, 1971, BIOCHEMISTRY-US, V10, P4233, DOI 10.1021/bi00799a013; Redl B, 2000, BBA-PROTEIN STRUCT M, V1482, P241, DOI 10.1016/S0167-4838(00)00142-4; Saijyothi AV, 2010, ELECTROPHORESIS, V31, P3420, DOI 10.1002/elps.201000271; Samudre S, 2011, INVEST OPHTH VIS SCI, V52, P6265, DOI 10.1167/iovs.10-6220; Sanghi S, 2001, J MOL BIOL, V310, P127, DOI 10.1006/jmbi.2001.4748; Schiffman RM, 2000, ARCH OPHTHALMOL-CHIC, V118, P615, DOI 10.1001/archopht.118.5.615; Tervo T, 1997, EXP EYE RES, V64, P501, DOI 10.1006/exer.1996.0226; Tomosugi N, 2005, J PROTEOME RES, V4, P820, DOI 10.1021/pr0497576; Tsai PS, 2006, BRIT J OPHTHALMOL, V90, P372, DOI 10.1136/bjo.2005.080846; Tsubota K, 2001, LANCET, V357, P688, DOI 10.1016/S0140-6736(00)04140-4; Vesaluoma M, 1997, CURR EYE RES, V16, P19, DOI 10.1076/ceyr.16.1.19.5119; WARNER TF, 1988, MED HYPOTHESES, V26, P99, DOI 10.1016/0306-9877(88)90060-6; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; Wong TT, 2011, INVEST OPHTH VIS SCI; Zhou L, 2003, RAPID COMMUN MASS SP, V17, P401, DOI 10.1002/rcm.925	43	47	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51979	10.1371/journal.pone.0051979	http://dx.doi.org/10.1371/journal.pone.0051979			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272196	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000312483300045
J	Wang, YJ; van der Walt, A; Paine, M; Klistorner, A; Butzkueven, H; Egan, GF; Kilpatrick, TJ; Kolbe, SC				Wang, Yejun; van der Walt, Anneke; Paine, Mark; Klistorner, Alexander; Butzkueven, Helmut; Egan, Gary F.; Kilpatrick, Trevor J.; Kolbe, Scott C.			Optic Nerve Magnetisation Transfer Ratio after Acute Optic Neuritis Predicts Axonal and Visual Outcomes	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS BRAIN; CONTRAST LETTER ACUITY; COHERENCE TOMOGRAPHY; DYSFUNCTION; LESIONS; MYELIN; MRI	Magnetisation transfer ratio (MTR) can reveal the degree of proton exchange between free water and macromolecules and was suggested to be pathological informative. We aimed to investigate changes in optic nerve MTR over 12 months following acute optic neuritis (ON) and to determine whether MTR measurements can predict clinical and paraclinical outcomes at 6 and 12 months. Thirty-seven patients with acute ON were studied within 2 weeks of presentation and at 1, 3, 6 and 12 months. Assessments included optic nerve MTR, retinal nerve fibre layer (RNFL) thickness, multifocal visual evoked potential (mfVEP) amplitude and latency and high (100%) and low (2.5%) contrast letter acuity. Eleven healthy controls were scanned twice four weeks apart for comparison with patients. Patient unaffected optic nerve MTR did not significantly differ from controls at any time-point. Compared to the unaffected nerve, affected optic nerve MTR was significantly reduced at 3 months (mean percentage interocular difference = -9.24%, p = 0.01), 6 months (mean = -12.48%, p<0.0001) and 12 months (mean = -7.61%, p = 0.003). Greater reduction in MTR at 3 months in patients was associated with subsequent loss of high contrast letter acuity at 6 (rho = 0.60, p = 0.0003) and 12 (rho = 0.44, p = 0.009) months, low contrast letter acuity at 6 (rho = 0.35, p = 0.047) months, and RNFL thinning at 12 (rho = 0.35, p = 0.044) months. Stratification of individual patient MTR time courses based on flux over 12 months (stable, putative remyelination and putative degeneration) predicted RNFL thinning at 12 months (F-2,F-32 = 3.59, p = 0.02). In conclusion, these findings indicate that MTR flux after acute ON is predictive of axonal degeneration and visual disability outcomes.	[Wang, Yejun; van der Walt, Anneke; Kilpatrick, Trevor J.; Kolbe, Scott C.] Univ Melbourne, Ctr Neurosci Res, Parkville, Vic 3052, Australia; [Butzkueven, Helmut] Univ Melbourne, Dept Med, Parkville, Vic 3052, Australia; [van der Walt, Anneke; Butzkueven, Helmut; Kilpatrick, Trevor J.] Royal Melbourne Hosp, Dept Neurol, Parkville, Vic 3050, Australia; [Paine, Mark] Royal Victoria Eye & Ear Hosp, Melbourne, Vic, Australia; [Klistorner, Alexander] Sydney Eye Hosp, Sydney, NSW, Australia; [Egan, Gary F.] Monash Univ, Clayton, Vic, Australia	University of Melbourne; University of Melbourne; Royal Melbourne Hospital; Royal Victorian Eye & Ear Hospital; Monash University	Kolbe, SC (corresponding author), Univ Melbourne, Ctr Neurosci Res, Parkville, Vic 3052, Australia.	kolbes@unimelb.edu.au	Egan, Gary F./A-1381-2013	Butzkueven, Helmut/0000-0003-3940-8727; Klistorner, Alexander/0000-0003-0361-6399; Egan, Gary/0000-0002-3186-4026; Kilpatrick, Trevor/0000-0003-3999-085X; Kolbe, Scott/0000-0003-4685-1380	National MS Society [RG4211A4/2]; National Health and Medical Research Council of Australia [628415]; Bayer Australia; Biogen Idec; Merck Serono; GlaxoSmithKline; Sanofi Aventis; Novartis; Bayer Schering pharma	National MS Society(National Multiple Sclerosis Society); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Bayer Australia; Biogen Idec(Biogen); Merck Serono(Merck & Company); GlaxoSmithKline(GlaxoSmithKline); Sanofi Aventis(Sanofi-Aventis); Novartis(Novartis); Bayer Schering pharma(Bayer AG)	This research was supported by the National MS Society (grant RG4211A4/2#) and the National Health and Medical Research Council of Australia (grant 628415). The authors received small unrestricted grants from Bayer Australia, Biogen Idec, Merck Serono and GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. van der Walt has received travel support from Bayer Australia and Sanofi Aventis. She has received unrestricted grants from Bayer Asutralia and Biogen Idec. Dr. Klistorner is supported by an unrestricted grant from Biogen Idec. Dr. Butzkueven has served on scientific advisory boards for Biogen Idec, Novartis and Sanofi-Aventis and has received conference travel support from Novartis, Biogen Idec and Sanofi Aventis. He serves on steering committees for trials conducted by Merck Serono, Biogen Idec and Novartis. Dr. Butzkueven has received research support from Merck Serono, Novartis and Biogen Idec in his capacity as honorary chair of the MSBase Foundation. Dr. Kilpatrick has served on scientific advisory boards for GlaxoSmithKline, Neurosciences Victoria and the Victorian Neurotrauma Initiative; has received funding for travel from Bayer Schering pharma, Sanofi Aventis and Merck Serono; served on the editorial board of Therapeutic Advances in Neurological Disorders; is listed as an inventor on patents re: HIV test kit method for detecting anti-HIV-1 antibodies in saliva; A method of modulating cell survival and reagents useful for the same; Methods for the treatment and prophylaxis of demyelinating disease; and Method of treatment in the field of inflammatory neurodegeneration; and receives research support from Bayer Schering Pharma, Biogen IDEC. Dr. Egan serves on an ARC college of experts panel for which he receives personal compensation, he is a member of the Neurosciences Victoria scientific advisory board; he has received travel expenses and/or honoraria for lectures or educational activities not funded by industry; he is an associate editor of Human Brain Mapping, he serves on the editorial boards of Neuroimage and the Journal of Imaging Technology.	Baier ML, 2005, NEUROLOGY, V64, P992, DOI 10.1212/01.WNL.0000154521.40686.63; Balcer LJ, 2003, NEUROLOGY, V61, P1367, DOI 10.1212/01.WNL.0000094315.19931.90; BECH RW, 1991, ARCH OPHTHALMOL-CHIC, V109, P1673, DOI 10.1001/archopht.1991.01080120057025; Bland JM, 1996, BRIT MED J, V313, P41, DOI 10.1136/bmj.313.7048.41; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Costello F, 2008, MULT SCLER J, V14, P893, DOI 10.1177/1352458508091367; Costello F, 2006, ANN NEUROL, V59, P963, DOI 10.1002/ana.20851; Fraser CL, 2006, OPHTHALMOLOGY, V113, P315, DOI 10.1016/j.ophtha.2005.10.017; Gareau PJ, 2000, J MAGN RESON IMAGING, V11, P586, DOI 10.1002/1522-2586(200006)11:6<586::AID-JMRI3>3.0.CO;2-V; HALLIDAY AM, 1972, LANCET, V1, P982; Hickman SJ, 2004, BRAIN, V127, P692, DOI 10.1093/brain/awh076; Klistorner A, 2011, NEUROIMAGE, V56, P21, DOI 10.1016/j.neuroimage.2011.02.041; Klistorner A, 2008, ANN NEUROL, V64, P325, DOI 10.1002/ana.21474; Klistorner A, 2007, INVEST OPHTH VIS SCI, V48, P4549, DOI 10.1167/iovs.07-0381; Klistorner A, 2009, DOC OPHTHALMOL, V118, P129, DOI 10.1007/s10633-008-9147-4; Kolappan M, 2009, J NEUROL, V256, P305, DOI 10.1007/s00415-009-0123-z; Melzi L, 2007, MULT SCLER, V13, P265, DOI 10.1177/1352458506071212; O'Riordan JI, 1998, BRAIN, V121, P495, DOI 10.1093/brain/121.3.495; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; REGAN D, 1977, BRAIN, V100, P563, DOI 10.1093/brain/100.3.563; Schmierer K, 2004, ANN NEUROL, V56, P407, DOI 10.1002/ana.20202; Schmierer K, 2007, J MAGN RESON IMAGING, V26, P41, DOI 10.1002/jmri.20984; THORPE JW, 1995, J NEUROL NEUROSUR PS, V59, P487, DOI 10.1136/jnnp.59.5.487; Trip S, 2007, MULT SCLER J, V13, P875, DOI 10.1177/1352458507076952; Trip SA, 2006, NEUROIMAGE, V31, P286, DOI 10.1016/j.neuroimage.2005.11.051; Trip SA, 2005, ANN NEUROL, V58, P383, DOI 10.1002/ana.20575; van Waesberghe JHTM, 1999, ANN NEUROL, V46, P747; WOLFF SD, 1989, MAGNET RESON MED, V10, P135, DOI 10.1002/mrm.1910100113	28	12	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52291	10.1371/journal.pone.0052291	http://dx.doi.org/10.1371/journal.pone.0052291			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272235	Green Published, gold			2022-12-27	WOS:000312483300077
J	Churan, J; Guitton, D; Pack, CC				Churan, Jan; Guitton, Daniel; Pack, Christopher C.			Perisaccadic Remapping and Rescaling of Visual Responses in Macaque Superior Colliculus	PLOS ONE			English	Article							SACCADIC EYE-MOVEMENTS; UPDATING SPATIAL REPRESENTATIONS; PARIETAL CORTEX; COROLLARY DISCHARGE; AREA LIP; DYNAMIC CIRCUITRY; RECEPTIVE-FIELDS; MONKEY STRIATE; V4 NEURONS; BRAIN	Visual neurons have spatial receptive fields that encode the positions of objects relative to the fovea. Because foveate animals execute frequent saccadic eye movements, this position information is constantly changing, even though the visual world is generally stationary. Interestingly, visual receptive fields in many brain regions have been found to exhibit changes in strength, size, or position around the time of each saccade, and these changes have often been suggested to be involved in the maintenance of perceptual stability. Crucial to the circuitry underlying perisaccadic changes in visual receptive fields is the superior colliculus (SC), a brainstem structure responsible for integrating visual and oculomotor signals. In this work we have studied the time-course of receptive field changes in the SC. We find that the distribution of the latencies of SC responses to stimuli placed outside the fixation receptive field is bimodal: The first mode is comprised of early responses that are temporally locked to the onset of the visual probe stimulus and stronger for probes placed closer to the classical receptive field. We suggest that such responses are therefore consistent with a perisaccadic rescaling, or enhancement, of weak visual responses within a fixed spatial receptive field. The second mode is more similar to the remapping that has been reported in the cortex, as responses are time-locked to saccade onset and stronger for stimuli placed in the postsaccadic receptive field location. We suggest that these two temporal phases of spatial updating may represent different sources of input to the SC.	[Churan, Jan; Guitton, Daniel; Pack, Christopher C.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada	McGill University	Churan, J (corresponding author), McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada.	jan.churan@gmail.com			CIHR [MOP-115178, MOP-9222]; NSERC [341534-12]; EJLB Foundation	CIHR(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); EJLB Foundation	CIHR grant to C. Pack MOP-115178, CIHR grant to D. Guitton MOP-9222, NSERC grant to C. Pack 341534-12, and EJLB Foundation grant to C. Pack. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman RA, 2007, J NEUROPHYSIOL, V98, P105, DOI 10.1152/jn.00330.2007; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Choi WY, 2006, NEURON, V50, P491, DOI 10.1016/j.neuron.2006.03.032; Churan J, 2011, J NEUROPHYSIOL, V106, P1862, DOI 10.1152/jn.00288.2011; Crapse TB, 2008, CURR OPIN NEUROBIOL, V18, P552, DOI 10.1016/j.conb.2008.09.017; DUFFY FH, 1975, BRAIN RES, V89, P121; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Dunn CA, 2010, J NEUROPHYSIOL, V104, P1267, DOI 10.1152/jn.00675.2009; Ferraina S, 2002, J NEUROPHYSIOL, V87, P845, DOI 10.1152/jn.00317.2001; GOLDBERG ME, 1972, J NEUROPHYSIOL, V35, P542, DOI 10.1152/jn.1972.35.4.542; Han X, 2009, P NATL ACAD SCI USA, V106, P13046, DOI 10.1073/pnas.0902412106; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Heiser LM, 2006, J NEUROPHYSIOL, V95, P2751, DOI 10.1152/jn.00054.2005; Heiser LM, 2005, J NEUROPHYSIOL, V94, P3249, DOI 10.1152/jn.00029.2005; Leichnetz GR, 2001, ANAT RECORD, V263, P215, DOI 10.1002/ar.1082; Li XB, 2008, J NEUROSCI, V28, P4561, DOI 10.1523/JNEUROSCI.5683-07.2008; Lynch JC, 2006, PROG BRAIN RES, V151, P461, DOI 10.1016/S0079-6123(05)51015-X; Maunsell JHR, 1999, VISUAL NEUROSCI, V16, P1, DOI 10.1017/S0952523899156177; MAYS LE, 1980, SCIENCE, V208, P1163, DOI 10.1126/science.6769161; Nakamura K, 2002, P NATL ACAD SCI USA, V99, P4026, DOI 10.1073/pnas.052379899; Pare M, 1997, J NEUROPHYSIOL, V78, P3493, DOI 10.1152/jn.1997.78.6.3493; Pare M, 2001, J NEUROPHYSIOL, V85, P2545, DOI 10.1152/jn.2001.85.6.2545; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; RICHMOND BJ, 1980, J NEUROPHYSIOL, V43, P1156, DOI 10.1152/jn.1980.43.4.1156; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; Sommer MA, 2008, ANNU REV NEUROSCI, V31, P317, DOI 10.1146/annurev.neuro.31.060407.125627; Sommer MA, 2008, PERCEPTION, V37, P408, DOI 10.1068/p5873; Sommer MA, 2006, NATURE, V444, P374, DOI 10.1038/nature05279; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; Tolias AS, 2001, NEURON, V29, P757, DOI 10.1016/S0896-6273(01)00250-1; Umeno MM, 1997, J NEUROPHYSIOL, V78, P1373, DOI 10.1152/jn.1997.78.3.1373; Umeno MM, 2001, J NEUROPHYSIOL, V86, P2344, DOI 10.1152/jn.2001.86.5.2344; Vaziri S, 2006, J NEUROSCI, V26, P4188, DOI 10.1523/JNEUROSCI.4747-05.2006; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; WALKER MF, 1995, J NEUROPHYSIOL, V73, P1988, DOI 10.1152/jn.1995.73.5.1988; WURTZ RH, 1976, J NEUROPHYSIOL, V39, P745, DOI 10.1152/jn.1976.39.4.745; WURTZ RH, 1976, J NEUROPHYSIOL, V39, P766, DOI 10.1152/jn.1976.39.4.766; Wurtz RH, 2008, VISION RES, V48, P2070, DOI 10.1016/j.visres.2008.03.021; ZARETSKY M, 1979, NATURE, V280, P583, DOI 10.1038/280583a0	40	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52195	10.1371/journal.pone.0052195	http://dx.doi.org/10.1371/journal.pone.0052195			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284931	Green Published, Green Submitted, gold			2022-12-27	WOS:000312435900085
J	Conte, D; Huh, M; Goodall, E; Delorme, M; Parks, RJ; Picketts, DJ				Conte, Damiano; Huh, Michael; Goodall, Emma; Delorme, Marilyne; Parks, Robin J.; Picketts, David J.			Loss of Atrx Sensitizes Cells to DNA Damaging Agents through p53-Mediated Death Pathways	PLOS ONE			English	Article							X SYNDROME PROTEIN; MENTAL-RETARDATION; TARGETED DISRUPTION; NUCLEAR-BODIES; CANCER-THERAPY; FREQUENT ATRX; HELPER VIRUS; MUTATIONS; CHROMATIN; EXPRESSION	Prevalent cell death in forebrain- and Sertoli cell-specific Atrx knockout mice suggest that Atrx is important for cell survival. However, conditional ablation in other tissues is not associated with increased death indicating that diverse cell types respond differently to the loss of this chromatin remodeling protein. Here, primary macrophages isolated from Atrx(f/f) mice were infected with adenovirus expressing Cre recombinase or beta-galactosidase, and assayed for cell survival under different experimental conditions. Macrophages survive without Atrx but undergo rapid apoptosis upon lipopolysaccharide (LPS) activation suggesting that chromatin reorganization in response to external stimuli is compromised. Using this system we next tested the effect of different apoptotic stimuli on cell survival. We observed that survival of Atrx-null cells were similar to wild type cells in response to serum withdrawal, anti-Fas antibody, C2 ceramide or dexamethasone treatment but were more sensitive to 5-fluorouracil (5-FU). Cell survival could be rescued by re-introducing Atrx or by removal of p53 demonstrating the cell autonomous nature of the effect and its p53-dependence. Finally, we demonstrate that multiple primary cell types (myoblasts, embryonic fibroblasts and neurospheres) were sensitive to 5-FU, cisplatin, and UV light treatment. Together, our results suggest that cells lacking Atrx are more sensitive to DNA damaging agents and that this may result in enhanced death during development when cells are at their proliferative peak. Moreover, it identifies potential treatment options for cancers associated with ATRX mutations, including glioblastoma and pancreatic neuroendocrine tumors.	[Conte, Damiano; Huh, Michael; Goodall, Emma; Delorme, Marilyne; Parks, Robin J.; Picketts, David J.] Ottawa Hosp Res Inst, Regenerat Med Program, Ottawa, ON, Canada; [Goodall, Emma] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Delorme, Marilyne; Parks, Robin J.; Picketts, David J.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Parks, Robin J.; Picketts, David J.] Univ Ottawa, Dept Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa	Picketts, DJ (corresponding author), Ottawa Hosp Res Inst, Regenerat Med Program, Ottawa, ON, Canada.	dpicketts@ohri.ca			Canadian Institutes of Health Research [MOP-84412]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	DJP is funded by operating grant MOP-84412 from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison CL, 1997, J GEN VIROL, V78, P1653, DOI 10.1099/0022-1317-78-7-1653; Alexiadis V, 2002, GENE DEV, V16, P2767, DOI 10.1101/gad.1032102; ANTON M, 1995, J VIROL, V69, P4600, DOI 10.1128/JVI.69.8.4600-4606.1995; Aucott R, 2008, J CELL BIOL, V183, P597, DOI 10.1083/jcb.200804041; Bagheri-Fam S, 2011, HUM MOL GENET, V20, P2213, DOI 10.1093/hmg/ddr109; Berube NG, 2008, EUR J HUM GENET, V16, P192, DOI 10.1038/sj.ejhg.5201943; Berube NG, 2005, J CLIN INVEST, V115, P258, DOI 10.1172/JCI200522329; Berube NG, 2000, HUM MOL GENET, V9, P539, DOI 10.1093/hmg/9.4.539; Cardoso C, 1998, HUM MOL GENET, V7, P679, DOI 10.1093/hmg/7.4.679; Chester N, 1998, GENE DEV, V12, P3382, DOI 10.1101/gad.12.21.3382; Conte D, 2006, MOL CELL BIOL, V26, P699, DOI 10.1128/MCB.26.2.699-708.2006; Dhayalan A, 2011, HUM MOL GENET, V20, P2195, DOI 10.1093/hmg/ddr107; Dobrovolskaia MA, 2002, MICROBES INFECT, V4, P903, DOI 10.1016/S1286-4579(02)01613-1; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Eustermann S, 2011, NAT STRUCT MOL BIOL, V18, P777, DOI 10.1038/nsmb.2070; Garrick D, 2006, PLOS GENET, V2, P438, DOI 10.1371/journal.pgen.0020058; Gibbons R, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-15; Gibbons RJ, 2008, HUM MUTAT, V29, P796, DOI 10.1002/humu.20734; GIBBONS RJ, 1995, CELL, V80, P837, DOI 10.1016/0092-8674(95)90287-2; Gibbons RJ, 2000, NAT GENET, V24, P368, DOI 10.1038/74191; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Golub EI, 1997, NUCLEIC ACIDS RES, V25, P4106, DOI 10.1093/nar/25.20.4106; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Hogan B, 1994, MANIPULATING MOUSE E; Hong YK, 2009, BIOCHEM BIOPH RES CO, V384, P160, DOI 10.1016/j.bbrc.2009.04.112; Hubberstey AV, 2002, CANCER GENE THER, V9, P321, DOI 10.1038/sj.cgt.7700436; Imreh G, 2011, J CELL SCI, V124, P2951, DOI 10.1242/jcs.081612; Iwase S, 2011, NAT STRUCT MOL BIOL, V18, P769, DOI 10.1038/nsmb.2062; Jaskelioff M, 2003, J BIOL CHEM, V278, P9212, DOI 10.1074/jbc.M211545200; Jiao YC, 2012, ONCOTARGET, V3, P709, DOI 10.18632/oncotarget.588; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Law MJ, 2010, CELL, V143, P367, DOI 10.1016/j.cell.2010.09.023; Lebel M, 1998, P NATL ACAD SCI USA, V95, P13097, DOI 10.1073/pnas.95.22.13097; Lebwohl D, 1998, EUR J CANCER, V34, P1522, DOI 10.1016/S0959-8049(98)00224-X; Lee NG, 2007, FEBS LETT, V581, P2625, DOI 10.1016/j.febslet.2007.05.005; LEWIS PW, 2010, P NATL ACAD SCI US; Liu XY, 2012, ACTA NEUROPATHOL, V124, P615, DOI 10.1007/s00401-012-1031-3; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Lovejoy CA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002772; McDowell TL, 1999, P NATL ACAD SCI USA, V96, P13983, DOI 10.1073/pnas.96.24.13983; Medina CF, 2009, HUM MOL GENET, V18, P966, DOI 10.1093/hmg/ddn424; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Nan XS, 2007, P NATL ACAD SCI USA, V104, P2709, DOI 10.1073/pnas.0608056104; Parks RJ, 1996, P NATL ACAD SCI USA, V93, P13565, DOI 10.1073/pnas.93.24.13565; Picketts DJ, 1998, MAMM GENOME, V9, P400, DOI 10.1007/s003359900781; Ritchie K, 2008, J CELL BIOL, V180, P315, DOI 10.1083/jcb.200706083; Ross PJ, 2009, COLD SPRING HARB PRO, V2009; Sargent KL, 2004, GENE THER, V11, P504, DOI 10.1038/sj.gt.3302107; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Seah C, 2008, J NEUROSCI, V28, P12570, DOI 10.1523/JNEUROSCI.4048-08.2008; Sladek Z, 2009, RES VET SCI, V86, P235, DOI 10.1016/j.rvsc.2008.07.016; Solomon LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007106; Steensma DP, 2004, BLOOD, V103, P2019, DOI 10.1182/blood-2003-09-3360; Tan TLR, 1999, CURR BIOL, V9, P325, DOI 10.1016/S0960-9822(99)80142-0; Tang J, 2004, J BIOL CHEM, V279, P20369, DOI 10.1074/jbc.M401321200; Tang J, 2006, NAT CELL BIOL, V8, P855, DOI 10.1038/ncb1442; Wong LH, 2010, GENOME RES, V20, P351, DOI 10.1101/gr.101477.109; Xue YT, 2003, P NATL ACAD SCI USA, V100, P10635, DOI 10.1073/pnas.1937626100; Yamagata K, 1998, P NATL ACAD SCI USA, V95, P8733, DOI 10.1073/pnas.95.15.8733; Yankiwski V, 2000, P NATL ACAD SCI USA, V97, P5214, DOI 10.1073/pnas.090525897	61	26	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52167	10.1371/journal.pone.0052167	http://dx.doi.org/10.1371/journal.pone.0052167			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284920	Green Published, gold, Green Submitted			2022-12-27	WOS:000312435900083
J	Ichise, T; Yoshida, N; Ichise, H				Ichise, Taeko; Yoshida, Nobuaki; Ichise, Hirotake			Ras/MAPK Signaling Modulates VEGFR-3 Expression through Ets-Mediated p300 Recruitment and Histone Acetylation on the Vegfr3 Gene in Lymphatic Endothelial Cells	PLOS ONE			English	Article							GROWTH-FACTOR-C; TRANSCRIPTION FACTORS; KAPOSI-SARCOMA; MOUSE EMBRYOS; PROX1; LYMPHANGIOGENESIS; KINASE; PHOSPHORYLATION; ANGIOGENESIS; INFLAMMATION	Modulation of VEGFR-3 expression is important for altering lymphatic endothelial cell (LEC) characteristics during the lymphangiogenic processes that occur under developmental, physiological, and pathological conditions. However, the mechanisms underlying the modulation of Vegfr3 gene expression remain largely unknown. Using genetically engineered mice and LECs, we demonstrated previously that Ras signaling is involved not only in VEGFR-3-induced signal transduction but also in Vegfr3 gene expression. Here, we investigated the roles of the transcription factor Ets and the histone acetyltransferase p300 in LECs in Ras-mediated transcriptional regulation of Vegfr3. Ras activates Ets proteins via MAPK-induced phosphorylation. Ets knockdown, similar to Ras knockdown, resulted in a decrease in both Vegfr3 transcript levels and acetylated histone H3 on the Vegfr3 gene. Vegfr3 knockdown results in altered LEC phenotypes, such as aberrant cell proliferation and network formation, and Ets knockdown led to milder but similar phenotypic changes. We identified evolutionarily conserved, non-coding regulatory elements within the Vegfr3 gene that harbor Ets-binding motifs and have enhancer activities in LECs. Chromatin immunoprecipitation (ChIP) assays revealed that acetylated histone H3 on the regulatory elements of the Vegfr3 gene was decreased following Ras and Ets knockdown, and that activated Ets proteins, together with p300, were associated with these regulatory elements, consistent with a reduction in Vegfr3 gene expression in p300-knockdown LECs. Our findings demonstrate a link between Ras signaling and Ets- and p300-mediated transcriptional regulation of Vegfr3, and provide a potential mechanism by which VEGFR-3 expression levels may be modulated during lymphangiogenesis.	[Ichise, Taeko; Yoshida, Nobuaki; Ichise, Hirotake] Univ Tokyo, Lab Dev Genet, Ctr Expt Med & Syst Biol, Inst Med Sci,Minato Ku, Tokyo, Japan	University of Tokyo	Ichise, H (corresponding author), Univ Tokyo, Lab Dev Genet, Ctr Expt Med & Syst Biol, Inst Med Sci,Minato Ku, Tokyo, Japan.	h-ichise@ims.u-tokyo.ac.jp	Ichise, Hirotake/V-3536-2019	Ichise, Hirotake/0000-0002-3424-6637; Ichise, Taeko/0000-0002-1441-1463	Japan Society for the Promotion of Science; "Center of Education and Research for the Advanced Genome-Based Medicine - For personalized medicine and the control of worldwide infectious diseases'', MEXT, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); "Center of Education and Research for the Advanced Genome-Based Medicine - For personalized medicine and the control of worldwide infectious diseases'', MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Japan Society for the Promotion of Science (to TI. and HI) and in part by the Global COE Program "Center of Education and Research for the Advanced Genome-Based Medicine - For personalized medicine and the control of worldwide infectious diseases'', MEXT, Japan (to NY and HI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Baluk P, 2005, J CLIN INVEST, V115, P247, DOI 10.1172/JCI200522037; Bedford DC, 2010, EPIGENETICS-US, V5, P9, DOI 10.4161/epi.5.1.10449; BRUNNER D, 1994, NATURE, V370, P386, DOI 10.1038/370386a0; Chen L, 2010, J CELL BIOL, V189, P417, DOI 10.1083/jcb.200912037; De Val S, 2009, DEV CELL, V16, P180, DOI 10.1016/j.devcel.2009.01.014; De Val S, 2008, CELL, V135, P1053, DOI 10.1016/j.cell.2008.10.049; Dumont DJ, 1998, SCIENCE, V282, P946, DOI 10.1126/science.282.5390.946; Flister MJ, 2010, BLOOD, V115, P418, DOI 10.1182/blood-2008-12-196840; Foulds CE, 2004, MOL CELL BIOL, V24, P10954, DOI 10.1128/MCB.24.24.10954-10964.2004; Haiko P, 2008, MOL CELL BIOL, V28, P4843, DOI 10.1128/MCB.02214-07; He YL, 2002, J NATL CANCER I, V94, P819, DOI 10.1093/jnci/94.11.819; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Hong YK, 2004, NAT GENET, V36, P683, DOI 10.1038/ng1383; Hong YK, 2002, DEV DYNAM, V225, P351, DOI 10.1002/dvdy.10163; Huang HY, 2001, LAB INVEST, V81, P1729, DOI 10.1038/labinvest.3780386; Huggenberger R, 2011, BLOOD, V117, P4667, DOI 10.1182/blood-2010-10-316356; Ichise T, 2010, DEVELOPMENT, V137, P1003, DOI 10.1242/dev.043489; Iljin K, 2001, FASEB J, V15, P1028, DOI 10.1096/fj.00-0383com; Jones D, 2012, ARTERIOSCL THROM VAS, V32, P633, DOI 10.1161/ATVBAHA.111.243576; Karkkainen MJ, 2001, P NATL ACAD SCI USA, V98, P12677, DOI 10.1073/pnas.221449198; Karkkainen MJ, 2000, NAT GENET, V25, P153, DOI 10.1038/75997; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Lapinski PE, 2012, J CLIN INVEST, V122, P733, DOI 10.1172/JCI46116; Lee S, 2009, BLOOD, V113, P1856, DOI 10.1182/blood-2008-03-145789; Meadows SM, 2011, SEMIN CELL DEV BIOL, V22, P976, DOI 10.1016/j.semcdb.2011.09.009; Mishima K, 2007, MOL BIOL CELL, V18, P1421, DOI 10.1091/mbc.E06-09-0780; Nelson ML, 2010, P NATL ACAD SCI USA, V107, P10026, DOI 10.1073/pnas.0915137107; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Pan MR, 2009, J CELL SCI, V122, P3358, DOI 10.1242/jcs.050005; Petrova TV, 2002, EMBO J, V21, P4593, DOI 10.1093/emboj/cdf470; Pytowski B, 2005, JNCI-J NATL CANCER I, V97, P14, DOI 10.1093/jnci/dji003; Shawber CJ, 2007, J CLIN INVEST, V117, P3369, DOI 10.1172/JCI24311; Shikama N, 2003, EMBO J, V22, P5175, DOI 10.1093/emboj/cdg502; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Wang HW, 2004, NAT GENET, V36, P687, DOI 10.1038/ng1384; Wasylyk C, 1997, ONCOGENE, V14, P899, DOI 10.1038/sj.onc.1200914; Wei G, 2009, BLOOD, V114, P1123, DOI 10.1182/blood-2009-03-211391; Yamaguchi T, 2008, FEBS J, V275, P1988, DOI 10.1111/j.1742-4658.2008.06353.x; Yang BS, 1996, MOL CELL BIOL, V16, P538; Yoshimatsu Y, 2011, J CELL SCI, V124, P2753, DOI 10.1242/jcs.083998; Zhang LQ, 2010, CELL RES, V20, P1319, DOI 10.1038/cr.2010.116	42	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51639	10.1371/journal.pone.0051639	http://dx.doi.org/10.1371/journal.pone.0051639			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284731	Green Published, Green Submitted, gold			2022-12-27	WOS:000312435900037
J	Yu, ML; Liu, CH; Huang, CF; Tseng, TC; Huang, JF; Dai, CY; Lin, ZY; Chen, SC; Wang, LY; Juo, SHH; Chuang, WL; Kao, JH				Yu, Ming-Lung; Liu, Chen-Hua; Huang, Chung-Feng; Tseng, Tai-Chung; Huang, Jee-Fu; Dai, Chia-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chuang, Wan-Long; Kao, Jia-Horng			Revisiting the Stopping Rule for Hepatitis C Genotype 1 Patients Treated with Peginterferon Plus Ribavirin	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; INTERLEUKIN-28B GENETIC-VARIANTS; EARLY IDENTIFICATION; IL28B POLYMORPHISM; VIRAL KINETICS; INTERFERON; ASSOCIATION; INFECTION; THERAPY; MULTICENTER	Background: The current stopping rule for peginterferon/ribavirin therapy in hepatitis C virus genotype-1 (HCV-1) patients is based on an early virological response (EVR, defined as >2 log(10) viral reduction at treatment week 12). We aimed to explore rapid stopping rules at week 4. Methods: We randomly allocated 528 HCV-1 patients into training and validation sets (at a 1: 2 ratio). The interleukin-28B rs8099917 genotypes and on-treatment virological responses were evaluated to determine the negative predictive value (NPV) for achieving a sustained virological response (SVR, defined as undetectable HCV RNA 24 weeks after end-of-treatment). The study was approved by the ethics committees of the participating hospitals. All of the patients gave written informed consent before enrollment. Results: A poor week 4 response (W4R), defined as a HCV RNA reduction of <1 log(10) IU/mL at week 4 or a week 4 HCV RNA. 10,000 IU/mL with interleukin-28B non-TT genotype, had the highest NPV (95%). In the complete sample, poor W4R could identify 43.4% (59/136) of the non-responders, with an NPV of 95% and a false negative rate of only 0.8% (3/396). The multivariate analysis revealed that a poor W4R was the most important negative predictor (odds ratio/95% confidence intervals: 49.01/13.70-175.37), followed by the lack of an EVR. In addition to HCV RNA <1 log(10) IU/mL reduction, using the criteria of HCV RNA >10,000 IU/mL/non-TT genotype helped identifying an additional one-third of non-SVR patients at W4. Using the strategy of sequential rapid stopping rule strategy could identify 53.7% (73/136) of the non-responders (43.4% at week 4 and an addition 11.3% at week 12), as compared to 40.4% for the classical week-12 early stopping rule. Conclusions: Sequential rapid stopping rules using on-treatment virological responses and interleukin-28B genotype can rapidly identify additional peginterferon/ribavirin non-responders.	[Yu, Ming-Lung; Huang, Chung-Feng; Huang, Jee-Fu; Dai, Chia-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Chuang, Wan-Long] Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan; [Yu, Ming-Lung] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Kaohsiung Municipal Ta Tung Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Yu, Ming-Lung; Huang, Chung-Feng; Huang, Jee-Fu; Dai, Chia-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Juo, Suh-Hang Hank; Chuang, Wan-Long] Kaohsiung Med Univ, Hepatitis Res Ctr, Coll Med, Fac Internal Med, Kaohsiung, Taiwan; [Liu, Chen-Hua; Kao, Jia-Horng] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Liu, Chen-Hua; Kao, Jia-Horng] Natl Taiwan Univ Hosp, Hepatitis Res Ctr, Taipei, Taiwan; [Liu, Chen-Hua; Kao, Jia-Horng] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Huang, Chung-Feng] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Kaohsiung Municipal Ta Tung Hosp, Dept Occupat Med, Kaohsiung, Taiwan; [Huang, Chung-Feng] Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med, Kaohsiung, Taiwan; [Tseng, Tai-Chung] Buddhist Tzu Chi Gen Hosp, Taipei Branch, Dept Internal Med, Taipei, Taiwan; [Huang, Jee-Fu] Kaohsiung Med Univ Hosp, Kaohsiung Municipal Hsiao Kang Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Juo, Suh-Hang Hank] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan; [Juo, Suh-Hang Hank] Kaohsiung Med Univ, Dept Med Genet, Kaohsiung, Taiwan; [Juo, Suh-Hang Hank] Kaohsiung Med Univ, Dept Neurol, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Buddhist Tzu Chi General Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University	Kao, JH (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	fish6069@gmail.com	Kao, Jia-Horng/AAB-8947-2019; Liu, Chen-Hua/F-6608-2018; Yu, Ming-Lung/AAZ-4306-2020; Chuang, Wan-Long/ABF-7427-2021; Huang, Jee-Fu/AAX-4622-2020	Kao, Jia-Horng/0000-0002-2442-7952; Liu, Chen-Hua/0000-0003-3622-9707; Yu, Ming-Lung/0000-0001-8145-1900; Chuang, Wan-Long/0000-0002-2376-421X; Huang, Jee-Fu/0000-0002-2752-7051	Kaohsiung Medical University Hospital [KMUH100-9I02]; National Science Council, Taiwan [NSC 100-2314-B-037 -014 -MY2]	Kaohsiung Medical University Hospital; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a grant from the Kaohsiung Medical University Hospital (KMUH100-9I02) and a grant from the National Science Council, Taiwan (NSC 100-2314-B-037 -014 -MY2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bochud PY, 2011, J HEPATOL, V55, P980, DOI 10.1016/j.jhep.2011.01.050; Chayama K, 2011, HEPATOLOGY, V54, p1428A; Ciesla A, 2012, WORLD J GASTROENTERO, V18, P4892, DOI 10.3748/wjg.v18.i35.4892; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Davis GL, 2003, HEPATOLOGY, V38, P645, DOI 10.1053/jhep.2003.50364; El-Awady MK, 2012, HEPAT MON, V12, P271, DOI 10.5812/hepatmon.835; Eurich D, 2011, LIVER TRANSPLANT, V17, P289, DOI 10.1002/lt.22235; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Graziadei IW, 2012, LIVER TRANSPLANT, V18, P671, DOI 10.1002/lt.23402; Huang CF, 2012, ANTIVIR RES, V93, P239, DOI 10.1016/j.antiviral.2011.12.002; Huang CF, 2012, J HEPATOL, V56, P34, DOI 10.1016/j.jhep.2011.03.029; Huang CF, 2010, J GASTROEN HEPATOL, V25, P758, DOI 10.1111/j.1440-1746.2009.06148.x; Huang CF, 2010, J INFECT DIS, V201, P751, DOI 10.1086/650470; Huang JF, 2007, ALIMENT PHARM THER, V25, P1029, DOI 10.1111/j.1365-2036.2007.03297.x; Ito K, 2011, J CLIN MICROBIOL, V49, P1853, DOI 10.1128/JCM.02139-10; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Jensen DM, 2006, HEPATOLOGY, V43, P954, DOI 10.1002/hep.21159; Liu CH, 2012, ANTIVIR THE IN PRESS; Liu CH, 2008, CLIN INFECT DIS, V47, P1260, DOI 10.1086/592579; Lopez-Rodriguez R, 2011, CLIN PHARMACOL THER, V90, P712, DOI 10.1038/clpt.2011.189; Mangia A, 2005, NEW ENGL J MED, V352, P2609, DOI 10.1056/NEJMoa042608; Mangia A, 2011, HEPATOLOGY, V54, P772, DOI 10.1002/hep.24458; Martinez SM, 2011, ALIMENT PHARM THER, V33, P138, DOI 10.1111/j.1365-2036.2010.04500.x; Ogawa E, 2012, J HEPATOL, V57, P534, DOI 10.1016/j.jhep.2012.04.027; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Reau N, 2011, AM J GASTROENTEROL, V106, P452, DOI 10.1038/ajg.2010.424; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Yu ML, 2008, HEPATOLOGY, V47, P1884, DOI 10.1002/hep.22319; Yu ML, 2006, ANTIVIR THER, V11, P985; Yu ML, 2007, GUT, V56, P553, DOI 10.1136/gut.2006.102558; Yu ML, 2011, HEPATOLOGY, V53, P7, DOI 10.1002/hep.23976; Yu ML, 2009, J GASTROEN HEPATOL, V24, P336, DOI 10.1111/j.1440-1746.2009.05789.x; Zeuzem S, 2001, GASTROENTEROLOGY, V120, P1438, DOI 10.1053/gast.2001.24006	36	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52048	10.1371/journal.pone.0052048	http://dx.doi.org/10.1371/journal.pone.0052048			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284866	Green Published, Green Submitted, gold			2022-12-27	WOS:000313158800025
J	Couteau, C; Chauvet, C; Paparis, E; Coiffard, L				Couteau, Celine; Chauvet, Catherine; Paparis, Eva; Coiffard, Laurence			UV Filters, Ingredients with a Recognized Anti-Inflammatory Effect	PLOS ONE			English	Article							IN-VITRO; BENZIMIDAZOLE DERIVATIVES; PROTECTION FACTORS; INHIBITORS; ANALOGS; CYCLOOXYGENASE; INFLAMMATION; SELECTIVITY; KETOPROFEN; AGENTS	Background: To explain observed differences during SPF determination using either an in vivo or in vitro method, we hypothesized on the presence of ingredients having anti-inflammatory properties. Methodology/Principal Findings: To research our hypothesis, we studied the 21 UV filters both available on the market and authorized by European regulations and subjected these filters to the phorbol-myristate-acetate test using mice. We then catalogued the 13 filters demonstrating a significant anti-inflammatory effect with edema inhibition percentages of more than 70%. The filters are: diethylhexyl butamido triazone (92%), benzophenone-5 and titanium dioxide (90%), benzophenone-3 (83%), octocrylene and isoamyl p-methoxycinnamate (82%), PEG-25 PABA and homosalate (80%), octyl triazone and phenylbenzimidazole sulfonic acid (78%), octyl dimethyl PABA (75%), bis-ethylhexyloxyphenol methoxyphenyl triazine and diethylamino hydroxybenzoyl hexylbenzoate (70%). These filters were tested at various concentrations, including their maximum authorized dose. We detected a dose-response relationship. Conclusions/Significance: The anti-inflammatory effect of a sunscreen ingredient may affect the in vivo SPF value. Citation: Couteau C, Chauvet C, Paparis E, Coiffard L (2012) UV Filters, Ingredients with a Recognized Anti-Inflammatory Effect. PLoS ONE 7(12): e46187. doi:10.1371/journal.pone.0046187	[Couteau, Celine; Paparis, Eva; Coiffard, Laurence] Univ Nantes, Nantes Atlantic Univ, MMS, EA 2160,FR CNRS 3473,Fac Pharm, Nantes, France; [Chauvet, Catherine] Univ Nantes, Nantes Atlantic Univ, Pharmacochem Dept, Fac Pharm,IICiMed UPRES EA 1155, Nantes, France	Nantes Universite; Nantes Universite	Coiffard, L (corresponding author), Univ Nantes, Nantes Atlantic Univ, MMS, EA 2160,FR CNRS 3473,Fac Pharm, Nantes, France.	laurence.coiffard@univ-nantes.fr						Alaric J, 2011, BIOORGAN MED CHEM, V21, P4633; Bendova H, 2007, TOXICOL IN VITRO, V21, P1268, DOI 10.1016/j.tiv.2007.08.022; Breteche A, 2002, J ENZYM INHIB MED CH, V17, P415, DOI 10.1080/1475636021000005695; CARLSON RP, 1985, AGENTS ACTIONS, V17, P197, DOI 10.1007/BF01966592; Collin X, 2001, J PHARM PHARMACOL, V53, P417, DOI 10.1211/0022357011775505; Couteau C, 2007, PHARMAZIE, V62, P449, DOI 10.1691/ph.2007.6.6247; Couteau C, 2007, J PHARMACEUT BIOMED, V44, P270, DOI 10.1016/j.jpba.2007.01.052; DIFFEY BL, 1989, J SOC COSMET CHEM, V40, P127; Doiron J, 2009, BIOORG MED CHEM LETT, V19, P1118, DOI 10.1016/j.bmcl.2008.12.108; Fu Y, 2004, BIOCHEM BIOPH RES CO, V322, P263, DOI 10.1016/j.bbrc.2004.07.094; Garoli D, 2009, J DERMATOL SCI, V56, P89, DOI 10.1016/j.jdermsci.2009.07.015; Isbrucker RA, 2006, REGUL TOXICOL PHARM, V46, P167, DOI 10.1016/j.yrtph.2006.06.002; Khanum SA, 2004, BIOORG CHEM, V32, P211, DOI 10.1016/j.bioorg.2004.04.003; LAZER ES, 1987, J MED CHEM, V30, P726, DOI 10.1021/jm00387a026; Leite GD, 2011, FITOTERAPIA, V82, P208, DOI 10.1016/j.fitote.2010.09.012; Lopez-Rodriguez ML, 1999, J MED CHEM, V42, P5020, DOI 10.1021/jm991076c; McKay DL, 2006, PHYTOTHER RES, V20, P519, DOI 10.1002/ptr.1900; Mirzoeva OK, 1996, PROSTAG LEUKOTR ESS, V55, P441, DOI 10.1016/S0952-3278(96)90129-5; Moyal D, 2000, PHOTODERMATOL PHOTO, V16, P245, DOI 10.1034/j.1600-0781.2000.160602.x; Ottosen ER, 2003, J MED CHEM, V46, P5651, DOI 10.1021/jm030851s; Palomer A, 2000, J MED CHEM, V43, P2280, DOI 10.1021/jm9906217; Palomer A, 2002, BIOORG MED CHEM LETT, V12, P533, DOI 10.1016/S0960-894X(01)00800-9; Schulze R., 1956, PARFUM KOSMET, V37, P310; Touaibia M, 2009, MINI REVIEWS IN MEDI, V11, P695; Venu TD, 2007, BIOORGAN MED CHEM, V15, P3505, DOI 10.1016/j.bmc.2007.02.051; Zhang B, 2006, EUR J PHARMACOL, V530, P166, DOI 10.1016/j.ejphar.2005.11.030	26	26	28	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e46187	10.1371/journal.pone.0046187	http://dx.doi.org/10.1371/journal.pone.0046187			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284607	Green Submitted, Green Published, gold			2022-12-27	WOS:000312794500001
J	Gravning, J; Orn, S; Kaasboll, OJ; Martinov, VN; Manhenke, C; Dickstein, K; Edvardsen, T; Attramadal, H; Ahmed, MS				Gravning, Jorgen; Orn, Stein; Kaasboll, Ole Jorgen; Martinov, Vladimir N.; Manhenke, Cord; Dickstein, Kenneth; Edvardsen, Thor; Attramadal, Havard; Ahmed, Mohammed Shakil			Myocardial Connective Tissue Growth Factor (CCN2/CTGF) Attenuates Left Ventricular Remodeling after Myocardial Infarction	PLOS ONE			English	Article							CARDIAC STEM-CELLS; MICROVASCULAR OBSTRUCTION; HEART; CTGF; FIBROBLASTS; REPERFUSION; MECHANISMS; EXPRESSION; ISCHEMIA; PROMOTER	Aims: Myocardial CCN2/CTGF is induced in heart failure of various etiologies. However, its role in the pathophysiology of left ventricular (LV) remodeling after myocardial infarction (MI) remains unresolved. The current study explores the role of CTGF in infarct healing and LV remodeling in an animal model and in patients admitted for acute ST-elevation MI. Methods and Results: Transgenic mice with cardiac-restricted overexpression of CTGF (Tg-CTGF) and non-transgenic littermate controls (NLC) were subjected to permanent ligation of the left anterior descending coronary artery. Despite similar infarct size (area of infarction relative to area at risk) 24 hours after ligation of the coronary artery in Tg-CTGF and NLC mice, Tg-CTGF mice disclosed smaller area of scar tissue, smaller increase of cardiac hypertrophy, and less LV dilatation and deterioration of LV function 4 weeks after MI. Tg-CTGF mice also revealed substantially reduced mortality after MI. Remote/peri-infarct tissue of Tg-CTGF mice contained reduced numbers of leucocytes, macrophages, and cells undergoing apoptosis as compared with NLC mice. In a cohort of patients with acute ST-elevation MI (n = 42) admitted to hospital for percutaneous coronary intervention (PCI) serum-CTGF levels (s-CTGF) were monitored and related to infarct size and LV function assessed by cardiac MRI. Increase in s-CTGF levels after MI was associated with reduced infarct size and improved LV ejection fraction one year after MI, as well as attenuated levels of CRP and GDF-15. Conclusion: Increased myocardial CTGF activities after MI are associated with attenuation of LV remodeling and improved LV function mediated by attenuation of inflammatory responses and inhibition of apoptosis.	[Gravning, Jorgen; Kaasboll, Ole Jorgen; Martinov, Vladimir N.; Edvardsen, Thor; Attramadal, Havard; Ahmed, Mohammed Shakil] Univ Oslo, Rikshosp, Inst Surg Res, Oslo Univ Hosp, N-0027 Oslo, Norway; [Gravning, Jorgen; Kaasboll, Ole Jorgen; Martinov, Vladimir N.; Edvardsen, Thor; Attramadal, Havard; Ahmed, Mohammed Shakil] Univ Oslo, Ctr Heart Failure Res, N-0027 Oslo, Norway; [Orn, Stein; Manhenke, Cord; Dickstein, Kenneth] Stavanger Univ Hosp, Div Cardiol, Stavanger, Norway; [Dickstein, Kenneth] Univ Bergen, Inst Internal Med, Bergen, Norway; [Edvardsen, Thor; Attramadal, Havard] Univ Oslo, Rikshosp, Dept Cardiol, Oslo Univ Hosp, N-0027 Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; Stavanger University Hospital; University of Bergen; University of Oslo; National Hospital Norway	Attramadal, H (corresponding author), Univ Oslo, Rikshosp, Inst Surg Res, Oslo Univ Hosp, N-0027 Oslo, Norway.	havard.attramadal@medisin.uio.no	Ørn, Stein/ABD-5883-2020; Edvardsen, Thor/F-4079-2012	Ørn, Stein/0000-0002-5098-4592; Edvardsen, Thor/0000-0002-3800-765X; Attramadal, Havard/0000-0001-9506-0687	South-Eastern Norway Regional Health Authority [2009086, 2011006]; Norwegian Council on Cardiovascular Disease [6484]; Norwegian Research Council	South-Eastern Norway Regional Health Authority; Norwegian Council on Cardiovascular Disease; Norwegian Research Council(Research Council of NorwayEuropean Commission)	This study was supported by grants from the South-Eastern Norway Regional Health Authority (grant numbers 2009086 and 2011006), The Norwegian Council on Cardiovascular Disease (grant number 6484), and The Norwegian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MS, 2011, AM J PHYSIOL-HEART C, V300, pH1291, DOI 10.1152/ajpheart.00604.2010; Ahmed MS, 2004, J MOL CELL CARDIOL, V36, P393, DOI 10.1016/j.yjmcc.2003.12.004; Angert D, 2011, CIRC RES, V108, P1226, DOI 10.1161/CIRCRESAHA.110.239046; Bergestuen DS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-6; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Chen MM, 2000, J MOL CELL CARDIOL, V32, P1805, DOI 10.1006/jmcc.2000.1215; Fonseca C, 2007, NEW ENGL J MED, V357, P1210, DOI 10.1056/NEJMoa067655; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Gressner AM, 2006, CLIN CHEM, V52, P1815, DOI 10.1373/clinchem.2006.070466; Kempf T, 2007, J AM COLL CARDIOL, V50, P1054, DOI 10.1016/j.jacc.2007.04.091; Koitabashi N, 2008, EUR J HEART FAIL, V10, P373, DOI 10.1016/j.ejheart.2008.02.011; Lakkisto P, 2011, EXP BIOL MED, V236, P1437, DOI 10.1258/ebm.2011.011148; Lin J, 1998, CARDIOVASC RES, V38, P802, DOI 10.1016/S0008-6363(98)00055-8; Manhenke C, 2011, INT J CARDIOLOGY; Michael LH, 1995, AM J PHYSIOL-HEART C, V269, pH2147, DOI 10.1152/ajpheart.1995.269.6.H2147; Orn S, 2007, AM J CARDIOL, V99, P1109, DOI 10.1016/j.amjcard.2006.11.059; Orn S, 2009, EUR HEART J, V30, P1978, DOI 10.1093/eurheartj/ehp219; Orn S, 2009, EUR HEART J, V30, P1180, DOI 10.1093/eurheartj/ehp070; Panek AN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006743; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; Stastna M, 2010, PROTEOMICS, V10, P245, DOI 10.1002/pmic.200900515; Tateishi K, 2007, BIOCHEM BIOPH RES CO, V352, P635, DOI 10.1016/j.bbrc.2006.11.096; Touvron M, 2012, DIS MODEL MECH, V5, P481, DOI 10.1242/dmm.009456; van Almen GC, 2011, AGING CELL, V10, P769, DOI 10.1111/j.1474-9726.2011.00714.x; Wang B, 2010, J MED GENET, V47, P391, DOI 10.1136/jmg.2009.073098	25	49	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52120	10.1371/journal.pone.0052120	http://dx.doi.org/10.1371/journal.pone.0052120			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284892	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500094
J	Knol, AC; Nguyen, JM; Pandolfino, MC; Quereux, G; Brocard, A; Peuvrel, L; Saint-Jean, M; Saiagh, S; Khammari, A; Dreno, B				Knol, Anne-Chantal; Nguyen, Jean-Michel; Pandolfino, Marie-Christine; Quereux, Gaelle; Brocard, Anabelle; Peuvrel, Lucie; Saint-Jean, Melanie; Saiagh, Soraya; Khammari, Amir; Dreno, Brigitte			Tissue Biomarkers in Melanoma Patients Treated with TIL	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; STAGE-III MELANOMA; METASTATIC MELANOMA; ADOPTIVE TRANSFER; CLINICAL ACTIVITY; ADJUVANT THERAPY; REACTIVE TIL; PHASE-II; T-CELLS; IMMUNOTHERAPY	While treating stage III melanoma patients with autologous therapeutic TIL in an adjuvant setting, we previously reported a significant benefit of treatment on both progression-free survival and overall survival in patients with only one invaded lymph node (early stage III) compared to patients with more than one invaded lymph nodes (advanced stage III). In this context, in order to understand the difference of activity of TIL therapy according to the progression of the illness at stage III, the first objective of the present study was to determine potential differences in the characteristics of TIL populations obtained from an early stage III and a more advanced stage III when tumor burden is more important. The second objective was to determine possible differences in tissue expression level of several molecules involved in interactions between tumor cells and T cells between early and advanced stage III considering that the tumor microenvironment of invaded lymph nodes could become more tolerant with the progression of the disease. A total of 47 samples of melanoma invaded LN from stage IIIb (AJCC 2007) melanoma patients treated with TIL plus IL-2 were included in this study. We confirmed that both PFS and OS were significantly associated to the presence of tumor-reactive T-cells among TIL injected to the patients and that these tumor reactive T cells were more frequently observed at the early stage III. Moreover, while analyzing the expression of 17 markers on 34/47 tumor specimens using immunohistochemistry, we identified that 3 tissue markers involved in interactions between melanoma cells and T cells have a significant difference of expression between early and advanced stage III: MHC class I, adhesion molecule ICAM-1 and the co-stimulation molecule LFA-3 had a significantly weaker expression in melanoma tissue specimens from advanced stage III. In addition, the expression of the alpha chain of the IL-2 receptor (CD25) and the nuclear transcription factor Foxp3 was significantly increased in the melanoma tissue specimens from advanced stage III. Our results suggest differences in the immunological status of the tumor microenvironment between early and advanced stage III, which could explain the difference in clinical response to TIL infusion in an adjuvant setting between early and advanced stage III.	[Knol, Anne-Chantal; Nguyen, Jean-Michel; Pandolfino, Marie-Christine; Quereux, Gaelle; Brocard, Anabelle; Peuvrel, Lucie; Saint-Jean, Melanie; Khammari, Amir; Dreno, Brigitte] INSERM, CRCNA, U892, Nantes, France; [Quereux, Gaelle; Brocard, Anabelle; Peuvrel, Lucie; Saint-Jean, Melanie; Khammari, Amir; Dreno, Brigitte] Unite Cancerodermatol CIC Biotherapie INSERM 0503, Nantes, France; [Pandolfino, Marie-Christine; Saiagh, Soraya; Dreno, Brigitte] Unite Therapie Cellulaire & Genique, Nantes, France; [Nguyen, Jean-Michel] Hop St Jacques, PIMESP SEB, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes	Dreno, B (corresponding author), INSERM, CRCNA, U892, Nantes, France.	brigitte.dreno@wanadoo.fr	KNOL, Anne Chantal C/K-7974-2015	KNOL, Anne Chantal C/0000-0003-4011-5008; Peuvrel, Lucie/0000-0002-4347-915X	la Ligue Nationale contre le cancer; la Societe Francaise de Dermatologie; l'Association Francaise contre les Myopathies; European Program "Cancer Immunotherapy"	la Ligue Nationale contre le cancer(Ligue nationale contre le cancer); la Societe Francaise de Dermatologie; l'Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); European Program "Cancer Immunotherapy"	This work was supported by grants from "la Ligue Nationale contre le cancer", from "la Societe Francaise de Dermatologie", from "l'Association Francaise contre les Myopathies" and from the European Program "Cancer Immunotherapy". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berd David, 2004, Expert Rev Vaccines, V3, P521, DOI 10.1586/14760584.3.5.521; Besser MJ, 2010, CLIN CANCER RES, V16, P2646, DOI 10.1158/1078-0432.CCR-10-0041; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; Carretero R, 2012, INT J CANCER, V131, P387, DOI 10.1002/ijc.26471; Chebassier N, 2004, EXP DERMATOL, V13, P484, DOI 10.1111/j.0906-6705.2004.00197.x; Dreno B, 2002, CANCER IMMUNOL IMMUN, V51, P539, DOI 10.1007/s00262-002-0315-1; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Gajewski TF, 2010, CANCER J, V16, P399, DOI 10.1097/PPO.0b013e3181eacbd8; Garrido F, 2010, INT J CANCER, V127, P249, DOI 10.1002/ijc.25270; GERVOIS N, 1990, EUR J IMMUNOL, V20, P825, DOI 10.1002/eji.1830200417; Hamid O, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-204; Harlin H, 2009, CANCER RES, V69, P3077, DOI 10.1158/0008-5472.CAN-08-2281; JOTEREAU F, 1991, J IMMUNOTHER, V10, P405, DOI 10.1097/00002371-199112000-00003; Jotereau F, 2003, B CANCER, V90, P583; JUNG T, 1993, J IMMUNOL METHODS, V159, P197, DOI 10.1016/0022-1759(93)90158-4; Khammari A, 2007, CANCER IMMUNOL IMMUN, V56, P1853, DOI 10.1007/s00262-007-0340-1; Knol AC, 2011, EXP DERMATOL, V20, P430, DOI 10.1111/j.1600-0625.2011.01260.x; Labarriere N, 2002, CANCER IMMUNOL IMMUN, V51, P532, DOI 10.1007/s00262-002-0313-3; Pandolfino MC, 2010, CYTOTECHNOLOGY, V62, P403, DOI 10.1007/s10616-010-9286-9; Pandolfino MC, 2001, CANCER IMMUNOL IMMUN, V50, P134, DOI 10.1007/PL00006683; Quereux G, 2007, EUR J DERMATOL, V17, P295, DOI 10.1684/ejd.2009.0203; Ribas A, 2009, CLIN CANCER RES, V15, P390, DOI 10.1158/1078-0432.CCR-08-0783; ROSENBERG SA, 1994, J NATL CANCER I, V86, P1159, DOI 10.1093/jnci/86.15.1159; ROSENBERG SA, 1988, NEW ENGL J MED, V319, P1676, DOI 10.1056/NEJM198812223192527; Somasundaram R, 2002, CANCER RES, V62, P5267; Terabe M, 2004, CURR OPIN IMMUNOL, V16, P157, DOI 10.1016/j.coi.2004.01.010; Yuan JD, 2011, CANCER IMMUNOL IMMUN, V60, P1137, DOI 10.1007/s00262-011-1011-9	27	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e48729	10.1371/journal.pone.0048729	http://dx.doi.org/10.1371/journal.pone.0048729			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284620	gold, Green Published, Green Submitted			2022-12-27	WOS:000312794500007
J	Lei, C; Wang, YL; Huang, YR; Yu, H; Huang, YL; Wu, LT; Huang, LM				Lei, Cui; Wang, Yanlin; Huang, Yurong; Yu, Han; Huang, Yiling; Wu, Liting; Huang, Liming			Up-regulated miR155 Reverses the Epithelial-mesenchymal Transition Induced by EGF and Increases Chemo-sensitivity to Cisplatin in Human Caski Cervical Cancer Cells	PLOS ONE			English	Article							BREAST-CANCER; CYCLIN D1; GROWTH; EXPRESSION; MICRORNA-155; PROGRESSION; PATHWAY; CARCINOMA; MIR-155; GENE	The epithelial-mesenchymal transition (EMT) induced by EGF promotes cervical cancer progression; however, the mechanisms underlying the EGF-induced EMT remain unclear. In this study, we reported that miR155 overexpression suppressed EGF-induced EMT, decreased migration/invasion capacities, inhibited cell proliferation and increased the chemo-sensitivity to DDP in human Caski cervical cancer cells. Further, the overexpression of miR155 increased TP53 expression but reduced SMAD2, and CCND1 expression levels. These data suggest that miR155 negatively regulates EGF-induced EMT. We conclude that miR155 does not act as an oncogene but as a tumour suppressor in Caski cells.	[Lei, Cui; Wang, Yanlin; Huang, Yurong; Yu, Han; Huang, Yiling; Wu, Liting; Huang, Liming] Three Gorges Univ, Inst Mol Biol, Yichang, Peoples R China; [Lei, Cui; Wang, Yanlin] Wuhan Univ, Zhongnan Hosp, Dept Oncol, Wuhan 430072, Peoples R China; [Lei, Cui] Three Gorges Univ, Dept Gynecol, Renhe Hosp, Yichang, Peoples R China	China Three Gorges University; Wuhan University; China Three Gorges University	Huang, LM (corresponding author), Three Gorges Univ, Inst Mol Biol, Yichang, Peoples R China.	Hlmyj8265@sina.com			Natural Science Foundation of Hubei province [2011CDB181]; Independent Research Fund, Wuhan University [201130302020016]	Natural Science Foundation of Hubei province(Natural Science Foundation of Hubei Province); Independent Research Fund, Wuhan University	Financial support for this work was provided by the Natural Science Foundation of Hubei province (Grant no. 2011CDB181), Independent Research Fund, Wuhan University (no. 201130302020016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackland ML, 2003, LAB INVEST, V83, P435, DOI 10.1097/01.LAB.0000059927.97515.FD; Ahmad A, 2011, CANCER RES, V71, P3400, DOI 10.1158/0008-5472.CAN-10-0965; Castilla MA, 2011, J PATHOL, V223, P72, DOI 10.1002/path.2802; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Gironella M, 2007, P NATL ACAD SCI USA, V104, P16170, DOI 10.1073/pnas.0703942104; Greither T, 2010, INT J CANCER, V126, P73, DOI 10.1002/ijc.24687; Hagemann T, 2007, BRIT J CANCER, V96, P321, DOI 10.1038/sj.bjc.6603543; Iida K, 2011, BRIT J CANCER, V105, P420, DOI 10.1038/bjc.2011.222; Jiang SA, 2010, CANCER RES, V70, P3119, DOI 10.1158/0008-5472.CAN-09-4250; Kim NH, 2011, J CELL BIOL, V195, P417, DOI 10.1083/jcb.201103097; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Lee MY, 2008, CLIN CANCER RES, V14, P4743, DOI 10.1158/1078-0432.CCR-08-0234; Li QQ, 2009, CLIN CANCER RES, V15, P2657, DOI 10.1158/1078-0432.CCR-08-2372; Moes M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035440; Narayanan R, 2012, INT J ONCOL, V40, P13, DOI 10.3892/ijo.2011.1211; Ono Y, 2012, CANCER SCI, V103, P317, DOI 10.1111/j.1349-7006.2011.02133.x; Polyak K, 2009, NAT REV CANCER, P9265; Qi ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038842; Ryu JK, 2010, PANCREATOLOGY, V10, P66, DOI 10.1159/000231984; Shen MR, 2006, CARCINOGENESIS, V27, P962, DOI 10.1093/carcin/bgi336; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tobin NP, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-417; Xia H, 2012, CANC GENE THER, DOI 10.1038; Xiang X, 2011, ONCOGENE, V30, P3440, DOI 10.1038/onc.2011.54; Zheng L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019390	25	43	46	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52310	10.1371/journal.pone.0052310	http://dx.doi.org/10.1371/journal.pone.0052310			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284982	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500142
J	Nelissen, J; Nuyts, K; De Zotti, M; Lavigne, R; Lamberigts, C; De Borggraeve, WM				Nelissen, Jo; Nuyts, Koen; De Zotti, Marta; Lavigne, Rob; Lamberigts, Chris; De Borggraeve, Wim M.			Total Synthesis of Septocylindrin B and C-Terminus Modified Analogues	PLOS ONE			English	Article							ELUCIDATION; PEPTAIBOLS; PEPTIDES	The total synthesis is reported of the peptaibol Septocylindrin B which is related to the well documented channel forming peptaibol antibiotic Alamethicin. Several analogues were synthesized with a modified C-terminus, to investigate the SAR of the terminal residue Phaol. All these peptides were tested for their membrane perturbation properties by fluorescent dye leakage assay and for their antibacterial activity.	[Nelissen, Jo; Nuyts, Koen; De Borggraeve, Wim M.] Katholieke Univ Leuven, Dept Chem, B-3001 Heverlee, Belgium; [De Zotti, Marta] Univ Padua, Dept Chem, Padua, Italy; [Lavigne, Rob; Lamberigts, Chris] Katholieke Univ Leuven, Biosyst Dept, Lab Gene Technol, B-3001 Heverlee, Belgium	KU Leuven; University of Padua; KU Leuven	De Borggraeve, WM (corresponding author), Katholieke Univ Leuven, Dept Chem, B-3001 Heverlee, Belgium.	Wim.DeBorggraeve@chem.kuleuven.be	De Zotti, Marta/A-3265-2014; Nuyts, Koen/L-9930-2017; De Borggraeve, Wim/AGE-5612-2022	De Zotti, Marta/0000-0002-3302-6499; Nuyts, Koen/0000-0003-0387-9965; De Borggraeve, Wim/0000-0001-7813-6192; Lamberigts, Chris/0000-0002-7484-0059; Lavigne, Rob/0000-0001-7377-1314	Institute for the Promotion of Innovation through Science and Technology in Flanders (Belgium, I.W.T.); KU Leuven [OT/11/047/TBA]; IOF Knowledge Platform grant of the KU Leuven [IOF/KP/09/003]; FWO Vlaanderen [G.0599.11]	Institute for the Promotion of Innovation through Science and Technology in Flanders (Belgium, I.W.T.)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); KU Leuven(KU Leuven); IOF Knowledge Platform grant of the KU Leuven; FWO Vlaanderen(FWO)	JN thanks the Institute for the Promotion of Innovation through Science and Technology in Flanders (Belgium, I.W.T., www.iwt.be) for financial support. KN thanks KU Leuven for financial support (Project OT/11/047/TBA). CL is supported by the IOF Knowledge Platform grant ("Functional peptidomics" IOF/KP/09/003) of the KU Leuven. This work was also partly supported by a grant of the FWO Vlaanderen (G.0599.11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amyes SGB, 2007, INT J ANTIMICROB AG, V29, pS43, DOI 10.1016/S0924-8579(07)72177-5; Crisma M, 2007, ANGEW CHEM INT EDIT, V46, P2047, DOI 10.1002/anie.200604417; Kastin AJ, 2006, HANDBOOK OF BIOLOGICALLY ACTIVE PEPTIDES, pXXXIX, DOI 10.1016/B978-012369442-3/50002-7; Kaul R, 2004, TETRAHEDRON LETT, V69, P6131; KUMAZAWA S, 1994, J ANTIBIOT, V47, P1136, DOI 10.7164/antibiotics.47.1136; Mattheus W, 2010, CHEM BIOL, V17, P149, DOI 10.1016/j.chembiol.2010.01.014; Navath RS, 2006, TETRAHEDRON LETT, V47, P389, DOI 10.1016/j.tetlet.2005.11.003; Nelissen J, 2011, J PEPT SCI, V17, P527, DOI 10.1002/psc.1362; Peggion C, 2004, BIOPOLYMERS, V76, P485, DOI 10.1002/bip.20161; Peggion C, 2007, EUR J BIOCHEM, V4, P1183; Stella L, 2007, CHEM BIODIVERS, V4, P1299, DOI 10.1002/cbdv.200790111; Summers MY, 2007, J NAT PROD, V70, P391, DOI 10.1021/np060571q; Theis C, 2008, CHEM BIODIVERS, V5, P2337, DOI 10.1002/cbdv.200890200; Toniolo C., 2009, PEPTAIBIOTICS	14	4	4	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51708	10.1371/journal.pone.0051708	http://dx.doi.org/10.1371/journal.pone.0051708			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284749	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500041
J	Norder, G; Roelen, CAM; van Rhenen, W; Buitenhuis, J; Bultmann, U; Anema, JR				Norder, Giny; Roelen, Corne A. M.; van Rhenen, Willem; Buitenhuis, Jan; Bultmann, Ute; Anema, Johannes R.			Predictors of Recurrent Sickness Absence Due to Depressive Disorders - A Delphi Approach Involving Scientists and Physicians	PLOS ONE			English	Article							WORK-ENVIRONMENT; MAJOR DEPRESSION; ALL-CAUSE; EMPLOYEES; RISK; HEALTH; PREVENTION; MORTALITY; SYMPTOMS; IMPACT	Background: Depression is a common and highly recurrent mental disorder that is accompanied by poor functioning at home and at work. Not all depressed employees report sick and little is known about variables associated with sickness absence (SA) due to depression. Recurrent SA due to depression tends to marginalize employees from the workforce and exclude them from social participation. Therefore, this study sought group consensus on factors predicting recurrent SA due to depression. Methodology/principal findings: 23 scientists in the field of work and mental health and 23 physicians with expertise in assessing work disability were invited for a Delphi study. Sixty-seven factors retrieved from the literature were scored for their impact on the recurrence of SA due to depression, range 1 (no impact) to 10 (very high impact) in two Delphi rounds. The third Delphi round addressed the assessability and modifiability of elected predictors. Group consensus was defined as 75% agreement. In the first round (response 78%), group consensus was reached on a high impact of 13 factors on recurrent SA due to depression. The second round (response 79%) added another 8 factors with high impact on recurrent SA due to depression. The panelists were of the opinion that stressful life and work events, age at first diagnosis, duration of the last depressive episode, anxiety, lifetime number of depressive episodes, and psychological work demands were readily assessable in consultation with patients. Furthermore, work factors, particularly decision latitude, psychological job demands, and commitment to work, were recognized as modifiable. Conclusions/significance: Although results have to be validated with further quantitative research, physicians may identify employees at risk of recurrent SA due to depression and may support them to adjust their work aimed at increasing commitment to work and preventing future SA due to depression.	[Norder, Giny; Roelen, Corne A. M.; van Rhenen, Willem] 365 Occupat Hlth Serv Utrecht, Utrecht, Netherlands; [Norder, Giny; Roelen, Corne A. M.; Bultmann, Ute] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Groningen, Netherlands; [van Rhenen, Willem] Business Univ Nyenrode, Ctr Human Resource Org & Management Effectiveness, Breukelen, Netherlands; [Buitenhuis, Jan] Unive Insurances Med Dept, Assen, Netherlands; [Anema, Johannes R.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [Anema, Johannes R.] Res Ctr Insurance Med, Amsterdam, Netherlands	University of Groningen; Vrije Universiteit Amsterdam	Norder, G (corresponding author), 365 Occupat Hlth Serv Utrecht, Utrecht, Netherlands.	giny.norder@365.nl	van Rhenen, Willem/AAS-9406-2021	Bultmann, Ute/0000-0001-9589-9220				American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Berto Patrizia, 2000, J Ment Health Policy Econ, V3, P3, DOI 10.1002/1099-176X(200003)3:1<3::AID-MHP68>3.0.CO;2-H; Bultmann U, 2006, SOC PSYCH PSYCH EPID, V41, P875, DOI 10.1007/s00127-006-0110-y; Bultmann U, 2008, EUR J PUBLIC HEALTH, V18, P232, DOI 10.1093/eurpub/ckm132; Burcusa SL, 2007, CLIN PSYCHOL REV, V27, P959, DOI 10.1016/j.cpr.2007.02.005; de Vries G, 2012, J AFFECT DISORDERS, V136, P1017, DOI 10.1016/j.jad.2011.06.035; Dutch Institute for Health Care Improvement, 2009, MULT GUID DEPR; Ferrie JE, 2009, J EPIDEMIOL COMMUN H, V63, P50, DOI 10.1136/jech.2008.074369; Gelenberg AJ, 2010, J CLIN PSYCHIAT, V71, P6; Goldberg D, 2010, BRIT J PSYCHIAT, V196, P255, DOI 10.1192/bjp.bp.109.072405; Goodman CM, 1987, J ADV NURS, V7, P451; Green B, 1999, HEALTH SOC CARE COMM, V7, P198, DOI 10.1046/j.1365-2524.1999.00176.x; Guzman J, 2007, SPINE, V32, P807, DOI 10.1097/01.brs.0000259080.51541.17; Hardeveld F, 2010, ACTA PSYCHIAT SCAND, V122, P184, DOI 10.1111/j.1600-0447.2009.01519.x; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Head J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1469; Hjarsbech PU, 2011, J AFFECT DISORDERS, V129, P87, DOI 10.1016/j.jad.2010.07.033; Holma IAK, 2012, ACTA PSYCHIAT SCAND, V125, P325, DOI 10.1111/j.1600-0447.2011.01785.x; Hu TW, 2006, J MENT HEALTH POLICY, V9, P3; Keeney S, 2001, INT J NURS STUD, V38, P195, DOI 10.1016/S0020-7489(00)00044-4; Kessing Lars Vedel, 2005, Curr Psychiatry Rep, V7, P413, DOI 10.1007/s11920-005-0061-0; Koopmans PC, 2008, INT ARCH OCC ENV HEA, V81, P711, DOI 10.1007/s00420-007-0243-7; Koopmans PC, 2011, INT ARCH OCC ENV HEA, V84, P193, DOI 10.1007/s00420-010-0540-4; Kurdyak P, 2011, CAN MED ASSOC J, V183, P1955, DOI 10.1503/cmaj.111664; Lagerveld SE, 2010, J OCCUP REHABIL, V20, P275, DOI 10.1007/s10926-009-9224-x; Lerner D, 2004, PSYCHIAT SERV, V55, P1371, DOI 10.1176/appi.ps.55.12.1371; Lerner D, 2008, J OCCUP ENVIRON MED, V50, P401, DOI 10.1097/JOM.0b013e31816bae50; Lexis MAS, 2011, OCCUP ENVIRON MED, V68, P400, DOI 10.1136/oem.2010.057877; MCKENNA HP, 1994, J ADV NURS, V19, P1221, DOI 10.1111/j.1365-2648.1994.tb01207.x; Melchior M, 2010, AM J EPIDEMIOL, V172, P700, DOI 10.1093/aje/kwq186; Melchior M, 2009, AM J PUBLIC HEALTH, V99, P1417, DOI 10.2105/AJPH.2008.142273; Monroe SM, 2011, PSYCHOL REV, V118, P655, DOI 10.1037/a0025190; Overland S, 2008, SLEEP, V31, P875, DOI 10.1093/sleep/31.6.875; Pezawas L, 2005, INT REV PSYCHIATR, V17, P63, DOI 10.1080/00207390500064650; Robinson OJ, 2008, PSYCHOL MED, V38, P315, DOI 10.1017/S0033291707001249; Sandanger I, 2000, SCAND J PUBLIC HEALT, V28, P244, DOI 10.1080/14034940050500474; Sobocki P, 2006, J MENT HEALTH POLICY, V9, P87; Stansfeld S, 2006, SCAND J WORK ENV HEA, V32, P443, DOI 10.5271/sjweh.1050; Stroud CB, 2008, J ABNORM PSYCHOL, V117, P206, DOI 10.1037/0021-843X.117.1.206; Sumsion T., 1998, BRIT J OCCUP THER, V61, P153, DOI [10.1177/030802269806100403, DOI 10.1177/030802269806100403]; Vahtera J, 2010, J EPIDEMIOL COMMUN H, V64, P311, DOI 10.1136/jech.2008.083923; van Oostrom SH, 2010, OCCUP ENVIRON MED, V67, P596, DOI 10.1136/oem.2009.050849; Vittengl JR, 2007, J CONSULT CLIN PSYCH, V75, P475, DOI 10.1037/0022-006X.75.3.475; Woo JM, 2008, INT J DISABIL HUM DE, V7, P185	44	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51792	10.1371/journal.pone.0051792	http://dx.doi.org/10.1371/journal.pone.0051792			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	060RA	23284768	gold, Green Published, Green Submitted			2022-12-27	WOS:000312794500047
J	Norrelgen, F; Lilja, A; Ingvar, M; Gisselgard, J; Fransson, P				Norrelgen, Fritjof; Lilja, Anders; Ingvar, Martin; Gisselgard, Jens; Fransson, Peter			Language Lateralization in Children Aged 10 to 11 Years: A Combined fMRI and Dichotic Listening Study	PLOS ONE			English	Article							CONSONANT-VOWEL SYLLABLES; WADA TEST; BRAIN ACTIVATION; FUNCTIONAL MRI; INTRASUBJECT REPRODUCIBILITY; EPILEPSY; DOMINANCE; COMPREHENSION; PARADIGM; ADULTS	Objective: The aims of this study were to develop and assess a method to map language networks in children with two auditory fMRI protocols in combination with a dichotic listening task (DL). The method is intended for pediatric patients prior to epilepsy surgery. To evaluate the potential clinical usefulness of the method we first wanted to assess data from a group of healthy children. Methods: In a first step language test materials were developed, intended for subsequent implementation in fMRI protocols. An evaluation of this material was done in 30 children with typical development, 10 from the 1st, 4th and the 7th grade, respectively. The language test material was then adapted and implemented in two fMRI protocols intended to target frontal and posterior language networks. In a second step language lateralization was assessed in 17 typical 10-11 year olds with fMRI and DL. To reach a conclusion about language lateralization, firstly, quantitative analyses of the index data from the two fMRI tasks and the index data from the DL task were done separately. In a second step a set of criteria were applied to these results to reach a conclusion about language lateralization. The steps of these analyses are described in detail. Results: The behavioral assessment of the language test material showed that it was well suited for typical children. The results of the language lateralization assessments, based on fMRI data and DL data, showed that for 15 of the 17 subjects (88%) a conclusion could be reached about hemispheric language dominance. In 2 cases (12%) DL provided critical data. Conclusions: The employment of DL combined with language mapping using fMRI for assessing hemispheric language dominance is novel and it was deemed valuable since it provided additional information compared to the results gained from each method individually.	[Norrelgen, Fritjof; Ingvar, Martin; Fransson, Peter] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Norrelgen, Fritjof] Karolinska Univ Hosp, Dept Speech & Language Pathol, Stockholm, Sweden; [Lilja, Anders] Karolinska Univ Hosp, Dept Neuroradiol, Stockholm, Sweden; [Gisselgard, Jens] Stavanger Univ Hosp, Div Psychiat, Reg Ctr Clin Res Psychosis, Stavanger, Norway	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Stavanger University Hospital	Norrelgen, F (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	fritjof.norrelgen@karolinska.se	Fransson, Peter/M-5679-2014	Fransson, Peter/0000-0002-1305-9875; Ingvar, Martin/0000-0002-9041-5714; Norrelgen, Fritjof/0000-0003-3363-0925	Stockholm County Council; Karolinska Institutet	Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet)	Financial support was provided through the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Z, 2003, NEUROLOGY, V60, P1598, DOI 10.1212/01.WNL.0000059865.32155.86; Arora J, 2009, EPILEPSIA, V50, P2225, DOI 10.1111/j.1528-1167.2009.02136.x; Binder JR, 2011, EPILEPSY BEHAV, V20, P214, DOI 10.1016/j.yebeh.2010.08.004; Binder JR, 1996, NEUROLOGY, V46, P978, DOI 10.1212/WNL.46.4.978; Bishop D., 2009, TROG 2 TEST RECEPTIO; Bishop D. V. M, 1989, TEST RECEPTION GRAMM, V2; Byars AW, 2002, J CHILD NEUROL, V17, P885, DOI 10.1177/08830738020170122201; Dragovic M, 2004, LATERALITY, V9, P411, DOI 10.1080/13576500342000248; Fernandez G, 2003, NEUROLOGY, V60, P969, DOI 10.1212/01.WNL.0000049934.34209.2E; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gaillard WD, 2004, NEUROLOGY, V63, P1403, DOI 10.1212/01.wnl.0000141852.65175.a7; Gaillard WD, 2003, HUM BRAIN MAPP, V18, P176, DOI 10.1002/hbm.10091; Gaillard WD, 2002, NEUROLOGY, V59, P256, DOI 10.1212/WNL.59.2.256; Gaillard WD, 2001, NEUROLOGY, V57, P47, DOI 10.1212/WNL.57.1.47; Hammeke T A, 2000, Adv Neurol, V83, P221; Harrington GS, 2006, AM J NEURORADIOL, V27, P938; Holland SK, 2007, INT J AUDIOL, V46, P533, DOI 10.1080/14992020701448994; Hugdahl K, 1999, NEUROPSYCHOLOGIA, V37, P431, DOI 10.1016/S0028-3932(98)00101-8; Hugdahl K, 1997, ARCH NEUROL-CHICAGO, V54, P1494, DOI 10.1001/archneur.1997.00550240046011; Hugdahl K, 1997, J CLIN EXP NEUROPSYC, V19, P667, DOI 10.1080/01688639708403752; HUGDAHL K, 1986, CORTEX, V22, P417, DOI 10.1016/S0010-9452(86)80005-3; Hugdahl K, 2001, DEV NEUROPSYCHOL, V20, P445, DOI 10.1207/S15326942DN2001_8; HUGDAHL K, 1989, NEUROPSYCHOLOGIA, V27, P999, DOI 10.1016/0028-3932(89)90075-4; HUGDAHL K, 1987, J CLIN EXP NEUROPSYC, V9, P631, DOI 10.1080/01688638708405207; Hugdahl K, 1994, DIKOTISK LYSSNING ME; Just MA, 1996, SCIENCE, V274, P114, DOI 10.1126/science.274.5284.114; Lidzba K, 2011, BRAIN LANG, V119, P6, DOI 10.1016/j.bandl.2011.02.003; Loddenkemper T, 2008, EPILEPSY BEHAV, V13, P551, DOI 10.1016/j.yebeh.2008.05.014; Medina LS, 2004, RADIOLOGY, V230, P49, DOI 10.1148/radiol.2301021122; O'Shaughnessy ES, 2008, J CHILD NEUROL, V23, P791, DOI 10.1177/0883073807313047; Pellock JM, 2004, NEUROLOGY, V62, pS17, DOI 10.1212/WNL.62.5_suppl_2.S17; Roder B, 2002, NEUROIMAGE, V15, P1003, DOI 10.1006/nimg.2001.1026; Rutten GJM, 2002, NEUROIMAGE, V17, P447, DOI 10.1006/nimg.2002.1196; Rydberg S, 1974, MANUAL SPIQ SNABBT P; SCHACHTER SC, 1993, ANN NY ACAD SCI, V682, P402, DOI 10.1111/j.1749-6632.1993.tb23006.x; Sharan A, 2011, EPILEPSY BEHAV, V20, P209, DOI 10.1016/j.yebeh.2010.11.013; Shurtleff H, 2010, J NEUROSURG-PEDIATR, V5, P500, DOI 10.3171/2009.11.PEDS09248; Spanaki Marianna V., 2001, Epilepsia, V42, P78; Spencer S, 2008, LANCET NEUROL, V7, P525, DOI 10.1016/S1474-4422(08)70109-1; Spritzer SD, 2012, NEUROLOGIST, V18, P329, DOI 10.1097/NRL.0b013e31826ac675; Swanson SJ, 2007, NEUROPSYCHOL REV, V17, P491, DOI 10.1007/s11065-007-9050-x; Tervaniemi M, 2003, BRAIN RES REV, V43, P231, DOI 10.1016/j.brainresrev.2003.08.004; van den Noort M, 2008, NEUROIMAGE, V40, P902, DOI 10.1016/j.neuroimage.2007.11.051; Wada J, 2007, J NEUROSURG, V106, P1117, DOI 10.3171/jns.2007.106.6.1117; Wang YY, 2012, BRAIN RES, V1447, P79, DOI 10.1016/j.brainres.2012.02.001; Wellmer J, 2009, EPILEPSIA, V50, P2213, DOI 10.1111/j.1528-1167.2009.02102.x; Wiig E.H., 1989, TEST LANGUAGE COMPET; Wilke M, 2007, J NEUROSCI METH, V163, P128, DOI 10.1016/j.jneumeth.2007.01.026; Wood AG, 2004, NEUROLOGY, V63, P1035, DOI 10.1212/01.WNL.0000140707.61952.CA	49	8	8	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51872	10.1371/journal.pone.0051872	http://dx.doi.org/10.1371/journal.pone.0051872			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284796	Green Submitted, Green Published, gold			2022-12-27	WOS:000312794500057
J	Sun, GX; Shan, J; Li, YP; Zhou, YN; Guo, YJ; Wu, WQ; Yang, T; Xia, MJ; Feng, L				Sun, Guixiang; Shan, Juan; Li, Youping; Zhou, Yanni; Guo, Yingjia; Wu, Wenqiao; Yang, Tong; Xia, Mengjuan; Feng, Li			Adoptive Infusion of Tolerogenic Dendritic Cells Prolongs the Survival of Pancreatic Islet Allografts: A Systematic Review of 13 Mouse and Rat Studies	PLOS ONE			English	Article							ACQUIRED THYMIC TOLERANCE; ALLOIMMUNE RESPONSES; IMMUNOLOGICAL-TOLERANCE; INDUCTION; TRANSPLANTATION; IMMUNOTHERAPY	Objective: The first Phase I study of autologous tolerogenic dendritic cells (Tol-DCs) in Type 1 diabetes (T1D) patients was recently completed. Pancreatic islet transplantation is an effective therapy for T1D, and infusion of Tol-DCs can control diabetes development while promoting graft survival. In this study, we aim to systematically review islet allograft survival following infusion of Tol-DCs induced by different methods, to better understand the mechanisms that mediate this process. Methods: We searched PubMed and Embase (from inception to February 29th, 2012) for relevant publications. Data were extracted and quality was assessed by two independent reviewers. We semiquantitatively analyzed the effects of Tol-DCs on islet allograft survival using mixed leukocyte reaction, Th1/Th2 differentiation, Treg induction, and cytotoxic T lymphocyte activity as mechanisms related-outcomes. We discussed the results with respect to possible mechanisms that promote survival. Results: Thirteen articles were included. The effects of Tol-DCs induced by five methods on allograft survival were different. Survival by each method was prolonged as follows: allopeptide-pulsed Tol-DCs (42.14 +/- 44 days), drug intervention (39 days), mesenchymal stem cell induction (23 days), genetic modification (8.99 +/- 4.75 days), and other derivation (2.61 +/- 6.98 days). The results indicate that Tol-DC dose and injection influenced graft survival. Single-dose injections of 10(4) Tol-DCs were the most effective for allograft survival, and multiple injections were not superior. Tol-DCs were also synergistic with immunosuppressive drugs or costimulation inhibitors. Possible mechanisms include donor specific T cell hyporesponsiveness, Th2 differentiation, Treg induction, cytotoxicity against allograft reduction, and chimerism induction. Conclusions: Tol-DCs induced by five methods prolong MHC mismatched islet allograft survival to different degrees, but allopeptide-pulsed host DCs perform the best. Immunosuppressive or costimulatory blockade are synergistic with Tol-DC on graft survival. Multiple injections are not superior to single injection. Yet more rigorously designed studies with larger sample sizes are still needed in future.	[Sun, Guixiang; Shan, Juan; Li, Youping; Zhou, Yanni; Guo, Yingjia; Wu, Wenqiao; Yang, Tong; Xia, Mengjuan; Feng, Li] Sichuan Univ, W China Hosp, Minist China, Key Lab Transplant Engn & Immunol Hlth, Chengdu 610064, Sichuan Provinc, Peoples R China; [Shan, Juan; Feng, Li] Sichuan Univ, W China Hosp, Regenerat Med Res Ctr, Chengdu 610064, Sichuan Provinc, Peoples R China; [Li, Youping] Sichuan Univ, W China Hosp, Chinese Cochrane Ctr, Chinese Evidence Based Med Ctr, Chengdu 610064, Sichuan Provinc, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Li, YP (corresponding author), Sichuan Univ, W China Hosp, Minist China, Key Lab Transplant Engn & Immunol Hlth, Chengdu 610064, Sichuan Provinc, Peoples R China.	yzmylab@hotmail.com	Zhou, Yanni/GPS-4233-2022	Zhou, Yanni/0000-0003-3642-4166	National Basic Research Program of China [2009CB522401]; Natural Science Foundation of China [81273255]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China No. 2009CB522401, and by the Natural Science Foundation of China No. 81273255. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2000, TRANSPLANTATION, V69, P221, DOI 10.1097/00007890-200001270-00005; Brissova M, 2008, DIABETES, V57, P2269, DOI 10.2337/db08-0814; Chaib E, 1994, Transpl Int, V7 Suppl 1, pS423; Conde E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033258; Ezzelarab M, 2011, SEMIN IMMUNOL, V23, P252, DOI 10.1016/j.smim.2011.06.007; Figdor CG, 2004, NAT MED, V10, P475, DOI 10.1038/nm1039; Giannoukakis N, 2011, DIABETES CARE, V34, P2026, DOI 10.2337/dc11-0472; Hauben E, 2008, BLOOD, V112, P1214, DOI 10.1182/blood-2007-08-109843; Hilkens CMU, 2010, INT REV IMMUNOL, V29, P156, DOI 10.3109/08830180903281193; Hsu FJ, 1996, NAT MED, V2, P52, DOI 10.1038/nm0196-52; Huang YF, 2010, TRANSPLANTATION, V90, P1307, DOI 10.1097/TP.0b013e3181fdd9eb; Jonas S, 1999, ANN NY ACAD SCI, V890, P2, DOI 10.1111/j.1749-6632.1999.tb07975.x; Kalantari T, 2011, IMMUNOL RES, V51, P153, DOI 10.1007/s12026-011-8255-5; Kim YS, 2006, INT IMMUNOL, V18, P1771, DOI 10.1093/intimm/dxl111; Li QS, 2010, VACCINE, V28, P8300, DOI 10.1016/j.vaccine.2010.09.094; Liang XY, 2003, TRANSPLANTATION, V76, P721, DOI 10.1097/01.TP.0000076470.35404.49; Lo J, 2006, AUTOIMMUN REV, V5, P419, DOI 10.1016/j.autrev.2005.12.001; Mendieta-Zeron H, 2011, IMMUNOTHERAPY-UK, V3, P1499, DOI [10.2217/IMT.11.142, 10.2217/imt.11.142]; MENGER MD, 1991, LANGENBECK ARCH CHIR, V376, P214; O'Rourke RW, 2000, TRANSPLANTATION, V69, P1440, DOI 10.1097/00007890-200004150-00039; Oluwole OO, 2001, DIABETES, V50, P1546, DOI 10.2337/diabetes.50.7.1546; OLUWOLE SF, 1995, CELL IMMUNOL, V162, P33, DOI 10.1006/cimm.1995.1048; Rastellini C, 1995, TRANSPLANTATION, V60, P1366; Roskott AMC, 2011, TRANSPL INT, V24, P107, DOI 10.1111/j.1432-2277.2010.01187.x; Shirasugi N, 2002, J IMMUNOL, V169, P2677, DOI 10.4049/jimmunol.169.5.2677; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Stepkowski SM, 2006, TRANSPLANTATION, V82, P1756, DOI 10.1097/01.tp.0000250732.30273.9b; Wu WQ, 2012, CHIN J EVID BASED ME, V5, P139, DOI DOI 10.1111/J.1756-5391.2012.01191.X; Yang DF, 2008, TRANSPL IMMUNOL, V19, P197, DOI 10.1016/j.trim.2008.05.005; [张春桃 Zhang Chuntao], 2010, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V10, P740; Zhu HF, 2008, CELL MOL IMMUNOL, V5, P41, DOI 10.1038/cmi.2008.5	31	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52096	10.1371/journal.pone.0052096	http://dx.doi.org/10.1371/journal.pone.0052096			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272217	Green Published, gold, Green Submitted			2022-12-27	WOS:000312483300063
J	Bhattacharyya, M; Upadhyay, R; Vishveshwara, S				Bhattacharyya, Moitrayee; Upadhyay, Roopali; Vishveshwara, Saraswathi			Interaction Signatures Stabilizing the NAD(P)-Binding Rossmann Fold: A Structure Network Approach	PLOS ONE			English	Article							PROTEIN-STRUCTURE; EVOLUTION; SEQUENCE; FAMILIES; NUMBER	The fidelity of the folding pathways being encoded in the amino acid sequence is met with challenge in instances where proteins with no sequence homology, performing different functions and no apparent evolutionary linkage, adopt a similar fold. The problem stated otherwise is that a limited fold space is available to a repertoire of diverse sequences. The key question is what factors lead to the formation of a fold from diverse sequences. Here, with the NAD(P)-binding Rossmann fold domains as a case study and using the concepts of network theory, we have unveiled the consensus structural features that drive the formation of this fold. We have proposed a graph theoretic formalism to capture the structural details in terms of the conserved atomic interactions in global milieu, and hence extract the essential topological features from diverse sequences. A unified mathematical representation of the different structures together with a judicious concoction of several network parameters enabled us to probe into the structural features driving the adoption of the NAD(P)-binding Rossmann fold. The atomic interactions at key positions seem to be better conserved in proteins, as compared to the residues participating in these interactions. We propose a "spatial motif" and several "fold specific hot spots" that form the signature structural blueprints of the NAD(P)-binding Rossmann fold domain. Excellent agreement of our data with previous experimental and theoretical studies validates the robustness and validity of the approach. Additionally, comparison of our results with statistical coupling analysis (SCA) provides further support. The methodology proposed here is general and can be applied to similar problems of interest.	[Bhattacharyya, Moitrayee; Upadhyay, Roopali; Vishveshwara, Saraswathi] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Vishveshwara, S (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	sv@mbu.iisc.ernet.in			Department of Science and Technology for Mathematical Biology, Government of India [DSTO773]; Council for Scientific and Industrial Research (CSIR)	Department of Science and Technology for Mathematical Biology, Government of India(Department of Science & Technology (India)); Council for Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	The support from the Department of Science and Technology for Mathematical Biology (DSTO773), Government of India, is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MB and SV thank the Council for Scientific and Industrial Research (CSIR) for senior research fellowship and emeritus professorship respectively. We also thank Prof. Rama Ranganathan for providing the SCA codes.	Andreeva A, 2006, CURR OPIN STRUC BIOL, V16, P399, DOI 10.1016/j.sbi.2006.04.003; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Bhattacharyya M, 2010, PROTEINS, V78, P506, DOI 10.1002/prot.22573; Brenner SE, 2000, NUCLEIC ACIDS RES, V28, P254, DOI 10.1093/nar/28.1.254; Brinda KV, 2005, BIOPHYS J, V89, P4159, DOI 10.1529/biophysj.105.064485; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; Choi IG, 2006, P NATL ACAD SCI USA, V103, P14056, DOI 10.1073/pnas.0606239103; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Deb D, 2009, BIOPHYS J, V97, P1787, DOI 10.1016/j.bpj.2009.07.016; Dokholyan NV, 2002, P NATL ACAD SCI USA, V99, P14132, DOI 10.1073/pnas.202497999; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Hoang TX, 2004, P NATL ACAD SCI USA, V101, P7960, DOI 10.1073/pnas.0402525101; Jeffery CJ, 2003, TRENDS GENET, V19, P415, DOI 10.1016/S0168-9525(03)00167-7; Kanna N, 1999, J MOL BIOL, V292, P441, DOI 10.1006/jmbi.1999.3058; Keskin O, 2000, BIOPHYS J, V78, P2093, DOI 10.1016/S0006-3495(00)76756-7; Kleiger G, 2002, J MOL BIOL, V323, P69, DOI 10.1016/S0022-2836(02)00885-9; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Lee D, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-2; Lesk AM, 1995, CURR OPIN STRUC BIOL, V5, P775, DOI 10.1016/0959-440X(95)80010-7; Liu XS, 2004, PROTEINS, V54, P491, DOI 10.1002/prot.10514; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; LopezHernandez E, 1996, FOLD DES, V1, P43, DOI 10.1016/S1359-0278(96)00011-9; Mirny LA, 1999, J MOL BIOL, V291, P177, DOI 10.1006/jmbi.1999.2911; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Orengo CA, 2005, ANNU REV BIOCHEM, V74, P867, DOI 10.1146/annurev.biochem.74.082803.133029; ORENGO CA, 1994, NATURE, V372, P631, DOI 10.1038/372631a0; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Raimondi F, 2012, J BIOMOL STRUCT DYN, P1; Redfern OC, 2008, CURR OPIN STRUC BIOL, V18, P394, DOI 10.1016/j.sbi.2008.05.007; Rose GD, 2006, P NATL ACAD SCI USA, V103, P16623, DOI 10.1073/pnas.0606843103; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; Russ WP, 2005, NATURE, V437, P579, DOI 10.1038/nature03990; Smock RG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.65; Soundararajan V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009391; Sukhwal A, 2011, ACTA CRYSTALLOGR D, V67, P429, DOI 10.1107/S0907444911007062; Taylor WR, 2007, CURR OPIN STRUC BIOL, V17, P354, DOI 10.1016/j.sbi.2007.06.002; Vijayabaskar MS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002505; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wolf YI, 2000, J MOL BIOL, V299, P897, DOI 10.1006/jmbi.2000.3786; Worth CL, 2009, NAT REV MOL CELL BIO, V10, P709, DOI 10.1038/nrm2762; Zhang Y, 2005, P NATL ACAD SCI USA, V102, P1029, DOI 10.1073/pnas.0407152101	42	17	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51676	10.1371/journal.pone.0051676	http://dx.doi.org/10.1371/journal.pone.0051676			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284738	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000312435900041
J	Kaminski, KP; Petersen, AH; Sonderkaer, M; Pedersen, LH; Pedersen, H; Feder, C; Nielsen, KL				Kaminski, Kacper Piotr; Petersen, Annabeth Hogh; Sonderkaer, Mads; Pedersen, Lars Haastrup; Pedersen, Henrik; Feder, Christian; Nielsen, Kare L.			Transcriptome Analysis Suggests That Starch Synthesis May Proceed via Multiple Metabolic Routes in High Yielding Potato Cultivars	PLOS ONE			English	Article							ANTISENSE REPRESSION; PHOSPHOGLUCOMUTASE; CARBON; PLANTS	Background: Glucose-6-phosphate is imported into the amyloplast of potato tubers and thought to constitute the precursor for starch synthesis in potato tubers. However, recently it was shown that glucose-1-phosphate can also be imported into the amyloplast and incorporated into starch via an ATP independent mechanism under special conditions. Nonetheless, glucose-6-phosphate is believed to be the quantitatively important precursor for starch synthesis in potato. Principal Finding: Potato tubers of the high yielding cv Kuras had low gene expression of plastidial phophoglucomutase (PGM) and normal levels of transcripts for other enzymes involved in starch metabolism in comparison with medium and low yielding cultivars as determined by DeepSAGE transcriptome profiling. The decrease in PGM activity in Kuras was confirmed by measuring the enzyme activity from potato tuber extracts. Contrary to expectations, this combination lead to a higher level of intracellular glucose-1-phosphate (G1P) in Kuras suggesting that G1P is directly imported into plastids and can be quantitatively important for starch synthesis under normal conditions in high yielding cultivars. Significance: This could open entirely new possibilities for metabolic engineering of the starch metabolism in potato via the so far uncharacterized G1P transporter. The perspectives are to increase yield and space efficiency of this important crop. In the light of the increasing demands imposed on agriculture to support a growing global population this presents an exciting new possibility.	[Kaminski, Kacper Piotr] Aarhus Univ, Dept Agroecol, Aarhus, Denmark; [Kaminski, Kacper Piotr; Petersen, Annabeth Hogh; Sonderkaer, Mads; Pedersen, Lars Haastrup; Nielsen, Kare L.] Aalborg Univ, Dept Biotechnol Chem & Environm Engn, Aalborg, Denmark; [Pedersen, Henrik] AKV Langholt Amba, Langholt, Denmark; [Feder, Christian] KMC, Brande, Denmark	Aarhus University; Aalborg University	Nielsen, KL (corresponding author), Aalborg Univ, Dept Biotechnol Chem & Environm Engn, Aalborg, Denmark.	kln@bio.aau.dk	Nielsen, Kåre Lehmann L/A-1181-2013	Nielsen, Kåre Lehmann L/0000-0002-5598-4401; Sonderkaer, Mads/0000-0002-9309-7459	Danish Strategic Research Council [2101-07-0116]	Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF))	This work was supported by the Danish Strategic Research Council (grant no 2101-07-0116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fernie AR, 2002, PLANT PHYSIOL BIOCH, V40, P921, DOI 10.1016/S0981-9428(02)01457-2; Fernie AR, 2002, PLANTA, V214, P510, DOI 10.1007/s004250100644; Fettke J, 2010, NEW PHYTOL, V185, P663, DOI 10.1111/j.1469-8137.2009.03126.x; Geigenberger P, 2001, PLANT PHYSIOL, V125, P1667, DOI 10.1104/pp.125.4.1667; James MG, 2003, CURR OPIN PLANT BIOL, V6, P215, DOI 10.1016/S1369-5266(03)00042-6; Jeong JS, 2007, J CHROMATOGR A, V1164, P167, DOI 10.1016/j.chroma.2007.07.007; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Lytovchenko A, 2007, CURR OPIN PLANT BIOL, V10, P227, DOI 10.1016/j.pbi.2007.04.002; Nielsen Kare Lehmann, 2008, V387, P81; Nielsen KL, 2008, NEXT GENERATION SEQU, P229; Regierer B, 2002, NAT BIOTECHNOL, V20, P1256, DOI 10.1038/nbt760; STARK DM, 1992, SCIENCE, V258, P287, DOI 10.1126/science.258.5080.287; Streb S, 2009, PLANT PHYSIOL, V151, P1769, DOI 10.1104/pp.109.144931; Sweetlove LJ, 1999, PLANTA, V209, P330, DOI 10.1007/s004250050640; Tauberger E, 2000, PLANT J, V23, P43, DOI 10.1046/j.1365-313x.2000.00783.x; Tjaden J, 1998, PLANT J, V16, P531, DOI 10.1046/j.1365-313X.1998.00317.x; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158	18	17	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51248	10.1371/journal.pone.0051248	http://dx.doi.org/10.1371/journal.pone.0051248			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V30PH	23284672	Green Submitted, Green Published, gold			2022-12-27	WOS:000208827400001
J	N'Tumba-Byn, T; Moison, D; Lacroix, M; Lecureuil, C; Lesage, L; Prud'homme, SM; Pozzi-Gaudin, S; Frydman, R; Benachi, A; Livera, G; Rouiller-Fabre, V; Habert, R				N'Tumba-Byn, Thierry; Moison, Delphine; Lacroix, Marlene; Lecureuil, Charlotte; Lesage, Laetitia; Prud'homme, Sophie M.; Pozzi-Gaudin, Stephanie; Frydman, Rene; Benachi, Alexandra; Livera, Gabriel; Rouiller-Fabre, Virginie; Habert, Rene			Differential Effects of Bisphenol A and Diethylstilbestrol on Human, Rat and Mouse Fetal Leydig Cell Function	PLOS ONE			English	Article							TESTICULAR DYSGENESIS SYNDROME; TESTIS IN-VITRO; HORMONE CONCENTRATIONS; ENDOCRINE DISRUPTORS; LACTATIONAL EXPOSURE; ANOGENITAL DISTANCE; TESTOSTERONE; GERM; STEROIDOGENESIS; NUMBER	Endocrine disruptors (ED) have been incriminated in the current increase of male reproductive alterations. Bisphenol A (BPA) is a widely used weak estrogenic environmental ED and it is debated whether BPA concentrations within the average internal exposure are toxic. In the present study we investigated the effects of 10(-12) to 10(-5) M BPA concentrations on fetal Leydig cell function, as fetal life is a critical period of sensitivity to ED effects on male reproductive function. To this aim, fetal testes from human at 6.5-10.5 gestational weeks (GW) or from rat and mouse at a comparable critical period of development (14.5 days post-coitum (dpc) for rat and 12.5 dpc for mouse) were explanted and cultured using our validated organotypic culture system in the presence or absence of BPA for 1-3 days. BPA concentrations as low as 10(-8) M reduced testosterone secretion by human testes from day 1 of culture onwards, but not by mouse and rat testes where concentrations equal to 10(-5) M BPA were required. Similarly, 10(-8) M BPA reduced INSL3 mRNA levels only in human cultured testes. On the contrary, 10(-5) and 10(-6) M diethylstilbestrol (DES), a classical estrogenic compound, affected testosterone secretion only in rat and mouse testis cultures, but not in human testis cultures. Lastly, contrarily to the DES effect, the negative effect of BPA on testosterone produced by the mouse fetal testis was maintained after invalidation of estrogen receptor alpha (ER alpha). In conclusion, these results evidenced i) a deleterious effect of BPA on fetal Leydig cells function in human for concentrations from 10(-8) M upwards, ii) species-specific differences raising concerns about extrapolation of data from rodent studies to human risk assessment, iii) a specific signaling pathway for BPA which differs from the DES one and which does not involve ER alpha.	[N'Tumba-Byn, Thierry; Moison, Delphine; Lecureuil, Charlotte; Lesage, Laetitia; Prud'homme, Sophie M.; Livera, Gabriel; Rouiller-Fabre, Virginie; Habert, Rene] Univ Paris Diderot, Lab Dev Gonads, Unit Stem Cells & Radiat, Fontenay Aux Roses, France; [N'Tumba-Byn, Thierry; Moison, Delphine; Lecureuil, Charlotte; Lesage, Laetitia; Prud'homme, Sophie M.; Livera, Gabriel; Rouiller-Fabre, Virginie; Habert, Rene] LDG, SCSR, IRCM, DSV,CEA, Fontenay Aux Roses, France; [N'Tumba-Byn, Thierry; Moison, Delphine; Lecureuil, Charlotte; Lesage, Laetitia; Prud'homme, Sophie M.; Livera, Gabriel; Rouiller-Fabre, Virginie; Habert, Rene] INSERM, Unite 967, Fontenay Aux Roses, France; [Lacroix, Marlene] INRA, UMR1331, TOXALIM, F-31931 Toulouse, France; [Pozzi-Gaudin, Stephanie; Frydman, Rene; Benachi, Alexandra] Univ Paris 11, Hop A Beclere, Serv Gynecol Obstetr & Med Reprod, Clamart, France	UDICE-French Research Universities; Universite Paris Cite; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; UDICE-French Research Universities; Universite Paris Saclay	Habert, R (corresponding author), Univ Paris Diderot, Lab Dev Gonads, Unit Stem Cells & Radiat, Fontenay Aux Roses, France.	rene.habert@cea.fr	Lécureuil, Charlotte/B-4841-2016; LIVERA, Gabriel/F-5740-2019	Lécureuil, Charlotte/0000-0002-7339-9185; LIVERA, Gabriel/0000-0001-8436-4730; Prud'homme, Sophie/0000-0002-7199-1839; Lacroix, Marlene/0000-0002-6981-8340; ROUILLER-FABRE, Virginie/0000-0002-3927-5701; LESAGE, LAETITIA/0000-0001-8592-2482; Habert, Rene/0000-0002-6045-0324	French Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement et du Travail [ANSES] [EST62010/2/046]; Agence Nationale de la Recherche [ANR] [MECABPA]; Ministere de l'Ecologie, du Developpement Durable, des Transports et du Logement; Universite Paris Diderot; INSERM; CEA; Region Ile-de-France (DIM Sante-Environnement-Toxicologie)	French Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement et du Travail [ANSES](French National Research Agency (ANR)); Agence Nationale de la Recherche [ANR](French National Research Agency (ANR)); Ministere de l'Ecologie, du Developpement Durable, des Transports et du Logement; Universite Paris Diderot; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CEA(French Atomic Energy Commission); Region Ile-de-France (DIM Sante-Environnement-Toxicologie)(Region Ile-de-France)	This work was supported by the French Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement et du Travail [ANSES contrat EST62010/2/046], by the Agence Nationale de la Recherche [ANR, contrat MECABPA] and by the Ministere de l'Ecologie, du Developpement Durable, des Transports et du Logement [Programme ANTIOPES - Storm]. It was also supported by Universite Paris Diderot, INSERM and CEA. Thierry N'Tumba-Byn holds a fellowship from the Region Ile-de-France (DIM Sante-Environnement-Toxicologie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akingbemi BT, 2004, ENDOCRINOLOGY, V145, P592, DOI 10.1210/en.2003-1174; Angenard G, 2010, ENVIRON HEALTH PERSP, V118, P331, DOI 10.1289/ehp.0900975; Bay K, 2011, NAT REV UROL, V8, P187, DOI 10.1038/nrurol.2011.23; Bouskine A, 2009, ENVIRON HEALTH PERSP, V117, P1053, DOI 10.1289/ehp.0800367; Cabaton NJ, 2011, ENVIRON HEALTH PERSP, V119, P547, DOI 10.1289/ehp.1002559; Chauvigne F, 2009, ENVIRON HEALTH PERSP, V117, P515, DOI 10.1289/ehp.11870; Chevalier N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034672; Delbes G, 2005, ENDOCRINOLOGY, V146, P2454, DOI 10.1210/en.2004-1540; Delbes G, 2007, TOXICOL SCI, V99, P234, DOI 10.1093/toxsci/kfm160; Dupont S, 2000, DEVELOPMENT, V127, P4277; Evtouchenko L, 1996, CELL TRANSPLANT, V5, P453, DOI 10.1016/0963-6897(96)00079-6; Fenichel P, 2012, HUM REPROD, V27, P983, DOI 10.1093/humrep/der451; Galloway T, 2010, ENVIRON HEALTH PERSP, V118, P1603, DOI 10.1289/ehp.1002367; Gaskell TL, 2003, J CLIN ENDOCR METAB, V88, P424, DOI 10.1210/jc.2002-020811; Gaspari L, 2011, HUM REPROD, V26, P3155, DOI 10.1093/humrep/der283; HABERT R, 1991, MOL CELL ENDOCRINOL, V82, P199, DOI 10.1016/0303-7207(91)90032-N; HABERT R, 1984, J STEROID BIOCHEM, V21, P193, DOI 10.1016/0022-4731(84)90383-2; Habert R, 2009, FOLIA HISTOCHEM CYTO, V47, pS67, DOI 10.2478/v10042-009-0056-5; Hanaoka T, 2002, OCCUP ENVIRON MED, V59, P625, DOI 10.1136/oem.59.9.625; Howdeshell KL, 2008, TOXICOL SCI, V102, P371, DOI 10.1093/toxsci/kfm306; Ikezuki Y, 2002, HUM REPROD, V17, P2839, DOI 10.1093/humrep/17.11.2839; Ivell R, 2009, HUM REPROD UPDATE, V15, P463, DOI 10.1093/humupd/dmp011; Kobayashi K, 2002, IND HEALTH, V40, P375, DOI 10.2486/indhealth.40.375; Kristensen DM, 2011, HUM REPROD, V26, P235, DOI 10.1093/humrep/deq323; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Lacroix MZ, 2011, TALANTA, V85, P2053, DOI 10.1016/j.talanta.2011.07.040; Lambrot R, 2006, BIOCHIMIE, V88, P1831, DOI 10.1016/j.biochi.2006.09.022; Lambrot R, 2009, ENVIRON HEALTH PERSP, V117, P32, DOI 10.1289/ehp.11146; Lambrot R, 2006, J CLIN ENDOCR METAB, V91, P2696, DOI 10.1210/jc.2005-2113; Lassurguere J, 2003, TOXICOL SCI, V73, P160, DOI 10.1093/toxsci/kfg065; LECERF L, 1993, ENDOCRINOLOGY, V133, P2313, DOI 10.1210/en.133.5.2313; Lehraiki A, 2011, TOXICOL IN VITRO, V25, P1542, DOI 10.1016/j.tiv.2011.05.017; Lehraiki A, 2009, TOXICOL SCI, V111, P372, DOI 10.1093/toxsci/kfp153; Leridon H, 2008, HUM REPROD, V23, P1312, DOI 10.1093/humrep/den106; Livera G, 2000, BIOL REPROD, V62, P1303, DOI 10.1095/biolreprod62.5.1303; Livera G, 2006, CELL TISSUE RES, V324, P507, DOI 10.1007/s00441-006-0167-7; Main KM, 2010, BEST PRACT RES CL EN, V24, P279, DOI 10.1016/j.beem.2009.10.003; Mazur CS, 2010, DRUG METAB DISPOS, V38, P2232, DOI 10.1124/dmd.110.034819; Meeker JD, 2010, ENVIRON SCI TECHNOL, V44, P1458, DOI 10.1021/es9028292; Mendiola J, 2010, ENVIRON HEALTH PERSP, V118, P1286, DOI 10.1289/ehp.1002037; Merlet J, 2007, P NATL ACAD SCI USA, V104, P3615, DOI 10.1073/pnas.0611421104; Miao MH, 2011, BIRTH DEFECTS RES A, V91, P867, DOI 10.1002/bdra.22845; Muczynski V, 2012, TOXICOL APPL PHARM, V261, P97, DOI 10.1016/j.taap.2012.03.016; Murono EP, 2001, REPROD TOXICOL, V15, P551, DOI 10.1016/S0890-6238(01)00158-7; Murray TJ, 2007, REPROD TOXICOL, V23, P383, DOI 10.1016/j.reprotox.2006.10.002; Nakamura D, 2010, TOXICOL LETT, V194, P16, DOI 10.1016/j.toxlet.2010.02.002; Olaso R, 1998, ENDOCRINOLOGY, V139, P733, DOI 10.1210/en.139.2.733; Salian S, 2011, REPROD TOXICOL, V31, P359, DOI 10.1016/j.reprotox.2010.10.008; Scott HM, 2009, ENDOCR REV, V30, P883, DOI 10.1210/er.2009-0016; Sharpe Richard M, 2008, Fertil Steril, V89, pe33, DOI 10.1016/j.fertnstert.2007.12.026; Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972; Soto AM, 2010, NAT REV ENDOCRINOL, V6, P364, DOI 10.1038/nrendo.2010.87; Swaab DF, 2007, BEST PRACT RES CL EN, V21, P431, DOI 10.1016/j.beem.2007.04.003; Takayanagi S, 2006, TOXICOL LETT, V167, P95, DOI 10.1016/j.toxlet.2006.08.012; Talsness CE, 2009, PHILOS T R SOC B, V364, P2079, DOI 10.1098/rstb.2008.0281; Tanaka M, 2006, HUM EXP TOXICOL, V25, P369, DOI 10.1191/0960327106ht638oa; Taylor JA, 2011, ENVIRON HEALTH PERSP, V119, P422, DOI 10.1289/ehp.1002514; Teeguarden JG, 2011, TOXICOL SCI, V123, P48, DOI 10.1093/toxsci/kfr160; Thuillier R, 2009, MICROSC RES TECHNIQ, V72, P773, DOI 10.1002/jemt.20756; Toppari J, 1996, ENVIRON HEALTH PERSP, V104, P741, DOI 10.2307/3432709; Toppari J, 2010, BIRTH DEFECTS RES A, V88, P910, DOI 10.1002/bdra.20707; Tyl RW, 2009, ENVIRON HEALTH PERSP, V117, P1644, DOI 10.1289/ehp.0900893; Tyl RW, 2002, TOXICOL SCI, V68, P121, DOI 10.1093/toxsci/68.1.121; van den Driesche S, 2011, INT J ANDROL, V34, pE578, DOI 10.1111/j.1365-2605.2011.01175.x; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; Vom Saal FS, 2011, TOXICOL SCI; Welsh M, 2008, J CLIN INVEST, V118, P1479, DOI 10.1172/JCI34241; Ye LP, 2011, TOXICOL LETT, V207, P137, DOI 10.1016/j.toxlet.2011.09.001; Zhang XW, 2011, TOXICOL SCI, V121, P320, DOI 10.1093/toxsci/kfr061	71	85	85	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51579	10.1371/journal.pone.0051579	http://dx.doi.org/10.1371/journal.pone.0051579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284716	gold, Green Submitted, Green Published			2022-12-27	WOS:000312435900028
J	Stoyanova, E; Cloutier, G; Felfly, H; Lemsaddek, W; Ah-Son, N; Trudel, M				Stoyanova, Ekatherina; Cloutier, Guy; Felfly, Hady; Lemsaddek, Wafaa; Ah-Son, Nicolas; Trudel, Marie			Evidence for a Novel Mechanism Independent of Myocardial Iron in beta-Thalassemia Cardiac Pathogenesis	PLOS ONE			English	Article							SICKLE-CELL-DISEASE; ECHOCARDIOGRAPHIC-ASSESSMENT; MAGNETIC-RESONANCE; MAJOR PATIENTS; HEART-FAILURE; M-MODE; ANEMIA; OVERLOAD; DEFEROXAMINE; HYPERTROPHY	Human beta-thalassemia major is one of the most prevalent genetic diseases characterized by decrease/absence of beta-globin chain production with reduction of erythrocyte number. The main cause of death of treated beta-thalassemia major patients with chronic blood transfusion is early cardiac complications that have been attributed to secondary iron overload despite optimal chelation. Herein, we investigated pathophysiological mechanisms of cardiovascular dysfunction in a severe murine model of beta-thalassemia from 6 to 15-months of age in the absence of confounding effects related to transfusion. Our longitudinal echocardiography analysis showed that beta-thalassemic mice first display a significant increase of cardiac output in response to limited oxygen-carrying erythrocytes that progressed rapidly to left ventricular hypertrophy and structural remodeling. Following this compensated hypertrophy, beta-thalassemic mice developed age-dependent deterioration of left ventricular contractility and dysfunction that led toward decompensated heart failure. Consistently, murine beta-thalassemic hearts histopathology revealed cardiac remodeling with increased interstitial fibrosis but virtual absence of myocardial iron deposits. Importantly, development of thalassemic cardiac hypertrophy and dysfunction independently of iron overload has uncoupled these cardiopathogenic processes. Altogether our study on beta-thalassemia major hemoglobinopathy points to two successive phases resulting from severe chronic anemia and from secondarily induced mechanisms as pathophysiologic contributors to thalassemic cardiopathy.	[Stoyanova, Ekatherina; Felfly, Hady; Lemsaddek, Wafaa; Ah-Son, Nicolas; Trudel, Marie] Univ Montreal, Fac Med, Inst Rech Clin Montreal Mol Genet & Dev, Montreal, PQ H3C 3J7, Canada; [Cloutier, Guy] Univ Montreal Hosp Res Ctr CRCHUM, Lab Biorheol & Med Ultrason, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal	Trudel, M (corresponding author), Univ Montreal, Fac Med, Inst Rech Clin Montreal Mol Genet & Dev, Montreal, PQ H3C 3J7, Canada.	trudelm@ircm.qc.ca		Trudel, Marie/0000-0003-0057-2669	Canadian Blood Services/Canadian Institute for Health Research (CBS/CIHR); National Institute of Health [R01HL078655]; Programme canadien des bourses de la francophonie (PCBF) studentship	Canadian Blood Services/Canadian Institute for Health Research (CBS/CIHR)(Canadian Institutes of Health Research (CIHR)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Programme canadien des bourses de la francophonie (PCBF) studentship	This study was supported by grants from the Canadian Blood Services/Canadian Institute for Health Research (CBS/CIHR) to MT, the National Institute of Health (R01HL078655 to MT and GC. HF is a recipient from the Programme canadien des bourses de la francophonie (PCBF) studentship and WL is a recipient from CBS/CIHR fellowship award. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aessopos A, 2004, EUR J HAEMATOL, V73, P359, DOI 10.1111/j.1600-0609.2004.00304.x; Aessopos A, 2005, CHEST, V127, P1523, DOI 10.1378/chest.127.5.1523; Aessopos A, 2004, CLIN INVEST MED, V27, P265; Aessopos A, 2008, EUR J HAEMATOL, V80, P93, DOI 10.1111/j.1600-0609.2007.01018.x; Anand IS, 2008, HEART FAIL REV, V13, P379, DOI 10.1007/s10741-008-9088-8; Anderson LJ, 2001, EUR HEART J, V22, P2171, DOI 10.1053/euhj.2001.2822; BAHL VK, 1992, AM HEART J, V124, P1516, DOI 10.1016/0002-8703(92)90066-5; Beauchemin H, 2004, J BIOL CHEM, V279, P19471, DOI 10.1074/jbc.M309989200; BOWENS C, 1993, ANESTH ANALG, V76, P1027; Brili SV, 1997, CLIN CARDIOL, V20, P541, DOI 10.1002/clc.4960200607; Cunningham MJ, 2004, BLOOD, V104, P34, DOI 10.1182/blood-2003-09-3167; Engle M A, 1985, Trans Am Clin Climatol Assoc, V96, P24; Felfly H, 2007, MOL THER, V15, P1701, DOI 10.1038/sj.mt.6300204; Felfly H, 2010, BRIT J HAEMATOL, V148, P646, DOI 10.1111/j.1365-2141.2009.07985.x; Hahalis G, 2005, AM J MED, V118, P957, DOI 10.1016/j.amjmed.2005.02.021; IIMOTO DS, 1988, CIRC RES, V63, P399, DOI 10.1161/01.RES.63.2.399; Jensen PD, 2004, BRIT J HAEMATOL, V124, P697, DOI 10.1111/j.1365-2141.2004.04838.x; Kato GJ, 2007, BLOOD REV, V21, P37, DOI 10.1016/j.blre.2006.07.001; Kawabata H, 2001, BLOOD, V98, P1949, DOI 10.1182/blood.V98.6.1949; LOMBARDO T, 1995, ANN HEMATOL, V71, P135, DOI 10.1007/s002770050097; Mavrogeni SI, 2005, EUR J HAEMATOL, V75, P241, DOI 10.1111/j.1600-0609.2005.00474.x; Modell B, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-42; Morris Claudia R, 2008, Hematology Am Soc Hematol Educ Program, P177, DOI 10.1182/asheducation-2008.1.177; Naito Y, 2009, AM J PHYSIOL-HEART C, V296, pH585, DOI 10.1152/ajpheart.00463.2008; OLIVETTI G, 1992, AM J PATHOL, V141, P227; Origa R, 2008, HAEMATOL-HEMATOL J, V93, P1095, DOI 10.3324/haematol.12484; Papakonstantinou O, 2009, J MAGN RESON IMAGING, V29, P853, DOI 10.1002/jmri.21707; Pennell DJ, 2006, BLOOD, V107, P3738, DOI 10.1182/blood-2005-07-2948; Pereira AA, 2003, KIDNEY INT, V64, pS32, DOI 10.1046/j.1523-1755.64.s87.6.x; Pollick C, 1995, J Am Soc Echocardiogr, V8, P602, DOI 10.1016/S0894-7317(05)80373-6; Qian ZM, 2007, BBA-MOL BASIS DIS, V1772, P527, DOI 10.1016/j.bbadis.2007.02.006; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; ROY SB, 1963, CIRCULATION, V28, P346, DOI 10.1161/01.CIR.28.3.346; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Schrier SL, 2005, ANNU REV MED, V56, P157, DOI 10.1146/annurev.med.56.082103.104718; SKOW LC, 1983, CELL, V34, P1043, DOI 10.1016/0092-8674(83)90562-7; Stoyanova E, 2007, PHYSIOL GENOMICS, V29, P84, DOI 10.1152/physiolgenomics.00305.2005; Stoyanova E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038089; Sun XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006596; Tanner MA, 2006, J CARDIOVASC MAGN R, V8, P543, DOI 10.1080/10976640600698155; Telfer PT, 2009, HAEMATOL-HEMATOL J, V94, P1777, DOI 10.3324/haematol.2009.009118; Wandt B, 1999, HEART, V82, P192, DOI 10.1136/hrt.82.2.192; Weatherhall DJ, 2001, THALASSEMIA SYNDROME; Wood JC, 2004, BLOOD, V103, P1934, DOI 10.1182/blood-2003-06-1919; Yang XP, 1999, AM J PHYSIOL-HEART C, V277, pH1967, DOI 10.1152/ajpheart.1999.277.5.H1967	45	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52128	10.1371/journal.pone.0052128	http://dx.doi.org/10.1371/journal.pone.0052128			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284899	gold, Green Published, Green Submitted			2022-12-27	WOS:000312435900078
J	Shi, HY; Lee, HH; Tsai, JT; Ho, WH; Chen, CF; Lee, KT; Chiu, CC				Shi, Hon-Yi; Lee, Hao-Hsien; Tsai, Jinn-Tsong; Ho, Wen-Hsien; Chen, Chieh-Fan; Lee, King-Teh; Chiu, Chong-Chi			Comparisons of Prediction Models of Quality of Life after Laparoscopic Cholecystectomy: A Longitudinal Prospective Study	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORKS; VALIDATION; CONVERSION; OUTCOMES	Background: Few studies of laparoscopic cholecystectomy (LC) outcome have used longitudinal data for more than two years. Moreover, no studies have considered group differences in factors other than outcome such as age and nonsurgical treatment. Additionally, almost all published articles agree that the essential issue of the internal validity (reproducibility) of the artificial neural network (ANN), support vector machine (SVM), Gaussian process regression (GPR) and multiple linear regression (MLR) models has not been adequately addressed. This study proposed to validate the use of these models for predicting quality of life (QOL) after LC and to compare the predictive capability of ANNs with that of SVM, GPR and MLR. Methodology/Principal Findings: A total of 400 LC patients completed the SF-36 and the Gastrointestinal Quality of Life Index at baseline and at 2 years postoperatively. The criteria for evaluating the accuracy of the system models were mean square error (MSE) and mean absolute percentage error (MAPE). A global sensitivity analysis was also performed to assess the relative significance of input parameters in the system model and to rank the variables in order of importance. Compared to SVM, GPR and MLR models, the ANN model generally had smaller MSE and MAPE values in the training data set and test data set. Most ANN models had MAPE values ranging from 4.20% to 8.60%, and most had high prediction accuracy. The global sensitivity analysis also showed that preoperative functional status was the best parameter for predicting QOL after LC. Conclusions/Significance: Compared with SVM, GPR and MLR models, the ANN model in this study was more accurate in predicting patient-reported QOL and had higher overall performance indices. Further studies of this model may consider the effect of a more detailed database that includes complications and clinical examination findings as well as more detailed outcome data.	[Lee, Hao-Hsien; Chiu, Chong-Chi] Chi Mei Med Ctr, Dept Surg, Liouying, Taiwan; [Shi, Hon-Yi; Ho, Wen-Hsien; Lee, King-Teh] Kaohsiung Med Univ, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan; [Tsai, Jinn-Tsong] Natl Pingtung Univ Educ, Dept Comp Sci, Pingtung, Taiwan; [Chen, Chieh-Fan] Kaohsiung Municipal United Hosp, Emergency Dept, Kaohsiung, Taiwan; [Chen, Chieh-Fan] Meiho Univ, Dept Hlth Business Adm, Pigntung, Taiwan; [Lee, King-Teh] Kaohsiung Med Univ Hosp, Dept Surg, Div Hepatobiliary Surg, Kaohsiung, Taiwan; [Chiu, Chong-Chi] Chi Mei Med Ctr, Dept Gen Surg, Tainan, Taiwan; [Chiu, Chong-Chi] Taipei Med Univ, Taipei, Taiwan; [Chiu, Chong-Chi] Chia Nan Univ Pharm & Sci, Tainan, Taiwan	Chi Mei Hospital; Kaohsiung Medical University; National Pingtung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Chi Mei Hospital; Taipei Medical University; Chia Nan University of Pharmacy & Science	Chiu, CC (corresponding author), Chi Mei Med Ctr, Dept Surg, Liouying, Taiwan.	chiuchongchi@yahoo.com.tw			National Science Council, Taiwan, Republic of China [NSC99-2314-B-037-069-MY3]	National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This work was in part supported by the National Science Council, Taiwan, Republic of China, under grant numbers NSC99-2314-B-037-069-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Buddingh KT, 2011, J GASTROINTEST SURG, V15, P1069, DOI 10.1007/s11605-011-1413-1; Chen CF, 2011, COMPUT MATH METHOD M, V2011, DOI 10.1155/2011/395690; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Das A, 2003, LANCET, V362, P1261, DOI 10.1016/S0140-6736(03)14568-0; Eldar S, 2002, WORLD J SURG, V26, P79; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Gholipour C, 2009, BMC SURG, V9, DOI 10.1186/1471-2482-9-13; Ho WH, 2010, NONLINEAR DYNAM, V61, P29, DOI 10.1007/s11071-009-9629-2; Hsu CE, 2010, SURG ENDOSC, V24, P3127, DOI 10.1007/s00464-010-1103-1; Joseph S, 2011, SURG ENDOSC, V25, P3008, DOI 10.1007/s00464-011-1661-x; Kapoor A, 2010, INT J COMPUT VISION, V88, P169, DOI 10.1007/s11263-009-0268-3; Lancichinetti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018961; Liew PL, 2007, DIGEST LIVER DIS, V39, P356, DOI 10.1016/j.dld.2007.01.003; Lugtenberg M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025987; Noble H, 2011, SURG ENDOSC, V25, P130, DOI 10.1007/s00464-010-1146-3; Piaggi P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013624; Quintana JM, 2005, QUAL LIFE RES, V14, P815, DOI 10.1007/s11136-004-1259-z; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; RUMELHART DE, 1986, LEARNING INTERNAL RE, V1, P318; Salvatore S, 2011, INT UROGYNECOL J, V22, P453, DOI 10.1007/s00192-010-1300-4; Sampson DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024973; Segal ME, 2006, J HEAD TRAUMA REHAB, V21, P298, DOI 10.1097/00001199-200607000-00003; Shi HY, 2011, QUAL LIFE RES, V20, P335, DOI 10.1007/s11136-010-9760-z; Shi HY, 2011, SURG ENDOSC, V25, P2132, DOI 10.1007/s00464-010-1508-x; Shi HY, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-261; Shi HY, 2009, J GASTROINTEST SURG, V13, P1651, DOI 10.1007/s11605-009-0962-z; Tao MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024661; TETKO IV, 1995, J CHEM INF COMP SCI, V35, P826, DOI 10.1021/ci00027a006; Thakur V, 2011, ANN SURG, V253, P244, DOI 10.1097/SLA.0b013e318207bf52; WARE JE, 1995, MED CARE, V33, pAS264, DOI 10.1097/00005650-199501001-00005; Zou Jinming, 2008, V458, P15	31	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e51285	10.1371/journal.pone.0051285	http://dx.doi.org/10.1371/journal.pone.0051285			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	064DQ	23284677	gold, Green Published, Green Submitted			2022-12-27	WOS:000313051500009
J	Chaidir, L; Ganiem, AR; vander Zanden, A; Muhsinin, S; Kusumaningrum, T; Kusumadewi, I; van der Ven, A; Alisjahbana, B; Parwati, I; van Crevel, R				Chaidir, Lidya; Ganiem, Ahmad Rizal; vander Zanden, Adri; Muhsinin, Soni; Kusumaningrum, Tina; Kusumadewi, Inri; van der Ven, Andre; Alisjahbana, Bachti; Parwati, Ida; van Crevel, Reinout			Comparison of Real Time IS6110-PCR, Microscopy, and Culture for Diagnosis of Tuberculous Meningitis in a Cohort of Adult Patients in Indonesia	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; MYCOBACTERIUM-TUBERCULOSIS; CEREBROSPINAL-FLUID; HIV-INFECTION; PCR; CRITERIA; UTILITY	Background: Bacteriological confirmation of tuberculous (TB) meningitis is difficult. Culture is slow and microscopy has insufficient sensitivity. We evaluated real time PCR targeting insertion sequence IS6110 among 230 consecutive adult patients with subacute meningitis in a referral hospital in Indonesia. Methods: Cerebrospinal fluid (CSF) samples were examined using microscopy, solid and liquid culture, and real time IS6110-PCR with a fluorescence-labeled probe using DNA extracted from CSF. CSF samples from 40 non-infectious neurology patients were used as negative controls. IS6110-PCR results were linked with clinical and CSF characteristics. Results: Most patients presented with subacute meningitis, after a median of 14 days of symptoms (range 7-30). After exclusion of cryptococcal and bacterial meningitis, 207 patients were classified as definite or probable TB meningitis; 17.9% with HIV infection. Among this group IS6110-PCR gave the highest positivity rate (68%, 95% CI 62-74%) compared with microscopy of ZN-stained slides (11%, 95% CI 7-15%), and mycobacterial culture using solid (36%, 95% CI 29-42%) and liquid (44%, 95% CI 37-51%) media. IS6110-PCR was positive in 92% of patients with culture-positive and 42% of patients with culture-negative probable TB meningitis. Among culture-negative patients, a positive PCR was associated with a history of TB treatment, a longer duration of illness, a higher CSF cell count and protein, and a lower CSF glucose. IS6110-PCR was negative in all CSF samples from non-meningitis control patients. Conclusions: Real time IS6110-PCR is a quick, sensitive, and specific test for diagnosing of TB meningitis in this setting. Its performance in other (less-developed) settings needs further study.	[Chaidir, Lidya; Muhsinin, Soni; Kusumaningrum, Tina; Kusumadewi, Inri; Alisjahbana, Bachti] Padjadjaran State Univ, Hasan Sadikin Hosp, Fac Med, Hlth Res Unit, Bandung, Indonesia; [Ganiem, Ahmad Rizal] Padjadjaran State Univ, Hasan Sadikin Hosp, Fac Med, Dept Neurol, Bandung, Indonesia; [vander Zanden, Adri] Lab Med Microbiol & Publ Hlth, Enschede, Netherlands; [Parwati, Ida] Padjadjaran State Univ, Hasan Sadikin Hosp, Fac Med, Dept Clin Pathol, Bandung, Indonesia; [van der Ven, Andre; van Crevel, Reinout] Radboud Univ Nijmegen, Med Ctr, Dept Med, Nijmegen, Netherlands	Dr Hasan Sadikin General Hospital; Universitas Padjadjaran; Dr Hasan Sadikin General Hospital; Universitas Padjadjaran; Dr Hasan Sadikin General Hospital; Universitas Padjadjaran; Radboud University Nijmegen	Chaidir, L (corresponding author), Padjadjaran State Univ, Hasan Sadikin Hosp, Fac Med, Hlth Res Unit, Bandung, Indonesia.	lidya.upk.unpad@gmail.com	GANIEM, AHMAD RIZAL/GSE-0143-2022; Muhsinin, Soni/AAD-7905-2021; van Crevel, reinout/A-6636-2010; CHAIDIR, LIDYA/GSM-8277-2022; Muhsinin, Soni/U-9983-2019; van der Ven, A.J.A.M./H-8102-2014	van Crevel, reinout/0000-0002-6233-6410; van der Ven, A.J.A.M./0000-0003-1833-3391; Parwati, Ida/0000-0002-9700-589X	Royal Academy of Arts and Sciences (KNAW), The Netherlands [07-MP-10]; European Commission [SANTE/2005/105-033]; Netherlands Organization for Scientific Research (NWO) [017.106.310]; IMPACT, a 5-year HIV program	Royal Academy of Arts and Sciences (KNAW), The Netherlands(Netherlands Government); European Commission(European CommissionEuropean Commission Joint Research Centre); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); IMPACT, a 5-year HIV program	This study was financially supported by the Royal Academy of Arts and Sciences (KNAW, http://www.knaw.nl; 07-MP-10), The Netherlands and by IMPACT, a 5-year HIV program supported by the European Commission (SANTE/2005/105-033). Reinout van Crevel has a VIDI-grant from the Netherlands Organization for Scientific Research (NWO, http://www.nwo.nl; 017.106.310). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHUJA GK, 1994, TUBERCLE LUNG DIS, V75, P149, DOI 10.1016/0962-8479(94)90045-0; Bhigjee AI, 2007, INT J INFECT DIS, V11, P348, DOI 10.1016/j.ijid.2006.07.007; Caws M, 2000, J CLIN MICROBIOL, V38, P3150, DOI 10.1128/JCM.38.9.3150-3155.2000; Desai D, 2006, RES MICROBIOL, V157, P967, DOI 10.1016/j.resmic.2006.08.002; Deshpande PS, 2007, FLUIDS BARRIERS CNS, V4, DOI 10.1186/1743-8454-4-10; Ganiem AR, 2009, AIDS, V23, P2309, DOI 10.1097/QAD.0b013e3283320de8; Ganiem AR, 2012, PLOS NEGLEC IN PRESS; Haldar S, 2009, J MED MICROBIOL, V58, P616, DOI 10.1099/jmm.0.006015-0; Hillemann D, 2011, J CLIN MICROBIOL, V49, P1202, DOI 10.1128/JCM.02268-10; Hooker JAG, 2003, INT J TUBERC LUNG D, V7, P787; Huang CT, 2010, INFECTION, V38, P373, DOI 10.1007/s15010-010-0045-9; Katrak SM, 2000, J NEUROL SCI, V181, P118, DOI 10.1016/S0022-510X(00)00440-8; Kox LFF, 1995, NEUROLOGY, V45, P2228, DOI 10.1212/WNL.45.12.2228; Kusum S, 2011, J NEUROL, V258, P1781, DOI 10.1007/s00415-011-6010-4; Marais S, 2010, LANCET INFECT DIS, V10, P803, DOI 10.1016/S1473-3099(10)70138-9; Nguyen LN, 1996, ARCH NEUROL-CHICAGO, V53, P771, DOI 10.1001/archneur.1996.00550080093017; NOORDHOEK GT, 1994, J CLIN MICROBIOL, V32, P277, DOI 10.1128/JCM.32.2.277-284.1994; Pai M, 2003, LANCET INFECT DIS, V3, P633, DOI 10.1016/S1473-3099(03)00772-2; Parwati I, 2008, J CLIN MICROBIOL, V46, P3639, DOI 10.1128/JCM.00605-08; Quan C, 2006, J CLIN MICROBIOL, V44, P3160, DOI 10.1128/JCM.00333-06; Rafi W, 2007, INT J TUBERC LUNG D, V11, P209; Savelkoul PHM, 2006, J MICROBIOL METH, V66, P177, DOI 10.1016/j.mimet.2005.12.003; SCARPELLINI P, 1995, AIDS, V9, P895, DOI 10.1097/00002030-199508000-00010; Sharma P, 2011, EUR J INTERN MED, V22, P289, DOI 10.1016/j.ejim.2011.01.007; Sumi MG, 2002, DIAGN MICR INFEC DIS, V42, P35, DOI 10.1016/S0732-8893(01)00342-X; Takahashi T, 2005, NEUROLOGY, V64, P1789, DOI 10.1212/01.WNL.0000162052.13838.B2; Thwaites GE, 2005, J INFECT DIS, V192, P2134, DOI 10.1086/498220; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Thwaites GE, 2004, J CLIN MICROBIOL, V42, P378, DOI 10.1128/JCM.42.1.378-379.2004; Thwaites GE, 2005, J INFECT DIS, V192, P79, DOI 10.1086/430616; van Crevel R, 2001, EMERG INFECT DIS, V7, P880; Yeh TH, 1997, J FORMOS MED ASSOC, V96, P461	32	36	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52001	10.1371/journal.pone.0052001	http://dx.doi.org/10.1371/journal.pone.0052001			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284850	Green Published, Green Submitted, gold			2022-12-27	WOS:000313158800021
J	Bader, O; Schwarz, A; Kraneveld, EA; Tangwattanchuleeporn, M; Schmidt, P; Jacobsen, MD; Gross, U; De Groot, PWJ; Weig, M				Bader, Oliver; Schwarz, Alexander; Kraneveld, Eefje A.; Tangwattanchuleeporn, Marut; Schmidt, Pia; Jacobsen, Mette D.; Gross, Uwe; De Groot, Piet W. J.; Weig, Michael			Gross Karyotypic and Phenotypic Alterations among Different Progenies of the Candida glabrata CBS138/ATCC2001 Reference Strain	PLOS ONE			English	Article							WALL PROTEINS; ELECTROPHORETIC KARYOTYPES; CHROMOSOME INSTABILITY; GEL-ELECTROPHORESIS; BIOFILM FORMATION; GENE-EXPRESSION; CELL-WALL; ALBICANS; YEAST; EVOLUTION	Genomic plasticity is a mechanism for adaptation to environmental cues such as host responses and antifungal drug pressure in many fungi including the human pathogenic yeast Candida glabrata. In this study we evaluated the phenotypic and genotypic stability of the world-wide used C. glabrata reference strain CBS138/ ATCC2001 under laboratory conditions. A set of ten lineages of this wild type strain and genetically modified progenies were obtained from different scientific laboratories, and analyzed for genotypic and phenotypic alterations. Even though the derivates were indistinguishable by multi locus sequence typing, different phenotypic groups that correlated with specific karyotypic changes were observed. In addition, modifications in the adherence capacity to plastic surface emerged that were shown to correlate with quantitative changes in adhesin gene expression rather than subtelomeric gene loss or differences in the number of macrosatellite repeats within adhesin genes. These results confirm the genomic plasticity of C. glabrata and show that chromosomal aberrations and functional adaptations may occur not only during infection and under antimicrobial therapy, but also under laboratory conditions without extreme selective pressures. These alterations can significantly affect phenotypic properties such as cell surface attributes including adhesion and the cell wall carbohydrate composition and therefore, if unnoticed, may adulterate the outcome of genetic studies.	[Bader, Oliver; Schwarz, Alexander; Tangwattanchuleeporn, Marut; Schmidt, Pia; Gross, Uwe; Weig, Michael] Univ Med Ctr Gottingen, Inst Med Microbiol, Gottingen, Germany; [Bader, Oliver; Schwarz, Alexander; Tangwattanchuleeporn, Marut; Schmidt, Pia; Gross, Uwe; Weig, Michael] Univ Med Ctr Gottingen, German Natl Reference Ctr System Mycoses, Gottingen, Germany; [Kraneveld, Eefje A.] Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Prevent Dent, Amsterdam, Netherlands; [Kraneveld, Eefje A.] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Jacobsen, Mette D.] Inst Med Sci, Aberdeen Fungal Grp, Aberdeen, Scotland; [De Groot, Piet W. J.] Univ Castilla La Mancha, Reg Ctr Biomed Res, Albacete, Spain	University of Gottingen; University of Gottingen; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Aberdeen; Universidad de Castilla-La Mancha	Weig, M (corresponding author), Univ Med Ctr Gottingen, Inst Med Microbiol, Gottingen, Germany.	mweig@gwdg.de	De Groot, Piet/L-7737-2014; Bader, Oliver/C-7650-2015	De Groot, Piet/0000-0002-3112-6947; Bader, Oliver/0000-0002-1534-440X	German Research Foundation (DFG) [WE 3537/1-2]; DFG; Gottingen University, Germany; BBSRC [BB/F00513X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F00513X/1] Funding Source: researchfish	German Research Foundation (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Gottingen University, Germany; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work and its publication was supported by the German Research Foundation (DFG) grants WE 3537/1-2 to MW and the Open Access funding program of the DFG and the publishing funds of the Gottingen University, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2008, YEAST, V25, P433, DOI 10.1002/yea.1597; Arbour M, 2009, FEMS YEAST RES, V9, P1070, DOI 10.1111/j.1567-1364.2009.00563.x; ASAKURA K, 1991, J GEN MICROBIOL, V137, P2531, DOI 10.1099/00221287-137-11-2531; Bader O, 2001, MOL MICROBIOL, V41, P1431, DOI 10.1046/j.1365-2958.2001.02614.x; Barchiesi F, 1999, EUR J CLIN MICROBIOL, V18, P184, DOI 10.1007/s100960050255; Bouchonville K, 2009, EUKARYOT CELL, V8, P1554, DOI 10.1128/EC.00209-09; Brisse S, 2009, EUKARYOT CELL, V8, P287, DOI 10.1128/EC.00215-08; Calcagno AM, 2003, MOL MICROBIOL, V50, P1309, DOI 10.1046/j.1365-2958.2003.03755.x; de Groot PWJ, 2008, EUKARYOT CELL, V7, P1951, DOI 10.1128/EC.00284-08; De las Penas A, 2003, GENE DEV, V17, P2245, DOI 10.1101/gad.1121003; de Meeus T, 2002, J CLIN MICROBIOL, V40, P2199, DOI 10.1128/JCM.40.6.2199-2206.2002; Dodgson AR, 2003, J CLIN MICROBIOL, V41, P5709, DOI 10.1128/JCM.41.12.5709-5717.2003; Domergue R, 2005, SCIENCE, V308, P866, DOI 10.1126/science.1108640; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Fabre E, 2005, MOL BIOL EVOL, V22, P856, DOI 10.1093/molbev/msi070; Fischer G, 2006, PLOS GENET, V2, P253, DOI 10.1371/journal.pgen.0020032; Gregori C, 2007, EUKARYOT CELL, V6, P1635, DOI 10.1128/EC.00106-07; HITCHCOCK CA, 1993, ANTIMICROB AGENTS CH, V37, P1962, DOI 10.1128/AAC.37.9.1962; Iraqui I, 2005, MOL MICROBIOL, V55, P1259, DOI 10.1111/j.1365-2958.2004.04475.x; Juarez-Reyes A, 2012, GENETICS, V190, P101, DOI 10.1534/genetics.111.135251; KAUFMANN CS, 1989, J CLIN MICROBIOL, V27, P2165, DOI 10.1128/JCM.27.10.2165-2168.1989; KITADA K, 1995, GENE, V165, P203, DOI 10.1016/0378-1119(95)00552-H; Klempp-Selb B, 2000, MYCOSES, V43, P159, DOI 10.1046/j.1439-0507.2000.00555.x; Klis FM, 2010, YEAST, V27, P489, DOI 10.1002/yea.1747; Kraneveld EA, 2011, MYCOPATHOLOGIA, V172, P415, DOI 10.1007/s11046-011-9446-2; Lin CY, 2007, J CLIN MICROBIOL, V45, P2452, DOI 10.1128/JCM.00699-07; Lowman DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027614; Muller H, 2009, FUNGAL GENET BIOL, V46, P264, DOI 10.1016/j.fgb.2008.11.006; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Polakova S, 2009, P NATL ACAD SCI USA, V106, P2688, DOI 10.1073/pnas.0809793106; Rolland T, 2010, NUCLEIC ACIDS RES, V38, P4731, DOI 10.1093/nar/gkq207; Rustchenko E, 2007, FEMS YEAST RES, V7, P2, DOI 10.1111/j.1567-1364.2006.00150.x; SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5; Selmecki A, 2006, SCIENCE, V313, P367, DOI 10.1126/science.1128242; Sherman DJ, 2009, NUCLEIC ACIDS RES, V37, pD550, DOI 10.1093/nar/gkn859; Shin JH, 2007, J CLIN MICROBIOL, V45, P2385, DOI 10.1128/JCM.00381-07; Ueno K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024759; Verstrepen KJ, 2006, MOL MICROBIOL, V60, P5, DOI 10.1111/j.1365-2958.2006.05072.x; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Weig M, 2004, MICROBIOL-SGM, V150, P3129, DOI 10.1099/mic.0.27256-0; Weig M, 2001, MICROBIOL-SGM, V147, P2007, DOI 10.1099/00221287-147-8-2007; Zepelin MBV, 2007, J ANTIMICROB CHEMOTH, V60, P424, DOI 10.1093/jac/dkm145	42	26	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52218	10.1371/journal.pone.0052218	http://dx.doi.org/10.1371/journal.pone.0052218			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284942	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500117
J	Harper, KN; Fyumagwa, RD; Hoare, R; Wambura, PN; Coppenhaver, DH; Sapolsky, RM; Alberts, SC; Tung, J; Rogers, J; Kilewo, M; Batamuzi, EK; Leendertz, FH; Armelagos, GJ; Knauf, S				Harper, Kristin N.; Fyumagwa, Robert D.; Hoare, Richard; Wambura, Philemon N.; Coppenhaver, Dorian H.; Sapolsky, Robert M.; Alberts, Susan C.; Tung, Jenny; Rogers, Jeffrey; Kilewo, Morris; Batamuzi, Emmanuel K.; Leendertz, Fabian H.; Armelagos, George J.; Knauf, Sascha			Treponema pallidum Infection in the Wild Baboons of East Africa: Distribution and Genetic Characterization of the Strains Responsible	PLOS ONE			English	Article							SEQUENCE CONSERVATION; YAWS; POPULATION; SYPHILIS; DISEASE	It has been known for decades that wild baboons are naturally infected with Treponema pallidum, the bacterium that causes the diseases syphilis (subsp.pallidum), yaws (subsp.pertenue), and bejel (subsp.endemicum) in humans. Recently, a form of T. pallidum infection associated with severe genital lesions has been described in wild baboons at Lake Manyara National Park in Tanzania. In this study, we investigated ten additional sites in Tanzania and Kenya using a combination of macroscopic observation and serology, in order to determine whether the infection was present in each area. In addition, we obtained genetic sequence data from six polymorphic regions using T. pallidum strains collected from baboons at two different Tanzanian sites. We report that lesions consistent with T. pallidum infection were present at four of the five Tanzanian sites examined, and serology was used to confirm treponemal infection at three of these. By contrast, no signs of treponemal infection were observed at the six Kenyan sites, and serology indicated T. pallidum was present at only one of them. A survey of sexually mature baboons at Lake Manyara National Park in 2006 carried out as part of this study indicated that roughly ten percent displayed T. pallidum-associated lesions severe enough to cause major structural damage to the genitalia. Finally, we found that T. pallidum strains from Lake Manyara National Park and Serengeti National Park were genetically distinct, and a phylogeny suggested that baboon strains may have diverged prior to the clade containing human strains. We conclude that T. pallidum infection associated with genital lesions appears to be common in the wild baboons of the regions studied in Tanzania. Further study is needed to elucidate the infection's transmission mode, its associated morbidity and mortality, and the relationship between baboon and human strains.	[Harper, Kristin N.] Columbia Univ, Med Ctr, Dept Environm Hlth Sci, New York, NY 10027 USA; [Fyumagwa, Robert D.; Hoare, Richard] Tanzania Wildlife Res Inst, Wildlife Vet Program, Arusha, Tanzania; [Wambura, Philemon N.] Sokoine Univ Agr, Fac Vet Med, Dept Vet Microbiol & Parasitol, Morogoro, Tanzania; [Coppenhaver, Dorian H.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA; [Sapolsky, Robert M.] Stanford Univ, Stanford, CA 94305 USA; [Sapolsky, Robert M.; Alberts, Susan C.] Natl Museums Kenya, Inst Primate Res, Nairobi, Kenya; [Alberts, Susan C.] Duke Univ, Dept Biol, Durham, NC USA; [Tung, Jenny] Duke Univ, Dept Evolutionary Anthropol, Durham, NC USA; [Tung, Jenny] Duke Univ, Populat Res Inst, Durham, NC USA; [Rogers, Jeffrey] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Kilewo, Morris] Tanzania Natl Pk, Dept Ecol, Arusha, Tanzania; [Batamuzi, Emmanuel K.] Sokoine Univ Agr, Dept Vet Surg & Theriogenol, Morogoro, Tanzania; [Leendertz, Fabian H.] Robert Koch Inst, Res Grp Emerging Zoonoses, Berlin, Germany; [Armelagos, George J.] Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA; [Knauf, Sascha] Leibniz Inst Primate Res, German Primate Ctr, Pathol Unit, Gottingen, Germany	Columbia University; Sokoine University of Agriculture; University of Texas System; University of Texas Medical Branch Galveston; Stanford University; Duke University; Duke University; Duke University; Baylor College of Medicine; Sokoine University of Agriculture; Robert Koch Institute; Emory University; Deutsches Primatenzentrum (DPZ)	Harper, KN (corresponding author), Columbia Univ, Med Ctr, Dept Environm Hlth Sci, New York, NY 10027 USA.	kh2383@columbia.edu	Knauf, Sascha/F-1661-2017; Leendertz, Fabian Hubertus/H-8902-2019	Knauf, Sascha/0000-0001-5744-4946; 	National Science Foundation [0622399]; Wenner-Gren Foundation; The Messerli Foundation of Switzerland; Robert Wood Johnson Health & Society Scholar; Howard Hughes Medical Institute; German Academic Exchange Program [D/06/43974]; Christian Vogel Fond; World Association of Zoos and Aquariums [07002]; University of Leipzig; Justis Liebig University; Wuppertal Zoo; German Primate Centre; Robert-Koch-Institute; Scil Animal Care Company; Telinject Inc.; Translogistic Inc.;  [5-R25-CA 094061]; NATIONAL CANCER INSTITUTE [R25CA094061] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Wenner-Gren Foundation; The Messerli Foundation of Switzerland; Robert Wood Johnson Health & Society Scholar; Howard Hughes Medical Institute(Howard Hughes Medical Institute); German Academic Exchange Program(Deutscher Akademischer Austausch Dienst (DAAD)); Christian Vogel Fond; World Association of Zoos and Aquariums; University of Leipzig; Justis Liebig University; Wuppertal Zoo; German Primate Centre; Robert-Koch-Institute; Scil Animal Care Company; Telinject Inc.; Translogistic Inc.; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by dissertation improvement grants from the National Science Foundation (Award Number 0622399) and the Wenner-Gren Foundation to KNH as well as by The Messerli Foundation of Switzerland. KNH was a Cancer Epidemiology Training Fellow (5-R25-CA 094061), a Robert Wood Johnson Health & Society Scholar, and a Howard Hughes Medical Institute Pre-doctoral Fellow at the time of this work. SK received support from the German Academic Exchange Program (grant No. D/06/43974), the Christian Vogel Fond 2006, World Association of Zoos and Aquariums (project No. 07002), University of Leipzig, Justis Liebig University, and the Wuppertal Zoo. The German Primate Centre, Robert-Koch-Institute, Scil Animal Care Company, Telinject Inc., and Translogistic Inc. also supported analyses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project received support from the Scil Animal Care Company, Telinject Inc., and Translogistic Inc. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Baylet R, 1971, Bull Soc Pathol Exot Filiales, V64, P842; Baylet R, 1971, Bull Soc Pathol Exot Filiales, V64, P836; Cameron CE, 1999, INFECT IMMUN, V67, P3168, DOI 10.1128/IAI.67.6.3168-3170.1999; Cameron CE, 2000, J INFECT DIS, V181, P1401, DOI 10.1086/315399; Cejkova D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001471; Centurion-Lara A, 1998, J INFECT DIS, V177, P1036, DOI 10.1086/515247; Centurion-Lara A, 2006, J CLIN MICROBIOL, V44, P3377, DOI 10.1128/JCM.00784-06; Charpentier MJE, 2012, MOL ECOL, V21, P715, DOI 10.1111/j.1365-294X.2011.05302.x; Cousins D., 1972, International Zoo Yearbook, V12, P211, DOI 10.1111/j.1748-1090.1972.tb02330.x; FELSENFELD O, 1971, FOLIA PRIMATOL, V16, P294, DOI 10.1159/000155411; FRIBOURG-BLANC A, 1966, Bulletin de la Societe de Pathologie Exotique, V59, P54; Fribourg-Blanc A, 1969, Primates Med, V3, P113; FRIBOURGBLANC A, 1972, B SOC FR DERMATOL SY, V79, P454; Gray RR, 2006, MOL BIOL EVOL, V23, P2220, DOI 10.1093/molbev/msl092; Hackett C.J., 1953, B WORLD HEALTH ORGAN, V8, P127; Harper KN, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000148; Izard J, 1999, J BACTERIOL, V181, P6739, DOI 10.1128/JB.181.21.6739-6746.1999; KARESH W, 2000, CANOPEE, V18, P16; Knauf S, 2012, VET PATHOL, V49, P292, DOI 10.1177/0300985811402839; Kuhn U, 1970, TREPONEMATOSES, V3, P71; Levrero F, 2007, AM J PHYS ANTHROPOL, V132, P568, DOI 10.1002/ajpa.20560; Lovell NC, 2000, PRIMATES, V41, P275, DOI 10.1007/BF02557597; Maurice J, 2012, LANCET, V379, P1377, DOI 10.1016/S0140-6736(12)60581-9; Mlengeya T. D. K., 2004, DISTRIBUTION PATTERN; MOLLARET H H, 1967, Medecine d'Afrique Noire, V14, P397; NOORDHOEK GT, 1990, INFECT IMMUN, V58, P2011, DOI 10.1128/IAI.58.6.2011-2013.1990; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Smajs D, 2012, INFECT GENET EVOL, V12, P191, DOI 10.1016/j.meegid.2011.12.001; Smajs D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020415; SMITH JL, 1971, BRIT J VENER DIS, V47, P226; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wallis J, 1999, INT J PRIMATOL, V20, P803, DOI 10.1023/A:1020879700286	33	40	40	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e50882	10.1371/journal.pone.0050882	http://dx.doi.org/10.1371/journal.pone.0050882			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284649	Green Published, gold			2022-12-27	WOS:000312794500017
J	Liu, O; Jia, LX; Liu, XX; Wang, YL; Wang, XL; Qin, YW; Du, J; Zhang, HJ				Liu, Ou; Jia, Lixin; Liu, Xiaoxi; Wang, Yueli; Wang, Xiaolong; Qin, Yanwen; Du, Jie; Zhang, Hongjia			Clopidogrel, a Platelet P2Y12 Receptor Inhibitor, Reduces Vascular Inflammation and Angiotensin II Induced-Abdominal Aortic Aneurysm Progression	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; WALL STRESS; MATRIX METALLOPROTEINASES; EXPRESSION; ATHEROSCLEROSIS; TRANSPLANTS; DISSECTION; THROMBUS; RUPTURE; DISEASE	Medial degeneration and inflammation are features of abdominal aortic aneurysms (AAAs). However, the early inflammatory event initiating aneurysm formation remains to be identified. Activated platelets release abundant proinflammatory cytokines and are involved in initial inflammation in various vascular diseases. We investigated the role of platelets in progression of AAA in vivo and in vitro. Histological studies of tissues of patients with AAA revealed that the number of platelets was increased in aneurysm sites along with the increased infiltration of T lymphocytes and augmented angiogenesis. In a murine model of AAA, apolipoprotein E-knockout mice infused with 1,000 ng/kg/min angiotensin II, treatment with clopidogrel, an inhibitor of platelets, significantly suppressed aneurysm formation (47% decrease, P<0.05). The clopidogrel also suppressed changes in aortic expansion, elastic lamina degradation and inflammatory cytokine expression. Moreover, the infiltration of macrophages and production of matrix metalloproteinases (MMPs) were also significantly reduced by clopidogrel treatment. In vitro incubation of macrophages with isolated platelets stimulated MMP activity by 45%. These results demonstrate a critical role for platelets in vascular inflammation and AAA progression.	[Liu, Ou; Jia, Lixin; Liu, Xiaoxi; Wang, Yueli; Qin, Yanwen; Du, Jie; Zhang, Hongjia] Capital Med Univ, Minist Educ, Key Lab Remodeling Related Cardiovasc Dis, Beijing, Peoples R China; [Liu, Ou; Jia, Lixin; Liu, Xiaoxi; Wang, Yueli; Qin, Yanwen; Du, Jie; Zhang, Hongjia] Capital Med Univ, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China; [Liu, Ou; Liu, Xiaoxi; Wang, Xiaolong; Zhang, Hongjia] Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiovasc Surg, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University	Du, J (corresponding author), Capital Med Univ, Minist Educ, Key Lab Remodeling Related Cardiovasc Dis, Beijing, Peoples R China.	jdu@bcm.edu; zhanghongjia722@hotmail.com	Liu, Ou/O-1168-2016; Qin, Yanwen/AAM-6961-2020	Qin, Yanwen/0000-0002-5185-9726	National Natural Science Foundation of China [81170283, 30872536, 81070251]; Beijing Natural Science Foundation [7112041]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1074]; International Science & Technology Cooperation Program of China [2010DFB30040]; Program for New Century Excellent Talents in University [NCET-11-0899]; Scientific Research Common Program of Beijing Municipal Commission of Education [SQKM201210025017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); International Science & Technology Cooperation Program of China; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Scientific Research Common Program of Beijing Municipal Commission of Education(Beijing Municipal Commission of Education)	This study was supported by grants from the National Natural Science Foundation of China (81170283, 30872536, and 81070251), Beijing Natural Science Foundation (7112041), Program for Changjiang Scholars and Innovative Research Team in University (IRT1074), International Science & Technology Cooperation Program of China (2010DFB30040), Program for New Century Excellent Talents in University (NCET-11-0899), and Scientific Research Common Program of Beijing Municipal Commission of Education (SQKM201210025017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badovinac VP, 2004, NAT IMMUNOL, V5, P809, DOI 10.1038/ni1098; BRADBURY AW, 1995, J VASC SURG, V21, P484, DOI 10.1016/S0741-5214(95)70291-1; Bruemmer D, 2003, J CLIN INVEST, V112, P1318, DOI 10.1172/JCI200318141; Chen XL, 1998, CIRC RES, V83, P952; Curci JA, 1998, J CLIN INVEST, V102, P1900, DOI 10.1172/JCI2182; Dai JP, 2009, J VASC SURG, V49, P719, DOI 10.1016/j.jvs.2008.09.057; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Daugherty A, 2004, ARTERIOSCL THROM VAS, V24, P429, DOI 10.1161/01.ATV.0000118013.72016.ea; Elzey BD, 2003, IMMUNITY, V19, P9, DOI 10.1016/S1074-7613(03)00177-8; Fillinger MF, 2003, J VASC SURG, V37, P724, DOI 10.1067/mva.2003.213; FOUSER LS, 1980, AM J CLIN PATHOL, V74, P701; FREESTONE T, 1995, ARTERIOSCL THROM VAS, V15, P1145, DOI 10.1161/01.ATV.15.8.1145; Gavrila D, 2005, ARTERIOSCL THROM VAS, V25, P1671, DOI 10.1161/01.ATV.0000172631.50972.0f; Gleissner CA, 2008, ARTERIOSCL THROM VAS, V28, P1920, DOI 10.1161/ATVBAHA.108.169417; Gresele P, 1998, J CLIN INVEST, V101, P667, DOI 10.1172/JCI575; Hans SS, 2005, J VASC SURG, V41, P584, DOI 10.1016/j.jvs.2005.01.004; Hao L, 2006, ARTERIOSCL THROM VAS, V26, P819, DOI 10.1161/01.ATV.0000204344.90301.7c; HARA K, 1991, INT J CARDIOL, V32, P231, DOI 10.1016/0167-5273(91)90330-R; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; Herbert JM, 2004, EXPERT OPIN INV DRUG, V13, P457, DOI 10.1517/13543784.13.5.457; Kajimoto K, 2009, ATHEROSCLEROSIS, V206, P505, DOI 10.1016/j.atherosclerosis.2009.03.028; KAMP TJ, 1994, AM HEART J, V128, P1234, DOI 10.1016/0002-8703(94)90756-0; Kantelhardt Sven R, 2003, Cardiol Rev, V11, P240, DOI 10.1097/01.CRD.0000078443.08887.28; Kintscher U, 2002, CIRC RES, V91, pE35, DOI 10.1161/01.RES.0000046017.96083.34; Kirk AD, 2009, AM J TRANSPLANT, V9, P14, DOI 10.1111/j.1600-6143.2008.02473.x; Ko HM, 2005, FEBS LETT, V579, P6451, DOI 10.1016/j.febslet.2005.10.027; Korshunov VA, 2003, ARTERIOSCL THROM VAS, V23, P2185, DOI 10.1161/01.ATV.0000103120.06092.14; Krettek A, 2003, ARTERIOSCL THROM VAS, V23, P582, DOI 10.1161/01.ATV.0000064372.78561.A5; Kuivaniemi H, 2008, CIRCULATION, V117, P242, DOI 10.1161/CIRCULATIONAHA.107.690982; Lehoux S, 2004, CIRCULATION, V109, P1041, DOI 10.1161/01.CIR.0000115521.95662.7A; Lindeman JHN, 2009, CIRCULATION, V119, P2209, DOI 10.1161/CIRCULATIONAHA.108.806505; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Patel SR, 2009, J CLIN INVEST, V119, P2787, DOI 10.1172/JCI39590; Pyo R, 2000, J CLIN INVEST, V105, P1641, DOI 10.1172/JCI8931; Rajagopalan S, 1996, J CLIN INVEST, V98, P2572, DOI 10.1172/JCI119076; Risinger GM, 2006, J BIOL CHEM, V281, P25915, DOI 10.1074/jbc.M513513200; Sakalihasan N, 2005, LANCET, V365, P1577, DOI 10.1016/S0140-6736(05)66459-8; Saraff K, 2003, ARTERIOSCL THROM VAS, V23, P1621, DOI 10.1161/01.ATV.0000085631.76095.64; Satoh K, 2009, NAT MED, V15, P649, DOI 10.1038/nm.1958; Satta J, 1996, J VASC SURG, V23, P737, DOI 10.1016/S0741-5214(96)80062-0; Smyth SS, 2009, J THROMB HAEMOST, V7, P1759, DOI 10.1111/j.1538-7836.2009.03586.x; Thompson RW, 2002, NEW ENGL J MED, V346, P1484, DOI 10.1056/NEJM200205093461910; Truijers M, 2007, EUR J VASC ENDOVASC, V33, P401, DOI 10.1016/j.ejvs.2006.10.009; Venkatasubramaniam AK, 2004, EUR J VASC ENDOVASC, V28, P168, DOI 10.1016/j.ejvs.2004.03.029; Weyrich A, 2007, CURR PHARM DESIGN, V13, P1685, DOI 10.2174/138161207780831374; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Zhao LZ, 2009, J NEUROSCI, V29, P3603, DOI 10.1523/JNEUROSCI.5302-08.2009	47	49	50	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51707	10.1371/journal.pone.0051707	http://dx.doi.org/10.1371/journal.pone.0051707			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284748	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500040
J	Savarese, M; Piluso, G; Orteschi, D; Di Fruscio, G; Dionisi, M; Blanco, FD; Torella, A; Giugliano, T; Iacomino, M; Zollino, M; Neri, G; Nigro, V				Savarese, Marco; Piluso, Giulio; Orteschi, Daniela; Di Fruscio, Giuseppina; Dionisi, Manuela; Blanco, Francesca del Vecchio; Torella, Annalaura; Giugliano, Teresa; Iacomino, Michele; Zollino, Marcella; Neri, Giovanni; Nigro, Vincenzo			Enhancer Chip: Detecting Human Copy Number Variations in Regulatory Elements	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; ULTRACONSERVED ELEMENTS; MICROARRAY; TRANSLOCATION; DATABASE; DNA	Critical functional properties are embedded in the non-coding portion of the human genome. Recent successful studies have shown that variations in distant-acting gene enhancer sequences can contribute to disease. In fact, various disorders, such as thalassaemias, preaxial polydactyly or susceptibility to Hirschsprung's disease, may be the result of rearrangements of enhancer elements. We have analyzed the distribution of enhancer loci in the genome and compared their localization to that of previously described copy-number variations (CNVs). These data suggest a negative selection of copy number variable enhancers. To identify CNVs covering enhancer elements, we have developed a simple and cost-effective test. Here we describe the gene selection, design strategy and experimental validation of a customized oligonucleotide Array-Based Comparative Genomic Hybridization (aCGH), designated Enhancer Chip. It has been designed to investigate CNVs, allowing the analysis of all the genome with a 300 Kb resolution and specific disease regions (telomeres, centromeres and selected disease loci) at a tenfold higher resolution. Moreover, this is the first aCGH able to test over 1,250 enhancers, in order to investigate their potential pathogenic role. Validation experiments have demonstrated that Enhancer Chip efficiently detects duplications and deletions covering enhancer loci, demonstrating that it is a powerful instrument to detect and characterize copy number variable enhancers.	[Savarese, Marco; Piluso, Giulio; Di Fruscio, Giuseppina; Dionisi, Manuela; Blanco, Francesca del Vecchio; Torella, Annalaura; Giugliano, Teresa; Iacomino, Michele; Nigro, Vincenzo] Seconda Univ Napoli, Dipartimento Patol Gen, Naples, Italy; [Orteschi, Daniela; Zollino, Marcella; Neri, Giovanni] Univ Cattolica Sacro Cuore, Ist Genet Med, Policlin A Gemelli, Rome, Italy; [Savarese, Marco; Nigro, Vincenzo] Telethon Inst Genet & Med TIGEM, Naples, Italy	Universita della Campania Vanvitelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM)	Nigro, V (corresponding author), Seconda Univ Napoli, Dipartimento Patol Gen, Naples, Italy.	vinnigro@gmail.com	PILUSO, Giulio/AAA-3400-2019; Iacomino, Michele/AAB-2366-2019; Nigro, Vincenzo/AAB-2274-2022; Savarese, Marco/J-8307-2016; Piluso, Giulio/AAA-3661-2019; Zollino, Marcella/AAC-3891-2022	PILUSO, Giulio/0000-0001-9418-125X; Iacomino, Michele/0000-0003-4788-9719; Savarese, Marco/0000-0002-2591-244X; Zollino, Marcella/0000-0003-4871-9519; Nigro, Vincenzo/0000-0002-3378-5006; Torella, Annalaura/0000-0003-2479-6018	Ministero della Salute [223143, RF-MUL-2007-666195]; Telethon-UILDM (Italy)	Ministero della Salute(Ministry of Health, Italy); Telethon-UILDM (Italy)(Fondazione Telethon)	This study was supported by grants from FP7/2007-2013 under grant agreement number 223143 (project acronym: TECHGENE), from Ministero della Salute (RF-MUL-2007-666195) and from Telethon-UILDM (Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahituv N, 2007, PLOS BIOL, V5, P1906, DOI 10.1371/journal.pbio.0050234; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Belloni E, 1996, NAT GENET, V14, P353, DOI 10.1038/ng1196-353; Boone PM, 2010, HUM MUTAT, V31, P1326, DOI 10.1002/humu.21360; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Crolla JA, 2002, AM J HUM GENET, V71, P1138, DOI 10.1086/344396; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Grice EA, 2005, HUM MOL GENET, V14, P3837, DOI 10.1093/hmg/ddi408; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; KIOUSSIS D, 1983, NATURE, V306, P662, DOI 10.1038/306662a0; Klopocki E, 2011, ANNU REV GENOM HUM G, V12, P53, DOI 10.1146/annurev-genom-082410-101404; Lehmann OJ, 2003, TRENDS GENET, V19, P339, DOI 10.1016/S0168-9525(03)00111-2; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Marcinkowska M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-183; May D, 2012, NAT GENET, V44, P89, DOI 10.1038/ng.1006; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Narlikar Leelavati, 2009, Briefings in Functional Genomics & Proteomics, V8, P215, DOI 10.1093/bfgp/elp014; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Pfeifer D, 1999, AM J HUM GENET, V65, P111, DOI 10.1086/302455; Piluso G, 2011, CLIN CHEM, V57, P1584, DOI 10.1373/clinchem.2011.168898; Taylor James, 2007, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1005s19; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Wong LJC, 2008, CLIN CHEM, V54, P1141, DOI 10.1373/clinchem.2008.103721; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Yatsenko SA, 2009, J MOL DIAGN, V11, P226, DOI 10.2353/jmoldx.2009.080064	28	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52264	10.1371/journal.pone.0052264	http://dx.doi.org/10.1371/journal.pone.0052264			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284961	Green Submitted, gold, Green Published			2022-12-27	WOS:000312794500129
J	Takizawa, H; Hiroi, N; Funahashi, A				Takizawa, Hiromu; Hiroi, Noriko; Funahashi, Akira			Mathematical Modeling of Sustainable Synaptogenesis by Repetitive Stimuli Suggests Signaling Mechanisms In Vivo	PLOS ONE			English	Article							LONG-TERM POTENTIATION; LASTING SYNAPTIC ENHANCEMENT; LATE-PHASE LTP; PROTEIN-SYNTHESIS; DENDRITIC SPINE; DENTATE GYRUS; ACTIN POLYMERIZATION; POSTSYNAPTIC DENSITY; HIPPOCAMPAL-NEURONS; MESSENGER-RNA	The mechanisms of long-term synaptic maintenance are a key component to understanding the mechanism of long-term memory. From biological experiments, a hypothesis arose that repetitive stimuli with appropriate intervals are essential to maintain new synapses for periods of longer than a few days. We successfully reproduce the time-course of relative numbers of synapses with our mathematical model in the same conditions as biological experiments, which used Adenosine-3', 5'-cyclic monophosphorothioate, Sp-isomer (Sp-cAMPS) as external stimuli. We also reproduce synaptic maintenance responsiveness to intervals of Sp-cAMPS treatment accompanied by PKA activation. The model suggests a possible mechanism of sustainable synaptogenesis which consists of two steps. First, the signal transduction from an external stimulus triggers the synthesis of a new signaling protein. Second, the new signaling protein is required for the next signal transduction with the same stimuli. As a result, the network component is modified from the first network, and a different signal is transferred which triggers the synthesis of another new signaling molecule. We refer to this hypothetical mechanism as network succession. We build our model on the basis of two hypotheses: (1) a multi-step network succession induces downregulation of SSH and COFILIN gene expression, which triggers the production of stable F-actin; (2) the formation of a complex of stable F-actin with Drebrin at PSD is the critical mechanism to achieve long-term synaptic maintenance. Our simulation shows that a three-step network succession is sufficient to reproduce sustainable synapses for a period longer than 14 days. When we change the network structure to a single step network, the model fails to follow the exact condition of repetitive signals to reproduce a sufficient number of synapses. Another advantage of the three-step network succession is that this system indicates a greater tolerance of parameter changes than the single step network.	[Takizawa, Hiromu; Hiroi, Noriko; Funahashi, Akira] Keio Univ, Dept Biosci & Informat, Yokohama, Kanagawa 223, Japan	Keio University	Hiroi, N (corresponding author), Keio Univ, Dept Biosci & Informat, Yokohama, Kanagawa 223, Japan.	hiroi@bio.keio.ac.jp	Hiroi, Noriko/D-2467-2014; Funahashi, Akira/C-4923-2014; Hiroi, Noriko/AAE-2657-2019	Hiroi, Noriko/0000-0002-0214-373X; Funahashi, Akira/0000-0003-0605-239X; Hiroi, Noriko/0000-0002-0214-373X	Japan Society for the Promotion of Science (JSPS); KAKENHI [22710221]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research, KAKENHI 22710221 (http://www.jsps.go.jp/english/e-grants/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajay SM, 2004, EUR J NEUROSCI, V20, P2671, DOI 10.1111/j.1460-9568.2004.03725.x; AMARAL DG, 1981, J COMP NEUROL, V195, P51, DOI 10.1002/cne.901950106; Arikkath J, 2008, TRENDS NEUROSCI, V31, P487, DOI 10.1016/j.tins.2008.07.001; Aslam N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.38; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Bear MF, 1996, P NATL ACAD SCI USA, V93, P13453, DOI 10.1073/pnas.93.24.13453; Bhalla US, 2002, METHOD ENZYMOL, V345, P3; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bornstein BJ, 2008, BIOINFORMATICS, V24, P880, DOI 10.1093/bioinformatics/btn051; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Breindl C, 2010, POSTPRINT SERIES STU, V2009-42, P1; BUCHS PA, 1993, DEV BRAIN RES, V71, P81, DOI 10.1016/0165-3806(93)90108-M; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Carroll RC, 2002, TRENDS NEUROSCI, V25, P571, DOI 10.1016/S0166-2236(02)02272-5; Dailey ME, 1996, J NEUROSCI, V16, P2983; de Lecea L, 1998, J NEUROSCI RES, V53, P269, DOI 10.1002/(SICI)1097-4547(19980801)53:3<269::AID-JNR1>3.0.CO;2-8; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; Fiala JC, 1998, J NEUROSCI, V18, P8900; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Funahashi A, 2008, P IEEE, V96, P1254, DOI 10.1109/JPROC.2008.925458; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Hu NW, 2003, J NEUROPHYSIOL, V89, P2354, DOI 10.1152/jn.01027.2002; Huang F, 2007, J NEUROSCI, V27, P9054, DOI 10.1523/JNEUROSCI.2410-07.2007; Huang YY, 1996, LEARN MEMORY, V3, P74, DOI 10.1101/lm.3.2-3.74; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Johnson OL, 2004, BRAIN RES, V996, P89, DOI 10.1016/j.brainres.2003.10.011; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kawaai K, 2010, J NEUROSCI RES, V88, P2911, DOI 10.1002/jnr.22457; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kubota Y, 2001, J COMPUT NEUROSCI, V11, P263, DOI 10.1023/A:1013727331979; Le Novere N, 2009, NAT BIOTECHNOL, V27, P735, DOI 10.1038/nbt.1558; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Lu B, 1999, J NEUROSCI RES, V58, P76, DOI 10.1002/(SICI)1097-4547(19991001)58:1<76::AID-JNR8>3.0.CO;2-0; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; Migues PV, 2010, NAT NEUROSCI, V13, P630, DOI 10.1038/nn.2531; Miller P, 2005, PLOS BIOL, V3, P705, DOI 10.1371/journal.pbio.0030107; Moga DE, 2004, NEUROSCIENCE, V125, P7, DOI 10.1016/j.neuroscience.2004.02.004; Moodie S., 2011, NAT PREC, DOI [10.1038/npre.2011.3721.4, DOI 10.1038/NPRE.2011.3721.4]; Morgado-Bernal I, 2011, NEUROSCIENCE, V176, P12, DOI 10.1016/j.neuroscience.2010.12.056; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Ostroff LE, 2010, P NATL ACAD SCI USA, V107, P9418, DOI 10.1073/pnas.0913384107; Rao A, 2000, HIPPOCAMPUS, V10, P527, DOI 10.1002/1098-1063(2000)10:5<527::AID-HIPO3>3.0.CO;2-B; Rex CS, 2007, J NEUROSCI, V27, P3017, DOI 10.1523/JNEUROSCI.4037-06.2007; Rodriguez JJ, 2005, EUR J NEUROSCI, V21, P2384, DOI 10.1111/j.1460-9568.2005.04068.x; Soosairajah J, 2005, EMBO J, V24, P473, DOI 10.1038/sj.emboj.7600543; Spratley SJ, 2011, J BIOL CHEM, V286, P34254, DOI 10.1074/jbc.M111.259424; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Takahashi H, 2003, J NEUROSCI, V23, P6586; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Taniguchi N, 2006, NEUROSCI LETT, V406, P38, DOI 10.1016/j.neulet.2006.06.071; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Tominaga-Yoshino K, 2002, NEUROSCI RES, V44, P357, DOI 10.1016/S0168-0102(02)00155-4; Tominaga-Yoshino K, 2008, HIPPOCAMPUS, V18, P281, DOI 10.1002/hipo.20391; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; WALSH DA, 1971, J BIOL CHEM, V246, P1977; Yamamoto M, 2005, BRAIN RES, V1042, P6, DOI 10.1016/j.brainres.2005.01.102; Yin Y, 2002, P NATL ACAD SCI USA, V99, P2368, DOI 10.1073/pnas.042693699; Zhabotinsky AM, 2000, BIOPHYS J, V79, P2211, DOI 10.1016/S0006-3495(00)76469-1; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	84	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51000	10.1371/journal.pone.0051000	http://dx.doi.org/10.1371/journal.pone.0051000			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284653	Green Submitted, gold, Green Published			2022-12-27	WOS:000312794500018
J	Albi, E; Curcio, F; Spelat, R; Lazzarini, A; Lazzarini, R; Cataldi, S; Loreti, E; Ferri, I; Ambesi-Impiombato, FS				Albi, Elisabetta; Curcio, Francesco; Spelat, Renza; Lazzarini, Andrea; Lazzarini, Remo; Cataldi, Samuela; Loreti, Elisabetta; Ferri, Ivana; Ambesi-Impiombato, Francesco Saverio			Loss of Parafollicular Cells during Gravitational Changes (Microgravity, Hypergravity) and the Secret Effect of Pleiotrophin	PLOS ONE			English	Article							THYROID C-CELLS; FOLLICULAR CELLS; IN-VITRO; RATS; HYPOTHYROIDISM; EXPRESSION; RECEPTOR; MODELS; GLAND	It is generally known that bone loss is one of the most important complications for astronauts who are exposed to long-term microgravity in space. Changes in blood flow, systemic hormones, and locally produced factors were indicated as important elements contributing to the response of osteoblastic cells to loading, but research in this field still has many questions. Here, the possible biological involvement of thyroid C cells is being investigated. The paper is a comparison between a case of a wild type single mouse and a over-expressing pleiotrophin single mouse exposed to hypogravity conditions during the first animal experiment of long stay in International Space Station (91 days) and three similar mice exposed to hypergravity (2Gs) conditions. We provide evidence that both microgravity and hypergravity induce similar loss of C cells with reduction of calcitonin production. Pleiotrophin over-expression result in some protection against negative effects of gravity change. Potential implication of the gravity mechanic forces in the regulation of bone homeostasis via thyroid equilibrium is discussed.	[Albi, Elisabetta; Lazzarini, Andrea] Ctr Ric Anal Biochim Specialist, Lab Nucl Lipid BioPathol, Perugia, Italy; [Curcio, Francesco; Spelat, Renza; Lazzarini, Andrea; Lazzarini, Remo; Cataldi, Samuela; Ambesi-Impiombato, Francesco Saverio] Univ Udine, Dept Clin & Biol Sci, I-33100 Udine, Italy; [Loreti, Elisabetta; Ferri, Ivana] Univ Perugia, Inst Pathol Anat & Histol, I-06100 Perugia, Italy	University of Udine; University of Perugia	Albi, E (corresponding author), Ctr Ric Anal Biochim Specialist, Lab Nucl Lipid BioPathol, Perugia, Italy.	elisabetta.albi@yahoo.com	Spelat, Renza/AAZ-2980-2021; Curcio, Francesco/K-4669-2014; Albi, Elisabetta/K-3369-2016	Spelat, Renza/0000-0001-5794-8976; Albi, Elisabetta/0000-0002-5745-5343; CURCIO, Francesco/0000-0002-9070-4807	Italian Space Agenzy	Italian Space Agenzy	Italian Space Agenzy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHREN B, 1991, ACTA ENDOCRINOL-COP, V124, P225, DOI 10.1530/acta.0.1240225; Albi E, 2012, ARCH BIOCHEM BIOPHYS, V518, P16, DOI 10.1016/j.abb.2011.12.001; Carmeliet G, 2001, CRIT REV EUKAR GENE, V11, P131; Dadan J, 2001, FOLIA HISTOCHEM CYTO, V39, P189; Dai KS, 2009, THROMB HAEMOSTASIS, V101, P902, DOI 10.1160/TH08-11-0750; De Miguel M, 2005, HISTOL HISTOPATHOL, V20, P713, DOI 10.14670/HH-20.713; Esenyel M, 2012, RHEUMATOL INT, V28; Giangregorio L, 2002, SPORTS MED, V32, P459, DOI 10.2165/00007256-200232070-00005; Gorgiladze G I, 2011, Aviakosm Ekolog Med, V45, P28; Heer M, 2002, NUTRITION, V18, P853, DOI 10.1016/S0899-9007(02)00905-X; Heer M, 1999, Eur J Med Res, V4, P357; KALISNIK M, 1988, AM J ANAT, V183, P148, DOI 10.1002/aja.1001830205; Klein-Nulend J, 2003, ADV SPACE RES-SERIES, V32, P1551, DOI 10.1016/S0273-1177(03)90395-4; Loomer PM, 2001, CRIT REV ORAL BIOL M, V12, P252, DOI 10.1177/10454411010120030401; Manzano AI, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-105; Martin-Lacave I, 2009, J ANAT, V214, P301, DOI 10.1111/j.1469-7580.2008.01044.x; Martinez DA, 1998, AVIAT SPACE ENVIR MD, V69, pA17; Masini MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035418; Morillo-Bernal J, 2009, J ANAT, V215, P150, DOI 10.1111/j.1469-7580.2009.01095.x; SAWICKI B, 1995, ACTA HISTOCHEM, V97, P389, DOI 10.1016/S0065-1281(11)80064-4; Tare RS, 2002, J BONE MINER RES, V17, P2009, DOI 10.1359/jbmr.2002.17.11.2009; Tavella S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033179; Usenko VS, 1999, ANAT REC, V256, P7; Zbucki RL, 2007, FOLIA HISTOCHEM CYTO, V45, P115	24	16	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e48518	10.1371/journal.pone.0048518	http://dx.doi.org/10.1371/journal.pone.0048518			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284618	Green Published, gold, Green Submitted			2022-12-27	WOS:000312694300005
J	Calverley, M; Erickson, S; Read, AJ; Harmsen, AG				Calverley, Matthew; Erickson, Sara; Read, Amanda J.; Harmsen, Allen G.			Resident Alveolar Macrophages Are Susceptible to and Permissive of Coxiella burnetii Infection	PLOS ONE			English	Article							INFLAMMATORY DENDRITIC CELLS; Q-FEVER; FUNCTIONAL-CHARACTERIZATION; CHEMOKINE RECEPTOR; MICE; MONOCYTES; LUNG; RESPONSES; KINETICS; ANTIGEN	Coxiella burnetii, the causative agent of Q fever, is a zoonotic disease with potentially life-threatening complications in humans. Inhalation of low doses of Coxiella bacteria can result in infection of the host alveolar macrophage (AM). However, it is not known whether a subset of AMs within the heterogeneous population of macrophages in the infected lung is particularly susceptible to infection. We have found that lower doses of both phase I and phase II Nine Mile C. burnetii multiply and are less readily cleared from the lungs of mice compared to higher infectious doses. We have additionally identified AM resident within the lung prior to and shortly following infection, opposed to newly recruited monocytes entering the lung during infection, as being most susceptible to infection. These resident cells remain infected up to twelve days after the onset of infection, serving as a permissive niche for the maintenance of bacterial infection. A subset of infected resident AMs undergo a distinguishing phenotypic change during the progression of infection exhibiting an increase in surface integrin CD11b expression and continued expression of the surface integrin CD11c. The low rate of phase I and II Nine Mile C. burnetii growth in murine lungs may be a direct result of the limited size of the susceptible resident AM cell population.	[Calverley, Matthew; Erickson, Sara; Harmsen, Allen G.] Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA; [Read, Amanda J.] Univ Texas San Antonio, Off Senior Associate Vice President Res, San Antonio, TX USA	Montana State University System; Montana State University Bozeman; University of Texas System; University of Texas at San Antonio (UTSA)	Harmsen, AG (corresponding author), Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA.	aharmsen@montana.edu			National Institutes of Health/Rocky Mountain Regional Center of Excellence [U54-AI06535]; NIH/COBRE [P20GM103500]; INBRE-BRIN [P20GM103474]; Montana State University Agricultural Station; MJ Murdock Charitable Trust; National Institutes of Health under Ruth L. Kirschstein National Research Service Award from the NIH/NIAID [F31AI081492]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI081492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103500, P20GM103474] Funding Source: NIH RePORTER	National Institutes of Health/Rocky Mountain Regional Center of Excellence; NIH/COBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); INBRE-BRIN(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Montana State University Agricultural Station; MJ Murdock Charitable Trust; National Institutes of Health under Ruth L. Kirschstein National Research Service Award from the NIH/NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health/Rocky Mountain Regional Center of Excellence GRANT# U54-AI06535, NIH/COBRE GRANT#P20GM103500 and INBRE-BRIN GRANT# P20GM103474. Additional support was provided through The Montana State University Agricultural Station and the MJ Murdock Charitable Trust. This research was also supported by the National Institutes of Health under Ruth L. Kirschstein National Research Service Award F31AI081492 from the NIH/NIAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andoh M, 2003, INFECT IMMUN, V71, P4717, DOI 10.1128/IAI.71.8.4717-4723.2003; BARBOSA IL, 1991, CLIN EXP IMMUNOL, V86, P173; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Burges A, 1997, Eur J Med Res, V2, P149; Chen L, 2000, CLIN EXP IMMUNOL, V120, P125, DOI 10.1046/j.1365-2249.2000.01196.x; Chen L, 2001, EUR J IMMUNOL, V31, P265, DOI 10.1002/1521-4141(200101)31:1<265::AID-IMMU265>3.3.CO;2-C; Coleman SA, 2004, J BACTERIOL, V186, P7344, DOI 10.1128/JB.186.21.7344-7352.2004; CROFTON RW, 1978, J EXP MED, V148, P1, DOI 10.1084/jem.148.1.1; da Silva MF, 2011, IMMUNOBIOLOGY, V216, P821, DOI 10.1016/j.imbio.2010.12.002; Davidson BA, 2005, EXP LUNG RES, V31, P323, DOI 10.1080/01902140590918524; Delsing CE, 2011, ADV EXP MED BIOL, V719, P133, DOI 10.1007/978-1-4614-0204-6_12; Denison AM, 2007, FEMS MICROBIOL LETT, V267, P102, DOI 10.1111/j.1574-6968.2006.00544.x; DUDLEY D, 1989, BIOCHEM BIOPH RES CO, V160, P346, DOI 10.1016/0006-291X(89)91662-8; Dunay IR, 2010, INFECT IMMUN, V78, P1564, DOI 10.1128/IAI.00472-09; Gama JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002503; Garn H, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-4; Gonzalez-Juarrero M, 2003, J IMMUNOL, V171, P3128, DOI 10.4049/jimmunol.171.6.3128; Goto Y, 2003, AM J PHYSIOL-CELL PH, V285, pC253, DOI 10.1152/ajpcell.00035.2003; Guth AM, 2009, AM J PHYSIOL-LUNG C, V296, pL936, DOI 10.1152/ajplung.90625.2008; Jager C, 1998, EPIDEMIOL INFECT, V120, P157, DOI 10.1017/S0950268897008510; Jiang-Shieh YF, 2010, J ANAT, V216, P407, DOI 10.1111/j.1469-7580.2009.01190.x; KHAVKIN T, 1988, INFECT IMMUN, V56, P1792, DOI 10.1128/IAI.56.7.1792-1799.1988; Kurihara T, 1997, J EXP MED, V186, P1757, DOI 10.1084/jem.186.10.1757; LEHNERT BE, 1986, J LEUKOCYTE BIOL, V39, P285, DOI 10.1002/jlb.39.3.285; Madariaga MG, 2003, LANCET INFECT DIS, V3, P709, DOI 10.1016/S1473-3099(03)00804-1; Maus UA, 2006, AM J RESP CELL MOL, V35, P227, DOI 10.1165/rcmb.2005-0241OC; Mishra MK, 2012, AM J PATHOL, V181, P642, DOI 10.1016/j.ajpath.2012.05.011; Padigel UM, 2006, INFECT IMMUN, V74, P3232, DOI 10.1128/IAI.02067-05; Read AJ, 2010, INFECT IMMUN, V78, P3019, DOI 10.1128/IAI.00101-10; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Russell-Lodrigue KE, 2006, INFECT IMMUN, V74, P6085, DOI 10.1128/IAI.00763-06; Russell-Lodrigue KE, 2009, INFECT IMMUN, V77, P5640, DOI 10.1128/IAI.00851-09; Schreiber HA, 2011, J CLIN INVEST, V121, P3902, DOI 10.1172/JCI45113; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; STEIN A, 1993, MICROB PATHOGENESIS, V15, P177, DOI 10.1006/mpat.1993.1068; Tateno H, 2007, MOL CELL BIOL, V27, P5699, DOI 10.1128/MCB.00383-07; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Waag DM, 2007, VACCINE, V25, P7288, DOI 10.1016/j.vaccine.2007.08.002; Zamboni DS, 2004, INFECT IMMUN, V72, P2395, DOI 10.1128/IAI.72.4.2395-2399.2004	39	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51941	10.1371/journal.pone.0051941	http://dx.doi.org/10.1371/journal.pone.0051941			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284825	Green Published, Green Submitted, gold			2022-12-27	WOS:000312694300064
J	Elser, JA; Margulies, KB				Elser, Jeremy A.; Margulies, Kenneth B.			Hybrid Mathematical Model of Cardiomyocyte Turnover in the Adult Human Heart	PLOS ONE			English	Article							AGING HUMAN HEART; HYPERTROPHY; APOPTOSIS; RENEWAL; NUCLEI; PLOIDY; LEVEL	Rationale: The capacity for cardiomyocyte regeneration in the healthy adult human heart is fundamentally relevant for both myocardial homeostasis and cardiomyopathy therapeutics. However, estimates of cardiomyocyte turnover rates conflict greatly, with a study employing C14 pulse-chase methodology concluding 1% annual turnover in youth declining to 0.5% with aging and another using cell population dynamics indicating substantial, age-increasing turnover (4% increasing to 20%). Objective: Create a hybrid mathematical model to critically examine rates of cardiomyocyte turnover derived from alternative methodologies. Methods and Results: Examined in isolation, the cell population analysis exhibited severe sensitivity to a stem cell expansion exponent (20% variation causing 2-fold turnover change) and apoptosis rate. Similarly, the pulse-chase model was acutely sensitive to assumptions of instantaneous incorporation of atmospheric C14 into the body (4-fold impact on turnover in young subjects) while numerical restrictions precluded otherwise viable solutions. Incorporating considerations of primary variable sensitivity and controversial model assumptions, an unbiased numerical solver identified a scenario of significant, age-increasing turnover (4-6% increasing to 15-22% with age) that was compatible with data from both studies, provided that successive generations of cardiomyocytes experienced higher attrition rates than predecessors. Conclusions: Assignment of histologically-observed stem/progenitor cells into discrete regenerative phenotypes in the cell population model strongly influenced turnover dynamics without being directly testable. Alternatively, C14 trafficking assumptions and restrictive models in the pulse-chase model artificially eliminated high-turnover solutions. Nevertheless, discrepancies among recent cell turnover estimates can be explained and reconciled. The hybrid mathematical model provided herein permits further examination of these and forthcoming datasets.	[Margulies, Kenneth B.] Univ Penn, Sch Med, Dept Internal Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Elser, Jeremy A.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Margulies, KB (corresponding author), Univ Penn, Sch Med, Dept Internal Med, Cardiovasc Inst, Philadelphia, PA 19104 USA.	ken.margulies@uphs.upenn.edu			American Heart Association; National Institutes of Health [R01HL089847]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089847] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding provided by American Heart Association Pre-doctoral Fellowship to JAE and National Institutes of Health R01HL089847 to KBM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler C P, 1975, Recent Adv Stud Cardiac Struct Metab, V8, P373; Adler CP, 1991, DEV REGENERATIVE POT, P13; Bayes-Genis A, 2002, CARDIOVASC RES, V56, P404, DOI 10.1016/S0008-6363(02)00597-7; Bergmann O, 2011, EXP CELL RES, V317, P188, DOI 10.1016/j.yexcr.2010.08.017; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; BRODSKY VY, 1994, VIRCHOWS ARCH, V424, P429; BROECKER WS, 1959, SCIENCE, V130, P331, DOI 10.1126/science.130.3371.331-a; Herget GW, 1997, CARDIOVASC RES, V36, P45, DOI 10.1016/S0008-6363(97)00140-5; Kajstura J, 2012, CIRC RES, V110, pE19, DOI 10.1161/CIRCRESAHA.111.259721; Kajstura J, 2010, CIRC RES, V107, P1374, DOI 10.1161/CIRCRESAHA.110.231498; Kajstura J, 2010, CIRC RES, V107, P305, DOI 10.1161/CIRCRESAHA.110.223024; Kelly KJ, 2003, AM J PHYSIOL-CELL PH, V284, pC1309, DOI 10.1152/ajpcell.00353.2002; Kubo H, 2008, CIRCULATION, V118, P649, DOI 10.1161/CIRCULATIONAHA.107.761031; Levin I, 2004, RADIOCARBON, V46, P1261, DOI 10.1017/S0033822200033130; Levin I, 2008, SCI TOTAL ENVIRON, V391, P211, DOI 10.1016/j.scitotenv.2007.10.019; Mallat Z, 2001, J GERONTOL A-BIOL, V56, pM719, DOI 10.1093/gerona/56.11.M719; OLIVETTI G, 1991, CIRC RES, V68, P1560, DOI 10.1161/01.RES.68.6.1560; Parmacek MS, 2009, NEW ENGL J MED, V361, P86, DOI 10.1056/NEJMcibr0903347; Porrello E, 2012, CIRC RES, V107, P1292; Rupp S, 2008, EUR HEART J, V29, P1867, DOI 10.1093/eurheartj/ehn223; Scudamore CL, 2010, COMP CLIN PATHOL, V20, P95; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; TAKAMATSU T, 1983, HISTOCHEMISTRY, V77, P485, DOI 10.1007/BF00495803; Urbanek K, 2003, P NATL ACAD SCI USA, V100, P10440, DOI 10.1073/pnas.1832855100	24	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51683	10.1371/journal.pone.0051683	http://dx.doi.org/10.1371/journal.pone.0051683			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284740	Green Published, gold, Green Submitted			2022-12-27	WOS:000312694300036
J	Garcia, M; Bellosillo, B; Sanchez-Gonzalez, B; Garcia-Payarols, F; Seoane, A; Ferrer, AM; Gimeno, E; Barranco, LE; Torner, A; Sole, F; Besses, C; Serrano, S; Salar, A				Garcia, Mar; Bellosillo, Beatriz; Sanchez-Gonzalez, Blanca; Garcia-Payarols, Francesc; Seoane, Agustin; Maria Ferrer, Ana; Gimeno, Eva; Eugenio Barranco, Luis; Torner, Ariadna; Sole, Francesc; Besses, Carles; Serrano, Sergi; Salar, Antonio			Study of Regulatory T-Cells in Patients with Gastric Malt Lymphoma: Influence on Treatment Response and Outcome	PLOS ONE			English	Article							FOLLICULAR LYMPHOMA; INDEPENDENT PREDICTOR; HIGH NUMBERS; TISSUE; SURVIVAL; MICROENVIRONMENT; CHEMOTHERAPY; FLUDARABINE; EXPRESSION; PROGNOSIS	Purpose: FOXP3+ regulatory T cells (Treg) play an essential role in modulating host responses to tumors and infections. The role of these cells in the pathogenesis of MALT lymphomas remains unknown. The aims of the study were to quantify the number of infiltrating FOXP3+ and CD3+ cells in patients with gastric MALT lymphoma at diagnosis and to study kinetics of these cells and CD20+ tumor cells after treatment and during long-term follow-up. Methods: FOXP3+, CD3+ and CD20+ cells were analyzed by immunohistochemistry and the number of cells was quantified using a micrometric ocular. Samples of 35 patients with gastric MALT lymphoma at diagnosis and after treatment were included. Diagnostic samples were compared to 19 cases of chronic gastritis and diffuse large B-cell lymphoma (DLBCL) of the stomach. Results: The median number of FOXP3+ infiltrating cells was higher (27 cells/cm(2)) in gastric MALT patients than in DLBCL (10 cells; p = 0.162) but similar to chronic gastritis (20 cells; p = 0.605). No characteristic or specific distribution pattern of infiltrating FOXP3+ cells was found. Gastric MALT lymphoma patients responding to bacterial eradication therapy had higher number of FOXP3+ cells at study entry. Kinetics of both infiltrating FOXP3+ cells and tumor CD20+ cells were strongly dependent on the treatment administered. Discussion: Gastric MALT lymphomas have a number of Treg cells more similar to chronic gastritis than to DLBCL. Patients with higher number of tumor infiltrating FOXP3+ cells at study entry seem to have better response to antibiotics. Kinetics of Treg and tumor cells are influenced by type of treatment.	[Garcia, Mar; Bellosillo, Beatriz; Maria Ferrer, Ana; Torner, Ariadna; Sole, Francesc; Serrano, Sergi] Hosp del Mar, Dept Pathol, Barcelona, Spain; [Sanchez-Gonzalez, Blanca; Garcia-Payarols, Francesc; Gimeno, Eva; Besses, Carles; Salar, Antonio] Hosp del Mar, Dept Hematol, Barcelona, Spain; [Seoane, Agustin; Eugenio Barranco, Luis] Hosp del Mar, Dept Gastroenterol, Barcelona, Spain; [Garcia, Mar; Bellosillo, Beatriz; Sanchez-Gonzalez, Blanca; Garcia-Payarols, Francesc; Seoane, Agustin; Maria Ferrer, Ana; Gimeno, Eva; Eugenio Barranco, Luis; Torner, Ariadna; Sole, Francesc; Besses, Carles; Serrano, Sergi; Salar, Antonio] Hosp del Mar Med Res Inst IMIM, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Garcia, M (corresponding author), Hosp del Mar, Dept Pathol, Barcelona, Spain.	94972@parcdesalutmar.cat	Garcia, Mar/GOG-9086-2022; Solé, Francesc/K-8373-2012; Barranco Priego, Luis/AFV-2437-2022	Garcia, Mar/0000-0003-2078-8205; Solé, Francesc/0000-0002-3251-2161; Barranco Priego, Luis/0000-0002-7352-7415; Ana, Ferrer/0000-0002-3381-9472; Seoane Urgorri, Agustin/0000-0001-8023-4445; Salar, Antonio/0000-0002-4652-4825	Instituto de Salud Carlos III, Spanish Ministry of Science and Technology [FIS-FEDER 07/0586]	Instituto de Salud Carlos III, Spanish Ministry of Science and Technology(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government)	This work received grant support from Instituto de Salud Carlos III, Spanish Ministry of Science and Technology grant (FIS-FEDER 07/0586). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvaro T, 2005, CLIN CANCER RES, V11, P1467, DOI 10.1158/1078-0432.CCR-04-1869; Alvaro T, 2006, J CLIN ONCOL, V24, P5350, DOI 10.1200/JCO.2006.06.4766; Beyer M, 2006, BLOOD, V108, P804, DOI 10.1182/blood-2006-02-002774; Carreras J, 2006, BLOOD, V108, P2957, DOI 10.1182/blood-2006-04-018218; Cavalli F, 2001, MALT LYMPHOMAS HEMAT, P241; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; Copie-Bergman C, 2003, GUT, V52, P1656, DOI 10.1136/gut.52.11.1656; Craig VJ, 2010, LEUKEMIA, V24, P1186, DOI 10.1038/leu.2010.76; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; de Boer JP, 2011, LEUKEMIA LYMPHOMA, V52, P2262, DOI 10.3109/10428194.2011.607527; de Jong D, 2009, HAEMATOL-HEMATOL J, V94, P70, DOI 10.3324/haematol.13574; Farinha P, 2010, BLOOD, V115, P289, DOI 10.1182/blood-2009-07-235598; Gjerdrum LM, 2007, LEUKEMIA, V21, P2512, DOI 10.1038/sj.leu.2404913; Glas AM, 2007, J CLIN ONCOL, V25, P390, DOI 10.1200/JCO.2006.06.1648; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Isaacson P.G., 2008, WHO CLASSIFICATION T, V4th, P214; Jiang H, 2006, NEW ENGL J MED, V354, P1166, DOI 10.1056/NEJMra055446; Kim WY, 2009, ANN ONCOL, V20, P1688, DOI 10.1093/annonc/mdp056; Lee AM, 2006, J CLIN ONCOL, V24, P5052, DOI 10.1200/JCO.2006.06.4642; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Mittal S, 2008, BLOOD, V111, P5359, DOI 10.1182/blood-2007-08-105395; ROHATINER A, 1994, ANN ONCOL, V5, P397, DOI 10.1093/oxfordjournals.annonc.a058869; Ruskone -Fourmestraux A, 2011, GUT, V60, P747, DOI 10.1136/gut.2010.224949; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Salar A, 2005, J CLIN ONCOL, V23, P7361, DOI 10.1200/JCO.2005.02.6138; Salar A, 2009, CANCER, V115, P5210, DOI 10.1002/cncr.24605; Santon A, 2008, LEUKEMIA LYMPHOMA, V49, P1516, DOI 10.1080/10428190802210692; Tiemessen MM, 2007, P NATL ACAD SCI USA, V104, P19446, DOI 10.1073/pnas.0706832104; Tzankov A, 2008, HAEMATOLOGICA, V93, P193, DOI 10.3324/haematol.11702; Yang ZZ, 2007, BLOOD, V110, P2537, DOI 10.1182/blood-2007-03-082578	30	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51681	10.1371/journal.pone.0051681	http://dx.doi.org/10.1371/journal.pone.0051681			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284739	Green Published, gold, Green Submitted			2022-12-27	WOS:000312694300035
J	Wan, M; Bolger, N; Champagne, FA				Wan, Michele; Bolger, Niall; Champagne, Frances A.			Human Perception of Fear in Dogs Varies According to Experience with Dogs	PLOS ONE			English	Article							EMOTIONAL FACIAL EXPRESSIONS; BITE PREVENTION PROGRAM; EDUCATIONAL INTERVENTION; STRUCTURAL RULES; RECOGNITION; CHILDREN; ACCURACY; STRESS; BARKS; INFORMATION	To investigate the role of experience in humans' perception of emotion using canine visual signals, we asked adults with various levels of dog experience to interpret the emotions of dogs displayed in videos. The video stimuli had been pre-categorized by an expert panel of dog behavior professionals as showing examples of happy or fearful dog behavior. In a sample of 2,163 participants, the level of dog experience strongly predicted identification of fearful, but not of happy, emotional examples. The probability of selecting the "fearful" category to describe fearful examples increased with experience and ranged from. 30 among those who had never lived with a dog to greater than. 70 among dog professionals. In contrast, the probability of selecting the "happy" category to describe happy emotional examples varied little by experience, ranging from. 90 to. 93. In addition, the number of physical features of the dog that participants reported using for emotional interpretations increased with experience, and in particular, more-experienced respondents were more likely to attend to the ears. Lastly, more-experienced respondents provided lower difficulty and higher accuracy self-ratings than less-experienced respondents when interpreting both happy and fearful emotional examples. The human perception of emotion in other humans has previously been shown to be sensitive to individual differences in social experience, and the results of the current study extend the notion of experience-dependent processes from the intraspecific to the interspecific domain.	[Wan, Michele; Bolger, Niall; Champagne, Frances A.] Columbia Univ, Dept Psychol, New York, NY 10027 USA	Columbia University	Wan, M (corresponding author), Columbia Univ, Dept Psychol, New York, NY 10027 USA.	msw2111@columbia.edu	Bolger, Niall/A-9934-2008; Bolger, Niall/Y-6435-2019; Champagne, Frances Anne/Q-1220-2018	Bolger, Niall/0000-0001-8698-8117; Bolger, Niall/0000-0001-8698-8117; Champagne, Frances Anne/0000-0002-3922-084X	Department of Psychology, Columbia University	Department of Psychology, Columbia University	This research was funded by the Department of Psychology, Columbia University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2007, INTRO CATEGORICAL DA; Beerda B, 1999, PHYSIOL BEHAV, V66, P233, DOI 10.1016/S0031-9384(98)00289-3; Beerda B, 1998, APPL ANIM BEHAV SCI, V58, P365, DOI 10.1016/S0168-1591(97)00145-7; Beerda B, 2000, ANIM WELFARE, V9, P49; Bradshaw John W. S., 1995, P115; CAMRAS LA, 1985, J NONVERBAL BEHAV, V9, P84, DOI 10.1007/BF00987140; Carstensen LL, 2000, J PERS SOC PSYCHOL, V79, P644, DOI 10.1037//0022-3514.79.4.644; Chapman S, 2000, BRIT MED J, V320, P1512, DOI 10.1136/bmj.320.7248.1512; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; Dreschel NA, 2005, APPL ANIM BEHAV SCI, V95, P153, DOI 10.1016/j.applanim.2005.04.009; Durand K, 2007, J EXP CHILD PSYCHOL, V97, P14, DOI 10.1016/j.jecp.2006.12.001; Ekman P., 1976, PICTURES FACIAL AFFE; Elfenbein HA, 2003, J PERS SOC PSYCHOL, V85, P276, DOI 10.1037/0022-3514.85.2.276; Elfenbein HA, 2002, PSYCHOL BULL, V128, P203, DOI 10.1037//0033-2909.128.2.203; Fox M., 1971, BEHAV WOLVES DOGS RE; Frith CD, 2007, CURR BIOL, V17, pR724, DOI 10.1016/j.cub.2007.05.068; Guo K, 2010, PERCEPTION, V39, P533, DOI 10.1068/p6517; Hennessy MB, 2001, APPL ANIM BEHAV SCI, V73, P217, DOI 10.1016/S0168-1591(01)00139-3; Hess U, 1997, J NONVERBAL BEHAV, V21, P241, DOI 10.1023/A:1024952730333; Hetts S, 2000, CANINE BEHAV OBSERVI; Kalnajs S, 2006, LANGUAGE DOGS; KOLB B, 1992, BRAIN COGNITION, V20, P74, DOI 10.1016/0278-2626(92)90062-Q; Kubinyi E, 2009, BEHAV PROCESS, V81, P392, DOI 10.1016/j.beproc.2009.04.004; Kujala MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039145; Lakestani NN, 2006, P 40 INT C INT SOC A, P233; Lakestani NN, 2007, STUDY DOG BITES THEI; Landsberg G., 1997, HDB BEHAV PROBLEMS D; Leppanen JM, 2004, PSYCHOL RES-PSYCH FO, V69, P22, DOI 10.1007/s00426-003-0157-2; Ley JM, 2009, APPL ANIM BEHAV SCI, V116, P220, DOI 10.1016/j.applanim.2008.09.009; Magrath RD, 2012, P ROY SOC B-BIOL SCI, V279, P902, DOI 10.1098/rspb.2011.1362; McConnell P., 2005, LOVE DOG UNDERSTANDI; Meints K, 2010, P 2 CAN SCI FOR VIEN, P99; Meints K, 2010, P 2 CAN SCI FOR VIEN, P149; Meints K, 2009, J PEDIATR PSYCHOL, V34, P1084, DOI 10.1093/jpepsy/jsp053; Mirza RS, 2003, BEHAVIOUR, V140, P1359, DOI 10.1163/156853903771980620; Molnar C, 2010, Q J EXP PSYCHOL, V63, P1004, DOI 10.1080/17470210903168243; Morris PH, 2008, COGNITION EMOTION, V22, P3, DOI 10.1080/02699930701273716; MORTON ES, 1977, AM NAT, V111, P855, DOI 10.1086/283219; Ogata N, 2006, J VET BEHAV, V1, P55, DOI 10.1016/j.jveb.2006.06.002; Olsson A, 2007, NAT NEUROSCI, V10, P1095, DOI 10.1038/nn1968; Overall KL, 2001, J AM VET MED ASSOC, V218, P1923, DOI 10.2460/javma.2001.218.1923; Palermo R, 2004, BEHAV RES METH INS C, V36, P634, DOI 10.3758/BF03206544; Panksepp J, 2005, CONSCIOUS COGN, V14, P30, DOI 10.1016/j.concog.2004.10.004; Pollak SD, 2002, P NATL ACAD SCI USA, V99, P9072, DOI 10.1073/pnas.142165999; Pollak SD, 2002, DEV PSYCHOL, V38, P784, DOI 10.1037/0012-1649.38.5.784; Pollak SD, 2000, DEV PSYCHOL, V36, P679, DOI 10.1037//0012-1649.36.5.679; Pongracz P, 2005, J COMP PSYCHOL, V119, P136, DOI 10.1037/0735-7036.119.2.136; Pongracz P, 2006, APPL ANIM BEHAV SCI, V100, P228, DOI 10.1016/j.applanim.2005.12.004; Pongracz P, 2011, APPL ANIM BEHAV SCI, V135, P95, DOI 10.1016/j.applanim.2011.09.005; Rugaas T., 2006, TALKING TERMS DOGS C; Simon RW, 2004, AM J SOCIOL, V109, P1137, DOI 10.1086/382111; Smith ML, 2005, PSYCHOL SCI, V16, P184, DOI 10.1111/j.0956-7976.2005.00801.x; Spiegel IB, 2000, ANTHROZOOS, V13, P164, DOI 10.2752/089279300786999789; Stetina BU, 2011, J VET BEHAV, V6, P108, DOI 10.1016/j.jveb.2010.11.004; Sullivan MW, 2008, CHILD MALTREATMENT, V13, P301, DOI 10.1177/1077559507313725; Tami G, 2009, APPL ANIM BEHAV SCI, V120, P159, DOI 10.1016/j.applanim.2009.06.009; Vicari S, 2000, ACTA PAEDIATR, V89, P836, DOI 10.1080/080352500750043756; Wan M, 2009, APPL ANIM BEHAV SCI, V121, P206, DOI 10.1016/j.applanim.2009.09.015; Wilson F, 2003, J COMMUNITY PSYCHOL, V31, P75, DOI 10.1002/jcop.10038	59	47	47	5	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51775	10.1371/journal.pone.0051775	http://dx.doi.org/10.1371/journal.pone.0051775			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	059HF	23284765	Green Published, gold			2022-12-27	WOS:000312694300042
J	Ozersky, T; Evans, DO; Barton, DR				Ozersky, Ted; Evans, David O.; Barton, David R.			Invasive Mussels Alter the Littoral Food Web of a Large Lake: Stable Isotopes Reveal Drastic Shifts in Sources and Flow of Energy	PLOS ONE			English	Article							BENTHIC INVERTEBRATES; DREISSENA-POLYMORPHA; ZEBRA MUSSELS; TROPHIC POSITION; PHOSPHORUS; CARBON; ALGAE; RATIOS; GROWTH; PRESERVATION	We investigated how establishment of invasive dreissenid mussels impacted the structure and energy sources of the littoral benthic food web of a large temperate lake. We combined information about pre- and postdreissenid abundance, biomass, and secondary production of the littoral benthos with results of carbon and nitrogen stable isotope analysis of archival (predreissenid) and recent (postdreissenid) samples of all common benthic taxa. This approach enabled us to determine the importance of benthic and sestonic carbon to the littoral food web before, and more than a decade after dreissenid establishment. Long term dreissenid presence was associated with a 32-fold increase in abundance, 6-fold increase in biomass, and 14-fold increase in secondary production of the littoral benthos. Dreissenids comprised a large portion of the post-invasion benthos, making up 13, 38, and 56% of total abundance, biomass, and secondary production, respectively. The predreissenid food web was supported primarily by benthic primary production, while sestonic material was relatively more important to the postdreissenid food web. The absolute importance of both sestonic material and benthic primary production to the littoral benthos increased considerably following dreissenid establishment. Our results show drastic alterations to food web structure and suggest that dreissenid mussels redirect energy and material from the water column to the littoral benthos both through biodeposition of sestonic material as well as stimulation of benthic primary production.	[Ozersky, Ted; Evans, David O.] Trent Univ, Ontario Minist Nat Resources, Peterborough, ON K9J 7B8, Canada; [Barton, David R.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	Ministry of Natural Resources & Forestry; Trent University; University of Waterloo	Ozersky, T (corresponding author), Wellesley Coll, Dept Biol Sci, Wellesley, MA 02181 USA.	tozersky@gmail.com			Environment Canada; Ontario Ministry of Natural Resources	Environment Canada(CGIAR); Ontario Ministry of Natural Resources	Lake Simcoe Clean Up Fund grant from Environment Canada to the authors, and research funding to DOE from Ontario Ministry of Natural Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTON D R, 1978, Journal of Great Lakes Research, V4, P27; Beekey MA, 2004, OECOLOGIA, V141, P164, DOI 10.1007/s00442-004-1632-1; BENKE AC, 1993, PROC INT ASSOC THEOR, V25, P15; Botts PS, 1996, J N AM BENTHOL SOC, V15, P179, DOI 10.2307/1467947; BRUNER KA, 1994, J GREAT LAKES RES, V20, P735, DOI 10.1016/S0380-1330(94)71191-6; Campbell LM, 2009, J GREAT LAKES RES, V35, P224, DOI 10.1016/j.jglr.2009.02.002; Eimers MC, 2005, J GREAT LAKES RES, V31, P322; Evans DO, 2011, J GREAT LAKES RES, V37, P36, DOI 10.1016/j.jglr.2011.04.002; Evans DO, 1996, CAN J FISH AQUAT SCI, V53, P194, DOI 10.1139/cjfas-53-S1-194; FRANCE RL, 1995, MAR ECOL PROG SER, V124, P307, DOI 10.3354/meps124307; Garton DW, 2005, CAN J FISH AQUAT SCI, V62, P1119, DOI 10.1139/F05-025; Gergs R, 2011, BIOL INVASIONS, V13, P2727, DOI 10.1007/s10530-011-9943-8; Gergs R, 2009, FRESHWATER BIOL, V54, P1379, DOI 10.1111/j.1365-2427.2009.02188.x; Gorokhova E, 2005, OECOLOGIA, V143, P251, DOI 10.1007/s00442-004-1791-0; Hecky RE, 1995, J N AM BENTHOL SOC, V14, P631, DOI 10.2307/1467546; Hecky RE, 2004, CAN J FISH AQUAT SCI, V61, P1285, DOI 10.1139/F04-065; Hershey AE, 2006, LIMNOL OCEANOGR, V51, P177, DOI 10.4319/lo.2006.51.1.0177; Higgins SN, 2010, ECOL MONOGR, V80, P179, DOI 10.1890/09-1249.1; Hill WR, 2008, LIMNOL OCEANOGR, V53, P1217, DOI 10.4319/lo.2008.53.4.1217; Hiriart-Baer VP, 2011, J GREAT LAKES RES, V37, P764, DOI 10.1016/j.jglr.2011.08.014; IZVEKOVA E I, 1972, Polskie Archiwum Hydrobiologii, V19, P203; Korinkova Tereza, 2011, Malacologica Bohemoslovaca, V10, P1; LAWS EA, 1995, GEOCHIM COSMOCHIM AC, V59, P1131, DOI 10.1016/0016-7037(95)00030-4; Limen H, 2005, J GREAT LAKES RES, V31, P97, DOI 10.1016/S0380-1330(05)70241-0; Lombardo P, 2002, ARCH HYDROBIOL, V155, P667; Lorrain A, 2003, ANAL CHIM ACTA, V491, P125, DOI 10.1016/S0003-2670(03)00815-8; MacLeod NA, 1998, CAN J FISH AQUAT SCI, V55, P1919, DOI 10.1139/cjfas-55-8-1919; Malkin SY, 2008, LIMNOL OCEANOGR, V53, P1111, DOI 10.4319/lo.2008.53.3.1111; Mayer CM, 2002, J N AM BENTHOL SOC, V21, P616, DOI 10.2307/1468434; Merritt R.W., 1996, INTRO AQUATIC INSECT; Mills EL, 2003, CAN J FISH AQUAT SCI, V60, P471, DOI 10.1139/F03-033; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Mitchell MJ, 1996, CAN J FISH AQUAT SCI, V53, P1445, DOI 10.1139/cjfas-53-6-1445; MORIN A, 1992, CAN J FISH AQUAT SCI, V49, P532, DOI 10.1139/f92-063; Morrison HA, 1998, ENVIRON SCI TECHNOL, V32, P3862, DOI 10.1021/es980434i; MURVOSH CM, 1971, ECOL MONOGR, V41, P79, DOI 10.2307/1942436; Nilsson E, 2012, FRESHWATER BIOL, V57, P10, DOI 10.1111/j.1365-2427.2011.02688.x; Ozersky T, 2011, J N AM BENTHOL SOC, V30, P913, DOI 10.1899/10-122.1; Ozersky T, 2009, J GREAT LAKES RES, V35, P321, DOI 10.1016/j.jglr.2009.05.001; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Rennie MD, 2012, CAN J ZOOL, V90, P1320, DOI 10.1139/z2012-101; Rennie MD, 2009, OECOLOGIA, V159, P789, DOI 10.1007/s00442-008-1271-z; STANCZYKOWSKA A, 1993, HYDROBIOLOGIA, V251, P73, DOI 10.1007/BF00007167; Stewart TW, 1998, J N AM BENTHOL SOC, V17, P81, DOI 10.2307/1468053; Strayer DL, 2010, FRESHWATER BIOL, V55, P152, DOI 10.1111/j.1365-2427.2009.02380.x; Vadeboncoeur Y, 2002, BIOSCIENCE, V52, P44, DOI 10.1641/0006-3568(2002)052[0044:PTLBTR]2.0.CO;2; Vander Zanden MJ, 1999, NATURE, V401, P464, DOI 10.1038/46762; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Ward JM, 2007, DIVERS DISTRIB, V13, P155, DOI 10.1111/j.1472-4642.2007.00336.x; Winter JG, 2011, J GREAT LAKES RES, V37, P63, DOI 10.1016/j.jglr.2010.05.002; Young JD, 2011, J GREAT LAKES RES, V37, P7, DOI 10.1016/j.jglr.2010.12.008	53	36	38	1	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51249	10.1371/journal.pone.0051249	http://dx.doi.org/10.1371/journal.pone.0051249			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284673	gold, Green Published, Green Submitted			2022-12-27	WOS:000312435900017
J	Xiang, XY; Deng, ZB; Zhuang, XY; Ju, SW; Mu, JY; Jiang, H; Zhang, LF; Yan, J; Miller, D; Zhang, HG				Xiang, Xiaoyu; Deng, ZhongBin; Zhuang, Xiaoying; Ju, Songwen; Mu, Jingyao; Jiang, Hong; Zhang, Lifeng; Yan, Jun; Miller, Donald; Zhang, Huang-Ge			Grhl2 Determines the Epithelial Phenotype of Breast Cancers and Promotes Tumor Progression	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; E-CADHERIN; METASTASIS; DISSEMINATION; CELLS; REGULATOR; STATES	Until now the essential transcription factor that determines the epithelial phenotype of breast cancer has not been identified and its role in epithelial-to-mesenchymal transition (EMT) and tumor progression remain unclear. Here, by analyzing large expression profiles of human breast cancer cells, we found an extraordinary correlation between the expression of Grainyhead transcription factor Grhl2 and epithelial marker E-cadherin. Knockdown of Grhl2 expression by shRNA in human mammary epithelial cell MCF10A leads to down-regulation of E-cadherin and EMT. Grhl2 is down-regulated in disseminated cancer cells that have undergone EMT, and over-expression of Grhl2 is sufficient to induce epithelial gene expression. Large clinical datasets reveal that expression of Grhl2 is significantly associated with poor relapse free survival and increased risk of metastasis in breast cancer patients. In mouse models, over-expression of Grhl2 significantly promotes tumor growth and metastasis. Further testing of several Grhl2 regulated genes leads to the same conclusions that the tumorigenic and metastatic potentials of tumor cells are linked to epithelial phenotype but not mesenchymal phenotype. In conclusion, our findings indicate that Grhl2 plays an essential role in the determination of epithelial phenotype of breast cancers, EMT and tumor progression.	[Zhang, Huang-Ge] Louisville Vet Adm, Med Ctr, Louisville, KY USA; [Xiang, Xiaoyu; Deng, ZhongBin; Zhuang, Xiaoying; Ju, Songwen; Mu, Jingyao; Jiang, Hong; Zhang, Lifeng; Miller, Donald; Zhang, Huang-Ge] Univ Louisville, Brown Canc Ctr, Dept Microbiol & Immunol, Louisville, KY 40292 USA; [Yan, Jun] Univ Louisville, Brown Canc Ctr, Dept Med, Louisville, KY 40292 USA	University of Louisville; University of Louisville	Zhang, HG (corresponding author), Louisville Vet Adm, Med Ctr, Louisville, KY USA.	H0Zhan17@louisville.edu	Yan, Jun/A-8988-2008	Miller, Donald/0000-0002-7881-8801	National Institutes of Health (NIH) [RO1CA137037, RO1CA116092]; Louisville Veterans Administration Medical Center (VAMC) Merit Review Grants; Susan G. Komen Breast Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA116092, R01CA137037] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisville Veterans Administration Medical Center (VAMC) Merit Review Grants; Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institutes of Health (NIH) (RO1CA137037 and RO1CA116092); the Louisville Veterans Administration Medical Center (VAMC) Merit Review Grants (H.-G.Z.); and a grant from the Susan G. Komen Breast Cancer Foundation. The authors thank Dr. Jerald Ainsworth for editorial assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhat-Nakshatri P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-411; Boglev Y, 2011, DEV BIOL, V349, P512, DOI 10.1016/j.ydbio.2010.11.011; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Celia-Terrassa T, 2012, J CLIN INVEST, V122, P1849, DOI 10.1172/JCI59218; Chaffer CL, 2007, CELLS TISSUES ORGANS, V185, P7, DOI 10.1159/000101298; Chiu HS, 2010, DEV BIOL, V344, P1071, DOI 10.1016/j.ydbio.2010.05.495; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Dykxhoorn DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007181; Filant J, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097089; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Gumireddy K, 2009, NAT CELL BIOL, V11, P1297, DOI 10.1038/ncb1974; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hajra KM, 2002, CANCER RES, V62, P1613; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Hollestelle A, 2010, BREAST CANCER RES TR, V121, P53, DOI 10.1007/s10549-009-0460-8; Korpal M, 2011, NAT MED ADV; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Morel AP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002723; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Pyrgaki C, 2011, DEV BIOL, V353, P38, DOI 10.1016/j.ydbio.2011.02.027; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Santisteban M, 2009, CANCER RES, V69, P2887, DOI 10.1158/0008-5472.CAN-08-3343; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Warzecha CC, 2010, EMBO J, V29, P3286, DOI 10.1038/emboj.2010.195; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Werth M, 2010, DEVELOPMENT, V137, P3835, DOI 10.1242/dev.055483; Winuthayanon W, 2010, P NATL ACAD SCI USA, V107, P19272, DOI 10.1073/pnas.1013226107; Xiang X, 2011, ONCOGENE, V30, P3440, DOI 10.1038/onc.2011.54; Yan W, 2010, J BIOL CHEM, V285, P14042, DOI 10.1074/jbc.M110.105262; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yori JL, 2010, J BIOL CHEM, V285, P16854, DOI 10.1074/jbc.M110.114546; Yu ZQ, 2008, DEV BIOL, V319, P56, DOI 10.1016/j.ydbio.2008.04.001	41	67	71	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e50781	10.1371/journal.pone.0050781	http://dx.doi.org/10.1371/journal.pone.0050781			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284647	gold, Green Published, Green Submitted			2022-12-27	WOS:000312435900009
J	Woodward, LJ; Clark, CAC; Bora, S; Inder, TE				Woodward, Lianne J.; Clark, Caron A. C.; Bora, Samudragupta; Inder, Terrie E.			Neonatal White Matter Abnormalities an Important Predictor of Neurocognitive Outcome for Very Preterm Children	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; EXECUTIVE FUNCTION; PREMATURE-INFANT; BEHAVIORAL OUTCOMES; PRESCHOOL-CHILDREN; BAYLEY SCALES; BORN PRETERM; BRAIN-INJURY; SCHOOL-AGE; ADOLESCENTS	Background: Cerebral white matter abnormalities on term MRI are a strong predictor of motor disability in children born very preterm. However, their contribution to cognitive impairment is less certain. Objective: Examine relationships between the presence and severity of cerebral white matter abnormalities on neonatal MRI and a range of neurocognitive outcomes assessed at ages 4 and 6 years. Design/Methods: The study sample consisted of a regionally representative cohort of 104 very preterm (<= 32 weeks gestation) infants born from 1998-2000 and a comparison group of 107 full-term infants. At term equivalent, all preterm infants underwent a structural MRI scan that was analyzed qualitatively for the presence and severity of cerebral white matter abnormalities, including cysts, signal abnormalities, loss of white matter volume, ventriculomegaly, and corpus callosal thinning/myelination. At corrected ages 4 and 6 years, all children underwent a comprehensive neurodevelopmental assessment that included measures of general intellectual ability, language development, and executive functioning. Results: At 4 and 6 years, very preterm children without cerebral white matter abnormalities showed no apparent neurocognitive impairments relative to their full-term peers on any of the domain specific measures of intelligence, language, and executive functioning. In contrast, children born very preterm with mild and moderate-to-severe white matter abnormalities were characterized by performance impairments across all measures and time points, with more severe cerebral abnormalities being associated with increased risks of cognitive impairment. These associations persisted after adjustment for gender, neonatal medical risk factors, and family social risk. Conclusions: Findings highlight the importance of cerebral white matter connectivity for later intact cognitive functioning amongst children born very preterm. Preterm born children without cerebral white matter abnormalities on their term MRI appear to be spared many of the cognitive impairments commonly associated with preterm birth. Further follow-up will be important to assess whether this finding persists into the school years.	[Woodward, Lianne J.; Bora, Samudragupta] Univ Canterbury, Dept Psychol, Canterbury Child Dev Res Grp, Christchurch 1, New Zealand; [Woodward, Lianne J.] New Zealand Brain Res Inst, Christchurch, New Zealand; [Clark, Caron A. C.] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA; [Inder, Terrie E.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Inder, Terrie E.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Inder, Terrie E.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA	University of Canterbury; University of Oregon; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Woodward, LJ (corresponding author), Univ Canterbury, Dept Psychol, Canterbury Child Dev Res Grp, Christchurch 1, New Zealand.	lianne.woodward@canterbury.ac.nz		Clark, Caron/0000-0002-9907-0548	New Zealand Health Research Council of New Zealand [03/196]; Neurological Foundation of New Zealand [0227PG]; Canterbury Medical Research Foundation [05/01]	New Zealand Health Research Council of New Zealand; Neurological Foundation of New Zealand; Canterbury Medical Research Foundation	Funding for this study was provided by the following funding organizations: the New Zealand Health Research Council of New Zealand (ref no: 03/196) (URL: http://www.hrc.govt.nz/); the Neurological Foundation of New Zealand (ref no. 0227PG) (URL: http://www.neurological.org.nz/) and Canterbury Medical Research Foundation (ref. no. 05/01) (URL: http://www.cmrf.org.nz/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allin MPG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024525; Anderson PJ, 2010, ARCH PEDIAT ADOL MED, V164, P352, DOI 10.1001/archpediatrics.2010.20; Baron IS, 2010, NEUROPSYCHOL REV, V20, P430, DOI 10.1007/s11065-010-9132-z; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Boardman J P, 2007, Minerva Pediatr, V59, P349; Cheong JLY, 2009, AM J NEURORADIOL, V30, P623, DOI 10.3174/ajnr.A1399; Conners C., 2001, CONNERS KIDDIE CONTI; de Kieviet JF, 2012, DEV MED CHILD NEUROL, V54, P313, DOI 10.1111/j.1469-8749.2011.04216.x; Eikenes L, 2011, NEUROIMAGE, V54, P1774, DOI 10.1016/j.neuroimage.2010.10.037; Espy KA, 1997, DEV NEUROPSYCHOL, V13, P495, DOI 10.1080/87565649709540690; Hack M, 2005, PEDIATRICS, V116, P333, DOI 10.1542/peds.2005-0173; Haynes RL, 2008, PEDIATR RES, V63, P656, DOI 10.1203/PDR.0b013e31816c825c; Heron M, 2010, PEDIATRICS, V125, P4, DOI 10.1542/peds.2009-2416; HUGHES C, 1993, DEV PSYCHOL, V29, P498, DOI 10.1037/0012-1649.29.3.498; Inder TE, 1999, ANN NEUROL, V46, P755, DOI 10.1002/1531-8249(199911)46:5<755::AID-ANA11>3.0.CO;2-0; Inder TE, 2003, AM J NEURORADIOL, V24, P805; Inder TE, 2003, J PEDIATR-US, V143, P171, DOI 10.1067/S0022-3476(03)00357-3; Iwata S, 2012, PEDIATRICS, V129, pE1138, DOI 10.1542/peds.2011-1735; Jacques S, 2001, DEV NEUROPSYCHOL, V20, P573, DOI 10.1207/875656401753549807; Johnson S, 2009, ARCH DIS CHILD-FETAL, V94, pF283, DOI 10.1136/adc.2008.152793; Johnson S, 2007, SEMIN FETAL NEONAT M, V12, P363, DOI 10.1016/j.siny.2007.05.004; Korkman M., 2007, NEPSY 2, V2nd; Larroque B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021361; Litt J, 2005, J LEARN DISABIL-US, V38, P130, DOI 10.1177/00222194050380020301; LOBELLO SG, 1991, J SCHOOL PSYCHOL, V29, P229, DOI 10.1016/0022-4405(91)90004-B; Marlow N, 2004, ARCH DIS CHILD-FETAL, V89, pF224, DOI 10.1136/adc.2002.019752; Miller SP, 2005, J PEDIATR-US, V147, P609, DOI 10.1016/j.jpeds.2005.06.033; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; Moore T, 2012, J PEDIATR-US, V160, P553, DOI 10.1016/j.jpeds.2011.09.047; Morrow CE, 2004, J PEDIATR PSYCHOL, V29, P543, DOI 10.1093/jpepsy/jsh056; Myers E, 2009, CLIN PERINATOL, V36, P773, DOI 10.1016/j.clp.2009.07.008; Nosarti C, 2008, BRAIN, V131, P205, DOI 10.1093/brain/awm282; Pritchard VE, 2009, EARLY HUM DEV, V85, P215, DOI 10.1016/j.earlhumdev.2008.10.004; Roberts G, 2010, ARCH DIS CHILD, V95, P786, DOI 10.1136/adc.2009.160283; Skiold B, 2012, J PEDIATR-US, V160, P559, DOI 10.1016/j.jpeds.2011.09.053; Skranes J, 2007, BRAIN, V130, P654, DOI 10.1093/brain/awm001; Spittle AJ, 2011, DEV MED CHILD NEUROL, V53, P1000, DOI 10.1111/j.1469-8749.2011.04095.x; Taylor HG, 2011, DEV NEUROPSYCHOL, V36, P96, DOI 10.1080/87565641.2011.540544; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Wechsler D, 1974, WECHSLER INTELLIGENC; Wechsler D., 2014, WECHSLER PRESCHOOL P; WELSH MC, 1991, DEV NEUROPSYCHOL, V7, P131, DOI 10.1080/87565649109540483; Wiig E., 1992, CLIN EVALUATION LANG; Williams J, 2010, DEV MED CHILD NEUROL, V52, P232, DOI 10.1111/j.1469-8749.2009.03544.x; Wocadlo C, 2006, EARLY HUM DEV, V82, P29, DOI 10.1016/j.earlhumdev.2005.06.005; WOLKE D, 1994, EUR J PEDIATR, V153, P906, DOI 10.1007/s004310050239; Woodcock R. W., 2001, WOODCOCK JOHNSON 3 T; Woodward LJ, 2009, ARCH DIS CHILD-FETAL, V94, pF339, DOI 10.1136/adc.2008.146282; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792; Woodward LJ, 2011, DEV NEUROPSYCHOL, V36, P22, DOI 10.1080/87565641.2011.540530	50	182	185	1	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e51879	10.1371/journal.pone.0051879	http://dx.doi.org/10.1371/journal.pone.0051879			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23284800	Green Published, gold			2022-12-27	WOS:000313051500016
J	Clouthier, CM; Morin, S; Gobeil, SMC; Doucet, N; Blanchet, J; Nguyen, E; Gagne, SM; Pelletier, JN				Clouthier, Christopher M.; Morin, Sebastien; Gobeil, Sophie M. C.; Doucet, Nicolas; Blanchet, Jonathan; Nguyen, Elisabeth; Gagne, Stephane M.; Pelletier, Joelle N.			Chimeric beta-Lactamases: Global Conservation of Parental Function and Fast Time-Scale Dynamics with Increased Slow Motions	PLOS ONE			English	Article							BACKBONE RESONANCE ASSIGNMENTS; MODEL-FREE APPROACH; MOLECULAR-DYNAMICS; RELAXATION DATA; TEM-1; NMR; ENZYME; PSE-4; MACROMOLECULES; RECOMBINATION	Enzyme engineering has been facilitated by recombination of close homologues, followed by functional screening. In one such effort, chimeras of two class-A beta-lactamases - TEM-1 and PSE-4 - were created according to structure-guided protein recombination and selected for their capacity to promote bacterial proliferation in the presence of ampicillin (Voigt et al., Nat. Struct. Biol. 2002 9: 553). To provide a more detailed assessment of the effects of protein recombination on the structure and function of the resulting chimeric enzymes, we characterized a series of functional TEM-1/PSE-4 chimeras possessing between 17 and 92 substitutions relative to TEM-1 beta-lactamase. Circular dichroism and thermal scanning fluorimetry revealed that the chimeras were generally well folded. Despite harbouring important sequence variation relative to either of the two 'parental' beta-lactamases, the chimeric beta-lactamases displayed substrate recognition spectra and reactivity similar to their most closely-related parent. To gain further insight into the changes induced by chimerization, the chimera with 17 substitutions was investigated by NMR spin relaxation. While high order was conserved on the ps-ns timescale, a hallmark of class A beta-lactamases, evidence of additional slow motions on the ms-ms timescale was extracted from model-free calculations. This is consistent with the greater number of resonances that could not be assigned in this chimera relative to the parental beta-lactamases, and is consistent with this well-folded and functional chimeric beta-lactamase displaying increased slow time-scale motions.	[Clouthier, Christopher M.; Morin, Sebastien; Gobeil, Sophie M. C.; Doucet, Nicolas; Blanchet, Jonathan; Nguyen, Elisabeth; Gagne, Stephane M.; Pelletier, Joelle N.] Univ Laval, Quebec Network Res Prot Struct Funct & Engn, PROTEO, Laval, PQ, Canada; [Clouthier, Christopher M.; Blanchet, Jonathan; Nguyen, Elisabeth; Pelletier, Joelle N.] Univ Montreal, Dept Chim, Montreal, PQ H3C 3J7, Canada; [Morin, Sebastien; Gagne, Stephane M.] Univ Laval, Dept Biochim Microbiol & Bioinformat, Laval, PQ, Canada; [Doucet, Nicolas] Univ Quebec, INRS Inst Armand Frappier, Laval, PQ, Canada; [Gobeil, Sophie M. C.; Pelletier, Joelle N.] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada	Laval University; Universite de Montreal; Laval University; University of Quebec; Institut national de la recherche scientifique (INRS); Universite de Montreal	Pelletier, JN (corresponding author), Univ Laval, Quebec Network Res Prot Struct Funct & Engn, PROTEO, Laval, PQ, Canada.	joelle.pelletier@umontreal.ca		gobeil, sophie/0000-0002-0057-2477; Morin, Sebastien/0000-0003-4426-326X	Fonds de la recherche en sante du Quebec (FRSQ); PROTEO-Fonds quebecois de la recherche sur la nature et les technologies (FQRNT); Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Foundation for Innovation (Innovation and New Opportunity); NSERC; FRSQ; PROTEO; FQRNT	Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); PROTEO-Fonds quebecois de la recherche sur la nature et les technologies (FQRNT); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (Innovation and New Opportunity)(Canada Foundation for Innovation); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); FRSQ(Fonds de la Recherche en Sante du Quebec); PROTEO; FQRNT(FQRNT)	This work was supported by operating grants from the Fonds de la recherche en sante du Quebec (FRSQ), PROTEO-Fonds quebecois de la recherche sur la nature et les technologies (FQRNT) and the Natural Sciences and Engineering Research Council of Canada (NSERC), and infrastructure grants from the Canada Foundation for Innovation (Innovation and New Opportunity). S. Morin is the recipient of scholarships from NSERC and FRSQ. S. Gobeil is the recipient of scholarships from PROTEO and FQRNT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, INFORM THEORY EXTENS; AMBLER RP, 1991, BIOCHEM J, V276, P269, DOI 10.1042/bj2760269; Balamurali MM, 2008, PROTEIN SCI, V17, P1815, DOI 10.1110/ps.036376.108; Bebrone C, 2001, ANTIMICROB AGENTS CH, V45, P1868, DOI 10.1128/AAC.45.6.1868-1871.2001; Bhabha G, 2011, SCIENCE, V332, P234, DOI 10.1126/science.1198542; Bos F, 2009, BIOPHYS J, V97, P2550, DOI 10.1016/j.bpj.2009.08.031; Bolduc OR, 2009, ANAL CHEM, V81, P6779, DOI 10.1021/ac900956y; Bouthors AT, 1998, BIOCHEM J, V330, P1443, DOI 10.1042/bj3301443; Bush K, 2010, CRIT CARE, V14, DOI 10.1186/cc8892; Cantu C, 1998, J BIOL CHEM, V273, P26603, DOI 10.1074/jbc.273.41.26603; Carbone MN, 2007, CURR OPIN STRUC BIOL, V17, P454, DOI 10.1016/j.sbi.2007.08.005; Carroll MJ, 2012, NAT CHEM BIOL, V8, P246, DOI [10.1038/NCHEMBIO.769, 10.1038/nchembio.769]; d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P121, DOI 10.1007/s10858-007-9213-3; d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P107, DOI 10.1007/s10858-007-9214-2; d'Auvergne EJ, 2006, J BIOMOL NMR, V35, P117, DOI 10.1007/s10858-006-9007-z; d'Auvergne EJ, 2003, J BIOMOL NMR, V25, P25, DOI 10.1023/A:1021902006114; De Wals PY, 2009, PROTEIN SCI, V18, P147, DOI 10.1002/pro.25; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Doucet N, 2004, J BIOL CHEM, V279, P46295, DOI 10.1074/jbc.M407606200; DOUCET N, 2009, PROTEIN ENG HDB, P187; Doucet N, 2007, J BIOL CHEM, V282, P21448, DOI 10.1074/jbc.M609777200; Doucet N, 2007, PROTEINS, V69, P340, DOI 10.1002/prot.21485; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P5380, DOI 10.1073/pnas.0500729102; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FARROW NA, 1995, J BIOMOL NMR, V6, P153, DOI 10.1007/BF00211779; Fisette O, 2010, BIOPHYS J, V98, P637, DOI 10.1016/j.bpj.2009.08.061; Heinzelman P, 2009, J BIOL CHEM, V284, P26229, DOI 10.1074/jbc.C109.034058; Heinzelman P, 2009, P NATL ACAD SCI USA, V106, P5610, DOI 10.1073/pnas.0901417106; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hiraga K, 2003, J MOL BIOL, V330, P287, DOI 10.1016/S0022-2836(03)00590-4; Huang WZ, 1996, J MOL BIOL, V258, P688, DOI 10.1006/jmbi.1996.0279; JELSCH C, 1993, PROTEINS, V16, P364, DOI 10.1002/prot.340160406; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Layton CJ, 2010, BIOCHEMISTRY-US, V49, P10831, DOI 10.1021/bi101414z; LeMaster DM, 2005, STRUCTURE, V13, P1153, DOI 10.1016/j.str.2005.05.007; Lim D, 2001, BIOCHEMISTRY-US, V40, P395, DOI 10.1021/bi001653v; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, BIOPHYS J, V37, pA380; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Ma BY, 2010, CURR OPIN CHEM BIOL, V14, P652, DOI 10.1016/j.cbpa.2010.08.012; Meyer MM, 2006, PROTEIN ENG DES SEL, V19, P563, DOI 10.1093/protein/gzl045; Meyer MM, 2003, PROTEIN SCI, V12, P1686, DOI 10.1110/ps.0306603; Morin S, 2006, J BIOMOL NMR, V36, P11, DOI 10.1007/s10858-005-5343-7; Morin S, 2011, PROG NUCL MAG RES SP, V59, P245, DOI 10.1016/j.pnmrs.2010.12.003; Morin S, 2010, BIOMOL NMR ASSIGN, V4, P127, DOI 10.1007/s12104-010-9227-8; Morin S, 2009, J BIOMOL NMR, V45, P361, DOI 10.1007/s10858-009-9381-4; Morin S, 2009, BIOPHYS J, V96, P4681, DOI 10.1016/j.bpj.2009.02.068; Nagel ZD, 2009, NAT CHEM BIOL, V5, P696, DOI 10.1038/nchembio0909-696c; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; O'Maille PE, 2002, J MOL BIOL, V321, P677, DOI 10.1016/S0022-2836(02)00675-7; Otey CR, 2004, CHEM BIOL, V11, P309, DOI 10.1016/j.chembiol.2004.02.018; Roccatano D, 2005, J COMPUT AID MOL DES, V19, P329, DOI 10.1007/s10822-005-7003-0; Savard PY, 2006, BIOCHEMISTRY-US, V45, P11414, DOI 10.1021/bi060414q; Savard PY, 2004, J BIOMOL NMR, V29, P433, DOI 10.1023/B:JNMR.0000032503.96942.68; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Savoie A, 2000, PROTEIN ENG, V13, P267, DOI 10.1093/protein/13.4.267; Sosa-Peinado A, 2000, PROTEIN EXPRES PURIF, V19, P235, DOI 10.1006/prep.2000.1243; Stec B, 2005, ACTA CRYSTALLOGR D, V61, P1072, DOI 10.1107/S0907444905014356; Tousignant A, 2004, CHEM BIOL, V11, P1037, DOI 10.1016/j.chembiol.2004.06.007; Tribuddharat C, 2003, ANTIMICROB AGENTS CH, V47, P2082, DOI 10.1128/AAC.47.7.2082-2087.2003; Voigt CA, 2002, NAT STRUCT BIOL, V9, P553, DOI 10.1038/nsb805; Wang XJ, 2002, PROTEINS, V47, P86, DOI 10.1002/prot.10058; Zhu G, 2000, J MAGN RESON, V143, P423, DOI 10.1006/jmre.2000.2022	64	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52283	10.1371/journal.pone.0052283	http://dx.doi.org/10.1371/journal.pone.0052283			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284969	gold, Green Published			2022-12-27	WOS:000313158800042
J	Cruz-Cordova, A; Rocha-Ramirez, LM; Ochoa, SA; Gonzalez-Pedrajo, B; Espinosa, N; Eslava, C; Hernandez-Chinas, U; Mendoza-Hernandez, G; Rodriguez-Leviz, A; Valencia-Mayoral, P; Sadowinski-Pine, S; Hernandez-Castro, R; Estrada-Garcia, I; Munoz-Hernandez, O; Rosas, I; Xicohtencatl-Cortes, J				Cruz-Cordova, Ariadnna; Rocha-Ramirez, Luz M.; Ochoa, Sara A.; Gonzalez-Pedrajo, Bertha; Espinosa, Norma; Eslava, Carlos; Hernandez-Chinas, Ulises; Mendoza-Hernandez, Guillermo; Rodriguez-Leviz, Alejandra; Valencia-Mayoral, Pedro; Sadowinski-Pine, Stanislaw; Hernandez-Castro, Rigoberto; Estrada-Garcia, Iris; Munoz-Hernandez, Onofre; Rosas, Irma; Xicohtencatl-Cortes, Juan			Flagella from Five Cronobacter Species Induce Pro-Inflammatory Cytokines in Macrophage Derivatives from Human Monocytes	PLOS ONE			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; NITRIC-OXIDE SYNTHASE; MEMBRANE PROTEIN-A; DUBLINENSIS SP-NOV; ENTEROBACTER-SAKAZAKII; NECROTIZING ENTEROCOLITIS; BIOFILM FORMATION; EPITHELIAL-CELLS; STAINLESS-STEEL; RAT MODEL	Cronobacter spp. are opportunistic pathogens linked to lie-threatening infections in neonates and contaminated powdered infant formula that has been epidemiologically associated with these cases. Clinical symptoms of Cronobacter include necrotizing enterocolitis, bacteremia, and meningitis. Flagella from C. sakazakii are involved in biofilm formation and its adhesion to epithelial cells. We investigated the role of flagella from C. sakazakii ST1 and ST4, C. malonaticus, C. muytjensii, C. turicensis and C. dublinensis during the activation of cytokines (IL-8, TNF-alpha, and IL-10) in macrophage derivatives from human monocytes, which has not been extensively studied. The production and identity of flagella from the five Cronobacter species were visualized and recognized with anti-flagella antibodies by immunogold labeling through transmission electron microscopy. Purified flagella were dissociated into monomers in 12% SDS-PAGE Coomassie blue-stained gels showing a band of similar to 28 kDa and, in addition, mass spectrometry revealed the presence of several peptides that correspond to flagellin. Flagella (100 ng) induced the release of IL-8 (3314-6025 pg/ml), TNF-alpha (39-359 pg/ml), and IL-10 (2-96 pg/ml), in macrophage isolates from human monocytes and similar results were obtained when flagella were dissociated into monomers. Inhibition assays using three dilutions of anti-flagella antibodies (1: 10, 1: 100, and 1: 200) suppressed the secretion of IL-8, TNF-alpha, and IL-10 between 95-100% using 100 ng of protein. A transfection assay using 293-hTLR5 cells showed IL-8 release of 197 pg/ml and suppression in the secretion of IL-8 when anti-hTLR5-IgA antibodies were used at different concentrations. These observations suggest that flagella and flagellin are involved in an inflammatory response dependent on TLR5 recognition, which could contribute to the pathogenesis of the bacteria.	[Cruz-Cordova, Ariadnna; Rocha-Ramirez, Luz M.; Ochoa, Sara A.; Munoz-Hernandez, Onofre; Xicohtencatl-Cortes, Juan] Hosp Infantil Mexico Dr Federico Gomez, Dept Infectol, Lab Bacteriol Intestinal, Mexico City, DF, Mexico; [Gonzalez-Pedrajo, Bertha; Espinosa, Norma] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Genet Mol, Mexico City 04510, DF, Mexico; [Eslava, Carlos; Hernandez-Chinas, Ulises] Univ Nacl Autonoma Mexico, Fac Med, Dept Salud Publ, Mexico City 04510, DF, Mexico; [Mendoza-Hernandez, Guillermo] Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Mexico City 04510, DF, Mexico; [Rodriguez-Leviz, Alejandra; Valencia-Mayoral, Pedro; Sadowinski-Pine, Stanislaw] Hosp Infantil Mexico Federico Gomez Dr Marquez 16, Dept Patol, Mexico City, DF, Mexico; [Hernandez-Castro, Rigoberto] Hosp Gen Dr Manuel Gea Gonzalez, Dept Ecol Agentes Patogenos, Tlalpan, Mexico; [Estrada-Garcia, Iris] Univ Nacl Autonoma Mexico, Ctr Ciencias Atmosfera, Mexico City 04510, DF, Mexico; [Rosas, Irma] IPN Unidad Profes Prolongac, Escuela Nacl Ciencias Biol, Dept Inmunol Mol, Miguel Hidalgo, DF, Mexico	Hospital Infantil de Mexico Federico Gomez; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Hospital Infantil de Mexico Federico Gomez; Universidad Nacional Autonoma de Mexico	Xicohtencatl-Cortes, J (corresponding author), Hosp Infantil Mexico Dr Federico Gomez, Dept Infectol, Lab Bacteriol Intestinal, Mexico City, DF, Mexico.	juanxico@yahoo.com	Córdova, Ariadnna Cruz/AAF-9654-2021; Xicohtencatl-Cortes, Juan/ABD-5463-2020	HERNANDEZ, ULISES/0000-0003-4708-8807	Hospital Infantil de Mexico Federico Gomez [HIM/2010/026, HIM/2011/082]; CONACyT (Consejo Nacional de Ciencia y Tecnologia.) [133451]	Hospital Infantil de Mexico Federico Gomez; CONACyT (Consejo Nacional de Ciencia y Tecnologia.)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the grant number HIM/2010/026 and HIM/2011/082 of Federal Funds from Hospital Infantil de Mexico Federico Gomez and CONACyT (Consejo Nacional de Ciencia y Tecnologia.) 133451. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-223; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Beuchat LR, 2009, INT J FOOD MICROBIOL, V136, P204, DOI 10.1016/j.ijfoodmicro.2009.02.029; Bowen AB, 2006, EMERG INFECT DIS, V12, P1185, DOI 10.3201/eid1708.051509; Buzzo CL, 2010, J BIOL CHEM, V285, P32087, DOI 10.1074/jbc.M110.124297; Cruz A, 2011, CAN J MICROBIOL, V57, P735, DOI [10.1139/W11-063, 10.1139/w11-063]; Eaves-Pyles T, 2001, J IMMUNOL, V166, P1248, DOI 10.4049/jimmunol.166.2.1248; Emami CN, 2012, J SURG RES, V172, P18, DOI 10.1016/j.jss.2011.04.019; FARMER JJ, 1980, INT J SYST BACTERIOL, V30, P569, DOI 10.1099/00207713-30-3-569; Feldman M, 1998, INFECT IMMUN, V66, P43, DOI 10.1128/IAI.66.1.43-51.1998; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Friedemann M, 2007, INT J FOOD MICROBIOL, V116, P1, DOI 10.1016/j.ijfoodmicro.2006.12.018; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Giron JA, 2005, COLONIZATION OF MUCOSAL SURFACES, P213; Grimm M, 2008, J FOOD PROTECT, V71, P13, DOI 10.4315/0362-028X-71.1.13; Gurtler JB, 2005, INT J FOOD MICROBIOL, V104, P1, DOI 10.1016/j.ijfoodmicro.2005.02.013; Hamby SE, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-204; Hartmann I, 2010, APPL ENVIRON MICROB, V76, P2251, DOI 10.1128/AEM.00930-09; Hilbert DW, 2008, MICROBES INFECT, V10, P114, DOI 10.1016/j.micinf.2007.10.012; Honko AN, 2005, IMMUNOL RES, V33, P83, DOI 10.1385/IR:33:1:083; Huang LY, 2009, J CLIN MICROBIOL, V47, P3427, DOI 10.1128/JCM.00373-09; Hunter CJ, 2008, J INFECT DIS, V198, P586, DOI 10.1086/590186; Hurrell E, 2009, INT J FOOD MICROBIOL, V136, P227, DOI 10.1016/j.ijfoodmicro.2009.08.007; Hurrell E, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-146; Iversen C, 2004, J CLIN MICROBIOL, V42, P5368, DOI 10.1128/JCM.42.11.5368-5370.2004; Iversen C, 2008, INT J SYST EVOL MICR, V58, P1442, DOI 10.1099/ijs.0.65577-0; Iversen C, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-64; Jandhyala DM, 2010, INFECT IMMUN, V78, P2984, DOI 10.1128/IAI.00383-10; Joseph S, 2012, J CLIN MICROBIOL, V50, P3031, DOI 10.1128/JCM.00905-12; Joseph S, 2011, EMERG INFECT DIS, V17, P1713, DOI 10.3201/eid1709.110260; Joshep S, 2012, IJSEM, V62, P1277; Kandhai MC, 2004, LANCET, V363, P39, DOI 10.1016/S0140-6736(03)15169-0; Kim H, 2008, J FOOD PROTECT, V71, P940, DOI 10.4315/0362-028X-71.5.940; Kim H, 2007, APPL ENVIRON MICROB, V73, P1256, DOI 10.1128/AEM.01766-06; Klumpp DJ, 2001, INFECT IMMUN, V69, P6689, DOI 10.1128/IAI.69.11.6689-6695.2001; Kucerova E, 2011, QUAL ASSUR SAF CROP, V3, P104, DOI 10.1111/j.1757-837X.2011.00104.x; Kucerova E, 2010, PLOS ONE, V5, pA51, DOI 10.1371/journal.pone.0009556; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai KK, 2001, MEDICINE, V80, P113, DOI 10.1097/00005792-200103000-00004; Ledesma MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012127; Lehner A, 2005, J FOOD PROTECT, V68, P2287, DOI 10.4315/0362-028X-68.11.2287; Lopez-Boado YS, 2005, INFECT IMMUN, V73, P7525, DOI 10.1128/IAI.73.11.7525-7534.2005; Mange JP, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-58; McDermott PF, 2000, INFECT IMMUN, V68, P5525, DOI 10.1128/IAI.68.10.5525-5529.2000; Mittal R, 2009, J IMMUNOL, V183, P6588, DOI 10.4049/jimmunol.0902029; Mittal R, 2009, LAB INVEST, V89, P263, DOI 10.1038/labinvest.2008.164; Mullane N, 2008, APPL ENVIRON MICROB, V74, P5913, DOI 10.1128/AEM.00745-08; Newton K., 2012, COLD SPRING HARB PER, V4; Pagotto FJ, 2003, J FOOD PROTECT, V66, P370, DOI 10.4315/0362-028X-66.3.370; Quintero M, 2011, CURR MICROBIOL, V62, P1448, DOI 10.1007/s00284-011-9882-8; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Singamsetty VK, 2008, MICROB PATHOGENESIS, V45, P181, DOI 10.1016/j.micpath.2008.05.006; Smith K, 2003, POETRY REV, V93, P5; Townsend SM, 2007, MICROBIOL-SGM, V153, P3538, DOI 10.1099/mic.0.2007/009316-0; Ulises HC, 2009, PEPTIDES, V30, P2127, DOI 10.1016/j.peptides.2009.09.019; Urban TA, 2004, INFECT IMMUN, V72, P5126, DOI 10.1128/IAI.72.9.5126-5134.2004; Wyant TL, 1999, INFECT IMMUN, V67, P3619, DOI 10.1128/IAI.67.7.3619-3624.1999; Xicohtencati-Cortes J, 2007, J CLIN INVEST, V117, P3519, DOI 10.1172/JCI30727; Xicohtencatl-Cortes J, 2006, MOL CELL PROTEOMICS, V5, P2374, DOI 10.1074/mcp.M600228-MCP200; Yan XH, 2011, APPL ENVIRON MICROB, V77, P1833, DOI 10.1128/AEM.02374-10; Zhou X, 2003, INFECT IMMUN, V71, P2120, DOI 10.1128/IAI.71.4.2120-2129.2003; Zogaj X, 2003, INFECT IMMUN, V71, P4151, DOI 10.1128/IAI.71.7.4151-4158.2003	62	41	43	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52091	10.1371/journal.pone.0052091	http://dx.doi.org/10.1371/journal.pone.0052091			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284883	Green Published, gold, Green Submitted			2022-12-27	WOS:000313158800029
J	Liao, JM; Zeng, SX; Zhou, X; Lu, H				Liao, Jun-Ming; Zeng, Shelya X.; Zhou, Xiang; Lu, Hua			Global Effect of Inauhzin on Human p53-Responsive Transcriptome	PLOS ONE			English	Article							GENE-EXPRESSION; P53 FUNCTION; DNA-DAMAGE; DOWN-REGULATION; TUMOR-GROWTH; C-MYC; ACETYLATION; ACTIVATION; RESTORATION; BINDING	Background: Previously, we reported that Inauhzin (INZ) induces p53 activity and suppresses tumor growth by inhibiting Sirt1. However, it remains unknown whether INZ may globally affect p53-dependent gene expression or not. Herein, we have conducted microarray and real-time PCR analyses of gene expression to determine the global effect of INZ on human p53-responsive transcriptome. Methodology/Principal Findings: In this study, we conducted microarray analysis followed by PCR validation of general gene expression in HCT116(p53+/+) and HCT116(p53-/-) cells treated with or without INZ. Microarray data showed that 324 genes were up-regulated by >= 2.3-fold and 266 genes were down-regulated by >= 2-fold in response to INZ treatment in a p53-dependent manner. GO analysis for these genes further revealed that INZ affects several biological processes, including apoptosis (GO:0006915), cell cycle (GO:0007049), immune system process (GO:0002376), and cell adhesion (GO:0007155), which are in line with p53 functions in cells. Also, pathway and STRING analyses of these genes indicated that the p53-signaling pathway is the most significant pathway responsive to INZ treatment as predicted, since a number of these p53 target genes have been previously reported and some of them were validated by RT-qPCR. Finally, among the 9 tested and highly expressed genes, ACBD4, APOBEC3C, and FLJ14327 could be novel p53 target genes, for they were up-regulated by INZ in HCT116(p53+/+) cells, but not in HCT116(p53-/-) cells. Conclusions/Significance: From our whole genome microarray analysis followed by validation with RT-qPCR, we found that INZ can indeed induce the expression of p53 target genes at a larger scale or globally. Our findings not only verify that INZ indeed activates the p53 signaling pathway, but also provide useful information for identifying novel INZ and/or p53 targets. The global effect of INZ on human p53-responsive transcriptome could also be instrumental to the future design of INZ clinical trials.	[Lu, Hua] Tulane Univ, Sch Med, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; Tulane Univ, Sch Med, Tulane Canc Ctr, New Orleans, LA 70112 USA	Tulane University; Tulane University	Lu, H (corresponding author), Tulane Univ, Sch Med, Dept Biochem & Mol Biol, 1430 Tulane Ave, New Orleans, LA 70112 USA.	hlu2@tulane.edu	Zhou, Xiang/J-5046-2017	Zhou, Xiang/0000-0002-1172-7948	NIH-NCI [CA095441, CA 079721, CA129828, CA172468]; NATIONAL CANCER INSTITUTE [R01CA079721, R01CA095441, R01CA129828, R01CA172468] Funding Source: NIH RePORTER	NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	HL was supported in part by NIH-NCI grants CA095441, CA 079721, CA129828, and CA172468. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aryee MJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-409; Bansal N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026156; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Barsotti A, 2011, J BIOL CHEM; Bender A, 2007, CHEMMEDCHEM, V2, P861, DOI 10.1002/cmdc.200700026; Bohlig L, 2011, NUCLEIC ACIDS RES, V39, P440, DOI 10.1093/nar/gkq796; Braun CJ, 2008, CANCER RES, V68, P10094, DOI 10.1158/0008-5472.CAN-08-1569; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Chang RL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000938; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; de Lange J, 2012, ONCOGENE, V31, P1105, DOI 10.1038/onc.2011.309; Di Giovanni S, 2006, EMBO J, V25, P4084, DOI 10.1038/sj.emboj.7601292; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Faraonio R, 2006, J BIOL CHEM, V281, P39776, DOI 10.1074/jbc.M605707200; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; Jin L, 2011, P NATL ACAD SCI USA, V108, P15840, DOI 10.1073/pnas.1019312108; Kastan MB, 2007, CELL, V128, P837, DOI 10.1016/j.cell.2007.02.022; Kavurma MM, 2007, BIOCHEM J, V407, P79, DOI 10.1042/BJ20070380; Knights CD, 2006, J CELL BIOL, V173, P533, DOI 10.1083/jcb.200512059; Knouf E.C., 2011, NUCL ACIDS RES; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kumar A, 2011, ARTERIOSCL THROM VAS, V31, P133, DOI 10.1161/ATVBAHA.110.215061; Lain S, 2008, CANCER CELL, V13, P454, DOI 10.1016/j.ccr.2008.03.004; Lee MLT, 2000, P NATL ACAD SCI USA, V97, P9834, DOI 10.1073/pnas.97.18.9834; Liao JM, 2012, CELL CYCLE, V11, P2624, DOI 10.4161/cc.20809; Liao JM, 2011, J BIOL CHEM, V286, P33901, DOI 10.1074/jbc.M111.262030; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019; Mutharasan RK, 2011, AM J PHYSIOL-HEART C, V301, pH1519, DOI 10.1152/ajpheart.01080.2010; Nadon R, 2002, TRENDS GENET, V18, P265, DOI 10.1016/S0168-9525(02)02665-3; Rouault JP, 1996, NAT GENET, V14, P482, DOI 10.1038/ng1296-482; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Scarola M, 2010, CANCER RES, V70, P6925, DOI 10.1158/0008-5472.CAN-10-0141; Shangary S, 2008, P NATL ACAD SCI USA, V105, P3933, DOI 10.1073/pnas.0708917105; St Clair S, 2004, MOL CELL, V16, P725; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tabe Y, 2009, CLIN CANCER RES, V15, P933, DOI 10.1158/1078-0432.CCR-08-0399; Tanaka T, 2007, CELL, V130, P638, DOI 10.1016/j.cell.2007.08.001; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang YL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-59; Xiao JN, 2011, EMBO J, V30, P524, DOI 10.1038/emboj.2010.347; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yan HL, 2009, EMBO J, V28, P2719, DOI 10.1038/emboj.2009.214; Yang YH, 2002, NAT REV GENET, V3, P579, DOI 10.1038/nrg863; Yu X, 2012, CANCER CELL, V21, P614, DOI 10.1016/j.ccr.2012.03.042; Zauli G, 2012, HAEMATOLOGICA; Zhang Q, 2012, EMBO MOL MED, V4, P298, DOI 10.1002/emmm.201100211; Zhang Y, 2012, CANC BIOL THER, P13; Zhang Y, 2011, EMBO REP, V12, P811, DOI 10.1038/embor.2011.98; Zhou X, 2012, ONCOGENE	63	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52172	10.1371/journal.pone.0052172	http://dx.doi.org/10.1371/journal.pone.0052172			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284922	Green Submitted, Green Published, gold			2022-12-27	WOS:000313158800037
J	Yiallourou, TI; Kroger, JR; Stergiopulos, N; Maintz, D; Martin, BA; Bunck, AC				Yiallourou, Theresia I.; Kroeger, Jan Robert; Stergiopulos, Nikolaos; Maintz, David; Martin, Bryn A.; Bunck, Alexander C.			Comparison of 4D Phase-Contrast MRI Flow Measurements to Computational Fluid Dynamics Simulations of Cerebrospinal Fluid Motion in the Cervical Spine	PLOS ONE			English	Article							PRESSURE WAVE-PROPAGATION; CHIARI-I MALFORMATION; SUBARACHNOID SPACE; MAGNETIC-RESONANCE; FORAMEN MAGNUM; CSF FLOW; HYDRODYNAMICS; MODEL; ARACHNOIDITIS; 3RD-VENTRICLE	Cerebrospinal fluid (CSF) dynamics in the cervical spinal subarachnoid space (SSS) have been thought to be important to help diagnose and assess craniospinal disorders such as Chiari I malformation (CM). In this study we obtained time-resolved three directional velocity encoded phase-contrast MRI (4D PC MRI) in three healthy volunteers and four CM patients and compared the 4D PC MRI measurements to subject-specific 3D computational fluid dynamics (CFD) simulations. The CFD simulations considered the geometry to be rigid-walled and did not include small anatomical structures such as nerve roots, denticulate ligaments and arachnoid trabeculae. Results were compared at nine axial planes along the cervical SSS in terms of peak CSF velocities in both the cranial and caudal direction and visual interpretation of thru-plane velocity profiles. 4D PC MRI peak CSF velocities were consistently greater than the CFD peak velocities and these differences were more pronounced in CM patients than in healthy subjects. In the upper cervical SSS of CM patients the 4D PC MRI quantified stronger fluid jets than the CFD. Visual interpretation of the 4D PC MRI thru-plane velocity profiles showed greater pulsatile movement of CSF in the anterior SSS in comparison to the posterior and reduction in local CSF velocities near nerve roots. CFD velocity profiles were relatively uniform around the spinal cord for all subjects. This study represents the first comparison of 4D PC MRI measurements to CFD of CSF flow in the cervical SSS. The results highlight the utility of 4D PC MRI for evaluation of complex CSF dynamics and the need for improvement of CFD methodology. Future studies are needed to investigate whether integration of fine anatomical structures and gross motion of the brain and/or spinal cord into the computational model will lead to a better agreement between the two techniques.	[Yiallourou, Theresia I.; Stergiopulos, Nikolaos; Martin, Bryn A.] Ecole Polytech Fed Lausanne, Lab Hemodynam & Cardiovasc Technol, Lausanne, Switzerland; [Kroeger, Jan Robert; Bunck, Alexander C.] Univ Hosp Munster, Dept Clin Radiol, Munster, Germany; [Maintz, David; Bunck, Alexander C.] Univ Hosp Cologne, Dept Radiol, Cologne, Germany; [Martin, Bryn A.] Univ Akron, Conquer Chiari Res Ctr, Akron, OH 44325 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Munster; University of Cologne; University System of Ohio; University of Akron	Martin, BA (corresponding author), Ecole Polytech Fed Lausanne, Lab Hemodynam & Cardiovasc Technol, Lausanne, Switzerland.	director@chiari-research.org	Martin, Bryn A./N-6640-2016; Bunck, Alexander C/M-6389-2014; Maintz, David/ABG-3220-2020; Kroeger, Jan Robert/GNP-1512-2022	Martin, Bryn A./0000-0003-1234-7880; Bunck, Alexander C/0000-0003-0986-0042; Kroeger, Jan Robert/0000-0003-1218-7610; Stergiopulos, Nikolaos/0000-0002-0519-0160	Swiss National Science Foundation [205321_132695/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Source of funding: Swiss National Science Foundation, Grant No. 205321_132695/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baledent O, 2004, INVEST RADIOL, V39, P45, DOI 10.1097/01.rli.0000100892.87214.49; Baledent O, 2001, INVEST RADIOL, V36, P368, DOI 10.1097/00004424-200107000-00003; Berkouk K, 2003, J BIOMECH ENG-T ASME, V125, P852, DOI 10.1115/1.1634280; Bertram CD, 2008, MED BIOL ENG COMPUT, V46, P701, DOI 10.1007/s11517-008-0332-0; Bertram CD, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001165; Bertram CD, 2009, J FLUID STRUCT, V25, P1189, DOI 10.1016/j.jfluidstructs.2009.06.008; Bertram CD, 2005, J BIOMECH ENG-T ASME, V127, P1099, DOI 10.1115/1.2073607; Bilston LE, 2006, CLIN BIOMECH, V21, P579, DOI 10.1016/j.clinbiomech.2006.01.009; Bottan S, 2012, IEEE T BIOMEDICAL EN; BRUNHOLZL C, 1989, VASA-J VASCULAR DIS, V18, P205; Bunck AC, 2012, EUR RADIOL, V22, P1860, DOI 10.1007/s00330-012-2457-7; Bunck AC, 2011, EUR RADIOL, V21, P1788, DOI 10.1007/s00330-011-2105-7; Carpenter PW, 2003, J BIOMECH ENG-T ASME, V125, P857, DOI 10.1115/1.1634281; Cirovic S, 2002, J FLUID STRUCT, V16, P1029, DOI 10.1006/jfls.2002.0457; Cirovic S, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4005853; Cirovic S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005159; CLOYD MW, 1974, J COMP NEUROL, V153, P325, DOI 10.1002/cne.901530402; Cousins J, 2009, AM J NEURORADIOL, V30, P1587, DOI 10.3174/ajnr.A1507; Daners MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037502; Elliott NSJ, 2011, MED ENG PHYS, V33, P874, DOI 10.1016/j.medengphy.2010.07.009; Elliott NSJ, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3072894; Gupta A, 2009, ANN ONCOL, V20, P399, DOI 10.1093/annonc/mdp021; Gupta S, 2010, J R SOC INTERFACE, V7, P1195, DOI 10.1098/rsif.2010.0033; Gupta S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005171; Hentschel S, 2010, AM J NEURORADIOL, V31, P997, DOI 10.3174/ajnr.A1995; Iskandar BJ, 2004, J NEUROSURG, V101, P169, DOI 10.3171/ped.2004.101.2.0169; Johnson KM, 2010, MAGN RESON MED, V63, P349, DOI 10.1002/mrm.22202; Kalata W, 2009, IEEE T BIO-MED ENG, V56, P1765, DOI 10.1109/TBME.2008.2011647; Krueger KD, 2010, AM J NEURORADIOL, V31, P1837, DOI 10.3174/ajnr.A2268; Kurtcuoglu V, 2005, LECT NOTES COMPUT SC, V3749, P786; Kurtcuoglu V, 2007, J BIOMECH, V40, P1235, DOI 10.1016/j.jbiomech.2006.05.031; Linge SO, 2010, AM J NEURORADIOL, V31, P185, DOI 10.3174/ajnr.A1766; Linninger AA, 2009, J MATH BIOL, V59, P729, DOI 10.1007/s00285-009-0250-2; Loth F, 2001, J BIOMECH ENG-T ASME, V123, P71, DOI 10.1115/1.1336144; Martin BA, 2005, J BIOMECH ENG-T ASME, V127, P1110, DOI 10.1115/1.2073687; Martin BA, 2009, CEREBROSPINAL FLUID, V31, P6; Martin BA, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000089; Ng I, 2004, NEUROSURGERY, V54, P593, DOI 10.1227/01.NEU.0000108639.16783.39; Quigley MF, 2004, RADIOLOGY, V232, P229, DOI 10.1148/radiol.2321030666; Roldan A, 2009, AM J NEURORADIOL, V30, P941, DOI 10.3174/ajnr.A1489; ROSSITTI S, 1995, ARQ NEURO-PSIQUIAT, V53, P333, DOI 10.1590/S0004-282X1995000200028; Rutkowska G, 2012, AJNR AM J NEURORADIO; Santini F, 2009, MAGN RESON MED, V62, P966, DOI 10.1002/mrm.22087; Shaffer N, 2011, NEUROL RES, V33, P247, DOI 10.1179/016164111X12962202723805; Sigmund EE, 2011, NMR BIOMED; Stadlbauer A, 2012, EUR RADIOL, V22, P232, DOI 10.1007/s00330-011-2247-7; Stadlbauer A, 2010, NEUROIMAGE, V51, P42, DOI 10.1016/j.neuroimage.2010.01.110; Stockman HW, 2007, J BIOMECH ENG-T ASME, V129, P666, DOI 10.1115/1.2768112; Wagshul ME, 2006, J NEUROSURG, V104, P810, DOI 10.3171/jns.2006.104.5.810; YAMADA S, 1975, CHILD BRAIN, V1, P187	50	54	54	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52284	10.1371/journal.pone.0052284	http://dx.doi.org/10.1371/journal.pone.0052284			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284970	Green Published, Green Submitted, gold			2022-12-27	WOS:000313158800043
J	Leach, S; Clements, JD; Kaim, J; Lundgren, A				Leach, Susannah; Clements, John D.; Kaim, Joanna; Lundgren, Anna			The Adjuvant Double Mutant Escherichia coli Heat Labile Toxin Enhances IL-17A Production in Human T Cells Specific for Bacterial Vaccine Antigens	PLOS ONE			English	Article							HUMAN TH17 CELLS; HELPER-CELLS; T(H)17 CELLS; TGF-BETA; RESPONSES; ENTEROTOXIN; CYTOKINE; COLONIZATION; EXPRESSION; DISTINCT	The strong adjuvant activity and low enterotoxicity of the novel mucosal adjuvant double mutant Escherichia coli heat labile toxin, LT(R192G/L211A) or dmLT, demonstrated in mice, makes this molecule a promising adjuvant candidate. However, little is known about the mechanisms responsible for the adjuvant effect of dmLT or whether dmLT also has an adjuvant function in humans. We investigated the effect of dmLT on human T cell responses to different bacterial vaccine antigens: the mycobacterial purified protein derivative (PPD) antigen, tested in individuals previously vaccinated with Bacillus Calmette-Guerin, the LT binding subunit (LTB), evaluated in subjects immunised with oral inactivated whole cell vaccines against enterotoxigenic Escherichia coli, and Streptococcus pneumoniae whole cell vaccine antigens, tested in subjects naturally exposed to pneumococci. We found that dmLT enhanced the production of IL-17A by peripheral blood mononuclear cells in response to all antigens tested. dmLT had comparable effects on IL-17A responses to PPD as the single mutant LT(R192G) adjuvant, which has demonstrated clinical adjuvant activity in humans. Neutralisation of IL-1 beta and IL-23, but not IL-6, suppressed the IL-17A-enhancing effect of dmLT. Furthermore, CD4+ T cells produced higher levels of IL-17A when stimulated with monocytes pulsed with PPD and dmLT compared to PPD alone, supporting an important role of antigen presenting cells in enhancing IL-17A responses. dmLT also potentiated mitogen-induced IL-17A and IL-13 production. However, dmLT had variable influences on IFN-gamma responses to the different stimuli tested. Our demonstration of a potent ability of dmLT to enhance human Th17 type T cell responses to bacterial vaccine antigens encourages further evaluation of the adjuvant function of dmLT in humans.	[Leach, Susannah; Kaim, Joanna; Lundgren, Anna] Univ Gothenburg, Dept Microbiol & Immunol, Gothenburg Univ Vaccine Res Inst GUVAX, Gothenburg, Sweden; [Clements, John D.] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA	University of Gothenburg; Tulane University	Lundgren, A (corresponding author), Univ Gothenburg, Dept Microbiol & Immunol, Gothenburg Univ Vaccine Res Inst GUVAX, Gothenburg, Sweden.	anna.lundgren@microbio.gu.se	Leach, Susannah/ABA-6448-2020	Leach, Susannah/0000-0002-9614-2753	Goteborg Medical Society; Adlerbertska Forskningsstiftelsen; Wilhelm och Martina Lundgren Vetenskapsfond	Goteborg Medical Society; Adlerbertska Forskningsstiftelsen; Wilhelm och Martina Lundgren Vetenskapsfond	This study was supported by grants from The Goteborg Medical Society (http://www.goteborgslakaresallskap.se), Adlerbertska Forskningsstiftelsen (http://www.gu.se/forskning/stipendier/gustipendier/adlerbertska_forskningsstiftelsen), and Wilhelm och Martina Lundgren Vetenskapsfond (http://www.wmlundgren.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Annunziato F, 2011, CYTOKINE, V56, P112, DOI 10.1016/j.cyto.2011.06.009; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Brereton CF, 2011, J IMMUNOL, V186, P5896, DOI 10.4049/jimmunol.1003789; CROFT M, 1994, J IMMUNOL, V152, P2675; DANIS VA, 1990, CLIN EXP IMMUNOL, V80, P435; Datta SK, 2010, P NATL ACAD SCI USA, V107, P10638, DOI 10.1073/pnas.1002348107; DICKINSON BL, 1995, INFECT IMMUN, V63, P1617, DOI 10.1128/IAI.63.5.1617-1623.1995; Doreau A, 2009, NAT IMMUNOL, V10, P778, DOI 10.1038/ni.1741; Freytag LC, 2005, VACCINE, V23, P1804, DOI 10.1016/j.vaccine.2004.11.010; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Holmgren J, 2012, CURR OPIN IMMUNOL, V24, P343, DOI 10.1016/j.coi.2012.03.014; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Jaffar Z, 2009, J IMMUNOL, V182, P4507, DOI 10.4049/jimmunol.0900237; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kotloff KL, 2001, INFECT IMMUN, V69, P3581, DOI 10.1128/IAI.69.6.3581-3590.2001; Lalor MK, 2010, VACCINE, V28, P1635, DOI 10.1016/j.vaccine.2009.11.004; Lebens M, 1996, INFECT IMMUN, V64, P2144, DOI 10.1128/IAI.64.6.2144-2150.1996; Lee WW, 2010, BLOOD, V115, P530, DOI 10.1182/blood-2009-08-236521; Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159; Lu YJ, 2010, CLIN VACCINE IMMUNOL, V17, P1005, DOI 10.1128/CVI.00036-10; Lundgren A, 2012, VACCINE, V30, P3897, DOI 10.1016/j.vaccine.2012.03.082; Malley R, 2005, P NATL ACAD SCI USA, V102, P4848, DOI 10.1073/pnas.0501254102; Malley R, 2001, INFECT IMMUN, V69, P4870, DOI 10.1128/IAI.69.8.4870-4873.2001; Mills KHG, 2008, EUR J IMMUNOL, V38, P2636, DOI 10.1002/eji.200838535; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Norton EB, 2012, INFECT IMMUN; Norton EB, 2011, CLIN VACCINE IMMUNOL, V18, P546, DOI 10.1128/CVI.00538-10; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Ryan EJ, 2000, J IMMUNOL, V165, P5750, DOI 10.4049/jimmunol.165.10.5750; Scott DA, 1997, J INFECT DIS, V176, pS183, DOI 10.1086/513791; Scriba TJ, 2008, J IMMUNOL, V180, P1962, DOI 10.4049/jimmunol.180.3.1962; Summerton NA, 2010, VACCINE, V28, P1404, DOI 10.1016/j.vaccine.2009.10.147; SVENNERHOLM AM, 1978, CURR MICROBIOL, V1, P19, DOI 10.1007/BF02601701; Takagi R, 2008, J IMMUNOL, V181, P186, DOI 10.4049/jimmunol.181.1.186; Tobias J, 2010, VACCINE, V28, P6977, DOI 10.1016/j.vaccine.2010.08.047; Tribble DR, 2008, CAMPYLOBACTER, 3RD EDITION, P429; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Zhang Z, 2009, J CLIN INVEST, V119, P1899, DOI 10.1172/JCI36731	41	46	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51718	10.1371/journal.pone.0051718	http://dx.doi.org/10.1371/journal.pone.0051718			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284753	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500043
J	Rathakrishnan, A; Wang, SM; Hu, YL; Khan, AM; Ponnampalavanar, S; Lum, LCS; Manikam, R; Sekaran, SD				Rathakrishnan, Anusyah; Wang, Seok Mui; Hu, Yongli; Khan, Asif M.; Ponnampalavanar, Sasheela; Lum, Lucy Chai See; Manikam, Rishya; Sekaran, Shamala Devi			Cytokine Expression Profile of Dengue Patients at Different Phases of Illness	PLOS ONE			English	Article							PLATELET-ACTIVATING-FACTOR; NECROSIS-FACTOR-ALPHA; VIRUS-INFECTION; HEMORRHAGIC-FEVER; INTERFERON-GAMMA; LIVER-INJURY; INDUCIBLE PROTEIN-10; ADHESION MOLECULES; ENDOTHELIAL-CELLS; DISEASE SEVERITY	Background: Dengue is an important medical problem, with symptoms ranging from mild dengue fever to severe forms of the disease, where vascular leakage leads to hypovolemic shock. Cytokines have been implicated to play a role in the progression of severe dengue disease; however, their profile in dengue patients and the synergy that leads to continued plasma leakage is not clearly understood. Herein, we investigated the cytokine kinetics and profiles of dengue patients at different phases of illness to further understand the role of cytokines in dengue disease. Methods and Findings: Circulating levels of 29 different types of cytokines were assessed by bead-based ELISA method in dengue patients at the 3 different phases of illness. The association between significant changes in the levels of cytokines and clinical parameters were analyzed. At the febrile phase, IP-10 was significant in dengue patients with and without warning signs. However, MIP-1 beta was found to be significant in only patients with warning signs at this phase. IP-10 was also significant in both with and without warning signs patients during defervescence. At this phase, MIP-1b beta and G-CSF were significant in patients without warning signs, whereas MCP-1 was noted to be elevated significantly in patients with warning signs. Significant correlations between the levels of VEGF, RANTES, IL-7, IL-12, PDGF and IL-5 with platelets; VEGF with lymphocytes and neutrophils; G-CSF and IP-10 with atypical lymphocytes and various other cytokines with the liver enzymes were observed in this study. Conclusions: The cytokine profile patterns discovered between the different phases of illness indicate an essential role in dengue pathogenesis and with further studies may serve as predictive markers for progression to dengue with warning signs.	[Rathakrishnan, Anusyah; Sekaran, Shamala Devi] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Wang, Seok Mui] Univ Teknol MARA, Fac Med, Inst Med Mol Biotechnol, Selangor, Malaysia; [Hu, Yongli; Khan, Asif M.] Perdana Univ, Grad Sch Med, Serdang, Selangor, Malaysia; [Khan, Asif M.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Ponnampalavanar, Sasheela] Univ Malaya, Med Ctr, Dept Infect Dis, Kuala Lumpur, Malaysia; [Lum, Lucy Chai See] Univ Malaya, Fac Med, Dept Paediat, Kuala Lumpur, Malaysia; [Manikam, Rishya] Univ Malaya, Med Ctr, Dept Trauma & Emergency Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Teknologi MARA; Perdana University; Johns Hopkins University; Universiti Malaya; Universiti Malaya; Universiti Malaya	Sekaran, SD (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	shamalamy@yahoo.com	Lum, Lucy/Q-9871-2017; Wang, Seok Mui/X-5856-2019; LA SRI PONNAMPALAVANAR, SASHEELA SRI/B-9703-2010; Manikam, Rishya/F-5908-2014; Devi, Shamala Devi/B-9735-2010; wang, seok mui/C-3205-2011; Khan, Mohammad Asif/F-4663-2010; Sekaran, Shamala Devi/B-8482-2008; Khan, M. Asif/ABE-7839-2021	Lum, Lucy/0000-0002-7452-4208; Wang, Seok Mui/0000-0002-3631-6504; Devi, Shamala Devi/0000-0002-0478-0425; Khan, Mohammad Asif/0000-0001-9202-279X; Sekaran, Shamala Devi/0000-0002-0478-0425; Khan, M. Asif/0000-0001-9202-279X; sri la sri ponnampalavanar, sasheela/0000-0002-4506-1304	High Impact Research (HIR) [J-00000-73560]; University Malaya Research Grant (UMRG) [RG081/09HTM]; University Malaya Peruntukan Jangka Pendek (UMPJP) [FS245/008B]	High Impact Research (HIR); University Malaya Research Grant (UMRG); University Malaya Peruntukan Jangka Pendek (UMPJP)	Project was funded by High Impact Research (HIR) J-00000-73560; University Malaya Research Grant (UMRG) RG081/09HTM; and University Malaya Peruntukan Jangka Pendek (UMPJP) FS245/008B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson R, 1997, J VIROL, V71, P4226, DOI 10.1128/JVI.71.6.4226-4232.1997; ANGIOLILLO AL, 1995, J EXP MED, V182, P155, DOI 10.1084/jem.182.1.155; Azeredo EL, 2006, CLIN EXP IMMUNOL, V143, P345, DOI 10.1111/j.1365-2249.2006.02996.x; Becerra A, 2009, J MED VIROL, V81, P1403, DOI 10.1002/jmv.21538; Bosch I, 2002, J VIROL, V76, P5588, DOI 10.1128/JVI.76.11.5588-5597.2002; Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86; Bruno CM, 2011, ANN SAUDI MED, V31, P360, DOI 10.4103/0256-4947.83215; BURKEGAFFNEY A, 1993, IMMUNOPHARMACOLOGY, V25, P1, DOI 10.1016/0162-3109(93)90025-L; Bussolati B, 2000, CLIN EXP IMMUNOL, V122, P471, DOI 10.1046/j.1365-2249.2000.01392.x; Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848; Cardier JE, 2006, ENDOTHELIUM-J ENDOTH, V13, P335, DOI 10.1080/10623320600972135; Chakravarti A, 2006, INDIAN J MED RES, V123, P25; Chaturvedi UC, 2009, INDIAN J MED RES, V129, P1; Chaturvedi UC, 2000, FEMS IMMUNOL MED MIC, V28, P183, DOI 10.1111/j.1574-695X.2000.tb01474.x; Chen JC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-165; Chen LC, 2006, AM J TROP MED HYG, V74, P142, DOI 10.4269/ajtmh.2006.74.142; CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; CZAJA MJ, 1994, J LEUKOCYTE BIOL, V55, P120, DOI 10.1002/jlb.55.1.120; DAHINDEN CA, 1994, J EXP MED, V179, P751, DOI 10.1084/jem.179.2.751; Dewberry RM, 2003, CIRC RES, V92, P1285, DOI 10.1161/01.RES.0000078172.52740.9B; Dinarello CA, 1999, METHODS, V19, P121, DOI 10.1006/meth.1999.0837; Elsammak MY, 2008, PARASITE IMMUNOL, V30, P603, DOI 10.1111/j.1365-3024.2008.01061.x; Gabay C, 1997, J CLIN INVEST, V99, P2930, DOI 10.1172/JCI119488; Gear ARL, 2003, MICROCIRCULATION, V10, P335, DOI 10.1038/sj.mn.7800198; Gonzalez D, 2005, INT J INFECT DIS, V9, P280, DOI 10.1016/j.ijid.2004.07.012; Green S, 1999, J MED VIROL, V59, P329, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt;329::AID-JMV12&gt;3.0.CO;2-G; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; HALSTEAD SB, 1970, YALE J BIOL MED, V42, P311; HALSTEAD SB, 1980, AM J TROP MED HYG, V29, P638, DOI 10.4269/ajtmh.1980.29.638; Heil M, 2000, EUR J CELL BIOL, V79, P850, DOI 10.1078/0171-9335-00113; Horras CJ, 2011, CYTOKINE GROWTH F R, V22, P35, DOI 10.1016/j.cytogfr.2011.01.001; Hsieh MF, 2006, J IMMUNOL, V177, P1855, DOI 10.4049/jimmunol.177.3.1855; Hung NT, 2005, AM J TROP MED HYG, V72, P370; Jamaluddin MS, 2009, ARTERIOSCL THROM VAS, V29, P2146, DOI 10.1161/ATVBAHA.109.194134; Khongphatthanayothin A, 2006, JPN J INFECT DIS, V59, P186; Kishimoto S, 1996, J IMMUNOL, V157, P4126; Kohno K, 1997, J IMMUNOL, V158, P1541; Kono H, 2001, AM J PHYSIOL-GASTR L, V280, pG1289, DOI 10.1152/ajpgi.2001.280.6.G1289; Koraka P, 2001, J CLIN MICROBIOL, V39, P4332, DOI 10.1128/JCM.39.12.4332-4338.2001; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; KURANE I, 1991, J CLIN INVEST, V88, P1473, DOI 10.1172/JCI115457; Kurane I, 1992, Semin Immunol, V4, P121; LAM S K, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P532; Lee YR, 2006, J GEN VIROL, V87, P3623, DOI 10.1099/vir.0.82093-0; Leifeld L, 2002, HEPATOLOGY, V36, P1001, DOI 10.1053/jhep.2002.35532; Mathew A, 2008, IMMUNOL REV, V225, P300, DOI 10.1111/j.1600-065X.2008.00678.x; MINTY A, 1993, NATURE, V362, P248, DOI 10.1038/362248a0; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; Mustafa AS, 2001, FEMS IMMUNOL MED MIC, V30, P229, DOI 10.1111/j.1574-695X.2001.tb01575.x; Narumi S, 1997, J IMMUNOL, V158, P5536; Perez AB, 2004, J MED VIROL, V73, P230, DOI 10.1002/jmv.20080; Priyadarshini D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008709; Seki T, 2012, INFECT IMMUN, V80, P159, DOI 10.1128/IAI.05581-11; Sierra B, 2010, CYTOKINE, V52, P175, DOI 10.1016/j.cyto.2010.06.010; Talavera D, 2004, J GEN VIROL, V85, P1801, DOI 10.1099/vir.0.19652-0; [TDR WHO World Health O Special Programme for R Training in Tropical D World Health Organization Department of Control of Neglected Tropical D World Health Organization E], 2009, DENGUE GUIDELINES FO; Tung KH, 2010, J CHIN MED ASSOC, V73, P67, DOI 10.1016/S1726-4901(10)70004-6; Tyner JW, 2005, NAT MED, V11, P1180, DOI 10.1038/nm1303; Wasilewska A, 2005, PEDIATR INT, V47, P424, DOI 10.1111/j.1442-200x.2005.02078.x; Watt G, 2003, AM J TROP MED HYG, V68, P536, DOI 10.4269/ajtmh.2003.68.536; Webster DP, 2009, LANCET INFECT DIS, V9, P678, DOI 10.1016/S1473-3099(09)70254-3; Yong Y. K., 2007, SMJ Singapore Medical Journal, V48, P662; Yoshidome H, 1999, AM J PATHOL, V155, P1059, DOI 10.1016/S0002-9440(10)65208-X	64	124	125	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52215	10.1371/journal.pone.0052215	http://dx.doi.org/10.1371/journal.pone.0052215			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284941	gold, Green Published			2022-12-27	WOS:000312794500116
J	Voets, GM; Platteel, TN; Fluit, AC; Scharringa, J; Schapendonk, CM; Stuart, JC; Bonten, MJM; Leverstein-van Hal, MA				Voets, Guido M.; Platteel, Tamara N.; Fluit, Ad C.; Scharringa, Jelle; Schapendonk, Claudia M.; Stuart, James Cohen; Bonten, Marc J. M.; Leverstein-van Hal, Maurine A.		Natl ESBL Surveillance Working Grp	Population Distribution of Beta-Lactamase Conferring Resistance to Third-Generation Cephalosporins in Human Clinical Enterobacteriaceae in The Netherlands	PLOS ONE			English	Article							ESCHERICHIA-COLI; MOLECULAR CHARACTERIZATION; CANADIAN HOSPITALS; NATIONWIDE SURVEY; PREVALENCE; AMPC; EPIDEMIOLOGY; EVOLUTION; ANIMALS; CLOACAE	There is a global increase in infections caused by Enterobacteriaceae with plasmid-borne beta-lactamases that confer resistance to third-generation cephalosporins. The epidemiology of these bacteria is not well understood, and was, therefore, investigated in a selection of 636 clinical Enterobacteriaceae with a minimal inhibitory concentration >1 mg/L for ceftazidime/ceftriaxone from a national survey (75% E. coli, 11% E. cloacae, 11% K. pneumoniae, 2% K. oxytoca, 2% P. mirabilis). Isolates were investigated for extended-spectrum beta-lactamases (ESBLs) and ampC genes using microarray, PCR, gene sequencing and molecular straintyping (Diversilab and multi-locus sequence typing (MLST)). ESBL genes were demonstrated in 512 isolates (81%); of which 446 (87%) belonged to the CTX-M family. Among 314 randomly selected and sequenced isolates, bla(CTX-M-15) was most prevalent (n = 124, 39%), followed by bla(CTX-M-1) (n = 47, 15%), bla(CTX-M-14) (n = 15, 5%), bla(SHV-12) (n = 24, 8%) and bla(TEM-52) (n = 13, 4%). Among 181 isolates with MIC >= 16 mg/L for cefoxitin plasmid encoded AmpCs were detected in 32 and 27 were of the CMY-2 group. Among 102 E. coli isolates with MIC >= 16 mg/L for cefoxitin ampC promoter mutations were identified in 29 (28%). Based on Diversilab genotyping of 608 isolates (similarity cut-off >98%) discriminatory indices of bacteria with ESBL and/or ampC genes were 0.994, 0.985 and 0.994 for E. coli, K. pneumoniae and E. cloacae, respectively. Based on similarity cut-off >95% two large clusters of E. coli were apparent (of 43 and 30 isolates) and 21 of 21 that were typed by belonged to ST131 of which 13 contained bla(CTX-M-15). Our findings demonstrate that bla(CTX-M-15) is the most prevalent ESBL and we report a larger than previously reported prevalence of ampC genes among Enterobacteriaceae responsible for resistance to third-generation cephalosporins.	[Voets, Guido M.; Platteel, Tamara N.; Fluit, Ad C.; Scharringa, Jelle; Schapendonk, Claudia M.; Stuart, James Cohen; Bonten, Marc J. M.; Leverstein-van Hal, Maurine A.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Platteel, Tamara N.] SALTRO, Dept Med Microbiol, Utrecht, Netherlands; [Leverstein-van Hal, Maurine A.] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands	Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment	Voets, GM (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.	g.voets@umcutrecht.nl						Al Naiemi N, 2005, J CLIN MICROBIOL, V43, P4862, DOI 10.1128/JCM.43.9.4862-4864.2005; Bogaerts P, 2010, PATHOL BIOL, V58, P78, DOI 10.1016/j.patbio.2009.07.035; Brigante G, 2005, INT J ANTIMICROB AG, V25, P157, DOI 10.1016/j.ijantimicag.2004.09.013; Caroff N, 1999, FEMS MICROBIOL LETT, V173, P459, DOI 10.1016/S0378-1097(99)00111-1; Cortes P, 2010, APPL ENVIRON MICROB, V76, P2799, DOI 10.1128/AEM.02421-09; Corvec S, 2010, DIAGN MICR INFEC DIS, V67, P277, DOI 10.1016/j.diagmicrobio.2010.02.007; Dierikx C, 2010, VET MICROBIOL, V145, P273, DOI 10.1016/j.vetmic.2010.03.019; Empel J, 2008, ANTIMICROB AGENTS CH, V52, P2449, DOI 10.1128/AAC.00043-08; Fluit AC, 2010, J CLIN MICROBIOL, V48, P3979, DOI 10.1128/JCM.01191-10; Galas M, 2008, ANTIMICROB AGENTS CH, V52, P786, DOI 10.1128/AAC.00906-07; Gniadkowski M, 2008, CLIN MICROBIOL INFEC, V14, P11, DOI 10.1111/j.1469-0691.2007.01854.x; Haldorsen B, 2008, J ANTIMICROB CHEMOTH, V62, P694, DOI 10.1093/jac/dkn257; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x; Luzzaro F, 2006, J CLIN MICROBIOL, V44, P1659, DOI 10.1128/JCM.44.5.1659-1664.2006; Mulvey MR, 2005, ANTIMICROB AGENTS CH, V49, P358, DOI 10.1128/AAC.49.1.358-365.2005; Olesen I, 2004, MICROB DRUG RESIST, V10, P334, DOI 10.1089/mdr.2004.10.334; Paauw A, 2006, EMERG INFECT DIS, V12, P807; Paniague R, 2010, DIAGN MICR INFEC DIS, V67, P376, DOI 10.1016/j.diagmicrobio.2010.03.012; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Platell JL, 2011, VET MICROBIOL, V153, P99, DOI 10.1016/j.vetmic.2011.05.007; Rodriguez-Villalobos H, 2011, J ANTIMICROB CHEMOTH, V66, P37, DOI 10.1093/jac/dkq388; Rottman M, 2002, FEMS MICROBIOL LETT, V210, P87, DOI 10.1016/S0378-1097(02)00613-4; Siu LK, 2003, ANTIMICROB AGENTS CH, V47, P2138, DOI 10.1128/AAC.47.7.2138-2144.2003; Smet A, 2008, ANTIMICROB AGENTS CH, V52, P1238, DOI 10.1128/AAC.01285-07; Sturm PDJ, 2010, MICROB DRUG RESIST, V16, P55, DOI 10.1089/mdr.2009.0107; Voets GM, 2011, INT J ANTIMICROB AG, V37, P356, DOI 10.1016/j.ijantimicag.2011.01.005; Wiegand I, 2007, J CLIN MICROBIOL, V45, P1167, DOI 10.1128/JCM.01988-06; Woodford N, 2007, J ANTIMICROB CHEMOTH, V59, P102, DOI 10.1093/jac/dkl456; Zhanel GG, 2010, ANTIMICROB AGENTS CH, V54, P4684, DOI 10.1128/AAC.00469-10	30	45	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52102	10.1371/journal.pone.0052102	http://dx.doi.org/10.1371/journal.pone.0052102			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284886	Green Submitted, Green Published, gold			2022-12-27	WOS:000312794500091
J	Westerman, LJ; Stel, HV; Schipper, MEI; Bakker, LJ; Neefjes-Borst, EA; van den Brande, JHM; Boel, ECH; Seldenrijk, KA; Siersema, PD; Bonten, MJM; Kusters, JG				Westerman, Laurens J.; Stel, Herbert V.; Schipper, Marguerite E. I.; Bakker, Leendert J.; Neefjes-Borst, Eskelina A.; van den Brande, Jan H. M.; Boel, Edwin C. H.; Seldenrijk, Kees A.; Siersema, Peter D.; Bonten, Marc J. M.; Kusters, Johannes G.			Development of a Real-Time PCR for Identification of Brachyspira Species in Human Colonic Biopsies	PLOS ONE			English	Article							HUMAN INTESTINAL SPIROCHETOSIS; 16S RIBOSOMAL-RNA; IN-SITU HYBRIDIZATION; SEQUENCE ALIGNMENT; TREPONEMA-HYODYSENTERIAE; CLINICAL-SIGNIFICANCE; SERPULINA PILOSICOLI; SWINE DYSENTERY; SP-NOV; AALBORGI	Background: Brachyspira species are fastidious anaerobic microorganisms, that infect the colon of various animals. The genus contains both important pathogens of livestock as well as commensals. Two species are known to infect humans: B. aalborgi and B. pilosicoli. There is some evidence suggesting that the veterinary pathogenic B. pilosicoli is a potential zoonotic agent, however, since diagnosis in humans is based on histopathology of colon biopsies, species identification is not routinely performed in human materials. Methods: The study population comprised 57 patients with microscopic evidence of Brachyspira infection and 26 patients with no histopathological evidence of Brachyspira infection. Concomitant faecal samples were available from three infected patients. Based on publically available 16S rDNA gene sequences of all Brachyspira species, species-specific primer sets were designed. DNA was extracted and tested by real-time PCR and 16S rDNA was sequenced. Results: Sensitivity and specificity for identification of Brachyspira species in colon biopsies was 100% and 87.7% respectively. Sequencing revealed B. pilosicoli in 15.4% of patients, B. aalborgi in 76.9% and a third species, tentatively named "Brachyspira hominis", in 26.2%. Ten patients (12.3%) had a double and two (3.1%) a triple infection. The presence of Brachyspira pilosicoli was significantly associated with inflammatory changes in the colon-biopsy (p = 0.028). Conclusions: This newly designed PCR allows for sub-differentiation of Brachyspira species in patient material and thus allows large-scaled surveillance studies to elucidate the pathogenicity of human Brachyspira infections. One-third of affected patients appeared to be infected with a novel species.	[Westerman, Laurens J.; Boel, Edwin C. H.; Bonten, Marc J. M.; Kusters, Johannes G.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Stel, Herbert V.] Tergooiziekenhuizen, Dept Pathol, Hilversum, Netherlands; [Schipper, Marguerite E. I.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Bakker, Leendert J.] Tergooiziekenhuizen, Cent Lab Bacteriol & Serol, Hilversum, Netherlands; [Neefjes-Borst, Eskelina A.] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands; [van den Brande, Jan H. M.] Tergooiziekenhuizen, Dept Internal Med, Hilversum, Netherlands; [Seldenrijk, Kees A.] St Antonius Hosp, Dept Pathol, Nieuwegein, Netherlands; [Siersema, Peter D.] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; St. Antonius Hospital Utrecht; Utrecht University; Utrecht University Medical Center	Kusters, JG (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.	H.Kusters@UMCUtrecht.nl	Siersema, Peter/V-1636-2019; Westerman, Laurens/H-1630-2013	Neefjes-Borst, Andra/0000-0001-7945-7916				Atyeo RF, 1999, VET MICROBIOL, V67, P47, DOI 10.1016/S0378-1135(99)00030-9; Bait-Merabet Lilia, 2008, Ann Clin Microbiol Antimicrob, V7, P19, DOI 10.1186/1476-0711-7-19; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FREIER SM, 1986, P NATL ACAD SCI USA, V83, P9373, DOI 10.1073/pnas.83.24.9373; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; GLOCK RD, 1972, VET MED SM ANIM CLIN, V67, P65; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; GREER CE, 1991, AM J CLIN PATHOL, V95, P117, DOI 10.1093/ajcp/95.2.117; Gudnason H, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm671; Hampson DJ, 2006, EMERG INFECT DIS, V12, P869, DOI 10.3201/eid1205.051180; HARRIS DL, 1972, J AM VET MED ASSOC, V160, P561; HOVINDHOUGEN K, 1982, J CLIN MICROBIOL, V16, P1127, DOI 10.1128/JCM.16.6.1127-1136.1982; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jensen TK, 2004, J MED MICROBIOL, V53, P341, DOI 10.1099/jmm.0.05402-0; Jensen TK, 2001, J CLIN MICROBIOL, V39, P4111, DOI 10.1128/JCM.39.11.4111-4118.2001; KASBOHRER A, 1990, DEUT MED WOCHENSCHR, V115, P1499, DOI 10.1055/s-2008-1065183; Korner M, 2003, INFECTION, V31, P341, DOI 10.1007/s15010-003-3145-y; LEE FD, 1971, GUT, V12, P126, DOI 10.1136/gut.12.2.126; LEE JI, 1994, J MED MICROBIOL, V40, P365, DOI 10.1099/00222615-40-5-365; McLaren AJ, 1997, J CLIN MICROBIOL, V35, P412, DOI 10.1128/JCM.35.2.412-417.1997; Mikosza Andrew S. J., 2001, Animal Health Research Reviews, V2, P101; Mikosza ASJ, 2003, J CLIN MICROBIOL, V41, P4492, DOI 10.1128/JCM.41.9.4492.2003; Mikosza ASJ, 2004, J MED MICROBIOL, V53, P333, DOI 10.1099/jmm.0.05430-0; Mikosza ASJ, 2001, FEMS MICROBIOL LETT, V197, P167, DOI 10.1111/j.1574-6968.2001.tb10599.x; Mikosza ASJ, 2001, J CLIN MICROBIOL, V39, P347, DOI 10.1128/JCM.39.1.347-350.2001; Munshi MA, 2003, J CLIN MICROBIOL, V41, P1187, DOI 10.1128/JCM.41.3.1187-1191.2003; NEEF NA, 1994, INFECT IMMUN, V62, P2395, DOI 10.1128/IAI.62.6.2395-2403.1994; Niesters HGM, 2002, J CLIN VIROL, V25, pS3; Pettersson B, 1996, J BACTERIOL, V178, P4189, DOI 10.1128/jb.178.14.4189-4199.1996; Pettersson B, 2000, SYST APPL MICROBIOL, V23, P355, DOI 10.1016/S0723-2020(00)80065-X; Phillips ND, 2006, VET MICROBIOL, V116, P239, DOI 10.1016/j.vetmic.2006.03.020; Prim N, 2011, J CLIN MICROBIOL, V49, P3697, DOI 10.1128/JCM.00680-11; Rohde J, 2002, J CLIN MICROBIOL, V40, P2598, DOI 10.1128/JCM.40.7.2598-2600.2002; Rozen S, 2000, Methods Mol Biol, V132, P365; Sato H, 2010, J MED MICROBIOL, V59, P791, DOI 10.1099/jmm.0.017376-0; Songer JG, 1976, INT PIG VET SOC 4 IN; Stanton TB, 1998, INT J SYST BACTERIOL, V48, P669, DOI 10.1099/00207713-48-3-669; Stanton TB, 1996, FEMS MICROBIOL LETT, V136, P181, DOI 10.1111/j.1574-6968.1996.tb08046.x; Stephens C. P., 2001, Animal Health Research Reviews, V2, P83; TAYLOR DJ, 1980, VET REC, V106, P326, DOI 10.1136/vr.106.15.326; TROTT DJ, 1995, INFECT IMMUN, V63, P3705, DOI 10.1128/IAI.63.9.3705-3710.1995; Trott DJ, 1996, INT J SYST BACTERIOL, V46, P206, DOI 10.1099/00207713-46-1-206; van Mook WNKA, 2004, EUR J GASTROEN HEPAT, V16, P83, DOI 10.1097/00042737-200401000-00013; Weisheit B, 2007, SCAND J GASTROENTERO, V42, P1422, DOI 10.1080/00365520701245629	45	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52281	10.1371/journal.pone.0052281	http://dx.doi.org/10.1371/journal.pone.0052281			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284968	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500134
J	Xu, HB; Luo, X; Qian, J; Pang, XH; Song, JY; Qian, GR; Chen, JH; Chen, SL				Xu, Haibin; Luo, Xiang; Qian, Jun; Pang, Xiaohui; Song, Jingyuan; Qian, Guangrui; Chen, Jinhui; Chen, Shilin			FastUniq: A Fast De Novo Duplicates Removal Tool for Paired Short Reads	PLOS ONE			English	Article							HUMAN GENOME; DNA-SEQUENCES; RNA-SEQ; RESOLUTION; DISCOVERY; ALIGNMENT; MUTATION	The presence of duplicates introduced by PCR amplification is a major issue in paired short reads from next-generation sequencing platforms. These duplicates might have a serious impact on research applications, such as scaffolding in whole-genome sequencing and discovering large-scale genome variations, and are usually removed. We present FastUniq as a fast de novo tool for removal of duplicates in paired short reads. FastUniq identifies duplicates by comparing sequences between read pairs and does not require complete genome sequences as prerequisites. FastUniq is capable of simultaneously handling reads with different lengths and results in highly efficient running time, which increases linearly at an average speed of 87 million reads per 10 minutes. FastUniq is freely available at http://sourceforge.net/projects/fastuniq/.	[Chen, Jinhui] Nanjing Forestry Univ, Minist Educ China, Key Lab Forest Genet & Biotechnol, Nanjing, Jiangsu, Peoples R China; [Xu, Haibin; Luo, Xiang; Qian, Jun; Pang, Xiaohui; Song, Jingyuan; Chen, Shilin] Chinese Acad Med Sci, Inst Med Plant Dev, Natl Engn Lab Breeding Endangered Med Mat, Beijing 100730, Peoples R China; [Xu, Haibin; Luo, Xiang; Qian, Jun; Pang, Xiaohui; Song, Jingyuan; Chen, Shilin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Qian, Guangrui] SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA	Ministry of Education, China; Nanjing Forestry University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Chen, JH (corresponding author), Nanjing Forestry Univ, Minist Educ China, Key Lab Forest Genet & Biotechnol, Nanjing, Jiangsu, Peoples R China.	Chenjh@njfu.edu.cn; slchen@implad.ac.cn		Xu, Haibin/0000-0002-9326-099X	Key National Natural Science Foundation of China [81130069]; Program for Changjiang Scholars and Innovative Research Team in University of Ministry of Education of China [IRT1150]; National Science Foundation of China [30901156, 31170619]	Key National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University of Ministry of Education of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Key National Natural Science Foundation of China [Grant number 81130069]; the Program for Changjiang Scholars and Innovative Research Team in University of Ministry of Education of China [Grant number IRT1150]; and the National Science Foundation of China [Grant numbers 30901156, 31170619]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Bowen ME, 2011, GENETICS; Bowne SJ, 2011, EUR J HUM GENET, V19, P1074, DOI 10.1038/ejhg.2011.86; Burriesci MS, 2012, BIOINFORMATICS, V28, P1324, DOI 10.1093/bioinformatics/bts123; Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Handsaker RE, 2011, NAT GENET, V43, P269, DOI 10.1038/ng.768; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r134; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Liu GE, 2009, GENOME RES, V19, P876, DOI 10.1101/gr.083972.108; Liu SZ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000733; Lu TT, 2010, GENOME RES, V20, P1238, DOI 10.1101/gr.106120.110; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Park H, 2010, NAT GENET, V42, P400, DOI 10.1038/ng.555; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Pireddu L, 2011, BIOINFORMATICS, V27, P2159, DOI 10.1093/bioinformatics/btr325; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Skelly DA, 2011, GENOME RES, V21, P1728, DOI 10.1101/gr.119784.110; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Turner Stephen, 2011, Curr Protoc Hum Genet, VChapter 1, DOI 10.1002/0471142905.hg0119s68; Van Nieuwerburgh F, 2011, NUCL ACIDS RES; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	28	180	195	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52249	10.1371/journal.pone.0052249	http://dx.doi.org/10.1371/journal.pone.0052249			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284954	Green Submitted, gold, Green Published			2022-12-27	WOS:000312794500125
J	Andrew, AS; Hu, T; Gu, J; Gui, J; Ye, YQ; Marsit, CJ; Kelsey, KT; Schned, AR; Tanyos, SA; Pendleton, EM; Mason, RA; Morlock, EV; Zens, MS; Li, ZZ; Moore, JH; Wu, XF; Karagas, MR				Andrew, Angeline S.; Hu, Ting; Gu, Jian; Gui, Jiang; Ye, Yuanqing; Marsit, Carmen J.; Kelsey, Karl T.; Schned, Alan R.; Tanyos, Sam A.; Pendleton, Eben M.; Mason, Rebecca A.; Morlock, Elaine V.; Zens, Michael S.; Li, Zhongze; Moore, Jason H.; Wu, Xifeng; Karagas, Margaret R.			HSD3B and Gene-Gene Interactions in a Pathway-Based Analysis of Genetic Susceptibility to Bladder Cancer	PLOS ONE			English	Article							MULTIFACTOR-DIMENSIONALITY REDUCTION; CONFERS SUSCEPTIBILITY; METABOLISM GENES; DNA-REPAIR; ASSOCIATION; RISK; TUMOR; POLYMORPHISMS; PROGRESSION; MECHANISMS	Bladder cancer is the 4th most common cancer among men in the U.S. We analyzed variant genotypes hypothesized to modify major biological processes involved in bladder carcinogenesis, including hormone regulation, apoptosis, DNA repair, immune surveillance, metabolism, proliferation, and telomere maintenance. Logistic regression was used to assess the relationship between genetic variation affecting these processes and susceptibility in 563 genotyped urothelial cell carcinoma cases and 863 controls enrolled in a case-control study of incident bladder cancer conducted in New Hampshire, U.S. We evaluated gene-gene interactions using Multifactor Dimensionality Reduction (MDR) and Statistical Epistasis Network analysis. The 3'UTR flanking variant form of the hormone regulation gene HSD3B2 was associated with increased bladder cancer risk in the New Hampshire population (adjusted OR 1.85 95%CI 1.31-2.62). This finding was successfully replicated in the Texas Bladder Cancer Study with 957 controls, 497 cases (adjusted OR 3.66 95%CI 1.06-12.63). The effect of this prevalent SNP was stronger among males (OR 2.13 95%CI 1.40-3.25) than females (OR 1.56 95%CI 0.83-2.95), (SNP-gender interaction P = 0.048). We also identified a SNP-SNP interaction between T-cell activation related genes GATA3 and CD81 (interaction P = 0.0003). The fact that bladder cancer incidence is 3-4 times higher in males suggests the involvement of hormone levels. This biologic process-based analysis suggests candidate susceptibility markers and supports the theory that disrupted hormone regulation plays a role in bladder carcinogenesis.	[Andrew, Angeline S.; Hu, Ting; Gui, Jiang; Marsit, Carmen J.; Schned, Alan R.; Tanyos, Sam A.; Pendleton, Eben M.; Mason, Rebecca A.; Morlock, Elaine V.; Zens, Michael S.; Li, Zhongze; Moore, Jason H.; Karagas, Margaret R.] Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Lebanon, NH USA; [Gu, Jian; Ye, Yuanqing; Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Kelsey, Karl T.] Brown Univ, Dept Epidemiol, Providence, RI 02912 USA; [Kelsey, Karl T.] Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA	Dartmouth College; Norris Cotton Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Brown University; Brown University	Andrew, AS (corresponding author), Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Lebanon, NH USA.	Angeline.Andrew@dartmouth.edu	Gu, Jian/Q-4780-2018; Moore, Jason H./AAV-9645-2021; Kelsey, Karl T/I-1252-2014	Gu, Jian/0000-0003-3499-0973; Moore, Jason H./0000-0002-5015-1099; Marsit, Carmen/0000-0003-4566-150X	National Cancer Institute [CA102327, CA121382, CA099500, CA82354, CA57494, CA078609, U01 CA 127615, R01 CA 74880, P50 CA 91846, R01 CA 131335]; National Institute of Environmental Health Sciences [ES00002, 5 P42 ES05947, ES07373]; National Center for Research Resources [RR028309, RR018787, RR024475]; National Institutes of Health [LM009012]; National Institute of General Medical Sciences [GM103534]; UT MD Anderson Cancer Center Research Trust; NATIONAL CANCER INSTITUTE [U01CA127615, P30CA016672, R01CA057494, R01CA078609, P30CA023108, R01CA131335, R01CA082354, R03CA099500, P50CA091846, R03CA121382, R01CA074880, K07CA102327] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024475, P20RR018787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES005947, P30ES000002, P42ES007373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103534] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009012] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); UT MD Anderson Cancer Center Research Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Funding in part for Dartmouth's research from National Cancer Institute (http://cancer.gov/) grant numbers CA102327, CA121382, CA099500, CA82354, CA57494, and CA078609; the National Institute of Environmental Health Sciences (http://www.niehs.nih.gov/) grant numbers ES00002, 5 P42 ES05947, and ES07373; the National Center for Research Resources (http://www.ncrr.nih.gov) grant numbers RR028309, RR018787 and RR024475; National Institutes of Health (http://nih.gov/) grant number LM009012; and National Institute of General Medical Sciences GM103534. Funding in part for MD Anderson Cancer Center's research from National Cancer Institute (http://cancer.gov/) grant numbers U01 CA 127615, R01 CA 74880, P50 CA 91846, and R01 CA 131335 and from the UT MD Anderson Cancer Center Research Trust (http://www.mdanderson.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew AS, 2009, HUM GENET, V125, P527, DOI 10.1007/s00439-009-0645-6; Bartsch H, 1999, CANCER DETECT PREV, V23, P445, DOI 10.1046/j.1525-1500.1999.99055.x; Beuten J, 2009, CANCER EPIDEM BIOMAR, V18, P1869, DOI 10.1158/1055-9965.EPI-09-0076; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; CANTOR KP, 1992, CANCER CAUSE CONTROL, V3, P57, DOI 10.1007/BF00051913; CARTWRIGHT RA, 1979, BRIT MED J, V2, P798, DOI 10.1136/bmj.2.6193.798-b; Chang BL, 2002, CANCER RES, V62, P1784; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; D'Amico F, 2007, PHARMACOGENOMICS, V8, P645, DOI 10.2217/14622416.8.6.645; de Visser KE, 2008, CANCER IMMUNOL IMMUN, V57, P1531, DOI 10.1007/s00262-008-0501-x; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dietrich K, 2011, EUR J CANCER, V47, P592, DOI 10.1016/j.ejca.2010.10.007; Fortuny Joan, 2007, BMC Urol, V7, P13, DOI 10.1186/1471-2490-7-13; Garcia-Closas M, 2007, CANCER EPIDEM BIOMAR, V16, P2269, DOI 10.1158/1055-9965.EPI-07-0449; Greene CS, 2009, BIODATA MIN, V2, DOI 10.1186/1756-0381-2-5; Groth A, 2011, J INNATE IMMUN, V3, P344, DOI 10.1159/000327014; Hahn Lance W, 2004, In Silico Biol, V4, P183; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Higgins JPT, 2007, AM J SURG PATHOL, V31, P673, DOI 10.1097/01.pas.0000213438.01278.5f; Hu T, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-364; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; KANTOR AF, 1985, INT J CANCER, V35, P703, DOI 10.1002/ijc.2910350602; Karagas MR, 1998, ENVIRON HEALTH PERSP, V106, P1047, DOI 10.1289/ehp.98106s41047; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Kirkali Z, 2005, UROLOGY, V66, P4, DOI 10.1016/j.urology.2005.07.062; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Miyamoto H, 2007, J NATL CANCER I, V99, P558, DOI 10.1093/jnci/djk113; Moore JH, 2004, EXPERT REV MOL DIAGN, V4, P795, DOI 10.1586/14737159.4.6.795; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Neslund-Dudas C, 2007, PROSTATE, V67, P1654, DOI 10.1002/pros.20625; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Ritchie MD, 2003, GENET EPIDEMIOL, V24, P150, DOI 10.1002/gepi.10218; Rothman N, 2010, NAT GENET, V42, P978, DOI 10.1038/ng.687; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Simons MP, 2007, IMMUNOL RES, V39, P79, DOI 10.1007/s12026-007-0084-1; Stern MC, 2009, CANCER RES, V69, P6857, DOI 10.1158/0008-5472.CAN-09-1091; SULLIVAN JW, 1982, J UROLOGY, V128, P281, DOI 10.1016/S0022-5347(17)52886-4; VanCompernolle SE, 2001, EUR J IMMUNOL, V31, P823, DOI 10.1002/1521-4141(200103)31:3<823::AID-IMMU823>3.3.CO;2-4; Wang L, 2007, J STEROID BIOCHEM, V107, P88, DOI 10.1016/j.jsbmb.2007.03.037; Wu XF, 2009, NAT GENET, V41, P991, DOI 10.1038/ng.421	43	74	75	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51301	10.1371/journal.pone.0051301	http://dx.doi.org/10.1371/journal.pone.0051301			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284679	Green Published, gold, Green Submitted			2022-12-27	WOS:000312694300017
J	Barragan-Martinez, C; Speck-Hernandez, CA; Montoya-Ortiz, G; Mantilla, RD; Anaya, JM; Rojas-Villarraga, A				Barragan-Martinez, Carolina; Speck-Hernandez, Cesar A.; Montoya-Ortiz, Gladis; Mantilla, Ruben D.; Anaya, Juan-Manuel; Rojas-Villarraga, Adriana			Organic Solvents as Risk Factor for Autoimmune Diseases: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							T-CELL-ACTIVATION; TRICHLOROETHENE-MEDIATED AUTOIMMUNITY; PRIMARY BILIARY-CIRRHOSIS; ALDEHYDE-PROTEIN ADDUCTS; VINYL-CHLORIDE DISEASE; MULTIPLE-SCLEROSIS; OCCUPATIONAL-EXPOSURE; ENVIRONMENTAL-FACTORS; LUPUS-ERYTHEMATOSUS; FEMALE MRL	Background: Genetic and epigenetic factors interacting with the environment over time are the main causes of complex diseases such as autoimmune diseases (ADs). Among the environmental factors are organic solvents (OSs), which are chemical compounds used routinely in commercial industries. Since controversy exists over whether ADs are caused by OSs, a systematic review and meta-analysis were performed to assess the association between OSs and ADs. Methods and Findings: The systematic search was done in the PubMed, SCOPUS, SciELO and LILACS databases up to February 2012. Any type of study that used accepted classification criteria for ADs and had information about exposure to OSs was selected. Out of a total of 103 articles retrieved, 33 were finally included in the meta-analysis. The final odds ratios (ORs) and 95% confidence intervals (CIs) were obtained by the random effect model. A sensitivity analysis confirmed results were not sensitive to restrictions on the data included. Publication bias was trivial. Exposure to OSs was associated to systemic sclerosis, primary systemic vasculitis and multiple sclerosis individually and also to all the ADs evaluated and taken together as a single trait (OR: 1.54; 95% CI: 1.25-1.92; p-value, 0.001). Conclusion: Exposure to OSs is a risk factor for developing ADs. As a corollary, individuals with non-modifiable risk factors (i.e., familial autoimmunity or carrying genetic factors) should avoid any exposure to OSs in order to avoid increasing their risk of ADs.	[Barragan-Martinez, Carolina; Speck-Hernandez, Cesar A.; Montoya-Ortiz, Gladis; Mantilla, Ruben D.; Anaya, Juan-Manuel; Rojas-Villarraga, Adriana] Univ Rosario, Sch Med & Hlth Sci, Ctr Autoimmune Dis Res CREA, Bogota, Colombia	Universidad del Rosario	Rojas-Villarraga, A (corresponding author), Univ Rosario, Sch Med & Hlth Sci, Ctr Autoimmune Dis Res CREA, Bogota, Colombia.	adrirojas@gmail.com	Speck-Hernandez, Cesar/S-2240-2018; Rojas-Villarraga, Adriana/J-2404-2016; Rojas-Villarraga, Adriana/T-7070-2018; Anaya, Juan-Manuel/J-1960-2016	Rojas-Villarraga, Adriana/0000-0003-3145-2440; Rojas-Villarraga, Adriana/0000-0003-3145-2440; Anaya, Juan-Manuel/0000-0002-6444-1249; Universidad del Rosario, Biblioteca/0000-0003-3491-9392	Universidad del Rosario, Bogota, Colombia; School of Medicine and Health Sciences, Universidad del Rosario	Universidad del Rosario, Bogota, Colombia; School of Medicine and Health Sciences, Universidad del Rosario	We would like to thank our colleagues Jenny Amaya-Amaya, Zayrho DeSanVicente-Celis, Manuel Amador-Patarroyo, Catalina Herrera-Diaz, Jorge Cardenas Roldan, Juliana M. Giraldo-Villamil, Juan C. Castellanos, Omar-Javier Calixto, and Julian Caro M. for their fruitful contributions. We specially thank professors Yolanda Torres and Carlos E. Trillos for his advice, and Cesar Mantilla, chemical engineer specialist in industrial hygiene for his advice. We also thanks the reviewers for their fruitful criticism. This work was supported by Universidad del Rosario, Bogota, Colombia.; This project did not have any specific funding, but the work was supported by the School of Medicine and Health Sciences, Universidad del Rosario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert DA, 2005, JCR-J CLIN RHEUMATOL, V11, P188, DOI 10.1097/01.rhu.0000173234.33984.4a; AMADUCCI L, 1982, ACTA NEUROL SCAND, V65, P94; AMADUCCI L, 1977, B I SIEROTER MILAN, V56, P613; Anaya Juan-Manuel, 2007, Expert Rev Clin Immunol, V3, P623, DOI 10.1586/1744666X.3.4.623; Anaya JM, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/297193; Anaya JM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3175; [Anonymous], SAF HLTH TOP SOLV; Aryal BK, 2001, AM J IND MED, V40, P271, DOI 10.1002/ajim.1098; Barbara G, 2011, J NEUROGASTROENTEROL, V17, P349, DOI 10.5056/jnm.2011.17.4.349; Benzarti A, 2010, OCCUPATIONAL ENV MED, V50, P501; BLACK CM, 1983, LANCET, V1, P53; Blossom SJ, 2007, J IMMUNOTOXICOL, V4, P129, DOI 10.1080/15476910701337035; Blossom SJ, 2006, TOXICOL SCI, V92, P103, DOI 10.1093/toxsci/kfj212; BOTTOMLEY WW, 1993, BRIT J DERMATOL, V128, P203, DOI 10.1111/j.1365-2133.1993.tb15152.x; BOVENZI M, 1995, SCAND J WORK ENV HEA, V21, P289, DOI 10.5271/sjweh.40; Bovenzi M, 2004, INT ARCH OCC ENV HEA, V77, P10, DOI 10.1007/s00420-003-0462-5; BRASINGTON RD, 1991, ARTHRITIS RHEUM, V34, P631, DOI 10.1002/art.1780340516; Brautbar N, 2004, ARCH ENVIRON HEALTH, V59, P515, DOI 10.1080/00039890409605167; BROGREN CH, 1986, ARCH TOXICOL, P460; Cai P, 2008, TOXICOL APPL PHARM, V228, P68, DOI 10.1016/j.taap.2007.11.031; Cai P, 2007, TOXICOL APPL PHARM, V220, P278, DOI 10.1016/j.taap.2007.01.020; Calvani N, ANN ITALIANI MED INT, V16, P175; CASETTA I, 1994, NEUROEPIDEMIOLOGY, V13, P120, DOI 10.1159/000110369; Chang C, 2010, J AUTOIMMUN, V34, pJ266, DOI 10.1016/j.jaut.2009.11.012; Chighizola C, 2012, AUTOIMMUN REV, V11, pA493, DOI 10.1016/j.autrev.2011.11.027; Cooper GS, 2008, ENVIRON HEALTH PERSP, V116, P695, DOI 10.1289/ehp.11092; Cooper GS, 2010, RHEUMATOLOGY, V49, P2172, DOI 10.1093/rheumatology/keq214; Cooper GS, 2004, J RHEUMATOL, V31, P1928; CZIRJAK L, 1989, ACTA DERM-VENEREOL, V69, P533; CZIRJAK L, 1994, DERMATOLOGY, V189, P399, DOI 10.1159/000246888; De Roos AJ, 2005, ANN EPIDEMIOL, V15, P762, DOI 10.1016/j.annepidem.2005.08.001; Diot E, 2002, OCCUP ENVIRON MED, V59, P545, DOI 10.1136/oem.59.8.545; Duntas LH, 2008, NAT CLIN PRACT ENDOC, V4, P454, DOI 10.1038/ncpendmet0896; Emara AM, 2008, J IMMUNOTOXICOL, V5, P69, DOI 10.1080/15476910802019029; Farhat SCL, 2011, AUTOIMMUN REV, V11, P14, DOI 10.1016/j.autrev.2011.06.008; Finckh A, 2006, ARTHRITIS RHEUM-US, V54, P3648, DOI 10.1002/art.22210; Flodin U, 2003, OCCUP ENVIRON MED, V60, P66, DOI 10.1136/oem.60.1.66; Flodin U, 1988, ARCH NEUROL-CHICAGO, V47, P128; Fored CM, 2004, J AM SOC NEPHROL, V15, P180, DOI 10.1097/01.ASN.0000103872.60993.06; Gamier R, 2006, ARCH MAL PROF ENVIRO, V67, P488, DOI ADMP-06-2006-67-3-1250-3274-101019-200518826; Garabrant DH, 2000, ARTHRITIS RES, V2, P5, DOI 10.1186/ar65; GARCIAZAMALLOA AM, 1994, ANN RHEUM DIS, V53, P618, DOI 10.1136/ard.53.9.618-a; George J, 1997, SCAND J IMMUNOL, V45, P1, DOI 10.1046/j.1365-3083.1997.d01-366.x; Gershwin ME, 2005, HEPATOLOGY, V42, P1194, DOI 10.1002/hep.20907; Gilbert Kathleen M, 2006, J Immunotoxicol, V3, P263, DOI 10.1080/15476910601023578; Gilbert KM, 2011, TOXICOL SCI, V119, P281, DOI 10.1093/toxsci/kfq345; Goldman J A, 1996, J Clin Rheumatol, V2, P185, DOI 10.1097/00124743-199608000-00005; Gourley M, 2007, NAT CLIN PRACT RHEUM, V3, P172, DOI 10.1038/ncprheum0435; Griffin JM, 2000, TOXICOL SCI, V57, P345, DOI 10.1093/toxsci/57.2.345; Griffin JM, 2000, IMMUNOPHARMACOLOGY, V46, P123, DOI 10.1016/S0162-3109(99)00164-2; GRONNING M, 1993, ACTA NEUROL SCAND, V88, P247; Grune T, 1997, FREE RADICAL BIO MED, V23, P357, DOI 10.1016/S0891-5849(96)00586-2; Halmes NC, 1997, TOXICOL LETT, V92, P187, DOI 10.1016/S0378-4274(97)00053-2; HATHAWAY JA, 1977, J OCCUP ENVIRON MED, V19, P269, DOI 10.1097/00043764-197704000-00008; Hendriksen PJM, 2007, TOXICOL APPL PHARM, V225, P171, DOI 10.1016/j.taap.2007.08.017; Hinnen U, 1995, SCHWEIZ MED WSCHR, V125, P2433; HOPKINS RS, 1991, NEUROEPIDEMIOLOGY, V10, P192, DOI 10.1159/000110269; Hsieh HI, 2007, TOXICOLOGY, V239, P34, DOI 10.1016/j.tox.2007.06.089; Jacob S, 2007, OCCUPATIONAL ENV MED; Jacob S, 2007, J AM SOC NEPHROL, V18, P274, DOI 10.1681/ASN.2006060652; JUNTUNEN J, 1989, BRIT J IND MED, V46, P417; Karamfilov T, 2003, HAUTARZT, V54, P448, DOI 10.1007/s00105-002-0448-3; Kettaneh A, 2007, J RHEUMATOL, V34, P97; KHAN MF, 1995, TOXICOL APPL PHARM, V134, P155, DOI 10.1006/taap.1995.1179; KILBURN KH, 1992, ENVIRON RES, V57, P1, DOI 10.1016/S0013-9351(05)80014-3; Kiyohara C, 2009, LUPUS, V18, P630, DOI 10.1177/0961203309102809; Koch-Henriksen N, 1989, Acta Neurol Scand Suppl, V124, P1; KOISCHWITZ D, 1980, FORTSCHR RONTG NEUEN, V132, P62; Lan Q, 2004, SCIENCE, V306, P1774, DOI 10.1126/science.1102443; Landtblom AM, 2006, OCCUP ENVIRON MED, V63, P387, DOI 10.1136/oem.2005.024604; Landtblom AM, 2003, NEUROL SCI, V24, P248, DOI 10.1007/s10072-003-0148-5; Landtblom AM, 1996, EPIDEMIOLOGY, V7, P429, DOI 10.1097/00001648-199607000-00015; LANDTBLOM AM, 1993, SCAND J WORK ENV HEA, V19, P399, DOI 10.5271/sjweh.1455; Lane SE, 2003, ARTHRITIS RHEUM-US, V48, P814, DOI 10.1002/art.10830; Lash LH, 2005, TOXICOL APPL PHARM, V206, P157, DOI 10.1016/j.taap.2004.09.023; Lozano-Calderon S, 2008, J HAND SURG-AM, V33A, P525, DOI 10.1016/j.jhsa.2008.01.004; LUNDBERG I, 1994, SCAND J RHEUMATOL, V23, P305, DOI 10.3109/03009749409099278; Magnant J, 2005, J RHEUMATOL, V32, P1713; MAGNAVITA N, 1986, ANGIOLOGY, V37, P382, DOI 10.1177/000331978603700508; Marrie RA, 2004, LANCET NEUROL, V3, P709, DOI 10.1016/S1474-4422(04)00933-0; McDermott C, 2008, TOXICOL SCI, V101, P263, DOI 10.1093/toxsci/kfm274; Miller FW, 2012, J AUTOIMMUN, V39, P259, DOI 10.1016/j.jaut.2012.05.002; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mortensen JT, 1998, EPIDEMIOLOGY, V9, P168, DOI 10.1097/00001648-199803000-00011; NELSON NA, 1994, OCCUP ENVIRON MED, V51, P302, DOI 10.1136/oem.51.5.302; Nietert PJ, 1998, ARTHRITIS RHEUM-US, V41, P1111, DOI 10.1002/1529-0131(199806)41:6<1111::AID-ART19>3.0.CO;2-J; Noordzij M, 2009, NEPHRON CLIN PRACT, V113, pC218, DOI 10.1159/000235610; Ohtsuka T, 2009, J DERMATOL, V36, P358, DOI 10.1111/j.1346-8138.2009.00653.x; Olsgard ML, 2008, J TOXICOL ENV HEAL A, V71, P1100, DOI 10.1080/15287390802114600; Palbykin B, 2011, CARDIOVASC TOXICOL, V11, P204, DOI 10.1007/s12012-011-9113-3; Park HJ, 2008, BIOMARK INSIGHTS, V3, P191; Peden-Adams MM, 2006, J ENVIRON SCI HEAL A, V41, P249, DOI 10.1080/10934520500455289; Petkova V, 1992, Probl Khig, V17, P195; Pigatto PD, 2010, TRENDS IMMUNOL, V31, P48, DOI 10.1016/j.it.2009.12.005; Povey A, 2001, ARTHRITIS RHEUM-US, V44, P662, DOI 10.1002/1529-0131(200103)44:3<662::AID-ANR115>3.3.CO;2-G; Pralong P, 2009, ANN DERMATOL VENER, V136, P713, DOI 10.1016/j.annder.2008.10.043; Prince MI, 2010, GUT, V59, P508, DOI 10.1136/gut.2009.184218; Purdie GL, 2011, J RHEUMATOL, V38, P1940, DOI 10.3899/jrheum.101129; Reis J, 2001, NEUROL SCI, V22, P155, DOI 10.1007/s100720170015; Rieger R, 2007, J AUTOIMMUN, V28, P76, DOI 10.1016/j.jaut.2007.02.003; Riise T, 2002, EPIDEMIOLOGY, V13, P718, DOI 10.1097/00001648-200211000-00018; Riise T, 2011, MULT SCLER J, V17, P780, DOI 10.1177/1352458510397686; Rook GAW, 2012, CLIN REV ALLERG IMMU, V42, P5, DOI 10.1007/s12016-011-8285-8; SAVIGE JA, 1989, AM J KIDNEY DIS, V14, P145, DOI 10.1016/S0272-6386(89)80190-8; SEATON MJ, 1995, CARCINOGENESIS, V16, P1519, DOI 10.1093/carcin/16.7.1519; Selmi G, 2012, J AUTOIMMUNITY; Serratrice J, 2001, CLIN RHEUMATOL, V20, P379, DOI 10.1007/s100670170032; SESSO R, 1990, BRAZ J MED BIOL RES, V23, P225; Shen T, 2007, TOXICOLOGY, V239, P186, DOI 10.1016/j.tox.2007.07.006; Shoenfeld Y, 2008, J AUTOIMMUN, V31, P325, DOI 10.1016/j.jaut.2008.08.004; Shoenfeld Y, 2011, J AUTOIMMUN, V36, P4, DOI 10.1016/j.jaut.2010.07.003; SILMAN AJ, 1992, ANN RHEUM DIS, V51, P1322, DOI 10.1136/ard.51.12.1322; Sinczuk-Walczak H, 1982, Med Pr, V33, P349; SOUBERBIELLE BE, 1990, ACTA NEUROL SCAND, V82, P303; SPARROW GP, 1977, CLIN EXP DERMATOL, V2, P17, DOI 10.1111/j.1365-2230.1977.tb01532.x; Stenager E, 2003, MULT SCLER, V9, P427, DOI 10.1191/1352458503ms941xx; Thompson AE, 2002, J RHEUMATOLOGY, V29; Tibon-Fisher O., 1992, Harefuah, V122, P530; Tibon-Fisher O, 1992, HAREFUAH, V122, P551; Wang GD, 2008, FREE RADICAL BIO MED, V44, P1475, DOI 10.1016/j.freeradbiomed.2008.01.012; Wang GD, 2007, J TOXICOL ENV HEAL A, V70, P1977, DOI 10.1080/15287390701550888; Wang GD, 2007, TOXICOLOGY, V229, P186, DOI 10.1016/j.tox.2006.10.014; Wang GD, 2012, TOXICOLOGY, V292, P113, DOI 10.1016/j.tox.2011.12.001; Wichmann G, 2005, TOXICOL IN VITRO, V19, P685, DOI 10.1016/j.tiv.2005.03.012; Youinou P, 2010, J AUTOIMMUN, V34, pJ163, DOI 10.1016/j.jaut.2009.12.005; Zachariae H, 1997, Ugeskr Laeger, V159, P2687; Zorzon M, 2003, NEUROL SCI, V24, P242, DOI 10.1007/s10072-003-0147-6	127	82	86	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51506	10.1371/journal.pone.0051506	http://dx.doi.org/10.1371/journal.pone.0051506			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284705	Green Published, gold, Green Accepted			2022-12-27	WOS:000312694300028
J	Byun, J; Kim, BT; Kim, YT; Jiao, ZX; Hur, EM; Zhou, FQ				Byun, Justin; Kim, Bo Taek; Kim, Yun Tai; Jiao, Zhongxian; Hur, Eun-Mi; Zhou, Feng-Quan			Slit2 Inactivates GSK3 beta to Signal Neurite Outgrowth Inhibition	PLOS ONE			English	Article							AXON GUIDANCE; GROWTH CONE; CANCER PROGRESSION; NEURONAL POLARITY; ROBO PATHWAY; ANGIOGENESIS; RECEPTORS; MIDLINE; ROLES; GENE	Slit molecules comprise one of the four canonical families of axon guidance cues that steer the growth cone in the developing nervous system. Apart from their role in axon pathfinding, emerging lines of evidence suggest that a wide range of cellular processes are regulated by Slit, ranging from branch formation and fasciculation during neurite outgrowth to tumor progression and to angiogenesis. However, the molecular and cellular mechanisms downstream of Slit remain largely unknown, in part, because of a lack of a readily manipulatable system that produces easily identifiable traits in response to Slit. The present study demonstrates the feasibility of using the cell line CAD as an assay system to dissect the signaling pathways triggered by Slit. Here, we show that CAD cells express receptors for Slit (Robo1 and Robo2) and that CAD cells respond to nanomolar concentrations of Slit2 by markedly decelerating the rate of process extension. Using this system, we reveal that Slit2 inactivates GSK3 beta and that inhibition of GSK3 beta is required for Slit2 to inhibit process outgrowth. Furthermore, we show that Slit2 induces GSK3 beta phosphorylation and inhibits neurite outgrowth in adult dorsal root ganglion neurons, validating Slit2 signaling in primary neurons. Given that CAD cells can be conveniently manipulated using standard molecular biological methods and that the process extension phenotype regulated by Slit2 can be readily traced and quantified, the use of a cell line CAD will facilitate the identification of downstream effectors and elucidation of signaling cascade triggered by Slit.	[Byun, Justin; Kim, Bo Taek; Kim, Yun Tai; Jiao, Zhongxian; Hur, Eun-Mi; Zhou, Feng-Quan] Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD 21218 USA; [Zhou, Feng-Quan] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA; [Kim, Yun Tai] Korea Food Res Inst, Songnam, South Korea; [Hur, Eun-Mi] Korea Inst Sci & Technol, Brain Sci Inst, Seoul, South Korea	Johns Hopkins University; Johns Hopkins University; Korea Food Research Institute (KFRI); Korea Institute of Science & Technology (KIST)	Hur, EM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD 21218 USA.	ehur@kist.re.kr; fzhou4@jhmi.edu	Hur, Eun Mi/AAU-4906-2021; Zhou, Fengquan/X-5782-2019	Zhou, Fengquan/0000-0002-1525-9969; Byun, Justin/0000-0002-7953-8238	National Alliance for Research on Schizophrenia and Depression (NARSAD); National Institutes of Health [R01NS064288]; Craig H. Neilsen Foundation; Korea Institute of Science and Technology; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064288] Funding Source: NIH RePORTER	National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Craig H. Neilsen Foundation; Korea Institute of Science and Technology(Korea Institute of Science & Technology (KIST)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Alliance for Research on Schizophrenia and Depression (NARSAD), National Institutes of Health grant R01NS064288, the Craig H. Neilsen Foundation and Intramural funding from Korea Institute of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews WD, 2007, J ANAT, V211, P188, DOI 10.1111/j.1469-7580.2007.00750.x; Ba-Charvet KTN, 2001, J NEUROSCI, V21, P4281; Bedell VM, 2005, P NATL ACAD SCI USA, V102, P6373, DOI 10.1073/pnas.0408318102; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Chedotal A, 2007, ADV EXP MED BIOL, V621, P65, DOI 10.1007/978-0-387-76715-4_5; Chivatakarn O, 2007, J NEUROSCI, V27, P7117, DOI 10.1523/JNEUROSCI.1541-07.2007; Cole A, 2004, BIOCHEM J, V377, P249, DOI 10.1042/BJ20031259; Dallol A, 2003, ONCOGENE, V22, P4611, DOI 10.1038/sj.onc.1206687; Dallol A, 2002, CANCER RES, V62, P5874; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Hannula-Jouppi K, 2005, PLOS GENET, V1, P467, DOI 10.1371/journal.pgen.0010050; Hartigan JA, 2001, BIOCHEM BIOPH RES CO, V284, P485, DOI 10.1006/bbrc.2001.4986; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Hur EM, 2011, GENE DEV, V25, P1968, DOI 10.1101/gad.17015911; Hur EM, 2011, P NATL ACAD SCI USA, V108, P5057, DOI 10.1073/pnas.1011258108; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Jaworski A, 2012, NAT NEUROSCI, V15, P367, DOI 10.1038/nn.3037; Jen JC, 2004, SCIENCE, V304, P1509, DOI 10.1126/science.1096437; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Jones CA, 2008, NAT MED, V14, P448, DOI 10.1038/nm1742; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kim WY, 2006, NEURON, V52, P981, DOI 10.1016/j.neuron.2006.10.031; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Lundstrom A, 2004, GENE DEV, V18, P2161, DOI 10.1101/gad.310204; Ma L, 2007, J NEUROSCI, V27, P6843, DOI 10.1523/JNEUROSCI.1479-07.2007; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; McGrath LM, 2006, TRENDS MOL MED, V12, P333, DOI 10.1016/j.molmed.2006.05.007; Narayan G, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-16; Nugent AA, 2012, CURR OPIN NEUROBIOL; Pujic Z, 2008, J NEUROSCI METH, V170, P220, DOI 10.1016/j.jneumeth.2008.01.014; Qi YP, 1997, J NEUROSCI, V17, P1217; SURI C, 1993, J NEUROSCI, V13, P1280; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tseng RC, 2010, CANCER RES, V70, P543, DOI 10.1158/0008-5472.CAN-09-2084; Wang B, 2003, CANCER CELL, V4, P19, DOI 10.1016/S1535-6108(03)00164-8; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Ye BQ, 2010, J IMMUNOL, V185, P6294, DOI 10.4049/jimmunol.1001648; Yeo SY, 2004, MECH DEVELOP, V121, P315, DOI 10.1016/j.mod.2004.03.006; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Ypsilanti AR, 2010, DEVELOPMENT, V137, P1939, DOI 10.1242/dev.044511; Yuasa-Kawada J, 2009, P NATL ACAD SCI USA, V106, P14530, DOI 10.1073/pnas.0801262106; Zhou FQ, 2006, J CELL SCI, V119, P2787, DOI 10.1242/jcs.03016	44	12	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51895	10.1371/journal.pone.0051895	http://dx.doi.org/10.1371/journal.pone.0051895			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284807	Green Published, Green Submitted, gold			2022-12-27	WOS:000312694300052
J	Kesse-Guyot, E; Andreeva, VA; Jeandel, C; Ferry, M; Touvier, M; Hercberg, S; Galan, P				Kesse-Guyot, Emmanuelle; Andreeva, Valentina A.; Jeandel, Claude; Ferry, Monique; Touvier, Mathilde; Hercberg, Serge; Galan, Pilar			Alcohol Consumption in Midlife and Cognitive Performance Assessed 13 Years Later in the SU.VI.MAX 2 Cohort	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; ANTIOXIDANT VITAMINS; ALZHEIMERS-DISEASE; DIETARY PATTERNS; DEMENTIA; PREVENTION; DRINKING; DECLINE; ADULTS; ASSOCIATION	Background: Associations between alcohol consumption and cognitive function are discordant and data focusing on midlife exposure are scarce. Objective: To estimate the association between midlife alcohol consumption and cognitive performance assessed 13 y later while accounting for comorbidities and diet. Methods: 3,088 French middle-aged adults included in the SU.VI.MAX (1994) study with available neuropsychological evaluation 13 y later. Data on alcohol consumption were obtained from repeated 24h dietary records collected in 1994-1996. Cognitive performance was assessed in 2007-2009 via a battery of 6 neuropsychological tests. A composite score was built as the mean of the standardized individual test scores (mean = 50, SD = 10). ANCOVA were performed to estimate mean differences in cognitive performance and 95% confidence intervals (CI). Results: In women, abstainers displayed lower cognitive scores than did low-to-moderate alcohol drinkers (1 to 2 drinks/day) (mean difference = 21.77; 95% CI: 23.29, 20.25). In men, heavy drinkers (. 3 drinks/day) had higher cognitive scores than did low-to-moderate (1 to 3 drinks/day) (mean difference = 1.05; 95% CI: 0.10, 1.99). However, a lower composite cognitive score was detected in male drinkers consuming >90 g/d (approximate to 8 drinks/d). A higher proportion of alcohol intake from beer was also associated with lower cognitive scores. These associations remained significant after adjustment for diet, comorbidities and sociodemographic factors. Conclusion: In men, heavy but not extreme drinking was associated with higher global cognitive scores. Given the known harmful effects of alcohol even in low doses regarding risk of cancer, the study does not provide a basis for modifying current public health messages. Trial Registration: ClinicalTrials.gov NCT00272428	[Kesse-Guyot, Emmanuelle; Andreeva, Valentina A.; Ferry, Monique; Touvier, Mathilde; Hercberg, Serge; Galan, Pilar] Univ Paris 13, CRNH Ile France, Cnam, UMR Inserm U557,Inra U1125, Bobigny, France; [Jeandel, Claude; Hercberg, Serge] CHU Montpellier, Ctr Gerontol Clin Antonin Balmes, Montpellier, France; [Hercberg, Serge] Hop Avicenne, Dept Sante Publ, F-93009 Bobigny, France	heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; Universite de Montpellier; CHU de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13	Kesse-Guyot, E (corresponding author), Univ Paris 13, CRNH Ile France, Cnam, UMR Inserm U557,Inra U1125, Bobigny, France.	e.kesse@uren.smbh.univ-paris13.fr	Andreeva, Valentina/F-2680-2017; HERCBERG, Serge/B-4429-2008; Kesse-Guyot, Emmanuelle/K-4689-2012; Serge, Hercberg/F-3038-2017; Pilar, Galan/F-2908-2017; Kesse-Guyot, Emmanuelle/F-2692-2017; Kesse-Guyot, Emmanuelle/ABH-7347-2020; Touvier, Mathilde/E-8817-2017	Andreeva, Valentina/0000-0001-9480-5210; HERCBERG, Serge/0000-0002-3168-1350; Serge, Hercberg/0000-0002-3168-1350; Pilar, Galan/0000-0003-1706-3107; Kesse-Guyot, Emmanuelle/0000-0002-9715-3534; Touvier, Mathilde/0000-0002-8322-8857	French National Research Agency [ANR-05-PNRA-010]; French Ministry of Health; Mederic; Sodexo; Ipsen; MGEN; Pierre Fabre	French National Research Agency(French National Research Agency (ANR)); French Ministry of Health; Mederic; Sodexo; Ipsen(Ipsen); MGEN; Pierre Fabre	This work was funded by the French National Research Agency (noANR-05-PNRA-010), the French Ministry of Health, Mederic, Sodexo, Ipsen, MGEN and Pierre Fabre. Mederic and MGEN are French health insurance organizations, which are complementary to the National Health Insurance System. Ipsen and Pierre Fabre are private pharmaceutical companies. Sodexo, a food catering company, supported the study by organizing meetings between researchers and study participants. Sponsors were not involved in the analysis or interpretation of findings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amieva H, 2005, BRAIN, V128, P1093, DOI 10.1093/brain/awh451; Arntzen KA, 2010, ACTA NEUROL SCAND, V122, P23, DOI 10.1111/j.1600-0404.2010.01371.x; Bate C, 2011, NEUROPHARMACOLOGY, V61, P1406, DOI 10.1016/j.neuropharm.2011.08.030; Britton A, 2004, AM J EPIDEMIOL, V160, P240, DOI 10.1093/aje/kwh206; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Coley N, 2008, EPIDEMIOL REV, V30, P35, DOI 10.1093/epirev/mxn010; Collins MA, 2009, ALCOHOL CLIN EXP RES, V33, P206, DOI 10.1111/j.1530-0277.2008.00828.x; de la Torre JC, 2010, J ALZHEIMERS DIS, V20, P861, DOI 10.3233/JAD-2010-091579; Delis DC, 2001, DELIS KAPLAN EXECUTI; Dufouil C, 1997, AM J EPIDEMIOL, V146, P405, DOI 10.1093/oxfordjournals.aje.a009293; Elias PK, 1999, AM J EPIDEMIOL, V150, P580; Estaquio C, 2009, J AM DIET ASSOC, V109, P1031, DOI 10.1016/j.jada.2009.03.012; Ganguli M, 2005, NEUROLOGY, V65, P1210, DOI 10.1212/01.wnl.0000180520.35181.24; Gordon R, 2012, PUBLIC HEALTH, V126, P3, DOI 10.1016/j.puhe.2011.09.014; Gross AL, 2011, J GERONTOL B-PSYCHOL, V66, P39, DOI 10.1093/geronb/gbq062; Gu Y, 2011, CURR ALZHEIMER RES; Gustaw-Rothenberg K, 2009, INT J ENV RES PUB HE, V6, P1335, DOI 10.3390/ijerph6041335; Hansel B, 2010, EUR J CLIN NUTR, V64, P561, DOI 10.1038/ejcn.2010.61; Hercberg S, 2004, ARCH INTERN MED, V164, P2335, DOI 10.1001/archinte.164.21.2335; Hercberg S, 1998, INT J VITAM NUTR RES, V68, P3; Hernan MA, 2006, J EPIDEMIOL COMMUN H, V60, P578, DOI 10.1136/jech.2004.029496; Hvidtfeldt UA, 2010, CIRCULATION, V121, P1589, DOI 10.1161/CIRCULATIONAHA.109.887513; Ivanoiu A, 2005, J NEUROL, V252, P47, DOI 10.1007/s00415-005-0597-2; Kalmijn S, 2002, AM J EPIDEMIOL, V156, P936, DOI 10.1093/aje/kwf135; Kesse-Guyot E, 2011, AM J CLIN NUTR, V94, P892, DOI 10.3945/ajcn.110.007815; Kesse-Guyot E, 2011, AM J CLIN NUTR, V93, P200, DOI 10.3945/ajcn.2010.29761; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Lobo E, 2010, AM J EPIDEMIOL, V172, P708, DOI 10.1093/aje/kwq187; Middleton LE, 2009, ARCH NEUROL-CHICAGO, V66, P1210, DOI 10.1001/archneurol.2009.201; Moullec N. le, 1996, Cahiers de Nutrition et de Dietetique, V31, P158; Neafsey EJ, 2011, NEUROPSYCH DIS TREAT, V7, P465, DOI 10.2147/NDT.S23159; Newby PK, 2004, NUTR REV, V62, P177, DOI [10.1111/j.1753-4887.2004.tb00040.x, 10.1301/rn.2004.may.177-203]; Ngandu T, 2007, DEMENT GERIATR COGN, V23, P140, DOI 10.1159/000097995; Panza F, 2009, J ALZHEIMERS DIS, V17, P7, DOI 10.3233/JAD-2009-1009; Parry CD, 2011, ADDICTION, V106, P1718, DOI 10.1111/j.1360-0443.2011.03605.x; Peters R, 2008, AGE AGEING, V37, P505, DOI 10.1093/ageing/afn095; Plassman BL, 2010, ANN INTERN MED, V153, P182, DOI 10.7326/0003-4819-153-3-201008030-00258; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rust John, 2009, MODERN PSYCHOMETRICS; Sabia S, 2011, ADDICTION, V106, P93, DOI 10.1111/j.1360-0443.2010.03106.x; Seaman SR, 2013, STAT METHODS MED RES, V22, P278, DOI 10.1177/0962280210395740; Siliquini R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-526; Sinforiani E, 2011, FUNCT NEUROL, V26, P103; Stampfer MJ, 2005, NEW ENGL J MED, V352, P245, DOI 10.1056/NEJMoa041152; Tangney CC, 2011, AM J CLIN NUTR, V93, P601, DOI 10.3945/ajcn.110.007369; Tucker KL, 2010, APPL PHYSIOL NUTR ME, V35, P211, DOI 10.1139/H10-010; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; World Health Organization, 2011, GLOB STAT REP ALC HL	48	10	10	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52311	10.1371/journal.pone.0052311	http://dx.doi.org/10.1371/journal.pone.0052311			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	059HF	23284983	Green Published, gold, Green Submitted			2022-12-27	WOS:000312694300086
J	Konarzewski, TK; Murray, BR; Godfree, RC				Konarzewski, Tara K.; Murray, Brad R.; Godfree, Robert C.			Rapid Development of Adaptive, Climate-Driven Clinal Variation in Seed Mass in the Invasive Annual Forb Echium plantagineum L.	PLOS ONE			English	Article							LOCAL ADAPTATION; SIZE VARIATION; GENETIC DIFFERENTIATION; PHENOTYPIC PLASTICITY; LATITUDINAL VARIATION; PLANT-POPULATIONS; FLOWERING TIME; EVOLUTION; RANGE; PATTERNS	We examined adaptive clinal variation in seed mass among populations of an invasive annual species, Echium plantagineum, in response to climatic selection. We collected seeds from 34 field populations from a 1,000 km long temperature and rainfall gradient across the species' introduced range in south-eastern Australia. Seeds were germinated, grown to reproductive age under common glasshouse conditions, and progeny seeds were harvested and weighed. Analyses showed that seed mass was significantly related to climatic factors, with populations sourced from hotter, more arid sites producing heavier seeds than populations from cooler and wetter sites. Seed mass was not related to edaphic factors. We also found that seed mass was significantly related to both longitude and latitude with each degree of longitude west and latitude north increasing seed mass by around 2.5% and 4% on average. There was little evidence that within-population or between-population variation in seed mass varied in a systematic manner across the study region. Our findings provide compelling evidence for development of a strong cline in seed mass across the geographic range of a widespread and highly successful invasive annual forb. Since large seed mass is known to provide reproductive assurance for plants in arid environments, our results support the hypothesis that the fitness and range potential of invasive species can increase as a result of genetic divergence of populations along broad climatic gradients. In E. plantagineum population-level differentiation has occurred in 150 years or less, indicating that the adaptation process can be rapid.	[Konarzewski, Tara K.; Godfree, Robert C.] CSIRO, Plant Ind, Canberra, ACT, Australia; [Konarzewski, Tara K.; Murray, Brad R.] Univ Technol Sydney, Sch Environm, Sydney, NSW 2007, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Technology Sydney	Godfree, RC (corresponding author), CSIRO, Plant Ind, Canberra, ACT, Australia.	Robert.Godfree@csiro.au		Murray, Brad/0000-0002-4734-5976	University of Technology Sydney; CSIRO Climate Adaptation Flagship; CSIRO Plant Industry	University of Technology Sydney; CSIRO Climate Adaptation Flagship(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); CSIRO Plant Industry(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	Funders were University of Technology Sydney (www.uts.edu.au), CSIRO Climate Adaptation Flagship (http://www.csiro.au/Organisation-Structure/Flagships/Climate-Adaptation-Flagship/ClimateAdaptationFlagshipOverview.aspx) and CSIRO Plant Industry (http://www.csiro.au/Organisation-Structure/Divisions/Plant-Industry.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIZEN MA, 1992, CAN J BOT, V70, P1218, DOI 10.1139/b92-153; Alexander JM, 2012, J ECOL, V100, P771, DOI 10.1111/j.1365-2745.2011.01951.x; Arim M, 2006, P NATL ACAD SCI USA, V103, P374, DOI 10.1073/pnas.0504272102; Barrett SCH, 2008, MOL ECOL, V17, P373, DOI 10.1111/j.1365-294X.2007.03503.x; Blood K., 2001, ENV WEEDS FIELD GUID; Bone E, 2001, GENETICA, V112, P165, DOI 10.1023/A:1013378014069; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; Boulli A, 2001, EUPHYTICA, V119, P309, DOI 10.1023/A:1017571904517; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; Bridle JR, 2007, TRENDS ECOL EVOL, V22, P140, DOI 10.1016/j.tree.2006.11.002; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; BROWN AHD, 1983, AUST J BIOL SCI, V36, P503, DOI 10.1071/BI9830503; Buckley YM, 2003, ECOLOGY, V84, P1434, DOI 10.1890/0012-9658(2003)084[1434:AIBAGS]2.0.CO;2; BURDON JJ, 1986, AUST J BIOL SCI, V39, P369, DOI 10.1071/BI9860369; Carter J, 2009, PALGR STUD ORAL HIST, P1, DOI 10.1017/CBO9780511575679.004; Colautti RI, 2010, P ROY SOC B-BIOL SCI, V277, P1799, DOI 10.1098/rspb.2009.2231; Davidson AM, 2011, ECOL LETT, V14, P419, DOI 10.1111/j.1461-0248.2011.01596.x; Daws MI, 2007, S AFR J BOT, V73, P138, DOI 10.1016/j.sajb.2006.09.003; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; DUMAS JB, 1981, ANN CHIM, V47, P195; Dytham C., 2011, CHOOSING USING STAT; Ebeling SK, 2011, J PLANT ECOL-UK, V4, P209, DOI 10.1093/jpe/rtr007; Etterson JR, 2004, EVOLUTION, V58, P1446, DOI 10.1111/j.0014-3820.2004.tb01726.x; Etterson JR, 2008, BOTANY, V86, P91, DOI 10.1139/B07-115; Fenner M, 2001, NEW ZEAL J ECOL, V25, P95; Franks SJ, 2007, P NATL ACAD SCI USA, V104, P1278, DOI 10.1073/pnas.0608379104; Friedman JM, 2008, EVOL APPL, V1, P598, DOI 10.1111/j.1752-4571.2008.00044.x; Grigulis K, 2001, J APPL ECOL, V38, P281, DOI 10.1046/j.1365-2664.2001.00587.x; Guo QF, 2000, ECOLOGY, V81, P2149, DOI 10.1890/0012-9658(2000)081[2149:COSSOP]2.0.CO;2; Hinz HL, 2004, WEED TECHNOL, V18, P1533, DOI 10.1614/0890-037X(2004)018[1533:CIPFTN]2.0.CO;2; Hoffmann AA, 1999, TRENDS ECOL EVOL, V14, P96, DOI 10.1016/S0169-5347(99)01595-5; HURKA H, 1979, BIOL ZBL, V98, P699; Jeffrey SJ, 2001, ENVIRON MODELL SOFTW, V16, P309, DOI 10.1016/S1364-8152(01)00008-1; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kirkpatrick M, 1997, AM NAT, V150, P1, DOI 10.1086/286054; Kollmann J, 2004, DIVERS DISTRIB, V10, P377, DOI 10.1111/j.1366-9516.2004.00126.x; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Leger EA, 2007, J EVOLUTION BIOL, V20, P1090, DOI 10.1111/j.1420-9101.2006.01292.x; LEISHMAN MR, 1994, J ECOL, V82, P249, DOI 10.2307/2261293; Leishman MR., 2000, SEEDS ECOLOGY REGENE, V2nd edition; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; Lioubimtseva E, 2004, ENVIRON MANAGE, V33, P5388; Maron JL, 2004, ECOL MONOGR, V74, P261, DOI 10.1890/03-4027; Maron JL, 2007, EVOLUTION, V61, P1912, DOI 10.1111/j.1558-5646.2007.00153.x; Mason RAB, 2008, GLOBAL ECOL BIOGEOGR, V17, P633, DOI 10.1111/j.1466-8238.2008.00402.x; Mealor BA, 2007, OIKOS, V116, P1493, DOI 10.1111/j.0030-1299.2007.15781.x; Mitchell CE, 2003, NATURE, V421, P625, DOI 10.1038/nature01317; Moles AT, 2007, GLOBAL ECOL BIOGEOGR, V16, P109, DOI 10.1111/j.1466-8238.2006.00259.x; Moles AT, 2005, P NATL ACAD SCI USA, V102, P10540, DOI 10.1073/pnas.0501473102; Montague JL, 2008, J EVOLUTION BIOL, V21, P234, DOI 10.1111/j.1420-9101.2007.01456.x; Monty A, 2009, J EVOLUTION BIOL, V22, P917, DOI 10.1111/j.1420-9101.2009.01728.x; Monty A, 2009, OECOLOGIA, V159, P305, DOI 10.1007/s00442-008-1228-2; Murray BR, 2004, J BIOGEOGR, V31, P379, DOI 10.1046/j.0305-0270.2003.00993.x; Murray BR, 2003, AUST J BOT, V51, P47, DOI 10.1071/BT02069; Muyt A, 2001, BUSH INVADERS S E AU; Parker IM, 2003, CONSERV BIOL, V17, P59, DOI 10.1046/j.1523-1739.2003.02019.x; Petanidou T, 2012, PERSPECT PLANT ECOL, V14, P3, DOI 10.1016/j.ppees.2011.08.003; Phillips PC, 1996, EVOLUTION, V50, P1334, DOI [10.2307/2410673, 10.1111/j.1558-5646.1996.tb02373.x]; Piggin C. M., 1995, BIOL AUSTR WEEDS, V1, P87; PIGGIN CM, 1976, WEED RES, V16, P337, DOI 10.1111/j.1365-3180.1976.tb00423.x; PIGGIN CM, 1982, J AUST I AGR SCI, V48, P3; RASMUSSON EM, 1968, MON WEATHER REV, V96, P720, DOI 10.1175/1520-0493(1968)096<0720:AWVTAT>2.0.CO;2; RAYMENT GE, 1992, AUSTR LAB HDB SOILS; Rees M, 1996, PHILOS T R SOC B, V351, P1299, DOI 10.1098/rstb.1996.0113; Reznick DN, 2001, GENETICA, V112, P183, DOI 10.1023/A:1013352109042; Ridley CE, 2010, EVOL APPL, V3, P64, DOI 10.1111/j.1752-4571.2009.00099.x; SCHLICHTING CD, 1986, ANNU REV ECOL SYST, V17, P667, DOI 10.1146/annurev.es.17.110186.003315; Scott BJ, 2000, AUST J EXP AGR, V40, P1173, DOI 10.1071/EA00014; Shea K, 2000, OECOLOGIA, V124, P615, DOI 10.1007/s004420000425; SNAYDON RW, 1982, EVOLUTION, V36, P289, DOI [10.2307/2408047, 10.1111/j.1558-5646.1982.tb05044.x]; Sokal RR., 1995, INTRO BIOSTATISTICS; STAMP NE, 1990, AM J BOT, V77, P874, DOI 10.2307/2444503; Telenius A, 1999, PLANT BIOLOGY, V1, P585, DOI 10.1111/j.1438-8677.1999.tb00788.x; Thackway R., 1995, INTERIM BIOGEOGRAPHI; Thompson JN, 1998, TRENDS ECOL EVOL, V13, P329, DOI 10.1016/S0169-5347(98)01378-0; Tukey JW., 1953, PROBLEM MULTIPLE COM; Vaughton G, 1998, J ECOL, V86, P563, DOI 10.1046/j.1365-2745.1998.00279.x; Vucetich JA, 2003, CONSERV GENET, V4, P639, DOI 10.1023/A:1025671831349; Weber E, 1998, AM J BOT, V85, P1110, DOI 10.2307/2446344; Whitney KD, 2008, DIVERS DISTRIB, V14, P569, DOI 10.1111/j.1472-4642.2008.00473.x; WINN AA, 1993, OECOLOGIA, V93, P55, DOI 10.1007/BF00321191	82	22	27	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e49000	10.1371/journal.pone.0049000	http://dx.doi.org/10.1371/journal.pone.0049000			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284621	Green Published, gold, Green Submitted			2022-12-27	WOS:000312694300006
J	Van Gramberg, JL; de Veer, MJ; O'Hehir, RE; Meeusen, ENT; Bischof, RJ				Van Gramberg, Jenna L.; de Veer, Michael J.; O'Hehir, Robyn E.; Meeusen, Els N. T.; Bischof, Robert J.			Induction of Allergic Responses to Peanut Allergen in Sheep	PLOS ONE			English	Article							ARA-H-I; ANAPHYLACTIC REACTIONS; ATOPIC-DERMATITIS; CROSS-REACTIVITY; FOOD ALLERGY; MODEL; IDENTIFICATION; ANTIBODIES; IMMUNOTHERAPY; CHALLENGE	Peanut allergy is the leading cause of deaths due to food-induced anaphylaxis but despite continued research, there are currently no specific treatments available. Challenge testing is limited in patients due to the high risk of adverse reactions, emphasising the need for an appropriate animal model. In the present study we examine the induction of allergic responses in a sheep model for peanut allergy. Sheep were sensitised with peanut (PN) extract and in separate injections with ovalbumin (OVA) or house dust mite (HDM) extract. Serum PN-specific IgE responses were detected in 40-50% of immunised sheep, while only 10% (1 of 10 sheep) showed detectable OVA-specific IgE. All PN-allergic sheep tested showed an Ara h 1-specific IgE response, while four out of five allergic sheep showed an Ara h 2-specific IgE response. Animals with high serum IgE levels to HDM were also PN IgE-positive. Of the PN-sensitised animals with high PN-specific IgE, 80% also showed an immediate hypersensitivity reaction following an intradermal PN injection. This new large animal model of peanut allergy may provide a useful tool for future investigations of allergen-associated immune mechanisms and specific immunotherapy.	[Van Gramberg, Jenna L.; de Veer, Michael J.; Meeusen, Els N. T.; Bischof, Robert J.] Monash Univ, Dept Physiol, Biotechnol Res Labs, Clayton, Vic 3168, Australia; [O'Hehir, Robyn E.] Alfred Hosp, Dept Allergy Immunol & Resp Med, Melbourne, Vic, Australia; [O'Hehir, Robyn E.] Monash Univ, Melbourne, Vic 3004, Australia	Monash University; Florey Institute of Neuroscience & Mental Health; Monash University	Bischof, RJ (corresponding author), Monash Univ, Dept Physiol, Biotechnol Res Labs, Clayton, Vic 3168, Australia.	rob.bischof@monash.edu	O'Hehir, Robyn E/H-3627-2011	O'Hehir, Robyn E/0000-0002-3489-7595; Meeusen, Els/0000-0003-1239-6287; Bischof, Robert/0000-0002-6649-9612	Australian Research Council (ARC)	Australian Research Council (ARC)(Australian Research Council)	This work was supported by a grant from the Australian Research Council (ARC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALBERSE RC, 1981, J ALLERGY CLIN IMMUN, V68, P356, DOI 10.1016/0091-6749(81)90133-0; [Anonymous], 2010, J ALLERGY CLIN IMMUN, V126, pS5, DOI 10.1016/j.jaci.2010.10.007; Bischof RJ, 2003, CLIN EXP ALLERGY, V33, P367, DOI 10.1046/j.1365-2222.2003.01534.x; Bischof RJ, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-16; Bock SA, 2001, J ALLERGY CLIN IMMUN, V107, P191, DOI 10.1067/mai.2001.112031; Breiteneder H, 2005, BIOTECHNOL ADV, V23, P395, DOI 10.1016/j.biotechadv.2005.05.004; BURKS AW, 1992, J ALLERGY CLIN IMMUN, V90, P962, DOI 10.1016/0091-6749(92)90469-I; BURKS AW, 1991, J ALLERGY CLIN IMMUN, V88, P172, DOI 10.1016/0091-6749(91)90325-I; BURKS AW, 1995, J CLIN INVEST, V96, P1715, DOI 10.1172/JCI118216; Comeau MR, 2010, MUCOSAL IMMUNOL, V3, P138, DOI 10.1038/mi.2009.134; De Jong EC, 1998, CLIN EXP ALLERGY, V28, P743, DOI 10.1046/j.1365-2222.1998.00301.x; de Leon MP, 2007, MOL IMMUNOL, V44, P463, DOI 10.1016/j.molimm.2006.02.016; de Leon Maria P., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000208; de Leon MP, 2003, CLIN EXP ALLERGY, V33, P1273, DOI 10.1046/j.1365-2222.2003.01761.x; Ermel RW, 1997, LAB ANIM SCI, V47, P40; Fischer R, 2005, AM J PATHOL, V167, P1621, DOI 10.1016/S0002-9440(10)61246-1; Gillman A, 2010, CLIN EXP ALLERGY, V40, P1295, DOI 10.1111/j.1365-2222.2010.03528.x; Helm RM, 2002, J ALLERGY CLIN IMMUN, V109, P136, DOI 10.1067/mai.2002.120551; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; Koppelman SJ, 2004, CLIN EXP ALLERGY, V34, P583, DOI 10.1111/j.1365-2222.2004.1923.x; Lack G, 2003, NEW ENGL J MED, V348, P977, DOI 10.1056/NEJMoa013536; Lack G, 1997, J ALLERGY CLIN IMMUN, V99, P530, DOI 10.1016/S0091-6749(97)70081-2; Li XM, 2000, J ALLERGY CLIN IMMUN, V106, P150, DOI 10.1067/mai.2000.107395; LOZA C, 1995, CLIN EXP ALLERGY, V25, P493, DOI 10.1111/j.1365-2222.1995.tb01086.x; Meeusen EN, 2009, DRUG DISCOV TODAY DI, V6, P101, DOI [DOI 10.1016/J.DDM0D.2009.12.002, 10.1016/j.ddmod.2009.12.002]; Morafo V, 2003, J ALLERGY CLIN IMMUN, V111, P1122, DOI 10.1067/mai.2003.1463; Morar N, 2006, J ALLERGY CLIN IMMUN, V118, P24, DOI 10.1016/j.jaci.2006.03.037; Osborne NJ, 2011, J ALLERGY CLIN IMMUN, V127, P668, DOI 10.1016/j.jaci.2011.01.039; Otsu K, 2011, DISCOV MED, V12, P319; Palmer GW, 2005, CLIN IMMUNOL, V115, P302, DOI 10.1016/j.clim.2005.02.011; Prickett SR, 2011, J ALLERGY CLIN IMMUN, V127, P608, DOI 10.1016/j.jaci.2010.09.027; Prioult G, 2005, IMMUNOL REV, V206, P204, DOI 10.1111/j.0105-2896.2005.00277.x; Pumphrey RSH, 2000, CLIN EXP ALLERGY, V30, P1144, DOI 10.1046/j.1365-2222.2000.00864.x; SAMPSON HA, 1992, NEW ENGL J MED, V327, P380, DOI 10.1056/NEJM199208063270603; Shaw RJ, 1997, VET IMMUNOL IMMUNOP, V57, P253, DOI 10.1016/S0165-2427(97)00010-X; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, pS116, DOI 10.1016/j.jaci.2009.08.028; Sicherer SH, 2001, J ALLERGY CLIN IMMUN, V108, P881, DOI 10.1067/mai.2001.118515; Strait RT, 2006, J CLIN INVEST, V116, P833, DOI 10.1172/JCI25575; Teuber SS, 2002, J ALLERGY CLIN IMMUN, V110, P921, DOI 10.1067/mai.2002.130056; Valenta R, 2004, ADV IMMUNOL, V82, P105, DOI 10.1016/S0065-2776(04)82003-0; Wang JL, 2007, CLIN EXP ALLERGY, V37, P651, DOI 10.1111/j.1365-2222.2007.02682.x	41	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51386	10.1371/journal.pone.0051386	http://dx.doi.org/10.1371/journal.pone.0051386			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284686	Green Submitted, Green Published, gold			2022-12-27	WOS:000312694300022
J	Vasaturo, A; Caserta, S; Russo, I; Preziosi, V; Ciacci, C; Guido, S				Vasaturo, Angela; Caserta, Sergio; Russo, Ilaria; Preziosi, Valentina; Ciacci, Carolina; Guido, Stefano			A Novel Chemotaxis Assay in 3-D Collagen Gels by Time-Lapse Microscopy	PLOS ONE			English	Article							LEUKOCYTE MIGRATION; CONTACT GUIDANCE; CELL CHEMOTAXIS; RAT MODEL; INTERLEUKIN-8; CHEMOKINES; INFLAMMATION; ORIENTATION; NEUTROPHILS; LOCOMOTION	The directional cell response to chemical gradients, referred to as chemotaxis, plays an important role in physiological and pathological processes including development, immune response and tumor cell invasion. Despite such implications, chemotaxis remains a challenging process to study under physiologically-relevant conditions in-vitro, mainly due to difficulties in generating a well characterized and sustained gradient in substrata mimicking the in-vivo environment while allowing dynamic cell imaging. Here, we describe a novel chemotaxis assay in 3D collagen gels, based on a reusable direct-viewing chamber in which a chemoattractant gradient is generated by diffusion through a porous membrane. The diffusion process has been analysed by monitoring the concentration of FITC-labelled dextran through epifluorescence microscopy and by comparing experimental data with theoretical and numerical predictions based on Fick's law. Cell migration towards chemoattractant gradients has been followed by time-lapse microscopy and quantified by cell tracking based on image analysis techniques. The results are expressed in terms of chemotactic index (I) and average cell velocity. The assay has been tested by comparing the migration of human neutrophils in isotropic conditions and in the presence of an Interleukin-8 (IL-8) gradient. In the absence of IL-8 stimulation, 80% of the cells showed a velocity ranging from 0 to 1 mm/min. However, in the presence of an IL-8 gradient, 60% of the cells showed an increase in velocity reaching values between 2 and 7 mm/min. Furthermore, after IL-8 addition, I increased from 0 to 0.25 and 0.25 to 0.5, respectively, for the two donors examined. These data indicate a pronounced directional migration of neutrophils towards the IL-8 gradient in 3D collagen matrix. The chemotaxis assay described here can be adapted to other cell types and may serve as a physiologically relevant method to study the directed locomotion of cells in a 3D environment in response to different chemoattractants.	[Vasaturo, Angela; Caserta, Sergio; Preziosi, Valentina; Guido, Stefano] Univ Naples Federico II, Dipartimento Ingn Chim, Naples, Italy; [Caserta, Sergio; Guido, Stefano] CEINGE Adv Biotechnol, Naples, Italy; [Russo, Ilaria; Ciacci, Carolina] Univ Salerno, Sch Med, Gastrointestinal Unit Baronissi, I-84100 Salerno, Italy	University of Naples Federico II; CEINGE Biotecnologie Avanzate; University of Salerno	Caserta, S (corresponding author), Univ Naples Federico II, Dipartimento Ingn Chim, Naples, Italy.	sergio.caserta@unina.it	Russo, Ilaria/V-2549-2017; Caserta, Sergio/E-4602-2012; Guido, Stefano/B-9928-2011; ciacci, carolina/A-2594-2012	Caserta, Sergio/0000-0002-4400-0059; Guido, Stefano/0000-0002-9247-6852; ciacci, carolina/0000-0002-7426-1145; Preziosi, Valentina/0000-0002-8852-5703; VASATURO, ANGELA/0000-0001-7985-3820	Italian Ministry of Research [prot. 2006099155, prot. 2008W3WBMH]	Italian Ministry of Research(Ministry of Education, Universities and Research (MIUR))	Financial support from the Italian Ministry of Research (PRIN 2006, prot. 2006099155 and PRIN 2008, prot. 2008W3WBMH) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baggiolini M, 2000, IMMUNOL TODAY, V21, P418, DOI 10.1016/S0167-5699(00)01672-8; BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265; Bonvin C, 2010, BIOTECHNOL BIOENG, V105, P982, DOI 10.1002/bit.22608; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; Buonomo R, 2012, J CELL PHYSIOL, V227, P2106, DOI 10.1002/jcp.22944; Caserta S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.137801; Clark R., 1996, Mezhdunarodnyi Sel'skokhozyaistvennyi Zhurnal, P3; Cristini V, 2005, CLIN CANCER RES, V11, P6772, DOI 10.1158/1078-0432.CCR-05-0852; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; D'Argenio G, 2012, DIGEST LIVER DIS, V44, P555, DOI 10.1016/j.dld.2012.01.009; Dallon JC, 1999, J THEOR BIOL, V199, P449, DOI 10.1006/jtbi.1999.0971; De Luca AC, 2008, MACROMOLECULES, V41, P5512, DOI 10.1021/ma800866m; Dertinger SKW, 2001, ANAL CHEM, V73, P1240, DOI 10.1021/ac001132d; Di Costanzo A, 2012, J BIOL CHEM, V287, P30170, DOI 10.1074/jbc.M112.349951; DICKINSON RB, 1994, ANN BIOMED ENG, V22, P342, DOI 10.1007/BF02368241; FREVERT CW, 1995, J IMMUNOL, V154, P335; Friedl P, 2000, CELL MOL LIFE SCI, V57, P41, DOI 10.1007/s000180050498; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Friedl Peter, 2004, Methods Mol Biol, V239, P77; Gionchetti P, 1997, GUT, V40, P102, DOI 10.1136/gut.40.1.102; Gobeaux F, 2008, J MOL BIOL, V376, P1509, DOI 10.1016/j.jmb.2007.12.047; GUIDO S, 1993, J CELL SCI, V105, P317; Haessler U, 2009, BIOMED MICRODEVICES, V11, P827, DOI 10.1007/s10544-009-9299-3; HARADA A, 1994, J LEUKOCYTE BIOL, V56, P559, DOI 10.1002/jlb.56.5.559; Haugh JM, 2006, CHEM ENG SCI, V61, P5603, DOI 10.1016/j.ces.2006.04.041; Herzmark P, 2007, P NATL ACAD SCI USA, V104, P13349, DOI 10.1073/pnas.0705889104; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Jeon NL, 2002, NAT BIOTECHNOL, V20, P826, DOI 10.1038/nbt712; Jonas A, 2010, LANGMUIR, V26, P14223, DOI 10.1021/la101498h; Kinoshita M, 2011, INFECT IMMUN, V79, P2670, DOI 10.1128/IAI.01298-10; Knapp DM, 1999, EXP CELL RES, V247, P543, DOI 10.1006/excr.1998.4364; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lin F, 2006, LAB CHIP, V6, P1462, DOI 10.1039/b607071j; Lin F, 2009, METHOD ENZYMOL, V461, P333, DOI 10.1016/S0076-6879(09)05415-9; Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253; Mathias JR, 2006, J LEUKOCYTE BIOL, V80, P1281, DOI 10.1189/jlb.0506346; MOGHE PV, 1995, J IMMUNOL METHODS, V180, P193, DOI 10.1016/0022-1759(94)00314-M; Muinonen-Martin AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015309; NELSON RD, 1975, J IMMUNOL, V115, P1650; Olson TS, 2002, AM J PHYSIOL-REG I, V283, pR7, DOI 10.1152/ajpregu.00738.2001; Pommella A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.138301; Raub CB, 2008, BIOPHYS J, V94, P2361, DOI 10.1529/biophysj.107.120006; Roebuck KA, 1999, J INTERF CYTOK RES, V19, P429, DOI 10.1089/107999099313866; Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Sasaki AT, 2006, EUR J CELL BIOL, V85, P873, DOI 10.1016/j.ejcb.2006.04.007; Schneider IC, 2005, J CELL BIOL, V171, P883, DOI 10.1083/jcb.200509028; Shao JB, 2009, LAB CHIP, V9, P3118, DOI 10.1039/b909312e; Silano M., 2012, PEDIAT RES; Sixt M, 2011, METHODS MOL BIOL, V769, P149, DOI 10.1007/978-1-61779-207-6_11; Tsai WC, 2000, INFECT IMMUN, V68, P4289, DOI 10.1128/IAI.68.7.4289-4296.2000; Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005; ZICHA D, 1991, J CELL SCI, V99, P769; ZIGMOND SH, 1973, J EXP MED, V137, P387, DOI 10.1084/jem.137.2.387; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	56	22	22	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52251	10.1371/journal.pone.0052251	http://dx.doi.org/10.1371/journal.pone.0052251			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284956	Green Published, gold, Green Submitted			2022-12-27	WOS:000312694300083
J	Kang, CB; Bharatham, N; Chia, J; Mu, YG; Baek, K; Yoon, HS				Kang, CongBao; Bharatham, Nagakumar; Chia, Joel; Mu, Yuguang; Baek, Kwanghee; Yoon, Ho Sup			The Natively Disordered Loop of Bcl-2 Undergoes Phosphorylation-Dependent Conformational Change and Interacts with Pin1	PLOS ONE			English	Article							SUBSTRATE; DOMAIN; RECOGNITION; DETERMINANTS; DEGRADATION; CALCINEURIN; MECHANISMS; SIMULATION; REGULATORS; APOPTOSIS	Bcl-2 plays a central role in the regulation of apoptosis. Structural studies of Bcl-2 revealed the presence of a flexible and natively disordered loop that bridges the Bcl-2 homology motifs, BH3 and BH4. This loop is phosphorylated on multiple sites in response to a variety of external stimuli, including the microtubule-targeting drugs, paclitaxel and colchicine. Currently, the underlying molecular mechanism of Bcl-2 phosphorylation and its biological significance remain elusive. In this study, we investigated the molecular characteristics of this anti-apoptotic protein. To this end, we generated synthetic peptides derived from the Bcl-2 loop, and multiple Bcl-2 loop truncation mutants that include the phosphorylation sites. Our results demonstrate that S87 in the flexible loop of Bcl-2 is the primary phosphorylation site for JNK and ERK2, suggesting some sequence or structural specificity for the phosphorylation by these kinases. Our NMR studies and molecular dynamics simulation studies support indicate that phosphorylation of S87 induces a conformational change in the peptide. Finally, we show that the phosphorylated peptides of the Bcl-2 loop can bind Pin1, further substantiating the phosphorylation-mediated conformation change of Bcl-2.	[Kang, CongBao; Bharatham, Nagakumar; Chia, Joel; Mu, Yuguang; Yoon, Ho Sup] Nanyang Technol Univ, Sch Biol Sci, Div Struct & Computat Biol, Singapore, Singapore; [Kang, CongBao] Agcy Sci Technol & Res, Ctr Expt Therapeut, Singapore, Singapore; [Baek, Kwanghee; Yoon, Ho Sup] Kyung Hee Univ, Coll Life Sci, Dept Genet Engn, Yongin, Gyeonggi Do, South Korea	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Experimental Drug Development Centre (EDDC); Experimental Therapeutics Centre; Kyung Hee University	Kang, CB (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Div Struct & Computat Biol, Singapore, Singapore.	cbkang@etc.a-star.edu.sg; hsyoon@ntu.edu.sg	Yoon, Ho Sup/A-2193-2011; Kang, Congbao/AAP-7572-2020; Baek, Kwanghee/N-2760-2018	Yoon, Ho Sup/0000-0002-8243-3904; Kang, Congbao/0000-0002-9886-9374; Baek, Kwanghee/0000-0002-1364-1355	Ministry of Health Singapore [NMRC/1177/2008]; Nanyang Technological University [URC/RG65/06]; A*STAR Investigatorship	Ministry of Health Singapore(Ministry of Health-Singapore); Nanyang Technological University(Nanyang Technological University); A*STAR Investigatorship(Agency for Science Technology & Research (A*STAR))	This work was supported by Ministry of Health Singapore Grant NMRC/1177/2008. Financial support from Nanyang Technological University (URC/RG65/06) to Yuguang Mu is also acknowledged. CK appreciate the support from A*STAR Investigatorship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barboule N, 2005, CELL CYCLE, V4, P590; Bassik MC, 2004, EMBO J, V23, P1207, DOI 10.1038/sj.emboj.7600104; Bayer E, 2003, J BIOL CHEM, V278, P26183, DOI 10.1074/jbc.M300721200; Blagosklonny MV, 2001, LEUKEMIA, V15, P869, DOI 10.1038/sj.leu.2402134; Breitschopf K, 2000, MOL CELL BIOL, V20, P1886, DOI 10.1128/MCB.20.5.1886-1896.2000; Brichese L, 2004, CELL CYCLE, V3, P1312, DOI 10.4161/cc.3.10.1166; CIECHANOVER A, 1994, FASEB J, V8, P182, DOI 10.1096/fasebj.8.2.8119489; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deng XM, 2000, P NATL ACAD SCI USA, V97, P1578, DOI 10.1073/pnas.97.4.1578; GONZALEZ FA, 1991, J BIOL CHEM, V266, P22159; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Huang STJ, 2002, FASEB J, V16, DOI 10.1096/fj.01-0852com; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kang CB, 2005, FEBS LETT, V579, P1469, DOI 10.1016/j.febslet.2005.01.053; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Khokhlatchev A, 1997, J BIOL CHEM, V272, P11057; Kim S, 2001, BIOCHEMISTRY-US, V40, P6776, DOI 10.1021/bi002700m; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lu KP, 2004, TRENDS BIOCHEM SCI, V29, P200, DOI 10.1016/j.tibs.2004.02.002; Mondragon A, 1997, BIOCHEMISTRY-US, V36, P4934, DOI 10.1021/bi9631935; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Pathan N, 2001, NEOPLASIA, V3, P550, DOI 10.1038/sj.neo.7900213; Petros AM, 2001, P NATL ACAD SCI USA, V98, P3012, DOI 10.1073/pnas.041619798; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Ruvolo PP, 2001, LEUKEMIA, V15, P515, DOI 10.1038/sj.leu.2402090; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Shen TY, 2001, J AM CHEM SOC, V123, P9107, DOI 10.1021/ja010190t; Shibasaki F, 1997, NATURE, V386, P728, DOI 10.1038/386728a0; Smet C, 2005, J MED CHEM, V48, P4815, DOI 10.1021/jm0500119; Tamura Y, 2004, FEBS LETT, V569, P249, DOI 10.1016/j.febslet.2004.06.003; Tholey A, 1999, BIOPHYS J, V76, P76, DOI 10.1016/S0006-3495(99)77179-1; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; Weiwad M, 2004, J MOL BIOL, V339, P635, DOI 10.1016/j.jmb.2004.02.021; Wintjens R, 2001, J BIOL CHEM, V276, P25150, DOI 10.1074/jbc.M010327200; Wong SE, 2005, J PHYS CHEM B, V109, P5249, DOI 10.1021/jp046333q; Zhang JL, 2003, J BIOL CHEM, V278, P29901, DOI 10.1074/jbc.M303909200	38	9	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52047	10.1371/journal.pone.0052047	http://dx.doi.org/10.1371/journal.pone.0052047			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272207	Green Published, gold			2022-12-27	WOS:000312483300053
J	Parnmen, S; Rangsiruji, A; Mongkolsuk, P; Boonpragob, K; Nutakki, A; Lumbsch, HT				Parnmen, Sittiporn; Rangsiruji, Achariya; Mongkolsuk, Pachara; Boonpragob, Kansri; Nutakki, Aparna; Lumbsch, H. Thorsten			Using Phylogenetic and Coalescent Methods to Understand the Species Diversity in the Cladia aggregata Complex (Ascomycota, Lecanorales)	PLOS ONE			English	Article							LICHEN-FORMING FUNGI; MOLECULAR PHYLOGENY; MORPHOLOGICAL CHARACTERS; GENEALOGICAL APPROACH; MAXIMUM-LIKELIHOOD; PARMELIOID LICHENS; BAYESIAN-INFERENCE; GROUP CLADONIACEAE; CRYPTIC DIVERSITY; PARMELIACEAE	The Cladia aggregata complex is one of the phenotypically most variable groups in lichenized fungi, making species determination difficult and resulting in different classifications accepting between one to eight species. Multi-locus DNA sequence data provide an avenue to test species delimitation scenarios using genealogical and coalescent methods, employing gene and species trees. Here we tested species delimitation in the complex using molecular data of four loci (nuITS and IGS rDNA, protein-coding GAPDH and Mcm-7), including 474 newly generated sequences. Using a combination of ML and Bayesian gene tree topologies, species tree inferences, coalescent-based species delimitation, and examination of phenotypic variation we assessed the circumscription of lineages. We propose that results from our analyses support a 12 species delimitation scenario, suggesting that there is a high level of species diversity in the complex. Morphological and chemical characters often do not characterize lineages but show some degree of plasticity within at least some of the clades. However, clades can often be characterized by a combination of several phenotypical characters. In contrast to the amount of homoplasy in the morphological characters, the data set exhibits some geographical patterns with putative species having distribution patterns, such as austral, Australasian or being endemic to Australia, New Zealand or Tasmania.	[Parnmen, Sittiporn; Lumbsch, H. Thorsten] Field Museum, Dept Bot, Chicago, IL USA; [Parnmen, Sittiporn; Rangsiruji, Achariya] Srinakharinwirot Univ, Dept Biol, Bangkok, Thailand; [Parnmen, Sittiporn; Mongkolsuk, Pachara; Boonpragob, Kansri] Ramkhamhang Univ, Dept Biol, Bangkok, Thailand; [Nutakki, Aparna] Univ Chicago, Dept Biol Sci, Chicago, IL 60637 USA	Field Museum of Natural History (Chicago); Srinakharinwirot University; Ramkhamhaeng University; University of Chicago	Lumbsch, HT (corresponding author), Field Museum, Dept Bot, Chicago, IL USA.	tlumbsch@fieldmuseum.org	Parnmen, Sittiporn/B-9203-2014	Parnmen, Sittiporn/0000-0002-0116-9436	Scholarship of The Field Museum; Graduate Fund of the Faculty of Science, Srinakharinwirot University; National Research Council of Thailand	Scholarship of The Field Museum; Graduate Fund of the Faculty of Science, Srinakharinwirot University; National Research Council of Thailand(National Research Council of Thailand (NRCT))	This work was financially supported by a Scholarship of The Field Museum, the Graduate Fund of the Faculty of Science, Srinakharinwirot University and the National Research Council of Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHTI T, 1982, LICHENOLOGIST, V14, P105, DOI 10.1017/S0024282982000255; Ahti T., 2000, FL NEOTROP MONOGR, V78, P1; Arguello A, 2007, BIOL J LINN SOC, V91, P455, DOI 10.1111/j.1095-8312.2007.00810.x; Articus K, 2002, MYCOL RES, V106, P412, DOI 10.1017/S0953756202005786; Avise J.C., 1990, Oxford Surveys in Evolutionary Biology, V7, P45; Birky CW, 2011, ZOOL J LINN SOC-LOND, V161, P723, DOI 10.1111/j.1096-3642.2010.00674.x; Blanco O, 2004, TAXON, V53, P959, DOI 10.2307/4135563; Blanco O, 2004, MYCOL RES, V108, P873, DOI 10.1017/S0953756204000723; Buschbom J, 2006, MOL BIOL EVOL, V23, P574, DOI 10.1093/molbev/msj063; Carbone I, 1999, MYCOLOGIA, V91, P553, DOI 10.2307/3761358; Molina MC, 2011, ORG DIVERS EVOL, V11, P331, DOI 10.1007/s13127-011-0060-4; Carstens BC, 2007, SYST BIOL, V56, P400, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Carstens BC, 2010, SYST BIOL, V59, P400, DOI 10.1093/sysbio/syq024; Cracraft J., 1983, Current Ornithology, V1, P159; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; Crespo A, 2010, IMA FUNGUS, V1, P167, DOI 10.5598/imafungus.2010.01.02.09; Crespo A, 2009, AN JARDIN BOT MADRID, V66, P71, DOI 10.3989/ajbm.2225; Cubero OF, 2004, MYCOL RES, V108, P498, DOI 10.1017/s095375620400975x; CULBERSON CF, 1983, BIOCHEM SYST ECOL, V11, P77, DOI 10.1016/0305-1978(83)90003-0; de Queiroz K, 2005, BIOESSAYS, V27, P1263, DOI 10.1002/bies.20325; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Molina MD, 2011, LICHENOLOGIST, V43, P585, DOI 10.1017/S0024282911000521; Dettman JR, 2003, EVOLUTION, V57, P2721; Dettman JR, 2003, EVOLUTION, V57, P2703, DOI 10.1554/03-073; Divakar PK, 2005, LICHENOLOGIST, V37, P55, DOI 10.1017/S0024282904014586; Divakar PK, 2005, LICHENOLOGIST, V37, P37, DOI 10.1017/S0024282904014641; Divakar PK, 2006, MOL PHYLOGENET EVOL, V40, P448, DOI 10.1016/j.ympev.2006.03.024; Divakar PK, 2010, FUNGAL DIVERS, V42, P47, DOI 10.1007/s13225-010-0027-3; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Elix JA, 2009, SYST BIODIVERS, V7, P479, DOI 10.1017/S1477200009990223; FEIGE GB, 1993, J CHROMATOGR, V646, P417, DOI 10.1016/0021-9673(93)83356-W; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fernandez-Mendoza F, 2011, MOL ECOL, V20, P1208, DOI 10.1111/j.1365-294X.2010.04993.x; Filson R.B., 1981, J HATTORI BOT LAB, V49, P1; Filson R.B., 1992, FLORA AUSTR, V54, P101; FILSON RB, 1978, LICHENOLOGIST, V10, P13, DOI 10.1017/S0024282978000043; Fontaneto D, 2011, HYDROBIOLOGIA, V662, P27, DOI 10.1007/s10750-010-0481-7; Fontaneto D, 2009, MOL PHYLOGENET EVOL, V53, P182, DOI 10.1016/j.ympev.2009.04.011; Galloway, 1985, SCH PERSISTENT ABSEN; GALLOWAY DJ, 1977, NOVA HEDWIGIA, V28, P475; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gattolliat JL, 2010, J N AM BENTHOL SOC, V29, P1042, DOI 10.1899/09-119.1; Goffinet B, 2003, BRYOLOGIST, V106, P349, DOI 10.1639/01; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; Hodkinson BP, 2011, BIBL LICHENOL, V106, P115; Hognabba F, 2003, CLADISTICS, V19, P224, DOI 10.1016/S0748-3007(03)00028-8; Hognabba F, 2006, MYCOL RES, V110, P1080, DOI 10.1016/j.mycres.2006.04.013; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jahns HM, 1973, HERZOGIA, V2, P437; Jahns HM, 1970, NOVA HEDWIGIA, V20, P1; JAHNS M, 1995, ANN BOT FENN, V32, P35; KANTVILAS G, 1987, MYCOTAXON, V29, P199; Kantvilas G, 1995, LICHENOLOGIST, V27, P433, DOI 10.1016/S0024-2829(95)80004-2; Kantvilas Gintaras, 1999, Muelleria, V12, P135; Kroken S, 2001, MYCOLOGIA, V93, P38, DOI 10.2307/3761604; Kubatko LS, 2009, BIOINFORMATICS, V25, P971, DOI 10.1093/bioinformatics/btp079; Lamb IM, 1972, OCCASIONAL PAPERS FA, V4, P1; Leavitt SD, 2011, MOL PHYLOGENET EVOL, V60, P317, DOI 10.1016/j.ympev.2011.05.012; Leavitt SD, 2011, MOL PHYLOGENET EVOL, V59, P587, DOI 10.1016/j.ympev.2011.03.020; Lorion J, 2010, MOL PHYLOGENET EVOL, V57, P71, DOI 10.1016/j.ympev.2010.05.027; Lucentini L, 2011, HYDROBIOLOGIA, V673, P215, DOI 10.1007/s10750-011-0778-1; Lucking R, 2008, SYST BIODIVERS, V6, P31, DOI 10.1017/S1477200007002629; Lumbsch H. T., 2007, MYCONET, V13, P1, DOI DOI 10.3158/1557.1; Lumbsch HT, 2008, AUST SYST BOT, V21, P217, DOI 10.1071/SB07049; Lumbsch HT, 2011, FUNGAL DIVERS, V50, P59, DOI 10.1007/s13225-011-0123-z; Lumbsch HT, 2010, AUST SYST BOT, V23, P239, DOI 10.1071/SB10010; Lumbsch H. Thorsten, 2002, P281; Lutzoni F, 2004, AM J BOT, V91, P1446, DOI 10.3732/ajb.91.10.1446; Maddison WP, 2009, MESQUITE MODULAR SYS; Mayr E., 1963, ANIMAL SPECIES EVOLU; McCune B, 2009, BRYOLOGIST, V112, P94, DOI 10.1639/0007-2745-112.1.94; McDonald T, 2003, BRYOLOGIST, V106, P61, DOI 10.1639/0007-2745(2003)106[0061:TLGSIT]2.0.CO;2; Miralles A, 2011, ZOOL SCR, V40, P16, DOI 10.1111/j.1463-6409.2010.00453.x; Molina MD, 2004, LICHENOLOGIST, V36, P37, DOI 10.1017/S0024282904013933; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Myllys L, 2002, LICHENOLOGIST, V34, P237, DOI 10.1006/lich.2002.0390; Myllys L, 2011, LICHENOLOGIST, V43, P617, DOI 10.1017/S0024282911000132; NEE S, 1992, P NATL ACAD SCI USA, V89, P8322, DOI 10.1073/pnas.89.17.8322; Nelsen MP, 2009, BRYOLOGIST, V112, P42, DOI 10.1639/0007-2745-112.1.42; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Otalora MAG, 2010, AM J BOT, V97, P216, DOI 10.3732/ajb.0900064; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pages M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-184; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paradis E, 2006, USE R, P8; Parnmen S, 2012, LICHENOLOGIST, V44, P297, DOI 10.1017/S0024282911000715; Parnmen S, 2010, TAXON, V59, P841, DOI 10.1002/tax.593013; Pecchia S, 2004, MYCOPATHOLOGIA, V157, P317, DOI 10.1023/B:MYCO.0000024185.66158.7e; Pino-Bodas R, 2012, LICHENOLOGIST, V44, P121, DOI 10.1017/S002428291100065X; Pino-Bodas R, 2011, ORG DIVERS EVOL, V11, P343, DOI 10.1007/s13127-011-0062-2; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Pons J, 2011, MOL PHYLOGENET EVOL, V59, P251, DOI 10.1016/j.ympev.2011.02.013; Pringle A, 2005, EVOLUTION, V59, P1886, DOI 10.1111/j.0014-3820.2005.tb01059.x; Printzen C, 2003, MOL ECOL, V12, P1473, DOI 10.1046/j.1365-294X.2003.01812.x; Printzen C, 2002, LICHENOLOGIST, V34, P101, DOI 10.1006/lich.2002.0381; Purvis O. W., 1997, V54, P109; Ruprecht U, 2010, ANTARCT SCI, V22, P727, DOI 10.1017/S0954102010000477; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Schmitt I, 2004, MOL PHYLOGENET EVOL, V33, P43, DOI 10.1016/j.ympev.2004.04.014; Schmitt I, 2009, PERSOONIA, V23, P35, DOI 10.3767/003158509X470602; Spribille T, 2011, MOL PHYLOGENET EVOL, V59, P603, DOI 10.1016/j.ympev.2011.03.021; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stenroos SK, 1998, AM J BOT, V85, P1548, DOI 10.2307/2446481; Tehler A, 2001, LICHENOLOGIST, V33, P403, DOI 10.1006/lich.2001.0342; Tehler A, 2007, CLADISTICS, V23, P432, DOI 10.1111/j.1096-0031.2007.00156.x; Thell A., 2009, BIBLIOTHECA LICHENOL, V99, P393; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; Velmala S, 2009, LICHENOLOGIST, V41, P231, DOI 10.1017/S0024282909008573; Verdon D, 1986, BRUNONIA, V9, P193, DOI DOI 10.1071/BRU9860193; Vondrak J, 2009, LICHENOLOGIST, V41, P571, DOI 10.1017/S0024282909008317; Vuataz L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019728; Wedin M, 1999, MYCOL RES, V103, P1131, DOI 10.1017/S0953756298008223; Wedin M, 2009, CLADISTICS, V25, P161, DOI 10.1111/j.1096-0031.2009.00240.x; White F.J., 1985, BRIT LICHEN SOC, V57, P1; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wiens JJ, 2002, SYST BIOL, V51, P69, DOI 10.1080/106351502753475880; Wirtz N, 2008, MYCOL RES, V112, P472, DOI 10.1016/j.mycres.2007.05.006; Wirtz N, 2012, ORG DIVERS EVOL, V12, P17, DOI 10.1007/s13127-011-0066-y; Zhou QM, 2006, J HATTORI BOT LAB, P871	123	51	52	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52245	10.1371/journal.pone.0052245	http://dx.doi.org/10.1371/journal.pone.0052245			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272229	Green Published, gold, Green Submitted			2022-12-27	WOS:000312483300072
J	Yang, J; Chen, JY; Yan, JY; Zhang, LP; Chen, G; He, LQ; Wang, YL				Yang, Jun; Chen, Jiyuan; Yan, Jingyin; Zhang, Liping; Chen, Gang; He, Liqun; Wang, Yanlin			Effect of Interleukin 6 Deficiency on Renal Interstitial Fibrosis	PLOS ONE			English	Article							EXPERIMENTAL GLOMERULONEPHRITIS; CIRCULATING FIBROCYTES; PERIPHERAL-BLOOD; T-CELLS; MYOFIBROBLASTS; DISEASE; DIFFERENTIATION; PROGRESSION; INFLAMMATION; FIBROBLAST	Our recent studies have shown that bone marrow-derived fibroblast precursors contribute significantly to the pathogenesis of renal fibrosis. However, the molecular mechanisms underlying the recruitment and activation of bone marrow-derived fibroblast precursors are incompletely understood. We found that interleukin 6 was induced in the kidney in a murine model of renal fibrosis induced by unilateral ureteral obstruction. Therefore, we investigated if interleukin 6 play a role in the recruitment and maturation of bone marrow-derived fibroblast precursors in the kidney during the development of renal fibrosis. Wild-type and interleukin 6 knockout mice were subjected to unilateral obstructive injury for up to two weeks. Interleukin 6 knockout mice accumulated similar number of bone marrow-derived fibroblast precursors and myofibroblasts in the kidney in response to obstructive injury compared to wild-type mice. Furthermore, IL-6 knockout mice expressed comparable alpha-SMA in the obstructed kidney compared to wild-type mice. Moreover, targeted disruption of Interleukin 6 did not affect gene expression of profibrotic chemokine and cytokines in the obstructed kidney. Finally, there were no significant differences in renal interstitial fibrosis or expression of extracellular matrix proteins between wild-type and interleukin 6 knockout mice following obstructive injury. Our results indicate that interleukin 6 does not play a significant role in the recruitment of bone marrow-derived fibroblast precursors and the development of renal fibrosis. Citation: Yang J, Chen J, Yan J, Zhang L, Chen G, et al. (2012) Effect of Interleukin 6 Deficiency on Renal Interstitial Fibrosis. PLoS ONE 7(12): e52415. doi:10.1371/journal.pone.0052415	[Yang, Jun; Chen, Jiyuan; Yan, Jingyin; Zhang, Liping; Wang, Yanlin] Baylor Coll Med, Dept Med, Div Nephrol, Houston, TX 77030 USA; [Yang, Jun] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Urol, Wuhan 430074, Hubei, Peoples R China; [Chen, Gang; He, Liqun] Shuguang Hosp, Dept Nephrol, Shanghai, Peoples R China	Baylor College of Medicine; Huazhong University of Science & Technology	Wang, YL (corresponding author), Baylor Coll Med, Dept Med, Div Nephrol, Houston, TX 77030 USA.	yanlinw@bcm.edu			NIH [K08HL092958, R01DK095835]; AHA grant [BGIA7840054]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL092958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095835] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by NIH grants - K08HL092958 and R01DK095835, an AHA grant - BGIA7840054, and a grant from Dr. and Mrs. Harold Selzman (to YW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556; BORDER WA, 1990, NATURE, V346, P371, DOI 10.1038/346371a0; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Broekema M, 2007, J AM SOC NEPHROL, V18, P165, DOI 10.1681/ASN.2005070730; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; CHEEVER AW, 1994, J IMMUNOL, V153, P753; Chen G, 2011, J AM SOC NEPHROL, V22, P1876, DOI 10.1681/ASN.2010080881; Cieslik KA, 2011, J MOL CELL CARDIOL, V50, P248, DOI 10.1016/j.yjmcc.2010.10.019; Eddy AA, 2005, ADV CHRONIC KIDNEY D, V12, P353, DOI 10.1053/j.ackd.2005.07.011; Eddy AA, 2000, PEDIATR NEPHROL, V15, P290, DOI 10.1007/s004670000461; Essawy M, 1997, NEPHROL DIAL TRANSPL, V12, P43, DOI 10.1093/ndt/12.1.43; Finkelman FD, 1999, CURR OPIN IMMUNOL, V11, P420, DOI 10.1016/S0952-7915(99)80070-3; Gadient RA, 1999, STEM CELLS, V17, P127, DOI 10.1002/stem.170127; Garcia GE, 2007, AM J PATHOL, V170, P1485, DOI 10.2353/ajpath.2007.060065; Grimm PC, 2001, NEW ENGL J MED, V345, P93, DOI 10.1056/NEJM200107123450203; Haudek SB, 2008, P NATL ACAD SCI USA, V105, P10179, DOI 10.1073/pnas.0804910105; Kielar ML, 2005, J AM SOC NEPHROL, V16, P3315, DOI 10.1681/asn.2003090757; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Li JH, 2007, STEM CELLS, V25, P697, DOI 10.1634/stemcells.2006-0133; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Matloubian M, 2000, NAT IMMUNOL, V1, P298, DOI 10.1038/79738; Metz CN, 2003, CELL MOL LIFE SCI, V60, P1342, DOI 10.1007/s00018-003-2328-0; Nath KA, 1998, KIDNEY INT, V54, P992, DOI 10.1046/j.1523-1755.1998.00079.x; Nechemia-Arbely Y, 2008, J AM SOC NEPHROL, V19, P1106, DOI 10.1681/ASN.2007070744; Neilson EG, 2006, NAT CLIN PRACT NEPHR, V2, P101, DOI 10.1038/ncpneph0093; Niedermeier M, 2009, P NATL ACAD SCI USA, V106, P17892, DOI 10.1073/pnas.0906070106; Pecoits R, 2003, NEPHROL DIAL TRANSPL, V18, P1042, DOI 10.1093/ndt/gfg111; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1, DOI 10.1152/ajpcell.1999.277.1.C1; Quan TE, 2004, INT J BIOCHEM CELL B, V36, P598, DOI 10.1016/j.biocel.2003.10.005; Roberts ISD, 1997, J CLIN PATHOL, V50, P123, DOI 10.1136/jcp.50.2.123; Sakai N, 2006, P NATL ACAD SCI USA, V103, P14098, DOI 10.1073/pnas.0511200103; Schainuck L I, 1970, Hum Pathol, V1, P631, DOI 10.1016/S0046-8177(70)80061-2; Shao DD, 2008, J LEUKOCYTE BIOL, V83, P1323, DOI 10.1189/jlb.1107782; Strutz F, 2006, NEPHROL DIAL TRANSPL, V21, P3368, DOI 10.1093/ndt/gfl199; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; ZHANG G, 1995, EXP NEPHROL, V3, P308; Zhang LP, 2009, AM J PATHOL, V175, P2518, DOI 10.2353/ajpath.2009.090275	38	32	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52415	10.1371/journal.pone.0052415	http://dx.doi.org/10.1371/journal.pone.0052415			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272241	gold, Green Published, Green Submitted			2022-12-27	WOS:000312483300083
J	Fuxjager, MJ; Barske, J; Du, SM; Day, LB; Schlinger, BA				Fuxjager, Matthew J.; Barske, Julia; Du, Sienmi; Day, Lainy B.; Schlinger, Barney A.			Androgens Regulate Gene Expression in Avian Skeletal Muscles	PLOS ONE			English	Article							RECEPTOR MESSENGER-RNA; SPEED VIDEO ANALYSIS; ESTROGEN-RECEPTOR; STEROID-RECEPTORS; RELAXATION SPEED; SEX STEROIDS; IGF-I; TESTOSTERONE; MYOSTATIN; COURTSHIP	Circulating androgens in adult reproductively active male vertebrates influence a diversity of organ systems and thus are considered costly. Recently, we obtained evidence that androgen receptors (AR) are expressed in several skeletal muscles of three passeriform birds, the golden-collared manakin (Manacus vitellinus), zebra finch (Taenopygia guttata), and ochrebellied flycatcher (Mionectes oleagieus). Because skeletal muscles that control wing movement make up the bulk of a bird's body mass, evidence for widespread effects of androgen action on these muscles would greatly expand the functional impact of androgens beyond their well-characterized effects on relatively discrete targets throughout the avian body. To investigate this issue, we use quantitative PCR (qPCR) to determine if androgens alter gene mRNA expression patterns in wing musculature of wild golden-collared manakins and captive zebra finches. In manakins, the androgen testosterone (T) up-regulated expression of parvalbumin (PV) and insulin-like growth factor I (IGF-I), two genes whose products enhance cellular Ca2+ cycling and hypertrophy of skeletal muscle fibers. In T-treated zebra finches, the anti-androgen flutamide blunted PV and IGF-I expression. These results suggest that certain transcriptional effects of androgen action via AR are conserved in passerine skeletal muscle tissue. When we examined wing muscles of manakins, zebra finches and ochrebellied flycatchers, we found that expression of PV and IGF-I varied across species and in a manner consistent with a function for AR-dependent gene regulation. Together, these findings imply that androgens have the potential to act on avian muscle in a way that may enhance the physicality required for successful reproduction.	[Fuxjager, Matthew J.; Du, Sienmi; Schlinger, Barney A.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Barske, Julia; Schlinger, Barney A.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Fuxjager, Matthew J.; Du, Sienmi; Schlinger, Barney A.] Univ Calif Los Angeles, Brain Res Inst, Neuroendocrinol Lab, Los Angeles, CA 90024 USA; [Day, Lainy B.] Univ Mississippi, Dept Biol, University, MS 38677 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Mississippi	Fuxjager, MJ (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA.	mfoxhunter@gmail.com		Day, Lainy/0000-0002-9122-3044	National Institutes of Health [T32 HD007228]; National Science Foundation [IOS 0646459]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065823] Funding Source: NIH RePORTER; Direct For Biological Sciences [1122180] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	M.J.F. was supported in part by National Institutes of Health training grant T32 HD007228 awarded to the Laboratory of Neuroendocrinology at UCLA. The research was funded by National Science Foundation grant IOS 0646459 (to BAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins-Regan E., 2005, HORMONES ANIMAL SOCI; Ball GF, 2003, ANN NY ACAD SCI, V1007, P211, DOI 10.1196/annals.1286.021; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; Barske J, 2011, P ROY SOC B-BIOL SCI, V278, P3523, DOI 10.1098/rspb.2011.0382; Bostwick KS, 2010, P R SOC B, V277, P835, DOI 10.1098/rspb.2009.1576; Bostwick KS, 2003, J EXP BIOL, V206, P3693, DOI 10.1242/jeb.00598; BRANTLEY RK, 1993, J MORPHOL, V216, P305, DOI 10.1002/jmor.1052160306; Buttemer WA, 2008, COMP BIOCHEM PHYS A, V150, P204, DOI 10.1016/j.cbpa.2006.06.047; Canoine V, 2007, DEV NEUROBIOL, V67, P57, DOI 10.1002/dneu.20296; Casto JM, 2001, AM NAT, V157, P408, DOI 10.1086/319318; CELIO MR, 1982, NATURE, V297, P504, DOI 10.1038/297504a0; Chapman F.M., 1935, B AM MUS NAT HIST, V68, P472; Chappell MA, 1997, BEHAVIOUR, V134, P511, DOI 10.1163/156853997X00502; Clark CJ, 2011, SCIENCE, V333, P1430, DOI 10.1126/science.1205222; COLEMAN ME, 1995, J BIOL CHEM, V270, P12109, DOI 10.1074/jbc.270.20.12109; CREWS D, 1986, SCIENCE, V231, P121, DOI 10.1126/science.3941893; DAAN S, 1990, AM J PHYSIOL, V259, pR333, DOI 10.1152/ajpregu.1990.259.2.R333; Day LB, 2007, HORM BEHAV, V51, P69, DOI 10.1016/j.yhbeh.2006.08.006; Day LB, 2006, HORM BEHAV, V49, P223, DOI 10.1016/j.yhbeh.2005.07.006; Duffy DL, 2000, BEHAV ECOL, V11, P654, DOI 10.1093/beheco/11.6.654; Feng NY, 2010, ENDOCRINOLOGY, V151, P1042, DOI 10.1210/en.2009-0901; Fusani L, 2007, ETHOLOGY, V113, P964, DOI 10.1111/j.1439-0310.2007.01395.x; Fusani L, 2007, HORM BEHAV, V51, P62, DOI 10.1016/j.yhbeh.2006.08.005; Fuxjager MJ, 2012, ENDOCRINOLOGY, V153, P3780, DOI 10.1210/en.2012-1313; Goymann W, 2007, HORM BEHAV, V51, P463, DOI 10.1016/j.yhbeh.2007.01.007; GROSSMAN CJ, 1985, SCIENCE, V227, P257, DOI 10.1126/science.3871252; Gu Z, 2004, ANIM GENET, V35, P470, DOI 10.1111/j.1365-2052.2004.01194.x; Guernec A, 2004, DOMEST ANIM ENDOCRIN, V26, P143, DOI 10.1016/j.domaniend.2003.10.001; HARTMAN FRANK A., 1961, SMITHSONIAN MISC COLL, V143, P1; Hau M, 2007, BIOESSAYS, V29, P133, DOI 10.1002/bies.20524; HEDENSTROM A, 1992, P ROY SOC B-BIOL SCI, V247, P183, DOI 10.1098/rspb.1992.0026; HEGNER RE, 1987, AUK, V104, P462, DOI 10.2307/4087545; HEIZMANN CW, 1982, P NATL ACAD SCI-BIOL, V79, P7243, DOI 10.1073/pnas.79.23.7243; Hirschenhauser K, 2003, HORM BEHAV, V43, P508, DOI 10.1016/S0018-506X(03)00027-8; HOU TT, 1991, J PHYSIOL-LONDON, V441, P285, DOI 10.1113/jphysiol.1991.sp018752; KETTERSON ED, 1992, AM NAT, V140, P980, DOI 10.1086/285451; KREBS HA, 1950, BIOCHIM BIOPHYS ACTA, V4, P249, DOI 10.1016/0006-3002(50)90032-1; Langley B, 2002, J BIOL CHEM, V277, P49831, DOI 10.1074/jbc.M204291200; Larsen ON, 2002, J EXP BIOL, V205, P25; Leska A, 2012, GEN COMP ENDOCR, V179, P63, DOI 10.1016/j.ygcen.2012.07.026; MARDEN JH, 1987, J EXP BIOL, V130, P235; Matheny RW, 2011, ENDOCRINOLOGY, V152, P1923, DOI 10.1210/en.2010-1279; McGraw KJ, 2007, BIOL LETTERS, V3, P375, DOI 10.1098/rsbl.2007.0190; McGraw KJ, 2006, BEHAV ECOL SOCIOBIOL, V60, P117, DOI 10.1007/s00265-005-0135-3; Mendler L, 2007, BIOCHEM BIOPH RES CO, V361, P237, DOI 10.1016/j.bbrc.2007.07.023; Metzdorf R, 1999, J COMP NEUROL, V407, P115; Mosler S, 2012, ARCH TOXICOL, V86, P109, DOI 10.1007/s00204-011-0740-z; Mozdziak PE, 1998, J APPL PHYSIOL, V84, P1359, DOI 10.1152/jappl.1998.84.4.1359; MUNTENER M, 1995, P NATL ACAD SCI USA, V92, P6504, DOI 10.1073/pnas.92.14.6504; Noriega NC, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-47; ORING LEWIS W., 1964, AUK, V81, P83; Price ER, 2011, J EXP BIOL, V214, P2823, DOI 10.1242/jeb.057620; RAND MN, 1992, J NEUROBIOL, V23, P17, DOI 10.1002/neu.480230104; REGNIER M, 1993, J PHYSIOL-LONDON, V461, P565, DOI 10.1113/jphysiol.1993.sp019529; REGNIER M, 1993, J NEUROBIOL, V24, P1215, DOI 10.1002/neu.480240908; RUBINSTEIN NA, 1983, EXP NEUROL, V82, P424, DOI 10.1016/0014-4886(83)90414-4; Sacheck JM, 2004, AM J PHYSIOL-ENDOC M, V287, pE591, DOI 10.1152/ajpendo.00073.2004; Schlinger BA, 2008, GEN COMP ENDOCR, V157, P254, DOI 10.1016/j.ygcen.2008.05.015; Schultz JD, 2001, J COMP PHYSIOL A, V187, P677; Serra C, 2011, ENDOCRINOLOGY, V152, P193, DOI 10.1210/en.2010-0802; Seward DJ, 2001, AM J PHYSIOL-CELL PH, V280, pC408, DOI 10.1152/ajpcell.2001.280.2.C408; Sibley CG, 1990, DISTRIBUTION TAXONOM; Singh R, 2003, ENDOCRINOLOGY, V144, P5081, DOI 10.1210/en.2003-0741; Swanson DL, 2009, PHYSL BIOCH ZOOL, V82; Thomas M, 2000, J BIOL CHEM, V275, P40235, DOI 10.1074/jbc.M004356200; TOBIAS ML, 1993, J NEUROSCI, V13, P324; Tomaszycki ML, 2006, HORM BEHAV, V50, P141, DOI 10.1016/j.yhbeh.2006.02.005; Tramontin AD, 2003, J NEUROBIOL, V57, P130, DOI 10.1002/neu.10263; Veney SL, 2004, GEN COMP ENDOCR, V136, P192, DOI 10.1016/j.ygcen.2003.12.017; VORNBERGER W, 1994, ENDOCRINOLOGY, V134, P2307, DOI 10.1210/en.134.5.2307; Wade J, 2000, J COMP NEUROL, V426, P154; Wainman P, 1941, ENDOCRINOLOGY, V29, P975, DOI 10.1210/endo-29-6-975; WESTCOTT DA, 1994, CONDOR, V96, P672, DOI 10.2307/1369470; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; Wood RI, 1999, J NEUROBIOL, V39, P359, DOI 10.1002/(SICI)1097-4695(19990605)39:3<359::AID-NEU3>3.0.CO;2-W; Wyce A, 2010, MOL ENDOCRINOL, V24, P1665, DOI 10.1210/me.2010-0138; Yoshioka M, 2006, J MOL ENDOCRINOL, V36, P247, DOI 10.1677/jme.1.01964; ZOPPI S, 1988, J STEROID BIOCHEM, V31, P677, DOI 10.1016/0022-4731(88)90018-0	78	39	39	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51482	10.1371/journal.pone.0051482	http://dx.doi.org/10.1371/journal.pone.0051482			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284699	Green Submitted, Green Published, gold			2022-12-27	WOS:000312435900022
J	Glennie, SJ; Banda, D; Mulwafu, W; Nkhata, R; Williams, NA; Heyderman, RS				Glennie, Sarah J.; Banda, Dominic; Mulwafu, Wakisa; Nkhata, Rose; Williams, Neil A.; Heyderman, Robert S.			Regulation of Naturally Acquired Mucosal Immunity to Streptococcus pneumoniae in Healthy Malawian Adults and Children	PLOS ONE			English	Article							NEISSERIA-MENINGITIDIS; PNEUMOCOCCAL CARRIAGE; CELL MEMORY; COLONIZATION; PROTECTION; ANTIBODIES; ANTIGENS	Worldwide, invasive pneumococcal disease caused by Streptococcus pneumoniae is most common in young children. In adults, disease rates decline following intermittent colonization and the acquisition of naturally acquired immunity. We characterized mucosal and systemic pneumococcal-specific T-cell responses in African children and adults who contend with intense rates of colonization, up to 100% and 60% respectively. We find most Malawian children have high pneumococcal-specific T-cell responses in tonsil tissue and peripheral blood. In addition, frequent commensalism generates CD25(hi) (Tregs) which modulate mucosal pneumococcal-specific T-cell responses in some children and >= 50% of adults. We propose that immune regulation may prolong pneumococcal colonization and predispose vulnerable individuals to disease.	[Glennie, Sarah J.; Banda, Dominic; Nkhata, Rose; Heyderman, Robert S.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Glennie, Sarah J.; Heyderman, Robert S.] Univ Liverpool, Liverpool Sch Trop Med, Clin Grp, Liverpool L3 5QA, Merseyside, England; [Mulwafu, Wakisa] Univ Malawi, Coll Med, Dept Surg, Blantyre, Malawi; [Williams, Neil A.] Univ Bristol, Sch Med Sci, Bristol BS8 1TD, Avon, England	University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool; University of Malawi; University of Bristol	Glennie, SJ (corresponding author), Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi.	sarah.glennie@liverpool.ac.uk		Heyderman, Robert/0000-0003-4573-449X	Wellcome Trust (United Kingdom) [083603/A/07/Z, 084679/Z/08/Z]	Wellcome Trust (United Kingdom)(Wellcome Trust)	This work was supported by a grant to NAW and RSH by the Wellcome Trust "083603/A/07/Z" (United Kingdom), a core programme grant to RSH by the Wellcome Trust "084679/Z/08/Z" (United Kingdom). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Darboe MK, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-195; Davenport V, 2008, J INFECT DIS, V198, P731, DOI 10.1086/590669; Davenport V, 2007, CELL MICROBIOL, V9, P1050, DOI 10.1111/j.1462-5822.2006.00851.x; Ferreira DM, 2011, TRENDS MICROBIOL, V19, P464, DOI 10.1016/j.tim.2011.06.003; French N, N ENGL J MED, V362, P812; Glennie SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025610; Glennie SJ, 2010, TRENDS MICROBIOL, V18, P487, DOI 10.1016/j.tim.2010.08.002; Iwajomo OH, 2011, J INFECT DIS, V204, P534, DOI 10.1093/infdis/jir316; Jambo KC, 2011, THORAX, V66, P375, DOI 10.1136/thx.2010.153825; Lipsitch M, 2005, PLOS MED, V2, P62, DOI 10.1371/journal.pmed.0020015; Mureithi MW, 2009, J INFECT DIS, V200, P783, DOI 10.1086/605023; Pido-Lopez J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002396; Trzcinski K, 2005, INFECT IMMUN, V73, P7043, DOI 10.1128/IAI.73.10.7043-7046.2005; Whitney CG, 2002, PEDIATR INFECT DIS J, V21, P961, DOI 10.1097/00006454-200210000-00016; Zhang QB, 2002, INFECT IMMUN, V70, P5363, DOI 10.1128/IAI.70.10.5363-5369.2002; Zhang QB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002175	17	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51425	10.1371/journal.pone.0051425	http://dx.doi.org/10.1371/journal.pone.0051425			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284694	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000312435900020
J	Smith, LM; Schiess, MC; Coffey, MP; Klaver, AC; Loeffler, DA				Smith, Lynnae M.; Schiess, Mya C.; Coffey, Mary P.; Klaver, Andrea C.; Loeffler, David A.			alpha-Synuclein and Anti-alpha-Synuclein Antibodies in Parkinson's Disease, Atypical Parkinson Syndromes, REM Sleep Behavior Disorder, and Healthy Controls	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; LEWY BODY; ELEVATED LEVELS; HUMAN PLASMA; AUTOANTIBODIES; AGGREGATION; DUPLICATION; BIOMARKER; DEMENTIA; MUTATION	alpha-synuclein is thought to play a key role in Parkinson's disease (PD) because it is the major protein in Lewy bodies, and because its gene mutations, duplication, and triplication are associated with early-onset PD. There are conflicting reports as to whether serum and plasma concentrations of alpha-synuclein and anti-alpha-synuclein antibodies differ between PD and control subjects. The objectives of this study were to compare the levels of alpha-synuclein and its antibodies between individuals with typical PD (n = 14), atypical Parkinson syndromes (n = 11), idiopathic rapid eye movement sleep behavior disorder (n = 10), and healthy controls (n = 9), to assess the strength of association between these serum proteins, and to determine group sizes needed for a high probability (80% power) of detecting statistical significance for 25% or 50% differences between typical PD and control subjects for these measurements. Analysis of log-transformed data found no statistically significant differences between groups for either alpha-synuclein or its antibodies. The concentrations of these proteins were weakly correlated (Spearman rho = 0.16). In subjects with typical PD and atypical Parkinson syndromes, anti-alpha-synuclein antibody levels above 1.5 mu g/ ml were detected only in subjects with no more than four years of clinical disease. Power analysis indicated that 236 and 73 samples per group would be required for an 80% probability that 25% and 50% differences, respectively, in mean alpha-synuclein levels between typical PD and control subjects would be statistically significant; for anti-asynuclein antibodies, 283 and 87 samples per group would be required. Our findings are consistent with those previous studies which suggested that serum concentrations of alpha-synuclein and its antibodies are not significantly altered in PD.	[Smith, Lynnae M.; Klaver, Andrea C.; Loeffler, David A.] Beaumont Hlth Syst, Dept Neurol Res, Royal Oak, MI USA; [Schiess, Mya C.] Univ Texas Houston, Sch Med, Dept Neurol, Houston, TX USA; [Coffey, Mary P.] Beaumont Hlth Syst, Dept Biostat, Royal Oak, MI USA	Beaumont Health; University of Texas System; University of Texas Health Science Center Houston; Beaumont Health	Loeffler, DA (corresponding author), Beaumont Hlth Syst, Dept Neurol Res, Royal Oak, MI USA.	DLoeffler@beaumont.edu			Oakland University - Beaumont Hospital	Oakland University - Beaumont Hospital	This study was supported by an Oakland University - Beaumont Hospital Multidisciplinary Grant and a donation from the family of Mr. Norman Merollis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba M, 1998, AM J PATHOL, V152, P879; Barbour R, 2008, NEURODEGENER DIS, V5, P55, DOI 10.1159/000112832; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Borghi R, 2000, NEUROSCI LETT, V287, P65, DOI 10.1016/S0304-3940(00)01153-8; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Duran R, 2010, MOVEMENT DISORD, V25, P489, DOI 10.1002/mds.22928; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Fahn S., 1987, RECENT DEV PARKINSON, P153; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Foulds PG, 2011, FASEB J, V25, P4127, DOI 10.1096/fj.10-179192; Gruden MA, 2012, NEUROIMMUNOMODULAT, V19, P334, DOI 10.1159/000341400; Gruden MA, 2011, J NEUROIMMUNOL, V233, P221, DOI 10.1016/j.jneuroim.2010.12.001; Hintze J., 2011, PASS11; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Iranzo A, 2011, J NEUROL SCI, V310, P283, DOI 10.1016/j.jns.2011.07.049; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Jellinger KA, 2003, MOVEMENT DISORD, V18, pS2, DOI 10.1002/mds.10557; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Laske C, 2011, DEMENT GERIATR COGN, V31, P413, DOI 10.1159/000329763; Lee PH, 2006, J NEURAL TRANSM, V113, P1435, DOI 10.1007/s00702-005-0427-9; Li QX, 2007, EXP NEUROL, V204, P583, DOI 10.1016/j.expneurol.2006.12.006; Maetzler W, 2011, J ALZHEIMERS DIS, V26, P171, DOI 10.3233/JAD-2011-110221; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; Masliah E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019338; Mollenhauer B, 2011, LANCET NEUROL, V10, P230, DOI 10.1016/S1474-4422(11)70014-X; Papachroni KK, 2007, J NEUROCHEM, V101, P749, DOI 10.1111/j.1471-4159.2006.04365.x; Park MJ, 2011, J CLIN NEUROL, V7, P215, DOI 10.3988/jcn.2011.7.4.215; Patrias LM, 2010, CLIN EXP IMMUNOL, V161, P527, DOI 10.1111/j.1365-2249.2010.04214.x; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; *SAS I, 2008, SAS SYST WIND VERS 9; Schenck CH, 1996, NEUROLOGY, V46, P388, DOI 10.1212/WNL.46.2.388; Schrag A, 2006, LANCET NEUROL, V5, P355, DOI 10.1016/S1474-4422(06)70411-2; Shi M, 2010, NEUROSCI LETT, V480, P78, DOI 10.1016/j.neulet.2010.06.009; Sidhu A, 2004, ANN NY ACAD SCI, V1035, P250, DOI 10.1196/annals.1332.016; Smith LM, 2012, INT IMMUNOPHARMACOL, V14, P550, DOI 10.1016/j.intimp.2012.09.007; Tokuda T, 2010, NEUROLOGY, V75, P1766, DOI 10.1212/WNL.0b013e3181fd613b; Wakabayashi K, 2007, NEUROPATHOLOGY, V27, P494, DOI 10.1111/j.1440-1789.2007.00803.x; Woulfe J, 2000, NEUROLOGY, V55, P1398, DOI 10.1212/WNL.55.9.1398; Woulfe JM, 2002, NEUROLOGY, V58, P1435, DOI 10.1212/WNL.58.9.1435; Yanamandra K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018513	43	44	49	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52285	10.1371/journal.pone.0052285	http://dx.doi.org/10.1371/journal.pone.0052285			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284971	Green Published, Green Submitted, gold			2022-12-27	WOS:000312435900087
J	Carlson, JE; Holsinger, KE				Carlson, Jane E.; Holsinger, Kent E.			Developmental Plasticity in Protea as an Evolutionary Response to Environmental Clines in the Cape Floristic Region	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; ECOLOGICAL SPECIATION; BIODIVERSITY HOTSPOT; NATURAL-SELECTION; PLANT; ADAPTATION; DIVERSITY; TRAITS; DIFFERENTIATION; EXPRESSION	Local adaptation along steep environmental gradients likely contributes to plant diversity in the Cape Region of South Africa, yet existing analyses of trait divergence are limited to static measurements of functional traits rather than trajectories of individual development. We explore whether five taxa of evergreen shrubs (Protea section Exsertae) differ in their developmental trajectories and capacity for plasticity using two environmentally-distinct common gardens in South Africa. We measured seedlings in the summer-dry season and winter-wet season of each of two consecutive years to characterize ontogeny and plasticity within years, as same-age leaf cohorts mature, and between years, i.e., from leaf one cohort to the next. We compared patterns of development between gardens to assess whether trait trajectories are programmed versus plastic and examined whether developmental differences covaried with characteristics of a seedling's home environment. We detected plasticity in developmental trajectories for leaf area, stomatal size, stomatal pore index, and to a limited extent specific leaf area, but not for stomatal density. We showed that the species growing in the harshest environments exhibits both the smallest increase in leaf area between years and the least change in SLA and photosynthetic rates as leaves age within years. These results show that within this clade, species have diverged in developmental trajectories and plasticity as well as in mean trait values. Some of these differences may be associated with adaptation to cold and drought stress within an environmentally-complex region. Citation: Carlson JE, Holsinger KE (2012) Developmental Plasticity in Protea as an Evolutionary Response to Environmental Clines in the Cape Floristic Region. PLoS ONE 7(12): e52035. doi:10.1371/journal.pone.0052035	[Carlson, Jane E.; Holsinger, Kent E.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT USA	University of Connecticut	Holsinger, KE (corresponding author), Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT USA.	kent.holsinger@uconn.edu	Holsinger, Kent/A-7435-2009	Holsinger, Kent/0000-0003-4312-3804; , Jane/0000-0003-2902-6055	United States National Science Foundation [DEB-0716622, DEB-1046328]; Direct For Biological Sciences [1046328] Funding Source: National Science Foundation	United States National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grants from the United States National Science Foundation: DEB-0716622 and DEB-1046328. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2008, J ECOL, V96, P536, DOI 10.1111/j.1365-2745.2008.01365.x; Alpert P, 2002, EVOL ECOL, V16, P285, DOI 10.1023/A:1019684612767; [Anonymous], 2006, SAS MIXED MODELS; ANTONOVICS J., 1971, Advances in Ecological Research, V7, P1, DOI 10.1016/S0065-2504(08)60202-0; Bell DL, 1999, AM J BOT, V86, P807, DOI 10.2307/2656702; Bukhov NG, 2004, CHLOROPHYLL FLUORESC; Carlson JE, 2011, EVOLUTION, V65, P108, DOI 10.1111/j.1558-5646.2010.01131.x; Carlson JE, 2010, AM J BOT, V97, P934, DOI 10.3732/ajb.0900348; Clausen J D, 1940, USITC PUBL; COOK SA, 1968, EVOLUTION, V22, P496, DOI 10.1111/j.1558-5646.1968.tb03988.x; Cowling RM, 1996, TRENDS ECOL EVOL, V11, P362, DOI 10.1016/0169-5347(96)10044-6; Cowling RM, 2002, DIVERS DISTRIB, V8; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; DIGGLE PK, 1994, AM J BOT, V81, P1354, DOI 10.2307/2445411; Diggle PK, 2002, EVOL ECOL, V16, P267, DOI 10.1023/A:1019680527788; Distler T, 2009, ANN MO BOT GARD, V96, P470, DOI 10.3417/2008034; Dunlap JM, 2001, CAN J BOT, V79, P528, DOI 10.1139/cjb-79-5-528; Edwards EJ, 2006, NEW PHYTOL, V172, P479, DOI 10.1111/j.1469-8137.2006.01850.x; Ellis AG, 2006, J ECOL, V94, P322, DOI 10.1111/j.1365-2745.2005.01074.x; FENSTER CB, 1991, EVOLUTION, V45, P398, DOI 10.1111/j.1558-5646.1991.tb04413.x; Forster MA, 2009, ANN BOT-LONDON, V103, P95, DOI 10.1093/aob/mcn210; Forsyth GG, 2007, CSIRNREECOER20070118; Franks PJ, 2009, PLANT CELL ENVIRON, V32, P1737, DOI [10.1111/j.1365-3040.2009.02031.x, 10.1111/j.1365-3040.2009.002031.x]; Friar EA, 2006, EVOLUTION, V60, P1777; Geber MA, 2003, INTERNATIONAL JOURNA, V164; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Gianoli E, 2005, EVOL ECOL, V19, P603, DOI 10.1007/s10682-005-2220-5; Goldblatt P., 2000, CAPE PLANTS A CONSPE; GOLIBER TE, 1990, AM J BOT, V77, P399, DOI 10.2307/2444726; Grime J. P., 1979, Plant strategies and vegetation processes.; Heschel MS, 2001, INT J PLANT SCI, V162, P1253, DOI 10.1086/322951; Jones C. S., 2001, B SOC ARGENT BOT, V36, P171; JONES CS, 1993, AM J BOT, V80, P778, DOI 10.2307/2445598; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; Latimer AM, 2009, OECOLOGIA, V160, P151, DOI 10.1007/s00442-009-1275-3; Linder HP, 2003, BIOL REV, V78, P597, DOI 10.1017/S1464793103006171; Linder HP, 2005, TRENDS PLANT SCI, V10, P536, DOI 10.1016/j.tplants.2005.09.006; Maherali H, 2009, NEW PHYTOL, V183, P908, DOI 10.1111/j.1469-8137.2009.02845.x; Maron JL, 2007, EVOLUTION, V61, P1912, DOI 10.1111/j.1558-5646.2007.00153.x; Masle J, 2005, NATURE, V436, P866, DOI 10.1038/nature03835; Paakkonen E, 1998, ANN BOT-LONDON, V82, P49, DOI 10.1006/anbo.1998.0656; Picotte JJ, 2007, OECOLOGIA, V153, P821, DOI 10.1007/s00442-007-0794-z; Prunier R, JOURNAL OF EVOLUTION; Prunier R, 2010, MOL ECOL, V19, P3968, DOI 10.1111/j.1365-294X.2010.04779.x; Qian H, 2000, NATURE, V407, P180, DOI 10.1038/35025052; Rebelo AG, 2004, PROTEA ATLAS PROJECT; Reich PB, 2003, INT J PLANT SCI, V164, pS143, DOI 10.1086/374368; Reynoso-Castillo GA, 2001, ACTA HORT ISHS, V545, P245; RICHARDSON DM, 1990, S AFR J BOT, V56, P214, DOI 10.1016/S0254-6299(16)31089-4; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rubin DB, 1996, J AM STAT ASSOC, V91, P473, DOI 10.1080/01621459.1996.10476908; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Rubin DB., 1987, MULTIPLE IMPUTATION, DOI 10.1002/9780470316696; Sack L, 2006, ANNU REV PLANT BIOL, V57, P361, DOI 10.1146/annurev.arplant.56.032604.144141; SAS Institute Inc, 2008, SAS STAT 9 2 USERS G; SAVILLE DJ, 1990, AM STAT, V44, P174, DOI 10.2307/2684163; Saville DJ, 2003, CAN J EXP PSYCHOL, V57, P167, DOI 10.1037/h0087423; Schlichting CD, 1998, PHENOTYPIC EVOLUTION; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Schnitzler J, 2011, SYST BIOL, V60, P343, DOI 10.1093/sysbio/syr006; Schulze R.E., 2007, 1489106 WRC; Stock W. D., 1997, P376; Sultan SE, 2003, EVOL DEV, V5, P25, DOI 10.1046/j.1525-142X.2003.03005.x; SULTAN SE, 1992, EVOL TREND PLANT, V6, P61; Valente LM, 2010, EVOLUTION, V64, P745, DOI 10.1111/j.1558-5646.2009.00856.x; van Kleunen M, 2005, NEW PHYTOL, V166, P49, DOI 10.1111/j.1469-8137.2004.01296.x; Verboom GA, 2004, AM J BOT, V91, P1364, DOI 10.3732/ajb.91.9.1364; WATSON MA, 1995, TRENDS ECOL EVOL, V10, P474; West-Eberhard Mary Jane, 2003, pi; Yu H, 2008, PLANT CELL, V20, P1134, DOI 10.1105/tpc.108.058263; Yuan Y, 2000, PROCEEDINGS OF THE 2	72	9	10	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e52035	10.1371/journal.pone.0052035	http://dx.doi.org/10.1371/journal.pone.0052035			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272203	gold, Green Published, Green Submitted			2022-12-27	WOS:000312386600054
J	Degaki, KY; Chen, ZL; Yamada, AT; Croy, BA				Degaki, Karina Y.; Chen, Zhilin; Yamada, Aureo T.; Croy, B. Anne			Delta-Like Ligand (DLL)1 Expression in Early Mouse Decidua and Its Localization to Uterine Natural Killer Cells	PLOS ONE			English	Article							INTERFERON-GAMMA CONTRIBUTES; GENE-EXPRESSION; NK CELLS; DECIDUALIZATION; DIFFERENTIATION; IMPLANTATION; ANGIOGENESIS; RECEPTOR; UTERUS; NOTCH1	Uterine vascular changes, critical for pregnancy success, occur at each implant site during endometrial decidualization. Mesometrial decidualization recruits high numbers of angiogenic, uterine Natural Killer (uNK) cells that trigger midpregnancy spiral arterial remodeling. We postulated that uNK cells contribute to early decidual angiogenesis as endothelial-cell extrinsic sources of Delta-like ligand 1 (DLL1), a molecule that induces endothelial tip cell differentiation and orthogonal vascular growth in other tissues. Virgin uteri expressed Dll1 mesometrially and anti-mesometrially and relative expression increased in both anatomic regions as pregnancy progressed. Analyses of transcripts from gd10.5 uNK cells flow sorted on the basis of expression of Dolichos biflorus agglutinin (DBA) lectin revealed that DBA+ but not DBA- uNK cells expressed Dll1. Immunostaining at gd4.5 found DLL1-expressing cells rare. At gd6.5, DBA+ uNK cells at all stages of maturation expressed DLL1. By gd10.5, DLL1 immunoreactivity was strongly expressed by some but not all DBA+ uNK cells and more weakly by DBA- cells. DLL1+ cells were mesometrially stratified and concentrated within central decidua basalis. Our data suggest that uNK cells have the potential to induce endothelial tip cell differentiation and to promote non-planar vascular growth within early decidua basalis.	[Degaki, Karina Y.; Chen, Zhilin; Croy, B. Anne] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Degaki, Karina Y.; Yamada, Aureo T.] Univ Campinas UNICAMP, Inst Biol, Sao Paulo, Brazil	Queens University - Canada; Universidade de Sao Paulo; Universidade Estadual de Campinas	Croy, BA (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	croya@queensu.ca	Yamada, Aureo T/F-7752-2012	Yamada, Aureo T/0000-0003-3620-9685	Natural Sciences and Engineering Research Council, Canada; Canadian Institutes for Health Research; Canada Research Chairs Program; Canada Foundation for Innovation; CAPES (Brazil); Foreign Affairs and International Trade Canada	Natural Sciences and Engineering Research Council, Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); CAPES (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Foreign Affairs and International Trade Canada	These studies were supported by awards from the Natural Sciences and Engineering Research Council, Canada, the Canadian Institutes for Health Research, the Canada Research Chairs Program, the Canada Foundation for Innovation, Foreign Affairs and International Trade Canada and CAPES (Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar Y, 2012, ENDOCRINOLOGY, V153, P2884, DOI 10.1210/en.2011-2122; Afshar Y, 2012, FASEB J, V26, P282, DOI 10.1096/fj.11-184663; Ashkar AA, 2003, J IMMUNOL, V171, P2937, DOI 10.4049/jimmunol.171.6.2937; Ashkar AA, 1999, BIOL REPROD, V61, P493, DOI 10.1095/biolreprod61.2.493; Ashkar AA, 2000, J EXP MED, V192, P259, DOI 10.1084/jem.192.2.259; Bany BM, 2012, REPRODUCTION, V143, P359, DOI 10.1530/REP-11-0325; Barber EM, 2003, J IMMUNOL, V171, P37, DOI 10.4049/jimmunol.171.1.37; Beck RC, 2009, BIOL BLOOD MARROW TR, V15, P1026, DOI 10.1016/j.bbmt.2009.06.002; Bondarenko GI, 2012, AM J REPROD IMMUNOL, V68, P309, DOI 10.1111/j.1600-0897.2012.01174.x; Carr DB, 2009, HYPERTENS PREGNANCY, V28, P42, DOI 10.1080/10641950802132803; Chen ZL, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102293; Cherrier M, 2012, CURR OPIN IMMUNOL, V24, P277, DOI 10.1016/j.coi.2012.03.011; Croy BA, 2006, IMMUNOL REV, V214, P161; Croy BA, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102830; Das A, 2009, P NATL ACAD SCI USA, V106, P12542, DOI 10.1073/pnas.0901647106; De Smet F, 2009, ARTERIOSCL THROM VAS, V29, P639, DOI 10.1161/ATVBAHA.109.185165; Dimitriadis E, 2010, INT J DEV BIOL, V54, P313, DOI 10.1387/ijdb.082772ed; Greenwood JD, 2000, PLACENTA, V21, P693, DOI 10.1053/plac.2000.0556; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; Hess AP, 2007, BIOL REPROD, V76, P102, DOI 10.1095/biolreprod.106.054791; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Kubota Y, 2008, J CLIN INVEST, V118, P2393, DOI 10.1172/JCI34882; Kume T, 2012, ADV EXP MED BIOL, V727, P210, DOI 10.1007/978-1-4614-0899-4_16; Laranjeiro R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034553; Lima PDA, 2012, J LEUKOCYTE BIOL, V92, P195, DOI 10.1189/jlb.0312136; Manaster I, 2010, J REPROD IMMUNOL, V84, P1, DOI 10.1016/j.jri.2009.10.009; Matsumoto H, 2002, J BIOL CHEM, V277, P29260, DOI 10.1074/jbc.M203996200; Mazella J, 2008, ENDOCRINOLOGY, V149, P15, DOI 10.1210/en.2007-0477; Mikhailik A, 2009, BIOCHEM BIOPH RES CO, V388, P479, DOI 10.1016/j.bbrc.2009.07.037; Napp LC, 2012, CIRC RES, V110, P530, DOI 10.1161/CIRCRESAHA.111.263319; Paffaro VA, 2003, PLACENTA, V24, P479, DOI 10.1053/plac.2002.0919; Plaisier M, 2011, BEST PRACT RES CL OB, V25, P259, DOI 10.1016/j.bpobgyn.2010.10.011; Robb L, 1998, NAT MED, V4, P303, DOI 10.1038/nm0398-303; Robert-Moreno A, 2008, EMBO J, V27, P1886, DOI 10.1038/emboj.2008.113; Salker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010287; Sorensen I, 2009, BLOOD, V113, P5680, DOI 10.1182/blood-2008-08-174508; STEWART CL, 1994, ANN NY ACAD SCI, V734, P157, DOI 10.1111/j.1749-6632.1994.tb21743.x; Tayade C, 2007, J IMMUNOL, V178, P4267, DOI 10.4049/jimmunol.178.7.4267; Villa N, 2001, MECH DEVELOP, V108, P161, DOI 10.1016/S0925-4773(01)00469-5; Wang CL, 2003, MICROSC RES TECHNIQ, V60, P420, DOI 10.1002/jemt.10280; Yadi H, 2008, J IMMUNOL, V181, P6140, DOI 10.4049/jimmunol.181.9.6140; Yinon Y, 2010, CIRCULATION, V122, P1846, DOI 10.1161/CIRCULATIONAHA.110.948455; Zhang JH, 2009, PLACENTA, V30, P968, DOI 10.1016/j.placenta.2009.08.011; Zhang J, 2008, BIOL REPROD, V79, P450, DOI 10.1095/biolreprod.108.067975; Zhang JH, 2012, J LEUKOCYTE BIOL, V91, P417, DOI 10.1189/jlb.1011501	45	25	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52037	10.1371/journal.pone.0052037	http://dx.doi.org/10.1371/journal.pone.0052037			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23284862	Green Submitted, Green Published, gold			2022-12-27	WOS:000313051500022
J	Isendahl, J; Turlej-Rogacka, A; Manjuba, C; Rodrigues, A; Giske, CG; Naucler, P				Isendahl, Joakim; Turlej-Rogacka, Agata; Manjuba, Cristovao; Rodrigues, Amabelia; Giske, Christian G.; Naucler, Pontus			Fecal Carriage of ESBL-Producing E. coli and K. pneumoniae in Children in Guinea-Bissau: A Hospital-Based Cross-Sectional Study	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; ESCHERICHIA-COLI; RISK-FACTORS; KLEBSIELLA-PNEUMONIAE; QUINOLONE RESISTANCE; RAPID DETECTION; ENTEROBACTERIACEAE; EPIDEMIOLOGY; INFECTIONS; PREVALENCE	Background: In recent years, the world has seen a surge in extended-spectrum beta-lactamase (ESBL)-producing bacteria. However, data on the dissemination of ESBL-producing Enterobacteriaceae in the community from systematically enrolled study subjects in Africa remains limited. To determine the prevalence, phenotypic resistance patterns and genetic characteristics of ESBL-producing E. coli and K. pneumoniae in fecal carriage and to analyze associated risk factors in children attending a pediatric emergency department in Guinea-Bissau. Methodology/Principal Findings: From June to September 2010, children <5 years of age with fever or tachycardia attending a pediatric emergency ward during the day was screened for ESBL carriage in feces. Socio-demographic and health seeking behavior data was collected. Antibiotic susceptibility was tested with VITEK2 and EUCAST disk diffusion method, molecular characterization of ESBL-encoding genes was performed with multiplex PCR and clonal relatedness was established by automated rep-PCR. Of 408 enrolled children 133 (32.6%) were ESBL carriers. In total, 83 E. coli and 91 K. pneumoniae ESBL-producing isolates were obtained. Nearly all isolates were multidrug-resistant. Co-resistance to ciprofloxacin, trimethoprim-sulfamethoxazole and aminoglycosides was common. Of the isolates, 38.5% were co-resistant to these classes plus extended-spectrum cephalosporins, which infers resistance to all easily available antibiotic agents for treatment of gram-negative sepsis in Guinea-Bissau. The predominant resistance-encoding gene subgroup was bla(CTX-M-1) and epidemiologic typing showed that the bacterial ESBL population was highly diverse both for E. coli and K. pneumoniae. Bed sharing with another child <5 years of age was a risk factor for ESBL carriage, indicating crowding as a potential risk factor for transmission of ESBL- producing bacteria. Conclusions/Significance: Prevalence of ESBL- producing bacteria in this population was high and clonally diverse. This is alarming considering the limited diagnostic and treatment possibilities in Guinea-Bissau and other resource-poor countries.	[Isendahl, Joakim; Turlej-Rogacka, Agata; Giske, Christian G.; Naucler, Pontus] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Turlej-Rogacka, Agata; Giske, Christian G.] Karolinska Inst, Dept Clin Microbiol, Stockholm, Sweden; [Manjuba, Cristovao] Hosp Nacl Simao Mendes, Dept Pediat, Bissau, Guinea Bissau; [Rodrigues, Amabelia] Inst Nacl Saude Publ, Bissau, Guinea Bissau; [Naucler, Pontus] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Isendahl, J (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	joakim.isendahl@ki.se		Isendahl, Joakim/0000-0002-0544-4343	Swedish Institute of Development Cooperation (SIDA)	Swedish Institute of Development Cooperation (SIDA)	This study was funded by a grant from the Swedish Institute of Development Cooperation (SIDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriatahina T, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-204; Birkett CI, 2007, J MED MICROBIOL, V56, P52, DOI 10.1099/jmm.0.46909-0; Bogaerts P, 2011, ANTIMICROB AGENTS CH, V55, P4457, DOI 10.1128/AAC.00353-11; Brolund A, 2010, J MICROBIOL METH, V83, P224, DOI 10.1016/j.mimet.2010.09.004; Canton R, 2006, CURR OPIN MICROBIOL, V9, P466, DOI 10.1016/j.mib.2006.08.011; Dromigny JA, 2005, J ANTIMICROB CHEMOTH, V56, P236, DOI 10.1093/jac/dki158; European Committee on Antimicrobial Susceptibility Testing, 2012, BREAKP TABL INT MICS; Falagas ME, 2009, J HOSP INFECT, V73, P345, DOI 10.1016/j.jhin.2009.02.021; Freeman JT, 2012, INT J INFECT DIS, V16, pE371, DOI 10.1016/j.ijid.2012.01.008; Herindrainy P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022738; Kariuki S, 2001, CURR OPIN INFECT DIS, V14, P579, DOI 10.1097/00001432-200110000-00012; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Livermore DM, 2008, CLIN MICROBIOL INFEC, V14, P3, DOI 10.1111/j.1469-0691.2007.01857.x; Livermore DM, 2012, KOREAN J INTERN MED, V27, P128, DOI 10.3904/kjim.2012.27.2.128; Lonchel CM, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-53; Luvsansharav UO, 2012, J ANTIMICROB CHEMOTH, V67, P1769, DOI 10.1093/jac/dks118; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mammeri H, 2005, ANTIMICROB AGENTS CH, V49, P71, DOI 10.1128/AAC.49.1.71-76.2005; Mora A, 2011, INT J ANTIMICROB AG, V37, P16, DOI 10.1016/j.ijantimicag.2010.09.012; Mshana SE, 2011, CLIN MICROBIOL INFEC, V17, P1279, DOI 10.1111/j.1469-0691.2011.03518.x; Namboodiri SS, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-44; Oteo J, 2010, CURR OPIN INFECT DIS, V23, P320, DOI 10.1097/QCO.0b013e3283398dc1; Paterson DL, 2006, AM J MED, V119, pS20, DOI 10.1016/j.amjmed.2006.03.013; Peirano G, 2011, J TRAVEL MED, V18, P299, DOI 10.1111/j.1708-8305.2011.00548.x; Peirano G, 2011, DIAGN MICR INFEC DIS, V69, P449, DOI 10.1016/j.diagmicrobio.2010.11.011; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Rahman EMA, 2011, J INVEST MED, V59, P1284, DOI 10.2130/JIM.0b013e318238748e; Reglier-Poupet H, 2008, J MED MICROBIOL, V57, P310, DOI 10.1099/jmm.0.47625-0; Rodriguez-Bano J, 2008, J ANTIMICROB CHEMOTH, V62, P1142, DOI 10.1093/jac/dkn293; Sanders CC, 2000, J CLIN MICROBIOL, V38, P570, DOI 10.1128/JCM.38.2.570-574.2000; Schwaber MJ, 2007, J ANTIMICROB CHEMOTH, V60, P913, DOI 10.1093/jac/dkm318; Talbot GH, 2006, CLIN INFECT DIS, V42, P657, DOI 10.1086/499819; Tumbarello M, 2008, ANTIMICROB AGENTS CH, V52, P3244, DOI 10.1128/AAC.00063-08; United Nations Department of Economic and Social Affairs Statistics Division, 2012, WORLD STAT POCK 20 5, V36, P87; Weisenberg SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045141; Wickramasinghe NH, 2012, J ANTIMICROB CHEMOTH, V67, P1108, DOI 10.1093/jac/dks018; Woerther PL, 2011, CLIN INFECT DIS, V53, P677, DOI 10.1093/cid/cir522	37	63	65	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51981	10.1371/journal.pone.0051981	http://dx.doi.org/10.1371/journal.pone.0051981			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284838	Green Submitted, Green Published, gold			2022-12-27	WOS:000312794500071
J	Shen, M; Wu, RX; Zhao, L; Li, J; Guo, HT; Fan, R; Cui, Y; Wang, YM; Yue, SQ; Pei, JM				Shen, Min; Wu, Rui-Xin; Zhao, Lei; Li, Juan; Guo, Hai-Tao; Fan, Rong; Cui, Yan; Wang, Yue-Min; Yue, Shu-Qiang; Pei, Jian-Ming			Resveratrol Attenuates Ischemia/Reperfusion Injury in Neonatal Cardiomyocytes and Its Underlying Mechanism	PLOS ONE			English	Article							PROTEIN-KINASE-C; CELL-DEATH; REPERFUSION INJURY; INFARCT SIZE; APOPTOSIS; SIRT1; MITOCHONDRIA; PATHOGENESIS; PHYTOALEXIN; INHIBITION	This study was designed to investigate whether Resveratrol (Res) could be a prophylactic factor in the prevention of I/R injury and to shed light on its underlying mechanism. Primary culture of neonatal rat cardiomyocytes were randomly distributed into three groups: the normal group (cultured cardiomyocytes were in normal conditions), the I/R group (cultured cardiomyocytes were subjected to 2 h simulated ischemia followed by 4 h reperfusion), and the Res+I/R group (100 mmol/L Res was administered before cardiomyocytes were subjected to 2 h simulated ischemia followed by 4 h reperfusion). To test the extent of cardiomyocyte injury, several indices were detected including cell viability, LDH activity, Na+-K+-ATPase and Ca2+-ATPase activity. To test apoptotic cell death, caspase-3 activity and the expression of Bcl-2/Bax were detected. To explore the underlying mechanism, several inhibitors, intracellular calcium, SOD activity and MDA content were used to identify some key molecules involved. Res increased cell viability, Na+-K+-ATPase and Ca2+-ATPase activity, Bcl-2 expression, and SOD level. While LDH activity, capase-3 activity, Bax expression, intracellular calcium and MDA content were decreased by Res. And the effect of Res was blocked completely by either L-NAME (an eNOS inhibitor) or MB (a cGMP inhibitor), and partly by either DS (a PKC inhibitor) or Glybenclamide (a K-ATP inhibitor). Our results suggest that Res attenuates I/R injury in cardiomyocytes by preventing cell apoptosis, decreasing LDH release and increasing ATPase activity. NO, cGMP, PKC and K-ATP may play an important role in the protective role of Res. Moreover, Res enhances the capacity of anti-oxygen free radical and alleviates intracellular calcium overload in cardiomyocytes.	[Yue, Shu-Qiang] Fourth Mil Med Univ, Xijing Hosp, Dept Hepatobiliary & Pancreas Surg, Xian 710032, Peoples R China; [Shen, Min; Wu, Rui-Xin; Zhao, Lei; Li, Juan; Guo, Hai-Tao; Fan, Rong; Wang, Yue-Min; Pei, Jian-Ming] Fourth Mil Med Univ, Natl Key Discipline Cell Biol, Dept Physiol, Xian 710032, Peoples R China; [Shen, Min] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Peoples R China; [Cui, Yan] Fourth Mil Med Univ, Dept Clin Nursing, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Yue, SQ (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Hepatobiliary & Pancreas Surg, Xian 710032, Peoples R China.	blanker36@163.com; jmpei8@fmmu.edu.cn	Zhao, Lei/AAF-3066-2020	Zhao, Lei/0000-0003-1263-1742	National Natural Science Foundation of China (NSFC) [30971060, 81270402, 30900535, 31100827]; Shanxi Province [2010K01-195, 2011JM4001]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shanxi Province	This work was supported by grants (NOs. 30971060, 81270402, 30900535, 31100827) from the National Natural Science Foundation of China (NSFC) and grants from Shanxi Province (NOs. 2010K01-195, 2011JM4001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afaq F, 2003, TOXICOL APPL PHARM, V186, P28, DOI 10.1016/S0041-008X(02)00014-5; Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Aluyen Julia Khristine, 2012, Journal of Dietary Supplements, V9, P45, DOI 10.3109/19390211.2011.650842; Athar M, 2007, TOXICOL APPL PHARM, V224, P274, DOI 10.1016/j.taap.2006.12.025; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Bratton SB, 2000, EXP CELL RES, V256, P27, DOI 10.1006/excr.2000.4835; Cain BS, 1999, J SURG RES, V81, P249, DOI 10.1006/jsre.1998.5508; Chakrabarty SP, 2011, CURR MOL MED, V11, P709; Chan CC, 2011, MOL NUTR FOOD RES, V55, P1841, DOI 10.1002/mnfr.201100374; Chen ZY, 2001, AM J PHYSIOL-HEART C, V280, pH2313, DOI 10.1152/ajpheart.2001.280.5.H2313; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Danz EDB, 2009, FREE RADICAL BIO MED, V46, P1589, DOI 10.1016/j.freeradbiomed.2009.03.011; Golstein P, 1997, SCIENCE, V275, P1081, DOI 10.1126/science.275.5303.1081; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Kajstura J, 1996, LAB INVEST, V74, P86; KRAJEWSKI S, 1993, CANCER RES, V53, P4701; Lee M, 2003, GENE THER, V10, P1535, DOI 10.1038/sj.gt.3302034; Li F, 2012, CURR PHARM DESIGN, V18, P27, DOI 10.2174/138161212798919075; Liu YG, 1996, CIRC RES, V78, P443, DOI 10.1161/01.RES.78.3.443; Lopez-Miranda V, 2012, REV NEUROLOGIA, V54, P349, DOI 10.33588/rn.5406.2011611; Mattson MP, 2003, TRENDS MOL MED, V9, P196, DOI 10.1016/S1471-4914(03)00046-7; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Ong ET, 2011, TOXICOL APPL PHARM, V256, P198, DOI 10.1016/j.taap.2011.08.013; Penumathsa SV, 2007, J MOL CELL CARDIOL, V42, P508, DOI 10.1016/j.yjmcc.2006.10.018; Pillai JB, 2005, J BIOL CHEM, V280, P43121, DOI 10.1074/jbc.M506162200; Piotrowska H, 2012, TOXICOL APPL PHARM, V263, P53, DOI 10.1016/j.taap.2012.05.023; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; Rabkin SW, 2000, EUR J PHARMACOL, V388, P209, DOI 10.1016/S0014-2999(99)00880-8; Rahal K, 2012, INFLAMM BOWEL DIS, V18, P613, DOI 10.1002/ibd.21843; Reed JC, 1998, ONCOGENE, V17, P3225, DOI 10.1038/sj.onc.1202591; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; Rush JWE, 2007, EXP BIOL MED, V232, P814; Sehirli O, 2007, TOXICOL APPL PHARM, V222, P33, DOI 10.1016/j.taap.2007.03.025; Stricker SA, 1999, MICROSC RES TECHNIQ, V46, P356, DOI 10.1002/(SICI)1097-0029(19990915)46:6<356::AID-JEMT4>3.0.CO;2-6; Tanno M, 2000, J CARDIOVASC PHARM, V35, P345, DOI 10.1097/00005344-200003000-00001; Turer AT, 2010, AM J CARDIOL, V106, P360, DOI 10.1016/j.amjcard.2010.03.032; Wallerath T, 2005, NITRIC OXIDE-BIOL CH, V12, P97, DOI 10.1016/j.niox.2004.12.004; WATERS DD, 1977, AM J CARDIOL, V39, P537, DOI 10.1016/S0002-9149(77)80163-X; Weiss JN, 2003, CIRC RES, V93, P292, DOI 10.1161/01.RES.0000087542.26971.D4; Whelan RS, 2010, ANNU REV PHYSIOL, V72, P19, DOI 10.1146/annurev.physiol.010908.163111; Xu Y, 2012, TOXICOL APPL PHARM, V259, P395, DOI 10.1016/j.taap.2011.09.028; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Yue TL, 2000, CIRC RES, V86, P692, DOI 10.1161/01.RES.86.6.692; Zhang C, 2012, INT J MOL MED, V29, P557, DOI 10.3892/ijmm.2012.885	45	49	55	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51223	10.1371/journal.pone.0051223	http://dx.doi.org/10.1371/journal.pone.0051223			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284668	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500023
J	Tan, MP; Jamsari, AFJ; Azizah, MNS				Tan, Min Pau; Jamsari, Amirul Firdaus Jamaluddin; Azizah, Mohd Nor Siti			Phylogeographic Pattern of the Striped Snakehead, Channa striata in Sundaland: Ancient River Connectivity, Geographical and Anthropogenic Singnatures	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; MITOCHONDRIAL-DNA; GENETIC DIVERSITY; FISHES; INTROGRESSION; EXTINCTION; CYPRINIDAE; HISTORY	A phylogeographic study of an economically important freshwater fish, the striped snakehead, Channa striata in Sundaland was carried out using data from mtDNA ND5 gene target to elucidate genetic patterning. Templates obtained from a total of 280 individuals representing 24 sampling sites revealed 27 putative haplotypes. Three distinct genetic lineages were apparent; 1) northwest Peninsular Malaysia, 2) southern Peninsular, east Peninsular, Sumatra and SW (western Sarawak) and 3) central west Peninsular and Malaysian Borneo (except SW). Genetic structuring between lineages showed a significant signature of natural geographical barriers that have been acting as effective dividers between these populations. However, genetic propinquity between the SW and southern Peninsular and east Peninsular Malaysia populations was taken as evidence of ancient river connectivity between these regions during the Pleistocene epoch. Alternatively, close genetic relationship between central west Peninsular Malaysia and Malaysian Borneo populations implied anthropogenic activities. Further, haplotype sharing between the east Peninsular Malaysia and Sumatra populations revealed extraordinary migration ability of C. striata (>500 km) through ancient connectivity. These results provide interesting insights into the historical and contemporary landscape arrangement in shaping genetic patterns of freshwater species in Sundaland.	[Tan, Min Pau; Jamsari, Amirul Firdaus Jamaluddin; Azizah, Mohd Nor Siti] Univ Sains Malaysia, Sch Biol Sci, Minden, Penang, Malaysia; [Azizah, Mohd Nor Siti] Univ Sains Malaysia, Ctr Marine & Coastal Studies, Minden, Penang, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia	Tan, MP (corresponding author), Univ Sains Malaysia, Sch Biol Sci, Minden, Penang, Malaysia.	minpau_84@yahoo.com	Nor, Siti Azizah Mohd/A-8275-2011; Jamaluddin, Jamsari Amirul Firdaus/AAP-4224-2020; Tan, Min Pau/S-4797-2019	Tan, Min Pau/0000-0003-0149-5247; JAMALUDDIN, JAMSARI AMIRUL FIRDAUS/0000-0002-3792-6873	Universiti Sains Malaysia under Research University Grant [1001/PBIOLOGI/8150123]	Universiti Sains Malaysia under Research University Grant(Universiti Sains Malaysia)	This research was funded by Universiti Sains Malaysia under Research University Grant (1001/PBIOLOGI/8150123). The funder had no rule in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson EAS, 2010, THESIS QUEENSLAND U; Ambak Mohd Azmi, 2006, Biotechnology, V5, P104; Amilhat E, 2005, J FISH BIOL, V67, P23, DOI 10.1111/j.0022-1112.2005.00927.x; Baie SH, 2000, J ETHNOPHARMACOL, V71, P93, DOI 10.1016/S0378-8741(99)00184-1; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berezina G, 2011, MED HLTH SCI J MHSJ, V6, P2, DOI DOI 10.15208/MHSJ.2010.99; Bernatchez L, 1998, MOL ECOL, V7, P431, DOI 10.1046/j.1365-294x.1998.00319.x; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Chubb AL, 1998, J HERED, V89, P8, DOI 10.1093/jhered/89.1.8; Courtenay Jr WR, 2004, IDENTITY INTRO SNAKE; de Bruyn M, 2005, HEREDITY, V94, P370, DOI 10.1038/sj.hdy.6800613; DODSON JJ, 1995, MOL ECOL, V4, P331, DOI 10.1111/j.1365-294X.1995.tb00226.x; Dominguez-Dominguez O, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-161; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Esa YB, 2008, ZOOL STUD, V47, P360; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; Hauser L, 2002, P NATL ACAD SCI USA, V99, P11742, DOI 10.1073/pnas.172242899; Helgason A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000343; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Inger RF, 1962, FRESH WATER FISHES N; JAIS AMM, 1994, GEN PHARMACOL, V25, P947, DOI 10.1016/0306-3623(94)90101-5; Jamsari AFJ, 2010, GENET MOL RES, V9, P1836, DOI 10.4238/vol9-3gmr933; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; Jiggins FM, 2003, GENETICS, V164, P5; Kamarudin K.R., 2009, J TROPICAL BIOL CONS, V5, P1; Kapuscinski AR, 2007, GENETIC GUIDELINES F; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kingman J., 1982, STOCH PROC APPL, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Kottelat M., 1993, FRESHWATER FISHES W; Lande R, 1998, RES POPUL ECOL, V40, P259, DOI 10.1007/BF02763457; Leong KO, 2003, THESIS U SAINS MALAY; Luikart G, 1998, MOL ECOL, V7, P963, DOI 10.1046/j.1365-294x.1998.00414.x; LYNCH M, 1990, MOL BIOL EVOL, V7, P377; Michel C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-49; Miya M, 2006, ICHTHYOL RES, V53, P75, DOI 10.1007/s10228-005-0303-5; Mohsin A. K. M., 1983, FRESHWATER FISHES PE; Mu XD, 2011, J ANIM VET ADV, V10, P555, DOI 10.3923/javaa.2011.555.561; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Newman D, 1997, EVOLUTION, V51, P354, DOI [10.2307/2411107, 10.1111/j.1558-5646.1997.tb02422.x]; Nguyen TTT, 2006, NACA MONOGRAPH; NorKarmila D, 2009, THESIS U SAINS MALAY; Posada D., 2004, COLLAPSE VER 1 2 TOO; Rambaut A., 2007, TRACER V1 4; Rambaut A, 2010, FIGTREE V131; Ramstad KM, 2004, MOL ECOL, V13, P277, DOI 10.1046/j.1365-294X.2003.2062.x; Roos H., 2004, THESIS U PRETORIA; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Ruzainah A, 2008, THESIS U SAINS MALAY; Ryan JRJ, 2006, ZOOL SCI, V23, P893, DOI 10.2108/zsj.23.893; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schuster W. H., 1952, 3 IPFC FISH S, P187; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Turner TF, 2004, J FISH BIOL, V64, P186, DOI 10.1111/j.1095-8649.2004.00299.x; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Wang JL, 2011, MITOCHONDR DNA, V22, P120, DOI 10.3109/19401736.2011.624599; Wang JP, 2000, MOL ECOL, V9, P1483, DOI 10.1046/j.1365-294x.2000.01023.x; Wang ZW, 2006, ENVIRON BIOL FISH, V75, P455, DOI 10.1007/s10641-006-0035-z; Yu L, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-198; Zakharov EV, 2009, HEREDITY, V102, P590, DOI 10.1038/hdy.2009.26; Zwick A, 2011, SYST ENTOMOL, V36, P31, DOI 10.1111/j.1365-3113.2010.00543.x	69	21	24	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52089	10.1371/journal.pone.0052089	http://dx.doi.org/10.1371/journal.pone.0052089			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284881	Green Submitted, Green Published, gold			2022-12-27	WOS:000312794500088
J	Wang, ZX; Zhang, LJ; Guha, G; Li, S; Kyrylkova, K; Kioussi, C; Leid, M; Ganguli-Indra, G; Indra, AK				Wang, Zhixing; Zhang, Ling-juan; Guha, Gunjan; Li, Shan; Kyrylkova, Kateryna; Kioussi, Chrissa; Leid, Mark; Ganguli-Indra, Gitali; Indra, Arup K.			Selective Ablation of Ctip2/Bcl11b in Epidermal Keratinocytes Triggers Atopic Dermatitis-Like Skin Inflammatory Responses in Adult Mice	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; RETINOID-X-RECEPTOR; NF-KAPPA-B; BARRIER FUNCTION; TRANSCRIPTIONAL REPRESSION; MOUSE KERATINOCYTES; TSLP EXPRESSION; T-LYMPHOCYTES; NURD COMPLEX; RXR-ALPHA	Background: Ctip2 is crucial for epidermal homeostasis and protective barrier formation in developing mouse embryos. Selective ablation of Ctip2 in epidermis leads to increased transepidermal water loss (TEWL), impaired epidermal proliferation, terminal differentiation, as well as altered lipid composition during development. However, little is known about the role of Ctip2 in skin homeostasis in adult mice. Methodology/Principal Findings: To study the role of Ctip2 in adult skin homeostasis, we utilized Ctip2(ep2/2) mouse model in which Ctip2 is selectively deleted in epidermal keratinocytes. Measurement of TEWL, followed by histological, immunohistochemical, and RT-qPCR analyses revealed an important role of Ctip2 in barrier maintenance and in regulating adult skin homeostasis. We demonstrated that keratinocytic ablation of Ctip2 leads to atopic dermatitis (AD)-like skin inflammation, characterized by alopecia, pruritus and scaling, as well as extensive infiltration of immune cells including T lymphocytes, mast cells, and eosinophils. We observed increased expression of T-helper 2 (Th2)-type cytokines and chemokines in the mutant skin, as well as systemic immune responses that share similarity with human AD patients. Furthermore, we discovered that thymic stromal lymphopoietin (TSLP) expression was significantly upregulated in the mutant epidermis as early as postnatal day 1 and ChIP assay revealed that TSLP is likely a direct transcriptional target of Ctip2 in epidermal keratinocytes. Conclusions/Significance: Our data demonstrated a cell-autonomous role of Ctip2 in barrier maintenance and epidermal homeostasis in adult mice skin. We discovered a crucial non-cell autonomous role of keratinocytic Ctip2 in suppressing skin inflammatory responses by regulating the expression of Th2-type cytokines. It is likely that the epidermal hyperproliferation in the Ctip2-lacking epidermis may be secondary to the compensatory response of the adult epidermis that is defective in barrier functions. Our results establish an initiating role of epidermal TSLP in AD pathogenesis via a novel repressive regulatory mechanism enforced by Ctip2.	[Wang, Zhixing; Zhang, Ling-juan; Guha, Gunjan; Li, Shan; Kyrylkova, Kateryna; Kioussi, Chrissa; Leid, Mark; Ganguli-Indra, Gitali; Indra, Arup K.] Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Kioussi, Chrissa; Leid, Mark; Ganguli-Indra, Gitali; Indra, Arup K.] Oregon State Univ, Mol Cell Biol Program, Corvallis, OR 97331 USA; [Leid, Mark; Indra, Arup K.] Oregon State Univ, Environm Hlth Sci Ctr, Corvallis, OR 97331 USA; [Indra, Arup K.] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA	Oregon State University; Oregon State University; Oregon State University; Oregon Health & Science University	Indra, AK (corresponding author), Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA.	arup.indra@oregonstate.edu	Guha, Gunjan/D-8197-2011; Zhang, Lingjuan/K-3080-2017; Indra, Arup/AAG-2376-2019; Indra, Gitali/G-2963-2016; Zhang, Ling-juan/V-6141-2019	Guha, Gunjan/0000-0002-9224-0241; Zhang, Lingjuan/0000-0001-6937-4578; Indra, Arup/0000-0001-6137-7555; Zhang, Ling-juan/0000-0001-6937-4578; Kioussi, Chrissa/0000-0001-8226-9908	National Institutes of Health [5R01AR056008-03]; Oregon Health and Science University Medical Research Foundation grant; National Institute of Environmental Health Sciences center [ES00210]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oregon Health and Science University Medical Research Foundation grant; National Institute of Environmental Health Sciences center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	These studies were supported by grant 5R01AR056008-03 (AI) from the National Institutes of Health, an Oregon Health and Science University Medical Research Foundation grant (AI), and a National Institute of Environmental Health Sciences center grant (ES00210) to Environmental Health Sciences Center, Oregon State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Argmann Carmen A, 2006, Curr Protoc Mol Biol, VChapter 29, DOI 10.1002/0471142727.mb29a03s75; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Avram D, 2000, J BIOL CHEM, V275, P10315, DOI 10.1074/jbc.275.14.10315; Barnes KC, 2010, J ALLERGY CLIN IMMUN, V125, P16, DOI 10.1016/j.jaci.2009.11.008; Biedermann T, 2004, J INVEST DERM SYMP P, V9, P5, DOI 10.1111/j.1087-0024.2004.00829.x; Boguniewicz M, 2011, IMMUNOL REV, V242, P233, DOI 10.1111/j.1600-065X.2011.01027.x; Brandt E, 2011, J CLIN CELLULAR IMMU; Cismasiu VB, 2005, ONCOGENE, V24, P6753, DOI 10.1038/sj.onc.1208904; Comeau MR, 2010, MUCOSAL IMMUNOL, V3, P138, DOI 10.1038/mi.2009.134; Cork MJ, 2009, J INVEST DERMATOL, V129, P1892, DOI 10.1038/jid.2009.133; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Demehri S, 2008, PLOS BIOL, V6, P992, DOI 10.1371/journal.pbio.0060123; Dubrac S, 2010, IMMUNOL CELL BIOL, V88, P400, DOI 10.1038/icb.2010.33; Dumortier A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009258; Fogg MI, 2003, J ALLERGY CLIN IMMUN, V112, P796, DOI 10.1016/S0091-6749(03)01715-9; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Ganguli-Indra G, 2009, EXP DERMATOL, V18, P994, DOI 10.1111/j.1600-0625.2009.00876.x; Golonzhka O, 2007, GENE EXPR PATTERNS, V7, P754, DOI 10.1016/j.modgep.2007.06.002; Golonzhka O, 2009, J INVEST DERMATOL, V129, P1459, DOI 10.1038/jid.2008.392; Grewe M, 1998, IMMUNOL TODAY, V19, P359, DOI 10.1016/S0167-5699(98)01285-7; Hyter S, 2010, PIGM CELL MELANOMA R, V23, P635, DOI 10.1111/j.1755-148X.2010.00732.x; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Indra AK, 2005, DEVELOPMENT, V132, P4533, DOI 10.1242/dev.02019; Indra AK, 2005, DEV BIOL, V285, P28, DOI 10.1016/j.ydbio.2005.05.043; Jakasa I, 2011, J INVEST DERMATOL, V131, P540, DOI 10.1038/jid.2010.307; Kashyap M, 2011, J IMMUNOL, V187, P1207, DOI 10.4049/jimmunol.1100355; Kastner P, 2010, EUR J IMMUNOL, V40, P2143, DOI 10.1002/eji.200940258; Lee HC, 2008, J IMMUNOL, V181, P5189, DOI 10.4049/jimmunol.181.8.5189; Lee HC, 2007, P NATL ACAD SCI USA, V104, P914, DOI 10.1073/pnas.0607305104; Leung DYM, 2003, LANCET, V361, P151, DOI 10.1016/S0140-6736(03)12193-9; Li M, 2005, P NATL ACAD SCI USA, V102, P14795, DOI 10.1073/pnas.0507385102; Li M, 2006, P NATL ACAD SCI USA, V103, P11736, DOI 10.1073/pnas.0604575103; Liang XB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029999; Liu YJ, 2006, J EXP MED, V203, P269, DOI 10.1084/jem.20051745; Liu YJ, 2009, ADV IMMUNOL, V101, P1, DOI 10.1016/S0065-2776(08)01001-8; Matsuki M, 1998, P NATL ACAD SCI USA, V95, P1044, DOI 10.1073/pnas.95.3.1044; Nakayama T, 2004, J VIROL, V78, P1665, DOI 10.1128/JVI.78.4.1665-1674.2004; Novak N, 2011, CURR OPIN IMMUNOL, V23, P778, DOI 10.1016/j.coi.2011.09.007; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; PROKSCH E, 1991, J CLIN INVEST, V87, P1668, DOI 10.1172/JCI115183; Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x; Quentmeier H, 2001, LEUKEMIA, V15, P1286, DOI 10.1038/sj.leu.2402175; Reche PA, 2001, J IMMUNOL, V167, P336, DOI 10.4049/jimmunol.167.1.336; Scharschmidt TC, 2008, J INVEST DERMATOL, V128, P1061, DOI 10.1038/sj.jid.5701201; Sebastian Katrin, 2008, Cell Commun Signal, V6, P5, DOI 10.1186/1478-811X-6-5; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Senawong T, 2003, J BIOL CHEM, V278, P43041, DOI 10.1074/jbc.M307477200; Soumelis V, 2002, NATURE IMMUNOLOGY; Strong CD, 2006, J CELL BIOL, V175, P661, DOI 10.1083/jcb.200605057; Takai T, 2012, ALLERGOL INT, V61, P3, DOI 10.2332/allergolint.11-RAI-0395; Tasian SK, 2012, BLOOD, V120, P833, DOI 10.1182/blood-2011-12-389932; Tokura Y, 2010, J DERMATOL SCI, V58, P1, DOI 10.1016/j.jdermsci.2010.02.008; Topark-Ngarm A, 2006, J BIOL CHEM, V281, P32272, DOI 10.1074/jbc.M602776200; VANVLIET E, 1993, INT ARCH ALLERGY IMM, V101, P392, DOI 10.1159/000236482; Wang ZX, 2011, J INVEST DERMATOL, V131, P177, DOI 10.1038/jid.2010.290; Wong CK, 2010, AM J RESP CELL MOL, V43, P305, DOI 10.1165/rcmb.2009-0168OC; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503; Zhang LJ, 2012, J CELL SCI, V125, P5733, DOI 10.1242/jcs.108969; Zhang LJ, 2012, J BIOL CHEM, V287, P26971, DOI 10.1074/jbc.M112.344176; Ziegler SF, 2010, CURR OPIN IMMUNOL, V22, P795, DOI 10.1016/j.coi.2010.10.020; Ziegler SF, 2010, NAT IMMUNOL, V11, P289, DOI 10.1038/ni.1852	62	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51262	10.1371/journal.pone.0051262	http://dx.doi.org/10.1371/journal.pone.0051262			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284675	Green Submitted, gold, Green Published			2022-12-27	WOS:000312794500025
J	Miotto, P; Forti, F; Ambrosi, A; Pellin, D; Veiga, DF; Balazsi, G; Gennaro, ML; Di Serio, C; Ghisotti, D; Cirillo, DM				Miotto, Paolo; Forti, Francesca; Ambrosi, Alessandro; Pellin, Danilo; Veiga, Diogo F.; Balazsi, Gabor; Gennaro, Maria L.; Di Serio, Clelia; Ghisotti, Daniela; Cirillo, Daniela M.			Genome-Wide Discovery of Small RNAs in Mycobacterium tuberculosis	PLOS ONE			English	Article							ANAEROBIC NITRATE REDUCTASE; REGULATORY RNAS; NONCODING RNAS; BOVIS BCG; GENE-EXPRESSION; IDENTIFICATION; TRANSCRIPTION; VIRULENCE; BACTERIA; DISRUPTION	Only few small RNAs (sRNAs) have been characterized in Mycobacterium tuberculosis and their role in regulatory networks is still poorly understood. Here we report a genome-wide characterization of sRNAs in M. tuberculosis integrating experimental and computational analyses. Global RNA-seq analysis of exponentially growing cultures of M. tuberculosis H37Rv had previously identified 1373 sRNA species. In the present report we show that 258 (19%) of these were also identified by microarray expression. This set included 22 intergenic sRNAs, 84 sRNAs mapping within 5'/3' UTRs, and 152 antisense sRNAs. Analysis of promoter and terminator consensus sequences identified sigma A promoter consensus sequences for 121 sRNAs (47%), terminator consensus motifs for 22 sRNAs (8.5%), and both motifs for 35 sRNAs (14%). Additionally, 20/23 candidates were visualized by Northern blot analysis and 59 end mapping by primer extension confirmed the RNA-seq data. We also used a computational approach utilizing functional enrichment to identify the pathways targeted by sRNA regulation. We found that antisense sRNAs preferentially regulated transcription of membrane-bound proteins. Genes putatively regulated by novel cis-encoded sRNAs were enriched for two-component systems and for functional pathways involved in hydrogen transport on the membrane.	[Miotto, Paolo; Cirillo, Daniela M.] Ist Sci San Raffaele, Emerging Bacterial Pathogens Unit, I-20132 Milan, Italy; [Forti, Francesca; Ghisotti, Daniela] Univ Milan, Dipartimento BioSci, Milan, Italy; [Ambrosi, Alessandro; Pellin, Danilo; Di Serio, Clelia] Univ Vita Salute San Raffaele, Univ Stat Ctr Biomed Sci, Milan, Italy; [Veiga, Diogo F.; Balazsi, Gabor] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Gennaro, Maria L.] Univ Med & Dent New Jersey, Publ Hlth Res Inst, Newark, NJ 07103 USA	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan; Vita-Salute San Raffaele University; University of Texas System; UTMD Anderson Cancer Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Cirillo, DM (corresponding author), Ist Sci San Raffaele, Emerging Bacterial Pathogens Unit, I-20132 Milan, Italy.	cirillo.daniela@hsr.it	ambrosi, alessandro/H-4424-2011; Miotto, Paolo/E-3940-2017; Cirillo, Daniela Maria/AAB-3646-2019; Veiga, Diogo Troggian/J-9279-2019; Di Serio, Clelia/AAO-5494-2020; GHISOTTI, DANIELA ERICA/B-7732-2017	ambrosi, alessandro/0000-0003-1976-5663; Miotto, Paolo/0000-0003-4610-2427; Cirillo, Daniela Maria/0000-0001-6415-1535; Veiga, Diogo Troggian/0000-0002-4018-5375; GHISOTTI, DANIELA ERICA/0000-0003-2924-5303; Balazsi, Gabor/0000-0002-6865-5818; Gennaro, Maria Laura/0000-0003-4801-3567; DI SERIO, Mariaclelia Stefania/0000-0001-6385-6058	European Community [FP7-223681]; European Society of Clinical Microbiology and Infectious Diseases	European Community(European Commission); European Society of Clinical Microbiology and Infectious Diseases	This work was partially supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement FP7-223681 to DMC and from the European Society of Clinical Microbiology and Infectious Diseases Research Grant 2011 to PM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnvig KB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002342; Arnvig KB, 2009, MOL MICROBIOL, V73, P397, DOI 10.1111/j.1365-2958.2009.06777.x; Atun R, 2010, LANCET, V376, P940, DOI 10.1016/S0140-6736(10)61428-6; Audas TE, 2012, MOL CELL, V45, P147, DOI 10.1016/j.molcel.2011.12.012; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; BOORSTEIN WR, 1989, METHOD ENZYMOL, V180, P347; COATES ARM, 1993, MOL MICROBIOL, V8, P787, DOI 10.1111/j.1365-2958.1993.tb01624.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; DEHO G, 1992, MOL MICROBIOL, V6, P3415, DOI 10.1111/j.1365-2958.1992.tb02209.x; DiChiara JM, 2010, NUCLEIC ACIDS RES, V38, P4067, DOI 10.1093/nar/gkq101; Dornenburg JE, 2010, MBIO, V1, DOI 10.1128/mBio.00024-10; Dudoit S., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1040; Ewann F, 2002, INFECT IMMUN, V70, P2256, DOI 10.1128/IAI.70.5.2256-2263.2002; Fritz C, 2002, INFECT IMMUN, V70, P286, DOI 10.1128/IAI.70.1.286-291.2002; Gardner PP, 2011, NUCLEIC ACIDS RES, V39, P5845, DOI 10.1093/nar/gkr168; Georg J, 2011, MICROBIOL MOL BIOL R, V75, P286, DOI 10.1128/MMBR.00032-10; Gopel Y, 2012, CURR OPIN MICROBIOL, V15, P132, DOI 10.1016/j.mib.2011.12.001; Gonzalez-Y-Merchand JA, 1998, J BACTERIOL, V180, P5756, DOI 10.1128/JB.180.21.5756-5761.1998; GonzalezyMerchand JA, 1996, MICROBIOL-UK, V142, P667, DOI 10.1099/13500872-142-3-667; Gottesman S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003798; Grundy FJ, 2006, CRIT REV BIOCHEM MOL, V41, P329, DOI 10.1080/10409230600914294; HOLM S, 1979, SCAND J STAT, V6, P65; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irnov AK, 2006, COLD SH Q B, V71, P239, DOI 10.1101/sqb.2006.71.021; Irnov I, 2010, NUCLEIC ACIDS RES, V38, P6637, DOI 10.1093/nar/gkq454; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Lee HJ, 2012, FEMS MICROBIOL LETT, V326, P131, DOI 10.1111/j.1574-6968.2011.02441.x; Levine E, 2008, CURR OPIN MICROBIOL, V11, P574, DOI 10.1016/j.mib.2008.09.016; Liu JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp080; Malhotra V, 2004, FEMS MICROBIOL LETT, V231, P237, DOI 10.1016/S0378-1097(04)00002-3; Masse E, 2007, CURR OPIN MICROBIOL, V10, P140, DOI 10.1016/j.mib.2007.03.013; Mitra A, 2008, TUBERCULOSIS, V88, P566, DOI 10.1016/j.tube.2008.06.004; Mitra A, 2011, NUCLEIC ACIDS RES, V39, pD129, DOI 10.1093/nar/gkq971; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P20130, DOI 10.1073/pnas.1112724108; Papenfort K, 2010, CELL HOST MICROBE, V8, P116, DOI 10.1016/j.chom.2010.06.008; Parish T, 2003, INFECT IMMUN, V71, P1134, DOI 10.1128/IAI.71.3.1134-1140.2003; Peirs P, 2005, INFECT IMMUN, V73, P1898, DOI 10.1128/IAI.73.3.1898-1902.2005; Pellin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032723; Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rasmussen S, 2009, MOL MICROBIOL, V73, P1043, DOI 10.1111/j.1365-2958.2009.06830.x; Repoila F, 2009, BIOL CELL, V101, P117, DOI 10.1042/BC20070137; Rohde KH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002769; Romby P, 2010, CELL MOL LIFE SCI, V67, P217, DOI 10.1007/s00018-009-0162-8; Russell DG, 2009, NAT REV IMMUNOL, V9, P594, DOI 10.1038/nri2591; Sachdeva P, 2010, FEBS J, V277, P605, DOI 10.1111/j.1742-4658.2009.07479.x; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Shinhara A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-428; Storz G, 2005, ANNU REV BIOCHEM, V74, P199, DOI 10.1146/annurev.biochem.74.082803.133136; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Szurmant H, 2010, CURR OPIN MICROBIOL, V13, P190, DOI 10.1016/j.mib.2010.01.007; Thomason MK, 2010, ANNU REV GENET, V44, P167, DOI 10.1146/annurev-genet-102209-163523; Toledo-Arana A, 2007, CURR OPIN MICROBIOL, V10, P182, DOI 10.1016/j.mib.2007.03.004; Vanzembergh F, 2010, TUBERCULOSIS, V90, P338, DOI 10.1016/j.tube.2010.09.004; Verma A, 1999, J BACTERIOL, V181, P4326, DOI 10.1128/JB.181.14.4326-4333.1999; Viegas SC, 2008, RNA BIOL, V5, P230, DOI 10.4161/rna.6915; Waddell SJ, 2007, CURR OPIN MICROBIOL, V10, P297, DOI 10.1016/j.mib.2007.05.013; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Weber I, 2000, MOL MICROBIOL, V35, P1017, DOI 10.1046/j.1365-2958.2000.01794.x; Wendisch V., 2007, MICROBIOLOGY MONOGRA, P129, DOI DOI 10.1007/7171_2006_070; Wolfe LM, 2010, J PROTEOME RES, V9, P5816, DOI 10.1021/pr1005873; Yao ZZ, 2006, BIOINFORMATICS, V22, P445, DOI 10.1093/bioinformatics/btk008; Zhou YX, 2011, J CELL PHYSIOL, V226, P968, DOI 10.1002/jcp.22483; Zvi A, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-18	65	52	55	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51950	10.1371/journal.pone.0051950	http://dx.doi.org/10.1371/journal.pone.0051950			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284830	Green Published, gold			2022-12-27	WOS:000312694300065
J	Martin, FL; Sangaralingham, SJ; Huntley, BK; McKie, PM; Ichiki, T; Chen, HH; Korinek, J; Harders, GE; Burnett, JC				Martin, Fernando L.; Sangaralingham, S. Jeson; Huntley, Brenda K.; McKie, Paul M.; Ichiki, Tomoko; Chen, Horng H.; Korinek, Josef; Harders, Gerald E.; Burnett, John C., Jr.			CD-NP: A Novel Engineered Dual Guanylyl Cyclase Activator with Anti-Fibrotic Actions in the Heart	PLOS ONE			English	Article							NATRIURETIC PEPTIDE RECEPTOR; ANGIOTENSIN-ALDOSTERONE SYSTEM; CARDIAC FIBROBLASTS; MYOCYTE APOPTOSIS; GENE-EXPRESSION; FIBROSIS; EXCRETION; FAMILY; CNP	Natriuretic peptides (NPs) are cardioprotective through the activation of guanylyl cyclase (GC) receptors A and B. CD-NP, also known as cenderitide, is a novel engineered NP that was designed to uniquely serve as a first-in-class dual GC receptor agonist. Recognizing the aldosterone suppressing actions of GC-A activation and the potent inhibitory actions on collagen synthesis and fibroblast proliferation through GC-B activation, the current study was designed to establish the anti-fibrotic actions of CD-NP, administered subcutaneously, in an experimental rat model of early cardiac fibrosis induced by unilateral nephrectomy (UNX). Our results demonstrate that a two week subcutaneous infusion of CD-NP significantly suppresses left ventricular fibrosis and circulating aldosterone, while preserving both systolic and diastolic function, in UNX rats compared to vehicle treated UNX rats. Additionally we also confirmed, in vitro, that CD-NP significantly generates the second messenger, cGMP, through both the GC-A and GC-B receptors. Taken together, this novel dual GC receptor activator may represent an innovative anti-fibrotic therapeutic agent. Citation: Martin FL, Sangaralingham SJ, Huntley BK, McKie PM, Ichiki T, et al. (2012) CD-NP: A Novel Engineered Dual Guanylyl Cyclase Activator with Anti-Fibrotic Actions in the Heart. PLoS ONE 7(12): e52422. doi:10.1371/journal.pone.0052422	[Martin, Fernando L.; Sangaralingham, S. Jeson; Huntley, Brenda K.; McKie, Paul M.; Ichiki, Tomoko; Chen, Horng H.; Korinek, Josef; Harders, Gerald E.; Burnett, John C., Jr.] Mayo Clin, Cardiorenal Res Lab, Div Cardiovasc Dis, Rochester, MN 55905 USA	Mayo Clinic	Sangaralingham, SJ (corresponding author), Mayo Clin, Cardiorenal Res Lab, Div Cardiovasc Dis, Rochester, MN 55905 USA.	sangaralingham.jeson@mayo.edu	Korinek, Josef/C-9936-2016	Korinek, Josef/0000-0002-4712-4444	National Institutes of Health [RO1 HL36634, R01 HL83231, PO1 HL76611]; Mayo Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076611, R01HL083231, R01HL036634] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants from the National Institutes of Health (RO1 HL36634, R01 HL83231 and PO1 HL76611) and the Mayo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brilla CG, 2000, CARDIOVASC RES, V47, P1, DOI 10.1016/S0008-6363(00)00092-4; Burniston JG, 2005, J MOL CELL CARDIOL, V39, P395, DOI 10.1016/j.yjmcc.2005.04.001; Dickey DM, 2011, J MOL CELL CARDIOL, V51, P67, DOI 10.1016/j.yjmcc.2011.03.013; Dickey DM, 2008, J BIOL CHEM, V283, P35003, DOI 10.1074/jbc.M804538200; Doyle DD, 2002, AM J PHYSIOL-HEART C, V282, pH2117, DOI 10.1152/ajpheart.00988.2001; Horio T, 2003, ENDOCRINOLOGY, V144, P2279, DOI 10.1210/en.2003-0128; Hu P, 2012, PEPTIDES, V37, P98, DOI 10.1016/j.peptides.2012.06.009; HUNT PJ, 1994, J CLIN ENDOCR METAB, V78, P1428, DOI 10.1210/jc.78.6.1428; Johar S, 2006, FASEB J, V20, P1546, DOI 10.1096/fj.05-4642fje; Kato T, 2005, J CLIN INVEST, V115, P2716, DOI 10.1172/JCI24280; KENNY AJ, 1993, BIOCHEM J, V291, P83, DOI 10.1042/bj2910083; KOLLER KJ, 1991, SCIENCE, V252, P120, DOI 10.1126/science.1672777; Lee CYW, 2009, J CLIN PHARMACOL, V49, P668, DOI 10.1177/0091270009336233; Lisy O, 2008, J AM COLL CARDIOL, V52, P60, DOI 10.1016/j.jacc.2008.02.077; LOWE DG, 1989, EMBO J, V8, P1377, DOI 10.1002/j.1460-2075.1989.tb03518.x; Mano A, 2004, CIRCULATION, V110, P317, DOI 10.1161/01.CIR.0000135599.33787.CA; Martin FL, 2012, AM J PHYSIOL-REG I, V302, pR292, DOI 10.1152/ajpregu.00194.2011; MAYES D, 1970, J CLIN ENDOCR METAB, V30, P682, DOI 10.1210/jcem-30-5-682; Murakami S, 2004, AM J PHYSIOL-LUNG C, V287, pL1172, DOI 10.1152/ajplung.00087.2004; Peltonen TO, 2007, CIRCULATION, V116, P1283, DOI 10.1161/CIRCULATIONAHA.106.685743; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; Sangaralingham SJ, 2012, CIRC-CARDIOVASC IMAG, V5, P518, DOI 10.1161/CIRCIMAGING.112.973057; Sangaralingham SJ, 2011, AM J PHYSIOL-RENAL, V301, pF943, DOI 10.1152/ajprenal.00170.2011; Sangaralingham SJ, 2011, HYPERTENSION, V57, P201, DOI 10.1161/HYPERTENSIONAHA.110.160796; SCHWEITZ H, 1992, J BIOL CHEM, V267, P13928; Socki T, 2005, J AM COLL CARDIOL, V45, P608, DOI 10.1016/j.jacc.2004.10.067; Steiner A L, 1970, Adv Biochem Psychopharmacol, V3, P89; SUGA SI, 1992, ENDOCRINOLOGY, V130, P229, DOI 10.1210/en.130.1.229; Surendran K, 2003, AM J PHYSIOL-RENAL, V284, pF653, DOI 10.1152/ajprenal.00343.2002; Tsuruda T, 2002, CIRC RES, V91, P1127, DOI 10.1161/01.RES.0000046234.73401.70; WEBER KT, 1991, CIRCULATION, V83, P1849, DOI 10.1161/01.CIR.83.6.1849; Young MJ, 2008, CURR OPIN NEPHROL HY, V17, P174, DOI 10.1097/MNH.0b013e3282f56854	32	44	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52422	10.1371/journal.pone.0052422	http://dx.doi.org/10.1371/journal.pone.0052422			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272242	gold, Green Submitted, Green Published			2022-12-27	WOS:000312483300084
J	Wang, Y; Loers, G; Pan, HC; Gouveia, R; Zhao, WJ; Shen, YQ; Kleene, R; Costa, J; Schachner, M				Wang, Yan; Loers, Gabriele; Pan, Hong-Chao; Gouveia, Ricardo; Zhao, Wei-Jiang; Shen, Yan-Qin; Kleene, Ralf; Costa, Julia; Schachner, Melitta			Antibody Fragments Directed against Different Portions of the Human Neural Cell Adhesion Molecule L1 Act as Inhibitors or Activators of L1 Function	PLOS ONE			English	Article							NEURITE OUTGROWTH; N-CAM; IMMUNOGLOBULIN SUPERFAMILY; RECOGNITION MOLECULES; STRUCTURAL-ANALYSIS; NERVOUS-SYSTEM; DOMAINS; EXPRESSION; SURFACE; PROLIFERATION	The neural cell adhesion molecule L1 plays important roles in neuronal migration and survival, neuritogenesis and synaptogenesis. L1 has also been found in tumors of different origins, with levels of L1 expression correlating positively with the metastatic potential of tumors. To select antibodies targeting the varied functions of L1, we screened the Tomlinson library of recombinant human antibody fragments to identify antibodies binding to recombinant human L1 protein comprising the entire extracellular domain of human L1. We obtained four L1 binding single-chain variable fragment antibodies (scFvs), named I4, I6, I13, and I27 and showed by enzyme-linked immunosorbent assay (ELISA) that scFvs I4 and I6 have high affinity to the immunoglobulin-like (Ig) domains 1-4 of L1, while scFvs I13 and I27 bind strongly to the fibronectin type III homologous (Fn) domains 1-3 of L1. Application of scFvs I4 and I6 to human SK-N-SH neuroblastoma cells reduced proliferation and transmigration of these cells. Treatment of SK-N-SH cells with scFvs I13 and I27 enhanced cell proliferation and migration, neurite outgrowth, and protected against the toxic effects of H2O2 by increasing the ratio of Bcl-2/Bax. In addition, scFvs I4 and I6 inhibited and scFvs I13 and I27 promoted phosphorylation of src and Erk. Our findings indicate that scFvs reacting with the immunoglobulin-like domains 1-4 inhibit L1 functions, whereas scFvs interacting with the fibronectin type III domains 1-3 trigger L1 functions of cultured neuroblastoma cells. Citation: Wang Y, Loers G, Pan H-C, Gouveia R, Zhao W-J, et al. (2012) Antibody Fragments Directed against Different Portions of the Human Neural Cell Adhesion Molecule L1 Act as Inhibitors or Activators of L1 Function. PLoS ONE 7(12): e52404. doi:10.1371/journal.pone.0052404	[Wang, Yan; Pan, Hong-Chao; Zhao, Wei-Jiang; Shen, Yan-Qin; Schachner, Melitta] Shantou Univ, Coll Med, Ctr Neurosci, Shantou, Guangdong, Peoples R China; [Loers, Gabriele; Kleene, Ralf] Univ Hamburg, Zentrum Mol Neurobiol Hamburg, Hamburg, Germany; [Gouveia, Ricardo; Costa, Julia] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Piscataway, NJ USA; [Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ USA	Shantou University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Universidade Nova de Lisboa; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Schachner, M (corresponding author), Shantou Univ, Coll Med, Ctr Neurosci, Shantou, Guangdong, Peoples R China.	schachner@stu.edu.cn	Costa, Júlia C/B-7131-2008; Wang, Yan/AAJ-1575-2020	Costa, Júlia C/0000-0001-7782-6319; Zhao, Wei-jiang/0000-0002-6556-2827; Gouveia, Ricardo/0000-0002-2968-1298	Li Ka Shing Shantou University Foundation; Fundacao para a Ciencia e Tecnologia, Portugal [PTDC/SAU-NEU/100724/2008]	Li Ka Shing Shantou University Foundation; Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was supported by the Li Ka Shing Shantou University Foundation (to MS) and the Fundacao para a Ciencia e Tecnologia, Portugal (project PTDC/SAU-NEU/100724/2008 to JC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPEL F, 1993, J NEUROSCI, V13, P4764; APPEL F, 1995, J NEUROBIOL, V28, P297, DOI 10.1002/neu.480280304; Blaess S, 1998, J NEUROCHEM, V71, P2615, DOI 10.1046/j.1471-4159.1998.71062615.x; Buchstaller A, 1996, J CELL BIOL, V135, P1593, DOI 10.1083/jcb.135.6.1593; Christofori G, 2003, EMBO J, V22, P2318, DOI 10.1093/emboj/cdg228; Dong L, 2003, MOL CELL NEUROSCI, V22, P234, DOI 10.1016/S1044-7431(02)00033-7; Drescher B, 1996, EUR J NEUROSCI, V8, P2467, DOI 10.1111/j.1460-9568.1996.tb01541.x; Eteshola E, 2010, J IMMUNOL METHODS, V358, P104, DOI 10.1016/j.jim.2010.04.003; FAISSNER A, 1984, DEV BRAIN RES, V15, P69, DOI 10.1016/0165-3806(84)90141-X; FISCHER G, 1986, J NEUROSCI, V6, P605; Fransen E, 1996, AM J MED GENET, V64, P73, DOI 10.1002/(SICI)1096-8628(19960712)64:1<73::AID-AJMG11>3.0.CO;2-P; Gouveia R, 2012, BBA-GEN SUBJECTS, V1820, P2007, DOI 10.1016/j.bbagen.2012.09.004; Gouveia R, 2010, J BIOTECHNOL, V145, P130, DOI 10.1016/j.jbiotec.2009.10.018; Gouveia RM, 2008, J BIOL CHEM, V283, P28038, DOI 10.1074/jbc.M804991200; Guseva D, 2011, EXP NEUROL, V229, P339, DOI 10.1016/j.expneurol.2011.02.018; Guseva D, 2009, BRAIN, V132, P2180, DOI 10.1093/brain/awp160; Hall H, 2000, J NEUROCHEM, V75, P336, DOI 10.1046/j.1471-4159.2000.0750336.x; Hall Heike, 2004, Angiogenesis, V7, P213, DOI 10.1007/s10456-004-1328-5; Haspel J, 2000, J NEUROBIOL, V42, P287, DOI 10.1002/(SICI)1097-4695(20000215)42:3<287::AID-NEU1>3.3.CO;2-O; He YN, 2009, STRUCTURE, V17, P460, DOI 10.1016/j.str.2009.01.009; Hoefnagel CA, 2011, EUR J NUCL MED, V38, P359; Islam R, 2004, MOL BIOL CELL, V15, P2003, DOI 10.1091/mbc.e03-05-0333; Itoh K, 2005, MOL CELL NEUROSCI, V30, P624, DOI 10.1016/j.mcn.2005.06.012; KADMON G, 1990, J CELL BIOL, V110, P209, DOI 10.1083/jcb.110.1.209; KADMON G, 1990, J CELL BIOL, V110, P193, DOI 10.1083/jcb.110.1.193; Kamiguchi H, 1997, J NEUROSCI RES, V49, P1, DOI 10.1002/(SICI)1097-4547(19970701)49:1<1::AID-JNR1>3.0.CO;2-H; Kenwrick S, 2000, HUM MOL GENET, V9, P879, DOI 10.1093/hmg/9.6.879; KRUSE J, 1984, NATURE, V311, P153, DOI 10.1038/311153a0; Kurumaji A, 2001, AM J MED GENET, V105, P99; Lee ES, 2012, EXP MOL MED, V44, P293, DOI 10.3858/emm.2012.44.4.027; Lieberoth A, 2009, J NEUROSCI, V29, P6677, DOI 10.1523/JNEUROSCI.4361-08.2009; LINDNER J, 1983, NATURE, V305, P427, DOI 10.1038/305427a0; Loers G, 2005, J NEUROCHEM, V92, P1463, DOI 10.1111/j.1471-4159.2004.02983.x; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; MARTINI R, 1986, J CELL BIOL, V103, P2439, DOI 10.1083/jcb.103.6.2439; Min JK, 2010, CLIN CANCER RES, V16, P3571, DOI 10.1158/1078-0432.CCR-09-3075; Miyahara R, 2001, J SURG ONCOL, V77, P49, DOI 10.1002/jso.1065; Montgomery AMP, 1996, J CELL BIOL, V132, P475, DOI 10.1083/jcb.132.3.475; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; Pavlou O, 2002, MOL CELL NEUROSCI, V20, P367, DOI 10.1006/mcne.2002.1105; POLTORAK M, 1995, EXP NEUROL, V131, P266, DOI 10.1016/0014-4886(95)90048-9; RATHJEN FG, 1984, EMBO J, V3, P1; Schafer MKE, 2010, CELL MOL LIFE SCI, V67, P2425, DOI 10.1007/s00018-010-0339-1; Schmid RS, 2000, J NEUROSCI, V20, P4177; SEILHEIMER B, 1988, J CELL BIOL, V107, P341, DOI 10.1083/jcb.107.1.341; Siesser PF, 2009, CELL ADHES MIGR, V3, P275, DOI 10.4161/cam.3.3.8689; Silletti S, 2000, J CELL BIOL, V149, P1485, DOI 10.1083/jcb.149.7.1485; Thelen K, 2002, J NEUROSCI, V22, P4918, DOI 10.1523/JNEUROSCI.22-12-04918.2002; TimorTritsch IE, 1996, PRENATAL DIAG, V16, P543, DOI 10.1002/(SICI)1097-0223(199606)16:6<543::AID-PD878>3.0.CO;2-I; Wei CH, 2011, FEBS LETT, V585, P153, DOI 10.1016/j.febslet.2010.11.028; Wolterink S, 2010, CANCER RES, V70, P2504, DOI 10.1158/0008-5472.CAN-09-3730; WOOD PM, 1990, J NEUROSCI, V10, P3635; Yip PM, 1998, MOL BIOL CELL, V9, P277, DOI 10.1091/mbc.9.2.277	54	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52404	10.1371/journal.pone.0052404	http://dx.doi.org/10.1371/journal.pone.0052404			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272240	Green Submitted, Green Published, gold			2022-12-27	WOS:000312483300082
J	Li, CH; Li, Z; Li, Y; Zhou, J; Zhang, CD; Su, XR; Li, TW				Li, Chenghua; Li, Zhen; Li, Ye; Zhou, Jun; Zhang, Chundan; Su, Xiurong; Li, Taiwu			A Ferritin from Dendrorhynchus zhejiangensis with Heavy Metals Detoxification Activity	PLOS ONE			English	Article							HORSE-SPLEEN FERRITIN; ION BINDING; IRON; EXPRESSION; HOMOLOG	Ferritin, an iron homeostasis protein, has important functions in transition and storage of toxic metal ions. In this study, the full-length cDNA of ferritin was isolated from Dendrorhynchus zhejiangensis by cDNA library and RACE approaches. The higher similarity and conserved motifs for ferritin were also identified in worm counterparts, indicating that it belonged to a new member of ferritin family. The temporal expression of worm ferritin in haemocytes was analyzed by RT-PCR, and revealed the ferritin could be induced by Cd2+, Pb2+ and Fe2+. The heavy metal binding activity of recombinant ferritin was further elucidated by atomic force microscopy (AFM). It was observed that the ferritin protein could form a chain of beads with different size against three metals exposure, and the largest one with 35 similar to 40 nm in height was identified in the Cd2+ challenge group. Our results indicated that worm ferritin was a promising candidate for heavy metals detoxification.	[Li, Chenghua; Li, Zhen; Li, Ye; Zhou, Jun; Zhang, Chundan; Su, Xiurong] Ningbo Univ, Sch Marine Sci, Ningbo 315211, Zhejiang, Peoples R China; [Li, Taiwu] Ningbo City Coll Vocat Technol, Ningbo, Zhejiang, Peoples R China	Ningbo University; Ningbo City College of Vocational Technology	Su, XR (corresponding author), Ningbo Univ, Sch Marine Sci, Ningbo 315211, Zhejiang, Peoples R China.	suxiurong@gmail.com	Li, Chenghua/L-9825-2019	Li, Chenghua/0000-0003-2978-8762	National Natural Science Foundation [41176123, 31272637]; Natural Science Foundation of Zhejiang Province [Y3100480]; KC Wong Magna Fund at Ningbo University	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); KC Wong Magna Fund at Ningbo University	This work was financially supported by the National Natural Science Foundation (No. 41176123 and No31272637), the Natural Science Foundation of Zhejiang Province (No. Y3100480), and KC Wong Magna Fund at Ningbo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arosio P, 2002, FREE RADICAL BIO MED, V33, P457, DOI 10.1016/S0891-5849(02)00842-0; Georgieva T, 2002, INSECT BIOCHEM MOLEC, V32, P295, DOI 10.1016/S0965-1748(01)00090-X; Haikarainen T, 2011, J MOL BIOL, V405, P448, DOI 10.1016/j.jmb.2010.10.058; HAINFELD JF, 1992, P NATL ACAD SCI USA, V89, P11064, DOI 10.1073/pnas.89.22.11064; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Huang H, 2000, ACTA BIOPHYSICA SINI, V16, P39; Jin CH, 2011, DEV COMP IMMUNOL, V35, P745, DOI 10.1016/j.dci.2011.02.006; Jung JH, 2011, J MAGN MAGN MATER, V323, P3077, DOI 10.1016/j.jmmm.2011.06.060; Khare G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018570; Li CH, 2011, FISH SHELLFISH IMMUN, V30, P1147, DOI 10.1016/j.fsi.2011.02.017; Li M, 2008, COMP BIOCHEM PHYS B, V150, P263, DOI 10.1016/j.cbpb.2008.03.014; Margarita EA, 2011, BIOORGAN MED CHEM, V19, P534; MELDRUM FC, 1995, J INORG BIOCHEM, V58, P59, DOI 10.1016/0162-0134(94)00037-B; PEAD S, 1995, J INORG BIOCHEM, V59, P15, DOI 10.1016/0162-0134(94)00050-K; Qiu GF, 2008, COMP BIOCHEM PHYS B, V150, P320, DOI 10.1016/j.cbpb.2008.03.016; Stephanie LD, 2009, ANAL BIOANAL CHEM, V394, P215; Su XR, 2009, FISH SHELLFISH IMMUN, V27, P466, DOI 10.1016/j.fsi.2009.06.014; Zhang JH, 2009, CHINESE SCI BULL, V54, P723, DOI 10.1007/s11434-008-0544-6; Zheng WJ, 2010, COMP BIOCHEM PHYS B, V156, P222, DOI 10.1016/j.cbpb.2010.03.012; Zhu B, 2011, FISH SHELLFISH IMMUN, V31, P453, DOI 10.1016/j.fsi.2011.06.020; Zoysa D, 2007, FISH SHELLFISH IMMUN, V23, P624	21	9	15	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e51428	10.1371/journal.pone.0051428	http://dx.doi.org/10.1371/journal.pone.0051428			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23284696	Green Published, gold, Green Submitted			2022-12-27	WOS:000313051500010
J	Rossi, R; Hale, C; Goulding, D; Andrews, R; Abdellah, Z; Fairchild, PJ; Dougan, G				Rossi, Raffaella; Hale, Christine; Goulding, David; Andrews, Robert; Abdellah, Zarah; Fairchild, Paul J.; Dougan, Gordon			Interaction of Salmonella Typhimurium with Dendritic Cells Derived from Pluripotent Embryonic Stem Cells	PLOS ONE			English	Article							ENTERICA SEROTYPE TYPHIMURIUM; EXPRESSION; IMMUNITY; DIFFERENTIATION; MACROPHAGES; ANTIGENS; SURVIVAL; BACTERIA; IL-23; INFECTIONS	Using an in vitro differentiation protocol we isolated cells with the properties of dendritic cells (DCs) from immunologically refractive pluripotent murine embryonic stem cells (ESCs). These ES-derived dendritic cells (ESDCs) expressed cytokines and were able to present antigen to a T cell line. Infection of ESDCs with Salmonella Typhimurium stimulated the expression of immune cell markers and thousands of murine genes, many associated with the immune response. Consequently, this system provides a novel in vitro model, amenable to genetic modification, for monitoring host/pathogen interactions.	[Rossi, Raffaella; Hale, Christine; Goulding, David; Andrews, Robert; Abdellah, Zarah; Dougan, Gordon] Wellcome Trust Sanger Inst, Cambridge, England; [Fairchild, Paul J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	Wellcome Trust Sanger Institute; University of Oxford	Dougan, G (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England.	gd1@sanger.ac.uk			Wellcome Trust [098051]; MRC [G0802538] Funding Source: UKRI; Medical Research Council [G0802538] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the Wellcome Trust grant number 098051. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 2005, GENOMICS, V86, P753, DOI 10.1016/j.ygeno.2005.08.003; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Brumell JH, 2004, CURR OPIN MICROBIOL, V7, P78, DOI 10.1016/j.mib.2003.12.005; BUCHMEIER NA, 1989, INFECT IMMUN, V57, P1; Cheminay C, 2005, J IMMUNOL, V174, P2892, DOI 10.4049/jimmunol.174.5.2892; Cid VJ, 2009, MICROBIOL-SGM, V155, P2461, DOI 10.1099/mic.0.032219-0; Dougan G, 2011, IMMUNOL REV, V240, P196, DOI 10.1111/j.1600-065X.2010.00999.x; Fairchild Paul J, 2007, Methods Mol Biol, V380, P59; Fairchild PJ, 2000, CURR BIOL, V10, P1515, DOI 10.1016/S0960-9822(00)00824-1; Fairchild PJ, 2003, METHOD ENZYMOL, V365, P169; Garcia-Del Portillo F, 2000, INFECT IMMUN, V68, P2985, DOI 10.1128/IAI.68.5.2985-2991.2000; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Horie K, 2011, NAT METHODS, V8, P1071, DOI [10.1038/NMETH.1739, 10.1038/nmeth.1739]; Huang Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr908; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; Kim H, 2011, BIOCHEM J, V440, P309, DOI 10.1042/BJ20110419; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Kirby AC, 2001, J IMMUNOL, V166, P6802, DOI 10.4049/jimmunol.166.11.6802; Layton AN, 2005, J BACTERIOL, V187, P3565, DOI 10.1128/JB.187.10.3565-3571.2005; Lee VT, 1999, IMMUNOL REV, V168, P241, DOI 10.1111/j.1600-065X.1999.tb01296.x; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; MacLennan C, 2004, J INFECT DIS, V190, P1755, DOI 10.1086/425021; McKelvie ND, 2004, VACCINE, V22, P3243, DOI 10.1016/j.vaccine.2004.05.014; Morelli AE, 2001, BLOOD, V98, P1512, DOI 10.1182/blood.V98.5.1512; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Niedergang F, 2000, P NATL ACAD SCI USA, V97, P14650, DOI 10.1073/pnas.97.26.14650; Persson J, 2007, IMMUNOGENETICS, V59, P761, DOI 10.1007/s00251-007-0248-0; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; Reimers M, 2006, METHOD ENZYMOL, V411, P119, DOI 10.1016/S0076-6879(06)11008-3; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rescigno M, 2007, ADV M C M, P81; Sanchez-Vargas FM, 2011, TRAVEL MED INFECT DI, V9, P263, DOI 10.1016/j.tmaid.2011.11.001; Shen ZH, 1997, J IMMUNOL, V158, P2723; Silk KM, 2011, GENE THER; Skinner JA, 2005, J IMMUNOL, V175, P4647, DOI 10.4049/jimmunol.175.7.4647; Smits HH, 2004, EUR J IMMUNOL, V34, P1371, DOI 10.1002/eji.200324815; Steele-Mortimer O, 1999, CELL MICROBIOL, V1, P33, DOI 10.1046/j.1462-5822.1999.00003.x; Sundquist M, 2004, CELL MICROBIOL, V6, P1, DOI 10.1046/j.1462-5822.2003.00336.x; Uchiya K, 2005, INFECT IMMUN, V73, P5587, DOI 10.1128/IAI.73.9.5587-5594.2005; van der Velden AWM, 2003, J IMMUNOL, V171, P6742, DOI 10.4049/jimmunol.171.12.6742; Vazquez-Torres A, 2000, SCIENCE, V287, P1655, DOI 10.1126/science.287.5458.1655; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Wu YZ, 2009, INT IMMUNOL, V21, P745, DOI 10.1093/intimm/dxp041; Yu J, 2009, INFECT IMMUN, V77, P585, DOI 10.1128/IAI.01003-08	46	9	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52232	10.1371/journal.pone.0052232	http://dx.doi.org/10.1371/journal.pone.0052232			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23284947	gold, Green Published			2022-12-27	WOS:000313051500026
J	Bi, CWC; Xu, L; Tian, XY; Liu, J; Zheng, KYZ; Lau, CW; Lau, DTW; Choi, RCY; Dong, TTX; Huang, Y; Tsim, KWK				Bi, Cathy W. C.; Xu, Li; Tian, Xiao Yu; Liu, Jian; Zheng, Ken Y. Z.; Lau, Chi Wai; Lau, David T. W.; Choi, Roy C. Y.; Dong, Tina T. X.; Huang, Yu; Tsim, Karl W. K.			Fo Shou San, an Ancient Chinese Herbal Decoction, Protects Endothelial Function through Increasing Endothelial Nitric Oxide Synthase Activity	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; FERULIC ACID; ANGELICAE SINENSIS; GINSENOSIDE RB1; REACTIVE OXYGEN; NADPH OXIDASE; CELLS; DYSFUNCTION; HOMOCYSTEINE; ACTIVATION	Fo Shou San (FSS) is an ancient herbal decoction comprised of Chuanxiong Rhizoma (CR; Chuanxiong) and Angelicae Sinensis Radix (ASR; Danggui) in a ratio of 2:3. Previous studies indicate that FSS promotes blood circulation and dissipates blood stasis, thus which is being used widely to treat vascular diseases. Here, we aim to determine the cellular mechanism for the vascular benefit of FSS. The treatment of FSS reversed homocysteine-induced impairment of acetylcholine (ACh)-evoked endothelium-dependent relaxation in aortic rings, isolated from rats. Like radical oxygen species (ROS) scavenger tempol, FSS attenuated homocysteine-stimulated ROS generation in cultured human umbilical vein endothelial cells (HUVECs), and it also stimulated the production of nitric oxide (NO) as measured by fluorescence dye and biochemical assay. In addition, the phosphorylation levels of both Akt kinase and endothelial NO synthases (eNOS) were markedly increased by FSS treatment, which was abolished by an Akt inhibitor triciribine. Likewise, triciribine reversed FSS-induced NO production in HUVECs. Finally, FSS elevated intracellular Ca2+ levels in HUVECs, and the Ca2+ chelator BAPTA-AM inhibited the FSS-stimulated eNOS phosphorylation. The present results show that this ancient herbal decoction benefits endothelial function through increased activity of Akt kinase and eNOS; this effect is causally via a rise of intracellular Ca2+ and a reduction of ROS.	[Bi, Cathy W. C.; Xu, Li; Zheng, Ken Y. Z.; Lau, David T. W.; Choi, Roy C. Y.; Dong, Tina T. X.; Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China; [Bi, Cathy W. C.; Xu, Li; Zheng, Ken Y. Z.; Lau, David T. W.; Choi, Roy C. Y.; Dong, Tina T. X.; Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Ctr Chinese Med, Hong Kong, Hong Kong, Peoples R China; [Tian, Xiao Yu; Liu, Jian; Lau, Chi Wai; Huang, Yu] Chinese Univ Hong Kong, Sch Biomed Sci, Li Ka Shing Inst Hlth Sci, Inst Vasc Med, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Chinese University of Hong Kong	Tsim, KWK (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China.	botsim@ust.hk	Huang, Yu/K-2866-2017; Tian, Xiao Yu/P-1092-2016	Huang, Yu/0000-0002-1277-6784; Tian, Xiao Yu/0000-0003-3472-9898; Lau, Tai Wai David/0000-0002-3443-1808; Tsim, Karl/0000-0003-4808-1674; Liu, Jian/0000-0001-9719-2923	Research Grants Council of Hong Kong [N_HKUST629/07, 662608, 662911, 661110]; Croucher Foundation [CAS-CF07/08.SC03]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Croucher Foundation	This research was supported by grants from Research Grants Council of Hong Kong (N_HKUST629/07, 662608, 662911 to KWKT; 661110 to DTWL), Croucher Foundation (CAS-CF07/08.SC03) to KWKT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Berndt N, 2010, CELL DEATH DIFFER, V17, P1795, DOI 10.1038/cdd.2010.63; Bi CWC, 2012, PLANTA MED, V78, P122, DOI 10.1055/s-0031-1280356; Bi CWC, 2010, PLANTA MED, V76, P1525, DOI 10.1055/s-0029-1241003; Cai H, 2008, CARDIOVASC RES, V77, P30, DOI 10.1093/cvr/cvm010; Chan WK, 2000, CARDIOVASC RES, V46, P180, DOI 10.1016/S0008-6363(99)00423-X; Chen ZY, 1998, LIFE SCI, V63, P1983, DOI 10.1016/S0024-3205(98)00476-7; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; Hasin T, 2011, BASIC RES CARDIOL, V106, P175, DOI 10.1007/s00395-010-0145-9; Hemmens B, 2000, J BIOL CHEM, V275, P35786, DOI 10.1074/jbc.M005976200; Higashi Y, 2002, AM J HYPERTENS, V15, P326, DOI 10.1016/S0895-7061(01)02317-2; Hink U, 2001, CIRC RES, V88, pE14; Hu QH, 2000, J BIOL CHEM, V275, P15749, DOI 10.1074/jbc.M000381200; Huang Y, 1999, BBA-GEN SUBJECTS, V1427, P322, DOI 10.1016/S0304-4165(99)00034-3; Ignarro LJ, 2002, J PHYSIOL PHARMACOL, V53, P503; Kietadisorn R, 2012, AM J PHYSIOL-ENDOC M, V302, pE481, DOI 10.1152/ajpendo.00540.2011; Lan TH, 2011, BIOCHEM PHARMACOL, V82, P148, DOI 10.1016/j.bcp.2011.04.001; Landmesser U, 2003, J CLIN INVEST, V111, P1201, DOI 10.1172/JCI200314172; Leber A, 1999, J BIOL CHEM, V274, P37658, DOI 10.1074/jbc.274.53.37658; Lee JH, 2003, J BIOL CHEM, V278, P51360, DOI 10.1074/jbc.M302332200; Leung KW, 2007, FEBS LETT, V581, P2423, DOI 10.1016/j.febslet.2007.04.055; Li JM, 2001, CARDIOVASC RES, V52, P477, DOI 10.1016/S0008-6363(01)00407-2; Li YB, 1998, J BIOL CHEM, V273, P2015, DOI 10.1074/jbc.273.4.2015; Ma ZC, 2010, BIOL PHARM BULL, V33, P29, DOI 10.1248/bpb.33.29; Michel T, 2010, PFLUG ARCH EUR J PHY, V459, P807, DOI 10.1007/s00424-009-0765-9; Mikkelsen RB, 2003, ONCOGENE, V22, P5734, DOI 10.1038/sj.onc.1206663; Moens AL, 2008, CIRCULATION, V117, P1810, DOI 10.1161/CIRCULATIONAHA.107.725481; Mollnau H, 2002, CIRC RES, V90, pE58, DOI 10.1161/01.RES.0000012569.55432.02; Ohashi R, 2006, J SURG RES, V133, P89, DOI 10.1016/j.jss.2005.09.016; Shao M.L., 2010, PHARMACOPOEIA PEOP 1, P144; Stanger O, 2003, CLIN CHEM LAB MED, V41, P1444, DOI 10.1515/CCLM.2003.222; Stuhlinger MC, 2001, CIRCULATION, V104, P2569, DOI 10.1161/hc4601.098514; Suzuki A, 2002, AM J HYPERTENS, V15, P351, DOI 10.1016/S0895-7061(01)02337-8; Suzuki A, 2007, AM J HYPERTENS, V20, P508, DOI 10.1016/j.amjhyper.2006.11.008; Takimoto E, 2005, J CLIN INVEST, V115, P1221, DOI 10.1172/JCI200521968; Tang EHC, 2007, BRIT J PHARMACOL, V151, P15, DOI 10.1038/sj.bjp.0707190; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; Wang BH, 2004, J CARDIOVASC PHARM, V43, P549, DOI 10.1097/00005344-200404000-00010; Wong WT, 2011, CELL METAB, V14, P104, DOI 10.1016/j.cmet.2011.05.009; Wong WT, 2010, J CARDIOVASC PHARM, V55, P300, DOI 10.1097/FJC.0b013e3181d7671c; Zou MH, 2002, J CLIN INVEST, V109, P817, DOI 10.1172/JCI200214442	41	30	33	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e51670	10.1371/journal.pone.0051670	http://dx.doi.org/10.1371/journal.pone.0051670			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284736	Green Published, gold, Green Submitted			2022-12-27	WOS:000313158800013
J	Racke, FK; Baird, M; Barth, RF; Huo, TY; Yang, WL; Gupta, N; Weldon, M; Rutledge, H				Racke, Frederick K.; Baird, Maureen; Barth, Rolf F.; Huo, Tianyao; Yang, Weilian; Gupta, Nilendu; Weldon, Michael; Rutledge, Heather			Unique In Vitro and In Vivo Thrombopoietic Activities of Ingenol 3,20 Dibenzoate, A Ca++-Independent Protein Kinase C Isoform Agonist	PLOS ONE			English	Article							HUMAN MEGAKARYOCYTE GROWTH; ACUTE MYELOID-LEUKEMIA; TRANSCRIPTION FACTORS FLI-1; HUMAN BONE-MARROW; DOUBLE-BLIND; PHORBOL DIESTERS; PROGENITOR CELLS; FACTOR EKLF; K562 CELLS; DIFFERENTIATION	Thrombopoiesis following severe bone marrow injury frequently is delayed, thereby resulting in life-threatening thrombocytopenia for which there are limited treatment options. The reasons for these delays in recovery are not well understood. Protein kinase C (PKC) agonists promote megakaryocyte differentiation in leukemia cell lines and primary cells. However, little is known about the megakaryopoietic effects of PKC agonists on primary CD34+ cells grown in culture or in vivo. Here we present evidence that the novel PKC isoform-selective agonist 3,20 ingenol dibenzoate (IDB) potently stimulates early megakaryopoiesis of human CD34+ cells. In contrast, broad spectrum PKC agonists failed to do so. In vivo, a single intraperitoneal injection of IDB selectively increased platelets in mice without affecting hemoglobin or white counts. Finally, IDB strongly mitigated radiation-induced thrombocytopenia, even when administered 24 hours after irradiation. Our data demonstrate that novel PKC isoform agonists such as IDB may represent a unique therapeutic strategy for accelerating the recovery of platelet counts following severe marrow injury.	[Racke, Frederick K.; Baird, Maureen; Barth, Rolf F.; Huo, Tianyao; Yang, Weilian; Rutledge, Heather] Ohio State Univ, Dept Pathol, Sch Med, Columbus, OH 43210 USA; [Gupta, Nilendu; Weldon, Michael] Ohio State Univ, Sch Med, Dept Radiat Oncol, Columbus, OH 43210 USA	Ohio State University; Ohio State University	Racke, FK (corresponding author), Quest Diagnost, Capistrano, CA USA.	frederick.k.racke@questdiagnostics.com	Gupta, Nilendu/E-3171-2011	Gupta, Nilendu/0000-0003-0461-0570	Department of Pathology, The Ohio State University, Columbus, Ohio	Department of Pathology, The Ohio State University, Columbus, Ohio	Internal funds for this work were provided by the Department of Pathology, The Ohio State University, Columbus, Ohio. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Archimbaud E, 1999, BLOOD, V94, P3694, DOI 10.1182/blood.V94.11.3694.423k18_3694_3701; Baatout S, 1998, HEMATOL CELL THER, V40, P33; BARTLEY TD, 1994, CELL, V77, P1117, DOI 10.1016/0092-8674(94)90450-2; Bassini A, 1999, BLOOD, V93, P1178, DOI 10.1182/blood.V93.4.1178.404k28_1178_1188; Bouilloux F, 2008, BLOOD, V112, P576, DOI 10.1182/blood-2007-07-098996; Cejas PJ, 2005, J BIOL CHEM, V280, P28412, DOI 10.1074/jbc.M500345200; Clay D, 2001, BLOOD, V97, P1982, DOI 10.1182/blood.V97.7.1982; Debili N, 1996, BLOOD, V88, P1284, DOI 10.1182/blood.V88.4.1284.bloodjournal8841284; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; DESAUVAGE FJ, 1994, NATURE, V369, P533, DOI 10.1038/369533a0; DRACHMAN JG, 1995, J BIOL CHEM, V270, P4979, DOI 10.1074/jbc.270.10.4979; Geissler K, 2003, ANN HEMATOL, V82, P677, DOI 10.1007/s00277-003-0737-7; Gobbi G, 2007, STEM CELLS, V25, P2322, DOI 10.1634/stemcells.2006-0839; Hart A, 2000, IMMUNITY, V13, P167, DOI 10.1016/S1074-7613(00)00017-0; Hilton DJ, 2009, BLOOD; Hofmann J, 1997, FASEB J, V11, P649, DOI 10.1096/fasebj.11.8.9240967; HUG H, 1993, BIOCHEM J, V291, P329, DOI 10.1042/bj2910329; Jaken S, 1996, CURR OPIN CELL BIOL, V8, P168, DOI 10.1016/S0955-0674(96)80062-7; Kaushansky K, 2000, LEUKEMIA, V14, P505, DOI 10.1038/sj.leu.2401620; Kruse EA, 2009, P NATL ACAD SCI USA, V106, P13814, DOI 10.1073/pnas.0906556106; LeNaour F, 1997, LEUKEMIA, V11, P1290, DOI 10.1038/sj.leu.2400721; LONG MW, 1984, J CLIN INVEST, V74, P1686, DOI 10.1172/JCI111585; LONG MW, 1985, J CLIN INVEST, V76, P431, DOI 10.1172/JCI111990; Manz MG, 2002, P NATL ACAD SCI USA, V99, P11872, DOI 10.1073/pnas.172384399; McCullough J, 2000, SEMIN HEMATOL, V37, P3, DOI 10.1016/S0037-1963(00)90047-7; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Myklebust JH, 2000, BLOOD, V95, P510, DOI 10.1182/blood.V95.2.510; Nakorn TN, 2003, P NATL ACAD SCI USA, V100, P205, DOI 10.1073/pnas.262655099; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.48.28495; PERKINS AC, 1995, NATURE, V375, P318; Pierce A, 1998, J CELL BIOL, V140, P1511, DOI 10.1083/jcb.140.6.1511; Racke F, 2004, ASH ANN M, V104, P1607; Racke FK, 1997, J BIOL CHEM, V272, P23366, DOI 10.1074/jbc.272.37.23366; Racke FK, 2001, J BIOL CHEM, V276, P522, DOI 10.1074/jbc.M005236200; Saito H, 1997, BAILLIERE CLIN HAEM, V10, P47, DOI 10.1016/S0950-3536(97)80050-9; Sandberg ML, 2005, DEV CELL, V8, P153, DOI 10.1016/j.devcel.2004.12.015; Schiffer CA, 2000, BLOOD, V95, P2530, DOI 10.1182/blood.V95.8.2530.008k31_2530_2535; St Louis DC, 1999, J IMMUNOL, V162, P3237; Starck J, 2003, MOL CELL BIOL, V23, P1390, DOI 10.1128/MCB.23.4.1390-1402.2003; Tallack MR, 2010, HAEMATOL-HEMATOL J, V95, P144, DOI 10.3324/haematol.2009.010017; Tewari R, 1998, EMBO J, V17, P2334, DOI 10.1093/emboj/17.8.2334; Vegiopoulos A, 2006, BLOOD, V107, P4703, DOI 10.1182/blood-2005-07-2968; Vitale M, 2006, EUR J HISTOCHEM, V50, P15; Whalen AM, 1997, MOL CELL BIOL, V17, P1947, DOI 10.1128/MCB.17.4.1947	45	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e51059	10.1371/journal.pone.0051059	http://dx.doi.org/10.1371/journal.pone.0051059			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284657	gold, Green Submitted, Green Published			2022-12-27	WOS:000313158800007
J	Chae, CS; Kwon, HK; Hwang, JS; Kim, JE; Im, SH				Chae, Chang-Suk; Kwon, Ho-Keun; Hwang, Ji-Sun; Kim, Jung-Eun; Im, Sin-Hyeog			Prophylactic Effect of Probiotics on the Development of Experimental Autoimmune Myasthenia Gravis	PLOS ONE			English	Article							REGULATORY T-CELLS; PLACEBO-CONTROLLED TRIAL; TOLEROGENIC DENDRITIC CELLS; INFLAMMATORY-BOWEL-DISEASE; ACETYLCHOLINE-RECEPTOR; LACTOBACILLUS-CASEI; C57BL/6 MICE; IFN-GAMMA; EXPERIMENTAL ARTHRITIS; MAINTAINING REMISSION	Probiotics are live bacteria that confer health benefits to the host physiology. Although protective role of probiotics have been reported in diverse diseases, no information is available whether probiotics can modulate neuromuscular immune disorders. We have recently demonstrated that IRT5 probiotics, a mixture of 5 probiotics, could suppress diverse experimental disorders in mice model. In this study we further investigated whether IRT5 probiotics could modulate the progression of experimental autoimmune myasthenia gravis (EAMG). Myasthenia gravis (MG) is a T cell dependent antibody mediated autoimmune disorder in which acetylcholine receptor (AChR) at the neuromuscular junction is the major autoantigen. Oral administration of IRT5 probiotics significantly reduced clinical symptoms of EAMG such as weight loss, body trembling and grip strength. Prophylactic effect of IRT5 probiotics on EMAG is mediated by down-regulation of effector function of AChR-reactive T cells and B cells. Administration of IRT5 probiotics decreased AChR-reactive lymphocyte proliferation, anti-AChR reactive IgG levels and inflammatory cytokine levels such as IFN-gamma, TNF-alpha, IL-6 and IL-17. Downregulation of inflammatory mediators in AChR-reactive lymphocytes by IRT5 probiotics is mediated by the generation of regulatory dendritic cells (rDCs) that express increased levels of IL-10, TGF-beta, arginase 1 and aldh1a2. Furthermore, DCs isolated from IRT5 probiotics-fed group effectively converted CD4(+) T cells into CD4+ Foxp3(+) regulatory T cells compared with control DCs. Our data suggest that IRT5 probiotics could be applicable to modulate antibody mediated autoimmune diseases including myasthenia gravis.	[Im, Sin-Hyeog] GIST, Sch Life Sci, Kwangju, South Korea; GIST, Immune Synapse Res Ctr, Kwangju, South Korea	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST)	Im, SH (corresponding author), GIST, Sch Life Sci, Kwangju, South Korea.	imsh@gist.ac.kr	Im, Sin-Hyeog/AAM-9586-2021; Im, Sin-Hyeog/E-6811-2013	Im, Sin-Hyeog/0000-0002-3173-1856; Im, Sin-Hyeog/0000-0002-3173-1856; KWON, HOKEUN/0000-0003-3175-0376	Regional Technology Innovation Program of the MOCIE [RTI05-01-01]; Mid-career Researcher Program through NRF (National Research Foundation, KOREA) [2011-0000126]; GIST (Gwangju Institute of Science and Technology)	Regional Technology Innovation Program of the MOCIE(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Mid-career Researcher Program through NRF (National Research Foundation, KOREA); GIST (Gwangju Institute of Science and Technology)	This research was supported by grants from the Regional Technology Innovation Program of the MOCIE (RTI05-01-01), Mid-career Researcher Program through NRF (National Research Foundation, KOREA) (2011-0000126) and by a Systems Biology Infrastructure Establishment Grant provided by GIST (Gwangju Institute of Science and Technology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akalin AS, 1997, J DAIRY SCI, V80, P2721, DOI 10.3168/jds.S0022-0302(97)76233-7; Alander M, 1999, APPL ENVIRON MICROB, V65, P351; Balasa B, 1998, J IMMUNOL, V161, P2856; Balasa B, 1997, J EXP MED, V186, P385, DOI 10.1084/jem.186.3.385; Baroja ML, 2007, CLIN EXP IMMUNOL, V149, P470, DOI 10.1111/j.1365-2249.2007.03434.x; Besselink MGH, 2008, LANCET, V371, P651, DOI 10.1016/S0140-6736(08)60207-X; Bowman LM, 2001, INFECT IMMUN, V69, P3719, DOI 10.1128/IAI.69.6.3719-3727.2001; Calcinaro F, 2005, DIABETOLOGIA, V48, P1565, DOI 10.1007/s00125-005-1831-2; Conti-Fine BM, 2006, J CLIN INVEST, V116, P2843, DOI 10.1172/JCI29894; de Roos NM, 2000, AM J CLIN NUTR, V71, P405; Deng CS, 2002, J IMMUNOL, V169, P1077, DOI 10.4049/jimmunol.169.2.1077; DRACHMAN DB, 1978, NEW ENGL J MED, V298, P1116, DOI 10.1056/NEJM197805182982004; Foligne B, 2005, GUT, V54, P727; Gervasio OL, 2005, J PHYSIOL-LONDON, V562, P673, DOI 10.1113/jphysiol.2004.077685; Gionchetti P, 2000, GASTROENTEROLOGY, V119, P305, DOI 10.1053/gast.2000.9370; Goluszko E, 2002, J NEUROIMMUNOL, V122, P85, DOI 10.1016/S0165-5728(01)00474-X; Gomez AM, 2011, J IMMUNOL, V186, P2503, DOI 10.4049/jimmunol.1002539; Gomez AM, 2010, AUTOIMMUNITY, V43, P353, DOI 10.3109/08916930903555943; GOMEZ CM, 1983, P NATL ACAD SCI-BIOL, V80, P4089, DOI 10.1073/pnas.80.13.4089; HOHLFELD R, 1984, NATURE, V310, P244, DOI 10.1038/310244a0; Im SH, 2001, FASEB J, V15, P2140, DOI 10.1096/fj.01-0072com; Im SH, 1999, J CLIN INVEST, V104, P1723, DOI 10.1172/JCI8121; Isolauri E, 2002, GUT, V50, P54, DOI 10.1136/gut.50.suppl_3.iii54; Isolauri E, 2000, CLIN EXP ALLERGY, V30, P1604, DOI 10.1046/j.1365-2222.2000.00943.x; ITOH T, 1995, LETT APPL MICROBIOL, V21, P137, DOI 10.1111/j.1472-765X.1995.tb01025.x; Kalliomaki M, 2001, LANCET, V357, P1076, DOI 10.1016/S0140-6736(00)04259-8; Karachunski PI, 2000, J IMMUNOL, V164, P5236, DOI 10.4049/jimmunol.164.10.5236; Kato I, 1998, LIFE SCI, V63, P635, DOI 10.1016/S0024-3205(98)00315-4; Kim N, 2007, CLIN IMMUNOL, V123, P30, DOI 10.1016/j.clim.2006.11.005; Kuhbacher T, 2006, GUT, V55, P833, DOI 10.1136/gut.2005.078303; Kwon HK, 2010, P NATL ACAD SCI USA, V107, P2159, DOI 10.1073/pnas.0904055107; Lavasani S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009009; LENNON VA, 1978, J EXP MED, V147, P973, DOI 10.1084/jem.147.4.973; Losen M, 2008, ANN NY ACAD SCI, V1132, P174, DOI 10.1196/annals.1405.034; Mahnke K, 2007, J DERMATOL SCI, V46, P159, DOI 10.1016/j.jdermsci.2007.03.002; Maiti PK, 2004, J NEUROIMMUNOL, V152, P112, DOI 10.1016/j.jneuroim.2004.04.010; Martinez-Martinez P, 2009, NEUROBIOL DIS, V35, P14, DOI 10.1016/j.nbd.2009.03.008; Mimura T, 2004, GUT, V53, P108, DOI 10.1136/gut.53.1.108; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Mu LL, 2009, IMMUNOLOGY, V128, pe826, DOI 10.1111/j.1365-2567.2009.03089.x; NEWSOMDAVIS J, 1978, NEUROLOGY, V28, P266, DOI 10.1212/WNL.28.3.266; Ostlie N, 2003, J IMMUNOL, V170, P604, DOI 10.4049/jimmunol.170.1.604; PACHNER AR, 1987, YALE J BIOL MED, V60, P169; Parvez S, 2006, J APPL MICROBIOL, V100, P1171, DOI 10.1111/j.1365-2672.2006.02963.x; PERDIGON G, 1995, J DAIRY SCI, V78, P1597, DOI 10.3168/jds.S0022-0302(95)76784-4; PINCHING AJ, 1976, LANCET, V2, P1373; Pochard P, 2002, J ALLERGY CLIN IMMUN, V110, P617, DOI 10.1067/mai.2002.128528; Reddy BS, 1999, J NUTR, V129, p1478S, DOI 10.1093/jn/129.7.1478S; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; SAHASHI K, 1980, J NEUROPATH EXP NEUR, V39, P160, DOI 10.1097/00005072-198003000-00005; Sheil B, 2004, GUT, V53, P694, DOI 10.1136/gut.2003.027789; Shida K, 1998, INT ARCH ALLERGY IMM, V115, P278, DOI 10.1159/000069458; Smits HH, 2005, J ALLERGY CLIN IMMUN, V115, P1260, DOI 10.1016/j.jaci.2005.03.036; So JS, 2008, MOL IMMUNOL, V46, P172, DOI 10.1016/j.molimm.2008.07.038; So JS, 2008, MOL IMMUNOL, V45, P2690, DOI 10.1016/j.molimm.2007.12.010; So JS, 2011, LIFE SCI, V88, P358, DOI 10.1016/j.lfs.2010.12.013; TOYKA KV, 1975, SCIENCE, V190, P397, DOI 10.1126/science.1179220; Viljanen M, 2005, J ALLERGY CLIN IMMUN, V115, P1254, DOI 10.1016/j.jaci.2005.03.047; Wang HB, 2000, INT IMMUNOL, V12, P1381, DOI 10.1093/intimm/12.10.1381; Wang W, 2007, J IMMUNOL, V178, P7072, DOI 10.4049/jimmunol.178.11.7072; Yi HJ, 2008, MOL IMMUNOL, V46, P192, DOI 10.1016/j.molimm.2008.08.264; Zocco MA, 2006, ALIMENT PHARM THER, V23, P1567, DOI 10.1111/j.1365-2036.2006.02927.x	62	33	33	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52119	10.1371/journal.pone.0052119	http://dx.doi.org/10.1371/journal.pone.0052119			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284891	Green Submitted, gold, Green Published			2022-12-27	WOS:000312794500093
J	Goertz, DE; Todorova, M; Mortazavi, O; Agache, V; Chen, B; Karshafian, R; Hynynen, K				Goertz, David E.; Todorova, Margarita; Mortazavi, Omid; Agache, Vlad; Chen, Branson; Karshafian, Raffi; Hynynen, Kullervo			Antitumor Effects of Combining Docetaxel (Taxotere) with the Antivascular Action of Ultrasound Stimulated Microbubbles	PLOS ONE			English	Article							INTENSITY FOCUSED ULTRASOUND; VASCULAR DISRUPTING AGENTS; TEMPERATURE-SENSITIVE LIPOSOMES; TUMOR BLOOD-VESSELS; 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID; SOLID TUMORS; IN-VIVO; DRUG-DELIVERY; INERTIAL CAVITATION; TARGETING AGENTS	Ultrasound stimulated microbubbles (USMB) are being investigated for their potential to promote the uptake of anticancer agents into tumor tissue by exploiting their ability to enhance microvascular permeability. At sufficiently high ultrasound transmit amplitudes it has also recently been shown that USMB treatments can, on their own, induce vascular damage, shutdown blood flow, and inhibit tumor growth. The objective of this study is to examine the antitumor effects of 'antivascular' USMB treatments in conjunction with chemotherapy, which differs from previous work which has sought to enhance drug uptake with USMBs by increasing vascular permeability. Conceptually this is a strategy similar to combining vascular disrupting agents with a chemotherapy, and we have selected the taxane docetaxel (Taxotere) for evaluating this approach as it has previously been shown to have potent antitumor effects when combined with small molecule vascular disrupting agents. Experiments were conducted on PC3 tumors implanted in athymic mice. USMB treatments were performed at a frequency of 1 MHz employing sequences of 50 ms bursts (0.00024 duty cycle) at 1.65 MPa. USMB treatments were administered on a weekly basis for 4 weeks with docetaxel (DTX) being given intravenously at a dose level of 5 mg/kg. The USMB treatments, either alone or in combination with DTX, induced an acute reduction in tumor perfusion which was accompanied at the 24 hour point by significantly enhanced necrosis and apoptosis. Longitudinal experiments showed a modest prolongation in survival but no significant growth inhibition occurred in DTX-only and USMB-only treatment groups relative to control tumors. The combined USMB-DTX treatment group produced tumor shrinkage in weeks 4-6, and significant growth inhibition and survival prolongation relative to the control (p<0.001), USMB-only (p<0.01) and DTX-only treatment groups (p<0.01). These results suggest the potential of enhancing the antitumor activity of docetaxel by combining it with antivascular USMB effects.	[Goertz, David E.; Todorova, Margarita; Hynynen, Kullervo] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Goertz, David E.; Todorova, Margarita; Mortazavi, Omid; Agache, Vlad; Chen, Branson; Hynynen, Kullervo] Sunnybrook Res Inst, Toronto, ON, Canada; [Karshafian, Raffi] Ryerson Univ, Dept Phys, Toronto, ON, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Toronto Metropolitan University	Goertz, DE (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.	goertz@sri.utoronto.ca		Chen, Branson/0000-0002-4224-0753	Ontario Research Fund	Ontario Research Fund	This work was funded by the Ontario Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekeredjian R, 2007, ULTRASOUND MED BIOL, V33, P1592, DOI 10.1016/j.ultrasmedbio.2007.05.003; Bissery MC, 1995, SEMIN ONCOL, V22, P3; Bohmer MR, 2010, J CONTROL RELEASE, V148, P18, DOI 10.1016/j.jconrel.2010.06.012; Burke CW, 2011, J NEUROSURG, V114, P1654, DOI 10.3171/2010.11.JNS101201; Chappell JC, 2005, ULTRASOUND MED BIOL, V31, P1411, DOI 10.1016/j.ultrasmedbio.2005.06.010; Chen H, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.034301; Ching LM, 2004, BRIT J CANCER, V90, P906, DOI 10.1038/sj.bjc.6601606; Ching LM, 2002, BRIT J CANCER, V86, P1937, DOI 10.1038/sj.bjc.6600368; Czarnota GJ, 2012, P NATL ACAD SCI USA, V109, pE2033, DOI 10.1073/pnas.1200053109; Deckers R, 2010, J CONTROL RELEASE, V148, P25, DOI 10.1016/j.jconrel.2010.07.117; Dromi S, 2007, CLIN CANCER RES, V13, P2722, DOI 10.1158/1078-0432.CCR-06-2443; Duan WR, 2003, J PATHOL, V199, P221, DOI 10.1002/path.1289; Fenton BM, 1999, BRIT J CANCER, V79, P464, DOI 10.1038/sj.bjc.6690072; Goertz DE, 2008, ULTRASON, P670, DOI 10.1109/ULTSYM.2008.0161; Goertz DE, 2009, IEEE ULTRASON S, P89; Head M, 2010, EXPERT OPIN INV DRUG, V19, P295, DOI 10.1517/13543780903540214; Heath CH, 2012, OTOLARYNG HEAD NECK, V146, P938, DOI 10.1177/0194599812436648; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Helfield BL, 2012, ULTRASOUND MED BIOL, V38, P1298, DOI 10.1016/j.ultrasmedbio.2012.03.005; Hori K, 2010, J PHARM SCI-US, V99, P2914, DOI 10.1002/jps.22038; Horsman MR, 2006, CANCER RES, V66, P11520, DOI 10.1158/0008-5472.CAN-06-2848; Hu X, INVEST RADIOL, V47, P398; Hwang JH, 2005, ULTRASOUND MED BIOL, V31, P553, DOI 10.1016/j.ultrasmedbio.2004.12.014; Hwang JH, 2006, ULTRASOUND MED BIOL, V32, P1611, DOI 10.1016/j.ultrasmedbio.2006.07.016; Hynynen K, 1996, ULTRASOUND MED BIOL, V22, P193, DOI 10.1016/0301-5629(95)02044-6; Jain RK, 2001, ADV DRUG DELIVER REV, V46, P149, DOI 10.1016/S0169-409X(00)00131-9; Karshafian R, 2009, ULTRASOUND MED BIOL, V35, P847, DOI 10.1016/j.ultrasmedbio.2008.10.013; Kim TJ, 2007, CANCER RES, V67, P9337, DOI 10.1158/0008-5472.CAN-06-4018; Krix M, 2003, ULTRASOUND MED BIOL, V29, P1093, DOI 10.1016/S0301-5629(03)00060-7; Leighton T., 1997, ACOUSTIC BUBBLE; Lin CY, 2012, INT J NANOMED, V7, P2143, DOI 10.2147/IJN.S29514; Lin CY, 2010, J CONTROL RELEASE, V146, P291, DOI 10.1016/j.jconrel.2010.05.033; Lin CY, 2010, ULTRASOUND MED BIOL, V36, P1460, DOI 10.1016/j.ultrasmedbio.2010.06.003; McDannold NJ, 2006, RADIOLOGY, V241, P95, DOI 10.1148/radiol.2411051170; McKeage M, 2006, CLIN CANCER RES, V12, P1776, DOI 10.1158/1078-0432.CCR-05-1939; McKeage MJ, 2008, EXPERT OPIN INV DRUG, V17, P23, DOI 10.1517/13543784.17.1.23; McKeage MJ, 2010, CANCER-AM CANCER SOC, V116, P1859, DOI 10.1002/cncr.24975; Miller DL, 2007, PROG BIOPHYS MOL BIO, V93, P314, DOI 10.1016/j.pbiomolbio.2006.07.027; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Pili R, 2010, CLIN CANCER RES, V16, P2906, DOI 10.1158/1078-0432.CCR-09-3026; Quesson B, 2010, MED PHYS, V37, P2533, DOI 10.1118/1.3413996; Ranjan A, 2012, J CONTROL RELEASE, V158, P487, DOI 10.1016/j.jconrel.2011.12.011; Rapoport N, 2007, JNCI-J NATL CANCER I, V99, P1095, DOI 10.1093/jnci/djm043; Schwartz EL, 2009, CLIN CANCER RES, V15, P2594, DOI 10.1158/1078-0432.CCR-08-2710; Shaked Y, 2007, CANCER RES, V67, P7055, DOI 10.1158/0008-5472.CAN-07-0905; Shaked Y, 2006, SCIENCE, V313, P1785, DOI 10.1126/science.1127592; Shaked Y, 2010, VASCULAR DISRUPTIVE AGENTS FOR THE TREATMENT OF CANCER, P117, DOI 10.1007/978-1-4419-6609-4_6; Siemann DW, 2008, ANTICANCER RES, V28, P2027; Siemann DW, 2011, CANCER TREAT REV, V37, P63, DOI 10.1016/j.ctrv.2010.05.001; Siemann DW, 2004, INT J RADIAT ONCOL, V60, P1233, DOI 10.1016/j.ijrobp.2004.08.002; Siemann DW, 2002, INT J CANCER, V99, P1, DOI 10.1002/ijc.10316; Siim BG, 2003, CANCER CHEMOTH PHARM, V51, P43, DOI 10.1007/s00280-002-0529-0; Skeel R.T, 2007, HDB CANC CHEMOTHERAP; Song J, 2002, CIRCULATION, V106, P1550, DOI 10.1161/01.CIR.0000028810.33423.95; Sorace AG, 2012, J DRUG TARGET, V20, P43, DOI 10.3109/1061186X.2011.622397; Staruch R, 2011, INT J HYPERTHER, V27, P156, DOI 10.3109/02656736.2010.518198; Tachibana K, 1999, LANCET, V353, P1409, DOI 10.1016/S0140-6736(99)01244-1; Tannock IF, 2002, CLIN CANCER RES, V8, P878; Taraboletti G, 2010, VASCULAR DISRUPTIVE AGENTS FOR THE TREATMENT OF CANCER, P77, DOI 10.1007/978-1-4419-6609-4_4; Tartis MS, 2006, ULTRASOUND MED BIOL, V32, P1771, DOI 10.1016/j.ultrasmedbio.2006.03.017; ter Haar GR, 2001, ECHOCARDIOGR-J CARD, V18, P317, DOI 10.1046/j.1540-8175.2001.00317.x; Ting CY, 2012, BIOMATERIALS, V33, P704, DOI 10.1016/j.biomaterials.2011.09.096; Tozer GM, 2005, NAT REV CANCER, V5, P423, DOI 10.1038/nrc1628; Treat LH, 2009, IMPACT FOCUSED ULTRA; Treat LH, 2007, INT J CANCER, V121, P901, DOI 10.1002/ijc.22732; Turnbull DH, 1996, ULTRASOUND MED BIOL, V22, P845, DOI 10.1016/0301-5629(96)00107-X; Unger EC, 2004, ADV DRUG DELIVER REV, V56, P1291, DOI 10.1016/j.addr.2003.12.006; Watanabe Y, 2008, CANCER SCI, V99, P2525, DOI 10.1111/j.1349-7006.2008.00989.x; Wood AKW, 2005, ULTRASOUND MED BIOL, V31, P1403, DOI 10.1016/j.ultrasmedbio.2005.06.008; Wood AKW, 2008, ACAD RADIOL, V15, P1133, DOI 10.1016/j.acra.2008.04.012; Wood AKW, 2010, ULTRASOUND MED BIOL, V36, P853, DOI 10.1016/j.ultrasmedbio.2010.02.001; Wu F, 2002, ULTRASOUND MED BIOL, V28, P535, DOI 10.1016/S0301-5629(01)00515-4; Yeung SCJ, 2007, J CLIN ENDOCR METAB, V92, P2902, DOI 10.1210/jc.2007-0027; Zhao YZ, 2011, J DRUG TARGET, V19, P154, DOI 10.3109/10611861003801834	74	74	76	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52307	10.1371/journal.pone.0052307	http://dx.doi.org/10.1371/journal.pone.0052307			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284980	Green Submitted, Green Published, gold			2022-12-27	WOS:000312794500141
J	Mateus, R; Pereira, T; Sousa, S; de Lima, JE; Pascoal, S; Saude, L; Jacinto, A				Mateus, Rita; Pereira, Telmo; Sousa, Sara; de Lima, Joana Esteves; Pascoal, Susana; Saude, Leonor; Jacinto, Antonio			In Vivo Cell and Tissue Dynamics Underlying Zebrafish Fin Fold Regeneration	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; BLASTEMA FORMATION; GENE-EXPRESSION; FUSION PROTEIN; MORPHOGENESIS; DEDIFFERENTIATION; PROLIFERATION; MIGRATION; FILAMENTS	Background: Zebrafish (Danio rerio) has a remarkable capacity to regenerate many organs and tissues. During larval stages the fin fold allows the possibility of performing long time-lapse imaging making this system very appealing to study the relationships between tissue movements, cell migration and proliferation necessary for the regeneration process. Results: Through the combined use of transgenic fluorescently-labeled animals and confocal microscopy imaging, we characterized in vivo the complete fin fold regeneration process. We show, for the first time, that there is an increase in the global rate of epidermal growth as a response to tissue loss. Also enhanced significantly is cell proliferation, which upon amputation happens in a broad area concerning the amputation level and not in a blastema-restricted way. This reveals a striking difference with regard to the adult fin regeneration system. Finally, an accumulation of migratory, shape-changing fibroblasts occurs proximally to the wound area, resembling a blastemal-like structure, which may act as a signaling center for the regeneration process to proceed. Conclusions: These findings provide a novel in vivo description of fundamental mechanisms occurring during the fin fold regeneration process, thereby contributing to a better knowledge of this regenerative system and to reveal variations in the epimorphic regeneration field.	[Mateus, Rita; Pereira, Telmo; Sousa, Sara; de Lima, Joana Esteves; Pascoal, Susana; Saude, Leonor; Jacinto, Antonio] Fac Med Lisbon, Inst Mol Med, Lisbon, Portugal; [Sousa, Sara] Univ Coimbra, Ctr Neurosci & Cell Biol, PhD Programme Expt Biol & Biomed PDBEB 5, Coimbra, Portugal; [Mateus, Rita; Pereira, Telmo; Saude, Leonor; Jacinto, Antonio] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Mateus, Rita; Pereira, Telmo; Jacinto, Antonio] Fac Ciencias Med, Ctr Estudos Doencas Cron, Lisbon, Portugal	Universidade de Lisboa; Universidade de Coimbra; Instituto Gulbenkian de Ciencia; Universidade Nova de Lisboa	Jacinto, A (corresponding author), Fac Med Lisbon, Inst Mol Med, Lisbon, Portugal.	antonio.jacinto@fcm.unl.pt	Mateus, Rita/V-6535-2019; Saúde, Leonor/D-2720-2012; Jacinto, Antonio/F-5729-2013; Mateus, Rita/GSN-1922-2022	Mateus, Rita/0000-0002-6023-3880; Saúde, Leonor/0000-0001-5933-8872; Jacinto, Antonio/0000-0002-4193-6089; Esteves de Lima, Joana/0000-0002-5497-5669; Sousa, Sara/0000-0001-5479-0325; Pascoal, Susana/0000-0002-2294-8084; Pereira, Telmo/0000-0002-6903-9187	Fundacao para a Ciencia e Tecnologia (FCT), Portugal; FCT; European Research Council [2007-StG-208631]	Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); European Research Council(European Research Council (ERC)European Commission)	RM, TP and SS receive PhD grants from Fundacao para a Ciencia e Tecnologia (FCT), Portugal. SP receives a post-doctoral grant from FCT. The research presented in this manuscript was partially funded by an European Research Council Starting Grant (2007-StG-208631). The funders had no role in study design; data collection, analysis, and interpretation; decision to publish, or preparation of the manuscript.	Balciunas D, 2006, PLOS GENET, V2, P1715, DOI 10.1371/journal.pgen.0020169; Behrndt M, 2012, SCIENCE, V338, P257, DOI 10.1126/science.1224143; Bessa J, 2009, DEV DYNAM, V238, P2409, DOI 10.1002/dvdy.22051; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Campbell LJ, 2008, CELL MOL LIFE SCI, V65, P73, DOI 10.1007/s00018-007-7433-z; Campbell LJ, 2011, DEV DYNAM, V240, P1826, DOI 10.1002/dvdy.22669; Chera S, 2009, DEV CELL, V17, P279, DOI 10.1016/j.devcel.2009.07.014; Cooper MS, 2005, DEV DYNAM, V232, P359, DOI 10.1002/dvdy.20252; DANE PJ, 1985, J EMBRYOL EXP MORPH, V87, P145; Danjo Y, 1998, J CELL SCI, V111, P3323; Duran I, 2011, DEV BIOL, V354, P160, DOI 10.1016/j.ydbio.2011.03.014; Echeverri K, 2001, DEV BIOL, V236, P151, DOI 10.1006/dbio.2001.0312; Feitosa NM, 2012, DEV BIOL, V369, P235, DOI 10.1016/j.ydbio.2012.06.023; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Ishida T, 2010, DEV BIOL, V340, P468, DOI 10.1016/j.ydbio.2010.01.036; Kawakami A, 2004, DEV DYNAM, V231, P693, DOI 10.1002/dvdy.20181; Kawakami A, 2010, DEV GROWTH DIFFER, V52, P77, DOI 10.1111/j.1440-169X.2009.01138.x; Knopf F, 2011, DEV CELL, V20, P713, DOI 10.1016/j.devcel.2011.04.014; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Lee Y, 2009, DEV BIOL, V331, P270, DOI 10.1016/j.ydbio.2009.05.545; MacManus CF, 2006, WOUND REPAIR REGEN, V14, P61, DOI 10.1111/j.1524-475X.2005.00089.x; Mathew LK, 2009, J BIOL CHEM, V284, P33642, DOI 10.1074/jbc.M109.011668; Morgan TH, 1901, SCIENCE, V14, P235, DOI 10.1126/science.14.346.235; Nechiporuk A, 2002, DEVELOPMENT, V129, P2607; Neugebauer JM, 2009, NATURE, V458, P651, DOI 10.1038/nature07753; Pauls S, 2001, DEV GENES EVOL, V211, P603, DOI 10.1007/s00427-001-0196-x; Pittlik S, 2012, DEV DYNAM, V241, P1205, DOI 10.1002/dvdy.23805; Quesada-Hernandez E, 2010, CURR BIOL, V20, P1966, DOI 10.1016/j.cub.2010.10.009; Santos-Ruiz L, 2002, DEV DYNAM, V223, P262, DOI 10.1002/dvdy.10055; Sepich DS, 2011, DEVELOPMENT, V138, P543, DOI 10.1242/dev.053959; Slanchev K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000563; Sousa S, 2011, DEVELOPMENT, V138, P3897, DOI 10.1242/dev.064717; Sugiyama M, 2009, P NATL ACAD SCI USA, V106, P20812, DOI 10.1073/pnas.0906464106; WOOD A, 1984, J CELL SCI, V66, P205; Wood W, 2002, NAT CELL BIOL, V4, P907, DOI 10.1038/ncb875; Yoshinari N, 2009, DEV BIOL, V325, P71, DOI 10.1016/j.ydbio.2008.09.028; Zhang JX, 2010, PROCEEDINGS OF THE 1ST INTERNATIONAL CONFERENCE ON SUSTAINABLE CONSTRUCTION & RISK MANAGEMENT, VOLS I AND II, P1; Zigman M, 2011, CURR BIOL, V21, P79, DOI 10.1016/j.cub.2010.12.005	38	36	36	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51766	10.1371/journal.pone.0051766	http://dx.doi.org/10.1371/journal.pone.0051766			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284763	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500044
J	Matsuura, K; Wada, M; Konishi, K; Sato, M; Iwamoto, U; Sato, Y; Tachibana, A; Kikuchi, T; Iwamiya, T; Shimizu, T; Yamashita, JK; Yamato, M; Hagiwara, N; Okano, T				Matsuura, Katsuhisa; Wada, Masanori; Konishi, Kanako; Sato, Michi; Iwamoto, Ushio; Sato, Yuko; Tachibana, Aki; Kikuchi, Tetsutaro; Iwamiya, Takahiro; Shimizu, Tatsuya; Yamashita, Jun K.; Yamato, Masayuki; Hagiwara, Nobuhisa; Okano, Teruo			Fabrication of Mouse Embryonic Stem Cell-Derived Layered Cardiac Cell Sheets Using a Bioreactor Culture System	PLOS ONE			English	Article							HEART FUNCTION; IN-VITRO; CARDIOMYOCYTES; TISSUE; EXPANSION; NEOVASCULARIZATION; DIFFERENTIATION; MYOCARDIUM; INDUCTION; APOPTOSIS	Bioengineered functional cardiac tissue is expected to contribute to the repair of injured heart tissue. We previously developed cardiac cell sheets using mouse embryonic stem (mES) cell-derived cardiomyocytes, a system to generate an appropriate number of cardiomyocytes derived from ES cells and the underlying mechanisms remain elusive. In the present study, we established a cultivation system with suitable conditions for expansion and cardiac differentiation of mES cells by embryoid body formation using a three-dimensional bioreactor. Daily conventional medium exchanges failed to prevent lactate accumulation and pH decreases in the medium, which led to insufficient cell expansion and cardiac differentiation. Conversely, a continuous perfusion system maintained the lactate concentration and pH stability as well as increased the cell number by up to 300-fold of the seeding cell number and promoted cardiac differentiation after 10 days of differentiation. After a further 8 days of cultivation together with a purification step, around 1 x 10(8) cardiomyocytes were collected in a 1-L bioreactor culture, and additional treatment with noggin and granulocyte colony stimulating factor increased the number of cardiomyocytes to around 5.5 x 10(8). Co-culture of mES cell-derived cardiomyocytes with an appropriate number of primary cultured fibroblasts on temperature-responsive culture dishes enabled the formation of cardiac cell sheets and created layered-dense cardiac tissue. These findings suggest that this bioreactor system with appropriate medium might be capable of preparing cardiomyocytes for cell sheet-based cardiac tissue.	[Matsuura, Katsuhisa; Kikuchi, Tetsutaro; Iwamiya, Takahiro; Shimizu, Tatsuya; Yamato, Masayuki; Okano, Teruo] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan; [Matsuura, Katsuhisa; Hagiwara, Nobuhisa] Tokyo Womens Med Univ, Dept Cardiol, Tokyo, Japan; [Wada, Masanori; Tachibana, Aki] ABLE Corp, Tokyo, Japan; [Konishi, Kanako; Sato, Michi; Iwamoto, Ushio; Sato, Yuko] Asahi Kasei Co LTD, Tokyo, Japan; [Kikuchi, Tetsutaro] CellSeed Inc, Tokyo, Japan; [Yamashita, Jun K.] Kyoto Univ, Lab Stem Cell Differentiat, Stem Cell Res Ctr, Inst Frontier Med, Kyoto, Japan	Tokyo Women's Medical University; Tokyo Women's Medical University; Asahi Kasei Corporation; Kyoto University	Okano, T (corresponding author), Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan.	tokano@abmes.twmu.ac.jp	Kikuchi, Tetsutaro/ABB-4442-2021; Tatsuya, Shimizu/AAN-5675-2021	Kikuchi, Tetsutaro/0000-0001-9119-1444; Iwamiya, Takahiro/0000-0001-6616-1104; Okano, Teruo/0000-0002-4470-9842	Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)"; Council for Science and Technology Policy (CSTP)	Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)"(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP))	This research was funded by a grant from the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)," initiated by the Council for Science and Technology Policy (CSTP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts. This research is fully granted by the Japan Society for the Promotion of Science (JSPS*) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)," initiated by the Council for Science and Technology Policy (CSTP). ABLE Corporation, Asahi Kasei Co. LTD and CellSeed Inc. have participated in the research as a collaborating institution, commissioned by the operational support institution of the research, Japan Science and Technology Agency (JST*). Although Tatsuya Shimizu and Masayuki Yamato are consultants for CellSeed, Inc., and Teruo Okano is an investor in CellSeed, Inc., this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. *JSPS is an independent administrative institution, established by way of a national law for the purpose of contributing to the advancement of science in all fields of the natural and social sciences and the humanities. *JST is an integrated organization of science and technology in Japan that establishes an infrastructure for the entire process from the creation of knowledge to the return the society.	Abranches E, 2007, BIOTECHNOL BIOENG, V96, P1211, DOI 10.1002/bit.21191; Bauwens C, 2005, BIOTECHNOL BIOENG, V90, P452, DOI 10.1002/bit.20445; Fernandes AM, 2007, J BIOTECHNOL, V132, P227, DOI 10.1016/j.jbiotec.2007.05.031; Haraguchi Y, 2012, NAT PROTOC, V7, P850, DOI 10.1038/nprot.2012.027; Kawamura M, 2012, CIRCULATION, V126, pS29, DOI 10.1161/CIRCULATIONAHA.111.084343; Kushida A, 1999, J BIOMED MATER RES, V45, P355, DOI 10.1002/(SICI)1097-4636(19990615)45:4<355::AID-JBM10>3.0.CO;2-7; Masumoto H, 2012, STEM CELLS, V30, P1196, DOI 10.1002/stem.1089; Matsuura K, 2004, J CELL BIOL, V167, P351, DOI 10.1083/jcb.200312111; Matsuura K, 2011, BIOMATERIALS, V32, P7355, DOI 10.1016/j.biomaterials.2011.05.042; Matsuura K, 2009, J CLIN INVEST, V119, P2204, DOI 10.1172/JCI37456; Memon IA, 2005, J THORAC CARDIOV SUR, V130, P1333, DOI 10.1016/j.jtcvs.2005.07.023; Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391; Niebruegge S, 2008, TISSUE ENG PT A, V14, P1591, DOI 10.1089/ten.tea.2007.0247; OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Ream M, 2008, AM J PHYSIOL-REG I, V295, pR583, DOI 10.1152/ajpregu.00771.2007; Sasaki D, 2009, BIOMATERIALS, V30, P4384, DOI 10.1016/j.biomaterials.2009.05.003; Schroeder M, 2005, BIOTECHNOL BIOENG, V92, P920, DOI 10.1002/bit.20668; Sekine H, 2008, CIRCULATION, V118, pS145, DOI 10.1161/CIRCULATIONAHA.107.757286; Sekine H, 2012, CELL TISSUE RES, V347, P775, DOI 10.1007/s00441-011-1267-6; Sekine H, 2011, TISSUE ENG PT A, V17, P2973, DOI 10.1089/ten.tea.2010.0659; Shimizu T, 2006, FASEB J, V20, P708, DOI 10.1096/fj.05-4715fje; Song H, 2010, P NATL ACAD SCI USA, V107, P3329, DOI 10.1073/pnas.0905729106; Thatte HS, 2004, ANN THORAC SURG, V77, P1376, DOI 10.1016/j.athoracsur.2003.07.047; Wang XL, 2006, BIOTECHNOL PROGR, V22, P811, DOI 10.1021/bp060018z; Want AJ, 2012, REGEN MED, V7, P71, DOI [10.2217/RME.11.101, 10.2217/rme.11.101]; Webster KA, 1999, J CLIN INVEST, V104, P239; Yamashita JK, 2005, FASEB J, V19, P1534, DOI 10.1096/fj.04-3540fje; Zandstra PW, 2003, TISSUE ENG, V9, P767, DOI 10.1089/107632703768247449; Zimmermann WH, 2006, CARDIOVASC RES, V71, P419, DOI 10.1016/j.cardiores.2006.03.023	30	29	30	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52176	10.1371/journal.pone.0052176	http://dx.doi.org/10.1371/journal.pone.0052176			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284924	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500106
J	Meihls, LN; Higdon, ML; Ellersieck, MR; Tabashnik, BE; Hibbard, BE				Meihls, Lisa N.; Higdon, Matthew L.; Ellersieck, Mark R.; Tabashnik, Bruce E.; Hibbard, Bruce E.			Greenhouse-Selected Resistance to Cry3Bb1-Producing Corn in Three Western Corn Rootworm Populations	PLOS ONE			English	Article							VIRGIFERA-VIRGIFERA COLEOPTERA; FIELD-EVOLVED RESISTANCE; TO-PLANT MOVEMENT; INSECT RESISTANCE; TRANSGENIC CORN; BACILLUS-THURINGIENSIS; FITNESS COSTS; BT MAIZE; LABORATORY COLONIES; LARVAE COLEOPTERA	Transgenic corn producing the Bacillus thuringiensis (Bt) toxin Cry3Bb1 has been useful for controlling western corn rootworm, Diabrotica virgifera virgifera LeConte, one of the most economically important crop pests in the United States. However, rapid evolution of resistance by this beetle to Bt corn producing Cry3Bb1 has been reported previously from the laboratory, greenhouse, and field. Here we selected in the greenhouse for resistance to Cry3Bb1 corn in three colonies of WCR derived from Kansas, Minnesota, and Wisconsin, respectively. Three generations of rearing on Cry3Bb1 corn significantly increased larval survival on Cry3Bb1 corn, resulting in similar survival in the greenhouse for selected colonies on Cry3Bb1 corn and isoline corn that does not produce Bt toxin. After four to seven generations of rearing on Cry3Bb1 corn, survival in the field on Cry3Bb1 corn relative to isoline corn more than doubled for selected colonies (72%) compared with control colonies (33%). For both selected and control colonies, survival in the field was significantly lower on Cry3Bb1 corn than on isoline corn. On isoline corn, most fitness components were similar for selected colonies and control colonies. However, fecundity was significantly lower for selected colonies than control colonies, indicating a fitness cost associated with resistance. The rapid evolution of resistance by western corn rootworm to Bt corn reported here and previously underlines the importance of effective resistance management for this pest.	[Meihls, Lisa N.] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Higdon, Matthew L.; Hibbard, Bruce E.] ARS, USDA, Plant Genet Res Unit, Columbia, MO USA; [Ellersieck, Mark R.] Univ Missouri Columbia, Dept Stat, Columbia, MO USA; [Tabashnik, Bruce E.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA	Cornell University; Boyce Thompson Institute for Plant Research; United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Arizona	Meihls, LN (corresponding author), Cornell Univ, Boyce Thompson Inst Plant Res, Tower Rd, Ithaca, NY 14853 USA.	lnm2m9@mail.missouri.edu		Hibbard, Bruce/0000-0001-8067-4416	Biotechnology Risk Assessment Program from USDA National Institute of Food and Agriculture [2006-33522-17716]; USDA-ARS; University of Missouri-Division of Plant Sciences	Biotechnology Risk Assessment Program from USDA National Institute of Food and Agriculture; USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); University of Missouri-Division of Plant Sciences	This research was supported, in part, by Biotechnology Risk Assessment Program Grant no. 2006-33522-17716 from the USDA National Institute of Food and Agriculture, USDA-ARS, and the University of Missouri-Division of Plant Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alyokhin A, 2011, NAT BIOTECHNOL, V29, P577, DOI 10.1038/nbt.1911; Bagla P, 2010, SCIENCE, V327, P1439, DOI 10.1126/science.327.5972.1439; BRANSON TF, 1976, ENTOMOL EXP APPL, V19, P148, DOI 10.1007/BF00345776; Carriere Y, 2010, EVOL APPL, V3, P561, DOI 10.1111/j.1752-4571.2010.00129.x; Clark TL, 2012, J APPL ENTOMOL, V136, P721, DOI 10.1111/j.1439-0418.2012.01709.x; Crowder DW, 2006, J ECON ENTOMOL, V99, P899, DOI 10.1603/0022-0493-99.3.899; Dhurua S, 2011, PEST MANAG SCI, V67, P898, DOI 10.1002/ps.2127; Environmental Protection Agency, 2011, BIOP REG ACT DOC BT1; Environmental Protection Agency, 2007, PEST FACT SHEET MOD; Environmental Protection Agency, 2009, PEST FACT SHEET MON; Environmental Protection Agency, 2005, EPA PUBL; Environmental Protection Agency, 2011, 2009 RES MON REV CRY; Environmental Protection Agency, 2011, BIOP REG ACT DOC MON; Environmental Protection Agency, 2005, FED REGISTER, V70, P17323; Environmental Protection Agency, 2010, BIOP REG ACT DOC OPT; Gassmann Aaron J, 2012, GM Crops Food, V3, P235, DOI 10.4161/gmcr.20744; Gassmann AJ, 2012, J INVERTEBR PATHOL, V110, P287, DOI 10.1016/j.jip.2012.04.006; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gassmann AJ, 2009, ANNU REV ENTOMOL, V54, P147, DOI 10.1146/annurev.ento.54.110807.090518; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Gould F, 2006, J ECON ENTOMOL, V99, P2091, DOI 10.1603/0022-0493-99.6.2091; Gray ME, 2012, B U ILLINOIS EXTENSI, V20; Hibbard BE, 2005, J ECON ENTOMOL, V98, P1126, DOI 10.1603/0022-0493-98.4.1126; Hibbard BE, 2004, J ECON ENTOMOL, V97, P871, DOI 10.1603/0022-0493(2004)097[0871:ROEDOE]2.0.CO;2; Jackson J.J., 1985, P237; JACKSON JJ, 1988, ENVIRON ENTOMOL, V17, P166, DOI 10.1093/ee/17.2.166; Kang J, 2009, J ECON ENTOMOL, V102, P2096, DOI 10.1603/029.102.0612; Kim KS, 2007, ENVIRON ENTOMOL, V36, P637, DOI 10.1603/0046-225X(2007)36[637:GDILCO]2.0.CO;2; KIRK VM, 1968, J ECON ENTOMOL, V61, P1322, DOI 10.1093/jee/61.5.1322; Kruger M, 2012, J APPL ENTOMOL, V136, P38, DOI 10.1111/j.1439-0418.2011.01616.x; Lefko SA, 2008, J APPL ENTOMOL, V132, P189, DOI 10.1111/j.1439-0418.2008.01279.x; LUTTRELL RG, 2004, 2004 BELTW COTT C SA, P1373; Malaeb ZA, 1997, ENVIRON MONIT ASSESS, V47, P255, DOI 10.1023/A:1005798521296; Meihls LN, 2011, J ECON ENTOMOL, V104, P1045, DOI 10.1603/EC10320; Meihls LN, 2008, P NATL ACAD SCI USA, V105, P19177, DOI 10.1073/pnas.0805565105; Monsanto, 2009, MONS BIOT TRAIT ACR; Murphy AF, 2010, J ECON ENTOMOL, V103, P147, DOI 10.1603/EC09156; Oleson JD, 2005, J ECON ENTOMOL, V98, P1, DOI 10.1603/0022-0493-98.1.1; Onstad DW, 2010, J ECON ENTOMOL, V103, P849, DOI 10.1603/EC09199; Onstad DW, 2001, J ECON ENTOMOL, V94, P529, DOI 10.1603/0022-0493-94.2.529; Oswald KJ, 2012, J APPL ENTOMOL, V136, P730, DOI 10.1111/j.1439-0418.2012.01704.x; Oswald KJ, 2011, J ECON ENTOMOL, V104, P1038, DOI 10.1603/EC10312; Oyediran IO, 2005, J ECON ENTOMOL, V98, P1679, DOI 10.1603/0022-0493-98.5.1679; Petzold-Maxwell JL, 2012, J ECON ENTOMOL, V105, P1407, DOI 10.1603/EC11425; Porter P, 2012, COMMUNICATION   0305; Ritchie W. W., 1992, 48 COOP EXT SERV; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; SAS, 2004, SAS VERS 931; SCHAAFSMA AW, 1991, CAN ENTOMOL, V123, P1183, DOI 10.4039/Ent1231183-6; Snedecor G.W., 1989, AMES IOWA STATE U PR; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; TABASHNIK BE, 1994, ANNU REV ENTOMOL, V39, P47, DOI 10.1146/annurev.en.39.010194.000403; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2012, J ECON ENTOMOL, V105, P767, DOI 10.1603/EC12080; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Tabashnik BE, 2009, P NATL ACAD SCI USA, V106, P11889, DOI 10.1073/pnas.0901351106; Tabashnik BE, 2008, P NATL ACAD SCI USA, V105, P19029, DOI 10.1073/pnas.0810763106; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; Zhao JZ, 2005, P NATL ACAD SCI USA, V102, P8426, DOI 10.1073/pnas.0409324102	59	44	44	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51055	10.1371/journal.pone.0051055	http://dx.doi.org/10.1371/journal.pone.0051055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284656	gold, Green Published, Green Submitted			2022-12-27	WOS:000312794500020
J	Schmidt-Lauber, C; Harrach, S; Pap, T; Fischer, M; Victor, M; Heitzmann, M; Hansen, U; Fobker, M; Brand, SM; Sindic, A; Pavenstadt, H; Edemir, B; Schlatter, E; Bertrand, J; Ciarimboli, G				Schmidt-Lauber, Christian; Harrach, Saliha; Pap, Thomas; Fischer, Meike; Victor, Marion; Heitzmann, Marianne; Hansen, Uwe; Fobker, Manfred; Brand, Stefan-Martin; Sindic, Aleksandra; Pavenstaedt, Hermann; Edemir, Bayram; Schlatter, Eberhard; Bertrand, Jessica; Ciarimboli, Giuliano			Transport Mechanisms and Their Pathology-Induced Regulation Govern Tyrosine Kinase Inhibitor Delivery in Rheumatoid Arthritis	PLOS ONE			English	Article							ORGANIC CATION TRANSPORTER; CHRONIC MYELOID-LEUKEMIA; GROWTH-FACTOR; DRUG TRANSPORTER; IMATINIB; EXPRESSION; PHARMACOKINETICS; PROLIFERATION; DISEASES; HOCT1	Background: Tyrosine kinase inhibitors (TKIs) are effective in treating malignant disorders and were lately suggested to have an impact on non-malignant diseases. However, in some inflammatory conditions like rheumatoid arthritis (RA) the in vivo effect seemed to be moderate. As most TKIs are taken up actively into cells by cell membrane transporters, this study aimed to evaluate the role of such transporters for the accumulation of the TKI Imatinib mesylates in RA synovial fibroblasts as well as their regulation under inflammatory conditions. Methodology/Principal Findings: The transport and accumulation of Imatinib was investigated in transporter-transfected HEK293 cells and human RA synovial fibroblasts (hRASF). Transporter expression was quantified by qRT-PCR. In transfection experiments, hMATE1 showed the highest apparent affinity for Imatinib among all known Imatinib transporters. Experiments quantifying the Imatinib uptake in the presence of specific transporter inhibitors and after siRNA knockdown of hMATE1 indeed identified hMATE1 to mediate Imatinib transport in hRASF. The anti-proliferative effect of Imatinib on PDGF stimulated hRASF was quantified by cell counting and directly correlated with the uptake activity of hMATE1. Expression of hMATE1 was investigated by Western blot and immuno-fluorescence. Imatinib transport under disease-relevant conditions, such as an altered pH and following stimulation with different cytokines, was also investigated by HPLC. The uptake was significantly reduced by an acidic extracellular pH as well as by the cytokines TNF alpha, IL-1 beta and IL-6, which all decreased the expression of hMATE1-mRNA and protein. Conclusion/Significance:The regulation of Imatinib uptake via hMATE1 in hRASF and resulting effects on their proliferation may explain moderate in vivo effects on RA. Moreover, our results suggest that investigating transporter mediated drug processing under normal and pathological conditions is important for developing intracellular acting drugs used in inflammatory diseases.	[Schmidt-Lauber, Christian; Harrach, Saliha; Fischer, Meike; Victor, Marion; Pavenstaedt, Hermann; Edemir, Bayram; Schlatter, Eberhard; Ciarimboli, Giuliano] Univ Hosp Munster, Dept Internal Med D, Munster, Germany; [Schmidt-Lauber, Christian; Harrach, Saliha; Pap, Thomas; Heitzmann, Marianne; Bertrand, Jessica] Univ Hosp Munster, Inst Expt Musculoskeletal Med, Munster, Germany; [Hansen, Uwe] Univ Hosp Munster, Inst Physiol Chem & Pathobiochem, Munster, Germany; [Fobker, Manfred] Univ Hosp Munster, Ctr Lab Med, Munster, Germany; [Brand, Stefan-Martin] Univ Hosp Munster, Leibniz Inst Arteriosclerosis Res, Munster, Germany; [Brand, Stefan-Martin] Univ Hosp Munster, Inst Sports Med, Munster, Germany; [Sindic, Aleksandra] Univ Zagreb, Croatian Inst Brain Res, Dept Physiol, Zagreb 41000, Croatia	University of Munster; University of Munster; University of Munster; University of Munster; University of Munster; University of Munster; University of Zagreb	Ciarimboli, G (corresponding author), Univ Hosp Munster, Dept Internal Med D, Munster, Germany.	gciari@uni-muenster.de	Edemir, Bayram/AAF-6845-2020; Dugandzic, Aleksandra/AAL-7581-2020	Ciarimboli, Giuliano/0000-0002-4365-3656	"Innovative Medizinische Forschung" of the Medical Faculty of Munster University [BE121009]	"Innovative Medizinische Forschung" of the Medical Faculty of Munster University	This work was funded by the "Innovative Medizinische Forschung" of the Medical Faculty of Munster University (BE121009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi N, 2011, MOD RHEUMATOL, V21, P267, DOI 10.1007/s10165-010-0392-5; Bach M, 2007, FEBS J, V274, P783, DOI 10.1111/j.1742-4658.2006.05623.x; Ciarimboli G, 2004, J CELL PHYSIOL, V201, P420, DOI 10.1002/jcp.20081; Distler JHW, 2010, ANN RHEUM DIS, V69, P48, DOI 10.1136/ard.2009.120196; FARR M, 1985, CLIN EXP RHEUMATOL, V3, P99; Bonilla-Hernan MG, 2011, RHEUMATOLOGY, V50, P1542, DOI 10.1093/rheumatology/ker192; Grigat S, 2009, DRUG METAB DISPOS, V37, P330, DOI 10.1124/dmd.108.023929; Grimminger F, 2010, NAT REV DRUG DISCOV, V9, P956, DOI 10.1038/nrd3297; GRONOWICZ G, 1992, J PERIODONTAL RES, V27, P562, DOI 10.1111/j.1600-0765.1992.tb01737.x; Grundemann D, 2005, P NATL ACAD SCI USA, V102, P5256, DOI 10.1073/pnas.0408624102; Ito S, 2010, J PHARMACOL EXP THER, V333, P341, DOI 10.1124/jpet.109.163642; Kameda H, 2006, CLIN EXP IMMUNOL, V144, P335, DOI 10.1111/j.1365-2249.2006.03067.x; Kay J, 2008, ARTHRITIS RHEUM, V58, P2543, DOI 10.1002/art.23696; Kido Y, 2011, J MED CHEM, V54, P4548, DOI 10.1021/jm2001629; le Coutre P, 2004, CANCER CHEMOTH PHARM, V53, P313, DOI 10.1007/s00280-003-0741-6; Li YP, 2003, FASEB J, V17, P1048, DOI 10.1096/fj.02-0759com; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Minematsu T, 2011, MOL CANCER THER, V10, P531, DOI 10.1158/1535-7163.MCT-10-0731; Paniagua RT, 2007, NAT CLIN PRACT RHEUM, V3, P190, DOI 10.1038/ncprheum0465; Peng B, 2004, J CLIN ONCOL, V22, P935, DOI 10.1200/JCO.2004.03.050; Rosenbloom J, 2010, ANN INTERN MED, V152, P159, DOI 10.7326/0003-4819-152-3-201002020-00007; Rosengren S, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2981; Sandler C, 2006, BIOCHEM BIOPH RES CO, V347, P31, DOI 10.1016/j.bbrc.2006.06.052; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Thomas J, 2004, BLOOD, V104, P3739, DOI 10.1182/blood-2003-12-4276; Wang L, 2008, CLIN PHARMACOL THER, V83, P258, DOI 10.1038/sj.clpt.6100268; Widmer N, 2004, J CHROMATOGR B, V803, P285, DOI 10.1016/j.jchromb.2004.01.006; Wilde S, 2009, CELL MOL LIFE SCI, V66, P1729, DOI 10.1007/s00018-009-9145-z; Zhang L, 1997, MOL PHARMACOL, V51, P913, DOI 10.1124/mol.51.6.913	29	20	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52247	10.1371/journal.pone.0052247	http://dx.doi.org/10.1371/journal.pone.0052247			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284953	gold, Green Submitted, Green Published			2022-12-27	WOS:000312794500124
J	Cheeseman, MT; Vowell, K; Hough, TA; Jones, L; Pathak, P; Tyrer, HE; Kelly, M; Cox, R; Warren, MV; Peters, J				Cheeseman, Michael T.; Vowell, Kate; Hough, Tertius A.; Jones, Lynn; Pathak, Paras; Tyrer, Hayley E.; Kelly, Michelle; Cox, Roger; Warren, Madhuri V.; Peters, Jo			A Mouse Model for Osseous Heteroplasia	PLOS ONE			English	Article							ALBRIGHT-HEREDITARY-OSTEODYSTROPHY; PROTEIN ALPHA-SUBUNIT; STIMULATORY G-PROTEIN; PSEUDOHYPOPARATHYROIDISM TYPE 1A; IMPRINTING CONTROL REGION; G(S)ALPHA GENE GNAS1; HETEROTOPIC OSSIFICATION; INACTIVATING MUTATIONS; EXTRASKELETAL OSSIFICATION; HORMONE RESISTANCE	GNAS/Gnas encodes G(s)alpha that is mainly biallelically expressed but shows imprinted expression in some tissues. In Albright Hereditary Osteodystrophy (AHO) heterozygous loss of function mutations of GNAS can result in ectopic ossification that tends to be superficial and attributable to haploinsufficiency of biallelically expressed G(s)alpha. Oed-Sml is a point missense mutation in exon 6 of the orthologous mouse locus Gnas. We report here both the late onset ossification and occurrence of benign cutaneous fibroepithelial polyps in Oed-Sml. These phenotypes are seen on both maternal and paternal inheritance of the mutant allele and are therefore due to an effect on biallelically expressed G(s)alpha. The ossification is confined to subcutaneous tissues and so resembles the ossification observed with AHO. Our mouse model is the first with both subcutaneous ossification and fibroepithelial polyps related to G(s)alpha deficiency. It is also the first mouse model described with a clinically relevant phenotype associated with a point mutation in G(s)alpha and may be useful in investigations of the mechanisms of heterotopic bone formation. Together with earlier results, our findings indicate that G(s)alpha signalling pathways play a vital role in repressing ectopic bone formation.	[Cheeseman, Michael T.; Tyrer, Hayley E.; Kelly, Michelle; Cox, Roger; Peters, Jo] Med Res Council Harwell, Mammalian Genet Unit, Harwell, Oxon, England; [Cheeseman, Michael T.; Vowell, Kate; Hough, Tertius A.; Jones, Lynn; Pathak, Paras] Med Res Council Harwell, Mary Lyon Ctr, Harwell, Oxon, England; [Warren, Madhuri V.] Pathol Diagnost Ltd, Cambridge, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Cheeseman, MT (corresponding author), Med Res Council Harwell, Mammalian Genet Unit, Harwell, Oxon, England.	m.cheeseman@har.mrc.ac.uk		Cox, Roger/0000-0001-7170-5014; Tyrer, Hayley/0000-0002-4447-828X	Medical Research Council; Biotechnology and Biological Sciences Research Council [BBS/E/D/20251969] Funding Source: researchfish; Medical Research Council [MC_U142636336, MC_UP_1502/1, MC_U142670371] Funding Source: researchfish; BBSRC [BBS/E/D/20251969] Funding Source: UKRI; MRC [MC_UP_1502/1, MC_U142670371, MC_U142636336] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	All co-authors with the exception of MVM are core funded by the Medical Research Council. (www.mrc.ac.uk/). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbite NS, 2008, AM J MED GENET A, V146A, P1788, DOI 10.1002/ajmg.a.32346; Ahmed SF, 1998, CLIN ENDOCRINOL, V49, P525, DOI 10.1046/j.1365-2265.1998.00572.x; Ahrens W, 2001, J CLIN ENDOCR METAB, V86, P4630, DOI 10.1210/jc.86.10.4630; Aldred MA, 2000, HUM MUTAT, V16, P183, DOI 10.1002/1098-1004(200009)16:3<183::AID-HUMU1>3.0.CO;2-L; Alvarez F, 2010, J EUR ACAD DERMATOL, V24, P974, DOI 10.1111/j.1468-3083.2009.03539.x; Bancroft JD, 2002, J NEUROPATH EXP NEUR, V5th; Bastepe M, 2005, HORM RES, V63, P65, DOI 10.1159/000083895; Burtis CA, 2005, TIETZ TXB CLIN CHEM; Castrop H, 2007, CELL TISSUE RES, V330, P487, DOI 10.1007/s00441-007-0491-6; Cattanach BM, 2000, HUM MOL GENET, V9, P2263, DOI 10.1093/oxfordjournals.hmg.a018917; Chen M, 2005, P NATL ACAD SCI USA, V102, P7386, DOI 10.1073/pnas.0408268102; Chen M, 2009, CELL METAB, V9, P548, DOI 10.1016/j.cmet.2009.05.004; CRAWFORD JA, 1993, J BIOL CHEM, V268, P9879; DAVIES SJ, 1993, J MED GENET, V30, P101, DOI 10.1136/jmg.30.2.101; de Sanctis L, 2004, J CLIN ENDOCR METAB, V89, P1650, DOI 10.1210/jc.2003-030850; Eddy MC, 2000, J BONE MINER RES, V15, P2074, DOI 10.1359/jbmr.2000.15.11.2074; Faust RA, 2003, AM J MED GENET A, V118A, P71, DOI 10.1002/ajmg.a.10170; Frohlich LF, 2010, P NATL ACAD SCI USA, V107, P9275, DOI 10.1073/pnas.0910224107; Garavelli Livia, 2005, Acta Biomed, V76, P45; Gelfand IM, 2006, J PEDIATR-US, V149, P877, DOI 10.1016/j.jpeds.2006.08.050; Germain-Lee EL, 2005, ENDOCRINOLOGY, V146, P4697, DOI 10.1210/en.2005-0681; Hayward BE, 1998, P NATL ACAD SCI USA, V95, P15475, DOI 10.1073/pnas.95.26.15475; Hudson J, 2000, J MED GENET, V37, pS79, DOI 10.1136/jmg.37.11.e35; Huso DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021755; IIRI T, 1994, NATURE, V371, P164, DOI 10.1038/371164a0; Kacerovska D, 2008, AM J DERMATOPATH, V30, P417, DOI 10.1097/DAD.0b013e318180ec0e; KAPLAN FS, 1994, J BONE JOINT SURG AM, V76A, P425, DOI 10.2106/00004623-199403000-00013; Kelly ML, 2009, INT J OBESITY, V33, P507, DOI 10.1038/ijo.2009.30; Klagge A, 2010, EXP CLIN ENDOCR DIAB, V118, P586, DOI 10.1055/s-0029-1237708; Klemke M, 2000, J BIOL CHEM, V275, P33633, DOI 10.1074/jbc.M006594200; Lebrun M, 2010, J CLIN ENDOCR METAB, V95, P3028, DOI 10.1210/jc.2009-1451; Linglart A, 2002, J CLIN ENDOCR METAB, V87, P189, DOI 10.1210/jc.87.1.189; Liu J, 2005, P NATL ACAD SCI USA, V102, P5513, DOI 10.1073/pnas.0408262102; Long DN, 2007, J CLIN ENDOCR METAB, V92, P1073, DOI 10.1210/jc.2006-1497; McKee PH, 2006, PATHOLOGY SKIN CLIN; Nwosu BU, 2009, NAT REV ENDOCRINOL, V5, P345, DOI 10.1038/nrendo.2009.81; Pasolli HA, 2000, J BIOL CHEM, V275, P33622, DOI 10.1074/jbc.M001335200; PATTEN JL, 1990, NEW ENGL J MED, V322, P1412, DOI 10.1056/NEJM199005173222002; Peters J, 1999, P NATL ACAD SCI USA, V96, P3830, DOI 10.1073/pnas.96.7.3830; Peters J, 2007, EPIGENETICS, V2, P207, DOI 10.4161/epi.2.4.5380; Pignolo RJ, 2011, J BONE MINER RES, V26, P2647, DOI 10.1002/jbmr.481; Plagge A, 2004, NAT GENET, V36, P818, DOI 10.1038/ng1397; Plagge A, 2005, MOL CELL BIOL, V25, P3019, DOI 10.1128/MCB.25.8.3019-3026.2005; Pohlenz J, 2003, EUR J ENDOCRINOL, V148, P463, DOI 10.1530/eje.0.1480463; Riepe FG, 2005, EUR J ENDOCRINOL, V152, P515, DOI 10.1530/eje.1.01879; Sakamoto A, 2009, ENDOCR RES, V34, P1, DOI 10.1080/07435800902841280; SCHWINDINGER WF, 1994, J BIOL CHEM, V269, P25387; Shapira H, 1996, HUM GENET, V97, P73; Shore EM, 2002, NEW ENGL J MED, V346, P99, DOI 10.1056/NEJMoa011262; Skinner JA, 2002, GENOMICS, V80, P373, DOI 10.1006/geno.2002.6842; Warner DR, 1998, J BIOL CHEM, V273, P23976, DOI 10.1074/jbc.273.37.23976; Warner DR, 1997, MOL ENDOCRINOL, V11, P1718, DOI 10.1210/me.11.11.1718; Weinstein LS, 2006, TRENDS PHARMACOL SCI, V27, P260, DOI 10.1016/j.tips.2006.03.005; Weinstein LS, 2004, ENDOCRINOLOGY, V145, P5459, DOI 10.1210/en.2004-0865; WEINSTEIN LS, 1990, P NATL ACAD SCI USA, V87, P8287, DOI 10.1073/pnas.87.21.8287; WEINSTEIN LS, 1992, GENOMICS, V13, P1319, DOI 10.1016/0888-7543(92)90056-X; Weinstein LS, 2001, ENDOCR REV, V22, P675, DOI 10.1210/er.22.5.675; Williamson CM, 2006, NAT GENET, V38, P350, DOI 10.1038/ng1731; Williamson CM, 2004, NAT GENET, V36, P894, DOI 10.1038/ng1398; WILSON LC, 1994, J MED GENET, V31, P779, DOI 10.1136/jmg.31.10.779; WILSON LC, 1994, J MED GENET, V31, P835, DOI 10.1136/jmg.31.11.835; Xie T, 2006, J BIOL CHEM, V281, P18989, DOI 10.1074/jbc.M511752200; Yeh GL, 2000, J BONE MINER RES, V15, P2063, DOI 10.1359/jbmr.2000.15.11.2063; Yu DW, 1999, J CLIN ENDOCR METAB, V84, P3254, DOI 10.1210/jc.84.9.3254; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715	65	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51835	10.1371/journal.pone.0051835	http://dx.doi.org/10.1371/journal.pone.0051835			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284784	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000312694300050
J	Decker, WK; Shah, N; Xing, DX; Lapushin, R; Li, SF; Robinson, SN; Yang, H; Parmar, S; Halpert, MM; Keating, MJ; Gribben, JG; Molldrem, JJ; Shpall, EJ; Wierda, WG				Decker, William K.; Shah, Nina; Xing, Dongxia; Lapushin, Ruth; Li, Sufang; Robinson, Simon N.; Yang, Hong; Parmar, Simrit; Halpert, Matthew M.; Keating, Michael J.; Gribben, John G.; Molldrem, Jeffrey J.; Shpall, Elizabeth J.; Wierda, William G.			Generation of Functional CLL-Specific Cord Blood CTL Using CD40-Ligated CLL APC	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; STEM-CELL TRANSPLANTATION; IMMUNOLOGICAL SYNAPSE FORMATION; GRAFT-VERSUS-LEUKEMIA; ALLOREACTIVE T-CELLS; CLASS-I; B-CLL; THERAPY; IMMUNODEFICIENCY; IMMUNOTHERAPY	Though remissions have been observed following allo-HSCT for the treatment of CLL, many CLL patients are ineligible for transplant due to the lack of HLA-compatible donors. The use of umbilical cord blood (UCB) permits transplantation of many patients who lack HLA-compatible donors due to reduced requirements for stringent HLA matching between graft and recipient; however, disease relapse remains a concern with this modality. The generation of CLL-specific CTL from UCB T-cells, primed and expanded against the leukemic clone, might enhance the GVL effect and improve outcomes with UCB transplantation. Here we report the generation of functional, CLL-specific CTL using CD40-ligated CLL cells to prime partially-HLA matched UCB T-cells. Functionality and specificity were demonstrated by immune synapse assay, IFN-gamma ELISpot, multi-parametric intracellular cytokine flow cytometry, and Cr-51 release assay. The use of patient-specific, non-CLL controls demonstrated the generation of both alloantigen and CLL-specific responses. Subsequently, we developed a clinically-applicable procedure permitting separation of alloreactive CTL from leukemia-specific CTL. Leukemia-specific CTL were able to mediate in vivo killing of CLL in humanized mice without concurrent or subsequent development of xenoGVHD. Our results demonstrate that generation of CLL-specific effectors from UCB is feasible and practical, and the results support further exploration of this strategy as a treatment modality for CLL.	[Decker, William K.; Halpert, Matthew M.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Shah, Nina; Xing, Dongxia; Li, Sufang; Robinson, Simon N.; Yang, Hong; Parmar, Simrit; Molldrem, Jeffrey J.; Shpall, Elizabeth J.] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA; [Lapushin, Ruth; Keating, Michael J.; Wierda, William G.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Gribben, John G.] Barts & London Queen Marys Sch Med & Dent, Inst Canc, London, England	Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of London; Queen Mary University London	Decker, WK (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.	decker@bcm.edu		Shiku, Hiroshi/0000-0002-0362-755X	CLL Global Alliance; NATIONAL CANCER INSTITUTE [P50CA100632, P01CA081534] Funding Source: NIH RePORTER	CLL Global Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a grant from the CLL Global Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bachmann MF, 1999, J EXP MED, V189, P1521, DOI 10.1084/jem.189.10.1521; Bagnara D, 2011, BLOOD, V117, P5463, DOI 10.1182/blood-2010-12-324210; Ben-Bassat I, 2007, BONE MARROW TRANSPL, V39, P441, DOI 10.1038/sj.bmt.1705619; Chen JZ, 2008, CANCER BIOL THER, V7, P174, DOI 10.4161/cbt.7.2.5262; Decker WK, 2006, VACCINE, V24, P3203, DOI 10.1016/j.vaccine.2006.01.029; Dilloo D, 1997, BLOOD, V90, P1927, DOI 10.1182/blood.V90.5.1927; Gribben JG, 2005, BLOOD, V106, P4389, DOI 10.1182/blood-2005-05-1778; Gribben JG, 2009, BIOL BLOOD MARROW TR, V15, P53, DOI 10.1016/j.bbmt.2008.10.022; Haller C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001212; Hamblin AD, 2008, BRIT MED BULL, V87, P49, DOI 10.1093/bmb/ldn034; Hoogendoorn M, 2004, LEUKEMIA, V18, P1278, DOI 10.1038/sj.leu.2403358; Hus I, 2005, LEUKEMIA, V19, P1621, DOI 10.1038/sj.leu.2403860; Kater AP, 2004, BRIT J HAEMATOL, V126, P512, DOI 10.1111/j.1365-2141.2004.05070.x; Kater AP, 2007, BLOOD, V110, P2811, DOI 10.1182/blood-2007-01-068932; Kato K, 1998, J CLIN INVEST, V101, P1133, DOI 10.1172/JCI1472; Khouri IF, 2004, EXP HEMATOL, V32, P28, DOI 10.1016/j.exphem.2003.09.021; King MA, 2009, CLIN EXP IMMUNOL, V157, P104, DOI 10.1111/j.1365-2249.2009.03933.x; Krackhardt AM, 2002, BLOOD, V100, P2123, DOI 10.1182/blood-2002-02-0513; Le Dieu R, 2006, SEMIN ONCOL, V33, P220, DOI 10.1053/j.seminoncol.2005.12.012; Martins SLR, 2004, BLOOD, V104, P3429, DOI 10.1182/blood-2004-05-1918; Mavroudis DA, 1998, BRIT J HAEMATOL, V101, P565; Mayr C, 2005, BLOOD, V106, P3223, DOI 10.1182/blood-2005-04-1742; McClune BL, 2012, BRIT J HAEMATOL, V156, P273, DOI 10.1111/j.1365-2141.2011.08842.x; Miller JS, 2005, BLOOD, V105, P3051, DOI 10.1182/blood-2004-07-2974; Miscia S, 1999, J IMMUNOL, V163, P2416; Mous R, 2006, LEUKEMIA, V20, P1096, DOI 10.1038/sj.leu.2404185; Nabhan C, 2008, LEUKEMIA RES, V32, P679, DOI 10.1016/j.leukres.2007.11.002; Nishida T, 2009, CLIN CANCER RES, V15, P4759, DOI 10.1158/1078-0432.CCR-09-0199; Parmar S, 2006, CYTOTHERAPY, V8, P149, DOI 10.1080/14653240600620812; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Ramsay AG, 2008, BLOOD, V112, p2333a; Ramsay AG, 2008, J CLIN INVEST, V118, P2427, DOI 10.1172/JCI35017; Ritgen M, 2008, LEUKEMIA, V22, P1377, DOI 10.1038/leu.2008.96; Rodrigues CA, 2009, J CLIN ONCOL, V27, P256, DOI 10.1200/JCO.2007.15.8865; Rudolph JM, 2009, J VIROL, V83, P11528, DOI 10.1128/JVI.01423-09; Samarasinghe S, 2010, BLOOD, V115, P396, DOI 10.1182/blood-2009-08-235895; Schmidt SM, 2003, BLOOD, V102, P571, DOI 10.1182/blood-2002-08-2554; Shah N, 2011, LEUKEMIA, V25, P1036, DOI 10.1038/leu.2011.30; Trojan A, 2000, NAT MED, V6, P667, DOI 10.1038/76243; Wierda WG, 2000, BLOOD, V96, P2917; Wolf D, 2008, VIROLOGY, V370, P45, DOI 10.1016/j.virol.2007.08.015; Xing DX, 2010, J IMMUNOTHER, V33, P684, DOI 10.1097/CJI.0b013e3181e475e9	42	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51390	10.1371/journal.pone.0051390	http://dx.doi.org/10.1371/journal.pone.0051390			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284688	Green Published, gold			2022-12-27	WOS:000312694300024
J	Kennedy, DM; Stanton, JAL; Garcia, JA; Mason, C; Rand, CJ; Kieser, JA; Tompkins, GR				Kennedy, Darnell M.; Stanton, Jo-Ann L.; Garcia, Jose A.; Mason, Chris; Rand, Christy J.; Kieser, Jules A.; Tompkins, Geoffrey R.			Microbial Analysis of Bite Marks by Sequence Comparison of Streptococcal DNA	PLOS ONE			English	Article							VIRIDANS GROUP STREPTOCOCCI; INTERGENIC SPACER REGION; PHYLOGENETIC-RELATIONSHIPS; ORAL STREPTOCOCCI; IDENTIFICATION; MITIS; DIVERSITY; BITEMARKS; LOCATION; DYNAMICS	Bite mark injuries often feature in violent crimes. Conventional morphometric methods for the forensic analysis of bite marks involve elements of subjective interpretation that threaten the credibility of this field. Human DNA recovered from bite marks has the highest evidentiary value, however recovery can be compromised by salivary components. This study assessed the feasibility of matching bacterial DNA sequences amplified from experimental bite marks to those obtained from the teeth responsible, with the aim of evaluating the capability of three genomic regions of streptococcal DNA to discriminate between participant samples. Bite mark and teeth swabs were collected from 16 participants. Bacterial DNA was extracted to provide the template for PCR primers specific for streptococcal 16S ribosomal RNA (16S rRNA) gene, 16S-23S intergenic spacer (ITS) and RNA polymerase beta subunit (rpoB). High throughput sequencing (GS FLX 454), followed by stringent quality filtering, generated reads from bite marks for comparison to those generated from teeth samples. For all three regions, the greatest overlaps of identical reads were between bite mark samples and the corresponding teeth samples. The average proportions of reads identical between bite mark and corresponding teeth samples were 0.31, 0.41 and 0.31, and for non-corresponding samples were 0.11, 0.20 and 0.016, for 16S rRNA, ITS and rpoB, respectively. The probabilities of correctly distinguishing matching and non-matching teeth samples were 0.92 for ITS, 0.99 for 16S rRNA and 1.0 for rpoB. These findings strongly support the tenet that bacterial DNA amplified from bite marks and teeth can provide corroborating information in the identification of assailants.	[Kennedy, Darnell M.; Kieser, Jules A.; Tompkins, Geoffrey R.] Univ Otago, Sch Dent, Sir John Walsh Res Inst, Dunedin, New Zealand; [Kennedy, Darnell M.; Stanton, Jo-Ann L.; Mason, Chris; Rand, Christy J.] Univ Otago, Dept Anat, Dunedin, New Zealand; [Garcia, Jose A.] Univ Otago, Dept Preventat & Social Med, Dunedin, New Zealand	University of Otago; University of Otago; University of Otago	Tompkins, GR (corresponding author), Univ Otago, Sch Dent, Sir John Walsh Res Inst, Dunedin, New Zealand.	geoffrey.tompkins@otago.ac.nz	Stanton, Jo-Ann L/C-6621-2009; Athens, Josie/Q-7172-2018	Stanton, Jo-Ann L/0000-0001-8139-4694; Athens, Josie/0000-0002-9897-0683; Rand, Christy/0000-0003-1617-6089	New Zealand Dental Research Foundation, Ministry of Science and Innovation; New Economy Research Fund [UOOX0809]	New Zealand Dental Research Foundation, Ministry of Science and Innovation; New Economy Research Fund	Funding came from the New Zealand Dental Research Foundation, Ministry of Science and Innovation and the New Economy Research Fund (UOOX0809). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Al-Talabani N, 2006, J FORENSIC SCI, V51, P1372, DOI 10.1111/j.1556-4029.2006.00265.x; Amerongen AVN, 2002, ORAL DIS, V8, P12, DOI 10.1034/j.1601-0825.2002.1o816.x; Bek-Thomsen M, 2008, INFECT IMMUN, V76, P1889, DOI 10.1128/IAI.01511-07; Borgula L M, 2003, J Forensic Odontostomatol, V21, P23; Chen CC, 2004, J CLIN MICROBIOL, V42, P2651, DOI 10.1128/JCM.42.6.2651-2657.2004; Clement JG, 2010, FORENSIC SCI INT, V201, P33, DOI 10.1016/j.forsciint.2010.03.006; Dekio I, 2005, J MED MICROBIOL, V54, P1231, DOI 10.1099/jmm.0.46075-0; Drancourt M, 2004, J CLIN MICROBIOL, V42, P497, DOI 10.1128/JCM.42.2.497-504.2004; Droege M, 2008, J BIOTECHNOL, V136, P3, DOI 10.1016/j.jbiotec.2008.03.021; Ellner PD, 2006, BIOMEDICAL SCI EXPER; Fitzsimmons S, 1996, CLIN DIAGN LAB IMMUN, V3, P517, DOI 10.1128/CDLI.3.5.517-522.1996; Freeman AJ, 2005, J FORENSIC SCI, V50, P1436; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Gao Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002719; Glazunova OO, 2009, INT J SYST EVOL MICR, V59, P2317, DOI 10.1099/ijs.0.005488-0; Hardie JM, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P76, DOI 10.1007/0-387-30744-3_2; Hassan AA, 2003, SYST APPL MICROBIOL, V26, P97, DOI 10.1078/072320203322337371; Herschaft EE, 2007, MANUAL FORENSIC ODON; Hohwy J, 2001, INFECT IMMUN, V69, P6055, DOI 10.1128/IAI.69.10.6055-6063.2001; Hoshino T, 2005, PEDIATR DENT J, V15, P185, DOI 10.1016/S0917-2394(05)70051-3; Hsu L, 2012, CURR MICROBIOL, V65, P207, DOI 10.1007/s00284-012-0148-x; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Innings A, 2005, J CLIN MICROBIOL, V43, P5983, DOI 10.1128/JCM.43.12.5983-5991.2005; KAWAMURA Y, 1995, INT J SYST BACTERIOL, V45, P406, DOI 10.1099/00207713-45-2-406; Kieser J, 2005, FOREN PATHOL REV, V3, P157, DOI 10.1007/978-1-59259-910-3_4; Kilian M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002683; Kirkwood B. R., 2003, MED STAT; Marsh P, 1999, ORAL MICROBIOLOGY, V4th; Mercer DK, 1999, APPL ENVIRON MICROB, V65, P6; Mora D, 2003, MICROBIOL-SGM, V149, P807, DOI 10.1099/mic.0.25925-0; NADANO D, 1993, CLIN CHEM, V39, P448; National Academy of Sciences, 2009, STRENGTHENING FORENS; NYVAD B, 1987, SCAND J DENT RES, V95, P369; PEARCE C, 1995, J MED MICROBIOL, V42, P67, DOI 10.1099/00222615-42-1-67; Plourd GJ, 2009, P AM ACAD FORENSIC S, P257; Pretty IA, 2001, SCI JUSTICE, V41, P85, DOI 10.1016/S1355-0306(01)71859-X; Pretty IA, 2000, J FORENSIC SCI, V45, P812; Pretty IA, 2005, FORENSIC SCI SER D, P547; Pretty IA, 2006, FORENSIC SCI INT, V159, pS110, DOI 10.1016/j.forsciint.2006.02.033; Pretty IA, 2010, FORENSIC SCI INT, V201, P38, DOI 10.1016/j.forsciint.2010.04.004; Rahimi M, 2005, J APPL MICROBIOL, V99, P1265, DOI 10.1111/j.1365-2672.2005.02703.x; ROTHWELL BR, 1995, J AM DENT ASSOC, V126, P223, DOI 10.14219/jada.archive.1995.0149; RUDNEY JD, 1994, J CLIN MICROBIOL, V32, P437, DOI 10.1128/JCM.32.2.437-443.1994; Rudney JD, 2003, ARCH ORAL BIOL, V48, P475, DOI 10.1016/S0003-9969(03)00043-8; SOCRANSKY SS, 1977, J PERIODONTAL RES, V12, P90, DOI 10.1111/j.1600-0765.1977.tb00112.x; Tapp J, 2003, INT J SYST EVOL MICR, V53, P1861, DOI 10.1099/ijs.0.02639-0; TENJO E, 1993, ELECTROPHORESIS, V14, P1042, DOI 10.1002/elps.11501401166; Truong TL, 2000, J MED MICROBIOL, V49, P63, DOI 10.1099/0022-1317-49-1-63; Whiley RA, 1998, ORAL MICROBIOL IMMUN, V13, P195, DOI 10.1111/j.1399-302X.1998.tb00698.x; Wisplinghoff H, 1999, J CLIN MICROBIOL, V37, P1876, DOI 10.1128/JCM.37.6.1876-1880.1999	51	7	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51757	10.1371/journal.pone.0051757	http://dx.doi.org/10.1371/journal.pone.0051757			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284761	Green Submitted, Green Published, gold			2022-12-27	WOS:000312694300041
J	Li, A; Song, TL; Wang, F; Liu, DY; Fan, ZP; Zhang, CM; He, JQ; Wang, SL				Li, Ang; Song, Tieli; Wang, Fu; Liu, Dayong; Fan, Zhipeng; Zhang, Chunmei; He, Junqi; Wang, Songlin			MicroRNAome and Expression Profile of Developing Tooth Germ in Miniature Pigs	PLOS ONE			English	Article							GENE-EXPRESSION; MODEL; DIFFERENTIATION; IDENTIFICATION; TRANSCRIPTOME; MORPHOGENESIS; PREDICTION; DISCOVERY; ABUNDANCE; IDENTITY	MicroRNAs (miRNAs) play important roles in the regulation of rodent tooth development, but little is known about their role in tooth development in large mammals. We identified 637 unique miRNA sequences in a large-scale screen for miRNA expression profiles in the developing lower deciduous molars of miniature pigs (Sus scrofa) using Illumina Solexa deep sequencing. These candidate miRNAs and another 105 known Sus scrofa miRNAs were included in the custom-designed microarray and used to analyze the miRNA expression profile in the bud, cap, early bell, and late bell stages of tooth development. Microarray analysis revealed 166 transcripts that were differentially expressed in the four stages. Bioinformatic analysis identified 18 key miRNAs, including let-7f, miR-128, miR-200b, and miR-200c, that might play key roles in tooth development. Taken together, our results not only identified the specific microRNAome and expression profile in developing lower deciduous molars of the miniature pig, but they also provided useful information for investigating the molecular mechanism of tooth development in the miniature pig.	[Li, Ang; Song, Tieli; Wang, Fu; Liu, Dayong; Fan, Zhipeng; Zhang, Chunmei; Wang, Songlin] Capital Med Univ, Sch Stomatol, Mol Lab Gene Therapy & Tooth Regenerat, Beijing Key Lab Tooth Regenerat & Funct Reconstru, Beijing, Peoples R China; [He, Junqi; Wang, Songlin] Capital Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Wang, SL (corresponding author), Capital Med Univ, Sch Stomatol, Mol Lab Gene Therapy & Tooth Regenerat, Beijing Key Lab Tooth Regenerat & Funct Reconstru, Beijing, Peoples R China.	slwang@ccmu.edu.cn	Liu, Dayong/E-3440-2018; Wang, Fu/P-9950-2019; Liu, Dayong/AAT-9061-2021; Liu, Dayong/AAG-4081-2020; Li, Ang/AAV-6381-2021	Liu, Dayong/0000-0001-8511-2658; Wang, Fu/0000-0001-9615-1038; Liu, Dayong/0000-0001-8511-2658; 	Beijing Municipal Committee for Science and Technology [Z121100005212004]; National Basic Research Program of China [2010CB944801]; Beijing Municipality [PHR20090510, PXM 2009-014226-074691, PXM2011-014226-07-000066]	Beijing Municipal Committee for Science and Technology; National Basic Research Program of China(National Basic Research Program of China); Beijing Municipality	This work was supported by the research grants from Beijing Municipal Committee for Science and Technology (No. Z121100005212004) to S.W., National Basic Research Program of China (No. 2010CB944801) to S.W., Beijing Municipality (PHR20090510, PXM 2009-014226-074691 and PXM2011-014226-07-000066) to S.W. and Z.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BIVIN WS, 1976, J DENT RES, V55, P591, DOI 10.1177/00220345760550040701; Bredel M, 2009, JAMA-J AM MED ASSOC, V302, P261, DOI 10.1001/jama.2009.997; Budhu A, 2006, CANCER CELL, V10, P99, DOI 10.1016/j.ccr.2006.06.016; Cao H, 2010, J DENT RES, V89, P779, DOI 10.1177/0022034510369304; Caton J, 2009, J ANAT, V214, P502, DOI 10.1111/j.1469-7580.2008.01014.x; Chai Y, 1999, MECH DEVELOP, V86, P63, DOI 10.1016/S0925-4773(99)00112-4; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-240; Chen JQ, 2009, DEV BIOL, V334, P174, DOI 10.1016/j.ydbio.2009.07.015; Gu YR, 2011, ANIM SCI J, V82, P722, DOI 10.1111/j.1740-0929.2011.00908.x; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Jevnaker AM, 2008, ARCH ORAL BIOL, V53, P629, DOI 10.1016/j.archoralbio.2008.01.014; Jheon AH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024536; Kapadia H, 2007, ORTHOD CRANIOFAC RES, V10, P236; Katzman S, 2007, SCIENCE, V317, P915, DOI 10.1126/science.1142430; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li GX, 2011, J CELL BIOCHEM, V112, P1318, DOI 10.1002/jcb.23045; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; McDaneld TG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-77; Michon F, 2010, DEV BIOL, V340, P355, DOI 10.1016/j.ydbio.2010.01.019; Nielsen M, 2010, ANIM GENET, V41, P159, DOI 10.1111/j.1365-2052.2009.01981.x; Ransohoff DF, 2004, NAT REV CANCER, V4, P309, DOI 10.1038/nrc1322; Reddy AM, 2008, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-65; Sehic A, 2011, PHYSIOL GENOMICS, V43, P488, DOI 10.1152/physiolgenomics.00248.2010; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Shi Y, 2009, SCI CHINA SER C, V52, P205, DOI 10.1007/s11427-009-0040-5; Stembirek J, 2010, EUR J ORAL SCI, V118, P547, DOI 10.1111/j.1600-0722.2010.00772.x; Teferedegne B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014416; Wang S, 2007, ORAL DIS, V13, P530, DOI 10.1111/j.1601-0825.2006.01337.x; Xie SS, 2010, ANIM GENET, V41, P179, DOI 10.1111/j.1365-2052.2009.01991.x; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Zhao SH, 2006, MAMM GENOME, V17, P777, DOI 10.1007/s00335-005-0155-3	33	21	22	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52256	10.1371/journal.pone.0052256	http://dx.doi.org/10.1371/journal.pone.0052256			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272230	Green Submitted, Green Published, gold			2022-12-27	WOS:000312483300073
J	Riley, L; Zhou, H; Lange, K; Sinsheimer, JS; Sehl, ME				Riley, Lindsay; Zhou, Hua; Lange, Kenneth; Sinsheimer, Janet S.; Sehl, Mary E.			Determining Duration of HER2-Targeted Therapy Using Stem Cell Extinction Models	PLOS ONE			English	Article							BREAST-CANCER; HER2; TRASTUZUMAB; TUMORIGENESIS; NUMBER	Introduction: Trastuzumab dramatically improves survival in breast cancer patients whose tumor overexpresses HER2. A subpopulation of cells in human breast tumors has been identified with characteristics of cancer stem cells. These breast cancer stem-like cells (BCSCs) rely on HER2 signaling for self-renewal, suggesting that HER2-targeted therapy targets BCSCs even when the bulk of the tumor does not overexpress HER2. In order to guide clinical trials examining HER2-targeted therapy in the adjuvant setting, we propose a mathematical model to examine BCSC population dynamics and predict optimal duration of therapy. Methods: Varying the susceptibility of BCSCs to HER2-targeted therapy, we quantify the average time to extinction of BCSCs. We expand our model using stochastic simulation to include the partially differentiated tumor cells (TCs) that represent bulk tumor population and examine effects of plasticity on required duration of therapy. Results: Lower susceptibility of BCSCs and increased rates of dedifferentiation entail longer extinction times, indicating a need for prolonged administration of HER2-targeted therapy. We predict that even when therapy does not appreciably reduce tumor size in the advanced cancer setting, it will eventually eradicate the tumor in the adjuvant setting as long as there is at least a modest effect on BCSCs. Conclusions: We anticipate that our results will inform clinical trials of targeted therapies in planning the duration of therapy needed to eradicate BCSCs. Our predictions also address safety, as longer duration of therapy entails a greater potential impact on normal stem cells that may also be susceptible to stem cell-targeted therapies.	[Sehl, Mary E.] Univ Calif Los Angeles, Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90024 USA; [Riley, Lindsay; Lange, Kenneth; Sinsheimer, Janet S.] Univ Calif Los Angeles, Sch Med, Dept Biomath, Los Angeles, CA 90024 USA; [Zhou, Hua] N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA; [Lange, Kenneth; Sinsheimer, Janet S.] Univ Calif Los Angeles, Sch Med, Dept Human Genet, Los Angeles, CA USA; [Lange, Kenneth] Univ Calif Los Angeles, Dept Stat, Los Angeles, CA USA; [Sinsheimer, Janet S.] Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of North Carolina; North Carolina State University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Sehl, ME (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90024 USA.	msehl@mednet.ucla.edu		Zhou, Hua/0000-0003-1320-7118	NCATS UCLA CTSI Grant [KL2TR000122]; USPHS [GM53275, MH59490]; NIH service award [GM008185]; Career Development Award from the ASCO Cancer Foundation; Breast Cancer Research Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000122] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053275, T32GM008185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH059490, R01MH059490] Funding Source: NIH RePORTER	NCATS UCLA CTSI Grant; USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NIH service award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Career Development Award from the ASCO Cancer Foundation; Breast Cancer Research Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research is supported in part by NCATS UCLA CTSI Grant KL2TR000122, USPHS grants GM53275 and MH59490 and NIH service award GM008185, and by a Career Development Award from the ASCO Cancer Foundation and the Breast Cancer Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abkowitz JL, 2002, BLOOD, V100, P2665, DOI 10.1182/blood-2002-03-0822; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ashkenazi R, 2008, NEOPLASIA, V10, P1170, DOI 10.1593/neo.08572; Ashkenazi R, 2007, STEM CELL REV, V3, P176, DOI 10.1007/s12015-007-0026-2; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Enderling H, 2007, J THEOR BIOL, V246, P245, DOI 10.1016/j.jtbi.2006.12.010; Ferguson T. S., 1996, COURSE LARGE SAMPLE; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Korkaya H, 2009, CLIN CANCER RES, V15, P1845, DOI 10.1158/1078-0432.CCR-08-3087; Liu SL, 2010, J CLIN ONCOL, V28, P4006, DOI 10.1200/JCO.2009.27.5388; Magnifico A, 2009, CLIN CANCER RES, V15, P2010, DOI 10.1158/1078-0432.CCR-08-1327; McDermott SP, 2010, MOL ONCOL, V4, P404, DOI 10.1016/j.molonc.2010.06.005; MEYSKENS FL, 1984, CANCER RES, V44, P271; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; NORTON L, 1988, CANCER RES, V48, P7067; Padhani AR, 2001, BRIT J RADIOL, V74, P983, DOI 10.1259/bjr.74.887.740983; Paik S, 2008, NEW ENGL J MED, V358, P1409, DOI 10.1056/NEJMc0801440; Redana S, 2007, ANN ONCOL, V18, P43; Sehl M, 2011, MATH BIOSCI, V234, P132, DOI 10.1016/j.mbs.2011.09.005; Sehl M, 2009, J COMPUT BIOL, V16, P1195, DOI 10.1089/cmb.2008.0249; Sehl ME, 2009, CANCER RES, V69, P9481, DOI 10.1158/0008-5472.CAN-09-2070; Slamon D, 2005, BREAST CANCER RES TR, V94, pS5; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Sottoriva A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001132; TOMITA K, 1979, CANCER RES, V39, P4407; Wicha MS, 2009, BREAST, V18, pS56, DOI 10.1016/S0960-9776(09)70274-7; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	29	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e46613	10.1371/journal.pone.0046613	http://dx.doi.org/10.1371/journal.pone.0046613			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23284608	gold, Green Published			2022-12-27	WOS:000313051500002
J	Hennebry, SC; Sait, LC; Mantena, R; Humphrey, TJ; Yang, J; Scott, T; Kupz, A; Richardson, SJ; Strugnell, RA				Hennebry, Sarah C.; Sait, Leanne C.; Mantena, Raju; Humphrey, Thomas J.; Yang, Ji; Scott, Timothy; Kupz, Andreas; Richardson, Samantha J.; Strugnell, Richard A.			Salmonella Typhimurium's Transthyretin-Like Protein Is a Host-Specific Factor Important in Fecal Survival in Chickens	PLOS ONE			English	Article							URIC-ACID; ESCHERICHIA-COLI; EVOLUTION; TRANSCRIPTION; OXIDATION; 5-HYDROXYISOURATE; ALLANTOIN; XANTHINE; NITROGEN; PRODUCT	The transthyretin-like protein (TLP) from Salmonella enterica subspecies I is a periplasmic protein with high level structural similarity to a protein found in mammals and fish. In humans, the protein homologue, transthyretin, binds and carries retinol and thyroxine, and a series of other, unrelated aromatic compounds. Here we show that the amino acid sequence of the TLP from different species, subspecies and serovars of the Salmonella genus is highly conserved and demonstrate that the TLP gene is constitutively expressed in S. Typhimurium and that copper and other divalent metal ions severely inhibit enzyme activity of the TLP, a cyclic amidohydrolase that hydrolyses 5-hydroxyisourate (5-HIU). In order to determine the in vivo role of the S. Typhimurium TLP, we constructed a strain of mouse-virulent S. Typhimurium SL1344 bearing a mutation in the TLP gene (SL1344 DyedX). We assessed the virulence of this strain via oral inoculation of mice and chickens. Whilst SL1344 DyedX induced a systemic infection in both organisms, the bacterial load detected in the faeces of infected chickens was significantly reduced when compared to the load of S. Typhimurium SL1344. These data demonstrate that the TLP gene is required for survival of S. Typhimurium in a high uric acid environment such as chicken faeces, and that metabolic traits of Salmonellae in natural and contrived hosts may be fundamentally different. Our data also highlight the importance of using appropriate animal models for the study of bacterial pathogenesis especially where host-specific virulence factors or traits are the subject of the study.	[Hennebry, Sarah C.; Richardson, Samantha J.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia; [Sait, Leanne C.; Humphrey, Thomas J.] Univ Bristol, Dept Vet Clin Sci, Bristol, Avon, England; [Hennebry, Sarah C.; Mantena, Raju; Yang, Ji; Scott, Timothy; Kupz, Andreas; Strugnell, Richard A.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Richardson, Samantha J.] RMIT Univ, Sch Med Sci, Bundoora, Vic, Australia	University of Melbourne; University of Bristol; University of Melbourne; Royal Melbourne Institute of Technology (RMIT)	Hennebry, SC (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia.	rastru@unimelb.edu.au	Kupz, Andreas/J-3844-2014	Kupz, Andreas/0000-0002-9259-7873; Scott, Timothy/0000-0001-7042-8609; Strugnell, Richard/0000-0003-0614-5641; Richardson, Samantha/0000-0002-1708-9430; Humphrey, Tom/0000-0001-7965-8988	NHMRC (National Health and Medical Research Council) of Australia	NHMRC (National Health and Medical Research Council) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by the NHMRC (National Health and Medical Research Council) of Australia under Project and Program Support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel FM., 1988, CURRENT PROTOCOLS MO; BARROW PA, 1987, RES VET SCI, V42, P194, DOI 10.1016/S0034-5288(18)30685-4; BARROW PA, 1988, AVIAN PATHOL, V17, P571, DOI 10.1080/03079458808436478; Baumler AJ, 1998, INFECT IMMUN, V66, P4579; BECKER BF, 1993, FREE RADICAL BIO MED, V14, P615, DOI 10.1016/0891-5849(93)90143-I; BRAUN EJ, 1989, J EXP ZOOL, P70, DOI 10.1002/jez.1402520512; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; EITEMAN MA, 1994, FRESEN J ANAL CHEM, V348, P680, DOI 10.1007/BF00325572; Govoni G, 1999, INFECT IMMUN, V67, P2225, DOI 10.1128/IAI.67.5.2225-2232.1999; Gowrishankar J, 1998, J BACTERIOL, V180, P6743, DOI 10.1128/JB.180.24.6743-6748.1998; GUTNICK D, 1969, J BACTERIOL, V100, P215, DOI 10.1128/JB.100.1.215-219.1969; Hennebry SC, 2006, PROTEINS, V64, P1024, DOI 10.1002/prot.21033; Hennebry SC, 2006, J MOL BIOL, V359, P1389, DOI 10.1016/j.jmb.2006.04.057; Hennebry SC, 2009, FEBS J, V276, P5367, DOI 10.1111/j.1742-4658.2009.07246.x; Hennebry SC, 2009, RECENT ADV TRANSTHYR; HUDSON GS, 1984, J MOL BIOL, V180, P1023, DOI 10.1016/0022-2836(84)90269-9; Kahn K, 1998, BIOCHEMISTRY-US, V37, P11651, DOI 10.1021/bi980446g; Kim GJ, 1998, BIOCHEM J, V330, P295, DOI 10.1042/bj3300295; Lee Y, 2005, FEBS LETT, V579, P4769, DOI 10.1016/j.febslet.2005.07.056; Lundberg E, 2006, J STRUCT BIOL, V155, P445, DOI 10.1016/j.jsb.2006.04.002; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Miller TM, 1974, EXPT MOL GENETICS; OCHMAN H, 1987, J MOL EVOL, V26, P74, DOI 10.1007/BF02111283; Ramazzina I, 2006, NAT CHEM BIOL, V2, P144, DOI 10.1038/nchembio768; Reitzer L, 2003, ANNU REV MICROBIOL, V57, P155, DOI 10.1146/annurev.micro.57.030502.090820; Richardson SJ, 2007, INT REV CYTOL, V258, P137, DOI 10.1016/S0074-7696(07)58003-4; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Samocha-Bonet D, 2005, J INORG BIOCHEM, V99, P1963, DOI 10.1016/j.jinorgbio.2005.06.006; Santos CXC, 1999, ARCH BIOCHEM BIOPHYS, V372, P285, DOI 10.1006/abbi.1999.1491; Schultz AC, 2001, J BACTERIOL, V183, P3293, DOI 10.1128/JB.183.11.3293-3302.2001; Simoyi MF, 2003, COMP BIOCHEM PHYS B, V135, P325, DOI 10.1016/S1096-4959(03)00086-1; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Wilkinson SP, 2004, J BIOL CHEM, V279, P51442, DOI 10.1074/jbc.M405586200; Xi HL, 2000, J BACTERIOL, V182, P5332, DOI 10.1128/JB.182.19.5332-5341.2000; Zanotti G, 2006, J MOL BIOL, V363, P1, DOI 10.1016/j.jmb.2006.07.079	35	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e46675	10.1371/journal.pone.0046675	http://dx.doi.org/10.1371/journal.pone.0046675			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284609	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000313158800001
J	Kuhs, KAL; Toporovski, R; Ginsberg, AA; Shedlock, DJ; Weiner, DB				Kuhs, Krystle A. Lang; Toporovski, Roberta; Ginsberg, Arielle A.; Shedlock, Devon J.; Weiner, David B.			Induction of Intrahepatic HCV NS4B, NS5A and NS5B-Specific Cellular Immune Responses following Peripheral Immunization	PLOS ONE			English	Article							HEPATITIS-C VIRUS; T-CELLS; SELECTIVE RETENTION; MEDIATED-IMMUNITY; VIRAL CLEARANCE; DNA VACCINE; INFECTION; LIVER; TOLERANCE; PROTEIN	Numerous studies have suggested that an effective Hepatitis C Virus (HCV) vaccine must induce strong cytotoxic and IFN-gamma+ T cell responses targeting the non-structural region of the virus. Most importantly, these responses must be able to migrate into and remain functional within the liver, an organ known to cause T cell tolerance. Using three novel HCV DNA vaccines encoding non-structural proteins NS4B, NS5A and NS5B, we assessed the ability of peripheral immunization to induce functional intrahepatic immunity both in the presence and absence of cognate HCV antigen expression within the liver. We have shown that these constructs induced potent HCV-specific CD4+ and CD8+ T cell responses in the spleen of C57BL/6 mice and that these responses were detected within the liver following peripheral immunization. Additionally, using a transfection method to express HCV antigen within the liver, we showed that intrahepatic HCV-specific T cells remained highly functional within the liver and retained the ability to become highly activated as evidenced by upregulation of IFN-gamma and clearance of HCV protein expressing hepatocytes. Taken together, these findings suggest that peripheral immunization can induce potent HCV-specific T cell responses able to traffic to and function within the tolerant environment of the liver.	[Kuhs, Krystle A. Lang; Toporovski, Roberta; Ginsberg, Arielle A.; Shedlock, Devon J.; Weiner, David B.] Univ Penn, Dept Pathol, Philadelphia, PA 19104 USA	University of Pennsylvania	Weiner, DB (corresponding author), Univ Penn, Dept Pathol, Philadelphia, PA 19104 USA.	dbweiner@mail.med.upenn.edu	Weiner, David B/H-8579-2014	Shedlock, Devon/0000-0003-1018-7510	Commonwealth Universal Research Enhancement (CURE) competitive grant program; Pennsylvania's share of the national tobacco settlement [RFA 08-07-07];  [SAP 4100051718]	Commonwealth Universal Research Enhancement (CURE) competitive grant program; Pennsylvania's share of the national tobacco settlement; 	This manuscript was supported by the Commonwealth Universal Research Enhancement (CURE) competitive grant program funded through Pennsylvania's share of the 2009-2010 national tobacco settlement (RFA 08-07-07). The title of the grant is "Development of a DNA Vaccine Strategy for Hepatitis C Virus" (SAP 4100051718). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlen G, 2005, J INFECT DIS, V192, P2112, DOI 10.1086/498218; Bassett SE, 2001, HEPATOLOGY, V33, P1479, DOI 10.1053/jhep.2001.24371; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Bowen DG, 2004, J CLIN INVEST, V114, P701, DOI 10.1172/JCI200421593; Crispe IN, 2003, NAT REV IMMUNOL, V3, P51, DOI 10.1038/nri981; Crispe IN, 2000, IMMUNOL REV, V174, P47, DOI 10.1034/j.1600-0528.2002.017412.x; DIEPOLDER HM, 1995, LANCET, V346, P1006, DOI 10.1016/S0140-6736(95)91691-1; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; FARCI P, 1992, SCIENCE, V258, P135, DOI 10.1126/science.1279801; Folgori A, 2006, NAT MED, V12, P190, DOI 10.1038/nm1353; GORCZYNSKI RM, 1994, TRANSPLANTATION, V58, P816, DOI 10.1097/00007890-199410150-00012; Gruener NH, 2001, J VIROL, V75, P5550, DOI 10.1128/JVI.75.12.5550-5558.2001; Kuhs KAL, 2011, HUM VACCINES, V7, P1326, DOI 10.4161/hv.7.12.18279; Laddy DJ, 2007, VACCINE, V25, P2984, DOI 10.1016/j.vaccine.2007.01.063; Limmer A, 2005, EUR J IMMUNOL, V35, P2970, DOI 10.1002/eji.200526034; Mehal WZ, 1999, J IMMUNOL, V163, P3202; Missale G, 1996, J CLIN INVEST, V98, P706, DOI 10.1172/JCI118842; Qian S, 1997, TRANSPL P, V29, P1168, DOI 10.1016/S0041-1345(96)00521-0; Qin WP, 2002, J BIOL CHEM, V277, P2132, DOI 10.1074/jbc.M106880200; Rolland M, 2007, J VIROL, V81, P8507, DOI 10.1128/JVI.02683-06; Rustgi VK, 2007, J GASTROENTEROL, V42, P513, DOI 10.1007/s00535-007-2064-6; Shoukry NH, 2004, ANNU REV MICROBIOL, V58, P391, DOI 10.1146/annurev.micro.58.030603.123836; Tellinghuisen TL, 2004, J BIOL CHEM, V279, P48576, DOI 10.1074/jbc.M407787200; Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395; THOMAS HC, 1976, CLIN EXP IMMUNOL, V26, P574; Yan J, 2007, MOL THER, V15, P411, DOI 10.1038/sj.mt.6300036; Yu GY, 2006, J VIROL, V80, P6013, DOI 10.1128/JVI.00053-06; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734	28	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52165	10.1371/journal.pone.0052165	http://dx.doi.org/10.1371/journal.pone.0052165			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284919	Green Published, Green Submitted, gold			2022-12-27	WOS:000313158800035
J	Fernandez, DC; Pasquini, LA; Dorfman, D; Marcos, HJA; Rosenstein, RE				Fernandez, Diego C.; Pasquini, Laura A.; Dorfman, Damian; Aldana Marcos, Hernan J.; Rosenstein, Ruth E.			Ischemic Conditioning Protects from Axoglial Alterations of the Optic Pathway Induced by Experimental Diabetes in Rats	PLOS ONE			English	Article							VISUAL-EVOKED-POTENTIALS; CONTRAST SENSITIVITY; PATTERN ELECTRORETINOGRAM; DISTAL AXONOPATHY; NEURONAL DEATH; DEGENERATION; RETINOPATHY; GLUTAMATE; RETINA	Diabetic retinopathy is a leading cause of blindness. Visual function disorders have been demonstrated in diabetics even before the onset of retinopathy. At early stages of experimental diabetes, axoglial alterations occur at the distal portion of the optic nerve. Although ischemic conditioning can protect neurons and synaptic terminals against ischemic damage, there is no information on its ability to protect axons. We analyzed the effect of ischemic conditioning on the early axoglial alterations in the distal portion of the optic nerve induced by experimental diabetes. Diabetes was induced in Wistar rats by an intraperitoneal injection of streptozotocin. Retinal ischemia was induced by increasing intraocular pressure to 120 mm Hg for 5 min; this maneuver started 3 days after streptozotocin injection and was weekly repeated in one eye, while the contralateral eye was submitted to a sham procedure. The application of ischemia pulses prevented a deficit in the anterograde transport from the retina to the superior colliculus, as well as an increase in astrocyte reactivity, ultraestructural myelin alterations, and altered morphology of oligodendrocyte lineage in the optic nerve distal portion at early stages of experimental diabetes. Ischemia tolerance prevented a significant decrease of retinal glutamine synthetase activity induced by diabetes. These results suggest that early vision loss in diabetes could be abated by ischemic conditioning which preserved axonal function and structure.	[Fernandez, Diego C.; Dorfman, Damian; Rosenstein, Ruth E.] Univ Buenos Aires, Lab Retinal Neurochem & Expt Ophthalmol, Dept Human Biochem, Sch Med,CEFyBO,CONICET, Buenos Aires, DF, Argentina; [Fernandez, Diego C.; Aldana Marcos, Hernan J.] Univ Moron, Histol Lab, Sch Med, Buenos Aires, DF, Argentina; [Pasquini, Laura A.] Univ Buenos Aires, CONICET, Dept Biol Chem, Buenos Aires, DF, Argentina; [Pasquini, Laura A.] Univ Buenos Aires, CONICET, Inst Chem & Biol Physicochem, IQUIFIB,Sch Pharm & Biochem, Buenos Aires, DF, Argentina; [Aldana Marcos, Hernan J.] Univ Belgrano, Histol Lab, Sch Sci, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Rosenstein, RE (corresponding author), Univ Buenos Aires, Lab Retinal Neurochem & Expt Ophthalmol, Dept Human Biochem, Sch Med,CEFyBO,CONICET, Buenos Aires, DF, Argentina.	ruthr@fmed.uba.ar	Pasquini, Laura/ABD-8106-2021	Fernandez, Diego Carlos/0000-0002-4363-1318	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 1623]; University of Buenos Aires [M062]; CONICET, Argentina [PIP 1911]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); University of Buenos Aires(University of Buenos Aires); CONICET, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This research was supported by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 1623); The University of Buenos Aires (M062); CONICET, (PIP 1911) Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; Beirowski B, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-6; BLOODWORTH JMB, 1962, DIABETES, V11, P1; BRESNICK GH, 1986, ARCH OPHTHALMOL-CHIC, V104, P989; Buckingham BP, 2008, J NEUROSCI, V28, P2735, DOI 10.1523/JNEUROSCI.4443-07.2008; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Conforti L, 2007, TRENDS NEUROSCI, V30, P159, DOI 10.1016/j.tins.2007.02.004; Crish SD, 2010, P NATL ACAD SCI USA, V107, P5196, DOI 10.1073/pnas.0913141107; DELLASALA S, 1985, BRIT J OPHTHALMOL, V69, P136, DOI 10.1136/bjo.69.2.136; Deng J, 2000, Yan Ke Xue Bao, V16, P199; FALSINI B, 1989, DOC OPHTHALMOL, V73, P193, DOI 10.1007/BF00155037; Fernandez DC, 2012, AM J PATHOL, V180, P303, DOI 10.1016/j.ajpath.2011.09.018; Fernandez DC, 2011, AM J PATHOL, V178, P2264, DOI 10.1016/j.ajpath.2011.01.040; Fernandez DC, 2009, J NEUROCHEM, V111, P488, DOI 10.1111/j.1471-4159.2009.06334.x; Fernandez DC, 2009, INVEST OPHTH VIS SCI, V50, P3922, DOI 10.1167/iovs.08-3344; Georgakopoulos CD, 2011, J PEDIAT OPHTH STRAB, V48, P92, DOI 10.3928/01913913-20100420-02; GHAFOUR IM, 1982, BRIT J OPHTHALMOL, V66, P492, DOI 10.1136/bjo.66.8.492; Hogins J, 2011, NEUROBIOL DIS, V43, P516, DOI 10.1016/j.nbd.2011.05.005; Kern TS, 2008, J PHYSIOL-LONDON, V586, P4401, DOI 10.1113/jphysiol.2008.156695; Kowluru RA, 2007, EXP DIABETES RES, DOI 10.1155/2007/43603; Lieth E, 1998, DIABETES, V47, P815, DOI 10.2337/diabetes.47.5.815; Lu MJ, 2007, EXP DIABETES RES, DOI 10.1155/2007/39765; Marcos HJA, 1996, BIOCELL, V20, P265; MARTINELLI V, 1992, ACTA DIABETOL, V29, P34, DOI 10.1007/BF00572827; Mizutani M, 1998, DIABETES, V47, P445, DOI 10.2337/diabetes.47.3.445; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pignataro Giuseppe, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P1; PRAGER TC, 1990, AM J OPHTHALMOL, V109, P279, DOI 10.1016/S0002-9394(14)74550-7; Roth S, 1998, INVEST OPHTH VIS SCI, V39, P777; SOKOL S, 1985, ARCH OPHTHALMOL-CHIC, V103, P51; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Tanaka K, 2000, NEUROSCI RES, V37, P15, DOI 10.1016/S0168-0102(00)00104-8; Uberall MA, 1996, NEUROPEDIATRICS, V27, P88, DOI 10.1055/s-2007-973755; Verrotti A, 2000, DEV MED CHILD NEUROL, V42, P240, DOI 10.1017/S0012162200000414; Villarroel M, 2010, WORLD J DIABETES, V1, P57, DOI 10.4239/wjd.v1.i2.57; Whitmire W, 2011, MOL VIS, V17, P300; Wolff BE, 2010, DOC OPHTHALMOL, V121, P189, DOI 10.1007/s10633-010-9245-y; Yu XH, 2009, EXP EYE RES, V89, P967, DOI 10.1016/j.exer.2009.08.006; Zeng KH, 2010, MOL CELL NEUROSCI, V45, P192, DOI 10.1016/j.mcn.2010.06.010; Zhang WQ, 2011, J CLIN NEUROSCI, V18, P685, DOI 10.1016/j.jocn.2010.08.027	40	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51966	10.1371/journal.pone.0051966	http://dx.doi.org/10.1371/journal.pone.0051966			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284834	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500070
J	Kallendrusch, S; Hobusch, C; Ehrlich, A; Nowicki, M; Ziebell, S; Bechmann, I; Geisslinger, G; Koch, M; Dehghani, F				Kallendrusch, Sonja; Hobusch, Constance; Ehrlich, Angela; Nowicki, Marcin; Ziebell, Simone; Bechmann, Ingo; Geisslinger, Gerd; Koch, Marco; Dehghani, Faramarz			Intrinsic Up-Regulation of 2-AG Favors an Area Specific Neuronal Survival in Different In Vitro Models of Neuronal Damage	PLOS ONE			English	Article							HIPPOCAMPAL SLICE CULTURES; CANNABINOID RECEPTOR CB1; FOCAL CEREBRAL-ISCHEMIA; KNOCK-OUT MICE; MONOACYLGLYCEROL LIPASE; ENDOCANNABINOID SYSTEM; INTERNATIONAL UNION; DIRECT SUPPRESSION; DENTATE GYRUS; BRAIN-INJURY	Background: The endocannabinoid 2-arachidonoyl glycerol (2-AG) acts as a retrograde messenger and modulates synaptic signaling e. g. in the hippocampus. 2-AG also exerts neuroprotective effects under pathological situations. To better understand the mechanism beyond physiological signaling we used Organotypic Entorhino-Hippocampal Slice Cultures (OHSC) and investigated the temporal regulation of 2-AG in different cell subsets during excitotoxic lesion and dendritic lesion of long range projections in the enthorhinal cortex (EC), dentate gyrus (DG) and the cornu ammonis region 1 (CA1). Results: 2-AG levels were elevated 24 h after excitotoxic lesion in CA1 and DG (but not EC) and 24 h after perforant pathway transection (PPT) in the DG only. After PPT diacylglycerol lipase alpha (DAGL) protein, the synthesizing enzyme of 2-AG was decreased when Dagl mRNA expression and 2-AG levels were enhanced. In contrast to DAGL, the 2-AG hydrolyzing enzyme monoacylglycerol lipase (MAGL) showed no alterations in total protein and mRNA expression after PPT in OHSC. MAGL immunoreaction underwent a redistribution after PPT and excitotoxic lesion since MAGL IR disappeared in astrocytes of lesioned OHSC. DAGL and MAGL immunoreactions were not detectable in microglia at all investigated time points. Thus, induction of the neuroprotective endocannabinoid 2-AG might be generally accomplished by down-regulation of MAGL in astrocytes after neuronal lesions. Conclusion: Increase in 2-AG levels during secondary neuronal damage reflects a general neuroprotective mechanism since it occurred independently in both different lesion models. This intrinsic up-regulation of 2-AG is synergistically controlled by DAGL and MAGL in neurons and astrocytes and thus represents a protective system for neurons that is involved in dendritic reorganisation.	[Kallendrusch, Sonja; Hobusch, Constance; Ehrlich, Angela; Nowicki, Marcin; Bechmann, Ingo; Koch, Marco; Dehghani, Faramarz] Univ Leipzig, Inst Anat, Leipzig, Germany; [Kallendrusch, Sonja] Lipid Signaling Forschungszentrum Frankfurt, Frankfurt, Germany; [Ziebell, Simone; Geisslinger, Gerd] Goethe Univ Frankfurt, Inst Pharmakol, Frankfurt, Germany; [Dehghani, Faramarz] Univ Halle Wittenberg, Inst Anat & Zellbiol, Halle, Germany	Leipzig University; Goethe University Frankfurt; Martin Luther University Halle Wittenberg	Dehghani, F (corresponding author), Univ Leipzig, Inst Anat, Leipzig, Germany.	Faramarz.Dehghani@medizin.uni-halle.de	Kallendrusch, Sonja/AAV-7179-2020; Kallendrusch, Sonja/ABG-1789-2021	Kallendrusch, Sonja/0000-0003-2474-8307	BMBF project Tierversuchsersatzmethoden; Lipid Signaling Forschungszentrum Frankfurt (LiFF)	BMBF project Tierversuchsersatzmethoden; Lipid Signaling Forschungszentrum Frankfurt (LiFF)	This study was supported by the BMBF project Tierversuchsersatzmethoden and by the Lipid Signaling Forschungszentrum Frankfurt (LiFF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishay P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010628; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Casteels C, 2011, EXP NEUROL, V229, P440, DOI 10.1016/j.expneurol.2011.03.014; Chanda PK, 2010, MOL PHARMACOL, V78, P996, DOI 10.1124/mol.110.068304; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Degn M, 2007, J NEUROCHEM, V103, P1907, DOI 10.1111/j.1471-4159.2007.04892.x; Del Turco Domenico, 2007, V399, P55, DOI 10.1007/978-1-59745-504-6_5; Deller T, 1997, ANN ANAT, V179, P501, DOI 10.1016/S0940-9602(97)80003-9; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Dittel BN, 2008, BRIT J PHARMACOL, V153, P271, DOI 10.1038/sj.bjp.0707493; Fernandez-Ruiz J, 2008, MOL CELL ENDOCRINOL, V286, pS91, DOI 10.1016/j.mce.2008.01.001; Fiskerstrand T, 2010, AM J HUM GENET, V87, P410, DOI 10.1016/j.ajhg.2010.08.002; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Frotscher M, 1997, TRENDS NEUROSCI, V20, P218, DOI 10.1016/S0166-2236(96)01018-1; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Garcia-Ovejero D, 2009, NEUROBIOL DIS, V33, P57, DOI 10.1016/j.nbd.2008.09.015; Gomez O, 2010, GLIA, V58, P1913, DOI 10.1002/glia.21061; Goncalves MB, 2008, MOL CELL NEUROSCI, V38, P526, DOI 10.1016/j.mcn.2008.05.001; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Kallendrusch S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033537; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006; Koch M, 2011, NEUROTOX RES, V19, P330, DOI 10.1007/s12640-010-9166-2; Kovac AD, 2004, BRAIN PATHOL, V14, P249; Kreutz S, 2007, EXP NEUROL, V203, P246, DOI 10.1016/j.expneurol.2006.08.010; Kristensen BW, 2001, BRAIN RES, V917, P21, DOI 10.1016/S0006-8993(01)02900-6; Ludanyi A, 2011, NEUROSCIENCE, V174, P50, DOI 10.1016/j.neuroscience.2010.10.062; Maresz K, 2007, NAT MED, V13, P492, DOI 10.1038/nm1561; Marsicano G, 2002, J NEUROCHEM, V80, P448, DOI 10.1046/j.0022-3042.2001.00716.x; McPartland JM, 2007, GENE, V397, P126, DOI 10.1016/j.gene.2007.04.017; Milton NGN, 2002, NEUROSCI LETT, V332, P127, DOI 10.1016/S0304-3940(02)00936-9; Mulder J, 2011, BRAIN, V134, P1041, DOI 10.1093/brain/awr046; Nagayama T, 1999, J NEUROSCI, V19, P2987; Pan B, 2011, J NEUROSCI, V31, P13420, DOI 10.1523/JNEUROSCI.2075-11.2011; Panikashvili D, 2006, NEUROBIOL DIS, V22, P257, DOI 10.1016/j.nbd.2005.11.004; Panikashvili D, 2005, J CEREBR BLOOD F MET, V25, P477, DOI 10.1038/sj.jcbfm.9600047; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Pisani V, 2011, MOVEMENT DISORD, V26, P216, DOI 10.1002/mds.23457; Ramirez JJ, 2001, RESTOR NEUROL NEUROS, V19, P237; Savinainen JR, 2012, ACTA PHYSIOL, V204, P267, DOI 10.1111/j.1748-1716.2011.02280.x; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Signoretti S, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10183; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Stella N, 2004, GLIA, V48, P267, DOI 10.1002/glia.20084; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Straiker A, 2011, BRIT J PHARMACOL, V164, P1672, DOI 10.1111/j.1476-5381.2011.01486.x; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Uchigashima M, 2007, J NEUROSCI, V27, P3663, DOI 10.1523/JNEUROSCI.0448-07.2007; Uchigashima M, 2011, J NEUROSCI, V31, P7700, DOI 10.1523/JNEUROSCI.5665-10.2011; van der Stelt M, 2005, NEUROMOL MED, V7, P37, DOI 10.1385/NMM:7:1-2:037; van der Stelt M, 2001, J NEUROSCI, V21, P6475, DOI 10.1523/JNEUROSCI.21-17-06475.2001; Walter L, 2004, J NEUROSCI, V24, P8068, DOI 10.1523/JNEUROSCI.2419-04.2004; Walter L, 2003, J NEUROSCI, V23, P1398, DOI 10.1523/JNEUROSCI.23-04-01398.2003; Wickliffe K, 2009, CHEM REV, V109, P1537, DOI 10.1021/cr800414e; Witting A, 2006, P NATL ACAD SCI USA, V103, P6362, DOI 10.1073/pnas.0510418103; Yazaki M, 2012, MOL BIOL CELL, V23, P12, DOI 10.1091/mbc.E11-07-0623; Yin H, 2010, J BIOL CHEM, V285, P13580, DOI 10.1074/jbc.M109.046359; Yoshida T, 2006, J NEUROSCI, V26, P4740, DOI 10.1523/JNEUROSCI.0054-06.2006; Zajicek JP, 2011, CNS DRUGS, V25, P187, DOI 10.2165/11539000-000000000-00000; Zhao Y, 2010, J CARDIOVASC PHARM, V55, P292, DOI 10.1097/FJC.0b013e3181d2644d	64	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51208	10.1371/journal.pone.0051208	http://dx.doi.org/10.1371/journal.pone.0051208			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284665	gold, Green Published, Green Submitted			2022-12-27	WOS:000312794500022
J	Kriegl, L; Jung, A; Horst, D; Rizzani, A; Jackstadt, R; Hermeking, H; Gallmeier, E; Gerbes, AL; Kirchner, T; Goke, B; De Toni, EN				Kriegl, Lydia; Jung, Andreas; Horst, David; Rizzani, Antonia; Jackstadt, Rene; Hermeking, Heiko; Gallmeier, Eike; Gerbes, Alexander L.; Kirchner, Thomas; Goeke, Burkhard; De Toni, Enrico N.			Microsatellite Instability, KRAS Mutations and Cellular Distribution of TRAIL-Receptors in Early Stage Colorectal Cancer	PLOS ONE			English	Article							APOPTOSIS-INDUCING LIGAND; NATURAL-KILLER-CELLS; HEPATOCELLULAR-CARCINOMA; COLON-CANCER; TUMOR-DEVELOPMENT; DEATH-RECEPTORS; PROGNOSTIC-SIGNIFICANCE; ADJUVANT THERAPY; PLUS IRINOTECAN; MISMATCH REPAIR	Background: The fact that the receptors for the TNF-related apoptosis inducing ligand (TRAIL) are almost invariably expressed in colorectal cancer (CRC) represents the rationale for the employment of TRAIL-receptors targeting compounds for the therapy of patients affected by this tumor. Yet, first reports on the use of these bioactive agents provided disappointing results. We therefore hypothesized that loss of membrane-bound TRAIL-R might be a feature of some CRC and that the evaluation of membrane staining rather than that of the overall expression of TRAIL-R might predict the response to TRAIL-R targeting compounds in this tumor. Aim and Methods: Thus, we evaluated the immunofluorescence pattern of TRAIL-receptors and E-cadherin to assess the fraction of membrane-bound TRAIL-receptors in 231 selected patients with early-stage CRC undergoing surgical treatment only. Moreover, we investigated whether membrane staining for TRAIL-receptors as well as the presence of KRAS mutations or of microsatellite instability (MSI) had an effect on survival and thus a prognostic effect. Results: As expected, almost all CRC samples stained positive for TRAIL-R1 and 2. Instead, membrane staining for these receptors was positive in only 71% and 16% of samples respectively. No correlation between KRAS mutation status or MSI-phenotype and prognosis could be detected. TRAIL-R1 staining intensity correlated with survival in univariate analysis, but only membranous staining of TRAIL-R1 and TRAIL-R2 on cell membranes was an independent predictor of survival (cox multivariate analysis: TRAIL-R1: p = 0.019, RR 2.06[1.12-3.77]; TRAIL-R2: p = 0.033, RR 3.63[1.11-11.84]). Conclusions: In contrast to the current assumptions, loss of membrane staining for TRAIL-receptors is a common feature of early stage CRC which supersedes the prognostic significance of their staining intensity. Failure to achieve therapeutic effects in recent clinical trials using TRAIL-receptors targeting compounds might be due to insufficient selection of patients bearing tumors with membrane-bound TRAIL-receptors.	[Rizzani, Antonia; Gallmeier, Eike; Gerbes, Alexander L.; Goeke, Burkhard; De Toni, Enrico N.] Univ Munich, Univ Hosp Grosshadern, Dept Med 2, Munich, Germany; [Kriegl, Lydia; Jung, Andreas; Horst, David; Jackstadt, Rene; Hermeking, Heiko; Kirchner, Thomas] Univ Munich, Inst Pathol, D-8000 Munich, Germany	University of Munich; University of Munich	De Toni, EN (corresponding author), Univ Munich, Univ Hosp Grosshadern, Dept Med 2, Munich, Germany.	enrico.detoni@med.uni-muenchen.de	De Toni, Enrico N/C-6496-2008		Deutsche Forschungsgemeinschaft (DFG) [DFG TO 605/2-1]; Else Kroner-Fresenius Stiftung [2011_A226]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Else Kroner-Fresenius Stiftung	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) with the grant DFG TO 605/2-1 to EDT and by the Else Kroner-Fresenius Stiftung with the grant 2011_A226 to EDT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubaker J, 2009, J PATHOL, V219, P435, DOI 10.1002/path.2625; Bavi P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-203; Boland CR, 1998, CANCER RES, V58, P5248; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; De Toni EN, 2008, CLIN CANCER RES, V14, P4713, DOI 10.1158/1078-0432.CCR-07-5019; Deschoolmeester V, 2008, J MOL DIAGN, V10, P154, DOI 10.2353/jmoldx.2008.070087; Elias A, 2009, CLIN CANCER RES, V15, P5457, DOI 10.1158/1078-0432.CCR-09-1125; Grosse-Wilde A, 2008, J CLIN INVEST, V118, P100, DOI 10.1172/JCI33061; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Hutchins G, 2011, J CLIN ONCOL, V29, P1261, DOI 10.1200/JCO.2010.30.1366; Jaitner S, 2012, CELL CYCLE, V11, P3331, DOI 10.4161/cc.21790; Jeng YM, 2002, CANCER LETT, V181, P205, DOI 10.1016/S0304-3835(02)00051-4; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kriegl L, 2010, CLIN CANCER RES, V16, P5529, DOI 10.1158/1078-0432.CCR-09-3403; McCarthy MM, 2005, CLIN CANCER RES, V11, P5188, DOI 10.1158/1078-0432.CCR-05-0158; Neumann J, 2009, PATHOL RES PRACT, V205, P858, DOI 10.1016/j.prp.2009.07.010; Niemoller O, 2009, RESULTS PROBL CELL D, V49, P219, DOI 10.1007/400_2009_17; Ogino S, 2005, J MOL DIAGN, V7, P413, DOI 10.1016/S1525-1578(10)60571-5; Ohira M, 2006, TRANSPLANTATION, V82, P1712, DOI 10.1097/01.tp.0000250935.41034.2d; Peeters M, 2010, J CLIN ONCOL, V28, P4706, DOI 10.1200/JCO.2009.27.6055; Poehlmann A, 2007, PATHOL RES PRACT, V203, P489, DOI 10.1016/j.prp.2007.06.001; Sargent DJ, 2010, J CLIN ONCOL, V28, P3219, DOI 10.1200/JCO.2009.27.1825; Schulze-Bergkamen H, 2009, GUT, V58, P1010, DOI 10.1136/gut.2008.164350; Shin MS, 2001, CANCER RES, V61, P4942; Sinicrope FA, 2011, JNCI-J NATL CANCER I, V103, P863, DOI 10.1093/jnci/djr153; SOBIN LH, 2010, TMN CLASSIFICATION M; Soria JC, 2010, J CLIN ONCOL, V28, P1527, DOI 10.1200/JCO.2009.25.4847; Strater J, 2002, CLIN CANCER RES, V8, P3734; Takeda K, 2002, J EXP MED, V195, P161, DOI 10.1084/jem.20011171; Takeda K, 2001, NAT MED, V7, P94, DOI 10.1038/83416; Trarbach T, 2010, BRIT J CANCER, V102, P506, DOI 10.1038/sj.bjc.6605507; Ullenhag GJ, 2007, CLIN CANCER RES, V13, P5070, DOI 10.1158/1078-0432.CCR-06-2547; van Geelen CM, 2006, J CLIN ONCOL, V24, P4998, DOI 10.1200/JCO.2006.06.8809; Van Geelen CMM, 2004, DRUG RESIST UPDATE, V7, P345, DOI 10.1016/j.drup.2004.11.002; Walczak H, 2006, APOPTOSIS CANC THERA, P31; Yamamoto T, 2004, CLIN CANCER RES, V10, P7884, DOI 10.1158/1078-0432.CCR-04-0794; Yue HH, 2005, CELL DEATH DIFFER, V12, P94, DOI 10.1038/sj.cdd.4401523; Zhang YQ, 2008, MOL CANCER RES, V6, P1861, DOI 10.1158/1541-7786.MCR-08-0313	40	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51654	10.1371/journal.pone.0051654	http://dx.doi.org/10.1371/journal.pone.0051654			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284732	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500037
J	Lichtenauer, M; Mildner, M; Werba, G; Beer, L; Hoetzenecker, K; Baumgartner, A; Hasun, M; Nickl, S; Mitterbauer, A; Zimmermann, M; Gyongyosi, M; Podesser, BK; Klepetko, W; Ankersmit, HJ				Lichtenauer, Michael; Mildner, Michael; Werba, Gregor; Beer, Lucian; Hoetzenecker, Konrad; Baumgartner, Andrea; Hasun, Matthias; Nickl, Stefanie; Mitterbauer, Andreas; Zimmermann, Matthias; Gyoengyoesi, Mariann; Podesser, Bruno Karl; Klepetko, Walter; Ankersmit, Hendrik Jan			Anti-Thymocyte Globulin Induces Neoangiogenesis and Preserves Cardiac Function after Experimental Myocardial Infarction	PLOS ONE			English	Article							REGULATORY T-CELLS; BLOOD MONONUCLEAR-CELLS; NONHUMAN PRIMATE MODEL; BONE-MARROW-CELLS; TIME RT-PCR; ANTITHYMOCYTE GLOBULIN; IN-VITRO; CORONARY-DISEASE; DENDRITIC CELLS; HEART-FAILURE	Rationale: Acute myocardial infarction (AMI) followed by ventricular remodeling is the major cause of congestive heart failure and death in western world countries. Objective: Of relevance are reports showing that infusion of apoptotic leucocytes or anti-lymphocyte serum after AMI reduces myocardial necrosis and preserves cardiac function. In order to corroborate this therapeutic mechanism, the utilization of an immunosuppressive agent with a comparable mechanism, such as anti-thymocyte globulin (ATG) was evaluated in this study. Methods and Results: AMI was induced in rats by ligation of the left anterior descending artery. Initially after the onset of ischemia, rabbit ATG (10 mg/rat) was injected intravenously. In vitro and in vivo experiments showed that ATG induced a pronounced release of pro-angiogenic and chemotactic factors. Moreover, paracrine factors released from ATG co-incubated cell cultures conferred a down-regulation of p53 in cardiac myocytes. Rats that were injected with ATG evidenced higher numbers of CD68+ macrophages in the ischemic myocardium. Animals injected with ATG evidenced less myocardial necrosis, showed a significant reduction of infarct dimension and an improvement of post-AMI remodeling after six weeks (infarct dimension 24.9% vs. 11.4%, p<0.01). Moreover, a higher vessel density in the peri-infarct region indicated a better collateralization in rats that were injected with ATG. Conclusions: These data indicate that ATG, a therapeutic agent successfully applied in clinical transplant immunology, triggered cardioprotective effects after AMI that salvaged ischemic myocardium by down-regulation of p53. This might have raised the resistance against apoptotic cell death during ischemia. The combination of these mechanisms seems to be causative for improved cardiac function and less ventricular remodeling after experimental AMI.	[Lichtenauer, Michael; Werba, Gregor; Beer, Lucian; Hoetzenecker, Konrad; Nickl, Stefanie; Mitterbauer, Andreas; Zimmermann, Matthias; Ankersmit, Hendrik Jan] Christian Doppler Lab Cardiac & Thorac Diag & Reg, Vienna, Austria; [Lichtenauer, Michael] Univ Hosp Jena, Dept Cardiol, Clin Internal Med 1, Jena, Germany; [Mildner, Michael] Med Univ Vienna, Dept Dermatol, Vienna, Austria; [Werba, Gregor; Beer, Lucian; Hoetzenecker, Konrad; Nickl, Stefanie; Mitterbauer, Andreas; Zimmermann, Matthias; Klepetko, Walter; Ankersmit, Hendrik Jan] Med Univ Vienna, Dept Thorac Surg, Vienna, Austria; [Baumgartner, Andrea; Hasun, Matthias; Podesser, Bruno Karl] Ludwig Boltzmann Cluster Cardiovasc Res, Vienna, Austria; [Gyoengyoesi, Mariann] Med Univ Vienna, Dept Cardiol, Vienna, Austria	Friedrich Schiller University of Jena; Medical University of Vienna; Medical University of Vienna; Ludwig Boltzmann Institute; Medical University of Vienna	Ankersmit, HJ (corresponding author), Christian Doppler Lab Cardiac & Thorac Diag & Reg, Vienna, Austria.	hendrik.ankersmit@meduniwien.ac.at	Zimmermann, Matthias/AAE-9681-2020; Lichtenauer, Michael/H-5139-2019	Lichtenauer, Michael/0000-0001-8403-3931; Werba, Gregor/0000-0003-1464-9065; Mildner, Michael/0000-0002-6892-925X; Hoetzenecker, Konrad/0000-0001-6775-7460; Lichtenauer, Michael/0000-0003-0755-7955; Podesser, Bruno/0000-0002-4641-7202; Zimmermann, Matthias/0000-0002-4610-7853; Nickl, Stefanie/0000-0002-3762-4840; Ankersmit, Hendrik Jan/0000-0002-8761-3517; Beer, Lucian/0000-0003-4388-7580	Christian Doppler Research Association; APOSCIENCE AG; Medical University Vienna	Christian Doppler Research Association; APOSCIENCE AG; Medical University Vienna	The study was funded by the Christian Doppler Research Association, APOSCIENCE AG and the Medical University Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankersmit HJ, 2009, EUR J CLIN INVEST, V39, P445, DOI 10.1111/j.1365-2362.2009.02111.x; Ankersmit HJ, 2002, CLIN EXP IMMUNOL, V128, P175, DOI 10.1046/j.1365-2249.2002.01836.x; Becker LC, 2005, CIRC RES, V96, P812, DOI 10.1161/01.RES.0000165652.82726.d9; Beiras-Fernandez A, 2004, TRANSPL INT, V17, P453, DOI 10.1007/s00147-004-0736-1; Beiras-Fernandez A, 2006, TRANSPL IMMUNOL, V15, P273, DOI 10.1016/j.trim.2006.02.003; Boenisch O, 2012, AM J TRANSPLANT, V12, P856, DOI 10.1111/j.1600-6143.2011.03978.x; Crow MT, 2006, CARDIOVASC RES, V70, P401, DOI 10.1016/j.cardiores.2006.04.003; Dewald O, 2005, CIRC RES, V96, P881, DOI 10.1161/01.RES.0000163017.13772.3a; Di Santo S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005643; Dobaczewski M, 2010, AM J PATHOL, V176, P2177, DOI 10.2353/ajpath.2010.090759; Dubey S, 2002, ANN HEMATOL, V81, P249, DOI 10.1007/s00277-002-0454-7; FOLDES I, 1970, EXPERIENTIA, V26, P741, DOI 10.1007/BF02232519; Genestier L, 1998, BLOOD, V91, P2360, DOI 10.1182/blood.V91.7.2360.2360_2360_2368; Geng YJ, 2003, ANN NY ACAD SCI, V1010, P687, DOI 10.1196/annals.1299.126; Gillet-Hladky S, 2006, TRANSPLANTATION, V82, P965, DOI 10.1097/01.tp.0000235549.47976.d0; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Henry TD, 2003, CIRCULATION, V107, P1359, DOI 10.1161/01.CIR.0000061911.47710.8A; HOLZINGER C, 1994, EUR J VASCULAR SURG, V8, P351, DOI 10.1016/S0950-821X(05)80155-0; Kadl A, 2002, VASC PHARMACOL, V38, P219, DOI 10.1016/S1537-1891(02)00172-6; Korf-Klingebiel M, 2008, EUR HEART J, V29, P2851, DOI 10.1093/eurheartj/ehn456; Lichtenauer M, 2011, BASIC RES C IN PRESS; Lichtenauer M, 2011, BASIC RES CARDIOL, V106, P645, DOI 10.1007/s00395-011-0173-0; Liehn EA, 2010, J AM COLL CARDIOL, V56, P1847, DOI 10.1016/j.jacc.2010.04.066; Liu H, 2011, CARDIOVASC RES, V89, P119, DOI 10.1093/cvr/cvq265; Liu P, 2008, SHOCK, V30, P545, DOI 10.1097/SHK.0b013e31816a192d; Lopez M, 2006, J AM SOC NEPHROL, V17, P2844, DOI 10.1681/ASN.2006050422; Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706; Meyer GP, 2009, EUR HEART J, V30, P2978, DOI 10.1093/eurheartj/ehp374; Mocanu MM, 2003, FEBS LETT, V555, P302, DOI 10.1016/S0014-5793(03)01260-2; Mohty M, 2007, LEUKEMIA, V21, P1387, DOI 10.1038/sj.leu.2404683; Monti P, 2003, INT IMMUNOPHARMACOL, V3, P189, DOI 10.1016/S1567-5769(02)00253-9; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Park HJ, 2008, INT J CARDIOL, V130, P409, DOI 10.1016/j.ijcard.2007.08.128; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Schuh A, 2009, BASIC RES CARDIOL, V104, P403, DOI 10.1007/s00395-008-0763-7; Shimony O, 2012, J CLIN IMMUNOL, V32, P173, DOI 10.1007/s10875-011-9599-2; Simons M, 2002, CIRCULATION, V105, P788, DOI 10.1161/hc0802.104407; Stewart DJ, 2009, MOL THER, V17, P1109, DOI 10.1038/mt.2009.70; Thum T, 2005, J AM COLL CARDIOL, V46, P1799, DOI 10.1016/j.jacc.2005.07.053; Velagaleti RS, 2008, CIRCULATION, V118, P2057, DOI 10.1161/CIRCULATIONAHA.108.784215; Yang ZJ, 2010, ATHEROSCLEROSIS, V211, P103, DOI 10.1016/j.atherosclerosis.2010.02.022; Zhang Y, 2011, J MOL CELL CARDIOL, V50, P471, DOI 10.1016/j.yjmcc.2010.11.006	44	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52101	10.1371/journal.pone.0052101	http://dx.doi.org/10.1371/journal.pone.0052101			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284885	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500090
J	Avila, JL; Troutman, S; Durham, A; Kissil, JL				Avila, Jacqueline L.; Troutman, Scott; Durham, Amy; Kissil, Joseph L.			Notch1 Is Not Required for Acinar-to-Ductal Metaplasia in a Model of Kras-Induced Pancreatic Ductal Adenocarcinoma	PLOS ONE			English	Article							LINEAGE TRACING REVEALS; CELL TRANSDIFFERENTIATION; INTRAEPITHELIAL NEOPLASIA; TUMOR-SUPPRESSOR; INACTIVATION; INDUCTION; PATHWAY; TRANSFORMATION; PROGRESSION; EXPRESSION	Pancreatic ductal adenocarcinoma is believed to arise from precursor lesions termed pancreatic intraepithelial neoplasia (PanIN). Mouse models have demonstrated that targeted expression of activated K-ras to mature acinar cells in the pancreas induces the spontaneous development of PanIN lesions; implying acinar-to-ductal metaplasia (ADM) is a key event in this process. Recent studies suggest Notch signaling is a key regulator of ADM. To assess if Notch1 is required for K-ras driven ADM we employed both an in vivo mouse model and in vitro explant culture system, in which an oncogenic allele of K-ras is activated and Notch1 is deleted simultaneously in acinar cells. Our results demonstrate that oncogenic K-ras is sufficient to drive ADM both in vitro and in vivo but that loss of Notch1 has a minimal effect on this process. Interestingly, while loss of Notch1 in vivo does not affect the severity of PanIN lesions observed, the overall numbers of lesions were greater in mice with deleted Notch1. This suggests Notch1 deletion renders acinar cells more susceptible to formation of K-ras-induced PanINs.	[Avila, Jacqueline L.; Troutman, Scott; Kissil, Joseph L.] Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, Philadelphia, PA 19104 USA; [Durham, Amy] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	The Wistar Institute; University of Pennsylvania	Kissil, JL (corresponding author), Scripps Res Inst, Jupiter, FL USA.	jkissil@scripps.edu			NIH [CA124495]; NATIONAL CANCER INSTITUTE [R01CA124495] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grant NIH CA124495 (J.K.). No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Aichler M, 2012, J PATHOL, V226, P723, DOI 10.1002/path.3017; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Cook N, 2012, J EXP MED, V209, P437, DOI 10.1084/jem.20111923; Demehri S, 2009, CANCER CELL, V16, P55, DOI 10.1016/j.ccr.2009.05.016; Desai BM, 2007, J CLIN INVEST, V117, P971, DOI 10.1172/JCI29988; Friedlander SYG, 2009, CANCER CELL, V16, P379, DOI 10.1016/j.ccr.2009.09.027; Gu GQ, 2003, MECH DEVELOP, V120, P35, DOI 10.1016/S0925-4773(02)00330-1; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Habbe N, 2008, P NATL ACAD SCI USA, V105, P18913, DOI 10.1073/pnas.0810097105; Hanlon L, 2010, CANCER RES, V70, P4280, DOI 10.1158/0008-5472.CAN-09-4645; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jean-Paul D, 2008, P NATL ACAD SCI USA, V105, P18907, DOI 10.1073/pnas.0810111105; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; Kopinke D, 2011, DEVELOPMENT, V138, P431, DOI 10.1242/dev.053843; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Mazur PK, 2010, P NATL ACAD SCI USA, V107, P13438, DOI 10.1073/pnas.1002423107; Mazzone M, 2010, P NATL ACAD SCI USA, V107, P5012, DOI 10.1073/pnas.1000896107; Means AL, 2005, DEVELOPMENT, V132, P3767, DOI 10.1242/dev.01925; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Morris JP, 2010, J CLIN INVEST, V120, P508, DOI 10.1172/JCI40045; Nakhai H, 2008, DEVELOPMENT, V135, P2757, DOI 10.1242/dev.013722; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Plentz R, 2009, GASTROENTEROLOGY, V136, P1741, DOI 10.1053/j.gastro.2009.01.008; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Rooman I, 2006, AM J PATHOL, V169, P1206, DOI 10.2353/ajpath.2006.050926; Sawey ET, 2007, P NATL ACAD SCI USA, V104, P19327, DOI 10.1073/pnas.0705953104; Scotti ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030509; Sivere JT, 2008, GASTROENTEROLOGY, V134, P544, DOI 10.1053/j.gastro.2007.11.003; Stanger BZ, 2005, CANCER CELL, V8, P185, DOI 10.1016/j.ccr.2005.07.015; Viatour P, 2011, J EXP MED, V208, P1963, DOI 10.1084/jem.20110198; Wang NJ, 2011, P NATL ACAD SCI USA, V108, P17761, DOI 10.1073/pnas.1114669108; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Zhao YT, 2007, J BIOL CHEM, V282, P11969, DOI 10.1074/jbc.M608974200; Zhu LQ, 2007, AM J PATHOL, V171, P263, DOI 10.2353/ajpath.2007.061176	39	14	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52133	10.1371/journal.pone.0052133	http://dx.doi.org/10.1371/journal.pone.0052133			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284900	gold, Green Submitted, Green Published			2022-12-27	WOS:000312694300074
J	Man, SL; Petersen, I; Thompson, M; Nazareth, I				Man, Shuk-Li; Petersen, Irene; Thompson, Mary; Nazareth, Irwin			Antiepileptic Drugs during Pregnancy in Primary Care: A UK Population Based Study	PLOS ONE			English	Article							BIPOLAR DISORDER; EPILEPSY; WOMEN; RISK	Objective: Antiepileptic drugs (AEDs) are commonly prescribed for epilepsy and bipolar disorder but little is known about their use in pregnancy. We examined secular trends in AED prescribing in pregnancy and pregnancy as a determinant for stopping AED prescribing. Methods: We identified 174,055 pregnancies from The Health Improvement Network UK primary care database. Secular trends in AED prescribing during pregnancy were examined between 1994 and 2009. We used Cox's regression analyses to compare time to discontinuation of AED prescriptions between pregnant and non-pregnant women and to identify predictors of discontinuation of AEDs in pregnancy. Results: Prescribing of carbamazepine and sodium valproate have declined since 1994 despite being the most commonly prescribed AEDs in pregnancy up to 2004. Prescribing of lamotrigine in pregnancy has steadily increased and has been the most popular AED prescribed in pregnancy since 2004. Pregnant women with epilepsy were twice as likely to stop receiving AEDs (Hazard Ratio (HR) 2.00, 95% Confidence Interval (CI) 1.62-2.47) when compared to non-pregnant women and for women with bipolar disorder this was even higher (HR 3.07, 95% CI 2.04-4.62). For pregnant women with epilepsy, those receiving AEDs less regularly before pregnancy were more likely to stop receiving AEDs in pregnancy. Conclusions: Lamotrigine has been increasingly prescribed in pregnancy over older AEDs namely carbamazepine and sodium valproate. Pregnancy is a strong determinant for the discontinuation of AED prescribing particularly for women with bipolar disorder. Citation: Man S-L, Petersen I, Thompson M, Nazareth I (2012) Antiepileptic Drugs during Pregnancy in Primary Care: A UK Population Based Study. PLoS ONE 7(12): e52339. doi:10.1371/journal.pone.0052339	[Man, Shuk-Li; Petersen, Irene; Nazareth, Irwin] UCL, Res Dept Primary Care & Populat Hlth, London, England; [Thompson, Mary] Cegedim Strateg Data Med Res UK, London, England	University of London; University College London	Man, SL (corresponding author), UCL, Res Dept Primary Care & Populat Hlth, London, England.	shuk-li.man.10@ucl.ac.uk	Petersen, Irene/C-5702-2009	Petersen, Irene/0000-0002-0037-7524; Nazareth, Irwin/0000-0003-2146-9628	Medical Research Council UK; Cegedim Strategic Data; Cegedim Strategic Data Medical Research UK; MRC [G0601726] Funding Source: UKRI; Medical Research Council [1029459, G0601726] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cegedim Strategic Data; Cegedim Strategic Data Medical Research UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is funded by the Medical Research Council UK and Cegedim Strategic Data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Shuk-Li Man's PhD is largely funded by the Medical Research Council, UK, but the authors also receive commercial funding for this research from Cegedim Strategic Data Medical Research UK, and Dr. Mary Thompson is also employed by Cegedim Strategic Data Medical Research UK. The authors declare that this does not alter their adherence to all the PLOS ONE policies on sharing data and materials.	Adab N, 2004, J NEUROL NEUROSUR PS, V75, P1575, DOI 10.1136/jnnp.2003.029132; Battino D, 2009, EPILEPSIA, V50, P2305, DOI 10.1111/j.1528-1167.2009.02093.x; Bengt K, 2005, REPROD TOXICOL, V8, P203, DOI [10.1016/0890-6238(94)90003-5, DOI 10.1016/0890-6238(94)90003-5]; Bourke Alison, 2004, Inform Prim Care, V12, P171; British Medical Association and Royal Pharmaceutical Society, 2011, BRIT NAT FORM 62; CLAYTONSMITH J, 1995, J MED GENET, V32, P724, DOI 10.1136/jmg.32.9.724; Crawford P, 2003, SEIZURE-EUR J EPILEP, V12, P502, DOI 10.1016/S1059-1311(03)00085-2; Einarson A, 2001, J PSYCHIATR NEUROSCI, V26, P44; Hayes J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028725; Holmes LB, 2008, NEUROLOGY, V70, P2152, DOI 10.1212/01.wnl.0000304343.45104.d6; Holmes LB, 2001, NEW ENGL J MED, V344, P1132, DOI 10.1056/NEJM200104123441504; Jentink J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6581; Jones I, 2005, BRIT J PSYCHIAT, V186, P453, DOI 10.1192/bjp.186.6.453; Jones I, 2001, AM J PSYCHIAT, V158, P913, DOI 10.1176/appi.ajp.158.6.913; Maguire A, 2009, PHARMACOEPIDEM DR S, V18, P76, DOI 10.1002/pds.1688; Mawer G, 2010, SEIZURE-EUR J EPILEP, V19, P112, DOI 10.1016/j.seizure.2009.11.008; Meador Kimford J, 2009, Epilepsy Behav, V15, P339, DOI 10.1016/j.yebeh.2009.04.026; Morrow J, 2006, J NEUROL NEUROSUR PS, V77, P193, DOI 10.1136/jnnp.2005.074203; National Institute for Clinical Excellence (Great Britain), 2012, EP DIAGN MAN EP AD C; National Institute for Health and Clinical Excellence, 2006, BIP DIS MAN BIP DIS; Nordeng H, 2010, EUR J CLIN PHARMACOL, V66, P207, DOI 10.1007/s00228-009-0744-2; Petersen I, 2011, J CLIN PSYCHIAT, V72, P979, DOI 10.4088/JCP.10m06090blu; The NHS Information Centre PaPCS, 2011, PRESCR COMPL REV PRO; Townsend P., 1986, INEQUALITIES HLTH NO; Vajda FJE, 2010, ACTA NEUROL SCAND, V121, P89, DOI 10.1111/j.1600-0404.2009.01260.x; Vajda FJE, 2006, EUR J NEUROL, V13, P645, DOI 10.1111/j.1468-1331.2006.01359.x; Viguera AC, 2007, AM J PSYCHIAT, V164, P1817, DOI 10.1176/appi.ajp.2007.06101639; WATERS CH, 1994, ARCH NEUROL-CHICAGO, V51, P250, DOI 10.1001/archneur.1994.00540150044014	29	43	43	5	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52339	10.1371/journal.pone.0052339	http://dx.doi.org/10.1371/journal.pone.0052339			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272239	Green Published, gold, Green Submitted			2022-12-27	WOS:000312483300081
J	Haanes, KA; Schwab, A; Novak, I				Haanes, Kristian A.; Schwab, Albrecht; Novak, Ivana			The P2X7 Receptor Supports Both Life and Death in Fibrogenic Pancreatic Stellate Cells	PLOS ONE			English	Article							FUNCTIONAL EVIDENCE; ATP; ACTIVATION; RELEASE; PROLIFERATION; CULTURE; MODEL	The pancreatic stellate cells (PSCs) have complex roles in pancreas, including tissue repair and fibrosis. PSCs surround ATP releasing exocrine cells, but little is known about purinergic receptors and their function in PSCs. Our aim was to resolve whether PSCs express the multifunctional P2X7 receptor and elucidate how it regulates PSC viability. The number of PSCs isolated from wild type (WT) mice was 50% higher than those from the Pfizer P2X7 receptor knock out (KO) mice. The P2X7 receptor protein and mRNA of all known isoforms were expressed in WT PSCs, while KO PSCs only expressed truncated versions of the receptor. In culture, the proliferation rate of the KO PSCs was significantly lower. Inclusion of apyrase reduced the proliferation rate in both WT and KO PSCs, indicating importance of endogenous ATP. Exogenous ATP had a two-sided effect. Proliferation of both WT and KO cells was stimulated with ATP in a concentration-dependent manner with a maximum effect at 100 mu ZM. At high ATP concentration (5 mM), WT PSCs, but not the KO PSCs died. The intracellular Ca2+ signals and proliferation rate induced by micromolar ATP concentrations were inhibited by the allosteric P2X7 receptor inhibitor az10606120. The P2X7 receptor-pore inhibitor A438079 partially prevented cell death induced by millimolar ATP concentrations. This study shows that ATP and P2X7 receptors are important regulators of PSC proliferation and death, and therefore might be potential targets for treatments of pancreatic fibrosis and cancer.	[Haanes, Kristian A.; Novak, Ivana] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Schwab, Albrecht] Univ Munster, Inst Physiol 2, Munster, Germany	University of Copenhagen; University of Munster	Novak, I (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	inovak@bio.ku.dk	Haanes, Kristian Agmund/I-5881-2013; Novak, Ivana/M-2791-2014	Haanes, Kristian Agmund/0000-0001-5182-8957; Novak, Ivana/0000-0002-8917-8010	Danish Council for Independent Research \ Natural Sciences; Lundbeck Foundation; Novo Nordisk Foundation; Carlsberg Foundation; FP7 Marie Curie Initial Training Network "IonTraC"; Lundbeck Foundation [R17-2007-1366] Funding Source: researchfish	Danish Council for Independent Research \ Natural Sciences(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Carlsberg Foundation(Carlsberg Foundation); FP7 Marie Curie Initial Training Network "IonTraC"; Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Danish Council for Independent Research vertical bar Natural Sciences, the Lundbeck Foundation, the Novo Nordisk Foundation, the Carlsberg Foundation and FP7 Marie Curie Initial Training Network "IonTraC". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinolfi Elena, 2005, Purinergic Signal, V1, P219, DOI 10.1007/s11302-005-6322-x; Adinolfi E, 2010, FASEB J, V24, P3393, DOI 10.1096/fj.09-153601; Amstrup J, 2003, BIOCHEM J, V374, P51, DOI 10.1042/BJ20030585; Apte MV, 1999, GUT, V44, P534, DOI 10.1136/gut.44.4.534; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Baricordi OR, 1999, J BIOL CHEM, V274, P33206, DOI 10.1074/jbc.274.47.33206; Bianchi BR, 1999, EUR J PHARMACOL, V376, P127, DOI 10.1016/S0014-2999(99)00350-7; Burnstock G, 2012, J ENDOCRINOL, V213, P123, DOI 10.1530/JOE-11-0434; Corriden R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3104re1; Cosen-Binker LI, 2008, J CLIN INVEST, V118, P2535, DOI 10.1172/JCI34672; Costa HM, 2011, PURINERG SIGNAL, V7, P7, DOI 10.1007/s11302-011-9215-1; Dalskov SM, 2005, NEUROCHEM INT, V46, P489, DOI 10.1016/j.neuint.2004.11.010; Erkan M, 2012, GUT, V61, P172, DOI 10.1136/gutjnl-2011-301220; Ferrari D, 1997, J IMMUNOL, V159, P1451; Fuller SJ, 2009, PURINERG SIGNAL, V5, P257, DOI 10.1007/s11302-009-9136-4; Glas R, 2009, DIABETOLOGIA, V52, P1579, DOI 10.1007/s00125-009-1349-0; Haanes KA, 2010, BIOCHEM J, V429, P303, DOI 10.1042/BJ20091337; Haber PS, 1999, AM J PATHOL, V155, P1087, DOI 10.1016/S0002-9440(10)65211-X; Hennigs JK, 2011, PANCREAS, V40, P740, DOI 10.1097/MPA.0b013e31821b5b68; Hoque R, 2011, GASTROENTEROLOGY, V141, P358, DOI 10.1053/j.gastro.2011.03.041; Jaster R, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-26; Jun DJ, 2007, J BIOL CHEM, V282, P37350, DOI 10.1074/jbc.M707915200; Kim M, 2001, EMBO J, V20, P6347, DOI 10.1093/emboj/20.22.6347; Klapperstuck M, 2001, J PHYSIOL-LONDON, V534, P25, DOI 10.1111/j.1469-7793.2001.00025.x; Kunzli BM, 2008, GASTROENTEROLOGY, V134, P292, DOI 10.1053/j.gastro.2007.10.030; Kunzli BM, 2007, AM J PHYSIOL-GASTR L, V292, pG223, DOI 10.1152/ajpgi.00259.2006; Lenertz LY, 2011, IMMUNOL RES, V50, P22, DOI 10.1007/s12026-011-8203-4; Masin M, 2011, BRIT J PHARMACOL, V165, P978; Michel AD, 2007, BRIT J PHARMACOL, V151, P84, DOI 10.1038/sj.bjp.0707196; Monif M, 2009, J NEUROSCI, V29, P3781, DOI 10.1523/JNEUROSCI.5512-08.2009; Nicke A, 2009, J BIOL CHEM, V284, P25813, DOI 10.1074/jbc.M109.033134; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Novak I, 2008, PURINERG SIGNAL, V4, P237, DOI 10.1007/s11302-007-9087-6; Obermuller S, 2005, J CELL SCI, V118, P4271, DOI 10.1242/jcs.02549; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; RUOSLAHTI E, 1984, CANCER METAST REV, V3, P43, DOI 10.1007/BF00047692; Schulze-Lohoff E, 1998, AM J PHYSIOL-RENAL, V275, pF962, DOI 10.1152/ajprenal.1998.275.6.F962; Senoo H, 2010, CELL BIOL INT, V34, P1247, DOI 10.1042/CBI20100321; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Virginio C, 1999, J PHYSIOL-LONDON, V519, P335, DOI 10.1111/j.1469-7793.1999.0335m.x; Won JH, 2011, MOL BIOL CELL, V22, P421, DOI 10.1091/mbc.E10-10-0807; Xu C, 2009, AM J PHYSIOL-RENAL, V296, pF1464, DOI 10.1152/ajprenal.90542.2008; Zimmermann A, 2002, GUT, V51, P574, DOI 10.1136/gut.51.4.574	44	50	50	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51164	10.1371/journal.pone.0051164	http://dx.doi.org/10.1371/journal.pone.0051164			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284663	Green Published, gold, Green Submitted			2022-12-27	WOS:000312435900014
J	Liang, J; Li, YP; Zhou, N; Teng, F; Zhao, J; Zou, CY; Qi, L				Liang, Jun; Li, Yanping; Zhou, Na; Teng, Fei; Zhao, Jing; Zou, Caiyan; Qi, Lu			Synergistic Effects of Serum Uric Acid and Cardiometabolic Risk Factors on Early Stage Atherosclerosis: The Cardiometabolic Risk in Chinese Study	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; LOW-GRADE INFLAMMATION; HEART-RATE; ARTERIAL STIFFNESS; CARDIOVASCULAR-DISEASE; ALL-CAUSE; MORTALITY; EVENTS; MARKER; MEN	Objective: To comprehensively examine the associations of serum uric acid (SUA) with central and peripheral arterial stiffness in Chinese adults, and particularly assess the interactions between SUA and other cardiometabolic risk factors. Methods: The study included 3,772 Chinese men and women with carotid radial pulse wave velocity (crPWV), carotid femoral PWV (cfPWV), carotid artery dorsalis pedis PWV (cdPWV) and SUA measured. Results: After adjustment for age, sex, and BMI, the levels of SUA were significantly associated with increasing trend of cfPWV, crPWV and cdPWV (P for trend <0.0001). Further adjustment for heart rate (HR), blood pressure (BP) and lipids attenuated the associations with crPWV and cdPWV to be non-significant (P = 0.1, P = 0.099 respectively), but the association between SUV and cfPWV remained significant (P = 0.004). We found significant interactions between SUA and HR or BP in relation to cfPWV (P for interaction = 0.03, 0.003 respectively). The associations between SUA and cfPWV were more evident among individuals with higher HR or normal BP than those with lower HR or hypertension. Conclusions: SUA was associated with elevated aortic arterial stiffness in Chinese adults, independent of conventional cardiovascular risk factors. BP and HR might modify the deleterious effects of SUA.	[Liang, Jun; Teng, Fei; Zhao, Jing; Zou, Caiyan] Southeast Univ, Affiliated Hosp, Xuzhou Med Coll, Xuzhou Clin Sch,Cent Hosp Xuzhou,Dept Endocrinol, Xuzhou, Jiangsu, Peoples R China; [Liang, Jun; Qi, Lu] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Li, Yanping; Qi, Lu] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Li, Yanping; Qi, Lu] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; [Zhou, Na] Oriental Peoples Hosp Xuzhou, Xuzhou, Jiangsu, Peoples R China	Southeast University - China; Xuzhou Medical University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Liang, J (corresponding author), Southeast Univ, Affiliated Hosp, Xuzhou Med Coll, Xuzhou Clin Sch,Cent Hosp Xuzhou,Dept Endocrinol, Xuzhou, Jiangsu, Peoples R China.	mwlj521@163.com; nhlqi@channing.harvard.edu	Li, Yanping/H-6437-2011	Li, Yanping/0000-0002-0412-2748	National Heart, Lung, and Blood Institute [HL071981]; Boston Obesity Nutrition Research Center [DK46200]; American Heart Association Scientist Development Award [0730094N]; Xuzhou medical leading talent grant; Xuzhou Science and Technology Board Foundation [XF11C067]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071981] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Boston Obesity Nutrition Research Center; American Heart Association Scientist Development Award(American Heart Association); Xuzhou medical leading talent grant; Xuzhou Science and Technology Board Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Lu Qi was supported by grants from the National Heart, Lung, and Blood Institute (HL071981), the Boston Obesity Nutrition Research Center (DK46200), and the American Heart Association Scientist Development Award (0730094N). Dr. Jun Liang was supported by Xuzhou medical leading talent grant & Xuzhou Science and Technology Board Foundation grant (XF11C067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benetos A, 2002, CIRCULATION, V105, P1202, DOI 10.1161/hc1002.105135; Chen JH, 2009, ARTHRIT RHEUM-ARTHR, V61, P225, DOI 10.1002/art.24164; Forman JP, 2009, ARCH INTERN MED, V169, P155, DOI 10.1001/archinternmed.2008.521; Fox K, 2007, J AM COLL CARDIOL, V50, P823, DOI 10.1016/j.jacc.2007.04.079; Gagliardi ACM, 2009, ATHEROSCLEROSIS, V202, P11, DOI 10.1016/j.atherosclerosis.2008.05.022; Group K.W., 2002, AM J KIDNEY DIS, V39, pS46, DOI DOI 10.1053/AJKD.2002.30943; Hakoda M, 2005, J RHEUMATOL, V32, P906; Ishizaka N, 2007, ATHEROSCLEROSIS, V192, P131, DOI 10.1016/j.atherosclerosis.2006.04.016; Krantz MJ, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-15; Lanza GA, 2006, ADV CARDIOL, V43, P1, DOI 10.1159/000095401; Liang J, 2009, J HYPERTENS, V27, P1761, DOI 10.1097/HJH.0b013e32832e0b44; Lin Y, 2011, J ENDOCRINOL INVEST; Mankovsky B, 2010, DIABETES METAB SYND, V4, P176, DOI 10.1016/j.dsx.2010.07.010; Meisinger C, 2008, ARTERIOSCL THROM VAS, V28, P1186, DOI 10.1161/ATVBAHA.107.160184; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Neogi T, 2009, J RHEUMATOL, V36, P378, DOI 10.3899/jrheum.080646; O'Rourke MF, 2001, BRIT J CLIN PHARMACO, V51, P507, DOI 10.1046/j.0306-5251.2001.01400.x; Palatini P, 2007, DRUGS, V67, P3, DOI 10.2165/00003495-200767002-00002; Palatini P, 2006, J HYPERTENS, V24, P1873, DOI 10.1097/01.hjh.0000242413.96277.5b; Shen L, 2011, CEREBROVASC DIS, V32, P16, DOI 10.1159/000330316; Sugawara J, 2005, J HUM HYPERTENS, V19, P401, DOI 10.1038/sj.jhh.1001838; Sulikowska B, 2012, KIDNEY BLOOD PRESS R, V35, P161, DOI 10.1159/000330717; Sutton-Tyrrell K, 2005, CIRCULATION, V111, P3384, DOI 10.1161/CIRCULATIONAHA.104.483628; Teng Fei, 2010, J HUMAN HYPERTENSION, V12, P31; Tomiyama H, 2007, HYPERTENS RES, V30, P417, DOI 10.1291/hypres.30.417; Tomiyama H, 2010, J HYPERTENS, V28, P687, DOI 10.1097/HJH.0b013e3283369fe8; Tsioufis C, 2011, J HUM HYPERTENS, V25, P554, DOI 10.1038/jhh.2010.98; Tsioufis C, 2007, EUR HEART J, V28, P1162, DOI 10.1093/eurheartj/ehm089	28	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51101	10.1371/journal.pone.0051101	http://dx.doi.org/10.1371/journal.pone.0051101			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284659	Green Published, gold, Green Submitted			2022-12-27	WOS:000312435900011
J	Reyes-Bermudez, A; Miller, DJ; Sprungala, S				Reyes-Bermudez, Alejandro; Miller, David J.; Sprungala, Susanne			The Neuronal Calcium Sensor Protein Acrocalcin: A Potential Target of Calmodulin Regulation during Development in the Coral Acropora millepora	PLOS ONE			English	Article							REEF CORALS; POCILLOPORA-DAMICORNIS; BINDING PROTEINS; PLANULA LARVA; PHOSPHORYLATION; LOCALIZATION; RECOGNITION; EXPRESSION; MECHANISM; RESPONSES	To understand the calcium-mediated signalling pathways underlying settlement and metamorphosis in the Scleractinian coral Acropora millepora, a predicted protein set derived from larval cDNAs was scanned for the presence of EF-hand domains (Pfam Id: PF00036). This approach led to the identification of a canonical calmodulin (AmCaM) protein and an uncharacterised member of the Neuronal Calcium Sensor (NCS) family of proteins known here as Acrocalcin (AmAC). While AmCaM transcripts were present throughout development, AmAC transcripts were not detected prior to gastrulation, after which relatively constant mRNA levels were detected until metamorphosis and settlement. The AmAC protein contains an internal CaM-binding site and was shown to interact in vitro with AmCaM. These results are consistent with the idea that AmAC is a target of AmCaM in vivo, suggesting that this interaction may regulate calcium-dependent processes during the development of Acropora millepora.	[Reyes-Bermudez, Alejandro; Miller, David J.; Sprungala, Susanne] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Reyes-Bermudez, Alejandro; Miller, David J.; Sprungala, Susanne] James Cook Univ, Sch Pharm & Mol Sci, Townsville, Qld 4811, Australia; [Reyes-Bermudez, Alejandro] Okinawa Inst Sci & Technol, Okinawa, Japan	James Cook University; James Cook University; Okinawa Institute of Science & Technology Graduate University	Sprungala, S (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	susanne.sprungala@jcu.edu.au		Reyes-Bermudez, Alejandro/0000-0002-4588-3770; Miller, David/0000-0003-0291-9531	School of Pharmacy and Molecular Sciences, James Cook University; ARC Centre of Excellence for Coral Reef Studies	School of Pharmacy and Molecular Sciences, James Cook University; ARC Centre of Excellence for Coral Reef Studies(Australian Research Council)	The work was supported by the School of Pharmacy and Molecular Sciences, James Cook University and the ARC Centre of Excellence for Coral Reef Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames JB, 2012, BBA-GEN SUBJECTS, V1820, P1205, DOI 10.1016/j.bbagen.2011.10.003; Amici M, 2009, BIOCHEM SOC T, V37, P1359, DOI 10.1042/BST0371359; Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Ball EE, 2002, INT J DEV BIOL, V46, P671; Ball EE, 2000, P 9 INT COR REEFS S, P395; Benaim G, 2002, EUR J BIOCHEM, V269, P3619, DOI 10.1046/j.1432-1033.2002.03038.x; Bhattacharya S, 2004, BBA-MOL CELL RES, V1742, P69, DOI 10.1016/j.bbamcr.2004.09.002; BURGESS WH, 1980, BIOCHIM BIOPHYS ACTA, V623, P257, DOI 10.1016/0005-2795(80)90254-8; Burgoyne RD, 2004, TRENDS NEUROSCI, V27, P203, DOI 10.1016/j.tins.2004.01.010; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Carafoli E, 1999, BIOCHEM BIOPH RES CO, V266, P624, DOI 10.1006/bbrc.1999.1879; Carafoli E, 2005, FEBS J, V272, P1073, DOI 10.1111/j.1742-4658.2005.04546.x; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; Chen IP, 2009, MAR BIOTECHNOL, V11, P141, DOI 10.1007/s10126-008-9129-2; Clode PL, 2004, TISSUE CELL, V36, P379, DOI 10.1016/j.tice.2004.06.005; Cyert MS, 2001, ANNU REV GENET, V35, P647, DOI 10.1146/annurev.genet.35.102401.091302; de Jong DM, 2006, DEV BIOL, V298, P632, DOI 10.1016/j.ydbio.2006.07.034; DECASTRO E, 1995, BIOCHEM BIOPH RES CO, V216, P133, DOI 10.1006/bbrc.1995.2601; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Grasso LC, 2011, DEV BIOL, V353, P411, DOI 10.1016/j.ydbio.2011.02.010; Grasso LC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-540; Gunderson L, 2007, CURR BIOL, V17, pR27, DOI 10.1016/j.cub.2006.11.034; Haeseleer F, 2002, BIOCHEM BIOPH RES CO, V290, P615, DOI 10.1006/bbrc.2001.6228; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; Haynes LP, 2006, PROTEOMICS, V6, P1822, DOI 10.1002/pmic.200500489; Hayward DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026411; Hayward DC, 2001, DEV GENES EVOL, V211, P10; Hilfiker S, 2003, BIOCHEM SOC T, V31, P828, DOI 10.1042/BST0310828; Ishida H, 2002, BIOCHEMISTRY-US, V41, P15536, DOI 10.1021/bi020330r; Ivings L, 2002, BIOCHEM J, V363, P599, DOI 10.1042/0264-6021:3630599; Jamieson G A Jr, 1980, Ann N Y Acad Sci, V356, P1, DOI 10.1111/j.1749-6632.1980.tb29593.x; Lab I, 2002, CALM TARG DAT; McCue HV, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004085; Morita M, 2009, MAR BIOTECHNOL, V11, P118, DOI 10.1007/s10126-008-9127-4; Morse ANC, 1996, BIOL BULL, V191, P149, DOI 10.2307/1542917; Moya A, 2012, MOL ECOL, V21, P2440, DOI 10.1111/j.1365-294X.2012.05554.x; O'Donnell SE, 2011, PROTEINS, V79, P765, DOI 10.1002/prot.22917; O'Donnell SE, 2009, METHOD ENZYMOL, V466, P503, DOI 10.1016/S0076-6879(09)66021-3; PONGS O, 1993, NEURON, V11, P15, DOI 10.1016/0896-6273(93)90267-U; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Reyes-Bermudez A, 2009, MAR GENOM, V2, P149, DOI 10.1016/j.margen.2009.07.002; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; VANDERMEULEN JH, 1973, MAR BIOL, V23, P47, DOI 10.1007/BF00394111; VANDERMEULEN JH, 1974, MAR BIOL, V27, P239, DOI 10.1007/BF00391949; VANDERMEULEN JH, 1975, MAR BIOL, V31, P69, DOI 10.1007/BF00390649; Veron J.E.N., 2000, CORALS WORLD, V1-3; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; WALLACE RW, 1982, J BIOL CHEM, V257, P1845; Weiss JL, 2010, CELL MOL NEUROBIOL, V30, P1283, DOI 10.1007/s10571-010-9588-7; Yuasa HJ, 2001, GENE, V279, P205, DOI 10.1016/S0378-1119(01)00755-7; Zoccola D, 2004, BBA-BIOMEMBRANES, V1663, P117, DOI 10.1016/j.bbamem.2004.02.010	55	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51689	10.1371/journal.pone.0051689	http://dx.doi.org/10.1371/journal.pone.0051689			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284743	Green Published, Green Accepted, gold			2022-12-27	WOS:000312435900044
J	Taiwo, EO; Yorio, JT; Yan, JS; Gerber, DE				Taiwo, Evelyn O.; Yorio, Jeffrey T.; Yan, Jingsheng; Gerber, David E.			How Have We Diagnosed Early-Stage Lung Cancer without Radiographic Screening? A Contemporary Single-Center Experience	PLOS ONE			English	Article							ACTION PROJECT; NEW-HAMPSHIRE; CELL TYPE; RADIATION; HISTORY	Background: The National Lung Screening Trial (NLST), which demonstrated a reduction in lung cancer mortality, may result in widespread computed tomography (CT)-based screening of select populations. How early-stage lung cancer has been diagnosed without screening, and what proportion of these cases would be captured by a screening program modeled on the NLST, is not currently known. We therefore evaluated current patterns of early-stage lung cancer presentation. Methodology/Principal Findings: We performed a single-institution retrospective analysis of patients diagnosed with stage I-II non-small cell lung cancer (NSCLC) from 2000-2009. Associations between patient and imaging characteristics were assessed using univariate and multivariate analyses. A total of 412 patients met criteria for analysis. Among those with available reason for initial imaging, the reason was symptoms in 51%, follow-up of other conditions in 43%, and screening in 6%. Reason for imaging was associated with race (P < 0.001), insurance type (P = 0.005), and disease stage (P < 0.001). Type of initial imaging was associated with reason for imaging (P < 0.001), year (chest x-ray 67% in 2000-2004 vs. 49% in 2005-2009; P < 0.001), and disease stage (P = 0.005). Among patients with available quantified smoking history, 48% were age 55-74 years and smoked 30-plus pack-years, therefore meeting NLST entry criteria. Conclusions/Significance: Symptoms remain a dominant but declining reason for detection of early-stage NSCLC. The proportion of cases detected initially by CT scan without antecedent chest x-ray has increased considerably. Because as few as half of cases meet NLST eligibility criteria, clinicians should remain aware of the diverse circumstances of early-stage lung cancer presentation to expedite therapy.	[Taiwo, Evelyn O.; Yorio, Jeffrey T.; Gerber, David E.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Taiwo, Evelyn O.; Gerber, David E.] Univ Texas SW Med Ctr Dallas, Div Hematol Oncol, Dallas, TX 75390 USA; [Yan, Jingsheng] Univ Texas SW Med Ctr Dallas, Div Biostat, Dept Clin Sci, Dallas, TX 75390 USA; [Yan, Jingsheng; Gerber, David E.] Univ Texas SW Med Ctr Dallas, Harold C Simmons Canc Ctr, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Gerber, DE (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	david.gerber@utsouthwestern.edu		Gerber, David/0000-0002-7812-6741	National Institutes of Health CTSA [KL2RR024983]; National Cancer Institute Clinical Investigator Team Leadership Award [1P30 CA142543-01]; NATIONAL CANCER INSTITUTE [P30CA142543] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024983] Funding Source: NIH RePORTER	National Institutes of Health CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Cancer Institute Clinical Investigator Team Leadership Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding provided by the National Institutes of Health CTSA Grant KL2RR024983 (North and Central Texas Clinical and Translational Science Initiative) (to DEG) and National Cancer Institute Clinical Investigator Team Leadership Award (1P30 CA142543-01 supplement) (to DEG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; [Anonymous], [No title captured]; [Anonymous], SEER FAST STATS; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Cardis E, 2005, BMJ-BRIT MED J, V331, P77, DOI 10.1136/bmj.38499.599861.E0; CHUTE CG, 1985, CANCER, V56, P2107, DOI 10.1002/1097-0142(19851015)56:8<2107::AID-CNCR2820560837>3.0.CO;2-T; Cuffe S, 2011, J THORAC ONCOL, V6, P818, DOI 10.1097/JTO.0b013e31820c2f2e; FEINSTEIN AR, 1964, ANN INTERN MED, V61, P27, DOI 10.7326/0003-4819-61-1-27; FONTANA RS, 1984, AM REV RESPIR DIS, V130, P561; Fontham ETH, 2012, AM CANC SOC INT GUID; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; GREENBERG ER, 1984, J NATL CANCER I, V72, P599; Henschke CI, 2001, ONCOLOGIST, V6, P147, DOI 10.1634/theoncologist.6-2-147; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; Henschke CI, 2006, NEW ENGL J MED, V355, P1763, DOI 10.1056/NEJMoa060476; Heuvers ME, 2012, NEW ENGL J MED, V366, P192, DOI 10.1056/NEJMc1111935; Hofman A, 2011, EUR J EPIDEMIOL, V26, P657, DOI 10.1007/s10654-011-9610-5; Huerta M, 2005, PREV MED, V41, P646, DOI 10.1016/j.ypmed.2005.01.011; HUHTI E, 1980, THORAX, V35, P660, DOI 10.1136/thx.35.9.660; HYDE L, 1974, CHEST, V65, P299, DOI 10.1378/chest.65.3.299; Kenkel D, 2003, ADDICTION, V98, P1307, DOI 10.1046/j.1360-0443.2003.00445.x; Klabunde CN, 2010, AM J PREV MED, V39, P411, DOI 10.1016/j.amepre.2010.07.004; Larson DB, 2011, RADIOLOGY, V258, P164, DOI 10.1148/radiol.10100640; Lewis Carmen L, 2006, BMC Geriatr, V6, P10, DOI 10.1186/1471-2318-6-10; Lewis CL, 2009, J GEN INTERN MED, V24, P816, DOI 10.1007/s11606-009-1006-9; Morgensztern D, 2010, J THORAC ONCOL, V5, P29, DOI 10.1097/JTO.0b013e3181c5920c; NCCN Guidelines &REG, 2012, NONSM CELL LUNG CANC; Port JL, 2011, ANN THORAC SURG, V92, P1951, DOI 10.1016/j.athoracsur.2011.06.082; TALA E, 1967, ACTA RADIOL DIAGN S, V268, P261	29	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52313	10.1371/journal.pone.0052313	http://dx.doi.org/10.1371/journal.pone.0052313			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284984	Green Published, Green Submitted, gold			2022-12-27	WOS:000313158800046
J	Anderson, OD; Dong, LL; Huo, NX; Gu, YQ				Anderson, Olin D.; Dong, Lingli; Huo, Naxin; Gu, Yong Q.			A New Class of Wheat Gliadin Genes and Proteins	PLOS ONE			English	Article							DISULFIDE BONDS; GAMMA-3 HORDEIN; FAMILY; SEQUENCE; LOCATION; GLUTEN; BARLEY; BREAD	The utility of mining DNA sequence data to understand the structure and expression of cereal prolamin genes is demonstrated by the identification of a new class of wheat prolamins. This previously unrecognized wheat prolamin class, given the name delta-gliadins, is the most direct ortholog of barley gamma 3-hordeins. Phylogenetic analysis shows that the orthologous delta-gliadins and gamma 3-hordeins form a distinct prolamin branch that existed separate from the gamma-gliadins and gamma-hordeins in an ancestral Triticeae prior to the branching of wheat and barley. The expressed delta-gliadins are encoded by a single gene in each of the hexaploid wheat genomes. This single delta-gliadin/gamma 3-hordein ortholog may be a general feature of the Triticeae tribe since examination of ESTs from three barley cultivars also confirms a single gamma 3-hordein gene. Analysis of ESTs and cDNAs shows that the genes are expressed in at least five hexaploid wheat cultivars in addition to diploids Triticum monococcum and Aegilops tauschii. The latter two sequences also allow assignment of the delta-gliadin genes to the A and D genomes, respectively, with the third sequence type assumed to be from the B genome. Two wheat cultivars for which there are sufficient ESTs show different patterns of expression, i.e., with cv Chinese Spring expressing the genes from the A and B genomes, while cv Recital has ESTs from the A and D genomes. Genomic sequences of Chinese Spring show that the D genome gene is inactivated by tandem premature stop codons. A fourth delta-gliadin sequence occurs in the D genome of both Chinese Spring and Ae. tauschii, but no ESTs match this sequence and limited genomic sequences indicates a pseudogene containing frame shifts and premature stop codons. Sequencing of BACs covering a 3 Mb region from Ae. tauschii locates the delta-gliadin gene to the complex Gli-1 plus Glu-3 region on chromosome 1.	[Anderson, Olin D.; Dong, Lingli; Huo, Naxin; Gu, Yong Q.] ARS, Genom & Gene Discovery Res Unit, Western Reg Res Ctr, USDA, Albany, CA 94710 USA; [Huo, Naxin] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Dong, Lingli] Chinese Acad Sci, Key Lab Plant Cell & Chromosome Engn, Inst Genet & Dev Biol, Beijing, Peoples R China	United States Department of Agriculture (USDA); University of California System; University of California Davis; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Anderson, OD (corresponding author), ARS, Genom & Gene Discovery Res Unit, Western Reg Res Ctr, USDA, Albany, CA 94710 USA.	olin.anderson@ars.usda.gov			Agricultural Research Service, United States Department of Agriculture; United States National Science Foundation [DBI-0701916, DBI-0822100]	Agricultural Research Service, United States Department of Agriculture(United States Department of Agriculture (USDA)USDA Agricultural Research Service); United States National Science Foundation(National Science Foundation (NSF))	This work was supported by the Agricultural Research Service, United States Department of Agriculture and by United States National Science Foundation grants DBI-0701916 and DBI-0822100. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson OD, 1997, THEOR APPL GENET, V95, P59, DOI 10.1007/s001220050532; Anderson OD, 2001, THEOR APPL GENET, V103, P323, DOI 10.1007/s00122-001-0551-3; Armstrong MJ, 2012, CURR OPIN GASTROEN, V28, P104, DOI 10.1097/MOG.0b013e32834d0844; Brenchley R, 2012, NATURE IN PRESS; CAMERONMILLS V, 1988, PLANT MOL BIOL, V11, P449, DOI 10.1007/BF00039026; Cassidy BG, 1998, THEOR APPL GENET, V96, P743, DOI 10.1007/s001220050797; D'Ovidio R, 2004, J CEREAL SCI, V39, P321, DOI 10.1016/j.jcs.2003.12.002; DOVIDIO R, 1995, CEREAL CHEM, V72, P443; Gil-Humanes J, 2008, J CEREAL SCI, V48, P565, DOI 10.1016/j.jcs.2008.03.005; KECK B, 1995, Z LEBENSM UNTERS FOR, V200, P432, DOI 10.1007/BF01193253; Kong XY, 2004, PLANT MOL BIOL, V54, P55, DOI 10.1023/B:PLAN.0000028768.21587.dc; MacRitchie F., 1992, Advances in Food and Nutrition Research, V36, P1, DOI 10.1016/S1043-4526(08)60104-7; MULLER S, 1995, J CEREAL SCI, V22, P21, DOI 10.1016/S0733-5210(05)80004-9; Muller S, 1997, J CEREAL SCI, V26, P169, DOI 10.1006/S0733-5210(97)90100-4; Piston F, 2004, THEOR APPL GENET, V108, P1359, DOI 10.1007/s00122-003-1548-x; RECHINGER KB, 1993, THEOR APPL GENET, V85, P829, DOI 10.1007/BF00225026; RECHINGER KB, 1993, PLANT J, V4, P841, DOI 10.1046/j.1365-313X.1993.04050841.x; SABELLI PA, 1991, THEOR APPL GENET, V83, P209, DOI 10.1007/BF00226253; Sato K, 2009, DNA RES, V16, P81, DOI 10.1093/dnares/dsn034; SHEWRY PR, 1985, FEBS LETT, V190, P61, DOI 10.1016/0014-5793(85)80427-0; Shewry PR, 2003, ADV GENET, V49, P111, DOI 10.1016/S0065-2660(03)01003-4; Snegaroff J, 2006, INT ARCH ALLERGY IMM, V139, P201, DOI 10.1159/000091165; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747	23	33	35	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52139	10.1371/journal.pone.0052139	http://dx.doi.org/10.1371/journal.pone.0052139			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284903	Green Submitted, Green Published, gold			2022-12-27	WOS:000312794500098
J	Libri, V; Brown, AP; Gambarota, G; Haddad, J; Shields, GS; Dawes, H; Pinato, DJ; Hoffman, E; Elliot, PJ; Vlasuk, GP; Jacobson, E; Wilkins, MR; Matthews, PM				Libri, Vincenzo; Brown, Andrew P.; Gambarota, Giulio; Haddad, Jonathan; Shields, Gregory S.; Dawes, Helen; Pinato, David J.; Hoffman, Ethan; Elliot, Peter J.; Vlasuk, George P.; Jacobson, Eric; Wilkins, Martin R.; Matthews, Paul M.			A Pilot Randomized, Placebo Controlled, Double Blind Phase I Trial of the Novel SIRT1 Activator SRT2104 in Elderly Volunteers	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; SKELETAL-MUSCLE; INSULIN; METABOLISM; P-31; VIVO; DEACETYLATES; RESVERATROL; PREDICTION; LONGEVITY	Background: SRT2104 has been developed as a selective small molecule activator of SIRT1, a NAD(+)-dependent deacetylase involved in the regulation of energy homeostasis and the modulation of various metabolic pathways, including glucose metabolism, oxidative stress and lipid metabolism. SIRT1 has been suggested as putative therapeutic target in multiple age-related diseases including type 2 diabetes and dyslipidemias. We report the first clinical trial of SRT2104 in elderly volunteers. Methods: Oral doses of 0.5 or 2.0 g SRT2104 or matching placebo were administered once daily for 28 days. Pharmacokinetic samples were collected through 24 hours post-dose on days 1 and 28. Multiple pharmacodynamic endpoints were explored with oral glucose tolerance tests (OGTT), serum lipid profiles, magnetic resonance imaging (MRI) for assessment of whole body visceral and subcutaneous fat, maximal aerobic capacity test and muscle 31P magnetic resonance spectroscopy (MRS) for estimation of mitochondrial oxidative capacity. Results: SRT2104 was generally safe and well tolerated. Pharmacokinetic exposure increased less than dose-proportionally. Mean Tmax was 2-4 hours with elimination half-life of 15-20 hours. Serum cholesterol, LDL levels and triglycerides decreased with treatment. No significant changes in OGTT responses were observed. 31P MRS showed trends for more rapid calculated adenosine diphosphate (ADP) and phosphocreatine (PCr) recoveries after exercise, consistent with increased mitochondrial oxidative phosphorylation. Conclusions: SRT2104 can be safely administered in elderly individuals and has biological effects in humans that are consistent with SIRT1 activation. The results of this study support further development of SRT2104 and may be useful in dose selection for future clinical trials in patients.	[Libri, Vincenzo; Pinato, David J.; Wilkins, Martin R.] Univ London Imperial Coll Sci Technol & Med, Imperial Ctr Translat & Expt Med, NIHR, Wellcome Trust Imperial Coll,Clin Res Facil, London, England; [Brown, Andrew P.] Imanova Ctr Imaging Sci, London, England; [Gambarota, Giulio; Shields, Gregory S.; Matthews, Paul M.] Univ London Imperial Coll Sci Technol & Med, GlaxoSmithKline, GSK Clin Imaging Ctr, London, England; [Haddad, Jonathan; Hoffman, Ethan; Elliot, Peter J.; Vlasuk, George P.; Jacobson, Eric] A GSK Co, Sirtris Pharmaceut, Cambridge, MA USA; [Dawes, Helen] Oxford Brookes Univ, Movement Sci Grp, Oxford OX3 0BP, England; [Matthews, Paul M.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Brain Sci, London, England	Imperial College London; University of London; King's College London; GlaxoSmithKline; Imperial College London; GlaxoSmithKline; Oxford Brookes University; Imperial College London	Libri, V (corresponding author), Univ London Imperial Coll Sci Technol & Med, Imperial Ctr Translat & Expt Med, NIHR, Wellcome Trust Imperial Coll,Clin Res Facil, London, England.	v.libri@imperial.ac.uk	Pinato, David James/ABB-3719-2020; gambarota, giulio/A-8949-2010	Matthews, Paul M/0000-0002-1619-8328; Pinato, David James/0000-0002-3529-0103; Dawes, Helen/0000-0002-2933-5213	Sirtris Pharmaceuticals; GSK Company (Cambridge, MA, USA); GlaxoSmithKline Pharmaceuticals, Clinical Imaging Centre (GSK-CIC, London, UK)	Sirtris Pharmaceuticals; GSK Company (Cambridge, MA, USA); GlaxoSmithKline Pharmaceuticals, Clinical Imaging Centre (GSK-CIC, London, UK)	This research was funded by by Sirtris Pharmaceuticals, a GSK Company (Cambridge, MA, USA) and GlaxoSmithKline Pharmaceuticals, Clinical Imaging Centre (GSK-CIC, London, UK). The funders did have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett DR, 2000, MED SCI SPORT EXER, V32, P70, DOI 10.1097/00005768-200001000-00012; Baur JA, 2010, MECH AGEING DEV, V131, P261, DOI 10.1016/j.mad.2010.02.007; Bemis JE, 2009, BIOORG MED CHEM LETT, V19, P2350, DOI 10.1016/j.bmcl.2008.11.106; Berggren JR, 2008, AM J PHYSIOL-ENDOC M, V294, pE726, DOI 10.1152/ajpendo.00354.2007; Borch-Johnsen K, 1998, BMJ-BRIT MED J, V317, P371; BORDONE L, 2006, PLOS BIOL, V4; Camins A, 2010, BBA-GENE REGUL MECH, V1799, P740, DOI 10.1016/j.bbagrm.2010.06.005; DANDURAND RJ, 1995, CHEST, V108, P182, DOI 10.1378/chest.108.1.182; Do GM, 2008, BIOCHEM BIOPH RES CO, V374, P55, DOI 10.1016/j.bbrc.2008.06.113; Elliott PJ, 2009, DRUG FUTURE, V34, P291, DOI 10.1358/dof.2009.034.04.1360696; Fabbrini E, 2010, J CLIN ENDOCR METAB, V95, P2727, DOI 10.1210/jc.2009-2622; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Gurd BJ, 2011, AM J PHYSIOL-REG I, V301, P67; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; He YL, 2007, J CLIN PHARMACOL, V47, P633, DOI 10.1177/0091270006299137; Heilbronn LK, 2006, JAMA-J AM MED ASSOC, V295, P1539, DOI 10.1001/jama.295.13.1539; Hoffmann E, 2013, BRIT J CLIN PHARMACO, V75, P186, DOI 10.1111/j.1365-2125.2012.04340.x; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; HUME R, 1966, J CLIN PATHOL, V19, P389, DOI 10.1136/jcp.19.4.389; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jacobson Elaine L, 2012, Subcell Biochem, V56, P37, DOI 10.1007/978-94-007-2199-9_3; Kelley DE, 2004, DIABETES CARE, V27, P33, DOI 10.2337/diacare.27.1.33; KEMP GJ, 1994, MAGN RESON QUART, V10, P43; Larson-Meyer DE, 2000, NMR BIOMED, V13, P14, DOI 10.1002/(SICI)1099-1492(200002)13:1<14::AID-NBM605>3.0.CO;2-0; Larson-Meyer DE, 2001, MUSCLE NERVE, V24, P1665, DOI 10.1002/mus.1202; Layec G, 2013, AGE, V35, P1183, DOI 10.1007/s11357-012-9442-6; Leibiger IB, 2006, NAT MED, V12, P34, DOI 10.1038/nm0106-34; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; MATTHEWS PM, 1991, NEUROLOGY, V41, P114, DOI 10.1212/WNL.41.1.114; Medicine ACoS, 2009, ACSMS GUID EX TEST P; Menzies KJ, 2012, MITOCHONDRION, V12, P5, DOI 10.1016/j.mito.2011.03.001; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Minor RK, 2011, SCI REP-UK, V1, DOI 10.1038/srep00070; Mooy JM, 1996, DIABETOLOGIA, V39, P298, DOI 10.1007/BF00418345; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1016/S1352-8661(01)00111-9; Nayagam VM, 2006, J BIOMOL SCREEN, V11, P959, DOI 10.1177/1087057106294710; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978; Qi YDM, 2010, ADA 70 SCI SESS, P390; Rofsky NM, 1999, RADIOLOGY, V212, P876, DOI 10.1148/radiology.212.3.r99se34876; Rostami-Hodjegan A, 2007, NAT REV DRUG DISCOV, V6, P140, DOI 10.1038/nrd2173; Schocke MFH, 2004, MAGN RESON IMAGING, V22, P109, DOI 10.1016/j.mri.2003.07.001; Suri VDM, 2011, ADA 71 SCI SESS, P1706; Thomas EL, 2011, EUR J CLIN NUTR, V65, P1256, DOI 10.1038/ejcn.2011.108; Thomas EL, 1998, J APPL PHYSIOL, V85, P1778, DOI 10.1152/jappl.1998.85.5.1778; Tomlin DL, 2001, SPORTS MED, V31, P1, DOI 10.2165/00007256-200131010-00001; Utzschneider KM, 2007, DIABETOLOGIA, V50, P2516, DOI 10.1007/s00125-007-0819-5; Vanderthommen M, 2003, J APPL PHYSIOL, V94, P1012, DOI 10.1152/japplphysiol.00887.2001; Yang HY, 2007, AGING CELL, V6, P35, DOI 10.1111/j.1474-9726.2006.00259.x; Zern TL, 2003, J NUTR, V133, P2268, DOI 10.1093/jn/133.7.2268	50	94	96	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51395	10.1371/journal.pone.0051395	http://dx.doi.org/10.1371/journal.pone.0051395			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284689	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500027
J	Swensen, JP; Dollar, AM				Swensen, John P.; Dollar, Aaron M.			The Connectedness of Packed Circles and Spheres with Application to Conductive Cellular Materials	PLOS ONE			English	Article							PACKING	In this paper, we examine the static connectivity of 2D and 3D arrays of spherical cells with conductive paths, and the associated power dissipation in the individual cells. Herein, we use the term "cellular material" to describe the ensemble of many cells, in contrast to the more traditional use of the term for foams and honeycomb materials. Using a numerical analytical approach from highly parallel resistor arrays, we examine the cells and ensemble structures in terms of their connectivity, defined as the number of cells that are dissipating power, as well as the redundancy and robustness to localized cell failure. We examine how the connectivity changes with the geometry of the conductive cell surface area, and in particular, the percentage of the cell half that is conductive and makes contact with neighboring cells. We find that the best connectivity exists when the conductive surface of the cell is approximately 80% of the hemisphere surface, addressing the tradeoff of maximizing contact with neighboring cells while minimizing shorts in the structure. In terms of robustness, the results show that, for the proposed circular and spherical cell design, the connectivity is a nearly linear function of the number of disconnects, indicating that there is not a catastrophic effect of isolated cell failures. In terms of structure size, the connectivity appears to plateau at around 60% for the planar structures and around 50% for the cubic structures of around 500 cells or greater with random cell orientation.	[Swensen, John P.; Dollar, Aaron M.] Yale Univ, Sch Engn & Appl Sci, New Haven, CT 06520 USA	Yale University	Swensen, JP (corresponding author), Yale Univ, Sch Engn & Appl Sci, New Haven, CT 06520 USA.	john.swensen@yale.edu	Swensen, John/AAC-8194-2020	Swensen, John/0000-0003-4562-6309; Dollar, Aaron/0000-0002-2409-4668	United States Air Force Office of Scientific Research [FA9550-11-1-0093]	United States Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This research was funded by the United States Air Force Office of Scientific Research under Grant #FA9550-11-1-0093. The URL of the granting agency is http://www.wpafb.af.mil/afrl/afosr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amengual A, 2000, AM J PHYS, V68, P175, DOI 10.1119/1.19396; Ashwin SS, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.061307; Barooah P, 2007, IEEE CONTR SYST MAG, V27, P57, DOI 10.1109/MCS.2007.384125; Blair D. L., 2001, PHYS REV E, V63; Christodoulou L, 2003, JOM-J MIN MET MAT S, V55, P39, DOI 10.1007/s11837-003-0008-z; Clusel M, 2009, NATURE, V460, P611, DOI 10.1038/nature08158; Gao GJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.061303; Gilpin K, 2010, IEEE INT CONF ROBOT, P2485, DOI 10.1109/ROBOT.2010.5509817; Hawkes E, 2010, P NATL ACAD SCI USA, V107, P12441, DOI 10.1073/pnas.0914069107; Holm R., 1967, ELECT CONTACTS THEOR, DOI 10.1007/978-3-662-06688-1; Johnson KL., 1985, CONTACT MECH, DOI [10.1017/CBO9781139171731, DOI 10.1201/B17588-12]; Jones W, 1985, THEORETICAL SOLID ST, V1; Mehrabian AR, 2011, J FRANKLIN I, V348, P12, DOI 10.1016/j.jfranklin.2009.02.006; Pouliquen O, 1997, PHYS REV LETT, V79, P3640, DOI 10.1103/PhysRevLett.79.3640; Shepherd RF, 2011, P NATL ACAD SCI USA, V108, P20400, DOI 10.1073/pnas.1116564108; Torquato S, 2000, PHYS REV LETT, V84, P2064, DOI 10.1103/PhysRevLett.84.2064; Torquato S, 2010, REV MOD PHYS, V82, P2633, DOI 10.1103/RevModPhys.82.2633; VENEZIAN G, 1994, AM J PHYS, V62, P1000, DOI 10.1119/1.17696; Vitelli V, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.021301; Wu FY, 2004, J PHYS A-MATH GEN, V37, P6653, DOI 10.1088/0305-4470/37/26/004; Xu N, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.038001	21	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51695	10.1371/journal.pone.0051695	http://dx.doi.org/10.1371/journal.pone.0051695			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284746	Green Published, gold			2022-12-27	WOS:000312794500039
J	Elley, CR; Gupta, AK; Webster, R; Selak, V; Jun, M; Patel, A; Rodgers, A; Thom, S				Elley, C. Raina; Gupta, Ajay K.; Webster, Ruth; Selak, Vanessa; Jun, Min; Patel, Anushka; Rodgers, Anthony; Thom, Simon			The Efficacy and Tolerability of 'Polypills': Meta-Analysis of Randomised Controlled Trials	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; PRIMARY PREVENTION; COST-EFFECTIVENESS; COMBINATION; ADHERENCE; RISK; DESIGN; THERAPY; PUBLICATION	Background: To assess the blood pressure and lipid-lowering efficacy and tolerability of 'polypills' used in cardiovascular disease prevention trials. Methodology/Principal Findings: Systematic review and meta-analysis. Search strategy: The Cochrane Central Register of Controlled Trials, Medline, and PubMed databases were searched for eligible trials. Study inclusion criteria: Randomised controlled trials of at least six weeks duration, which compared a 'polypill' (that included at least one anti-hypertensive and one lipid-lowering medication) with a placebo (or one active component). Outcome measures: Change from baseline in systolic and diastolic blood pressures, and total and LDL-cholesterol; discontinuation of study medication and reported adverse effects. Of 44 potentially eligible studies, six trials (including 2,218 patients without previous cardiovascular disease) fulfilled the inclusion criteria. Compared with placebo, 'polypills' reduced systolic blood pressure by -9.2 mmHg (95% confidence interval (CI): -13.4, -5.0) diastolic blood pressure by -5.0 mmHg (95% CI: -7.4, -2.6), total cholesterol by -1.22 mmol/L (95% CI: -1.60, -0.84) and LDL-cholesterol by -1.02 mmol/L (95% CI: -1.37, -0.67). However, those taking a 'polypill' (vs. placebo or component) were more likely to discontinue medication (20% vs 14%) (Odds ratio: 1.5 (95% CI: 1.2, 1.9)). There was no significant difference in reported adverse effects amongst those on a 'polypill' (36% vs. 28%) (OR: 1.3 (95% CI: 0.7, 2.5)). There was high statistical heterogeneity in comparisons for blood pressure and lipid-lowering but use of random-effects and quality-effects models produced very similar results. Conclusions/Significance: Compared with placebo, the 'polypills' reduced blood pressure and lipids. Tolerability was lower amongst those on 'polypills' than those on placebo or one component, but differences were moderate. Effectiveness trials are needed to help clarify the status of 'polypills' in primary care and prevention strategies.	[Elley, C. Raina; Selak, Vanessa] Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand; [Gupta, Ajay K.; Thom, Simon] Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, London, England; [Webster, Ruth; Jun, Min; Patel, Anushka; Rodgers, Anthony] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia	University of Auckland; Imperial College London; George Institute for Global Health; University of Sydney	Elley, CR (corresponding author), Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand.	c.elley@auckland.ac.nz	Gupta, Ajay/AAG-9859-2020	Gupta, Ajay/0000-0001-5807-8503; Webster, Ruth/0000-0002-7444-3037; Jun, Min/0000-0003-1460-7535; Patel, Anushka/0000-0003-3825-4092; Selak, Vanessa/0000-0002-9824-8674; Thom, Simon/0000-0002-3020-1351; Rodgers, Anthony/0000-0003-1282-1896	Dr Reddy's Ltd (DRL)	Dr Reddy's Ltd (DRL)	The authors have read the journal's policy and have the following conflicts: AR and RW have received a grant from Dr Reddy's Ltd (DRL) for the SPACE collaboration centre but this is unrelated to the current meta-analysis. DRL also provided a fixed dose combination formulation free of charge for four randomized controlled trials to assess the effectiveness of a "polypill-based strategy." CRE, VS, AP, ST and AR are investigators or are on the steering committee of at least one of these trials. The George Institute for Global Health is now negotiating a global license for these products, following a decision by DRL not to proceed with taking the products to market because of existing regulatory requirements. DRL has provided travel assistance to meetings on "polypills" for CRE, RW, VS, AP, ST and AR in the past. AKG has received travel assistance to attend a conference from Pfizer. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	[Anonymous], 2003, ADHERENCE LONG TERM; [Anonymous], 2012, NZ PRIM CAR HDB 2012, V3rd; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Banerjee A, 2010, LANCET, V375, P166, DOI 10.1016/S0140-6736(09)61296-4; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Calonge N, 2009, ANN INTERN MED, V150, P396; Chapman RH, 2005, ARCH INTERN MED, V165, P1147, DOI 10.1001/archinte.165.10.1147; Cholesterol Treatment Trialists' (CTT) Collaborators, 2012, LANCET, V6736, P60367, DOI DOI 10.1016/S0140-6736; Cobiac LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041842; Doi SAR, 2011, CONTEMP CLIN TRIALS, V32, P288, DOI 10.1016/j.cct.2010.12.006; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elley CR, 2008, DIABETES RES CLIN PR, V79, P468, DOI 10.1016/j.diabres.2007.09.018; Furukawa TA, 2006, J CLIN EPIDEMIOL, V59, P7, DOI 10.1016/j.jclinepi.2005.06.006; Gaziano TA, 2006, LANCET, V368, P679, DOI 10.1016/S0140-6736(06)69252-0; Grimm R, 2010, VASC HEALTH RISK MAN, V6, P261; Gupta AK, 2010, HYPERTENSION, V55, P399, DOI 10.1161/HYPERTENSIONAHA.109.139816; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kulkarni SP, 2006, AM HEART J, V151, P185, DOI 10.1016/j.ahj.2005.02.038; Lafeber M, 2011, EUR J PREV CARDIOL, P1; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Liew D, 2009, CLIN THER, V31, P2189, DOI 10.1016/j.clinthera.2009.10.015; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Liu HM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-458; Lonn E, 2010, CIRCULATION, V122, P2078, DOI 10.1161/CIRCULATIONAHA.109.873232; Malekzadeh F, 2010, INT J CLIN PRACT, V64, P1220, DOI 10.1111/j.1742-1241.2010.02412.x; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; National Institute for Health and Clinical Excellence, 2011, SEC PREV PRIM SEC CA; Neutel JM, 2009, J CLIN HYPERTENS, V11, P22, DOI 10.1111/j.1751-7176.2008.00058.x; Niens LM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000333; Rodgers A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019857; Sanz G, 2011, AM HEART J, V162, DOI 10.1016/j.ahj.2011.08.012; Selak V, 2011, CONTEMP CLIN TRIALS, V32, P909, DOI 10.1016/j.cct.2011.07.006; Selak V, 2009, NEW ZEAL MED J, V122, P41; Soliman EZ, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-3; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; The Cochrane Collaboration, 2011, COCHRANE HDB SYSTEMA; Thom S, 2012, EUR J PREVENTIVE CAR; van Gils PF, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000363; Wald DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041297; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; World Health Organization, 2002, WHO WELLC TRUST M 1; World Health Organization, 2008, GLOB BURD DIS 2004 U; Yusuf S, 2009, LANCET, V373, P1341, DOI 10.1016/S0140-6736(09)60611-5; Yusuf S, 2002, LANCET, V360, P2, DOI 10.1016/S0140-6736(02)09358-3; Yusuf S, 2012, CIRC-CARDIOVASC QUAL, V5, P463, DOI 10.1161/CIRCOUTCOMES.111.963637; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4; Zamorano J, 2010, POSTGRAD MED, V122, P7, DOI 10.3810/pgm.2010.03.2117	50	65	67	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52145	10.1371/journal.pone.0052145	http://dx.doi.org/10.1371/journal.pone.0052145			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284906	Green Published, Green Submitted, gold			2022-12-27	WOS:000312694300075
J	Hjelm, B; Forsstrom, B; Lofblom, J; Rockberg, J; Uhlen, M				Hjelm, Barbara; Forsstrom, Bjorn; Lofblom, John; Rockberg, Johan; Uhlen, Mathias			Parallel Immunizations of Rabbits Using the Same Antigen Yield Antibodies with Similar, but Not Identical, Epitopes	PLOS ONE			English	Article							AFFINITY REAGENTS; HUMAN PROTEOME; AMINO-ACID; PREDICTION; DISPLAY; GENERATION; PEPTIDE; ATLAS; MODEL	A problem for the generation of polyclonal antibodies is the potential difficulties for obtaining a renewable resource due to batch-to-batch variations when the same antigen is immunized into several separate animals. Here, we have investigated this issue by determining the epitopes of antibodies generated from parallel immunizations of rabbits with recombinant antigens corresponding to ten human protein targets. The epitopes were mapped by both a suspension bead array approach using overlapping synthetic 15-mer peptides and a bacterial display approach using expression of random fragments of the antigen on the surface of bacteria. Both methods determined antibody binding with the aid of fluorescent-based analysis. In addition, one polyclonal antibody was fractionated by peptide-specific affinity capture for in-depth comparison of epitopes. The results show that the same antigen immunized in several rabbits yields polyclonal antibodies with similar epitopes, but with larger differences in the relative amounts of antibodies to the different epitopes. In some cases, unique epitopes were observed for one of the immunizations. The results suggest that polyclonal antibodies generated by repeated immunizations do not display an identical epitope pattern, although many of the epitopes are similar.	[Hjelm, Barbara; Forsstrom, Bjorn; Lofblom, John; Rockberg, Johan; Uhlen, Mathias] Royal Inst Technol, Sch Biotechnol, AlbaNova Univ Ctr, Stockholm, Sweden; [Uhlen, Mathias] Royal Inst Technol, Sci Life Lab, Stockholm, Sweden	Royal Institute of Technology; Royal Institute of Technology	Uhlen, M (corresponding author), Royal Inst Technol, Sch Biotechnol, AlbaNova Univ Ctr, Stockholm, Sweden.	mathias.uhlen@scilifelab.se	Uhlen, Mathias/B-3262-2016; Uhlen, Mathias/AAV-8746-2021	Uhlen, Mathias/0000-0002-4858-8056; Lofblom, John/0000-0001-9423-0541	Knut and Alice Wallenberg Foundation; Swedish Research Council; VINNOVA ProNova center grant	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); VINNOVA ProNova center grant(Vinnova)	This work was supported by grants from the Knut and Alice Wallenberg Foundation, Swedish Research Council and the VINNOVA ProNova center grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Blythe MJ, 2005, PROTEIN SCI, V14, P246, DOI 10.1110/ps.041059505; Buus S, 2012, MOL CELL PROTEOMICS, V11, P1790, DOI 10.1074/mcp.M112.020800; Colwill K, 2011, NAT METHODS, V8, P551, DOI [10.1038/NMETH.1607, 10.1038/nmeth.1607]; Edwards AM, 2011, NATURE, V470, P163, DOI 10.1038/470163a; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; GEYSEN HM, 1987, SCIENCE, V235, P1184, DOI 10.1126/science.3823878; GEYSEN HM, 1984, P NATL ACAD SCI-BIOL, V81, P3998, DOI 10.1073/pnas.81.13.3998; Gloriam DE, 2010, MOL CELL PROTEOMICS, V9, P1, DOI 10.1074/mcp.M900185-MCP200; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Hjelm B, 2011, PROTEIN SCI, V20, P1824, DOI 10.1002/pro.716; Hjelm B, 2010, NEW BIOTECHNOL, V27, P129, DOI 10.1016/j.nbt.2009.11.001; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; John SH, 2006, DRUG DISCOV TODAY, V11, P655; Kiermer V, 2008, NAT METHODS, V5, P860, DOI 10.1038/nmeth1008-860; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Larsson K, 2009, J IMMUNOL METHODS, V342, P20, DOI 10.1016/j.jim.2008.11.013; Lofblom J, 2007, J APPL MICROBIOL, V102, P736, DOI 10.1111/j.1365-2672.2006.03127.x; Lofblom J, 2011, CURR OPIN BIOTECH, V22, P843, DOI 10.1016/j.copbio.2011.06.002; Nilsson P, 2005, PROTEOMICS, V5, P4327, DOI 10.1002/pmic.200500072; Partidos CD, 1997, J GEN VIROL, V78, P3227, DOI 10.1099/0022-1317-78-12-3227; Petersen G, 1995, MOL GEN GENET, V249, P425, DOI 10.1007/BF00287104; Rockberg J, 2009, PROTEIN SCI, V18, P2346, DOI 10.1002/pro.245; Rockberg J, 2008, NAT METHODS, V5, P1039, DOI 10.1038/nmeth.1272; Ton L, 2007, TRENDS BIOTECHNOL, V25, P390; Uhlen M, 2008, NAT METHODS, V5, P854, DOI 10.1038/nmeth1008-854; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; WANG LF, 1995, J IMMUNOL METHODS, V178, P1, DOI 10.1016/0022-1759(94)00235-O	28	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e45817	10.1371/journal.pone.0045817	http://dx.doi.org/10.1371/journal.pone.0045817			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284606	gold, Green Submitted, Green Published			2022-12-27	WOS:000312694300002
J	Sanggaard, KW; Danielsen, CC; Wogensen, L; Vinding, MS; Rydtoft, LM; Mortensen, MB; Karring, H; Nielsen, NC; Wang, T; Thogersen, IB; Enghild, JJ				Sanggaard, Kristian W.; Danielsen, Carl Chr.; Wogensen, Lise; Vinding, Mads S.; Rydtoft, Louise M.; Mortensen, Martin B.; Karring, Henrik; Nielsen, Niels Chr.; Wang, Tobias; Thogersen, Ida B.; Enghild, Jan J.			Unique Structural Features Facilitate Lizard Tail Autotomy	PLOS ONE			English	Article							FIBRILLAR ADHESIVE MICROSTRUCTURE; COLLAGENOUS TISSUE; CAUDAL AUTOTOMY; ECHINODERMATA; REGENERATION; OPHIUROIDEA; PEPTIDES; MOVEMENT; PROTEINS; OSIRIX	Autotomy refers to the voluntary shedding of a body part; a renowned example is tail loss among lizards as a response to attempted predation. Although many aspects of lizard tail autotomy have been studied, the detailed morphology and mechanism remains unclear. In the present study, we showed that tail shedding by the Tokay gecko (Gekko gecko) and the associated extracellular matrix (ECM) rupture were independent of proteolysis. Instead, lizard caudal autotomy relied on biological adhesion facilitated by surface microstructures. Results based on bio-imaging techniques demonstrated that the tail of Gekko gecko was pre-severed at distinct sites and that its structural integrity depended on the adhesion between these segments.	[Sanggaard, Kristian W.; Thogersen, Ida B.; Enghild, Jan J.] Aarhus Univ, Dept Mol Biol & Genet, Ctr Insoluble Prot Struct inSPIN, Interdiciplinary Nanosci Ctr iNANO, Aarhus, Denmark; [Danielsen, Carl Chr.] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Wogensen, Lise] Aarhus Univ, Dept Clin Med, Res Lab Biochem Pathol, Aarhus, Denmark; [Vinding, Mads S.; Nielsen, Niels Chr.] Aarhus Univ, Dept Chem, Ctr Insoluble Prot Structures inSPIN, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus, Denmark; [Rydtoft, Louise M.] Aarhus Univ, Dept Clin Med, Ctr Funct Integrat Neurosci, Aarhus, Denmark; [Mortensen, Martin B.] Aarhus Univ, Dept Clin Med, Dept Thorac & Cardiovasc Surg, Aarhus, Denmark; [Karring, Henrik] Univ So Denmark, Fac Engn, Inst Chem Engn Biotechnol & Environm Technol, Odense, Denmark; [Wang, Tobias] Aarhus Univ, Dept Biosci Zoophysiol, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; University of Southern Denmark; Aarhus University	Enghild, JJ (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Ctr Insoluble Prot Struct inSPIN, Interdiciplinary Nanosci Ctr iNANO, Aarhus, Denmark.	jje@mb.au.dk	Wang, Tobias/I-7946-2013; Vinding, Mads S./AAN-4915-2020	Wang, Tobias/0000-0002-4350-3682; Vinding, Mads S./0000-0002-0149-583X; Nielsen, Niels Chr./0000-0003-2978-4366; Karring, Henrik/0000-0002-4672-1503; Enghild, Jan Johannes/0000-0001-9292-9172; Mortensen, Martin Bodtker/0000-0003-2693-4154	Danish Council for Strategic Research, Programme Commission on Health, Food and Welfare [09-067076, NOVENIA]; Danish National Research Foundation, Centers of Excellence (inSPIN)	Danish Council for Strategic Research, Programme Commission on Health, Food and Welfare; Danish National Research Foundation, Centers of Excellence (inSPIN)	This work is supported by the Danish Council for Strategic Research (http://en.fi.dk/councils-commissions/the-danish-council-for-strategic-research), Programme Commission on Health, Food and Welfare (grant 09-067076, NOVENIA), and by the Danish National Research Foundation (http://www.dg.dk/en/), Centers of Excellence (inSPIN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD EN, 1984, J NAT HIST, V18, P127, DOI 10.1080/00222938400770131; Autumn K, 2000, NATURE, V405, P681, DOI 10.1038/35015073; Bateman PW, 2009, J ZOOL, V277, P1, DOI 10.1111/j.1469-7998.2008.00484.x; Bellairs AdA, 1985, AUTOTOMY REGENERATIO, P310; BURY AF, 1981, J CHROMATOGR, V213, P491, DOI 10.1016/S0021-9673(00)80500-2; Carbone G, 2011, SOFT MATTER, V7, P5545, DOI 10.1039/c0sm01482f; Cheung E, 2009, LANGMUIR, V25, P6613, DOI 10.1021/la900997p; CLARK DR, 1971, J EXP ZOOL, V176, P295, DOI 10.1002/jez.1401760305; Clause AR, 2006, J EXP ZOOL PART A, V305A, P965, DOI 10.1002/jez.a.346; DIAL BE, 1983, SCIENCE, V219, P391, DOI 10.1126/science.219.4583.391; DOBSON WE, 1985, J EXP MAR BIOL ECOL, V94, P223, DOI 10.1016/0022-0981(85)90060-7; Gorb S, 2007, J R SOC INTERFACE, V4, P271, DOI 10.1098/rsif.2006.0164; Higham TE, 2010, BIOL LETTERS, V6, P70, DOI 10.1098/rsbl.2009.0577; Maughan DW, 2005, MOL CELL PROTEOMICS, V4, P1541, DOI 10.1074/mcp.M500053-MCP200; Rosset A, 2004, INT CONGR SER, V1268, P1247, DOI 10.1016/j.ics.2004.03.048; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Seidler J, 2010, PROTEOMICS, V10, P634, DOI 10.1002/pmic.200900459; Sheppard L., 1972, British J Herpet, V4, P276; Shevchenko A, 2001, ANAL CHEM, V73, P1917, DOI 10.1021/ac0013709; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Varenberg M, 2008, J R SOC INTERFACE, V5, P785, DOI 10.1098/rsif.2007.1201; Wang DX, 2004, RAPID COMMUN MASS SP, V18, P96, DOI 10.1002/rcm.1289; WELGUS HG, 1981, J BIOL CHEM, V256, P9511; WILKIE IC, 1979, CELL TISSUE RES, V197, P515; Wilkie IC, 2005, PROG MOLEC, V39, P221; WILKIE IC, 1993, NATURE, V366, P519, DOI 10.1038/366519a0; Wilkie IC, 2001, MICROSC RES TECHNIQ, V55, P369, DOI 10.1002/jemt.1185	27	26	27	2	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51803	10.1371/journal.pone.0051803	http://dx.doi.org/10.1371/journal.pone.0051803			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284771	Green Published, gold			2022-12-27	WOS:000312694300044
J	Tang, XY; Jing, LF; Chen, J				Tang, Xinyan; Jing, Liufang; Chen, Jun			Changes in the Molecular Phenotype of Nucleus Pulposus Cells with Intervertebral Disc Aging	PLOS ONE			English	Article							PROTEIN GENE-EXPRESSION; GROWTH-FACTOR-I; LOW-BACK-PAIN; PROTEOGLYCAN SYNTHESIS; IMMUNOGLOBULIN SUPERFAMILY; DIFFERENTIAL EXPRESSION; EXTRACELLULAR-MATRIX; NOTOCHORDAL CELLS; ANNULUS FIBROSUS; CARTILAGE CELLS	Intervertebral disc (IVD) disorder and age-related degeneration are believed to contribute to low back pain. Cell-based therapies represent a promising strategy to treat disc degeneration; however, the cellular and molecular characteristics of disc cells during IVD maturation and aging still remain poorly defined. This study investigated novel molecular markers and their age-related changes in the rat IVD. Affymetrix cDNA microarray analysis was conducted to identify a new set of genes characterizing immature nucleus pulposus (NP) cells. Among these markers, select neuronal-related proteins (Basp1, Ncdn and Nrp-1), transcriptional factor (Brachyury T), and cell surface receptors (CD24, CD90, CD155 and CD221) were confirmed by real-time PCR and immunohistochemical (IHC) staining for differential expression between IVD tissue regions and among various ages (1, 12 and 21 months). NP cells generally possessed higher levels of mRNA or protein expression for all aforementioned markers, with the exception of CD90 in anulus fibrosus (AF) cells. In addition, CD protein (CD24 and CD90) and Brachyury (T) expression in immature disc cells were also confirmed via flow cytometry. Similar to IHC staining, results revealed a higher percentage of immature NP cells expressing CD24 and Brachyury, while higher percentage of immature AF cells was stained positively for CD90. Altogether, this study identifies that tissue-specific gene expression and age-related differential expression of the above markers do exist in immature and aged disc cells. These age-related phenotype changes provide a new insight for a molecular profile that may be used to characterize NP cells for developing cell-based regenerative therapy for IVD regeneration.	[Chen, Jun] Duke Univ, Med Ctr, Dept Orthoped Surg, Durham, NC 27710 USA; [Tang, Xinyan; Jing, Liufang] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA	Duke University; Duke University	Chen, J (corresponding author), Duke Univ, Med Ctr, Dept Orthoped Surg, Durham, NC 27710 USA.	junchen@duke.edu			NIH [AR057410, AR047442, EB002263]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057410, R01AR047442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002263] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The work was supported by the following NIH grants: AR057410, AR047442 and EB002263. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744; Aguiar DJ, 1999, EXP CELL RES, V246, P129, DOI 10.1006/excr.1998.4287; Antoniou J, 1996, J CLIN INVEST, V98, P996, DOI 10.1172/JCI118884; Baer AE, 2001, J ORTHOPAED RES, V19, P2, DOI 10.1016/S0736-0266(00)00003-6; Bayliss MT, 1992, LUMBAR SPINE BACK PA, P111; Biyani A, 2004, J AM ACAD ORTHOP SUR, V12, P106, DOI 10.5435/00124635-200403000-00006; Boos N, 2002, SPINE, V27, P2631, DOI 10.1097/00007632-200212010-00002; Bowles RD, 2011, P NATL ACAD SCI USA, V108, P13106, DOI 10.1073/pnas.1107094108; Boyd LM, 2004, SPINE, V29, P2217, DOI 10.1097/01.brs.0000142747.90488.1d; BUCKWALTER JA, 1995, SPINE, V20, P1307, DOI 10.1097/00007632-199506000-00022; Chen J, 2002, BIOCHEM BIOPH RES CO, V293, P932, DOI 10.1016/S0006-291X(02)00314-5; Chen J, 2006, EUR SPINE J, V15, pS303, DOI 10.1007/s00586-006-0088-x; Chen J, 2009, CONNECT TISSUE RES, V50, P294, DOI 10.3109/03008200802714925; Choi KS, 2008, DEV DYNAM, V237, P3953, DOI 10.1002/dvdy.21805; Dateki M, 2004, NEUROSCI LETT, V356, P107, DOI 10.1016/j.neulet.2003.11.026; Escalante NK, 2011, ARTERIOSCL THROM VAS, V31, P1177, DOI 10.1161/ATVBAHA.111.224162; Fleming A, 2001, J ANAT, V199, P177, DOI 10.1017/S0021878201008044; Fujisawa H, 1998, CURR OPIN NEUROBIOL, V8, P587, DOI 10.1016/S0959-4388(98)80085-8; Fujita N, 2005, BIOCHEM BIOPH RES CO, V338, P1890, DOI 10.1016/j.bbrc.2005.10.166; Gabr MA, 2011, J ORTHOP RES, V29, P1, DOI 10.1002/jor.21206; Gilchrist CL, 2011, EUR CELLS MATER, V21, P523, DOI 10.22203/eCM.v021a39; Gilchrist CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027170; Gilson A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2931; Goodfellow SJ, 2011, BIOCHEM J, V435, P113, DOI 10.1042/BJ20101734; Gruber HE, 1998, SPINE, V23, P751, DOI 10.1097/00007632-199804010-00001; Gruber HE, 2000, SPINE, V25, P2153, DOI 10.1097/00007632-200009010-00002; Guilak F, 1999, SPINE, V24, P2475, DOI 10.1097/00007632-199912010-00009; Hartl M, 2009, P NATL ACAD SCI USA, V106, P5604, DOI 10.1073/pnas.0812101106; Hayes AJ, 2001, MATRIX BIOL, V20, P107, DOI 10.1016/S0945-053X(01)00125-1; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; HERRMANN BG, 1994, TRENDS GENET, V10, P280, DOI 10.1016/0168-9525(90)90011-T; HUMZAH MD, 1988, ANAT RECORD, V220, P337, DOI 10.1002/ar.1092200402; Hunter CJ, 2004, J ANAT, V205, P357, DOI 10.1111/j.0021-8782.2004.00352.x; Iino S, 1999, NEUROSCIENCE, V91, P1435, DOI 10.1016/S0306-4522(98)00701-5; Istvanffy R, 2004, DEV GENES EVOL, V214, P206, DOI 10.1007/s00427-004-0396-2; Jing LF, 2012, J ORTHOP RES, V30, P1923, DOI 10.1002/jor.22158; Katz JN, 2006, J BONE JOINT SURG AM, V88A, P21, DOI 10.2106/JBJS.E.01273; Kim KW, 2003, SPINE, V28, P982, DOI 10.1097/00007632-200305150-00005; KISPERT A, 1993, EMBO J, V12, P4898, DOI 10.1002/j.1460-2075.1993.tb06179.x; Kristiansen G, 2004, J MOL HISTOL, V35, P255; Lange R, 2001, VIROLOGY, V285, P218, DOI 10.1006/viro.2001.0943; Le Maitre CL, 2005, J PATHOL, V207, P445, DOI 10.1002/path.1862; Lee CR, 2007, EUR SPINE J, V16, P2174, DOI 10.1007/s00586-007-0475-y; MENDELSOHN CL, 1989, CELL, V56, P855, DOI 10.1016/0092-8674(89)90690-9; Minogue BM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2929; Mochizuki R, 1999, BBA-GENE STRUCT EXPR, V1446, P397, DOI 10.1016/S0167-4781(99)00120-7; Nakamura Y, 2006, BRIT J DERMATOL, V154, P1062, DOI 10.1111/j.1365-2133.2006.07209.x; Nerlich AG, 1997, SPINE, V22, P2781, DOI 10.1097/00007632-199712150-00001; Nielsen PJ, 1997, BLOOD, V89, P1058, DOI 10.1182/blood.V89.3.1058; OEGEMA TR, 1993, CLIN SPORT MED, V12, P419; Okuda S, 2001, SPINE, V26, P2421, DOI 10.1097/00007632-200111150-00005; Osada R, 1996, J ORTHOP RES, V14, P690, DOI 10.1002/jor.1100140503; PEARCE RH, 1987, J ORTHOP RES, V5, P198, DOI 10.1002/jor.1100050206; POSTACCHINI F, 1984, SPINE, V9, P596, DOI 10.1097/00007632-198409000-00010; Rege TA, 2006, FASEB J, V20, P1045, DOI 10.1096/fj.05-5460rev; Risbud MV, 2007, SPINE, V32, P2537, DOI 10.1097/BRS.0b013e318158dea6; ROBERTS S, 1991, SPINE, V16, P1030, DOI 10.1097/00007632-199109000-00003; RUFAI A, 1995, ANAT EMBRYOL, V192, P53; Rutges J, 2010, OSTEOARTHR CARTILAGE, V18, P416, DOI 10.1016/j.joca.2009.09.009; Sakai D, 2009, SPINE, V34, P1448, DOI 10.1097/BRS.0b013e3181a55705; Sebastine IM, 2007, P ANN INT IEEE EMBS, P6401; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Soker S, 2002, J CELL BIOCHEM, V85, P357, DOI 10.1002/jcb.10140; Stevens JW, 2000, DEV DYNAM, V219, P381, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1060>3.0.CO;2-P; TAYLOR JR, 1988, BIOL INTERVERTEBRAL, P39; THOMPSON JP, 1991, SPINE, V16, P253, DOI 10.1097/00007632-199103000-00001; Tolofari SK, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2898; TROUT JJ, 1982, ANAT REC, V204, P307, DOI 10.1002/ar.1092040403; TROUT JJ, 1982, TISSUE CELL, V14, P359, DOI 10.1016/0040-8166(82)90033-7; Vujovic S, 2006, J PATHOL, V209, P157, DOI 10.1002/path.1969; Xu ZW, 2010, CELL MOL IMMUNOL, V7, P11, DOI 10.1038/cmi.2009.108; Yu J, 2002, J ANAT, V201, P465, DOI 10.1046/j.1469-7580.2002.00111.x; Zakharov VV, 2003, BBA-GEN SUBJECTS, V1622, P14, DOI 10.1016/S0304-4165(03)00099-0; Zhao CQ, 2007, AGEING RES REV, V6, P247, DOI 10.1016/j.arr.2007.08.001	74	73	79	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52020	10.1371/journal.pone.0052020	http://dx.doi.org/10.1371/journal.pone.0052020			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284858	Green Published, gold, Green Submitted			2022-12-27	WOS:000312694300070
J	Gu, LB; Kitamura, M				Gu, Liubao; Kitamura, Masanori			Sensitive Detection and Monitoring of Senescence-Associated Secretory Phenotype by SASP-RAP Assay	PLOS ONE			English	Article							CELLULAR SENESCENCE; GENE-EXPRESSION; ER STRESS; CANCER; INHIBITOR; CLONING; DRESSA; CELLS	Senescence-associated secretory phenotype (SASP) is characterized by abundant secretion of various proteins in senescent cells and implicated in tumor progression and inflammatory responses. However, the profile of secreted proteins in SASP is different from cell type to cell type, and currently, universal markers for SASP have not been reported. In the present investigation, we show that SASP-responsive alkaline phosphatase (SASP-RAP) serves as a sensitive, general and convenient marker for SASP. Etoposide-treated cells exhibited a senescent phenotype characterized by senile morphology, positive staining for senescence-associated beta-galactosidase, growth arrest and induction of p53 and p21(WAF1/CIP1). In SASP-RAP-transfected cells, exposure to etoposide increased secretion of SASP-RAP time-dependently. The kinetics of secretion was closely correlated with that of activation of the p21(WAF1/CIP1) promoter and the p16(INK4a) promoter. The enhanced secretion of SASP-RAP by senescence was also observed in cells treated with other senescence inducers such as trichostatin A, doxorubicin and 4-phenylbutylic acid. The induction of SASP-RAP by senescence was similarly observed in natural replicative senescence. To confirm selectivity of the SASP-RAP response, cells were treated with senescence-related and unrelated stimuli (IL-1 beta, LPS, TNF-alpha and TGF-beta), and induction of senescence markers and activity of SASP-RAP were evaluated in parallel. Unlike etoposide, senescence-unrelated stimuli did not induce p53 and p21(WAF1/CIP1), and it was correlated with lack of induction of SASP-RAP. In contrast, senescence-unrelated stimuli up-regulated conventional indicators for SASP, e.g., MMP-3, IL-6 and TIMP, without induction of senescence. SASP-RAP thus serves as a selective, convenient and general marker for detection and monitoring of SASP during cellular senescence.	[Gu, Liubao; Kitamura, Masanori] Univ Yamanashi, Dept Mol Signaling, Interdisciplinary Grad Sch Med & Engn, Chuo Ku, Yamanashi, Japan; [Gu, Liubao] Jiangsu Prov Inst Geriatr, Diabet Care & Res Ctr, Nanjing, Jiangsu, Peoples R China	University of Yamanashi	Kitamura, M (corresponding author), Univ Yamanashi, Dept Mol Signaling, Interdisciplinary Grad Sch Med & Engn, Chuo Ku, Yamanashi, Japan.	masanori@yamanashi.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [20390235]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aids for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (20390235) to M. Kitamura (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAM J, 1990, ANAL BIOCHEM, V188, P245, DOI 10.1016/0003-2697(90)90601-5; Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716; BERGER J, 1988, GENE, V66, P1, DOI 10.1016/0378-1119(88)90219-3; Campisi J, 2011, SEMIN CANCER BIOL, V21, P354, DOI 10.1016/j.semcancer.2011.09.001; Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; CULLEN BR, 1992, METHOD ENZYMOL, V216, P362; Demarchi F, 2010, CELL CYCLE, V9, P755, DOI 10.4161/cc.9.4.10637; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; DOCHERTY AJP, 1985, NATURE, V318, P66, DOI 10.1038/318066a0; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Funayama R, 2007, CHROMOSOMA, V116, P431, DOI 10.1007/s00412-007-0115-7; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hiramatsu N, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl515; HUPPI K, 1994, ONCOGENE, V9, P3017; Johno H, 2010, APPL BIOCHEM BIOTECH, V162, P1529, DOI 10.1007/s12010-010-8934-z; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Kasai A, 2005, ANAL BIOCHEM, V337, P84, DOI 10.1016/j.ab.2004.10.004; Kasai A, 2004, ANAL BIOCHEM, V335, P73, DOI 10.1016/j.ab.2004.08.017; Kato H, 2012, CELL DEATH DIFFER, V19, P310, DOI 10.1038/cdd.2011.98; Kitamura M, 2011, CELL DEATH DIFFER, V18, P1876, DOI 10.1038/cdd.2011.63; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Kulis M, 2010, ADV GENET, V70, P27, DOI [10.1016/S0065-2660(10)70002-X, 10.1016/B978-0-12-380866-0.60002-2]; Kurihara Y, 2002, BIOL PHARM BULL, V25, P1272, DOI 10.1248/bpb.25.1272; Leontieva OV, 2010, AGING-US, V2, P924, DOI 10.18632/aging.100265; MATRISIAN LM, 1985, EMBO J, V4, P1435, DOI 10.1002/j.1460-2075.1985.tb03799.x; Matsumoto N, 2000, BIOORG MED CHEM LETT, V10, P865, DOI 10.1016/S0960-894X(00)00114-1; Nakajima S, 2011, MOL CELL BIOL, V31, P1710, DOI 10.1128/MCB.00939-10; Narita M, 2007, BRIT J CANCER, V96, P686, DOI 10.1038/sj.bjc.6603636; Ogryzko VV, 1996, MOL CELL BIOL, V16, P5210; Ohtani N, 2007, P NATL ACAD SCI USA, V104, P15034, DOI 10.1073/pnas.0706949104; Qiu Z, 2009, IMMUNOBIOLOGY, V214, P835, DOI 10.1016/j.imbio.2009.06.007; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Shin DM, 2011, GERONTOLOGY, V57, P76, DOI 10.1159/000281882; Tominaga K, 1997, MOL IMMUNOL, V34, P1147, DOI 10.1016/S0161-5890(97)00145-4; VANSNICK J, 1988, EUR J IMMUNOL, V18, P193; WILSON VL, 1983, SCIENCE, V220, P1054	40	15	15	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52305	10.1371/journal.pone.0052305	http://dx.doi.org/10.1371/journal.pone.0052305			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272236	Green Submitted, Green Published, gold			2022-12-27	WOS:000312483300078
J	Tomasetti, M; Nocchi, L; Neuzil, J; Goodwin, J; Nguyen, M; Dong, LF; Manzella, N; Staffolani, S; Milanese, C; Garrone, B; Alleva, R; Borghi, B; Santarelli, L; Guerrieri, R				Tomasetti, Marco; Nocchi, Linda; Neuzil, Jiri; Goodwin, Jacob; Maria Nguyen; Dong, Lanfeng; Manzella, Nicola; Staffolani, Sara; Milanese, Claudio; Garrone, Beatrice; Alleva, Renata; Borghi, Battista; Santarelli, Lory; Guerrieri, Roberto			Alpha-Tocopheryl Succinate Inhibits Autophagic Survival of Prostate Cancer Cells Induced by Vitamin K3 and Ascorbate to Trigger Cell Death	PLOS ONE			English	Article							MEDIATED PROGRAMMED NECROSIS; RESPIRATORY COMPLEX-II; MITOCHONDRIAL AIF; INDUCED APOPTOSIS; CYTOTOXICITY; ACTIVATION; INDUCTION; MECHANISM; EFFECTOR; GROWTH	Background: The redox-silent vitamin E analog alpha-tocopheryl succinate (alpha-TOS) was found to synergistically cooperate with vitamin K3 (VK3) plus ascorbic acid (AA) in the induction of cancer cell-selective apoptosis via a caspase-independent pathway. Here we investigated the molecular mechanism(s) underlying cell death induced in prostate cancer cells by alpha-TOS, VK3 and AA, and the potential use of targeted drug combination in the treatment of prostate cancer. Methodology/Principal Findings: The generation of ROS, cellular response to oxidative stress, and autophagy were investigated in PC3 prostate cancer cells by using drugs at sub-toxic doses. We evaluated whether PARP1-mediated apoptosis-inducing factor (AIF) release plays a role in apoptosis induced by the combination of the agents. Next, the effect of the combination of alpha-TOS, VK3 and AA on tumor growth was examined in nude mice. VK3 plus AA induced early ROS formation associated with induction of autophagy in response to oxidative stress, which was reduced by alpha-TOS, preventing the formation of autophagosomes. alpha-TOS induced mitochondrial destabilization leading to the release of AIF. Translocation of AIF from mitochondria to the nucleus, a result of the combinatorial treatment, was mediated by PARP1 activation. The inhibition of AIF as well as of PARP1 efficiently attenuated apoptosis triggered by the drug combination. Using a mouse model of prostate cancer, the combination of alpha-TOS, VK3 and AA was more efficient in tumor suppression than when the drugs were given separately, without deleterious side effects. Conclusions/Significance: alpha-TOS, a mitochondria-targeting apoptotic agent, switches at sub-apoptotic doses from autophagy-dependent survival of cancer cells to their demise by promoting the induction of apoptosis. Given the grim prognosis for cancer patients, this finding is of potential clinical relevance.	[Tomasetti, Marco; Nocchi, Linda; Manzella, Nicola; Staffolani, Sara; Santarelli, Lory] Polytechn Univ Marche, Dept Mol & Clin Sci, Ancona, Italy; [Neuzil, Jiri; Goodwin, Jacob; Maria Nguyen; Dong, Lanfeng] Griffith Univ, Apoptosis Res Grp, Sch Med Sci, Southport, Qld 4215, Australia; [Neuzil, Jiri; Goodwin, Jacob; Maria Nguyen; Dong, Lanfeng] Griffith Univ, Griffith Hlth Inst, Southport, Qld 4215, Australia; [Neuzil, Jiri] Acad Sci Czech Republ, Mol Therapy Grp, Inst Biotechnol, Prague, Czech Republic; [Milanese, Claudio; Garrone, Beatrice] Angelini Res, Rome, Italy; [Alleva, Renata; Borghi, Battista] IRCCS Orthopaed Inst Rizzoli, Dept Anesthesiol, Res Unit, Bologna, Italy; [Guerrieri, Roberto] Univ Bologna, ARCES, Bologna, Italy	Marche Polytechnic University; Griffith University; Griffith University; Menzies Health Institute Queensland; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; University of Bologna	Tomasetti, M (corresponding author), Polytechn Univ Marche, Dept Mol & Clin Sci, Ancona, Italy.	m.tomasetti@univpm.it	Santarelli, Lory/AAU-4494-2020; Neuzil, Jiri/H-7204-2014; DONG, LANFENG/S-8805-2019	Neuzil, Jiri/0000-0002-2478-2460; Nocchi, Linda/0000-0002-2113-9031; Goodwin, Jacob/0000-0002-3834-3071; Dong, Lanfeng/0000-0002-9857-6352; santarelli, lory/0000-0003-1015-7098	Prostate Cancer Foundation of Australia; Polytechnic University of Marche	Prostate Cancer Foundation of Australia; Polytechnic University of Marche	This work was supported in part by a grant from the Prostate Cancer Foundation of Australia to JN, and the additional part by the Research funding of Polytechnic University of Marche. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck R, 2011, INVEST NEW DRUG, V29, P891, DOI 10.1007/s10637-010-9441-3; Biasutto L, 2010, MITOCHONDRION, V10, P670, DOI 10.1016/j.mito.2010.06.004; Blenn C, 2011, CELL MOL LIFE SCI, V68, P1455, DOI 10.1007/s00018-010-0533-1; Boujrad H, 2007, CELL CYCLE, V6, P2612, DOI 10.4161/cc.6.21.4842; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Chen P, 2012, ANTI-CANCER DRUG, V23, P437, DOI 10.1097/CAD.0b013e32834fd01f; Chen Q, 2008, P NATL ACAD SCI USA, V105, P11105, DOI 10.1073/pnas.0804226105; Dong LF, 2008, ONCOGENE, V27, P4324, DOI 10.1038/onc.2008.69; Dong LF, 2009, CLIN CANCER RES, V15, P1593, DOI 10.1158/1078-0432.CCR-08-2439; Du JA, 2010, CLIN CANCER RES, V16, P509, DOI 10.1158/1078-0432.CCR-09-1713; Esposti MD, 2002, METHODS, V26, P335, DOI 10.1016/S1046-2023(02)00039-7; Gilloteaux J, 2010, ULTRASTRUCT PATHOL, V34, P140, DOI 10.3109/01913121003662304; Hong SJ, 2004, TRENDS PHARMACOL SCI, V25, P259, DOI 10.1016/j.tips.2004.03.005; Kang YH, 2004, INT J CANCER, V112, P385, DOI 10.1002/ijc.20424; Kassouf W, 2006, J UROLOGY, V176, P1642, DOI 10.1016/j.juro.2006.06.042; Kondo Y, 2006, AUTOPHAGY, V2, P85, DOI 10.4161/auto.2.2.2463; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lorenzo HK, 1999, CELL DEATH DIFFER, V6, P516, DOI 10.1038/sj.cdd.4400527; Moubarak RS, 2007, MOL CELL BIOL, V27, P4844, DOI 10.1128/MCB.02141-06; Neuzil H, 2002, BIOCHEM BIOPH RES CO, V293, P1309, DOI 10.1016/S0006-291X(02)00358-3; Neuzil J, 2006, FEBS LETT, V580, P5125, DOI 10.1016/j.febslet.2006.05.072; Nocchi L, 2011, J BIOL CHEM, V286, P19478, DOI 10.1074/jbc.M110.217331; Norberg E, 2008, CELL DEATH DIFFER, V15, P1857, DOI 10.1038/cdd.2008.123; Ogawa M, 2007, INT J ONCOL, V31, P323; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Paglin S, 2001, CANCER RES, V61, P439; Prochazka L, 2010, APOPTOSIS, V15, P782, DOI 10.1007/s10495-010-0482-z; Ralph SJ, 2010, MOL ASPECTS MED, V31, P29, DOI 10.1016/j.mam.2009.12.006; Rohlena J, 2011, ANTIOXID REDOX SIGN, V15, P2951, DOI 10.1089/ars.2011.3990; Sasaki R, 2008, CANCER SCI, V99, P1040, DOI 10.1111/j.1349-7006.2008.00771.x; Sevrioukova IF, 2011, ANTIOXID REDOX SIGN, V14, P2545, DOI 10.1089/ars.2010.3445; Sinha S, 2008, ONCOGENE, V27, pS137, DOI 10.1038/onc.2009.51; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tareen Basir, 2008, Int J Med Sci, V5, P62; Tomasetti M, 2010, BRIT J CANCER, V102, P1224, DOI 10.1038/sj.bjc.6605617; Valis K, 2011, CANCER RES, V71, P946, DOI 10.1158/0008-5472.CAN-10-2203; Verrax F, 2005, FREE RADICAL RES, V39, P649, DOI 10.1080/10715760500097906; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; Weber T, 2003, BIOCHEMISTRY-US, V42, P4277, DOI 10.1021/bi020527j; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yu WP, 2003, CANCER RES, V63, P2483; Zhang WW, 2012, CELL SIGNAL, V24, P1037, DOI 10.1016/j.cellsig.2011.12.025	47	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52263	10.1371/journal.pone.0052263	http://dx.doi.org/10.1371/journal.pone.0052263			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272231	gold, Green Submitted, Green Published			2022-12-27	WOS:000312483300074
J	Kahlke, T; Thorvaldsen, S				Kahlke, Tim; Thorvaldsen, Steinar			Molecular Characterization of Cold Adaptation of Membrane Proteins in the Vibrionaceae Core-Genome	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; SIGNAL PEPTIDES; STRUCTURAL ADAPTATION; SECONDARY-STRUCTURE; PREDICTION; ENZYMES; IDENTIFICATION; TEMPERATURE; SEQUENCES; BACTERIA	Cold-adaptation strategies have been studied in multiple psychrophilic organisms, especially for psychrophilic enzymes. Decreased enzyme activity caused by low temperatures as well as a higher viscosity of the aqueous environment require certain adaptations to the metabolic machinery of the cell. In addition to this, low temperature has deleterious effects on the lipid bilayer of bacterial membranes and therefore might also affect the embedded membrane proteins. Little is known about the adaptation of membrane proteins to stresses of the cold. In this study we investigate a set of 66 membrane proteins from the core genome of the bacterial family Vibrionaceae to identify general characteristics that discern psychrophilic and mesophilic membrane proteins. Bioinformatical and statistical methods were used to analyze the alignments of the three temperature groups mesophilic, intermediate and psychrophilic. Surprisingly, our results show little or no adaptation to low temperature for those parts of the proteins that are predicted to be inside the membrane. However, changes in amino acid composition and hydrophobicity are found for complete sequences and sequence parts outside the lipid bilayer. Among others, the results presented here indicate a preference for helix-breaking and destabilizing amino acids Ile, Asp and Thr and an avoidance of the helix-forming amino acid Ala in the amino acid composition of psychrophilic membrane proteins. Furthermore, we identified a lower overall hydrophobicity of psychrophilic membrane proteins in comparison to their mesophilic homologs. These results support the stability-flexibility hypothesis and link the cold-adaptation strategies of membrane proteins to those of loop regions of psychrophilic enzymes.	[Kahlke, Tim] Univ Tromso, Fac Sci & Technol, Dept Chem, Tromso, Norway; [Thorvaldsen, Steinar] Univ Tromso, Fac Sci & Technol, Dept Math & Stat, Tromso, Norway; [Kahlke, Tim] Univ Tromso, Norwegian Struct Biol Ctr, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso	Kahlke, T (corresponding author), Univ Tromso, Fac Sci & Technol, Dept Chem, Tromso, Norway.	tim.kahlke@uit.no	Thorvaldsen, Steinar/GPG-0800-2022; Kahlke, Tim/P-1065-2017	Thorvaldsen, Steinar/0000-0003-3660-1417; Kahlke, Tim/0000-0002-9762-6573	National Program for Research in Functional Genomics in Norway (FUGE)	National Program for Research in Functional Genomics in Norway (FUGE)	The presented study was supported by the National Program for Research in Functional Genomics in Norway (FUGE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Budde I, 2006, MICROBIOL-SGM, V152, P831, DOI 10.1099/mic.0.28530-0; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; D'Amico S, 2006, EMBO REP, V7, P385, DOI 10.1038/sj.embor.7400662; DEMEL RA, 1990, BIOCHIM BIOPHYS ACTA, V1027, P155, DOI 10.1016/0005-2736(90)90079-4; Di Giulio M, 2005, GENE, V346, P1, DOI 10.1016/j.gene.2004.10.008; EGIDIUS E, 1986, INT J SYST BACTERIOL, V36, P518, DOI 10.1099/00207713-36-4-518; Garrity GM, 2005, BERGEYS MANUAL SYS B, V2; Georlette D, 2004, FEMS MICROBIOL REV, V28, P25, DOI 10.1016/j.femsre.2003.07.003; Gerday C, 2007, PHYSIOLOGY AND BIOCHEMISTRY OF EXTREMOPHILES, pXV; Gianese G, 2001, PROTEIN ENG, V14, P141, DOI 10.1093/protein/14.3.141; Gromiha MM, 2005, NUCLEIC ACIDS RES, V33, pW164, DOI 10.1093/nar/gki367; Grzymski JJ, 2006, APPL ENVIRON MICROB, V72, P1532, DOI 10.1128/AEM.72.2.1532-1541.2006; Haney PJ, 1999, P NATL ACAD SCI USA, V96, P3578, DOI 10.1073/pnas.96.7.3578; IZARD JW, 1994, MOL MICROBIOL, V13, P765, DOI 10.1111/j.1365-2958.1994.tb00469.x; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kahlke T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-179; Karan Ram, 2012, Aquat Biosyst, V8, P4, DOI 10.1186/2046-9063-8-4; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Leiros HKS, 1999, EXTREMOPHILES, V3, P205; LEWIS PN, 1970, P NATL ACAD SCI USA, V65, P810, DOI 10.1073/pnas.65.4.810; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Marx JC, 2004, CELL MOL BIOL, V50, P643; Mavromatis K, 2003, PROTEIN ENG, V16, P497, DOI 10.1093/protein/gzg069; McDonald JH, 2001, MOL BIOL EVOL, V18, P741, DOI 10.1093/oxfordjournals.molbev.a003856; Merlino A, 2010, J STRUCT BIOL, V172, P343, DOI 10.1016/j.jsb.2010.08.008; Metpally RPR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-11; Myers JK, 1997, BIOCHEMISTRY-US, V36, P10923, DOI 10.1021/bi9707180; Ng SYM, 2009, J BACTERIOL, V191, P6732, DOI 10.1128/JB.00673-09; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100; Pasamontes A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-257; PONNUSWAMY PK, 1993, INT J PEPT PROT RES, V42, P326; Riley M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-210; Russel NJ, 2007, PHYSL BIOCH EXTREMOP; Russell NJ, 1997, COMP BIOCHEM PHYS A, V118, P489, DOI 10.1016/S0300-9629(97)87354-9; Scherer S, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P210, DOI 10.1007/0-387-30742-7_8; Siddiqui KS, 2006, ANNU REV BIOCHEM, V75, P403, DOI 10.1146/annurev.biochem.75.103004.142723; Stoica Costin, 2007, REGNUM PROKARYOTAE; Thorvaldsen S, 2007, EXTREMOPHILES, V11, P719, DOI 10.1007/s00792-007-0093-y; Thorvaldsen S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-573; Thorvaldsen S, 2009, COMPUT BIOL CHEM, V33, P351, DOI 10.1016/j.compbiolchem.2009.07.002; Tronelli D, 2007, FEBS J, V274, P4595, DOI 10.1111/j.1742-4658.2007.05988.x; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; VONHEIJNE G, 1989, FEBS LETT, V244, P439, DOI 10.1016/0014-5793(89)80579-4; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635	48	11	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51761	10.1371/journal.pone.0051761	http://dx.doi.org/10.1371/journal.pone.0051761			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284762	Green Published, Green Submitted, gold			2022-12-27	WOS:000312435900053
J	Kammula, EC; Motter, J; Gorgels, A; Jonas, E; Hoffmann, S; Willbold, D				Kammula, Ellen C.; Moetter, Jessica; Gorgels, Alexandra; Jonas, Esther; Hoffmann, Silke; Willbold, Dieter			Brain Transcriptome-Wide Screen for HIV-1 Nef Protein Interaction Partners Reveals Various Membrane-Associated Proteins	PLOS ONE			English	Article							CD4 CYTOPLASMIC DOMAIN; VIRUS TYPE-1 NEF; ENDOPLASMIC-RETICULUM; HEPATOCELLULAR-CARCINOMA; DOWN-REGULATION; INFECTED PATIENTS; DILEUCINE MOTIF; T-CELLS; EXPRESSION; BINDING	HIV-1 Nef protein contributes essentially to the pathology of AIDS by a variety of protein-protein-interactions within the host cell. The versatile functionality of Nef is partially attributed to different conformational states and posttranslational modifications, such as myristoylation. Up to now, many interaction partners of Nef have been identified using classical yeast two-hybrid screens. Such screens rely on transcriptional activation of reporter genes in the nucleus to detect interactions. Thus, the identification of Nef interaction partners that are integral membrane proteins, membrane-associated proteins or other proteins that do not translocate into the nucleus is hampered. In the present study, a split-ubiquitin based yeast two-hybrid screen was used to identify novel membrane-localized interaction partners of Nef. More than 80% of the hereby identified interaction partners of Nef are transmembrane proteins. The identified hits are GPM6B, GPM6A, BAP31, TSPAN7, CYB5B, CD320/TCblR, VSIG4, PMEPA1, OCIAD1, ITGB1, CHN1, PH4, CLDN10, HSPA9, APR-3, PEBP1 and B3GNT, which are involved in diverse cellular processes like signaling, apoptosis, neurogenesis, cell adhesion and protein trafficking or quality control. For a subfraction of the hereby identified proteins we present data supporting their direct interaction with HIV-1 Nef. We discuss the results with respect to many phenotypes observed in HIV infected cells and patients. The identified Nef interaction partners may help to further elucidate the molecular basis of HIV-related diseases.	[Kammula, Ellen C.; Moetter, Jessica; Gorgels, Alexandra; Hoffmann, Silke; Willbold, Dieter] Forschungszentrum Julich, Inst Complex Syst, Struct Biochem ICS 6, D-52425 Julich, Germany; [Kammula, Ellen C.; Moetter, Jessica; Jonas, Esther; Willbold, Dieter] Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany	Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf	Willbold, D (corresponding author), Forschungszentrum Julich, Inst Complex Syst, Struct Biochem ICS 6, D-52425 Julich, Germany.	d.willbold@fz-juelich.de	Willbold, Dieter/A-6280-2013; Hoffmann, Silke/H-5059-2013	Willbold, Dieter/0000-0002-0065-7366; Hoffmann, Silke/0000-0003-1414-8957	Prasidentenfond der Helmholtzgemeinschaft (HGF, Virtual Institute of Structural Biology)	Prasidentenfond der Helmholtzgemeinschaft (HGF, Virtual Institute of Structural Biology)	This work was supported by a grant from the Prasidentenfond der Helmholtzgemeinschaft (HGF, Virtual Institute of Structural Biology) to DW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; Ances BM, 2008, INT REV PSYCHIATR, V20, P89, DOI 10.1080/09540260701877670; Andras IE, 2011, METHODS MOL BIOL, V762, P355, DOI 10.1007/978-1-61779-185-7_26; Baur AS, 2011, TRENDS MICROBIOL, V19, P435, DOI 10.1016/j.tim.2011.06.002; BENICHOU S, 1994, J BIOL CHEM, V269, P30073; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Bresnahan PA, 1998, CURR BIOL, V8, P1235, DOI 10.1016/S0960-9822(07)00517-9; Cettomai D, 2009, ARCH NEUROL-CHICAGO, V66, P255, DOI 10.1001/archneurol.2008.557; Charfi C, 2011, BLOOD, V117, P1899, DOI 10.1182/blood-2010-10-311001; Cheung ST, 2005, CLIN CANCER RES, V11, P551; Craig HM, 1998, P NATL ACAD SCI USA, V95, P11229, DOI 10.1073/pnas.95.19.11229; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Drabek K, 2011, J BONE MINER RES, V26, P2045, DOI 10.1002/jbmr.435; Fernandez ME, 2010, J NEUROSCI RES, V88, P1298, DOI 10.1002/jnr.22298; Fjorback AW, 2009, J MOL NEUROSCI, V37, P191, DOI 10.1007/s12031-008-9092-4; Foster JL, 2011, J NEUROIMMUNE PHARM, V6, P230, DOI 10.1007/s11481-011-9262-y; Fukushi M, 1999, FEBS LETT, V442, P83, DOI 10.1016/S0014-5793(98)01631-7; Gallina A, 2001, VIROLOGY, V283, P7, DOI 10.1006/viro.2001.0855; Geiger R, 2011, NAT CELL BIOL, V13, P1305, DOI 10.1038/ncb2339; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; Hansen TH, 2009, NAT REV IMMUNOL, V9, P503, DOI 10.1038/nri2575; Hoffmann S, 2007, BIOL CHEM, V388, P181, DOI 10.1515/BC.2007.020; Horberg MA, 2008, JAIDS-J ACQ IMM DEF, V47, P384, DOI 10.1097/QAI.0b013e318160d53e; Huang GW, 2011, J CANCER RES CLIN, V137, P1213, DOI 10.1007/s00432-011-0987-z; Hult B, 2008, INT REV PSYCHIATR, V20, P3, DOI 10.1080/09540260701862086; Ip YC, 2007, MOL CANCER THER, V6, P2858, DOI 10.1158/1535-7163.MCT-07-0453; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Jia X, 2012, NATURE STRUCTURAL MO; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Kasper MR, 2005, J BIOL CHEM, V280, P12840, DOI 10.1074/jbc.M413538200; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kirchhoff F, 2008, CELL MOL LIFE SCI, V65, P2621, DOI 10.1007/s00018-008-8094-2; Kirchhoff F, 2010, CELL HOST MICROBE, V8, P55, DOI 10.1016/j.chom.2010.06.004; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Kwak YT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-77; Ladasky JJ, 2006, J IMMUNOL, V177, P6172, DOI 10.4049/jimmunol.177.9.6172; Lal-Nag M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-235; Lamers SL, 2010, CURR HIV RES, V8, P638, DOI 10.2174/157016210794088209; Lanzafame M, 2009, Infez Med, V17, P35; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li L, 2000, J EXP MED, V191, P1077, DOI 10.1084/jem.191.6.1077; Liu YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024477; Lu XB, 1998, IMMUNITY, V8, P647, DOI 10.1016/S1074-7613(00)80569-5; Magadan JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000869; Mobius W, 2008, NEURON GLIA BIOL, V4, P111, DOI 10.1017/S1740925X0900009X; Mukerji J, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-33; Muratori C, 2009, CELL HOST MICROBE, V6, P218, DOI 10.1016/j.chom.2009.06.009; Ng FWH, 1997, J CELL BIOL, V139, P327, DOI 10.1083/jcb.139.2.327; Ohtsuki S, 2008, J NEUROCHEM, V104, P147, DOI 10.1111/j.1471-4159.2007.05008.x; Preusser A, 2002, BIOCHEM BIOPH RES CO, V292, P734, DOI 10.1006/bbrc.2002.6700; Preusser A, 2001, J VIROL, V75, P3960, DOI 10.1128/JVI.75.8.3960-3964.2001; Quadros EV, 2009, BLOOD, V113, P186, DOI 10.1182/blood-2008-05-158949; Regan JA, 2008, J VIROL, V82, P10042, DOI 10.1128/JVI.01240-08; Reggiori F, 2011, VIRUSES-BASEL, V3, P1610, DOI 10.3390/v3091610; Roeth JF, 2006, MICROBIOL MOL BIOL R, V70, P548, DOI 10.1128/MMBR.00042-05; Rossi F, 1997, VIROLOGY, V237, P33, DOI 10.1006/viro.1997.8752; Saeed M, 2011, J BIOL CHEM, V286, P37264, DOI 10.1074/jbc.M111.259085; Shelton MN, 2012, J VIROL, V86, P406, DOI 10.1128/JVI.05720-11; Tokarev Andrey, 2011, Cell Logist, V1, P90; Tran T, 2005, BIOCHEMISTRY-US, V44, P15042, DOI 10.1021/bi051403k; Wakana Y, 2008, MOL BIOL CELL, V19, P1825, DOI 10.1091/mbc.E07-08-0781; Watanabe W, 1997, BIOCHEM BIOPH RES CO, V238, P234, DOI 10.1006/bbrc.1997.7217; Werner H, 2001, MOL CELL NEUROSCI, V18, P593, DOI 10.1006/mcne.2001.1044; Witte V, 2004, MOL CELL, V13, P179, DOI 10.1016/S1097-2765(04)00004-8; Wonderlich ER, 2011, IMMUNOL RES, V50, P228, DOI 10.1007/s12026-011-8220-3; YAN YM, 1993, NEURON, V11, P423, DOI 10.1016/0896-6273(93)90147-J; Yeung ML, 2009, J BIOL CHEM, V284, P19463, DOI 10.1074/jbc.M109.010033; Yi L, 2010, J BIOL CHEM, V285, P30884, DOI 10.1074/jbc.M110.135947; Zhang YN, 2006, IMMUNOL RES, V35, P151, DOI 10.1385/IR:35:1:151; Zheng JY, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-79; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	71	16	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51578	10.1371/journal.pone.0051578	http://dx.doi.org/10.1371/journal.pone.0051578			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284715	Green Published, gold, Green Submitted			2022-12-27	WOS:000312435900027
J	Sakamuri, SSVP; Sukapaka, M; Prathipati, VK; Nemani, H; Putcha, UK; Pothana, S; Koppala, SR; Ponday, LRK; Acharya, V; Veetill, GN; Ayyalasomayajula, V				Sakamuri, Siva Sankara Vara Prasad; Sukapaka, Mahesh; Prathipati, Vijay Kumar; Nemani, Harishankar; Putcha, Uday Kumar; Pothana, Shailaja; Koppala, Swarupa Rani; Ponday, Lakshmi Raj Kumar; Acharya, Vani; Veetill, Giridharan Nappan; Ayyalasomayajula, Vajreswari			Carbenoxolone Treatment Ameliorated Metabolic Syndrome in WNIN/Ob Obese Rats, but Induced Severe Fat Loss and Glucose Intolerance in Lean Rats	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; ADIPOSE-TISSUE; INSULIN SENSITIVITY; ZUCKER RATS; 11BETA-HYDROXYSTEROID DEHYDROGENASE; SELECTIVE-INHIBITION; HYPERGLYCEMIC MICE; VISCERAL OBESITY; MESSENGER-RNA; RESISTANCE	Background: 11beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) regulates local glucocorticoid action in tissues by catalysing conversion of inactive glucocorticoids to active glucocorticoids. 11 beta-HSD1 inhibition ameliorates obesity and associated co-morbidities. Here, we tested the effect of 11 beta-HSD inhibitor, carbenoxolone (CBX) on obesity and associated comorbidities in obese rats of WNIN/Ob strain, a new animal model for genetic obesity. Methodology/Principal Findings: Subcutaneous injection of CBX (50 mg/kg body weight) or volume-matched vehicle was given once daily for four weeks to three month-old WNIN/Ob lean and obese rats (n = 6 for each phenotype and for each treatment). Body composition, plasma lipids and hormones were assayed. Hepatic steatosis, adipose tissue morphology, inflammation and fibrosis were also studied. Insulin resistance and glucose intolerance were determined along with tissue glycogen content. Gene expressions were determined in liver and adipose tissue. CBX significantly inhibited 11 beta-HSD1 activity in liver and adipose tissue of WNIN/Ob lean and obese rats. CBX significantly decreased body fat percentage, hypertriglyceridemia, hypercholesterolemia, insulin resistance in obese rats. CBX ameliorated hepatic steatosis, adipocyte hypertrophy, adipose tissue inflammation and fibrosis in obese rats. Tissue glycogen content was significantly decreased by CBX in liver and adipose tissue of obese rats. Severe fat loss and glucose-intolerance were observed in lean rats after CBX treatment. Conclusions/Significance: We conclude that 11 beta-HSD1 inhibition by CBX decreases obesity and associated co-morbidities in WNIN/Ob obese rats. Our study supports the hypothesis that inhibition of 11 beta-HSD1 is a key strategy to treat metabolic syndrome. Severe fat loss and glucose-intolerance by CBX treatment in lean rats suggest that chronic 11 beta-HSD1 inhibition may lead to insulin resistance in normal conditions.	[Sakamuri, Siva Sankara Vara Prasad; Prathipati, Vijay Kumar; Koppala, Swarupa Rani; Ponday, Lakshmi Raj Kumar; Acharya, Vani; Ayyalasomayajula, Vajreswari] Indian Council Med Res, Natl Inst Nutr, Dept Biochem, Hyderabad 500007, Andhra Pradesh, India; [Sukapaka, Mahesh; Nemani, Harishankar; Pothana, Shailaja; Veetill, Giridharan Nappan] Indian Council Med Res, Natl Ctr Lab Anim Sci, Dept Anim Physiol, Hyderabad 500007, Andhra Pradesh, India; [Putcha, Uday Kumar] Indian Council Med Res, Natl Inst Nutr, Dept Pathol, Hyderabad 500007, Andhra Pradesh, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN); Indian Council of Medical Research (ICMR); ICMR - National Animal Resource Facility for Biomedical Research (NARFBR); Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN)	Ayyalasomayajula, V (corresponding author), Indian Council Med Res, Natl Inst Nutr, Dept Biochem, Jamai Osmania Po, Hyderabad 500007, Andhra Pradesh, India.	vaj_lipidresearch@yahoo.com		Sakamuri, Siva Sankara Vara Prasad/0000-0003-3569-9985	Council of Scientific and Industrial Research (CSIR), India	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	We are grateful to Dr. B. Sesikeran, Director, of the Institute for constant encouragement during the conduct of the study. SSSVP thanks the Council of Scientific and Industrial Research (CSIR), India for the award of a research fellowship to carry out this work. SSSVP thanks Ms. M. V. Surekha and Mr. P. Srinivas for helping in histopathology-studies. SSSVP thanks Mr. Venu for helping in animal experiment & Mr. Murali for helping in western blotting.	Alberts P, 2003, ENDOCRINOLOGY, V144, P4755, DOI 10.1210/en.2003-0344; Alberts P, 2002, DIABETOLOGIA, V45, P1528, DOI 10.1007/s00125-002-0959-6; Andrews RC, 2003, J CLIN ENDOCR METAB, V88, P285, DOI 10.1210/jc.2002-021194; Berthiaume M, 2007, AM J PHYSIOL-ENDOC M, V293, pE1045, DOI 10.1152/ajpendo.00276.2007; Berthiaume M, 2007, ENDOCRINOLOGY, V148, P2391, DOI 10.1210/en.2006-1199; Capel F, 2009, DIABETES, V58, P1558, DOI 10.2337/db09-0033; Draper N, 2005, J ENDOCRINOL, V186, P251, DOI 10.1677/joe.1.06019; ElHadri K, 1997, BIOCHEM J, V323, P359, DOI 10.1042/bj3230359; Farb MG, 2011, J AM COLL CARDIOL, V58, P232, DOI 10.1016/j.jacc.2011.01.051; FOLCH J, 1957, J BIOL CHEM, V226, P497; Giridharan N., 1996, Scandinavian Journal of Laboratory Animal Science, V23, P131; HAUNER H, 1987, J CLIN ENDOCR METAB, V64, P832, DOI 10.1210/jcem-64-4-832; Hermanowski-Vosatka A, 2005, J EXP MED, V202, P517, DOI 10.1084/jem.20050119; Jeyakumar SM, 2007, OBESITY, V15, P322, DOI 10.1038/oby.2007.534; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Kim H, 2006, AM J PHYSIOL-ENDOC M, V290, pE1227, DOI 10.1152/ajpendo.00344.2005; KOUBI H, 1991, CAN J PHYSIOL PHARM, V69, P841, DOI 10.1139/y91-127; Liu J, 2011, ENDOCR J, V58, P199, DOI 10.1507/endocrj.K10E-318; Livingstone DEW, 2003, J PHARMACOL EXP THER, V305, P167, DOI 10.1124/jpet.102.044842; Livingstone DEW, 2000, ENDOCRINOLOGY, V141, P560, DOI 10.1210/en.141.2.560; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Morton NM, 2004, DIABETES, V53, P931, DOI 10.2337/diabetes.53.4.931; Muller C, 1997, DIABETOLOGIA, V40, P463, DOI 10.1007/s001250050701; Nuotio-Antar AM, 2007, AM J PHYSIOL-ENDOC M, V293, pE1517, DOI 10.1152/ajpendo.00522.2007; Paterson JM, 2004, P NATL ACAD SCI USA, V101, P7088, DOI 10.1073/pnas.0305524101; Paulmyer-Lacroix O, 2002, J CLIN ENDOCR METAB, V87, P2701, DOI 10.1210/jc.87.6.2701; Prasad SSSV, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-132; Rask E, 2001, J CLIN ENDOCR METAB, V86, P1418, DOI 10.1210/jc.86.3.1418; Rosmond R, 1998, J CLIN ENDOCR METAB, V83, P1853, DOI 10.1210/jc.83.6.1853; Schoiswohl G, 2010, J LIPID RES, V51, P490, DOI 10.1194/jlr.M001073; Seckl JR, 2004, RECENT PROG HORM RES, V59, P359, DOI 10.1210/rp.59.1.359; Silver DL, 1999, J BIOL CHEM, V274, P4140, DOI 10.1074/jbc.274.7.4140; Tomlinson JW, 2004, ENDOCR REV, V25, P831, DOI 10.1210/er.2003-0031; Venu L, 2004, DIABETOLOGIA, V47, P1493, DOI 10.1007/s00125-004-1506-4; Wamil M, 2011, DIABETES, V60, P1158, DOI 10.2337/db10-0830; Wang QH, 1999, MOL CELL BIOL, V19, P4008; Xue B, 2007, J BIOL CHEM, V282, P23829, DOI 10.1074/jbc.M609680200	38	21	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e50216	10.1371/journal.pone.0050216	http://dx.doi.org/10.1371/journal.pone.0050216			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284633	Green Published, Green Submitted, gold			2022-12-27	WOS:000312435900006
J	Wei, W; Lampe, L; Park, S; Vangara, BS; Waldo, GS; Cabantous, S; Subaran, SS; Yang, DM; Lakatta, EG; Lin, L				Wei, Wen; Lampe, Leonie; Park, Sungha; Vangara, Bhavana S.; Waldo, Geoffrey S.; Cabantous, Stephanie; Subaran, Sarah S.; Yang, Dongmei; Lakatta, Edward G.; Lin, Li			Disulfide Bonds within the C2 Domain of RAGE Play Key Roles in Its Dimerization and Biogenesis	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; INFLAMMATORY CELL RECRUITMENT; PEPTIDE-N-GLYCANASE; ENDOPLASMIC-RETICULUM; PATTERN-RECOGNITION; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; IMMUNE-RESPONSES; ENDPRODUCTS RAGE; REDOX REGULATION	Background: The receptor for advanced glycation end products (RAGE) on the cell surface transmits inflammatory signals. A member of the immunoglobulin superfamily, RAGE possesses the V, C1, and C2 ectodomains that collectively constitute the receptor's extracellular structure. However, the molecular mechanism of RAGE biogenesis remains unclear, impeding efforts to control RAGE signaling through cellular regulation. Methodology and Result: We used co-immunoprecipitation and crossing-linking to study RAGE oligomerization and found that RAGE forms dimer-based oligomers. Via non-reducing SDS-polyacrylamide gel electrophoresis and mutagenesis, we found that cysteines 259 and 301 within the C2 domain form intermolecular disulfide bonds. Using a modified tripartite split GFP complementation strategy and confocal microscopy, we also found that RAGE dimerization occurs in the endoplasmic reticulum (ER), and that RAGE mutant molecules without the double disulfide bridges are unstable, and are subjected to the ER-associated degradation. Conclusion: Disulfide bond-mediated RAGE dimerization in the ER is the critical step of RAGE biogenesis. Without formation of intermolecular disulfide bonds in the C2 region, RAGE fails to reach cell surface. Significance: This is the first report of RAGE intermolecular disulfide bond.	[Wei, Wen; Lampe, Leonie; Park, Sungha; Vangara, Bhavana S.; Subaran, Sarah S.; Yang, Dongmei; Lakatta, Edward G.; Lin, Li] Natl Inst Aging, Cardiovasc Sci Lab, Baltimore, MD USA; [Waldo, Geoffrey S.; Cabantous, Stephanie] Los Alamos Natl Lab, Biosci Lab, Los Alamos, NM USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); United States Department of Energy (DOE); Los Alamos National Laboratory	Lin, L (corresponding author), Natl Inst Aging, Cardiovasc Sci Lab, Baltimore, MD USA.	linli@mail.nih.gov	Cabantous, Stephanie/AAB-5113-2020; Cabantous, Stephanie/M-3282-2014; Lakatta, Edward G/AAL-1447-2020	Cabantous, Stephanie/0000-0002-8406-9421; Cabantous, Stephanie/0000-0002-8406-9421; Lakatta, Edward/0000-0002-4772-0035	National Institutes of Health, National Institute on Aging; NIH [RO1CA94102]; NIH Protein Structure Initiative [U54 GM074946-01US]; Oak Ridge Institute for Science and Education's Research Associates Program at the NIH; Roland Ernst Foundation; Korea Research Foundation [KRF-2009-013-E00008]; NIH, NIA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000796] Funding Source: NIH RePORTER	National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Protein Structure Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oak Ridge Institute for Science and Education's Research Associates Program at the NIH; Roland Ernst Foundation; Korea Research Foundation(National Research Foundation of Korea); NIH, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by the Intramural Research Program of the National Institutes of Health, National Institute on Aging (L. Lin and EGL), the NIH grant RO1CA94102 (L. Lin), and the NIH Protein Structure Initiative (U54 GM074946-01US, "Integrated Center for Structure and Function Innovation") (GSW and SC). WW and DY were supported in part by the Oak Ridge Institute for Science and Education's Research Associates Program at the NIH; L. Lampe was supported in part by the Roland Ernst Foundation; SP was supported in part by the Korea Research Foundation grant (KRF-2009-013-E00008; BV was supported by 2009 and 2010 Summer Student Internship Program of NIH, NIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2005, J NEUROCHEM, V92, P255, DOI 10.1111/j.1471-4159.2004.02864.x; Ahner A, 2004, TRENDS CELL BIOL, V14, P474, DOI 10.1016/j.tcb.2004.07.013; Allen RG, 2000, FREE RADICAL BIO MED, V28, P463, DOI 10.1016/S0891-5849(99)00242-7; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800; Chen VM, 2006, J THROMB HAEMOST, V4, P2533, DOI 10.1111/j.1538-7836.2006.02236.x; Dattilo BM, 2007, BIOCHEMISTRY-US, V46, P6957, DOI 10.1021/bi7003735; Hanford LE, 2004, J BIOL CHEM, V279, P50019, DOI 10.1074/jbc.M409782200; He M, 2011, EMBO REP, V12, P358, DOI 10.1038/embor.2011.28; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Janssen-Heininger YM, ANN N Y ACAD SCI, V1203, P23; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; Katiyar S, 2004, P NATL ACAD SCI USA, V101, P13774, DOI 10.1073/pnas.0405663101; Kinnula VL, 2007, CURR MED CHEM, V14, P213, DOI 10.2174/092986707779313345; Koch M, 2010, STRUCTURE, V18, P1342, DOI 10.1016/j.str.2010.05.017; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Lin L, 2000, EMBO J, V19, P4712, DOI 10.1093/emboj/19.17.4712; Lin L, 2006, CELL MOL IMMUNOL, V3, P351; Lin L, 2009, FRONT BIOSCI-LANDMRK, V14, P1403, DOI 10.2741/3315; Matthias LJ, 2003, ANTIOXID REDOX SIGN, V5, P133, DOI 10.1089/152308603321223621; Matthias LJ, 2002, NAT IMMUNOL, V3, P727, DOI 10.1038/ni815; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Orlova VV, 2007, EMBO J, V26, P1129, DOI 10.1038/sj.emboj.7601552; Pang J, 2009, PROTEIN SCI, V18, P1261, DOI 10.1002/pro.136; Park H, 2001, P NATL ACAD SCI USA, V98, P11163, DOI 10.1073/pnas.201393498; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987; Schwertassek U, 2007, EMBO J, V26, P3086, DOI 10.1038/sj.emboj.7601746; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Thornalley PJ, 2005, ANN NY ACAD SCI, V1043, P111, DOI 10.1196/annals.1333.014; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Urbonaviciute V, 2008, J EXP MED, V205, P3007, DOI 10.1084/jem.20081165; Uribarri J, 2007, J GERONTOL A-BIOL, V62, P427, DOI 10.1093/gerona/62.4.427; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; WALTER P, 1984, CELL, V38, P5, DOI 10.1016/0092-8674(84)90520-8; Xie JJ, 2008, J BIOL CHEM, V283, P27255, DOI 10.1074/jbc.M801622200; Xie J, 2007, J BIOL CHEM, V282, P4218, DOI 10.1074/jbc.M608888200; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yan SF, 2007, CURR MOL MED, V7, P699; Yan SF, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S146239940900101X; Yan SF, 2009, J MOL MED, V87, P235, DOI 10.1007/s00109-009-0439-2; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Yonekura H, 2003, BIOCHEM J, V370, P1097, DOI 10.1042/BJ20021371; Zong HL, 2010, J BIOL CHEM, V285, P23135, DOI 10.1074/jbc.M110.133827	45	29	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e50736	10.1371/journal.pone.0050736	http://dx.doi.org/10.1371/journal.pone.0050736			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284645	Green Submitted, gold, Green Published			2022-12-27	WOS:000312435900008
J	Zhang, JP; Lu, HY; Gu, WF; Wu, NQ; Zhou, KS; Hu, YY; Xin, YJ; Wang, C				Zhang, Jianping; Lu, Houyuan; Gu, Wanfa; Wu, Naiqin; Zhou, Kunshu; Hu, Yayi; Xin, Yingjun; Wang, Can			Early Mixed Farming of Millet and Rice 7800 Years Ago in the Middle Yellow River Region, China	PLOS ONE			English	Article							PHYTOLITH EVIDENCE; LOWER YANGTZE; DOMESTICATION; AGRICULTURE; WILD; CLASSIFICATION; RECONSTRUCTION; CULTIVATION; GRASSES; ORIGINS	The Peiligang Culture (9000-7000 cal. yr BP) in the Middle Yellow River region, North China, has long been considered representative of millet farming. It is still unclear, however, if broomcorn millet or foxtail millet was the first species domesticated during the Peiligang Culture. Furthermore, it is also unknown whether millet was cultivated singly or together with rice at the same period. In this study, phytolith analysis of samples from the Tanghu archaeological site reveals early crop information in the Middle Yellow River region, China. Our results show that broomcorn millet was the early dry farming species in the Peiligang Culture at 7800 cal. yr BP, while rice cultivation took place from 7800 to 4500 cal. yr BP. Our data provide new evidence of broomcorn millet and rice mixed farming at 7800 cal. yr BP in the Middle Yellow River region, which has implications for understanding the domestication process of the two crops, and the formation and continuance of the Ancient Yellow River Civilization.	[Zhang, Jianping; Lu, Houyuan; Wu, Naiqin; Zhou, Kunshu; Wang, Can] Chinese Acad Sci, Inst Geol & Geophys, Key Lab Cenozo Geol & Environm, Beijing, Peoples R China; [Gu, Wanfa; Hu, Yayi; Xin, Yingjun] Zhengzhou Prov Cultural Relics & Archaeol Res Ins, Zhengzhou, Peoples R China; [Wang, Can] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, JP (corresponding author), Chinese Acad Sci, Inst Geol & Geophys, Key Lab Cenozo Geol & Environm, Beijing, Peoples R China.	jpzhang@mail.iggcas.ac.cn	WANG, CAN/GWV-0969-2022; Lu, houyuan/AAD-3100-2019; Lu, houyuan/L-8661-2019; Liu, Kam-Biu/B-4966-2012; Zhang, Jianping/A-8167-2014	Lu, houyuan/0000-0001-5721-6679; Liu, Kam-Biu/0000-0002-0038-2198; Zhang, Jianping/0000-0003-0815-009X	National Natural Science Foundation of China [41102111]; "Strategic Priority Research Program" of the Chinese Academy of Sciences [XDA05130401, XDA05130602]; Key Program of the National Science Foundation of China [41230104]; National Basic Research Program of China [2010CB950201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Strategic Priority Research Program" of the Chinese Academy of Sciences(Chinese Academy of Sciences); Key Program of the National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (Grant No. 41102111), "Strategic Priority Research Program" of the Chinese Academy of Sciences (Grant Nos. XDA05130401 and XDA05130602), the Key Program of the National Science Foundation of China (Grant No. 41230104), and the National Basic Research Program of China (Grant No. 2010CB950201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, ASIAN PERSPECT, V45, P129; Barton L, 2009, P NATL ACAD SCI USA, V106, P5523, DOI 10.1073/pnas.0809960106; Chang K. -C, 1986, ARCHAEOLOGY ANCIENT; Chen X, 2003, ACTA ARCHAEOLOGICA S, P161; Cohen DJ, 2011, CURR ANTHROPOL, V52, pS273, DOI 10.1086/659965; Crawford G.W., 2006, E ASIA ARCHAEOLOGY, V3, P247; Crawford GW, 2006, BLACKW STUD GLOB ARC, P77, DOI 10.1002/9780470774670.ch5; Fujiwara H, 1976, ARCHAEOLOGY NATURAL, V9, P15; Fuller DQ, 2007, ANTIQUITY, V81, P316, DOI 10.1017/S0003598X0009520X; Fuller DQ, 2009, SCIENCE, V323, P1607, DOI 10.1126/science.1166605; Gu Y, 2012, QUATERN INT IN PRESS; Itzstein-Davey F, 2007, J ARCHAEOL SCI, V34, P2101, DOI 10.1016/j.jas.2007.02.018; Kondo R., 1994, OPAL PHYTOLITHS NZ; Lee GA, 2007, P NATL ACAD SCI USA, V104, P1087, DOI 10.1073/pnas.0609763104; Li XQ, 2007, HOLOCENE, V17, P555, DOI 10.1177/0959683607078978; Ling Q, 2006, DONGFANG KAOGU, V3, P307; Liu C, 2004, CULTURAL RELICS CENT, P26; Liu L, 2012, CAMB WOR ARCHAEOL, P1, DOI 10.1017/CBO9781139015301; Liu L, 2007, HOLOCENE, V17, P1059, DOI 10.1177/0959683607085121; Liu L, 2010, ANTIQUITY, V84, P816, DOI 10.1017/S0003598X00100249; Liu Li, 2004, CHINESE NEOLITHIC TR; Lu HY, 2006, QUATERNARY SCI REV, V25, P945, DOI 10.1016/j.quascirev.2005.07.014; Lu HY, 2009, P NATL ACAD SCI USA, V106, P7367, DOI 10.1073/pnas.0900158106; Lu HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004448; Lu HY, 2005, NATURE, V437, P967, DOI 10.1038/437967a; Lu HY, 2003, ESTUAR COAST SHELF S, V58, P587, DOI 10.1016/S0272-7714(03)00137-9; Lu HY, 2003, DIVERS DISTRIB, V9, P73, DOI 10.1046/j.1472-4642.2003.00166.x; Lu HY, 2002, BOREAS, V31, P378, DOI 10.1080/030094802320942581; Lu HY, 1998, THESIS CHINESE ACAD; Lu Q.S., 1999, SORGHUM; Lu T.L.D., 2002, ASIAN PERSPECT, V41, P1, DOI [10.1353/asi.2002.0007, DOI 10.1353/asi.2002.0007]; Mulholland S. C., 1992, PHYTOLITH SYSTEMATIC, P65; Pearsall DM., 2015, PALEOETHNOBOTANY HDB; Pearson GW, 1993, RADIOCARBON, V35, P193; Piperno D.R., 2006, PHYTOLITH COMPREHENS; Piperno D.R., 1988, PHYTOLITH ANAL ARCHA; Piperno DR, 2009, QUATERN INT, V193, P146, DOI 10.1016/j.quaint.2007.11.011; Qin L., 2009, NANJIAOKOU SANMENXIA, P427; Qin L., 2012, ARCHAEOBOTANICAL RES, P260; Runge F, 1999, REV PALAEOBOT PALYNO, V107, P23, DOI 10.1016/S0034-6667(99)00018-4; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904; TWISS PC, 1969, SOIL SCI SOC AM PRO, V33, P109, DOI 10.2136/sssaj1969.03615995003300010030x; Wang J, 1984, AGR ARCHAEOLOGY, P276; Wang Y., 1993, STUDY PHYTOLITH ITS; Xin Y, 2010, ARCHAEOLOGY, P387; Xu T, 1998, CULTURAL RELICS CENT, P12; Zhang JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019726; Zhang JP, 2010, BOREAS, V39, P592, DOI 10.1111/j.1502-3885.2010.00145.x; Zhang JZ, 1998, ANTIQUITY, V72, P897; Zhang S, 2007, CHINA CULTURAL RELIC; Zhang S, 2008, ARCHAEOLOGY, P387; [张永辉 Zhang Yonghui], 2011, [第四纪研究, Quaternary Sciences], V31, P891; Zhao ZJ, 2011, CURR ANTHROPOL, V52, pS295, DOI 10.1086/659308; Zhao ZJ, 1998, ECON BOT, V52, P134, DOI 10.1007/BF02861201; Zhao ZJ, 1998, ANTIQUITY, V72, P885, DOI 10.1017/S0003598X00087524; Zheng YF, 2003, J ARCHAEOL SCI, V30, P1215, DOI 10.1016/S0305-4403(02)00248-0; Zheng YunFei, 2003, Environmental Archaeology, V8, P177, DOI 10.1179/env.2003.8.2.177; Zheng YunFei, 1999, Chinese Journal of Rice Science, V13, P25; Zheng YunFei, 2004, Chinese Journal of Rice Science, V18, P119; [No title captured]	60	66	83	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52146	10.1371/journal.pone.0052146	http://dx.doi.org/10.1371/journal.pone.0052146			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	055RZ	23284907	Green Submitted, Green Published, gold			2022-12-27	WOS:000312435900080
J	Labeit, AM; Klotsche, J; Pieper, L; Pittrow, D; Einsle, F; Stalla, GK; Lehnert, H; Silber, S; Zeiher, AM; Marz, W; Wehling, M; Wittchen, HU				Labeit, Alexander Michael; Klotsche, Jens; Pieper, Lars; Pittrow, David; Einsle, Franziska; Stalla, Guenter Karl; Lehnert, Hendrik; Silber, Sigmund; Zeiher, Andreas Michael; Maerz, Winfried; Wehling, Martin; Wittchen, Hans-Ulrich			Changes in the Prevalence, Treatment and Control of Hypertension in Germany? A Clinical-Epidemiological Study of 50.000 Primary Care Patients	PLOS ONE			English	Article							SYSTOLIC BLOOD-PRESSURE; EUROPEAN COUNTRIES; RISK-FACTORS; MANAGEMENT; POPULATION; TRENDS; RECOMMENDATIONS; AWARENESS; CANADA; HEALTH	Introduction: Medical societies have developed guidelines for the detection, treatment and control of hypertension (HTN). Our analysis assessed the extent to which such guidelines were implemented in Germany in 2003 and 2001. Methods: Using standardized clinical diagnostic and treatment appraisal forms, blood pressure levels and patient questionnaires for 55,518 participants from the cross-sectional Targets and Essential Data for Commitment of Treatment (DETECT) study (2003) were analyzed. Physician's diagnosis of hypertension (HTNdoc) was defined as coding hypertension in the clinical appraisal questionnaire. Alternative definitions used were physician's diagnosis or the patient's self-reported diagnosis of hypertension (HTNdoc,pat), physician's or patient's self-reported diagnosis or a BP measurement with a systolic BP >= 140 mmHg and/or a diastolic BP >= 90 (HTNdoc,pat,bp) and diagnosis according to the National Health and Nutrition Examination Survey (HTNNHANES). The results were compared with the similar German HYDRA study to examine whether changes had occurred in diagnosis, treatment and adequate blood pressure control (BP below 140/90 mmHg) since 2001. Factors associated with pharmacotherapy and control were determined. Results: The overall prevalence rate for hypertension was 35.5% according to HTNdoc and 56.0% according to NHANES criteria. Among those defined by NHANES criteria, treatment and control rates were 56.0% and 20.3% in 2003, and these rates had improved from 55.3% and 18.0% in 2001. Significant predictors of receiving antihypertensive medication were: increasing age, female sex, obesity, previous myocardial infarction and the prevalence of comorbid conditions such as coronary heart disease (CHD), hyperlipidemia and diabetes mellitus (DM). Significant positive predictors of adequate blood pressure control were CHD and antihypertensive medication. Inadequate control was associated with increasing age, male sex and obesity. Conclusions: Rates of treated and controlled hypertension according to NHANES criteria in DETECT remained low between 2001 and 2003, although there was some minor improvement.	[Labeit, Alexander Michael; Wehling, Martin] Heidelberg Univ, Inst Expt & Clin Pharmacol & Toxicol, Med Fac Mannheim, Heidelberg, Germany; [Labeit, Alexander Michael] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Klotsche, Jens; Pieper, Lars; Pittrow, David; Einsle, Franziska; Wittchen, Hans-Ulrich] Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, Dresden, Germany; [Klotsche, Jens; Pieper, Lars; Pittrow, David; Einsle, Franziska; Wittchen, Hans-Ulrich] Tech Univ Dresden, Ctr Clin Epidemiol & Longitudinal Studies, Dresden, Germany; [Lehnert, Hendrik] Med Univ Lubeck, Dept Internal Med 1, D-23538 Lubeck, Germany; [Stalla, Guenter Karl] Max Planck Inst Psychiat, D-8000 Munich, Germany; [Zeiher, Andreas Michael] Goethe Univ Frankfurt, Dept Internal Med 3, Frankfurt, Germany; [Maerz, Winfried] Synlab Serv GmbH, Synlab Acad, Mannheim, Germany; [Maerz, Winfried] Heidelberg Univ, Mannheim Inst Publ Hlth, Med Fac Mannheim, D-6800 Mannheim, Germany; [Maerz, Winfried] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria	Ruprecht Karls University Heidelberg; University of Leicester; Technische Universitat Dresden; Technische Universitat Dresden; University of Lubeck; Max Planck Society; Goethe University Frankfurt; SYNLAB Group; Ruprecht Karls University Heidelberg; Medical University of Graz	Labeit, AM (corresponding author), Heidelberg Univ, Inst Expt & Clin Pharmacol & Toxicol, Med Fac Mannheim, Heidelberg, Germany.	al247@le.ac.uk	Wittchen, Hans-Ulrich/ABA-8901-2020; Labeit, Alexander/AAB-2707-2019; Wittchen, Hans-Ulrich/A-8507-2014; Pittrow, David/AAY-5042-2021	Wittchen, Hans-Ulrich/0000-0002-6311-7711; 	Pfizer; Sanofi-Aventis; Novartis; Takeda; Roche; Bristol-Myers; Daichii-Sankyo; Lilly; Novo-Nordisk	Pfizer(Pfizer); Sanofi-Aventis(Sanofi-Aventis); Novartis(Novartis); Takeda(Takeda Pharmaceutical Company Ltd); Roche(Roche Holding); Bristol-Myers(Bristol-Myers Squibb); Daichii-Sankyo(Daiichi Sankyo Company Limited); Lilly(Eli Lilly); Novo-Nordisk(Novo Nordisk)	The study was supported by an unrestricted educational grant from Pfizer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.; The authors have read the journal's policy and have the following conflicts: Alexander Michael Labeit, Jens Klotsche, Lars Pieper, David Pittrow, Franziska Einsle, Gunter Karl Stalla, Hendrik Lehnert, Andreas Michael Zeiher, Hans-Ulrich Wittchen: none. Sigmund Silber: The author served as an advisor or consultant for Abbott Laboratories, Boston Scientific, Medtronic. Martin Wehling: The author was employed by AstraZeneca R&D, Molndal, as director of discovery medicine (translational medicine) from 2003-2006, while on sabbatical leave from his professorship at the University of Heidelberg. After return to this position in January 2007, he receives lecturing and consulting fees from Sanofi-Aventis, Novartis, Takeda, Roche, Pfizer, Bristol-Myers, Daichii-Sankyo, Lilly and Novo-Nordisk. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. Winfried Marz is affiliated with Synlab Academy, Synlab Services GmbH, Mannheim, Germany, though it has no bearing on this manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; BURT VL, 1995, HYPERTENSION, V26, P60, DOI 10.1161/01.HYP.26.1.60; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Duggirala MK, 2005, AM J HYPERTENS, V18, P833, DOI 10.1016/j.amjhyper.2004.12.016; Gasse C, 2001, J HUM HYPERTENS, V15, P27, DOI 10.1038/sj.jhh.1001120; Hackam DG, 2010, CAN J CARDIOL, V26, P249, DOI 10.1016/S0828-282X(10)70379-2; Hajjar I, 2006, ANNU REV PUBL HEALTH, V27, P465, DOI 10.1146/annurev.publhealth.27.021405.102132; Hyman DJ, 2001, NEW ENGL J MED, V345, P479, DOI 10.1056/NEJMoa010273; Janhsen K, 2008, HYPERTONIE; Lloyd-Jones DM, 2005, JAMA-J AM MED ASSOC, V294, P466, DOI 10.1001/jama.294.4.466; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Meisinger C, 2006, J HYPERTENS, V24, P293, DOI 10.1097/01.hjh.0000200508.10324.8e; National Institute for Health and Clinical Excellence, 2011, HYPERT CLIN MAN PRI; National Institute for Health and Clinical Excellence, 2008, PREV CARD DIS POP LE, V25; Pieper L, 2005, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V48, P1374, DOI 10.1007/s00103-005-1164-9; Pittrow D, 2004, EUR J CLIN PHARMACOL, V60, P135, DOI 10.1007/s00228-004-0731-6; Powers BJ, 2011, ANN INTERN MED, V154, P781, DOI 10.7326/0003-4819-154-12-201106210-00005; Raum E, 2008, PHARMACOEPIDEM DR S, V17, P485, DOI 10.1002/pds.1589; Sharma AM, 2004, J HYPERTENS, V22, P479, DOI 10.1097/00004872-200403000-00009; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; STOCKWELL DH, 1994, AM J PUBLIC HEALTH, V84, P1768, DOI 10.2105/AJPH.84.11.1768; Thamm M, 1999, Gesundheitswesen, V61 Spec No, pS90; Turnbull F, 2005, ARCH INTERN MED, V165, P1410; Wang YR, 2007, ARCH INTERN MED, V167, P141, DOI 10.1001/archinte.167.2.141; Wittchen H U, 2003, Fortschr Med Orig, V121 Suppl 1, P2; Wittchen HU, 2005, CURR MED RES OPIN, V21, P619, DOI 10.1185/030079905X38187; Wolf-Maier K, 2004, HYPERTENSION, V43, P10, DOI 10.1161/01.HYP.0000103630.72812.10; Wolf-Maier K, 2003, JAMA-J AM MED ASSOC, V289, P2363, DOI 10.1001/jama.289.18.2363; World Health Organization, 2008, 2008 2013 ACT PLAN G; Zanchetti A, 2009, J HYPERTENS, V27, P923, DOI 10.1097/HJH.0b013e32832aa6b5	31	34	64	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52229	10.1371/journal.pone.0052229	http://dx.doi.org/10.1371/journal.pone.0052229			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23284945	Green Published, gold, Green Submitted			2022-12-27	WOS:000313051500025
J	Bragonzi, A; Farulla, I; Paroni, M; Twomey, KB; Pirone, L; Lore, NI; Bianconi, I; Dalmastri, C; Ryan, RP; Bevivino, A				Bragonzi, Alessandra; Farulla, Ilaria; Paroni, Moira; Twomey, Kate B.; Pirone, Luisa; Lore, Nicola Ivan; Bianconi, Irene; Dalmastri, Claudia; Ryan, Robert P.; Bevivino, Annamaria			Modelling Co-Infection of the Cystic Fibrosis Lung by Pseudomonas aeruginosa and Burkholderia cenocepacia Reveals Influences on Biofilm Formation and Host Response	PLOS ONE			English	Article							CEPACIA; INFECTIONS; APOPTOSIS; VIRULENCE; DYNAMICS; STRAINS	The Gram-negative bacteria Pseudomonas aeruginosa and Burkholderia cenocepacia are opportunistic human pathogens that are responsible for severe nosocomial infections in immunocompromised patients and those suffering from cystic fibrosis (CF). These two bacteria have been shown to form biofilms in the airways of CF patients that make such infections more difficult to treat. Only recently have scientists begun to appreciate the complicated interplay between microorganisms during polymicrobial infection of the CF airway and the implications they may have for disease prognosis and response to therapy. To gain insight into the possible role that interaction between strains of P. aeruginosa and B. cenocepacia may play during infection, we characterised co-inoculations of in vivo and in vitro infection models. Co-inoculations were examined in an in vitro biofilm model and in a murine model of chronic infection. Assessment of biofilm formation showed that B. cenocepacia positively influenced P. aeruginosa biofilm development by increasing biomass. Interestingly, co-infection experiments in the mouse model revealed that P. aeruginosa did not change its ability to establish chronic infection in the presence of B. cenocepacia but co-infection did appear to increase host inflammatory response. Taken together, these results indicate that the co-infection of P. aeruginosa and B. cenocepacia leads to increased biofilm formation and increased host inflammatory response in the mouse model of chronic infection. These observations suggest that alteration of bacterial behavior due to interspecies interactions may be important for disease progression and persistent infection.	[Bragonzi, Alessandra; Paroni, Moira; Lore, Nicola Ivan; Bianconi, Irene] Ist Sci San Raffaele, Infect & Cyst Fibrosis Unit, Div Immunol Transplantat & Infect Dis, I-20132 Milan, Italy; [Farulla, Ilaria; Pirone, Luisa; Dalmastri, Claudia; Bevivino, Annamaria] ENEA Casaccia Res Ctr, Tech Unit Sustainable Dev & Innovat Agroind Syst, Rome, Italy; [Twomey, Kate B.; Ryan, Robert P.] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, BioSci Inst, Cork, Ireland	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Italian National Agency New Technical Energy & Sustainable Economics Development; University College Cork	Bevivino, A (corresponding author), ENEA Casaccia Res Ctr, Tech Unit Sustainable Dev & Innovat Agroind Syst, Rome, Italy.	annamaria.bevivino@enea.it	Bragonzi, Alessandra/AAC-6751-2022; Lorè, Nicola Ivan/K-9285-2016; Paroni, Moira/K-6470-2016; Dalmastri, Claudia/AAD-1627-2021; Bevivino, Annamaria/F-4060-2015	Lorè, Nicola Ivan/0000-0001-9159-1632; Paroni, Moira/0000-0001-8199-3128; Bevivino, Annamaria/0000-0003-4277-7048; Bianconi, Irene/0000-0002-5923-4296; Ryan, Rober/0000-0002-7353-0913; Bragonzi, Alessandra/0000-0002-5808-7669	Italian Cystic Fibrosis Research Foundation (FCC) [7/2006, 7/2008]; Science Foundation of Ireland [SFI 09/SIRG/B1654]	Italian Cystic Fibrosis Research Foundation (FCC); Science Foundation of Ireland(Science Foundation Ireland)	This research was supported by grants from the Italian Cystic Fibrosis Research Foundation (FCC) (http://www.fibrosicisticaricerca.it/) to A. Bevivino (project FFC #7/2006, with the contribution of "Delegazione FFC di Latina"; project FFC #7/2008, with the contribution of "Associazione Siciliana Fibrosi Cistica"). K. B. T. and R. P. R. were supported in part by grants awarded by the Science Foundation of Ireland (SFI 09/SIRG/B1654 to R. P. R.). The funders had no role in study design, data collection, analysis and interpretation of the data, decision to publish, or preparation of the manuscript.	Al-Bakri AG, 2004, J APPL MICROBIOL, V96, P455, DOI 10.1111/j.1365-2672.2004.02201.x; Bevivino A, 2012, MICROBIOL-SGM, V158, P1325, DOI 10.1099/mic.0.056986-0; Bragonzi A, 2005, J INFECT DIS, V192, P410, DOI 10.1086/431516; Bragonzi A, 2006, MICROBIOL-SGM, V152, P3261, DOI 10.1099/mic.0.29175-0; Bragonzi A, 2010, INT J MED MICROBIOL, V300, P584, DOI 10.1016/j.ijmm.2010.08.012; Bragonzi A, 2009, AM J RESP CRIT CARE, V180, P138, DOI 10.1164/rccm.200812-1943OC; Burmolle M, 2006, APPL ENVIRON MICROB, V72, P3916, DOI 10.1128/AEM.03022-05; Coenye T, 2010, FUTURE MICROBIOL, V5, P1087, DOI 10.2217/FMB.10.68; Coggan KA, 2012, CURR ISSUES MOL BIOL, V14, P47; Dalton T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027317; Duan KM, 2003, MOL MICROBIOL, V50, P1477, DOI 10.1046/j.1365-2958.2003.03803.x; Eberl L, 2004, INT J MED MICROBIOL, V294, P123, DOI 10.1016/j.ijmm.2004.06.022; GILLIGAN PH, 1991, CLIN MICROBIOL REV, V4, P35, DOI 10.1128/CMR.4.1.35-51.1991; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Harrison F, 2007, MICROBIOL-SGM, V153, P917, DOI 10.1099/mic.0.2006/004077-0; Hassett DJ, 2010, EXPERT OPIN THER TAR, V14, P117, DOI 10.1517/14728220903454988; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Hoiby N, 2010, FUTURE MICROBIOL, V5, P1663, DOI [10.2217/fmb.10.125, 10.2217/FMB.10.125]; Huber B, 2001, MICROBIOL-SGM, V147, P2517, DOI 10.1099/00221287-147-9-2517; Hutchison ML, 1998, INFECT IMMUN, V66, P2033, DOI 10.1128/IAI.66.5.2033-2039.1998; Jones AM, 2004, THORAX, V59, P948, DOI 10.1136/thx.2003.017210; Kosai K, 2011, JPN J INFECT DIS, V64, P451; LiPuma JJ, 2010, CLIN MICROBIOL REV, V23, P299, DOI 10.1128/CMR.00068-09; Lopes SP, 2012, INT J ANTIMICROB AG, V40, P260, DOI 10.1016/j.ijantimicag.2012.04.020; Macho AP, 2007, MOL PLANT PATHOL, V8, P437, DOI 10.1111/J.1364-3703.2007.00404.X; McCloskey M, 2001, IRISH J MED SCI, V170, P28, DOI 10.1007/BF03167716; Mira NP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028831; Paroni M, 2013, J INFECT DIS, V208, P130, DOI 10.1093/infdis/jis636; Pirone L, 2008, ENVIRON MICROBIOL, V10, P2773, DOI 10.1111/j.1462-2920.2008.01697.x; Rajan Sujatha, 2002, Semin Respir Infect, V17, P47, DOI 10.1053/srin.2002.31690; Rogers GB, 2010, TRENDS MICROBIOL, V18, P357, DOI 10.1016/j.tim.2010.04.005; Rogers GB, 2009, J MED MICROBIOL, V58, P1401, DOI 10.1099/jmm.0.013334-0; Ryan RP, 2008, MOL MICROBIOL, V68, P75, DOI 10.1111/j.1365-2958.2008.06132.x; Ryan RP, 2009, ENVIRON MICROBIOL, V11, P1126, DOI 10.1111/j.1462-2920.2008.01842.x; Sibley CD, 2006, FUTURE MICROBIOL, V1, P53, DOI 10.2217/17460913.1.1.53; Sibley CD, 2011, CAN J MICROBIOL, V57, P69, DOI [10.1139/W10-105, 10.1139/w10-105]; Sibley CD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000184; Stoicov C, 2004, J IMMUNOL, V173, P3329, DOI 10.4049/jimmunol.173.5.3329; Stressmann FA, 2011, J CLIN MICROBIOL, V49, P281, DOI 10.1128/JCM.01650-10; Tomlin KL, 2001, CAN J MICROBIOL, V47, P949, DOI 10.1139/cjm-47-10-949; van Heeckeren AM, 2004, AM J PHYSIOL-LUNG C, V287, pL944, DOI 10.1152/ajplung.00387.2003; Vial L, 2011, ENVIRON MICROBIOL, V13, P1, DOI 10.1111/j.1462-2920.2010.02343.x; WHITEFORD ML, 1995, THORAX, V50, P1194, DOI 10.1136/thx.50.11.1194; Yang L, 2011, P NATL ACAD SCI USA, V108, P7481, DOI 10.1073/pnas.1018249108; Zemanick ET, 2011, CURR OPIN PEDIATR, V23, P319, DOI 10.1097/MOP.0b013e32834604f2; Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109	46	66	68	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52330	10.1371/journal.pone.0052330	http://dx.doi.org/10.1371/journal.pone.0052330			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284990	gold, Green Published, Green Submitted			2022-12-27	WOS:000313158800049
J	Gambardella, C; Pignatelli, A; Belluzzi, O				Gambardella, Cristina; Pignatelli, Angela; Belluzzi, Ottorino			The h-Current in the Substantia Nigra pars Compacta Neurons: A Re-examination	PLOS ONE			English	Article							ACTIVATED CATION CURRENT; CURRENT I-H; VENTRAL TEGMENTAL AREA; VOLTAGE-CLAMP ANALYSIS; PACE-MAKER CURRENT; DOPAMINERGIC-NEURONS; SINOATRIAL NODE; MIDBRAIN DOPAMINE; PACEMAKER CHANNELS; INWARD CURRENT	The properties of the hyperpolarization-activated cation current (I-h) were investigated in rat substantia nigra - pars compacta (SNc) principal neurons using patch-clamp recordings in thin slices. A reliable identification of single dopaminergic neurons was made possible by the use of a transgenic line of mice expressing eGFP under the tyrosine hydroxylase promoter. The effects of temperature and different protocols on the I-h kinetics showed that, at 37 degrees C and minimizing the disturbance of the intracellular milieu with perforated patch, this current actually activates at potentials more positive than what is generally indicated, with a half-activation potential of -77.05 mV and with a significant level of opening already at rest, thereby substantially contributing to the control of membrane potential, and ultimately playing a relevant function in the regulation of the cell excitability. The implications of the known influence of intracellular cAMP levels on I-h amplitude and kinetics were examined. The direct application of neurotransmitters (DA, 5-HT and noradrenaline) physiologically released onto SNc neurons and known to act on metabotropic receptors coupled to the cAMP pathway modify the I-h amplitude. Here, we show that direct activation of dopaminergic and of 5-HT receptors results in I-h inhibition of SNc DA cells, whereas noradrenaline has the opposite effect. Together, these data suggest that the modulation of I-h by endogenously released neurotransmitters acting on metabotropic receptors -mainly but not exclusively linked to the cAMP pathway-could contribute significantly to the control of SNc neuron excitability.	[Belluzzi, Ottorino] Univ Ferrara, Dipartimento Sci Vita & Biotecnol, I-44100 Ferrara, Italy; Ist Nazl Neurosci, Ferrara, Italy	University of Ferrara	Belluzzi, O (corresponding author), Univ Ferrara, Dipartimento Sci Vita & Biotecnol, I-44100 Ferrara, Italy.	mk5@unife.it	Pignatelli, Angela/L-4490-2013	Pignatelli, Angela/0000-0002-7160-1597; Belluzzi, Ottorino/0000-0002-7543-3818	Ministero della Universita e della Ricerca Scientifica (MIUR)	Ministero della Universita e della Ricerca Scientifica (MIUR)(Ministry of Education, Universities and Research (MIUR))	The research was supported by a grant from the Ministero della Universita e della Ricerca Scientifica (MIUR) - PRIN 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGHAJANIAN GK, 1977, N-S ARCH PHARMACOL, V297, P1, DOI 10.1007/BF00508803; [Anonymous], [No title captured]; Arencibia-Albite F, 2007, NEUROSCIENCE, V149, P303, DOI 10.1016/j.neuroscience.2007.08.009; AZMITIA EC, 1978, J COMP NEUROL, V179, P641, DOI 10.1002/cne.901790311; BANKS MI, 1993, J NEUROPHYSIOL, V70, P1420, DOI 10.1152/jn.1993.70.4.1420; BEAVO JA, 1970, MOL PHARMACOL, V6, P597; BERGER F, 1994, N-S ARCH PHARMACOL, V350, P677; BERNARDINI GL, 1991, J NEURAL TRANSM-GEN, V84, P183, DOI 10.1007/BF01244969; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; BOBKER DH, 1989, NEURON, V2, P1535, DOI 10.1016/0896-6273(89)90041-X; Bois P, 1996, BRIT J PHARMACOL, V118, P1051, DOI 10.1111/j.1476-5381.1996.tb15505.x; BOSMITH RE, 1993, BRIT J PHARMACOL, V110, P343, DOI 10.1111/j.1476-5381.1993.tb13815.x; Brent R. P., 1973, ALGORITHMS MINIMIZAT; Brown MTC, 2009, J NEUROSCI, V29, P2915, DOI 10.1523/JNEUROSCI.4423-08.2009; BROWN SJ, 1982, BRAIN RES, V234, P275, DOI 10.1016/0006-8993(82)90868-X; Bucchi A, 2002, J GEN PHYSIOL, V120, P1, DOI 10.1085/jgp.20028593; Bucchi A, 2006, J PHYSIOL-LONDON, V572, P335, DOI 10.1113/jphysiol.2005.100776; Cathala L, 1999, EUR J NEUROSCI, V11, P398, DOI 10.1046/j.1460-9568.1999.00452.x; Cathala L, 1997, J PHYSIOL-LONDON, V503, P87, DOI 10.1111/j.1469-7793.1997.087bi.x; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; CHERAMY A, 1981, NATURE, V289, P537, DOI 10.1038/289537a0; Chevallier S, 2006, J PHYSIOL-LONDON, V570, P525, DOI 10.1113/jphysiol.2005.098970; Cuevas J, 1997, J NEUROPHYSIOL, V78, P1890, DOI 10.1152/jn.1997.78.4.1890; Di Giovanni G, 2008, PROG BRAIN RES, V172, P45, DOI 10.1016/S0079-6123(08)00903-5; DIFRANCESCO D, 1986, J PHYSIOL-LONDON, V377, P61, DOI 10.1113/jphysiol.1986.sp016177; DIFRANCESCO D, 1986, NATURE, V324, P470, DOI 10.1038/324470a0; DIFRANCESCO D, 1980, J PHYSIOL-LONDON, V308, P353, DOI 10.1113/jphysiol.1980.sp013475; DIFRANCESCO D, 1981, J PHYSIOL-LONDON, V314, P377, DOI 10.1113/jphysiol.1981.sp013714; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; DIFRANCESCO D, 1982, J PHYSIOL-LONDON, V329, P485, DOI 10.1113/jphysiol.1982.sp014315; FIBIGER HC, 1977, NEUROSCIENCE, V2, P975, DOI 10.1016/0306-4522(77)90120-8; Fogle KJ, 2007, J NEUROSCI, V27, P2802, DOI 10.1523/JNEUROSCI.4376-06.2007; Ford CP, 2006, J NEUROSCI, V26, P2788, DOI 10.1523/JNEUROSCI.4331-05.2006; Forsythe G.E., 1976, COMPUTER METHODS MAT; Franz O, 2000, EUR J NEUROSCI, V12, P2685, DOI 10.1046/j.1460-9568.2000.00151.x; Gasparini S, 1999, EUR J NEUROSCI, V11, P3093, DOI 10.1046/j.1460-9568.1999.00728.x; GEFFEN LB, 1976, NATURE, V260, P258, DOI 10.1038/260258a0; Ghamari-Langroudi M, 2000, J NEUROSCI, V20, P4855; GRACE AA, 1989, J NEUROSCI, V9, P3463; GRENHOFF J, 1995, EUR J NEUROSCI, V7, P1707, DOI 10.1111/j.1460-9568.1995.tb00692.x; Guatteo E, 2005, J NEUROPHYSIOL, V94, P3069, DOI 10.1152/jn.00066.2005; GULLEY RL, 1971, TISSUE CELL, V3, P691, DOI 10.1016/S0040-8166(71)80014-9; Hahn J, 2003, J NEUROSCI, V23, P10859; Hahn J, 2006, J NEUROSCI, V26, P5240, DOI 10.1523/JNEUROSCI.4976-05.2006; Harris NC, 1995, J NEUROPHYSIOL, V74, P2366, DOI 10.1152/jn.1995.74.6.2366; HART G, 1983, J PHYSIOL-LONDON, V337, P401, DOI 10.1113/jphysiol.1983.sp014631; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; IMAI H, 1986, J COMP NEUROL, V243, P363, DOI 10.1002/cne.902430307; Inyushin MU, 2010, NEUROSCIENCE, V167, P287, DOI 10.1016/j.neuroscience.2010.01.052; JONES BE, 1977, BRAIN RES, V127, P23, DOI 10.1016/0006-8993(77)90378-X; KAMONDI A, 1991, J NEUROPHYSIOL, V66, P1902, DOI 10.1152/jn.1991.66.6.1902; KANG Y, 1993, NEUROSCI RES, V18, P209, DOI 10.1016/0168-0102(93)90056-V; Kennedy MJ, 2011, NEURON, V69, P856, DOI 10.1016/j.neuron.2011.02.032; KIM KM, 1995, NEUROSCIENCE, V69, P1145, DOI 10.1016/0306-4522(95)00326-E; Kiyatkin EA, 2010, FRONT BIOSCI-LANDMRK, V15, P73, DOI 10.2741/3608; Kjaerulff O, 2001, J NEUROPHYSIOL, V85, P580, DOI 10.1152/jn.2001.85.2.580; Klink R, 2001, J NEUROSCI, V21, P1452, DOI 10.1523/JNEUROSCI.21-05-01452.2001; Korotkova TM, 2004, MOL NEUROBIOL, V29, P243, DOI 10.1385/MN:29:3:243; Labouebe G, 2007, NAT NEUROSCI, V10, P1559, DOI 10.1038/nn2006; LACEY MG, 1989, J NEUROSCI, V9, P1233; LACEY MG, 1987, J PHYSIOL-LONDON, V392, P397, DOI 10.1113/jphysiol.1987.sp016787; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lee CR, 2009, J NEURAL TRANSM-SUPP, P71, DOI 10.1007/978-3-211-92660-4_6; LEVEY AI, 1993, P NATL ACAD SCI USA, V90, P8861, DOI 10.1073/pnas.90.19.8861; LINDVALL O, 1983, CHEM NEUROANATOMY, P229; Liss B, 2001, EMBO J, V20, P5715, DOI 10.1093/emboj/20.20.5715; Liu ZP, 2003, J NEUROPHYSIOL, V90, P3201, DOI 10.1152/jn.00281.2003; Macri V, 2004, J BIOL CHEM, V279, P16832, DOI 10.1074/jbc.M400518200; Macri V, 2002, J BIOL CHEM, V277, P35939, DOI 10.1074/jbc.M203485200; MANSOUR A, 1990, J NEUROSCI, V10, P2587; Margolis EB, 2006, P NATL ACAD SCI USA, V103, P2938, DOI 10.1073/pnas.0511159103; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; Matsushita N, 2002, J NEUROCHEM, V82, P295, DOI 10.1046/j.1471-4159.2002.00972.x; MAYER ML, 1983, J PHYSIOL-LONDON, V340, P19, DOI 10.1113/jphysiol.1983.sp014747; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P319, DOI 10.1113/jphysiol.1990.sp018332; MEADORWOODRUFF JH, 1989, P NATL ACAD SCI USA, V86, P7625, DOI 10.1073/pnas.86.19.7625; MENGOD G, 1989, P NATL ACAD SCI USA, V86, P8560, DOI 10.1073/pnas.86.21.8560; MERCURI NB, 1995, EUR J NEUROSCI, V7, P462, DOI 10.1111/j.1460-9568.1995.tb00342.x; Mistrik P, 2005, J BIOL CHEM, V280, P27056, DOI 10.1074/jbc.M502696200; Moore RY., 1984, CLASSICAL TRANSMIT 1, P123; MORI S, 1987, ANAT EMBRYOL, V176, P13, DOI 10.1007/BF00309747; Mrejeru A, 2011, J PHYSIOL-LONDON, V589, P2497, DOI 10.1113/jphysiol.2011.206631; NEDERGAARD S, 1991, NEUROREPORT, V2, P329; NEDERGAARD S, 1992, NEUROSCIENCE, V48, P423, DOI 10.1016/0306-4522(92)90502-S; NEDERGAARD S, 1988, NATURE, V333, P174, DOI 10.1038/333174a0; Neuhoff H, 2002, J NEUROSCI, V22, P1290, DOI 10.1523/JNEUROSCI.22-04-01290.2002; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Olijslagers JE, 2006, CURR NEUROPHARMACOL, V4, P59, DOI 10.2174/157015906775203020; Orio P, 2009, J PHYSIOL-LONDON, V587, P1961, DOI 10.1113/jphysiol.2008.165738; Parent M, 2011, J CHEM NEUROANAT, V41, P256, DOI 10.1016/j.jchemneu.2011.04.005; Pena F, 2006, EXP BRAIN RES, V173, P282, DOI 10.1007/s00221-006-0473-z; Proenza C, 2002, J BIOL CHEM, V277, P5101, DOI 10.1074/jbc.M106974200; PUCAK ML, 1995, CRIT REV NEUROBIOL, V9, P67; Puopolo M, 2007, J NEUROSCI, V27, P645, DOI 10.1523/JNEUROSCI.4341-06.2007; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Sawamoto K, 2001, J NEUROSCI, V21, P3895, DOI 10.1523/JNEUROSCI.21-11-03895.2001; SEAMON KB, 1981, J CYCLIC NUCL PROT, V7, P201; Seifert R, 1999, P NATL ACAD SCI USA, V96, P9391, DOI 10.1073/pnas.96.16.9391; Seutin V, 2001, NEUROREPORT, V12, P255, DOI 10.1097/00001756-200102120-00015; Seutin V, 2010, J NEUROPHYSIOL, V103, P3099, DOI 10.1152/jn.00513.2009; Shi WX, 2009, J NEURAL TRANSM-SUPP, P103, DOI 10.1007/978-3-211-92660-4_8; SILVA NL, 1990, J NEUROPHYSIOL, V64, P262, DOI 10.1152/jn.1990.64.1.262; STEINBUSCH HWM, 1981, NEUROSCIENCE, V6, P557, DOI 10.1016/0306-4522(81)90146-9; Suenari K, 2012, J CARDIOVASC ELECTRO; Svoboda KR, 1998, J NEUROSCI, V18, P7084; Takigawa T, 1999, J PHYSIOL-LONDON, V517, P385, DOI 10.1111/j.1469-7793.1999.0385t.x; Vandecasteele M, 2008, P NATL ACAD SCI USA, V105, P4904, DOI 10.1073/pnas.0703121105; Vargas G, 1999, J NEUROPHYSIOL, V81, P149, DOI 10.1152/jn.1999.81.1.149; Wahl-Schott C, 2009, CELL MOL LIFE SCI, V66, P470, DOI 10.1007/s00018-008-8525-0; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Watts AE, 1996, J NEUROPHYSIOL, V76, P2262, DOI 10.1152/jn.1996.76.4.2262; WHITE FJ, 1984, J PHARMACOL EXP THER, V231, P275; WOLLMUTH LP, 1992, J GEN PHYSIOL, V100, P749, DOI 10.1085/jgp.100.5.749; Yagi J, 1998, J NEUROPHYSIOL, V80, P1094, DOI 10.1152/jn.1998.80.3.1094; Yanagida H, 2000, AM J PHYSIOL-CELL PH, V278, pC40, DOI 10.1152/ajpcell.2000.278.1.C40; Yanovsky Y, 2005, NEUROSCIENCE, V136, P1027, DOI 10.1016/j.neuroscience.2005.08.026; YUNG WH, 1991, J PHYSIOL-LONDON, V436, P643, DOI 10.1113/jphysiol.1991.sp018571; Zolles G, 2006, NEURON, V52, P1027, DOI 10.1016/j.neuron.2006.12.005; Zong XG, 2005, J BIOL CHEM, V280, P34224, DOI 10.1074/jbc.M506544200	119	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52329	10.1371/journal.pone.0052329	http://dx.doi.org/10.1371/journal.pone.0052329			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284989	Green Published, gold, Green Submitted			2022-12-27	WOS:000313158800048
J	Liu, Q; Zhou, H; Zhang, K; Shi, XX; Fan, W; Zhu, RX; Yu, PS; Cao, ZW				Liu, Qi; Zhou, Han; Zhang, Kui; Shi, Xiaoxiao; Fan, Wei; Zhu, Ruixin; Yu, Philip S.; Cao, Zhiwei			In Silico Target-Specific siRNA Design Based on Domain Transfer in Heterogeneous Data	PLOS ONE			English	Article							RNA-INTERFERENCE; EXPRESSION; SELECTION; MICRORNA	RNA interference via exogenous small interference RNAs (siRNA) is a powerful tool in gene function study and disease treatment. Designing efficient and specific siRNA on target gene remains the key issue in RNAi. Although various in silico models have been proposed for rational siRNA design, most of them focus on the efficiencies of selected siRNAs, while limited effort has been made to improve their specificities targeted on specific mRNAs, which is related to reducing off-target effects (OTEs) in RNAi. In our study, we propose for the first time that the enhancement of target specificity of siRNA design can be achieved computationally by domain transfer in heterogeneous data sources from different siRNA targets. A transfer learning based method i.e., heterogeneous regression (HEGS) is presented for target-specific siRNA efficacy modeling and feature selection. Based on the model, (1) the target regression model can be built by extracting information from related data in other targets/experiments, thus increasing the target specificity in siRNA design with the help of information from siRNAs binding to other homologous genes, and (2) the potential features correlated to the current siRNA design can be identified even when there is lack of experimental validated siRNA affinity data on this target. In summary, our findings present useful instructions for a better target-specific siRNA design, with potential applications in genome-wide high-throughput screening of effective siRNA, and will provide further insights on the mechanism of RNAi.	[Liu, Qi; Zhou, Han; Zhang, Kui; Zhu, Ruixin; Cao, Zhiwei] Tongji Univ, Dept Bioinformat, Shanghai 200092, Peoples R China; [Shi, Xiaoxiao; Yu, Philip S.] Univ Illinois, Dept Comp Sci, Chicago, IL 60680 USA; [Fan, Wei] IBM Thomas J Watson Res Ctr, New York, NY USA	Tongji University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; International Business Machines (IBM)	Yu, PS (corresponding author), Univ Illinois, Dept Comp Sci, Chicago, IL 60680 USA.	psyu@uic.edu; zwcao@tongji.edu.cn	, 金石为开/AFU-9737-2022; Shi, Xiaoxiao/D-6554-2014	Shi, Xiaoxiao/0000-0002-1746-2792; Zhu, Ruixin/0000-0002-5070-6453	National Natural Science Foundation of China [30976611, 31100956, 61173117]; Shanghai Pujiang Talents Funding [11PJ1407400]; Doctoral Program of Higher Education of China [20100072110008, 20100072120050, 20110072120048]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Talents Funding; Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	1. National Natural Science Foundation of China (Grant No. 30976611, Grant No. 31100956 and Grant No. 61173117) (http://www.nsfc.gov.cn/), 2. Shanghai Pujiang Talents Funding (Grant No. 11PJ1407400) (http://www.stcsm.gov.cn/), 3. Doctoral Program of Higher Education of China (20100072110008, 20100072120050, 20110072120048) (http://www.moe.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvey A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.24; Braasch DA, 2001, CHEM BIOL, V8, P1, DOI 10.1016/S1074-5521(00)00058-2; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Huesken D, 2005, NAT BIOTECHNOL, V23, P995, DOI 10.1038/nbt1118; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jagla B, 2005, RNA, V11, P864, DOI 10.1261/rna.7275905; Kittler R, 2007, NAT METHODS, V4, P337, DOI 10.1038/NMETH1025; Klingelhoefer JW, 2009, BIOINFORMATICS, V25, P1594, DOI 10.1093/bioinformatics/btp284; Larsson E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.89; Li W, 2007, CELL MOL LIFE SCI, V64, P1785, DOI 10.1007/s00018-007-7057-3; Liu Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037879; Liu Q, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-181; Mahanthappa N, 2005, PHARMACOGENOMICS, V6, P879, DOI 10.2217/14622416.6.8.879; Matveeva O, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm088; Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191; Patzel V, 2005, NAT BIOTECHNOL, V23, P1440, DOI 10.1038/nbt1151; Pei Y, 2006, NAT METHODS, V3, P670, DOI 10.1038/NMETH911; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Saetrom P, 2004, BIOCHEM BIOPH RES CO, V321, P247, DOI 10.1016/j.bbrc.2004.06.116; Shabalina SA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-65; Shi X., 2010, P 2010 SIAM INT C DA, P814; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; Weinheim HKVC, 1994, J MED CHEM, V37, P2481; Wilson JA, 2003, P NATL ACAD SCI USA, V100, P2783, DOI 10.1073/pnas.252758799; Zhong EH, 2010, LECT NOTES ARTIF INT, V6323, P547, DOI 10.1007/978-3-642-15939-8_35	30	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e50697	10.1371/journal.pone.0050697	http://dx.doi.org/10.1371/journal.pone.0050697			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284642	gold, Green Published, Green Submitted			2022-12-27	WOS:000313158800005
J	Aillet, F; Lopitz-Otsoa, F; Egana, I; Hjerpe, R; Fraser, P; Hay, RT; Rodriguez, MS; Lang, V				Aillet, Fabienne; Lopitz-Otsoa, Fernando; Egana, Isabel; Hjerpe, Roland; Fraser, Paul; Hay, Ron T.; Rodriguez, Manuel S.; Lang, Valerie			Heterologous SUMO-2/3-Ubiquitin Chains Optimize I kappa B alpha Degradation and NF-kappa B Activity	PLOS ONE			English	Article							SUMO-1 MODIFICATION; UBIQUITIN CHAINS; ACTIVATION; BINDING; IDENTIFICATION; NEDDYLATION; SUMOYLATION; NEDD8; NEMO; PHOSPHORYLATION	The NF-kappa B pathway is regulated by SUMOylation at least at three levels: the inhibitory molecule I kappa B alpha, the IKK subunit gamma/NEMO and the p52 precursor p100. Here we investigate the role of SUMO-2/3 in the degradation of I kappa B alpha and activation of NF-kappa B mediated by TNF alpha. We found that under conditions of deficient SUMOylation, an important delay in both TNF alpha-mediated proteolysis of I kappa B alpha and NF-kappa B dependent transcription occurs. In vitro and ex vivo approaches, including the use of ubiquitin-traps (TUBEs), revealed the formation of chains on I kappa B alpha containing SUMO-2/3 and ubiquitin after TNF alpha stimulation. The integration of SUMO-2/3 appears to promote the formation of ubiquitin chains on I kappa B alpha after activation of the TNF alpha signalling pathway. Furthermore, heterologous chains of SUMO-2/3 and ubiquitin promote a more efficient degradation of I kappa B alpha by the 26S proteasome in vitro compared to chains of either SUMO-2/3 or ubiquitin alone. Consistently, Ubc9 silencing reduced the capture of I kappa B alpha modified with SUMO-ubiquitin hybrid chains that display a defective proteasome-mediated degradation. Thus, hybrid SUMO-2/3-ubiquitin chains increase the susceptibility of modified I kappa B alpha to the action of 26S proteasome, contributing to the optimal control of NF-kappa B activity after TNF alpha-stimulation.	[Aillet, Fabienne; Lopitz-Otsoa, Fernando; Egana, Isabel; Hjerpe, Roland; Rodriguez, Manuel S.; Lang, Valerie] CIBERehd, CIC bioGUNE, Prote Unit, Derio, Bizkaia, Spain; [Aillet, Fabienne; Rodriguez, Manuel S.] Inbiomed, Ubiquitylat & Canc Mol Biol Lab, San Sebastian, Gipuzkoa, Spain; [Fraser, Paul] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON M5S 1A1, Canada; [Fraser, Paul] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A1, Canada; [Hay, Ron T.] Univ Dundee, Sch Life Sci, Interdisciplinary Res Ctr, Dundee, Scotland	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIC bioGUNE; University of Toronto; University of Toronto; University of Dundee	Rodriguez, MS (corresponding author), Inbiomed, Ubiquitylat & Canc Mol Biol Lab, San Sebastian, Gipuzkoa, Spain.	msrodriguez@inbiomed.org	Lopitz-Otsoa, Fernando/A-1966-2017; RODRIGUEZ, Manuel S./D-5439-2018	Lopitz-Otsoa, Fernando/0000-0001-8452-6939; 	Ramon y Cajal Program; Ministerio de Educacion y Ciencia [BFU2008-01108/BMC, BFU2006-12991]; Fondo de Investigaciones Sanitarias (FIS) CIBERhed; Department of Industry, Tourism and Trade of the Government of the Autonomous Community of the Basque Country; Innovation Technology Department of the Bizkaia Country; Canadian Institutes for Health Research (CIHR); Alzheimer Society of Ontario	Ramon y Cajal Program(Spanish Government); Ministerio de Educacion y Ciencia(Spanish Government); Fondo de Investigaciones Sanitarias (FIS) CIBERhed(Instituto de Salud Carlos III); Department of Industry, Tourism and Trade of the Government of the Autonomous Community of the Basque Country; Innovation Technology Department of the Bizkaia Country; Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alzheimer Society of Ontario	This work was funded by the Ramon y Cajal Program, Ministerio de Educacion y Ciencia grant (BFU2008-01108/BMC) and (BFU2006-12991), Fondo de Investigaciones Sanitarias (FIS) CIBERhed, Department of Industry, Tourism and Trade of the Government of the Autonomous Community of the Basque Country (Etortek Research Programs 2005/2006) and from the Innovation Technology Department of the Bizkaia Country. PF is funded by Canadian Institutes for Health Research (CIHR) and Alzheimer Society of Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aad G, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.041805; Aillet F, 2012, METHODS MOL BIOL, V832, P173, DOI 10.1007/978-1-61779-474-2_12; ARENZANASEISDEDOS F, 1995, MOL CELL BIOL, V15, P2689; Bossis G, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-13; Carter S, 2008, CELL CYCLE, V7, P2519, DOI 10.4161/cc.7.16.6422; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Coux O, 1998, J BIOL CHEM, V273, P8820, DOI 10.1074/jbc.273.15.8820; Culver C, 2010, MOL CELL BIOL, V30, P4901, DOI 10.1128/MCB.00409-10; Da Silva-Ferrada E, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/875148; Da Silva-Ferrada E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025397; Danielsen JMR, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003590; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Desterro JMP, 1999, J BIOL CHEM, V274, P10618, DOI 10.1074/jbc.274.15.10618; Dorval V, 2007, BIOCHEM J, V404, P309, DOI 10.1042/BJ20061451; Gareau JR, 2012, J BIOL CHEM, V287, P4740, DOI 10.1074/jbc.M111.321141; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hjerpe R, 2012, J MOL BIOL, V421, P27, DOI 10.1016/j.jmb.2012.05.013; Hjerpe R, 2012, BIOCHEM J, V441, P927, DOI 10.1042/BJ20111671; Hjerpe R, 2009, EMBO REP, V10, P1250, DOI 10.1038/embor.2009.192; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Kim EM, 2011, MOL IMMUNOL, V48, P2189, DOI 10.1016/j.molimm.2011.05.002; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lang V, 2003, MOL CELL BIOL, V23, P402, DOI 10.1128/MCB.23.1.402-413.2003; Lang V, 2008, BIOCHEM SOC T, V36, P853, DOI 10.1042/BST0360853; Leidecker O, 2012, CELL CYCLE, V11, P1142, DOI 10.4161/cc.11.6.19559; Liu Q, 2009, J BIOL CHEM, V284, P13686, DOI 10.1074/jbc.M809275200; Mabb AM, 2007, CELL MOL LIFE SCI, V64, P1979, DOI 10.1007/s00018-007-7005-2; Mabb AM, 2006, NAT CELL BIOL, V8, P986, DOI 10.1038/ncb1458; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Rodriguez MS, 1996, ONCOGENE, V12, P2425; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Roff M, 1996, J BIOL CHEM, V271, P7844, DOI 10.1074/jbc.271.13.7844; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Shimada K, 2008, BONE, V42, P886, DOI 10.1016/j.bone.2008.01.009; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Tatham MH, 2009, NAT PROTOC, V4, P1363, DOI 10.1038/nprot.2009.128; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Vatsyayan J, 2008, EMBO REP, V9, P885, DOI 10.1038/embor.2008.122; Vertegaal ACO, 2011, CHEM REV, V111, P7923, DOI 10.1021/cr200187e; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158	50	45	48	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51672	10.1371/journal.pone.0051672	http://dx.doi.org/10.1371/journal.pone.0051672			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284737	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500038
J	Ji, JJ; Chen, LW; Duan, XZ; Song, XQ; Su, WT; Zhang, P; Li, L; Bai, SY; Sun, YC; Inagaki, N				Ji, Juan Juan; Chen, Lianwan; Duan, Xuezhi; Song, Xueqin; Su, Wenting; Zhang, Peng; Li, Li; Bai, Shuyun; Sun, Yingchun; Inagaki, Nobuya			BK Channels Reveal Novel Phosphate Sensitivity in SNr Neurons	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; ACTIVATED POTASSIUM CHANNEL; LARGE-CONDUCTANCE; SUBSTANTIA-NIGRA; NEOCORTICAL NEURONS; PYRAMIDAL NEURONS; RAT-BRAIN; ATP; DEPRIVATION; SUBUNIT	Whether large conductance Ca2+-activated potassium (BK) channels are present in the substantia nigra pars reticulata (SNr) is a matter of debate. Using the patch-clamp technique, we examined the functional expression of BK channels in neurons of the SNr and showed that the channels were activated or inhibited by internal high-energy phosphates (IHEPs) at positive and negative membrane potentials, respectively. SNr neurons showed membrane potential hyperpolarization under glucose-deprivation conditions which was attenuated by paxilline, a specific BK channel blocker. In addition, Fluo-3 fluorescence recording detected an increase in the level of internal free calcium ([Ca2+](i)) during ischemic hyperpolarization. These results confirm that BK channels are present in SNr neurons and indicate that their unique IHEP sensitivity is requisite in neuronal ischemic responses. Bearing in mind that the K-ATP channel blocker tolbutamide also attenuated the hyperpolarization, we suggest that BK channels may play a protective role in the basal ganglia by modulating the excitability of SNr neurons along with K-ATP channels under ischemic stresses.	[Ji, Juan Juan; Chen, Lianwan; Song, Xueqin; Su, Wenting; Zhang, Peng; Li, Li; Bai, Shuyun] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Duan, Xuezhi; Sun, Yingchun] NE Normal Univ, Dept Phys, Changchun 130024, Peoples R China; [Inagaki, Nobuya] Kyoto Univ, Dept Diabet & Clin Nutr, Grad Sch Med, Sakyo Ku, Kyoto, Japan	Chinese Academy of Sciences; Institute of Biophysics, CAS; Northeast Normal University - China; Kyoto University	Ji, JJ (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China.	jijj@ibp.ac.cn	Duan, Xuezhi/AHC-2964-2022	Inagaki, Nobuya/0000-0001-8261-2593	Chinese Academy of Sciences [KSCX2-SW-217]; National Natural Science Foundation of China [30370459]; National Key Basic Research and Development Program [2005CB522804, 2006CB504101]; Akita university school	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research and Development Program(National Basic Research Program of China); Akita university school	This work was supported by grants from the 100 Talents Program of the Chinese Academy of Sciences, the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-SW-217), the National Natural Science Foundation of China (30370459), the National Key Basic Research and Development Program(2005CB522804, 2006CB504101), and the international fund of Akita university school. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE N, 1994, JPN J PHYSIOL, V44, P433, DOI 10.2170/jjphysiol.44.433; Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Benhassine N, 2009, PFLUG ARCH EUR J PHY, V457, P1133, DOI 10.1007/s00424-008-0569-3; Bennett BD, 2000, J NEUROSCI, V20, P8493, DOI 10.1523/JNEUROSCI.20-22-08493.2000; Brodie MS, 2007, ALCOHOL CLIN EXP RES, V31, P1625, DOI 10.1111/j.1530-0277.2007.00469.x; Chang CP, 1997, MOL BRAIN RES, V45, P33, DOI 10.1016/S0169-328X(96)00230-6; Chen L, 2007, ACTA BIOPHYSICA SINI, V23, P7; Chen LW, 2011, BRAIN RES, V1390, P99, DOI 10.1016/j.brainres.2011.03.022; DWORETZKY SI, 1994, MOL BRAIN RES, V27, P189, DOI 10.1016/0169-328X(94)90203-8; ERECINSKA M, 1989, J CEREBR BLOOD F MET, V9, P2, DOI 10.1038/jcbfm.1989.2; Gessner G, 2012, P NATL ACAD SCI USA, V109, P3552, DOI 10.1073/pnas.1114321109; Gong LW, 2002, BRAIN RES, V951, P130, DOI 10.1016/S0006-8993(02)03151-7; Gu N, 2007, J PHYSIOL-LONDON, V580, P859, DOI 10.1113/jphysiol.2006.126367; Hall AC, 1997, J BIOL RHYTHM, V12, P388, DOI 10.1177/074873049701200501; Jiang C, 1997, J NEUROPHYSIOL, V77, P93, DOI 10.1152/jn.1997.77.1.93; JIANG C, 1994, J NEUROSCI, V14, P5590; Kandel ER, 2001, PRINCIPLES NEURAL SC, P1302; Knaus HG, 1996, J NEUROSCI, V16, P955; KNAUS HG, 1994, BIOCHEMISTRY-US, V33, P5819, DOI 10.1021/bi00185a021; LEE K, 1995, J PHYSIOL-LONDON, V488, P319, DOI 10.1113/jphysiol.1995.sp020969; Li W, 2007, J CELL PHYSIOL, V212, P348, DOI 10.1002/jcp.21007; Liss B, 1999, EMBO J, V18, P833, DOI 10.1093/emboj/18.4.833; Liu HJ, 1999, J CLIN INVEST, V104, P577, DOI 10.1172/JCI7291; MacKinnon R, 1998, SCIENCE, V280, P106, DOI 10.1126/science.280.5360.106; Marinelli S, 2000, NEUROPHARMACOLOGY, V39, P1021, DOI 10.1016/S0028-3908(99)00186-0; Martin G, 2004, J NEUROSCI, V24, P6563, DOI 10.1523/JNEUROSCI.0684-04.2004; Matthews EA, 2008, P NATL ACAD SCI USA, V105, P15154, DOI 10.1073/pnas.0805855105; Meera P, 2000, P NATL ACAD SCI USA, V97, P5562, DOI 10.1073/pnas.100118597; MINTA A, 1989, J BIOL CHEM, V264, P8171; MOURRE C, 1989, BRAIN RES, V486, P159, DOI 10.1016/0006-8993(89)91288-2; N'Gouemo P, 2011, EXPERT OPIN THER TAR, V15, P1283, DOI 10.1517/14728222.2011.620607; Pisani A, 1999, J NEUROPHYSIOL, V81, P2508, DOI 10.1152/jn.1999.81.5.2508; Piwonska M, 2008, NEUROSCIENCE, V153, P446, DOI 10.1016/j.neuroscience.2008.01.050; Redgrave P, 2010, NAT REV NEUROSCI, V11, P760, DOI 10.1038/nrn2915; Richards CD, 1997, NEUROSCIENCE, V80, P545, DOI 10.1016/S0306-4522(97)00093-6; Roman GC, 2002, LANCET NEUROL, V1, P426, DOI 10.1016/S1474-4422(02)00190-4; Sanchez M, 1996, NEUROPHARMACOLOGY, V35, P963, DOI 10.1016/0028-3908(96)00137-2; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; Song X, 2010, NEUROSCIENCE, V169, P1548, DOI 10.1016/j.neuroscience.2010.06.026; Stanford IM, 1996, NEUROSCIENCE, V74, P499, DOI 10.1016/0306-4522(96)00151-0; Strobaek D, 1996, NEUROPHARMACOLOGY, V35, P903, DOI 10.1016/0028-3908(96)00096-2; Su WT, 2010, NEUROSCI LETT, V471, P1, DOI 10.1016/j.neulet.2009.12.058; Thanvi B, 2005, AGE AGEING, V34, P114, DOI 10.1093/ageing/afi025; TREHERNE JM, 1991, J NEUROENDOCRINOL, V3, P323, DOI 10.1111/j.1365-2826.1991.tb00282.x; Yamada K, 2001, SCIENCE, V292, P1543, DOI 10.1126/science.1059829; YOSHIDA A, 1991, JPN J PHYSIOL, V41, P297, DOI 10.2170/jjphysiol.41.297	47	0	0	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52148	10.1371/journal.pone.0052148	http://dx.doi.org/10.1371/journal.pone.0052148			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284908	gold, Green Submitted, Green Published			2022-12-27	WOS:000312794500101
J	Nicholson, JD; Puche, AC; Guo, Y; Weinreich, D; Slater, BJ; Bernstein, SL				Nicholson, James D.; Puche, Adam C.; Guo, Yan; Weinreich, Daniel; Slater, Bernard J.; Bernstein, Steven L.			PGJ(2) Provides Prolonged CNS Stroke Protection by Reducing White Matter Edema	PLOS ONE			English	Article							ISCHEMIC OPTIC NEUROPATHY; ACTIVATED RECEPTOR-GAMMA; 15D-PROSTAGLANDIN J(2); PRIMATE MODEL; CELL-DEATH; BRAIN; RAT; APOPTOSIS; NEUROPROTECTION; INJURY	Few clinically effective approaches reduce CNS-white matter injury. After early in-vivo white matter infarct, NFkB-driven pro-inflammatory signals can amplify a relatively small amount of vascular damage, resulting in progressive endothelial dysfunction to create a severe ischemic lesion. This process can be minimized by 15-deoxy-Delta(12,14)-prostaglandin J2 (PGJ(2)), an analog of the metabolically active PGD(2) metabolite. We evaluated PGJ(2)'s effects and mechanisms using rodent anterior ischemic optic neuropathy (rAION); an in vivo white matter ischemia model. PGJ(2) administration systemically administered either acutely or 5 hours post-insult results in significant neuroprotection, with stereologic evaluation showing improved neuronal survival 30 days post-infarct. Quantitative capillary vascular analysis reveals that PGJ(2) improves perfusion at 1 day post-infarct by reducing tissue edema. Our results suggest that PGJ2 acts by reducing NFkB signaling through preventing p65 nuclear localization and inhibiting inflammatory gene expression. Importantly, PGJ(2) showed no in vivo toxicity structurally as measured by optic nerve (ON) myelin thickness, functionally by ON-compound action potentials, on a cellular basis by oligodendrocyte precursor survival or changes in ON-myelin gene expression. PGJ(2) may be a clinically useful neuroprotective agent for ON and other CNS infarcts involving white matter, with mechanisms of action enabling effective treatment beyond the currently considered maximal time for intervention.	[Nicholson, James D.; Guo, Yan; Slater, Bernard J.; Bernstein, Steven L.] Univ Maryland, Baltimore Sch Med, Dept Ophthalmol & Visual Sci, Baltimore, MD 21201 USA; [Puche, Adam C.; Bernstein, Steven L.] Univ Maryland, Baltimore Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Weinreich, Daniel] Univ Maryland, Baltimore Sch Med, Dept Pharmacol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Bernstein, SL (corresponding author), Univ Maryland, Baltimore Sch Med, Dept Ophthalmol & Visual Sci, Baltimore, MD 21201 USA.	slbernst@umaryland.edu		Slater, Bernard/0000-0001-6895-137X	NIH from NEI [RO1-EY015304, RO1-EY019529]; NATIONAL EYE INSTITUTE [R01EY019529, R01EY015304] Funding Source: NIH RePORTER	NIH from NEI; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by NIH grants RO1-EY015304 and RO1-EY019529 from the NEI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JJ, 2007, MOL IMMUNOL, V44, P123, DOI 10.1016/j.molimm.2006.07.287; Arnold AC, 2003, J NEURO-OPHTHALMOL, V23, P157, DOI 10.1097/00041327-200306000-00012; Bernstein SL, 2003, INVEST OPHTH VIS SCI, V44, P4153, DOI 10.1167/iovs.03-0274; Bosomtwi A, 2011, BRAIN RES, V1381, P217, DOI 10.1016/j.brainres.2011.01.009; Bristow MS, 2005, J CEREBR BLOOD F MET, V25, P1280, DOI 10.1038/sj.jcbfm.9600135; Campbell SJ, 2007, J NEUROCHEM, V103, P2245, DOI 10.1111/j.1471-4159.2007.04928.x; Chen CS, 2008, INVEST OPHTH VIS SCI, V49, P2985, DOI 10.1167/iovs.07-1651; Cho WH, 2006, NEUROCHEM RES, V31, P1247, DOI 10.1007/s11064-006-9157-0; Dickstein JB, 2011, AM J PHYSL; Donnan GA, 2008, STROKE, V39, P242, DOI 10.1161/STROKEAHA.107.493296; Farkas RH, 2001, INT OPHTHALMOL CLIN, V41, P111, DOI 10.1097/00004397-200101000-00011; Garcia-Bueno B, 2005, PSYCHOPHARMACOLOGY, V180, P513, DOI 10.1007/s00213-005-2195-5; Genovese T, 2008, SHOCK, V30, P142, DOI 10.1097/SHK.0b013e31815dd381; Giri S, 2004, J IMMUNOL, V173, P5196, DOI 10.4049/jimmunol.173.8.5196; Gur RC, 1999, J NEUROSCI, V19, P4065; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Kim GS, 2011, J CEREB BLOOD FLOW M, P1; Kunte H, 2007, STROKE, V38, P2526, DOI 10.1161/STROKEAHA.107.482216; LEE HB, 1985, J NUCL MED, V26, P72; Li ZM, 2004, J NEUROSCI RES, V78, P824, DOI 10.1002/jnr.20346; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; Liang XB, 2005, J NEUROCHEM, V92, P477, DOI 10.1111/j.1471-4159.2004.02870.x; Lin TN, 2006, ARTERIOSCL THROM VAS, V26, P481, DOI 10.1161/01.ATV.0000201933.53964.5b; Martone R, 2003, P NATL ACAD SCI USA, V100, P12247, DOI 10.1073/pnas.2135255100; Morris DC, 2000, BRAIN RES, V876, P31, DOI 10.1016/S0006-8993(00)02543-9; Morrison JC, 1999, INVEST OPHTH VIS SCI, V40, P1702; Ou ZS, 2006, BRAIN RES, V1096, P196, DOI 10.1016/j.brainres.2006.04.062; Pereira MP, 2006, J CEREBR BLOOD F MET, V26, P218, DOI 10.1038/sj.jcbfm.9600182; Salgado C, 2011, ARCH OPHTHALMOL-CHIC, V129, P1583, DOI 10.1001/archophthalmol.2011.351; Sasaguri T, 2004, CURR VASC PHARMACOL, V2, P103, DOI 10.2174/1570161043476384; Schmitz C, 2000, J CHEM NEUROANAT, V20, P93, DOI 10.1016/S0891-0618(00)00066-1; Simard JM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000522; Simard JM, 2010, STROKE, V41, P531, DOI 10.1161/STROKEAHA.109.572644; Simard JM, 2009, J NEUROTRAUM, V26, P2257, DOI 10.1089/neu.2009.1021; Simard JM, 2006, NAT MED, V12, P433, DOI 10.1038/nm1390; Slater BJ, 2008, INVEST OPHTH VIS SCI, V49, P3671, DOI 10.1167/iovs.07-0504; Taniike M, 2002, J NEUROSCI, V22, P4885, DOI 10.1523/JNEUROSCI.22-12-04885.2002; Tuttolomondo A, 2009, CURR TOP MED CHEM, V9, P1240, DOI 10.2174/156802609789869619; Witt KA, 2005, J NEUROCHEM, V92, P203, DOI 10.1111/j.1471-4159.2004.02871.x; Xiang ZM, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-18; Zhang C, 2009, BRAIN RES, V1264, P67, DOI 10.1016/j.brainres.2008.12.075; Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197	42	24	27	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e50021	10.1371/journal.pone.0050021	http://dx.doi.org/10.1371/journal.pone.0050021			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284631	gold, Green Published, Green Submitted			2022-12-27	WOS:000312794500011
J	Perez-Pepe, M; Slomiansky, V; Loschi, M; Luchelli, L; Neme, M; Thomas, MG; Boccaccio, GL				Perez-Pepe, Marcelo; Slomiansky, Victoria; Loschi, Mariela; Luchelli, Luciana; Neme, Maximiliano; Gabriela Thomas, Maria; Lidia Boccaccio, Graciela			BUHO: A MATLAB Script for the Study of Stress Granules and Processing Bodies by High-Throughput Image Analysis	PLOS ONE			English	Article							MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; CYTOPLASMIC GRANULES; DNA-REPLICATION; UV-IRRADIATION; LIVING CELLS; P-BODIES; TRANSLATION; DYNAMICS; SITES	The spontaneous and reversible formation of foci and filaments that contain proteins involved in different metabolic processes is common in both the nucleus and the cytoplasm. Stress granules (SGs) and processing bodies (PBs) belong to a novel family of cellular structures collectively known as mRNA silencing foci that harbour repressed mRNAs and their associated proteins. SGs and PBs are highly dynamic and they form upon stress and dissolve thus releasing the repressed mRNAs according to changes in cell physiology. In addition, aggregates containing abnormal proteins are frequent in neurodegenerative disorders. In spite of the growing relevance of these supramolecular aggregates to diverse cellular functions a reliable automated tool for their systematic analysis is lacking. Here we report a MATLAB Script termed BUHO for the high-throughput image analysis of cellular foci. We used BUHO to assess the number, size and distribution of distinct objects with minimal deviation from manually obtained parameters. BUHO successfully addressed the induction of both SGs and PBs in mammalian and insect cells exposed to different stress stimuli. We also used BUHO to assess the dynamics of specific mRNA-silencing foci termed Smaug 1 foci (S-foci) in primary neurons upon synaptic stimulation. Finally, we used BUHO to analyze the role of candidate genes on SG formation in an RNAi-based experiment. We found that FAK56D, GCN2 and PP1 govern SG formation. The role of PP1 is conserved in mammalian cells as judged by the effect of the PP1 inhibitor salubrinal, and involves dephosphorylation of the translation factor eIF2a. All these experiments were analyzed manually and by BUHO and the results differed in less than 5% of the average value. The automated analysis by this user-friendly method will allow high-throughput image processing in short times by providing a robust, flexible and reliable alternative to the laborious and sometimes unfeasible visual scrutiny.	[Perez-Pepe, Marcelo; Slomiansky, Victoria; Loschi, Mariela; Luchelli, Luciana; Neme, Maximiliano; Gabriela Thomas, Maria; Lidia Boccaccio, Graciela] Fdn Inst Leloir, Buenos Aires, DF, Argentina; [Perez-Pepe, Marcelo; Slomiansky, Victoria; Loschi, Mariela; Luchelli, Luciana; Gabriela Thomas, Maria; Lidia Boccaccio, Graciela] Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Buenos Aires, RA-1405 Buenos Aires, DF, Argentina; [Slomiansky, Victoria; Loschi, Mariela; Luchelli, Luciana; Lidia Boccaccio, Graciela] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina	Leloir Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Boccaccio, GL (corresponding author), Fdn Inst Leloir, Buenos Aires, DF, Argentina.	gboccaccio@leloir.org.ar		Perez-Pepe, Marcelo/0000-0002-5712-0973	University of Buenos Aires, Argentina [UBACyT X311]; Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET) [PIP 6173]; Agencia Nacional de Promocion Cientifica y Tecnologica, (ANPCyT), Argentina [PICT 38006, PICT 1965]	University of Buenos Aires, Argentina(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica, (ANPCyT), Argentina(ANPCyT)	This work was supported by the following grants UBACyT X311 from University of Buenos Aires, Argentina; PIP 6173 from Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET); PICT 38006 and PICT 1965 from Agencia Nacional de Promocion Cientifica y Tecnologica, (ANPCyT), Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizer A, 2008, MOL BIOL CELL, V19, P4154, DOI 10.1091/mbc.E08-05-0513; An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; An S, 2010, P NATL ACAD SCI USA, V107, P12872, DOI 10.1073/pnas.1008451107; Andersen PL, 2011, MOL BIOL CELL, V22, P2373, DOI 10.1091/mbc.E10-12-0938; Anderson P, 2002, CELL STRESS CHAPERON, V7, P213, DOI 10.1379/1466-1268(2002)007<0213:VSTROE>2.0.CO;2; Aragon T, 2009, NATURE, V457, P736, DOI 10.1038/nature07641; Baez MV, 2005, J BIOL CHEM, V280, P43131, DOI 10.1074/jbc.M508374200; Beckham CJ, 2008, CELL HOST MICROBE, V3, P206, DOI 10.1016/j.chom.2008.03.004; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Buchan JR, 2011, J CELL SCI, V124, P228, DOI 10.1242/jcs.078444; Buchan JR, 2010, METHOD ENZYMOL, V470, P619, DOI 10.1016/S0076-6879(10)70025-2; Campbell SG, 2005, J CELL BIOL, V170, P925, DOI 10.1083/jcb.200503162; Campbell SG, 2006, CELL CYCLE, V5, P678, DOI 10.4161/cc.5.7.2607; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; DORMANN D, 2010, EMBO J; Thomas MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036447; Thomas MG, 2011, CELL SIGNAL, V23, P324, DOI 10.1016/j.cellsig.2010.08.011; Thomas MG, 2009, J CELL SCI, V122, P563, DOI 10.1242/jcs.038208; Gaillard H, 2008, MOL BIOL CELL, V19, P4980, DOI 10.1091/mbc.E08-02-0193; Hua YM, 2004, FEBS LETT, V572, P69, DOI 10.1016/j.febslet.2004.07.010; Kedersha N, 2008, METHOD ENZYMOL, V448, P521, DOI 10.1016/S0076-6879(08)02626-8; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Loschi M, 2009, J CELL SCI, V122, P3973, DOI 10.1242/jcs.051383; Mao YTS, 2011, TRENDS GENET, V27, P295, DOI 10.1016/j.tig.2011.05.006; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; Moreno JA, 2012, NATURE; Narayanaswamy R, 2009, P NATL ACAD SCI USA, V106, P10147, DOI 10.1073/pnas.0812771106; Noree C, 2010, J CELL BIOL, V190, P541, DOI 10.1083/jcb.201003001; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Pascual M, 2012, COMMUNICATI IN PRESS, V5, P4; Raaben M, 2007, CELL MICROBIOL, V9, P2218, DOI 10.1111/j.1462-5822.2007.00951.x; Solomon DA, 2004, J CELL BIOL, V166, P455, DOI 10.1083/jcb.200312048; Soria G, 2008, J CELL SCI, V121, P3271, DOI 10.1242/jcs.027730; Takahara T, 2012, MOL CELL, V47, P242, DOI 10.1016/j.molcel.2012.05.019; Taylor EJ, 2010, MOL BIOL CELL, V21, P2202, DOI 10.1091/mbc.E09-11-0962; Thomas MG, 2005, MOL BIOL CELL, V16, P405, DOI 10.1091/mbc.E04-06-0516; Tsai NP, 2008, EMBO J, V27, P715, DOI 10.1038/emboj.2008.19; Baez MV, 2011, J CELL BIOL, V195, P1141, DOI 10.1083/jcb.201108159; Walther TC, 2006, NATURE, V439, P998, DOI 10.1038/nature04472; White JP, 2012, TRENDS MICROBIOL	40	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51495	10.1371/journal.pone.0051495	http://dx.doi.org/10.1371/journal.pone.0051495			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284702	gold, Green Submitted, Green Published			2022-12-27	WOS:000312794500030
J	Samy, RP; Rajendran, P; Li, F; Anandi, NM; Stiles, BG; Ignacimuthu, S; Sethi, G; Chow, VTK				Samy, Ramar Perumal; Rajendran, Peramaiyan; Li, Feng; Anandi, Narayana Moorthy; Stiles, Bradley G.; Ignacimuthu, Savarimuthu; Sethi, Gautam; Chow, Vincent T. K.			Identification of a Novel Calotropis procera Protein That Can Suppress Tumor Growth in Breast Cancer through the Suppression of NF-kappa B Pathway	PLOS ONE			English	Article							BRCA1/2 MUTATION CARRIERS; S-TRANSFERASE EXPRESSION; CULEX-QUINQUEFASCIATUS; MAMMOGRAPHIC DENSITY; MAMMARY-TUMORS; PLANT-EXTRACTS; RATS; CELLS; RISK; APOPTOSIS	Breast cancer is the most common cancer among women. To date, improvements in hormonal and cytotoxic therapies have not yet led to a sustained remission or cure. In the present study, we investigated the in vitro and in vivo antitumor activities of a novel Calotropis procera protein (CP-P) isolated from root bark. CP-P protein inhibited the proliferation and induced apoptosis of breast cancer cells through the suppression of nuclear factor kappaB (NF-kB) activation. CP-P, when administered individually or in combination with cyclophosphamide (CYC, 0.2 mg/kg) to rats with 7, 12-dimethyl benz(a) anthracene (DMBA)-induced breast cancer decreased tumor volume significantly without affecting the body weight. To elucidate the anticancer mechanism of CP-P, antioxidant activities such as superoxide dismutase (SOD), catalase (CAT), glutathione-s-transferase (GST) and non-enzymatic antioxidant - reduced glutathione (GSH), vitamin E and C generation in the breast were analyzed by various assays. SOD, CAT, GST, GSH, vitamin E and C levels were high in combination-treated groups (CP-P+CYC) versus the CYC alone-treated groups. Also, the combination was more effective in down-regulating the expression of NF-kB-regulated gene products (cyclin D1 and Bcl-2) in breast tumor tissues. Our findings indicate that CP-P possesses significant antitumor activity comparable to a commonly used anticancer drug, cyclophosphamide, and may form the basis of a novel therapy for breast cancer.	[Samy, Ramar Perumal; Anandi, Narayana Moorthy; Chow, Vincent T. K.] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Microbiol,Infect Dis Programme, Singapore 117548, Singapore; [Rajendran, Peramaiyan; Li, Feng; Sethi, Gautam] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Pharmacol,Clin Res Ctr, Singapore 117548, Singapore; [Ignacimuthu, Savarimuthu] Loyola Coll, Entomol Res Inst, Chennai, Tamil Nadu, India; [Stiles, Bradley G.] USA, Integrated Toxicol Div, Med Res Inst Infect Dis, Ft Detrick, MD USA; [Stiles, Bradley G.] Wilson Coll, Chambersburg, PA USA	National University of Singapore; National University of Singapore; Loyola College - Chennai	Samy, RP (corresponding author), Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Microbiol,Infect Dis Programme, Singapore 117548, Singapore.	rperumalsamy@yahoo.co.uk	Ignacimuthu, S/ABH-3983-2020; R., Ponalagusamy/B-5250-2014; Rajendran, Peramaiyan/I-3877-2012; Sethi, Gautam/F-2372-2011; Rajendran, Peramaiyan/K-3287-2019	Ignacimuthu, S/0000-0002-8467-789X; R., Ponalagusamy/0000-0002-9868-3764; Rajendran, Peramaiyan/0000-0001-6354-4388; Sethi, Gautam/0000-0002-8677-8475; Chow, Vincent/0000-0003-2634-6213	Council of Scientific and Industrial Research [2000-CSIR]; Extramural Research Division, Government of India, New Delhi; NUS Academic Research Fund (ARF)	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Extramural Research Division, Government of India, New Delhi; NUS Academic Research Fund (ARF)	The authors acknowledge the Council of Scientific and Industrial Research (2000-CSIR), Extramural Research Division, Government of India, New Delhi for the award of Research Associate (RA) to first author and financial assistance to carry out this work. The work was also supported in part by the grants from NUS Academic Research Fund (ARF) to GS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2010, BREAST CANCER RES TR, V122, P579, DOI 10.1007/s10549-009-0704-7; Akinmoladun AC, 2010, J MED FOOD, V13, P444, DOI 10.1089/jmf.2008.0292; Ali NOM, 2010, EUR REV MED PHARMACO, V14, P925; Andrieu N, 2006, J CLIN ONCOL, V24, P3361, DOI 10.1200/JCO.2005.03.3126; Badami S, 2003, PHYTOTHER RES, V17, P1001, DOI 10.1002/ptr.1229; Ballard-Barbash R, 2010, ENERG BALANCE CANCER, V1, P1, DOI 10.1007/978-1-4419-5515-9_1; Bargou RC, 1997, J CLIN INVEST, V100, P2961, DOI 10.1172/JCI119849; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunello A, 2008, RECENT PAT ANTI-CANC, V3, P187, DOI 10.2174/157489208786242313; Buchholz TA, 2005, CLIN CANCER RES, V11, P8398, DOI 10.1158/1078-0432.CCR-05-0885; Circosta C, 2001, FARMACO, V56, P373, DOI 10.1016/S0014-827X(01)01089-8; Clarkson RWE, 2000, J BIOL CHEM, V275, P12737, DOI 10.1074/jbc.275.17.12737; Cogswell PC, 2000, ONCOGENE, V19, P1123, DOI 10.1038/sj.onc.1203412; de Lima JM, 2011, TOXICON, V57, P183, DOI 10.1016/j.toxicon.2010.11.007; Dieye A M, 1993, Dakar Med, V38, P69; Flom JD, 2009, BREAST CANC IN PRESS; FORSTROM JW, 1978, BIOCHEMISTRY-US, V17, P2639, DOI 10.1021/bi00606a028; Gierach GL, 2010, BREAST CANCER RES TR, V123, P245, DOI 10.1007/s10549-010-0749-7; Greenlee H, 2009, BREAST CANC IN PRESS; Guo SQ, 2005, J NUTR, V135, p2978S, DOI 10.1093/jn/135.12.2978S; Gupta S, 2005, THERIOGENOLOGY, V64, P1273, DOI 10.1016/j.theriogenology.2005.03.008; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hasan S. Z., 2009, Biological Forum, V1, P12; Heusinger K, 2011, EUR J CANCER PREV, V20, P1, DOI 10.1097/CEJ.0b013e328341e2ce; Jain PK, 1985, J RES AYUR SIDHA, V6, P88; Jeune MAL, 2005, J MED FOOD, V8, P469, DOI 10.1089/jmf.2005.8.469; JOHANSSON LH, 1988, ANAL BIOCHEM, V174, P331, DOI 10.1016/0003-2697(88)90554-4; Kamath JV, 2002, FITOTERAPIA, V73, P111, DOI 10.1016/S0367-326X(02)00005-9; Kelemen LE, 2008, AM J EPIDEMIOL, V167, P1027, DOI 10.1093/aje/kwn063; Khalili-Azad T, 2009, NEOPLASMA, V56, P22, DOI 10.4149/neo_2009_01_22; Kumar Nagi B, 2005, Cancer Control, V12, P149; Kumar VL, 2011, PHYTOTHER RES; Latiff AA, 2010, CLIN TER, V161, P359; Li F, 2010, BRIT J PHARMACOL, V161, P541, DOI 10.1111/j.1476-5381.2010.00874.x; Li F, 2010, BBA-REV CANCER, V1805, P167, DOI 10.1016/j.bbcan.2010.01.002; Lima JV, 2010, J ETHNOPHARMACOL, V129, P327, DOI 10.1016/j.jep.2010.03.038; Lin YL, 2008, PHYTOTHER RES, V22, P1440, DOI 10.1002/ptr.2439; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Magalhaes HIF, 2010, AN ACAD BRAS CIENC, V82, P407, DOI 10.1590/S0001-37652010000200017; Maier CM, 2002, NEUROSCIENTIST, V8, P323, DOI 10.1177/107385840200800408; Malejka-Giganti D, 2005, CANCER DETECT PREV, V29, P338, DOI 10.1016/j.cdp.2005.01.005; Matthew KM, 1981, FLORA TAMIL NADU CAR, V1, P469; Morsy Tosson A., 2001, Journal of the Egyptian Society of Parasitology, V31, P107; MOSSA JS, 1991, AM J CHINESE MED, V19, P223, DOI 10.1142/S0192415X91000302; Moustafa AMY, 2010, PHARM BIOL, V48, P1080, DOI 10.3109/13880200903490513; Muraina IA, 2010, PHARM BIOL, V48, P1103, DOI 10.3109/13880200903505633; Murti Y, 2010, Int J Ayurveda Res, V1, P14, DOI 10.4103/0974-7788.59938; Narod SA, 2006, LANCET ONCOL, V7, P402, DOI 10.1016/S1470-2045(06)70624-6; Oliveira JS, 2010, N-S ARCH PHARMACOL, V382, P139, DOI 10.1007/s00210-010-0525-6; Omaye ST, 1979, VITAMINS COENZYMES M, V62, P3; Pandey M., 2011, J PHARMACOGN PHYTOTH, V3, P113; Perumal Samy R, 2007, NATURE P; Prasad G., 1985, J NATL MED ASSOC, V27, P7; Rishton GM, 2008, AM J CARDIOL, V101, p43D, DOI 10.1016/j.amjcard.2008.02.007; Roomi MW, 2005, BREAST CANCER RES, V7, pR291, DOI 10.1186/bcr989; Sagiv SK, 2009, ENVIRON RES, V109, P287, DOI 10.1016/j.envres.2008.11.005; Samy RP, 2008, J CELL PHYSIOL, V216, P54, DOI 10.1002/jcp.21373; Samy RP, 2006, CHEM-BIOL INTERACT, V164, P1, DOI 10.1016/j.cbi.2006.08.018; Schmidt B, 2008, METABOLISM, V57, pS3, DOI 10.1016/j.metabol.2008.03.001; Sethi G, 2006, J BIOL CHEM, V281, P23425, DOI 10.1074/jbc.M602627200; Sethi G, 2009, TRENDS PHARMACOL SCI, V30, P313, DOI 10.1016/j.tips.2009.03.004; Shahi M, 2010, J VECTOR DIS, V47, P185; Shanmugam MK, 2011, J MOL MED, V89, P713, DOI 10.1007/s00109-011-0746-2; Souza DP, 2011, PLANTA; Sovak MA, 1999, CELL GROWTH DIFFER, V10, P537; Steiner C, 2007, CARCINOGENESIS, V28, P738, DOI 10.1093/carcin/bgl180; de Freitas CDT, 2011, PLANT PHYSIOL BIOCH, V49, P738, DOI 10.1016/j.plaphy.2011.01.027; TERRIER P, 1990, AM J PATHOL, V137, P845; Tikoo K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-107; Tour N, 2011, J NAT MED-TOKYO, V65, P598, DOI 10.1007/s11418-011-0522-1; Vachon CM, 2007, CANCER EPIDEM BIOMAR, V16, P921, DOI 10.1158/1055-9965.EPI-06-1047; Valderrama B, 2002, CHEM BIOL, V9, P555, DOI 10.1016/S1074-5521(02)00149-7; Vecanova J, 2011, BRATISL MED J, V112, P67; Verma R., 2010, ETHNOBOT LEAFLETS, V14, P721; Xiang YJ, 2009, NATURE METHODS, V6, P1	75	26	30	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e48514	10.1371/journal.pone.0048514	http://dx.doi.org/10.1371/journal.pone.0048514			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284617	Green Published, Green Submitted, gold			2022-12-27	WOS:000312794500006
J	Shen, XY; Liu, HF; Hu, ZH; Hu, HJ; Shi, PC				Shen, Xiaoyan; Liu, Huafeng; Hu, Zhenghui; Hu, Hongjie; Shi, Pengcheng			The Relationship between Cerebral Glucose Metabolism and Age: Report of a Large Brain PET Data Set	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; FUNCTIONAL NEUROANATOMY; HEALTHY-YOUNG; OLDER ADULTS; ATROPHY; GENDER; FDG; ATTENTION; DEMENTIA; REGION	Cerebral glucose metabolism is a reliable index of neural activity and may provide evidence for brain function in healthy adults. We studied the correlation between cerebral glucose metabolism and age under the resting-state in both sexes with position emission tomography. Statistical test of age effect on cerebral glucose metabolism was performed using the statistical parametric mapping software with a voxel-by-voxel approach (p = 0: 05 family wise error corrected, 100-voxel threshold). The subjects consisted of 108 females (mean +/- S.D. = 45 +/- 10 years) and 126 males (mean +/- S.D. = 49 +/- 11 years). We showed here that brain activity in the frontal and temporal lobes in both sexes decreased significantly with normal aging. The glucose metabolism in the caudate bilaterally showed a negative correlation with age in males, but not in females. Few regions in males were shown with an increased glucose metabolism with age. Although the mechanisms of brain aging are still unknown, a map of brain areas susceptible to age was described in this report.	[Shen, Xiaoyan; Liu, Huafeng; Hu, Zhenghui] Zhejiang Univ, Dept Opt Engn, State Key Lab Modern Opt Instrumentat, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Huafeng; Shi, Pengcheng] Rochester Inst Technol, B Thomas Golisano Coll Comp & Informat Sci, Rochester, NY 14623 USA; [Hu, Hongjie] Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Radiol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Rochester Institute of Technology; Zhejiang University	Liu, HF (corresponding author), Zhejiang Univ, Dept Opt Engn, State Key Lab Modern Opt Instrumentat, Hangzhou 310003, Zhejiang, Peoples R China.	hxlast@rit.edu; zhenghui@zju.edu.cn; hongjiehu@zju.edu.cn			National Basic Research Program of China [2010CB732504]	National Basic Research Program of China(National Basic Research Program of China)	This work is supported by the National Basic Research Program of China (no. 2010CB732504). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROOKS RA, 1982, J NUCL MED, V23, P538; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Chiappe P, 2002, ADV PSY RES, V9, P29; DELEON MJ, 1987, NEUROBIOL AGING, V8, P319, DOI 10.1016/0197-4580(87)90070-4; Ernst M, 1998, J NEUROPSYCH CLIN N, V10, P168, DOI 10.1176/jnp.10.2.168; Garraux G, 1999, NEUROIMAGE, V10, P149, DOI 10.1006/nimg.1999.0463; GEINISMAN Y, 1995, PROG NEUROBIOL, V45, P223, DOI 10.1016/0301-0082(94)00047-L; Grady CL, 2002, PSYCHOL AGING, V17, P7, DOI 10.1037//0882-7974.17.1.7; GUR RC, 1995, SCIENCE, V267, P528, DOI 10.1126/science.7824953; Gur RC, 2002, AM J GERIAT PSYCHIAT, V10, P72, DOI 10.1176/appi.ajgp.10.1.72; Hazlett EA, 1998, NEUROBIOL AGING, V19, P437, DOI 10.1016/S0197-4580(98)00075-X; Herholz K, 2002, NEUROIMAGE, V17, P302, DOI 10.1006/nimg.2002.1208; Ilbanez V, 2004, BRAIN RES BULL, V63, P147, DOI 10.1016/j.brainresbull.2004.02.003; Kalpouzos G., 2007, NEUROBIOL AGING, V5, P1; Kawachi T, 2002, J NEUROL SCI, V199, P79, DOI 10.1016/S0022-510X(02)00112-0; KUMAR A, 1992, J NUCL MED, V33, P2103; KUSHNER M, 1987, J NUCL MED, V28, P1667; Madden DJ, 1999, HUM BRAIN MAPP, V7, P115, DOI 10.1002/(SICI)1097-0193(1999)7:2<115::AID-HBM5>3.0.CO;2-N; Mattay VS, 2002, NEUROLOGY, V58, P630, DOI 10.1212/WNL.58.4.630; MILLER EK, 1993, J NEUROSCI, V13, P1460; Moeller JR, 1996, J CEREBR BLOOD F MET, V16, P385, DOI 10.1097/00004647-199605000-00005; Murphy DGM, 1996, ARCH GEN PSYCHIAT, V53, P585; Pardo JV, 2007, NEUROIMAGE, V35, P1231, DOI 10.1016/j.neuroimage.2006.12.044; PARKIN AJ, 1992, PSYCHOL AGING, V7, P290, DOI 10.1037/0882-7974.7.2.290; Petit-Taboue MC, 1998, NEUROIMAGE, V7, P176, DOI 10.1006/nimg.1997.0318; PHELPS ME, 1979, ANN NEUROL, V6, P371, DOI 10.1002/ana.410060502; Posner MI, 1998, PHILOS T R SOC B, V353, P1915, DOI 10.1098/rstb.1998.0344; Rasgon NL, 2001, PSYCHIAT RES-NEUROIM, V107, P11, DOI 10.1016/S0925-4927(01)00084-1; RAZ N, 1995, NEUROBIOL LEARN MEM, V63, P133, DOI 10.1006/nlme.1995.1013; Reuter-Lorenz PA, 2000, J COGNITIVE NEUROSCI, V12, P174, DOI 10.1162/089892900561814; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; SALMON E, 1991, ACTA NEUROL BELG, V91, P288; Scarmeas N, 2003, NEUROIMAGE, V19, P1215, DOI 10.1016/S1053-8119(03)00074-0; SCHLAGETER NL, 1987, J NEUROL NEUROSUR PS, V50, P779, DOI 10.1136/jnnp.50.6.779; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; van Veen V, 2009, NAT NEUROSCI, V12, P1469, DOI 10.1038/nn.2413; WANG GJ, 1994, J NUCL MED, V35, P1457; Willis MW, 2002, PSYCHIAT RES-NEUROIM, V114, P23, DOI 10.1016/S0925-4927(01)00126-3; Yanase D, 2005, EUR J NUCL MED MOL I, V32, P794, DOI 10.1007/s00259-005-1767-2; YOSHII F, 1988, J CEREBR BLOOD F MET, V8, P654, DOI 10.1038/jcbfm.1988.112	41	22	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e51517	10.1371/journal.pone.0051517	http://dx.doi.org/10.1371/journal.pone.0051517			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284706	Green Published, gold, Green Submitted			2022-12-27	WOS:000312794500031
J	Amici, F; Barney, B; Johnson, VE; Call, J; Aureli, F				Amici, Federica; Barney, Bradley; Johnson, Valen E.; Call, Josep; Aureli, Filippo			A Modular Mind? A Test Using Individual Data from Seven Primate Species	PLOS ONE			English	Article							GENERAL COGNITIVE-ABILITY; HETEROGENEOUS STOCK MICE; FISSION-FUSION DYNAMICS; APES PAN-TROGLODYTES; INHIBITORY CONTROL; GREAT APES; BAYESIAN-ANALYSIS; GORILLA-GORILLA; PONGO-PYGMAEUS; INTELLIGENCE	It has long been debated whether the mind consists of specialized and independently evolving modules, or whether and to what extent a general factor accounts for the variance in performance across different cognitive domains. In this study, we used a hierarchical Bayesian model to re-analyse individual level data collected on seven primate species (chimpanzees, bonobos, orangutans, gorillas, spider monkeys, brown capuchin monkeys and long-tailed macaques) across 17 tasks within four domains (inhibition, memory, transposition and support). Our modelling approach evidenced the existence of both a domain-specific factor and a species factor, each accounting for the same amount (17%) of the observed variance. In contrast, inter-individual differences played a minimal role. These results support the hypothesis that the mind of primates is (at least partially) modular, with domain-specific cognitive skills undergoing different evolutionary pressures in different species in response to specific ecological and social demands.	[Amici, Federica; Call, Josep] Max Planck Inst Evolutionary Anthropol, Dept Comparat & Dev Psychol, Leipzig, Germany; [Barney, Bradley] Kennesaw State Univ, Dept Math & Stat, Kennesaw, GA USA; [Johnson, Valen E.] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Aureli, Filippo] Univ Veracruzana, Inst Neuroetol, Xalapa 91000, Veracruz, Mexico; [Aureli, Filippo] Liverpool John Moores Univ, Res Ctr Evolutionary Anthropol & Palaeoecol, Liverpool L3 5UX, Merseyside, England	Max Planck Society; University System of Georgia; Kennesaw State University; University of Texas System; UTMD Anderson Cancer Center; Universidad Veracruzana; Liverpool John Moores University	Amici, F (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Comparat & Dev Psychol, Leipzig, Germany.	abbepu@yahoo.it	; Amici, Federica/F-8996-2016	Call Balaguer, Josep/0000-0002-8597-8336; Aureli, Filippo/0000-0002-0671-013X; Amici, Federica/0000-0003-3539-1067	SEDSU [012-984 NESTPathfinder]; INCORE [043318]; European Community; Humboldt Research Fellowship for Postdoctoral Researchers [1138999]	SEDSU; INCORE(European Commission); European Community(European Commission); Humboldt Research Fellowship for Postdoctoral Researchers	Data collection was funded by a SEDSU project (contract number 012-984 NESTPathfinder) and supported by an INCORE project (contract number 043318), both funded by the European Community's Sixth Framework Programme (FP6/2002-2006). This work was written while Federica Amici held a Humboldt Research Fellowship for Postdoctoral Researchers (Humboldt ID number: 1138999). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT JH, 1993, J AM STAT ASSOC, V88, P669, DOI 10.2307/2290350; Amici F, 2008, CURR BIOL, V18, P1415, DOI 10.1016/j.cub.2008.08.020; Amici F, 2010, AM J PHYS ANTHROPOL, V143, P188, DOI 10.1002/ajpa.21305; ANDERSON B, 1993, NEUROSCI LETT, V153, P98, DOI 10.1016/0304-3940(93)90086-Z; Anderson Britt, 2000, Novartis Foundation Symposium, V233, P79, DOI 10.1002/0470870850.ch5; Atkinson R. C., 1968, PSYCHOL LEARN MOTIVA, V2, P89, DOI 10.1016/S0079-7421(08)60422-3; Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; Banerjee K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005883; Barkow J. H., 1992, ADAPTED MIND EVOLUTI, Patent No. [2201.07245, 220107245]; Barney, 2011, THESIS; Barrett L, 2003, TRENDS COGN SCI, V7, P494, DOI 10.1016/j.tics.2003.09.005; Barth J, 2006, J EXP PSYCHOL ANIM B, V32, P239, DOI 10.1037/0097-7403.32.3.239; Barton RA, 2000, NATURE, V405, P1055, DOI 10.1038/35016580; Barton Robert, 1999, P167, DOI 10.1017/CBO9780511542466.010; Boogert NJ, 2011, ANIM BEHAV, V81, P1209, DOI 10.1016/j.anbehav.2011.03.004; Carruthers P, 2003, MIND LANG, V18, P502, DOI 10.1111/1468-0017.00240; Chandra SBC, 2000, J COMP PSYCHOL, V114, P86, DOI 10.1037//0735-7036.114.1.86; Colom R, 2006, NEUROIMAGE, V31, P1359, DOI 10.1016/j.neuroimage.2006.01.006; Conway ARA, 2003, TRENDS COGN SCI, V7, P547, DOI 10.1016/j.tics.2003.10.005; Crinella FM, 1995, INTELLIGENCE, V21, P225, DOI 10.1016/0160-2896(95)90027-6; de Winter W, 2001, NATURE, V409, P710, DOI 10.1038/35055547; Deaner R. O., 2006, EVOL PSYCHOL, V4, DOI [10.1177/147470490600400114, DOI 10.1177/147470490600400114]; Deaner RO, 2000, BRAIN BEHAV EVOLUT, V55, P44, DOI 10.1159/000006641; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; Fodor J. A, 1983, MODULARITY MIND; Gallistel C.Randy., 2000, NEW COGNITIVE NEUROS, V2nd ed., P1179; GALLISTEL R, 1990, ORG LEARNING; Galsworthy MJ, 2005, BEHAV GENET, V35, P675, DOI 10.1007/s10519-005-3423-9; Galsworthy MJ, 2002, GENES BRAIN BEHAV, V1, P88, DOI 10.1034/j.1601-183X.2002.10204.x; Haier RJ, 2004, NEUROIMAGE, V23, P425, DOI 10.1016/j.neuroimage.2004.04.025; Harlow HF, 1934, J COMP PSYCHOL, V18, P423, DOI 10.1037/h0073305; Herrmann E, 2008, J COMP PSYCHOL, V122, P220, DOI 10.1037/0735-7036.122.2.220; Herrmann E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012438; Herrmann E, 2010, PSYCHOL SCI, V21, P102, DOI 10.1177/0956797609356511; Jensen A.R., 1998, G FACTOR SCI MENTAL; JENSEN AR, 1993, CURRENT DIRECTIONS P, V2, P53, DOI DOI 10.1111/1467-8721.EP10770697; Johnson VE, 2007, BAYESIAN ANAL, V2, P719, DOI 10.1214/07-BA229; Johnson VE, 2002, J AM STAT ASSOC, V97, P8, DOI 10.1198/016214502753479185; Keagy J, 2011, ANIM BEHAV, V81, P1063, DOI 10.1016/j.anbehav.2011.02.018; Kolata S, 2005, NEUROBIOL LEARN MEM, V84, P241, DOI 10.1016/j.nlm.2005.07.006; Kolata S, 2008, INTELLIGENCE, V36, P619, DOI 10.1016/j.intell.2007.12.001; Kralik JD, 2005, J COMP PSYCHOL, V119, P78, DOI 10.1037/0735-7036.119.1.78; Kralik JD, 2002, J COMP PSYCHOL, V116, P39, DOI 10.1037//0735-7036.116.1.39; Lee JJ, 2007, INTELLIGENCE, V35, P253, DOI 10.1016/j.intell.2006.08.003; Locurto C, 2003, GENES BRAIN BEHAV, V2, P40, DOI 10.1034/j.1601-183X.2003.00006.x; Locurto C, 1998, J COMP PSYCHOL, V112, P344, DOI 10.1037/0735-7036.112.4.344; MacLean EL, 2012, ANIM COGN, V15, P223, DOI 10.1007/s10071-011-0448-8; MacLullich AMJ, 2002, NEUROLOGY, V59, P169, DOI 10.1212/WNL.59.2.169; Matzel LD, 2003, J NEUROSCI, V23, P6423; Matzel LD, 2006, NEUROBIOL LEARN MEM, V86, P228, DOI 10.1016/j.nlm.2006.03.004; Pennington BF, 2000, J COGNITIVE NEUROSCI, V12, P223, DOI 10.1162/089892900561850; Pinker S., 1997, MIND WORKS; Plomin R, 2001, NAT REV NEUROSCI, V2, P136, DOI 10.1038/35053584; Reader SM, 2011, PHILOS T R SOC B, V366, P1017, DOI 10.1098/rstb.2010.0342; REGOLIN L, 1994, ANIM BEHAV, V47, P123, DOI 10.1006/anbe.1994.1014; Rosati AG, 2007, CURR BIOL, V17, P1663, DOI 10.1016/j.cub.2007.08.033; Schmitt V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032024; Semendeferi K, 1997, J HUM EVOL, V32, P375, DOI 10.1006/jhev.1996.0099; Semendeferi Katerina, 1999, P70, DOI 10.1017/CBO9780511542305.004; Shettleworth S. J., 2009, COGNITION EVOLUTION; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; Sperber D., 1996, EXPLAINING CULTURE; Sprague J. M., 1976, PROGR PSYCHOBIOLOGY, V6, P245; Tomasello M, 1997, PRIMATE COGNITION; Van Schaik CP, 2003, ANIMAL SOCIAL COMPLEXITY, P5; Vlamings PHJM, 2010, ANIM COGN, V13, P273, DOI 10.1007/s10071-009-0265-5; WILLERMAN L, 1987, PERS INDIV DIFFER, V8, P943, DOI 10.1016/0191-8869(87)90145-0; Yuan Y, 2012, BIOMETRICS, V68, P156, DOI 10.1111/j.1541-0420.2011.01668.x; [No title captured]	69	38	38	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51918	10.1371/journal.pone.0051918	http://dx.doi.org/10.1371/journal.pone.0051918			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	059HF	23284816	Green Published, gold, Green Submitted			2022-12-27	WOS:000312694300056
J	Khan, I; Kumar, N; Pant, I; Narra, S; Kondaiah, P				Khan, Imran; Kumar, Neeraj; Pant, Ila; Narra, Sivakrishna; Kondaiah, Paturu			Activation of TGF-beta Pathway by Areca Nut Constituents: A Possible Cause of Oral Submucous Fibrosis	PLOS ONE			English	Article							LYSYL OXIDASE; PATHOGENESIS; EXPRESSION	Oral submucous fibrosis (OSF) is a chronic inflammatory disease characterized by the accumulation of excess collagen, and areca nut chewing has been proposed as an important etiological factor for disease manifestation. Activation of transforming growth factor-beta signaling has been postulated as the main causative event for increased collagen production in OSF. Oral epithelium plays important roles in OSF, and arecoline has been shown to induce TGF-beta in epithelial cells. In an attempt to understand the role of areca nut constituents in the manifestation of OSF, we studied the global gene expression profile in epithelial cells (HaCaT) following treatment with areca nut water extract or TGF-beta. Interestingly, 64% of the differentially regulated genes by areca nut water extract matches with the TGF-beta induced gene expression profile. Out of these, expression of 57% of genes was compromised in the presence of ALK5 (T beta RI) inhibitor and 7% were independently induced by areca nut, highlighting the importance of TGF-beta in areca nut actions. Areca nut water extract treatment induced p-SMAD2 and TGF-beta downstream targets in HaCaT cells but not in human gingival fibroblast cells (hGF), suggesting epithelial cells could be the source of TGF-beta in promoting OSF. Water extract of areca nut consists of polyphenols and alkaloids. Both polyphenol and alkaloid fractions of areca nut were able to induce TGF-beta signaling and its downstream targets. Also, SMAD-2 was phosphorylated following treatment of HaCaT cells by Catechin, Tannin and alkaloids namely Arecoline, Arecaidine and Guvacine. Moreover, both polyphenols and alkaloids induced TGF-beta 2 and THBS1 (activator of latent TGF-beta) in HaCaT cells suggesting areca nut mediated activation of p-SMAD2 involves up-regulation and activation of TGF-beta. These data suggest a major causative role for TGF-beta that is induced by areca nut in OSF progression.	[Khan, Imran; Kumar, Neeraj; Pant, Ila; Narra, Sivakrishna; Kondaiah, Paturu] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Kondaiah, P (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	paturu@mrdg.iisc.ernet.in	khan, imran/K-9921-2013; Pant, Ila/AAG-9501-2020	khan, imran/0000-0001-6888-7347; Pant, Ila/0000-0003-0517-6542; sivakrishna, Narra/0000-0002-2254-0935	Department of Science and Technology (DST), Government of India; DST (Fund for Improvement of Science and Technology); Council of Scientific and Industrial Research, New Delhi	Department of Science and Technology (DST), Government of India(Department of Science & Technology (India)); DST (Fund for Improvement of Science and Technology); Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	The authors acknowledge Department of Science and Technology (DST), Government of India, for funding this study and Infrastructural support from DST (Fund for Improvement of Science and Technology) and University Grants Commission, Government of India, to the Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science. IK is recipient of a fellowship from Council of Scientific and Industrial Research, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Haque MF, 2000, J ORAL PATHOL MED, V29, P123, DOI 10.1034/j.1600-0714.2000.290304.x; HARVEY W, 1986, ARCH ORAL BIOL, V31, P45, DOI 10.1016/0003-9969(86)90112-3; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2004, IARC Monogr Eval Carcinog Risks Hum, V85, P1; Ihn H, 2002, CURR OPIN RHEUMATOL, V14, P681, DOI 10.1097/00002281-200211000-00009; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; JENG JH, 1994, J DENT RES, V73, P1043, DOI 10.1177/00220345940730050501; Khan I, 2011, GROWTH FACTORS, V29, P119, DOI 10.3109/08977194.2011.582839; Krieg T, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2188; Le PV, 1996, ORAL SURG ORAL MED O, V81, P148, DOI 10.1016/S1079-2104(96)80404-5; Moutasim KA, 2011, J PATHOL, V223, P366, DOI 10.1002/path.2786; Nigam M, 2008, LIFE SCI, V82, P577, DOI 10.1016/j.lfs.2007.11.028; Perera MWS, 2007, J ORAL PATHOL MED, V36, P273, DOI 10.1111/j.1600-0714.2007.00523.x; Rajalalitha P, 2005, J ORAL PATHOL MED, V34, P321, DOI 10.1111/j.1600-0714.2005.00325.x; Ranganathan P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-98; Shanley CJ, 1997, J VASC SURG, V25, P446, DOI 10.1016/S0741-5214(97)70254-4; SINOR PN, 1990, J ORAL PATHOL MED, V19, P94, DOI 10.1111/j.1600-0714.1990.tb00804.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Thangjam GS, 2009, J PERIODONTAL RES, V44, P736, DOI 10.1111/j.1600-0765.2008.01185.x; Thangjam GS, 2009, J DENT RES, V88, P170, DOI 10.1177/0022034508329633; Tilakaratne WM, 2006, ORAL ONCOL, V42, P561, DOI 10.1016/j.oraloncology.2005.08.005; Trivedy C, 1999, J ORAL PATHOL MED, V28, P246; Tullberg-Reinert H, 1999, HISTOCHEM CELL BIOL, V112, P271, DOI 10.1007/s004180050447; Zavadil J, 2001, P NATL ACAD SCI USA, V98, P6686, DOI 10.1073/pnas.111614398; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888	25	72	72	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e51806	10.1371/journal.pone.0051806	http://dx.doi.org/10.1371/journal.pone.0051806			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284772	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000312694300045
J	Mirpuri, J; Sotnikov, I; Myers, L; Denning, TL; Yarovinsky, F; Parkos, CA; Denning, PW; Louis, NA				Mirpuri, Julie; Sotnikov, Ilya; Myers, Loren; Denning, Timothy L.; Yarovinsky, Felix; Parkos, Charles A.; Denning, Patricia W.; Louis, Nancy A.			Lactobacillus rhamnosus (LGG) Regulates IL-10 Signaling in the Developing Murine Colon through Upregulation of the IL-10R2 Receptor Subunit	PLOS ONE			English	Article							PLATELET-ACTIVATING-FACTOR; TUMOR-NECROSIS-FACTOR; EXPERIMENTAL NECROTIZING ENTEROCOLITIS; MACROPHAGE INFLAMMATORY PROTEIN-2; INTESTINAL EPITHELIAL-CELLS; GUANYLATE-BINDING PROTEIN-1; IFN-ALPHA-A; EXPERIMENTAL COLITIS; GENE-EXPRESSION; HUMAN-MILK	The intestinal microflora is critical for normal development, with aberrant colonization increasing the risk for necrotizing enterocolitis (NEC). In contrast, probiotic bacteria have been shown to decrease its incidence. Multiple pro-and anti-inflammatory cytokines have been identified as markers of intestinal inflammation, both in human patients with NEC and in models of immature intestine. Specifically, IL-10 signaling attenuates intestinal responses to gut dysbiosis, and disruption of this pathway exacerbates inflammation in murine models of NEC. However, the effects of probiotics on IL-10 and its signaling pathway, remain poorly defined. Real-time PCR profiling revealed developmental regulation of MIP-2, TNF-alpha, IL-12, IL-10 and the IL-10R2 subunit of the IL-10 receptor in immature murine colon, while the expression of IL-6 and IL-18 was independent of postnatal age. Enteral administration of the probiotic Lactobacillus rhamnosus GG (LGG) down-regulated the expression of TNF-alpha and MIP-2 and yet failed to alter IL-10 mRNA and protein expression. LGG did however induce mRNA expression of the IL-10R2 subunit of the IL-10 receptor. IL-10 receptor activation has been associated with signal transducer and activator of transcription (STAT) 3-dependent induction of members of the suppressors of cytokine signaling (SOCS) family. In 2 week-old mice, LGG also induced STAT3 phosphorylation, increased colonic expression of SOCS-3, and attenuated colonic production of MIP-2 and TNF-alpha. These LGG-dependent changes in phosphoSTAT3, SOCS3, MIP-2 and TNF-alpha were all inhibited by antibody-mediated blockade of the IL-10 receptor. Thus LGG decreased baseline proinflammatory cytokine expression in the developing colon through upregulation of IL-10 receptor-mediated signaling, most likely due to the combined induction of phospho-STAT3 and SOCS3. Furthermore, LGG-dependent increases in IL-10R2 were associated with reductions in TNF-alpha, MIP-2 and disease severity in a murine model of intestinal injury in the immature colon.	[Mirpuri, Julie; Sotnikov, Ilya; Myers, Loren; Denning, Timothy L.; Denning, Patricia W.; Louis, Nancy A.] Emory Univ, Dept Pediat, Div Neonatal Perinatal Med, Atlanta, GA 30322 USA; [Mirpuri, Julie] Univ Texas SW, Dept Pediat, Dallas, TX USA; [Denning, Timothy L.; Parkos, Charles A.] Emory Univ, Dept Pathol & Lab Med, Epithelial Pathobiol Unit, Atlanta, GA 30322 USA; [Yarovinsky, Felix] Univ Texas SW, Dept Immunol, Dallas, TX USA	Emory University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Emory University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Mirpuri, J (corresponding author), Emory Univ, Dept Pediat, Div Neonatal Perinatal Med, Atlanta, GA 30322 USA.	julie.mirpuri@utsouthwestern.edu; nlouis@emory.edu	Denning, Patricia W/G-4485-2011; Louis, Nancy/G-5163-2011; Denning, Timothy/F-2271-2011	Louis, Nancy/0000-0001-7092-8136; Denning, Timothy/0000-0002-1072-7444; Yarovinsky, Felix/0000-0001-5825-8002; Sotnikov, ILya/0000-0001-9968-2803; Mirpuri, Julie/0000-0003-4255-3474	National Institutes of Health [DK62007, K12 HD 068369, R03DK076613, R01HD059122, AA01787001, AI083554, DK79392, DK 063399]; Crohn's and Colitis Foundation of America; Emory Egleston Children's Research Center; Children's Medical Center Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD068369, R01HD059122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK076613, R01DK079392] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Emory Egleston Children's Research Center; Children's Medical Center Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants DK62007 (N.A.L), K12 HD 068369 (J.M.), R03DK076613 & R01HD059122 (P. W. D.); AA01787001 & AI083554 (T. L. D); DK79392 (C. A. P.); DK 063399 (C. A. P., N.A.L, P. W. D., and T. L. D.). Additional support came from a Career Development Award from the Crohn's and Colitis Foundation of America, an Emory Egleston Children's Research Center seed grant (T. L. D.) and a Children's Medical Center Foundation Grant (J.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akisu M, 2003, EUR J PEDIATR SURG, V13, P319, DOI 10.1055/s-2003-43580; AlFaleh K, 2011, COCHRANE DB SYST REV, DOI [10.1097/AOG.0b013e3181726f2f, 10.1002/14651858.CD005496.pub3]; Aste-Amezaga M, 1998, J IMMUNOL, V160, P5936; Bahjat KS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000568; Bin-Nun A, 2005, J PEDIATR-US, V147, P192, DOI 10.1016/j.jpeds.2005.03.054; Butel MJ, 1998, J MED MICROBIOL, V47, P391, DOI 10.1099/00222615-47-5-391; Caplan MS, 1999, GASTROENTEROLOGY, V117, P577, DOI 10.1016/S0016-5085(99)70450-6; Chiu BC, 2007, AM J PATHOL, V171, P829, DOI 10.2353/ajpath.2007.061122; Chokshi NK, 2008, J AM COLL SURGEONS, V207, pS14, DOI 10.1016/j.jamcollsurg.2008.06.013; Claud EC, 2003, PEDIATR RES, V53, P419, DOI 10.1203/01.PDR.0000050141.73528.AD; Dani C, 2002, BIOL NEONATE, V82, P103, DOI 10.1159/000063096; De Groote MA, 2005, PEDIATR INFECT DIS J, V24, P278, DOI 10.1097/01.inf.0000154588.79356.e6; De la Cochetiere MF, 2004, PEDIATR RES, V56, P366, DOI 10.1203/01.PDR.0000134251.45878.D5; Denning TL, 2000, INT IMMUNOL, V12, P133, DOI 10.1093/intimm/12.2.133; Deshpande G, 2010, PEDIATRICS, V125, P921, DOI 10.1542/peds.2009-1301; Donnelly RP, 1999, J INTERF CYTOK RES, V19, P563, DOI 10.1089/107999099313695; Edelson MB, 1999, PEDIATRICS, V103, P766, DOI 10.1542/peds.103.4.766; Emami CN, 2012, AM J SURG, V203, P428, DOI 10.1016/j.amjsurg.2011.08.016; FINBLOOM DS, 1995, J IMMUNOL, V155, P1079; Fituch CC, 2004, ACTA PAEDIATR, V93, P1496, DOI 10.1080/08035250410022314; Ford H, 1997, J PEDIATR SURG, V32, P275, DOI 10.1016/S0022-3468(97)90194-9; Frost BL, 2008, SEMIN PERINATOL, V32, P100, DOI 10.1053/j.semperi.2008.01.001; GAROFALO R, 1995, PEDIATR RES, V37, P444, DOI 10.1203/00006450-199504000-00010; GREIG PC, 1995, AM J OBSTET GYNECOL, V173, P1223, DOI 10.1016/0002-9378(95)91358-0; Halpern MD, 2006, AM J PHYSIOL-GASTR L, V290, pG757, DOI 10.1152/ajpgi.00408.2005; Halpern MD, 2002, PEDIATR RES, V51, P733, DOI 10.1023/01.PDR.0000017480.64723.56; Han XB, 2004, AM J PHYSIOL-GASTR L, V287, pG1220, DOI 10.1152/ajpgi.00231.2004; HARRIS MC, 1994, J PEDIATR-US, V124, P105, DOI 10.1016/S0022-3476(94)70264-0; Hobbie S, 1997, J IMMUNOL, V159, P5550; Hoyos A B, 1999, Int J Infect Dis, V3, P197, DOI 10.1016/S1201-9712(99)90024-3; HSUEH W, 1987, FASEB J, V1, P403, DOI 10.1096/fasebj.1.5.3678700; HUANG L, 1994, IMMUNOLOGY, V83, P65; Hunter CJ, 2009, INFECT IMMUN, V77, P1031, DOI 10.1128/IAI.01192-08; Jilling T, 2006, J IMMUNOL, V177, P3273, DOI 10.4049/jimmunol.177.5.3273; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; KASAMA T, 1995, J CLIN INVEST, V95, P2868, DOI 10.1172/JCI117993; Khailova L, 2009, AM J PHYSIOL-GASTR L, V297, pG940, DOI 10.1152/ajpgi.00141.2009; Kopydlowski KM, 1999, J IMMUNOL, V163, P1537; Kotenko SV, 1997, EMBO J, V16, P5894, DOI 10.1093/emboj/16.19.5894; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Land MH, 2005, PEDIATRICS, V115, P178, DOI 10.1542/peds.2004-2137; Lee J, 2006, ANN NY ACAD SCI, V1072, P351, DOI 10.1196/annals.1326.022; Li N, 2009, PEDIATR RES, V66, P203, DOI 10.1203/PDR.0b013e3181aabd4f; Liedel JL, 2011, PEDIATR RES, V69, P395, DOI 10.1203/PDR.0b013e3182114ec9; Lin PW, 2008, SEMIN PERINATOL, V32, P70, DOI 10.1053/j.semperi.2008.01.004; Lin PW, 2009, FREE RADICAL BIO MED, V47, P1205, DOI 10.1016/j.freeradbiomed.2009.07.033; LIU Y, 1994, J IMMUNOL, V152, P1821; Louis NA, 2008, J IMMUNOL, V180, P4246, DOI 10.4049/jimmunol.180.6.4246; LUCAS A, 1990, LANCET, V336, P1519, DOI 10.1016/0140-6736(90)93304-8; Madsen KL, 2002, INFLAMM BOWEL DIS, V8, P390, DOI 10.1097/00054725-200211000-00003; Maheshwari A, 2010, GASTROENTEROLOGY; MALEFYT RD, 1991, J EXP MED, V174, P1209; McInnes IB, 2000, IMMUNOL TODAY, V21, P312, DOI 10.1016/S0167-5699(00)01648-0; Mirpuri J, 2010, J IMMUNOL, V184, P7186, DOI 10.4049/jimmunol.0903116; MORECROFT J, 1994, ACTA PAEDIATR, V83, P18, DOI 10.1111/j.1651-2227.1994.tb13235.x; Murray PJ, 2006, CURR OPIN PHARMACOL, V6, P379, DOI 10.1016/j.coph.2006.01.010; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; Patel RM, 2012, AM J PATHOL, V180, P626, DOI 10.1016/j.ajpath.2011.10.025; Rachmilewitz D, 2004, GASTROENTEROLOGY, V126, P520, DOI 10.1053/j.gastro.2003.11.019; Rajasingh J, 2006, FASEB J, V20, P2112, DOI 10.1096/fj.06-6084fje; Rakoff-Nahoum S, 2008, MUCOSAL IMMUNOL, V1, pS10, DOI 10.1038/mi.2008.49; Ren Y, 2005, HISTOPATHOLOGY, V46, P659, DOI 10.1111/j.1365-2559.2005.02159.x; Sasaki A, 2000, J BIOL CHEM, V275, P29338, DOI 10.1074/jbc.M003456200; Schnoor M, 2009, MUCOSAL IMMUNOL, V2, P33, DOI 10.1038/mi.2008.62; Smallie T, 2010, J EXP MED, V207, P2081, DOI 10.1084/jem.20100414; STANDIFORD TJ, 1995, J IMMUNOL, V155, P2222; SUN X, 1994, GUT, V35, P215, DOI 10.1136/gut.35.2.215; Sun XM, 1997, AM J PHYSIOL-GASTR L, V273, pG56, DOI 10.1152/ajpgi.1997.273.1.G56; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; TAN XD, 1993, AM J PATHOL, V142, P1858; Waeytens A, 2008, INFLAMM BOWEL DIS, V14, P471, DOI 10.1002/ibd.20346; Weitkamp J.H., 2012, GUT; Zein E F, 2008, Ann Biol Clin (Paris), V66, P195, DOI 10.1684/abc.2008.0210	73	39	41	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51955	10.1371/journal.pone.0051955	http://dx.doi.org/10.1371/journal.pone.0051955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272193	gold, Green Published, Green Submitted			2022-12-27	WOS:000312483300042
J	Weber, SS; Parente, AFA; Borges, CL; Parente, JA; Bailao, AM; Soares, CMD				Weber, Simone Schneider; Alves Parente, Ana Flavia; Borges, Clayton Luiz; Parente, Juliana Alves; Bailao, Alexandre Melo; de Almeida Soares, Celia Maria			Analysis of the Secretomes of Paracoccidioides Mycelia and Yeast Cells	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CRYPTOCOCCUS-NEOFORMANS; HISTOPLASMA-CAPSULATUM; MACROPHAGE FUNCTIONS; PROTEIN SECRETION; POSTTRANSLATIONAL MODIFICATIONS; EXTRACELLULAR VESICLES; ASPERGILLUS-FUMIGATUS; PROTEOMIC ANALYSIS; CANDIDA-GLABRATA	Paracoccidioides, a complex of several phylogenetic species, is the causative agent of paracoccidioidomycosis. The ability of pathogenic fungi to develop a multifaceted response to the wide variety of stressors found in the host environment is important for virulence and pathogenesis. Extracellular proteins represent key mediators of the host-parasite interaction. To analyze the expression profile of the proteins secreted by Paracoccidioides, Pb01 mycelia and yeast cells, we used a proteomics approach combining two-dimensional electrophoresis with matrix-assisted laser desorption ionization quadrupole time-of-flight mass spectrometry (MALDI-Q-TOF MS/MS). From three biological replicates, 356 and 388 spots were detected, in mycelium and yeast cell secretomes, respectively. In this study, 160 non-redundant proteins/isoforms were indentified, including 30 and 24 proteins preferentially secreted in mycelia and yeast cells, respectively. In silico analyses revealed that 65% of the identified proteins/isoforms were secreted primarily via non-conventional pathways. We also investigated the influence of protein export inhibition in the phagocytosis of Paracoccidioides by macrophages. The addition of Brefeldin A to the culture medium significantly decreased the production of secreted proteins by both Paracoccidioides and internalized yeast cells by macrophages. In contrast, the addition of concentrated culture supernatant to the co-cultivation significantly increased the number of internalized yeast cells by macrophages. Importantly, the proteins detected in the fungal secretome were also identified within macrophages. These results indicate that Paracoccidioides extracellular proteins are important for the fungal interaction with the host.	[Weber, Simone Schneider; Alves Parente, Ana Flavia; Borges, Clayton Luiz; Parente, Juliana Alves; Bailao, Alexandre Melo; de Almeida Soares, Celia Maria] Univ Fed Goias, Inst Ciencias Biol, Mol Biol Lab, Goiania, Go, Brazil	Universidade Federal de Goias	Soares, CMD (corresponding author), Univ Fed Goias, Inst Ciencias Biol, Mol Biol Lab, Goiania, Go, Brazil.	cmasoares@gmail.com	BORGES, CLAYTON LUIZ/GQB-5595-2022; Bailao, Alexandre Melo/H-1272-2013; Soares, Celia/N-6395-2014	Bailao, Alexandre Melo/0000-0001-7754-4047; Weber, Simone/0000-0002-4181-142X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [558923/2009-7, 563398/2010-5, 477962/2010-6, 473277/2011-5]; Financiadora de Estudos e Projetos (FINEP) [0107055200]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [PNPD 024979/09-5]; Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG); CNPq PhD fellowship	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG)(Fundacao de Amparo a Pesquisa do Estado do Goias (FAPEG)); CNPq PhD fellowship	This work performed at Universidade Federal de Goias was supported by the following grants: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (558923/2009-7, 563398/2010-5, 477962/2010-6 and 473277/2011-5), Financiadora de Estudos e Projetos (FINEP) (0107055200), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (PNPD 024979/09-5) and Fundacao de Amparo a Pesquisa do Estado de Goias (FAPEG). SSW is the recipient of a CNPq PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque PC, 2008, CELL MICROBIOL, V10, P1695, DOI 10.1111/j.1462-5822.2008.01160.x; Almeida SR, 1998, MED MYCOL, V36, P405, DOI 10.1080/02681219880000641; Bailao AM, 2007, FEMS IMMUNOL MED MIC, V51, P43, DOI 10.1111/j.1574-695X.2007.00277.x; Barbosa MS, 2006, INFECT IMMUN, V74, P382, DOI 10.1128/IAI.74.1.382-389.2006; Beck MR, 2009, MOL MICROBIOL, V72, P344, DOI 10.1111/j.1365-2958.2009.06647.x; Bonin-Debs AL, 2004, EXPERT OPIN BIOL TH, V4, P551, DOI 10.1517/eobt.4.4.551.29788; Borges CL, 2010, FEMS YEAST RES, V10, P104, DOI 10.1111/j.1567-1364.2009.00594.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buckova M, 2010, CURR MICROBIOL, V61, P241, DOI 10.1007/s00284-010-9601-x; Carrero LL, 2008, FUNGAL GENET BIOL, V45, P605, DOI 10.1016/j.fgb.2008.02.002; Choi J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-105; Cleves AE, 1996, J CELL BIOL, V133, P1017, DOI 10.1083/jcb.133.5.1017; Tacco BACD, 2009, MED MYCOL, V47, P845, DOI 10.3109/13693780802695512; Desjardins CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002345; Eisenhaber B, 2004, J MOL BIOL, V337, P243, DOI 10.1016/j.jmb.2004.01.025; EISSENBERG LG, 1993, J EXP MED, V177, P1605, DOI 10.1084/jem.177.6.1605; Fernandez-Arenas E, 2009, CELL MICROBIOL, V11, P560, DOI 10.1111/j.1462-5822.2008.01274.x; Fortier AH, 2006, CURRENT PROTOCOLS IM, P11; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Hassani K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018724; HAYES JD, 1995, FREE RADICAL RES, V22, P193, DOI 10.3109/10715769509147539; Herbert B, 2001, ELECTROPHORESIS, V22, P2046, DOI 10.1002/1522-2683(200106)22:10<2046::AID-ELPS2046>3.0.CO;2-C; Holbrook ED, 2008, CURR OPIN MICROBIOL, V11, P318, DOI 10.1016/j.mib.2008.05.010; Holbrook ED, 2011, J PROTEOME RES, V10, P1929, DOI 10.1021/pr1011697; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; JACKSON A, 1992, P NATL ACAD SCI USA, V89, P10691, DOI 10.1073/pnas.89.22.10691; Jeffery CJ, 2009, MOL BIOSYST, V5, P345, DOI 10.1039/b900658n; Kaur R, 2007, P NATL ACAD SCI USA, V104, P7628, DOI 10.1073/pnas.0611195104; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Konno AYC, 2009, MICROBES INFECT, V11, P92, DOI 10.1016/j.micinf.2008.10.011; Lacaz C, 1994, PARACOCCIDIOIDOMYCOS, P1; Liu H, 2005, MOL CELL BIOL, V25, P3117, DOI 10.1128/MCB.25.8.3117-3126.2005; Matute DR, 2006, MOL BIOL EVOL, V23, P65, DOI 10.1093/molbev/msj008; MORGAN A, 1992, BIOCHEM J, V286, P807, DOI 10.1042/bj2860807; Murad AM, 2011, J SEP SCI, V34, P2618, DOI 10.1002/jssc.201100238; Naderer T, 2008, CELL MICROBIOL, V10, P301, DOI 10.1111/j.1462-5822.2007.01096.x; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Nogueira SV, 2010, INFECT IMMUN, V78, P4040, DOI 10.1128/IAI.00221-10; Nombela C, 2006, TRENDS MICROBIOL, V14, P15, DOI 10.1016/j.tim.2005.11.009; Nosanchuk Joshua D, 2008, Commun Integr Biol, V1, P37; Oliveira DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011113; Oliveira DL, 2010, INFECT IMMUN, V78, P1601, DOI 10.1128/IAI.01171-09; Parente AFA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022810; Parente JA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-292; Pereira LA, 2007, FEMS YEAST RES, V7, P1381, DOI 10.1111/j.1567-1364.2007.00292.x; Popi AF, 2002, CELL IMMUNOL, V218, P87, DOI 10.1016/S0008-8749(02)00576-2; Ramana J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009695; Ranganathan S, 2009, GENOME MED, V1, DOI 10.1186/gm113; RESTREPO A, 2005, PRINCIPLES PRACTICE, P3062; Rezende TCV, 2011, J PROTEOMICS, V75, P572, DOI 10.1016/j.jprot.2011.08.020; Rodrigues ML, 2008, EUKARYOT CELL, V7, P58, DOI 10.1128/EC.00370-07; Roth D, 1999, FEBS LETT, V460, P411, DOI 10.1016/S0014-5793(99)01383-6; RUBARTELLI A, 1990, EMBO J, V9, P1503, DOI 10.1002/j.1460-2075.1990.tb08268.x; Sambrook J., 2001, MOL CLONING LAB MANU; San-Blas G, 2002, MED MYCOL, V40, P225, DOI 10.1080/mmy.40.3.225.242; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Seider K, 2011, J IMMUNOL, V187, P3072, DOI 10.4049/jimmunol.1003730; Chaves DFS, 2009, J PROTEOMICS, V73, P50, DOI 10.1016/j.jprot.2009.07.012; Seo J, 2004, J BIOCHEM MOL BIOL, V37, P35; Shah P, 2009, J PROTEOME RES, V8, P1123, DOI 10.1021/pr8003002; Shaw MM, 2003, PROTEOMICS, V3, P1408, DOI 10.1002/pmic.200300471; Silverman JM, 2012, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00026; Silverman JM, 2010, J IMMUNOL, V185, P5011, DOI 10.4049/jimmunol.1000541; Silverman JM, 2010, J CELL SCI, V123, P842, DOI 10.1242/jcs.056465; Teixeira MM, 2009, MOL PHYLOGENET EVOL, V52, P273, DOI 10.1016/j.ympev.2009.04.005; Teutschbein J, 2010, J PROTEOME RES, V9, P3427, DOI 10.1021/pr9010684; Tjalsma H, 2004, MICROBIOL MOL BIOL R, V68, P207, DOI 10.1128/MMBR.68.2.207-233.2004; Tucker SC, 2002, P NATL ACAD SCI USA, V99, P3165, DOI 10.1073/pnas.052702799; Vaejo MC, 2012, J PROTEOME RES, V11, P1676, DOI 10.1021/pr200872s; Vallejo MC, 2011, EUKARYOT CELL, V10, P343, DOI 10.1128/EC.00227-10; Waditee-Sirisattha R, 2012, FEMS MICROBIOL LETT; Wartenberg D, 2011, INT J MED MICROBIOL, V301, P602, DOI 10.1016/j.ijmm.2011.04.016; Yang H, 2006, ONCOGENE, V25, P4585, DOI 10.1038/sj.onc.1209481; Youseff BH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002713; Zhu K, 2005, ANAL CHEM, V77, P2745, DOI 10.1021/ac048494w	76	41	42	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e52470	10.1371/journal.pone.0052470	http://dx.doi.org/10.1371/journal.pone.0052470			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23272246	Green Published, gold, Green Submitted			2022-12-27	WOS:000312483300088
J	Barua, D; Goldstein, B				Barua, Dipak; Goldstein, Byron			A Mechanistic Model of Early Fc epsilon RI Signaling: Lipid Rafts and the Question of Protection from Dephosphorylation	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHATASES; DETERGENT-RESISTANT MEMBRANES; HIGH-AFFINITY RECEPTOR; CELL ANTIGEN RECEPTOR; RBL-2H3 MAST-CELLS; PLASMA-MEMBRANE; IGE RECEPTOR; LYN KINASE; HEMATOPOIETIC-CELLS; MOLECULAR-DYNAMICS	We present a model of the early events in mast cell signaling mediated by Fc epsilon RI where the plasma membrane is composed of many small ordered lipid domains (rafts), surrounded by a non-order region of lipids consisting of the remaining plasma membrane. The model treats the rafts as transient structures that constantly form and breakup, but that maintain a fixed average number per cell. The rafts have a high propensity for harboring Lyn kinase, aggregated, but not unaggregated receptors, and the linker for the activation of T cells (LAT). Phosphatase activity in the rafts is substantially reduced compared to the nonraft region. We use the model to analyze published experiments on the rat basophilic leukemia (RBL)-2H3 cell line that seem to contradict the notion that rafts offer protection. In these experiments IgE was cross-linked with a multivalent antigen and then excess monovalent hapten was added to break-up cross-links. The dephosphorylation of the unaggregated receptor (nonraft associated) and of LAT (raft associated) were then monitored in time and found to decay at similar rates, leading to the conclusion that rafts offer no protection from dephosphorylation. In the model, because the rafts are transient, a protein that is protected while in a raft will be subject to dephosphorylation when the raft breaks up and the protein finds itself in the nonraft region of the membrane. We show that the model is consistent with the receptor and LAT dephosphorylation experiments while still allowing rafts to enhance signaling by providing substantial protection from phosphatases.	[Barua, Dipak; Goldstein, Byron] Los Alamos Natl Lab, Theoret Biol & Biophys Grp, Div Theoret, Los Alamos, NM USA; [Barua, Dipak] Los Alamos Natl Lab, Ctr Nonlinear Studies, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory	Goldstein, B (corresponding author), Los Alamos Natl Lab, Theoret Biol & Biophys Grp, Div Theoret, Los Alamos, NM USA.	bxg@lanl.gov		Barua, Dipak/0000-0001-8394-1233	National Institute of General Medical Sciences of the National Institutes of Health [R37-GM035556]; Department of Energy [DE-AC52-06NA25396]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035556] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under award number R37-GM035556 and the Department of Energy through contract DE-AC52-06NA25396. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews NL, 2009, IMMUNITY, V31, P469, DOI 10.1016/j.immuni.2009.06.026; Arudchandran R, 2000, J EXP MED, V191, P47, DOI 10.1084/jem.191.1.47; Babiychuk EB, 2002, FASEB J, V16, DOI 10.1096/fj.02-0070com; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Chatterjee S, 2001, CELL MOL LIFE SCI, V58, P1969, DOI 10.1007/PL00000831; Das R, 2008, BIOPHYS J, V94, P4996, DOI 10.1529/biophysj.107.105502; Davey AM, 2007, BIOPHYS J, V92, P343, DOI 10.1529/biophysj.106.088815; Dykstra M, 2003, ANNU REV IMMUNOL, V21, P457, DOI 10.1146/annurev.immunol.21.120601.141021; Elson EL, 2010, ANNU REV BIOPHYS, V39, P207, DOI 10.1146/annurev.biophys.093008.131238; Faeder James R., 2009, V500, P113, DOI 10.1007/978-1-59745-525-1_5; Faeder JR, 2003, J IMMUNOL, V170, P3769, DOI 10.4049/jimmunol.170.7.3769; Fan J, 2010, FEBS LETT, V584, P1678, DOI 10.1016/j.febslet.2009.10.051; FIELD KA, 1995, P NATL ACAD SCI USA, V92, P9201, DOI 10.1073/pnas.92.20.9201; Field KA, 1997, J BIOL CHEM, V272, P4276, DOI 10.1074/jbc.272.7.4276; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; Ge MT, 2003, BIOPHYS J, V85, P1278, DOI 10.1016/S0006-3495(03)74563-9; Gidwani A, 2001, BIOCHEMISTRY-US, V40, P12422, DOI 10.1021/bi010496c; GOLDSTEIN B, 1984, BIOPHYS J, V46, P573, DOI 10.1016/S0006-3495(84)84056-4; Harder T, 2004, CURR OPIN IMMUNOL, V16, P353, DOI 10.1016/j.coi.2004.03.013; Holowka D, 2005, BBA-MOL CELL RES, V1746, P252, DOI 10.1016/j.bbamcr.2005.06.007; Holowka D, 2001, SEMIN IMMUNOL, V13, P99, DOI 10.1006/smim.2000.0301; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Janes PW, 2000, SEMIN IMMUNOL, V12, P23, DOI 10.1006/smim.2000.0204; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Karpen HE, 2001, J BIOL CHEM, V276, P19503, DOI 10.1074/jbc.M010832200; Katagiri YU, 2001, MICROBIOL IMMUNOL, V45, P1; KIHARA H, 1994, J BIOL CHEM, V269, P22427; Kovarova M, 2001, MOL CELL BIOL, V21, P8318, DOI 10.1128/MCB.21.24.8318-8328.2001; Kurzchalia TV, 1999, CURR OPIN CELL BIOL, V11, P424, DOI 10.1016/S0955-0674(99)80061-1; Kusumi A, 2004, TRAFFIC, V5, P213, DOI 10.1111/j.1600-0854.2004.0178.x; Larson DR, 2005, J CELL BIOL, V171, P527, DOI 10.1083/jcb.200503110; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; LIU FT, 1980, J IMMUNOL, V124, P2728; Mao SY, 1997, J BIOL CHEM, V272, P14067, DOI 10.1074/jbc.272.22.14067; Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910; Peirce M, 2000, J BIOL CHEM, V275, P34976, DOI 10.1074/jbc.M005819200; Pierce SK, 2002, NAT REV IMMUNOL, V2, P96, DOI 10.1038/nri726; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; PRIBLUDA VS, 1994, P NATL ACAD SCI USA, V91, P11246, DOI 10.1073/pnas.91.23.11246; Pyenta PS, 2001, BIOPHYS J, V80, P2120, DOI 10.1016/S0006-3495(01)76185-1; Rajendran L, 2003, P NATL ACAD SCI USA, V100, P8241, DOI 10.1073/pnas.1331629100; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; Rodgers W, 1996, J CELL BIOL, V135, P1515, DOI 10.1083/jcb.135.6.1515; Rosenbluth MJ, 2006, BIOPHYS J, V90, P2994, DOI 10.1529/biophysj.105.067496; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; Saitoh S, 2003, J EXP MED, V198, P831, DOI 10.1084/jem.20030574; Sengupta P, 2007, SEMIN CELL DEV BIOL, V18, P583, DOI 10.1016/j.semcdb.2007.07.010; Sheets ED, 1999, J CELL BIOL, V145, P877, DOI 10.1083/jcb.145.4.877; Shogomori H, 2005, J BIOL CHEM, V280, P18931, DOI 10.1074/jbc.M500247200; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; SOTIRELLIS N, 1995, J BIOL CHEM, V270, P29773; Tanimura N, 2003, J CELL BIOL, V160, P125, DOI 10.1083/jcb.200207096; THOMAS JL, 1994, J CELL BIOL, V125, P795, DOI 10.1083/jcb.125.4.795; Tolar P, 2004, EUR J IMMUNOL, V34, P1136, DOI 10.1002/eji.200324505; Torigoe C, 1997, P NATL ACAD SCI USA, V94, P1372, DOI 10.1073/pnas.94.4.1372; Wilson BS, 2002, MOL IMMUNOL, V38, P1259, DOI 10.1016/S0161-5890(02)00073-1; Wilson BS, 2001, J CELL BIOL, V154, P645, DOI 10.1083/jcb.200104049; Wofsy C, 1997, J IMMUNOL, V159, P5984; Wofsy C, 1999, P NATL ACAD SCI USA, V96, P8615, DOI 10.1073/pnas.96.15.8615; Young RM, 2005, J BIOL CHEM, V280, P1230, DOI 10.1074/jbc.M408339200; Young RM, 2003, J BIOL CHEM, V278, P20746, DOI 10.1074/jbc.M211402200; Zhang J, 2002, MOL CELL BIOL, V22, P8144, DOI 10.1128/MCB.22.23.8144-8154.2002; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	68	21	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51669	10.1371/journal.pone.0051669	http://dx.doi.org/10.1371/journal.pone.0051669			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284735	Green Submitted, Green Published, gold			2022-12-27	WOS:000312435900040
J	Eddison, M; Belay, AT; Sokolowski, MB; Heberlein, U				Eddison, Mark; Belay, Amsale T.; Sokolowski, Marla B.; Heberlein, Ulrike			A Genetic Screen for Olfactory Habituation Mutations in Drosophila: Analysis of Novel Foraging Alleles and an Underlying Neural Circuit	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; GILL-WITHDRAWAL REFLEX; SUCROSE RESPONSIVENESS; MYELINATED AXONS; MUSHROOM BODIES; ANTENNAL LOBE; BINGE ETHANOL; GAIN-CONTROL; CGMP; APLYSIA	Habituation is a form of non-associative learning that enables animals to reduce their reaction to repeated harmless stimuli. When exposed to ethanol vapor, Drosophila show an olfactory-mediated startle response characterized by a transient increase in locomotor activity. Upon repeated exposures, this olfactory startle attenuates with the characteristics of habituation. Here we describe the results of a genetic screen to identify olfactory startle habituation (OSH) mutants. One mutation is a transcript specific allele of foraging (for) encoding a cGMP-dependent kinase. We show this allele of for reduces expression of a for-T1 isoform expressed in the head and functions normally to inhibit OSH. We localize for-T1 function to a limited set of neurons that include olfactory receptor neurons (ORNs) and the mushroom body (MB). Overexpression of for-T1 in ORNs inhibits OSH, an effect also seen upon synaptic silencing of the ORNs; for-T1 may therefore function in ORNs to decrease synaptic release upon repeated exposure to ethanol vapor. Overall, this work contributes to our understanding of the genes and neurons underlying olfactory habituation in Drosophila.	[Eddison, Mark; Heberlein, Ulrike] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Belay, Amsale T.; Sokolowski, Marla B.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada	University of California System; University of California San Francisco; University of Toronto	Eddison, M (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	mark.eddison@ucsf.edu		Eddison, Mark/0000-0003-0280-8137; Sokolowski, Marla/0000-0002-7462-8007	National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism; Wheeler Center; Canadian Institute for Health Research of Canada (CIHR); Natural Sciences and Engineering Council of Canada; CIHR; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010035] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Wheeler Center; Canadian Institute for Health Research of Canada (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Research was supported by the National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism(UH) and the Wheeler Center (to ME). This work was also supported by grants from the Canadian Institute for Health Research of Canada (CIHR) (to MBS), the Natural Sciences and Engineering Council of Canada (to MBS) and a CIHR training grant (to ATB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo SF, 2007, LEARN MEMORY, V14, P376, DOI 10.1101/lm.566007; AULD VJ, 1995, CELL, V81, P757, DOI 10.1016/0092-8674(95)90537-5; Banerjee S, 2008, J NEUROSCI RES, V86, P1189, DOI 10.1002/jnr.21574; Belay AT, 2007, J COMP NEUROL, V504, P570, DOI 10.1002/cne.21466; Best AR, 2005, J NEUROSCI, V25, P2513, DOI 10.1523/JNEUROSCI.5298-04.2005; Bhat MA, 2003, CURR OPIN NEUROBIOL, V13, P552, DOI 10.1016/j.conb.2003.09.004; BRAND AH, 1993, DEVELOPMENT, V118, P401; CASTELLUCCI V, 1970, SCIENCE, V167, P1745, DOI 10.1126/science.167.3926.1745; Cho W, 2004, GENES BRAIN BEHAV, V3, P127, DOI 10.1111/j.1601-183x.2004.00061.x; Christoffersen GRJ, 1997, PROG NEUROBIOL, V53, P45, DOI 10.1016/S0301-0082(97)00031-2; Das S, 2011, P NATL ACAD SCI USA, V108, pE646, DOI 10.1073/pnas.1106411108; Davies SA, 2006, CELL SIGNAL, V18, P409, DOI 10.1016/j.cellsig.2005.08.011; Davis RL, 2011, NEURON, V70, P8, DOI 10.1016/j.neuron.2011.03.012; Engel JE, 2000, LEARN MEMORY, V7, P341, DOI 10.1101/lm.31600; Fitzpatrick MJ, 2004, INTEGR COMP BIOL, V44, P28, DOI 10.1093/icb/44.1.28; Frankland PW, 2004, MOL PSYCHIATR, V9, P417, DOI 10.1038/sj.mp.4001432; GEYER MA, 1982, PSYCHOPHYSIOLOGY, V19, P1, DOI 10.1111/j.1469-8986.1982.tb02589.x; Glanzman DL, 2009, NEUROBIOL LEARN MEM, V92, P147, DOI 10.1016/j.nlm.2009.03.005; Gover TD, 2009, NEUROBIOL LEARN MEM, V92, P155, DOI 10.1016/j.nlm.2009.03.006; GROVES P M, 1970, Psychological Review, V77, P419, DOI 10.1037/h0029810; Hofmann F, 2006, PHYSIOL REV, V86, P1, DOI 10.1152/physrev.00015.2005; HOYLE G, 1952, NATURE, V169, P281, DOI 10.1038/169281a0; Hunt PS, 2004, NEUROTOXICOL TERATOL, V26, P451, DOI 10.1016/j.ntt.2004.01.003; KORPI ER, 1994, ALCOHOL ALCOHOLISM, V29, P115; Kroner C, 1996, EUR J BIOCHEM, V236, P632, DOI 10.1111/j.1432-1033.1996.00632.x; KUPFERMANN I, 1970, SCIENCE, V167, P1743, DOI 10.1126/science.167.3926.1743; Lamb RS, 1998, MOL BIOL CELL, V9, P3505, DOI 10.1091/mbc.9.12.3505; Larkin Aoife, 2010, Learn Mem, V17, P645, DOI 10.1101/lm.1839010; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Ludewig K, 2003, BIOL PSYCHIAT, V54, P121, DOI 10.1016/S0006-3223(02)01925-X; Martin JR, 1998, LEARN MEMORY, V5, P179; Massa J, 2012, J ATTEN DISORD, V16, P553, DOI 10.1177/1087054711423621; Masse NY, 2009, CURR BIOL, V19, pR700, DOI 10.1016/j.cub.2009.06.026; McCann C, 2011, P NATL ACAD SCI USA, V108, pE655, DOI 10.1073/pnas.1107198108; Mery F, 2007, P NATL ACAD SCI USA, V104, P13051, DOI 10.1073/pnas.0702923104; Moon C, 1998, J NEUROSCI, V18, P3195; Neale BM, 2010, J AM ACAD CHILD PSY, V49, P906, DOI 10.1016/j.jaac.2010.06.007; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; ORNITZ EM, 1993, J AUTISM DEV DISORD, V23, P619, DOI 10.1007/BF01046105; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; PINSKER H, 1970, SCIENCE, V167, P1740, DOI 10.1126/science.167.3926.1740; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Prasad HC, 2005, P NATL ACAD SCI USA, V102, P11545, DOI 10.1073/pnas.0501432102; Rankin CH, 2009, NEUROBIOL LEARN MEM, V92, P135, DOI 10.1016/j.nlm.2008.09.012; Renger JJ, 1999, J NEUROSCI, V19; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; Salzer JL, 2003, NEURON, V40, P297, DOI 10.1016/S0896-6273(03)00628-7; Scheiner R, 2004, LEARN MEMORY, V11, P303, DOI 10.1101/lm.71604; Schulte J, 2003, J CELL BIOL, V161, P991, DOI 10.1083/jcb.200303192; Sharma P, 2009, J NEUROSCI METH, V182, P43, DOI 10.1016/j.jneumeth.2009.05.024; Sudhakaran IP, 2012, J NEUROSCI, V32, P7225, DOI 10.1523/JNEUROSCI.1099-12.2012; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Thompson RF, 2009, NEUROBIOL LEARN MEM, V92, P127, DOI 10.1016/j.nlm.2008.07.011; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang JW, 2012, DEV NEUROBIOL, V72, P87, DOI 10.1002/dneu.20936; Wilson DA, 2008, J NEUROPHYSIOL, V100, P2, DOI 10.1152/jn.90479.2008; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wolf FW, 2007, P NATL ACAD SCI USA, V104, P4653, DOI 10.1073/pnas.0700493104; Wolf FW, 2002, J NEUROSCI, V22, P11035; Xue J, 2004, BIOCHEM J, V381, P753, DOI 10.1042/BJ20040455; Xue J, 2000, J BIOL CHEM, V275, P10047, DOI 10.1074/jbc.275.14.10047; Yao X., 2007, V179, P527; Zhang YW, 2007, J NEUROSCI, V27, P10878, DOI 10.1523/JNEUROSCI.0034-07.2007	65	17	17	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51684	10.1371/journal.pone.0051684	http://dx.doi.org/10.1371/journal.pone.0051684			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284741	Green Submitted, Green Published, gold			2022-12-27	WOS:000312435900042
J	Moore, JAY; Bellchambers, LM; Depczynski, MR; Evans, RD; Evans, SN; Field, SN; Friedman, KJ; Gilmour, JP; Holmes, TH; Middlebrook, R; Radford, BT; Ridgway, T; Shedrawi, G; Taylor, H; Thomson, DP; Wilson, SK				Moore, James A. Y.; Bellchambers, Lynda M.; Depczynski, Martial R.; Evans, Richard D.; Evans, Scott N.; Field, Stuart N.; Friedman, Kim J.; Gilmour, James P.; Holmes, Thomas H.; Middlebrook, Rachael; Radford, Ben T.; Ridgway, Tyrone; Shedrawi, George; Taylor, Heather; Thomson, Damian P.; Wilson, Shaun K.			Unprecedented Mass Bleaching and Loss of Coral across 12 degrees of Latitude in Western Australia in 2010-11	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CLIMATE-CHANGE; INDIAN-OCEAN; MORTALITY; THRESHOLDS; IMPACTS; FUTURE; RESILIENCE; ISLAND; CONSERVATION	Background: Globally, coral bleaching has been responsible for a significant decline in both coral cover and diversity over the past two decades. During the summer of 2010-11, anomalous large-scale ocean warming induced unprecedented levels of coral bleaching accompanied by substantial storminess across more than 12 degrees of latitude and 1200 kilometers of coastline in Western Australia (WA). Methodology/Principal Findings: Extreme La-Nina conditions caused extensive warming of waters and drove considerable storminess and cyclonic activity across WA from October 2010 to May 2011. Satellite-derived sea surface temperature measurements recorded anomalies of up to 5 degrees C above long-term averages. Benthic surveys quantified the extent of bleaching at 10 locations across four regions from tropical to temperate waters. Bleaching was recorded in all locations across regions and ranged between 17% (+/- 5.5) in the temperate Perth region, to 95% (+/- 3.5) in the Exmouth Gulf of the tropical Ningaloo region. Coincident with high levels of bleaching, three cyclones passed in close proximity to study locations around the time of peak temperatures. Follow-up surveys revealed spatial heterogeneity in coral cover change with four of ten locations recording significant loss of coral cover. Relative decreases ranged between 22%-83.9% of total coral cover, with the greatest losses in the Exmouth Gulf. Conclusions/Significance: The anomalous thermal stress of 2010-11 induced mass bleaching of corals along central and southern WA coral reefs. Significant coral bleaching was observed at multiple locations across the tropical-temperate divide spanning more than 1200 km of coastline. Resultant spatially patchy loss of coral cover under widespread and high levels of bleaching and cyclonic activity, suggests a degree of resilience for WA coral communities. However, the spatial extent of bleaching casts some doubt over hypotheses suggesting that future impacts to coral reefs under forecast warming regimes may in part be mitigated by southern thermal refugia.	[Moore, James A. Y.; Evans, Richard D.; Field, Stuart N.; Friedman, Kim J.; Holmes, Thomas H.; Shedrawi, George; Wilson, Shaun K.] Dept Environm & Conservat, Marine Sci Program, Kensington, NSW, Australia; [Bellchambers, Lynda M.; Evans, Scott N.] Dept Fisheries WA, Biodivers & Biosecur Branch, Hillarys, WA, Australia; [Depczynski, Martial R.; Gilmour, James P.; Radford, Ben T.; Ridgway, Tyrone] Australian Inst Marine Sci, Crawley, WA, Australia; [Evans, Richard D.; Field, Stuart N.; Friedman, Kim J.; Gilmour, James P.; Holmes, Thomas H.; Radford, Ben T.; Ridgway, Tyrone; Wilson, Shaun K.] Univ Western Australia, Oceans Inst, Crawley, WA, Australia; [Middlebrook, Rachael] Dept Environm & Conservat, Pilbara Reg Serv, Karratha, NSW, Australia; [Taylor, Heather] Dept Environm & Conservat, Pilbara Reg Serv, Exmouth, NSW, Australia; [Thomson, Damian P.] CSIRO, Marine & Atmospher Res, Floreat, WA, Australia	Australian Institute of Marine Science; University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Moore, JAY (corresponding author), Dept Environm & Conservat, Marine Sci Program, Kensington, NSW, Australia.	james.moore@dec.wa.gov.au	Thomson, Damian P/C-3047-2014; Evans, Richard D/K-5779-2013; Moore, James/K-3698-2013; Middlebrook, Rachael/AAM-6912-2021; Evans, Richard D./O-3559-2019; depczynski, martial/B-7689-2008; Wilson, Shaun/K-8597-2019	Moore, James/0000-0003-4641-8667; Evans, Richard D./0000-0003-4364-4810; depczynski, martial/0000-0001-8723-0076; Wilson, Shaun/0000-0002-4590-0948; Shedrawi, George/0000-0002-4507-7293; Thomson, Damian/0000-0001-5485-1562	Department of Environment and Conservation WA; Department of Fisheries WA; Australian Institute of Marine Science; Western Australian Marine Science Institution; Commonwealth Scientific and Industrial Research Organisation	Department of Environment and Conservation WA; Department of Fisheries WA; Australian Institute of Marine Science; Western Australian Marine Science Institution; Commonwealth Scientific and Industrial Research Organisation(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	This study was funded by the Department of Environment and Conservation WA, the Department of Fisheries WA, the Australian Institute of Marine Science, the Western Australian Marine Science Institution and the Commonwealth Scientific and Industrial Research Organisation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043878; Abrego D, 2008, P ROY SOC B-BIOL SCI, V275, P2273, DOI 10.1098/rspb.2008.0180; Ateweberhan M, 2011, CORAL REEFS, V30, P739, DOI 10.1007/s00338-011-0775-x; Baird A., 1999, REEF RES, V9, P6; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Berkelmans R, 1999, CORAL REEFS, V18, P55, DOI 10.1007/s003380050154; Berkelmans R, 2004, CORAL REEFS, V23, P74, DOI 10.1007/s00338-003-0353-y; Berkelmans R, 2002, MAR ECOL PROG SER, V229, P73, DOI 10.3354/meps229073; Berkelmans R., 2009, V205, P103; Brandt ME, 2009, ECOLOGY, V90, P2859, DOI 10.1890/08-0445.1; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Celliers L, 2002, MAR POLLUT BULL, V44, P1380, DOI 10.1016/S0025-326X(02)00302-8; Cooper TF, 2012, SCIENCE, V335, P593, DOI 10.1126/science.1214570; DONE TJ, 1992, CONT SHELF RES, V12, P859, DOI 10.1016/0278-4343(92)90048-O; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; Donner Simon D., 2009, V205, P159; Eakin C. M., 2009, V205, P41; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Fabricius KE, 2008, LIMNOL OCEANOGR, V53, P690, DOI 10.4319/lo.2008.53.2.0690; Fisher R, 2011, CONSERV LETT, V4, P64, DOI 10.1111/j.1755-263X.2010.00146.x; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; Glynn P.W., 1990, Elsevier Oceanography Series, V52, P55; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; Goreau T, 2000, CONSERV BIOL, V14, P5, DOI 10.1046/j.1523-1739.2000.00011.x; GOREAU TJ, 1994, AMBIO, V23, P176; Graham NAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003039; Greenstein BJ, 2008, GLOBAL CHANGE BIOL, V14, P513, DOI 10.1111/j.1365-2486.2007.01506.x; Halford AR, 2009, GLOBAL CHANGE BIOL, V15, P3031, DOI 10.1111/j.1365-2486.2009.01972.x; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harrison PL, 2011, CORAL REEFS, V30, P775, DOI 10.1007/s00338-011-0778-7; Heron SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012210; Hill JJ, 2004, METHODS ECOLOGICAL M; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoeke RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018038; Howells EJ, 2012, NAT CLIM CHANGE, V2, P116, DOI 10.1038/NCLIMATE1330; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Kleypas JA, 1999, AM ZOOL, V39, P146; Leujak W, 2007, J EXP MAR BIOL ECOL, V351, P168, DOI 10.1016/j.jembe.2007.06.028; Liu G, 2006, P 10 INT COR REEF S; Liu G, 2008, P 11 INT COR REEF S, P951; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Manzello DP, 2007, MAR POLLUT BULL, V54, P1923, DOI 10.1016/j.marpolbul.2007.08.009; Manzello DP, 2007, P NATL ACAD SCI USA, V104, P12035, DOI 10.1073/pnas.0701194104; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Masiri I, 2008, INT J REMOTE SENS, V29, P4443, DOI 10.1080/01431160801930255; Maynard JA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032175; McClanahan TR, 2007, CORAL REEFS, V26, P695, DOI 10.1007/s00338-006-0193-7; McClanahan TR, 2007, MAR ECOL PROG SER, V337, P1, DOI 10.3354/meps337001; McClanahan TR, 2007, ECOL MONOGR, V77, P503, DOI 10.1890/06-1182.1; McClanahan TR, 2004, MAR BIOL, V144, P1239, DOI 10.1007/s00227-003-1271-9; McClanahan TR, 2004, MAR POLLUT BULL, V48, P327, DOI 10.1016/j.marpolbul.2003.08.024; McWilliams JP, 2005, ECOLOGY, V86, P2055, DOI 10.1890/04-1657; Michael KJ, 2012, MAR FRESHWATER RES, V63, P142, DOI 10.1071/MF11106; Miller J, 2009, CORAL REEFS, V28, P925, DOI 10.1007/s00338-009-0531-7; Morton B, 2002, J MOLLUS STUD, V68, P217, DOI 10.1093/mollus/68.3.217; Mumby PJ, 2004, MAR POLLUT BULL, V48, P219, DOI 10.1016/j.marpolbul.2003.10.031; Mumby PJ, 2001, MAR ECOL PROG SER, V222, P209, DOI 10.3354/meps222209; Oliver J. K., 2009, V205, P21; Pearce AF, 2012, J MAR SYST; Silverstein RN, 2011, MAR ECOL PROG SER, V422, P63, DOI 10.3354/meps08934; Smith LD, 2008, CORAL REEFS, V27, P197, DOI 10.1007/s00338-007-0311-1; Spillman CM, 2009, CORAL REEFS, V28, P197, DOI 10.1007/s00338-008-0438-8; Taylor J. G., 1999, Journal of the Royal Society of Western Australia, V82, P57; Thomson DP, 2011, CORAL REEFS, V30, P1107, DOI 10.1007/s00338-011-0811-x; Thomson DP, 2010, CORAL REEFS, V29, P923, DOI 10.1007/s00338-010-0650-1; Trapon Melanie L., 2011, Journal of Marine Biology, V2011, P1, DOI 10.1155/2011/807625; Veron J.E.N., 1988, HERMATYPIC CORALS W; Veron John E.N., 2011, Diversity, V3, P262; Webster PJ, 2005, SCIENCE, V309, P1844, DOI 10.1126/science.1116448; West J, 2003, COMMENTARY, V115, P17; Weymouth GT, 2001, AUST METEOROL MAG, V50, P263; Wilkinson C, 1999, AMBIO, V28, P188; Wilkinson C, 2008, STATUS CORAL REEFS W; Williams EH, 1990, ATOLL RES B, P330, DOI DOI 10.5479/SI.00775630.335.1; Woo M, 2006, CONT SHELF RES, V26, P132, DOI 10.1016/j.csr.2005.07.007; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	83	82	83	0	175	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51807	10.1371/journal.pone.0051807	http://dx.doi.org/10.1371/journal.pone.0051807			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284773	gold, Green Submitted, Green Published			2022-12-27	WOS:000312435900055
J	Real, A; Comino, I; de Lorenzo, L; Merchan, F; Gil-Humanes, J; Gimenez, MJ; Lopez-Casado, MA; Torres, MI; Cebolla, A; Sousa, C; Barro, F; Piston, F				Real, Ana; Comino, Isabel; de Lorenzo, Laura; Merchan, Francisco; Gil-Humanes, Javier; Gimenez, Maria J.; Angel Lopez-Casado, Miguel; Isabel Torres, Ma; Cebolla, Angel; Sousa, Carolina; Barro, Francisco; Piston, Fernando			Molecular and Immunological Characterization of Gluten Proteins Isolated from Oat Cultivars That Differ in Toxicity for Celiac Disease	PLOS ONE			English	Article							POLYACRYLAMIDE-GEL ELECTROPHORESIS; PERFORMANCE LIQUID-CHROMATOGRAPHY; PROLAMIN STORAGE PROTEINS; GAMMA-GLIADIN; MONOCLONAL-ANTIBODIES; MESSENGER-RNAS; WHEAT; CEREAL; SUBUNITS; CLONING	A strict gluten-free diet (GFD) is the only currently available therapeutic treatment for patients with celiac disease (CD). Traditionally, treatment with a GFD has excluded wheat, barley and rye, while the presence of oats is a subject of debate. The most-recent research indicates that some cultivars of oats can be a safe part of a GFD. In order to elucidate the toxicity of the prolamins from oat varieties with low, medium, and high CD toxicity, the avenin genes of these varieties were cloned and sequenced, and their expression quantified throughout the grain development. At the protein level, we have accomplished an exhaustive characterization and quantification of avenins by RP-HPLC and an analysis of immunogenicity of peptides present in prolamins of different oat cultivars. Avenin sequences were classified into three different groups, which have homology with S-rich prolamins of Triticeae. Avenin proteins presented a lower proline content than that of wheat gliadin; this may contribute to the low toxicity shown by oat avenins. The expression of avenin genes throughout the development stages has shown a pattern similar to that of prolamins of wheat and barley. RP-HPLC chromatograms showed protein peaks in the alcohol-soluble and reduced-soluble fractions. Therefore, oat grains had both monomeric and polymeric avenins, termed in this paper gliadin-and glutenin-like avenins. We found a direct correlation between the immunogenicity of the different oat varieties and the presence of the specific peptides with a higher/lower potential immunotoxicity. The specific peptides from the oat variety with the highest toxicity have shown a higher potential immunotoxicity. These results suggest that there is wide range of variation of potential immunotoxicity of oat cultivars that could be due to differences in the degree of immunogenicity in their sequences.	[Gil-Humanes, Javier; Gimenez, Maria J.; Barro, Francisco; Piston, Fernando] Inst Agr Sostenible CSIC, Cordoba, Spain; [Real, Ana; Comino, Isabel; de Lorenzo, Laura; Merchan, Francisco; Sousa, Carolina] Univ Seville, Dept Microbiol & Parasitol, Fac Farm, Seville, Spain; [Angel Lopez-Casado, Miguel] Hosp Virgen Nieves, Granada, Spain; [Isabel Torres, Ma] Campus Univ Lagunillas, Dept Biol Expt, Jaen, Spain; [Cebolla, Angel] Biomedal SL, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS); University of Sevilla; Hospital Universitario Virgen de las Nieves	Piston, F (corresponding author), Inst Agr Sostenible CSIC, Cordoba, Spain.	fpiston@ias.csic.es	Gil-Humanes, Javier/AAU-4381-2020; Piston, Fernando/AAD-6975-2020; MI, Torres/G-8789-2015; Torres, Maria/GVU-3391-2022; Barro, Francisco/J-3254-2014; Barro, Francisco/E-8572-2017	MI, Torres/0000-0002-9309-3837; Barro, Francisco/0000-0002-7652-229X; Gil Humanes, Javier/0000-0002-7283-6945; Piston, Fernando/0000-0002-5496-0205; Gimenez, Maria Jose/0000-0003-3854-5746; Merchan Ignacio, Francisco/0000-0003-4375-2627; Sousa Martin, Carolina/0000-0002-9235-9496	Spanish Ministerio de Economia y Competitividad (MINECO, Programa INNPACTO) [IPT-2011-1321-010000]; European Regional Development Fund (FEDER); Ramon y Cajal research contract from the MINECO [RYC-2010-07345]	Spanish Ministerio de Economia y Competitividad (MINECO, Programa INNPACTO); European Regional Development Fund (FEDER)(European Commission); Ramon y Cajal research contract from the MINECO	This work was supported by the Spanish Ministerio de Economia y Competitividad (MINECO, Programa INNPACTO, IPT-2011-1321-010000) and the European Regional Development Fund (FEDER). FP is supported by a Ramon y Cajal research contract from the MINECO (RYC-2010-07345). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arentz-Hansen H, 2004, PLOS MED, V1, P84, DOI 10.1371/journal.pmed.0010001; Bolker GRWIR, 2009, GPLOTS VARIOUS R PRO; Brennan CS, 2005, J CEREAL SCI, V42, P1, DOI 10.1016/j.jcs.2005.01.002; BURNOUF T, 1985, THEOR APPL GENET, V70, P610, DOI 10.1007/BF00252286; CHESNUT RS, 1989, PLANT CELL, V1, P913, DOI 10.1105/tpc.1.9.913; Comino I, 2011, GUT, V60, P915, DOI 10.1136/gut.2010.225268; D'Ovidio R, 2004, J CEREAL SCI, V39, P321, DOI 10.1016/j.jcs.2003.12.002; de Mendiburu F, 2012, AGRICOLAE STAT PROCE; DOVIDIO R, 1991, PLANT SCI, V75, P229, DOI 10.1016/0168-9452(91)90238-4; Dvoracek V, 2003, PLANT SOIL ENVIRON, V49, P486, DOI 10.17221/4182-PSE; EPPENDORFER WH, 1977, J SCI FOOD AGR, V28, P152, DOI 10.1002/jsfa.2740280207; Ferrante P, 2006, PROTEOMICS, V6, P1908, DOI 10.1002/pmic.200500236; FORDE J, 1985, NUCLEIC ACIDS RES, V13, P6817, DOI 10.1093/nar/13.19.6817; Fox J., 2019, R COMPANION APPL REG, V.; Gianibelli MC, 2001, CEREAL CHEM, V78, P635, DOI 10.1094/CCHEM.2001.78.6.635; Han ZX, 2010, GENETICA, V138, P227, DOI 10.1007/s10709-009-9415-6; Hausch F, 2002, AM J PHYSIOL-GASTR L, V283, pG996, DOI 10.1152/ajpgi.00136.2002; JANATUINEN EK, 1995, NEW ENGL J MED, V333, P1033, DOI 10.1056/NEJM199510193331602; Lamacchia C, 2010, J FOOD ENG, V96, P97, DOI 10.1016/j.jfoodeng.2009.07.001; LAPVETELAINEN A, 1995, CEREAL CHEM, V72, P259; LOOKHART GL, 1985, CEREAL CHEM, V62, P345; LOOKHART GL, 1985, CEREAL CHEM, V62, P162; MARSH MN, 1995, BAILLIERE CLIN GASTR, V9, P273, DOI 10.1016/0950-3528(95)90032-2; Masci S, 1999, J CEREAL SCI, V29, P17, DOI 10.1006/jcrs.1998.0224; Moron B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002294; Moron B, 2008, AM J CLIN NUTR, V87, P405, DOI 10.1093/ajcn/87.2.405; Osborne T B, 1908, Science, V28, P417, DOI 10.1126/science.28.718.417; Piston F, 2006, J CEREAL SCI, V43, P120, DOI 10.1016/j.jcs.2005.07.002; Piston F, 2004, THEOR APPL GENET, V108, P1359, DOI 10.1007/s00122-003-1548-x; Piston F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024754; Pulido OM, 2009, ADV FOOD NUTR RES, V57, P235, DOI 10.1016/S1043-4526(09)57006-4; ROBERT LS, 1983, CEREAL CHEM, V60, P438; Schuppan D, 2000, GASTROENTEROLOGY, V119, P234, DOI 10.1053/gast.2000.8521; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; SHEWRY PR, 1984, PHILOS T ROY SOC B, V304, P297, DOI 10.1098/rstb.1984.0025; SHEWRY PR, 1995, PLANT CELL, V7, P945, DOI 10.1105/tpc.7.7.945; Shewry PR, 2002, J EXP BOT, V53, P947, DOI 10.1093/jexbot/53.370.947; SHEWRY PR, 1990, BIOCHEM J, V267, P1; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; Stern M, 2001, EUR J GASTROEN HEPAT, V13, P741, DOI 10.1097/00042737-200106000-00023; Suttie J. M., 2004, FODDER OATS WORLD OV; Team RDC, 2012, R LANG ENV STAT COMP; West J, 2003, GASTROENTEROLOGY, V125, P429, DOI 10.1016/S0016-5085(03)00891-6; WIESER H, 1989, J CEREAL SCI, V9, P221, DOI 10.1016/S0733-5210(89)80004-9; Wieser H, 1998, CEREAL CHEM, V75, P644, DOI 10.1094/CCHEM.1998.75.5.644; Wieser H, 1996, ACTA PAEDIATR, V85, P3, DOI 10.1111/j.1651-2227.1996.tb14239.x; WIESER H, 1980, Z LEBENSM UNTERS FOR, V170, P17, DOI 10.1007/BF01113461; Wieser H, 2008, CEREAL CHEM, V85, P1, DOI 10.1094/CCHEM-85-1-0001; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x	50	55	57	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e48365	10.1371/journal.pone.0048365	http://dx.doi.org/10.1371/journal.pone.0048365			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284616	gold, Green Published			2022-12-27	WOS:000312435900002
J	Ting, CH; Wen, HL; Liu, HC; Hsieh-Li, HM; Li, H; Lin-Chao, S				Ting, Chen-Hung; Wen, Hsin-Lan; Liu, Hui-Chun; Hsieh-Li, Hsiu-Mei; Li, Hung; Lin-Chao, Sue			The Spinal Muscular Atrophy Disease Protein SMN Is Linked to the Golgi Network	PLOS ONE			English	Article							SURVIVAL MOTOR-NEURON; DETERMINING GENE-PRODUCT; ACTIN MESSENGER-RNA; SINGLE NUCLEOTIDE; GROWTH CONES; IN-VITRO; COMPLEX; LOCALIZATION; TRANSPORT; AXONS	Proximal spinal muscular atrophy (SMA) is a neurodegenerative disorder caused by deficiency of the ubiquitous Survival of Motor Neuron (SMN) protein. SMN has been shown to be transported in granules along the axon and moved through cytoskeletal elements. However, the role and nature of SMN granules are still not well characterized. Here, using immunocytochemical methods and time-lapse studies we show that SMN granules colocalize with the Golgi apparatus in motor neuron-like NSC34 cells. Electron microscopy clearly revealed that SMN granules are transported into the Golgi stack and aggregate in the trans-Golgi apparatus. SMN granules are characterized as either coated or un-coated and behave like regulated secretory granules. Treatment of cells with monensin to disrupt Golgi-mediated granule secretion decreased SMN expression in neurites and caused growth cone defects similar to those seen in SMN knockdown cells. Knockdown of Cop-alpha, the protein that coats vesicles transporting proteins between the Golgi compartments, caused SMN granule accumulation in the Golgi apparatus. In addition to the well-studied role of SMN in small nuclear ribonucleoprotein (SnRNP) assembly, this work links SMN granules with the Golgi network and thus sheds light on Golgi-mediated SMN granule transport.	[Ting, Chen-Hung; Wen, Hsin-Lan; Liu, Hui-Chun; Li, Hung; Lin-Chao, Sue] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Liu, Hui-Chun] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Hsieh-Li, Hsiu-Mei] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan	Academia Sinica - Taiwan; National Defense Medical Center; National Taiwan Normal University	Ting, CH (corresponding author), Acad Sinica, Inst Mol Biol, Taipei, Taiwan.	koichiting@gmail.com; mbsue@gate.sinica.edu.tw	Lin-Chao, Sue/AAZ-8246-2021; Lin-Chao, Sue/AGI-2030-2022	Lin-Chao, Sue/0000-0002-8415-9304; Lin-Chao, Sue/0000-0002-8415-9304; Ting, Chen-Hung/0000-0002-6093-0600	National Science Council, Taiwan [NSC100-2321-B-001-008]; Academia Sinica [AS034006, AS022323]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	This work was supported by the research grant NSC100-2321-B-001-008 from the National Science Council, Taiwan (http://web1.nsc.gov.tw) and Academia Sinica (AS034006 and AS022323; http://www.sinica.edu.tw/index.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buhler D, 1999, HUM MOL GENET, V8, P2351, DOI 10.1093/hmg/8.13.2351; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Cho SC, 2010, GENE DEV, V24, P438, DOI 10.1101/gad.1884910; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; Elsner M, 2003, MOL MEMBR BIOL, V20, P221, DOI 10.1080/0968768031000114024; Fallini C, 2011, J NEUROSCI, V31, P3914, DOI 10.1523/JNEUROSCI.3631-10.2011; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Gavrilov DK, 1998, NAT GENET, V20, P230, DOI 10.1038/3030; Gonatas NK, 2006, J NEUROL SCI, V246, P21, DOI 10.1016/j.jns.2006.01.019; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Hubers L, 2011, HUM MOL GENET, V20, P553, DOI 10.1093/hmg/ddq500; Kim T, 2006, PHYSIOLOGY, V21, P124, DOI 10.1152/physiol.00043.2005; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Matusica D, 2008, J NEUROSCI RES, V86, P553, DOI 10.1002/jnr.21507; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Pagliardini S, 2000, HUM MOL GENET, V9, P47, DOI 10.1093/hmg/9.1.47; Peter CJ, 2011, HUM MOL GENET, V20, P1701, DOI 10.1093/hmg/ddr046; Piazzon N, 2008, J BIOL CHEM, V283, P5598, DOI 10.1074/jbc.M707304200; RODRIGUES NR, 1995, HUM MOL GENET, V4, P631, DOI 10.1093/hmg/4.4.631; Rossoll W, 2002, HUM MOL GENET, V11, P93, DOI 10.1093/hmg/11.1.93; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Setola V, 2007, P NATL ACAD SCI USA, V104, P1959, DOI 10.1073/pnas.0610660104; Taylor JE, 1998, EUR J HUM GENET, V6, P467, DOI 10.1038/sj.ejhg.5200210; Ting CH, 2007, HUM MOL GENET, V16, P499, DOI 10.1093/hmg/ddl482; Todd AG, 2010, J MOL BIOL, V401, P681, DOI 10.1016/j.jmb.2010.06.058; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Wen HL, 2010, HUM MOL GENET, V19, P1766, DOI 10.1093/hmg/ddq058; Zhang HLL, 2003, J NEUROSCI, V23, P6627; Zhang HL, 2007, J NEUROSCI RES, V85, P2657, DOI 10.1002/jnr.21308; Zhang HL, 2006, J NEUROSCI, V26, P8622, DOI 10.1523/JNEUROSCI.3967-05.2006; Zheng Y, 2008, NAT CELL BIOL, V10, P1172, DOI 10.1038/ncb1777	36	28	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e51826	10.1371/journal.pone.0051826	http://dx.doi.org/10.1371/journal.pone.0051826			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284781	Green Submitted, Green Published, gold			2022-12-27	WOS:000312435900056
J	Champagne, E; Tremblay, JP; Cote, SD				Champagne, Emilie; Tremblay, Jean-Pierre; Cote, Steeve D.			Tolerance of an Expanding Subarctic Shrub, Betula glandulosa, to Simulated Caribou Browsing	PLOS ONE			English	Article							PUBESCENS SSP TORTUOSA; PLANT TOLERANCE; MOUNTAIN BIRCH; HERBIVORY; RESPONSES; GROWTH; TUNDRA; OVERCOMPENSATION; AVAILABILITY; CONSEQUENCES	Densification of the shrub layer has been reported in many subarctic regions, raising questions about the implication for large herbivores and their resources. Shrubs can tolerate browsing and their level of tolerance could be affected by browsing and soils productivity, eventually modifying resource availability for the caribou. Our objective was to assess the compensatory growth potential of a subarctic shrub, Betula glandulosa Michx., in relation with caribou browsing and nutriment availability for the plants. We used a simulated browsing (0, 25 and 75% of available shoots) and nitrogen-fertilisation (0 and 10 g m 22) experiment to test two main hypotheses linking tolerance to resource availability, the Compensatory Continuum Hypothesis and the Growth Rate Hypothesis as well as the predictions from the Limiting Resource Model. We seek to explicitly integrate the relative browsing pressure in our predictions since the amount of tissues removed could affect the capacity of long-lived plants to compensate. Birches fully compensated for moderate browsing with an overall leaf biomass similar to unbrowsed birches but undercompensated under heavy browsing pressure. The main mechanism explaining compensation appears to be the conversion of short shoots into long shoots. The leaf area increased under heavy browsing pressure but only led to undercompensation. Fertilisation for two consecutive years did not influence the response of birch, thus we conclude that our results support the LRM hypothesis of equal tolerance under both high and low nitrogen availability. Our results highlight that the potential for compensatory growth in dwarf birch is surpassed under heavy browsing pressure independently of the fertilisation regime. In the context of the worldwide decline in caribou herds, the reduction in browsing pressure could act synergistically with global climate change to promote the current shrub expansion reported in subarctic regions. Citation: Champagne E, Tremblay J-P, Cote SD (2012) Tolerance of an Expanding Subarctic Shrub, Betula glandulosa, to Simulated Caribou Browsing. PLoS ONE 7(12): e51940. doi: 10.1371/journal.pone.0051940	[Champagne, Emilie; Tremblay, Jean-Pierre; Cote, Steeve D.] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; [Champagne, Emilie; Tremblay, Jean-Pierre; Cote, Steeve D.] Univ Laval, Ctr Etud Nord, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University	Tremblay, JP (corresponding author), Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada.	jean-pierre.tremblay@bio.ulaval.ca	Champagne, Emilie/I-4364-2019	Champagne, Emilie/0000-0003-1550-2735; Tremblay, Jean-Pierre/0000-0003-0978-529X	Natural Sciences and Engineering Research Council of Canada; Association of Canadian Universities for Northern Studies; Beverly and Qamarniqjuak management board; NSERC; Ressources naturelles et Faune Quebec; ArcticNet; Fonds de recherche sur la nature et les technologies du Gouvernement du Quebec; Hydro Quebec; Xstrata Nickel; Federation des pourvoiries du Quebec inc.; Federation quebecoise des chasseurs et pecheurs; First Air; Makivik Corporation; CARMA; International Polar Year; Canada Foundation for Innovation; Institute for Environmental Monitoring and Research; Fondation de la Faune du Quebec; Ouranos; Canadian Wildlife Federation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Association of Canadian Universities for Northern Studies; Beverly and Qamarniqjuak management board; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ressources naturelles et Faune Quebec; ArcticNet; Fonds de recherche sur la nature et les technologies du Gouvernement du Quebec; Hydro Quebec; Xstrata Nickel; Federation des pourvoiries du Quebec inc.; Federation quebecoise des chasseurs et pecheurs; First Air; Makivik Corporation; CARMA; International Polar Year; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Institute for Environmental Monitoring and Research; Fondation de la Faune du Quebec; Ouranos; Canadian Wildlife Federation	E.C. received scholarships from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/), Association of Canadian Universities for Northern Studies (http://www.acuns.ca/) and the Beverly and Qamarniqjuak management board (http://www.arctic-caribou.com/). This project is part of the Caribou Ungava research program (http://www.caribou-ungava.ulaval.ca/en/accueil/) funded by NSERC, Ressources naturelles et Faune Quebec, ArcticNet, Fonds de recherche sur la nature et les technologies du Gouvernement du Quebec, Hydro Quebec, Xstrata Nickel, Federation des pourvoiries du Quebec inc., Federation quebecoise des chasseurs et pecheurs, First Air, Makivik Corporation, CARMA, International Polar Year, Canada Foundation for Innovation, Institute for Environmental Monitoring and Research, Fondation de la Faune du Quebec, Ouranos, and the Canadian Wildlife Federation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors declare their commercial funders as a competing interest. This project is part of the Caribou Ungava research program (http://www.caribou-ungava.ulaval.ca/en/accueil/) funded by NSERC, Ressources naturelles et Faune Quebec, ArcticNet, Fonds de recherche sur la nature et les technologies du Gouvernement du Quebec, Hydro Quebec, Xstrata Nickel, Federation des pourvoiries du Quebec inc., Federation quebecoise des chasseurs et pecheurs, First Air, Makivik Corporation, CARMA, International Polar Year, Canada Foundation for Innovation, Institute for Environmental Monitoring and Research, Fondation de la Faune du Quebec, Ouranos, and the Canadian Wildlife Federation. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aerts R, 2009, FUNCT ECOL, V23, P680, DOI 10.1111/j.1365-2435.2009.01566.x; Allard M., 1987, G OG PHYS QUATER, V41, P141, DOI [10.7202/032671ar, DOI 10.7202/032671AR]; ALWARD RD, 1993, OECOLOGIA, V95, P358, DOI 10.1007/BF00320989; Banta JA, 2010, OIKOS, V119, P359, DOI 10.1111/j.1600-0706.2009.17726.x; Baraza E, 2010, ECOSCIENCE, V17, P156, DOI 10.2980/17-2-3286; Barry KM, 2012, TREE PHYSIOL, V32, P24, DOI 10.1093/treephys/tpr128; BELSKY AJ, 1986, AM NAT, V127, P870, DOI 10.1086/284531; BELSKY AJ, 1993, EVOL ECOL, V7, P109, DOI 10.1007/BF01237737; BERGERUD AT, 1972, J WILDLIFE MANAGE, V36, P913, DOI 10.2307/3799448; Bergstrom Roger, 2003, Journal for Nature Conservation (Jena), V10, P203, DOI 10.1078/1617-1381-00020; Brathen KA, 2004, J VEG SCI, V15, P653, DOI 10.1111/j.1654-1103.2004.tb02307.x; Bret-Harte MS, 2001, ECOLOGY, V82, P18, DOI 10.1890/0012-9658(2001)082[0018:DPABNT]2.0.CO;2; BRYANT JP, 1983, OIKOS, V40, P357, DOI 10.2307/3544308; CRETE M, 1990, ARCTIC, V43, P60; DANELL K, 1994, J MAMMAL, V75, P833, DOI 10.2307/1382465; DANELL K, 1989, OIKOS, V55, P11, DOI 10.2307/3565866; DeGroot WJ, 1997, J ECOL, V85, P241, DOI 10.2307/2960655; Diamond D, 1992, 13107062D LECH INSTR; Federer W.T., 2007, VARIATIONS SPLIT PLO; Gerhart KL, 1996, CAN J ZOOL, V74, P136, DOI 10.1139/z96-018; Gornall JL, 2009, OECOLOGIA, V161, P747, DOI 10.1007/s00442-009-1427-5; Gough L, 2007, OIKOS, V116, P407, DOI 10.1111/j.0030-1299.2007.15449.x; Guillet C, 2006, OIKOS, V113, P33, DOI 10.1111/j.0030-1299.2006.13545.x; Haukioja E, 2000, EVOL ECOL, V14, P551, DOI 10.1023/A:1011091606022; HAUKIOJA E, 1990, OECOLOGIA, V82, P238, DOI 10.1007/BF00323540; Hawkes CV, 2001, ECOLOGY, V82, P2045, DOI 10.1890/0012-9658(2001)082[2045:TIOHOP]2.0.CO;2; HERMANUTZ LA, 1989, AM J BOT, V76, P755, DOI 10.2307/2444422; Hester A. J., 2006, LARGE HERBIVORE ECOL, P97; Hester AJ, 2000, FORESTRY, V73, P381, DOI 10.1093/forestry/73.4.381; HILBERT DW, 1981, OECOLOGIA, V51, P14, DOI 10.1007/BF00344645; Hobbie SE, 2005, J ECOL, V93, P770, DOI 10.1111/j.1365-2745.2005.01006.x; Ishihara M, 2004, CAN J BOT, V82, P1393, DOI [10.1139/b04-099, 10.1139/B04-099]; JONASSON S, 1988, OIKOS, V52, P101, DOI 10.2307/3565988; Kaitaniemi P, 1999, ECOLOGY, V80, P524, DOI 10.1890/0012-9658(1999)080[0524:EOCDOG]2.0.CO;2; LEHTILA K, 1994, ECOLOGY, V75, P945, DOI 10.2307/1939418; Lehtila K, 2000, OIKOS, V90, P160, DOI 10.1034/j.1600-0706.2000.900116.x; Littell R. C., 2006, SAS SYSTEM MIXED MOD; MAILLETTE L, 1982, J APPL ECOL, V19, P203, DOI 10.2307/2403005; Manseau M, 1996, RELATION RECIPROQUE; MASCHINSKI J, 1989, AM NAT, V134, P1, DOI 10.1086/284962; MAYCOCK PF, 1966, ARCTIC, V19, P114; Melnychuk MC, 2005, CAN J BOT, V83, P399, DOI [10.1139/B05-013, 10.1139/b05-013]; MRN, 2002, CART GEOL QUEB; Nadelhoffer K.J., 1992, ARCTIC ECOSYSTEMS CH, P281, DOI DOI 10.1016/B978-0-12-168250-7.50019-5; Naito AT, 2011, PROG PHYS GEOG, V35, P423, DOI 10.1177/0309133311403538; Pajunen AM, 2009, ARCT ANTARCT ALP RES, V41, P478, DOI 10.1657/1938-4246-41.4.478; Palacio S, 2008, FUNCT ECOL, V22, P808, DOI 10.1111/j.1365-2435.2008.01433.x; PARKINSON JA, 1975, COMMUN SOIL SCI PLAN, V6, P1, DOI 10.1080/00103627509366539; Persson IL, 2007, OIKOS, V116, P1639, DOI [10.1111/j.2007.0030-1299.15946.x, 10.1111/j.0030-1299.2007.15946.x]; Post E, 2008, P NATL ACAD SCI USA, V105, P12353, DOI 10.1073/pnas.0802421105; Ropars P, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/015501; ROSENTHAL JP, 1994, TRENDS ECOL EVOL, V9, P145, DOI 10.1016/0169-5347(94)90180-5; [SAS I Institute S], 2008, SAS WIND V9 2; [SAS I Institute S], 2008, LSMEANS STAT; [SAS I Institute S], 2008, GLIMMIX PROC; SENN J, 1994, FUNCT ECOL, V8, P494, DOI 10.2307/2390074; Sturm M, 2001, NATURE, V411, P546, DOI 10.1038/35079180; Tremblay B, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/035501; van der Wal R, 2006, OIKOS, V114, P177, DOI 10.1111/j.2006.0030-1299.14264.x; Vors LS, 2009, GLOBAL CHANGE BIOL, V15, P2626, DOI 10.1111/j.1365-2486.2009.01974.x; Walker DA, 2005, J VEG SCI, V16, P267, DOI 10.1111/j.1654-1103.2005.tb02365.x; Wise MJ, 2008, AM NAT, V172, P635, DOI 10.1086/591691; Wise MJ, 2007, AM NAT, V169, P443, DOI 10.1086/512044; Wise MJ, 2005, OIKOS, V109, P417, DOI 10.1111/j.0030-1299.2005.13878.x	64	11	11	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51940	10.1371/journal.pone.0051940	http://dx.doi.org/10.1371/journal.pone.0051940			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272191	gold, Green Published			2022-12-27	WOS:000312386600050
J	Kelleher, RJ; Geigenmuller, U; Hovhannisyan, H; Trautman, E; Pinard, R; Rathmell, B; Carpenter, R; Margulies, D				Kelleher, Raymond J., III; Geigenmueller, Ute; Hovhannisyan, Hayk; Trautman, Edwin; Pinard, Robert; Rathmell, Barbara; Carpenter, Randall; Margulies, David			High-Throughput Sequencing of mGluR Signaling Pathway Genes Reveals Enrichment of Rare Variants in Autism	PLOS ONE			English	Article							COPY-NUMBER VARIATION; ACTIVATED PROTEIN-KINASES; LONG-TERM DEPRESSION; DE-NOVO; SYNAPTIC PLASTICITY; LEARNING-DEFICITS; MOUSE MODEL; MUTATIONS; HOMER; DISEASE	Identification of common molecular pathways affected by genetic variation in autism is important for understanding disease pathogenesis and devising effective therapies. Here, we test the hypothesis that rare genetic variation in the metabotropic glutamate-receptor (mGluR) signaling pathway contributes to autism susceptibility. Single-nucleotide variants in genes encoding components of the mGluR signaling pathway were identified by high-throughput multiplex sequencing of pooled samples from 290 non-syndromic autism cases and 300 ethnically matched controls on two independent next-generation platforms. This analysis revealed significant enrichment of rare functional variants in the mGluR pathway in autism cases. Higher burdens of rare, potentially deleterious variants were identified in autism cases for three pathway genes previously implicated in syndromic autism spectrum disorder, TSC1, TSC2, and SHANK3, suggesting that genetic variation in these genes also contributes to risk for non-syndromic autism. In addition, our analysis identified HOMER1, which encodes a postsynaptic density-localized scaffolding protein that interacts with Shank3 to regulate mGluR activity, as a novel autism-risk gene. Rare, potentially deleterious HOMER1 variants identified uniquely in the autism population affected functionally important protein regions or regulatory sequences and co-segregated closely with autism among children of affected families. We also identified rare ASD-associated coding variants predicted to have damaging effects on components of the Ras/MAPK cascade. Collectively, these findings suggest that altered signaling downstream of mGluRs contributes to the pathogenesis of non-syndromic autism.	[Kelleher, Raymond J., III] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Kelleher, Raymond J., III] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Kelleher, Raymond J., III] Harvard Univ, Sch Med, Program Neurosci, Boston, MA USA; [Geigenmueller, Ute; Hovhannisyan, Hayk; Trautman, Edwin; Pinard, Robert; Margulies, David] Correlagen Diagnost Inc, Waltham, MA USA; [Rathmell, Barbara; Carpenter, Randall] Seaside Therapeut, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Kelleher, RJ (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	kelleher@helix.mgh.harvard.edu	Sala, Carlo/A-2493-2009	Sala, Carlo/0000-0003-0662-9523; Crater, Glenn/0000-0002-1159-1323	Pew Scholars Program in Biomedical Sciences; John Merck Scholars Fund; NIMH [K02 MH087796]; Simons Foundation Autism Research Initiative; NATIONAL INSTITUTE OF MENTAL HEALTH [U24MH081810, K02MH087796] Funding Source: NIH RePORTER	Pew Scholars Program in Biomedical Sciences; John Merck Scholars Fund; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Foundation Autism Research Initiative; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	RJK was supported by awards from the Pew Scholars Program in Biomedical Sciences, the John Merck Scholars Fund, the NIMH (K02 MH087796), and the Simons Foundation Autism Research Initiative. These funding institutions had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Seaside Therapeutics and Correlagen Diagnostics contributed funding for this study. These companies had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript due to their employment of one or more of the authors of the study.	Abankwa D, 2008, EMBO J, V27, P727, DOI 10.1038/emboj.2008.10; Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aoki Y, 2008, HUM MUTAT, V29, P992, DOI 10.1002/humu.20748; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Berkel S, 2010, NAT GENET, V42, P489, DOI 10.1038/ng.589; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Chen JM, 2006, HUM GENET, V120, P1, DOI 10.1007/s00439-006-0180-7; Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211; Costa RM, 2002, NATURE, V415, P526, DOI 10.1038/nature711; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; El-Fishawy P, 2010, PSYCHIAT CLIN N AM, V33, P83, DOI 10.1016/j.psc.2009.12.002; Gai X, 2011, MOL PSYCHIATR; Gallagher SM, 2004, J NEUROSCI, V24, P4859, DOI 10.1523/JNEUROSCI.5407-03.2004; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hamdan FF, 2009, NEW ENGL J MED, V360, P599, DOI 10.1056/NEJMoa0805392; Hayashi MK, 2009, CELL, V137, P159, DOI 10.1016/j.cell.2009.01.050; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Krueger DD, ANN REV MED; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Nava C, 2007, J MED GENET, V44, P763, DOI 10.1136/jmg.2007.050450; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Ronesi JA, 2008, J NEUROSCI, V28, P543, DOI 10.1523/JNEUROSCI.5019-07.2008; Ronesi JA, 2012, NAT NEUROSCI, V15, P431, DOI 10.1038/nn.3033; Rumbaugh G, 2006, P NATL ACAD SCI USA, V103, P4344, DOI 10.1073/pnas.0600084103; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Schaaf CP, 2011, HUM MOL GENET, V20, P3366, DOI 10.1093/hmg/ddr243; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Thusberg J, 2011, HUM MUTAT, V32, P358, DOI 10.1002/humu.21445; Toro R, 2010, TRENDS GENET, V26, P363, DOI 10.1016/j.tig.2010.05.007; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Wiznitzer M, 2004, J CHILD NEUROL, V19, P675, DOI 10.1177/08830738040190090701; Xiao B, 2000, CURR OPIN NEUROBIOL, V10, P370, DOI 10.1016/S0959-4388(00)00087-8; Zhao X, 2007, P NATL ACAD SCI USA, V104, P12831, DOI 10.1073/pnas.0705803104	53	114	116	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35003	10.1371/journal.pone.0035003	http://dx.doi.org/10.1371/journal.pone.0035003			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558107	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000020
J	Wang, F; Bobrow, L; Liu, J; Spencer, L; Blumberg, HP				Wang, Fei; Bobrow, Laurel; Liu, Jie; Spencer, Linda; Blumberg, Hilary P.			Corticolimbic Functional Connectivity in Adolescents with Bipolar Disorder	PLOS ONE			English	Article							EMOTIONAL FACES; ANTERIOR CINGULATE; PREFRONTAL CORTEX; RESTING STATE; FACIAL EXPRESSIONS; NEURAL SYSTEMS; AMYGDALA; TRAIT; CHILDREN; ABNORMALITIES	Convergent evidence supports regional dysfunction within a corticolimbic neural system that subserves emotional processing and regulation in adolescents and adults with bipolar disorder (BD), with abnormalities prominent within the amygdala and its major anterior paralimbic cortical connection sites including ventral anterior cingulate, orbitofrontal, insular and temporopolar cortices. Recent studies of adults with BD demonstrate abnormalities in the functional connectivity between the amygdala and anterior paralimbic regions suggesting an important role for the connections between these regions in the development of the disorder. This study tests the hypothesis that these functional connectivity abnormalities are present in adolescents with BD. Fifty-seven adolescents, twenty-one with BD and thirty-six healthy comparison (HC) adolescents, participated in functional magnetic resonance imaging while processing emotional face stimuli. The BD and HC groups were compared in the strength of functional connectivity from amygdala to the anterior paralimbic cortical regions, and explored in remaining brain regions. Functional connectivity was decreased in the BD group, compared to the HC group, during processing of emotional faces in ventral anterior cingulate (VACC), orbitofrontal, insular and temporopolar cortices (p<0.005). Orbitofrontal and VACC findings for the happy condition, and additionally right insula for the neutral condition, survived multiple comparison correction. Exploratory analyses did not reveal additional regions of group differences. This study provides evidence for decreased functional connectivity between the amygdala and anterior paralimbic cortices in adolescents with BD. This suggests that amygdala-anterior paralimbic connectivity abnormalities are early features of BD that emerge at least by adolescence in the disorder.	[Wang, Fei; Bobrow, Laurel; Liu, Jie; Spencer, Linda; Blumberg, Hilary P.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA; [Blumberg, Hilary P.] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06510 USA; [Blumberg, Hilary P.] Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University	Blumberg, HP (corresponding author), Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA.	Hilary.blumberg@yale.edu	Liu, Jie/K-3142-2015	Blumberg, Hilary/0000-0002-6363-4698	National Institute of Health (NIH) [R01MH69747, RC1MH088366, R01MH070902, RL1DA024856, K01MH086621]; CTSA from the NIH National Center for Research Resources [UL1RR0249139]; National Alliance for Research on Schizophrenia and Depression (Great Neck, New York); Attias Family Foundation; Women's Health Research at Yale - The Ethel F. Donaghue Women's Health Investigator Program at Yale (New Haven, Connecticut); Klingenstein Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069747, K01MH086621, RC1MH088366, R01MH070902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [RL1DA024856] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTSA from the NIH National Center for Research Resources; National Alliance for Research on Schizophrenia and Depression (Great Neck, New York)(NARSAD); Attias Family Foundation; Women's Health Research at Yale - The Ethel F. Donaghue Women's Health Investigator Program at Yale (New Haven, Connecticut); Klingenstein Foundation(Klingenstein Philanthropies); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the National Institute of Health (NIH) R01MH69747 [HPB], RC1MH088366 [HPB], R01MH070902 [HPB], RL1DA024856 [HPB, FW], K01MH086621 [FW]; CTSA UL1RR0249139 from the NIH National Center for Research Resources [HPB, FW] the National Alliance for Research on Schizophrenia and Depression (Great Neck, New York) [FW, HPB]; The Attias Family Foundation [HPB]; Women's Health Research at Yale - The Ethel F. Donaghue Women's Health Investigator Program at Yale (New Haven, Connecticut) [HPB]; and the Klingenstein Foundation [FW]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMARAL DG, 1984, J COMP NEUROL, V230, P465, DOI 10.1002/cne.902300402; Anand A, 2009, PSYCHIAT RES-NEUROIM, V171, P189, DOI 10.1016/j.pscychresns.2008.03.012; Blumberg HP, 2003, ARCH GEN PSYCHIAT, V60, P1201, DOI 10.1001/archpsyc.60.12.1201; de Almeida JRC, 2009, BIOL PSYCHIAT, V66, P451, DOI 10.1016/j.biopsych.2009.03.024; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Cerullo MA, 2012, BIPOLAR DISORD, V14, P175, DOI 10.1111/j.1399-5618.2012.01002.x; Chang K, 2005, J AM ACAD CHILD PSY, V44, P565, DOI 10.1097/01.chi.0000159948.75136.0d; Chang K, 2004, ARCH GEN PSYCHIAT, V61, P781, DOI 10.1001/archpsyc.61.8.781; Chen BK, 2004, BIOL PSYCHIAT, V56, P399, DOI 10.1016/j.biopsych.2004.06.024; Chen CH, 2006, BIOL PSYCHIAT, V59, P31, DOI 10.1016/j.biopsych.2005.06.008; Chepenik LG, 2010, PSYCHIAT RES-NEUROIM, V182, P207, DOI 10.1016/j.pscychresns.2010.04.002; Chiu S, 2008, J AFFECT DISORDERS, V105, P93, DOI 10.1016/j.jad.2007.04.019; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Cunningham MG, 2002, J COMP NEUROL, V453, P116, DOI 10.1002/cne.10376; DelBello MP, 2004, BIPOLAR DISORD, V6, P43, DOI 10.1046/j.1399-5618.2003.00087.x; Dickstein DP, 2007, BIPOLAR DISORD, V9, P679, DOI 10.1111/j.1399-5618.2007.00418.x; Dickstein DP, 2010, BIOL PSYCHIAT, V68, P839, DOI 10.1016/j.biopsych.2010.06.029; Dickstein DP, 2005, ARCH GEN PSYCHIAT, V62, P734, DOI 10.1001/archpsyc.62.7.734; Farrow TFD, 2005, BIOL PSYCHIAT, V58, P713, DOI 10.1016/j.biopsych.2005.04.033; Foland LC, 2008, PSYCHIAT RES-NEUROIM, V162, P27, DOI 10.1016/j.pscychresns.2007.04.007; Frazier JA, 2005, BIPOLAR DISORD, V7, P555, DOI 10.1111/j.1399-5618.2005.00258.x; Gogtay N, 2007, J CHILD PSYCHOL PSYC, V48, P852, DOI 10.1111/j.1469-7610.2007.01747.x; Kalmar JH, 2009, J AM ACAD CHILD PSY, V48, P636, DOI 10.1097/CHI.0b013e31819f6fbc; Kaur S, 2005, AM J PSYCHIAT, V162, P1637, DOI 10.1176/appi.ajp.162.9.1637; Kim E, 2009, PROG NEURO-PSYCHOPH, V33, P1409, DOI 10.1016/j.pnpbp.2009.07.019; Ladouceur CD, 2011, J AM ACAD CHILD PSY, V50, P1275, DOI 10.1016/j.jaac.2011.09.023; Lawrence NS, 2004, BIOL PSYCHIAT, V55, P578, DOI 10.1016/j.biopsych.2003.11.017; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Liu J, 2012, BIPOLAR DISORD, V14, P432, DOI 10.1111/j.1399-5618.2012.01018.x; Liu J, 2012, J AM ACAD CHILD PSY, V51, P304, DOI 10.1016/j.jaac.2011.12.014; Mesulam MM, 1985, CEREBRAL CORTEX; Najt P, 2007, NEUROSCI LETT, V413, P183, DOI 10.1016/j.neulet.2006.10.016; Passarotti AM, 2010, J INT NEUROPSYCH SOC, V16, P106, DOI 10.1017/S1355617709991019; Pavuluri MN, 2007, BIOL PSYCHIAT, V62, P158, DOI 10.1016/j.biopsych.2006.07.011; Pavuluri MN, 2009, J AM ACAD CHILD PSY, V48, P308, DOI 10.1097/CHI.0b013e3181948fc7; Perlman SB, 2012, BIPOLAR DISORD, V14, P162, DOI 10.1111/j.1399-5618.2012.00999.x; Rich BA, 2008, J CHILD PSYCHOL PSYC, V49, P88, DOI 10.1111/j.1469-7610.2007.01819.x; Rich BA, 2006, P NATL ACAD SCI USA, V103, P8900, DOI 10.1073/pnas.0603246103; Shah MP, 2009, NEUROPSYCHOPHARMACOL, V34, P1301, DOI 10.1038/npp.2008.204; Van der Schot A, 2010, PSYCHIAT RES-NEUROIM, V184, P135, DOI 10.1016/j.pscychresns.2010.07.009; Versace A, 2010, BIOL PSYCHIAT, V67, P422, DOI 10.1016/j.biopsych.2009.11.025; Wang F, 2011, BRAIN, V134, P2005, DOI 10.1093/brain/awr124; Wang F, 2009, BIOL PSYCHIAT, V66, P516, DOI 10.1016/j.biopsych.2009.03.023; Wilke M, 2004, PSYCHIAT RES-NEUROIM, V131, P57, DOI 10.1016/j.pscychresns.2004.01.004; Womer FY, 2009, ACTA NEUROPSYCHIATR, V21, P228, DOI 10.1111/j.1601-5215.2009.00414.x	45	41	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50177	10.1371/journal.pone.0050177	http://dx.doi.org/10.1371/journal.pone.0050177			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	047ER	23185566	Green Published, Green Submitted, gold			2022-12-27	WOS:000311821000194
J	Zhao, MR; Wang, C; Zhang, CL; Wen, YZ; Liu, WP				Zhao, Meirong; Wang, Cui; Zhang, Chunlong; Wen, Yuezhong; Liu, Weiping			Enantioselective Cytotoxicity Profile of o,p '-DDT in PC 12 Cells	PLOS ONE			English	Article							DDT INDUCES APOPTOSIS; IN-VITRO; ORGANOCHLORINE PESTICIDES; OXIDATIVE STRESS; INSECTICIDE ACETOFENATE; NEUROBLASTOMA-CELLS; ESTROGENIC ACTIVITY; MONONUCLEAR-CELLS; RISK-ASSESSMENT; EXPRESSION	Background: The continued uses of dichlordiphenyltrichloroethane (DDT) for indoor vector control in some developing countries have recently fueled intensive debates toward the global ban of this persistent legacy contaminant. Current approaches for ecological and health risk assessment has ignored the chiral nature of DDT. In this study by employing an array of cytotoxicity related endpoints, we investigated the enantioselective cytotoxicity of o,p'-DDT. Principal Findings: we demonstrated for the first time that R-(2)-o,p'-DDT caused more neuron cell death by inducing more severe oxidative stress, which selectively imbalanced the transcription of stress-related genes (SOD1, SOD2, HSP70) and enzyme (superoxide dismutase and lactate dehydrogenase) activities, and greater cellular apoptosis compared to its enantiomer S-(+)-o,p'-DDT at the level comparable to malaria area exposure (parts per million). We further elucidated enantioselective modes of action using microarray combined with enzyme-linked immunosorbent assay. The enantioselective apoptosis might involve three signaling pathways via caspase 3, tumor protein 53 (p53) and NFkB. Conclusions: Based on DDT stereochemistry and results reported for other chiral pesticides, our results pointed to the same directional enantioselectivity of chiral DDT toward mammalian cells. We proposed that risk assessment on DDT should consider the enantiomer ratio and enantioselectivities.	[Zhao, Meirong; Wang, Cui] Zhejiang Univ Technol, Res Ctr Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Zhang, Chunlong] Univ Houston Clear Lake City, Houston, TX 77058 USA; [Wen, Yuezhong; Liu, Weiping] Zhejiang Univ, Inst Environm Sci, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University of Technology; University of Houston System; University of Houston; University of Houston Clear Lake; Zhejiang University	Zhao, MR (corresponding author), Zhejiang Univ Technol, Res Ctr Environm Sci, Hangzhou, Zhejiang, Peoples R China.	Wliu@zju.edu.cn	Zhang, Chunlong/N-2564-2014; Liu, Weiping/E-9208-2010; Wen, Yue/GYQ-5844-2022; wen, Yuezhong/A-7651-2011; Zhao, Meirong/E-9679-2014	Zhang, Chunlong/0000-0003-4782-5424; Liu, Weiping/0000-0002-1173-892X; Zhao, Meirong/0000-0003-3132-9223; Zhang, Chun-Lei/0000-0003-1296-1370; zhen, xuechu/0000-0001-7458-2566	National Basic Research Program of China [2009CB421603]; National Natural Science Foundations of China [21077094, 20837002]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Basic Research Program of China (2009CB421603) and the National Natural Science Foundations of China (21077094,20837002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegria-Torres JA, 2009, TOXICOL IN VITRO, V23, P1000, DOI 10.1016/j.tiv.2009.06.021; Anantharam V, 2007, NEUROCHEM INT, V50, P834, DOI 10.1016/j.neuint.2007.02.003; Bagchi D, 1995, TOXICOLOGY, V104, P129, DOI 10.1016/0300-483X(95)03156-A; Baker SJ, 1998, ONCOGENE, V17, P3261, DOI 10.1038/sj.onc.1202568; Bollimuntha S, 2005, J BIOL CHEM, V280, P2132, DOI 10.1074/jbc.M407384200; Bosma H, 2000, LANCET, V356, P912, DOI 10.1016/S0140-6736(00)02685-4; BUSER HR, 1995, ANAL CHEM, V67, P2691, DOI 10.1021/ac00111a030; Carlson K, 2000, TOXICOL APPL PHARM, V168, P102, DOI 10.1006/taap.2000.8997; Cohn BA, 2007, ENVIRON HEALTH PERSP, V115, P1406, DOI 10.1289/ehp.10260; de Joode BV, 2001, LANCET, V357, P1014, DOI 10.1016/S0140-6736(00)04249-5; Ennaceur S, 2008, ENVIRON RES, V108, P86, DOI 10.1016/j.envres.2008.05.005; Ennaceur S, 2010, INT J ENVIRON AN CH, V90, P821, DOI 10.1080/03067311003778615; Forsyth D J, 1973, Arch Environ Contam Toxicol, V1, P1, DOI 10.1007/BF02030141; Frigo DE, 2005, TOXICOL LETT, V155, P227, DOI 10.1016/j.toxlet.2004.09.008; Hemish J, 2003, J BIOL CHEM, V278, P42321, DOI 10.1074/jbc.M308192200; Hoekstra PF, 2001, TOXICOL LETT, V125, P75, DOI 10.1016/S0378-4274(01)00410-6; Hu F, 2010, ENVIRON TOXICOL CHEM, V29, P683, DOI 10.1002/etc.73; Jia Z, 2007, FREE RADICAL BIO MED, V42, P288, DOI 10.1016/j.freeradbiomed.2006.10.047; Kedziora-Kornatowska KZ, 2000, IUBMB LIFE, V49, P303; Kurt-Karakus PB, 2007, ENVIRON SCI TECHNOL, V41, P4965, DOI 10.1021/es0620787; Lascombe I, 2000, ENVIRON HEALTH PERSP, V108, P621, DOI 10.2307/3434882; Leber ER, 1994, PATTYS IND HYGIENE B, V2, P1503; Li L, 2010, J ENVIRON SCI-CHINA, V22, P1980, DOI 10.1016/S1001-0742(09)60349-1; Liu HG, 2010, TOXICOLOGY, V276, P115, DOI 10.1016/j.tox.2010.07.018; Liu HG, 2008, TOXICOLOGY, V253, P89, DOI 10.1016/j.tox.2008.08.015; Liu WP, 2005, P NATL ACAD SCI USA, V102, P701, DOI 10.1073/pnas.0408847102; Lu XT, 2011, ENVIRON TOXICOL, V26, P271, DOI 10.1002/tox.20553; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; MCBLAIN WA, 1987, LIFE SCI, V40, P215, DOI 10.1016/0024-3205(87)90361-4; MCBLAIN WA, 1977, CAN J ZOOL, V55, P562, DOI 10.1139/z77-071; Moran JM, 2008, J TOXICOL ENV HEAL A, V71, P1457, DOI 10.1080/15287390802329364; OEHME M, 1994, HRC-J HIGH RES CHROM, V17, P583; Perez-Maldonado IN, 2004, ENVIRON RES, V94, P38, DOI 10.1016/S0013-9351(03)00112-9; Qian HF, 2009, CHEMOSPHERE, V76, P885, DOI 10.1016/j.chemosphere.2009.05.009; Qiu XH, 2004, ENVIRON SCI TECHNOL, V38, P1368, DOI 10.1021/es035052d; Rohrdanz E, 1998, FREE RADICAL BIO MED, V24, P27, DOI 10.1016/S0891-5849(97)00159-7; Shi YQ, 2010, TOXICOL LETT, V193, P79, DOI 10.1016/j.toxlet.2009.12.008; Shinomiya N, 2003, TOXICOL LETT, V137, P175, DOI 10.1016/S0378-4274(02)00401-0; Slater AFG, 1995, TOXICOL LETT, V82-3, P149, DOI 10.1016/0378-4274(95)03474-9; Song Y, 2008, TOXICOLOGY, V253, P53, DOI 10.1016/j.tox.2008.08.013; Stanley Jacob K., 2009, Integrated Environmental Assessment and Management, V5, P364, DOI 10.1897/IEAM_2008-076.1; Stemmler I, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL041340; Tebourbi O, 1998, B ENVIRON CONTAM TOX, V61, P216, DOI 10.1007/s001289900751; UNEP, 2002, STOCKH CONV PERS ORG; van den Berg H, 2009, ENVIRON HEALTH PERSP, V117, P1656, DOI 10.1289/ehp.0900785; Van Dyk JC, 2010, SCI TOTAL ENVIRON, V408, P2745, DOI 10.1016/j.scitotenv.2010.03.002; Wang C, 2010, CHIRALITY, V22, P612, DOI 10.1002/chir.20800; Wang LM, 2009, ENVIRON TOXICOL CHEM, V28, P1, DOI 10.1897/08-055.1; Xu C, 2008, CHEM RES TOXICOL, V21, P1050, DOI 10.1021/tx8000016; Yang HY, 2010, CHEMOSPHERE, V80, P652, DOI 10.1016/j.chemosphere.2010.04.052; Zhao MR, 2008, ENVIRON TOXICOL CHEM, V27, P1194, DOI 10.1897/07-482.1; Zhao MR, 2010, ENVIRON POLLUT, V158, P1968, DOI 10.1016/j.envpol.2009.10.027; Zhao MR, 2009, ENVIRON TOXICOL CHEM, V28, P578, DOI 10.1897/08-246.1	54	45	46	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2012	7	8							e43823	10.1371/journal.pone.0043823	http://dx.doi.org/10.1371/journal.pone.0043823			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998GM	22937105	gold, Green Published, Green Submitted			2022-12-27	WOS:000308225500107
J	Song, YX; Zhou, X; Wang, ZN; Gao, P; Li, AL; Liang, JW; Zhu, JL; Xu, YY; Xu, HM				Song, Yong-Xi; Zhou, Xin; Wang, Zhen-Ning; Gao, Peng; Li, Ai-Lin; Liang, Ji-Wang; Zhu, Jin-Liang; Xu, Ying-Ying; Xu, Hui-Mian			The Association between Individual SNPs or Haplotypes of Matrix Metalloproteinase 1 and Gastric Cancer Susceptibility, Progression and Prognosis	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; MALDI-TOF MS; PROMOTER POLYMORPHISM; NO ASSOCIATION; RISK; MMP-1; MATRIX-METALLOPROTEINASE-1; GENES; EPIDEMIOLOGY; GENOTYPES	Background: The single nucleotide polymorphisms (SNPs) in matrix metalloproteinase 1(MMP-1) play important roles in some cancers. This study examined the associations between individual SNPs or haplotypes in MMP-1 and susceptibility, clinicopathological parameters and prognosis of gastric cancer in a large sample of the Han population in northern China. Methods: In this case-controlled study, there were 404 patients with gastric cancer and 404 healthy controls. Seven SNPs were genotyped using the MALDI-TOF MS system. Then, SPSS software, Haploview 4.2 software, Haplo. states software and THEsias software were used to estimate the association between individual SNPs or haplotypes of MMP-1 and gastric cancer susceptibility, progression and prognosis. Results: Among seven SNPs, there were no individual SNPs correlated to gastric cancer risk. Moreover, only the rs470206 genotype had a correlation with histologic grades, and the patients with GA/AA had well cell differentiation compared to the patients with genotype GG (OR = 0.573; 95% CI: 0.353-0.929; P = 0.023). Then, we constructed a four-marker haplotype block that contained 4 common haplotypes: TCCG, GCCG, TTCG and TTTA. However, all four common haplotypes had no correlation with gastric cancer risk and we did not find any relationship between these haplotypes and clinicopathological parameters in gastric cancer. Furthermore, neither individual SNPs nor haplotypes had an association with the survival of patients with gastric cancer. Conclusions: This study evaluated polymorphisms of the MMP-1 gene in gastric cancer with a MALDI-TOF MS method in a large northern Chinese case-controlled cohort. Our results indicated that these seven SNPs of MMP-1 might not be useful as significant markers to predict gastric cancer susceptibility, progression or prognosis, at least in the Han population in northern China.	[Song, Yong-Xi; Wang, Zhen-Ning; Gao, Peng; Li, Ai-Lin; Liang, Ji-Wang; Zhu, Jin-Liang; Xu, Ying-Ying; Xu, Hui-Mian] China Med Univ, Dept Surg Oncol & Gen Surg, Hosp 1, Shenyang 110001, Peoples R China; [Zhou, Xin] China Med Univ, Dept Gynecol & Obstet, ShengJing Hosp, Shenyang 110001, Peoples R China	China Medical University; China Medical University	Wang, ZN (corresponding author), China Med Univ, Dept Surg Oncol & Gen Surg, Hosp 1, Shenyang 110001, Peoples R China.	josieon826@yahoo.com.cn	Xu, Yingying/E-3884-2018; Gao, Peng/B-8031-2013; wang, zhen ning/E-1878-2011	Xu, Yingying/0000-0003-4924-9379; wang, zhen ning/0000-0003-0557-3097; Yu, Jiguo/0000-0001-7607-475X; Stal, Per/0000-0002-9340-5298	National Science Foundation of China [30972879, 81172370]; Program of Scientific and Technological Department of Liaoning Province [2010225032]; Natural Science Foundation of Liaoning Province [20092129]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Scientific and Technological Department of Liaoning Province; Natural Science Foundation of Liaoning Province(Natural Science Foundation of Liaoning Province)	This work was supported by National Science Foundation of China (No. 30972879 and No. 81172370), the Program of Scientific and Technological Department of Liaoning Province (No. 2010225032) and Natural Science Foundation of Liaoning Province (No. 20092129). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beeghly-Fadiel A, 2009, CANCER EPIDEM BIOMAR, V18, P1324, DOI 10.1158/1055-9965.EPI-09-0046; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Buetow KH, 2001, P NATL ACAD SCI USA, V98, P581, DOI 10.1073/pnas.021506298; Camp NJ, 2012, CANCER EPIDEM BIOMAR, V21, P176, DOI 10.1158/1055-9965.EPI-11-0845; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fang WL, 2010, ASS MATRIX METALLOPR; Fumagalli D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-101; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Ghilardi G, 2001, CLIN CANCER RES, V7, P2344; Hagleitner MM, 2011, PEDIATR BLOOD CANCER, V56, P35, DOI 10.1002/pbc.22654; Hettiaratchi A, 2007, BRIT J CANCER, V96, P783, DOI 10.1038/sj.bjc.6603630; Hinoda Y, 2002, INT J CANCER, V102, P526, DOI 10.1002/ijc.10750; Horn H, 2010, PHARMACOGENET GENOM, V20, P598, DOI 10.1097/FPC.0b013e32833deb16; Hughes S, 2007, CLIN CANCER RES, V13, P6673, DOI 10.1158/1078-0432.CCR-07-0884; Jaremko M, 2005, HUM MUTAT, V25, P232, DOI 10.1002/humu.20141; Jin X, 2005, WORLD J GASTROENTERO, V11, P2385, DOI 10.3748/wjg.v11.i16.2385; Justenhoven C, 2004, CANCER EPIDEM BIOMAR, V13, P2059; Krejs GJ, 2010, DIGEST DIS, V28, P600, DOI 10.1159/000320277; Li AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030277; Lips EH, 2005, CANCER RES, V65, P10188, DOI 10.1158/0008-5472.CAN-05-2486; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Matsumura S, 2004, J CANCER RES CLIN, V130, P259, DOI 10.1007/s00432-004-0543-1; Nam SI, 2011, LARYNGOSCOPE, V121, P171, DOI 10.1002/lary.21334; Ostrovsky O, 2009, J LEUKOCYTE BIOL, V86, P445, DOI 10.1189/jlb.1208735; Pharoah PDP, 2004, NAT REV CANCER, V4, P850, DOI 10.1038/nrc1476; Przybylowska K, 2006, BREAST CANCER RES TR, V95, P65, DOI 10.1007/s10549-005-9042-6; Pusch W, 2002, PHARMACOGENOMICS, V3, P537, DOI 10.1517/14622416.3.4.537; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Shimizu Y, 2008, AURIS NASUS LARYNX, V35, P381, DOI 10.1016/j.anl.2007.12.002; Su L, 2006, CARCINOGENESIS, V27, P1024, DOI 10.1093/carcin/bgi283; Su L, 2005, CANCER EPIDEM BIOMAR, V14, P567, DOI 10.1158/1055-9965.EPI-04-0482; Sun T, 2006, CLIN CANCER RES, V12, P7009, DOI 10.1158/1078-0432.CCR-06-0464; Tregouet DA, 2004, EUR J HUM GENET, V12, P971, DOI 10.1038/sj.ejhg.5201238; Xu EP, 2005, J BIOCHEM BIOPH METH, V63, P222, DOI 10.1016/j.jbbm.2005.03.007; Yu CY, 2004, CANCER RES, V64, P7622, DOI 10.1158/0008-5472.CAN-04-1521; Yue ZY, 2010, J SURG ONCOL, V102, P68, DOI 10.1002/jso.21584; Zinzindohoue F, 2005, CLIN CANCER RES, V11, P594	39	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e38002	10.1371/journal.pone.0038002	http://dx.doi.org/10.1371/journal.pone.0038002			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	23284946	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338900072
J	Li, RG; Gao, S; Hernandez, AG; Wechter, WP; Fei, ZJ; Ling, KS				Li, Rugang; Gao, Shan; Hernandez, Alvaro G.; Wechter, W. Patrick; Fei, Zhangjun; Ling, Kai-Shu			Deep Sequencing of Small RNAs in Tomato for Virus and Viroid Identification and Strain Differentiation	PLOS ONE			English	Article							PEPINO-MOSAIC-VIRUS; 1ST REPORT; GREENHOUSE TOMATOES; NATURAL INFECTION; DISCOVERY; ALIGNMENT; EVOLUTION; PATHOGEN; INSIGHTS; REVEALS	Small RNAs (sRNA), including microRNAs (miRNA) and small interfering RNAs (siRNA), are produced abundantly in plants and animals and function in regulating gene expression or in defense against virus or viroid infection. Analysis of siRNA profiles upon virus infection in plant may allow for virus identification, strain differentiation, and de novo assembly of virus genomes. In the present study, four suspected virus-infected tomato samples collected in the U. S. and Mexico were used for sRNA library construction and deep sequencing. Each library generated between 5-7 million sRNA reads, of which more than 90% were from the tomato genome. Upon in-silico subtraction of the tomato sRNAs, the remaining highly enriched, virus-like siRNA pools were assembled with or without reference virus or viroid genomes. A complete genome was assembled for Potato spindle tuber viroid (PSTVd) using siRNA alone. In addition, a near complete virus genome (98%) also was assembled for Pepino mosaic virus (PepMV). A common mixed infection of two strains of PepMV (EU and US1), which shared 82% of genome nucleotide sequence identity, also could be differentially assembled into their respective genomes. Using de novo assembly, a novel potyvirus with less than 60% overall genome nucleotide sequence identity to other known viruses was discovered and its full genome sequence obtained. Taken together, these data suggest that the sRNA deep sequencing technology will likely become an efficient and powerful generic tool for virus identification in plants and animals.	[Li, Rugang; Wechter, W. Patrick; Ling, Kai-Shu] ARS, US Vegetable Lab, USDA, Charleston, SC USA; [Gao, Shan; Fei, Zhangjun] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Hernandez, Alvaro G.] Univ Illinois, WM Keck Ctr Comparat & Funct Genom, Urbana, IL USA; [Fei, Zhangjun] USDA, Robert W Holley Ctr Agr & Hlth, Ithaca, NY USA	United States Department of Agriculture (USDA); Cornell University; Boyce Thompson Institute for Plant Research; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA)	Li, RG (corresponding author), ARS, US Vegetable Lab, USDA, Charleston, SC USA.	zf25@Cornell.edu; kai.ling@ars.usda.gov	Li, Cong-jun/J-8572-2014; Fei, Zhangjun/H-5152-2012; Ling, Kai-Shu/ABE-9461-2020; Li, Weizhong/A-9735-2008; Khafipour, Ehsan/E-4140-2016	Li, Cong-jun/0000-0003-1389-9820; Li, Weizhong/0000-0003-1804-9403; Li, Rugang/0000-0001-6514-496X; Khafipour, Ehsan/0000-0003-4673-7633; Fei, Zhangjun/0000-0001-9684-1450; Li, Ru/0000-0001-7332-7790	U.S. Department of Agriculture, National Institute of Food and Agriculture, Specialty Crop Research Initiative [SCRI-600-25320]; National Science Foundation [IOS-1110080]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR025030] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005978] Funding Source: NIH RePORTER	U.S. Department of Agriculture, National Institute of Food and Agriculture, Specialty Crop Research Initiative; National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work is supported by a grant from the U.S. Department of Agriculture, National Institute of Food and Agriculture, Specialty Crop Research Initiative (SCRI-600-25320) to KSL and by National Science Foundation (IOS-1110080) to ZF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams IP, 2009, MOL PLANT PATHOL, V10, P537, DOI [10.1111/J.1364-3703.2009.00545.X, 10.1111/j.1364-3703.2009.00545.x]; Al Rwahnih M, 2009, VIROLOGY, V387, P395, DOI 10.1016/j.virol.2009.02.028; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Bao Y, 2008, ENCY VIROLOGY, V5, P342; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Coetzee B, 2010, VIROLOGY, V400, P157, DOI 10.1016/j.virol.2010.01.023; Cotillon AC, 2002, ARCH VIROL, V147, P2231, DOI 10.1007/s00705-002-0873-8; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Hagen C, 2011, ARCH VIROL, V156, P1209, DOI 10.1007/s00705-011-0979-y; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hanssen IM, 2010, MOL PLANT MICROBE IN, V23, P539, DOI 10.1094/MPMI-23-5-0539; Hanssen IM, 2010, MOL PLANT PATHOL, V11, P179, DOI 10.1111/j.1364-3703.2009.00600.x; Isakov O, 2011, BIOINFORMATICS, V27, P2027, DOI 10.1093/bioinformatics/btr349; Itaya A, 2007, J VIROL, V81, P2980, DOI 10.1128/JVI.02339-06; JONES RAC, 1980, ANN APPL BIOL, V94, P61, DOI 10.1111/j.1744-7348.1980.tb03896.x; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Ling KS, 2010, PLANT DIS, V94, P1376, DOI 10.1094/PDIS-07-10-0516; Ling KS, 2009, PLANT DIS, V93, P1216, DOI 10.1094/PDIS-93-11-1216A; Ling KS, 2009, PLANT DIS, V93, P1075, DOI 10.1094/PDIS-93-10-1075B; Ling KS, 2009, PLANT DIS, V93, P839, DOI 10.1094/PDIS-93-8-0839B; Ling KS, 2007, VIRUS GENES, V34, P1, DOI 10.1007/s11262-006-0003-x; Ling KS, 2008, PLANT DIS, V92, P1683, DOI 10.1094/PDIS-92-12-1683; Machida S, 2007, J GEN VIROL, V88, P3452, DOI 10.1099/vir.0.83228-0; Margis R, 2006, FEBS LETT, V580, P2442, DOI 10.1016/j.febslet.2006.03.072; Maroon-Lango CJ, 2005, ARCH VIROL, V150, P1187, DOI 10.1007/s00705-005-0495-z; Martin R, 2007, VIROLOGY, V367, P135, DOI 10.1016/j.virol.2007.05.011; Mlotshwa S, 2008, TRENDS PLANT SCI, V13, P375, DOI 10.1016/j.tplants.2008.04.009; Navarro B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007686; The Tomato Genome Consortium, 2012, NATURE IN PRESS; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van der Vlugt R A A, 2000, Plant Dis, V84, P103, DOI 10.1094/PDIS.2000.84.1.103C; Vodovar N, 2011, J VIROL, V85, P11016, DOI 10.1128/JVI.05647-11; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; Wu QF, 2012, P NATL ACAD SCI USA, V109, P3938, DOI 10.1073/pnas.1117815109; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Wylie SJ, 2012, ARCH VIROL, V157, P271, DOI 10.1007/s00705-011-1166-x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	41	279	296	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37127	10.1371/journal.pone.0037127	http://dx.doi.org/10.1371/journal.pone.0037127			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623984	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343500061
J	Li, RW; Wu, ST; Baldwin, RL; Li, WZ; Li, CJ				Li, Robert W.; Wu, Sitao; Baldwin, Ransom L.; Li, Weizhong; Li, Congjun			Perturbation Dynamics of the Rumen Microbiota in Response to Exogenous Butyrate	PLOS ONE			English	Article							VOLATILE FATTY-ACIDS; HUMAN GUT; BUTYRIVIBRIO-FIBRISOLVENS; RUMINAL BUTYRATE; RESISTANT STARCH; LARGE-INTESTINE; FAST PROGRAM; DAIRY-COWS; MILK-YIELD; METABOLISM	The capacity of the rumen microbiota to produce volatile fatty acids (VFAs) has important implications in animal well-being and production. We investigated temporal changes of the rumen microbiota in response to butyrate infusion using pyrosequencing of the 16S rRNA gene. Twenty one phyla were identified in the rumen microbiota of dairy cows. The rumen microbiota harbored 54.5 +/- 6.1 genera (mean +/- SD) and 127.3 +/- 4.4 operational taxonomic units (OTUs), respectively. However, the core microbiome comprised of 26 genera and 82 OTUs. Butyrate infusion altered molar percentages of 3 major VFAs. Butyrate perturbation had a profound impact on the rumen microbial composition. A 72 h-infusion led to a significant change in the numbers of sequence reads derived from 4 phyla, including 2 most abundant phyla, Bacteroidetes and Firmicutes. As many as 19 genera and 43 OTUs were significantly impacted by butyrate infusion. Elevated butyrate levels in the rumen seemingly had a stimulating effect on butyrate-producing bacteria populations. The resilience of the rumen microbial ecosystem was evident as the abundance of the microorganisms returned to their pre-disturbed status after infusion withdrawal. Our findings provide insight into perturbation dynamics of the rumen microbial ecosystem and should guide efforts in formulating optimal uses of probiotic bacteria treating human diseases.	[Li, Robert W.; Baldwin, Ransom L.; Li, Congjun] ARS, USDA, Bovine Funct Genom Lab, Beltsville, MD USA; [Wu, Sitao; Li, Weizhong] Univ Calif San Diego, Ctr Res Biol Syst, San Diego, CA 92103 USA	United States Department of Agriculture (USDA); University of California System; University of California San Diego	Li, RW (corresponding author), ARS, USDA, Bovine Funct Genom Lab, Beltsville, MD USA.	robert.li@ars.usda.gov	Li, Cong-jun/J-8572-2014; Fei, Zhangjun/H-5152-2012; Ling, Kai-Shu/ABE-9461-2020; Li, Weizhong/A-9735-2008; Khafipour, Ehsan/E-4140-2016	Li, Cong-jun/0000-0003-1389-9820; Li, Weizhong/0000-0003-1804-9403; Li, Rugang/0000-0001-6514-496X; Khafipour, Ehsan/0000-0003-4673-7633; Fei, Zhangjun/0000-0001-9684-1450; Li, Ru/0000-0001-7332-7790	National Center for Research Resources (NCRR) [R01RR025030]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR025030] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005978] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	SW and WL are supported by Award Number R01RR025030 from the National Center for Research Resources (NCRR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NCRR or the National Institutes of Health. SW and WL are supported by Award Number R01RR025030 from the National Center for Research Resources (NCRR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NCRR or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Barcenilla A, 2000, APPL ENVIRON MICROB, V66, P1654, DOI 10.1128/AEM.66.4.1654-1661.2000; Belenguer A, 2006, APPL ENVIRON MICROB, V72, P3593, DOI 10.1128/AEM.72.5.3593-3599.2006; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; BUGAUT M, 1987, COMP BIOCHEM PHYS B, V86, P439, DOI 10.1016/0305-0491(87)90433-0; Duncan SH, 2007, APPL ENVIRON MICROB, V73, P1073, DOI 10.1128/AEM.02340-06; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; HUHTANEN P, 1993, J DAIRY SCI, V76, P1114, DOI 10.3168/jds.S0022-0302(93)77440-8; Kristensen NB, 2004, J ANIM SCI, V82, P2033; Li CJ, 2007, FUNCT INTEGR GENOMIC, V7, P193, DOI 10.1007/s10142-006-0043-2; Li CJ, 2008, GENE REGUL SYST BIO, V2, P113; Li F, 2008, J BACTERIOL, V190, P843, DOI 10.1128/JB.01417-07; Li RW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-234; Li RW, 2012, ENVIRON MICROBIOL, V14, P129, DOI 10.1111/j.1462-2920.2011.02543.x; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lopez S, 2003, J ANIM SCI, V81, P2609; Louis P, 2007, J APPL MICROBIOL, V102, P1197, DOI 10.1111/j.1365-2672.2007.03322.x; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Miettinen H, 1996, J DAIRY SCI, V79, P851, DOI 10.3168/jds.S0022-0302(96)76434-2; Mrazek J, 2006, FOLIA MICROBIOL, V51, P294, DOI 10.1007/BF02931817; Niu BF, 2011, BIOINFORMATICS, V27, P1704, DOI 10.1093/bioinformatics/btr252; Ohkawara S, 2005, J NUTR, V135, P2878, DOI 10.1093/jn/135.12.2878; Ohkawara S, 2006, CLIN VACCINE IMMUNOL, V13, P1231, DOI 10.1128/CVI.00267-06; Pitt RE, 1996, J ANIM SCI, V74, P226; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1016/S0378-1097(02)01106-0; Russell JB, 2001, SCIENCE, V292, P1119, DOI 10.1126/science.1058830; Sato T, 2008, FEMS MICROBIOL ECOL, V66, P528, DOI 10.1111/j.1574-6941.2008.00528.x; Silvi S, 1999, J APPL MICROBIOL, V86, P521, DOI 10.1046/j.1365-2672.1999.00696.x; STORRY JE, 1966, BRIT J NUTR, V20, P217, DOI 10.1079/BJN19660023; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weimer PJ, 2010, J DAIRY SCI, V93, P5902, DOI 10.3168/jds.2010-3500; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015	35	279	296	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e29392	10.1371/journal.pone.0029392	http://dx.doi.org/10.1371/journal.pone.0029392			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22623984	Green Published, Green Submitted, gold			2022-12-27	WOS:000301357100009
J	Wang, XM; Mao, XO; Xie, L; Sun, F; Greenberg, DA; Jin, KL				Wang, Xiaomei; Mao, XiaoOu; Xie, Lin; Sun, Fen; Greenberg, David A.; Jin, Kunlin			Conditional Depletion of Neurogenesis Inhibits Long-Term Recovery after Experimental Stroke in Mice	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; SUBVENTRICULAR ZONE; FOREBRAIN NEUROGENESIS; BRAIN; CELLS; REPLACEMENT; PRECURSORS; MIGRATION; NEURONS	We reported previously that ablation of doublecortin (DCX)-immunopositive newborn neurons in mice worsens anatomical and functional outcome measured 1 day after experimental stroke, but whether this effect persists is unknown. We generated transgenic mice that express herpes simplex virus thymidine kinase under control of the DCX promoter (DCX-TK transgenic mice). DCX-expressing and recently divided cells in the rostral subventricular zone (SVZ) and hippocampus of DCX-TK transgenic mice, but not wild-type mice, were specifically depleted after ganciclovir (GCV) treatment for 14 days. Focal cerebral ischemia was induced by permanent distal middle cerebral artery occlusion (MCAO) on day 14 of vehicle or GCV treatment, and mice were killed 12 weeks after MCAO. Infarct volume was significantly increased and neurologic deficits were more severe in GCV- compared to vehicle-treated DCX-TK transgenic mice at first 8 weeks, after depletion of DCX- and bromodeoxyuridine-immunoreactive cells in the SVZ and dentate gyrus following focal ischemia. Our results indicate that endogenous neurogenesis in a critical period following experimental stroke influences the course of long-term recovery.	[Wang, Xiaomei; Mao, XiaoOu; Xie, Lin; Sun, Fen; Greenberg, David A.; Jin, Kunlin] Buck Inst Res Aging, Novato, CA USA; [Jin, Kunlin] Univ N Texas Hlth Sci Ctr Ft Worth, Dept Pharmacol & Neurosci, Ft Worth, TX USA; [Jin, Kunlin] Univ N Texas Hlth Sci Ctr Ft Worth, Inst Aging & Alzheimers Dis Res, Ft Worth, TX USA	Buck Institute for Research on Aging; University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center	Wang, XM (corresponding author), Buck Inst Res Aging, Novato, CA USA.	kunlin.jin@unthsc.edu	Pausch, Hubert/U-5934-2019; Sun, Fen/I-8516-2016; Zeng, Maomao/M-1422-2013; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Prokopenko, Mikhail/A-3995-2008; Wang, X. Rosalind/B-7097-2008	Pausch, Hubert/0000-0002-0501-6760; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Tang, Hailiang/0000-0003-1852-3128; SUN, FEN/0000-0003-2094-9494; Wurmser, Christine/0000-0003-0649-6206; Yu, Zhuowei/0000-0002-9152-6491; Wang, Xuelong/0000-0003-4616-1531; Kou, Xiaoxing/0000-0001-9680-0077; Prokopenko, Mikhail/0000-0002-4215-0344; Miller, Jennifer/0000-0003-2110-3693; Wang, X. Rosalind/0000-0001-5454-6197; Fries, Ruedi/0000-0002-4657-1787; Mao, Ying/0000-0001-8055-115X	United States Public Health Service Grant [NS57186, AG21980, NS44921, NS62414]	United States Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service)	This work was supported by United States Public Health Service Grants NS57186 and AG21980 (to KJ) and NS44921 and NS62414 (to DAG). The URL of any funder's website is www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameh EA, 2009, SURG INFECT, V10, P105, DOI 10.1089/sur.2007.082; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Encarnacion A, 2011, J NEUROSCI METH, V196, P247, DOI 10.1016/j.jneumeth.2011.01.010; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gu WG, 2000, J CEREBR BLOOD F MET, V20, P1166, DOI 10.1097/00004647-200008000-00002; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jin KL, 2010, AGING CELL, V9, P1076, DOI 10.1111/j.1474-9726.2010.00638.x; Jin KL, 2010, P NATL ACAD SCI USA, V107, P7993, DOI 10.1073/pnas.1000154107; Jorgensen H S, 1999, Phys Med Rehabil Clin N Am, V10, P887; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Lai B, 2008, NEUROSCI LETT, V442, P305, DOI 10.1016/j.neulet.2008.07.032; Liu JL, 1998, J NEUROSCI, V18, P7768; Mayo NE, 1999, DISABIL REHABIL, V21, P258; MCDERMOTT KW, 1991, J ANAT, V178, P45; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; OHLSSON AL, 1995, STROKE, V26, P644, DOI 10.1161/01.STR.26.4.644; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Raber J, 2004, ANN NEUROL, V55, P381, DOI 10.1002/ana.10853; REARDON JE, 1989, J BIOL CHEM, V264, P19039; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhu CL, 2009, J NEUROCHEM, V111, P1447, DOI 10.1111/j.1471-4159.2009.06413.x	26	658	680	34	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38932	10.1371/journal.pone.0038932	http://dx.doi.org/10.1371/journal.pone.0038932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22808095	Green Submitted, gold, Green Published			2022-12-27	WOS:000305652700041
J	Wang, XJ; Wei, DL; Song, ZG; Jiao, HC; Lin, H				Wang, Xiao Juan; Wei, Dai Lin; Song, Zhi Gang; Jiao, Hong Chao; Lin, Hai			Effects of Fatty Acid Treatments on the Dexamethasone-Induced Intramuscular Lipid Accumulation in Chickens	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE CELLS; INDUCED INSULIN-RESISTANCE; MAMMALIAN TARGET; GENE-EXPRESSION; DOWN-REGULATION; PPAR-ALPHA; RAT; RECEPTOR; LIVER	Background: Glucocorticoid has an important effect on lipid metabolism in muscles, and the type of fatty acid likely affects mitochondrial utilization. Therefore, we hypothesize that the different fatty acid types treatment may affect the glucocorticoid induction of intramuscular lipid accumulation. Methodology/Principal Findings: The effect of dexamethasone (DEX) on fatty acid metabolism and storage in skeletal muscle of broiler chickens (Gallus gallus domesticus) was investigated with and without fatty acid treatments. Male Arbor Acres chickens (31 d old) were treated with either palmitic acid (PA) or oleic acid (OA) for 7 days, followed by DEX administration for 3 days (35-37 d old). The DEX-induced lipid uptake and oxidation imbalance, which was estimated by increased fatty acid transport protein 1 (FATP1) expression and decreased carnitine palmitoyl transferase 1 activity, contributed to skeletal muscle lipid accumulation. More sensitive than glycolytic muscle, the oxidative muscle in DEX-treated chickens showed a decrease in the AMP to ATP ratio, a decrease in AMP-activated protein kinase (AMPK) alpha phosphorylation and its activity, as well as an increase in the phosphorylation of mammalian target of rapamycin (mTOR) and ribosomal p70S6 kinase, without Akt activation. DEX-stimulated lipid deposition was augmented by PA, but alleviated by OA, in response to pathways that were regulated differently, including AMPK, mTOR and FATP1. Conclusions: DEX-induced intramuscular lipid accumulation was aggravated by SFA but alleviated by unsaturated fatty acid. The suppressed AMPK and augmented mTOR signaling pathways were involved in glucocortcoid-mediated enhanced intramuscular fat accumulation.	[Wang, Xiao Juan; Song, Zhi Gang; Jiao, Hong Chao; Lin, Hai] Shandong Agr Univ, Dept Anim Sci, Tai An, Shandong, Peoples R China; [Wei, Dai Lin] Taian Cent Hosp, Dept Endocrine, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Wang, XJ (corresponding author), Shandong Agr Univ, Dept Anim Sci, Tai An, Shandong, Peoples R China.	hailin@sdau.edu.cn	Pausch, Hubert/U-5934-2019; Sun, Fen/I-8516-2016; Zeng, Maomao/M-1422-2013; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Prokopenko, Mikhail/A-3995-2008; Wang, X. Rosalind/B-7097-2008	Pausch, Hubert/0000-0002-0501-6760; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Tang, Hailiang/0000-0003-1852-3128; SUN, FEN/0000-0003-2094-9494; Wurmser, Christine/0000-0003-0649-6206; Yu, Zhuowei/0000-0002-9152-6491; Wang, Xuelong/0000-0003-4616-1531; Kou, Xiaoxing/0000-0001-9680-0077; Prokopenko, Mikhail/0000-0002-4215-0344; Miller, Jennifer/0000-0003-2110-3693; Wang, X. Rosalind/0000-0001-5454-6197; Fries, Ruedi/0000-0002-4657-1787; Mao, Ying/0000-0001-8055-115X	Shandong Science Fund for Distinguished Youth Scholars; National Basic Research Program of China [2004CB117507]; National Natural Science Foundation of China [30771573]; Research Fund for the Doctoral Program of Higher Education of China	Shandong Science Fund for Distinguished Youth Scholars; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from the Shandong Science Fund for Distinguished Youth Scholars, the National Basic Research Program of China (2004CB117507), the National Natural Science Foundation of China (No.30771573), and Research Fund for the Doctoral Program of Higher Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the sponsoring agencies.	Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513; Aoki M, 2001, P NATL ACAD SCI USA, V98, P136, DOI 10.1073/pnas.011528498; Berthiaume M, 2007, AM J PHYSIOL-ENDOC M, V293, pE1045, DOI 10.1152/ajpendo.00276.2007; BIEBER LL, 1972, ANAL BIOCHEM, V50, P509, DOI 10.1016/0003-2697(72)90061-9; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Bowes SB, 1996, J ENDOCRINOL, V148, P501, DOI 10.1677/joe.0.1480501; Braun EJ, 2008, COMP BIOCHEM PHYS B, V151, P1, DOI 10.1016/j.cbpb.2008.05.007; Cai YL, 2009, COMP BIOCHEM PHYS C, V150, P164, DOI 10.1016/j.cbpc.2009.04.005; Caton PW, 2011, BIOCHEM J, V437, P521, DOI 10.1042/BJ20110702; Christ-Crain M, 2008, FASEB J, V22, P1672, DOI 10.1096/fj.07-094144; Chuang JC, 2010, J LIPID RES, V51, P1344, DOI 10.1194/jlr.M002196; Clark H, 2004, EUR J BIOCHEM, V271, P2215, DOI 10.1111/j.1432-1033.2004.04151.x; Close B, 1997, LAB ANIM-UK, V31, P1, DOI 10.1258/002367797780600297; Coll T, 2006, DIABETES, V55, P2779, DOI 10.2337/db05-1494; Cota D, 2009, OBESITY, V17, P1641, DOI 10.1038/oby.2009.84; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; de Oliveira C, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-11; Duchene S, 2008, DOMEST ANIM ENDOCRIN, V34, P1, DOI 10.1016/j.domaniend.2006.09.002; Dupont J, 1999, J ENDOCRINOL, V162, P67, DOI 10.1677/joe.0.1620067; Dupont JL, 2004, DOMEST ANIM ENDOCRIN, V26, P127, DOI 10.1016/j.domaniend.2003.09.004; Dupont J, 2008, J ENDOCRINOL, V197, P531, DOI 10.1677/JOE-08-0055; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Foucaud L, 1998, BBA-LIPID LIPID MET, V1391, P204, DOI 10.1016/S0005-2760(97)00213-0; Gao D, 2009, BRIT J NUTR, V102, P1557, DOI 10.1017/S0007114509990948; Gaster M, 2005, DIABETES, V54, P648, DOI 10.2337/diabetes.54.3.648; GRIFFIN HD, 1982, BRIT POULTRY SCI, V23, P307, DOI 10.1080/00071688208447962; Halevy O, 2000, J NUTR, V130, P858, DOI 10.1093/jn/130.4.858; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hayat MA, 1973, PRINCIPLES TECHNIQUE, V3, P237; Hickson-Bick DLM, 2000, J MOL CELL CARDIOL, V32, P511, DOI 10.1006/jmcc.1999.1098; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hu ZY, 2009, J CLIN INVEST, V119, P3059, DOI 10.1172/JCI38770; HUNNICUTT JW, 1994, DIABETES, V43, P540, DOI 10.2337/diabetes.43.4.540; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kamara K, 1998, PHYSIOL BEHAV, V64, P1, DOI 10.1016/S0031-9384(97)00534-9; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Koh EH, 2003, DIABETES, V52, P2331, DOI 10.2337/diabetes.52.9.2331; Korach-Andre M, 2005, AM J PHYSIOL-ENDOC M, V288, pE106, DOI 10.1152/ajpendo.00089.2004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee WJ, 2006, BIOCHEM BIOPH RES CO, V340, P291, DOI 10.1016/j.bbrc.2005.12.011; Lillie RD, 1976, HISTOPATHOLOGIC TECH, Vfourth, P559; Lin H, 2004, COMP BIOCHEM PHYS B, V139, P737, DOI 10.1016/j.cbpc.2004.09.013; Liu ZQ, 2004, AM J PHYSIOL-ENDOC M, V287, pE275, DOI 10.1152/ajpendo.00457.2003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mordier S, 2007, BIOCHEM BIOPH RES CO, V362, P206, DOI 10.1016/j.bbrc.2007.08.004; Nader N, 2010, MOL ENDOCRINOL, V24, P1748, DOI 10.1210/me.2010-0192; Nakken GN, 2010, J APPL PHYSIOL, V108, P298, DOI 10.1152/japplphysiol.00906.2009; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Prasad SSSV, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-111; Proszkowiec-Weglarz M, 2006, COMP BIOCHEM PHYS B, V143, P92, DOI 10.1016/j.cbpb.2005.10.009; Qi D, 2004, DIABETES, V53, P1790, DOI 10.2337/diabetes.53.7.1790; Qi D, 2006, AM J PHYSIOL-ENDOC M, V291, P420; Rivas DA, 2009, J ENDOCRINOL, V202, P441, DOI 10.1677/JOE-09-0202; Ruddock MW, 2008, J BIOCHEM, V144, P599, DOI 10.1093/jb/mvn105; Ruderman NB, 2006, OBESITY, V14, p25S, DOI 10.1038/oby.2006.279; Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048; RYDER JM, 1985, J AGR FOOD CHEM, V33, P678, DOI 10.1021/jf00064a027; Saha AK, 2003, MOL CELL BIOCHEM, V253, P65, DOI 10.1023/A:1026053302036; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Sekulic A, 2000, CANCER RES, V60, P3504; Shah OJ, 2000, AM J PHYSIOL, V279, P74; SIMON J, 1974, ENDOCRINOLOGY, V95, P1439, DOI 10.1210/endo-95-5-1439; Sipula IJ, 2006, METABOLISM, V55, P1637, DOI 10.1016/j.metabol.2006.08.002; SMOLENSKI RT, 1993, BIOMED CHROMATOGR, V7, P189, DOI 10.1002/bmc.1130070404; Staiger H, 2005, DIABETOLOGIA, V48, P2115, DOI 10.1007/s00125-005-1895-z; Stuart M, 2010, END ABSTR, V21, P180; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wang XJ, 2012, STRESS, V15, P443, DOI 10.3109/10253890.2011.639413; Wang XJ, 2010, COMP BIOCHEM PHYS C, V151, P447, DOI 10.1016/j.cbpc.2010.01.010; Watt MJ, 2006, J PHYSIOL-LONDON, V574, P139, DOI 10.1113/jphysiol.2006.107318; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Zhang JL, 2004, AM J PHYSIOL-ENDOC M, V286, pE168, DOI 10.1152/ajpendo.00232.2003; Zhao JP, 2009, COMP BIOCHEM PHYS C, V149, P448, DOI 10.1016/j.cbpc.2008.10.106	75	658	680	34	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36663	10.1371/journal.pone.0036663	http://dx.doi.org/10.1371/journal.pone.0036663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22808095	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500022
J	Wang, XL; Wurmser, C; Pausch, H; Jung, S; Reinhardt, F; Tetens, J; Thaller, G; Fries, R				Wang, Xiaolong; Wurmser, Christine; Pausch, Hubert; Jung, Simone; Reinhardt, Friedrich; Tetens, Jens; Thaller, Georg; Fries, Ruedi			Identification and Dissection of Four Major QTL Affecting Milk Fat Content in the German Holstein-Friesian Population	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; GROWTH-HORMONE RECEPTOR; MISSENSE MUTATION; GENE; DGAT1; AGPAT6; YIELD; TRANSCRIPTION; EXPRESSION; TISSUE	Milk composition traits exhibit a complex genetic architecture with a small number of major quantitative trait loci (QTL) explaining a large fraction of the genetic variation and numerous QTL with minor effects. In order to identify QTL for milk fat percentage (FP) in the German Holstein-Friesian (HF) population, a genome-wide association study (GWAS) was performed. The study population consisted of 2327 progeny-tested bulls. Genotypes were available for 44,280 SNPs. Phenotypes in the form of estimated breeding values (EBVs) for FP were used as highly heritable traits. A variance components-based approach was used to account for population stratification. The GWAS identified four major QTL regions explaining 46.18% of the FP EBV variance. Besides two previously known FP QTL on BTA14 (P = 8.91x10-(198)) and BTA20 (P = 7.03x10(-12)) within DGAT1 and GHR, respectively, we uncovered two additional QTL regions on BTA5 (P = 2.00x10(-13)) and BTA27 (P = 9.83x10(-5)) encompassing EPS8 and GPAT4, respectively. EPS8 and GPAT4 are involved in lipid metabolism in mammals. Re-sequencing of EPS8 and GPAT4 revealed 50 polymorphisms. Genotypes for five of them were inferred for the entire study population. Two polymorphisms affecting potential transcription factor binding sites of EPS8 (P = 1.40x10(-12)) and GPAT4 (P = 5.18x10(-5)), respectively, were highly significantly associated with the FP EBV. Our results provide evidence that alteration of regulatory sites is an important aspect of genetic variation of complex traits in cattle.	[Wang, Xiaolong; Wurmser, Christine; Pausch, Hubert; Jung, Simone; Fries, Ruedi] Tech Univ Muenchen, Chair Anim Breeding, Freising Weihenstephan, Germany; [Reinhardt, Friedrich] Vereinigte Informat Syst Tierhaltung wV, Verden, Germany; [Tetens, Jens; Thaller, Georg] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany	Technical University of Munich; University of Kiel	Wang, XL (corresponding author), Tech Univ Muenchen, Chair Anim Breeding, Freising Weihenstephan, Germany.	xiaolong.wang@tierzucht.tum.de	Pausch, Hubert/U-5934-2019; Sun, Fen/I-8516-2016; Zeng, Maomao/M-1422-2013; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Prokopenko, Mikhail/A-3995-2008; Wang, X. Rosalind/B-7097-2008	Pausch, Hubert/0000-0002-0501-6760; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Tang, Hailiang/0000-0003-1852-3128; SUN, FEN/0000-0003-2094-9494; Wurmser, Christine/0000-0003-0649-6206; Yu, Zhuowei/0000-0002-9152-6491; Wang, Xuelong/0000-0003-4616-1531; Kou, Xiaoxing/0000-0001-9680-0077; Prokopenko, Mikhail/0000-0002-4215-0344; Miller, Jennifer/0000-0003-2110-3693; Wang, X. Rosalind/0000-0001-5454-6197; Fries, Ruedi/0000-0002-4657-1787; Mao, Ying/0000-0001-8055-115X	German Ministry of Education and Research, BMBF [0315134A, 0315134D, 0315131A]; Forderverein Biotechnologieforschung e.V. (FBF), Bonn; Lohmann Tierzucht GmbH, Cuxhaven; China Scholarship Council (CSC)	German Ministry of Education and Research, BMBF(Federal Ministry of Education & Research (BMBF)); Forderverein Biotechnologieforschung e.V. (FBF), Bonn; Lohmann Tierzucht GmbH, Cuxhaven; China Scholarship Council (CSC)(China Scholarship Council)	This study is part of the projects FUGATO-plus GenoTrack and FUGATO-plus MeGA-M and was financially supported by the German Ministry of Education and Research, BMBF (grants 0315134A, 0315134D and 0315131A), the Forderverein Biotechnologieforschung e.V. (FBF), Bonn, and Lohmann Tierzucht GmbH, Cuxhaven. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the vit w.V. Verden for providing phenotype data and the China Scholarship Council (CSC) for supporting X. Wang by a grant.	Beigneux AP, 2006, J LIPID RES, V47, P734, DOI 10.1194/jlr.M500556-JLR200; Bionaz M, 2008, J NUTR, V138, P1019, DOI 10.1093/jn/138.6.1019; Blott S, 2003, GENETICS, V163, P253; Bouwman AC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-43; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Buttchereit N, 2010, J DAIRY SCI, V93, P1702, DOI 10.3168/jds.2009-2198; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Chatterjee S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005197; Cohen-Zinder M, 2005, GENOME RES, V15, P936, DOI 10.1101/gr.3806705; Ed L, 2009, BIOINFORMATICS, V25, P1836, DOI 10.1093/bioinformatics/btp314; FAZIOLI F, 1993, EMBO J, V12, P3799, DOI 10.1002/j.1460-2075.1993.tb06058.x; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gremme G, 2005, INFORM SOFTWARE TECH, V47, P965, DOI 10.1016/j.infsof.2005.09.005; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Guo DL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000446; Hamza MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004907; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Loor JJ, 2005, PHYSIOL GENOMICS, V23, P217, DOI 10.1152/physiolgenomics.00132.2005; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Portales-Casamar E, 2009, JASPAR 2010 GREATLY; Quackenbush J, 2001, NUCLEIC ACIDS RES, V29, P159, DOI 10.1093/nar/29.1.159; Schennink A, 2007, ANIM GENET, V38, P467, DOI 10.1111/j.1365-2052.2007.01635.x; Schennink A, 2009, ANIM GENET, V40, P909, DOI 10.1111/j.1365-2052.2009.01940.x; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Signorelli F, 2009, LIVEST SCI, V125, P74, DOI 10.1016/j.livsci.2009.02.014; Thaller G, 2003, J ANIM SCI, V81, P1911; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Vergnes L, 2006, J LIPID RES, V47, P745, DOI 10.1194/jlr.M500553-JLR200; Viitala S, 2006, GENETICS, V173, P2151, DOI 10.1534/genetics.105.046730; Winter A, 2002, P NATL ACAD SCI USA, V99, P9300, DOI 10.1073/pnas.142293799; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	35	658	680	34	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40711	10.1371/journal.pone.0040711	http://dx.doi.org/10.1371/journal.pone.0040711			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808095	gold, Green Submitted, Green Published			2022-12-27	WOS:000306362400093
